{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Instructions\n",
    "\n",
    "We first downloaded the files from this link <http://nlp.stanford.edu/software/stanford-corenlp-full-2017-06-09.zip> \n",
    "\n",
    "Then we dragged the pubmed folder into that same folder, with the copied abstracts (if you don't want to re-download them all again).\n",
    "\n",
    "There are a few files you will need to make sure are present:\n",
    "\n",
    "`lexparser-gui.bat                  \n",
    "lexparser-gui.command              \n",
    "lexparser-gui.sh                   \n",
    "lexparser-lang-train-test.sh       \n",
    "lexparser-lang.sh                  \n",
    "lexparser.bat                      \n",
    "lexparser.sh                       `\n",
    "\n",
    "You will also need to add the `edu` folder that can be found here:\n",
    "<https://www.dropbox.com/s/t9uk4z1xznpo0jz/jars.zip?dl=0>\n",
    "\n",
    "Add the .zip extension to the `stanford-corenlp-3.8.0-models.jar` file, and unzip it. Copy that `edu` folder and paste it in to your home directory."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Here is a list of some of the files you should see in your home folder..."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "build.xml\t\t\tlexparser.sh\r\n",
      "corenlp.sh\t\t\tLIBRARY-LICENSES\r\n",
      "CoreNLP-to-HTML.xsl\t\tLICENSE.txt\r\n",
      "edu\t\t\t\tMakefile\r\n",
      "ejml-0.23.jar\t\t\tmore_abstracts.json\r\n",
      "ejml-0.23-src.zip\t\tparsing_notebook.ipynb\r\n",
      "input.txt\t\t\tpatterns\r\n",
      "input.txt.xml\t\t\tpom.xml\r\n",
      "javax.json-api-1.0-sources.jar\tprotobuf.jar\r\n",
      "javax.json.jar\t\t\tpubmed\r\n",
      "joda-time-2.9-sources.jar\tREADME.txt\r\n",
      "joda-time.jar\t\t\tSemgrexDemo.java\r\n",
      "jollyday-0.4.9-sources.jar\tShiftReduceDemo.java\r\n",
      "jollyday.jar\t\t\tslf4j-api.jar\r\n",
      "KeywordSentences.py\t\tslf4j-simple.jar\r\n",
      "KeywordSentences.txt\t\tstanford-corenlp-3.8.0.jar\r\n",
      "lexparser2.sh\t\t\tstanford-corenlp-3.8.0-javadoc.jar\r\n",
      "lexparser.bat\t\t\tstanford-corenlp-3.8.0-models.jar\r\n",
      "lexparser_caseless.sh\t\tstanford-corenlp-3.8.0-sources.jar\r\n",
      "lexparser-gui.bat\t\tStanfordCoreNlpDemo.java\r\n",
      "lexparser-gui.command\t\tStanfordDependenciesManual.pdf\r\n",
      "lexparser-gui.sh\t\tsutime\r\n",
      "lexparser-lang.sh\t\ttokensregex\r\n",
      "lexparser-lang-train-test.sh\txom-1.2.10-src.jar\r\n",
      "lexparser_rnn.sh\t\txom.jar\r\n"
     ]
    }
   ],
   "source": [
    "!ls"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Parsing the Pubmed Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "import pubmed.utils as pb\n",
    "import json\n",
    "from pprint import pprint\n",
    "# utf-8 support\n",
    "import codecs\n",
    "# spit abstracts to sentences\n",
    "from nltk.tokenize import sent_tokenize"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "search_term = 'ACE inhibitor'\n",
    "max_results = 100\n",
    "query = pb.PubMedQuery(search_term, max_results)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Num abstracts:  899\n"
     ]
    }
   ],
   "source": [
    "ids = query.id_getter()\n",
    "print \"Num abstracts: \", len(ids)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## This is to just download a few of the abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {
    "collapsed": false,
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "CPU times: user 160 ms, sys: 0 ns, total: 160 ms\n",
      "Wall time: 2.12 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "#I just tried to download a few \n",
    "# if you don't want to download all abstracts, please do not use the download_all_abstracts() method, but rather the \n",
    "# abstract_getter() as below\n",
    "pb.PubMedQuery.COUNT = 0\n",
    "max_results = 25\n",
    "query = pb.PubMedQuery(search_term, max_results)\n",
    "ids = query.id_getter()\n",
    "abstracts = query.abstract_getter(ids)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## This is to download a TON of the abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "# %%time\n",
    "# pb.PubMedQuery.COUNT = 0\n",
    "# max_results = 100\n",
    "#full_query = pb.download_all_abstracts(search_term, max_results)\n",
    "#ids = full_query.id_getter()\n",
    "#abstracts = full_query.id_getter(ids)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Save abstracts to JSON file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Saving to my_ten_abstracts.json\n"
     ]
    }
   ],
   "source": [
    "json_file = 'my_ten_abstracts.json'\n",
    "#json_file = 'more_abstracts.json'\n",
    "print 'Saving to ' + json_file\n",
    "with codecs.open(json_file, 'w','utf-8') as outfile:\n",
    "    json.dump(abstracts, outfile, indent=4)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## We might not need all the sentences in the abstract, so I am seeing what would happen if we just parse out the ones with key words, and write them to a textfile, and then parse the resulting file.\n",
    "\n",
    "Keyword selection could happen here in the sentence tokenizer."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sentences:  234\n"
     ]
    }
   ],
   "source": [
    "sentences = []\n",
    "with codecs.open('my_ten_abstracts.json','r','utf-8') as data_file:    \n",
    "    data = json.load(data_file)\n",
    "    for abstract in data.itervalues():\n",
    "        sentences.append(sent_tokenize(abstract))\n",
    "    # flatten the list of abstracts into one long list of sentences\n",
    "    sentences = [sent for s in sentences for sent in s]\n",
    "    print \"Sentences: \",len(sentences)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "keyword = 'ACEI'\n",
    "key_sentences = []\n",
    "transformed_sentences = pb.ace_substitutor(sentences, 'ACEI')\n",
    "for sent in transformed_sentences:\n",
    "    if keyword in sent:\n",
    "        key_sentences.append(sent)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Overwriting KeywordSentences.py\n"
     ]
    }
   ],
   "source": [
    "%%writefile KeywordSentences.py\n",
    "import json\n",
    "import codecs\n",
    "import pubmed.utils as pb\n",
    "\n",
    "#change keyword to ACE\n",
    "keyword = 'ACEI'\n",
    "with codecs.open('my_ten_abstracts.json','r','utf-8') as data_file:    \n",
    "    data = json.load(data_file)\n",
    "    #pick snippets related to ACE inhibitors\n",
    "    for abstract in data.itervalues():\n",
    "        transformed_abstract = pb.ace_substitutor(abstract, 'ACEI') \n",
    "        if keyword in transformed_abstract:\n",
    "            print transformed_abstract.encode('utf-8') + '\\n'\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "!python2 KeywordSentences.py > KeywordSentences.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "renin-angiotensin-aldosterone system (raas) antagonists, including ACEI, angiotensin receptor blockers (arb), and mineralocorticoid receptor antagonists (mra) decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia, especially when used in combination. prevention of hyperkalemia and its associated complications requires careful patient selection, counseling regarding dietary potassium intake, awareness of drug interactions, and regular laboratory surveillance. recent data suggests that the risk of hyperkalemia may be further moderated through the use of combined angiotensin-neprilysin inhibitors, novel mras, and novel potassium binding agents. clinicians should be mindful of the risk of hyperkalemia when prescribing raas inhibitors to patients with heart failure. in patients at highest risk, such as those with diabetes, the elderly, and advanced chronic kidney disease, more intensive laboratory surveillance of potassium and creatinine may be required. novel therapies hold promise for reducing the risk of hyperkalemia and enhancing the tolerability of raas antagonists.\r\n",
      "\r\n",
      "heart failure is a disease with a high prevalence and incidence. new therapeutic approaches are needed to prevent the onset of heart failure and to reduce the high morbidity and mortality associated with this disease. an optimized therapy of arterial hypertension in patients with risk factors and the use of the sglt2 inhibitor empagliflozin in type 2 diabetics are proven strategies to prevent heart failure. the therapeutic options in heart failure with preserved ejection fraction are still insufficient. in heart failure with reduced ejection fraction sacubitril/valsartan, the first approved angiotensin receptor-neprilysin inhibitor, is superior to an ACEI (ACEI) inhibitor. whether digitalis affects the prognosis in heart failure remains unclear; however, serum concentration should be targeted at the lower therapeutic range. iron supplementation in heart failure with reduced systolic function and iron deficiency improves symptoms and quality of life.\r\n",
      "\r\n",
      "participants (n=418) underwent one of the following 3 conditions: i) multicomponent exercise training 3times/week (mex; n=116); ii) ACEI used mono-dose daily (ACEI; n=70); iii) combined exercise and ACEI drugs (aceimex; n=232). the trial was completed by 82% of the participants (n=342): mex (n=90); ACEI (n=66); aceimex (n=186). baseline and 2-year follow-up evaluations included the senior fitness test battery, short form health survey 36 (sf-36), the health history questionnaires, anthropometric and hemodynamic profile.\r\n",
      "\r\n",
      "heart failure (hf) prevalence continues to rise and remains a significant burden to patients, caregivers, providers, and the healthcare system. guideline-directed medical therapy with standard neurohormonal blockade has been the cornerstone of medical management for many years. despite aggressive utilization of ACEI, angiotensin receptor blockers, beta-blockers, and aldosterone antagonists, hf hospitalizations and readmissions are common and residual mortality remains high. with the development of two novel medical therapies (sacubitril/valsartan and ivabradine), the american college of cardiology, american heart association, and heart failure society of america released a pharmacologic update to provide guidelines for incorporation of these agents into clinical practice. although effective via different mechanisms of action, both agents now have a prominent role in risk reduction. hf medical regimens often become quite complex, especially when associated with comorbid conditions, and require frequent follow-up. providers must be proficient in patient monitoring, medication dose titration, and therapy optimization. individualized patient care strategies such as guideline-directed therapy can promote long-term adherence and quality of life.\r\n",
      "\r\n",
      "we included a group with no dd (n=649), a group with grade 1 dd (n=2875), and those with grades 2 and 3 (n=1357) who had normal ejection fraction. the prevalence of grade 2 or 3 dd with preserved ejection fraction was 25%; 95% ci: 24-26. the absolute change of ACEI-inhibitor use before and after the echocardiogram increased by 14, 19, 23, 27 in patients without dd, those with grade 1, grade 2 or 3 asymptomatic and grade 2 or 3 symptomatic, respectively. the use of Î²-blocker, statin, and diuretic had similar trends.\r\n",
      "\r\n"
     ]
    }
   ],
   "source": [
    "#This mimics the format that the example parser file has\n",
    "!head KeywordSentences.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "!chmod a+x lexparser.sh"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Testing with PCFG Model*\n",
    "\n",
    "*notice I made a change to the lexparser file to allow for more memory"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "#!/usr/bin/env bash\r\n",
      "#\r\n",
      "# Runs the English PCFG parser on one or more files, printing trees only\r\n",
      "\r\n",
      "if [ ! $# -ge 1 ]; then\r\n",
      "  echo Usage: `basename $0` 'file(s)'\r\n",
      "  echo\r\n",
      "  exit\r\n",
      "fi\r\n",
      "\r\n",
      "scriptdir=`dirname $0`\r\n",
      "\r\n",
      "java -mx500m -cp \"$scriptdir/*:\" edu.stanford.nlp.parser.lexparser.LexicalizedParser \\\r\n",
      " -outputFormat \"penn,typedDependencies\" edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz $*\r\n"
     ]
    }
   ],
   "source": [
    "!cat ./lexparser.sh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsing [sent. 1 len. 44]: renin-angiotensin-aldosterone system -LRB- raas -RRB- antagonists , including ACEI , angiotensin receptor blockers -LRB- arb -RRB- , and mineralocorticoid receptor antagonists -LRB- mra -RRB- decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia , especially when used in combination .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ renin-angiotensin-aldosterone) (NN system)\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNS raas))\n",
      "          (-RRB- -RRB-))\n",
      "        (NNS antagonists))\n",
      "      (, ,)\n",
      "      (PP (VBG including)\n",
      "        (NP (NNP ACEI)))\n",
      "      (, ,))\n",
      "    (VP (VBD angiotensin)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN receptor) (NNS blockers))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN arb))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ mineralocorticoid) (NN receptor) (NNS antagonists))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN mra))\n",
      "            (-RRB- -RRB-))))\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (VB decrease)\n",
      "            (NP (NN mortality)\n",
      "              (CC and)\n",
      "              (NN morbidity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN heart) (NN failure))))\n",
      "          (CC but)\n",
      "          (VP (VB increase)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP (NN hyperkalemia)))))))\n",
      "      (, ,)\n",
      "      (SBAR\n",
      "        (WHADVP (RB especially) (WRB when))\n",
      "        (S\n",
      "          (VP (VBN used)\n",
      "            (PP (IN in)\n",
      "              (NP (NN combination)))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(antagonists-6, renin-angiotensin-aldosterone-1)\n",
      "compound(antagonists-6, system-2)\n",
      "appos(antagonists-6, raas-4)\n",
      "nsubj(angiotensin-11, antagonists-6)\n",
      "case(ACEI-9, including-8)\n",
      "nmod:including(antagonists-6, ACEI-9)\n",
      "root(ROOT-0, angiotensin-11)\n",
      "compound(blockers-13, receptor-12)\n",
      "dobj(angiotensin-11, blockers-13)\n",
      "appos(blockers-13, arb-15)\n",
      "cc(blockers-13, and-18)\n",
      "amod(antagonists-21, mineralocorticoid-19)\n",
      "compound(antagonists-21, receptor-20)\n",
      "dobj(angiotensin-11, antagonists-21)\n",
      "conj:and(blockers-13, antagonists-21)\n",
      "appos(antagonists-21, mra-23)\n",
      "dep(angiotensin-11, decrease-25)\n",
      "dobj(decrease-25, mortality-26)\n",
      "cc(mortality-26, and-27)\n",
      "dobj(decrease-25, morbidity-28)\n",
      "conj:and(mortality-26, morbidity-28)\n",
      "case(failure-31, in-29)\n",
      "compound(failure-31, heart-30)\n",
      "nmod:in(decrease-25, failure-31)\n",
      "cc(decrease-25, but-32)\n",
      "dep(angiotensin-11, increase-33)\n",
      "conj:but(decrease-25, increase-33)\n",
      "det(risk-35, the-34)\n",
      "dobj(increase-33, risk-35)\n",
      "case(hyperkalemia-37, of-36)\n",
      "nmod:of(risk-35, hyperkalemia-37)\n",
      "advmod(when-40, especially-39)\n",
      "advmod(used-41, when-40)\n",
      "advcl(angiotensin-11, used-41)\n",
      "case(combination-43, in-42)\n",
      "nmod:in(used-41, combination-43)\n",
      "\n",
      "Parsing [sent. 2 len. 28]: prevention of hyperkalemia and its associated complications requires careful patient selection , counseling regarding dietary potassium intake , awareness of drug interactions , and regular laboratory surveillance .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN prevention))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN hyperkalemia))\n",
      "          (CC and)\n",
      "          (NP (PRP$ its) (JJ associated) (NNS complications)))))\n",
      "    (VP (VBZ requires)\n",
      "      (NP\n",
      "        (NP (JJ careful) (NN patient) (NN selection))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN counseling))\n",
      "          (PP (VBG regarding)\n",
      "            (NP\n",
      "              (NP (JJ dietary) (NN potassium) (NN intake))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN awareness))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN drug) (NNS interactions))))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (JJ regular) (NN laboratory) (NN surveillance)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(requires-8, prevention-1)\n",
      "case(hyperkalemia-3, of-2)\n",
      "nmod:of(prevention-1, hyperkalemia-3)\n",
      "cc(hyperkalemia-3, and-4)\n",
      "nmod:poss(complications-7, its-5)\n",
      "amod(complications-7, associated-6)\n",
      "nmod:of(prevention-1, complications-7)\n",
      "conj:and(hyperkalemia-3, complications-7)\n",
      "root(ROOT-0, requires-8)\n",
      "amod(selection-11, careful-9)\n",
      "compound(selection-11, patient-10)\n",
      "dobj(requires-8, selection-11)\n",
      "appos(selection-11, counseling-13)\n",
      "case(intake-17, regarding-14)\n",
      "amod(intake-17, dietary-15)\n",
      "compound(intake-17, potassium-16)\n",
      "nmod:regarding(counseling-13, intake-17)\n",
      "nmod:regarding(counseling-13, awareness-19)\n",
      "conj:and(intake-17, awareness-19)\n",
      "case(interactions-22, of-20)\n",
      "compound(interactions-22, drug-21)\n",
      "nmod:of(awareness-19, interactions-22)\n",
      "cc(intake-17, and-24)\n",
      "amod(surveillance-27, regular-25)\n",
      "compound(surveillance-27, laboratory-26)\n",
      "nmod:regarding(counseling-13, surveillance-27)\n",
      "conj:and(intake-17, surveillance-27)\n",
      "\n",
      "Parsing [sent. 3 len. 29]: recent data suggests that the risk of hyperkalemia may be further moderated through the use of combined angiotensin-neprilysin inhibitors , novel mras , and novel potassium binding agents .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ recent) (NNS data))\n",
      "    (VP (VBZ suggests)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN risk))\n",
      "            (PP (IN of)\n",
      "              (NP (NN hyperkalemia))))\n",
      "          (VP (MD may)\n",
      "            (VP (VB be)\n",
      "              (VP (RBR further) (VBN moderated)\n",
      "                (PP (IN through)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN use))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (VBN combined) (JJ angiotensin-neprilysin) (NNS inhibitors))\n",
      "                        (, ,)\n",
      "                        (NP (NN novel) (NNS mras))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP (NN novel) (NN potassium) (VBG binding) (NNS agents))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(data-2, recent-1)\n",
      "nsubj(suggests-3, data-2)\n",
      "root(ROOT-0, suggests-3)\n",
      "mark(moderated-12, that-4)\n",
      "det(risk-6, the-5)\n",
      "nsubjpass(moderated-12, risk-6)\n",
      "case(hyperkalemia-8, of-7)\n",
      "nmod:of(risk-6, hyperkalemia-8)\n",
      "aux(moderated-12, may-9)\n",
      "auxpass(moderated-12, be-10)\n",
      "advmod(moderated-12, further-11)\n",
      "ccomp(suggests-3, moderated-12)\n",
      "case(use-15, through-13)\n",
      "det(use-15, the-14)\n",
      "nmod:through(moderated-12, use-15)\n",
      "case(inhibitors-19, of-16)\n",
      "amod(inhibitors-19, combined-17)\n",
      "amod(inhibitors-19, angiotensin-neprilysin-18)\n",
      "nmod:of(use-15, inhibitors-19)\n",
      "compound(mras-22, novel-21)\n",
      "nmod:of(use-15, mras-22)\n",
      "conj:and(inhibitors-19, mras-22)\n",
      "cc(inhibitors-19, and-24)\n",
      "compound(agents-28, novel-25)\n",
      "compound(agents-28, potassium-26)\n",
      "amod(agents-28, binding-27)\n",
      "nmod:of(use-15, agents-28)\n",
      "conj:and(inhibitors-19, agents-28)\n",
      "\n",
      "Parsing [sent. 4 len. 19]: clinicians should be mindful of the risk of hyperkalemia when prescribing raas inhibitors to patients with heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS clinicians))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ mindful)\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP (NN hyperkalemia))))))\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (VBG prescribing) (NNS raas))\n",
      "            (VP (VBZ inhibitors)\n",
      "              (PP (TO to)\n",
      "                (NP\n",
      "                  (NP (NNS patients))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN heart) (NN failure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(mindful-4, clinicians-1)\n",
      "aux(mindful-4, should-2)\n",
      "cop(mindful-4, be-3)\n",
      "root(ROOT-0, mindful-4)\n",
      "case(risk-7, of-5)\n",
      "det(risk-7, the-6)\n",
      "nmod:of(mindful-4, risk-7)\n",
      "case(hyperkalemia-9, of-8)\n",
      "nmod:of(risk-7, hyperkalemia-9)\n",
      "advmod(inhibitors-13, when-10)\n",
      "amod(raas-12, prescribing-11)\n",
      "nsubj(inhibitors-13, raas-12)\n",
      "advcl(mindful-4, inhibitors-13)\n",
      "case(patients-15, to-14)\n",
      "nmod:to(inhibitors-13, patients-15)\n",
      "case(failure-18, with-16)\n",
      "compound(failure-18, heart-17)\n",
      "nmod:with(patients-15, failure-18)\n",
      "\n",
      "Parsing [sent. 5 len. 33]: in patients at highest risk , such as those with diabetes , the elderly , and advanced chronic kidney disease , more intensive laboratory surveillance of potassium and creatinine may be required .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP\n",
      "        (NP (NNS patients))\n",
      "        (PP (IN at)\n",
      "          (NP (JJS highest) (NN risk)))\n",
      "        (, ,)\n",
      "        (PP (JJ such) (IN as)\n",
      "          (NP\n",
      "            (NP (DT those))\n",
      "            (PP (IN with)\n",
      "              (NP (NN diabetes)))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the)\n",
      "        (ADJP (JJ elderly) (, ,)\n",
      "          (CC and)\n",
      "          (JJ advanced))\n",
      "        (JJ chronic) (NN kidney) (NN disease) (, ,)\n",
      "        (ADJP (RBR more) (JJ intensive))\n",
      "        (NN laboratory) (NN surveillance))\n",
      "      (PP (IN of)\n",
      "        (NP (NN potassium)\n",
      "          (CC and)\n",
      "          (NN creatinine))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN required))))\n",
      "    (. .)))\n",
      "\n",
      "case(patients-2, in-1)\n",
      "nmod:in(required-32, patients-2)\n",
      "case(risk-5, at-3)\n",
      "amod(risk-5, highest-4)\n",
      "nmod:at(patients-2, risk-5)\n",
      "case(those-9, such-7)\n",
      "mwe(such-7, as-8)\n",
      "nmod:such_as(patients-2, those-9)\n",
      "case(diabetes-11, with-10)\n",
      "nmod:with(those-9, diabetes-11)\n",
      "det(surveillance-25, the-13)\n",
      "amod(surveillance-25, elderly-14)\n",
      "cc(elderly-14, and-16)\n",
      "conj:and(elderly-14, advanced-17)\n",
      "amod(surveillance-25, advanced-17)\n",
      "amod(surveillance-25, chronic-18)\n",
      "compound(surveillance-25, kidney-19)\n",
      "compound(surveillance-25, disease-20)\n",
      "advmod(intensive-23, more-22)\n",
      "amod(surveillance-25, intensive-23)\n",
      "compound(surveillance-25, laboratory-24)\n",
      "nsubjpass(required-32, surveillance-25)\n",
      "case(potassium-27, of-26)\n",
      "nmod:of(surveillance-25, potassium-27)\n",
      "cc(potassium-27, and-28)\n",
      "nmod:of(surveillance-25, creatinine-29)\n",
      "conj:and(potassium-27, creatinine-29)\n",
      "aux(required-32, may-30)\n",
      "auxpass(required-32, be-31)\n",
      "root(ROOT-0, required-32)\n",
      "\n",
      "Parsing [sent. 6 len. 18]: novel therapies hold promise for reducing the risk of hyperkalemia and enhancing the tolerability of raas antagonists .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN novel) (NNS therapies))\n",
      "    (VP (VBP hold)\n",
      "      (NP (NN promise))\n",
      "      (PP (IN for)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN risk))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN hyperkalemia)))))\n",
      "            (CC and)\n",
      "            (VP (VBG enhancing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN tolerability))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ raas) (NNS antagonists)))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(therapies-2, novel-1)\n",
      "nsubj(hold-3, therapies-2)\n",
      "root(ROOT-0, hold-3)\n",
      "dobj(hold-3, promise-4)\n",
      "mark(reducing-6, for-5)\n",
      "advcl(hold-3, reducing-6)\n",
      "det(risk-8, the-7)\n",
      "dobj(reducing-6, risk-8)\n",
      "case(hyperkalemia-10, of-9)\n",
      "nmod:of(risk-8, hyperkalemia-10)\n",
      "cc(reducing-6, and-11)\n",
      "advcl(hold-3, enhancing-12)\n",
      "conj:and(reducing-6, enhancing-12)\n",
      "det(tolerability-14, the-13)\n",
      "dobj(enhancing-12, tolerability-14)\n",
      "case(antagonists-17, of-15)\n",
      "amod(antagonists-17, raas-16)\n",
      "nmod:of(tolerability-14, antagonists-17)\n",
      "\n",
      "Parsing [sent. 7 len. 12]: heart failure is a disease with a high prevalence and incidence .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN heart) (NN failure))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (NN disease))\n",
      "        (PP (IN with)\n",
      "          (NP (DT a) (JJ high) (NN prevalence)\n",
      "            (CC and)\n",
      "            (NN incidence)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(disease-5, failure-2)\n",
      "cop(disease-5, is-3)\n",
      "det(disease-5, a-4)\n",
      "root(ROOT-0, disease-5)\n",
      "case(prevalence-9, with-6)\n",
      "det(prevalence-9, a-7)\n",
      "amod(prevalence-9, high-8)\n",
      "nmod:with(disease-5, prevalence-9)\n",
      "cc(prevalence-9, and-10)\n",
      "nmod:with(disease-5, incidence-11)\n",
      "conj:and(prevalence-9, incidence-11)\n",
      "\n",
      "Parsing [sent. 8 len. 25]: new therapeutic approaches are needed to prevent the onset of heart failure and to reduce the high morbidity and mortality associated with this disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ new) (JJ therapeutic) (NNS approaches))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN needed)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (TO to)\n",
      "              (VP (VB prevent)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN onset))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN heart) (NN failure))))))\n",
      "            (CC and)\n",
      "            (VP (TO to)\n",
      "              (VP (VB reduce)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ high) (NN morbidity)\n",
      "                    (CC and)\n",
      "                    (NN mortality))\n",
      "                  (VP (VBN associated)\n",
      "                    (PP (IN with)\n",
      "                      (NP (DT this) (NN disease)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(approaches-3, new-1)\n",
      "amod(approaches-3, therapeutic-2)\n",
      "nsubjpass(needed-5, approaches-3)\n",
      "auxpass(needed-5, are-4)\n",
      "root(ROOT-0, needed-5)\n",
      "mark(prevent-7, to-6)\n",
      "ccomp(needed-5, prevent-7)\n",
      "det(onset-9, the-8)\n",
      "dobj(prevent-7, onset-9)\n",
      "case(failure-12, of-10)\n",
      "compound(failure-12, heart-11)\n",
      "nmod:of(onset-9, failure-12)\n",
      "cc(prevent-7, and-13)\n",
      "mark(reduce-15, to-14)\n",
      "ccomp(needed-5, reduce-15)\n",
      "conj:and(prevent-7, reduce-15)\n",
      "det(morbidity-18, the-16)\n",
      "amod(morbidity-18, high-17)\n",
      "dobj(reduce-15, morbidity-18)\n",
      "cc(morbidity-18, and-19)\n",
      "dobj(reduce-15, mortality-20)\n",
      "conj:and(morbidity-18, mortality-20)\n",
      "acl(morbidity-18, associated-21)\n",
      "case(disease-24, with-22)\n",
      "det(disease-24, this-23)\n",
      "nmod:with(associated-21, disease-24)\n",
      "\n",
      "Parsing [sent. 9 len. 31]: an optimized therapy of arterial hypertension in patients with risk factors and the use of the sglt2 inhibitor empagliflozin in type 2 diabetics are proven strategies to prevent heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT an) (JJ optimized) (NN therapy))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (JJ arterial) (NN hypertension))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN risk) (NNS factors))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT the) (NN use))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (DT the) (JJ sglt2) (NN inhibitor) (NN empagliflozin))\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (ADJP (NN type) (CD 2))\n",
      "                        (NNS diabetics)))))))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN proven)\n",
      "        (NP (NNS strategies))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB prevent)\n",
      "              (NP (NN heart) (NN failure)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(therapy-3, an-1)\n",
      "amod(therapy-3, optimized-2)\n",
      "nsubjpass(proven-25, therapy-3)\n",
      "case(hypertension-6, of-4)\n",
      "amod(hypertension-6, arterial-5)\n",
      "nmod:of(therapy-3, hypertension-6)\n",
      "case(patients-8, in-7)\n",
      "nmod:in(hypertension-6, patients-8)\n",
      "case(factors-11, with-9)\n",
      "compound(factors-11, risk-10)\n",
      "nmod:with(patients-8, factors-11)\n",
      "cc(patients-8, and-12)\n",
      "det(use-14, the-13)\n",
      "nmod:in(hypertension-6, use-14)\n",
      "conj:and(patients-8, use-14)\n",
      "case(empagliflozin-19, of-15)\n",
      "det(empagliflozin-19, the-16)\n",
      "amod(empagliflozin-19, sglt2-17)\n",
      "compound(empagliflozin-19, inhibitor-18)\n",
      "nmod:of(use-14, empagliflozin-19)\n",
      "case(diabetics-23, in-20)\n",
      "amod(diabetics-23, type-21)\n",
      "compound(type-21, 2-22)\n",
      "nmod:in(empagliflozin-19, diabetics-23)\n",
      "auxpass(proven-25, are-24)\n",
      "root(ROOT-0, proven-25)\n",
      "dobj(proven-25, strategies-26)\n",
      "mark(prevent-28, to-27)\n",
      "advcl(proven-25, prevent-28)\n",
      "compound(failure-30, heart-29)\n",
      "dobj(prevent-28, failure-30)\n",
      "\n",
      "Parsing [sent. 10 len. 14]: the therapeutic options in heart failure with preserved ejection fraction are still insufficient .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (JJ therapeutic) (NNS options))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN heart) (NN failure))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ preserved) (NN ejection) (NN fraction))))))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB still))\n",
      "      (ADJP (JJ insufficient)))\n",
      "    (. .)))\n",
      "\n",
      "det(options-3, the-1)\n",
      "amod(options-3, therapeutic-2)\n",
      "nsubj(insufficient-13, options-3)\n",
      "case(failure-6, in-4)\n",
      "compound(failure-6, heart-5)\n",
      "nmod:in(options-3, failure-6)\n",
      "case(fraction-10, with-7)\n",
      "amod(fraction-10, preserved-8)\n",
      "compound(fraction-10, ejection-9)\n",
      "nmod:with(failure-6, fraction-10)\n",
      "cop(insufficient-13, are-11)\n",
      "advmod(insufficient-13, still-12)\n",
      "root(ROOT-0, insufficient-13)\n",
      "\n",
      "Parsing [sent. 11 len. 26]: in heart failure with reduced ejection fraction sacubitril/valsartan , the first approved angiotensin receptor-neprilysin inhibitor , is superior to an ACEI -LRB- ACEI -RRB- inhibitor .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP\n",
      "        (NP (NN heart) (NN failure))\n",
      "        (PP (IN with)\n",
      "          (NP (VBN reduced) (NN ejection)))))\n",
      "    (NP\n",
      "      (NP (NN fraction) (NN sacubitril/valsartan))\n",
      "      (, ,)\n",
      "      (NP (DT the) (JJ first) (JJ approved) (NN angiotensin) (NN receptor-neprilysin) (NN inhibitor))\n",
      "      (, ,))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ superior)\n",
      "        (PP (TO to)\n",
      "          (NP (DT an) (NNP ACEI)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP ACEI))\n",
      "              (-RRB- -RRB-))\n",
      "            (NN inhibitor)))))\n",
      "    (. .)))\n",
      "\n",
      "case(failure-3, in-1)\n",
      "compound(failure-3, heart-2)\n",
      "nmod:in(superior-18, failure-3)\n",
      "case(ejection-6, with-4)\n",
      "amod(ejection-6, reduced-5)\n",
      "nmod:with(failure-3, ejection-6)\n",
      "compound(sacubitril/valsartan-8, fraction-7)\n",
      "nsubj(superior-18, sacubitril/valsartan-8)\n",
      "det(inhibitor-15, the-10)\n",
      "amod(inhibitor-15, first-11)\n",
      "amod(inhibitor-15, approved-12)\n",
      "compound(inhibitor-15, angiotensin-13)\n",
      "compound(inhibitor-15, receptor-neprilysin-14)\n",
      "appos(sacubitril/valsartan-8, inhibitor-15)\n",
      "cop(superior-18, is-17)\n",
      "root(ROOT-0, superior-18)\n",
      "case(inhibitor-25, to-19)\n",
      "det(inhibitor-25, an-20)\n",
      "compound(inhibitor-25, ACEI-21)\n",
      "appos(inhibitor-25, ACEI-23)\n",
      "nmod:to(superior-18, inhibitor-25)\n",
      "\n",
      "Parsing [sent. 12 len. 24]: whether digitalis affects the prognosis in heart failure remains unclear ; however , serum concentration should be targeted at the lower therapeutic range .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP (NN digitalis))\n",
      "          (VP (VBZ affects)\n",
      "            (NP\n",
      "              (NP (DT the) (NN prognosis))\n",
      "              (PP (IN in)\n",
      "                (NP (NN heart) (NN failure)))))))\n",
      "      (VP (VBZ remains)\n",
      "        (ADJP (JJ unclear))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (ADVP (RB however))\n",
      "      (, ,)\n",
      "      (NP (NN serum) (NN concentration))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN targeted)\n",
      "            (PP (IN at)\n",
      "              (NP (DT the) (JJR lower) (JJ therapeutic) (NN range)))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(affects-3, whether-1)\n",
      "nsubj(affects-3, digitalis-2)\n",
      "csubj(remains-9, affects-3)\n",
      "det(prognosis-5, the-4)\n",
      "dobj(affects-3, prognosis-5)\n",
      "case(failure-8, in-6)\n",
      "compound(failure-8, heart-7)\n",
      "nmod:in(prognosis-5, failure-8)\n",
      "root(ROOT-0, remains-9)\n",
      "xcomp(remains-9, unclear-10)\n",
      "advmod(targeted-18, however-12)\n",
      "compound(concentration-15, serum-14)\n",
      "nsubjpass(targeted-18, concentration-15)\n",
      "aux(targeted-18, should-16)\n",
      "auxpass(targeted-18, be-17)\n",
      "parataxis(remains-9, targeted-18)\n",
      "case(range-23, at-19)\n",
      "det(range-23, the-20)\n",
      "amod(range-23, lower-21)\n",
      "amod(range-23, therapeutic-22)\n",
      "nmod:at(targeted-18, range-23)\n",
      "\n",
      "Parsing [sent. 13 len. 19]: iron supplementation in heart failure with reduced systolic function and iron deficiency improves symptoms and quality of life .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN iron) (NN supplementation))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN heart) (NN failure))\n",
      "          (PP (IN with)\n",
      "            (NP (VBN reduced) (JJ systolic) (NN function)\n",
      "              (CC and)\n",
      "              (NN iron) (NN deficiency))))))\n",
      "    (VP (VBZ improves)\n",
      "      (NP\n",
      "        (NP (NNS symptoms)\n",
      "          (CC and)\n",
      "          (NN quality))\n",
      "        (PP (IN of)\n",
      "          (NP (NN life)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(supplementation-2, iron-1)\n",
      "nsubj(improves-13, supplementation-2)\n",
      "case(failure-5, in-3)\n",
      "compound(failure-5, heart-4)\n",
      "nmod:in(supplementation-2, failure-5)\n",
      "case(function-9, with-6)\n",
      "amod(function-9, reduced-7)\n",
      "amod(function-9, systolic-8)\n",
      "nmod:with(failure-5, function-9)\n",
      "cc(function-9, and-10)\n",
      "compound(deficiency-12, iron-11)\n",
      "nmod:with(failure-5, deficiency-12)\n",
      "conj:and(function-9, deficiency-12)\n",
      "root(ROOT-0, improves-13)\n",
      "dobj(improves-13, symptoms-14)\n",
      "cc(symptoms-14, and-15)\n",
      "dobj(improves-13, quality-16)\n",
      "conj:and(symptoms-14, quality-16)\n",
      "case(life-18, of-17)\n",
      "nmod:of(symptoms-14, life-18)\n",
      "\n",
      "Parsing [sent. 14 len. 57]: participants -LRB- n = 418 -RRB- underwent one of the following 3 conditions : i -RRB- multicomponent exercise training 3times/week -LRB- mex ; n = 116 -RRB- ; ii -RRB- ACEI used mono-dose daily -LRB- ACEI ; n = 70 -RRB- ; iii -RRB- combined exercise and ACEI drugs -LRB- aceimex ; n = 232 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS participants))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (VP (VBN n)\n",
      "          (S\n",
      "            (VP (SYM =)\n",
      "              (NP (CD 418)))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD underwent)\n",
      "      (S\n",
      "        (NP\n",
      "          (NP (CD one))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (VBG following) (CD 3) (NNS conditions))))\n",
      "        (: :)\n",
      "        (NP (FW i))\n",
      "        (-RRB- -RRB-)\n",
      "        (VP\n",
      "          (VP (VBP multicomponent)\n",
      "            (VP (VB exercise)\n",
      "              (NP (NN training) (NNS 3times/week))\n",
      "              (FRAG (-LRB- -LRB-)\n",
      "                (NP (NN mex))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP (NNP n) (NNP =) (NNP 116) (-RRB- -RRB-))\n",
      "                  (: ;)\n",
      "                  (NP (NN ii)))\n",
      "                (-RRB- -RRB-))))\n",
      "          (PRN\n",
      "            (S\n",
      "              (NP (NNP ACEI))\n",
      "              (VP (VBD used)\n",
      "                (NP\n",
      "                  (NP (JJ mono-dose) (NN daily))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NNP ACEI))\n",
      "                      (: ;)\n",
      "                      (NP\n",
      "                        (NP (NN n))\n",
      "                        (SBAR\n",
      "                          (S\n",
      "                            (VP (SYM =)\n",
      "                              (NP (CD 70)))))))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (: ;)\n",
      "                  (NP (NN iii)))))\n",
      "            (-RRB- -RRB-))\n",
      "          (NP\n",
      "            (NP (VBN combined) (NN exercise))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (CD ACEI) (NNS drugs))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (NN aceimex))\n",
      "                  (: ;)\n",
      "                  (NP\n",
      "                    (NP (NN n))\n",
      "                    (SBAR\n",
      "                      (S\n",
      "                        (VP (SYM =)\n",
      "                          (NP (CD 232)))))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(underwent-7, participants-1)\n",
      "dep(participants-1, n-3)\n",
      "dep(418-5, =-4)\n",
      "ccomp(n-3, 418-5)\n",
      "root(ROOT-0, underwent-7)\n",
      "nsubj(multicomponent-17, one-8)\n",
      "case(conditions-13, of-9)\n",
      "det(conditions-13, the-10)\n",
      "amod(conditions-13, following-11)\n",
      "nummod(conditions-13, 3-12)\n",
      "nmod:of(one-8, conditions-13)\n",
      "nsubj(multicomponent-17, i-15)\n",
      "ccomp(underwent-7, multicomponent-17)\n",
      "xcomp(multicomponent-17, exercise-18)\n",
      "compound(3times/week-20, training-19)\n",
      "dobj(exercise-18, 3times/week-20)\n",
      "dep(exercise-18, mex-22)\n",
      "compound(116-26, n-24)\n",
      "compound(116-26, =-25)\n",
      "dep(mex-22, 116-26)\n",
      "dep(116-26, ii-29)\n",
      "nsubj(used-32, ACEI-31)\n",
      "parataxis(multicomponent-17, used-32)\n",
      "amod(daily-34, mono-dose-33)\n",
      "dobj(used-32, daily-34)\n",
      "dep(daily-34, ACEI-36)\n",
      "dep(ACEI-36, n-38)\n",
      "dep(70-40, =-39)\n",
      "acl:relcl(n-38, 70-40)\n",
      "dep(daily-34, iii-43)\n",
      "amod(exercise-46, combined-45)\n",
      "dobj(multicomponent-17, exercise-46)\n",
      "cc(exercise-46, and-47)\n",
      "nummod(drugs-49, ACEI-48)\n",
      "dobj(multicomponent-17, drugs-49)\n",
      "conj:and(exercise-46, drugs-49)\n",
      "dep(drugs-49, aceimex-51)\n",
      "dep(aceimex-51, n-53)\n",
      "dep(232-55, =-54)\n",
      "acl:relcl(n-53, 232-55)\n",
      "\n",
      "Parsing [sent. 15 len. 37]: the trial was completed by 82 % of the participants -LRB- n = 342 -RRB- : mex -LRB- n = 90 -RRB- ; ACEI -LRB- n = 66 -RRB- ; aceimex -LRB- n = 186 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN trial))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN completed)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (CD 82) (NN %))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NNS participants))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP n)\n",
      "                        (QP (CD =) (CD 342)))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (: :)\n",
      "                    (NP (NN mex)))))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 90)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (NNP ACEI))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 66)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (NN aceimex))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 186)))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(trial-2, the-1)\n",
      "nsubjpass(completed-4, trial-2)\n",
      "auxpass(completed-4, was-3)\n",
      "root(ROOT-0, completed-4)\n",
      "case(%-7, by-5)\n",
      "nummod(%-7, 82-6)\n",
      "nmod:by(completed-4, %-7)\n",
      "case(participants-10, of-8)\n",
      "det(participants-10, the-9)\n",
      "nmod:of(%-7, participants-10)\n",
      "appos(participants-10, n-12)\n",
      "compound(342-14, =-13)\n",
      "nummod(n-12, 342-14)\n",
      "dep(participants-10, mex-17)\n",
      "dep(%-7, n-19)\n",
      "dep(90-21, =-20)\n",
      "ccomp(n-19, 90-21)\n",
      "dep(%-7, ACEI-24)\n",
      "dep(ACEI-24, n-26)\n",
      "dep(66-28, =-27)\n",
      "ccomp(n-26, 66-28)\n",
      "dep(%-7, aceimex-31)\n",
      "dep(aceimex-31, n-33)\n",
      "dep(186-35, =-34)\n",
      "ccomp(n-33, 186-35)\n",
      "\n",
      "Parsing [sent. 16 len. 31]: baseline and 2-year follow-up evaluations included the senior fitness test battery , short form health survey 36 -LRB- sf-36 -RRB- , the health history questionnaires , anthropometric and hemodynamic profile .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN baseline)\n",
      "      (CC and)\n",
      "      (JJ 2-year) (NN follow-up) (NNS evaluations))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ senior) (NN fitness) (NN test) (NN battery))\n",
      "        (, ,)\n",
      "        (NP (JJ short) (NN form) (NN health) (NN survey) (CD 36) (-LRB- -LRB-) (NN sf-36) (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (NP (DT the) (NN health) (NN history) (NN questionnaires))\n",
      "        (, ,)\n",
      "        (NP (NN anthropometric))\n",
      "        (CC and)\n",
      "        (NP (JJ hemodynamic) (NN profile))))\n",
      "    (. .)))\n",
      "\n",
      "compound(evaluations-5, baseline-1)\n",
      "cc(baseline-1, and-2)\n",
      "conj:and(baseline-1, 2-year-3)\n",
      "compound(evaluations-5, 2-year-3)\n",
      "compound(evaluations-5, follow-up-4)\n",
      "nsubj(included-6, evaluations-5)\n",
      "root(ROOT-0, included-6)\n",
      "det(battery-11, the-7)\n",
      "amod(battery-11, senior-8)\n",
      "compound(battery-11, fitness-9)\n",
      "compound(battery-11, test-10)\n",
      "dobj(included-6, battery-11)\n",
      "amod(sf-36-19, short-13)\n",
      "compound(sf-36-19, form-14)\n",
      "compound(sf-36-19, health-15)\n",
      "compound(sf-36-19, survey-16)\n",
      "nummod(sf-36-19, 36-17)\n",
      "dobj(included-6, sf-36-19)\n",
      "conj:and(battery-11, sf-36-19)\n",
      "det(questionnaires-25, the-22)\n",
      "compound(questionnaires-25, health-23)\n",
      "compound(questionnaires-25, history-24)\n",
      "dobj(included-6, questionnaires-25)\n",
      "conj:and(battery-11, questionnaires-25)\n",
      "dobj(included-6, anthropometric-27)\n",
      "conj:and(battery-11, anthropometric-27)\n",
      "cc(battery-11, and-28)\n",
      "amod(profile-30, hemodynamic-29)\n",
      "dobj(included-6, profile-30)\n",
      "conj:and(battery-11, profile-30)\n",
      "\n",
      "Parsing [sent. 17 len. 26]: heart failure -LRB- hf -RRB- prevalence continues to rise and remains a significant burden to patients , caregivers , providers , and the healthcare system .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN heart) (NN failure))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN hf))\n",
      "        (-RRB- -RRB-)))\n",
      "    (ADVP (RB prevalence))\n",
      "    (VP\n",
      "      (VP (VBZ continues)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB rise)))))\n",
      "      (CC and)\n",
      "      (VP (VBZ remains)\n",
      "        (NP (DT a) (JJ significant) (NN burden))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (, ,)\n",
      "            (NP (NNS caregivers))\n",
      "            (, ,)\n",
      "            (NP (NNS providers))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (DT the) (NN healthcare) (NN system))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(continues-7, failure-2)\n",
      "nsubj:xsubj(rise-9, failure-2)\n",
      "nsubj(remains-11, failure-2)\n",
      "appos(failure-2, hf-4)\n",
      "advmod(continues-7, prevalence-6)\n",
      "root(ROOT-0, continues-7)\n",
      "mark(rise-9, to-8)\n",
      "xcomp(continues-7, rise-9)\n",
      "cc(continues-7, and-10)\n",
      "conj:and(continues-7, remains-11)\n",
      "det(burden-14, a-12)\n",
      "amod(burden-14, significant-13)\n",
      "xcomp(remains-11, burden-14)\n",
      "case(patients-16, to-15)\n",
      "nmod:to(remains-11, patients-16)\n",
      "nmod:to(remains-11, caregivers-18)\n",
      "conj:and(patients-16, caregivers-18)\n",
      "nmod:to(remains-11, providers-20)\n",
      "conj:and(patients-16, providers-20)\n",
      "cc(patients-16, and-22)\n",
      "det(system-25, the-23)\n",
      "compound(system-25, healthcare-24)\n",
      "nmod:to(remains-11, system-25)\n",
      "conj:and(patients-16, system-25)\n",
      "\n",
      "Parsing [sent. 18 len. 18]: guideline-directed medical therapy with standard neurohormonal blockade has been the cornerstone of medical management for many years .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ guideline-directed) (JJ medical) (NN therapy))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ standard) (JJ neurohormonal) (NN blockade))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN been)\n",
      "        (NP\n",
      "          (NP (DT the) (NN cornerstone))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ medical) (NN management))))\n",
      "        (PP (IN for)\n",
      "          (NP (JJ many) (NNS years)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-3, guideline-directed-1)\n",
      "amod(therapy-3, medical-2)\n",
      "nsubj(cornerstone-11, therapy-3)\n",
      "case(blockade-7, with-4)\n",
      "amod(blockade-7, standard-5)\n",
      "amod(blockade-7, neurohormonal-6)\n",
      "nmod:with(therapy-3, blockade-7)\n",
      "aux(cornerstone-11, has-8)\n",
      "cop(cornerstone-11, been-9)\n",
      "det(cornerstone-11, the-10)\n",
      "root(ROOT-0, cornerstone-11)\n",
      "case(management-14, of-12)\n",
      "amod(management-14, medical-13)\n",
      "nmod:of(cornerstone-11, management-14)\n",
      "case(years-17, for-15)\n",
      "amod(years-17, many-16)\n",
      "nmod:for(cornerstone-11, years-17)\n",
      "\n",
      "Parsing [sent. 19 len. 28]: despite aggressive utilization of ACEI , angiotensin receptor blockers , beta-blockers , and aldosterone antagonists , hf hospitalizations and readmissions are common and residual mortality remains high .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP\n",
      "        (NP (JJ aggressive) (NN utilization))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNP ACEI))\n",
      "            (, ,)\n",
      "            (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "            (, ,)\n",
      "            (NP (NNS beta-blockers))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (JJ aldosterone) (NNS antagonists))))))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN hf) (NNS hospitalizations)\n",
      "        (CC and)\n",
      "        (NNS readmissions))\n",
      "      (VP (VBP are)\n",
      "        (ADJP (JJ common))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ residual) (NN mortality))\n",
      "      (VP (VBZ remains)\n",
      "        (ADJP (JJ high))))\n",
      "    (. .)))\n",
      "\n",
      "case(utilization-3, despite-1)\n",
      "amod(utilization-3, aggressive-2)\n",
      "nmod:despite(common-22, utilization-3)\n",
      "case(ACEI-5, of-4)\n",
      "nmod:of(utilization-3, ACEI-5)\n",
      "compound(blockers-9, angiotensin-7)\n",
      "compound(blockers-9, receptor-8)\n",
      "nmod:of(utilization-3, blockers-9)\n",
      "conj:and(ACEI-5, blockers-9)\n",
      "nmod:of(utilization-3, beta-blockers-11)\n",
      "conj:and(ACEI-5, beta-blockers-11)\n",
      "cc(ACEI-5, and-13)\n",
      "amod(antagonists-15, aldosterone-14)\n",
      "nmod:of(utilization-3, antagonists-15)\n",
      "conj:and(ACEI-5, antagonists-15)\n",
      "compound(hospitalizations-18, hf-17)\n",
      "nsubj(common-22, hospitalizations-18)\n",
      "cc(hospitalizations-18, and-19)\n",
      "conj:and(hospitalizations-18, readmissions-20)\n",
      "nsubj(common-22, readmissions-20)\n",
      "cop(common-22, are-21)\n",
      "root(ROOT-0, common-22)\n",
      "cc(common-22, and-23)\n",
      "amod(mortality-25, residual-24)\n",
      "nsubj(remains-26, mortality-25)\n",
      "conj:and(common-22, remains-26)\n",
      "xcomp(remains-26, high-27)\n",
      "\n",
      "Parsing [sent. 20 len. 46]: with the development of two novel medical therapies -LRB- sacubitril/valsartan and ivabradine -RRB- , the american college of cardiology , american heart association , and heart failure society of america released a pharmacologic update to provide guidelines for incorporation of these agents into clinical practice .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN with)\n",
      "      (NP\n",
      "        (NP (DT the) (NN development))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (CD two) (JJ novel) (JJ medical) (NNS therapies))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (JJ sacubitril/valsartan)\n",
      "                (CC and)\n",
      "                (JJ ivabradine))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN american) (NN college))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN cardiology))\n",
      "          (, ,)\n",
      "          (NP (NN american) (NN heart) (NN association))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (NN heart) (NN failure) (NN society))\n",
      "            (PP (IN of)\n",
      "              (NP (NN america)))))))\n",
      "    (VP (VBD released)\n",
      "      (NP (DT a) (JJ pharmacologic) (NN update))\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB provide)\n",
      "            (NP\n",
      "              (NP (NNS guidelines))\n",
      "              (PP (IN for)\n",
      "                (NP\n",
      "                  (NP (NN incorporation))\n",
      "                  (PP (IN of)\n",
      "                    (NP (DT these) (NNS agents))))))\n",
      "            (PP (IN into)\n",
      "              (NP (JJ clinical) (NN practice)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(development-3, with-1)\n",
      "det(development-3, the-2)\n",
      "nmod:with(released-31, development-3)\n",
      "case(therapies-8, of-4)\n",
      "nummod(therapies-8, two-5)\n",
      "amod(therapies-8, novel-6)\n",
      "amod(therapies-8, medical-7)\n",
      "nmod:of(development-3, therapies-8)\n",
      "dep(therapies-8, sacubitril/valsartan-10)\n",
      "cc(sacubitril/valsartan-10, and-11)\n",
      "dep(therapies-8, ivabradine-12)\n",
      "conj:and(sacubitril/valsartan-10, ivabradine-12)\n",
      "det(college-17, the-15)\n",
      "compound(college-17, american-16)\n",
      "nsubj(released-31, college-17)\n",
      "case(cardiology-19, of-18)\n",
      "nmod:of(college-17, cardiology-19)\n",
      "compound(association-23, american-21)\n",
      "compound(association-23, heart-22)\n",
      "nmod:of(college-17, association-23)\n",
      "conj:and(cardiology-19, association-23)\n",
      "cc(cardiology-19, and-25)\n",
      "compound(society-28, heart-26)\n",
      "compound(society-28, failure-27)\n",
      "nmod:of(college-17, society-28)\n",
      "conj:and(cardiology-19, society-28)\n",
      "case(america-30, of-29)\n",
      "nmod:of(society-28, america-30)\n",
      "root(ROOT-0, released-31)\n",
      "det(update-34, a-32)\n",
      "amod(update-34, pharmacologic-33)\n",
      "dobj(released-31, update-34)\n",
      "mark(provide-36, to-35)\n",
      "advcl(released-31, provide-36)\n",
      "dobj(provide-36, guidelines-37)\n",
      "case(incorporation-39, for-38)\n",
      "nmod:for(guidelines-37, incorporation-39)\n",
      "case(agents-42, of-40)\n",
      "det(agents-42, these-41)\n",
      "nmod:of(incorporation-39, agents-42)\n",
      "case(practice-45, into-43)\n",
      "amod(practice-45, clinical-44)\n",
      "nmod:into(provide-36, practice-45)\n",
      "\n",
      "Parsing [sent. 21 len. 19]: although effective via different mechanisms of action , both agents now have a prominent role in risk reduction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN although)\n",
      "      (S\n",
      "        (ADJP (JJ effective))\n",
      "        (PP (IN via)\n",
      "          (NP\n",
      "            (NP (JJ different) (NNS mechanisms))\n",
      "            (PP (IN of)\n",
      "              (NP (NN action)))))))\n",
      "    (, ,)\n",
      "    (NP (DT both) (NNS agents))\n",
      "    (ADVP (RB now))\n",
      "    (VP (VBP have)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prominent) (NN role))\n",
      "        (PP (IN in)\n",
      "          (NP (NN risk) (NN reduction)))))\n",
      "    (. .)))\n",
      "\n",
      "mark(effective-2, although-1)\n",
      "advcl(have-12, effective-2)\n",
      "case(mechanisms-5, via-3)\n",
      "amod(mechanisms-5, different-4)\n",
      "dep(effective-2, mechanisms-5)\n",
      "case(action-7, of-6)\n",
      "nmod:of(mechanisms-5, action-7)\n",
      "det(agents-10, both-9)\n",
      "nsubj(have-12, agents-10)\n",
      "advmod(have-12, now-11)\n",
      "root(ROOT-0, have-12)\n",
      "det(role-15, a-13)\n",
      "amod(role-15, prominent-14)\n",
      "dobj(have-12, role-15)\n",
      "case(reduction-18, in-16)\n",
      "compound(reduction-18, risk-17)\n",
      "nmod:in(role-15, reduction-18)\n",
      "\n",
      "Parsing [sent. 22 len. 20]: hf medical regimens often become quite complex , especially when associated with comorbid conditions , and require frequent follow-up .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ hf) (JJ medical) (NNS regimens))\n",
      "    (ADVP (RB often))\n",
      "    (VP\n",
      "      (VP (VBP become)\n",
      "        (NP (RB quite) (JJ complex))\n",
      "        (, ,)\n",
      "        (SBAR\n",
      "          (WHADVP (RB especially) (WRB when))\n",
      "          (S\n",
      "            (VP (JJ associated)\n",
      "              (PP (IN with)\n",
      "                (NP (JJ comorbid) (NNS conditions))))))\n",
      "        (, ,))\n",
      "      (CC and)\n",
      "      (VP (VBP require)\n",
      "        (NP (JJ frequent) (NN follow-up))))\n",
      "    (. .)))\n",
      "\n",
      "amod(regimens-3, hf-1)\n",
      "amod(regimens-3, medical-2)\n",
      "nsubj(become-5, regimens-3)\n",
      "nsubj(require-17, regimens-3)\n",
      "advmod(become-5, often-4)\n",
      "root(ROOT-0, become-5)\n",
      "advmod(complex-7, quite-6)\n",
      "xcomp(become-5, complex-7)\n",
      "advmod(when-10, especially-9)\n",
      "advmod(associated-11, when-10)\n",
      "advcl(become-5, associated-11)\n",
      "case(conditions-14, with-12)\n",
      "amod(conditions-14, comorbid-13)\n",
      "nmod:with(associated-11, conditions-14)\n",
      "cc(become-5, and-16)\n",
      "conj:and(become-5, require-17)\n",
      "amod(follow-up-19, frequent-18)\n",
      "dobj(require-17, follow-up-19)\n",
      "\n",
      "Parsing [sent. 23 len. 16]: providers must be proficient in patient monitoring , medication dose titration , and therapy optimization .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS providers))\n",
      "    (VP (MD must)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ proficient)\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (JJ patient) (NN monitoring))\n",
      "              (, ,)\n",
      "              (NP (NN medication) (NN dose) (NN titration))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NN therapy) (NN optimization)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(proficient-4, providers-1)\n",
      "aux(proficient-4, must-2)\n",
      "cop(proficient-4, be-3)\n",
      "root(ROOT-0, proficient-4)\n",
      "case(monitoring-7, in-5)\n",
      "amod(monitoring-7, patient-6)\n",
      "nmod:in(proficient-4, monitoring-7)\n",
      "compound(titration-11, medication-9)\n",
      "compound(titration-11, dose-10)\n",
      "nmod:in(proficient-4, titration-11)\n",
      "conj:and(monitoring-7, titration-11)\n",
      "cc(monitoring-7, and-13)\n",
      "compound(optimization-15, therapy-14)\n",
      "nmod:in(proficient-4, optimization-15)\n",
      "conj:and(monitoring-7, optimization-15)\n",
      "\n",
      "Parsing [sent. 24 len. 17]: individualized patient care strategies such as guideline-directed therapy can promote long-term adherence and quality of life .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ individualized) (JJ patient) (NN care) (NNS strategies))\n",
      "      (PP (JJ such) (IN as)\n",
      "        (NP (JJ guideline-directed) (NN therapy))))\n",
      "    (VP (MD can)\n",
      "      (VP (VB promote)\n",
      "        (NP\n",
      "          (NP (JJ long-term) (NN adherence)\n",
      "            (CC and)\n",
      "            (NN quality))\n",
      "          (PP (IN of)\n",
      "            (NP (NN life))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(strategies-4, individualized-1)\n",
      "amod(strategies-4, patient-2)\n",
      "compound(strategies-4, care-3)\n",
      "nsubj(promote-10, strategies-4)\n",
      "case(therapy-8, such-5)\n",
      "mwe(such-5, as-6)\n",
      "amod(therapy-8, guideline-directed-7)\n",
      "nmod:such_as(strategies-4, therapy-8)\n",
      "aux(promote-10, can-9)\n",
      "root(ROOT-0, promote-10)\n",
      "amod(adherence-12, long-term-11)\n",
      "dobj(promote-10, adherence-12)\n",
      "cc(adherence-12, and-13)\n",
      "dobj(promote-10, quality-14)\n",
      "conj:and(adherence-12, quality-14)\n",
      "case(life-16, of-15)\n",
      "nmod:of(adherence-12, life-16)\n",
      "\n",
      "Parsing [sent. 25 len. 43]: we included a group with no dd -LRB- n = 649 -RRB- , a group with grade 1 dd -LRB- n = 2875 -RRB- , and those with grades 2 and 3 -LRB- n = 1357 -RRB- who had normal ejection fraction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (DT a) (NN group))\n",
      "          (PP (IN with)\n",
      "            (NP (DT no) (NN dd))))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN n)\n",
      "            (S\n",
      "              (VP (SYM =)\n",
      "                (NP (CD 649)))))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT a) (NN group))\n",
      "          (PP (IN with)\n",
      "            (NP (NN grade) (CD 1) (NN dd))))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN n)\n",
      "            (S\n",
      "              (VP (SYM =)\n",
      "                (NP (CD 2875)))))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (NNS grades) (CD 2)\n",
      "                (CC and)\n",
      "                (CD 3))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 1357)))))\n",
      "                (-RRB- -RRB-))\n",
      "              (SBAR\n",
      "                (WHNP (WP who))\n",
      "                (S\n",
      "                  (VP (VBD had)\n",
      "                    (NP (JJ normal) (NN ejection) (NN fraction))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(included-2, we-1)\n",
      "root(ROOT-0, included-2)\n",
      "det(group-4, a-3)\n",
      "dobj(included-2, group-4)\n",
      "case(dd-7, with-5)\n",
      "neg(dd-7, no-6)\n",
      "nmod:with(group-4, dd-7)\n",
      "dep(group-4, n-9)\n",
      "dep(649-11, =-10)\n",
      "ccomp(n-9, 649-11)\n",
      "det(group-15, a-14)\n",
      "dobj(included-2, group-15)\n",
      "conj:and(group-4, group-15)\n",
      "case(dd-19, with-16)\n",
      "compound(dd-19, grade-17)\n",
      "nummod(dd-19, 1-18)\n",
      "nmod:with(group-15, dd-19)\n",
      "dep(group-4, n-21)\n",
      "dep(2875-23, =-22)\n",
      "ccomp(n-21, 2875-23)\n",
      "cc(group-4, and-26)\n",
      "dobj(included-2, those-27)\n",
      "conj:and(group-4, those-27)\n",
      "case(grades-29, with-28)\n",
      "nmod:with(those-27, grades-29)\n",
      "nsubj(had-39, grades-29)\n",
      "nummod(grades-29, 2-30)\n",
      "cc(grades-29, and-31)\n",
      "nmod:with(those-27, 3-32)\n",
      "conj:and(grades-29, 3-32)\n",
      "nsubj(had-39, 3-32)\n",
      "dep(grades-29, n-34)\n",
      "dep(1357-36, =-35)\n",
      "ccomp(n-34, 1357-36)\n",
      "ref(grades-29, who-38)\n",
      "acl:relcl(grades-29, had-39)\n",
      "amod(fraction-42, normal-40)\n",
      "compound(fraction-42, ejection-41)\n",
      "dobj(had-39, fraction-42)\n",
      "\n",
      "Parsing [sent. 26 len. 22]: the prevalence of grade 2 or 3 dd with preserved ejection fraction was 25 % ; 95 % ci : 24-26 .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT the) (NN prevalence))\n",
      "        (PP (IN of)\n",
      "          (NP (NN grade) (CD 2))))\n",
      "      (CC or)\n",
      "      (NP\n",
      "        (NP (CD 3) (NN dd))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ preserved) (NN ejection) (NN fraction)))))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (CD 25) (NN %))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (ADJP (CD 95) (NN %))\n",
      "            (NN ci)))\n",
      "        (: :)\n",
      "        (NP (CD 24-26))))\n",
      "    (. .)))\n",
      "\n",
      "det(prevalence-2, the-1)\n",
      "nsubj(%-15, prevalence-2)\n",
      "case(grade-4, of-3)\n",
      "nmod:of(prevalence-2, grade-4)\n",
      "nummod(grade-4, 2-5)\n",
      "cc(prevalence-2, or-6)\n",
      "nummod(dd-8, 3-7)\n",
      "conj:or(prevalence-2, dd-8)\n",
      "nsubj(%-15, dd-8)\n",
      "case(fraction-12, with-9)\n",
      "amod(fraction-12, preserved-10)\n",
      "compound(fraction-12, ejection-11)\n",
      "nmod:with(dd-8, fraction-12)\n",
      "cop(%-15, was-13)\n",
      "nummod(%-15, 25-14)\n",
      "root(ROOT-0, %-15)\n",
      "compound(%-18, 95-17)\n",
      "amod(ci-19, %-18)\n",
      "dep(%-15, ci-19)\n",
      "dep(%-15, 24-26-21)\n",
      "\n",
      "Parsing [sent. 27 len. 44]: the absolute change of ACEI-inhibitor use before and after the echocardiogram increased by 14 , 19 , 23 , 27 in patients without dd , those with grade 1 , grade 2 or 3 asymptomatic and grade 2 or 3 symptomatic , respectively .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (JJ absolute) (NN change))\n",
      "      (PP (IN of)\n",
      "        (NP (NNP ACEI-inhibitor))))\n",
      "    (VP (VBP use)\n",
      "      (SBAR (IN before)\n",
      "        (CC and)\n",
      "        (RB after)\n",
      "        (S\n",
      "          (NP (DT the) (NN echocardiogram))\n",
      "          (VP (VBD increased)\n",
      "            (PP (IN by)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (CD 14))\n",
      "                  (, ,)\n",
      "                  (NP (CD 19))\n",
      "                  (, ,)\n",
      "                  (NP (CD 23))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (CD 27))\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (NP (NNS patients))\n",
      "                        (PP (IN without)\n",
      "                          (NP (NN dd))))))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (DT those))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN grade) (CD 1)))))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN grade) (CD 2))\n",
      "                  (CC or)\n",
      "                  (NP (CD 3) (NN asymptomatic)))\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (NN grade) (CD 2))\n",
      "                  (CC or)\n",
      "                  (NP (CD 3) (NN symptomatic)))))\n",
      "            (, ,)\n",
      "            (ADVP (RB respectively))))))\n",
      "    (. .)))\n",
      "\n",
      "det(change-3, the-1)\n",
      "amod(change-3, absolute-2)\n",
      "nsubj(use-6, change-3)\n",
      "case(ACEI-inhibitor-5, of-4)\n",
      "nmod:of(change-3, ACEI-inhibitor-5)\n",
      "root(ROOT-0, use-6)\n",
      "mark(increased-12, before-7)\n",
      "cc(increased-12, and-8)\n",
      "advmod(increased-12, after-9)\n",
      "det(echocardiogram-11, the-10)\n",
      "nsubj(increased-12, echocardiogram-11)\n",
      "advcl(use-6, increased-12)\n",
      "case(14-14, by-13)\n",
      "nmod:by(increased-12, 14-14)\n",
      "amod(14-14, 19-16)\n",
      "amod(14-14, 23-18)\n",
      "appos(14-14, 27-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(27-20, patients-22)\n",
      "case(dd-24, without-23)\n",
      "nmod:without(patients-22, dd-24)\n",
      "appos(14-14, those-26)\n",
      "case(grade-28, with-27)\n",
      "nmod:with(those-26, grade-28)\n",
      "nummod(grade-28, 1-29)\n",
      "nmod:by(increased-12, grade-31)\n",
      "conj:and(14-14, grade-31)\n",
      "nummod(grade-31, 2-32)\n",
      "cc(grade-31, or-33)\n",
      "nummod(asymptomatic-35, 3-34)\n",
      "conj:and(14-14, asymptomatic-35)\n",
      "conj:or(grade-31, asymptomatic-35)\n",
      "cc(14-14, and-36)\n",
      "nmod:by(increased-12, grade-37)\n",
      "conj:and(14-14, grade-37)\n",
      "nummod(grade-37, 2-38)\n",
      "cc(grade-37, or-39)\n",
      "nummod(symptomatic-41, 3-40)\n",
      "conj:and(14-14, symptomatic-41)\n",
      "conj:or(grade-37, symptomatic-41)\n",
      "advmod(increased-12, respectively-43)\n",
      "\n",
      "Parsing [sent. 28 len. 13]: the use of Î²-blocker , statin , and diuretic had similar trends .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN Î²-blocker))\n",
      "          (, ,)\n",
      "          (NP (NN statin))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP (NN diuretic)))))\n",
      "    (VP (VBD had)\n",
      "      (NP (JJ similar) (NNS trends)))\n",
      "    (. .)))\n",
      "\n",
      "det(use-2, the-1)\n",
      "nsubj(had-10, use-2)\n",
      "case(Î²-blocker-4, of-3)\n",
      "nmod:of(use-2, Î²-blocker-4)\n",
      "nmod:of(use-2, statin-6)\n",
      "conj:and(Î²-blocker-4, statin-6)\n",
      "cc(Î²-blocker-4, and-8)\n",
      "nmod:of(use-2, diuretic-9)\n",
      "conj:and(Î²-blocker-4, diuretic-9)\n",
      "root(ROOT-0, had-10)\n",
      "amod(trends-12, similar-11)\n",
      "dobj(had-10, trends-12)\n",
      "\n",
      "Parsing [sent. 29 len. 15]: a total of 514 patients -LRB- 340 females -RRB- aged 22-97 years were studied .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT a) (NN total))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (CD 514) (NNS patients))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD 340) (NNS females))\n",
      "            (-RRB- -RRB-))\n",
      "          (VP (VBN aged)\n",
      "            (NP (CD 22-97) (NNS years))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN studied)))\n",
      "    (. .)))\n",
      "\n",
      "det(total-2, a-1)\n",
      "nsubjpass(studied-14, total-2)\n",
      "case(patients-5, of-3)\n",
      "nummod(patients-5, 514-4)\n",
      "nmod:of(total-2, patients-5)\n",
      "nummod(females-8, 340-7)\n",
      "appos(patients-5, females-8)\n",
      "acl(patients-5, aged-10)\n",
      "nummod(years-12, 22-97-11)\n",
      "nmod:tmod(aged-10, years-12)\n",
      "auxpass(studied-14, were-13)\n",
      "root(ROOT-0, studied-14)\n",
      "\n",
      "Parsing [sent. 30 len. 51]: thirteen percent , 27.6 % , 26.7 % , 22.0 % , and 10.7 % were on 1 , 2 , 3 , 4 , and â¥ 5 medicines , respectively , for control of their blood pressure with the frequency of adverse effects increasing proportionately up to four medicines .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN thirteen) (NN percent))\n",
      "      (, ,)\n",
      "      (NP (CD 27.6) (NN %))\n",
      "      (, ,)\n",
      "      (NP (CD 26.7) (NN %))\n",
      "      (, ,)\n",
      "      (NP (CD 22.0) (NN %))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (CD 10.7) (NN %)))\n",
      "    (VP (VBD were)\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (CD 1))\n",
      "          (, ,)\n",
      "          (NP (CD 2))\n",
      "          (, ,)\n",
      "          (NP (CD 3))\n",
      "          (, ,)\n",
      "          (NP (CD 4))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (QP (CD â¥) (CD 5))\n",
      "            (NNS medicines))))\n",
      "      (, ,)\n",
      "      (ADVP (RB respectively))\n",
      "      (, ,)\n",
      "      (PP (IN for)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (NN control))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (PRP$ their) (NN blood) (NN pressure))\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN frequency))\n",
      "                    (PP (IN of)\n",
      "                      (NP (JJ adverse) (NNS effects))))))))\n",
      "          (VP (VBG increasing)\n",
      "            (NP (NN proportionately))\n",
      "            (PRT (RP up))\n",
      "            (PP (TO to)\n",
      "              (NP (CD four) (NNS medicines)))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(percent-2, thirteen-1)\n",
      "nsubj(1-18, percent-2)\n",
      "nummod(%-5, 27.6-4)\n",
      "conj:and(percent-2, %-5)\n",
      "nsubj(1-18, %-5)\n",
      "nummod(%-8, 26.7-7)\n",
      "conj:and(percent-2, %-8)\n",
      "nsubj(1-18, %-8)\n",
      "nummod(%-11, 22.0-10)\n",
      "conj:and(percent-2, %-11)\n",
      "nsubj(1-18, %-11)\n",
      "cc(percent-2, and-13)\n",
      "nummod(%-15, 10.7-14)\n",
      "conj:and(percent-2, %-15)\n",
      "nsubj(1-18, %-15)\n",
      "cop(1-18, were-16)\n",
      "case(1-18, on-17)\n",
      "root(ROOT-0, 1-18)\n",
      "conj:and(1-18, 2-20)\n",
      "conj:and(1-18, 3-22)\n",
      "conj:and(1-18, 4-24)\n",
      "cc(1-18, and-26)\n",
      "compound(5-28, â¥-27)\n",
      "nummod(medicines-29, 5-28)\n",
      "conj:and(1-18, medicines-29)\n",
      "advmod(1-18, respectively-31)\n",
      "mark(increasing-45, for-33)\n",
      "nsubj(increasing-45, control-34)\n",
      "case(pressure-38, of-35)\n",
      "nmod:poss(pressure-38, their-36)\n",
      "compound(pressure-38, blood-37)\n",
      "nmod:of(control-34, pressure-38)\n",
      "case(frequency-41, with-39)\n",
      "det(frequency-41, the-40)\n",
      "nmod:with(pressure-38, frequency-41)\n",
      "case(effects-44, of-42)\n",
      "amod(effects-44, adverse-43)\n",
      "nmod:of(frequency-41, effects-44)\n",
      "advcl(1-18, increasing-45)\n",
      "dobj(increasing-45, proportionately-46)\n",
      "compound:prt(increasing-45, up-47)\n",
      "case(medicines-50, to-48)\n",
      "nummod(medicines-50, four-49)\n",
      "nmod:to(increasing-45, medicines-50)\n",
      "\n",
      "Parsing [sent. 31 len. 18]: adverse reactions to antihypertensive medicines were reported by a total of 93 -LRB- 18.1 % -RRB- patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ adverse) (NNS reactions))\n",
      "      (PP (TO to)\n",
      "        (NP (JJ antihypertensive) (NNS medicines))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN reported)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (DT a) (NN total))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ 93)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (QP (CD 18.1) (NN %)))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS patients)))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(reactions-2, adverse-1)\n",
      "nsubjpass(reported-7, reactions-2)\n",
      "case(medicines-5, to-3)\n",
      "amod(medicines-5, antihypertensive-4)\n",
      "nmod:to(reactions-2, medicines-5)\n",
      "auxpass(reported-7, were-6)\n",
      "root(ROOT-0, reported-7)\n",
      "case(total-10, by-8)\n",
      "det(total-10, a-9)\n",
      "nmod:by(reported-7, total-10)\n",
      "case(patients-17, of-11)\n",
      "amod(patients-17, 93-12)\n",
      "compound(%-15, 18.1-14)\n",
      "dep(patients-17, %-15)\n",
      "nmod:of(total-10, patients-17)\n",
      "\n",
      "Parsing [sent. 32 len. 53]: diuretics - 27.9 % , calcium channel blockers -LRB- ccbs -RRB- - 26.8 % , and ACEI - 26.8 % accounted for most of the adverse reactions seen , notably frequent micturition and headaches -LRB- ccb -RRB- ; excessive micturition and dizziness -LRB- diuretics -RRB- ; dry irritating cough -LRB- ACEI -RRB- .\n",
      "(ROOT\n",
      "  (NP\n",
      "    (NP (NNS diuretics))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 27.9) (NN %))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBZ ccbs))\n",
      "          (-RRB- -RRB-))))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 26.8) (NN %))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NNP ACEI)))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 26.8) (NN %))\n",
      "      (VP (VBN accounted)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (JJS most))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT the) (JJ adverse) (NNS reactions))\n",
      "                        (VP (VBN seen)))\n",
      "                      (, ,)\n",
      "                      (ADVP (RB notably))\n",
      "                      (NP\n",
      "                        (NP (JJ frequent) (NN micturition)\n",
      "                          (CC and)\n",
      "                          (NNS headaches))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NN ccb))\n",
      "                          (-RRB- -RRB-))))))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP (JJ excessive) (NN micturition))\n",
      "                  (CC and)\n",
      "                  (NP (NN dizziness))))\n",
      "              (-LRB- -LRB-)\n",
      "              (NP (NNS diuretics))\n",
      "              (-RRB- -RRB-))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (JJ dry) (VBG irritating) (NN cough))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP ACEI))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, diuretics-1)\n",
      "nummod(%-4, 27.9-3)\n",
      "dep(diuretics-1, %-4)\n",
      "compound(blockers-8, calcium-6)\n",
      "compound(blockers-8, channel-7)\n",
      "appos(%-4, blockers-8)\n",
      "dep(blockers-8, ccbs-10)\n",
      "nummod(%-14, 26.8-13)\n",
      "dep(diuretics-1, %-14)\n",
      "cc(%-14, and-16)\n",
      "dep(diuretics-1, ACEI-17)\n",
      "conj:and(%-14, ACEI-17)\n",
      "nummod(%-20, 26.8-19)\n",
      "dep(diuretics-1, %-20)\n",
      "acl(%-20, accounted-21)\n",
      "case(most-23, for-22)\n",
      "nmod:for(accounted-21, most-23)\n",
      "case(reactions-27, of-24)\n",
      "det(reactions-27, the-25)\n",
      "amod(reactions-27, adverse-26)\n",
      "nmod:of(most-23, reactions-27)\n",
      "acl(reactions-27, seen-28)\n",
      "advmod(micturition-32, notably-30)\n",
      "amod(micturition-32, frequent-31)\n",
      "appos(reactions-27, micturition-32)\n",
      "cc(micturition-32, and-33)\n",
      "appos(reactions-27, headaches-34)\n",
      "conj:and(micturition-32, headaches-34)\n",
      "appos(micturition-32, ccb-36)\n",
      "amod(micturition-40, excessive-39)\n",
      "dep(most-23, micturition-40)\n",
      "cc(micturition-40, and-41)\n",
      "dep(most-23, dizziness-42)\n",
      "conj:and(micturition-40, dizziness-42)\n",
      "dep(most-23, diuretics-44)\n",
      "amod(cough-49, dry-47)\n",
      "amod(cough-49, irritating-48)\n",
      "dep(most-23, cough-49)\n",
      "appos(cough-49, ACEI-51)\n",
      "\n",
      "Parsing [sent. 33 len. 21]: notable complaints for all patients using the checklist were increased frequency of micturition , reduction in libido , and headaches .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ notable) (NNS complaints))\n",
      "      (PP (IN for)\n",
      "        (NP\n",
      "          (NP (DT all) (NNS patients))\n",
      "          (VP (VBG using)\n",
      "            (NP (DT the) (NN checklist))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN increased)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NN frequency))\n",
      "            (PP (IN of)\n",
      "              (NP (NN micturition))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (NN reduction))\n",
      "            (PP (IN in)\n",
      "              (NP (NN libido))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP (NNS headaches)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(complaints-2, notable-1)\n",
      "nsubjpass(increased-10, complaints-2)\n",
      "case(patients-5, for-3)\n",
      "det(patients-5, all-4)\n",
      "nmod:for(complaints-2, patients-5)\n",
      "acl(patients-5, using-6)\n",
      "det(checklist-8, the-7)\n",
      "dobj(using-6, checklist-8)\n",
      "auxpass(increased-10, were-9)\n",
      "root(ROOT-0, increased-10)\n",
      "dobj(increased-10, frequency-11)\n",
      "case(micturition-13, of-12)\n",
      "nmod:of(frequency-11, micturition-13)\n",
      "dobj(increased-10, reduction-15)\n",
      "conj:and(frequency-11, reduction-15)\n",
      "case(libido-17, in-16)\n",
      "nmod:in(reduction-15, libido-17)\n",
      "cc(frequency-11, and-19)\n",
      "dobj(increased-10, headaches-20)\n",
      "conj:and(frequency-11, headaches-20)\n",
      "\n",
      "Parsing [sent. 34 len. 17]: the reactions resulted in the discontinuation and substitution of therapy in 49.5 % of the patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNS reactions))\n",
      "    (VP (VBD resulted)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the) (NN discontinuation)\n",
      "            (CC and)\n",
      "            (NN substitution))\n",
      "          (PP (IN of)\n",
      "            (NP (NN therapy)))))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (CD 49.5) (NN %))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NNS patients))))))\n",
      "    (. .)))\n",
      "\n",
      "det(reactions-2, the-1)\n",
      "nsubj(resulted-3, reactions-2)\n",
      "root(ROOT-0, resulted-3)\n",
      "case(discontinuation-6, in-4)\n",
      "det(discontinuation-6, the-5)\n",
      "nmod:in(resulted-3, discontinuation-6)\n",
      "cc(discontinuation-6, and-7)\n",
      "nmod:in(resulted-3, substitution-8)\n",
      "conj:and(discontinuation-6, substitution-8)\n",
      "case(therapy-10, of-9)\n",
      "nmod:of(discontinuation-6, therapy-10)\n",
      "case(%-13, in-11)\n",
      "nummod(%-13, 49.5-12)\n",
      "nmod:in(resulted-3, %-13)\n",
      "case(patients-16, of-14)\n",
      "det(patients-16, the-15)\n",
      "nmod:of(%-13, patients-16)\n",
      "\n",
      "Parsing [sent. 35 len. 28]: in clinical setting , congestive heart failure -LRB- chf -RRB- and chronic kidney disease -LRB- ckd -RRB- often co-exist in patients due to common underlying predisposing factors .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (JJ clinical) (NN setting)))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (JJ congestive) (NN heart) (NN failure))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN chf))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (JJ chronic) (NN kidney) (NN disease)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN ckd))\n",
      "        (-RRB- -RRB-)))\n",
      "    (ADVP (RB often))\n",
      "    (VP (VB co-exist)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (ADJP (JJ due)\n",
      "            (PP (TO to)\n",
      "              (NP (JJ common) (JJ underlying) (NN predisposing) (NNS factors)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(setting-3, in-1)\n",
      "amod(setting-3, clinical-2)\n",
      "nmod:in(co-exist-19, setting-3)\n",
      "amod(failure-7, congestive-5)\n",
      "compound(failure-7, heart-6)\n",
      "nsubj(co-exist-19, failure-7)\n",
      "appos(failure-7, chf-9)\n",
      "cc(failure-7, and-11)\n",
      "amod(disease-14, chronic-12)\n",
      "compound(disease-14, kidney-13)\n",
      "conj:and(failure-7, disease-14)\n",
      "nsubj(co-exist-19, disease-14)\n",
      "appos(failure-7, ckd-16)\n",
      "advmod(co-exist-19, often-18)\n",
      "root(ROOT-0, co-exist-19)\n",
      "case(patients-21, in-20)\n",
      "nmod:in(co-exist-19, patients-21)\n",
      "amod(patients-21, due-22)\n",
      "case(factors-27, to-23)\n",
      "amod(factors-27, common-24)\n",
      "amod(factors-27, underlying-25)\n",
      "compound(factors-27, predisposing-26)\n",
      "nmod:to(due-22, factors-27)\n",
      "\n",
      "Parsing [sent. 36 len. 20]: an intricate equilibrium between the cardiovascular and renal system is maintained through rennin angiotensin-aldosterone axis and autonomic nervous system .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT an) (JJ intricate) (NN equilibrium))\n",
      "      (PP (IN between)\n",
      "        (NP (DT the) (JJ cardiovascular)\n",
      "          (CC and)\n",
      "          (JJ renal) (NN system))))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN maintained)\n",
      "        (PP (IN through)\n",
      "          (NP\n",
      "            (NP (JJ rennin) (JJ angiotensin-aldosterone) (NNS axis))\n",
      "            (CC and)\n",
      "            (NP (JJ autonomic) (JJ nervous) (NN system))))))\n",
      "    (. .)))\n",
      "\n",
      "det(equilibrium-3, an-1)\n",
      "amod(equilibrium-3, intricate-2)\n",
      "nsubjpass(maintained-11, equilibrium-3)\n",
      "case(system-9, between-4)\n",
      "det(system-9, the-5)\n",
      "amod(system-9, cardiovascular-6)\n",
      "cc(cardiovascular-6, and-7)\n",
      "conj:and(cardiovascular-6, renal-8)\n",
      "amod(system-9, renal-8)\n",
      "nmod:between(equilibrium-3, system-9)\n",
      "auxpass(maintained-11, is-10)\n",
      "root(ROOT-0, maintained-11)\n",
      "case(axis-15, through-12)\n",
      "amod(axis-15, rennin-13)\n",
      "amod(axis-15, angiotensin-aldosterone-14)\n",
      "nmod:through(maintained-11, axis-15)\n",
      "cc(axis-15, and-16)\n",
      "amod(system-19, autonomic-17)\n",
      "amod(system-19, nervous-18)\n",
      "nmod:through(maintained-11, system-19)\n",
      "conj:and(axis-15, system-19)\n",
      "\n",
      "Parsing [sent. 37 len. 32]: consequent to favorable hemodynamic modification , ACEI and angiotensin receptor blocking -LRB- arb -RRB- therapy have proven to be an indispensable aspect of heart failure management with morbidity and mortality benefit .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (JJ consequent)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (JJ favorable) (JJ hemodynamic) (NN modification))\n",
      "            (, ,)\n",
      "            (NP (NNP ACEI))\n",
      "            (CC and)\n",
      "            (NP (NN angiotensin)))))\n",
      "      (JJ receptor) (FW blocking)\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN arb))\n",
      "        (-RRB- -RRB-))\n",
      "      (NN therapy))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN proven)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ indispensable) (NN aspect))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NN heart) (NN failure) (NN management))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN morbidity)\n",
      "                        (CC and)\n",
      "                        (NN mortality) (NN benefit)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-15, consequent-1)\n",
      "case(modification-5, to-2)\n",
      "amod(modification-5, favorable-3)\n",
      "amod(modification-5, hemodynamic-4)\n",
      "nmod:to(consequent-1, modification-5)\n",
      "nmod:to(consequent-1, ACEI-7)\n",
      "conj:and(modification-5, ACEI-7)\n",
      "cc(modification-5, and-8)\n",
      "nmod:to(consequent-1, angiotensin-9)\n",
      "conj:and(modification-5, angiotensin-9)\n",
      "amod(therapy-15, receptor-10)\n",
      "compound(therapy-15, blocking-11)\n",
      "appos(therapy-15, arb-13)\n",
      "nsubj(proven-17, therapy-15)\n",
      "nsubj:xsubj(aspect-22, therapy-15)\n",
      "aux(proven-17, have-16)\n",
      "root(ROOT-0, proven-17)\n",
      "mark(aspect-22, to-18)\n",
      "cop(aspect-22, be-19)\n",
      "det(aspect-22, an-20)\n",
      "amod(aspect-22, indispensable-21)\n",
      "xcomp(proven-17, aspect-22)\n",
      "case(management-26, of-23)\n",
      "compound(management-26, heart-24)\n",
      "compound(management-26, failure-25)\n",
      "nmod:of(aspect-22, management-26)\n",
      "case(benefit-31, with-27)\n",
      "compound(benefit-31, morbidity-28)\n",
      "cc(morbidity-28, and-29)\n",
      "conj:and(morbidity-28, mortality-30)\n",
      "compound(benefit-31, mortality-30)\n",
      "nmod:with(management-26, benefit-31)\n",
      "\n",
      "Parsing [sent. 38 len. 27]: additionally , progression to end stage renal failure may be halted by renin angiotensin aldosterone system -LRB- raas -RRB- blockade in patients with preexisting renal dysfunction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB additionally))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN progression))\n",
      "      (PP (TO to)\n",
      "        (NP (NN end) (NN stage) (JJ renal) (NN failure))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN halted)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (JJ renin)\n",
      "                (ADJP (RB angiotensin) (JJ aldosterone))\n",
      "                (NN system)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNS raas))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NN blockade))\n",
      "              (PP (IN in)\n",
      "                (NP (NNS patients)))))\n",
      "          (PP (IN with)\n",
      "            (S\n",
      "              (VP (VBG preexisting)\n",
      "                (NP (JJ renal) (NN dysfunction))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(halted-11, additionally-1)\n",
      "nsubjpass(halted-11, progression-3)\n",
      "case(failure-8, to-4)\n",
      "compound(failure-8, end-5)\n",
      "compound(failure-8, stage-6)\n",
      "amod(failure-8, renal-7)\n",
      "nmod:to(progression-3, failure-8)\n",
      "aux(halted-11, may-9)\n",
      "auxpass(halted-11, be-10)\n",
      "root(ROOT-0, halted-11)\n",
      "case(blockade-20, by-12)\n",
      "amod(blockade-20, renin-13)\n",
      "advmod(aldosterone-15, angiotensin-14)\n",
      "amod(blockade-20, aldosterone-15)\n",
      "compound(blockade-20, system-16)\n",
      "appos(blockade-20, raas-18)\n",
      "nmod:by(halted-11, blockade-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(blockade-20, patients-22)\n",
      "mark(preexisting-24, with-23)\n",
      "advcl(halted-11, preexisting-24)\n",
      "amod(dysfunction-26, renal-25)\n",
      "dobj(preexisting-24, dysfunction-26)\n",
      "\n",
      "Parsing [sent. 39 len. 29]: however , concern over the safety of raas blockade in presence of renal impairment has led to profound underutilization of these drugs in chf patients with renal insufficiency .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN concern))\n",
      "      (PP (IN over)\n",
      "        (NP\n",
      "          (NP (DT the) (NN safety))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ raas) (NN blockade))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NN presence))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ renal) (NN impairment))))))))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN led)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (JJ profound) (NN underutilization))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT these) (NNS drugs))\n",
      "                (PP (IN in)\n",
      "                  (NP (NN chf) (NNS patients)))))))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ renal) (NN insufficiency)))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(led-16, however-1)\n",
      "nsubj(led-16, concern-3)\n",
      "case(safety-6, over-4)\n",
      "det(safety-6, the-5)\n",
      "nmod:over(concern-3, safety-6)\n",
      "case(blockade-9, of-7)\n",
      "amod(blockade-9, raas-8)\n",
      "nmod:of(safety-6, blockade-9)\n",
      "case(presence-11, in-10)\n",
      "nmod:in(blockade-9, presence-11)\n",
      "case(impairment-14, of-12)\n",
      "amod(impairment-14, renal-13)\n",
      "nmod:of(presence-11, impairment-14)\n",
      "aux(led-16, has-15)\n",
      "root(ROOT-0, led-16)\n",
      "case(underutilization-19, to-17)\n",
      "amod(underutilization-19, profound-18)\n",
      "nmod:to(led-16, underutilization-19)\n",
      "case(drugs-22, of-20)\n",
      "det(drugs-22, these-21)\n",
      "nmod:of(underutilization-19, drugs-22)\n",
      "case(patients-25, in-23)\n",
      "compound(patients-25, chf-24)\n",
      "nmod:in(drugs-22, patients-25)\n",
      "case(insufficiency-28, with-26)\n",
      "amod(insufficiency-28, renal-27)\n",
      "nmod:with(led-16, insufficiency-28)\n",
      "\n",
      "Parsing [sent. 40 len. 18]: this review aims to provide a simplified guide to pathophysiology and management options of this perplexing situation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN review))\n",
      "    (VP (VBZ aims)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB provide)\n",
      "            (NP (DT a) (VBN simplified) (NN guide))\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN pathophysiology)\n",
      "                  (CC and)\n",
      "                  (NN management) (NNS options))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT this) (JJ perplexing) (NN situation)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(review-2, this-1)\n",
      "nsubj(aims-3, review-2)\n",
      "nsubj:xsubj(provide-5, review-2)\n",
      "root(ROOT-0, aims-3)\n",
      "mark(provide-5, to-4)\n",
      "xcomp(aims-3, provide-5)\n",
      "det(guide-8, a-6)\n",
      "amod(guide-8, simplified-7)\n",
      "dobj(provide-5, guide-8)\n",
      "case(options-13, to-9)\n",
      "compound(options-13, pathophysiology-10)\n",
      "cc(pathophysiology-10, and-11)\n",
      "conj:and(pathophysiology-10, management-12)\n",
      "compound(options-13, management-12)\n",
      "nmod:to(provide-5, options-13)\n",
      "case(situation-17, of-14)\n",
      "det(situation-17, this-15)\n",
      "amod(situation-17, perplexing-16)\n",
      "nmod:of(options-13, situation-17)\n",
      "\n",
      "Parsing [sent. 41 len. 19]: dihydropyridine calcium channel blockers may possess antioxidant properties , and might improve micro and macrovascular structure and function .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ dihydropyridine) (NN calcium) (NN channel) (NNS blockers))\n",
      "    (VP\n",
      "      (VP (MD may)\n",
      "        (VP (VB possess)\n",
      "          (NP (JJ antioxidant) (NNS properties))))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (VP (MD might)\n",
      "        (VP (VB improve)\n",
      "          (NP (JJ micro)\n",
      "            (CC and)\n",
      "            (NN macrovascular) (NN structure)\n",
      "            (CC and)\n",
      "            (NN function)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(blockers-4, dihydropyridine-1)\n",
      "compound(blockers-4, calcium-2)\n",
      "compound(blockers-4, channel-3)\n",
      "nsubj(possess-6, blockers-4)\n",
      "nsubj(improve-12, blockers-4)\n",
      "aux(possess-6, may-5)\n",
      "root(ROOT-0, possess-6)\n",
      "amod(properties-8, antioxidant-7)\n",
      "dobj(possess-6, properties-8)\n",
      "cc(possess-6, and-10)\n",
      "aux(improve-12, might-11)\n",
      "conj:and(possess-6, improve-12)\n",
      "amod(structure-16, micro-13)\n",
      "cc(micro-13, and-14)\n",
      "conj:and(micro-13, macrovascular-15)\n",
      "amod(structure-16, macrovascular-15)\n",
      "dobj(improve-12, structure-16)\n",
      "cc(structure-16, and-17)\n",
      "dobj(improve-12, function-18)\n",
      "conj:and(structure-16, function-18)\n",
      "\n",
      "Parsing [sent. 42 len. 16]: combination treatment with an ACEI may have additional advantages , compared with a thiazide diuretic .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN combination) (NN treatment))\n",
      "      (PP (IN with)\n",
      "        (NP (DT an) (NNP ACEI))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB have)\n",
      "        (NP (JJ additional) (NNS advantages))\n",
      "        (, ,)\n",
      "        (PP (VBN compared)\n",
      "          (PP (IN with)\n",
      "            (NP (DT a) (JJ thiazide) (NN diuretic))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(treatment-2, combination-1)\n",
      "nsubj(have-7, treatment-2)\n",
      "case(ACEI-5, with-3)\n",
      "det(ACEI-5, an-4)\n",
      "nmod:with(treatment-2, ACEI-5)\n",
      "aux(have-7, may-6)\n",
      "root(ROOT-0, have-7)\n",
      "amod(advantages-9, additional-8)\n",
      "dobj(have-7, advantages-9)\n",
      "case(diuretic-15, compared-11)\n",
      "mwe(compared-11, with-12)\n",
      "det(diuretic-15, a-13)\n",
      "amod(diuretic-15, thiazide-14)\n",
      "advcl(have-7, diuretic-15)\n",
      "\n",
      "Parsing [sent. 43 len. 49]: the aim of the present study is to investigate the effects of a short-term treatment with lercanidipine , and to compare two combination treatments : lercanidipine + enalapril vs. lercanidipine + hydrochlorothiazide on structural alterations in retinal arterioles , on skin capillary density and on large artery distensibility .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN aim))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ present) (NN study))))\n",
      "    (VP (VBZ is)\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (TO to)\n",
      "            (VP (VB investigate)\n",
      "              (NP\n",
      "                (NP (DT the) (NNS effects))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT a) (JJ short-term) (NN treatment))))\n",
      "              (PP (IN with)\n",
      "                (NP (NN lercanidipine)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (VP (TO to)\n",
      "            (VP (VB compare)\n",
      "              (NP\n",
      "                (NP (CD two) (NN combination) (NNS treatments))\n",
      "                (: :)\n",
      "                (NP\n",
      "                  (NP (JJ lercanidipine) (JJ +) (NN enalapril))\n",
      "                  (PP (IN vs.)\n",
      "                    (NP\n",
      "                      (NP (JJ lercanidipine) (JJ +) (NN hydrochlorothiazide))\n",
      "                      (PP (IN on)\n",
      "                        (NP\n",
      "                          (NP (JJ structural) (NNS alterations))\n",
      "                          (PP (IN in)\n",
      "                            (NP (JJ retinal) (NNS arterioles))))))))\n",
      "                (, ,))\n",
      "              (PP\n",
      "                (PP (IN on)\n",
      "                  (NP (NN skin) (NN capillary) (NN density)))\n",
      "                (CC and)\n",
      "                (PP (IN on)\n",
      "                  (NP (JJ large) (NN artery) (NN distensibility)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(aim-2, the-1)\n",
      "nsubj(is-7, aim-2)\n",
      "case(study-6, of-3)\n",
      "det(study-6, the-4)\n",
      "amod(study-6, present-5)\n",
      "nmod:of(aim-2, study-6)\n",
      "root(ROOT-0, is-7)\n",
      "mark(investigate-9, to-8)\n",
      "ccomp(is-7, investigate-9)\n",
      "det(effects-11, the-10)\n",
      "dobj(investigate-9, effects-11)\n",
      "case(treatment-15, of-12)\n",
      "det(treatment-15, a-13)\n",
      "amod(treatment-15, short-term-14)\n",
      "nmod:of(effects-11, treatment-15)\n",
      "case(lercanidipine-17, with-16)\n",
      "nmod:with(investigate-9, lercanidipine-17)\n",
      "cc(investigate-9, and-19)\n",
      "mark(compare-21, to-20)\n",
      "ccomp(is-7, compare-21)\n",
      "conj:and(investigate-9, compare-21)\n",
      "conj:and(investigate-9, compare-21')\n",
      "conj:and(compare-21, compare-21')\n",
      "nummod(treatments-24, two-22)\n",
      "compound(treatments-24, combination-23)\n",
      "dobj(compare-21, treatments-24)\n",
      "amod(enalapril-28, lercanidipine-26)\n",
      "amod(enalapril-28, +-27)\n",
      "dep(treatments-24, enalapril-28)\n",
      "case(hydrochlorothiazide-32, vs.-29)\n",
      "amod(hydrochlorothiazide-32, lercanidipine-30)\n",
      "amod(hydrochlorothiazide-32, +-31)\n",
      "nmod:vs.(enalapril-28, hydrochlorothiazide-32)\n",
      "case(alterations-35, on-33)\n",
      "amod(alterations-35, structural-34)\n",
      "nmod:on(hydrochlorothiazide-32, alterations-35)\n",
      "case(arterioles-38, in-36)\n",
      "amod(arterioles-38, retinal-37)\n",
      "nmod:in(alterations-35, arterioles-38)\n",
      "case(density-43, on-40)\n",
      "compound(density-43, skin-41)\n",
      "compound(density-43, capillary-42)\n",
      "nmod:on(compare-21, density-43)\n",
      "cc(compare-21, and-44)\n",
      "case(distensibility-48, on-45)\n",
      "amod(distensibility-48, large-46)\n",
      "compound(distensibility-48, artery-47)\n",
      "nmod:on(compare-21', distensibility-48)\n",
      "\n",
      "Parsing [sent. 44 len. 23]: thirty essential hypertension patients are included in the study , and treated for 4 weeks with lercanidipine 20 mg per day orally .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (CD thirty) (JJ essential))\n",
      "      (NN hypertension) (NNS patients))\n",
      "    (VP (VBP are)\n",
      "      (VP\n",
      "        (VP (VBN included)\n",
      "          (PP (IN in)\n",
      "            (NP (DT the) (NN study))))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (VP (VBN treated)\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (CD 4) (NNS weeks))\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (ADJP (JJ lercanidipine)\n",
      "                      (NP (CD 20)))\n",
      "                    (NN mg))\n",
      "                  (PP (IN per)\n",
      "                    (NP (NN day) (NN orally))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(essential-2, thirty-1)\n",
      "amod(patients-4, essential-2)\n",
      "compound(patients-4, hypertension-3)\n",
      "nsubjpass(included-6, patients-4)\n",
      "nsubjpass(treated-12, patients-4)\n",
      "auxpass(included-6, are-5)\n",
      "root(ROOT-0, included-6)\n",
      "case(study-9, in-7)\n",
      "det(study-9, the-8)\n",
      "nmod:in(included-6, study-9)\n",
      "cc(included-6, and-11)\n",
      "conj:and(included-6, treated-12)\n",
      "case(weeks-15, for-13)\n",
      "nummod(weeks-15, 4-14)\n",
      "nmod:for(treated-12, weeks-15)\n",
      "case(mg-19, with-16)\n",
      "amod(mg-19, lercanidipine-17)\n",
      "dep(lercanidipine-17, 20-18)\n",
      "nmod:with(weeks-15, mg-19)\n",
      "case(orally-22, per-20)\n",
      "compound(orally-22, day-21)\n",
      "nmod:per(mg-19, orally-22)\n",
      "\n",
      "Parsing [sent. 45 len. 28]: then , they were treated for 6 months with lercanidipine + enalapril -LRB- n = 15 -RRB- or lercanidipine + hydrochlorothiazide -LRB- n = 15 -RRB- combinations .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB then))\n",
      "    (, ,)\n",
      "    (NP (PRP they))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN treated)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (CD 6) (NNS months))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ lercanidipine) (JJ +) (NN enalapril))))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 15)))))\n",
      "              (-RRB- -RRB-))\n",
      "            (CC or)\n",
      "            (NP\n",
      "              (ADJP (JJ lercanidipine) (JJ +))\n",
      "              (JJ hydrochlorothiazide)\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 15)))))\n",
      "                (-RRB- -RRB-))\n",
      "              (NN combinations))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(treated-5, then-1)\n",
      "nsubjpass(treated-5, they-3)\n",
      "auxpass(treated-5, were-4)\n",
      "root(ROOT-0, treated-5)\n",
      "case(months-8, for-6)\n",
      "nummod(months-8, 6-7)\n",
      "nmod:for(treated-5, months-8)\n",
      "case(enalapril-12, with-9)\n",
      "amod(enalapril-12, lercanidipine-10)\n",
      "amod(enalapril-12, +-11)\n",
      "nmod:with(months-8, enalapril-12)\n",
      "dep(months-8, n-14)\n",
      "dep(15-16, =-15)\n",
      "ccomp(n-14, 15-16)\n",
      "cc(months-8, or-18)\n",
      "amod(+-20, lercanidipine-19)\n",
      "amod(combinations-27, +-20)\n",
      "amod(combinations-27, hydrochlorothiazide-21)\n",
      "dep(combinations-27, n-23)\n",
      "dep(15-25, =-24)\n",
      "ccomp(n-23, 15-25)\n",
      "nmod:for(treated-5, combinations-27)\n",
      "conj:or(months-8, combinations-27)\n",
      "\n",
      "Parsing [sent. 46 len. 32]: investigations were performed on basal condition , after appropriate wash out of previous treatments , after 4 weeks of lercanidipine monotherapy treatment , and at the end of the combination treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS investigations))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN performed)\n",
      "        (PP\n",
      "          (PP (IN on)\n",
      "            (NP (JJ basal) (NN condition)))\n",
      "          (, ,)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (JJ appropriate) (NN wash))\n",
      "              (PP (RB out) (IN of)\n",
      "                (NP (JJ previous) (NNS treatments)))))\n",
      "          (, ,)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (CD 4) (NNS weeks))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ lercanidipine) (JJ monotherapy) (NN treatment)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (PP (IN at)\n",
      "            (NP\n",
      "              (NP (DT the) (NN end))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN combination) (NN treatment))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(performed-3, investigations-1)\n",
      "nsubjpass(performed-3', investigations-1)\n",
      "nsubjpass(performed-3'', investigations-1)\n",
      "nsubjpass(performed-3''', investigations-1)\n",
      "auxpass(performed-3, were-2)\n",
      "root(ROOT-0, performed-3)\n",
      "conj:and(performed-3, performed-3')\n",
      "conj:and(performed-3, performed-3'')\n",
      "conj:and(performed-3, performed-3''')\n",
      "case(condition-6, on-4)\n",
      "amod(condition-6, basal-5)\n",
      "nmod:on(performed-3, condition-6)\n",
      "case(wash-10, after-8)\n",
      "amod(wash-10, appropriate-9)\n",
      "nmod:after(performed-3'', wash-10)\n",
      "case(treatments-14, out-11)\n",
      "mwe(out-11, of-12)\n",
      "amod(treatments-14, previous-13)\n",
      "nmod:out_of(wash-10, treatments-14)\n",
      "case(weeks-18, after-16)\n",
      "nummod(weeks-18, 4-17)\n",
      "nmod:after(performed-3', weeks-18)\n",
      "case(treatment-22, of-19)\n",
      "amod(treatment-22, lercanidipine-20)\n",
      "amod(treatment-22, monotherapy-21)\n",
      "nmod:of(weeks-18, treatment-22)\n",
      "cc(performed-3, and-24)\n",
      "case(end-27, at-25)\n",
      "det(end-27, the-26)\n",
      "nmod:at(performed-3''', end-27)\n",
      "case(treatment-31, of-28)\n",
      "det(treatment-31, the-29)\n",
      "compound(treatment-31, combination-30)\n",
      "nmod:of(end-27, treatment-31)\n",
      "\n",
      "Parsing [sent. 47 len. 27]: non-invasive measurements of wall-to-lumen ratio -LRB- wlr -RRB- and other morphological parameters of retinal arterioles were performed using either scanning laser doppler flowmetry or adaptive optics .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (ADJP (JJ non-invasive))\n",
      "        (NNS measurements))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ wall-to-lumen) (NN ratio))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NN wlr))\n",
      "              (-RRB- -RRB-)))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (JJ other) (JJ morphological) (NNS parameters))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ retinal) (NNS arterioles)))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN performed)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (CC either)\n",
      "            (VBG scanning)\n",
      "            (NP (NN laser) (NN doppler) (NN flowmetry)\n",
      "              (CC or)\n",
      "              (NN adaptive) (NNS optics))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(measurements-2, non-invasive-1)\n",
      "nsubjpass(performed-17, measurements-2)\n",
      "case(ratio-5, of-3)\n",
      "amod(ratio-5, wall-to-lumen-4)\n",
      "nmod:of(measurements-2, ratio-5)\n",
      "appos(ratio-5, wlr-7)\n",
      "cc(ratio-5, and-9)\n",
      "amod(parameters-12, other-10)\n",
      "amod(parameters-12, morphological-11)\n",
      "nmod:of(measurements-2, parameters-12)\n",
      "conj:and(ratio-5, parameters-12)\n",
      "case(arterioles-15, of-13)\n",
      "amod(arterioles-15, retinal-14)\n",
      "nmod:of(parameters-12, arterioles-15)\n",
      "auxpass(performed-17, were-16)\n",
      "root(ROOT-0, performed-17)\n",
      "xcomp(performed-17, using-18)\n",
      "dep(using-18, either-19)\n",
      "conj(using-18, scanning-20)\n",
      "compound(flowmetry-23, laser-21)\n",
      "compound(flowmetry-23, doppler-22)\n",
      "dobj(using-18, flowmetry-23)\n",
      "cc(flowmetry-23, or-24)\n",
      "compound(optics-26, adaptive-25)\n",
      "dobj(using-18, optics-26)\n",
      "conj:or(flowmetry-23, optics-26)\n",
      "\n",
      "Parsing [sent. 48 len. 25]: capillary density was evaluated by capillaroscopy , while pulse wave velocity was measured , and central blood pressures were assessed by pressure waveform analysis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ capillary) (NN density))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN evaluated)\n",
      "          (PP (IN by)\n",
      "            (NP (NN capillaroscopy)))\n",
      "          (, ,)\n",
      "          (SBAR (IN while)\n",
      "            (S\n",
      "              (NP (NN pulse) (NN wave) (NN velocity))\n",
      "              (VP (VBD was)\n",
      "                (VP (VBN measured))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ central) (NN blood) (NNS pressures))\n",
      "      (VP (VBD were)\n",
      "        (VP (VBN assessed)\n",
      "          (PP (IN by)\n",
      "            (NP (NN pressure) (NN waveform) (NN analysis))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(density-2, capillary-1)\n",
      "nsubjpass(evaluated-4, density-2)\n",
      "auxpass(evaluated-4, was-3)\n",
      "root(ROOT-0, evaluated-4)\n",
      "case(capillaroscopy-6, by-5)\n",
      "nmod:by(evaluated-4, capillaroscopy-6)\n",
      "mark(measured-13, while-8)\n",
      "compound(velocity-11, pulse-9)\n",
      "compound(velocity-11, wave-10)\n",
      "nsubjpass(measured-13, velocity-11)\n",
      "auxpass(measured-13, was-12)\n",
      "advcl(evaluated-4, measured-13)\n",
      "cc(evaluated-4, and-15)\n",
      "amod(pressures-18, central-16)\n",
      "compound(pressures-18, blood-17)\n",
      "nsubjpass(assessed-20, pressures-18)\n",
      "auxpass(assessed-20, were-19)\n",
      "conj:and(evaluated-4, assessed-20)\n",
      "case(analysis-24, by-21)\n",
      "compound(analysis-24, pressure-22)\n",
      "compound(analysis-24, waveform-23)\n",
      "nmod:by(assessed-20, analysis-24)\n",
      "\n",
      "Parsing [sent. 49 len. 49]: a significant improvement of wlr and other indices of retinal artery structure is observed with both technical approaches after treatment with lercanidipine alone , with a further improvement after treatment with lercanidipine + enalapril , while after treatment with lercanidipine + hydrochlorothiazide , the improvement is partially blunted .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT a) (JJ significant) (NN improvement))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN wlr)\n",
      "            (CC and)\n",
      "            (JJ other) (NNS indices))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ retinal) (NN artery) (NN structure))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ observed)\n",
      "        (PP (IN with)\n",
      "          (NP (DT both) (JJ technical) (NNS approaches))))\n",
      "      (PP (IN after)\n",
      "        (NP\n",
      "          (NP (NN treatment))\n",
      "          (PP (IN with)\n",
      "            (NP (NN lercanidipine)))))\n",
      "      (ADVP\n",
      "        (ADVP (RB alone))\n",
      "        (PRN (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (DT a) (JJ further) (NN improvement))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (NN treatment))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ lercanidipine) (JJ +) (NN enalapril)))))))\n",
      "          (, ,))\n",
      "        (SBAR (IN while)\n",
      "          (S\n",
      "            (PP (IN after)\n",
      "              (NP\n",
      "                (NP (NN treatment))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ lercanidipine) (JJ +) (NN hydrochlorothiazide)))))\n",
      "            (, ,)\n",
      "            (NP (DT the) (NN improvement))\n",
      "            (VP (VBZ is)\n",
      "              (ADVP (RB partially))\n",
      "              (VP (VBN blunted)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(improvement-3, a-1)\n",
      "amod(improvement-3, significant-2)\n",
      "nsubj(observed-14, improvement-3)\n",
      "case(indices-8, of-4)\n",
      "compound(indices-8, wlr-5)\n",
      "cc(wlr-5, and-6)\n",
      "conj:and(wlr-5, other-7)\n",
      "compound(indices-8, other-7)\n",
      "nmod:of(improvement-3, indices-8)\n",
      "case(structure-12, of-9)\n",
      "amod(structure-12, retinal-10)\n",
      "compound(structure-12, artery-11)\n",
      "nmod:of(indices-8, structure-12)\n",
      "cop(observed-14, is-13)\n",
      "root(ROOT-0, observed-14)\n",
      "case(approaches-18, with-15)\n",
      "det(approaches-18, both-16)\n",
      "amod(approaches-18, technical-17)\n",
      "nmod:with(observed-14, approaches-18)\n",
      "case(treatment-20, after-19)\n",
      "nmod:after(observed-14, treatment-20)\n",
      "case(lercanidipine-22, with-21)\n",
      "nmod:with(treatment-20, lercanidipine-22)\n",
      "advmod(observed-14, alone-23)\n",
      "case(improvement-28, with-25)\n",
      "det(improvement-28, a-26)\n",
      "amod(improvement-28, further-27)\n",
      "dep(alone-23, improvement-28)\n",
      "case(treatment-30, after-29)\n",
      "nmod:after(improvement-28, treatment-30)\n",
      "case(enalapril-34, with-31)\n",
      "amod(enalapril-34, lercanidipine-32)\n",
      "amod(enalapril-34, +-33)\n",
      "nmod:with(treatment-30, enalapril-34)\n",
      "mark(blunted-48, while-36)\n",
      "case(treatment-38, after-37)\n",
      "nmod:after(blunted-48, treatment-38)\n",
      "case(hydrochlorothiazide-42, with-39)\n",
      "amod(hydrochlorothiazide-42, lercanidipine-40)\n",
      "amod(hydrochlorothiazide-42, +-41)\n",
      "nmod:with(treatment-38, hydrochlorothiazide-42)\n",
      "det(improvement-45, the-44)\n",
      "nsubjpass(blunted-48, improvement-45)\n",
      "auxpass(blunted-48, is-46)\n",
      "advmod(blunted-48, partially-47)\n",
      "advcl(alone-23, blunted-48)\n",
      "\n",
      "Parsing [sent. 50 len. 14]: central systolic and diastolic blood pressures are similarly reduced by both therapeutic strategies .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ central)\n",
      "      (ADJP (JJ systolic)\n",
      "        (CC and)\n",
      "        (JJ diastolic))\n",
      "      (NN blood) (NNS pressures))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB similarly))\n",
      "      (VP (VBN reduced)\n",
      "        (PP (IN by)\n",
      "          (NP (DT both) (JJ therapeutic) (NNS strategies)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(pressures-6, central-1)\n",
      "amod(pressures-6, systolic-2)\n",
      "cc(systolic-2, and-3)\n",
      "conj:and(systolic-2, diastolic-4)\n",
      "amod(pressures-6, diastolic-4)\n",
      "compound(pressures-6, blood-5)\n",
      "nsubjpass(reduced-9, pressures-6)\n",
      "auxpass(reduced-9, are-7)\n",
      "advmod(reduced-9, similarly-8)\n",
      "root(ROOT-0, reduced-9)\n",
      "case(strategies-13, by-10)\n",
      "det(strategies-13, both-11)\n",
      "amod(strategies-13, therapeutic-12)\n",
      "nmod:by(reduced-9, strategies-13)\n",
      "\n",
      "Parsing [sent. 51 len. 12]: capillary density is increased only after treatment with lercanidipine + enalapril .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ capillary) (NN density))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN increased)\n",
      "        (ADVP (RB only))\n",
      "        (PP (IN after)\n",
      "          (NP (NN treatment)))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ lercanidipine) (JJ +) (NN enalapril)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(density-2, capillary-1)\n",
      "nsubjpass(increased-4, density-2)\n",
      "auxpass(increased-4, is-3)\n",
      "root(ROOT-0, increased-4)\n",
      "advmod(increased-4, only-5)\n",
      "case(treatment-7, after-6)\n",
      "nmod:after(increased-4, treatment-7)\n",
      "case(enalapril-11, with-8)\n",
      "amod(enalapril-11, lercanidipine-9)\n",
      "amod(enalapril-11, +-10)\n",
      "nmod:with(increased-4, enalapril-11)\n",
      "\n",
      "Parsing [sent. 52 len. 41]: in conclusion , lercanidipine both in monotherapy and in combination with enalapril but not with hydrochlorothiazide is able to improve microvascular structure ; on the other hand , a decrease in central blood pressure is observed with both therapeutic combinations .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (NN conclusion)))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (S\n",
      "        (VP (VB lercanidipine)\n",
      "          (PP (DT both)\n",
      "            (PP (IN in)\n",
      "              (NP (NN monotherapy)))\n",
      "            (CC and)\n",
      "            (PP (IN in)\n",
      "              (NP (NN combination))))\n",
      "          (PP\n",
      "            (PP (IN with)\n",
      "              (NP (NN enalapril)))\n",
      "            (CONJP (CC but)\n",
      "              (RB not))\n",
      "            (PP (IN with)\n",
      "              (NP (NN hydrochlorothiazide))))))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ able)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB improve)\n",
      "                (NP (NN microvascular) (NN structure))))))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (PP (IN on)\n",
      "        (NP (DT the) (JJ other) (NN hand)))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (NN decrease))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ central) (NN blood) (NN pressure))))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN observed)\n",
      "          (PP (IN with)\n",
      "            (NP (DT both) (JJ therapeutic) (NNS combinations))))))\n",
      "    (. .)))\n",
      "\n",
      "case(conclusion-2, in-1)\n",
      "nmod:in(able-18, conclusion-2)\n",
      "conj(lercanidipine-4, lercanidipine-4')\n",
      "conj:and(lercanidipine-4, lercanidipine-4')\n",
      "csubj(able-18, lercanidipine-4)\n",
      "csubj(able-18, lercanidipine-4')\n",
      "cc:preconj(monotherapy-7, both-5)\n",
      "case(monotherapy-7, in-6)\n",
      "nmod:in(lercanidipine-4, monotherapy-7)\n",
      "cc(lercanidipine-4, and-8)\n",
      "case(combination-10, in-9)\n",
      "nmod:in(lercanidipine-4', combination-10)\n",
      "case(enalapril-12, with-11)\n",
      "nmod:with(lercanidipine-4, enalapril-12)\n",
      "cc(not-14, but-13)\n",
      "cc(lercanidipine-4, not-14)\n",
      "case(hydrochlorothiazide-16, with-15)\n",
      "nmod:with(lercanidipine-4', hydrochlorothiazide-16)\n",
      "cop(able-18, is-17)\n",
      "root(ROOT-0, able-18)\n",
      "mark(improve-20, to-19)\n",
      "xcomp(able-18, improve-20)\n",
      "compound(structure-22, microvascular-21)\n",
      "dobj(improve-20, structure-22)\n",
      "case(hand-27, on-24)\n",
      "det(hand-27, the-25)\n",
      "amod(hand-27, other-26)\n",
      "nmod:on(observed-36, hand-27)\n",
      "det(decrease-30, a-29)\n",
      "nsubjpass(observed-36, decrease-30)\n",
      "case(pressure-34, in-31)\n",
      "amod(pressure-34, central-32)\n",
      "compound(pressure-34, blood-33)\n",
      "nmod:in(decrease-30, pressure-34)\n",
      "auxpass(observed-36, is-35)\n",
      "parataxis(able-18, observed-36)\n",
      "case(combinations-40, with-37)\n",
      "det(combinations-40, both-38)\n",
      "amod(combinations-40, therapeutic-39)\n",
      "nmod:with(observed-36, combinations-40)\n",
      "\n",
      "Parsing [sent. 53 len. 23]: hypereosinophilic syndrome -LRB- hes -RRB- is a heterogeneous group of hematological disorders characterized by a chronic , unexplained hypereosinophilia with tissue damage .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ hypereosinophilic) (NN syndrome))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN hes))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ heterogeneous) (NN group))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (JJ hematological) (NNS disorders))\n",
      "            (VP (VBN characterized)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (DT a) (JJ chronic) (, ,) (JJ unexplained) (NN hypereosinophilia))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN tissue) (NN damage))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(syndrome-2, hypereosinophilic-1)\n",
      "nsubj(group-9, syndrome-2)\n",
      "appos(syndrome-2, hes-4)\n",
      "cop(group-9, is-6)\n",
      "det(group-9, a-7)\n",
      "amod(group-9, heterogeneous-8)\n",
      "root(ROOT-0, group-9)\n",
      "case(disorders-12, of-10)\n",
      "amod(disorders-12, hematological-11)\n",
      "nmod:of(group-9, disorders-12)\n",
      "acl(disorders-12, characterized-13)\n",
      "case(hypereosinophilia-19, by-14)\n",
      "det(hypereosinophilia-19, a-15)\n",
      "amod(hypereosinophilia-19, chronic-16)\n",
      "amod(hypereosinophilia-19, unexplained-18)\n",
      "nmod:by(characterized-13, hypereosinophilia-19)\n",
      "case(damage-22, with-20)\n",
      "compound(damage-22, tissue-21)\n",
      "nmod:with(hypereosinophilia-19, damage-22)\n",
      "\n",
      "Parsing [sent. 54 len. 18]: cardiac involvement occurs in â¼ 20 % of patients with hes and represents a major turning point .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ cardiac) (NN involvement))\n",
      "    (VP\n",
      "      (VP (VBZ occurs)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (CD â¼) (CD 20))\n",
      "              (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN hes))))))))\n",
      "      (CC and)\n",
      "      (VP (VBZ represents)\n",
      "        (NP (DT a) (JJ major) (NN turning) (NN point))))\n",
      "    (. .)))\n",
      "\n",
      "amod(involvement-2, cardiac-1)\n",
      "nsubj(occurs-3, involvement-2)\n",
      "nsubj(represents-13, involvement-2)\n",
      "root(ROOT-0, occurs-3)\n",
      "case(%-7, in-4)\n",
      "compound(20-6, â¼-5)\n",
      "nummod(%-7, 20-6)\n",
      "nmod:in(occurs-3, %-7)\n",
      "case(patients-9, of-8)\n",
      "nmod:of(%-7, patients-9)\n",
      "case(hes-11, with-10)\n",
      "nmod:with(patients-9, hes-11)\n",
      "cc(occurs-3, and-12)\n",
      "conj:and(occurs-3, represents-13)\n",
      "det(point-17, a-14)\n",
      "amod(point-17, major-15)\n",
      "compound(point-17, turning-16)\n",
      "dobj(represents-13, point-17)\n",
      "\n",
      "Parsing [sent. 55 len. 20]: cardiac injuries related to eosinophilia are divided into three chronological phases : eosinophilic infiltration , thrombosis , and fibrosis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ cardiac) (NNS injuries))\n",
      "      (VP (VBN related)\n",
      "        (PP (TO to)\n",
      "          (NP (NN eosinophilia)))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN divided)\n",
      "        (PP (IN into)\n",
      "          (NP\n",
      "            (NP (CD three) (JJ chronological) (NNS phases))\n",
      "            (: :)\n",
      "            (NP (JJ eosinophilic) (NN infiltration))\n",
      "            (, ,)\n",
      "            (NP (NNS thrombosis))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (NN fibrosis))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(injuries-2, cardiac-1)\n",
      "nsubjpass(divided-7, injuries-2)\n",
      "acl(injuries-2, related-3)\n",
      "case(eosinophilia-5, to-4)\n",
      "nmod:to(related-3, eosinophilia-5)\n",
      "auxpass(divided-7, are-6)\n",
      "root(ROOT-0, divided-7)\n",
      "case(phases-11, into-8)\n",
      "nummod(phases-11, three-9)\n",
      "amod(phases-11, chronological-10)\n",
      "nmod:into(divided-7, phases-11)\n",
      "amod(infiltration-14, eosinophilic-13)\n",
      "nmod:into(divided-7, infiltration-14)\n",
      "conj:and(phases-11, infiltration-14)\n",
      "nmod:into(divided-7, thrombosis-16)\n",
      "conj:and(phases-11, thrombosis-16)\n",
      "cc(phases-11, and-18)\n",
      "nmod:into(divided-7, fibrosis-19)\n",
      "conj:and(phases-11, fibrosis-19)\n",
      "\n",
      "Parsing [sent. 56 len. 24]: we report a case of a 33-year-old woman diagnosed with hes , with pulmonary and gastrointestinal involvement and eosinophilic myocarditis in cardiogenic shock .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBP report)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT a) (NN case))\n",
      "            (PP (IN of)\n",
      "              (NP (DT a) (JJ 33-year-old) (NN woman))))\n",
      "          (VP (VBD diagnosed)\n",
      "            (PP (IN with)\n",
      "              (NP (NN hes)))\n",
      "            (, ,)\n",
      "            (PP (IN with)\n",
      "              (NP (JJ pulmonary)\n",
      "                (CC and)\n",
      "                (JJ gastrointestinal) (NN involvement)\n",
      "                (CC and)\n",
      "                (NN eosinophilic) (NNS myocarditis)))\n",
      "            (PP (IN in)\n",
      "              (NP (JJ cardiogenic) (NN shock)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(report-2, we-1)\n",
      "root(ROOT-0, report-2)\n",
      "det(case-4, a-3)\n",
      "nsubj(diagnosed-9, case-4)\n",
      "case(woman-8, of-5)\n",
      "det(woman-8, a-6)\n",
      "amod(woman-8, 33-year-old-7)\n",
      "nmod:of(case-4, woman-8)\n",
      "ccomp(report-2, diagnosed-9)\n",
      "case(hes-11, with-10)\n",
      "nmod:with(diagnosed-9, hes-11)\n",
      "case(involvement-17, with-13)\n",
      "amod(involvement-17, pulmonary-14)\n",
      "cc(pulmonary-14, and-15)\n",
      "conj:and(pulmonary-14, gastrointestinal-16)\n",
      "amod(involvement-17, gastrointestinal-16)\n",
      "nmod:with(diagnosed-9, involvement-17)\n",
      "cc(involvement-17, and-18)\n",
      "compound(myocarditis-20, eosinophilic-19)\n",
      "nmod:with(diagnosed-9, myocarditis-20)\n",
      "conj:and(involvement-17, myocarditis-20)\n",
      "case(shock-23, in-21)\n",
      "amod(shock-23, cardiogenic-22)\n",
      "nmod:in(diagnosed-9, shock-23)\n",
      "\n",
      "Parsing [sent. 57 len. 18]: the evolution was favorable with dobutamine , anticoagulation , corticosteroids , and later , Î²-blockers and ACEI .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN evolution))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ favorable)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN dobutamine))\n",
      "            (, ,)\n",
      "            (NP (NN anticoagulation))\n",
      "            (, ,)\n",
      "            (NP (NNS corticosteroids))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (ADVP (RB later))\n",
      "            (, ,)\n",
      "            (NP (NNS Î²-blockers))\n",
      "            (CC and)\n",
      "            (NP (NNP ACEI))))))\n",
      "    (. .)))\n",
      "\n",
      "det(evolution-2, the-1)\n",
      "nsubj(favorable-4, evolution-2)\n",
      "cop(favorable-4, was-3)\n",
      "root(ROOT-0, favorable-4)\n",
      "case(dobutamine-6, with-5)\n",
      "nmod:with(favorable-4, dobutamine-6)\n",
      "nmod:with(favorable-4, anticoagulation-8)\n",
      "conj:and(dobutamine-6, anticoagulation-8)\n",
      "nmod:with(favorable-4, corticosteroids-10)\n",
      "conj:and(dobutamine-6, corticosteroids-10)\n",
      "cc(dobutamine-6, and-12)\n",
      "advmod(dobutamine-6, later-13)\n",
      "nmod:with(favorable-4, Î²-blockers-15)\n",
      "conj:and(dobutamine-6, Î²-blockers-15)\n",
      "cc(dobutamine-6, and-16)\n",
      "nmod:with(favorable-4, ACEI-17)\n",
      "conj:and(dobutamine-6, ACEI-17)\n",
      "\n",
      "Parsing [sent. 58 len. 12]: cardiac involvement in hes is rare but carries a poor prognosis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ cardiac) (NN involvement))\n",
      "      (PP (IN in)\n",
      "        (NP (NN hes))))\n",
      "    (VP\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ rare)))\n",
      "      (CC but)\n",
      "      (VP (VBZ carries)\n",
      "        (NP (DT a) (JJ poor) (NN prognosis))))\n",
      "    (. .)))\n",
      "\n",
      "amod(involvement-2, cardiac-1)\n",
      "nsubj(rare-6, involvement-2)\n",
      "nsubj(carries-8, involvement-2)\n",
      "case(hes-4, in-3)\n",
      "nmod:in(involvement-2, hes-4)\n",
      "cop(rare-6, is-5)\n",
      "root(ROOT-0, rare-6)\n",
      "cc(rare-6, but-7)\n",
      "conj:but(rare-6, carries-8)\n",
      "det(prognosis-11, a-9)\n",
      "amod(prognosis-11, poor-10)\n",
      "dobj(carries-8, prognosis-11)\n",
      "\n",
      "Parsing [sent. 59 len. 12]: corticosteroids are considered by many to be the mainstay of treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS corticosteroids))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN considered)\n",
      "        (PP (IN by)\n",
      "          (NP (JJ many)))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (NP\n",
      "                (NP (DT the) (NN mainstay))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN treatment)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(considered-3, corticosteroids-1)\n",
      "nsubj:xsubj(mainstay-9, corticosteroids-1)\n",
      "auxpass(considered-3, are-2)\n",
      "root(ROOT-0, considered-3)\n",
      "case(many-5, by-4)\n",
      "nmod:by(considered-3, many-5)\n",
      "mark(mainstay-9, to-6)\n",
      "cop(mainstay-9, be-7)\n",
      "det(mainstay-9, the-8)\n",
      "xcomp(considered-3, mainstay-9)\n",
      "case(treatment-11, of-10)\n",
      "nmod:of(mainstay-9, treatment-11)\n",
      "\n",
      "Parsing [sent. 60 len. 13]: although new treatments have been suggested , only a few seem promising .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN although)\n",
      "      (S\n",
      "        (NP (JJ new) (NNS treatments))\n",
      "        (VP (VBP have)\n",
      "          (VP (VBN been)\n",
      "            (VP (VBN suggested))))))\n",
      "    (, ,)\n",
      "    (ADVP (RB only))\n",
      "    (NP (DT a) (JJ few))\n",
      "    (VP (VBP seem)\n",
      "      (S\n",
      "        (VP (VBG promising))))\n",
      "    (. .)))\n",
      "\n",
      "mark(suggested-6, although-1)\n",
      "amod(treatments-3, new-2)\n",
      "nsubjpass(suggested-6, treatments-3)\n",
      "aux(suggested-6, have-4)\n",
      "auxpass(suggested-6, been-5)\n",
      "advcl(seem-11, suggested-6)\n",
      "advmod(few-10, only-8)\n",
      "det(few-10, a-9)\n",
      "nsubj(seem-11, few-10)\n",
      "root(ROOT-0, seem-11)\n",
      "xcomp(seem-11, promising-12)\n",
      "\n",
      "Parsing [sent. 61 len. 31]: the burden of heart failure has long plagued the productive years of the population , with therapeutic advances in the timely treatment of ischemic heart disease decreasing its associated mortality .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN burden))\n",
      "      (PP (IN of)\n",
      "        (NP (NN heart) (NN failure))))\n",
      "    (VP (VBZ has)\n",
      "      (ADVP (RB long))\n",
      "      (VP (VBN plagued)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ productive) (NNS years))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NN population))))\n",
      "        (, ,)\n",
      "        (PP (IN with)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ therapeutic) (NNS advances))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ timely) (NN treatment))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ ischemic) (NN heart) (NN disease))))))\n",
      "            (VP (VBG decreasing)\n",
      "              (NP (PRP$ its) (VBN associated) (NN mortality)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(burden-2, the-1)\n",
      "nsubj(plagued-8, burden-2)\n",
      "case(failure-5, of-3)\n",
      "compound(failure-5, heart-4)\n",
      "nmod:of(burden-2, failure-5)\n",
      "aux(plagued-8, has-6)\n",
      "advmod(plagued-8, long-7)\n",
      "root(ROOT-0, plagued-8)\n",
      "det(years-11, the-9)\n",
      "amod(years-11, productive-10)\n",
      "dobj(plagued-8, years-11)\n",
      "case(population-14, of-12)\n",
      "det(population-14, the-13)\n",
      "nmod:of(years-11, population-14)\n",
      "mark(decreasing-27, with-16)\n",
      "amod(advances-18, therapeutic-17)\n",
      "nsubj(decreasing-27, advances-18)\n",
      "case(treatment-22, in-19)\n",
      "det(treatment-22, the-20)\n",
      "amod(treatment-22, timely-21)\n",
      "nmod:in(advances-18, treatment-22)\n",
      "case(disease-26, of-23)\n",
      "amod(disease-26, ischemic-24)\n",
      "compound(disease-26, heart-25)\n",
      "nmod:of(treatment-22, disease-26)\n",
      "advcl(plagued-8, decreasing-27)\n",
      "nmod:poss(mortality-30, its-28)\n",
      "amod(mortality-30, associated-29)\n",
      "dobj(decreasing-27, mortality-30)\n",
      "\n",
      "Parsing [sent. 62 len. 13]: ACEI and Î²-blockers have impacted heart failure therapeutics in a revolutionary way .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNP ACEI))\n",
      "      (CC and)\n",
      "      (NP (NNS Î²-blockers)))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN impacted)\n",
      "        (NP (NN heart) (NN failure) (NNS therapeutics))\n",
      "        (PP (IN in)\n",
      "          (NP (DT a) (JJ revolutionary) (NN way)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(impacted-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, Î²-blockers-3)\n",
      "nsubj(impacted-5, Î²-blockers-3)\n",
      "aux(impacted-5, have-4)\n",
      "root(ROOT-0, impacted-5)\n",
      "compound(therapeutics-8, heart-6)\n",
      "compound(therapeutics-8, failure-7)\n",
      "dobj(impacted-5, therapeutics-8)\n",
      "case(way-12, in-9)\n",
      "det(way-12, a-10)\n",
      "amod(way-12, revolutionary-11)\n",
      "nmod:in(impacted-5, way-12)\n",
      "\n",
      "Parsing [sent. 63 len. 44]: the importance of blockade of the renin-angiotensin system and adrenergic stimulation are fully accepted concepts that apply in young and old , symptomatic and asymptomatic , borderline low and very low ejection fraction -LRB- ef -RRB- , left ventricular failure and biventricular failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN importance))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN blockade))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ renin-angiotensin) (NN system))\n",
      "              (CC and)\n",
      "              (NP (JJ adrenergic) (NN stimulation)))))))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB fully))\n",
      "      (VP (VBN accepted)\n",
      "        (NP\n",
      "          (NP (NNS concepts))\n",
      "          (SBAR\n",
      "            (WHNP (WDT that))\n",
      "            (S\n",
      "              (VP (VBP apply)\n",
      "                (PP (IN in)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (ADJP\n",
      "                          (ADJP (JJ young)\n",
      "                            (CC and)\n",
      "                            (JJ old))\n",
      "                          (, ,)\n",
      "                          (ADJP (JJ symptomatic)\n",
      "                            (CC and)\n",
      "                            (JJ asymptomatic))\n",
      "                          (, ,)\n",
      "                          (ADJP (JJ borderline) (JJ low))\n",
      "                          (CC and)\n",
      "                          (ADJP (RB very) (JJ low)))\n",
      "                        (NN ejection) (NN fraction))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN ef))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP (JJ left) (NN ventricular) (NN failure)\n",
      "                      (CC and)\n",
      "                      (NN biventricular) (NN failure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(importance-2, the-1)\n",
      "nsubjpass(accepted-14, importance-2)\n",
      "case(blockade-4, of-3)\n",
      "nmod:of(importance-2, blockade-4)\n",
      "case(system-8, of-5)\n",
      "det(system-8, the-6)\n",
      "amod(system-8, renin-angiotensin-7)\n",
      "nmod:of(blockade-4, system-8)\n",
      "cc(system-8, and-9)\n",
      "amod(stimulation-11, adrenergic-10)\n",
      "nmod:of(blockade-4, stimulation-11)\n",
      "conj:and(system-8, stimulation-11)\n",
      "auxpass(accepted-14, are-12)\n",
      "advmod(accepted-14, fully-13)\n",
      "root(ROOT-0, accepted-14)\n",
      "dobj(accepted-14, concepts-15)\n",
      "nsubj(apply-17, concepts-15)\n",
      "ref(concepts-15, that-16)\n",
      "acl:relcl(concepts-15, apply-17)\n",
      "case(fraction-33, in-18)\n",
      "amod(fraction-33, young-19)\n",
      "cc(young-19, and-20)\n",
      "conj:and(young-19, old-21)\n",
      "amod(fraction-33, old-21)\n",
      "conj:and(young-19, symptomatic-23)\n",
      "amod(fraction-33, symptomatic-23)\n",
      "cc(symptomatic-23, and-24)\n",
      "conj:and(young-19, asymptomatic-25)\n",
      "conj:and(symptomatic-23, asymptomatic-25)\n",
      "amod(low-28, borderline-27)\n",
      "conj:and(young-19, low-28)\n",
      "amod(fraction-33, low-28)\n",
      "cc(young-19, and-29)\n",
      "advmod(low-31, very-30)\n",
      "conj:and(young-19, low-31)\n",
      "amod(fraction-33, low-31)\n",
      "compound(fraction-33, ejection-32)\n",
      "nmod:in(apply-17, fraction-33)\n",
      "appos(fraction-33, ef-35)\n",
      "amod(failure-40, left-38)\n",
      "compound(failure-40, ventricular-39)\n",
      "appos(fraction-33, failure-40)\n",
      "cc(failure-40, and-41)\n",
      "compound(failure-43, biventricular-42)\n",
      "appos(fraction-33, failure-43)\n",
      "conj:and(failure-40, failure-43)\n",
      "\n",
      "Parsing [sent. 64 len. 25]: despite several interventions , both pharmaceutical and device based for the treatment of ensuing heart failure , the incidence is increasing in large proportions .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP\n",
      "        (NP (JJ several) (NNS interventions))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT both) (NN pharmaceutical)\n",
      "            (CC and)\n",
      "            (NN device))\n",
      "          (VP (VBN based)\n",
      "            (PP (IN for)\n",
      "              (NP\n",
      "                (NP (DT the) (NN treatment))\n",
      "                (PP (IN of)\n",
      "                  (NP (VBG ensuing) (NN heart) (NN failure)))))))))\n",
      "    (, ,)\n",
      "    (NP (DT the) (NN incidence))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBG increasing)\n",
      "        (PP (IN in)\n",
      "          (NP (JJ large) (NNS proportions)))))\n",
      "    (. .)))\n",
      "\n",
      "case(interventions-3, despite-1)\n",
      "amod(interventions-3, several-2)\n",
      "nmod:despite(increasing-21, interventions-3)\n",
      "cc:preconj(pharmaceutical-6, both-5)\n",
      "appos(interventions-3, pharmaceutical-6)\n",
      "cc(pharmaceutical-6, and-7)\n",
      "appos(interventions-3, device-8)\n",
      "conj:and(pharmaceutical-6, device-8)\n",
      "acl(pharmaceutical-6, based-9)\n",
      "case(treatment-12, for-10)\n",
      "det(treatment-12, the-11)\n",
      "nmod:for(based-9, treatment-12)\n",
      "case(failure-16, of-13)\n",
      "amod(failure-16, ensuing-14)\n",
      "compound(failure-16, heart-15)\n",
      "nmod:of(treatment-12, failure-16)\n",
      "det(incidence-19, the-18)\n",
      "nsubj(increasing-21, incidence-19)\n",
      "aux(increasing-21, is-20)\n",
      "root(ROOT-0, increasing-21)\n",
      "case(proportions-24, in-22)\n",
      "amod(proportions-24, large-23)\n",
      "nmod:in(increasing-21, proportions-24)\n",
      "\n",
      "Parsing [sent. 65 len. 8]: newer molecules like sacubitril show more promise .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJR newer) (NNS molecules))\n",
      "      (PP (IN like)\n",
      "        (NP (NN sacubitril))))\n",
      "    (VP (VBP show)\n",
      "      (NP (JJR more) (NN promise)))\n",
      "    (. .)))\n",
      "\n",
      "amod(molecules-2, newer-1)\n",
      "nsubj(show-5, molecules-2)\n",
      "case(sacubitril-4, like-3)\n",
      "nmod:like(molecules-2, sacubitril-4)\n",
      "root(ROOT-0, show-5)\n",
      "amod(promise-7, more-6)\n",
      "dobj(show-5, promise-7)\n",
      "\n",
      "Parsing [sent. 66 len. 17]: despite these novel therapies , several patients relentlessly progress to a stage of advanced heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP (DT these) (NN novel) (NNS therapies)))\n",
      "    (, ,)\n",
      "    (NP (JJ several) (NNS patients))\n",
      "    (ADVP (RB relentlessly))\n",
      "    (VP (VB progress)\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (DT a) (NN stage))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ advanced) (NN heart) (NN failure))))))\n",
      "    (. .)))\n",
      "\n",
      "case(therapies-4, despite-1)\n",
      "det(therapies-4, these-2)\n",
      "compound(therapies-4, novel-3)\n",
      "nmod:despite(progress-9, therapies-4)\n",
      "amod(patients-7, several-6)\n",
      "nsubj(progress-9, patients-7)\n",
      "advmod(progress-9, relentlessly-8)\n",
      "root(ROOT-0, progress-9)\n",
      "case(stage-12, to-10)\n",
      "det(stage-12, a-11)\n",
      "nmod:to(progress-9, stage-12)\n",
      "case(failure-16, of-13)\n",
      "amod(failure-16, advanced-14)\n",
      "compound(failure-16, heart-15)\n",
      "nmod:of(stage-12, failure-16)\n",
      "\n",
      "Parsing [sent. 67 len. 18]: the use of left-ventricular-assist devices has variable clinical benefit , with some patients progressing to heart transplantation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ left-ventricular-assist) (NNS devices))))\n",
      "    (VP (VBZ has)\n",
      "      (NP (JJ variable) (JJ clinical) (NN benefit))\n",
      "      (, ,)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (DT some) (NNS patients))\n",
      "          (VP (VBG progressing)\n",
      "            (PP (TO to)\n",
      "              (NP (NN heart) (NN transplantation)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(use-2, the-1)\n",
      "nsubj(has-6, use-2)\n",
      "case(devices-5, of-3)\n",
      "amod(devices-5, left-ventricular-assist-4)\n",
      "nmod:of(use-2, devices-5)\n",
      "root(ROOT-0, has-6)\n",
      "amod(benefit-9, variable-7)\n",
      "amod(benefit-9, clinical-8)\n",
      "dobj(has-6, benefit-9)\n",
      "case(patients-13, with-11)\n",
      "det(patients-13, some-12)\n",
      "nmod:with(has-6, patients-13)\n",
      "acl(patients-13, progressing-14)\n",
      "case(transplantation-17, to-15)\n",
      "compound(transplantation-17, heart-16)\n",
      "nmod:to(progressing-14, transplantation-17)\n",
      "\n",
      "Parsing [sent. 68 len. 12]: liver fibrosis is a common response to many chronic liver diseases .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN liver) (NN fibrosis))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ common) (NN response))\n",
      "        (PP (TO to)\n",
      "          (NP (JJ many) (JJ chronic) (NN liver) (NNS diseases)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(fibrosis-2, liver-1)\n",
      "nsubj(response-6, fibrosis-2)\n",
      "cop(response-6, is-3)\n",
      "det(response-6, a-4)\n",
      "amod(response-6, common-5)\n",
      "root(ROOT-0, response-6)\n",
      "case(diseases-11, to-7)\n",
      "amod(diseases-11, many-8)\n",
      "amod(diseases-11, chronic-9)\n",
      "compound(diseases-11, liver-10)\n",
      "nmod:to(response-6, diseases-11)\n",
      "\n",
      "Parsing [sent. 69 len. 29]: the aim of our study was to explore whether pharmacotherapy for concurrent diseases affects overall mortality , liver-related mortality and liver-related morbidity in patients with chronic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN aim))\n",
      "      (PP (IN of)\n",
      "        (NP (PRP$ our) (NN study))))\n",
      "    (VP (VBD was)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB explore)\n",
      "            (SBAR (IN whether)\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (NN pharmacotherapy))\n",
      "                  (PP (IN for)\n",
      "                    (NP (JJ concurrent) (NNS diseases))))\n",
      "                (VP (VBZ affects)\n",
      "                  (NP\n",
      "                    (NP (JJ overall) (NN mortality))\n",
      "                    (, ,)\n",
      "                    (NP (JJ liver-related) (NN mortality))\n",
      "                    (CC and)\n",
      "                    (NP (JJ liver-related) (NN morbidity)))\n",
      "                  (PP (IN in)\n",
      "                    (NP\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP (JJ chronic) (NN liver) (NN disease))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(aim-2, the-1)\n",
      "nsubj(was-6, aim-2)\n",
      "nsubj:xsubj(explore-8, aim-2)\n",
      "case(study-5, of-3)\n",
      "nmod:poss(study-5, our-4)\n",
      "nmod:of(aim-2, study-5)\n",
      "root(ROOT-0, was-6)\n",
      "mark(explore-8, to-7)\n",
      "xcomp(was-6, explore-8)\n",
      "mark(affects-14, whether-9)\n",
      "nsubj(affects-14, pharmacotherapy-10)\n",
      "case(diseases-13, for-11)\n",
      "amod(diseases-13, concurrent-12)\n",
      "nmod:for(pharmacotherapy-10, diseases-13)\n",
      "ccomp(explore-8, affects-14)\n",
      "amod(mortality-16, overall-15)\n",
      "dobj(affects-14, mortality-16)\n",
      "amod(mortality-19, liver-related-18)\n",
      "dobj(affects-14, mortality-19)\n",
      "conj:and(mortality-16, mortality-19)\n",
      "cc(mortality-16, and-20)\n",
      "amod(morbidity-22, liver-related-21)\n",
      "dobj(affects-14, morbidity-22)\n",
      "conj:and(mortality-16, morbidity-22)\n",
      "case(patients-24, in-23)\n",
      "nmod:in(affects-14, patients-24)\n",
      "case(disease-28, with-25)\n",
      "amod(disease-28, chronic-26)\n",
      "compound(disease-28, liver-27)\n",
      "nmod:with(patients-24, disease-28)\n",
      "\n",
      "Parsing [sent. 70 len. 30]: we performed a register-based cohort study of all patients with a first-time diagnosis of chronic liver disease between 2005 and 2012 in sweden -LRB- n = 70 546 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD performed)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ register-based) (NN cohort) (NN study))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT all) (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (DT a) (JJ first-time) (NN diagnosis)))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ chronic) (NN liver) (NN disease)))\n",
      "            (PP (IN between)\n",
      "              (NP (CD 2005)\n",
      "                (CC and)\n",
      "                (CD 2012)))\n",
      "            (PP (IN in)\n",
      "              (NP (NN sweden)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 70) (CD 546)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(performed-2, we-1)\n",
      "root(ROOT-0, performed-2)\n",
      "det(study-6, a-3)\n",
      "amod(study-6, register-based-4)\n",
      "compound(study-6, cohort-5)\n",
      "dobj(performed-2, study-6)\n",
      "case(patients-9, of-7)\n",
      "det(patients-9, all-8)\n",
      "nmod:of(study-6, patients-9)\n",
      "case(diagnosis-13, with-10)\n",
      "det(diagnosis-13, a-11)\n",
      "amod(diagnosis-13, first-time-12)\n",
      "nmod:with(patients-9, diagnosis-13)\n",
      "case(disease-17, of-14)\n",
      "amod(disease-17, chronic-15)\n",
      "compound(disease-17, liver-16)\n",
      "nmod:of(patients-9, disease-17)\n",
      "case(2005-19, between-18)\n",
      "nmod:between(patients-9, 2005-19)\n",
      "cc(2005-19, and-20)\n",
      "nmod:between(patients-9, 2012-21)\n",
      "conj:and(2005-19, 2012-21)\n",
      "case(sweden-23, in-22)\n",
      "nmod:in(patients-9, sweden-23)\n",
      "dep(patients-9, n-25)\n",
      "dep(546-28, =-26)\n",
      "nummod(546-28, 70-27)\n",
      "ccomp(n-25, 546-28)\n",
      "\n",
      "Parsing [sent. 71 len. 18]: data from the patient register , the prescribed drug register and the death certificate register were linked .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS data))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ patient) (NN register))\n",
      "          (, ,)\n",
      "          (NP (DT the) (JJ prescribed) (NN drug) (NN register))\n",
      "          (CC and)\n",
      "          (NP (DT the) (NN death) (NN certificate) (NN register)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN linked)))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(linked-17, data-1)\n",
      "case(register-5, from-2)\n",
      "det(register-5, the-3)\n",
      "amod(register-5, patient-4)\n",
      "nmod:from(data-1, register-5)\n",
      "det(register-10, the-7)\n",
      "amod(register-10, prescribed-8)\n",
      "compound(register-10, drug-9)\n",
      "nmod:from(data-1, register-10)\n",
      "conj:and(register-5, register-10)\n",
      "cc(register-5, and-11)\n",
      "det(register-15, the-12)\n",
      "compound(register-15, death-13)\n",
      "compound(register-15, certificate-14)\n",
      "nmod:from(data-1, register-15)\n",
      "conj:and(register-5, register-15)\n",
      "auxpass(linked-17, were-16)\n",
      "root(ROOT-0, linked-17)\n",
      "\n",
      "Parsing [sent. 72 len. 27]: we studied whether the use of statins , ACEI , angiotensin receptor blockers and antibiotics affected the risk of total mortality , liver-specific mortality and morbidity .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD studied)\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN use))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS statins))\n",
      "                (, ,)\n",
      "                (NP (NNP ACEI))\n",
      "                (, ,)\n",
      "                (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "                (CC and)\n",
      "                (NP (NNS antibiotics)))))\n",
      "          (VP (VBD affected)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (JJ total) (NN mortality))\n",
      "                  (, ,)\n",
      "                  (NP (JJ liver-specific) (NN mortality))\n",
      "                  (CC and)\n",
      "                  (NP (NN morbidity)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(studied-2, we-1)\n",
      "root(ROOT-0, studied-2)\n",
      "mark(affected-16, whether-3)\n",
      "det(use-5, the-4)\n",
      "nsubj(affected-16, use-5)\n",
      "case(statins-7, of-6)\n",
      "nmod:of(use-5, statins-7)\n",
      "nmod:of(use-5, ACEI-9)\n",
      "conj:and(statins-7, ACEI-9)\n",
      "compound(blockers-13, angiotensin-11)\n",
      "compound(blockers-13, receptor-12)\n",
      "nmod:of(use-5, blockers-13)\n",
      "conj:and(statins-7, blockers-13)\n",
      "cc(statins-7, and-14)\n",
      "nmod:of(use-5, antibiotics-15)\n",
      "conj:and(statins-7, antibiotics-15)\n",
      "ccomp(studied-2, affected-16)\n",
      "det(risk-18, the-17)\n",
      "dobj(affected-16, risk-18)\n",
      "case(mortality-21, of-19)\n",
      "amod(mortality-21, total-20)\n",
      "nmod:of(risk-18, mortality-21)\n",
      "amod(mortality-24, liver-specific-23)\n",
      "nmod:of(risk-18, mortality-24)\n",
      "conj:and(mortality-21, mortality-24)\n",
      "cc(mortality-21, and-25)\n",
      "nmod:of(risk-18, morbidity-26)\n",
      "conj:and(mortality-21, morbidity-26)\n",
      "\n",
      "Parsing [sent. 73 len. 50]: we found a reduction in mortality risk for statin users -LRB- n = 11 245 -RRB- with hazard ratios from 0.57 -LRB- 95 % , ci 0.32-0 .99 -RRB- for patients with autoimmune hepatitis , to 0.84 -LRB- 95 % , ci 0.75-0 .95 -RRB- for alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD found)\n",
      "      (NP\n",
      "        (NP (DT a) (NN reduction))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NN mortality) (NN risk))\n",
      "            (PP (IN for)\n",
      "              (NP (NN statin) (NNS users)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 11) (CD 245)))))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (PP (IN with)\n",
      "        (NP (NN hazard) (NNS ratios)))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD 0.57))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 95) (NN %))\n",
      "                (, ,)\n",
      "                (NP (NN ci) (CD 0.32-0) (NNP .99)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ autoimmune) (NN hepatitis)))))))\n",
      "      (, ,)\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD 0.84))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 95) (NN %))\n",
      "                (, ,)\n",
      "                (NP (NN ci) (CD 0.75-0) (NNP .95)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP (JJ alcoholic) (NN liver) (NN disease))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(found-2, we-1)\n",
      "root(ROOT-0, found-2)\n",
      "det(reduction-4, a-3)\n",
      "dobj(found-2, reduction-4)\n",
      "case(risk-7, in-5)\n",
      "compound(risk-7, mortality-6)\n",
      "nmod:in(reduction-4, risk-7)\n",
      "case(users-10, for-8)\n",
      "compound(users-10, statin-9)\n",
      "nmod:for(risk-7, users-10)\n",
      "dep(risk-7, n-12)\n",
      "dep(245-15, =-13)\n",
      "nummod(245-15, 11-14)\n",
      "ccomp(n-12, 245-15)\n",
      "case(ratios-19, with-17)\n",
      "compound(ratios-19, hazard-18)\n",
      "nmod:with(found-2, ratios-19)\n",
      "case(0.57-21, from-20)\n",
      "nmod:from(found-2, 0.57-21)\n",
      "nummod(%-24, 95-23)\n",
      "dep(0.57-21, %-24)\n",
      "compound(.99-28, ci-26)\n",
      "nummod(.99-28, 0.32-0-27)\n",
      "appos(%-24, .99-28)\n",
      "case(patients-31, for-30)\n",
      "nmod:for(0.57-21, patients-31)\n",
      "case(hepatitis-34, with-32)\n",
      "amod(hepatitis-34, autoimmune-33)\n",
      "nmod:with(patients-31, hepatitis-34)\n",
      "case(0.84-37, to-36)\n",
      "nmod:to(found-2, 0.84-37)\n",
      "nummod(%-40, 95-39)\n",
      "dep(0.84-37, %-40)\n",
      "compound(.95-44, ci-42)\n",
      "nummod(.95-44, 0.75-0-43)\n",
      "appos(%-40, .95-44)\n",
      "case(disease-49, for-46)\n",
      "amod(disease-49, alcoholic-47)\n",
      "compound(disease-49, liver-48)\n",
      "nmod:for(0.84-37, disease-49)\n",
      "\n",
      "Parsing [sent. 74 len. 27]: there was a significant reduced liver-related mortality for patients with alcoholic liver disease who used ACEI , 0.85 -LRB- 95 % , ci 0.65-0 .96 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ significant) (JJ reduced) (JJ liver-related) (NN mortality))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (JJ alcoholic) (NN liver) (NN disease)))))\n",
      "        (SBAR\n",
      "          (WHNP (WP who))\n",
      "          (S\n",
      "            (VP (VBD used)\n",
      "              (NP\n",
      "                (NP (NNP ACEI) (, ,) (NNP 0.85))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 95) (NN %))\n",
      "                    (, ,)\n",
      "                    (NP (NN ci) (CD 0.65-0) (NNP .96)))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "det(mortality-7, a-3)\n",
      "amod(mortality-7, significant-4)\n",
      "amod(mortality-7, reduced-5)\n",
      "amod(mortality-7, liver-related-6)\n",
      "nsubj(was-2, mortality-7)\n",
      "nsubj(used-15, mortality-7)\n",
      "case(patients-9, for-8)\n",
      "nmod:for(mortality-7, patients-9)\n",
      "case(disease-13, with-10)\n",
      "amod(disease-13, alcoholic-11)\n",
      "compound(disease-13, liver-12)\n",
      "nmod:with(patients-9, disease-13)\n",
      "ref(mortality-7, who-14)\n",
      "acl:relcl(mortality-7, used-15)\n",
      "compound(0.85-18, ACEI-16)\n",
      "dobj(used-15, 0.85-18)\n",
      "nummod(%-21, 95-20)\n",
      "dep(0.85-18, %-21)\n",
      "compound(.96-25, ci-23)\n",
      "nummod(.96-25, 0.65-0-24)\n",
      "appos(%-21, .96-25)\n",
      "\n",
      "Parsing [sent. 75 len. 34]: there were increased overall mortality risks for antibiotic users -LRB- n = 44 572 -RRB- , with hazard ratios up to 1.67 -LRB- 95 % ci , 1.55-1 .80 -RRB- for viral hepatitis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD were)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (VBN increased) (JJ overall) (NN mortality) (NNS risks))\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (JJ antibiotic) (NNS users))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 44) (CD 572)))))\n",
      "                (-RRB- -RRB-))))\n",
      "          (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP (NN hazard) (NNS ratios))))\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (IN up) (TO to) (CD 1.67)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (ADJP (CD 95) (NN %))\n",
      "                  (NN ci))\n",
      "                (, ,)\n",
      "                (NP (CD 1.55-1) (CD .80)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP (JJ viral) (NN hepatitis))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(were-2, there-1)\n",
      "root(ROOT-0, were-2)\n",
      "amod(risks-6, increased-3)\n",
      "amod(risks-6, overall-4)\n",
      "compound(risks-6, mortality-5)\n",
      "iobj(were-2, risks-6)\n",
      "case(users-9, for-7)\n",
      "amod(users-9, antibiotic-8)\n",
      "nmod:for(risks-6, users-9)\n",
      "dep(users-9, n-11)\n",
      "dep(572-14, =-12)\n",
      "nummod(572-14, 44-13)\n",
      "ccomp(n-11, 572-14)\n",
      "case(ratios-19, with-17)\n",
      "compound(ratios-19, hazard-18)\n",
      "nmod:with(risks-6, ratios-19)\n",
      "dep(1.67-22, up-20)\n",
      "mwe(up-20, to-21)\n",
      "dep(risks-6, 1.67-22)\n",
      "compound(%-25, 95-24)\n",
      "amod(ci-26, %-25)\n",
      "dep(1.67-22, ci-26)\n",
      "nummod(.80-29, 1.55-1-28)\n",
      "appos(ci-26, .80-29)\n",
      "case(hepatitis-33, for-31)\n",
      "amod(hepatitis-33, viral-32)\n",
      "nmod:for(1.67-22, hepatitis-33)\n",
      "\n",
      "Parsing [sent. 76 len. 25]: statin use was associated with decreased risks of liver-specific mortality and morbidity , and reduced total mortality foremost among patients with alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN statin) (NN use))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (VBN decreased) (NNS risks))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ liver-specific) (NN mortality)\n",
      "                  (CC and)\n",
      "                  (NN morbidity))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (VBN reduced) (JJ total) (NN mortality))\n",
      "              (ADVP (RB foremost)\n",
      "                (PP (IN among)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ alcoholic) (NN liver) (NN disease)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(use-2, statin-1)\n",
      "nsubjpass(associated-4, use-2)\n",
      "auxpass(associated-4, was-3)\n",
      "root(ROOT-0, associated-4)\n",
      "case(risks-7, with-5)\n",
      "amod(risks-7, decreased-6)\n",
      "nmod:with(associated-4, risks-7)\n",
      "case(mortality-10, of-8)\n",
      "amod(mortality-10, liver-specific-9)\n",
      "nmod:of(risks-7, mortality-10)\n",
      "cc(mortality-10, and-11)\n",
      "nmod:of(risks-7, morbidity-12)\n",
      "conj:and(mortality-10, morbidity-12)\n",
      "cc(risks-7, and-14)\n",
      "amod(mortality-17, reduced-15)\n",
      "amod(mortality-17, total-16)\n",
      "nmod:with(associated-4, mortality-17)\n",
      "conj:and(risks-7, mortality-17)\n",
      "advmod(mortality-17, foremost-18)\n",
      "case(patients-20, among-19)\n",
      "nmod:among(foremost-18, patients-20)\n",
      "case(disease-24, with-21)\n",
      "amod(disease-24, alcoholic-22)\n",
      "compound(disease-24, liver-23)\n",
      "nmod:with(patients-20, disease-24)\n",
      "\n",
      "Parsing [sent. 77 len. 14]: ACEI was associated with reduced liver-related mortality among patients with alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (VBN reduced) (JJ liver-related) (NN mortality))\n",
      "            (PP (IN among)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ alcoholic) (NN liver) (NN disease)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(associated-3, ACEI-1)\n",
      "auxpass(associated-3, was-2)\n",
      "root(ROOT-0, associated-3)\n",
      "case(mortality-7, with-4)\n",
      "amod(mortality-7, reduced-5)\n",
      "amod(mortality-7, liver-related-6)\n",
      "nmod:with(associated-3, mortality-7)\n",
      "case(patients-9, among-8)\n",
      "nmod:among(mortality-7, patients-9)\n",
      "case(disease-13, with-10)\n",
      "amod(disease-13, alcoholic-11)\n",
      "compound(disease-13, liver-12)\n",
      "nmod:with(patients-9, disease-13)\n",
      "\n",
      "Parsing [sent. 78 len. 7]: this article is protected by copyright .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN article))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN protected)\n",
      "        (PP (IN by)\n",
      "          (NP (NN copyright)))))\n",
      "    (. .)))\n",
      "\n",
      "det(article-2, this-1)\n",
      "nsubjpass(protected-4, article-2)\n",
      "auxpass(protected-4, is-3)\n",
      "root(ROOT-0, protected-4)\n",
      "case(copyright-6, by-5)\n",
      "nmod:by(protected-4, copyright-6)\n",
      "\n",
      "Parsing [sent. 79 len. 4]: all rights reserved .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT all) (NNS rights))\n",
      "    (VP (VBD reserved))\n",
      "    (. .)))\n",
      "\n",
      "det(rights-2, all-1)\n",
      "nsubj(reserved-3, rights-2)\n",
      "root(ROOT-0, reserved-3)\n",
      "\n",
      "Parsing [sent. 80 len. 44]: fabry 's disease -LRB- fd -RRB- is a severe congenital metabolic disorder characterized by the deficient activity of lysosomal exoglycohydrolase alpha-galactosidase , characterized by glycosphingolipid deposition in several cells , such as capillary endothelial cells , renal , cardiac , and nerve cells .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (NN fabry) (POS 's))\n",
      "        (NN disease))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN fd))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ severe) (JJ congenital) (JJ metabolic) (NN disorder))\n",
      "        (VP (VBN characterized)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ deficient) (NN activity))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ lysosomal) (NN exoglycohydrolase) (NN alpha-galactosidase))\n",
      "                    (, ,)\n",
      "                    (VP (VBN characterized)\n",
      "                      (PP (IN by)\n",
      "                        (NP\n",
      "                          (NP (JJ glycosphingolipid) (NN deposition))\n",
      "                          (PP (IN in)\n",
      "                            (NP (JJ several) (NNS cells))))))\n",
      "                    (, ,))\n",
      "                  (PP (JJ such) (IN as)\n",
      "                    (NP\n",
      "                      (NP (JJ capillary) (JJ endothelial) (NNS cells))\n",
      "                      (, ,)\n",
      "                      (NP (JJ renal))\n",
      "                      (, ,)\n",
      "                      (NP (JJ cardiac))\n",
      "                      (, ,)\n",
      "                      (CC and)\n",
      "                      (NP (NN nerve) (NNS cells)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(disease-3, fabry-1)\n",
      "case(fabry-1, 's-2)\n",
      "nsubj(disorder-12, disease-3)\n",
      "appos(disease-3, fd-5)\n",
      "cop(disorder-12, is-7)\n",
      "det(disorder-12, a-8)\n",
      "amod(disorder-12, severe-9)\n",
      "amod(disorder-12, congenital-10)\n",
      "amod(disorder-12, metabolic-11)\n",
      "root(ROOT-0, disorder-12)\n",
      "acl(disorder-12, characterized-13)\n",
      "case(activity-17, by-14)\n",
      "det(activity-17, the-15)\n",
      "amod(activity-17, deficient-16)\n",
      "nmod:by(characterized-13, activity-17)\n",
      "case(alpha-galactosidase-21, of-18)\n",
      "amod(alpha-galactosidase-21, lysosomal-19)\n",
      "compound(alpha-galactosidase-21, exoglycohydrolase-20)\n",
      "nmod:of(activity-17, alpha-galactosidase-21)\n",
      "acl(alpha-galactosidase-21, characterized-23)\n",
      "case(deposition-26, by-24)\n",
      "amod(deposition-26, glycosphingolipid-25)\n",
      "nmod:by(characterized-23, deposition-26)\n",
      "case(cells-29, in-27)\n",
      "amod(cells-29, several-28)\n",
      "nmod:in(deposition-26, cells-29)\n",
      "case(cells-35, such-31)\n",
      "mwe(such-31, as-32)\n",
      "amod(cells-35, capillary-33)\n",
      "amod(cells-35, endothelial-34)\n",
      "nmod:such_as(alpha-galactosidase-21, cells-35)\n",
      "nmod:such_as(alpha-galactosidase-21, renal-37)\n",
      "conj:and(cells-35, renal-37)\n",
      "nmod:such_as(alpha-galactosidase-21, cardiac-39)\n",
      "conj:and(cells-35, cardiac-39)\n",
      "cc(cells-35, and-41)\n",
      "compound(cells-43, nerve-42)\n",
      "nmod:such_as(alpha-galactosidase-21, cells-43)\n",
      "conj:and(cells-35, cells-43)\n",
      "\n",
      "Parsing [sent. 81 len. 27]: as a systemic disease leading to a contemporaneous myocardial and renal dysfunction , fd might be an example of cardiorenal syndrome type 5 -LRB- crs-5 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN as)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ systemic) (NN disease))\n",
      "        (VP (VBG leading)\n",
      "          (PP (TO to)\n",
      "            (NP\n",
      "              (NP (DT a) (JJ contemporaneous) (NN myocardial))\n",
      "              (CC and)\n",
      "              (NP (JJ renal) (NN dysfunction)))))))\n",
      "    (, ,)\n",
      "    (NP (NN fd))\n",
      "    (VP (MD might)\n",
      "      (VP (VB be)\n",
      "        (NP\n",
      "          (NP (DT an) (NN example))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ cardiorenal) (NN syndrome))\n",
      "                (ADJP (NN type) (CD 5)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (ADJP (JJ crs-5))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(disease-4, as-1)\n",
      "det(disease-4, a-2)\n",
      "amod(disease-4, systemic-3)\n",
      "nmod:as(example-18, disease-4)\n",
      "acl(disease-4, leading-5)\n",
      "case(myocardial-9, to-6)\n",
      "det(myocardial-9, a-7)\n",
      "amod(myocardial-9, contemporaneous-8)\n",
      "nmod:to(leading-5, myocardial-9)\n",
      "cc(myocardial-9, and-10)\n",
      "amod(dysfunction-12, renal-11)\n",
      "nmod:to(leading-5, dysfunction-12)\n",
      "conj:and(myocardial-9, dysfunction-12)\n",
      "nsubj(example-18, fd-14)\n",
      "aux(example-18, might-15)\n",
      "cop(example-18, be-16)\n",
      "det(example-18, an-17)\n",
      "root(ROOT-0, example-18)\n",
      "case(syndrome-21, of-19)\n",
      "amod(syndrome-21, cardiorenal-20)\n",
      "nmod:of(example-18, syndrome-21)\n",
      "amod(syndrome-21, type-22)\n",
      "compound(type-22, 5-23)\n",
      "dep(syndrome-21, crs-5-25)\n",
      "\n",
      "Parsing [sent. 82 len. 29]: kidney damage is commonly characterized by proteinuria , isosthenuria and altered tubular function when occurs at the second-third decade , azotemia and end-stage renal disease in third-fifth decade .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN kidney) (NN damage))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB commonly))\n",
      "      (VP (VBN characterized)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NN proteinuria))\n",
      "            (, ,)\n",
      "            (NP (NN isosthenuria))\n",
      "            (CC and)\n",
      "            (NP (JJ altered) (JJ tubular) (NN function))))\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (VP (VBZ occurs)\n",
      "              (PP (IN at)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ second-third) (NN decade))\n",
      "                  (, ,)\n",
      "                  (NP (NN azotemia))\n",
      "                  (CC and)\n",
      "                  (NP (JJ end-stage) (JJ renal) (NN disease))))\n",
      "              (PP (IN in)\n",
      "                (NP (JJ third-fifth) (NN decade))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(damage-2, kidney-1)\n",
      "nsubjpass(characterized-5, damage-2)\n",
      "auxpass(characterized-5, is-3)\n",
      "advmod(characterized-5, commonly-4)\n",
      "root(ROOT-0, characterized-5)\n",
      "case(proteinuria-7, by-6)\n",
      "nmod:by(characterized-5, proteinuria-7)\n",
      "nmod:by(characterized-5, isosthenuria-9)\n",
      "conj:and(proteinuria-7, isosthenuria-9)\n",
      "cc(proteinuria-7, and-10)\n",
      "amod(function-13, altered-11)\n",
      "amod(function-13, tubular-12)\n",
      "nmod:by(characterized-5, function-13)\n",
      "conj:and(proteinuria-7, function-13)\n",
      "advmod(occurs-15, when-14)\n",
      "advcl(characterized-5, occurs-15)\n",
      "case(decade-19, at-16)\n",
      "det(decade-19, the-17)\n",
      "amod(decade-19, second-third-18)\n",
      "nmod:at(occurs-15, decade-19)\n",
      "nmod:at(occurs-15, azotemia-21)\n",
      "conj:and(decade-19, azotemia-21)\n",
      "cc(decade-19, and-22)\n",
      "amod(disease-25, end-stage-23)\n",
      "amod(disease-25, renal-24)\n",
      "nmod:at(occurs-15, disease-25)\n",
      "conj:and(decade-19, disease-25)\n",
      "case(decade-28, in-26)\n",
      "amod(decade-28, third-fifth-27)\n",
      "nmod:in(occurs-15, decade-28)\n",
      "\n",
      "Parsing [sent. 83 len. 23]: beyond the irreversible glomerular , tubular and vascular damages , the podocytes foot process effacement is the major cause of kidney dysfunction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN beyond)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ irreversible) (NN glomerular))\n",
      "        (, ,)\n",
      "        (NP (JJ tubular))\n",
      "        (CC and)\n",
      "        (NP (NN vascular) (NNS damages))))\n",
      "    (, ,)\n",
      "    (NP (DT the) (JJ podocytes) (NN foot) (NN process) (NN effacement))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ major) (NN cause))\n",
      "        (PP (IN of)\n",
      "          (NP (NN kidney) (NN dysfunction)))))\n",
      "    (. .)))\n",
      "\n",
      "case(glomerular-4, beyond-1)\n",
      "det(glomerular-4, the-2)\n",
      "amod(glomerular-4, irreversible-3)\n",
      "nmod:beyond(cause-19, glomerular-4)\n",
      "conj:and(glomerular-4, tubular-6)\n",
      "nmod:beyond(cause-19, tubular-6)\n",
      "cc(glomerular-4, and-7)\n",
      "compound(damages-9, vascular-8)\n",
      "conj:and(glomerular-4, damages-9)\n",
      "nmod:beyond(cause-19, damages-9)\n",
      "det(effacement-15, the-11)\n",
      "amod(effacement-15, podocytes-12)\n",
      "compound(effacement-15, foot-13)\n",
      "compound(effacement-15, process-14)\n",
      "nsubj(cause-19, effacement-15)\n",
      "cop(cause-19, is-16)\n",
      "det(cause-19, the-17)\n",
      "amod(cause-19, major-18)\n",
      "root(ROOT-0, cause-19)\n",
      "case(dysfunction-22, of-20)\n",
      "compound(dysfunction-22, kidney-21)\n",
      "nmod:of(cause-19, dysfunction-22)\n",
      "\n",
      "Parsing [sent. 84 len. 39]: myocardial damage is usually observed with right and left ventricular hypertrophy , arrhythmias -LRB- due to sinus node and conduction system impairment -RRB- , diastolic dysfunction , congestive heart failure , myocardial ischemia , fibrosis and cardiac death .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ myocardial) (NN damage))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB usually))\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN right)\n",
      "              (CC and)\n",
      "              (JJ left) (NN ventricular) (NN hypertrophy))\n",
      "            (, ,)\n",
      "            (NP (NNS arrhythmias))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (ADJP (JJ due)\n",
      "                (PP (TO to)\n",
      "                  (NP (JJ sinus) (NN node)\n",
      "                    (CC and)\n",
      "                    (NN conduction) (NN system) (NN impairment))))\n",
      "              (-RRB- -RRB-))\n",
      "            (, ,)\n",
      "            (NP (JJ diastolic) (NN dysfunction))\n",
      "            (, ,)\n",
      "            (NP (JJ congestive) (NN heart) (NN failure))\n",
      "            (, ,)\n",
      "            (NP (JJ myocardial) (NN ischemia))\n",
      "            (, ,)\n",
      "            (NP (NN fibrosis))\n",
      "            (CC and)\n",
      "            (NP (JJ cardiac) (NN death))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(damage-2, myocardial-1)\n",
      "nsubjpass(observed-5, damage-2)\n",
      "auxpass(observed-5, is-3)\n",
      "advmod(observed-5, usually-4)\n",
      "root(ROOT-0, observed-5)\n",
      "case(hypertrophy-11, with-6)\n",
      "compound(hypertrophy-11, right-7)\n",
      "cc(right-7, and-8)\n",
      "conj:and(right-7, left-9)\n",
      "compound(hypertrophy-11, left-9)\n",
      "compound(hypertrophy-11, ventricular-10)\n",
      "nmod:with(observed-5, hypertrophy-11)\n",
      "nmod:with(observed-5, arrhythmias-13)\n",
      "conj:and(hypertrophy-11, arrhythmias-13)\n",
      "dep(hypertrophy-11, due-15)\n",
      "case(node-18, to-16)\n",
      "amod(node-18, sinus-17)\n",
      "nmod:to(due-15, node-18)\n",
      "cc(node-18, and-19)\n",
      "compound(impairment-22, conduction-20)\n",
      "compound(impairment-22, system-21)\n",
      "nmod:to(due-15, impairment-22)\n",
      "conj:and(node-18, impairment-22)\n",
      "amod(dysfunction-26, diastolic-25)\n",
      "nmod:with(observed-5, dysfunction-26)\n",
      "conj:and(hypertrophy-11, dysfunction-26)\n",
      "amod(failure-30, congestive-28)\n",
      "compound(failure-30, heart-29)\n",
      "nmod:with(observed-5, failure-30)\n",
      "conj:and(hypertrophy-11, failure-30)\n",
      "amod(ischemia-33, myocardial-32)\n",
      "nmod:with(observed-5, ischemia-33)\n",
      "conj:and(hypertrophy-11, ischemia-33)\n",
      "nmod:with(observed-5, fibrosis-35)\n",
      "conj:and(hypertrophy-11, fibrosis-35)\n",
      "cc(hypertrophy-11, and-36)\n",
      "amod(death-38, cardiac-37)\n",
      "nmod:with(observed-5, death-38)\n",
      "conj:and(hypertrophy-11, death-38)\n",
      "\n",
      "Parsing [sent. 85 len. 67]: the enzymatic replacement therapy is essential for the management of fd , as well as the control of renal -LRB- with anti-proteinuric agents such as ACEI - and/or angiotensin ii receptor blockers -RRB- , brain -LRB- coated aspirin , clopidogrel and statins to prevent strokes -RRB- and heart complications -LRB- calcium channel blockers for ischemic cardiomyopathy , warfarin and amiodarone or cardioverter device for arrhythmias -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (JJ enzymatic) (NN replacement) (NN therapy))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ essential)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (DT the) (NN management))\n",
      "              (PP (IN of)\n",
      "                (NP (NN fd))))\n",
      "            (, ,)\n",
      "            (CONJP (RB as) (RB well) (IN as))\n",
      "            (NP\n",
      "              (NP (DT the) (NN control))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ renal))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (PP (IN with)\n",
      "                        (NP\n",
      "                          (NP (JJ anti-proteinuric) (NNS agents))\n",
      "                          (PP (JJ such) (IN as)\n",
      "                            (NP\n",
      "                              (NP (NNP ACEI))\n",
      "                              (: -)\n",
      "                              (NP (JJ and/or) (NN angiotensin) (NN ii) (NN receptor) (NNS blockers))))))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (NN brain))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (VP (VBN coated)\n",
      "                          (NP (NN aspirin) (, ,) (NN clopidogrel)\n",
      "                            (CC and)\n",
      "                            (NNS statins))\n",
      "                          (S\n",
      "                            (VP (TO to)\n",
      "                              (VP (VB prevent)\n",
      "                                (NP (NNS strokes))))))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (CC and)\n",
      "                    (NP (NN heart) (NNS complications)))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "                        (PP (IN for)\n",
      "                          (NP (JJ ischemic) (NN cardiomyopathy) (, ,) (NN warfarin)\n",
      "                            (CC and)\n",
      "                            (NN amiodarone))))\n",
      "                      (CC or)\n",
      "                      (NP\n",
      "                        (NP (NN cardioverter) (NN device))\n",
      "                        (PP (IN for)\n",
      "                          (NP (NNS arrhythmias)))))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(therapy-4, the-1)\n",
      "amod(therapy-4, enzymatic-2)\n",
      "compound(therapy-4, replacement-3)\n",
      "nsubj(essential-6, therapy-4)\n",
      "cop(essential-6, is-5)\n",
      "root(ROOT-0, essential-6)\n",
      "case(management-9, for-7)\n",
      "det(management-9, the-8)\n",
      "nmod:for(essential-6, management-9)\n",
      "case(fd-11, of-10)\n",
      "nmod:of(management-9, fd-11)\n",
      "cc(management-9, as-13)\n",
      "mwe(as-13, well-14)\n",
      "mwe(as-13, as-15)\n",
      "det(control-17, the-16)\n",
      "nmod:for(essential-6, control-17)\n",
      "conj:and(management-9, control-17)\n",
      "case(renal-19, of-18)\n",
      "nmod:of(control-17, renal-19)\n",
      "case(agents-23, with-21)\n",
      "amod(agents-23, anti-proteinuric-22)\n",
      "nmod:with(renal-19, agents-23)\n",
      "case(ACEI-26, such-24)\n",
      "mwe(such-24, as-25)\n",
      "nmod:such_as(agents-23, ACEI-26)\n",
      "amod(blockers-32, and/or-28)\n",
      "compound(blockers-32, angiotensin-29)\n",
      "compound(blockers-32, ii-30)\n",
      "compound(blockers-32, receptor-31)\n",
      "dep(ACEI-26, blockers-32)\n",
      "nmod:of(control-17, brain-35)\n",
      "conj:and(renal-19, brain-35)\n",
      "dep(brain-35, coated-37)\n",
      "dobj(coated-37, aspirin-38)\n",
      "dobj(coated-37, clopidogrel-40)\n",
      "conj:and(aspirin-38, clopidogrel-40)\n",
      "cc(aspirin-38, and-41)\n",
      "dobj(coated-37, statins-42)\n",
      "conj:and(aspirin-38, statins-42)\n",
      "mark(prevent-44, to-43)\n",
      "advcl(coated-37, prevent-44)\n",
      "dobj(prevent-44, strokes-45)\n",
      "cc(renal-19, and-47)\n",
      "compound(complications-49, heart-48)\n",
      "nmod:of(control-17, complications-49)\n",
      "conj:and(renal-19, complications-49)\n",
      "compound(blockers-53, calcium-51)\n",
      "compound(blockers-53, channel-52)\n",
      "dep(renal-19, blockers-53)\n",
      "case(cardiomyopathy-56, for-54)\n",
      "amod(cardiomyopathy-56, ischemic-55)\n",
      "nmod:for(blockers-53, cardiomyopathy-56)\n",
      "nmod:for(blockers-53, warfarin-58)\n",
      "conj:and(cardiomyopathy-56, warfarin-58)\n",
      "cc(cardiomyopathy-56, and-59)\n",
      "nmod:for(blockers-53, amiodarone-60)\n",
      "conj:and(cardiomyopathy-56, amiodarone-60)\n",
      "cc(blockers-53, or-61)\n",
      "compound(device-63, cardioverter-62)\n",
      "dep(renal-19, device-63)\n",
      "conj:or(blockers-53, device-63)\n",
      "case(arrhythmias-65, for-64)\n",
      "nmod:for(device-63, arrhythmias-65)\n",
      "\n",
      "Parsing [sent. 86 len. 24]: nonsteroidal antiinflammatory agents , Î²-lactam antibiotics , non-Î² lactam antibiotics , and ACEI are the most common classes of drugs that cause angioedema .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ nonsteroidal) (NN antiinflammatory) (NNS agents))\n",
      "      (, ,)\n",
      "      (NP (JJ Î²-lactam) (NNS antibiotics))\n",
      "      (, ,)\n",
      "      (NP (JJ non-Î²) (NN lactam) (NNS antibiotics))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NNP ACEI)))\n",
      "    (VP (VBP are)\n",
      "      (NP\n",
      "        (NP (DT the) (RBS most) (JJ common) (NNS classes))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNS drugs))\n",
      "            (SBAR\n",
      "              (WHNP (WDT that))\n",
      "              (S\n",
      "                (VP (VBP cause)\n",
      "                  (NP (NN angioedema)))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(agents-3, nonsteroidal-1)\n",
      "compound(agents-3, antiinflammatory-2)\n",
      "nsubj(classes-18, agents-3)\n",
      "amod(antibiotics-6, Î²-lactam-5)\n",
      "conj:and(agents-3, antibiotics-6)\n",
      "nsubj(classes-18, antibiotics-6)\n",
      "amod(antibiotics-10, non-Î²-8)\n",
      "compound(antibiotics-10, lactam-9)\n",
      "conj:and(agents-3, antibiotics-10)\n",
      "nsubj(classes-18, antibiotics-10)\n",
      "cc(agents-3, and-12)\n",
      "conj:and(agents-3, ACEI-13)\n",
      "nsubj(classes-18, ACEI-13)\n",
      "cop(classes-18, are-14)\n",
      "det(classes-18, the-15)\n",
      "advmod(classes-18, most-16)\n",
      "amod(classes-18, common-17)\n",
      "root(ROOT-0, classes-18)\n",
      "case(drugs-20, of-19)\n",
      "nmod:of(classes-18, drugs-20)\n",
      "nsubj(cause-22, drugs-20)\n",
      "ref(drugs-20, that-21)\n",
      "acl:relcl(drugs-20, cause-22)\n",
      "dobj(cause-22, angioedema-23)\n",
      "\n",
      "Parsing [sent. 87 len. 30]: drug-induced angioedema is known to occur via mechanisms mediated by histamine , bradykinin , or leukotriene , and an understanding of these mechanisms is crucial in guiding therapeutic decisions .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ drug-induced) (NN angioedema))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN known)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB occur)\n",
      "                (PP (IN via)\n",
      "                  (NP\n",
      "                    (NP (NNS mechanisms))\n",
      "                    (VP (VBN mediated)\n",
      "                      (PP (IN by)\n",
      "                        (NP\n",
      "                          (NP (NN histamine))\n",
      "                          (, ,)\n",
      "                          (NP (NN bradykinin))\n",
      "                          (, ,)\n",
      "                          (CC or)\n",
      "                          (NP (NN leukotriene)))))))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT an) (NN understanding))\n",
      "        (PP (IN of)\n",
      "          (NP (DT these) (NNS mechanisms))))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ crucial)\n",
      "          (PP (IN in)\n",
      "            (NP (VBG guiding) (JJ therapeutic) (NNS decisions))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(angioedema-2, drug-induced-1)\n",
      "nsubjpass(known-4, angioedema-2)\n",
      "nsubj:xsubj(occur-6, angioedema-2)\n",
      "auxpass(known-4, is-3)\n",
      "root(ROOT-0, known-4)\n",
      "mark(occur-6, to-5)\n",
      "xcomp(known-4, occur-6)\n",
      "case(mechanisms-8, via-7)\n",
      "nmod:via(occur-6, mechanisms-8)\n",
      "acl(mechanisms-8, mediated-9)\n",
      "case(histamine-11, by-10)\n",
      "nmod:by(mediated-9, histamine-11)\n",
      "nmod:by(mediated-9, bradykinin-13)\n",
      "conj:or(histamine-11, bradykinin-13)\n",
      "cc(histamine-11, or-15)\n",
      "nmod:by(mediated-9, leukotriene-16)\n",
      "conj:or(histamine-11, leukotriene-16)\n",
      "cc(known-4, and-18)\n",
      "det(understanding-20, an-19)\n",
      "nsubj(crucial-25, understanding-20)\n",
      "case(mechanisms-23, of-21)\n",
      "det(mechanisms-23, these-22)\n",
      "nmod:of(understanding-20, mechanisms-23)\n",
      "cop(crucial-25, is-24)\n",
      "conj:and(known-4, crucial-25)\n",
      "case(decisions-29, in-26)\n",
      "amod(decisions-29, guiding-27)\n",
      "amod(decisions-29, therapeutic-28)\n",
      "nmod:in(crucial-25, decisions-29)\n",
      "\n",
      "Parsing [sent. 88 len. 35]: nonallergic angioedema occurs in patients with genetic variants that affect metabolism or synthesis of bradykinin , substance p , prostaglandins , or leukotrienes , or when patients are taking drugs that have synergistic mechanisms .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ nonallergic) (NN angioedema))\n",
      "    (VP (VBZ occurs)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ genetic) (NNS variants)))))\n",
      "      (SBAR\n",
      "        (SBAR\n",
      "          (WHNP (WDT that))\n",
      "          (S\n",
      "            (VP (VBP affect)\n",
      "              (NP\n",
      "                (NP (NN metabolism)\n",
      "                  (CC or)\n",
      "                  (NN synthesis))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NN bradykinin))\n",
      "                    (, ,)\n",
      "                    (NP (NN substance) (NN p))\n",
      "                    (, ,)\n",
      "                    (NP (NNS prostaglandins))\n",
      "                    (, ,)\n",
      "                    (CC or)\n",
      "                    (NP (NNS leukotrienes))))))))\n",
      "        (, ,)\n",
      "        (CC or)\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (NNS patients))\n",
      "            (VP (VBP are)\n",
      "              (VP (VBG taking)\n",
      "                (NP\n",
      "                  (NP (NNS drugs))\n",
      "                  (SBAR\n",
      "                    (WHNP (WDT that))\n",
      "                    (S\n",
      "                      (VP (VBP have)\n",
      "                        (NP (JJ synergistic) (NNS mechanisms))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(angioedema-2, nonallergic-1)\n",
      "nsubj(occurs-3, angioedema-2)\n",
      "root(ROOT-0, occurs-3)\n",
      "case(patients-5, in-4)\n",
      "nmod:in(occurs-3, patients-5)\n",
      "case(variants-8, with-6)\n",
      "amod(variants-8, genetic-7)\n",
      "nmod:with(patients-5, variants-8)\n",
      "nsubj(affect-10, that-9)\n",
      "dep(occurs-3, affect-10)\n",
      "dobj(affect-10, metabolism-11)\n",
      "cc(metabolism-11, or-12)\n",
      "dobj(affect-10, synthesis-13)\n",
      "conj:or(metabolism-11, synthesis-13)\n",
      "case(bradykinin-15, of-14)\n",
      "nmod:of(metabolism-11, bradykinin-15)\n",
      "compound(p-18, substance-17)\n",
      "nmod:of(metabolism-11, p-18)\n",
      "conj:or(bradykinin-15, p-18)\n",
      "nmod:of(metabolism-11, prostaglandins-20)\n",
      "conj:or(bradykinin-15, prostaglandins-20)\n",
      "cc(bradykinin-15, or-22)\n",
      "nmod:of(metabolism-11, leukotrienes-23)\n",
      "conj:or(bradykinin-15, leukotrienes-23)\n",
      "cc(affect-10, or-25)\n",
      "advmod(taking-29, when-26)\n",
      "nsubj(taking-29, patients-27)\n",
      "aux(taking-29, are-28)\n",
      "dep(occurs-3, taking-29)\n",
      "conj:or(affect-10, taking-29)\n",
      "dobj(taking-29, drugs-30)\n",
      "nsubj(have-32, drugs-30)\n",
      "ref(drugs-30, that-31)\n",
      "acl:relcl(drugs-30, have-32)\n",
      "amod(mechanisms-34, synergistic-33)\n",
      "dobj(have-32, mechanisms-34)\n",
      "\n",
      "Parsing [sent. 89 len. 15]: the mainstay in treatment of nonallergic drug-induced angioedema is cessation of the offending agents .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN mainstay))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN treatment))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ nonallergic) (JJ drug-induced) (NN angioedema))))))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (NN cessation))\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ offending) (NNS agents)))))\n",
      "    (. .)))\n",
      "\n",
      "det(mainstay-2, the-1)\n",
      "nsubj(cessation-10, mainstay-2)\n",
      "case(treatment-4, in-3)\n",
      "nmod:in(mainstay-2, treatment-4)\n",
      "case(angioedema-8, of-5)\n",
      "amod(angioedema-8, nonallergic-6)\n",
      "amod(angioedema-8, drug-induced-7)\n",
      "nmod:of(treatment-4, angioedema-8)\n",
      "cop(cessation-10, is-9)\n",
      "root(ROOT-0, cessation-10)\n",
      "case(agents-14, of-11)\n",
      "det(agents-14, the-12)\n",
      "amod(agents-14, offending-13)\n",
      "nmod:of(cessation-10, agents-14)\n",
      "\n",
      "Parsing [sent. 90 len. 50]: raas , a major pharmacological target in cardiovascular medicine , is inhibited by pharmacological classes including ACEI -LRB- ACEI -RRB- inhibitors -LRB- aceis -RRB- , angiotensin-ii type 1 blockers -LRB- arbs -RRB- and aldosterone receptors antagonists , in addition to the recently introduced direct renin inhibitors -LRB- dris -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS raas))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ major) (JJ pharmacological) (NN target))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ cardiovascular) (NN medicine))))\n",
      "      (, ,))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP (JJ inhibited)\n",
      "            (PP (IN by)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (JJ pharmacological) (NNS classes))\n",
      "                  (PP (VBG including)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (NNP ACEI)\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP ACEI))\n",
      "                            (-RRB- -RRB-))\n",
      "                          (NNP inhibitors))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NNS aceis))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (, ,)\n",
      "                      (NP\n",
      "                        (NP (JJ angiotensin-ii) (NN type) (CD 1) (NNS blockers))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NNS arbs))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (CC and)\n",
      "                      (NP (JJ aldosterone) (NNS receptors) (NNS antagonists))\n",
      "                      (, ,))))\n",
      "                (CONJP (IN in) (NN addition) (TO to))\n",
      "                (NP (DT the)\n",
      "                  (ADJP (RB recently) (VBN introduced))\n",
      "                  (JJ direct) (NN renin)))))\n",
      "          (NNS inhibitors))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNS dris))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(inhibitors-46, raas-1)\n",
      "det(target-6, a-3)\n",
      "amod(target-6, major-4)\n",
      "amod(target-6, pharmacological-5)\n",
      "appos(raas-1, target-6)\n",
      "case(medicine-9, in-7)\n",
      "amod(medicine-9, cardiovascular-8)\n",
      "nmod:in(target-6, medicine-9)\n",
      "cop(inhibitors-46, is-11)\n",
      "amod(inhibitors-46, inhibited-12)\n",
      "case(classes-15, by-13)\n",
      "amod(classes-15, pharmacological-14)\n",
      "nmod:by(inhibited-12, classes-15)\n",
      "case(inhibitors-21, including-16)\n",
      "compound(inhibitors-21, ACEI-17)\n",
      "appos(inhibitors-21, ACEI-19)\n",
      "nmod:including(classes-15, inhibitors-21)\n",
      "appos(inhibitors-21, aceis-23)\n",
      "amod(blockers-29, angiotensin-ii-26)\n",
      "compound(blockers-29, type-27)\n",
      "nummod(blockers-29, 1-28)\n",
      "nmod:including(classes-15, blockers-29)\n",
      "conj:and(inhibitors-21, blockers-29)\n",
      "appos(blockers-29, arbs-31)\n",
      "cc(inhibitors-21, and-33)\n",
      "amod(antagonists-36, aldosterone-34)\n",
      "compound(antagonists-36, receptors-35)\n",
      "nmod:including(classes-15, antagonists-36)\n",
      "conj:and(inhibitors-21, antagonists-36)\n",
      "cc(classes-15, in-38)\n",
      "dep(in-38, addition-39)\n",
      "dep(in-38, to-40)\n",
      "det(renin-45, the-41)\n",
      "advmod(introduced-43, recently-42)\n",
      "amod(renin-45, introduced-43)\n",
      "amod(renin-45, direct-44)\n",
      "nmod:by(inhibited-12, renin-45)\n",
      "conj:in(classes-15, renin-45)\n",
      "root(ROOT-0, inhibitors-46)\n",
      "appos(inhibitors-46, dris-48)\n",
      "\n",
      "Parsing [sent. 91 len. 36]: however , currently used raas inhibitors still can not achieve their desired effects and are associated with certain drawbacks , such as adverse side effects , incomplete blockage of the system and poor end-organ protection .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (ADVP (RB currently))\n",
      "    (VP (VBD used)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP (NNS raas) (NNS inhibitors))\n",
      "          (ADVP (RB still))\n",
      "          (VP\n",
      "            (VP (MD can) (RB not)\n",
      "              (VP (VB achieve)\n",
      "                (NP (PRP$ their) (VBN desired) (NNS effects))))\n",
      "            (CC and)\n",
      "            (VP (VBP are)\n",
      "              (VP (VBN associated)\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP (JJ certain) (NNS drawbacks))\n",
      "                    (, ,)\n",
      "                    (PP (JJ such) (IN as)\n",
      "                      (NP (JJ adverse) (NN side) (NNS effects)))\n",
      "                    (, ,)\n",
      "                    (ADJP (JJ incomplete) (JJ blockage))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN system))\n",
      "                        (CC and)\n",
      "                        (NP (JJ poor) (JJ end-organ) (NN protection))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(used-4, however-1)\n",
      "advmod(used-4, currently-3)\n",
      "root(ROOT-0, used-4)\n",
      "compound(inhibitors-6, raas-5)\n",
      "nsubj(achieve-10, inhibitors-6)\n",
      "nsubjpass(associated-16, inhibitors-6)\n",
      "advmod(achieve-10, still-7)\n",
      "aux(achieve-10, can-8)\n",
      "neg(achieve-10, not-9)\n",
      "ccomp(used-4, achieve-10)\n",
      "nmod:poss(effects-13, their-11)\n",
      "amod(effects-13, desired-12)\n",
      "dobj(achieve-10, effects-13)\n",
      "cc(achieve-10, and-14)\n",
      "auxpass(associated-16, are-15)\n",
      "ccomp(used-4, associated-16)\n",
      "conj:and(achieve-10, associated-16)\n",
      "case(drawbacks-19, with-17)\n",
      "amod(drawbacks-19, certain-18)\n",
      "nmod:with(associated-16, drawbacks-19)\n",
      "case(effects-25, such-21)\n",
      "mwe(such-21, as-22)\n",
      "amod(effects-25, adverse-23)\n",
      "compound(effects-25, side-24)\n",
      "nmod:such_as(drawbacks-19, effects-25)\n",
      "amod(blockage-28, incomplete-27)\n",
      "amod(drawbacks-19, blockage-28)\n",
      "case(system-31, of-29)\n",
      "det(system-31, the-30)\n",
      "nmod:of(drawbacks-19, system-31)\n",
      "cc(system-31, and-32)\n",
      "amod(protection-35, poor-33)\n",
      "amod(protection-35, end-organ-34)\n",
      "nmod:of(drawbacks-19, protection-35)\n",
      "conj:and(system-31, protection-35)\n",
      "\n",
      "Parsing [sent. 92 len. 42]: in this review , we discuss the efficiency and specificity of the current raas inhibitors and propose some recommendations for achieving better treatments with better end-organ protection.hypertension research advance online publication , 6 july 2017 ; doi :10.1038 / hr .2017.65 .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (DT this) (NN review)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP\n",
      "      (VP (VB discuss)\n",
      "        (NP\n",
      "          (NP (DT the) (NN efficiency)\n",
      "            (CC and)\n",
      "            (NN specificity))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (JJ current) (NNS raas) (NNS inhibitors)))))\n",
      "      (CC and)\n",
      "      (VP (VB propose)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT some) (NNS recommendations))\n",
      "            (PP (IN for)\n",
      "              (S\n",
      "                (VP (VBG achieving)\n",
      "                  (NP (JJR better) (NNS treatments))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJR better) (JJ end-organ) (NN protection.hypertension) (NN research) (NN advance) (JJ online) (NNS publication)))))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (CD 6))\n",
      "            (NP (NNP july) (CD 2017)))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (QP (CD doi) (CD :10.1038))\n",
      "            (NNS /))\n",
      "          (NP (NN hr) (CD .2017.65)))))\n",
      "    (. .)))\n",
      "\n",
      "case(review-3, in-1)\n",
      "det(review-3, this-2)\n",
      "nmod:in(discuss-6, review-3)\n",
      "nsubj(discuss-6, we-5)\n",
      "nsubj(propose-17, we-5)\n",
      "root(ROOT-0, discuss-6)\n",
      "det(efficiency-8, the-7)\n",
      "dobj(discuss-6, efficiency-8)\n",
      "cc(efficiency-8, and-9)\n",
      "dobj(discuss-6, specificity-10)\n",
      "conj:and(efficiency-8, specificity-10)\n",
      "case(inhibitors-15, of-11)\n",
      "det(inhibitors-15, the-12)\n",
      "amod(inhibitors-15, current-13)\n",
      "compound(inhibitors-15, raas-14)\n",
      "nmod:of(efficiency-8, inhibitors-15)\n",
      "cc(discuss-6, and-16)\n",
      "conj:and(discuss-6, propose-17)\n",
      "det(recommendations-19, some-18)\n",
      "dobj(propose-17, recommendations-19)\n",
      "mark(achieving-21, for-20)\n",
      "acl(recommendations-19, achieving-21)\n",
      "amod(treatments-23, better-22)\n",
      "dobj(achieving-21, treatments-23)\n",
      "case(publication-31, with-24)\n",
      "amod(publication-31, better-25)\n",
      "amod(publication-31, end-organ-26)\n",
      "compound(publication-31, protection.hypertension-27)\n",
      "compound(publication-31, research-28)\n",
      "compound(publication-31, advance-29)\n",
      "amod(publication-31, online-30)\n",
      "nmod:with(achieving-21, publication-31)\n",
      "appos(recommendations-19, 6-33)\n",
      "dep(6-33, july-34)\n",
      "nummod(july-34, 2017-35)\n",
      "compound(:10.1038-38, doi-37)\n",
      "nummod(/-39, :10.1038-38)\n",
      "dep(recommendations-19, /-39)\n",
      "dep(recommendations-19, hr-40)\n",
      "nummod(hr-40, .2017.65-41)\n",
      "\n",
      "Parsing [sent. 93 len. 25]: the progression of chronic kidney disease ckd is largely independent of the underlying kidney disorder once renal function has fallen below a critical level .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN progression))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ chronic) (NN kidney) (NN disease) (NN ckd))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (RB largely) (JJ independent)\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ underlying) (NN kidney) (NN disorder))))\n",
      "      (SBAR (IN once)\n",
      "        (S\n",
      "          (NP (JJ renal) (NN function))\n",
      "          (VP (VBZ has)\n",
      "            (VP (VBN fallen)\n",
      "              (PP (IN below)\n",
      "                (NP (DT a) (JJ critical) (NN level))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(progression-2, the-1)\n",
      "nsubj(independent-10, progression-2)\n",
      "case(ckd-7, of-3)\n",
      "amod(ckd-7, chronic-4)\n",
      "compound(ckd-7, kidney-5)\n",
      "compound(ckd-7, disease-6)\n",
      "nmod:of(progression-2, ckd-7)\n",
      "cop(independent-10, is-8)\n",
      "advmod(independent-10, largely-9)\n",
      "root(ROOT-0, independent-10)\n",
      "case(disorder-15, of-11)\n",
      "det(disorder-15, the-12)\n",
      "amod(disorder-15, underlying-13)\n",
      "compound(disorder-15, kidney-14)\n",
      "nmod:of(independent-10, disorder-15)\n",
      "mark(fallen-20, once-16)\n",
      "amod(function-18, renal-17)\n",
      "nsubj(fallen-20, function-18)\n",
      "aux(fallen-20, has-19)\n",
      "advcl(independent-10, fallen-20)\n",
      "case(level-24, below-21)\n",
      "det(level-24, a-22)\n",
      "amod(level-24, critical-23)\n",
      "nmod:below(fallen-20, level-24)\n",
      "\n",
      "Parsing [sent. 94 len. 19]: hypertension is an independent risk factor for disease progression in both adult and pediatric patients with kidney disorders .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN hypertension))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an) (JJ independent) (NN risk) (NN factor))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN disease) (NN progression))\n",
      "              (PP (IN in)\n",
      "                (NP (DT both) (NN adult))))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (JJ pediatric) (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (NN kidney) (NNS disorders))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(factor-6, hypertension-1)\n",
      "cop(factor-6, is-2)\n",
      "det(factor-6, an-3)\n",
      "amod(factor-6, independent-4)\n",
      "compound(factor-6, risk-5)\n",
      "root(ROOT-0, factor-6)\n",
      "case(progression-9, for-7)\n",
      "compound(progression-9, disease-8)\n",
      "nmod:for(factor-6, progression-9)\n",
      "case(adult-12, in-10)\n",
      "det(adult-12, both-11)\n",
      "nmod:in(progression-9, adult-12)\n",
      "cc(progression-9, and-13)\n",
      "amod(patients-15, pediatric-14)\n",
      "nmod:for(factor-6, patients-15)\n",
      "conj:and(progression-9, patients-15)\n",
      "case(disorders-18, with-16)\n",
      "compound(disorders-18, kidney-17)\n",
      "nmod:with(patients-15, disorders-18)\n",
      "\n",
      "Parsing [sent. 95 len. 33]: optimal blood pressure control -LRB- 130 / 80mm hg -RRB- represents a main goal of conservative therapy in patients with chronic kidney disease ckd but it is rarely achieved in clinical practice .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (JJ optimal) (NN blood) (NN pressure) (NN control))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (QP (CD 130) (CD /))\n",
      "            (NN 80mm) (NN hg))\n",
      "          (-RRB- -RRB-)))\n",
      "      (VP (VBZ represents)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ main) (NN goal))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ conservative) (NN therapy))))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (JJ chronic) (NN kidney) (NN disease) (NN ckd)))))))\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBZ is)\n",
      "        (ADVP (RB rarely))\n",
      "        (VP (VBN achieved)\n",
      "          (PP (IN in)\n",
      "            (NP (JJ clinical) (NN practice))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(control-4, optimal-1)\n",
      "compound(control-4, blood-2)\n",
      "compound(control-4, pressure-3)\n",
      "nsubj(represents-11, control-4)\n",
      "compound(/-7, 130-6)\n",
      "nummod(hg-9, /-7)\n",
      "compound(hg-9, 80mm-8)\n",
      "appos(control-4, hg-9)\n",
      "root(ROOT-0, represents-11)\n",
      "det(goal-14, a-12)\n",
      "amod(goal-14, main-13)\n",
      "dobj(represents-11, goal-14)\n",
      "case(therapy-17, of-15)\n",
      "amod(therapy-17, conservative-16)\n",
      "nmod:of(goal-14, therapy-17)\n",
      "case(patients-19, in-18)\n",
      "nmod:in(represents-11, patients-19)\n",
      "case(ckd-24, with-20)\n",
      "amod(ckd-24, chronic-21)\n",
      "compound(ckd-24, kidney-22)\n",
      "compound(ckd-24, disease-23)\n",
      "nmod:with(patients-19, ckd-24)\n",
      "cc(represents-11, but-25)\n",
      "nsubjpass(achieved-29, it-26)\n",
      "auxpass(achieved-29, is-27)\n",
      "advmod(achieved-29, rarely-28)\n",
      "conj:but(represents-11, achieved-29)\n",
      "case(practice-32, in-30)\n",
      "amod(practice-32, clinical-31)\n",
      "nmod:in(achieved-29, practice-32)\n",
      "\n",
      "Parsing [sent. 96 len. 18]: ACEI and angiotensin receptor blockers are more effective than other drugs in slowing progression of proteinuric ckd .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI)\n",
      "      (CC and)\n",
      "      (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "    (VP (VBP are)\n",
      "      (ADJP (RBR more) (JJ effective)\n",
      "        (PP (IN than)\n",
      "          (NP\n",
      "            (NP (JJ other) (NNS drugs))\n",
      "            (PP (IN in)\n",
      "              (NP\n",
      "                (NP (VBG slowing) (NN progression))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ proteinuric) (NN ckd)))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(blockers-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, angiotensin-3)\n",
      "compound(blockers-5, angiotensin-3)\n",
      "compound(blockers-5, receptor-4)\n",
      "nsubj(effective-8, blockers-5)\n",
      "cop(effective-8, are-6)\n",
      "advmod(effective-8, more-7)\n",
      "root(ROOT-0, effective-8)\n",
      "case(drugs-11, than-9)\n",
      "amod(drugs-11, other-10)\n",
      "nmod:than(effective-8, drugs-11)\n",
      "case(progression-14, in-12)\n",
      "amod(progression-14, slowing-13)\n",
      "nmod:in(drugs-11, progression-14)\n",
      "case(ckd-17, of-15)\n",
      "amod(ckd-17, proteinuric-16)\n",
      "nmod:of(progression-14, ckd-17)\n",
      "\n",
      "Parsing [sent. 97 len. 20]: dietary salt restriction -LRB- â¤ 100 meq/die of nacl -RRB- may be useful to correct the extracellular volume expansion .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ dietary) (NN salt) (NN restriction))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP\n",
      "            (QP (CD â¤) (CD 100))\n",
      "            (NN meq/die))\n",
      "          (PP (IN of)\n",
      "            (NP (NN nacl))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ useful)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB correct)\n",
      "                (NP (DT the) (NN extracellular) (NN volume) (NN expansion))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(restriction-3, dietary-1)\n",
      "compound(restriction-3, salt-2)\n",
      "nsubj(useful-13, restriction-3)\n",
      "nsubj:xsubj(correct-15, restriction-3)\n",
      "compound(100-6, â¤-5)\n",
      "nummod(meq/die-7, 100-6)\n",
      "dep(restriction-3, meq/die-7)\n",
      "case(nacl-9, of-8)\n",
      "nmod:of(meq/die-7, nacl-9)\n",
      "aux(useful-13, may-11)\n",
      "cop(useful-13, be-12)\n",
      "root(ROOT-0, useful-13)\n",
      "mark(correct-15, to-14)\n",
      "xcomp(useful-13, correct-15)\n",
      "det(expansion-19, the-16)\n",
      "compound(expansion-19, extracellular-17)\n",
      "compound(expansion-19, volume-18)\n",
      "dobj(correct-15, expansion-19)\n",
      "\n",
      "Parsing [sent. 98 len. 33]: if this intervention fails , hypertension can be treated by thiazide diuretics in patients with mild ckd , whereas loop diuretics at adequate doses are indicated in patients with more advanced ckd .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN if)\n",
      "      (S\n",
      "        (NP (DT this) (NN intervention))\n",
      "        (VP (VBZ fails))))\n",
      "    (, ,)\n",
      "    (NP (NN hypertension))\n",
      "    (VP (MD can)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN treated)\n",
      "          (PP (IN by)\n",
      "            (NP (JJ thiazide) (NNS diuretics)))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ mild) (NN ckd)))))\n",
      "          (, ,)\n",
      "          (SBAR (IN whereas)\n",
      "            (S\n",
      "              (NP\n",
      "                (NP (NN loop) (NNS diuretics))\n",
      "                (PP (IN at)\n",
      "                  (NP (JJ adequate) (NNS doses))))\n",
      "              (VP (VBP are)\n",
      "                (VP (VBN indicated)\n",
      "                  (PP (IN in)\n",
      "                    (NP\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP\n",
      "                          (ADJP (RBR more) (JJ advanced))\n",
      "                          (NN ckd))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(fails-4, if-1)\n",
      "det(intervention-3, this-2)\n",
      "nsubj(fails-4, intervention-3)\n",
      "advcl(treated-9, fails-4)\n",
      "nsubjpass(treated-9, hypertension-6)\n",
      "aux(treated-9, can-7)\n",
      "auxpass(treated-9, be-8)\n",
      "root(ROOT-0, treated-9)\n",
      "case(diuretics-12, by-10)\n",
      "amod(diuretics-12, thiazide-11)\n",
      "nmod:by(treated-9, diuretics-12)\n",
      "case(patients-14, in-13)\n",
      "nmod:in(treated-9, patients-14)\n",
      "case(ckd-17, with-15)\n",
      "amod(ckd-17, mild-16)\n",
      "nmod:with(patients-14, ckd-17)\n",
      "mark(indicated-26, whereas-19)\n",
      "compound(diuretics-21, loop-20)\n",
      "nsubjpass(indicated-26, diuretics-21)\n",
      "case(doses-24, at-22)\n",
      "amod(doses-24, adequate-23)\n",
      "nmod:at(diuretics-21, doses-24)\n",
      "auxpass(indicated-26, are-25)\n",
      "advcl(treated-9, indicated-26)\n",
      "case(patients-28, in-27)\n",
      "nmod:in(indicated-26, patients-28)\n",
      "case(ckd-32, with-29)\n",
      "advmod(advanced-31, more-30)\n",
      "amod(ckd-32, advanced-31)\n",
      "nmod:with(patients-28, ckd-32)\n",
      "\n",
      "Parsing [sent. 99 len. 49]: the beneficial effects of ACEI -LRB- ACEI -RRB- inhibitors and angiotensin ii -LRB- aii -RRB- receptor antagonists in patients with heart failure secondary to reduced ejection fraction -LRB- hfref -RRB- are felt to result from prevention of the adverse effects of aii on systemic afterload and renal homeostasis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "        (PP (IN of)\n",
      "          (NP (NNP ACEI)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP ACEI))\n",
      "              (-RRB- -RRB-))\n",
      "            (NN inhibitors))))\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP\n",
      "            (QP (CD angiotensin) (CD ii)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN aii))\n",
      "            (-RRB- -RRB-))\n",
      "          (NN receptor) (NNS antagonists))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NN heart) (NN failure))\n",
      "                  (ADJP (JJ secondary)\n",
      "                    (PP (TO to)\n",
      "                      (NP (JJ reduced) (NN ejection) (NN fraction)))))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN hfref))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN felt)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB result)\n",
      "              (PP (IN from)\n",
      "                (NP\n",
      "                  (NP (NN prevention))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (DT the) (JJ adverse) (NNS effects))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NN aii)))))))\n",
      "              (PP (IN on)\n",
      "                (NP (JJ systemic) (JJ afterload)\n",
      "                  (CC and)\n",
      "                  (JJ renal) (NNS homeostasis))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(effects-3, the-1)\n",
      "amod(effects-3, beneficial-2)\n",
      "nsubjpass(felt-32, effects-3)\n",
      "nsubj:xsubj(result-34, effects-3)\n",
      "case(inhibitors-9, of-4)\n",
      "compound(inhibitors-9, ACEI-5)\n",
      "appos(inhibitors-9, ACEI-7)\n",
      "nmod:of(effects-3, inhibitors-9)\n",
      "cc(effects-3, and-10)\n",
      "compound(ii-12, angiotensin-11)\n",
      "nummod(antagonists-17, ii-12)\n",
      "appos(antagonists-17, aii-14)\n",
      "compound(antagonists-17, receptor-16)\n",
      "conj:and(effects-3, antagonists-17)\n",
      "nsubjpass(felt-32, antagonists-17)\n",
      "nsubj:xsubj(result-34, antagonists-17)\n",
      "case(patients-19, in-18)\n",
      "nmod:in(antagonists-17, patients-19)\n",
      "case(failure-22, with-20)\n",
      "compound(failure-22, heart-21)\n",
      "nmod:with(patients-19, failure-22)\n",
      "amod(failure-22, secondary-23)\n",
      "case(fraction-27, to-24)\n",
      "amod(fraction-27, reduced-25)\n",
      "compound(fraction-27, ejection-26)\n",
      "nmod:to(secondary-23, fraction-27)\n",
      "appos(failure-22, hfref-29)\n",
      "auxpass(felt-32, are-31)\n",
      "root(ROOT-0, felt-32)\n",
      "mark(result-34, to-33)\n",
      "xcomp(felt-32, result-34)\n",
      "case(prevention-36, from-35)\n",
      "nmod:from(result-34, prevention-36)\n",
      "case(effects-40, of-37)\n",
      "det(effects-40, the-38)\n",
      "amod(effects-40, adverse-39)\n",
      "nmod:of(prevention-36, effects-40)\n",
      "case(aii-42, of-41)\n",
      "nmod:of(effects-40, aii-42)\n",
      "case(afterload-45, on-43)\n",
      "amod(afterload-45, systemic-44)\n",
      "nmod:on(result-34, afterload-45)\n",
      "cc(afterload-45, and-46)\n",
      "amod(homeostasis-48, renal-47)\n",
      "nmod:on(result-34, homeostasis-48)\n",
      "conj:and(afterload-45, homeostasis-48)\n",
      "\n",
      "Parsing [sent. 100 len. 30]: however , aii can activate the sympathetic nervous system and part of the beneficial effects of ACEI and aii antagonists may result from their ability to inhibit such activation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN aii))\n",
      "      (VP (MD can)\n",
      "        (VP (VB activate)\n",
      "          (NP\n",
      "            (NP (DT the)\n",
      "              (ADJP (JJ sympathetic) (JJ nervous))\n",
      "              (NN system))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (NN part))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NNP ACEI))))))))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN aii) (NNS antagonists))\n",
      "      (VP (MD may)\n",
      "        (VP (VB result)\n",
      "          (PP (IN from)\n",
      "            (NP (PRP$ their) (NN ability)\n",
      "              (S\n",
      "                (VP (TO to)\n",
      "                  (VP (VB inhibit)\n",
      "                    (NP (JJ such) (NN activation))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(activate-5, however-1)\n",
      "nsubj(activate-5, aii-3)\n",
      "aux(activate-5, can-4)\n",
      "root(ROOT-0, activate-5)\n",
      "det(system-9, the-6)\n",
      "amod(nervous-8, sympathetic-7)\n",
      "amod(system-9, nervous-8)\n",
      "dobj(activate-5, system-9)\n",
      "cc(system-9, and-10)\n",
      "dobj(activate-5, part-11)\n",
      "conj:and(system-9, part-11)\n",
      "case(effects-15, of-12)\n",
      "det(effects-15, the-13)\n",
      "amod(effects-15, beneficial-14)\n",
      "nmod:of(part-11, effects-15)\n",
      "case(ACEI-17, of-16)\n",
      "nmod:of(effects-15, ACEI-17)\n",
      "cc(activate-5, and-18)\n",
      "compound(antagonists-20, aii-19)\n",
      "nsubj(result-22, antagonists-20)\n",
      "aux(result-22, may-21)\n",
      "conj:and(activate-5, result-22)\n",
      "case(ability-25, from-23)\n",
      "nmod:poss(ability-25, their-24)\n",
      "nmod:from(result-22, ability-25)\n",
      "mark(inhibit-27, to-26)\n",
      "acl(ability-25, inhibit-27)\n",
      "amod(activation-29, such-28)\n",
      "dobj(inhibit-27, activation-29)\n",
      "\n",
      "Parsing [sent. 101 len. 48]: we examined the acute effects of the ACEI captopril -LRB- 25 mg , n = 9 -RRB- and the aii receptor antagonist losartan -LRB- 50 mg , n = 10 -RRB- on hemodynamics as well as total body and cardiac norepinephrine spillover in patients with chronic hfref .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD examined)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ acute) (NNS effects))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT the) (NNP ACEI) (NN captopril))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 25) (NN mg))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (SBAR\n",
      "                    (S\n",
      "                      (VP (SYM =)\n",
      "                        (NP (CD 9)))))))\n",
      "              (-RRB- -RRB-))\n",
      "            (CC and)\n",
      "            (NP (DT the) (JJ aii) (NN receptor) (NN antagonist) (NN losartan))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 50) (NN mg))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (SBAR\n",
      "                    (S\n",
      "                      (VP (SYM =)\n",
      "                        (NP (CD 10)))))))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (NNS hemodynamics))\n",
      "          (CONJP (RB as) (RB well) (IN as))\n",
      "          (NP (JJ total) (NN body)\n",
      "            (CC and)\n",
      "            (JJ cardiac) (NN norepinephrine) (NN spillover))))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ chronic) (NN hfref))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(examined-2, we-1)\n",
      "root(ROOT-0, examined-2)\n",
      "det(effects-5, the-3)\n",
      "amod(effects-5, acute-4)\n",
      "dobj(examined-2, effects-5)\n",
      "case(captopril-9, of-6)\n",
      "det(captopril-9, the-7)\n",
      "compound(captopril-9, ACEI-8)\n",
      "nmod:of(effects-5, captopril-9)\n",
      "nummod(mg-12, 25-11)\n",
      "dep(captopril-9, mg-12)\n",
      "appos(mg-12, n-14)\n",
      "dep(9-16, =-15)\n",
      "acl:relcl(n-14, 9-16)\n",
      "cc(captopril-9, and-18)\n",
      "det(losartan-23, the-19)\n",
      "amod(losartan-23, aii-20)\n",
      "compound(losartan-23, receptor-21)\n",
      "compound(losartan-23, antagonist-22)\n",
      "nmod:of(effects-5, losartan-23)\n",
      "conj:and(captopril-9, losartan-23)\n",
      "nummod(mg-26, 50-25)\n",
      "dep(captopril-9, mg-26)\n",
      "appos(mg-26, n-28)\n",
      "dep(10-30, =-29)\n",
      "acl:relcl(n-28, 10-30)\n",
      "case(hemodynamics-33, on-32)\n",
      "nmod:on(examined-2, hemodynamics-33)\n",
      "cc(hemodynamics-33, as-34)\n",
      "mwe(as-34, well-35)\n",
      "mwe(as-34, as-36)\n",
      "amod(body-38, total-37)\n",
      "nmod:on(examined-2, body-38)\n",
      "conj:and(hemodynamics-33, body-38)\n",
      "cc(body-38, and-39)\n",
      "amod(spillover-42, cardiac-40)\n",
      "compound(spillover-42, norepinephrine-41)\n",
      "conj:and(hemodynamics-33, spillover-42)\n",
      "conj:and(body-38, spillover-42)\n",
      "case(patients-44, in-43)\n",
      "nmod:in(examined-2, patients-44)\n",
      "case(hfref-47, with-45)\n",
      "amod(hfref-47, chronic-46)\n",
      "nmod:with(patients-44, hfref-47)\n",
      "\n",
      "Parsing [sent. 102 len. 20]: hemodynamic and neurochemical measurements were made at baseline and at 1 , 2 and 4 hours after oral dosing .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (JJ hemodynamic)\n",
      "        (CC and)\n",
      "        (JJ neurochemical))\n",
      "      (NNS measurements))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN made)\n",
      "        (PP\n",
      "          (PP (IN at)\n",
      "            (NP (NN baseline)))\n",
      "          (CC and)\n",
      "          (PP (IN at)\n",
      "            (NP (CD 1) (, ,) (CD 2)\n",
      "              (CC and)\n",
      "              (CD 4)))\n",
      "          (NP (NNS hours)))\n",
      "        (PP (IN after)\n",
      "          (NP (JJ oral) (NN dosing)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(measurements-4, hemodynamic-1)\n",
      "cc(hemodynamic-1, and-2)\n",
      "conj:and(hemodynamic-1, neurochemical-3)\n",
      "amod(measurements-4, neurochemical-3)\n",
      "nsubjpass(made-6, measurements-4)\n",
      "auxpass(made-6, were-5)\n",
      "root(ROOT-0, made-6)\n",
      "case(baseline-8, at-7)\n",
      "nmod:at(hours-16, baseline-8)\n",
      "cc(hours-16, and-9)\n",
      "case(1-11, at-10)\n",
      "nmod(made-6, 1-11)\n",
      "conj:and(hours-16, 1-11)\n",
      "nummod(1-11, 2-13)\n",
      "cc(1-11, and-14)\n",
      "conj:and(1-11, 4-15)\n",
      "conj:and(hours-16, 4-15)\n",
      "nmod(made-6, hours-16)\n",
      "case(dosing-19, after-17)\n",
      "amod(dosing-19, oral-18)\n",
      "nmod:after(made-6, dosing-19)\n",
      "\n",
      "Parsing [sent. 103 len. 25]: administration of both drugs caused significant reductions in systemic arterial , cardiac filling and pulmonary artery pressures -LRB- p < 0.05 vs baseline -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN administration))\n",
      "      (PP (IN of)\n",
      "        (NP (DT both) (NNS drugs))))\n",
      "    (VP (VBD caused)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (JJ significant) (NNS reductions))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ systemic) (NN arterial))))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (JJ cardiac) (NN filling))\n",
      "          (CC and)\n",
      "          (NP (JJ pulmonary) (NN artery) (NNS pressures)))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN p)\n",
      "            (S\n",
      "              (VP (VBG <)\n",
      "                (NP (CD 0.05) (NN vs) (NN baseline)))))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(caused-5, administration-1)\n",
      "case(drugs-4, of-2)\n",
      "det(drugs-4, both-3)\n",
      "nmod:of(administration-1, drugs-4)\n",
      "root(ROOT-0, caused-5)\n",
      "amod(reductions-7, significant-6)\n",
      "dobj(caused-5, reductions-7)\n",
      "case(arterial-10, in-8)\n",
      "amod(arterial-10, systemic-9)\n",
      "nmod:in(reductions-7, arterial-10)\n",
      "amod(filling-13, cardiac-12)\n",
      "appos(reductions-7, filling-13)\n",
      "cc(filling-13, and-14)\n",
      "amod(pressures-17, pulmonary-15)\n",
      "compound(pressures-17, artery-16)\n",
      "appos(reductions-7, pressures-17)\n",
      "conj:and(filling-13, pressures-17)\n",
      "dep(reductions-7, p-19)\n",
      "xcomp(p-19, <-20)\n",
      "nummod(baseline-23, 0.05-21)\n",
      "compound(baseline-23, vs-22)\n",
      "dobj(<-20, baseline-23)\n",
      "\n",
      "Parsing [sent. 104 len. 13]: there was no significant difference in the magnitude of those hemodynamic effects .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT no) (JJ significant) (NN difference))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN magnitude))\n",
      "            (PP (IN of)\n",
      "              (NP (DT those) (JJ hemodynamic) (NNS effects)))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "neg(difference-5, no-3)\n",
      "amod(difference-5, significant-4)\n",
      "nsubj(was-2, difference-5)\n",
      "case(magnitude-8, in-6)\n",
      "det(magnitude-8, the-7)\n",
      "nmod:in(difference-5, magnitude-8)\n",
      "case(effects-12, of-9)\n",
      "det(effects-12, those-10)\n",
      "amod(effects-12, hemodynamic-11)\n",
      "nmod:of(magnitude-8, effects-12)\n",
      "\n",
      "Parsing [sent. 105 len. 23]: plasma concentrations of aii were significantly decreased by captopril and increased by losartan -LRB- p < 0.05 vs baseline for both -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN plasma) (NNS concentrations))\n",
      "      (PP (IN of)\n",
      "        (NP (NN aii))))\n",
      "    (VP (VBD were)\n",
      "      (ADVP (RB significantly))\n",
      "      (VP\n",
      "        (VP (VBN decreased)\n",
      "          (PP (IN by)\n",
      "            (NP (NN captopril))))\n",
      "        (CC and)\n",
      "        (VP (VBN increased)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (NN losartan))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN p)\n",
      "                  (S\n",
      "                    (VP (VBG <)\n",
      "                      (NP (CD 0.05) (NN vs) (NN baseline))\n",
      "                      (PP (IN for)\n",
      "                        (NP (DT both))))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(concentrations-2, plasma-1)\n",
      "nsubjpass(decreased-7, concentrations-2)\n",
      "nsubjpass(increased-11, concentrations-2)\n",
      "case(aii-4, of-3)\n",
      "nmod:of(concentrations-2, aii-4)\n",
      "auxpass(decreased-7, were-5)\n",
      "advmod(decreased-7, significantly-6)\n",
      "root(ROOT-0, decreased-7)\n",
      "case(captopril-9, by-8)\n",
      "nmod:by(decreased-7, captopril-9)\n",
      "cc(decreased-7, and-10)\n",
      "conj:and(decreased-7, increased-11)\n",
      "case(losartan-13, by-12)\n",
      "nmod:by(increased-11, losartan-13)\n",
      "dep(losartan-13, p-15)\n",
      "xcomp(p-15, <-16)\n",
      "nummod(baseline-19, 0.05-17)\n",
      "compound(baseline-19, vs-18)\n",
      "dobj(<-16, baseline-19)\n",
      "case(both-21, for-20)\n",
      "nmod:for(<-16, both-21)\n",
      "\n",
      "Parsing [sent. 106 len. 37]: total body sympathetic activity increased in response to both captopril and losartan -LRB- p < 0.05 vs baseline for both -RRB- , however there was no change in cardiac sympathetic activity in response to either drug .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ total) (NN body) (JJ sympathetic) (NN activity))\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN in)\n",
      "          (NP (NN response)))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (DT both) (NN captopril)\n",
      "              (CC and)\n",
      "              (NN losartan))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (NN p) (NNS <))\n",
      "                (NP\n",
      "                  (NP (CD 0.05) (NN vs) (NN baseline))\n",
      "                  (PP (IN for)\n",
      "                    (NP (DT both)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (, ,)\n",
      "    (ADVP (RB however))\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT no) (NN change))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (JJ cardiac) (JJ sympathetic) (NN activity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN response))))))\n",
      "      (PP (TO to)\n",
      "        (NP (DT either) (NN drug))))\n",
      "    (. .)))\n",
      "\n",
      "amod(activity-4, total-1)\n",
      "compound(activity-4, body-2)\n",
      "amod(activity-4, sympathetic-3)\n",
      "nsubj(was-25, activity-4)\n",
      "acl(activity-4, increased-5)\n",
      "case(response-7, in-6)\n",
      "nmod:in(increased-5, response-7)\n",
      "case(captopril-10, to-8)\n",
      "cc:preconj(captopril-10, both-9)\n",
      "nmod:to(increased-5, captopril-10)\n",
      "cc(captopril-10, and-11)\n",
      "nmod:to(increased-5, losartan-12)\n",
      "conj:and(captopril-10, losartan-12)\n",
      "compound(<-15, p-14)\n",
      "dep(captopril-10, <-15)\n",
      "nummod(baseline-18, 0.05-16)\n",
      "compound(baseline-18, vs-17)\n",
      "dep(<-15, baseline-18)\n",
      "case(both-20, for-19)\n",
      "nmod:for(baseline-18, both-20)\n",
      "expl(was-25, however-23)\n",
      "dep(however-23, there-24)\n",
      "root(ROOT-0, was-25)\n",
      "neg(change-27, no-26)\n",
      "nsubj(was-25, change-27)\n",
      "case(activity-31, in-28)\n",
      "amod(activity-31, cardiac-29)\n",
      "amod(activity-31, sympathetic-30)\n",
      "nmod:in(change-27, activity-31)\n",
      "case(response-33, in-32)\n",
      "nmod:in(activity-31, response-33)\n",
      "case(drug-36, to-34)\n",
      "det(drug-36, either-35)\n",
      "nmod:to(was-25, drug-36)\n",
      "\n",
      "Parsing [sent. 107 len. 29]: the results of the current study do not support the hypothesis that the acute inhibition of the renin angiotensin system has sympathoinhibitory effects in patients with chronic hfref .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NNS results))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ current) (NN study))))\n",
      "    (VP (VBP do) (RB not)\n",
      "      (VP (VB support)\n",
      "        (NP (DT the) (NNS hypothesis))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (DT the) (JJ acute) (NN inhibition))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN renin) (NN angiotensin) (NN system))))\n",
      "            (VP (VBZ has)\n",
      "              (NP\n",
      "                (NP (JJ sympathoinhibitory) (NNS effects))\n",
      "                (PP (IN in)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ chronic) (NN hfref)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(results-2, the-1)\n",
      "nsubj(support-9, results-2)\n",
      "case(study-6, of-3)\n",
      "det(study-6, the-4)\n",
      "amod(study-6, current-5)\n",
      "nmod:of(results-2, study-6)\n",
      "aux(support-9, do-7)\n",
      "neg(support-9, not-8)\n",
      "root(ROOT-0, support-9)\n",
      "det(hypothesis-11, the-10)\n",
      "dobj(support-9, hypothesis-11)\n",
      "mark(has-21, that-12)\n",
      "det(inhibition-15, the-13)\n",
      "amod(inhibition-15, acute-14)\n",
      "nsubj(has-21, inhibition-15)\n",
      "case(system-20, of-16)\n",
      "det(system-20, the-17)\n",
      "compound(system-20, renin-18)\n",
      "compound(system-20, angiotensin-19)\n",
      "nmod:of(inhibition-15, system-20)\n",
      "ccomp(support-9, has-21)\n",
      "amod(effects-23, sympathoinhibitory-22)\n",
      "dobj(has-21, effects-23)\n",
      "case(patients-25, in-24)\n",
      "nmod:in(effects-23, patients-25)\n",
      "case(hfref-28, with-26)\n",
      "amod(hfref-28, chronic-27)\n",
      "nmod:with(patients-25, hfref-28)\n",
      "\n",
      "Parsing [sent. 108 len. 39]: the improvement of the physical functioning and hrqol in older hypertensive adults using ACEI medications only occur if they adopt an exercise training regimen , increasing also the management of the blood pressure and other cardiovascular risk factors .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN improvement))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ physical) (NN functioning)\n",
      "            (CC and)\n",
      "            (NN hrqol))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (JJR older) (NN hypertensive) (NNS adults))\n",
      "              (VP (VBG using)\n",
      "                (NP (CD ACEI) (NNS medications))))))))\n",
      "    (ADVP (RB only))\n",
      "    (VP (VBP occur)\n",
      "      (SBAR (IN if)\n",
      "        (S\n",
      "          (NP (PRP they))\n",
      "          (VP (VBP adopt)\n",
      "            (NP (DT an) (NN exercise) (NN training) (NN regimen))\n",
      "            (, ,)\n",
      "            (S\n",
      "              (VP (VBG increasing)\n",
      "                (ADVP (RB also))\n",
      "                (NP\n",
      "                  (NP (DT the) (NN management))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN blood) (NN pressure))\n",
      "                      (CC and)\n",
      "                      (NP (JJ other) (JJ cardiovascular) (NN risk) (NNS factors)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(improvement-2, the-1)\n",
      "nsubj(occur-17, improvement-2)\n",
      "case(functioning-6, of-3)\n",
      "det(functioning-6, the-4)\n",
      "amod(functioning-6, physical-5)\n",
      "nmod:of(improvement-2, functioning-6)\n",
      "cc(functioning-6, and-7)\n",
      "nmod:of(improvement-2, hrqol-8)\n",
      "conj:and(functioning-6, hrqol-8)\n",
      "case(adults-12, in-9)\n",
      "amod(adults-12, older-10)\n",
      "compound(adults-12, hypertensive-11)\n",
      "nmod:in(functioning-6, adults-12)\n",
      "acl(adults-12, using-13)\n",
      "nummod(medications-15, ACEI-14)\n",
      "dobj(using-13, medications-15)\n",
      "advmod(occur-17, only-16)\n",
      "root(ROOT-0, occur-17)\n",
      "mark(adopt-20, if-18)\n",
      "nsubj(adopt-20, they-19)\n",
      "advcl(occur-17, adopt-20)\n",
      "det(regimen-24, an-21)\n",
      "compound(regimen-24, exercise-22)\n",
      "compound(regimen-24, training-23)\n",
      "dobj(adopt-20, regimen-24)\n",
      "advcl(adopt-20, increasing-26)\n",
      "advmod(increasing-26, also-27)\n",
      "det(management-29, the-28)\n",
      "dobj(increasing-26, management-29)\n",
      "case(pressure-33, of-30)\n",
      "det(pressure-33, the-31)\n",
      "compound(pressure-33, blood-32)\n",
      "nmod:of(management-29, pressure-33)\n",
      "cc(pressure-33, and-34)\n",
      "amod(factors-38, other-35)\n",
      "amod(factors-38, cardiovascular-36)\n",
      "compound(factors-38, risk-37)\n",
      "nmod:of(management-29, factors-38)\n",
      "conj:and(pressure-33, factors-38)\n",
      "\n",
      "Parsing [sent. 109 len. 15]: agreement in the 20 % sampling between investigators was high -LRB- 96 % -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN agreement))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the)\n",
      "            (ADJP (CD 20) (NN %))\n",
      "            (NN sampling))\n",
      "          (PP (IN between)\n",
      "            (NP (NNS investigators))))))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ high))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 96) (NN %))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(high-10, agreement-1)\n",
      "case(sampling-6, in-2)\n",
      "det(sampling-6, the-3)\n",
      "compound(%-5, 20-4)\n",
      "amod(sampling-6, %-5)\n",
      "nmod:in(agreement-1, sampling-6)\n",
      "case(investigators-8, between-7)\n",
      "nmod:between(sampling-6, investigators-8)\n",
      "cop(high-10, was-9)\n",
      "root(ROOT-0, high-10)\n",
      "nummod(%-13, 96-12)\n",
      "dep(high-10, %-13)\n",
      "\n",
      "Parsing [sent. 110 len. 30]: the mean qtc in the acs group was 457 ms and the mean qtc in the etoh withdrawal-related group was 468 ms -LRB- diff 11 , not significant -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ mean) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (NN acs) (NN group))))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (QP (CD 457) (CD ms)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ mean) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (JJ etoh) (JJ withdrawal-related) (NN group))))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP (CD 468) (NN ms))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (NN diff) (CD 11))\n",
      "              (, ,)\n",
      "              (NP (RB not) (JJ significant)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "det(qtc-3, the-1)\n",
      "amod(qtc-3, mean-2)\n",
      "nsubj(ms-10, qtc-3)\n",
      "case(group-7, in-4)\n",
      "det(group-7, the-5)\n",
      "compound(group-7, acs-6)\n",
      "nmod:in(qtc-3, group-7)\n",
      "cop(ms-10, was-8)\n",
      "compound(ms-10, 457-9)\n",
      "root(ROOT-0, ms-10)\n",
      "cc(ms-10, and-11)\n",
      "det(qtc-14, the-12)\n",
      "amod(qtc-14, mean-13)\n",
      "nsubj(ms-22, qtc-14)\n",
      "case(group-19, in-15)\n",
      "det(group-19, the-16)\n",
      "amod(group-19, etoh-17)\n",
      "amod(group-19, withdrawal-related-18)\n",
      "nmod:in(qtc-14, group-19)\n",
      "cop(ms-22, was-20)\n",
      "nummod(ms-22, 468-21)\n",
      "conj:and(ms-10, ms-22)\n",
      "dep(ms-22, diff-24)\n",
      "nummod(diff-24, 11-25)\n",
      "neg(significant-28, not-27)\n",
      "appos(diff-24, significant-28)\n",
      "\n",
      "Parsing [sent. 111 len. 35]: significantly more patients had a prolonged qtc in the etoh withdrawal group than in the acs group 62 % vs 46 % ; diff 16 ; 95 % ci -LRB- 0.1 , 30 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (RB significantly) (JJR more))\n",
      "      (NNS patients))\n",
      "    (VP (VBD had)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prolonged) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))\n",
      "      (PP (IN than) (IN in)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN acs) (NN group) (CD 62) (NN %) (NN vs))\n",
      "            (ADJP (CD 46) (NN %)))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (NP (NN diff) (CD 16))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP\n",
      "                (ADJP (CD 95) (NN %))\n",
      "                (NN ci))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (CD 0.1))\n",
      "                (, ,)\n",
      "                (NP (CD 30))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(more-2, significantly-1)\n",
      "amod(patients-3, more-2)\n",
      "nsubj(had-4, patients-3)\n",
      "root(ROOT-0, had-4)\n",
      "det(qtc-7, a-5)\n",
      "amod(qtc-7, prolonged-6)\n",
      "dobj(had-4, qtc-7)\n",
      "case(group-12, in-8)\n",
      "det(group-12, the-9)\n",
      "amod(group-12, etoh-10)\n",
      "compound(group-12, withdrawal-11)\n",
      "nmod:in(qtc-7, group-12)\n",
      "case(vs-20, than-13)\n",
      "case(vs-20, in-14)\n",
      "det(vs-20, the-15)\n",
      "compound(vs-20, acs-16)\n",
      "compound(vs-20, group-17)\n",
      "nummod(vs-20, 62-18)\n",
      "compound(vs-20, %-19)\n",
      "nmod:in(had-4, vs-20)\n",
      "compound(%-22, 46-21)\n",
      "amod(vs-20, %-22)\n",
      "dep(vs-20, diff-24)\n",
      "nummod(diff-24, 16-25)\n",
      "compound(%-28, 95-27)\n",
      "amod(ci-29, %-28)\n",
      "dep(diff-24, ci-29)\n",
      "appos(ci-29, 0.1-31)\n",
      "dep(0.1-31, 30-33)\n",
      "\n",
      "Parsing [sent. 112 len. 43]: there was significantly more use of clopidogrel , acetylsalicylic acid , ACEI , and statins -LRB- p < 0.05 for all -RRB- in the acs group compared with the etoh withdrawal group ; however , there was no difference in Î²-blocker usage .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP\n",
      "            (ADJP (RB significantly) (JJR more))\n",
      "            (NN use))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN clopidogrel))\n",
      "              (, ,)\n",
      "              (NP (JJ acetylsalicylic) (NN acid))\n",
      "              (, ,)\n",
      "              (NP (NNP ACEI))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NNS statins))))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05))\n",
      "              (PP (IN for)\n",
      "                (NP (DT all))))\n",
      "            (-RRB- -RRB-)))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN acs) (NN group))\n",
      "            (PP (VBN compared)\n",
      "              (PP (IN with)\n",
      "                (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (ADVP (RB however))\n",
      "      (, ,)\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP (DT no) (NN difference))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ Î²-blocker) (NN usage))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "advmod(more-4, significantly-3)\n",
      "amod(use-5, more-4)\n",
      "nsubj(was-2, use-5)\n",
      "case(clopidogrel-7, of-6)\n",
      "nmod:of(use-5, clopidogrel-7)\n",
      "amod(acid-10, acetylsalicylic-9)\n",
      "nmod:of(use-5, acid-10)\n",
      "conj:and(clopidogrel-7, acid-10)\n",
      "nmod:of(use-5, ACEI-12)\n",
      "conj:and(clopidogrel-7, ACEI-12)\n",
      "cc(clopidogrel-7, and-14)\n",
      "nmod:of(use-5, statins-15)\n",
      "conj:and(clopidogrel-7, statins-15)\n",
      "dep(use-5, p-17)\n",
      "nummod(0.05-19, <-18)\n",
      "dobj(p-17, 0.05-19)\n",
      "case(all-21, for-20)\n",
      "nmod:for(p-17, all-21)\n",
      "case(group-26, in-23)\n",
      "det(group-26, the-24)\n",
      "compound(group-26, acs-25)\n",
      "nmod:in(was-2, group-26)\n",
      "case(group-32, compared-27)\n",
      "mwe(compared-27, with-28)\n",
      "det(group-32, the-29)\n",
      "amod(group-32, etoh-30)\n",
      "compound(group-32, withdrawal-31)\n",
      "nmod:compared_with(group-26, group-32)\n",
      "advmod(was-37, however-34)\n",
      "expl(was-37, there-36)\n",
      "parataxis(was-2, was-37)\n",
      "neg(difference-39, no-38)\n",
      "nsubj(was-37, difference-39)\n",
      "case(usage-42, in-40)\n",
      "amod(usage-42, Î²-blocker-41)\n",
      "nmod:in(difference-39, usage-42)\n",
      "\n",
      "Parsing [sent. 113 len. 36]: there was a significantly higher admission rate : 100 % of acs compared with 76 % of the etoh withdrawal group -LRB- p < 0.01 , diff 24 , 95 % confidence interval 18-29 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP (DT a)\n",
      "          (ADJP (RB significantly) (JJR higher))\n",
      "          (NN admission) (NN rate))))\n",
      "    (: :)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (CD 100) (NN %))\n",
      "        (PP (IN of)\n",
      "          (NP (NN acs))))\n",
      "      (PP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (CD 76) (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NNP p) (NNP <) (NNP 0.01))\n",
      "          (, ,)\n",
      "          (NP (NN diff) (CD 24))\n",
      "          (, ,)\n",
      "          (NP (CD 95) (NN %) (NN confidence) (JJ interval) (NNS 18-29)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "det(rate-7, a-3)\n",
      "advmod(higher-5, significantly-4)\n",
      "amod(rate-7, higher-5)\n",
      "compound(rate-7, admission-6)\n",
      "nsubj(was-2, rate-7)\n",
      "nummod(%-10, 100-9)\n",
      "parataxis(was-2, %-10)\n",
      "case(acs-12, of-11)\n",
      "nmod:of(%-10, acs-12)\n",
      "case(%-16, compared-13)\n",
      "mwe(compared-13, with-14)\n",
      "nummod(%-16, 76-15)\n",
      "advcl(%-10, %-16)\n",
      "case(group-21, of-17)\n",
      "det(group-21, the-18)\n",
      "amod(group-21, etoh-19)\n",
      "compound(group-21, withdrawal-20)\n",
      "nmod:of(%-16, group-21)\n",
      "compound(0.01-25, p-23)\n",
      "compound(0.01-25, <-24)\n",
      "dep(%-10, 0.01-25)\n",
      "appos(0.01-25, diff-27)\n",
      "nummod(diff-27, 24-28)\n",
      "nummod(18-29-34, 95-30)\n",
      "compound(18-29-34, %-31)\n",
      "compound(18-29-34, confidence-32)\n",
      "amod(18-29-34, interval-33)\n",
      "appos(0.01-25, 18-29-34)\n",
      "\n",
      "Parsing [sent. 114 len. 10]: electrolytes were not significantly different in the two groups .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS electrolytes))\n",
      "    (VP (VBD were) (RB not)\n",
      "      (ADJP (RB significantly) (JJ different)\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (CD two) (NNS groups)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(different-5, electrolytes-1)\n",
      "cop(different-5, were-2)\n",
      "neg(different-5, not-3)\n",
      "advmod(different-5, significantly-4)\n",
      "root(ROOT-0, different-5)\n",
      "case(groups-9, in-6)\n",
      "det(groups-9, the-7)\n",
      "nummod(groups-9, two-8)\n",
      "nmod:in(different-5, groups-9)\n",
      "\n",
      "Parsing [sent. 115 len. 22]: the study compared two cohort groups , those with acs and those with etoh withdrawal-related ed visits over a 1-year period .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN study))\n",
      "    (VP (VBD compared)\n",
      "      (NP\n",
      "        (NP (CD two) (JJ cohort) (NNS groups))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP (NN acs))))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ etoh) (JJ withdrawal-related) (NN ed) (NNS visits)))))\n",
      "      (PP (IN over)\n",
      "        (NP (DT a) (JJ 1-year) (NN period))))\n",
      "    (. .)))\n",
      "\n",
      "det(study-2, the-1)\n",
      "nsubj(compared-3, study-2)\n",
      "root(ROOT-0, compared-3)\n",
      "nummod(groups-6, two-4)\n",
      "amod(groups-6, cohort-5)\n",
      "dobj(compared-3, groups-6)\n",
      "dobj(compared-3, those-8)\n",
      "conj:and(groups-6, those-8)\n",
      "case(acs-10, with-9)\n",
      "nmod:with(those-8, acs-10)\n",
      "cc(groups-6, and-11)\n",
      "dobj(compared-3, those-12)\n",
      "conj:and(groups-6, those-12)\n",
      "case(visits-17, with-13)\n",
      "amod(visits-17, etoh-14)\n",
      "amod(visits-17, withdrawal-related-15)\n",
      "compound(visits-17, ed-16)\n",
      "nmod:with(those-12, visits-17)\n",
      "case(period-21, over-18)\n",
      "det(period-21, a-19)\n",
      "amod(period-21, 1-year-20)\n",
      "nmod:over(compared-3, period-21)\n",
      "\n",
      "Parsing [sent. 116 len. 13]: we compared ecg qtc , cardiac medication use , and electrolyte differences .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD compared)\n",
      "      (NP\n",
      "        (NP (NN ecg) (NN qtc))\n",
      "        (, ,)\n",
      "        (NP (JJ cardiac) (NN medication) (NN use))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (JJ electrolyte) (NNS differences))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(compared-2, we-1)\n",
      "root(ROOT-0, compared-2)\n",
      "compound(qtc-4, ecg-3)\n",
      "dobj(compared-2, qtc-4)\n",
      "amod(use-8, cardiac-6)\n",
      "compound(use-8, medication-7)\n",
      "dobj(compared-2, use-8)\n",
      "conj:and(qtc-4, use-8)\n",
      "cc(qtc-4, and-10)\n",
      "amod(differences-12, electrolyte-11)\n",
      "dobj(compared-2, differences-12)\n",
      "conj:and(qtc-4, differences-12)\n",
      "\n",
      "Parsing [sent. 117 len. 23]: we considered a qtc of > 450 ms elevated for men and > 470 ms elevated for women based on the literature .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD considered)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT a) (NN qtc))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (QP (CD >) (CD 450))\n",
      "                (NN ms))))\n",
      "          (VP (VBD elevated)\n",
      "            (SBAR (IN for)\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (NNS men))\n",
      "                  (CC and)\n",
      "                  (NP\n",
      "                    (QP (CD >) (CD 470))\n",
      "                    (NN ms)))\n",
      "                (VP (VBD elevated)\n",
      "                  (PP (IN for)\n",
      "                    (NP (NNS women)))\n",
      "                  (PP (VBN based)\n",
      "                    (PP (IN on)\n",
      "                      (NP (DT the) (NN literature)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(considered-2, we-1)\n",
      "root(ROOT-0, considered-2)\n",
      "det(qtc-4, a-3)\n",
      "nsubj(elevated-9, qtc-4)\n",
      "case(ms-8, of-5)\n",
      "compound(450-7, >-6)\n",
      "nummod(ms-8, 450-7)\n",
      "nmod:of(qtc-4, ms-8)\n",
      "ccomp(considered-2, elevated-9)\n",
      "mark(elevated-16, for-10)\n",
      "nsubj(elevated-16, men-11)\n",
      "cc(men-11, and-12)\n",
      "compound(470-14, >-13)\n",
      "nummod(ms-15, 470-14)\n",
      "conj:and(men-11, ms-15)\n",
      "nsubj(elevated-16, ms-15)\n",
      "advcl(elevated-9, elevated-16)\n",
      "case(women-18, for-17)\n",
      "nmod:for(elevated-16, women-18)\n",
      "case(literature-22, based-19)\n",
      "mwe(based-19, on-20)\n",
      "det(literature-22, the-21)\n",
      "advcl(elevated-16, literature-22)\n",
      "\n",
      "Parsing [sent. 118 len. 43]: fifty subjects in whom an ecg , serum osmolality , and etoh level were recorded within 2 hours of one another and who were administered a clinical institute withdrawal assessment protocol were compared with 203 patients with acs during the same period .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ fifty) (NNS subjects))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (SBAR\n",
      "            (WHNP (WP whom))\n",
      "            (S\n",
      "              (NP\n",
      "                (NP (DT an) (NN ecg))\n",
      "                (, ,)\n",
      "                (NP (NN serum) (NN osmolality))\n",
      "                (, ,)\n",
      "                (CC and)\n",
      "                (NP (JJ etoh) (NN level)))\n",
      "              (VP (VBD were)\n",
      "                (VP (VBN recorded)\n",
      "                  (PP (IN within)\n",
      "                    (NP\n",
      "                      (NP (CD 2) (NNS hours))\n",
      "                      (PP (IN of)\n",
      "                        (NP (CD one) (DT another)))))))))\n",
      "          (CC and)\n",
      "          (SBAR\n",
      "            (WHNP (WP who))\n",
      "            (S\n",
      "              (VP (VBD were)\n",
      "                (VP (VBN administered)\n",
      "                  (NP (DT a) (JJ clinical) (NN institute) (NN withdrawal) (NN assessment) (NN protocol)))))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (CD 203) (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (NN acs)))))\n",
      "        (PP (IN during)\n",
      "          (NP (DT the) (JJ same) (NN period)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(subjects-2, fifty-1)\n",
      "nsubjpass(compared-33, subjects-2)\n",
      "case(recorded-15, in-3)\n",
      "dobj(recorded-15, whom-4)\n",
      "det(ecg-6, an-5)\n",
      "nsubjpass(recorded-15, ecg-6)\n",
      "compound(osmolality-9, serum-8)\n",
      "conj:and(ecg-6, osmolality-9)\n",
      "nsubjpass(recorded-15, osmolality-9)\n",
      "cc(ecg-6, and-11)\n",
      "amod(level-13, etoh-12)\n",
      "conj:and(ecg-6, level-13)\n",
      "nsubjpass(recorded-15, level-13)\n",
      "auxpass(recorded-15, were-14)\n",
      "nmod:in(subjects-2, recorded-15)\n",
      "case(hours-18, within-16)\n",
      "nummod(hours-18, 2-17)\n",
      "nmod:within(recorded-15, hours-18)\n",
      "case(one-20, of-19)\n",
      "nmod:of(hours-18, one-20)\n",
      "dep(one-20, another-21)\n",
      "cc(recorded-15, and-22)\n",
      "nsubjpass(administered-25, who-23)\n",
      "auxpass(administered-25, were-24)\n",
      "nmod:in(subjects-2, administered-25)\n",
      "conj:and(recorded-15, administered-25)\n",
      "det(protocol-31, a-26)\n",
      "amod(protocol-31, clinical-27)\n",
      "compound(protocol-31, institute-28)\n",
      "compound(protocol-31, withdrawal-29)\n",
      "compound(protocol-31, assessment-30)\n",
      "dobj(administered-25, protocol-31)\n",
      "auxpass(compared-33, were-32)\n",
      "root(ROOT-0, compared-33)\n",
      "case(patients-36, with-34)\n",
      "nummod(patients-36, 203-35)\n",
      "nmod:with(compared-33, patients-36)\n",
      "case(acs-38, with-37)\n",
      "nmod:with(patients-36, acs-38)\n",
      "case(period-42, during-39)\n",
      "det(period-42, the-40)\n",
      "amod(period-42, same-41)\n",
      "nmod:during(compared-33, period-42)\n",
      "\n",
      "Parsing [sent. 119 len. 7]: we excluded patients with incomplete data .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBN excluded)\n",
      "      (NP (NNS patients))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ incomplete) (NNS data))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(excluded-2, we-1)\n",
      "root(ROOT-0, excluded-2)\n",
      "dobj(excluded-2, patients-3)\n",
      "case(data-6, with-4)\n",
      "amod(data-6, incomplete-5)\n",
      "nmod:with(excluded-2, data-6)\n",
      "\n",
      "Parsing [sent. 120 len. 15]: medications compared included clopidogrel , acetylsalicylic acid , Î²-blockers , ACEI , and statins .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS medications))\n",
      "      (VP (VBN compared)))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (NN clopidogrel))\n",
      "        (, ,)\n",
      "        (NP (JJ acetylsalicylic) (NN acid))\n",
      "        (, ,)\n",
      "        (NP (NNS Î²-blockers))\n",
      "        (, ,)\n",
      "        (NP (NNP ACEI))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (NNS statins))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(included-3, medications-1)\n",
      "acl(medications-1, compared-2)\n",
      "root(ROOT-0, included-3)\n",
      "dobj(included-3, clopidogrel-4)\n",
      "amod(acid-7, acetylsalicylic-6)\n",
      "dobj(included-3, acid-7)\n",
      "conj:and(clopidogrel-4, acid-7)\n",
      "dobj(included-3, Î²-blockers-9)\n",
      "conj:and(clopidogrel-4, Î²-blockers-9)\n",
      "dobj(included-3, ACEI-11)\n",
      "conj:and(clopidogrel-4, ACEI-11)\n",
      "cc(clopidogrel-4, and-13)\n",
      "dobj(included-3, statins-14)\n",
      "conj:and(clopidogrel-4, statins-14)\n",
      "\n",
      "Parsing [sent. 121 len. 15]: ecg qt and qtc , as well as electrolytes , were recorded and compared .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN ecg) (NN qt)\n",
      "        (CC and)\n",
      "        (NN qtc))\n",
      "      (, ,)\n",
      "      (CONJP (RB as) (RB well) (IN as))\n",
      "      (NP (NNS electrolytes))\n",
      "      (, ,))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN recorded)\n",
      "        (CC and)\n",
      "        (VBN compared)))\n",
      "    (. .)))\n",
      "\n",
      "compound(qt-2, ecg-1)\n",
      "nsubjpass(recorded-12, qt-2)\n",
      "nsubjpass(compared-14, qt-2)\n",
      "cc(qt-2, and-3)\n",
      "conj:and(qt-2, qtc-4)\n",
      "nsubjpass(recorded-12, qtc-4)\n",
      "cc(qt-2, as-6)\n",
      "mwe(as-6, well-7)\n",
      "mwe(as-6, as-8)\n",
      "conj:and(qt-2, electrolytes-9)\n",
      "nsubjpass(recorded-12, electrolytes-9)\n",
      "auxpass(recorded-12, were-11)\n",
      "root(ROOT-0, recorded-12)\n",
      "cc(recorded-12, and-13)\n",
      "conj:and(recorded-12, compared-14)\n",
      "\n",
      "Parsing [sent. 122 len. 21]: data were extracted by two investigators with a 20 % sample re-evaluated by the other extractor as a reliability measure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS data))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN extracted)\n",
      "        (PP (IN by)\n",
      "          (NP (CD two) (NNS investigators)))\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (DT a)\n",
      "              (ADJP (CD 20) (NN %))\n",
      "              (NN sample))\n",
      "            (VP (VBN re-evaluated)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ other) (NN extractor))\n",
      "                  (PP (IN as)\n",
      "                    (NP (DT a) (JJ reliability) (NN measure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(extracted-3, data-1)\n",
      "auxpass(extracted-3, were-2)\n",
      "root(ROOT-0, extracted-3)\n",
      "case(investigators-6, by-4)\n",
      "nummod(investigators-6, two-5)\n",
      "nmod:by(extracted-3, investigators-6)\n",
      "case(sample-11, with-7)\n",
      "det(sample-11, a-8)\n",
      "compound(%-10, 20-9)\n",
      "amod(sample-11, %-10)\n",
      "nmod:with(extracted-3, sample-11)\n",
      "acl(sample-11, re-evaluated-12)\n",
      "case(extractor-16, by-13)\n",
      "det(extractor-16, the-14)\n",
      "amod(extractor-16, other-15)\n",
      "nmod:by(re-evaluated-12, extractor-16)\n",
      "case(measure-20, as-17)\n",
      "det(measure-20, a-18)\n",
      "amod(measure-20, reliability-19)\n",
      "nmod:as(extractor-16, measure-20)\n",
      "\n",
      "Parsing [sent. 123 len. 13]: descriptive statistics including medians and interquartile ranges were measured for continuous variables .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ descriptive) (NNS statistics))\n",
      "      (PP (VBG including)\n",
      "        (NP\n",
      "          (NP (NNS medians))\n",
      "          (CC and)\n",
      "          (NP (JJ interquartile) (NNS ranges)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN measured)\n",
      "        (PP (IN for)\n",
      "          (NP (JJ continuous) (NNS variables)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(statistics-2, descriptive-1)\n",
      "nsubjpass(measured-9, statistics-2)\n",
      "case(medians-4, including-3)\n",
      "nmod:including(statistics-2, medians-4)\n",
      "cc(medians-4, and-5)\n",
      "amod(ranges-7, interquartile-6)\n",
      "nmod:including(statistics-2, ranges-7)\n",
      "conj:and(medians-4, ranges-7)\n",
      "auxpass(measured-9, were-8)\n",
      "root(ROOT-0, measured-9)\n",
      "case(variables-12, for-10)\n",
      "amod(variables-12, continuous-11)\n",
      "nmod:for(measured-9, variables-12)\n",
      "\n",
      "Parsing [sent. 124 len. 19]: comparisons were made using two-tailed t tests for parametric data and the mann-whitney u test for nonparametric data .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS comparisons))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN made)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ two-tailed) (NN t) (NNS tests))\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ parametric) (NNS data))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT the) (JJ mann-whitney) (NN u) (NN test))\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ nonparametric) (NNS data)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(made-3, comparisons-1)\n",
      "auxpass(made-3, were-2)\n",
      "root(ROOT-0, made-3)\n",
      "xcomp(made-3, using-4)\n",
      "amod(tests-7, two-tailed-5)\n",
      "compound(tests-7, t-6)\n",
      "dobj(using-4, tests-7)\n",
      "case(data-10, for-8)\n",
      "amod(data-10, parametric-9)\n",
      "nmod:for(tests-7, data-10)\n",
      "cc(tests-7, and-11)\n",
      "det(test-15, the-12)\n",
      "amod(test-15, mann-whitney-13)\n",
      "compound(test-15, u-14)\n",
      "dobj(using-4, test-15)\n",
      "conj:and(tests-7, test-15)\n",
      "case(data-18, for-16)\n",
      "amod(data-18, nonparametric-17)\n",
      "nmod:for(test-15, data-18)\n",
      "\n",
      "Parsing [sent. 125 len. 42]: heart failure with preserved ejection fraction -LRB- hfpef -RRB- makes up half of diagnosed heart failure cases and has similar outcomes compared to heart failure with reduced ejection fraction -LRB- hfref -RRB- but a discrepancy in knowledge and approach to treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN heart) (NN failure))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ preserved) (NN ejection) (NN fraction))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN hfpef))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (VP\n",
      "      (VP (VBZ makes)\n",
      "        (PRT (RP up))\n",
      "        (NP\n",
      "          (NP (NN half))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ diagnosed) (NN heart) (NN failure) (NNS cases)))))\n",
      "      (CC and)\n",
      "      (VP (VBZ has)\n",
      "        (NP\n",
      "          (NP (JJ similar) (NNS outcomes))\n",
      "          (PP (VBN compared)\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN heart) (NN failure))\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (VBN reduced) (NN ejection) (NN fraction))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN hfref))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (PP (CC but)\n",
      "                      (NP\n",
      "                        (NP (DT a) (NN discrepancy))\n",
      "                        (PP (IN in)\n",
      "                          (NP (NN knowledge)\n",
      "                            (CC and)\n",
      "                            (NN approach)))))))))))\n",
      "        (PP (TO to)\n",
      "          (NP (NN treatment)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(makes-10, failure-2)\n",
      "nsubj(has-19, failure-2)\n",
      "case(fraction-6, with-3)\n",
      "amod(fraction-6, preserved-4)\n",
      "compound(fraction-6, ejection-5)\n",
      "nmod:with(failure-2, fraction-6)\n",
      "appos(fraction-6, hfpef-8)\n",
      "root(ROOT-0, makes-10)\n",
      "compound:prt(makes-10, up-11)\n",
      "dobj(makes-10, half-12)\n",
      "case(cases-17, of-13)\n",
      "amod(cases-17, diagnosed-14)\n",
      "compound(cases-17, heart-15)\n",
      "compound(cases-17, failure-16)\n",
      "nmod:of(half-12, cases-17)\n",
      "cc(makes-10, and-18)\n",
      "conj:and(makes-10, has-19)\n",
      "amod(outcomes-21, similar-20)\n",
      "dobj(has-19, outcomes-21)\n",
      "case(failure-25, compared-22)\n",
      "mwe(compared-22, to-23)\n",
      "compound(failure-25, heart-24)\n",
      "acl(outcomes-21, failure-25)\n",
      "case(fraction-29, with-26)\n",
      "amod(fraction-29, reduced-27)\n",
      "compound(fraction-29, ejection-28)\n",
      "nmod:with(failure-25, fraction-29)\n",
      "appos(fraction-29, hfref-31)\n",
      "case(discrepancy-35, but-33)\n",
      "det(discrepancy-35, a-34)\n",
      "nmod:but(fraction-29, discrepancy-35)\n",
      "case(knowledge-37, in-36)\n",
      "nmod:in(discrepancy-35, knowledge-37)\n",
      "cc(knowledge-37, and-38)\n",
      "nmod:in(discrepancy-35, approach-39)\n",
      "conj:and(knowledge-37, approach-39)\n",
      "case(treatment-41, to-40)\n",
      "nmod:to(has-19, treatment-41)\n",
      "\n",
      "Parsing [sent. 126 len. 36]: hfpef is diagnosed using the following criteria : symptoms , preserved ejection fraction -LRB- greater than 50 % -RRB- , and evidence of abnormal left ventricular filling or relaxation , or diastolic distensibility or stiffness .\n",
      "(ROOT\n",
      "  (SINV\n",
      "    (S\n",
      "      (NP (NN hfpef))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN diagnosed)\n",
      "          (S\n",
      "            (VP (VBG using)\n",
      "              (NP\n",
      "                (NP (DT the) (VBG following) (NNS criteria))\n",
      "                (: :)\n",
      "                (NP (NNS symptoms))))))))\n",
      "    (, ,)\n",
      "    (VP (VBD preserved))\n",
      "    (NP\n",
      "      (NP (NN ejection) (NN fraction))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (QP (JJR greater) (IN than) (CD 50))\n",
      "          (NN %))\n",
      "        (-RRB- -RRB-))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP (NN evidence))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (JJ abnormal) (JJ left) (NN ventricular) (NN filling))\n",
      "              (CC or)\n",
      "              (NP (NN relaxation)))\n",
      "            (, ,)\n",
      "            (CC or)\n",
      "            (NP\n",
      "              (NP (JJ diastolic) (NN distensibility))\n",
      "              (CC or)\n",
      "              (NP (NNS stiffness)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(diagnosed-3, hfpef-1)\n",
      "auxpass(diagnosed-3, is-2)\n",
      "ccomp(preserved-11, diagnosed-3)\n",
      "xcomp(diagnosed-3, using-4)\n",
      "det(criteria-7, the-5)\n",
      "amod(criteria-7, following-6)\n",
      "dobj(using-4, criteria-7)\n",
      "dep(criteria-7, symptoms-9)\n",
      "root(ROOT-0, preserved-11)\n",
      "compound(fraction-13, ejection-12)\n",
      "nsubj(preserved-11, fraction-13)\n",
      "advmod(50-17, greater-15)\n",
      "advmod(50-17, than-16)\n",
      "nummod(%-18, 50-17)\n",
      "appos(fraction-13, %-18)\n",
      "cc(fraction-13, and-21)\n",
      "nsubj(preserved-11, evidence-22)\n",
      "conj:and(fraction-13, evidence-22)\n",
      "case(filling-27, of-23)\n",
      "amod(filling-27, abnormal-24)\n",
      "amod(filling-27, left-25)\n",
      "compound(filling-27, ventricular-26)\n",
      "nmod:of(evidence-22, filling-27)\n",
      "cc(filling-27, or-28)\n",
      "nmod:of(evidence-22, relaxation-29)\n",
      "conj:or(filling-27, relaxation-29)\n",
      "cc(filling-27, or-31)\n",
      "amod(distensibility-33, diastolic-32)\n",
      "nmod:of(evidence-22, distensibility-33)\n",
      "conj:or(filling-27, distensibility-33)\n",
      "cc(distensibility-33, or-34)\n",
      "conj:or(filling-27, stiffness-35)\n",
      "conj:or(distensibility-33, stiffness-35)\n",
      "\n",
      "Parsing [sent. 127 len. 41]: studies conducted to examine the efficacy of angiotensin receptor blockers -LRB- irbesartan and candesartan -RRB- , thiazide diuretics -LRB- chlorthalidone -RRB- , and ACEI -LRB- perindopril -RRB- in the treatment of hfpef , showed moderate efficacy but no clear benefit .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS studies))\n",
      "      (VP (VBN conducted)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB examine)\n",
      "              (NP\n",
      "                (NP (DT the) (NN efficacy))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN irbesartan)\n",
      "                          (CC and)\n",
      "                          (NNS candesartan))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (JJ thiazide) (NNS diuretics))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN chlorthalidone))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (CC and)\n",
      "                    (NP\n",
      "                      (NP (NNP ACEI))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (ADJP (JJ perindopril))\n",
      "                        (-RRB- -RRB-))))))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN treatment))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN hfpef))))))))))\n",
      "    (, ,)\n",
      "    (VP (VBD showed)\n",
      "      (NP\n",
      "        (NP (JJ moderate) (NN efficacy))\n",
      "        (PP (CC but)\n",
      "          (NP (DT no) (JJ clear) (NN benefit)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(showed-34, studies-1)\n",
      "acl(studies-1, conducted-2)\n",
      "mark(examine-4, to-3)\n",
      "xcomp(conducted-2, examine-4)\n",
      "det(efficacy-6, the-5)\n",
      "dobj(examine-4, efficacy-6)\n",
      "case(blockers-10, of-7)\n",
      "compound(blockers-10, angiotensin-8)\n",
      "compound(blockers-10, receptor-9)\n",
      "nmod:of(efficacy-6, blockers-10)\n",
      "appos(blockers-10, irbesartan-12)\n",
      "cc(irbesartan-12, and-13)\n",
      "appos(blockers-10, candesartan-14)\n",
      "conj:and(irbesartan-12, candesartan-14)\n",
      "amod(diuretics-18, thiazide-17)\n",
      "nmod:of(efficacy-6, diuretics-18)\n",
      "conj:and(blockers-10, diuretics-18)\n",
      "appos(diuretics-18, chlorthalidone-20)\n",
      "cc(blockers-10, and-23)\n",
      "nmod:of(efficacy-6, ACEI-24)\n",
      "conj:and(blockers-10, ACEI-24)\n",
      "dep(ACEI-24, perindopril-26)\n",
      "case(treatment-30, in-28)\n",
      "det(treatment-30, the-29)\n",
      "nmod:in(examine-4, treatment-30)\n",
      "case(hfpef-32, of-31)\n",
      "nmod:of(treatment-30, hfpef-32)\n",
      "root(ROOT-0, showed-34)\n",
      "amod(efficacy-36, moderate-35)\n",
      "dobj(showed-34, efficacy-36)\n",
      "case(benefit-40, but-37)\n",
      "neg(benefit-40, no-38)\n",
      "amod(benefit-40, clear-39)\n",
      "nmod:but(efficacy-36, benefit-40)\n",
      "\n",
      "Parsing [sent. 128 len. 40]: recently , the fda has approved a novel drug , which combines an angiotensin receptor neprilysin inhibitor and angiotensin receptor blocker -LRB- valsartan -RRB- named lcz696 -LRB- entresto -RRB- for possible treatment of heart failure with reduced ejection fraction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB recently))\n",
      "    (, ,)\n",
      "    (NP (DT the) (NN fda))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN approved)\n",
      "        (NP\n",
      "          (NP (DT a) (NN novel) (NN drug))\n",
      "          (, ,)\n",
      "          (SBAR\n",
      "            (WHNP (WDT which))\n",
      "            (S\n",
      "              (VP (VBZ combines)\n",
      "                (NP\n",
      "                  (NP (DT an) (NN angiotensin) (NN receptor) (NN neprilysin) (NN inhibitor)\n",
      "                    (CC and)\n",
      "                    (NN angiotensin) (NN receptor) (NN blocker))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (NN valsartan))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (VP (VBN named)\n",
      "                    (NP\n",
      "                      (NP (JJ lcz696) (-LRB- -LRB-) (NN entresto) (-RRB- -RRB-))\n",
      "                      (PP (IN for)\n",
      "                        (NP\n",
      "                          (NP (JJ possible) (NN treatment))\n",
      "                          (PP (IN of)\n",
      "                            (NP (NN heart) (NN failure))))))\n",
      "                    (PP (IN with)\n",
      "                      (NP (VBN reduced) (NN ejection) (NN fraction)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(approved-6, recently-1)\n",
      "det(fda-4, the-3)\n",
      "nsubj(approved-6, fda-4)\n",
      "aux(approved-6, has-5)\n",
      "root(ROOT-0, approved-6)\n",
      "det(drug-9, a-7)\n",
      "compound(drug-9, novel-8)\n",
      "dobj(approved-6, drug-9)\n",
      "nsubj(combines-12, drug-9)\n",
      "ref(drug-9, which-11)\n",
      "acl:relcl(drug-9, combines-12)\n",
      "det(inhibitor-17, an-13)\n",
      "compound(inhibitor-17, angiotensin-14)\n",
      "compound(inhibitor-17, receptor-15)\n",
      "compound(inhibitor-17, neprilysin-16)\n",
      "dobj(combines-12, inhibitor-17)\n",
      "cc(inhibitor-17, and-18)\n",
      "compound(blocker-21, angiotensin-19)\n",
      "compound(blocker-21, receptor-20)\n",
      "dobj(combines-12, blocker-21)\n",
      "conj:and(inhibitor-17, blocker-21)\n",
      "appos(inhibitor-17, valsartan-23)\n",
      "acl(inhibitor-17, named-25)\n",
      "amod(entresto-28, lcz696-26)\n",
      "dobj(named-25, entresto-28)\n",
      "case(treatment-32, for-30)\n",
      "amod(treatment-32, possible-31)\n",
      "nmod:for(entresto-28, treatment-32)\n",
      "case(failure-35, of-33)\n",
      "compound(failure-35, heart-34)\n",
      "nmod:of(treatment-32, failure-35)\n",
      "case(fraction-39, with-36)\n",
      "amod(fraction-39, reduced-37)\n",
      "compound(fraction-39, ejection-38)\n",
      "nmod:with(named-25, fraction-39)\n",
      "\n",
      "Parsing [sent. 129 len. 29]: in this article , we will discuss the failure of previous treatment modalities and the promise that lcz696 -LRB- entresto -RRB- may hold for treating patients with hfpef .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (DT this) (NN article)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (MD will)\n",
      "      (VP (VB discuss)\n",
      "        (NP\n",
      "          (NP (DT the) (NN failure))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ previous) (NN treatment) (NNS modalities))\n",
      "              (CC and)\n",
      "              (NP (DT the) (NN promise)))))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (NNS lcz696))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP entresto))\n",
      "                (-RRB- -RRB-)))\n",
      "            (VP (MD may)\n",
      "              (VP (VB hold)\n",
      "                (PP (IN for)\n",
      "                  (S\n",
      "                    (VP (VBG treating)\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP (NN hfpef))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "case(article-3, in-1)\n",
      "det(article-3, this-2)\n",
      "nmod:in(discuss-7, article-3)\n",
      "nsubj(discuss-7, we-5)\n",
      "aux(discuss-7, will-6)\n",
      "root(ROOT-0, discuss-7)\n",
      "det(failure-9, the-8)\n",
      "dobj(discuss-7, failure-9)\n",
      "case(modalities-13, of-10)\n",
      "amod(modalities-13, previous-11)\n",
      "compound(modalities-13, treatment-12)\n",
      "nmod:of(failure-9, modalities-13)\n",
      "cc(modalities-13, and-14)\n",
      "det(promise-16, the-15)\n",
      "nmod:of(failure-9, promise-16)\n",
      "conj:and(modalities-13, promise-16)\n",
      "mark(hold-23, that-17)\n",
      "nsubj(hold-23, lcz696-18)\n",
      "appos(lcz696-18, entresto-20)\n",
      "aux(hold-23, may-22)\n",
      "ccomp(discuss-7, hold-23)\n",
      "mark(treating-25, for-24)\n",
      "advcl(hold-23, treating-25)\n",
      "dobj(treating-25, patients-26)\n",
      "case(hfpef-28, with-27)\n",
      "nmod:with(treating-25, hfpef-28)\n",
      "\n",
      "Parsing [sent. 130 len. 18]: several medications have been used perioperatively in patients undergoing noncardiac surgery in an attempt to improve outcomes .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ several) (NNS medications))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN been)\n",
      "        (VP (VBN used)\n",
      "          (ADVP (RB perioperatively))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (VP (VBG undergoing)\n",
      "                (NP (JJ noncardiac) (NN surgery))\n",
      "                (PP (IN in)\n",
      "                  (NP (DT an) (NN attempt)\n",
      "                    (S\n",
      "                      (VP (TO to)\n",
      "                        (VP (VB improve)\n",
      "                          (NP (NNS outcomes)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(medications-2, several-1)\n",
      "nsubjpass(used-5, medications-2)\n",
      "aux(used-5, have-3)\n",
      "auxpass(used-5, been-4)\n",
      "root(ROOT-0, used-5)\n",
      "advmod(used-5, perioperatively-6)\n",
      "case(patients-8, in-7)\n",
      "nmod:in(used-5, patients-8)\n",
      "acl(patients-8, undergoing-9)\n",
      "amod(surgery-11, noncardiac-10)\n",
      "dobj(undergoing-9, surgery-11)\n",
      "case(attempt-14, in-12)\n",
      "det(attempt-14, an-13)\n",
      "nmod:in(undergoing-9, attempt-14)\n",
      "mark(improve-16, to-15)\n",
      "acl(attempt-14, improve-16)\n",
      "dobj(improve-16, outcomes-17)\n",
      "\n",
      "Parsing [sent. 131 len. 41]: antiplatelet therapy for primary prevention of cardiovascular events should generally be discontinued seven to 10 days before surgery to avoid increasing the risk of bleeding , unless the risk of a major adverse cardiac event exceeds the risk of bleeding .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ antiplatelet) (NN therapy))\n",
      "      (PP (IN for)\n",
      "        (NP\n",
      "          (NP (JJ primary) (NN prevention))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ cardiovascular) (NNS events))))))\n",
      "    (VP (MD should)\n",
      "      (ADVP (RB generally))\n",
      "      (VP (VB be)\n",
      "        (VP (VBN discontinued)\n",
      "          (PP\n",
      "            (NP\n",
      "              (QP (CD seven) (TO to) (CD 10))\n",
      "              (NNS days))\n",
      "            (IN before)\n",
      "            (NP (NN surgery)))\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB avoid)\n",
      "                (S\n",
      "                  (VP (VBG increasing)\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN risk))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NN bleeding))))))\n",
      "                (, ,)\n",
      "                (SBAR (IN unless)\n",
      "                  (S\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN risk))\n",
      "                      (PP (IN of)\n",
      "                        (NP (DT a) (JJ major) (JJ adverse) (JJ cardiac) (NN event))))\n",
      "                    (VP (VBZ exceeds)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN risk))\n",
      "                        (PP (IN of)\n",
      "                          (NP (NN bleeding)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-2, antiplatelet-1)\n",
      "nsubjpass(discontinued-12, therapy-2)\n",
      "nsubj:xsubj(avoid-20, therapy-2)\n",
      "case(prevention-5, for-3)\n",
      "amod(prevention-5, primary-4)\n",
      "nmod:for(therapy-2, prevention-5)\n",
      "case(events-8, of-6)\n",
      "amod(events-8, cardiovascular-7)\n",
      "nmod:of(prevention-5, events-8)\n",
      "aux(discontinued-12, should-9)\n",
      "advmod(discontinued-12, generally-10)\n",
      "auxpass(discontinued-12, be-11)\n",
      "root(ROOT-0, discontinued-12)\n",
      "compound(10-15, seven-13)\n",
      "dep(10-15, to-14)\n",
      "nummod(days-16, 10-15)\n",
      "nmod:before(discontinued-12, days-16)\n",
      "case(days-16, before-17)\n",
      "dep(days-16, surgery-18)\n",
      "mark(avoid-20, to-19)\n",
      "xcomp(discontinued-12, avoid-20)\n",
      "xcomp(avoid-20, increasing-21)\n",
      "det(risk-23, the-22)\n",
      "dobj(increasing-21, risk-23)\n",
      "case(bleeding-25, of-24)\n",
      "nmod:of(risk-23, bleeding-25)\n",
      "mark(exceeds-36, unless-27)\n",
      "det(risk-29, the-28)\n",
      "nsubj(exceeds-36, risk-29)\n",
      "case(event-35, of-30)\n",
      "det(event-35, a-31)\n",
      "amod(event-35, major-32)\n",
      "amod(event-35, adverse-33)\n",
      "amod(event-35, cardiac-34)\n",
      "nmod:of(risk-29, event-35)\n",
      "advcl(avoid-20, exceeds-36)\n",
      "det(risk-38, the-37)\n",
      "dobj(exceeds-36, risk-38)\n",
      "case(bleeding-40, of-39)\n",
      "nmod:of(risk-38, bleeding-40)\n",
      "\n",
      "Parsing [sent. 132 len. 24]: antiplatelet therapy for secondary prevention should be continued perioperatively , except before procedures with very high bleeding risk , such as intracranial procedures .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ antiplatelet) (NN therapy))\n",
      "      (PP (IN for)\n",
      "        (NP (JJ secondary) (NN prevention))))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN continued)\n",
      "          (PP\n",
      "            (ADVP (RB perioperatively))\n",
      "            (, ,) (IN except) (IN before)\n",
      "            (NP\n",
      "              (NP (NNS procedures))\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (ADJP (RB very) (JJ high))\n",
      "                  (NN bleeding) (NN risk)))\n",
      "              (, ,)\n",
      "              (PP (JJ such) (IN as)\n",
      "                (NP (JJ intracranial) (NNS procedures))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-2, antiplatelet-1)\n",
      "nsubjpass(continued-8, therapy-2)\n",
      "case(prevention-5, for-3)\n",
      "amod(prevention-5, secondary-4)\n",
      "nmod:for(therapy-2, prevention-5)\n",
      "aux(continued-8, should-6)\n",
      "auxpass(continued-8, be-7)\n",
      "root(ROOT-0, continued-8)\n",
      "advmod(procedures-13, perioperatively-9)\n",
      "case(procedures-13, except-11)\n",
      "case(procedures-13, before-12)\n",
      "nmod:before(continued-8, procedures-13)\n",
      "case(risk-18, with-14)\n",
      "advmod(high-16, very-15)\n",
      "amod(risk-18, high-16)\n",
      "compound(risk-18, bleeding-17)\n",
      "nmod:with(procedures-13, risk-18)\n",
      "case(procedures-23, such-20)\n",
      "mwe(such-20, as-21)\n",
      "amod(procedures-23, intracranial-22)\n",
      "nmod:such_as(procedures-13, procedures-23)\n",
      "\n",
      "Parsing [sent. 133 len. 50]: antiplatelet drugs should be continued and surgery delayed , if possible , for at least 14 days after percutaneous coronary intervention without stent placement , 30 days after percutaneous coronary intervention with bare-metal stent placement , and six to 12 months after percutaneous coronary intervention with drug-eluting stent placement .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN antiplatelet) (NNS drugs))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN surgery))\n",
      "      (VP (VBN delayed)\n",
      "        (PRN (, ,)\n",
      "          (SBAR (IN if)\n",
      "            (FRAG (JJ possible)))\n",
      "          (, ,))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (QP (IN at) (JJS least) (CD 14))\n",
      "                (NNS days))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN without)\n",
      "                    (NP (JJ stent) (NN placement))))))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP (CD 30) (NNS days))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ bare-metal) (NN stent) (NN placement))))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP\n",
      "                (QP (CD six) (TO to) (CD 12))\n",
      "                (NNS months))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ drug-eluting) (NN stent) (NN placement))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(drugs-2, antiplatelet-1)\n",
      "nsubjpass(continued-5, drugs-2)\n",
      "aux(continued-5, should-3)\n",
      "auxpass(continued-5, be-4)\n",
      "root(ROOT-0, continued-5)\n",
      "cc(continued-5, and-6)\n",
      "nsubj(delayed-8, surgery-7)\n",
      "conj:and(continued-5, delayed-8)\n",
      "mark(possible-11, if-10)\n",
      "parataxis(delayed-8, possible-11)\n",
      "case(days-17, for-13)\n",
      "case(least-15, at-14)\n",
      "nmod:npmod(14-16, least-15)\n",
      "nummod(days-17, 14-16)\n",
      "nmod:for(delayed-8, days-17)\n",
      "case(intervention-21, after-18)\n",
      "amod(intervention-21, percutaneous-19)\n",
      "amod(intervention-21, coronary-20)\n",
      "nmod:after(days-17, intervention-21)\n",
      "case(placement-24, without-22)\n",
      "amod(placement-24, stent-23)\n",
      "nmod:without(intervention-21, placement-24)\n",
      "nummod(days-27, 30-26)\n",
      "nmod:for(delayed-8, days-27)\n",
      "conj:and(days-17, days-27)\n",
      "case(intervention-31, after-28)\n",
      "amod(intervention-31, percutaneous-29)\n",
      "amod(intervention-31, coronary-30)\n",
      "nmod:after(days-27, intervention-31)\n",
      "case(placement-35, with-32)\n",
      "amod(placement-35, bare-metal-33)\n",
      "compound(placement-35, stent-34)\n",
      "nmod:with(intervention-31, placement-35)\n",
      "cc(days-17, and-37)\n",
      "compound(12-40, six-38)\n",
      "dep(12-40, to-39)\n",
      "nummod(months-41, 12-40)\n",
      "nmod:for(delayed-8, months-41)\n",
      "conj:and(days-17, months-41)\n",
      "case(intervention-45, after-42)\n",
      "amod(intervention-45, percutaneous-43)\n",
      "amod(intervention-45, coronary-44)\n",
      "nmod:after(months-41, intervention-45)\n",
      "case(placement-49, with-46)\n",
      "amod(placement-49, drug-eluting-47)\n",
      "compound(placement-49, stent-48)\n",
      "nmod:with(intervention-45, placement-49)\n",
      "\n",
      "Parsing [sent. 134 len. 52]: perioperative beta blockers are recommended for patients already receiving these agents , and it is reasonable to consider starting therapy in patients with known or strongly suspected coronary artery disease or who are at high risk of perioperative cardiac events and are undergoing procedures with a high risk of cardiovascular complications .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ perioperative) (NN beta) (NNS blockers))\n",
      "      (VP (VBP are)\n",
      "        (VP (VBN recommended)\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (VP\n",
      "                (ADVP (RB already))\n",
      "                (VBG receiving)\n",
      "                (NP (DT these) (NNS agents))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ reasonable)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB consider)\n",
      "                (S\n",
      "                  (VP (VBG starting)\n",
      "                    (NP\n",
      "                      (NP (NN therapy))\n",
      "                      (PP (IN in)\n",
      "                        (NP (NNS patients))))\n",
      "                    (PP (IN with)\n",
      "                      (S\n",
      "                        (VP\n",
      "                          (VP (VBN known))\n",
      "                          (CC or)\n",
      "                          (VP\n",
      "                            (ADVP (RB strongly))\n",
      "                            (VBN suspected)\n",
      "                            (NP\n",
      "                              (NP (JJ coronary) (NN artery) (NN disease))\n",
      "                              (CC or)\n",
      "                              (SBAR\n",
      "                                (WHNP (WP who))\n",
      "                                (S\n",
      "                                  (VP (VBP are)\n",
      "                                    (PP (IN at)\n",
      "                                      (NP\n",
      "                                        (NP (JJ high) (NN risk))\n",
      "                                        (PP (IN of)\n",
      "                                          (NP (JJ perioperative) (JJ cardiac) (NNS events))))))))))\n",
      "                          (CC and)\n",
      "                          (VP (VBP are)\n",
      "                            (VP (VBG undergoing)\n",
      "                              (NP (NNS procedures))\n",
      "                              (PP (IN with)\n",
      "                                (NP\n",
      "                                  (NP (DT a) (JJ high) (NN risk))\n",
      "                                  (PP (IN of)\n",
      "                                    (NP (JJ cardiovascular) (NNS complications))))))))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(blockers-3, perioperative-1)\n",
      "compound(blockers-3, beta-2)\n",
      "nsubjpass(recommended-5, blockers-3)\n",
      "auxpass(recommended-5, are-4)\n",
      "root(ROOT-0, recommended-5)\n",
      "case(patients-7, for-6)\n",
      "nmod:for(recommended-5, patients-7)\n",
      "advmod(receiving-9, already-8)\n",
      "acl(patients-7, receiving-9)\n",
      "det(agents-11, these-10)\n",
      "dobj(receiving-9, agents-11)\n",
      "cc(recommended-5, and-13)\n",
      "nsubj(reasonable-16, it-14)\n",
      "nsubj:xsubj(consider-18, it-14)\n",
      "cop(reasonable-16, is-15)\n",
      "conj:and(recommended-5, reasonable-16)\n",
      "mark(consider-18, to-17)\n",
      "xcomp(reasonable-16, consider-18)\n",
      "xcomp(consider-18, starting-19)\n",
      "dobj(starting-19, therapy-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(therapy-20, patients-22)\n",
      "mark(known-24, with-23)\n",
      "advcl(starting-19, known-24)\n",
      "cc(known-24, or-25)\n",
      "advmod(suspected-27, strongly-26)\n",
      "advcl(starting-19, suspected-27)\n",
      "conj:or(known-24, suspected-27)\n",
      "amod(disease-30, coronary-28)\n",
      "compound(disease-30, artery-29)\n",
      "dobj(suspected-27, disease-30)\n",
      "cc(disease-30, or-31)\n",
      "nsubj(risk-36, who-32)\n",
      "cop(risk-36, are-33)\n",
      "case(risk-36, at-34)\n",
      "amod(risk-36, high-35)\n",
      "dobj(suspected-27, risk-36)\n",
      "conj:or(disease-30, risk-36)\n",
      "case(events-40, of-37)\n",
      "amod(events-40, perioperative-38)\n",
      "amod(events-40, cardiac-39)\n",
      "nmod:of(risk-36, events-40)\n",
      "cc(known-24, and-41)\n",
      "aux(undergoing-43, are-42)\n",
      "advcl(starting-19, undergoing-43)\n",
      "conj:and(known-24, undergoing-43)\n",
      "dobj(undergoing-43, procedures-44)\n",
      "case(risk-48, with-45)\n",
      "det(risk-48, a-46)\n",
      "amod(risk-48, high-47)\n",
      "nmod:with(undergoing-43, risk-48)\n",
      "case(complications-51, of-49)\n",
      "amod(complications-51, cardiovascular-50)\n",
      "nmod:of(risk-48, complications-51)\n",
      "\n",
      "Parsing [sent. 135 len. 21]: long-term statin therapy should be continued perioperatively or started in patients with clinical indications who are not already receiving statins .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ long-term) (NN statin) (NN therapy))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP\n",
      "          (VP (VBN continued)\n",
      "            (ADVP (RB perioperatively)))\n",
      "          (CC or)\n",
      "          (VP (VBN started)\n",
      "            (PP (IN in)\n",
      "              (NP (NNS patients))))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (JJ clinical) (NNS indications))\n",
      "              (SBAR\n",
      "                (WHNP (WP who))\n",
      "                (S\n",
      "                  (VP (VBP are) (RB not)\n",
      "                    (ADVP (RB already))\n",
      "                    (VP (VBG receiving)\n",
      "                      (NP (NNS statins)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-3, long-term-1)\n",
      "compound(therapy-3, statin-2)\n",
      "nsubjpass(continued-6, therapy-3)\n",
      "nsubjpass(started-9, therapy-3)\n",
      "aux(continued-6, should-4)\n",
      "auxpass(continued-6, be-5)\n",
      "root(ROOT-0, continued-6)\n",
      "advmod(continued-6, perioperatively-7)\n",
      "cc(continued-6, or-8)\n",
      "conj:or(continued-6, started-9)\n",
      "case(patients-11, in-10)\n",
      "nmod:in(started-9, patients-11)\n",
      "case(indications-14, with-12)\n",
      "amod(indications-14, clinical-13)\n",
      "nmod:with(continued-6, indications-14)\n",
      "nsubj(receiving-19, indications-14)\n",
      "ref(indications-14, who-15)\n",
      "aux(receiving-19, are-16)\n",
      "neg(receiving-19, not-17)\n",
      "advmod(receiving-19, already-18)\n",
      "acl:relcl(indications-14, receiving-19)\n",
      "dobj(receiving-19, statins-20)\n",
      "\n",
      "Parsing [sent. 136 len. 15]: clonidine should not be started perioperatively , but long-term clonidine regimens may be continued .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN clonidine))\n",
      "      (VP (MD should) (RB not)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN started)\n",
      "            (ADVP (RB perioperatively))))))\n",
      "    (, ,)\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (JJ long-term) (NN clonidine) (NNS regimens))\n",
      "      (VP (MD may)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(started-5, clonidine-1)\n",
      "aux(started-5, should-2)\n",
      "neg(started-5, not-3)\n",
      "auxpass(started-5, be-4)\n",
      "root(ROOT-0, started-5)\n",
      "advmod(started-5, perioperatively-6)\n",
      "cc(started-5, but-8)\n",
      "amod(regimens-11, long-term-9)\n",
      "compound(regimens-11, clonidine-10)\n",
      "nsubjpass(continued-14, regimens-11)\n",
      "aux(continued-14, may-12)\n",
      "auxpass(continued-14, be-13)\n",
      "conj:but(started-5, continued-14)\n",
      "\n",
      "Parsing [sent. 137 len. 25]: ACEI and angiotensin receptor blockers generally can be continued perioperatively if patients are hemodynamically stable and have good renal function and normal electrolyte levels .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI)\n",
      "      (CC and)\n",
      "      (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "    (ADVP (RB generally))\n",
      "    (VP (MD can)\n",
      "      (VP\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)\n",
      "            (ADVP (RB perioperatively))\n",
      "            (SBAR (IN if)\n",
      "              (S\n",
      "                (NP (NNS patients))\n",
      "                (VP (VBP are)\n",
      "                  (ADJP (RB hemodynamically) (JJ stable)))))))\n",
      "        (CC and)\n",
      "        (VP (VB have)\n",
      "          (NP (JJ good) (JJ renal) (NN function)\n",
      "            (CC and)\n",
      "            (JJ normal) (NN electrolyte) (NNS levels)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(blockers-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, angiotensin-3)\n",
      "compound(blockers-5, angiotensin-3)\n",
      "compound(blockers-5, receptor-4)\n",
      "nsubjpass(continued-9, blockers-5)\n",
      "nsubj(have-17, blockers-5)\n",
      "advmod(continued-9, generally-6)\n",
      "aux(continued-9, can-7)\n",
      "auxpass(continued-9, be-8)\n",
      "root(ROOT-0, continued-9)\n",
      "advmod(continued-9, perioperatively-10)\n",
      "mark(stable-15, if-11)\n",
      "nsubj(stable-15, patients-12)\n",
      "cop(stable-15, are-13)\n",
      "advmod(stable-15, hemodynamically-14)\n",
      "advcl(continued-9, stable-15)\n",
      "cc(continued-9, and-16)\n",
      "conj:and(continued-9, have-17)\n",
      "amod(function-20, good-18)\n",
      "amod(function-20, renal-19)\n",
      "dobj(have-17, function-20)\n",
      "cc(function-20, and-21)\n",
      "amod(levels-24, normal-22)\n",
      "compound(levels-24, electrolyte-23)\n",
      "dobj(have-17, levels-24)\n",
      "conj:and(function-20, levels-24)\n",
      "\n",
      "Parsing [sent. 138 len. 28]: to assess drug adherence of patients with hypertension , an analytical method was developed and validated using ultra performance liquid chromatography tandem mass spectrometry -LRB- uplc-ms/ms -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (VP (TO to)\n",
      "        (VP (VB assess)\n",
      "          (NP\n",
      "            (NP (NN drug) (NN adherence))\n",
      "            (PP (IN of)\n",
      "              (NP (NNS patients))))\n",
      "          (PP (IN with)\n",
      "            (NP (NN hypertension))))))\n",
      "    (, ,)\n",
      "    (NP (DT an) (JJ analytical) (NN method))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN developed)\n",
      "        (CC and)\n",
      "        (VBN validated)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP (NN ultra) (NN performance) (NN liquid) (NN chromatography) (NN tandem))\n",
      "              (ADJP (RB mass) (JJ spectrometry))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNS uplc-ms/ms))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(assess-2, to-1)\n",
      "advcl(developed-14, assess-2)\n",
      "compound(adherence-4, drug-3)\n",
      "dobj(assess-2, adherence-4)\n",
      "case(patients-6, of-5)\n",
      "nmod:of(adherence-4, patients-6)\n",
      "case(hypertension-8, with-7)\n",
      "nmod:with(assess-2, hypertension-8)\n",
      "det(method-12, an-10)\n",
      "amod(method-12, analytical-11)\n",
      "nsubjpass(developed-14, method-12)\n",
      "nsubjpass(validated-16, method-12)\n",
      "auxpass(developed-14, was-13)\n",
      "root(ROOT-0, developed-14)\n",
      "cc(developed-14, and-15)\n",
      "conj:and(developed-14, validated-16)\n",
      "xcomp(developed-14, using-17)\n",
      "compound(tandem-22, ultra-18)\n",
      "compound(tandem-22, performance-19)\n",
      "compound(tandem-22, liquid-20)\n",
      "compound(tandem-22, chromatography-21)\n",
      "dobj(using-17, tandem-22)\n",
      "advmod(spectrometry-24, mass-23)\n",
      "amod(tandem-22, spectrometry-24)\n",
      "appos(tandem-22, uplc-ms/ms-26)\n",
      "\n",
      "Parsing [sent. 139 len. 65]: the method includes eight frequently prescribed antihypertensive drugs from four classes and their active metabolites : ACEI enalapril and perindopril -LRB- active metabolites respectively enalaprilate and perindoprilate -RRB- , angiotensin ii receptor blockers losartan -LRB- with the active metabolite losartan carboxylic acid -RRB- and valsartan , calcium channel blockers amlodipine and nifedipine and diuretics hydrochlorothiazide and spironolactone -LRB- with the active metabolite canrenone -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (DT the) (NN method))\n",
      "      (VP (VBZ includes)\n",
      "        (NP (CD eight))\n",
      "        (UCP\n",
      "          (VP\n",
      "            (ADVP (RB frequently))\n",
      "            (VBN prescribed)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ antihypertensive) (NNS drugs))\n",
      "                (PP (IN from)\n",
      "                  (NP\n",
      "                    (NP (CD four) (NNS classes))\n",
      "                    (CC and)\n",
      "                    (NP (PRP$ their) (JJ active) (NNS metabolites)))))\n",
      "              (: :)\n",
      "              (NP\n",
      "                (NP (NNP ACEI))\n",
      "                (ADJP (JJ enalapril)\n",
      "                  (CC and)\n",
      "                  (JJ perindopril)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (S\n",
      "                  (NP (JJ active) (NNS metabolites))\n",
      "                  (ADVP (RB respectively))\n",
      "                  (VP (VBP enalaprilate)\n",
      "                    (CC and)\n",
      "                    (VBP perindoprilate)))\n",
      "                (-RRB- -RRB-))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN angiotensin) (NN ii) (NN receptor) (NNS blockers))\n",
      "                (VP (VBN losartan)\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (PP (IN with)\n",
      "                      (NP (DT the) (JJ active) (JJ metabolite) (NN losartan) (JJ carboxylic) (NN acid)))\n",
      "                    (-RRB- -RRB-))))))\n",
      "          (CC and)\n",
      "          (ADJP (JJ valsartan)))))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "      (ADJP (JJ amlodipine)\n",
      "        (CC and)\n",
      "        (JJ nifedipine)))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NNS diuretics))\n",
      "      (ADJP\n",
      "        (ADJP (JJ hydrochlorothiazide)\n",
      "          (CC and)\n",
      "          (JJ spironolactone))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (PP (IN with)\n",
      "            (NP (DT the) (JJ active) (NN metabolite) (NN canrenone)))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "det(method-2, the-1)\n",
      "nsubj(includes-3, method-2)\n",
      "nsubj(amlodipine-50, method-2)\n",
      "nsubj(hydrochlorothiazide-55, method-2)\n",
      "root(ROOT-0, includes-3)\n",
      "dobj(includes-3, eight-4)\n",
      "advmod(prescribed-6, frequently-5)\n",
      "dep(includes-3, prescribed-6)\n",
      "amod(drugs-8, antihypertensive-7)\n",
      "dobj(prescribed-6, drugs-8)\n",
      "case(classes-11, from-9)\n",
      "nummod(classes-11, four-10)\n",
      "nmod:from(drugs-8, classes-11)\n",
      "cc(classes-11, and-12)\n",
      "nmod:poss(metabolites-15, their-13)\n",
      "amod(metabolites-15, active-14)\n",
      "nmod:from(drugs-8, metabolites-15)\n",
      "conj:and(classes-11, metabolites-15)\n",
      "dep(drugs-8, ACEI-17)\n",
      "amod(ACEI-17, enalapril-18)\n",
      "cc(enalapril-18, and-19)\n",
      "amod(ACEI-17, perindopril-20)\n",
      "conj:and(enalapril-18, perindopril-20)\n",
      "amod(metabolites-23, active-22)\n",
      "nsubj(enalaprilate-25, metabolites-23)\n",
      "nsubj(perindoprilate-27, metabolites-23)\n",
      "advmod(enalaprilate-25, respectively-24)\n",
      "dep(drugs-8, enalaprilate-25)\n",
      "cc(enalaprilate-25, and-26)\n",
      "dep(drugs-8, perindoprilate-27)\n",
      "conj:and(enalaprilate-25, perindoprilate-27)\n",
      "compound(blockers-33, angiotensin-30)\n",
      "compound(blockers-33, ii-31)\n",
      "compound(blockers-33, receptor-32)\n",
      "appos(drugs-8, blockers-33)\n",
      "acl(blockers-33, losartan-34)\n",
      "case(acid-42, with-36)\n",
      "det(acid-42, the-37)\n",
      "amod(acid-42, active-38)\n",
      "amod(acid-42, metabolite-39)\n",
      "compound(acid-42, losartan-40)\n",
      "amod(acid-42, carboxylic-41)\n",
      "dep(losartan-34, acid-42)\n",
      "cc(prescribed-6, and-44)\n",
      "dep(includes-3, valsartan-45)\n",
      "conj:and(prescribed-6, valsartan-45)\n",
      "compound(blockers-49, calcium-47)\n",
      "compound(blockers-49, channel-48)\n",
      "dep(amlodipine-50, blockers-49)\n",
      "conj:and(includes-3, amlodipine-50)\n",
      "cc(amlodipine-50, and-51)\n",
      "conj:and(includes-3, nifedipine-52)\n",
      "conj:and(amlodipine-50, nifedipine-52)\n",
      "cc(includes-3, and-53)\n",
      "dep(hydrochlorothiazide-55, diuretics-54)\n",
      "conj:and(includes-3, hydrochlorothiazide-55)\n",
      "cc(hydrochlorothiazide-55, and-56)\n",
      "conj:and(includes-3, spironolactone-57)\n",
      "conj:and(hydrochlorothiazide-55, spironolactone-57)\n",
      "case(canrenone-63, with-59)\n",
      "det(canrenone-63, the-60)\n",
      "amod(canrenone-63, active-61)\n",
      "compound(canrenone-63, metabolite-62)\n",
      "dep(hydrochlorothiazide-55, canrenone-63)\n",
      "\n",
      "Parsing [sent. 140 len. 21]: this study demonstrates that ACEI-is/arbs therapy decreases the loss of residual renal function , mainly for patients with peritoneal dialysis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN study))\n",
      "    (VP (VBZ demonstrates)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP ACEI-is/arbs) (NN therapy))\n",
      "          (VP (VBZ decreases)\n",
      "            (NP\n",
      "              (NP (DT the) (NN loss))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ residual) (JJ renal) (NN function))))\n",
      "            (, ,)\n",
      "            (PP\n",
      "              (ADVP (RB mainly))\n",
      "              (IN for)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ peritoneal) (NN dialysis)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(study-2, this-1)\n",
      "nsubj(demonstrates-3, study-2)\n",
      "root(ROOT-0, demonstrates-3)\n",
      "mark(decreases-7, that-4)\n",
      "compound(therapy-6, ACEI-is/arbs-5)\n",
      "nsubj(decreases-7, therapy-6)\n",
      "ccomp(demonstrates-3, decreases-7)\n",
      "det(loss-9, the-8)\n",
      "dobj(decreases-7, loss-9)\n",
      "case(function-13, of-10)\n",
      "amod(function-13, residual-11)\n",
      "amod(function-13, renal-12)\n",
      "nmod:of(loss-9, function-13)\n",
      "advmod(patients-17, mainly-15)\n",
      "case(patients-17, for-16)\n",
      "nmod:for(decreases-7, patients-17)\n",
      "case(dialysis-20, with-18)\n",
      "amod(dialysis-20, peritoneal-19)\n",
      "nmod:with(patients-17, dialysis-20)\n",
      "\n",
      "Parsing [sent. 141 len. 28]: overall , ACEI-is and arbs do not reduce cardiovascular events in dialysis patients , however , treatment with arb seems to reduce cardiovascular events including heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ overall) (, ,) (NNS ACEI-is)\n",
      "        (CC and)\n",
      "        (NNS arbs))\n",
      "      (VP (VBP do) (RB not)\n",
      "        (VP (VB reduce)\n",
      "          (NP (JJ cardiovascular) (NNS events))\n",
      "          (PP (IN in)\n",
      "            (NP (NN dialysis) (NNS patients)))\n",
      "          (, ,)\n",
      "          (ADVP (RB however)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN treatment))\n",
      "      (PP (IN with)\n",
      "        (NP (NN arb))))\n",
      "    (VP (VBZ seems)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB reduce)\n",
      "            (NP\n",
      "              (NP (JJ cardiovascular) (NNS events))\n",
      "              (PP (VBG including)\n",
      "                (NP (NN heart) (NN failure))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(reduce-8, overall-1)\n",
      "conj:and(overall-1, ACEI-is-3)\n",
      "nsubj(reduce-8, ACEI-is-3)\n",
      "cc(overall-1, and-4)\n",
      "conj:and(overall-1, arbs-5)\n",
      "nsubj(reduce-8, arbs-5)\n",
      "aux(reduce-8, do-6)\n",
      "neg(reduce-8, not-7)\n",
      "ccomp(seems-20, reduce-8)\n",
      "amod(events-10, cardiovascular-9)\n",
      "dobj(reduce-8, events-10)\n",
      "case(patients-13, in-11)\n",
      "compound(patients-13, dialysis-12)\n",
      "nmod:in(reduce-8, patients-13)\n",
      "advmod(reduce-8, however-15)\n",
      "nsubj(seems-20, treatment-17)\n",
      "nsubj:xsubj(reduce-22, treatment-17)\n",
      "case(arb-19, with-18)\n",
      "nmod:with(treatment-17, arb-19)\n",
      "root(ROOT-0, seems-20)\n",
      "mark(reduce-22, to-21)\n",
      "xcomp(seems-20, reduce-22)\n",
      "amod(events-24, cardiovascular-23)\n",
      "dobj(reduce-22, events-24)\n",
      "case(failure-27, including-25)\n",
      "compound(failure-27, heart-26)\n",
      "nmod:including(events-24, failure-27)\n",
      "\n",
      "Parsing [sent. 142 len. 13]: ACEI-is and arbs do not induce an extra risk of side effects .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS ACEI-is)\n",
      "      (CC and)\n",
      "      (NNS arbs))\n",
      "    (VP (VBP do) (RB not)\n",
      "      (VP (VB induce)\n",
      "        (NP\n",
      "          (NP (DT an) (JJ extra) (NN risk))\n",
      "          (PP (IN of)\n",
      "            (NP (NN side) (NNS effects))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(induce-6, ACEI-is-1)\n",
      "cc(ACEI-is-1, and-2)\n",
      "conj:and(ACEI-is-1, arbs-3)\n",
      "nsubj(induce-6, arbs-3)\n",
      "aux(induce-6, do-4)\n",
      "neg(induce-6, not-5)\n",
      "root(ROOT-0, induce-6)\n",
      "det(risk-9, an-7)\n",
      "amod(risk-9, extra-8)\n",
      "dobj(induce-6, risk-9)\n",
      "case(effects-12, of-10)\n",
      "compound(effects-12, side-11)\n",
      "nmod:of(risk-9, effects-12)\n",
      "\n",
      "Parsing [sent. 143 len. 11]: eleven trials included 1856 participants who were receiving dialysis therapy .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS eleven) (NNS trials))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (CD 1856) (NNS participants))\n",
      "        (SBAR\n",
      "          (WHNP (WP who))\n",
      "          (S\n",
      "            (VP (VBD were)\n",
      "              (VP (VBG receiving)\n",
      "                (NP (NN dialysis) (NN therapy))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(trials-2, eleven-1)\n",
      "nsubj(included-3, trials-2)\n",
      "root(ROOT-0, included-3)\n",
      "nummod(participants-5, 1856-4)\n",
      "dobj(included-3, participants-5)\n",
      "nsubj(receiving-8, participants-5)\n",
      "ref(participants-5, who-6)\n",
      "aux(receiving-8, were-7)\n",
      "acl:relcl(participants-5, receiving-8)\n",
      "compound(therapy-10, dialysis-9)\n",
      "dobj(receiving-8, therapy-10)\n",
      "\n",
      "Parsing [sent. 144 len. 42]: compared with placebo or other active agents groups , arb therapy reduced the risk of heart failure events by 33 % -LRB- rr 0.67 , 95 % ci 0.47 to 0.93 -RRB- with similar decrement in blood pressure in dialysis patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (VBN compared)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (NN placebo))\n",
      "          (CC or)\n",
      "          (NP (JJ other) (JJ active) (NNS agents) (NNS groups)))))\n",
      "    (, ,)\n",
      "    (NP (NN arb) (NN therapy))\n",
      "    (VP (VBD reduced)\n",
      "      (NP\n",
      "        (NP (DT the) (NN risk))\n",
      "        (PP (IN of)\n",
      "          (NP (NN heart) (NN failure) (NNS events))))\n",
      "      (PP (IN by)\n",
      "        (NP\n",
      "          (NP (CD 33) (NN %))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP\n",
      "                (ADJP\n",
      "                  (QP (CD rr) (CD 0.67)))\n",
      "                (, ,)\n",
      "                (ADJP (CD 95) (NN %))\n",
      "                (NN ci) (NN 0.47))\n",
      "              (PP (TO to)\n",
      "                (NP (CD 0.93))))\n",
      "            (-RRB- -RRB-))))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ similar) (NN decrement))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NN blood) (NN pressure))\n",
      "              (PP (IN in)\n",
      "                (NP (NN dialysis) (NNS patients))))))))\n",
      "    (. .)))\n",
      "\n",
      "case(placebo-3, compared-1)\n",
      "mwe(compared-1, with-2)\n",
      "advcl(reduced-12, placebo-3)\n",
      "cc(placebo-3, or-4)\n",
      "amod(groups-8, other-5)\n",
      "amod(groups-8, active-6)\n",
      "compound(groups-8, agents-7)\n",
      "conj:or(placebo-3, groups-8)\n",
      "advcl(reduced-12, groups-8)\n",
      "compound(therapy-11, arb-10)\n",
      "nsubj(reduced-12, therapy-11)\n",
      "root(ROOT-0, reduced-12)\n",
      "det(risk-14, the-13)\n",
      "dobj(reduced-12, risk-14)\n",
      "case(events-18, of-15)\n",
      "compound(events-18, heart-16)\n",
      "compound(events-18, failure-17)\n",
      "nmod:of(risk-14, events-18)\n",
      "case(%-21, by-19)\n",
      "nummod(%-21, 33-20)\n",
      "nmod:by(reduced-12, %-21)\n",
      "compound(0.67-24, rr-23)\n",
      "nummod(0.47-29, 0.67-24)\n",
      "compound(%-27, 95-26)\n",
      "amod(0.47-29, %-27)\n",
      "compound(0.47-29, ci-28)\n",
      "dep(%-21, 0.47-29)\n",
      "case(0.93-31, to-30)\n",
      "nmod:to(0.47-29, 0.93-31)\n",
      "case(decrement-35, with-33)\n",
      "amod(decrement-35, similar-34)\n",
      "nmod:with(reduced-12, decrement-35)\n",
      "case(pressure-38, in-36)\n",
      "compound(pressure-38, blood-37)\n",
      "nmod:in(decrement-35, pressure-38)\n",
      "case(patients-41, in-39)\n",
      "compound(patients-41, dialysis-40)\n",
      "nmod:in(pressure-38, patients-41)\n",
      "\n",
      "Parsing [sent. 145 len. 20]: indirect comparison suggested that fewer cardiovascular events happened during treatment with arb -LRB- 0.77 , 0.63 to 0.94 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ indirect) (NN comparison))\n",
      "    (VP (VBD suggested)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (JJR fewer) (JJ cardiovascular) (NNS events))\n",
      "          (VP (VBD happened)\n",
      "            (PP (IN during)\n",
      "              (NP (NN treatment)))\n",
      "            (PP (IN with)\n",
      "              (NP (NN arb)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 0.77))\n",
      "                (, ,)\n",
      "                (NP (CD 0.63) (TO to) (CD 0.94)))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(comparison-2, indirect-1)\n",
      "nsubj(suggested-3, comparison-2)\n",
      "root(ROOT-0, suggested-3)\n",
      "mark(happened-8, that-4)\n",
      "amod(events-7, fewer-5)\n",
      "amod(events-7, cardiovascular-6)\n",
      "nsubj(happened-8, events-7)\n",
      "ccomp(suggested-3, happened-8)\n",
      "case(treatment-10, during-9)\n",
      "nmod:during(happened-8, treatment-10)\n",
      "case(arb-12, with-11)\n",
      "nmod:with(happened-8, arb-12)\n",
      "dep(happened-8, 0.77-14)\n",
      "nummod(0.94-18, 0.63-16)\n",
      "dep(0.94-18, to-17)\n",
      "appos(0.77-14, 0.94-18)\n",
      "\n",
      "Parsing [sent. 146 len. 55]: the results indicated no significant differences between the two treatment regimens with regard to frequency of myocardial infarction -LRB- 1.0 , 0.45 to 2.22 -RRB- , stroke -LRB- 1.16 , 0.69 to 1.96 -RRB- , cardiovascular death -LRB- 0.89 , 0.64 to 1.26 -RRB- and all-cause mortality -LRB- 0.94 , 0.75 to 1.17 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNS results))\n",
      "    (VP (VBD indicated)\n",
      "      (NP\n",
      "        (NP (DT no) (JJ significant) (NNS differences))\n",
      "        (PP (IN between)\n",
      "          (NP (DT the) (CD two) (NN treatment) (NNS regimens))))\n",
      "      (PP (IN with)\n",
      "        (NP (NN regard)))\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (NN frequency))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ myocardial) (NN infarction))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 1.0))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.45) (TO to) (CD 2.22)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN stroke))\n",
      "                (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (CD 1.16))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (QP (CD 0.69) (TO to) (CD 1.96))))\n",
      "                (-RRB- -RRB-))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (JJ cardiovascular) (NN death))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (NNP 0.89))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.64) (TO to) (CD 1.26)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (JJ all-cause) (NN mortality))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 0.94))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.75) (TO to) (CD 1.17)))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(results-2, the-1)\n",
      "nsubj(indicated-3, results-2)\n",
      "root(ROOT-0, indicated-3)\n",
      "neg(differences-6, no-4)\n",
      "amod(differences-6, significant-5)\n",
      "dobj(indicated-3, differences-6)\n",
      "case(regimens-11, between-7)\n",
      "det(regimens-11, the-8)\n",
      "nummod(regimens-11, two-9)\n",
      "compound(regimens-11, treatment-10)\n",
      "nmod:between(differences-6, regimens-11)\n",
      "case(regard-13, with-12)\n",
      "nmod:with(indicated-3, regard-13)\n",
      "case(frequency-15, to-14)\n",
      "nmod:to(indicated-3, frequency-15)\n",
      "case(infarction-18, of-16)\n",
      "amod(infarction-18, myocardial-17)\n",
      "nmod:of(frequency-15, infarction-18)\n",
      "dep(infarction-18, 1.0-20)\n",
      "nummod(2.22-24, 0.45-22)\n",
      "dep(2.22-24, to-23)\n",
      "appos(1.0-20, 2.22-24)\n",
      "nmod:of(frequency-15, stroke-27)\n",
      "conj:and(infarction-18, stroke-27)\n",
      "dep(stroke-27, 1.16-29)\n",
      "compound(1.96-33, 0.69-31)\n",
      "dep(1.96-33, to-32)\n",
      "appos(1.16-29, 1.96-33)\n",
      "amod(death-37, cardiovascular-36)\n",
      "nmod:of(frequency-15, death-37)\n",
      "conj:and(infarction-18, death-37)\n",
      "dep(death-37, 0.89-39)\n",
      "nummod(1.26-43, 0.64-41)\n",
      "dep(1.26-43, to-42)\n",
      "appos(0.89-39, 1.26-43)\n",
      "cc(infarction-18, and-45)\n",
      "amod(mortality-47, all-cause-46)\n",
      "nmod:of(frequency-15, mortality-47)\n",
      "conj:and(infarction-18, mortality-47)\n",
      "dep(mortality-47, 0.94-49)\n",
      "nummod(1.17-53, 0.75-51)\n",
      "dep(1.17-53, to-52)\n",
      "appos(0.94-49, 1.17-53)\n",
      "\n",
      "Parsing [sent. 147 len. 60]: five studies reported the renoprotective effect and revealed that ACEI/arb therapy significantly slowed the rate of decline in both residual renal function -LRB- md 0.93 ml/min/1 .73 m -LRB- 2 -RRB- , 0.38 to 1.47 ml/min/1 .73 m -LRB- 2 -RRB- -RRB- and urine volume -LRB- md 167 ml , 95 % ci 21 ml to 357 ml -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (CD five) (NNS studies))\n",
      "    (VP\n",
      "      (VP (VBD reported)\n",
      "        (NP (DT the) (JJ renoprotective) (NN effect)))\n",
      "      (CC and)\n",
      "      (VP (VBD revealed)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP (NNP ACEI/arb) (NN therapy))\n",
      "            (ADVP (RB significantly))\n",
      "            (VP (VBD slowed)\n",
      "              (NP\n",
      "                (NP (DT the) (NN rate))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN decline))))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT both) (JJ residual) (JJ renal) (NN function))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NN md))\n",
      "                      (NP\n",
      "                        (NP (CD 0.93) (JJ ml/min/1) (CD .73) (NNS m))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 2))\n",
      "                          (-RRB- -RRB-))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP\n",
      "                            (QP (CD 0.38) (TO to) (CD 1.47))\n",
      "                            (JJ ml/min/1) (CD .73) (NNS m))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (CD 2))\n",
      "                            (-RRB- -RRB-)))))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (CC and)\n",
      "                  (NP (NN urine) (NN volume))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (QP (CD md) (CD 167))\n",
      "                        (NNP ml) (, ,)\n",
      "                        (ADJP (CD 95) (NN %))\n",
      "                        (JJ ci) (CD 21) (NN ml))\n",
      "                      (PP (TO to)\n",
      "                        (NP (CD 357) (NN ml))))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nummod(studies-2, five-1)\n",
      "nsubj(reported-3, studies-2)\n",
      "nsubj(revealed-8, studies-2)\n",
      "root(ROOT-0, reported-3)\n",
      "det(effect-6, the-4)\n",
      "amod(effect-6, renoprotective-5)\n",
      "dobj(reported-3, effect-6)\n",
      "cc(reported-3, and-7)\n",
      "conj:and(reported-3, revealed-8)\n",
      "mark(slowed-13, that-9)\n",
      "compound(therapy-11, ACEI/arb-10)\n",
      "nsubj(slowed-13, therapy-11)\n",
      "advmod(slowed-13, significantly-12)\n",
      "ccomp(revealed-8, slowed-13)\n",
      "det(rate-15, the-14)\n",
      "dobj(slowed-13, rate-15)\n",
      "case(decline-17, of-16)\n",
      "nmod:of(rate-15, decline-17)\n",
      "case(function-22, in-18)\n",
      "det(function-22, both-19)\n",
      "amod(function-22, residual-20)\n",
      "amod(function-22, renal-21)\n",
      "nmod:in(slowed-13, function-22)\n",
      "dep(function-22, md-24)\n",
      "nummod(m-28, 0.93-25)\n",
      "amod(m-28, ml/min/1-26)\n",
      "nummod(m-28, .73-27)\n",
      "dep(md-24, m-28)\n",
      "appos(m-28, 2-30)\n",
      "compound(1.47-35, 0.38-33)\n",
      "dep(1.47-35, to-34)\n",
      "nummod(m-38, 1.47-35)\n",
      "amod(m-38, ml/min/1-36)\n",
      "nummod(m-38, .73-37)\n",
      "appos(m-28, m-38)\n",
      "appos(m-38, 2-40)\n",
      "cc(function-22, and-43)\n",
      "compound(volume-45, urine-44)\n",
      "nmod:in(slowed-13, volume-45)\n",
      "conj:and(function-22, volume-45)\n",
      "compound(167-48, md-47)\n",
      "nummod(ml-55, 167-48)\n",
      "compound(ml-55, ml-49)\n",
      "compound(%-52, 95-51)\n",
      "amod(ml-55, %-52)\n",
      "amod(ml-55, ci-53)\n",
      "nummod(ml-55, 21-54)\n",
      "dep(function-22, ml-55)\n",
      "case(ml-58, to-56)\n",
      "nummod(ml-58, 357-57)\n",
      "nmod:to(ml-55, ml-58)\n",
      "\n",
      "Parsing [sent. 148 len. 13]: no difference in drug-related adverse events was observed in both treatment groups .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT no) (NN difference))\n",
      "      (PP (IN in)\n",
      "        (NP (JJ drug-related) (JJ adverse) (NNS events))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN in)\n",
      "          (NP (DT both) (NN treatment) (NNS groups)))))\n",
      "    (. .)))\n",
      "\n",
      "neg(difference-2, no-1)\n",
      "nsubjpass(observed-8, difference-2)\n",
      "case(events-6, in-3)\n",
      "amod(events-6, drug-related-4)\n",
      "amod(events-6, adverse-5)\n",
      "nmod:in(difference-2, events-6)\n",
      "auxpass(observed-8, was-7)\n",
      "root(ROOT-0, observed-8)\n",
      "case(groups-12, in-9)\n",
      "det(groups-12, both-10)\n",
      "compound(groups-12, treatment-11)\n",
      "nmod:in(observed-8, groups-12)\n",
      "\n",
      "Parsing [sent. 149 len. 32]: the role of ACEI and angiotensin receptor blockers -LRB- arbs -RRB- reducing risk of cardiovascular events -LRB- cves -RRB- and preserving kidney function in patients with chronic kidney disease is well-documented .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN role))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NNP ACEI)\n",
      "              (CC and)\n",
      "              (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNS arbs))\n",
      "              (-RRB- -RRB-)))\n",
      "          (VP\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP (NN risk))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ cardiovascular) (NNS events))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNS cves))\n",
      "                      (-RRB- -RRB-))))))\n",
      "            (CC and)\n",
      "            (VP (VBG preserving)\n",
      "              (NP (NN kidney) (NN function))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NNS patients))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ chronic) (NN kidney) (NN disease))))))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ well-documented)))\n",
      "    (. .)))\n",
      "\n",
      "det(role-2, the-1)\n",
      "nsubj(well-documented-31, role-2)\n",
      "case(blockers-8, of-3)\n",
      "compound(blockers-8, ACEI-4)\n",
      "cc(ACEI-4, and-5)\n",
      "conj:and(ACEI-4, angiotensin-6)\n",
      "compound(blockers-8, angiotensin-6)\n",
      "compound(blockers-8, receptor-7)\n",
      "nmod:of(role-2, blockers-8)\n",
      "appos(blockers-8, arbs-10)\n",
      "dep(blockers-8, reducing-12)\n",
      "dobj(reducing-12, risk-13)\n",
      "case(events-16, of-14)\n",
      "amod(events-16, cardiovascular-15)\n",
      "nmod:of(risk-13, events-16)\n",
      "appos(events-16, cves-18)\n",
      "cc(reducing-12, and-20)\n",
      "dep(blockers-8, preserving-21)\n",
      "conj:and(reducing-12, preserving-21)\n",
      "compound(function-23, kidney-22)\n",
      "dobj(preserving-21, function-23)\n",
      "case(patients-25, in-24)\n",
      "nmod:in(preserving-21, patients-25)\n",
      "case(disease-29, with-26)\n",
      "amod(disease-29, chronic-27)\n",
      "compound(disease-29, kidney-28)\n",
      "nmod:with(patients-25, disease-29)\n",
      "cop(well-documented-31, is-30)\n",
      "root(ROOT-0, well-documented-31)\n",
      "\n",
      "Parsing [sent. 150 len. 18]: however , the efficacy and safety of these agents in dialysis patients is still a controversial issue .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN efficacy)\n",
      "        (CC and)\n",
      "        (NN safety))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT these) (NNS agents))\n",
      "          (PP (IN in)\n",
      "            (NP (NN dialysis) (NNS patients))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB still))\n",
      "      (NP (DT a) (JJ controversial) (NN issue)))\n",
      "    (. .)))\n",
      "\n",
      "advmod(issue-17, however-1)\n",
      "det(efficacy-4, the-3)\n",
      "nsubj(issue-17, efficacy-4)\n",
      "cc(efficacy-4, and-5)\n",
      "conj:and(efficacy-4, safety-6)\n",
      "nsubj(issue-17, safety-6)\n",
      "case(agents-9, of-7)\n",
      "det(agents-9, these-8)\n",
      "nmod:of(efficacy-4, agents-9)\n",
      "case(patients-12, in-10)\n",
      "compound(patients-12, dialysis-11)\n",
      "nmod:in(agents-9, patients-12)\n",
      "cop(issue-17, is-13)\n",
      "advmod(issue-17, still-14)\n",
      "det(issue-17, a-15)\n",
      "amod(issue-17, controversial-16)\n",
      "root(ROOT-0, issue-17)\n",
      "\n",
      "Parsing [sent. 151 len. 56]: mex and aceimex groups improved all physical functional status outcomes , decreased systolic -LRB- sbp -RRB- and diastolic blood pressure -LRB- p < 0.001 -RRB- and augmented the physical functioning , role physical and physical component score -LRB- pcs -RRB- -LRB- p < 0.05 -RRB- , but also bodily pain -LRB- p < 0.05 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN mex)\n",
      "      (CC and)\n",
      "      (NN aceimex) (NNS groups))\n",
      "    (VP\n",
      "      (VP (VBD improved)\n",
      "        (NP (DT all)\n",
      "          (ADJP (JJ physical) (JJ functional))\n",
      "          (NN status) (NNS outcomes)))\n",
      "      (, ,)\n",
      "      (VP (VBD decreased)\n",
      "        (NP\n",
      "          (NP (JJ systolic) (-LRB- -LRB-) (NN sbp) (-RRB- -RRB-))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (JJ diastolic) (NN blood) (NN pressure))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p)\n",
      "                (QP (CD <) (CD 0.001)))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (CC and)\n",
      "      (VP (VBD augmented)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (JJ physical) (NN functioning))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NN role) (JJ physical)\n",
      "                  (CC and)\n",
      "                  (JJ physical) (NN component) (NN score))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN pcs))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN p)\n",
      "                  (NP (CD <) (CD 0.05)))\n",
      "                (-RRB- -RRB-))))\n",
      "          (, ,)\n",
      "          (CONJP (CC but)\n",
      "            (RB also))\n",
      "          (NP\n",
      "            (NP (JJ bodily) (NN pain))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p) (NNP <) (NNP 0.05))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(groups-4, mex-1)\n",
      "cc(mex-1, and-2)\n",
      "conj:and(mex-1, aceimex-3)\n",
      "compound(groups-4, aceimex-3)\n",
      "nsubj(improved-5, groups-4)\n",
      "nsubj(decreased-12, groups-4)\n",
      "nsubj(augmented-27, groups-4)\n",
      "root(ROOT-0, improved-5)\n",
      "det(outcomes-10, all-6)\n",
      "amod(functional-8, physical-7)\n",
      "amod(outcomes-10, functional-8)\n",
      "compound(outcomes-10, status-9)\n",
      "dobj(improved-5, outcomes-10)\n",
      "conj:and(improved-5, decreased-12)\n",
      "amod(sbp-15, systolic-13)\n",
      "dobj(decreased-12, sbp-15)\n",
      "cc(sbp-15, and-17)\n",
      "amod(pressure-20, diastolic-18)\n",
      "compound(pressure-20, blood-19)\n",
      "dobj(decreased-12, pressure-20)\n",
      "conj:and(sbp-15, pressure-20)\n",
      "appos(pressure-20, p-22)\n",
      "compound(0.001-24, <-23)\n",
      "nummod(p-22, 0.001-24)\n",
      "cc(improved-5, and-26)\n",
      "conj:and(improved-5, augmented-27)\n",
      "det(functioning-30, the-28)\n",
      "amod(functioning-30, physical-29)\n",
      "dobj(augmented-27, functioning-30)\n",
      "nmod:npmod(physical-33, role-32)\n",
      "appos(functioning-30, physical-33)\n",
      "cc(physical-33, and-34)\n",
      "amod(score-37, physical-35)\n",
      "compound(score-37, component-36)\n",
      "appos(functioning-30, score-37)\n",
      "conj:and(physical-33, score-37)\n",
      "appos(physical-33, pcs-39)\n",
      "dep(physical-33, p-42)\n",
      "nummod(0.05-44, <-43)\n",
      "dobj(p-42, 0.05-44)\n",
      "cc(functioning-30, but-47)\n",
      "advmod(pain-50, also-48)\n",
      "amod(pain-50, bodily-49)\n",
      "dobj(augmented-27, pain-50)\n",
      "conj:and(functioning-30, pain-50)\n",
      "compound(0.05-54, p-52)\n",
      "compound(0.05-54, <-53)\n",
      "appos(pain-50, 0.05-54)\n",
      "\n",
      "Parsing [sent. 152 len. 48]: the ACEI group reduced the upper body strength , upper and lower body flexibility and aerobic endurance -LRB- p < 0.05 -RRB- ; worsened the anthropometric profile , and sbp -LRB- p < 0.001 -RRB- ; and decreased general health and pcs -LRB- p < 0.05 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNP ACEI) (NN group))\n",
      "    (VP (VBD reduced)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (DT the) (JJ upper) (NN body) (NN strength))\n",
      "          (, ,)\n",
      "          (NP (JJ upper))\n",
      "          (CC and)\n",
      "          (NP (JJR lower) (NN body) (NN flexibility)))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ aerobic) (NNS endurance))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (: ;)\n",
      "        (NP\n",
      "          (NP\n",
      "            (ADVP (RB worsened))\n",
      "            (DT the) (JJ anthropometric) (NN profile))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (NN sbp))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p)\n",
      "                (QP (CD <) (CD 0.001)))\n",
      "              (-RRB- -RRB-))))\n",
      "        (: ;)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (VBN decreased) (JJ general) (NN health))\n",
      "            (CC and)\n",
      "            (NP (NN pcs)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "det(group-3, the-1)\n",
      "compound(group-3, ACEI-2)\n",
      "nsubj(reduced-4, group-3)\n",
      "root(ROOT-0, reduced-4)\n",
      "det(strength-8, the-5)\n",
      "amod(strength-8, upper-6)\n",
      "compound(strength-8, body-7)\n",
      "dobj(reduced-4, strength-8)\n",
      "dobj(reduced-4, upper-10)\n",
      "conj:and(strength-8, upper-10)\n",
      "cc(strength-8, and-11)\n",
      "amod(flexibility-14, lower-12)\n",
      "compound(flexibility-14, body-13)\n",
      "dobj(reduced-4, flexibility-14)\n",
      "conj:and(strength-8, flexibility-14)\n",
      "cc(strength-8, and-15)\n",
      "amod(endurance-17, aerobic-16)\n",
      "dobj(reduced-4, endurance-17)\n",
      "conj:and(strength-8, endurance-17)\n",
      "dep(endurance-17, p-19)\n",
      "nummod(0.05-21, <-20)\n",
      "dobj(p-19, 0.05-21)\n",
      "advmod(profile-27, worsened-24)\n",
      "det(profile-27, the-25)\n",
      "amod(profile-27, anthropometric-26)\n",
      "dobj(reduced-4, profile-27)\n",
      "conj:and(strength-8, profile-27)\n",
      "cc(profile-27, and-29)\n",
      "conj:and(strength-8, sbp-30)\n",
      "conj:and(profile-27, sbp-30)\n",
      "appos(sbp-30, p-32)\n",
      "compound(0.001-34, <-33)\n",
      "nummod(p-32, 0.001-34)\n",
      "cc(strength-8, and-37)\n",
      "amod(health-40, decreased-38)\n",
      "amod(health-40, general-39)\n",
      "dobj(reduced-4, health-40)\n",
      "conj:and(strength-8, health-40)\n",
      "cc(health-40, and-41)\n",
      "conj:and(strength-8, pcs-42)\n",
      "conj:and(health-40, pcs-42)\n",
      "dep(health-40, p-44)\n",
      "nummod(0.05-46, <-45)\n",
      "dobj(p-44, 0.05-46)\n",
      "\n",
      "Parsed file: KeywordSentences.txt [152 sentences].\n",
      "Parsed 4222 words in 152 sentences (59.37 wds/sec; 2.14 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsing [sent. 1 len. 44]: renin-angiotensin-aldosterone system -LRB- raas -RRB- antagonists , including ACEI , angiotensin receptor blockers -LRB- arb -RRB- , and mineralocorticoid receptor antagonists -LRB- mra -RRB- decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia , especially when used in combination .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ renin-angiotensin-aldosterone) (NN system)\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNS raas))\n",
      "          (-RRB- -RRB-))\n",
      "        (NNS antagonists))\n",
      "      (, ,)\n",
      "      (PP (VBG including)\n",
      "        (NP (NNP ACEI)))\n",
      "      (, ,))\n",
      "    (VP (VBD angiotensin)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN receptor) (NNS blockers))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN arb))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ mineralocorticoid) (NN receptor) (NNS antagonists))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN mra))\n",
      "            (-RRB- -RRB-))))\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (VB decrease)\n",
      "            (NP (NN mortality)\n",
      "              (CC and)\n",
      "              (NN morbidity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN heart) (NN failure))))\n",
      "          (CC but)\n",
      "          (VP (VB increase)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP (NN hyperkalemia)))))))\n",
      "      (, ,)\n",
      "      (SBAR\n",
      "        (WHADVP (RB especially) (WRB when))\n",
      "        (S\n",
      "          (VP (VBN used)\n",
      "            (PP (IN in)\n",
      "              (NP (NN combination)))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(antagonists-6, renin-angiotensin-aldosterone-1)\n",
      "compound(antagonists-6, system-2)\n",
      "appos(antagonists-6, raas-4)\n",
      "nsubj(angiotensin-11, antagonists-6)\n",
      "case(ACEI-9, including-8)\n",
      "nmod:including(antagonists-6, ACEI-9)\n",
      "root(ROOT-0, angiotensin-11)\n",
      "compound(blockers-13, receptor-12)\n",
      "dobj(angiotensin-11, blockers-13)\n",
      "appos(blockers-13, arb-15)\n",
      "cc(blockers-13, and-18)\n",
      "amod(antagonists-21, mineralocorticoid-19)\n",
      "compound(antagonists-21, receptor-20)\n",
      "dobj(angiotensin-11, antagonists-21)\n",
      "conj:and(blockers-13, antagonists-21)\n",
      "appos(antagonists-21, mra-23)\n",
      "dep(angiotensin-11, decrease-25)\n",
      "dobj(decrease-25, mortality-26)\n",
      "cc(mortality-26, and-27)\n",
      "dobj(decrease-25, morbidity-28)\n",
      "conj:and(mortality-26, morbidity-28)\n",
      "case(failure-31, in-29)\n",
      "compound(failure-31, heart-30)\n",
      "nmod:in(decrease-25, failure-31)\n",
      "cc(decrease-25, but-32)\n",
      "dep(angiotensin-11, increase-33)\n",
      "conj:but(decrease-25, increase-33)\n",
      "det(risk-35, the-34)\n",
      "dobj(increase-33, risk-35)\n",
      "case(hyperkalemia-37, of-36)\n",
      "nmod:of(risk-35, hyperkalemia-37)\n",
      "advmod(when-40, especially-39)\n",
      "advmod(used-41, when-40)\n",
      "advcl(angiotensin-11, used-41)\n",
      "case(combination-43, in-42)\n",
      "nmod:in(used-41, combination-43)\n",
      "\n",
      "Parsing [sent. 2 len. 28]: prevention of hyperkalemia and its associated complications requires careful patient selection , counseling regarding dietary potassium intake , awareness of drug interactions , and regular laboratory surveillance .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN prevention))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN hyperkalemia))\n",
      "          (CC and)\n",
      "          (NP (PRP$ its) (JJ associated) (NNS complications)))))\n",
      "    (VP (VBZ requires)\n",
      "      (NP\n",
      "        (NP (JJ careful) (NN patient) (NN selection))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN counseling))\n",
      "          (PP (VBG regarding)\n",
      "            (NP\n",
      "              (NP (JJ dietary) (NN potassium) (NN intake))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN awareness))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN drug) (NNS interactions))))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (JJ regular) (NN laboratory) (NN surveillance)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(requires-8, prevention-1)\n",
      "case(hyperkalemia-3, of-2)\n",
      "nmod:of(prevention-1, hyperkalemia-3)\n",
      "cc(hyperkalemia-3, and-4)\n",
      "nmod:poss(complications-7, its-5)\n",
      "amod(complications-7, associated-6)\n",
      "nmod:of(prevention-1, complications-7)\n",
      "conj:and(hyperkalemia-3, complications-7)\n",
      "root(ROOT-0, requires-8)\n",
      "amod(selection-11, careful-9)\n",
      "compound(selection-11, patient-10)\n",
      "dobj(requires-8, selection-11)\n",
      "appos(selection-11, counseling-13)\n",
      "case(intake-17, regarding-14)\n",
      "amod(intake-17, dietary-15)\n",
      "compound(intake-17, potassium-16)\n",
      "nmod:regarding(counseling-13, intake-17)\n",
      "nmod:regarding(counseling-13, awareness-19)\n",
      "conj:and(intake-17, awareness-19)\n",
      "case(interactions-22, of-20)\n",
      "compound(interactions-22, drug-21)\n",
      "nmod:of(awareness-19, interactions-22)\n",
      "cc(intake-17, and-24)\n",
      "amod(surveillance-27, regular-25)\n",
      "compound(surveillance-27, laboratory-26)\n",
      "nmod:regarding(counseling-13, surveillance-27)\n",
      "conj:and(intake-17, surveillance-27)\n",
      "\n",
      "Parsing [sent. 3 len. 29]: recent data suggests that the risk of hyperkalemia may be further moderated through the use of combined angiotensin-neprilysin inhibitors , novel mras , and novel potassium binding agents .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ recent) (NNS data))\n",
      "    (VP (VBZ suggests)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN risk))\n",
      "            (PP (IN of)\n",
      "              (NP (NN hyperkalemia))))\n",
      "          (VP (MD may)\n",
      "            (VP (VB be)\n",
      "              (VP (RBR further) (VBN moderated)\n",
      "                (PP (IN through)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN use))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (VBN combined) (JJ angiotensin-neprilysin) (NNS inhibitors))\n",
      "                        (, ,)\n",
      "                        (NP (NN novel) (NNS mras))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP (NN novel) (NN potassium) (VBG binding) (NNS agents))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(data-2, recent-1)\n",
      "nsubj(suggests-3, data-2)\n",
      "root(ROOT-0, suggests-3)\n",
      "mark(moderated-12, that-4)\n",
      "det(risk-6, the-5)\n",
      "nsubjpass(moderated-12, risk-6)\n",
      "case(hyperkalemia-8, of-7)\n",
      "nmod:of(risk-6, hyperkalemia-8)\n",
      "aux(moderated-12, may-9)\n",
      "auxpass(moderated-12, be-10)\n",
      "advmod(moderated-12, further-11)\n",
      "ccomp(suggests-3, moderated-12)\n",
      "case(use-15, through-13)\n",
      "det(use-15, the-14)\n",
      "nmod:through(moderated-12, use-15)\n",
      "case(inhibitors-19, of-16)\n",
      "amod(inhibitors-19, combined-17)\n",
      "amod(inhibitors-19, angiotensin-neprilysin-18)\n",
      "nmod:of(use-15, inhibitors-19)\n",
      "compound(mras-22, novel-21)\n",
      "nmod:of(use-15, mras-22)\n",
      "conj:and(inhibitors-19, mras-22)\n",
      "cc(inhibitors-19, and-24)\n",
      "compound(agents-28, novel-25)\n",
      "compound(agents-28, potassium-26)\n",
      "amod(agents-28, binding-27)\n",
      "nmod:of(use-15, agents-28)\n",
      "conj:and(inhibitors-19, agents-28)\n",
      "\n",
      "Parsing [sent. 4 len. 19]: clinicians should be mindful of the risk of hyperkalemia when prescribing raas inhibitors to patients with heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS clinicians))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ mindful)\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP (NN hyperkalemia))))))\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (VBG prescribing) (NNS raas))\n",
      "            (VP (VBZ inhibitors)\n",
      "              (PP (TO to)\n",
      "                (NP\n",
      "                  (NP (NNS patients))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN heart) (NN failure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(mindful-4, clinicians-1)\n",
      "aux(mindful-4, should-2)\n",
      "cop(mindful-4, be-3)\n",
      "root(ROOT-0, mindful-4)\n",
      "case(risk-7, of-5)\n",
      "det(risk-7, the-6)\n",
      "nmod:of(mindful-4, risk-7)\n",
      "case(hyperkalemia-9, of-8)\n",
      "nmod:of(risk-7, hyperkalemia-9)\n",
      "advmod(inhibitors-13, when-10)\n",
      "amod(raas-12, prescribing-11)\n",
      "nsubj(inhibitors-13, raas-12)\n",
      "advcl(mindful-4, inhibitors-13)\n",
      "case(patients-15, to-14)\n",
      "nmod:to(inhibitors-13, patients-15)\n",
      "case(failure-18, with-16)\n",
      "compound(failure-18, heart-17)\n",
      "nmod:with(patients-15, failure-18)\n",
      "\n",
      "Parsing [sent. 5 len. 33]: in patients at highest risk , such as those with diabetes , the elderly , and advanced chronic kidney disease , more intensive laboratory surveillance of potassium and creatinine may be required .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP\n",
      "        (NP (NNS patients))\n",
      "        (PP (IN at)\n",
      "          (NP (JJS highest) (NN risk)))\n",
      "        (, ,)\n",
      "        (PP (JJ such) (IN as)\n",
      "          (NP\n",
      "            (NP (DT those))\n",
      "            (PP (IN with)\n",
      "              (NP (NN diabetes)))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the)\n",
      "        (ADJP (JJ elderly) (, ,)\n",
      "          (CC and)\n",
      "          (JJ advanced))\n",
      "        (JJ chronic) (NN kidney) (NN disease) (, ,)\n",
      "        (ADJP (RBR more) (JJ intensive))\n",
      "        (NN laboratory) (NN surveillance))\n",
      "      (PP (IN of)\n",
      "        (NP (NN potassium)\n",
      "          (CC and)\n",
      "          (NN creatinine))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN required))))\n",
      "    (. .)))\n",
      "\n",
      "case(patients-2, in-1)\n",
      "nmod:in(required-32, patients-2)\n",
      "case(risk-5, at-3)\n",
      "amod(risk-5, highest-4)\n",
      "nmod:at(patients-2, risk-5)\n",
      "case(those-9, such-7)\n",
      "mwe(such-7, as-8)\n",
      "nmod:such_as(patients-2, those-9)\n",
      "case(diabetes-11, with-10)\n",
      "nmod:with(those-9, diabetes-11)\n",
      "det(surveillance-25, the-13)\n",
      "amod(surveillance-25, elderly-14)\n",
      "cc(elderly-14, and-16)\n",
      "conj:and(elderly-14, advanced-17)\n",
      "amod(surveillance-25, advanced-17)\n",
      "amod(surveillance-25, chronic-18)\n",
      "compound(surveillance-25, kidney-19)\n",
      "compound(surveillance-25, disease-20)\n",
      "advmod(intensive-23, more-22)\n",
      "amod(surveillance-25, intensive-23)\n",
      "compound(surveillance-25, laboratory-24)\n",
      "nsubjpass(required-32, surveillance-25)\n",
      "case(potassium-27, of-26)\n",
      "nmod:of(surveillance-25, potassium-27)\n",
      "cc(potassium-27, and-28)\n",
      "nmod:of(surveillance-25, creatinine-29)\n",
      "conj:and(potassium-27, creatinine-29)\n",
      "aux(required-32, may-30)\n",
      "auxpass(required-32, be-31)\n",
      "root(ROOT-0, required-32)\n",
      "\n",
      "Parsing [sent. 6 len. 18]: novel therapies hold promise for reducing the risk of hyperkalemia and enhancing the tolerability of raas antagonists .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN novel) (NNS therapies))\n",
      "    (VP (VBP hold)\n",
      "      (NP (NN promise))\n",
      "      (PP (IN for)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN risk))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN hyperkalemia)))))\n",
      "            (CC and)\n",
      "            (VP (VBG enhancing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN tolerability))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ raas) (NNS antagonists)))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(therapies-2, novel-1)\n",
      "nsubj(hold-3, therapies-2)\n",
      "root(ROOT-0, hold-3)\n",
      "dobj(hold-3, promise-4)\n",
      "mark(reducing-6, for-5)\n",
      "advcl(hold-3, reducing-6)\n",
      "det(risk-8, the-7)\n",
      "dobj(reducing-6, risk-8)\n",
      "case(hyperkalemia-10, of-9)\n",
      "nmod:of(risk-8, hyperkalemia-10)\n",
      "cc(reducing-6, and-11)\n",
      "advcl(hold-3, enhancing-12)\n",
      "conj:and(reducing-6, enhancing-12)\n",
      "det(tolerability-14, the-13)\n",
      "dobj(enhancing-12, tolerability-14)\n",
      "case(antagonists-17, of-15)\n",
      "amod(antagonists-17, raas-16)\n",
      "nmod:of(tolerability-14, antagonists-17)\n",
      "\n",
      "Parsing [sent. 7 len. 12]: heart failure is a disease with a high prevalence and incidence .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN heart) (NN failure))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (NN disease))\n",
      "        (PP (IN with)\n",
      "          (NP (DT a) (JJ high) (NN prevalence)\n",
      "            (CC and)\n",
      "            (NN incidence)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(disease-5, failure-2)\n",
      "cop(disease-5, is-3)\n",
      "det(disease-5, a-4)\n",
      "root(ROOT-0, disease-5)\n",
      "case(prevalence-9, with-6)\n",
      "det(prevalence-9, a-7)\n",
      "amod(prevalence-9, high-8)\n",
      "nmod:with(disease-5, prevalence-9)\n",
      "cc(prevalence-9, and-10)\n",
      "nmod:with(disease-5, incidence-11)\n",
      "conj:and(prevalence-9, incidence-11)\n",
      "\n",
      "Parsing [sent. 8 len. 25]: new therapeutic approaches are needed to prevent the onset of heart failure and to reduce the high morbidity and mortality associated with this disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ new) (JJ therapeutic) (NNS approaches))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN needed)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (TO to)\n",
      "              (VP (VB prevent)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN onset))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN heart) (NN failure))))))\n",
      "            (CC and)\n",
      "            (VP (TO to)\n",
      "              (VP (VB reduce)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ high) (NN morbidity)\n",
      "                    (CC and)\n",
      "                    (NN mortality))\n",
      "                  (VP (VBN associated)\n",
      "                    (PP (IN with)\n",
      "                      (NP (DT this) (NN disease)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(approaches-3, new-1)\n",
      "amod(approaches-3, therapeutic-2)\n",
      "nsubjpass(needed-5, approaches-3)\n",
      "auxpass(needed-5, are-4)\n",
      "root(ROOT-0, needed-5)\n",
      "mark(prevent-7, to-6)\n",
      "ccomp(needed-5, prevent-7)\n",
      "det(onset-9, the-8)\n",
      "dobj(prevent-7, onset-9)\n",
      "case(failure-12, of-10)\n",
      "compound(failure-12, heart-11)\n",
      "nmod:of(onset-9, failure-12)\n",
      "cc(prevent-7, and-13)\n",
      "mark(reduce-15, to-14)\n",
      "ccomp(needed-5, reduce-15)\n",
      "conj:and(prevent-7, reduce-15)\n",
      "det(morbidity-18, the-16)\n",
      "amod(morbidity-18, high-17)\n",
      "dobj(reduce-15, morbidity-18)\n",
      "cc(morbidity-18, and-19)\n",
      "dobj(reduce-15, mortality-20)\n",
      "conj:and(morbidity-18, mortality-20)\n",
      "acl(morbidity-18, associated-21)\n",
      "case(disease-24, with-22)\n",
      "det(disease-24, this-23)\n",
      "nmod:with(associated-21, disease-24)\n",
      "\n",
      "Parsing [sent. 9 len. 31]: an optimized therapy of arterial hypertension in patients with risk factors and the use of the sglt2 inhibitor empagliflozin in type 2 diabetics are proven strategies to prevent heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT an) (JJ optimized) (NN therapy))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (JJ arterial) (NN hypertension))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN risk) (NNS factors))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT the) (NN use))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (DT the) (JJ sglt2) (NN inhibitor) (NN empagliflozin))\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (ADJP (NN type) (CD 2))\n",
      "                        (NNS diabetics)))))))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN proven)\n",
      "        (NP (NNS strategies))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB prevent)\n",
      "              (NP (NN heart) (NN failure)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(therapy-3, an-1)\n",
      "amod(therapy-3, optimized-2)\n",
      "nsubjpass(proven-25, therapy-3)\n",
      "case(hypertension-6, of-4)\n",
      "amod(hypertension-6, arterial-5)\n",
      "nmod:of(therapy-3, hypertension-6)\n",
      "case(patients-8, in-7)\n",
      "nmod:in(hypertension-6, patients-8)\n",
      "case(factors-11, with-9)\n",
      "compound(factors-11, risk-10)\n",
      "nmod:with(patients-8, factors-11)\n",
      "cc(patients-8, and-12)\n",
      "det(use-14, the-13)\n",
      "nmod:in(hypertension-6, use-14)\n",
      "conj:and(patients-8, use-14)\n",
      "case(empagliflozin-19, of-15)\n",
      "det(empagliflozin-19, the-16)\n",
      "amod(empagliflozin-19, sglt2-17)\n",
      "compound(empagliflozin-19, inhibitor-18)\n",
      "nmod:of(use-14, empagliflozin-19)\n",
      "case(diabetics-23, in-20)\n",
      "amod(diabetics-23, type-21)\n",
      "compound(type-21, 2-22)\n",
      "nmod:in(empagliflozin-19, diabetics-23)\n",
      "auxpass(proven-25, are-24)\n",
      "root(ROOT-0, proven-25)\n",
      "dobj(proven-25, strategies-26)\n",
      "mark(prevent-28, to-27)\n",
      "advcl(proven-25, prevent-28)\n",
      "compound(failure-30, heart-29)\n",
      "dobj(prevent-28, failure-30)\n",
      "\n",
      "Parsing [sent. 10 len. 14]: the therapeutic options in heart failure with preserved ejection fraction are still insufficient .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (JJ therapeutic) (NNS options))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN heart) (NN failure))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ preserved) (NN ejection) (NN fraction))))))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB still))\n",
      "      (ADJP (JJ insufficient)))\n",
      "    (. .)))\n",
      "\n",
      "det(options-3, the-1)\n",
      "amod(options-3, therapeutic-2)\n",
      "nsubj(insufficient-13, options-3)\n",
      "case(failure-6, in-4)\n",
      "compound(failure-6, heart-5)\n",
      "nmod:in(options-3, failure-6)\n",
      "case(fraction-10, with-7)\n",
      "amod(fraction-10, preserved-8)\n",
      "compound(fraction-10, ejection-9)\n",
      "nmod:with(failure-6, fraction-10)\n",
      "cop(insufficient-13, are-11)\n",
      "advmod(insufficient-13, still-12)\n",
      "root(ROOT-0, insufficient-13)\n",
      "\n",
      "Parsing [sent. 11 len. 26]: in heart failure with reduced ejection fraction sacubitril/valsartan , the first approved angiotensin receptor-neprilysin inhibitor , is superior to an ACEI -LRB- ACEI -RRB- inhibitor .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP\n",
      "        (NP (NN heart) (NN failure))\n",
      "        (PP (IN with)\n",
      "          (NP (VBN reduced) (NN ejection)))))\n",
      "    (NP\n",
      "      (NP (NN fraction) (NN sacubitril/valsartan))\n",
      "      (, ,)\n",
      "      (NP (DT the) (JJ first) (JJ approved) (NN angiotensin) (NN receptor-neprilysin) (NN inhibitor))\n",
      "      (, ,))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ superior)\n",
      "        (PP (TO to)\n",
      "          (NP (DT an) (NNP ACEI)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP ACEI))\n",
      "              (-RRB- -RRB-))\n",
      "            (NN inhibitor)))))\n",
      "    (. .)))\n",
      "\n",
      "case(failure-3, in-1)\n",
      "compound(failure-3, heart-2)\n",
      "nmod:in(superior-18, failure-3)\n",
      "case(ejection-6, with-4)\n",
      "amod(ejection-6, reduced-5)\n",
      "nmod:with(failure-3, ejection-6)\n",
      "compound(sacubitril/valsartan-8, fraction-7)\n",
      "nsubj(superior-18, sacubitril/valsartan-8)\n",
      "det(inhibitor-15, the-10)\n",
      "amod(inhibitor-15, first-11)\n",
      "amod(inhibitor-15, approved-12)\n",
      "compound(inhibitor-15, angiotensin-13)\n",
      "compound(inhibitor-15, receptor-neprilysin-14)\n",
      "appos(sacubitril/valsartan-8, inhibitor-15)\n",
      "cop(superior-18, is-17)\n",
      "root(ROOT-0, superior-18)\n",
      "case(inhibitor-25, to-19)\n",
      "det(inhibitor-25, an-20)\n",
      "compound(inhibitor-25, ACEI-21)\n",
      "appos(inhibitor-25, ACEI-23)\n",
      "nmod:to(superior-18, inhibitor-25)\n",
      "\n",
      "Parsing [sent. 12 len. 24]: whether digitalis affects the prognosis in heart failure remains unclear ; however , serum concentration should be targeted at the lower therapeutic range .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP (NN digitalis))\n",
      "          (VP (VBZ affects)\n",
      "            (NP\n",
      "              (NP (DT the) (NN prognosis))\n",
      "              (PP (IN in)\n",
      "                (NP (NN heart) (NN failure)))))))\n",
      "      (VP (VBZ remains)\n",
      "        (ADJP (JJ unclear))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (ADVP (RB however))\n",
      "      (, ,)\n",
      "      (NP (NN serum) (NN concentration))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN targeted)\n",
      "            (PP (IN at)\n",
      "              (NP (DT the) (JJR lower) (JJ therapeutic) (NN range)))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(affects-3, whether-1)\n",
      "nsubj(affects-3, digitalis-2)\n",
      "csubj(remains-9, affects-3)\n",
      "det(prognosis-5, the-4)\n",
      "dobj(affects-3, prognosis-5)\n",
      "case(failure-8, in-6)\n",
      "compound(failure-8, heart-7)\n",
      "nmod:in(prognosis-5, failure-8)\n",
      "root(ROOT-0, remains-9)\n",
      "xcomp(remains-9, unclear-10)\n",
      "advmod(targeted-18, however-12)\n",
      "compound(concentration-15, serum-14)\n",
      "nsubjpass(targeted-18, concentration-15)\n",
      "aux(targeted-18, should-16)\n",
      "auxpass(targeted-18, be-17)\n",
      "parataxis(remains-9, targeted-18)\n",
      "case(range-23, at-19)\n",
      "det(range-23, the-20)\n",
      "amod(range-23, lower-21)\n",
      "amod(range-23, therapeutic-22)\n",
      "nmod:at(targeted-18, range-23)\n",
      "\n",
      "Parsing [sent. 13 len. 19]: iron supplementation in heart failure with reduced systolic function and iron deficiency improves symptoms and quality of life .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN iron) (NN supplementation))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN heart) (NN failure))\n",
      "          (PP (IN with)\n",
      "            (NP (VBN reduced) (JJ systolic) (NN function)\n",
      "              (CC and)\n",
      "              (NN iron) (NN deficiency))))))\n",
      "    (VP (VBZ improves)\n",
      "      (NP\n",
      "        (NP (NNS symptoms)\n",
      "          (CC and)\n",
      "          (NN quality))\n",
      "        (PP (IN of)\n",
      "          (NP (NN life)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(supplementation-2, iron-1)\n",
      "nsubj(improves-13, supplementation-2)\n",
      "case(failure-5, in-3)\n",
      "compound(failure-5, heart-4)\n",
      "nmod:in(supplementation-2, failure-5)\n",
      "case(function-9, with-6)\n",
      "amod(function-9, reduced-7)\n",
      "amod(function-9, systolic-8)\n",
      "nmod:with(failure-5, function-9)\n",
      "cc(function-9, and-10)\n",
      "compound(deficiency-12, iron-11)\n",
      "nmod:with(failure-5, deficiency-12)\n",
      "conj:and(function-9, deficiency-12)\n",
      "root(ROOT-0, improves-13)\n",
      "dobj(improves-13, symptoms-14)\n",
      "cc(symptoms-14, and-15)\n",
      "dobj(improves-13, quality-16)\n",
      "conj:and(symptoms-14, quality-16)\n",
      "case(life-18, of-17)\n",
      "nmod:of(symptoms-14, life-18)\n",
      "\n",
      "Parsing [sent. 14 len. 57]: participants -LRB- n = 418 -RRB- underwent one of the following 3 conditions : i -RRB- multicomponent exercise training 3times/week -LRB- mex ; n = 116 -RRB- ; ii -RRB- ACEI used mono-dose daily -LRB- ACEI ; n = 70 -RRB- ; iii -RRB- combined exercise and ACEI drugs -LRB- aceimex ; n = 232 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS participants))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (VP (VBN n)\n",
      "          (S\n",
      "            (VP (SYM =)\n",
      "              (NP (CD 418)))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD underwent)\n",
      "      (S\n",
      "        (NP\n",
      "          (NP (CD one))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (VBG following) (CD 3) (NNS conditions))))\n",
      "        (: :)\n",
      "        (NP (FW i))\n",
      "        (-RRB- -RRB-)\n",
      "        (VP\n",
      "          (VP (VBP multicomponent)\n",
      "            (VP (VB exercise)\n",
      "              (NP (NN training) (NNS 3times/week))\n",
      "              (FRAG (-LRB- -LRB-)\n",
      "                (NP (NN mex))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP (NNP n) (NNP =) (NNP 116) (-RRB- -RRB-))\n",
      "                  (: ;)\n",
      "                  (NP (NN ii)))\n",
      "                (-RRB- -RRB-))))\n",
      "          (PRN\n",
      "            (S\n",
      "              (NP (NNP ACEI))\n",
      "              (VP (VBD used)\n",
      "                (NP\n",
      "                  (NP (JJ mono-dose) (NN daily))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NNP ACEI))\n",
      "                      (: ;)\n",
      "                      (NP\n",
      "                        (NP (NN n))\n",
      "                        (SBAR\n",
      "                          (S\n",
      "                            (VP (SYM =)\n",
      "                              (NP (CD 70)))))))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (: ;)\n",
      "                  (NP (NN iii)))))\n",
      "            (-RRB- -RRB-))\n",
      "          (NP\n",
      "            (NP (VBN combined) (NN exercise))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (CD ACEI) (NNS drugs))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (NN aceimex))\n",
      "                  (: ;)\n",
      "                  (NP\n",
      "                    (NP (NN n))\n",
      "                    (SBAR\n",
      "                      (S\n",
      "                        (VP (SYM =)\n",
      "                          (NP (CD 232)))))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(underwent-7, participants-1)\n",
      "dep(participants-1, n-3)\n",
      "dep(418-5, =-4)\n",
      "ccomp(n-3, 418-5)\n",
      "root(ROOT-0, underwent-7)\n",
      "nsubj(multicomponent-17, one-8)\n",
      "case(conditions-13, of-9)\n",
      "det(conditions-13, the-10)\n",
      "amod(conditions-13, following-11)\n",
      "nummod(conditions-13, 3-12)\n",
      "nmod:of(one-8, conditions-13)\n",
      "nsubj(multicomponent-17, i-15)\n",
      "ccomp(underwent-7, multicomponent-17)\n",
      "xcomp(multicomponent-17, exercise-18)\n",
      "compound(3times/week-20, training-19)\n",
      "dobj(exercise-18, 3times/week-20)\n",
      "dep(exercise-18, mex-22)\n",
      "compound(116-26, n-24)\n",
      "compound(116-26, =-25)\n",
      "dep(mex-22, 116-26)\n",
      "dep(116-26, ii-29)\n",
      "nsubj(used-32, ACEI-31)\n",
      "parataxis(multicomponent-17, used-32)\n",
      "amod(daily-34, mono-dose-33)\n",
      "dobj(used-32, daily-34)\n",
      "dep(daily-34, ACEI-36)\n",
      "dep(ACEI-36, n-38)\n",
      "dep(70-40, =-39)\n",
      "acl:relcl(n-38, 70-40)\n",
      "dep(daily-34, iii-43)\n",
      "amod(exercise-46, combined-45)\n",
      "dobj(multicomponent-17, exercise-46)\n",
      "cc(exercise-46, and-47)\n",
      "nummod(drugs-49, ACEI-48)\n",
      "dobj(multicomponent-17, drugs-49)\n",
      "conj:and(exercise-46, drugs-49)\n",
      "dep(drugs-49, aceimex-51)\n",
      "dep(aceimex-51, n-53)\n",
      "dep(232-55, =-54)\n",
      "acl:relcl(n-53, 232-55)\n",
      "\n",
      "Parsing [sent. 15 len. 37]: the trial was completed by 82 % of the participants -LRB- n = 342 -RRB- : mex -LRB- n = 90 -RRB- ; ACEI -LRB- n = 66 -RRB- ; aceimex -LRB- n = 186 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN trial))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN completed)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (CD 82) (NN %))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NNS participants))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP n)\n",
      "                        (QP (CD =) (CD 342)))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (: :)\n",
      "                    (NP (NN mex)))))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 90)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (NNP ACEI))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 66)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (NN aceimex))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 186)))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(trial-2, the-1)\n",
      "nsubjpass(completed-4, trial-2)\n",
      "auxpass(completed-4, was-3)\n",
      "root(ROOT-0, completed-4)\n",
      "case(%-7, by-5)\n",
      "nummod(%-7, 82-6)\n",
      "nmod:by(completed-4, %-7)\n",
      "case(participants-10, of-8)\n",
      "det(participants-10, the-9)\n",
      "nmod:of(%-7, participants-10)\n",
      "appos(participants-10, n-12)\n",
      "compound(342-14, =-13)\n",
      "nummod(n-12, 342-14)\n",
      "dep(participants-10, mex-17)\n",
      "dep(%-7, n-19)\n",
      "dep(90-21, =-20)\n",
      "ccomp(n-19, 90-21)\n",
      "dep(%-7, ACEI-24)\n",
      "dep(ACEI-24, n-26)\n",
      "dep(66-28, =-27)\n",
      "ccomp(n-26, 66-28)\n",
      "dep(%-7, aceimex-31)\n",
      "dep(aceimex-31, n-33)\n",
      "dep(186-35, =-34)\n",
      "ccomp(n-33, 186-35)\n",
      "\n",
      "Parsing [sent. 16 len. 31]: baseline and 2-year follow-up evaluations included the senior fitness test battery , short form health survey 36 -LRB- sf-36 -RRB- , the health history questionnaires , anthropometric and hemodynamic profile .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN baseline)\n",
      "      (CC and)\n",
      "      (JJ 2-year) (NN follow-up) (NNS evaluations))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ senior) (NN fitness) (NN test) (NN battery))\n",
      "        (, ,)\n",
      "        (NP (JJ short) (NN form) (NN health) (NN survey) (CD 36) (-LRB- -LRB-) (NN sf-36) (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (NP (DT the) (NN health) (NN history) (NN questionnaires))\n",
      "        (, ,)\n",
      "        (NP (NN anthropometric))\n",
      "        (CC and)\n",
      "        (NP (JJ hemodynamic) (NN profile))))\n",
      "    (. .)))\n",
      "\n",
      "compound(evaluations-5, baseline-1)\n",
      "cc(baseline-1, and-2)\n",
      "conj:and(baseline-1, 2-year-3)\n",
      "compound(evaluations-5, 2-year-3)\n",
      "compound(evaluations-5, follow-up-4)\n",
      "nsubj(included-6, evaluations-5)\n",
      "root(ROOT-0, included-6)\n",
      "det(battery-11, the-7)\n",
      "amod(battery-11, senior-8)\n",
      "compound(battery-11, fitness-9)\n",
      "compound(battery-11, test-10)\n",
      "dobj(included-6, battery-11)\n",
      "amod(sf-36-19, short-13)\n",
      "compound(sf-36-19, form-14)\n",
      "compound(sf-36-19, health-15)\n",
      "compound(sf-36-19, survey-16)\n",
      "nummod(sf-36-19, 36-17)\n",
      "dobj(included-6, sf-36-19)\n",
      "conj:and(battery-11, sf-36-19)\n",
      "det(questionnaires-25, the-22)\n",
      "compound(questionnaires-25, health-23)\n",
      "compound(questionnaires-25, history-24)\n",
      "dobj(included-6, questionnaires-25)\n",
      "conj:and(battery-11, questionnaires-25)\n",
      "dobj(included-6, anthropometric-27)\n",
      "conj:and(battery-11, anthropometric-27)\n",
      "cc(battery-11, and-28)\n",
      "amod(profile-30, hemodynamic-29)\n",
      "dobj(included-6, profile-30)\n",
      "conj:and(battery-11, profile-30)\n",
      "\n",
      "Parsing [sent. 17 len. 26]: heart failure -LRB- hf -RRB- prevalence continues to rise and remains a significant burden to patients , caregivers , providers , and the healthcare system .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN heart) (NN failure))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN hf))\n",
      "        (-RRB- -RRB-)))\n",
      "    (ADVP (RB prevalence))\n",
      "    (VP\n",
      "      (VP (VBZ continues)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB rise)))))\n",
      "      (CC and)\n",
      "      (VP (VBZ remains)\n",
      "        (NP (DT a) (JJ significant) (NN burden))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (, ,)\n",
      "            (NP (NNS caregivers))\n",
      "            (, ,)\n",
      "            (NP (NNS providers))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (DT the) (NN healthcare) (NN system))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(continues-7, failure-2)\n",
      "nsubj:xsubj(rise-9, failure-2)\n",
      "nsubj(remains-11, failure-2)\n",
      "appos(failure-2, hf-4)\n",
      "advmod(continues-7, prevalence-6)\n",
      "root(ROOT-0, continues-7)\n",
      "mark(rise-9, to-8)\n",
      "xcomp(continues-7, rise-9)\n",
      "cc(continues-7, and-10)\n",
      "conj:and(continues-7, remains-11)\n",
      "det(burden-14, a-12)\n",
      "amod(burden-14, significant-13)\n",
      "xcomp(remains-11, burden-14)\n",
      "case(patients-16, to-15)\n",
      "nmod:to(remains-11, patients-16)\n",
      "nmod:to(remains-11, caregivers-18)\n",
      "conj:and(patients-16, caregivers-18)\n",
      "nmod:to(remains-11, providers-20)\n",
      "conj:and(patients-16, providers-20)\n",
      "cc(patients-16, and-22)\n",
      "det(system-25, the-23)\n",
      "compound(system-25, healthcare-24)\n",
      "nmod:to(remains-11, system-25)\n",
      "conj:and(patients-16, system-25)\n",
      "\n",
      "Parsing [sent. 18 len. 18]: guideline-directed medical therapy with standard neurohormonal blockade has been the cornerstone of medical management for many years .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ guideline-directed) (JJ medical) (NN therapy))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ standard) (JJ neurohormonal) (NN blockade))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN been)\n",
      "        (NP\n",
      "          (NP (DT the) (NN cornerstone))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ medical) (NN management))))\n",
      "        (PP (IN for)\n",
      "          (NP (JJ many) (NNS years)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-3, guideline-directed-1)\n",
      "amod(therapy-3, medical-2)\n",
      "nsubj(cornerstone-11, therapy-3)\n",
      "case(blockade-7, with-4)\n",
      "amod(blockade-7, standard-5)\n",
      "amod(blockade-7, neurohormonal-6)\n",
      "nmod:with(therapy-3, blockade-7)\n",
      "aux(cornerstone-11, has-8)\n",
      "cop(cornerstone-11, been-9)\n",
      "det(cornerstone-11, the-10)\n",
      "root(ROOT-0, cornerstone-11)\n",
      "case(management-14, of-12)\n",
      "amod(management-14, medical-13)\n",
      "nmod:of(cornerstone-11, management-14)\n",
      "case(years-17, for-15)\n",
      "amod(years-17, many-16)\n",
      "nmod:for(cornerstone-11, years-17)\n",
      "\n",
      "Parsing [sent. 19 len. 28]: despite aggressive utilization of ACEI , angiotensin receptor blockers , beta-blockers , and aldosterone antagonists , hf hospitalizations and readmissions are common and residual mortality remains high .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP\n",
      "        (NP (JJ aggressive) (NN utilization))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNP ACEI))\n",
      "            (, ,)\n",
      "            (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "            (, ,)\n",
      "            (NP (NNS beta-blockers))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (JJ aldosterone) (NNS antagonists))))))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN hf) (NNS hospitalizations)\n",
      "        (CC and)\n",
      "        (NNS readmissions))\n",
      "      (VP (VBP are)\n",
      "        (ADJP (JJ common))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ residual) (NN mortality))\n",
      "      (VP (VBZ remains)\n",
      "        (ADJP (JJ high))))\n",
      "    (. .)))\n",
      "\n",
      "case(utilization-3, despite-1)\n",
      "amod(utilization-3, aggressive-2)\n",
      "nmod:despite(common-22, utilization-3)\n",
      "case(ACEI-5, of-4)\n",
      "nmod:of(utilization-3, ACEI-5)\n",
      "compound(blockers-9, angiotensin-7)\n",
      "compound(blockers-9, receptor-8)\n",
      "nmod:of(utilization-3, blockers-9)\n",
      "conj:and(ACEI-5, blockers-9)\n",
      "nmod:of(utilization-3, beta-blockers-11)\n",
      "conj:and(ACEI-5, beta-blockers-11)\n",
      "cc(ACEI-5, and-13)\n",
      "amod(antagonists-15, aldosterone-14)\n",
      "nmod:of(utilization-3, antagonists-15)\n",
      "conj:and(ACEI-5, antagonists-15)\n",
      "compound(hospitalizations-18, hf-17)\n",
      "nsubj(common-22, hospitalizations-18)\n",
      "cc(hospitalizations-18, and-19)\n",
      "conj:and(hospitalizations-18, readmissions-20)\n",
      "nsubj(common-22, readmissions-20)\n",
      "cop(common-22, are-21)\n",
      "root(ROOT-0, common-22)\n",
      "cc(common-22, and-23)\n",
      "amod(mortality-25, residual-24)\n",
      "nsubj(remains-26, mortality-25)\n",
      "conj:and(common-22, remains-26)\n",
      "xcomp(remains-26, high-27)\n",
      "\n",
      "Parsing [sent. 20 len. 46]: with the development of two novel medical therapies -LRB- sacubitril/valsartan and ivabradine -RRB- , the american college of cardiology , american heart association , and heart failure society of america released a pharmacologic update to provide guidelines for incorporation of these agents into clinical practice .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN with)\n",
      "      (NP\n",
      "        (NP (DT the) (NN development))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (CD two) (JJ novel) (JJ medical) (NNS therapies))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (JJ sacubitril/valsartan)\n",
      "                (CC and)\n",
      "                (JJ ivabradine))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN american) (NN college))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN cardiology))\n",
      "          (, ,)\n",
      "          (NP (NN american) (NN heart) (NN association))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (NN heart) (NN failure) (NN society))\n",
      "            (PP (IN of)\n",
      "              (NP (NN america)))))))\n",
      "    (VP (VBD released)\n",
      "      (NP (DT a) (JJ pharmacologic) (NN update))\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB provide)\n",
      "            (NP\n",
      "              (NP (NNS guidelines))\n",
      "              (PP (IN for)\n",
      "                (NP\n",
      "                  (NP (NN incorporation))\n",
      "                  (PP (IN of)\n",
      "                    (NP (DT these) (NNS agents))))))\n",
      "            (PP (IN into)\n",
      "              (NP (JJ clinical) (NN practice)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(development-3, with-1)\n",
      "det(development-3, the-2)\n",
      "nmod:with(released-31, development-3)\n",
      "case(therapies-8, of-4)\n",
      "nummod(therapies-8, two-5)\n",
      "amod(therapies-8, novel-6)\n",
      "amod(therapies-8, medical-7)\n",
      "nmod:of(development-3, therapies-8)\n",
      "dep(therapies-8, sacubitril/valsartan-10)\n",
      "cc(sacubitril/valsartan-10, and-11)\n",
      "dep(therapies-8, ivabradine-12)\n",
      "conj:and(sacubitril/valsartan-10, ivabradine-12)\n",
      "det(college-17, the-15)\n",
      "compound(college-17, american-16)\n",
      "nsubj(released-31, college-17)\n",
      "case(cardiology-19, of-18)\n",
      "nmod:of(college-17, cardiology-19)\n",
      "compound(association-23, american-21)\n",
      "compound(association-23, heart-22)\n",
      "nmod:of(college-17, association-23)\n",
      "conj:and(cardiology-19, association-23)\n",
      "cc(cardiology-19, and-25)\n",
      "compound(society-28, heart-26)\n",
      "compound(society-28, failure-27)\n",
      "nmod:of(college-17, society-28)\n",
      "conj:and(cardiology-19, society-28)\n",
      "case(america-30, of-29)\n",
      "nmod:of(society-28, america-30)\n",
      "root(ROOT-0, released-31)\n",
      "det(update-34, a-32)\n",
      "amod(update-34, pharmacologic-33)\n",
      "dobj(released-31, update-34)\n",
      "mark(provide-36, to-35)\n",
      "advcl(released-31, provide-36)\n",
      "dobj(provide-36, guidelines-37)\n",
      "case(incorporation-39, for-38)\n",
      "nmod:for(guidelines-37, incorporation-39)\n",
      "case(agents-42, of-40)\n",
      "det(agents-42, these-41)\n",
      "nmod:of(incorporation-39, agents-42)\n",
      "case(practice-45, into-43)\n",
      "amod(practice-45, clinical-44)\n",
      "nmod:into(provide-36, practice-45)\n",
      "\n",
      "Parsing [sent. 21 len. 19]: although effective via different mechanisms of action , both agents now have a prominent role in risk reduction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN although)\n",
      "      (S\n",
      "        (ADJP (JJ effective))\n",
      "        (PP (IN via)\n",
      "          (NP\n",
      "            (NP (JJ different) (NNS mechanisms))\n",
      "            (PP (IN of)\n",
      "              (NP (NN action)))))))\n",
      "    (, ,)\n",
      "    (NP (DT both) (NNS agents))\n",
      "    (ADVP (RB now))\n",
      "    (VP (VBP have)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prominent) (NN role))\n",
      "        (PP (IN in)\n",
      "          (NP (NN risk) (NN reduction)))))\n",
      "    (. .)))\n",
      "\n",
      "mark(effective-2, although-1)\n",
      "advcl(have-12, effective-2)\n",
      "case(mechanisms-5, via-3)\n",
      "amod(mechanisms-5, different-4)\n",
      "dep(effective-2, mechanisms-5)\n",
      "case(action-7, of-6)\n",
      "nmod:of(mechanisms-5, action-7)\n",
      "det(agents-10, both-9)\n",
      "nsubj(have-12, agents-10)\n",
      "advmod(have-12, now-11)\n",
      "root(ROOT-0, have-12)\n",
      "det(role-15, a-13)\n",
      "amod(role-15, prominent-14)\n",
      "dobj(have-12, role-15)\n",
      "case(reduction-18, in-16)\n",
      "compound(reduction-18, risk-17)\n",
      "nmod:in(role-15, reduction-18)\n",
      "\n",
      "Parsing [sent. 22 len. 20]: hf medical regimens often become quite complex , especially when associated with comorbid conditions , and require frequent follow-up .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ hf) (JJ medical) (NNS regimens))\n",
      "    (ADVP (RB often))\n",
      "    (VP\n",
      "      (VP (VBP become)\n",
      "        (NP (RB quite) (JJ complex))\n",
      "        (, ,)\n",
      "        (SBAR\n",
      "          (WHADVP (RB especially) (WRB when))\n",
      "          (S\n",
      "            (VP (JJ associated)\n",
      "              (PP (IN with)\n",
      "                (NP (JJ comorbid) (NNS conditions))))))\n",
      "        (, ,))\n",
      "      (CC and)\n",
      "      (VP (VBP require)\n",
      "        (NP (JJ frequent) (NN follow-up))))\n",
      "    (. .)))\n",
      "\n",
      "amod(regimens-3, hf-1)\n",
      "amod(regimens-3, medical-2)\n",
      "nsubj(become-5, regimens-3)\n",
      "nsubj(require-17, regimens-3)\n",
      "advmod(become-5, often-4)\n",
      "root(ROOT-0, become-5)\n",
      "advmod(complex-7, quite-6)\n",
      "xcomp(become-5, complex-7)\n",
      "advmod(when-10, especially-9)\n",
      "advmod(associated-11, when-10)\n",
      "advcl(become-5, associated-11)\n",
      "case(conditions-14, with-12)\n",
      "amod(conditions-14, comorbid-13)\n",
      "nmod:with(associated-11, conditions-14)\n",
      "cc(become-5, and-16)\n",
      "conj:and(become-5, require-17)\n",
      "amod(follow-up-19, frequent-18)\n",
      "dobj(require-17, follow-up-19)\n",
      "\n",
      "Parsing [sent. 23 len. 16]: providers must be proficient in patient monitoring , medication dose titration , and therapy optimization .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS providers))\n",
      "    (VP (MD must)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ proficient)\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (JJ patient) (NN monitoring))\n",
      "              (, ,)\n",
      "              (NP (NN medication) (NN dose) (NN titration))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NN therapy) (NN optimization)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(proficient-4, providers-1)\n",
      "aux(proficient-4, must-2)\n",
      "cop(proficient-4, be-3)\n",
      "root(ROOT-0, proficient-4)\n",
      "case(monitoring-7, in-5)\n",
      "amod(monitoring-7, patient-6)\n",
      "nmod:in(proficient-4, monitoring-7)\n",
      "compound(titration-11, medication-9)\n",
      "compound(titration-11, dose-10)\n",
      "nmod:in(proficient-4, titration-11)\n",
      "conj:and(monitoring-7, titration-11)\n",
      "cc(monitoring-7, and-13)\n",
      "compound(optimization-15, therapy-14)\n",
      "nmod:in(proficient-4, optimization-15)\n",
      "conj:and(monitoring-7, optimization-15)\n",
      "\n",
      "Parsing [sent. 24 len. 17]: individualized patient care strategies such as guideline-directed therapy can promote long-term adherence and quality of life .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ individualized) (JJ patient) (NN care) (NNS strategies))\n",
      "      (PP (JJ such) (IN as)\n",
      "        (NP (JJ guideline-directed) (NN therapy))))\n",
      "    (VP (MD can)\n",
      "      (VP (VB promote)\n",
      "        (NP\n",
      "          (NP (JJ long-term) (NN adherence)\n",
      "            (CC and)\n",
      "            (NN quality))\n",
      "          (PP (IN of)\n",
      "            (NP (NN life))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(strategies-4, individualized-1)\n",
      "amod(strategies-4, patient-2)\n",
      "compound(strategies-4, care-3)\n",
      "nsubj(promote-10, strategies-4)\n",
      "case(therapy-8, such-5)\n",
      "mwe(such-5, as-6)\n",
      "amod(therapy-8, guideline-directed-7)\n",
      "nmod:such_as(strategies-4, therapy-8)\n",
      "aux(promote-10, can-9)\n",
      "root(ROOT-0, promote-10)\n",
      "amod(adherence-12, long-term-11)\n",
      "dobj(promote-10, adherence-12)\n",
      "cc(adherence-12, and-13)\n",
      "dobj(promote-10, quality-14)\n",
      "conj:and(adherence-12, quality-14)\n",
      "case(life-16, of-15)\n",
      "nmod:of(adherence-12, life-16)\n",
      "\n",
      "Parsing [sent. 25 len. 43]: we included a group with no dd -LRB- n = 649 -RRB- , a group with grade 1 dd -LRB- n = 2875 -RRB- , and those with grades 2 and 3 -LRB- n = 1357 -RRB- who had normal ejection fraction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (DT a) (NN group))\n",
      "          (PP (IN with)\n",
      "            (NP (DT no) (NN dd))))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN n)\n",
      "            (S\n",
      "              (VP (SYM =)\n",
      "                (NP (CD 649)))))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT a) (NN group))\n",
      "          (PP (IN with)\n",
      "            (NP (NN grade) (CD 1) (NN dd))))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN n)\n",
      "            (S\n",
      "              (VP (SYM =)\n",
      "                (NP (CD 2875)))))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (NNS grades) (CD 2)\n",
      "                (CC and)\n",
      "                (CD 3))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 1357)))))\n",
      "                (-RRB- -RRB-))\n",
      "              (SBAR\n",
      "                (WHNP (WP who))\n",
      "                (S\n",
      "                  (VP (VBD had)\n",
      "                    (NP (JJ normal) (NN ejection) (NN fraction))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(included-2, we-1)\n",
      "root(ROOT-0, included-2)\n",
      "det(group-4, a-3)\n",
      "dobj(included-2, group-4)\n",
      "case(dd-7, with-5)\n",
      "neg(dd-7, no-6)\n",
      "nmod:with(group-4, dd-7)\n",
      "dep(group-4, n-9)\n",
      "dep(649-11, =-10)\n",
      "ccomp(n-9, 649-11)\n",
      "det(group-15, a-14)\n",
      "dobj(included-2, group-15)\n",
      "conj:and(group-4, group-15)\n",
      "case(dd-19, with-16)\n",
      "compound(dd-19, grade-17)\n",
      "nummod(dd-19, 1-18)\n",
      "nmod:with(group-15, dd-19)\n",
      "dep(group-4, n-21)\n",
      "dep(2875-23, =-22)\n",
      "ccomp(n-21, 2875-23)\n",
      "cc(group-4, and-26)\n",
      "dobj(included-2, those-27)\n",
      "conj:and(group-4, those-27)\n",
      "case(grades-29, with-28)\n",
      "nmod:with(those-27, grades-29)\n",
      "nsubj(had-39, grades-29)\n",
      "nummod(grades-29, 2-30)\n",
      "cc(grades-29, and-31)\n",
      "nmod:with(those-27, 3-32)\n",
      "conj:and(grades-29, 3-32)\n",
      "nsubj(had-39, 3-32)\n",
      "dep(grades-29, n-34)\n",
      "dep(1357-36, =-35)\n",
      "ccomp(n-34, 1357-36)\n",
      "ref(grades-29, who-38)\n",
      "acl:relcl(grades-29, had-39)\n",
      "amod(fraction-42, normal-40)\n",
      "compound(fraction-42, ejection-41)\n",
      "dobj(had-39, fraction-42)\n",
      "\n",
      "Parsing [sent. 26 len. 22]: the prevalence of grade 2 or 3 dd with preserved ejection fraction was 25 % ; 95 % ci : 24-26 .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT the) (NN prevalence))\n",
      "        (PP (IN of)\n",
      "          (NP (NN grade) (CD 2))))\n",
      "      (CC or)\n",
      "      (NP\n",
      "        (NP (CD 3) (NN dd))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ preserved) (NN ejection) (NN fraction)))))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (CD 25) (NN %))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (ADJP (CD 95) (NN %))\n",
      "            (NN ci)))\n",
      "        (: :)\n",
      "        (NP (CD 24-26))))\n",
      "    (. .)))\n",
      "\n",
      "det(prevalence-2, the-1)\n",
      "nsubj(%-15, prevalence-2)\n",
      "case(grade-4, of-3)\n",
      "nmod:of(prevalence-2, grade-4)\n",
      "nummod(grade-4, 2-5)\n",
      "cc(prevalence-2, or-6)\n",
      "nummod(dd-8, 3-7)\n",
      "conj:or(prevalence-2, dd-8)\n",
      "nsubj(%-15, dd-8)\n",
      "case(fraction-12, with-9)\n",
      "amod(fraction-12, preserved-10)\n",
      "compound(fraction-12, ejection-11)\n",
      "nmod:with(dd-8, fraction-12)\n",
      "cop(%-15, was-13)\n",
      "nummod(%-15, 25-14)\n",
      "root(ROOT-0, %-15)\n",
      "compound(%-18, 95-17)\n",
      "amod(ci-19, %-18)\n",
      "dep(%-15, ci-19)\n",
      "dep(%-15, 24-26-21)\n",
      "\n",
      "Parsing [sent. 27 len. 44]: the absolute change of ACEI-inhibitor use before and after the echocardiogram increased by 14 , 19 , 23 , 27 in patients without dd , those with grade 1 , grade 2 or 3 asymptomatic and grade 2 or 3 symptomatic , respectively .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (JJ absolute) (NN change))\n",
      "      (PP (IN of)\n",
      "        (NP (NNP ACEI-inhibitor))))\n",
      "    (VP (VBP use)\n",
      "      (SBAR (IN before)\n",
      "        (CC and)\n",
      "        (RB after)\n",
      "        (S\n",
      "          (NP (DT the) (NN echocardiogram))\n",
      "          (VP (VBD increased)\n",
      "            (PP (IN by)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (CD 14))\n",
      "                  (, ,)\n",
      "                  (NP (CD 19))\n",
      "                  (, ,)\n",
      "                  (NP (CD 23))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (CD 27))\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (NP (NNS patients))\n",
      "                        (PP (IN without)\n",
      "                          (NP (NN dd))))))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (DT those))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN grade) (CD 1)))))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN grade) (CD 2))\n",
      "                  (CC or)\n",
      "                  (NP (CD 3) (NN asymptomatic)))\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (NN grade) (CD 2))\n",
      "                  (CC or)\n",
      "                  (NP (CD 3) (NN symptomatic)))))\n",
      "            (, ,)\n",
      "            (ADVP (RB respectively))))))\n",
      "    (. .)))\n",
      "\n",
      "det(change-3, the-1)\n",
      "amod(change-3, absolute-2)\n",
      "nsubj(use-6, change-3)\n",
      "case(ACEI-inhibitor-5, of-4)\n",
      "nmod:of(change-3, ACEI-inhibitor-5)\n",
      "root(ROOT-0, use-6)\n",
      "mark(increased-12, before-7)\n",
      "cc(increased-12, and-8)\n",
      "advmod(increased-12, after-9)\n",
      "det(echocardiogram-11, the-10)\n",
      "nsubj(increased-12, echocardiogram-11)\n",
      "advcl(use-6, increased-12)\n",
      "case(14-14, by-13)\n",
      "nmod:by(increased-12, 14-14)\n",
      "amod(14-14, 19-16)\n",
      "amod(14-14, 23-18)\n",
      "appos(14-14, 27-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(27-20, patients-22)\n",
      "case(dd-24, without-23)\n",
      "nmod:without(patients-22, dd-24)\n",
      "appos(14-14, those-26)\n",
      "case(grade-28, with-27)\n",
      "nmod:with(those-26, grade-28)\n",
      "nummod(grade-28, 1-29)\n",
      "nmod:by(increased-12, grade-31)\n",
      "conj:and(14-14, grade-31)\n",
      "nummod(grade-31, 2-32)\n",
      "cc(grade-31, or-33)\n",
      "nummod(asymptomatic-35, 3-34)\n",
      "conj:and(14-14, asymptomatic-35)\n",
      "conj:or(grade-31, asymptomatic-35)\n",
      "cc(14-14, and-36)\n",
      "nmod:by(increased-12, grade-37)\n",
      "conj:and(14-14, grade-37)\n",
      "nummod(grade-37, 2-38)\n",
      "cc(grade-37, or-39)\n",
      "nummod(symptomatic-41, 3-40)\n",
      "conj:and(14-14, symptomatic-41)\n",
      "conj:or(grade-37, symptomatic-41)\n",
      "advmod(increased-12, respectively-43)\n",
      "\n",
      "Parsing [sent. 28 len. 13]: the use of Î²-blocker , statin , and diuretic had similar trends .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN Î²-blocker))\n",
      "          (, ,)\n",
      "          (NP (NN statin))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP (NN diuretic)))))\n",
      "    (VP (VBD had)\n",
      "      (NP (JJ similar) (NNS trends)))\n",
      "    (. .)))\n",
      "\n",
      "det(use-2, the-1)\n",
      "nsubj(had-10, use-2)\n",
      "case(Î²-blocker-4, of-3)\n",
      "nmod:of(use-2, Î²-blocker-4)\n",
      "nmod:of(use-2, statin-6)\n",
      "conj:and(Î²-blocker-4, statin-6)\n",
      "cc(Î²-blocker-4, and-8)\n",
      "nmod:of(use-2, diuretic-9)\n",
      "conj:and(Î²-blocker-4, diuretic-9)\n",
      "root(ROOT-0, had-10)\n",
      "amod(trends-12, similar-11)\n",
      "dobj(had-10, trends-12)\n",
      "\n",
      "Parsing [sent. 29 len. 15]: a total of 514 patients -LRB- 340 females -RRB- aged 22-97 years were studied .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT a) (NN total))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (CD 514) (NNS patients))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD 340) (NNS females))\n",
      "            (-RRB- -RRB-))\n",
      "          (VP (VBN aged)\n",
      "            (NP (CD 22-97) (NNS years))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN studied)))\n",
      "    (. .)))\n",
      "\n",
      "det(total-2, a-1)\n",
      "nsubjpass(studied-14, total-2)\n",
      "case(patients-5, of-3)\n",
      "nummod(patients-5, 514-4)\n",
      "nmod:of(total-2, patients-5)\n",
      "nummod(females-8, 340-7)\n",
      "appos(patients-5, females-8)\n",
      "acl(patients-5, aged-10)\n",
      "nummod(years-12, 22-97-11)\n",
      "nmod:tmod(aged-10, years-12)\n",
      "auxpass(studied-14, were-13)\n",
      "root(ROOT-0, studied-14)\n",
      "\n",
      "Parsing [sent. 30 len. 51]: thirteen percent , 27.6 % , 26.7 % , 22.0 % , and 10.7 % were on 1 , 2 , 3 , 4 , and â¥ 5 medicines , respectively , for control of their blood pressure with the frequency of adverse effects increasing proportionately up to four medicines .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN thirteen) (NN percent))\n",
      "      (, ,)\n",
      "      (NP (CD 27.6) (NN %))\n",
      "      (, ,)\n",
      "      (NP (CD 26.7) (NN %))\n",
      "      (, ,)\n",
      "      (NP (CD 22.0) (NN %))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (CD 10.7) (NN %)))\n",
      "    (VP (VBD were)\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (CD 1))\n",
      "          (, ,)\n",
      "          (NP (CD 2))\n",
      "          (, ,)\n",
      "          (NP (CD 3))\n",
      "          (, ,)\n",
      "          (NP (CD 4))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (QP (CD â¥) (CD 5))\n",
      "            (NNS medicines))))\n",
      "      (, ,)\n",
      "      (ADVP (RB respectively))\n",
      "      (, ,)\n",
      "      (PP (IN for)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (NN control))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (PRP$ their) (NN blood) (NN pressure))\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN frequency))\n",
      "                    (PP (IN of)\n",
      "                      (NP (JJ adverse) (NNS effects))))))))\n",
      "          (VP (VBG increasing)\n",
      "            (NP (NN proportionately))\n",
      "            (PRT (RP up))\n",
      "            (PP (TO to)\n",
      "              (NP (CD four) (NNS medicines)))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(percent-2, thirteen-1)\n",
      "nsubj(1-18, percent-2)\n",
      "nummod(%-5, 27.6-4)\n",
      "conj:and(percent-2, %-5)\n",
      "nsubj(1-18, %-5)\n",
      "nummod(%-8, 26.7-7)\n",
      "conj:and(percent-2, %-8)\n",
      "nsubj(1-18, %-8)\n",
      "nummod(%-11, 22.0-10)\n",
      "conj:and(percent-2, %-11)\n",
      "nsubj(1-18, %-11)\n",
      "cc(percent-2, and-13)\n",
      "nummod(%-15, 10.7-14)\n",
      "conj:and(percent-2, %-15)\n",
      "nsubj(1-18, %-15)\n",
      "cop(1-18, were-16)\n",
      "case(1-18, on-17)\n",
      "root(ROOT-0, 1-18)\n",
      "conj:and(1-18, 2-20)\n",
      "conj:and(1-18, 3-22)\n",
      "conj:and(1-18, 4-24)\n",
      "cc(1-18, and-26)\n",
      "compound(5-28, â¥-27)\n",
      "nummod(medicines-29, 5-28)\n",
      "conj:and(1-18, medicines-29)\n",
      "advmod(1-18, respectively-31)\n",
      "mark(increasing-45, for-33)\n",
      "nsubj(increasing-45, control-34)\n",
      "case(pressure-38, of-35)\n",
      "nmod:poss(pressure-38, their-36)\n",
      "compound(pressure-38, blood-37)\n",
      "nmod:of(control-34, pressure-38)\n",
      "case(frequency-41, with-39)\n",
      "det(frequency-41, the-40)\n",
      "nmod:with(pressure-38, frequency-41)\n",
      "case(effects-44, of-42)\n",
      "amod(effects-44, adverse-43)\n",
      "nmod:of(frequency-41, effects-44)\n",
      "advcl(1-18, increasing-45)\n",
      "dobj(increasing-45, proportionately-46)\n",
      "compound:prt(increasing-45, up-47)\n",
      "case(medicines-50, to-48)\n",
      "nummod(medicines-50, four-49)\n",
      "nmod:to(increasing-45, medicines-50)\n",
      "\n",
      "Parsing [sent. 31 len. 18]: adverse reactions to antihypertensive medicines were reported by a total of 93 -LRB- 18.1 % -RRB- patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ adverse) (NNS reactions))\n",
      "      (PP (TO to)\n",
      "        (NP (JJ antihypertensive) (NNS medicines))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN reported)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (DT a) (NN total))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ 93)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (QP (CD 18.1) (NN %)))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS patients)))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(reactions-2, adverse-1)\n",
      "nsubjpass(reported-7, reactions-2)\n",
      "case(medicines-5, to-3)\n",
      "amod(medicines-5, antihypertensive-4)\n",
      "nmod:to(reactions-2, medicines-5)\n",
      "auxpass(reported-7, were-6)\n",
      "root(ROOT-0, reported-7)\n",
      "case(total-10, by-8)\n",
      "det(total-10, a-9)\n",
      "nmod:by(reported-7, total-10)\n",
      "case(patients-17, of-11)\n",
      "amod(patients-17, 93-12)\n",
      "compound(%-15, 18.1-14)\n",
      "dep(patients-17, %-15)\n",
      "nmod:of(total-10, patients-17)\n",
      "\n",
      "Parsing [sent. 32 len. 53]: diuretics - 27.9 % , calcium channel blockers -LRB- ccbs -RRB- - 26.8 % , and ACEI - 26.8 % accounted for most of the adverse reactions seen , notably frequent micturition and headaches -LRB- ccb -RRB- ; excessive micturition and dizziness -LRB- diuretics -RRB- ; dry irritating cough -LRB- ACEI -RRB- .\n",
      "(ROOT\n",
      "  (NP\n",
      "    (NP (NNS diuretics))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 27.9) (NN %))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBZ ccbs))\n",
      "          (-RRB- -RRB-))))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 26.8) (NN %))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NNP ACEI)))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 26.8) (NN %))\n",
      "      (VP (VBN accounted)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (JJS most))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT the) (JJ adverse) (NNS reactions))\n",
      "                        (VP (VBN seen)))\n",
      "                      (, ,)\n",
      "                      (ADVP (RB notably))\n",
      "                      (NP\n",
      "                        (NP (JJ frequent) (NN micturition)\n",
      "                          (CC and)\n",
      "                          (NNS headaches))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NN ccb))\n",
      "                          (-RRB- -RRB-))))))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP (JJ excessive) (NN micturition))\n",
      "                  (CC and)\n",
      "                  (NP (NN dizziness))))\n",
      "              (-LRB- -LRB-)\n",
      "              (NP (NNS diuretics))\n",
      "              (-RRB- -RRB-))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (JJ dry) (VBG irritating) (NN cough))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP ACEI))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, diuretics-1)\n",
      "nummod(%-4, 27.9-3)\n",
      "dep(diuretics-1, %-4)\n",
      "compound(blockers-8, calcium-6)\n",
      "compound(blockers-8, channel-7)\n",
      "appos(%-4, blockers-8)\n",
      "dep(blockers-8, ccbs-10)\n",
      "nummod(%-14, 26.8-13)\n",
      "dep(diuretics-1, %-14)\n",
      "cc(%-14, and-16)\n",
      "dep(diuretics-1, ACEI-17)\n",
      "conj:and(%-14, ACEI-17)\n",
      "nummod(%-20, 26.8-19)\n",
      "dep(diuretics-1, %-20)\n",
      "acl(%-20, accounted-21)\n",
      "case(most-23, for-22)\n",
      "nmod:for(accounted-21, most-23)\n",
      "case(reactions-27, of-24)\n",
      "det(reactions-27, the-25)\n",
      "amod(reactions-27, adverse-26)\n",
      "nmod:of(most-23, reactions-27)\n",
      "acl(reactions-27, seen-28)\n",
      "advmod(micturition-32, notably-30)\n",
      "amod(micturition-32, frequent-31)\n",
      "appos(reactions-27, micturition-32)\n",
      "cc(micturition-32, and-33)\n",
      "appos(reactions-27, headaches-34)\n",
      "conj:and(micturition-32, headaches-34)\n",
      "appos(micturition-32, ccb-36)\n",
      "amod(micturition-40, excessive-39)\n",
      "dep(most-23, micturition-40)\n",
      "cc(micturition-40, and-41)\n",
      "dep(most-23, dizziness-42)\n",
      "conj:and(micturition-40, dizziness-42)\n",
      "dep(most-23, diuretics-44)\n",
      "amod(cough-49, dry-47)\n",
      "amod(cough-49, irritating-48)\n",
      "dep(most-23, cough-49)\n",
      "appos(cough-49, ACEI-51)\n",
      "\n",
      "Parsing [sent. 33 len. 21]: notable complaints for all patients using the checklist were increased frequency of micturition , reduction in libido , and headaches .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ notable) (NNS complaints))\n",
      "      (PP (IN for)\n",
      "        (NP\n",
      "          (NP (DT all) (NNS patients))\n",
      "          (VP (VBG using)\n",
      "            (NP (DT the) (NN checklist))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN increased)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NN frequency))\n",
      "            (PP (IN of)\n",
      "              (NP (NN micturition))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (NN reduction))\n",
      "            (PP (IN in)\n",
      "              (NP (NN libido))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP (NNS headaches)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(complaints-2, notable-1)\n",
      "nsubjpass(increased-10, complaints-2)\n",
      "case(patients-5, for-3)\n",
      "det(patients-5, all-4)\n",
      "nmod:for(complaints-2, patients-5)\n",
      "acl(patients-5, using-6)\n",
      "det(checklist-8, the-7)\n",
      "dobj(using-6, checklist-8)\n",
      "auxpass(increased-10, were-9)\n",
      "root(ROOT-0, increased-10)\n",
      "dobj(increased-10, frequency-11)\n",
      "case(micturition-13, of-12)\n",
      "nmod:of(frequency-11, micturition-13)\n",
      "dobj(increased-10, reduction-15)\n",
      "conj:and(frequency-11, reduction-15)\n",
      "case(libido-17, in-16)\n",
      "nmod:in(reduction-15, libido-17)\n",
      "cc(frequency-11, and-19)\n",
      "dobj(increased-10, headaches-20)\n",
      "conj:and(frequency-11, headaches-20)\n",
      "\n",
      "Parsing [sent. 34 len. 17]: the reactions resulted in the discontinuation and substitution of therapy in 49.5 % of the patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNS reactions))\n",
      "    (VP (VBD resulted)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the) (NN discontinuation)\n",
      "            (CC and)\n",
      "            (NN substitution))\n",
      "          (PP (IN of)\n",
      "            (NP (NN therapy)))))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (CD 49.5) (NN %))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NNS patients))))))\n",
      "    (. .)))\n",
      "\n",
      "det(reactions-2, the-1)\n",
      "nsubj(resulted-3, reactions-2)\n",
      "root(ROOT-0, resulted-3)\n",
      "case(discontinuation-6, in-4)\n",
      "det(discontinuation-6, the-5)\n",
      "nmod:in(resulted-3, discontinuation-6)\n",
      "cc(discontinuation-6, and-7)\n",
      "nmod:in(resulted-3, substitution-8)\n",
      "conj:and(discontinuation-6, substitution-8)\n",
      "case(therapy-10, of-9)\n",
      "nmod:of(discontinuation-6, therapy-10)\n",
      "case(%-13, in-11)\n",
      "nummod(%-13, 49.5-12)\n",
      "nmod:in(resulted-3, %-13)\n",
      "case(patients-16, of-14)\n",
      "det(patients-16, the-15)\n",
      "nmod:of(%-13, patients-16)\n",
      "\n",
      "Parsing [sent. 35 len. 28]: in clinical setting , congestive heart failure -LRB- chf -RRB- and chronic kidney disease -LRB- ckd -RRB- often co-exist in patients due to common underlying predisposing factors .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (JJ clinical) (NN setting)))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (JJ congestive) (NN heart) (NN failure))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN chf))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (JJ chronic) (NN kidney) (NN disease)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN ckd))\n",
      "        (-RRB- -RRB-)))\n",
      "    (ADVP (RB often))\n",
      "    (VP (VB co-exist)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (ADJP (JJ due)\n",
      "            (PP (TO to)\n",
      "              (NP (JJ common) (JJ underlying) (NN predisposing) (NNS factors)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(setting-3, in-1)\n",
      "amod(setting-3, clinical-2)\n",
      "nmod:in(co-exist-19, setting-3)\n",
      "amod(failure-7, congestive-5)\n",
      "compound(failure-7, heart-6)\n",
      "nsubj(co-exist-19, failure-7)\n",
      "appos(failure-7, chf-9)\n",
      "cc(failure-7, and-11)\n",
      "amod(disease-14, chronic-12)\n",
      "compound(disease-14, kidney-13)\n",
      "conj:and(failure-7, disease-14)\n",
      "nsubj(co-exist-19, disease-14)\n",
      "appos(failure-7, ckd-16)\n",
      "advmod(co-exist-19, often-18)\n",
      "root(ROOT-0, co-exist-19)\n",
      "case(patients-21, in-20)\n",
      "nmod:in(co-exist-19, patients-21)\n",
      "amod(patients-21, due-22)\n",
      "case(factors-27, to-23)\n",
      "amod(factors-27, common-24)\n",
      "amod(factors-27, underlying-25)\n",
      "compound(factors-27, predisposing-26)\n",
      "nmod:to(due-22, factors-27)\n",
      "\n",
      "Parsing [sent. 36 len. 20]: an intricate equilibrium between the cardiovascular and renal system is maintained through rennin angiotensin-aldosterone axis and autonomic nervous system .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT an) (JJ intricate) (NN equilibrium))\n",
      "      (PP (IN between)\n",
      "        (NP (DT the) (JJ cardiovascular)\n",
      "          (CC and)\n",
      "          (JJ renal) (NN system))))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN maintained)\n",
      "        (PP (IN through)\n",
      "          (NP\n",
      "            (NP (JJ rennin) (JJ angiotensin-aldosterone) (NNS axis))\n",
      "            (CC and)\n",
      "            (NP (JJ autonomic) (JJ nervous) (NN system))))))\n",
      "    (. .)))\n",
      "\n",
      "det(equilibrium-3, an-1)\n",
      "amod(equilibrium-3, intricate-2)\n",
      "nsubjpass(maintained-11, equilibrium-3)\n",
      "case(system-9, between-4)\n",
      "det(system-9, the-5)\n",
      "amod(system-9, cardiovascular-6)\n",
      "cc(cardiovascular-6, and-7)\n",
      "conj:and(cardiovascular-6, renal-8)\n",
      "amod(system-9, renal-8)\n",
      "nmod:between(equilibrium-3, system-9)\n",
      "auxpass(maintained-11, is-10)\n",
      "root(ROOT-0, maintained-11)\n",
      "case(axis-15, through-12)\n",
      "amod(axis-15, rennin-13)\n",
      "amod(axis-15, angiotensin-aldosterone-14)\n",
      "nmod:through(maintained-11, axis-15)\n",
      "cc(axis-15, and-16)\n",
      "amod(system-19, autonomic-17)\n",
      "amod(system-19, nervous-18)\n",
      "nmod:through(maintained-11, system-19)\n",
      "conj:and(axis-15, system-19)\n",
      "\n",
      "Parsing [sent. 37 len. 32]: consequent to favorable hemodynamic modification , ACEI and angiotensin receptor blocking -LRB- arb -RRB- therapy have proven to be an indispensable aspect of heart failure management with morbidity and mortality benefit .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (JJ consequent)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (JJ favorable) (JJ hemodynamic) (NN modification))\n",
      "            (, ,)\n",
      "            (NP (NNP ACEI))\n",
      "            (CC and)\n",
      "            (NP (NN angiotensin)))))\n",
      "      (JJ receptor) (FW blocking)\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN arb))\n",
      "        (-RRB- -RRB-))\n",
      "      (NN therapy))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN proven)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ indispensable) (NN aspect))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NN heart) (NN failure) (NN management))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN morbidity)\n",
      "                        (CC and)\n",
      "                        (NN mortality) (NN benefit)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-15, consequent-1)\n",
      "case(modification-5, to-2)\n",
      "amod(modification-5, favorable-3)\n",
      "amod(modification-5, hemodynamic-4)\n",
      "nmod:to(consequent-1, modification-5)\n",
      "nmod:to(consequent-1, ACEI-7)\n",
      "conj:and(modification-5, ACEI-7)\n",
      "cc(modification-5, and-8)\n",
      "nmod:to(consequent-1, angiotensin-9)\n",
      "conj:and(modification-5, angiotensin-9)\n",
      "amod(therapy-15, receptor-10)\n",
      "compound(therapy-15, blocking-11)\n",
      "appos(therapy-15, arb-13)\n",
      "nsubj(proven-17, therapy-15)\n",
      "nsubj:xsubj(aspect-22, therapy-15)\n",
      "aux(proven-17, have-16)\n",
      "root(ROOT-0, proven-17)\n",
      "mark(aspect-22, to-18)\n",
      "cop(aspect-22, be-19)\n",
      "det(aspect-22, an-20)\n",
      "amod(aspect-22, indispensable-21)\n",
      "xcomp(proven-17, aspect-22)\n",
      "case(management-26, of-23)\n",
      "compound(management-26, heart-24)\n",
      "compound(management-26, failure-25)\n",
      "nmod:of(aspect-22, management-26)\n",
      "case(benefit-31, with-27)\n",
      "compound(benefit-31, morbidity-28)\n",
      "cc(morbidity-28, and-29)\n",
      "conj:and(morbidity-28, mortality-30)\n",
      "compound(benefit-31, mortality-30)\n",
      "nmod:with(management-26, benefit-31)\n",
      "\n",
      "Parsing [sent. 38 len. 27]: additionally , progression to end stage renal failure may be halted by renin angiotensin aldosterone system -LRB- raas -RRB- blockade in patients with preexisting renal dysfunction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB additionally))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN progression))\n",
      "      (PP (TO to)\n",
      "        (NP (NN end) (NN stage) (JJ renal) (NN failure))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN halted)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (JJ renin)\n",
      "                (ADJP (RB angiotensin) (JJ aldosterone))\n",
      "                (NN system)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNS raas))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NN blockade))\n",
      "              (PP (IN in)\n",
      "                (NP (NNS patients)))))\n",
      "          (PP (IN with)\n",
      "            (S\n",
      "              (VP (VBG preexisting)\n",
      "                (NP (JJ renal) (NN dysfunction))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(halted-11, additionally-1)\n",
      "nsubjpass(halted-11, progression-3)\n",
      "case(failure-8, to-4)\n",
      "compound(failure-8, end-5)\n",
      "compound(failure-8, stage-6)\n",
      "amod(failure-8, renal-7)\n",
      "nmod:to(progression-3, failure-8)\n",
      "aux(halted-11, may-9)\n",
      "auxpass(halted-11, be-10)\n",
      "root(ROOT-0, halted-11)\n",
      "case(blockade-20, by-12)\n",
      "amod(blockade-20, renin-13)\n",
      "advmod(aldosterone-15, angiotensin-14)\n",
      "amod(blockade-20, aldosterone-15)\n",
      "compound(blockade-20, system-16)\n",
      "appos(blockade-20, raas-18)\n",
      "nmod:by(halted-11, blockade-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(blockade-20, patients-22)\n",
      "mark(preexisting-24, with-23)\n",
      "advcl(halted-11, preexisting-24)\n",
      "amod(dysfunction-26, renal-25)\n",
      "dobj(preexisting-24, dysfunction-26)\n",
      "\n",
      "Parsing [sent. 39 len. 29]: however , concern over the safety of raas blockade in presence of renal impairment has led to profound underutilization of these drugs in chf patients with renal insufficiency .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN concern))\n",
      "      (PP (IN over)\n",
      "        (NP\n",
      "          (NP (DT the) (NN safety))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ raas) (NN blockade))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NN presence))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ renal) (NN impairment))))))))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN led)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (JJ profound) (NN underutilization))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT these) (NNS drugs))\n",
      "                (PP (IN in)\n",
      "                  (NP (NN chf) (NNS patients)))))))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ renal) (NN insufficiency)))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(led-16, however-1)\n",
      "nsubj(led-16, concern-3)\n",
      "case(safety-6, over-4)\n",
      "det(safety-6, the-5)\n",
      "nmod:over(concern-3, safety-6)\n",
      "case(blockade-9, of-7)\n",
      "amod(blockade-9, raas-8)\n",
      "nmod:of(safety-6, blockade-9)\n",
      "case(presence-11, in-10)\n",
      "nmod:in(blockade-9, presence-11)\n",
      "case(impairment-14, of-12)\n",
      "amod(impairment-14, renal-13)\n",
      "nmod:of(presence-11, impairment-14)\n",
      "aux(led-16, has-15)\n",
      "root(ROOT-0, led-16)\n",
      "case(underutilization-19, to-17)\n",
      "amod(underutilization-19, profound-18)\n",
      "nmod:to(led-16, underutilization-19)\n",
      "case(drugs-22, of-20)\n",
      "det(drugs-22, these-21)\n",
      "nmod:of(underutilization-19, drugs-22)\n",
      "case(patients-25, in-23)\n",
      "compound(patients-25, chf-24)\n",
      "nmod:in(drugs-22, patients-25)\n",
      "case(insufficiency-28, with-26)\n",
      "amod(insufficiency-28, renal-27)\n",
      "nmod:with(led-16, insufficiency-28)\n",
      "\n",
      "Parsing [sent. 40 len. 18]: this review aims to provide a simplified guide to pathophysiology and management options of this perplexing situation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN review))\n",
      "    (VP (VBZ aims)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB provide)\n",
      "            (NP (DT a) (VBN simplified) (NN guide))\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN pathophysiology)\n",
      "                  (CC and)\n",
      "                  (NN management) (NNS options))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT this) (JJ perplexing) (NN situation)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(review-2, this-1)\n",
      "nsubj(aims-3, review-2)\n",
      "nsubj:xsubj(provide-5, review-2)\n",
      "root(ROOT-0, aims-3)\n",
      "mark(provide-5, to-4)\n",
      "xcomp(aims-3, provide-5)\n",
      "det(guide-8, a-6)\n",
      "amod(guide-8, simplified-7)\n",
      "dobj(provide-5, guide-8)\n",
      "case(options-13, to-9)\n",
      "compound(options-13, pathophysiology-10)\n",
      "cc(pathophysiology-10, and-11)\n",
      "conj:and(pathophysiology-10, management-12)\n",
      "compound(options-13, management-12)\n",
      "nmod:to(provide-5, options-13)\n",
      "case(situation-17, of-14)\n",
      "det(situation-17, this-15)\n",
      "amod(situation-17, perplexing-16)\n",
      "nmod:of(options-13, situation-17)\n",
      "\n",
      "Parsing [sent. 41 len. 19]: dihydropyridine calcium channel blockers may possess antioxidant properties , and might improve micro and macrovascular structure and function .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ dihydropyridine) (NN calcium) (NN channel) (NNS blockers))\n",
      "    (VP\n",
      "      (VP (MD may)\n",
      "        (VP (VB possess)\n",
      "          (NP (JJ antioxidant) (NNS properties))))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (VP (MD might)\n",
      "        (VP (VB improve)\n",
      "          (NP (JJ micro)\n",
      "            (CC and)\n",
      "            (NN macrovascular) (NN structure)\n",
      "            (CC and)\n",
      "            (NN function)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(blockers-4, dihydropyridine-1)\n",
      "compound(blockers-4, calcium-2)\n",
      "compound(blockers-4, channel-3)\n",
      "nsubj(possess-6, blockers-4)\n",
      "nsubj(improve-12, blockers-4)\n",
      "aux(possess-6, may-5)\n",
      "root(ROOT-0, possess-6)\n",
      "amod(properties-8, antioxidant-7)\n",
      "dobj(possess-6, properties-8)\n",
      "cc(possess-6, and-10)\n",
      "aux(improve-12, might-11)\n",
      "conj:and(possess-6, improve-12)\n",
      "amod(structure-16, micro-13)\n",
      "cc(micro-13, and-14)\n",
      "conj:and(micro-13, macrovascular-15)\n",
      "amod(structure-16, macrovascular-15)\n",
      "dobj(improve-12, structure-16)\n",
      "cc(structure-16, and-17)\n",
      "dobj(improve-12, function-18)\n",
      "conj:and(structure-16, function-18)\n",
      "\n",
      "Parsing [sent. 42 len. 16]: combination treatment with an ACEI may have additional advantages , compared with a thiazide diuretic .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN combination) (NN treatment))\n",
      "      (PP (IN with)\n",
      "        (NP (DT an) (NNP ACEI))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB have)\n",
      "        (NP (JJ additional) (NNS advantages))\n",
      "        (, ,)\n",
      "        (PP (VBN compared)\n",
      "          (PP (IN with)\n",
      "            (NP (DT a) (JJ thiazide) (NN diuretic))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(treatment-2, combination-1)\n",
      "nsubj(have-7, treatment-2)\n",
      "case(ACEI-5, with-3)\n",
      "det(ACEI-5, an-4)\n",
      "nmod:with(treatment-2, ACEI-5)\n",
      "aux(have-7, may-6)\n",
      "root(ROOT-0, have-7)\n",
      "amod(advantages-9, additional-8)\n",
      "dobj(have-7, advantages-9)\n",
      "case(diuretic-15, compared-11)\n",
      "mwe(compared-11, with-12)\n",
      "det(diuretic-15, a-13)\n",
      "amod(diuretic-15, thiazide-14)\n",
      "advcl(have-7, diuretic-15)\n",
      "\n",
      "Parsing [sent. 43 len. 49]: the aim of the present study is to investigate the effects of a short-term treatment with lercanidipine , and to compare two combination treatments : lercanidipine + enalapril vs. lercanidipine + hydrochlorothiazide on structural alterations in retinal arterioles , on skin capillary density and on large artery distensibility .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN aim))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ present) (NN study))))\n",
      "    (VP (VBZ is)\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (TO to)\n",
      "            (VP (VB investigate)\n",
      "              (NP\n",
      "                (NP (DT the) (NNS effects))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT a) (JJ short-term) (NN treatment))))\n",
      "              (PP (IN with)\n",
      "                (NP (NN lercanidipine)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (VP (TO to)\n",
      "            (VP (VB compare)\n",
      "              (NP\n",
      "                (NP (CD two) (NN combination) (NNS treatments))\n",
      "                (: :)\n",
      "                (NP\n",
      "                  (NP (JJ lercanidipine) (JJ +) (NN enalapril))\n",
      "                  (PP (IN vs.)\n",
      "                    (NP\n",
      "                      (NP (JJ lercanidipine) (JJ +) (NN hydrochlorothiazide))\n",
      "                      (PP (IN on)\n",
      "                        (NP\n",
      "                          (NP (JJ structural) (NNS alterations))\n",
      "                          (PP (IN in)\n",
      "                            (NP (JJ retinal) (NNS arterioles))))))))\n",
      "                (, ,))\n",
      "              (PP\n",
      "                (PP (IN on)\n",
      "                  (NP (NN skin) (NN capillary) (NN density)))\n",
      "                (CC and)\n",
      "                (PP (IN on)\n",
      "                  (NP (JJ large) (NN artery) (NN distensibility)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(aim-2, the-1)\n",
      "nsubj(is-7, aim-2)\n",
      "case(study-6, of-3)\n",
      "det(study-6, the-4)\n",
      "amod(study-6, present-5)\n",
      "nmod:of(aim-2, study-6)\n",
      "root(ROOT-0, is-7)\n",
      "mark(investigate-9, to-8)\n",
      "ccomp(is-7, investigate-9)\n",
      "det(effects-11, the-10)\n",
      "dobj(investigate-9, effects-11)\n",
      "case(treatment-15, of-12)\n",
      "det(treatment-15, a-13)\n",
      "amod(treatment-15, short-term-14)\n",
      "nmod:of(effects-11, treatment-15)\n",
      "case(lercanidipine-17, with-16)\n",
      "nmod:with(investigate-9, lercanidipine-17)\n",
      "cc(investigate-9, and-19)\n",
      "mark(compare-21, to-20)\n",
      "ccomp(is-7, compare-21)\n",
      "conj:and(investigate-9, compare-21)\n",
      "conj:and(investigate-9, compare-21')\n",
      "conj:and(compare-21, compare-21')\n",
      "nummod(treatments-24, two-22)\n",
      "compound(treatments-24, combination-23)\n",
      "dobj(compare-21, treatments-24)\n",
      "amod(enalapril-28, lercanidipine-26)\n",
      "amod(enalapril-28, +-27)\n",
      "dep(treatments-24, enalapril-28)\n",
      "case(hydrochlorothiazide-32, vs.-29)\n",
      "amod(hydrochlorothiazide-32, lercanidipine-30)\n",
      "amod(hydrochlorothiazide-32, +-31)\n",
      "nmod:vs.(enalapril-28, hydrochlorothiazide-32)\n",
      "case(alterations-35, on-33)\n",
      "amod(alterations-35, structural-34)\n",
      "nmod:on(hydrochlorothiazide-32, alterations-35)\n",
      "case(arterioles-38, in-36)\n",
      "amod(arterioles-38, retinal-37)\n",
      "nmod:in(alterations-35, arterioles-38)\n",
      "case(density-43, on-40)\n",
      "compound(density-43, skin-41)\n",
      "compound(density-43, capillary-42)\n",
      "nmod:on(compare-21, density-43)\n",
      "cc(compare-21, and-44)\n",
      "case(distensibility-48, on-45)\n",
      "amod(distensibility-48, large-46)\n",
      "compound(distensibility-48, artery-47)\n",
      "nmod:on(compare-21', distensibility-48)\n",
      "\n",
      "Parsing [sent. 44 len. 23]: thirty essential hypertension patients are included in the study , and treated for 4 weeks with lercanidipine 20 mg per day orally .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (CD thirty) (JJ essential))\n",
      "      (NN hypertension) (NNS patients))\n",
      "    (VP (VBP are)\n",
      "      (VP\n",
      "        (VP (VBN included)\n",
      "          (PP (IN in)\n",
      "            (NP (DT the) (NN study))))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (VP (VBN treated)\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (CD 4) (NNS weeks))\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (ADJP (JJ lercanidipine)\n",
      "                      (NP (CD 20)))\n",
      "                    (NN mg))\n",
      "                  (PP (IN per)\n",
      "                    (NP (NN day) (NN orally))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(essential-2, thirty-1)\n",
      "amod(patients-4, essential-2)\n",
      "compound(patients-4, hypertension-3)\n",
      "nsubjpass(included-6, patients-4)\n",
      "nsubjpass(treated-12, patients-4)\n",
      "auxpass(included-6, are-5)\n",
      "root(ROOT-0, included-6)\n",
      "case(study-9, in-7)\n",
      "det(study-9, the-8)\n",
      "nmod:in(included-6, study-9)\n",
      "cc(included-6, and-11)\n",
      "conj:and(included-6, treated-12)\n",
      "case(weeks-15, for-13)\n",
      "nummod(weeks-15, 4-14)\n",
      "nmod:for(treated-12, weeks-15)\n",
      "case(mg-19, with-16)\n",
      "amod(mg-19, lercanidipine-17)\n",
      "dep(lercanidipine-17, 20-18)\n",
      "nmod:with(weeks-15, mg-19)\n",
      "case(orally-22, per-20)\n",
      "compound(orally-22, day-21)\n",
      "nmod:per(mg-19, orally-22)\n",
      "\n",
      "Parsing [sent. 45 len. 28]: then , they were treated for 6 months with lercanidipine + enalapril -LRB- n = 15 -RRB- or lercanidipine + hydrochlorothiazide -LRB- n = 15 -RRB- combinations .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB then))\n",
      "    (, ,)\n",
      "    (NP (PRP they))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN treated)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (CD 6) (NNS months))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ lercanidipine) (JJ +) (NN enalapril))))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 15)))))\n",
      "              (-RRB- -RRB-))\n",
      "            (CC or)\n",
      "            (NP\n",
      "              (ADJP (JJ lercanidipine) (JJ +))\n",
      "              (JJ hydrochlorothiazide)\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 15)))))\n",
      "                (-RRB- -RRB-))\n",
      "              (NN combinations))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(treated-5, then-1)\n",
      "nsubjpass(treated-5, they-3)\n",
      "auxpass(treated-5, were-4)\n",
      "root(ROOT-0, treated-5)\n",
      "case(months-8, for-6)\n",
      "nummod(months-8, 6-7)\n",
      "nmod:for(treated-5, months-8)\n",
      "case(enalapril-12, with-9)\n",
      "amod(enalapril-12, lercanidipine-10)\n",
      "amod(enalapril-12, +-11)\n",
      "nmod:with(months-8, enalapril-12)\n",
      "dep(months-8, n-14)\n",
      "dep(15-16, =-15)\n",
      "ccomp(n-14, 15-16)\n",
      "cc(months-8, or-18)\n",
      "amod(+-20, lercanidipine-19)\n",
      "amod(combinations-27, +-20)\n",
      "amod(combinations-27, hydrochlorothiazide-21)\n",
      "dep(combinations-27, n-23)\n",
      "dep(15-25, =-24)\n",
      "ccomp(n-23, 15-25)\n",
      "nmod:for(treated-5, combinations-27)\n",
      "conj:or(months-8, combinations-27)\n",
      "\n",
      "Parsing [sent. 46 len. 32]: investigations were performed on basal condition , after appropriate wash out of previous treatments , after 4 weeks of lercanidipine monotherapy treatment , and at the end of the combination treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS investigations))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN performed)\n",
      "        (PP\n",
      "          (PP (IN on)\n",
      "            (NP (JJ basal) (NN condition)))\n",
      "          (, ,)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (JJ appropriate) (NN wash))\n",
      "              (PP (RB out) (IN of)\n",
      "                (NP (JJ previous) (NNS treatments)))))\n",
      "          (, ,)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (CD 4) (NNS weeks))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ lercanidipine) (JJ monotherapy) (NN treatment)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (PP (IN at)\n",
      "            (NP\n",
      "              (NP (DT the) (NN end))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN combination) (NN treatment))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(performed-3, investigations-1)\n",
      "nsubjpass(performed-3', investigations-1)\n",
      "nsubjpass(performed-3'', investigations-1)\n",
      "nsubjpass(performed-3''', investigations-1)\n",
      "auxpass(performed-3, were-2)\n",
      "root(ROOT-0, performed-3)\n",
      "conj:and(performed-3, performed-3')\n",
      "conj:and(performed-3, performed-3'')\n",
      "conj:and(performed-3, performed-3''')\n",
      "case(condition-6, on-4)\n",
      "amod(condition-6, basal-5)\n",
      "nmod:on(performed-3, condition-6)\n",
      "case(wash-10, after-8)\n",
      "amod(wash-10, appropriate-9)\n",
      "nmod:after(performed-3'', wash-10)\n",
      "case(treatments-14, out-11)\n",
      "mwe(out-11, of-12)\n",
      "amod(treatments-14, previous-13)\n",
      "nmod:out_of(wash-10, treatments-14)\n",
      "case(weeks-18, after-16)\n",
      "nummod(weeks-18, 4-17)\n",
      "nmod:after(performed-3', weeks-18)\n",
      "case(treatment-22, of-19)\n",
      "amod(treatment-22, lercanidipine-20)\n",
      "amod(treatment-22, monotherapy-21)\n",
      "nmod:of(weeks-18, treatment-22)\n",
      "cc(performed-3, and-24)\n",
      "case(end-27, at-25)\n",
      "det(end-27, the-26)\n",
      "nmod:at(performed-3''', end-27)\n",
      "case(treatment-31, of-28)\n",
      "det(treatment-31, the-29)\n",
      "compound(treatment-31, combination-30)\n",
      "nmod:of(end-27, treatment-31)\n",
      "\n",
      "Parsing [sent. 47 len. 27]: non-invasive measurements of wall-to-lumen ratio -LRB- wlr -RRB- and other morphological parameters of retinal arterioles were performed using either scanning laser doppler flowmetry or adaptive optics .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (ADJP (JJ non-invasive))\n",
      "        (NNS measurements))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ wall-to-lumen) (NN ratio))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NN wlr))\n",
      "              (-RRB- -RRB-)))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (JJ other) (JJ morphological) (NNS parameters))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ retinal) (NNS arterioles)))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN performed)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (CC either)\n",
      "            (VBG scanning)\n",
      "            (NP (NN laser) (NN doppler) (NN flowmetry)\n",
      "              (CC or)\n",
      "              (NN adaptive) (NNS optics))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(measurements-2, non-invasive-1)\n",
      "nsubjpass(performed-17, measurements-2)\n",
      "case(ratio-5, of-3)\n",
      "amod(ratio-5, wall-to-lumen-4)\n",
      "nmod:of(measurements-2, ratio-5)\n",
      "appos(ratio-5, wlr-7)\n",
      "cc(ratio-5, and-9)\n",
      "amod(parameters-12, other-10)\n",
      "amod(parameters-12, morphological-11)\n",
      "nmod:of(measurements-2, parameters-12)\n",
      "conj:and(ratio-5, parameters-12)\n",
      "case(arterioles-15, of-13)\n",
      "amod(arterioles-15, retinal-14)\n",
      "nmod:of(parameters-12, arterioles-15)\n",
      "auxpass(performed-17, were-16)\n",
      "root(ROOT-0, performed-17)\n",
      "xcomp(performed-17, using-18)\n",
      "dep(using-18, either-19)\n",
      "conj(using-18, scanning-20)\n",
      "compound(flowmetry-23, laser-21)\n",
      "compound(flowmetry-23, doppler-22)\n",
      "dobj(using-18, flowmetry-23)\n",
      "cc(flowmetry-23, or-24)\n",
      "compound(optics-26, adaptive-25)\n",
      "dobj(using-18, optics-26)\n",
      "conj:or(flowmetry-23, optics-26)\n",
      "\n",
      "Parsing [sent. 48 len. 25]: capillary density was evaluated by capillaroscopy , while pulse wave velocity was measured , and central blood pressures were assessed by pressure waveform analysis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ capillary) (NN density))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN evaluated)\n",
      "          (PP (IN by)\n",
      "            (NP (NN capillaroscopy)))\n",
      "          (, ,)\n",
      "          (SBAR (IN while)\n",
      "            (S\n",
      "              (NP (NN pulse) (NN wave) (NN velocity))\n",
      "              (VP (VBD was)\n",
      "                (VP (VBN measured))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ central) (NN blood) (NNS pressures))\n",
      "      (VP (VBD were)\n",
      "        (VP (VBN assessed)\n",
      "          (PP (IN by)\n",
      "            (NP (NN pressure) (NN waveform) (NN analysis))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(density-2, capillary-1)\n",
      "nsubjpass(evaluated-4, density-2)\n",
      "auxpass(evaluated-4, was-3)\n",
      "root(ROOT-0, evaluated-4)\n",
      "case(capillaroscopy-6, by-5)\n",
      "nmod:by(evaluated-4, capillaroscopy-6)\n",
      "mark(measured-13, while-8)\n",
      "compound(velocity-11, pulse-9)\n",
      "compound(velocity-11, wave-10)\n",
      "nsubjpass(measured-13, velocity-11)\n",
      "auxpass(measured-13, was-12)\n",
      "advcl(evaluated-4, measured-13)\n",
      "cc(evaluated-4, and-15)\n",
      "amod(pressures-18, central-16)\n",
      "compound(pressures-18, blood-17)\n",
      "nsubjpass(assessed-20, pressures-18)\n",
      "auxpass(assessed-20, were-19)\n",
      "conj:and(evaluated-4, assessed-20)\n",
      "case(analysis-24, by-21)\n",
      "compound(analysis-24, pressure-22)\n",
      "compound(analysis-24, waveform-23)\n",
      "nmod:by(assessed-20, analysis-24)\n",
      "\n",
      "Parsing [sent. 49 len. 49]: a significant improvement of wlr and other indices of retinal artery structure is observed with both technical approaches after treatment with lercanidipine alone , with a further improvement after treatment with lercanidipine + enalapril , while after treatment with lercanidipine + hydrochlorothiazide , the improvement is partially blunted .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT a) (JJ significant) (NN improvement))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN wlr)\n",
      "            (CC and)\n",
      "            (JJ other) (NNS indices))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ retinal) (NN artery) (NN structure))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ observed)\n",
      "        (PP (IN with)\n",
      "          (NP (DT both) (JJ technical) (NNS approaches))))\n",
      "      (PP (IN after)\n",
      "        (NP\n",
      "          (NP (NN treatment))\n",
      "          (PP (IN with)\n",
      "            (NP (NN lercanidipine)))))\n",
      "      (ADVP\n",
      "        (ADVP (RB alone))\n",
      "        (PRN (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (DT a) (JJ further) (NN improvement))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (NN treatment))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ lercanidipine) (JJ +) (NN enalapril)))))))\n",
      "          (, ,))\n",
      "        (SBAR (IN while)\n",
      "          (S\n",
      "            (PP (IN after)\n",
      "              (NP\n",
      "                (NP (NN treatment))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ lercanidipine) (JJ +) (NN hydrochlorothiazide)))))\n",
      "            (, ,)\n",
      "            (NP (DT the) (NN improvement))\n",
      "            (VP (VBZ is)\n",
      "              (ADVP (RB partially))\n",
      "              (VP (VBN blunted)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(improvement-3, a-1)\n",
      "amod(improvement-3, significant-2)\n",
      "nsubj(observed-14, improvement-3)\n",
      "case(indices-8, of-4)\n",
      "compound(indices-8, wlr-5)\n",
      "cc(wlr-5, and-6)\n",
      "conj:and(wlr-5, other-7)\n",
      "compound(indices-8, other-7)\n",
      "nmod:of(improvement-3, indices-8)\n",
      "case(structure-12, of-9)\n",
      "amod(structure-12, retinal-10)\n",
      "compound(structure-12, artery-11)\n",
      "nmod:of(indices-8, structure-12)\n",
      "cop(observed-14, is-13)\n",
      "root(ROOT-0, observed-14)\n",
      "case(approaches-18, with-15)\n",
      "det(approaches-18, both-16)\n",
      "amod(approaches-18, technical-17)\n",
      "nmod:with(observed-14, approaches-18)\n",
      "case(treatment-20, after-19)\n",
      "nmod:after(observed-14, treatment-20)\n",
      "case(lercanidipine-22, with-21)\n",
      "nmod:with(treatment-20, lercanidipine-22)\n",
      "advmod(observed-14, alone-23)\n",
      "case(improvement-28, with-25)\n",
      "det(improvement-28, a-26)\n",
      "amod(improvement-28, further-27)\n",
      "dep(alone-23, improvement-28)\n",
      "case(treatment-30, after-29)\n",
      "nmod:after(improvement-28, treatment-30)\n",
      "case(enalapril-34, with-31)\n",
      "amod(enalapril-34, lercanidipine-32)\n",
      "amod(enalapril-34, +-33)\n",
      "nmod:with(treatment-30, enalapril-34)\n",
      "mark(blunted-48, while-36)\n",
      "case(treatment-38, after-37)\n",
      "nmod:after(blunted-48, treatment-38)\n",
      "case(hydrochlorothiazide-42, with-39)\n",
      "amod(hydrochlorothiazide-42, lercanidipine-40)\n",
      "amod(hydrochlorothiazide-42, +-41)\n",
      "nmod:with(treatment-38, hydrochlorothiazide-42)\n",
      "det(improvement-45, the-44)\n",
      "nsubjpass(blunted-48, improvement-45)\n",
      "auxpass(blunted-48, is-46)\n",
      "advmod(blunted-48, partially-47)\n",
      "advcl(alone-23, blunted-48)\n",
      "\n",
      "Parsing [sent. 50 len. 14]: central systolic and diastolic blood pressures are similarly reduced by both therapeutic strategies .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ central)\n",
      "      (ADJP (JJ systolic)\n",
      "        (CC and)\n",
      "        (JJ diastolic))\n",
      "      (NN blood) (NNS pressures))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB similarly))\n",
      "      (VP (VBN reduced)\n",
      "        (PP (IN by)\n",
      "          (NP (DT both) (JJ therapeutic) (NNS strategies)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(pressures-6, central-1)\n",
      "amod(pressures-6, systolic-2)\n",
      "cc(systolic-2, and-3)\n",
      "conj:and(systolic-2, diastolic-4)\n",
      "amod(pressures-6, diastolic-4)\n",
      "compound(pressures-6, blood-5)\n",
      "nsubjpass(reduced-9, pressures-6)\n",
      "auxpass(reduced-9, are-7)\n",
      "advmod(reduced-9, similarly-8)\n",
      "root(ROOT-0, reduced-9)\n",
      "case(strategies-13, by-10)\n",
      "det(strategies-13, both-11)\n",
      "amod(strategies-13, therapeutic-12)\n",
      "nmod:by(reduced-9, strategies-13)\n",
      "\n",
      "Parsing [sent. 51 len. 12]: capillary density is increased only after treatment with lercanidipine + enalapril .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ capillary) (NN density))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN increased)\n",
      "        (ADVP (RB only))\n",
      "        (PP (IN after)\n",
      "          (NP (NN treatment)))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ lercanidipine) (JJ +) (NN enalapril)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(density-2, capillary-1)\n",
      "nsubjpass(increased-4, density-2)\n",
      "auxpass(increased-4, is-3)\n",
      "root(ROOT-0, increased-4)\n",
      "advmod(increased-4, only-5)\n",
      "case(treatment-7, after-6)\n",
      "nmod:after(increased-4, treatment-7)\n",
      "case(enalapril-11, with-8)\n",
      "amod(enalapril-11, lercanidipine-9)\n",
      "amod(enalapril-11, +-10)\n",
      "nmod:with(increased-4, enalapril-11)\n",
      "\n",
      "Parsing [sent. 52 len. 41]: in conclusion , lercanidipine both in monotherapy and in combination with enalapril but not with hydrochlorothiazide is able to improve microvascular structure ; on the other hand , a decrease in central blood pressure is observed with both therapeutic combinations .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (NN conclusion)))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (S\n",
      "        (VP (VB lercanidipine)\n",
      "          (PP (DT both)\n",
      "            (PP (IN in)\n",
      "              (NP (NN monotherapy)))\n",
      "            (CC and)\n",
      "            (PP (IN in)\n",
      "              (NP (NN combination))))\n",
      "          (PP\n",
      "            (PP (IN with)\n",
      "              (NP (NN enalapril)))\n",
      "            (CONJP (CC but)\n",
      "              (RB not))\n",
      "            (PP (IN with)\n",
      "              (NP (NN hydrochlorothiazide))))))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ able)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB improve)\n",
      "                (NP (NN microvascular) (NN structure))))))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (PP (IN on)\n",
      "        (NP (DT the) (JJ other) (NN hand)))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (NN decrease))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ central) (NN blood) (NN pressure))))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN observed)\n",
      "          (PP (IN with)\n",
      "            (NP (DT both) (JJ therapeutic) (NNS combinations))))))\n",
      "    (. .)))\n",
      "\n",
      "case(conclusion-2, in-1)\n",
      "nmod:in(able-18, conclusion-2)\n",
      "conj(lercanidipine-4, lercanidipine-4')\n",
      "conj:and(lercanidipine-4, lercanidipine-4')\n",
      "csubj(able-18, lercanidipine-4)\n",
      "csubj(able-18, lercanidipine-4')\n",
      "cc:preconj(monotherapy-7, both-5)\n",
      "case(monotherapy-7, in-6)\n",
      "nmod:in(lercanidipine-4, monotherapy-7)\n",
      "cc(lercanidipine-4, and-8)\n",
      "case(combination-10, in-9)\n",
      "nmod:in(lercanidipine-4', combination-10)\n",
      "case(enalapril-12, with-11)\n",
      "nmod:with(lercanidipine-4, enalapril-12)\n",
      "cc(not-14, but-13)\n",
      "cc(lercanidipine-4, not-14)\n",
      "case(hydrochlorothiazide-16, with-15)\n",
      "nmod:with(lercanidipine-4', hydrochlorothiazide-16)\n",
      "cop(able-18, is-17)\n",
      "root(ROOT-0, able-18)\n",
      "mark(improve-20, to-19)\n",
      "xcomp(able-18, improve-20)\n",
      "compound(structure-22, microvascular-21)\n",
      "dobj(improve-20, structure-22)\n",
      "case(hand-27, on-24)\n",
      "det(hand-27, the-25)\n",
      "amod(hand-27, other-26)\n",
      "nmod:on(observed-36, hand-27)\n",
      "det(decrease-30, a-29)\n",
      "nsubjpass(observed-36, decrease-30)\n",
      "case(pressure-34, in-31)\n",
      "amod(pressure-34, central-32)\n",
      "compound(pressure-34, blood-33)\n",
      "nmod:in(decrease-30, pressure-34)\n",
      "auxpass(observed-36, is-35)\n",
      "parataxis(able-18, observed-36)\n",
      "case(combinations-40, with-37)\n",
      "det(combinations-40, both-38)\n",
      "amod(combinations-40, therapeutic-39)\n",
      "nmod:with(observed-36, combinations-40)\n",
      "\n",
      "Parsing [sent. 53 len. 23]: hypereosinophilic syndrome -LRB- hes -RRB- is a heterogeneous group of hematological disorders characterized by a chronic , unexplained hypereosinophilia with tissue damage .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ hypereosinophilic) (NN syndrome))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN hes))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ heterogeneous) (NN group))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (JJ hematological) (NNS disorders))\n",
      "            (VP (VBN characterized)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (DT a) (JJ chronic) (, ,) (JJ unexplained) (NN hypereosinophilia))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN tissue) (NN damage))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(syndrome-2, hypereosinophilic-1)\n",
      "nsubj(group-9, syndrome-2)\n",
      "appos(syndrome-2, hes-4)\n",
      "cop(group-9, is-6)\n",
      "det(group-9, a-7)\n",
      "amod(group-9, heterogeneous-8)\n",
      "root(ROOT-0, group-9)\n",
      "case(disorders-12, of-10)\n",
      "amod(disorders-12, hematological-11)\n",
      "nmod:of(group-9, disorders-12)\n",
      "acl(disorders-12, characterized-13)\n",
      "case(hypereosinophilia-19, by-14)\n",
      "det(hypereosinophilia-19, a-15)\n",
      "amod(hypereosinophilia-19, chronic-16)\n",
      "amod(hypereosinophilia-19, unexplained-18)\n",
      "nmod:by(characterized-13, hypereosinophilia-19)\n",
      "case(damage-22, with-20)\n",
      "compound(damage-22, tissue-21)\n",
      "nmod:with(hypereosinophilia-19, damage-22)\n",
      "\n",
      "Parsing [sent. 54 len. 18]: cardiac involvement occurs in â¼ 20 % of patients with hes and represents a major turning point .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ cardiac) (NN involvement))\n",
      "    (VP\n",
      "      (VP (VBZ occurs)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (CD â¼) (CD 20))\n",
      "              (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN hes))))))))\n",
      "      (CC and)\n",
      "      (VP (VBZ represents)\n",
      "        (NP (DT a) (JJ major) (NN turning) (NN point))))\n",
      "    (. .)))\n",
      "\n",
      "amod(involvement-2, cardiac-1)\n",
      "nsubj(occurs-3, involvement-2)\n",
      "nsubj(represents-13, involvement-2)\n",
      "root(ROOT-0, occurs-3)\n",
      "case(%-7, in-4)\n",
      "compound(20-6, â¼-5)\n",
      "nummod(%-7, 20-6)\n",
      "nmod:in(occurs-3, %-7)\n",
      "case(patients-9, of-8)\n",
      "nmod:of(%-7, patients-9)\n",
      "case(hes-11, with-10)\n",
      "nmod:with(patients-9, hes-11)\n",
      "cc(occurs-3, and-12)\n",
      "conj:and(occurs-3, represents-13)\n",
      "det(point-17, a-14)\n",
      "amod(point-17, major-15)\n",
      "compound(point-17, turning-16)\n",
      "dobj(represents-13, point-17)\n",
      "\n",
      "Parsing [sent. 55 len. 20]: cardiac injuries related to eosinophilia are divided into three chronological phases : eosinophilic infiltration , thrombosis , and fibrosis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ cardiac) (NNS injuries))\n",
      "      (VP (VBN related)\n",
      "        (PP (TO to)\n",
      "          (NP (NN eosinophilia)))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN divided)\n",
      "        (PP (IN into)\n",
      "          (NP\n",
      "            (NP (CD three) (JJ chronological) (NNS phases))\n",
      "            (: :)\n",
      "            (NP (JJ eosinophilic) (NN infiltration))\n",
      "            (, ,)\n",
      "            (NP (NNS thrombosis))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (NN fibrosis))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(injuries-2, cardiac-1)\n",
      "nsubjpass(divided-7, injuries-2)\n",
      "acl(injuries-2, related-3)\n",
      "case(eosinophilia-5, to-4)\n",
      "nmod:to(related-3, eosinophilia-5)\n",
      "auxpass(divided-7, are-6)\n",
      "root(ROOT-0, divided-7)\n",
      "case(phases-11, into-8)\n",
      "nummod(phases-11, three-9)\n",
      "amod(phases-11, chronological-10)\n",
      "nmod:into(divided-7, phases-11)\n",
      "amod(infiltration-14, eosinophilic-13)\n",
      "nmod:into(divided-7, infiltration-14)\n",
      "conj:and(phases-11, infiltration-14)\n",
      "nmod:into(divided-7, thrombosis-16)\n",
      "conj:and(phases-11, thrombosis-16)\n",
      "cc(phases-11, and-18)\n",
      "nmod:into(divided-7, fibrosis-19)\n",
      "conj:and(phases-11, fibrosis-19)\n",
      "\n",
      "Parsing [sent. 56 len. 24]: we report a case of a 33-year-old woman diagnosed with hes , with pulmonary and gastrointestinal involvement and eosinophilic myocarditis in cardiogenic shock .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBP report)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT a) (NN case))\n",
      "            (PP (IN of)\n",
      "              (NP (DT a) (JJ 33-year-old) (NN woman))))\n",
      "          (VP (VBD diagnosed)\n",
      "            (PP (IN with)\n",
      "              (NP (NN hes)))\n",
      "            (, ,)\n",
      "            (PP (IN with)\n",
      "              (NP (JJ pulmonary)\n",
      "                (CC and)\n",
      "                (JJ gastrointestinal) (NN involvement)\n",
      "                (CC and)\n",
      "                (NN eosinophilic) (NNS myocarditis)))\n",
      "            (PP (IN in)\n",
      "              (NP (JJ cardiogenic) (NN shock)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(report-2, we-1)\n",
      "root(ROOT-0, report-2)\n",
      "det(case-4, a-3)\n",
      "nsubj(diagnosed-9, case-4)\n",
      "case(woman-8, of-5)\n",
      "det(woman-8, a-6)\n",
      "amod(woman-8, 33-year-old-7)\n",
      "nmod:of(case-4, woman-8)\n",
      "ccomp(report-2, diagnosed-9)\n",
      "case(hes-11, with-10)\n",
      "nmod:with(diagnosed-9, hes-11)\n",
      "case(involvement-17, with-13)\n",
      "amod(involvement-17, pulmonary-14)\n",
      "cc(pulmonary-14, and-15)\n",
      "conj:and(pulmonary-14, gastrointestinal-16)\n",
      "amod(involvement-17, gastrointestinal-16)\n",
      "nmod:with(diagnosed-9, involvement-17)\n",
      "cc(involvement-17, and-18)\n",
      "compound(myocarditis-20, eosinophilic-19)\n",
      "nmod:with(diagnosed-9, myocarditis-20)\n",
      "conj:and(involvement-17, myocarditis-20)\n",
      "case(shock-23, in-21)\n",
      "amod(shock-23, cardiogenic-22)\n",
      "nmod:in(diagnosed-9, shock-23)\n",
      "\n",
      "Parsing [sent. 57 len. 18]: the evolution was favorable with dobutamine , anticoagulation , corticosteroids , and later , Î²-blockers and ACEI .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN evolution))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ favorable)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN dobutamine))\n",
      "            (, ,)\n",
      "            (NP (NN anticoagulation))\n",
      "            (, ,)\n",
      "            (NP (NNS corticosteroids))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (ADVP (RB later))\n",
      "            (, ,)\n",
      "            (NP (NNS Î²-blockers))\n",
      "            (CC and)\n",
      "            (NP (NNP ACEI))))))\n",
      "    (. .)))\n",
      "\n",
      "det(evolution-2, the-1)\n",
      "nsubj(favorable-4, evolution-2)\n",
      "cop(favorable-4, was-3)\n",
      "root(ROOT-0, favorable-4)\n",
      "case(dobutamine-6, with-5)\n",
      "nmod:with(favorable-4, dobutamine-6)\n",
      "nmod:with(favorable-4, anticoagulation-8)\n",
      "conj:and(dobutamine-6, anticoagulation-8)\n",
      "nmod:with(favorable-4, corticosteroids-10)\n",
      "conj:and(dobutamine-6, corticosteroids-10)\n",
      "cc(dobutamine-6, and-12)\n",
      "advmod(dobutamine-6, later-13)\n",
      "nmod:with(favorable-4, Î²-blockers-15)\n",
      "conj:and(dobutamine-6, Î²-blockers-15)\n",
      "cc(dobutamine-6, and-16)\n",
      "nmod:with(favorable-4, ACEI-17)\n",
      "conj:and(dobutamine-6, ACEI-17)\n",
      "\n",
      "Parsing [sent. 58 len. 12]: cardiac involvement in hes is rare but carries a poor prognosis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ cardiac) (NN involvement))\n",
      "      (PP (IN in)\n",
      "        (NP (NN hes))))\n",
      "    (VP\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ rare)))\n",
      "      (CC but)\n",
      "      (VP (VBZ carries)\n",
      "        (NP (DT a) (JJ poor) (NN prognosis))))\n",
      "    (. .)))\n",
      "\n",
      "amod(involvement-2, cardiac-1)\n",
      "nsubj(rare-6, involvement-2)\n",
      "nsubj(carries-8, involvement-2)\n",
      "case(hes-4, in-3)\n",
      "nmod:in(involvement-2, hes-4)\n",
      "cop(rare-6, is-5)\n",
      "root(ROOT-0, rare-6)\n",
      "cc(rare-6, but-7)\n",
      "conj:but(rare-6, carries-8)\n",
      "det(prognosis-11, a-9)\n",
      "amod(prognosis-11, poor-10)\n",
      "dobj(carries-8, prognosis-11)\n",
      "\n",
      "Parsing [sent. 59 len. 12]: corticosteroids are considered by many to be the mainstay of treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS corticosteroids))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN considered)\n",
      "        (PP (IN by)\n",
      "          (NP (JJ many)))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (NP\n",
      "                (NP (DT the) (NN mainstay))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN treatment)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(considered-3, corticosteroids-1)\n",
      "nsubj:xsubj(mainstay-9, corticosteroids-1)\n",
      "auxpass(considered-3, are-2)\n",
      "root(ROOT-0, considered-3)\n",
      "case(many-5, by-4)\n",
      "nmod:by(considered-3, many-5)\n",
      "mark(mainstay-9, to-6)\n",
      "cop(mainstay-9, be-7)\n",
      "det(mainstay-9, the-8)\n",
      "xcomp(considered-3, mainstay-9)\n",
      "case(treatment-11, of-10)\n",
      "nmod:of(mainstay-9, treatment-11)\n",
      "\n",
      "Parsing [sent. 60 len. 13]: although new treatments have been suggested , only a few seem promising .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN although)\n",
      "      (S\n",
      "        (NP (JJ new) (NNS treatments))\n",
      "        (VP (VBP have)\n",
      "          (VP (VBN been)\n",
      "            (VP (VBN suggested))))))\n",
      "    (, ,)\n",
      "    (ADVP (RB only))\n",
      "    (NP (DT a) (JJ few))\n",
      "    (VP (VBP seem)\n",
      "      (S\n",
      "        (VP (VBG promising))))\n",
      "    (. .)))\n",
      "\n",
      "mark(suggested-6, although-1)\n",
      "amod(treatments-3, new-2)\n",
      "nsubjpass(suggested-6, treatments-3)\n",
      "aux(suggested-6, have-4)\n",
      "auxpass(suggested-6, been-5)\n",
      "advcl(seem-11, suggested-6)\n",
      "advmod(few-10, only-8)\n",
      "det(few-10, a-9)\n",
      "nsubj(seem-11, few-10)\n",
      "root(ROOT-0, seem-11)\n",
      "xcomp(seem-11, promising-12)\n",
      "\n",
      "Parsing [sent. 61 len. 31]: the burden of heart failure has long plagued the productive years of the population , with therapeutic advances in the timely treatment of ischemic heart disease decreasing its associated mortality .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN burden))\n",
      "      (PP (IN of)\n",
      "        (NP (NN heart) (NN failure))))\n",
      "    (VP (VBZ has)\n",
      "      (ADVP (RB long))\n",
      "      (VP (VBN plagued)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ productive) (NNS years))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NN population))))\n",
      "        (, ,)\n",
      "        (PP (IN with)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ therapeutic) (NNS advances))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ timely) (NN treatment))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ ischemic) (NN heart) (NN disease))))))\n",
      "            (VP (VBG decreasing)\n",
      "              (NP (PRP$ its) (VBN associated) (NN mortality)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(burden-2, the-1)\n",
      "nsubj(plagued-8, burden-2)\n",
      "case(failure-5, of-3)\n",
      "compound(failure-5, heart-4)\n",
      "nmod:of(burden-2, failure-5)\n",
      "aux(plagued-8, has-6)\n",
      "advmod(plagued-8, long-7)\n",
      "root(ROOT-0, plagued-8)\n",
      "det(years-11, the-9)\n",
      "amod(years-11, productive-10)\n",
      "dobj(plagued-8, years-11)\n",
      "case(population-14, of-12)\n",
      "det(population-14, the-13)\n",
      "nmod:of(years-11, population-14)\n",
      "mark(decreasing-27, with-16)\n",
      "amod(advances-18, therapeutic-17)\n",
      "nsubj(decreasing-27, advances-18)\n",
      "case(treatment-22, in-19)\n",
      "det(treatment-22, the-20)\n",
      "amod(treatment-22, timely-21)\n",
      "nmod:in(advances-18, treatment-22)\n",
      "case(disease-26, of-23)\n",
      "amod(disease-26, ischemic-24)\n",
      "compound(disease-26, heart-25)\n",
      "nmod:of(treatment-22, disease-26)\n",
      "advcl(plagued-8, decreasing-27)\n",
      "nmod:poss(mortality-30, its-28)\n",
      "amod(mortality-30, associated-29)\n",
      "dobj(decreasing-27, mortality-30)\n",
      "\n",
      "Parsing [sent. 62 len. 13]: ACEI and Î²-blockers have impacted heart failure therapeutics in a revolutionary way .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNP ACEI))\n",
      "      (CC and)\n",
      "      (NP (NNS Î²-blockers)))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN impacted)\n",
      "        (NP (NN heart) (NN failure) (NNS therapeutics))\n",
      "        (PP (IN in)\n",
      "          (NP (DT a) (JJ revolutionary) (NN way)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(impacted-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, Î²-blockers-3)\n",
      "nsubj(impacted-5, Î²-blockers-3)\n",
      "aux(impacted-5, have-4)\n",
      "root(ROOT-0, impacted-5)\n",
      "compound(therapeutics-8, heart-6)\n",
      "compound(therapeutics-8, failure-7)\n",
      "dobj(impacted-5, therapeutics-8)\n",
      "case(way-12, in-9)\n",
      "det(way-12, a-10)\n",
      "amod(way-12, revolutionary-11)\n",
      "nmod:in(impacted-5, way-12)\n",
      "\n",
      "Parsing [sent. 63 len. 44]: the importance of blockade of the renin-angiotensin system and adrenergic stimulation are fully accepted concepts that apply in young and old , symptomatic and asymptomatic , borderline low and very low ejection fraction -LRB- ef -RRB- , left ventricular failure and biventricular failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN importance))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN blockade))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ renin-angiotensin) (NN system))\n",
      "              (CC and)\n",
      "              (NP (JJ adrenergic) (NN stimulation)))))))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB fully))\n",
      "      (VP (VBN accepted)\n",
      "        (NP\n",
      "          (NP (NNS concepts))\n",
      "          (SBAR\n",
      "            (WHNP (WDT that))\n",
      "            (S\n",
      "              (VP (VBP apply)\n",
      "                (PP (IN in)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (ADJP\n",
      "                          (ADJP (JJ young)\n",
      "                            (CC and)\n",
      "                            (JJ old))\n",
      "                          (, ,)\n",
      "                          (ADJP (JJ symptomatic)\n",
      "                            (CC and)\n",
      "                            (JJ asymptomatic))\n",
      "                          (, ,)\n",
      "                          (ADJP (JJ borderline) (JJ low))\n",
      "                          (CC and)\n",
      "                          (ADJP (RB very) (JJ low)))\n",
      "                        (NN ejection) (NN fraction))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN ef))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP (JJ left) (NN ventricular) (NN failure)\n",
      "                      (CC and)\n",
      "                      (NN biventricular) (NN failure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(importance-2, the-1)\n",
      "nsubjpass(accepted-14, importance-2)\n",
      "case(blockade-4, of-3)\n",
      "nmod:of(importance-2, blockade-4)\n",
      "case(system-8, of-5)\n",
      "det(system-8, the-6)\n",
      "amod(system-8, renin-angiotensin-7)\n",
      "nmod:of(blockade-4, system-8)\n",
      "cc(system-8, and-9)\n",
      "amod(stimulation-11, adrenergic-10)\n",
      "nmod:of(blockade-4, stimulation-11)\n",
      "conj:and(system-8, stimulation-11)\n",
      "auxpass(accepted-14, are-12)\n",
      "advmod(accepted-14, fully-13)\n",
      "root(ROOT-0, accepted-14)\n",
      "dobj(accepted-14, concepts-15)\n",
      "nsubj(apply-17, concepts-15)\n",
      "ref(concepts-15, that-16)\n",
      "acl:relcl(concepts-15, apply-17)\n",
      "case(fraction-33, in-18)\n",
      "amod(fraction-33, young-19)\n",
      "cc(young-19, and-20)\n",
      "conj:and(young-19, old-21)\n",
      "amod(fraction-33, old-21)\n",
      "conj:and(young-19, symptomatic-23)\n",
      "amod(fraction-33, symptomatic-23)\n",
      "cc(symptomatic-23, and-24)\n",
      "conj:and(young-19, asymptomatic-25)\n",
      "conj:and(symptomatic-23, asymptomatic-25)\n",
      "amod(low-28, borderline-27)\n",
      "conj:and(young-19, low-28)\n",
      "amod(fraction-33, low-28)\n",
      "cc(young-19, and-29)\n",
      "advmod(low-31, very-30)\n",
      "conj:and(young-19, low-31)\n",
      "amod(fraction-33, low-31)\n",
      "compound(fraction-33, ejection-32)\n",
      "nmod:in(apply-17, fraction-33)\n",
      "appos(fraction-33, ef-35)\n",
      "amod(failure-40, left-38)\n",
      "compound(failure-40, ventricular-39)\n",
      "appos(fraction-33, failure-40)\n",
      "cc(failure-40, and-41)\n",
      "compound(failure-43, biventricular-42)\n",
      "appos(fraction-33, failure-43)\n",
      "conj:and(failure-40, failure-43)\n",
      "\n",
      "Parsing [sent. 64 len. 25]: despite several interventions , both pharmaceutical and device based for the treatment of ensuing heart failure , the incidence is increasing in large proportions .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP\n",
      "        (NP (JJ several) (NNS interventions))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT both) (NN pharmaceutical)\n",
      "            (CC and)\n",
      "            (NN device))\n",
      "          (VP (VBN based)\n",
      "            (PP (IN for)\n",
      "              (NP\n",
      "                (NP (DT the) (NN treatment))\n",
      "                (PP (IN of)\n",
      "                  (NP (VBG ensuing) (NN heart) (NN failure)))))))))\n",
      "    (, ,)\n",
      "    (NP (DT the) (NN incidence))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBG increasing)\n",
      "        (PP (IN in)\n",
      "          (NP (JJ large) (NNS proportions)))))\n",
      "    (. .)))\n",
      "\n",
      "case(interventions-3, despite-1)\n",
      "amod(interventions-3, several-2)\n",
      "nmod:despite(increasing-21, interventions-3)\n",
      "cc:preconj(pharmaceutical-6, both-5)\n",
      "appos(interventions-3, pharmaceutical-6)\n",
      "cc(pharmaceutical-6, and-7)\n",
      "appos(interventions-3, device-8)\n",
      "conj:and(pharmaceutical-6, device-8)\n",
      "acl(pharmaceutical-6, based-9)\n",
      "case(treatment-12, for-10)\n",
      "det(treatment-12, the-11)\n",
      "nmod:for(based-9, treatment-12)\n",
      "case(failure-16, of-13)\n",
      "amod(failure-16, ensuing-14)\n",
      "compound(failure-16, heart-15)\n",
      "nmod:of(treatment-12, failure-16)\n",
      "det(incidence-19, the-18)\n",
      "nsubj(increasing-21, incidence-19)\n",
      "aux(increasing-21, is-20)\n",
      "root(ROOT-0, increasing-21)\n",
      "case(proportions-24, in-22)\n",
      "amod(proportions-24, large-23)\n",
      "nmod:in(increasing-21, proportions-24)\n",
      "\n",
      "Parsing [sent. 65 len. 8]: newer molecules like sacubitril show more promise .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJR newer) (NNS molecules))\n",
      "      (PP (IN like)\n",
      "        (NP (NN sacubitril))))\n",
      "    (VP (VBP show)\n",
      "      (NP (JJR more) (NN promise)))\n",
      "    (. .)))\n",
      "\n",
      "amod(molecules-2, newer-1)\n",
      "nsubj(show-5, molecules-2)\n",
      "case(sacubitril-4, like-3)\n",
      "nmod:like(molecules-2, sacubitril-4)\n",
      "root(ROOT-0, show-5)\n",
      "amod(promise-7, more-6)\n",
      "dobj(show-5, promise-7)\n",
      "\n",
      "Parsing [sent. 66 len. 17]: despite these novel therapies , several patients relentlessly progress to a stage of advanced heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP (DT these) (NN novel) (NNS therapies)))\n",
      "    (, ,)\n",
      "    (NP (JJ several) (NNS patients))\n",
      "    (ADVP (RB relentlessly))\n",
      "    (VP (VB progress)\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (DT a) (NN stage))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ advanced) (NN heart) (NN failure))))))\n",
      "    (. .)))\n",
      "\n",
      "case(therapies-4, despite-1)\n",
      "det(therapies-4, these-2)\n",
      "compound(therapies-4, novel-3)\n",
      "nmod:despite(progress-9, therapies-4)\n",
      "amod(patients-7, several-6)\n",
      "nsubj(progress-9, patients-7)\n",
      "advmod(progress-9, relentlessly-8)\n",
      "root(ROOT-0, progress-9)\n",
      "case(stage-12, to-10)\n",
      "det(stage-12, a-11)\n",
      "nmod:to(progress-9, stage-12)\n",
      "case(failure-16, of-13)\n",
      "amod(failure-16, advanced-14)\n",
      "compound(failure-16, heart-15)\n",
      "nmod:of(stage-12, failure-16)\n",
      "\n",
      "Parsing [sent. 67 len. 18]: the use of left-ventricular-assist devices has variable clinical benefit , with some patients progressing to heart transplantation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ left-ventricular-assist) (NNS devices))))\n",
      "    (VP (VBZ has)\n",
      "      (NP (JJ variable) (JJ clinical) (NN benefit))\n",
      "      (, ,)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (DT some) (NNS patients))\n",
      "          (VP (VBG progressing)\n",
      "            (PP (TO to)\n",
      "              (NP (NN heart) (NN transplantation)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(use-2, the-1)\n",
      "nsubj(has-6, use-2)\n",
      "case(devices-5, of-3)\n",
      "amod(devices-5, left-ventricular-assist-4)\n",
      "nmod:of(use-2, devices-5)\n",
      "root(ROOT-0, has-6)\n",
      "amod(benefit-9, variable-7)\n",
      "amod(benefit-9, clinical-8)\n",
      "dobj(has-6, benefit-9)\n",
      "case(patients-13, with-11)\n",
      "det(patients-13, some-12)\n",
      "nmod:with(has-6, patients-13)\n",
      "acl(patients-13, progressing-14)\n",
      "case(transplantation-17, to-15)\n",
      "compound(transplantation-17, heart-16)\n",
      "nmod:to(progressing-14, transplantation-17)\n",
      "\n",
      "Parsing [sent. 68 len. 12]: liver fibrosis is a common response to many chronic liver diseases .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN liver) (NN fibrosis))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ common) (NN response))\n",
      "        (PP (TO to)\n",
      "          (NP (JJ many) (JJ chronic) (NN liver) (NNS diseases)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(fibrosis-2, liver-1)\n",
      "nsubj(response-6, fibrosis-2)\n",
      "cop(response-6, is-3)\n",
      "det(response-6, a-4)\n",
      "amod(response-6, common-5)\n",
      "root(ROOT-0, response-6)\n",
      "case(diseases-11, to-7)\n",
      "amod(diseases-11, many-8)\n",
      "amod(diseases-11, chronic-9)\n",
      "compound(diseases-11, liver-10)\n",
      "nmod:to(response-6, diseases-11)\n",
      "\n",
      "Parsing [sent. 69 len. 29]: the aim of our study was to explore whether pharmacotherapy for concurrent diseases affects overall mortality , liver-related mortality and liver-related morbidity in patients with chronic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN aim))\n",
      "      (PP (IN of)\n",
      "        (NP (PRP$ our) (NN study))))\n",
      "    (VP (VBD was)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB explore)\n",
      "            (SBAR (IN whether)\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (NN pharmacotherapy))\n",
      "                  (PP (IN for)\n",
      "                    (NP (JJ concurrent) (NNS diseases))))\n",
      "                (VP (VBZ affects)\n",
      "                  (NP\n",
      "                    (NP (JJ overall) (NN mortality))\n",
      "                    (, ,)\n",
      "                    (NP (JJ liver-related) (NN mortality))\n",
      "                    (CC and)\n",
      "                    (NP (JJ liver-related) (NN morbidity)))\n",
      "                  (PP (IN in)\n",
      "                    (NP\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP (JJ chronic) (NN liver) (NN disease))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(aim-2, the-1)\n",
      "nsubj(was-6, aim-2)\n",
      "nsubj:xsubj(explore-8, aim-2)\n",
      "case(study-5, of-3)\n",
      "nmod:poss(study-5, our-4)\n",
      "nmod:of(aim-2, study-5)\n",
      "root(ROOT-0, was-6)\n",
      "mark(explore-8, to-7)\n",
      "xcomp(was-6, explore-8)\n",
      "mark(affects-14, whether-9)\n",
      "nsubj(affects-14, pharmacotherapy-10)\n",
      "case(diseases-13, for-11)\n",
      "amod(diseases-13, concurrent-12)\n",
      "nmod:for(pharmacotherapy-10, diseases-13)\n",
      "ccomp(explore-8, affects-14)\n",
      "amod(mortality-16, overall-15)\n",
      "dobj(affects-14, mortality-16)\n",
      "amod(mortality-19, liver-related-18)\n",
      "dobj(affects-14, mortality-19)\n",
      "conj:and(mortality-16, mortality-19)\n",
      "cc(mortality-16, and-20)\n",
      "amod(morbidity-22, liver-related-21)\n",
      "dobj(affects-14, morbidity-22)\n",
      "conj:and(mortality-16, morbidity-22)\n",
      "case(patients-24, in-23)\n",
      "nmod:in(affects-14, patients-24)\n",
      "case(disease-28, with-25)\n",
      "amod(disease-28, chronic-26)\n",
      "compound(disease-28, liver-27)\n",
      "nmod:with(patients-24, disease-28)\n",
      "\n",
      "Parsing [sent. 70 len. 30]: we performed a register-based cohort study of all patients with a first-time diagnosis of chronic liver disease between 2005 and 2012 in sweden -LRB- n = 70 546 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD performed)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ register-based) (NN cohort) (NN study))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT all) (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (DT a) (JJ first-time) (NN diagnosis)))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ chronic) (NN liver) (NN disease)))\n",
      "            (PP (IN between)\n",
      "              (NP (CD 2005)\n",
      "                (CC and)\n",
      "                (CD 2012)))\n",
      "            (PP (IN in)\n",
      "              (NP (NN sweden)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 70) (CD 546)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(performed-2, we-1)\n",
      "root(ROOT-0, performed-2)\n",
      "det(study-6, a-3)\n",
      "amod(study-6, register-based-4)\n",
      "compound(study-6, cohort-5)\n",
      "dobj(performed-2, study-6)\n",
      "case(patients-9, of-7)\n",
      "det(patients-9, all-8)\n",
      "nmod:of(study-6, patients-9)\n",
      "case(diagnosis-13, with-10)\n",
      "det(diagnosis-13, a-11)\n",
      "amod(diagnosis-13, first-time-12)\n",
      "nmod:with(patients-9, diagnosis-13)\n",
      "case(disease-17, of-14)\n",
      "amod(disease-17, chronic-15)\n",
      "compound(disease-17, liver-16)\n",
      "nmod:of(patients-9, disease-17)\n",
      "case(2005-19, between-18)\n",
      "nmod:between(patients-9, 2005-19)\n",
      "cc(2005-19, and-20)\n",
      "nmod:between(patients-9, 2012-21)\n",
      "conj:and(2005-19, 2012-21)\n",
      "case(sweden-23, in-22)\n",
      "nmod:in(patients-9, sweden-23)\n",
      "dep(patients-9, n-25)\n",
      "dep(546-28, =-26)\n",
      "nummod(546-28, 70-27)\n",
      "ccomp(n-25, 546-28)\n",
      "\n",
      "Parsing [sent. 71 len. 18]: data from the patient register , the prescribed drug register and the death certificate register were linked .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS data))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ patient) (NN register))\n",
      "          (, ,)\n",
      "          (NP (DT the) (JJ prescribed) (NN drug) (NN register))\n",
      "          (CC and)\n",
      "          (NP (DT the) (NN death) (NN certificate) (NN register)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN linked)))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(linked-17, data-1)\n",
      "case(register-5, from-2)\n",
      "det(register-5, the-3)\n",
      "amod(register-5, patient-4)\n",
      "nmod:from(data-1, register-5)\n",
      "det(register-10, the-7)\n",
      "amod(register-10, prescribed-8)\n",
      "compound(register-10, drug-9)\n",
      "nmod:from(data-1, register-10)\n",
      "conj:and(register-5, register-10)\n",
      "cc(register-5, and-11)\n",
      "det(register-15, the-12)\n",
      "compound(register-15, death-13)\n",
      "compound(register-15, certificate-14)\n",
      "nmod:from(data-1, register-15)\n",
      "conj:and(register-5, register-15)\n",
      "auxpass(linked-17, were-16)\n",
      "root(ROOT-0, linked-17)\n",
      "\n",
      "Parsing [sent. 72 len. 27]: we studied whether the use of statins , ACEI , angiotensin receptor blockers and antibiotics affected the risk of total mortality , liver-specific mortality and morbidity .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD studied)\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN use))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS statins))\n",
      "                (, ,)\n",
      "                (NP (NNP ACEI))\n",
      "                (, ,)\n",
      "                (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "                (CC and)\n",
      "                (NP (NNS antibiotics)))))\n",
      "          (VP (VBD affected)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (JJ total) (NN mortality))\n",
      "                  (, ,)\n",
      "                  (NP (JJ liver-specific) (NN mortality))\n",
      "                  (CC and)\n",
      "                  (NP (NN morbidity)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(studied-2, we-1)\n",
      "root(ROOT-0, studied-2)\n",
      "mark(affected-16, whether-3)\n",
      "det(use-5, the-4)\n",
      "nsubj(affected-16, use-5)\n",
      "case(statins-7, of-6)\n",
      "nmod:of(use-5, statins-7)\n",
      "nmod:of(use-5, ACEI-9)\n",
      "conj:and(statins-7, ACEI-9)\n",
      "compound(blockers-13, angiotensin-11)\n",
      "compound(blockers-13, receptor-12)\n",
      "nmod:of(use-5, blockers-13)\n",
      "conj:and(statins-7, blockers-13)\n",
      "cc(statins-7, and-14)\n",
      "nmod:of(use-5, antibiotics-15)\n",
      "conj:and(statins-7, antibiotics-15)\n",
      "ccomp(studied-2, affected-16)\n",
      "det(risk-18, the-17)\n",
      "dobj(affected-16, risk-18)\n",
      "case(mortality-21, of-19)\n",
      "amod(mortality-21, total-20)\n",
      "nmod:of(risk-18, mortality-21)\n",
      "amod(mortality-24, liver-specific-23)\n",
      "nmod:of(risk-18, mortality-24)\n",
      "conj:and(mortality-21, mortality-24)\n",
      "cc(mortality-21, and-25)\n",
      "nmod:of(risk-18, morbidity-26)\n",
      "conj:and(mortality-21, morbidity-26)\n",
      "\n",
      "Parsing [sent. 73 len. 50]: we found a reduction in mortality risk for statin users -LRB- n = 11 245 -RRB- with hazard ratios from 0.57 -LRB- 95 % , ci 0.32-0 .99 -RRB- for patients with autoimmune hepatitis , to 0.84 -LRB- 95 % , ci 0.75-0 .95 -RRB- for alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD found)\n",
      "      (NP\n",
      "        (NP (DT a) (NN reduction))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NN mortality) (NN risk))\n",
      "            (PP (IN for)\n",
      "              (NP (NN statin) (NNS users)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 11) (CD 245)))))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (PP (IN with)\n",
      "        (NP (NN hazard) (NNS ratios)))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD 0.57))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 95) (NN %))\n",
      "                (, ,)\n",
      "                (NP (NN ci) (CD 0.32-0) (NNP .99)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ autoimmune) (NN hepatitis)))))))\n",
      "      (, ,)\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD 0.84))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 95) (NN %))\n",
      "                (, ,)\n",
      "                (NP (NN ci) (CD 0.75-0) (NNP .95)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP (JJ alcoholic) (NN liver) (NN disease))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(found-2, we-1)\n",
      "root(ROOT-0, found-2)\n",
      "det(reduction-4, a-3)\n",
      "dobj(found-2, reduction-4)\n",
      "case(risk-7, in-5)\n",
      "compound(risk-7, mortality-6)\n",
      "nmod:in(reduction-4, risk-7)\n",
      "case(users-10, for-8)\n",
      "compound(users-10, statin-9)\n",
      "nmod:for(risk-7, users-10)\n",
      "dep(risk-7, n-12)\n",
      "dep(245-15, =-13)\n",
      "nummod(245-15, 11-14)\n",
      "ccomp(n-12, 245-15)\n",
      "case(ratios-19, with-17)\n",
      "compound(ratios-19, hazard-18)\n",
      "nmod:with(found-2, ratios-19)\n",
      "case(0.57-21, from-20)\n",
      "nmod:from(found-2, 0.57-21)\n",
      "nummod(%-24, 95-23)\n",
      "dep(0.57-21, %-24)\n",
      "compound(.99-28, ci-26)\n",
      "nummod(.99-28, 0.32-0-27)\n",
      "appos(%-24, .99-28)\n",
      "case(patients-31, for-30)\n",
      "nmod:for(0.57-21, patients-31)\n",
      "case(hepatitis-34, with-32)\n",
      "amod(hepatitis-34, autoimmune-33)\n",
      "nmod:with(patients-31, hepatitis-34)\n",
      "case(0.84-37, to-36)\n",
      "nmod:to(found-2, 0.84-37)\n",
      "nummod(%-40, 95-39)\n",
      "dep(0.84-37, %-40)\n",
      "compound(.95-44, ci-42)\n",
      "nummod(.95-44, 0.75-0-43)\n",
      "appos(%-40, .95-44)\n",
      "case(disease-49, for-46)\n",
      "amod(disease-49, alcoholic-47)\n",
      "compound(disease-49, liver-48)\n",
      "nmod:for(0.84-37, disease-49)\n",
      "\n",
      "Parsing [sent. 74 len. 27]: there was a significant reduced liver-related mortality for patients with alcoholic liver disease who used ACEI , 0.85 -LRB- 95 % , ci 0.65-0 .96 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ significant) (JJ reduced) (JJ liver-related) (NN mortality))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (JJ alcoholic) (NN liver) (NN disease)))))\n",
      "        (SBAR\n",
      "          (WHNP (WP who))\n",
      "          (S\n",
      "            (VP (VBD used)\n",
      "              (NP\n",
      "                (NP (NNP ACEI) (, ,) (NNP 0.85))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 95) (NN %))\n",
      "                    (, ,)\n",
      "                    (NP (NN ci) (CD 0.65-0) (NNP .96)))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "det(mortality-7, a-3)\n",
      "amod(mortality-7, significant-4)\n",
      "amod(mortality-7, reduced-5)\n",
      "amod(mortality-7, liver-related-6)\n",
      "nsubj(was-2, mortality-7)\n",
      "nsubj(used-15, mortality-7)\n",
      "case(patients-9, for-8)\n",
      "nmod:for(mortality-7, patients-9)\n",
      "case(disease-13, with-10)\n",
      "amod(disease-13, alcoholic-11)\n",
      "compound(disease-13, liver-12)\n",
      "nmod:with(patients-9, disease-13)\n",
      "ref(mortality-7, who-14)\n",
      "acl:relcl(mortality-7, used-15)\n",
      "compound(0.85-18, ACEI-16)\n",
      "dobj(used-15, 0.85-18)\n",
      "nummod(%-21, 95-20)\n",
      "dep(0.85-18, %-21)\n",
      "compound(.96-25, ci-23)\n",
      "nummod(.96-25, 0.65-0-24)\n",
      "appos(%-21, .96-25)\n",
      "\n",
      "Parsing [sent. 75 len. 34]: there were increased overall mortality risks for antibiotic users -LRB- n = 44 572 -RRB- , with hazard ratios up to 1.67 -LRB- 95 % ci , 1.55-1 .80 -RRB- for viral hepatitis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD were)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (VBN increased) (JJ overall) (NN mortality) (NNS risks))\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (JJ antibiotic) (NNS users))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 44) (CD 572)))))\n",
      "                (-RRB- -RRB-))))\n",
      "          (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP (NN hazard) (NNS ratios))))\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (IN up) (TO to) (CD 1.67)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (ADJP (CD 95) (NN %))\n",
      "                  (NN ci))\n",
      "                (, ,)\n",
      "                (NP (CD 1.55-1) (CD .80)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP (JJ viral) (NN hepatitis))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(were-2, there-1)\n",
      "root(ROOT-0, were-2)\n",
      "amod(risks-6, increased-3)\n",
      "amod(risks-6, overall-4)\n",
      "compound(risks-6, mortality-5)\n",
      "iobj(were-2, risks-6)\n",
      "case(users-9, for-7)\n",
      "amod(users-9, antibiotic-8)\n",
      "nmod:for(risks-6, users-9)\n",
      "dep(users-9, n-11)\n",
      "dep(572-14, =-12)\n",
      "nummod(572-14, 44-13)\n",
      "ccomp(n-11, 572-14)\n",
      "case(ratios-19, with-17)\n",
      "compound(ratios-19, hazard-18)\n",
      "nmod:with(risks-6, ratios-19)\n",
      "dep(1.67-22, up-20)\n",
      "mwe(up-20, to-21)\n",
      "dep(risks-6, 1.67-22)\n",
      "compound(%-25, 95-24)\n",
      "amod(ci-26, %-25)\n",
      "dep(1.67-22, ci-26)\n",
      "nummod(.80-29, 1.55-1-28)\n",
      "appos(ci-26, .80-29)\n",
      "case(hepatitis-33, for-31)\n",
      "amod(hepatitis-33, viral-32)\n",
      "nmod:for(1.67-22, hepatitis-33)\n",
      "\n",
      "Parsing [sent. 76 len. 25]: statin use was associated with decreased risks of liver-specific mortality and morbidity , and reduced total mortality foremost among patients with alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN statin) (NN use))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (VBN decreased) (NNS risks))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ liver-specific) (NN mortality)\n",
      "                  (CC and)\n",
      "                  (NN morbidity))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (VBN reduced) (JJ total) (NN mortality))\n",
      "              (ADVP (RB foremost)\n",
      "                (PP (IN among)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ alcoholic) (NN liver) (NN disease)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(use-2, statin-1)\n",
      "nsubjpass(associated-4, use-2)\n",
      "auxpass(associated-4, was-3)\n",
      "root(ROOT-0, associated-4)\n",
      "case(risks-7, with-5)\n",
      "amod(risks-7, decreased-6)\n",
      "nmod:with(associated-4, risks-7)\n",
      "case(mortality-10, of-8)\n",
      "amod(mortality-10, liver-specific-9)\n",
      "nmod:of(risks-7, mortality-10)\n",
      "cc(mortality-10, and-11)\n",
      "nmod:of(risks-7, morbidity-12)\n",
      "conj:and(mortality-10, morbidity-12)\n",
      "cc(risks-7, and-14)\n",
      "amod(mortality-17, reduced-15)\n",
      "amod(mortality-17, total-16)\n",
      "nmod:with(associated-4, mortality-17)\n",
      "conj:and(risks-7, mortality-17)\n",
      "advmod(mortality-17, foremost-18)\n",
      "case(patients-20, among-19)\n",
      "nmod:among(foremost-18, patients-20)\n",
      "case(disease-24, with-21)\n",
      "amod(disease-24, alcoholic-22)\n",
      "compound(disease-24, liver-23)\n",
      "nmod:with(patients-20, disease-24)\n",
      "\n",
      "Parsing [sent. 77 len. 14]: ACEI was associated with reduced liver-related mortality among patients with alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (VBN reduced) (JJ liver-related) (NN mortality))\n",
      "            (PP (IN among)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ alcoholic) (NN liver) (NN disease)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(associated-3, ACEI-1)\n",
      "auxpass(associated-3, was-2)\n",
      "root(ROOT-0, associated-3)\n",
      "case(mortality-7, with-4)\n",
      "amod(mortality-7, reduced-5)\n",
      "amod(mortality-7, liver-related-6)\n",
      "nmod:with(associated-3, mortality-7)\n",
      "case(patients-9, among-8)\n",
      "nmod:among(mortality-7, patients-9)\n",
      "case(disease-13, with-10)\n",
      "amod(disease-13, alcoholic-11)\n",
      "compound(disease-13, liver-12)\n",
      "nmod:with(patients-9, disease-13)\n",
      "\n",
      "Parsing [sent. 78 len. 7]: this article is protected by copyright .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN article))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN protected)\n",
      "        (PP (IN by)\n",
      "          (NP (NN copyright)))))\n",
      "    (. .)))\n",
      "\n",
      "det(article-2, this-1)\n",
      "nsubjpass(protected-4, article-2)\n",
      "auxpass(protected-4, is-3)\n",
      "root(ROOT-0, protected-4)\n",
      "case(copyright-6, by-5)\n",
      "nmod:by(protected-4, copyright-6)\n",
      "\n",
      "Parsing [sent. 79 len. 4]: all rights reserved .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT all) (NNS rights))\n",
      "    (VP (VBD reserved))\n",
      "    (. .)))\n",
      "\n",
      "det(rights-2, all-1)\n",
      "nsubj(reserved-3, rights-2)\n",
      "root(ROOT-0, reserved-3)\n",
      "\n",
      "Parsing [sent. 80 len. 44]: fabry 's disease -LRB- fd -RRB- is a severe congenital metabolic disorder characterized by the deficient activity of lysosomal exoglycohydrolase alpha-galactosidase , characterized by glycosphingolipid deposition in several cells , such as capillary endothelial cells , renal , cardiac , and nerve cells .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (NN fabry) (POS 's))\n",
      "        (NN disease))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN fd))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ severe) (JJ congenital) (JJ metabolic) (NN disorder))\n",
      "        (VP (VBN characterized)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ deficient) (NN activity))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ lysosomal) (NN exoglycohydrolase) (NN alpha-galactosidase))\n",
      "                    (, ,)\n",
      "                    (VP (VBN characterized)\n",
      "                      (PP (IN by)\n",
      "                        (NP\n",
      "                          (NP (JJ glycosphingolipid) (NN deposition))\n",
      "                          (PP (IN in)\n",
      "                            (NP (JJ several) (NNS cells))))))\n",
      "                    (, ,))\n",
      "                  (PP (JJ such) (IN as)\n",
      "                    (NP\n",
      "                      (NP (JJ capillary) (JJ endothelial) (NNS cells))\n",
      "                      (, ,)\n",
      "                      (NP (JJ renal))\n",
      "                      (, ,)\n",
      "                      (NP (JJ cardiac))\n",
      "                      (, ,)\n",
      "                      (CC and)\n",
      "                      (NP (NN nerve) (NNS cells)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(disease-3, fabry-1)\n",
      "case(fabry-1, 's-2)\n",
      "nsubj(disorder-12, disease-3)\n",
      "appos(disease-3, fd-5)\n",
      "cop(disorder-12, is-7)\n",
      "det(disorder-12, a-8)\n",
      "amod(disorder-12, severe-9)\n",
      "amod(disorder-12, congenital-10)\n",
      "amod(disorder-12, metabolic-11)\n",
      "root(ROOT-0, disorder-12)\n",
      "acl(disorder-12, characterized-13)\n",
      "case(activity-17, by-14)\n",
      "det(activity-17, the-15)\n",
      "amod(activity-17, deficient-16)\n",
      "nmod:by(characterized-13, activity-17)\n",
      "case(alpha-galactosidase-21, of-18)\n",
      "amod(alpha-galactosidase-21, lysosomal-19)\n",
      "compound(alpha-galactosidase-21, exoglycohydrolase-20)\n",
      "nmod:of(activity-17, alpha-galactosidase-21)\n",
      "acl(alpha-galactosidase-21, characterized-23)\n",
      "case(deposition-26, by-24)\n",
      "amod(deposition-26, glycosphingolipid-25)\n",
      "nmod:by(characterized-23, deposition-26)\n",
      "case(cells-29, in-27)\n",
      "amod(cells-29, several-28)\n",
      "nmod:in(deposition-26, cells-29)\n",
      "case(cells-35, such-31)\n",
      "mwe(such-31, as-32)\n",
      "amod(cells-35, capillary-33)\n",
      "amod(cells-35, endothelial-34)\n",
      "nmod:such_as(alpha-galactosidase-21, cells-35)\n",
      "nmod:such_as(alpha-galactosidase-21, renal-37)\n",
      "conj:and(cells-35, renal-37)\n",
      "nmod:such_as(alpha-galactosidase-21, cardiac-39)\n",
      "conj:and(cells-35, cardiac-39)\n",
      "cc(cells-35, and-41)\n",
      "compound(cells-43, nerve-42)\n",
      "nmod:such_as(alpha-galactosidase-21, cells-43)\n",
      "conj:and(cells-35, cells-43)\n",
      "\n",
      "Parsing [sent. 81 len. 27]: as a systemic disease leading to a contemporaneous myocardial and renal dysfunction , fd might be an example of cardiorenal syndrome type 5 -LRB- crs-5 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN as)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ systemic) (NN disease))\n",
      "        (VP (VBG leading)\n",
      "          (PP (TO to)\n",
      "            (NP\n",
      "              (NP (DT a) (JJ contemporaneous) (NN myocardial))\n",
      "              (CC and)\n",
      "              (NP (JJ renal) (NN dysfunction)))))))\n",
      "    (, ,)\n",
      "    (NP (NN fd))\n",
      "    (VP (MD might)\n",
      "      (VP (VB be)\n",
      "        (NP\n",
      "          (NP (DT an) (NN example))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ cardiorenal) (NN syndrome))\n",
      "                (ADJP (NN type) (CD 5)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (ADJP (JJ crs-5))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(disease-4, as-1)\n",
      "det(disease-4, a-2)\n",
      "amod(disease-4, systemic-3)\n",
      "nmod:as(example-18, disease-4)\n",
      "acl(disease-4, leading-5)\n",
      "case(myocardial-9, to-6)\n",
      "det(myocardial-9, a-7)\n",
      "amod(myocardial-9, contemporaneous-8)\n",
      "nmod:to(leading-5, myocardial-9)\n",
      "cc(myocardial-9, and-10)\n",
      "amod(dysfunction-12, renal-11)\n",
      "nmod:to(leading-5, dysfunction-12)\n",
      "conj:and(myocardial-9, dysfunction-12)\n",
      "nsubj(example-18, fd-14)\n",
      "aux(example-18, might-15)\n",
      "cop(example-18, be-16)\n",
      "det(example-18, an-17)\n",
      "root(ROOT-0, example-18)\n",
      "case(syndrome-21, of-19)\n",
      "amod(syndrome-21, cardiorenal-20)\n",
      "nmod:of(example-18, syndrome-21)\n",
      "amod(syndrome-21, type-22)\n",
      "compound(type-22, 5-23)\n",
      "dep(syndrome-21, crs-5-25)\n",
      "\n",
      "Parsing [sent. 82 len. 29]: kidney damage is commonly characterized by proteinuria , isosthenuria and altered tubular function when occurs at the second-third decade , azotemia and end-stage renal disease in third-fifth decade .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN kidney) (NN damage))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB commonly))\n",
      "      (VP (VBN characterized)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NN proteinuria))\n",
      "            (, ,)\n",
      "            (NP (NN isosthenuria))\n",
      "            (CC and)\n",
      "            (NP (JJ altered) (JJ tubular) (NN function))))\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (VP (VBZ occurs)\n",
      "              (PP (IN at)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ second-third) (NN decade))\n",
      "                  (, ,)\n",
      "                  (NP (NN azotemia))\n",
      "                  (CC and)\n",
      "                  (NP (JJ end-stage) (JJ renal) (NN disease))))\n",
      "              (PP (IN in)\n",
      "                (NP (JJ third-fifth) (NN decade))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(damage-2, kidney-1)\n",
      "nsubjpass(characterized-5, damage-2)\n",
      "auxpass(characterized-5, is-3)\n",
      "advmod(characterized-5, commonly-4)\n",
      "root(ROOT-0, characterized-5)\n",
      "case(proteinuria-7, by-6)\n",
      "nmod:by(characterized-5, proteinuria-7)\n",
      "nmod:by(characterized-5, isosthenuria-9)\n",
      "conj:and(proteinuria-7, isosthenuria-9)\n",
      "cc(proteinuria-7, and-10)\n",
      "amod(function-13, altered-11)\n",
      "amod(function-13, tubular-12)\n",
      "nmod:by(characterized-5, function-13)\n",
      "conj:and(proteinuria-7, function-13)\n",
      "advmod(occurs-15, when-14)\n",
      "advcl(characterized-5, occurs-15)\n",
      "case(decade-19, at-16)\n",
      "det(decade-19, the-17)\n",
      "amod(decade-19, second-third-18)\n",
      "nmod:at(occurs-15, decade-19)\n",
      "nmod:at(occurs-15, azotemia-21)\n",
      "conj:and(decade-19, azotemia-21)\n",
      "cc(decade-19, and-22)\n",
      "amod(disease-25, end-stage-23)\n",
      "amod(disease-25, renal-24)\n",
      "nmod:at(occurs-15, disease-25)\n",
      "conj:and(decade-19, disease-25)\n",
      "case(decade-28, in-26)\n",
      "amod(decade-28, third-fifth-27)\n",
      "nmod:in(occurs-15, decade-28)\n",
      "\n",
      "Parsing [sent. 83 len. 23]: beyond the irreversible glomerular , tubular and vascular damages , the podocytes foot process effacement is the major cause of kidney dysfunction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN beyond)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ irreversible) (NN glomerular))\n",
      "        (, ,)\n",
      "        (NP (JJ tubular))\n",
      "        (CC and)\n",
      "        (NP (NN vascular) (NNS damages))))\n",
      "    (, ,)\n",
      "    (NP (DT the) (JJ podocytes) (NN foot) (NN process) (NN effacement))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ major) (NN cause))\n",
      "        (PP (IN of)\n",
      "          (NP (NN kidney) (NN dysfunction)))))\n",
      "    (. .)))\n",
      "\n",
      "case(glomerular-4, beyond-1)\n",
      "det(glomerular-4, the-2)\n",
      "amod(glomerular-4, irreversible-3)\n",
      "nmod:beyond(cause-19, glomerular-4)\n",
      "conj:and(glomerular-4, tubular-6)\n",
      "nmod:beyond(cause-19, tubular-6)\n",
      "cc(glomerular-4, and-7)\n",
      "compound(damages-9, vascular-8)\n",
      "conj:and(glomerular-4, damages-9)\n",
      "nmod:beyond(cause-19, damages-9)\n",
      "det(effacement-15, the-11)\n",
      "amod(effacement-15, podocytes-12)\n",
      "compound(effacement-15, foot-13)\n",
      "compound(effacement-15, process-14)\n",
      "nsubj(cause-19, effacement-15)\n",
      "cop(cause-19, is-16)\n",
      "det(cause-19, the-17)\n",
      "amod(cause-19, major-18)\n",
      "root(ROOT-0, cause-19)\n",
      "case(dysfunction-22, of-20)\n",
      "compound(dysfunction-22, kidney-21)\n",
      "nmod:of(cause-19, dysfunction-22)\n",
      "\n",
      "Parsing [sent. 84 len. 39]: myocardial damage is usually observed with right and left ventricular hypertrophy , arrhythmias -LRB- due to sinus node and conduction system impairment -RRB- , diastolic dysfunction , congestive heart failure , myocardial ischemia , fibrosis and cardiac death .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ myocardial) (NN damage))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB usually))\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN right)\n",
      "              (CC and)\n",
      "              (JJ left) (NN ventricular) (NN hypertrophy))\n",
      "            (, ,)\n",
      "            (NP (NNS arrhythmias))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (ADJP (JJ due)\n",
      "                (PP (TO to)\n",
      "                  (NP (JJ sinus) (NN node)\n",
      "                    (CC and)\n",
      "                    (NN conduction) (NN system) (NN impairment))))\n",
      "              (-RRB- -RRB-))\n",
      "            (, ,)\n",
      "            (NP (JJ diastolic) (NN dysfunction))\n",
      "            (, ,)\n",
      "            (NP (JJ congestive) (NN heart) (NN failure))\n",
      "            (, ,)\n",
      "            (NP (JJ myocardial) (NN ischemia))\n",
      "            (, ,)\n",
      "            (NP (NN fibrosis))\n",
      "            (CC and)\n",
      "            (NP (JJ cardiac) (NN death))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(damage-2, myocardial-1)\n",
      "nsubjpass(observed-5, damage-2)\n",
      "auxpass(observed-5, is-3)\n",
      "advmod(observed-5, usually-4)\n",
      "root(ROOT-0, observed-5)\n",
      "case(hypertrophy-11, with-6)\n",
      "compound(hypertrophy-11, right-7)\n",
      "cc(right-7, and-8)\n",
      "conj:and(right-7, left-9)\n",
      "compound(hypertrophy-11, left-9)\n",
      "compound(hypertrophy-11, ventricular-10)\n",
      "nmod:with(observed-5, hypertrophy-11)\n",
      "nmod:with(observed-5, arrhythmias-13)\n",
      "conj:and(hypertrophy-11, arrhythmias-13)\n",
      "dep(hypertrophy-11, due-15)\n",
      "case(node-18, to-16)\n",
      "amod(node-18, sinus-17)\n",
      "nmod:to(due-15, node-18)\n",
      "cc(node-18, and-19)\n",
      "compound(impairment-22, conduction-20)\n",
      "compound(impairment-22, system-21)\n",
      "nmod:to(due-15, impairment-22)\n",
      "conj:and(node-18, impairment-22)\n",
      "amod(dysfunction-26, diastolic-25)\n",
      "nmod:with(observed-5, dysfunction-26)\n",
      "conj:and(hypertrophy-11, dysfunction-26)\n",
      "amod(failure-30, congestive-28)\n",
      "compound(failure-30, heart-29)\n",
      "nmod:with(observed-5, failure-30)\n",
      "conj:and(hypertrophy-11, failure-30)\n",
      "amod(ischemia-33, myocardial-32)\n",
      "nmod:with(observed-5, ischemia-33)\n",
      "conj:and(hypertrophy-11, ischemia-33)\n",
      "nmod:with(observed-5, fibrosis-35)\n",
      "conj:and(hypertrophy-11, fibrosis-35)\n",
      "cc(hypertrophy-11, and-36)\n",
      "amod(death-38, cardiac-37)\n",
      "nmod:with(observed-5, death-38)\n",
      "conj:and(hypertrophy-11, death-38)\n",
      "\n",
      "Parsing [sent. 85 len. 67]: the enzymatic replacement therapy is essential for the management of fd , as well as the control of renal -LRB- with anti-proteinuric agents such as ACEI - and/or angiotensin ii receptor blockers -RRB- , brain -LRB- coated aspirin , clopidogrel and statins to prevent strokes -RRB- and heart complications -LRB- calcium channel blockers for ischemic cardiomyopathy , warfarin and amiodarone or cardioverter device for arrhythmias -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (JJ enzymatic) (NN replacement) (NN therapy))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ essential)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (DT the) (NN management))\n",
      "              (PP (IN of)\n",
      "                (NP (NN fd))))\n",
      "            (, ,)\n",
      "            (CONJP (RB as) (RB well) (IN as))\n",
      "            (NP\n",
      "              (NP (DT the) (NN control))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ renal))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (PP (IN with)\n",
      "                        (NP\n",
      "                          (NP (JJ anti-proteinuric) (NNS agents))\n",
      "                          (PP (JJ such) (IN as)\n",
      "                            (NP\n",
      "                              (NP (NNP ACEI))\n",
      "                              (: -)\n",
      "                              (NP (JJ and/or) (NN angiotensin) (NN ii) (NN receptor) (NNS blockers))))))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (NN brain))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (VP (VBN coated)\n",
      "                          (NP (NN aspirin) (, ,) (NN clopidogrel)\n",
      "                            (CC and)\n",
      "                            (NNS statins))\n",
      "                          (S\n",
      "                            (VP (TO to)\n",
      "                              (VP (VB prevent)\n",
      "                                (NP (NNS strokes))))))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (CC and)\n",
      "                    (NP (NN heart) (NNS complications)))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "                        (PP (IN for)\n",
      "                          (NP (JJ ischemic) (NN cardiomyopathy) (, ,) (NN warfarin)\n",
      "                            (CC and)\n",
      "                            (NN amiodarone))))\n",
      "                      (CC or)\n",
      "                      (NP\n",
      "                        (NP (NN cardioverter) (NN device))\n",
      "                        (PP (IN for)\n",
      "                          (NP (NNS arrhythmias)))))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(therapy-4, the-1)\n",
      "amod(therapy-4, enzymatic-2)\n",
      "compound(therapy-4, replacement-3)\n",
      "nsubj(essential-6, therapy-4)\n",
      "cop(essential-6, is-5)\n",
      "root(ROOT-0, essential-6)\n",
      "case(management-9, for-7)\n",
      "det(management-9, the-8)\n",
      "nmod:for(essential-6, management-9)\n",
      "case(fd-11, of-10)\n",
      "nmod:of(management-9, fd-11)\n",
      "cc(management-9, as-13)\n",
      "mwe(as-13, well-14)\n",
      "mwe(as-13, as-15)\n",
      "det(control-17, the-16)\n",
      "nmod:for(essential-6, control-17)\n",
      "conj:and(management-9, control-17)\n",
      "case(renal-19, of-18)\n",
      "nmod:of(control-17, renal-19)\n",
      "case(agents-23, with-21)\n",
      "amod(agents-23, anti-proteinuric-22)\n",
      "nmod:with(renal-19, agents-23)\n",
      "case(ACEI-26, such-24)\n",
      "mwe(such-24, as-25)\n",
      "nmod:such_as(agents-23, ACEI-26)\n",
      "amod(blockers-32, and/or-28)\n",
      "compound(blockers-32, angiotensin-29)\n",
      "compound(blockers-32, ii-30)\n",
      "compound(blockers-32, receptor-31)\n",
      "dep(ACEI-26, blockers-32)\n",
      "nmod:of(control-17, brain-35)\n",
      "conj:and(renal-19, brain-35)\n",
      "dep(brain-35, coated-37)\n",
      "dobj(coated-37, aspirin-38)\n",
      "dobj(coated-37, clopidogrel-40)\n",
      "conj:and(aspirin-38, clopidogrel-40)\n",
      "cc(aspirin-38, and-41)\n",
      "dobj(coated-37, statins-42)\n",
      "conj:and(aspirin-38, statins-42)\n",
      "mark(prevent-44, to-43)\n",
      "advcl(coated-37, prevent-44)\n",
      "dobj(prevent-44, strokes-45)\n",
      "cc(renal-19, and-47)\n",
      "compound(complications-49, heart-48)\n",
      "nmod:of(control-17, complications-49)\n",
      "conj:and(renal-19, complications-49)\n",
      "compound(blockers-53, calcium-51)\n",
      "compound(blockers-53, channel-52)\n",
      "dep(renal-19, blockers-53)\n",
      "case(cardiomyopathy-56, for-54)\n",
      "amod(cardiomyopathy-56, ischemic-55)\n",
      "nmod:for(blockers-53, cardiomyopathy-56)\n",
      "nmod:for(blockers-53, warfarin-58)\n",
      "conj:and(cardiomyopathy-56, warfarin-58)\n",
      "cc(cardiomyopathy-56, and-59)\n",
      "nmod:for(blockers-53, amiodarone-60)\n",
      "conj:and(cardiomyopathy-56, amiodarone-60)\n",
      "cc(blockers-53, or-61)\n",
      "compound(device-63, cardioverter-62)\n",
      "dep(renal-19, device-63)\n",
      "conj:or(blockers-53, device-63)\n",
      "case(arrhythmias-65, for-64)\n",
      "nmod:for(device-63, arrhythmias-65)\n",
      "\n",
      "Parsing [sent. 86 len. 24]: nonsteroidal antiinflammatory agents , Î²-lactam antibiotics , non-Î² lactam antibiotics , and ACEI are the most common classes of drugs that cause angioedema .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ nonsteroidal) (NN antiinflammatory) (NNS agents))\n",
      "      (, ,)\n",
      "      (NP (JJ Î²-lactam) (NNS antibiotics))\n",
      "      (, ,)\n",
      "      (NP (JJ non-Î²) (NN lactam) (NNS antibiotics))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NNP ACEI)))\n",
      "    (VP (VBP are)\n",
      "      (NP\n",
      "        (NP (DT the) (RBS most) (JJ common) (NNS classes))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNS drugs))\n",
      "            (SBAR\n",
      "              (WHNP (WDT that))\n",
      "              (S\n",
      "                (VP (VBP cause)\n",
      "                  (NP (NN angioedema)))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(agents-3, nonsteroidal-1)\n",
      "compound(agents-3, antiinflammatory-2)\n",
      "nsubj(classes-18, agents-3)\n",
      "amod(antibiotics-6, Î²-lactam-5)\n",
      "conj:and(agents-3, antibiotics-6)\n",
      "nsubj(classes-18, antibiotics-6)\n",
      "amod(antibiotics-10, non-Î²-8)\n",
      "compound(antibiotics-10, lactam-9)\n",
      "conj:and(agents-3, antibiotics-10)\n",
      "nsubj(classes-18, antibiotics-10)\n",
      "cc(agents-3, and-12)\n",
      "conj:and(agents-3, ACEI-13)\n",
      "nsubj(classes-18, ACEI-13)\n",
      "cop(classes-18, are-14)\n",
      "det(classes-18, the-15)\n",
      "advmod(classes-18, most-16)\n",
      "amod(classes-18, common-17)\n",
      "root(ROOT-0, classes-18)\n",
      "case(drugs-20, of-19)\n",
      "nmod:of(classes-18, drugs-20)\n",
      "nsubj(cause-22, drugs-20)\n",
      "ref(drugs-20, that-21)\n",
      "acl:relcl(drugs-20, cause-22)\n",
      "dobj(cause-22, angioedema-23)\n",
      "\n",
      "Parsing [sent. 87 len. 30]: drug-induced angioedema is known to occur via mechanisms mediated by histamine , bradykinin , or leukotriene , and an understanding of these mechanisms is crucial in guiding therapeutic decisions .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ drug-induced) (NN angioedema))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN known)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB occur)\n",
      "                (PP (IN via)\n",
      "                  (NP\n",
      "                    (NP (NNS mechanisms))\n",
      "                    (VP (VBN mediated)\n",
      "                      (PP (IN by)\n",
      "                        (NP\n",
      "                          (NP (NN histamine))\n",
      "                          (, ,)\n",
      "                          (NP (NN bradykinin))\n",
      "                          (, ,)\n",
      "                          (CC or)\n",
      "                          (NP (NN leukotriene)))))))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT an) (NN understanding))\n",
      "        (PP (IN of)\n",
      "          (NP (DT these) (NNS mechanisms))))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ crucial)\n",
      "          (PP (IN in)\n",
      "            (NP (VBG guiding) (JJ therapeutic) (NNS decisions))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(angioedema-2, drug-induced-1)\n",
      "nsubjpass(known-4, angioedema-2)\n",
      "nsubj:xsubj(occur-6, angioedema-2)\n",
      "auxpass(known-4, is-3)\n",
      "root(ROOT-0, known-4)\n",
      "mark(occur-6, to-5)\n",
      "xcomp(known-4, occur-6)\n",
      "case(mechanisms-8, via-7)\n",
      "nmod:via(occur-6, mechanisms-8)\n",
      "acl(mechanisms-8, mediated-9)\n",
      "case(histamine-11, by-10)\n",
      "nmod:by(mediated-9, histamine-11)\n",
      "nmod:by(mediated-9, bradykinin-13)\n",
      "conj:or(histamine-11, bradykinin-13)\n",
      "cc(histamine-11, or-15)\n",
      "nmod:by(mediated-9, leukotriene-16)\n",
      "conj:or(histamine-11, leukotriene-16)\n",
      "cc(known-4, and-18)\n",
      "det(understanding-20, an-19)\n",
      "nsubj(crucial-25, understanding-20)\n",
      "case(mechanisms-23, of-21)\n",
      "det(mechanisms-23, these-22)\n",
      "nmod:of(understanding-20, mechanisms-23)\n",
      "cop(crucial-25, is-24)\n",
      "conj:and(known-4, crucial-25)\n",
      "case(decisions-29, in-26)\n",
      "amod(decisions-29, guiding-27)\n",
      "amod(decisions-29, therapeutic-28)\n",
      "nmod:in(crucial-25, decisions-29)\n",
      "\n",
      "Parsing [sent. 88 len. 35]: nonallergic angioedema occurs in patients with genetic variants that affect metabolism or synthesis of bradykinin , substance p , prostaglandins , or leukotrienes , or when patients are taking drugs that have synergistic mechanisms .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ nonallergic) (NN angioedema))\n",
      "    (VP (VBZ occurs)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ genetic) (NNS variants)))))\n",
      "      (SBAR\n",
      "        (SBAR\n",
      "          (WHNP (WDT that))\n",
      "          (S\n",
      "            (VP (VBP affect)\n",
      "              (NP\n",
      "                (NP (NN metabolism)\n",
      "                  (CC or)\n",
      "                  (NN synthesis))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NN bradykinin))\n",
      "                    (, ,)\n",
      "                    (NP (NN substance) (NN p))\n",
      "                    (, ,)\n",
      "                    (NP (NNS prostaglandins))\n",
      "                    (, ,)\n",
      "                    (CC or)\n",
      "                    (NP (NNS leukotrienes))))))))\n",
      "        (, ,)\n",
      "        (CC or)\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (NNS patients))\n",
      "            (VP (VBP are)\n",
      "              (VP (VBG taking)\n",
      "                (NP\n",
      "                  (NP (NNS drugs))\n",
      "                  (SBAR\n",
      "                    (WHNP (WDT that))\n",
      "                    (S\n",
      "                      (VP (VBP have)\n",
      "                        (NP (JJ synergistic) (NNS mechanisms))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(angioedema-2, nonallergic-1)\n",
      "nsubj(occurs-3, angioedema-2)\n",
      "root(ROOT-0, occurs-3)\n",
      "case(patients-5, in-4)\n",
      "nmod:in(occurs-3, patients-5)\n",
      "case(variants-8, with-6)\n",
      "amod(variants-8, genetic-7)\n",
      "nmod:with(patients-5, variants-8)\n",
      "nsubj(affect-10, that-9)\n",
      "dep(occurs-3, affect-10)\n",
      "dobj(affect-10, metabolism-11)\n",
      "cc(metabolism-11, or-12)\n",
      "dobj(affect-10, synthesis-13)\n",
      "conj:or(metabolism-11, synthesis-13)\n",
      "case(bradykinin-15, of-14)\n",
      "nmod:of(metabolism-11, bradykinin-15)\n",
      "compound(p-18, substance-17)\n",
      "nmod:of(metabolism-11, p-18)\n",
      "conj:or(bradykinin-15, p-18)\n",
      "nmod:of(metabolism-11, prostaglandins-20)\n",
      "conj:or(bradykinin-15, prostaglandins-20)\n",
      "cc(bradykinin-15, or-22)\n",
      "nmod:of(metabolism-11, leukotrienes-23)\n",
      "conj:or(bradykinin-15, leukotrienes-23)\n",
      "cc(affect-10, or-25)\n",
      "advmod(taking-29, when-26)\n",
      "nsubj(taking-29, patients-27)\n",
      "aux(taking-29, are-28)\n",
      "dep(occurs-3, taking-29)\n",
      "conj:or(affect-10, taking-29)\n",
      "dobj(taking-29, drugs-30)\n",
      "nsubj(have-32, drugs-30)\n",
      "ref(drugs-30, that-31)\n",
      "acl:relcl(drugs-30, have-32)\n",
      "amod(mechanisms-34, synergistic-33)\n",
      "dobj(have-32, mechanisms-34)\n",
      "\n",
      "Parsing [sent. 89 len. 15]: the mainstay in treatment of nonallergic drug-induced angioedema is cessation of the offending agents .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN mainstay))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN treatment))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ nonallergic) (JJ drug-induced) (NN angioedema))))))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (NN cessation))\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ offending) (NNS agents)))))\n",
      "    (. .)))\n",
      "\n",
      "det(mainstay-2, the-1)\n",
      "nsubj(cessation-10, mainstay-2)\n",
      "case(treatment-4, in-3)\n",
      "nmod:in(mainstay-2, treatment-4)\n",
      "case(angioedema-8, of-5)\n",
      "amod(angioedema-8, nonallergic-6)\n",
      "amod(angioedema-8, drug-induced-7)\n",
      "nmod:of(treatment-4, angioedema-8)\n",
      "cop(cessation-10, is-9)\n",
      "root(ROOT-0, cessation-10)\n",
      "case(agents-14, of-11)\n",
      "det(agents-14, the-12)\n",
      "amod(agents-14, offending-13)\n",
      "nmod:of(cessation-10, agents-14)\n",
      "\n",
      "Parsing [sent. 90 len. 50]: raas , a major pharmacological target in cardiovascular medicine , is inhibited by pharmacological classes including ACEI -LRB- ACEI -RRB- inhibitors -LRB- aceis -RRB- , angiotensin-ii type 1 blockers -LRB- arbs -RRB- and aldosterone receptors antagonists , in addition to the recently introduced direct renin inhibitors -LRB- dris -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS raas))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ major) (JJ pharmacological) (NN target))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ cardiovascular) (NN medicine))))\n",
      "      (, ,))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP (JJ inhibited)\n",
      "            (PP (IN by)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (JJ pharmacological) (NNS classes))\n",
      "                  (PP (VBG including)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (NNP ACEI)\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP ACEI))\n",
      "                            (-RRB- -RRB-))\n",
      "                          (NNP inhibitors))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NNS aceis))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (, ,)\n",
      "                      (NP\n",
      "                        (NP (JJ angiotensin-ii) (NN type) (CD 1) (NNS blockers))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NNS arbs))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (CC and)\n",
      "                      (NP (JJ aldosterone) (NNS receptors) (NNS antagonists))\n",
      "                      (, ,))))\n",
      "                (CONJP (IN in) (NN addition) (TO to))\n",
      "                (NP (DT the)\n",
      "                  (ADJP (RB recently) (VBN introduced))\n",
      "                  (JJ direct) (NN renin)))))\n",
      "          (NNS inhibitors))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNS dris))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(inhibitors-46, raas-1)\n",
      "det(target-6, a-3)\n",
      "amod(target-6, major-4)\n",
      "amod(target-6, pharmacological-5)\n",
      "appos(raas-1, target-6)\n",
      "case(medicine-9, in-7)\n",
      "amod(medicine-9, cardiovascular-8)\n",
      "nmod:in(target-6, medicine-9)\n",
      "cop(inhibitors-46, is-11)\n",
      "amod(inhibitors-46, inhibited-12)\n",
      "case(classes-15, by-13)\n",
      "amod(classes-15, pharmacological-14)\n",
      "nmod:by(inhibited-12, classes-15)\n",
      "case(inhibitors-21, including-16)\n",
      "compound(inhibitors-21, ACEI-17)\n",
      "appos(inhibitors-21, ACEI-19)\n",
      "nmod:including(classes-15, inhibitors-21)\n",
      "appos(inhibitors-21, aceis-23)\n",
      "amod(blockers-29, angiotensin-ii-26)\n",
      "compound(blockers-29, type-27)\n",
      "nummod(blockers-29, 1-28)\n",
      "nmod:including(classes-15, blockers-29)\n",
      "conj:and(inhibitors-21, blockers-29)\n",
      "appos(blockers-29, arbs-31)\n",
      "cc(inhibitors-21, and-33)\n",
      "amod(antagonists-36, aldosterone-34)\n",
      "compound(antagonists-36, receptors-35)\n",
      "nmod:including(classes-15, antagonists-36)\n",
      "conj:and(inhibitors-21, antagonists-36)\n",
      "cc(classes-15, in-38)\n",
      "dep(in-38, addition-39)\n",
      "dep(in-38, to-40)\n",
      "det(renin-45, the-41)\n",
      "advmod(introduced-43, recently-42)\n",
      "amod(renin-45, introduced-43)\n",
      "amod(renin-45, direct-44)\n",
      "nmod:by(inhibited-12, renin-45)\n",
      "conj:in(classes-15, renin-45)\n",
      "root(ROOT-0, inhibitors-46)\n",
      "appos(inhibitors-46, dris-48)\n",
      "\n",
      "Parsing [sent. 91 len. 36]: however , currently used raas inhibitors still can not achieve their desired effects and are associated with certain drawbacks , such as adverse side effects , incomplete blockage of the system and poor end-organ protection .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (ADVP (RB currently))\n",
      "    (VP (VBD used)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP (NNS raas) (NNS inhibitors))\n",
      "          (ADVP (RB still))\n",
      "          (VP\n",
      "            (VP (MD can) (RB not)\n",
      "              (VP (VB achieve)\n",
      "                (NP (PRP$ their) (VBN desired) (NNS effects))))\n",
      "            (CC and)\n",
      "            (VP (VBP are)\n",
      "              (VP (VBN associated)\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP (JJ certain) (NNS drawbacks))\n",
      "                    (, ,)\n",
      "                    (PP (JJ such) (IN as)\n",
      "                      (NP (JJ adverse) (NN side) (NNS effects)))\n",
      "                    (, ,)\n",
      "                    (ADJP (JJ incomplete) (JJ blockage))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN system))\n",
      "                        (CC and)\n",
      "                        (NP (JJ poor) (JJ end-organ) (NN protection))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(used-4, however-1)\n",
      "advmod(used-4, currently-3)\n",
      "root(ROOT-0, used-4)\n",
      "compound(inhibitors-6, raas-5)\n",
      "nsubj(achieve-10, inhibitors-6)\n",
      "nsubjpass(associated-16, inhibitors-6)\n",
      "advmod(achieve-10, still-7)\n",
      "aux(achieve-10, can-8)\n",
      "neg(achieve-10, not-9)\n",
      "ccomp(used-4, achieve-10)\n",
      "nmod:poss(effects-13, their-11)\n",
      "amod(effects-13, desired-12)\n",
      "dobj(achieve-10, effects-13)\n",
      "cc(achieve-10, and-14)\n",
      "auxpass(associated-16, are-15)\n",
      "ccomp(used-4, associated-16)\n",
      "conj:and(achieve-10, associated-16)\n",
      "case(drawbacks-19, with-17)\n",
      "amod(drawbacks-19, certain-18)\n",
      "nmod:with(associated-16, drawbacks-19)\n",
      "case(effects-25, such-21)\n",
      "mwe(such-21, as-22)\n",
      "amod(effects-25, adverse-23)\n",
      "compound(effects-25, side-24)\n",
      "nmod:such_as(drawbacks-19, effects-25)\n",
      "amod(blockage-28, incomplete-27)\n",
      "amod(drawbacks-19, blockage-28)\n",
      "case(system-31, of-29)\n",
      "det(system-31, the-30)\n",
      "nmod:of(drawbacks-19, system-31)\n",
      "cc(system-31, and-32)\n",
      "amod(protection-35, poor-33)\n",
      "amod(protection-35, end-organ-34)\n",
      "nmod:of(drawbacks-19, protection-35)\n",
      "conj:and(system-31, protection-35)\n",
      "\n",
      "Parsing [sent. 92 len. 42]: in this review , we discuss the efficiency and specificity of the current raas inhibitors and propose some recommendations for achieving better treatments with better end-organ protection.hypertension research advance online publication , 6 july 2017 ; doi :10.1038 / hr .2017.65 .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (DT this) (NN review)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP\n",
      "      (VP (VB discuss)\n",
      "        (NP\n",
      "          (NP (DT the) (NN efficiency)\n",
      "            (CC and)\n",
      "            (NN specificity))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (JJ current) (NNS raas) (NNS inhibitors)))))\n",
      "      (CC and)\n",
      "      (VP (VB propose)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT some) (NNS recommendations))\n",
      "            (PP (IN for)\n",
      "              (S\n",
      "                (VP (VBG achieving)\n",
      "                  (NP (JJR better) (NNS treatments))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJR better) (JJ end-organ) (NN protection.hypertension) (NN research) (NN advance) (JJ online) (NNS publication)))))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (CD 6))\n",
      "            (NP (NNP july) (CD 2017)))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (QP (CD doi) (CD :10.1038))\n",
      "            (NNS /))\n",
      "          (NP (NN hr) (CD .2017.65)))))\n",
      "    (. .)))\n",
      "\n",
      "case(review-3, in-1)\n",
      "det(review-3, this-2)\n",
      "nmod:in(discuss-6, review-3)\n",
      "nsubj(discuss-6, we-5)\n",
      "nsubj(propose-17, we-5)\n",
      "root(ROOT-0, discuss-6)\n",
      "det(efficiency-8, the-7)\n",
      "dobj(discuss-6, efficiency-8)\n",
      "cc(efficiency-8, and-9)\n",
      "dobj(discuss-6, specificity-10)\n",
      "conj:and(efficiency-8, specificity-10)\n",
      "case(inhibitors-15, of-11)\n",
      "det(inhibitors-15, the-12)\n",
      "amod(inhibitors-15, current-13)\n",
      "compound(inhibitors-15, raas-14)\n",
      "nmod:of(efficiency-8, inhibitors-15)\n",
      "cc(discuss-6, and-16)\n",
      "conj:and(discuss-6, propose-17)\n",
      "det(recommendations-19, some-18)\n",
      "dobj(propose-17, recommendations-19)\n",
      "mark(achieving-21, for-20)\n",
      "acl(recommendations-19, achieving-21)\n",
      "amod(treatments-23, better-22)\n",
      "dobj(achieving-21, treatments-23)\n",
      "case(publication-31, with-24)\n",
      "amod(publication-31, better-25)\n",
      "amod(publication-31, end-organ-26)\n",
      "compound(publication-31, protection.hypertension-27)\n",
      "compound(publication-31, research-28)\n",
      "compound(publication-31, advance-29)\n",
      "amod(publication-31, online-30)\n",
      "nmod:with(achieving-21, publication-31)\n",
      "appos(recommendations-19, 6-33)\n",
      "dep(6-33, july-34)\n",
      "nummod(july-34, 2017-35)\n",
      "compound(:10.1038-38, doi-37)\n",
      "nummod(/-39, :10.1038-38)\n",
      "dep(recommendations-19, /-39)\n",
      "dep(recommendations-19, hr-40)\n",
      "nummod(hr-40, .2017.65-41)\n",
      "\n",
      "Parsing [sent. 93 len. 25]: the progression of chronic kidney disease ckd is largely independent of the underlying kidney disorder once renal function has fallen below a critical level .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN progression))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ chronic) (NN kidney) (NN disease) (NN ckd))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (RB largely) (JJ independent)\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ underlying) (NN kidney) (NN disorder))))\n",
      "      (SBAR (IN once)\n",
      "        (S\n",
      "          (NP (JJ renal) (NN function))\n",
      "          (VP (VBZ has)\n",
      "            (VP (VBN fallen)\n",
      "              (PP (IN below)\n",
      "                (NP (DT a) (JJ critical) (NN level))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(progression-2, the-1)\n",
      "nsubj(independent-10, progression-2)\n",
      "case(ckd-7, of-3)\n",
      "amod(ckd-7, chronic-4)\n",
      "compound(ckd-7, kidney-5)\n",
      "compound(ckd-7, disease-6)\n",
      "nmod:of(progression-2, ckd-7)\n",
      "cop(independent-10, is-8)\n",
      "advmod(independent-10, largely-9)\n",
      "root(ROOT-0, independent-10)\n",
      "case(disorder-15, of-11)\n",
      "det(disorder-15, the-12)\n",
      "amod(disorder-15, underlying-13)\n",
      "compound(disorder-15, kidney-14)\n",
      "nmod:of(independent-10, disorder-15)\n",
      "mark(fallen-20, once-16)\n",
      "amod(function-18, renal-17)\n",
      "nsubj(fallen-20, function-18)\n",
      "aux(fallen-20, has-19)\n",
      "advcl(independent-10, fallen-20)\n",
      "case(level-24, below-21)\n",
      "det(level-24, a-22)\n",
      "amod(level-24, critical-23)\n",
      "nmod:below(fallen-20, level-24)\n",
      "\n",
      "Parsing [sent. 94 len. 19]: hypertension is an independent risk factor for disease progression in both adult and pediatric patients with kidney disorders .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN hypertension))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an) (JJ independent) (NN risk) (NN factor))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN disease) (NN progression))\n",
      "              (PP (IN in)\n",
      "                (NP (DT both) (NN adult))))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (JJ pediatric) (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (NN kidney) (NNS disorders))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(factor-6, hypertension-1)\n",
      "cop(factor-6, is-2)\n",
      "det(factor-6, an-3)\n",
      "amod(factor-6, independent-4)\n",
      "compound(factor-6, risk-5)\n",
      "root(ROOT-0, factor-6)\n",
      "case(progression-9, for-7)\n",
      "compound(progression-9, disease-8)\n",
      "nmod:for(factor-6, progression-9)\n",
      "case(adult-12, in-10)\n",
      "det(adult-12, both-11)\n",
      "nmod:in(progression-9, adult-12)\n",
      "cc(progression-9, and-13)\n",
      "amod(patients-15, pediatric-14)\n",
      "nmod:for(factor-6, patients-15)\n",
      "conj:and(progression-9, patients-15)\n",
      "case(disorders-18, with-16)\n",
      "compound(disorders-18, kidney-17)\n",
      "nmod:with(patients-15, disorders-18)\n",
      "\n",
      "Parsing [sent. 95 len. 33]: optimal blood pressure control -LRB- 130 / 80mm hg -RRB- represents a main goal of conservative therapy in patients with chronic kidney disease ckd but it is rarely achieved in clinical practice .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (JJ optimal) (NN blood) (NN pressure) (NN control))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (QP (CD 130) (CD /))\n",
      "            (NN 80mm) (NN hg))\n",
      "          (-RRB- -RRB-)))\n",
      "      (VP (VBZ represents)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ main) (NN goal))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ conservative) (NN therapy))))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (JJ chronic) (NN kidney) (NN disease) (NN ckd)))))))\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBZ is)\n",
      "        (ADVP (RB rarely))\n",
      "        (VP (VBN achieved)\n",
      "          (PP (IN in)\n",
      "            (NP (JJ clinical) (NN practice))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(control-4, optimal-1)\n",
      "compound(control-4, blood-2)\n",
      "compound(control-4, pressure-3)\n",
      "nsubj(represents-11, control-4)\n",
      "compound(/-7, 130-6)\n",
      "nummod(hg-9, /-7)\n",
      "compound(hg-9, 80mm-8)\n",
      "appos(control-4, hg-9)\n",
      "root(ROOT-0, represents-11)\n",
      "det(goal-14, a-12)\n",
      "amod(goal-14, main-13)\n",
      "dobj(represents-11, goal-14)\n",
      "case(therapy-17, of-15)\n",
      "amod(therapy-17, conservative-16)\n",
      "nmod:of(goal-14, therapy-17)\n",
      "case(patients-19, in-18)\n",
      "nmod:in(represents-11, patients-19)\n",
      "case(ckd-24, with-20)\n",
      "amod(ckd-24, chronic-21)\n",
      "compound(ckd-24, kidney-22)\n",
      "compound(ckd-24, disease-23)\n",
      "nmod:with(patients-19, ckd-24)\n",
      "cc(represents-11, but-25)\n",
      "nsubjpass(achieved-29, it-26)\n",
      "auxpass(achieved-29, is-27)\n",
      "advmod(achieved-29, rarely-28)\n",
      "conj:but(represents-11, achieved-29)\n",
      "case(practice-32, in-30)\n",
      "amod(practice-32, clinical-31)\n",
      "nmod:in(achieved-29, practice-32)\n",
      "\n",
      "Parsing [sent. 96 len. 18]: ACEI and angiotensin receptor blockers are more effective than other drugs in slowing progression of proteinuric ckd .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI)\n",
      "      (CC and)\n",
      "      (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "    (VP (VBP are)\n",
      "      (ADJP (RBR more) (JJ effective)\n",
      "        (PP (IN than)\n",
      "          (NP\n",
      "            (NP (JJ other) (NNS drugs))\n",
      "            (PP (IN in)\n",
      "              (NP\n",
      "                (NP (VBG slowing) (NN progression))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ proteinuric) (NN ckd)))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(blockers-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, angiotensin-3)\n",
      "compound(blockers-5, angiotensin-3)\n",
      "compound(blockers-5, receptor-4)\n",
      "nsubj(effective-8, blockers-5)\n",
      "cop(effective-8, are-6)\n",
      "advmod(effective-8, more-7)\n",
      "root(ROOT-0, effective-8)\n",
      "case(drugs-11, than-9)\n",
      "amod(drugs-11, other-10)\n",
      "nmod:than(effective-8, drugs-11)\n",
      "case(progression-14, in-12)\n",
      "amod(progression-14, slowing-13)\n",
      "nmod:in(drugs-11, progression-14)\n",
      "case(ckd-17, of-15)\n",
      "amod(ckd-17, proteinuric-16)\n",
      "nmod:of(progression-14, ckd-17)\n",
      "\n",
      "Parsing [sent. 97 len. 20]: dietary salt restriction -LRB- â¤ 100 meq/die of nacl -RRB- may be useful to correct the extracellular volume expansion .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ dietary) (NN salt) (NN restriction))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP\n",
      "            (QP (CD â¤) (CD 100))\n",
      "            (NN meq/die))\n",
      "          (PP (IN of)\n",
      "            (NP (NN nacl))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ useful)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB correct)\n",
      "                (NP (DT the) (NN extracellular) (NN volume) (NN expansion))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(restriction-3, dietary-1)\n",
      "compound(restriction-3, salt-2)\n",
      "nsubj(useful-13, restriction-3)\n",
      "nsubj:xsubj(correct-15, restriction-3)\n",
      "compound(100-6, â¤-5)\n",
      "nummod(meq/die-7, 100-6)\n",
      "dep(restriction-3, meq/die-7)\n",
      "case(nacl-9, of-8)\n",
      "nmod:of(meq/die-7, nacl-9)\n",
      "aux(useful-13, may-11)\n",
      "cop(useful-13, be-12)\n",
      "root(ROOT-0, useful-13)\n",
      "mark(correct-15, to-14)\n",
      "xcomp(useful-13, correct-15)\n",
      "det(expansion-19, the-16)\n",
      "compound(expansion-19, extracellular-17)\n",
      "compound(expansion-19, volume-18)\n",
      "dobj(correct-15, expansion-19)\n",
      "\n",
      "Parsing [sent. 98 len. 33]: if this intervention fails , hypertension can be treated by thiazide diuretics in patients with mild ckd , whereas loop diuretics at adequate doses are indicated in patients with more advanced ckd .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN if)\n",
      "      (S\n",
      "        (NP (DT this) (NN intervention))\n",
      "        (VP (VBZ fails))))\n",
      "    (, ,)\n",
      "    (NP (NN hypertension))\n",
      "    (VP (MD can)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN treated)\n",
      "          (PP (IN by)\n",
      "            (NP (JJ thiazide) (NNS diuretics)))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ mild) (NN ckd)))))\n",
      "          (, ,)\n",
      "          (SBAR (IN whereas)\n",
      "            (S\n",
      "              (NP\n",
      "                (NP (NN loop) (NNS diuretics))\n",
      "                (PP (IN at)\n",
      "                  (NP (JJ adequate) (NNS doses))))\n",
      "              (VP (VBP are)\n",
      "                (VP (VBN indicated)\n",
      "                  (PP (IN in)\n",
      "                    (NP\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP\n",
      "                          (ADJP (RBR more) (JJ advanced))\n",
      "                          (NN ckd))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(fails-4, if-1)\n",
      "det(intervention-3, this-2)\n",
      "nsubj(fails-4, intervention-3)\n",
      "advcl(treated-9, fails-4)\n",
      "nsubjpass(treated-9, hypertension-6)\n",
      "aux(treated-9, can-7)\n",
      "auxpass(treated-9, be-8)\n",
      "root(ROOT-0, treated-9)\n",
      "case(diuretics-12, by-10)\n",
      "amod(diuretics-12, thiazide-11)\n",
      "nmod:by(treated-9, diuretics-12)\n",
      "case(patients-14, in-13)\n",
      "nmod:in(treated-9, patients-14)\n",
      "case(ckd-17, with-15)\n",
      "amod(ckd-17, mild-16)\n",
      "nmod:with(patients-14, ckd-17)\n",
      "mark(indicated-26, whereas-19)\n",
      "compound(diuretics-21, loop-20)\n",
      "nsubjpass(indicated-26, diuretics-21)\n",
      "case(doses-24, at-22)\n",
      "amod(doses-24, adequate-23)\n",
      "nmod:at(diuretics-21, doses-24)\n",
      "auxpass(indicated-26, are-25)\n",
      "advcl(treated-9, indicated-26)\n",
      "case(patients-28, in-27)\n",
      "nmod:in(indicated-26, patients-28)\n",
      "case(ckd-32, with-29)\n",
      "advmod(advanced-31, more-30)\n",
      "amod(ckd-32, advanced-31)\n",
      "nmod:with(patients-28, ckd-32)\n",
      "\n",
      "Parsing [sent. 99 len. 49]: the beneficial effects of ACEI -LRB- ACEI -RRB- inhibitors and angiotensin ii -LRB- aii -RRB- receptor antagonists in patients with heart failure secondary to reduced ejection fraction -LRB- hfref -RRB- are felt to result from prevention of the adverse effects of aii on systemic afterload and renal homeostasis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "        (PP (IN of)\n",
      "          (NP (NNP ACEI)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP ACEI))\n",
      "              (-RRB- -RRB-))\n",
      "            (NN inhibitors))))\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP\n",
      "            (QP (CD angiotensin) (CD ii)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN aii))\n",
      "            (-RRB- -RRB-))\n",
      "          (NN receptor) (NNS antagonists))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NN heart) (NN failure))\n",
      "                  (ADJP (JJ secondary)\n",
      "                    (PP (TO to)\n",
      "                      (NP (JJ reduced) (NN ejection) (NN fraction)))))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN hfref))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN felt)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB result)\n",
      "              (PP (IN from)\n",
      "                (NP\n",
      "                  (NP (NN prevention))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (DT the) (JJ adverse) (NNS effects))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NN aii)))))))\n",
      "              (PP (IN on)\n",
      "                (NP (JJ systemic) (JJ afterload)\n",
      "                  (CC and)\n",
      "                  (JJ renal) (NNS homeostasis))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(effects-3, the-1)\n",
      "amod(effects-3, beneficial-2)\n",
      "nsubjpass(felt-32, effects-3)\n",
      "nsubj:xsubj(result-34, effects-3)\n",
      "case(inhibitors-9, of-4)\n",
      "compound(inhibitors-9, ACEI-5)\n",
      "appos(inhibitors-9, ACEI-7)\n",
      "nmod:of(effects-3, inhibitors-9)\n",
      "cc(effects-3, and-10)\n",
      "compound(ii-12, angiotensin-11)\n",
      "nummod(antagonists-17, ii-12)\n",
      "appos(antagonists-17, aii-14)\n",
      "compound(antagonists-17, receptor-16)\n",
      "conj:and(effects-3, antagonists-17)\n",
      "nsubjpass(felt-32, antagonists-17)\n",
      "nsubj:xsubj(result-34, antagonists-17)\n",
      "case(patients-19, in-18)\n",
      "nmod:in(antagonists-17, patients-19)\n",
      "case(failure-22, with-20)\n",
      "compound(failure-22, heart-21)\n",
      "nmod:with(patients-19, failure-22)\n",
      "amod(failure-22, secondary-23)\n",
      "case(fraction-27, to-24)\n",
      "amod(fraction-27, reduced-25)\n",
      "compound(fraction-27, ejection-26)\n",
      "nmod:to(secondary-23, fraction-27)\n",
      "appos(failure-22, hfref-29)\n",
      "auxpass(felt-32, are-31)\n",
      "root(ROOT-0, felt-32)\n",
      "mark(result-34, to-33)\n",
      "xcomp(felt-32, result-34)\n",
      "case(prevention-36, from-35)\n",
      "nmod:from(result-34, prevention-36)\n",
      "case(effects-40, of-37)\n",
      "det(effects-40, the-38)\n",
      "amod(effects-40, adverse-39)\n",
      "nmod:of(prevention-36, effects-40)\n",
      "case(aii-42, of-41)\n",
      "nmod:of(effects-40, aii-42)\n",
      "case(afterload-45, on-43)\n",
      "amod(afterload-45, systemic-44)\n",
      "nmod:on(result-34, afterload-45)\n",
      "cc(afterload-45, and-46)\n",
      "amod(homeostasis-48, renal-47)\n",
      "nmod:on(result-34, homeostasis-48)\n",
      "conj:and(afterload-45, homeostasis-48)\n",
      "\n",
      "Parsing [sent. 100 len. 30]: however , aii can activate the sympathetic nervous system and part of the beneficial effects of ACEI and aii antagonists may result from their ability to inhibit such activation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN aii))\n",
      "      (VP (MD can)\n",
      "        (VP (VB activate)\n",
      "          (NP\n",
      "            (NP (DT the)\n",
      "              (ADJP (JJ sympathetic) (JJ nervous))\n",
      "              (NN system))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (NN part))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NNP ACEI))))))))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN aii) (NNS antagonists))\n",
      "      (VP (MD may)\n",
      "        (VP (VB result)\n",
      "          (PP (IN from)\n",
      "            (NP (PRP$ their) (NN ability)\n",
      "              (S\n",
      "                (VP (TO to)\n",
      "                  (VP (VB inhibit)\n",
      "                    (NP (JJ such) (NN activation))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(activate-5, however-1)\n",
      "nsubj(activate-5, aii-3)\n",
      "aux(activate-5, can-4)\n",
      "root(ROOT-0, activate-5)\n",
      "det(system-9, the-6)\n",
      "amod(nervous-8, sympathetic-7)\n",
      "amod(system-9, nervous-8)\n",
      "dobj(activate-5, system-9)\n",
      "cc(system-9, and-10)\n",
      "dobj(activate-5, part-11)\n",
      "conj:and(system-9, part-11)\n",
      "case(effects-15, of-12)\n",
      "det(effects-15, the-13)\n",
      "amod(effects-15, beneficial-14)\n",
      "nmod:of(part-11, effects-15)\n",
      "case(ACEI-17, of-16)\n",
      "nmod:of(effects-15, ACEI-17)\n",
      "cc(activate-5, and-18)\n",
      "compound(antagonists-20, aii-19)\n",
      "nsubj(result-22, antagonists-20)\n",
      "aux(result-22, may-21)\n",
      "conj:and(activate-5, result-22)\n",
      "case(ability-25, from-23)\n",
      "nmod:poss(ability-25, their-24)\n",
      "nmod:from(result-22, ability-25)\n",
      "mark(inhibit-27, to-26)\n",
      "acl(ability-25, inhibit-27)\n",
      "amod(activation-29, such-28)\n",
      "dobj(inhibit-27, activation-29)\n",
      "\n",
      "Parsing [sent. 101 len. 48]: we examined the acute effects of the ACEI captopril -LRB- 25 mg , n = 9 -RRB- and the aii receptor antagonist losartan -LRB- 50 mg , n = 10 -RRB- on hemodynamics as well as total body and cardiac norepinephrine spillover in patients with chronic hfref .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD examined)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ acute) (NNS effects))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT the) (NNP ACEI) (NN captopril))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 25) (NN mg))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (SBAR\n",
      "                    (S\n",
      "                      (VP (SYM =)\n",
      "                        (NP (CD 9)))))))\n",
      "              (-RRB- -RRB-))\n",
      "            (CC and)\n",
      "            (NP (DT the) (JJ aii) (NN receptor) (NN antagonist) (NN losartan))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 50) (NN mg))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (SBAR\n",
      "                    (S\n",
      "                      (VP (SYM =)\n",
      "                        (NP (CD 10)))))))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (NNS hemodynamics))\n",
      "          (CONJP (RB as) (RB well) (IN as))\n",
      "          (NP (JJ total) (NN body)\n",
      "            (CC and)\n",
      "            (JJ cardiac) (NN norepinephrine) (NN spillover))))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ chronic) (NN hfref))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(examined-2, we-1)\n",
      "root(ROOT-0, examined-2)\n",
      "det(effects-5, the-3)\n",
      "amod(effects-5, acute-4)\n",
      "dobj(examined-2, effects-5)\n",
      "case(captopril-9, of-6)\n",
      "det(captopril-9, the-7)\n",
      "compound(captopril-9, ACEI-8)\n",
      "nmod:of(effects-5, captopril-9)\n",
      "nummod(mg-12, 25-11)\n",
      "dep(captopril-9, mg-12)\n",
      "appos(mg-12, n-14)\n",
      "dep(9-16, =-15)\n",
      "acl:relcl(n-14, 9-16)\n",
      "cc(captopril-9, and-18)\n",
      "det(losartan-23, the-19)\n",
      "amod(losartan-23, aii-20)\n",
      "compound(losartan-23, receptor-21)\n",
      "compound(losartan-23, antagonist-22)\n",
      "nmod:of(effects-5, losartan-23)\n",
      "conj:and(captopril-9, losartan-23)\n",
      "nummod(mg-26, 50-25)\n",
      "dep(captopril-9, mg-26)\n",
      "appos(mg-26, n-28)\n",
      "dep(10-30, =-29)\n",
      "acl:relcl(n-28, 10-30)\n",
      "case(hemodynamics-33, on-32)\n",
      "nmod:on(examined-2, hemodynamics-33)\n",
      "cc(hemodynamics-33, as-34)\n",
      "mwe(as-34, well-35)\n",
      "mwe(as-34, as-36)\n",
      "amod(body-38, total-37)\n",
      "nmod:on(examined-2, body-38)\n",
      "conj:and(hemodynamics-33, body-38)\n",
      "cc(body-38, and-39)\n",
      "amod(spillover-42, cardiac-40)\n",
      "compound(spillover-42, norepinephrine-41)\n",
      "conj:and(hemodynamics-33, spillover-42)\n",
      "conj:and(body-38, spillover-42)\n",
      "case(patients-44, in-43)\n",
      "nmod:in(examined-2, patients-44)\n",
      "case(hfref-47, with-45)\n",
      "amod(hfref-47, chronic-46)\n",
      "nmod:with(patients-44, hfref-47)\n",
      "\n",
      "Parsing [sent. 102 len. 20]: hemodynamic and neurochemical measurements were made at baseline and at 1 , 2 and 4 hours after oral dosing .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (JJ hemodynamic)\n",
      "        (CC and)\n",
      "        (JJ neurochemical))\n",
      "      (NNS measurements))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN made)\n",
      "        (PP\n",
      "          (PP (IN at)\n",
      "            (NP (NN baseline)))\n",
      "          (CC and)\n",
      "          (PP (IN at)\n",
      "            (NP (CD 1) (, ,) (CD 2)\n",
      "              (CC and)\n",
      "              (CD 4)))\n",
      "          (NP (NNS hours)))\n",
      "        (PP (IN after)\n",
      "          (NP (JJ oral) (NN dosing)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(measurements-4, hemodynamic-1)\n",
      "cc(hemodynamic-1, and-2)\n",
      "conj:and(hemodynamic-1, neurochemical-3)\n",
      "amod(measurements-4, neurochemical-3)\n",
      "nsubjpass(made-6, measurements-4)\n",
      "auxpass(made-6, were-5)\n",
      "root(ROOT-0, made-6)\n",
      "case(baseline-8, at-7)\n",
      "nmod:at(hours-16, baseline-8)\n",
      "cc(hours-16, and-9)\n",
      "case(1-11, at-10)\n",
      "nmod(made-6, 1-11)\n",
      "conj:and(hours-16, 1-11)\n",
      "nummod(1-11, 2-13)\n",
      "cc(1-11, and-14)\n",
      "conj:and(1-11, 4-15)\n",
      "conj:and(hours-16, 4-15)\n",
      "nmod(made-6, hours-16)\n",
      "case(dosing-19, after-17)\n",
      "amod(dosing-19, oral-18)\n",
      "nmod:after(made-6, dosing-19)\n",
      "\n",
      "Parsing [sent. 103 len. 25]: administration of both drugs caused significant reductions in systemic arterial , cardiac filling and pulmonary artery pressures -LRB- p < 0.05 vs baseline -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN administration))\n",
      "      (PP (IN of)\n",
      "        (NP (DT both) (NNS drugs))))\n",
      "    (VP (VBD caused)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (JJ significant) (NNS reductions))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ systemic) (NN arterial))))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (JJ cardiac) (NN filling))\n",
      "          (CC and)\n",
      "          (NP (JJ pulmonary) (NN artery) (NNS pressures)))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN p)\n",
      "            (S\n",
      "              (VP (VBG <)\n",
      "                (NP (CD 0.05) (NN vs) (NN baseline)))))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(caused-5, administration-1)\n",
      "case(drugs-4, of-2)\n",
      "det(drugs-4, both-3)\n",
      "nmod:of(administration-1, drugs-4)\n",
      "root(ROOT-0, caused-5)\n",
      "amod(reductions-7, significant-6)\n",
      "dobj(caused-5, reductions-7)\n",
      "case(arterial-10, in-8)\n",
      "amod(arterial-10, systemic-9)\n",
      "nmod:in(reductions-7, arterial-10)\n",
      "amod(filling-13, cardiac-12)\n",
      "appos(reductions-7, filling-13)\n",
      "cc(filling-13, and-14)\n",
      "amod(pressures-17, pulmonary-15)\n",
      "compound(pressures-17, artery-16)\n",
      "appos(reductions-7, pressures-17)\n",
      "conj:and(filling-13, pressures-17)\n",
      "dep(reductions-7, p-19)\n",
      "xcomp(p-19, <-20)\n",
      "nummod(baseline-23, 0.05-21)\n",
      "compound(baseline-23, vs-22)\n",
      "dobj(<-20, baseline-23)\n",
      "\n",
      "Parsing [sent. 104 len. 13]: there was no significant difference in the magnitude of those hemodynamic effects .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT no) (JJ significant) (NN difference))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN magnitude))\n",
      "            (PP (IN of)\n",
      "              (NP (DT those) (JJ hemodynamic) (NNS effects)))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "neg(difference-5, no-3)\n",
      "amod(difference-5, significant-4)\n",
      "nsubj(was-2, difference-5)\n",
      "case(magnitude-8, in-6)\n",
      "det(magnitude-8, the-7)\n",
      "nmod:in(difference-5, magnitude-8)\n",
      "case(effects-12, of-9)\n",
      "det(effects-12, those-10)\n",
      "amod(effects-12, hemodynamic-11)\n",
      "nmod:of(magnitude-8, effects-12)\n",
      "\n",
      "Parsing [sent. 105 len. 23]: plasma concentrations of aii were significantly decreased by captopril and increased by losartan -LRB- p < 0.05 vs baseline for both -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN plasma) (NNS concentrations))\n",
      "      (PP (IN of)\n",
      "        (NP (NN aii))))\n",
      "    (VP (VBD were)\n",
      "      (ADVP (RB significantly))\n",
      "      (VP\n",
      "        (VP (VBN decreased)\n",
      "          (PP (IN by)\n",
      "            (NP (NN captopril))))\n",
      "        (CC and)\n",
      "        (VP (VBN increased)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (NN losartan))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN p)\n",
      "                  (S\n",
      "                    (VP (VBG <)\n",
      "                      (NP (CD 0.05) (NN vs) (NN baseline))\n",
      "                      (PP (IN for)\n",
      "                        (NP (DT both))))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(concentrations-2, plasma-1)\n",
      "nsubjpass(decreased-7, concentrations-2)\n",
      "nsubjpass(increased-11, concentrations-2)\n",
      "case(aii-4, of-3)\n",
      "nmod:of(concentrations-2, aii-4)\n",
      "auxpass(decreased-7, were-5)\n",
      "advmod(decreased-7, significantly-6)\n",
      "root(ROOT-0, decreased-7)\n",
      "case(captopril-9, by-8)\n",
      "nmod:by(decreased-7, captopril-9)\n",
      "cc(decreased-7, and-10)\n",
      "conj:and(decreased-7, increased-11)\n",
      "case(losartan-13, by-12)\n",
      "nmod:by(increased-11, losartan-13)\n",
      "dep(losartan-13, p-15)\n",
      "xcomp(p-15, <-16)\n",
      "nummod(baseline-19, 0.05-17)\n",
      "compound(baseline-19, vs-18)\n",
      "dobj(<-16, baseline-19)\n",
      "case(both-21, for-20)\n",
      "nmod:for(<-16, both-21)\n",
      "\n",
      "Parsing [sent. 106 len. 37]: total body sympathetic activity increased in response to both captopril and losartan -LRB- p < 0.05 vs baseline for both -RRB- , however there was no change in cardiac sympathetic activity in response to either drug .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ total) (NN body) (JJ sympathetic) (NN activity))\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN in)\n",
      "          (NP (NN response)))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (DT both) (NN captopril)\n",
      "              (CC and)\n",
      "              (NN losartan))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (NN p) (NNS <))\n",
      "                (NP\n",
      "                  (NP (CD 0.05) (NN vs) (NN baseline))\n",
      "                  (PP (IN for)\n",
      "                    (NP (DT both)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (, ,)\n",
      "    (ADVP (RB however))\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT no) (NN change))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (JJ cardiac) (JJ sympathetic) (NN activity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN response))))))\n",
      "      (PP (TO to)\n",
      "        (NP (DT either) (NN drug))))\n",
      "    (. .)))\n",
      "\n",
      "amod(activity-4, total-1)\n",
      "compound(activity-4, body-2)\n",
      "amod(activity-4, sympathetic-3)\n",
      "nsubj(was-25, activity-4)\n",
      "acl(activity-4, increased-5)\n",
      "case(response-7, in-6)\n",
      "nmod:in(increased-5, response-7)\n",
      "case(captopril-10, to-8)\n",
      "cc:preconj(captopril-10, both-9)\n",
      "nmod:to(increased-5, captopril-10)\n",
      "cc(captopril-10, and-11)\n",
      "nmod:to(increased-5, losartan-12)\n",
      "conj:and(captopril-10, losartan-12)\n",
      "compound(<-15, p-14)\n",
      "dep(captopril-10, <-15)\n",
      "nummod(baseline-18, 0.05-16)\n",
      "compound(baseline-18, vs-17)\n",
      "dep(<-15, baseline-18)\n",
      "case(both-20, for-19)\n",
      "nmod:for(baseline-18, both-20)\n",
      "expl(was-25, however-23)\n",
      "dep(however-23, there-24)\n",
      "root(ROOT-0, was-25)\n",
      "neg(change-27, no-26)\n",
      "nsubj(was-25, change-27)\n",
      "case(activity-31, in-28)\n",
      "amod(activity-31, cardiac-29)\n",
      "amod(activity-31, sympathetic-30)\n",
      "nmod:in(change-27, activity-31)\n",
      "case(response-33, in-32)\n",
      "nmod:in(activity-31, response-33)\n",
      "case(drug-36, to-34)\n",
      "det(drug-36, either-35)\n",
      "nmod:to(was-25, drug-36)\n",
      "\n",
      "Parsing [sent. 107 len. 29]: the results of the current study do not support the hypothesis that the acute inhibition of the renin angiotensin system has sympathoinhibitory effects in patients with chronic hfref .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NNS results))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ current) (NN study))))\n",
      "    (VP (VBP do) (RB not)\n",
      "      (VP (VB support)\n",
      "        (NP (DT the) (NNS hypothesis))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (DT the) (JJ acute) (NN inhibition))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN renin) (NN angiotensin) (NN system))))\n",
      "            (VP (VBZ has)\n",
      "              (NP\n",
      "                (NP (JJ sympathoinhibitory) (NNS effects))\n",
      "                (PP (IN in)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ chronic) (NN hfref)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(results-2, the-1)\n",
      "nsubj(support-9, results-2)\n",
      "case(study-6, of-3)\n",
      "det(study-6, the-4)\n",
      "amod(study-6, current-5)\n",
      "nmod:of(results-2, study-6)\n",
      "aux(support-9, do-7)\n",
      "neg(support-9, not-8)\n",
      "root(ROOT-0, support-9)\n",
      "det(hypothesis-11, the-10)\n",
      "dobj(support-9, hypothesis-11)\n",
      "mark(has-21, that-12)\n",
      "det(inhibition-15, the-13)\n",
      "amod(inhibition-15, acute-14)\n",
      "nsubj(has-21, inhibition-15)\n",
      "case(system-20, of-16)\n",
      "det(system-20, the-17)\n",
      "compound(system-20, renin-18)\n",
      "compound(system-20, angiotensin-19)\n",
      "nmod:of(inhibition-15, system-20)\n",
      "ccomp(support-9, has-21)\n",
      "amod(effects-23, sympathoinhibitory-22)\n",
      "dobj(has-21, effects-23)\n",
      "case(patients-25, in-24)\n",
      "nmod:in(effects-23, patients-25)\n",
      "case(hfref-28, with-26)\n",
      "amod(hfref-28, chronic-27)\n",
      "nmod:with(patients-25, hfref-28)\n",
      "\n",
      "Parsing [sent. 108 len. 39]: the improvement of the physical functioning and hrqol in older hypertensive adults using ACEI medications only occur if they adopt an exercise training regimen , increasing also the management of the blood pressure and other cardiovascular risk factors .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN improvement))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ physical) (NN functioning)\n",
      "            (CC and)\n",
      "            (NN hrqol))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (JJR older) (NN hypertensive) (NNS adults))\n",
      "              (VP (VBG using)\n",
      "                (NP (CD ACEI) (NNS medications))))))))\n",
      "    (ADVP (RB only))\n",
      "    (VP (VBP occur)\n",
      "      (SBAR (IN if)\n",
      "        (S\n",
      "          (NP (PRP they))\n",
      "          (VP (VBP adopt)\n",
      "            (NP (DT an) (NN exercise) (NN training) (NN regimen))\n",
      "            (, ,)\n",
      "            (S\n",
      "              (VP (VBG increasing)\n",
      "                (ADVP (RB also))\n",
      "                (NP\n",
      "                  (NP (DT the) (NN management))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN blood) (NN pressure))\n",
      "                      (CC and)\n",
      "                      (NP (JJ other) (JJ cardiovascular) (NN risk) (NNS factors)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(improvement-2, the-1)\n",
      "nsubj(occur-17, improvement-2)\n",
      "case(functioning-6, of-3)\n",
      "det(functioning-6, the-4)\n",
      "amod(functioning-6, physical-5)\n",
      "nmod:of(improvement-2, functioning-6)\n",
      "cc(functioning-6, and-7)\n",
      "nmod:of(improvement-2, hrqol-8)\n",
      "conj:and(functioning-6, hrqol-8)\n",
      "case(adults-12, in-9)\n",
      "amod(adults-12, older-10)\n",
      "compound(adults-12, hypertensive-11)\n",
      "nmod:in(functioning-6, adults-12)\n",
      "acl(adults-12, using-13)\n",
      "nummod(medications-15, ACEI-14)\n",
      "dobj(using-13, medications-15)\n",
      "advmod(occur-17, only-16)\n",
      "root(ROOT-0, occur-17)\n",
      "mark(adopt-20, if-18)\n",
      "nsubj(adopt-20, they-19)\n",
      "advcl(occur-17, adopt-20)\n",
      "det(regimen-24, an-21)\n",
      "compound(regimen-24, exercise-22)\n",
      "compound(regimen-24, training-23)\n",
      "dobj(adopt-20, regimen-24)\n",
      "advcl(adopt-20, increasing-26)\n",
      "advmod(increasing-26, also-27)\n",
      "det(management-29, the-28)\n",
      "dobj(increasing-26, management-29)\n",
      "case(pressure-33, of-30)\n",
      "det(pressure-33, the-31)\n",
      "compound(pressure-33, blood-32)\n",
      "nmod:of(management-29, pressure-33)\n",
      "cc(pressure-33, and-34)\n",
      "amod(factors-38, other-35)\n",
      "amod(factors-38, cardiovascular-36)\n",
      "compound(factors-38, risk-37)\n",
      "nmod:of(management-29, factors-38)\n",
      "conj:and(pressure-33, factors-38)\n",
      "\n",
      "Parsing [sent. 109 len. 15]: agreement in the 20 % sampling between investigators was high -LRB- 96 % -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN agreement))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the)\n",
      "            (ADJP (CD 20) (NN %))\n",
      "            (NN sampling))\n",
      "          (PP (IN between)\n",
      "            (NP (NNS investigators))))))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ high))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 96) (NN %))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(high-10, agreement-1)\n",
      "case(sampling-6, in-2)\n",
      "det(sampling-6, the-3)\n",
      "compound(%-5, 20-4)\n",
      "amod(sampling-6, %-5)\n",
      "nmod:in(agreement-1, sampling-6)\n",
      "case(investigators-8, between-7)\n",
      "nmod:between(sampling-6, investigators-8)\n",
      "cop(high-10, was-9)\n",
      "root(ROOT-0, high-10)\n",
      "nummod(%-13, 96-12)\n",
      "dep(high-10, %-13)\n",
      "\n",
      "Parsing [sent. 110 len. 30]: the mean qtc in the acs group was 457 ms and the mean qtc in the etoh withdrawal-related group was 468 ms -LRB- diff 11 , not significant -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ mean) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (NN acs) (NN group))))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (QP (CD 457) (CD ms)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ mean) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (JJ etoh) (JJ withdrawal-related) (NN group))))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP (CD 468) (NN ms))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (NN diff) (CD 11))\n",
      "              (, ,)\n",
      "              (NP (RB not) (JJ significant)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "det(qtc-3, the-1)\n",
      "amod(qtc-3, mean-2)\n",
      "nsubj(ms-10, qtc-3)\n",
      "case(group-7, in-4)\n",
      "det(group-7, the-5)\n",
      "compound(group-7, acs-6)\n",
      "nmod:in(qtc-3, group-7)\n",
      "cop(ms-10, was-8)\n",
      "compound(ms-10, 457-9)\n",
      "root(ROOT-0, ms-10)\n",
      "cc(ms-10, and-11)\n",
      "det(qtc-14, the-12)\n",
      "amod(qtc-14, mean-13)\n",
      "nsubj(ms-22, qtc-14)\n",
      "case(group-19, in-15)\n",
      "det(group-19, the-16)\n",
      "amod(group-19, etoh-17)\n",
      "amod(group-19, withdrawal-related-18)\n",
      "nmod:in(qtc-14, group-19)\n",
      "cop(ms-22, was-20)\n",
      "nummod(ms-22, 468-21)\n",
      "conj:and(ms-10, ms-22)\n",
      "dep(ms-22, diff-24)\n",
      "nummod(diff-24, 11-25)\n",
      "neg(significant-28, not-27)\n",
      "appos(diff-24, significant-28)\n",
      "\n",
      "Parsing [sent. 111 len. 35]: significantly more patients had a prolonged qtc in the etoh withdrawal group than in the acs group 62 % vs 46 % ; diff 16 ; 95 % ci -LRB- 0.1 , 30 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (RB significantly) (JJR more))\n",
      "      (NNS patients))\n",
      "    (VP (VBD had)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prolonged) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))\n",
      "      (PP (IN than) (IN in)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN acs) (NN group) (CD 62) (NN %) (NN vs))\n",
      "            (ADJP (CD 46) (NN %)))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (NP (NN diff) (CD 16))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP\n",
      "                (ADJP (CD 95) (NN %))\n",
      "                (NN ci))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (CD 0.1))\n",
      "                (, ,)\n",
      "                (NP (CD 30))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(more-2, significantly-1)\n",
      "amod(patients-3, more-2)\n",
      "nsubj(had-4, patients-3)\n",
      "root(ROOT-0, had-4)\n",
      "det(qtc-7, a-5)\n",
      "amod(qtc-7, prolonged-6)\n",
      "dobj(had-4, qtc-7)\n",
      "case(group-12, in-8)\n",
      "det(group-12, the-9)\n",
      "amod(group-12, etoh-10)\n",
      "compound(group-12, withdrawal-11)\n",
      "nmod:in(qtc-7, group-12)\n",
      "case(vs-20, than-13)\n",
      "case(vs-20, in-14)\n",
      "det(vs-20, the-15)\n",
      "compound(vs-20, acs-16)\n",
      "compound(vs-20, group-17)\n",
      "nummod(vs-20, 62-18)\n",
      "compound(vs-20, %-19)\n",
      "nmod:in(had-4, vs-20)\n",
      "compound(%-22, 46-21)\n",
      "amod(vs-20, %-22)\n",
      "dep(vs-20, diff-24)\n",
      "nummod(diff-24, 16-25)\n",
      "compound(%-28, 95-27)\n",
      "amod(ci-29, %-28)\n",
      "dep(diff-24, ci-29)\n",
      "appos(ci-29, 0.1-31)\n",
      "dep(0.1-31, 30-33)\n",
      "\n",
      "Parsing [sent. 112 len. 43]: there was significantly more use of clopidogrel , acetylsalicylic acid , ACEI , and statins -LRB- p < 0.05 for all -RRB- in the acs group compared with the etoh withdrawal group ; however , there was no difference in Î²-blocker usage .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP\n",
      "            (ADJP (RB significantly) (JJR more))\n",
      "            (NN use))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN clopidogrel))\n",
      "              (, ,)\n",
      "              (NP (JJ acetylsalicylic) (NN acid))\n",
      "              (, ,)\n",
      "              (NP (NNP ACEI))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NNS statins))))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05))\n",
      "              (PP (IN for)\n",
      "                (NP (DT all))))\n",
      "            (-RRB- -RRB-)))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN acs) (NN group))\n",
      "            (PP (VBN compared)\n",
      "              (PP (IN with)\n",
      "                (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (ADVP (RB however))\n",
      "      (, ,)\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP (DT no) (NN difference))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ Î²-blocker) (NN usage))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "advmod(more-4, significantly-3)\n",
      "amod(use-5, more-4)\n",
      "nsubj(was-2, use-5)\n",
      "case(clopidogrel-7, of-6)\n",
      "nmod:of(use-5, clopidogrel-7)\n",
      "amod(acid-10, acetylsalicylic-9)\n",
      "nmod:of(use-5, acid-10)\n",
      "conj:and(clopidogrel-7, acid-10)\n",
      "nmod:of(use-5, ACEI-12)\n",
      "conj:and(clopidogrel-7, ACEI-12)\n",
      "cc(clopidogrel-7, and-14)\n",
      "nmod:of(use-5, statins-15)\n",
      "conj:and(clopidogrel-7, statins-15)\n",
      "dep(use-5, p-17)\n",
      "nummod(0.05-19, <-18)\n",
      "dobj(p-17, 0.05-19)\n",
      "case(all-21, for-20)\n",
      "nmod:for(p-17, all-21)\n",
      "case(group-26, in-23)\n",
      "det(group-26, the-24)\n",
      "compound(group-26, acs-25)\n",
      "nmod:in(was-2, group-26)\n",
      "case(group-32, compared-27)\n",
      "mwe(compared-27, with-28)\n",
      "det(group-32, the-29)\n",
      "amod(group-32, etoh-30)\n",
      "compound(group-32, withdrawal-31)\n",
      "nmod:compared_with(group-26, group-32)\n",
      "advmod(was-37, however-34)\n",
      "expl(was-37, there-36)\n",
      "parataxis(was-2, was-37)\n",
      "neg(difference-39, no-38)\n",
      "nsubj(was-37, difference-39)\n",
      "case(usage-42, in-40)\n",
      "amod(usage-42, Î²-blocker-41)\n",
      "nmod:in(difference-39, usage-42)\n",
      "\n",
      "Parsing [sent. 113 len. 36]: there was a significantly higher admission rate : 100 % of acs compared with 76 % of the etoh withdrawal group -LRB- p < 0.01 , diff 24 , 95 % confidence interval 18-29 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP (DT a)\n",
      "          (ADJP (RB significantly) (JJR higher))\n",
      "          (NN admission) (NN rate))))\n",
      "    (: :)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (CD 100) (NN %))\n",
      "        (PP (IN of)\n",
      "          (NP (NN acs))))\n",
      "      (PP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (CD 76) (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NNP p) (NNP <) (NNP 0.01))\n",
      "          (, ,)\n",
      "          (NP (NN diff) (CD 24))\n",
      "          (, ,)\n",
      "          (NP (CD 95) (NN %) (NN confidence) (JJ interval) (NNS 18-29)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "det(rate-7, a-3)\n",
      "advmod(higher-5, significantly-4)\n",
      "amod(rate-7, higher-5)\n",
      "compound(rate-7, admission-6)\n",
      "nsubj(was-2, rate-7)\n",
      "nummod(%-10, 100-9)\n",
      "parataxis(was-2, %-10)\n",
      "case(acs-12, of-11)\n",
      "nmod:of(%-10, acs-12)\n",
      "case(%-16, compared-13)\n",
      "mwe(compared-13, with-14)\n",
      "nummod(%-16, 76-15)\n",
      "advcl(%-10, %-16)\n",
      "case(group-21, of-17)\n",
      "det(group-21, the-18)\n",
      "amod(group-21, etoh-19)\n",
      "compound(group-21, withdrawal-20)\n",
      "nmod:of(%-16, group-21)\n",
      "compound(0.01-25, p-23)\n",
      "compound(0.01-25, <-24)\n",
      "dep(%-10, 0.01-25)\n",
      "appos(0.01-25, diff-27)\n",
      "nummod(diff-27, 24-28)\n",
      "nummod(18-29-34, 95-30)\n",
      "compound(18-29-34, %-31)\n",
      "compound(18-29-34, confidence-32)\n",
      "amod(18-29-34, interval-33)\n",
      "appos(0.01-25, 18-29-34)\n",
      "\n",
      "Parsing [sent. 114 len. 10]: electrolytes were not significantly different in the two groups .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS electrolytes))\n",
      "    (VP (VBD were) (RB not)\n",
      "      (ADJP (RB significantly) (JJ different)\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (CD two) (NNS groups)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(different-5, electrolytes-1)\n",
      "cop(different-5, were-2)\n",
      "neg(different-5, not-3)\n",
      "advmod(different-5, significantly-4)\n",
      "root(ROOT-0, different-5)\n",
      "case(groups-9, in-6)\n",
      "det(groups-9, the-7)\n",
      "nummod(groups-9, two-8)\n",
      "nmod:in(different-5, groups-9)\n",
      "\n",
      "Parsing [sent. 115 len. 22]: the study compared two cohort groups , those with acs and those with etoh withdrawal-related ed visits over a 1-year period .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN study))\n",
      "    (VP (VBD compared)\n",
      "      (NP\n",
      "        (NP (CD two) (JJ cohort) (NNS groups))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP (NN acs))))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ etoh) (JJ withdrawal-related) (NN ed) (NNS visits)))))\n",
      "      (PP (IN over)\n",
      "        (NP (DT a) (JJ 1-year) (NN period))))\n",
      "    (. .)))\n",
      "\n",
      "det(study-2, the-1)\n",
      "nsubj(compared-3, study-2)\n",
      "root(ROOT-0, compared-3)\n",
      "nummod(groups-6, two-4)\n",
      "amod(groups-6, cohort-5)\n",
      "dobj(compared-3, groups-6)\n",
      "dobj(compared-3, those-8)\n",
      "conj:and(groups-6, those-8)\n",
      "case(acs-10, with-9)\n",
      "nmod:with(those-8, acs-10)\n",
      "cc(groups-6, and-11)\n",
      "dobj(compared-3, those-12)\n",
      "conj:and(groups-6, those-12)\n",
      "case(visits-17, with-13)\n",
      "amod(visits-17, etoh-14)\n",
      "amod(visits-17, withdrawal-related-15)\n",
      "compound(visits-17, ed-16)\n",
      "nmod:with(those-12, visits-17)\n",
      "case(period-21, over-18)\n",
      "det(period-21, a-19)\n",
      "amod(period-21, 1-year-20)\n",
      "nmod:over(compared-3, period-21)\n",
      "\n",
      "Parsing [sent. 116 len. 13]: we compared ecg qtc , cardiac medication use , and electrolyte differences .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD compared)\n",
      "      (NP\n",
      "        (NP (NN ecg) (NN qtc))\n",
      "        (, ,)\n",
      "        (NP (JJ cardiac) (NN medication) (NN use))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (JJ electrolyte) (NNS differences))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(compared-2, we-1)\n",
      "root(ROOT-0, compared-2)\n",
      "compound(qtc-4, ecg-3)\n",
      "dobj(compared-2, qtc-4)\n",
      "amod(use-8, cardiac-6)\n",
      "compound(use-8, medication-7)\n",
      "dobj(compared-2, use-8)\n",
      "conj:and(qtc-4, use-8)\n",
      "cc(qtc-4, and-10)\n",
      "amod(differences-12, electrolyte-11)\n",
      "dobj(compared-2, differences-12)\n",
      "conj:and(qtc-4, differences-12)\n",
      "\n",
      "Parsing [sent. 117 len. 23]: we considered a qtc of > 450 ms elevated for men and > 470 ms elevated for women based on the literature .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD considered)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT a) (NN qtc))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (QP (CD >) (CD 450))\n",
      "                (NN ms))))\n",
      "          (VP (VBD elevated)\n",
      "            (SBAR (IN for)\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (NNS men))\n",
      "                  (CC and)\n",
      "                  (NP\n",
      "                    (QP (CD >) (CD 470))\n",
      "                    (NN ms)))\n",
      "                (VP (VBD elevated)\n",
      "                  (PP (IN for)\n",
      "                    (NP (NNS women)))\n",
      "                  (PP (VBN based)\n",
      "                    (PP (IN on)\n",
      "                      (NP (DT the) (NN literature)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(considered-2, we-1)\n",
      "root(ROOT-0, considered-2)\n",
      "det(qtc-4, a-3)\n",
      "nsubj(elevated-9, qtc-4)\n",
      "case(ms-8, of-5)\n",
      "compound(450-7, >-6)\n",
      "nummod(ms-8, 450-7)\n",
      "nmod:of(qtc-4, ms-8)\n",
      "ccomp(considered-2, elevated-9)\n",
      "mark(elevated-16, for-10)\n",
      "nsubj(elevated-16, men-11)\n",
      "cc(men-11, and-12)\n",
      "compound(470-14, >-13)\n",
      "nummod(ms-15, 470-14)\n",
      "conj:and(men-11, ms-15)\n",
      "nsubj(elevated-16, ms-15)\n",
      "advcl(elevated-9, elevated-16)\n",
      "case(women-18, for-17)\n",
      "nmod:for(elevated-16, women-18)\n",
      "case(literature-22, based-19)\n",
      "mwe(based-19, on-20)\n",
      "det(literature-22, the-21)\n",
      "advcl(elevated-16, literature-22)\n",
      "\n",
      "Parsing [sent. 118 len. 43]: fifty subjects in whom an ecg , serum osmolality , and etoh level were recorded within 2 hours of one another and who were administered a clinical institute withdrawal assessment protocol were compared with 203 patients with acs during the same period .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ fifty) (NNS subjects))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (SBAR\n",
      "            (WHNP (WP whom))\n",
      "            (S\n",
      "              (NP\n",
      "                (NP (DT an) (NN ecg))\n",
      "                (, ,)\n",
      "                (NP (NN serum) (NN osmolality))\n",
      "                (, ,)\n",
      "                (CC and)\n",
      "                (NP (JJ etoh) (NN level)))\n",
      "              (VP (VBD were)\n",
      "                (VP (VBN recorded)\n",
      "                  (PP (IN within)\n",
      "                    (NP\n",
      "                      (NP (CD 2) (NNS hours))\n",
      "                      (PP (IN of)\n",
      "                        (NP (CD one) (DT another)))))))))\n",
      "          (CC and)\n",
      "          (SBAR\n",
      "            (WHNP (WP who))\n",
      "            (S\n",
      "              (VP (VBD were)\n",
      "                (VP (VBN administered)\n",
      "                  (NP (DT a) (JJ clinical) (NN institute) (NN withdrawal) (NN assessment) (NN protocol)))))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (CD 203) (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (NN acs)))))\n",
      "        (PP (IN during)\n",
      "          (NP (DT the) (JJ same) (NN period)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(subjects-2, fifty-1)\n",
      "nsubjpass(compared-33, subjects-2)\n",
      "case(recorded-15, in-3)\n",
      "dobj(recorded-15, whom-4)\n",
      "det(ecg-6, an-5)\n",
      "nsubjpass(recorded-15, ecg-6)\n",
      "compound(osmolality-9, serum-8)\n",
      "conj:and(ecg-6, osmolality-9)\n",
      "nsubjpass(recorded-15, osmolality-9)\n",
      "cc(ecg-6, and-11)\n",
      "amod(level-13, etoh-12)\n",
      "conj:and(ecg-6, level-13)\n",
      "nsubjpass(recorded-15, level-13)\n",
      "auxpass(recorded-15, were-14)\n",
      "nmod:in(subjects-2, recorded-15)\n",
      "case(hours-18, within-16)\n",
      "nummod(hours-18, 2-17)\n",
      "nmod:within(recorded-15, hours-18)\n",
      "case(one-20, of-19)\n",
      "nmod:of(hours-18, one-20)\n",
      "dep(one-20, another-21)\n",
      "cc(recorded-15, and-22)\n",
      "nsubjpass(administered-25, who-23)\n",
      "auxpass(administered-25, were-24)\n",
      "nmod:in(subjects-2, administered-25)\n",
      "conj:and(recorded-15, administered-25)\n",
      "det(protocol-31, a-26)\n",
      "amod(protocol-31, clinical-27)\n",
      "compound(protocol-31, institute-28)\n",
      "compound(protocol-31, withdrawal-29)\n",
      "compound(protocol-31, assessment-30)\n",
      "dobj(administered-25, protocol-31)\n",
      "auxpass(compared-33, were-32)\n",
      "root(ROOT-0, compared-33)\n",
      "case(patients-36, with-34)\n",
      "nummod(patients-36, 203-35)\n",
      "nmod:with(compared-33, patients-36)\n",
      "case(acs-38, with-37)\n",
      "nmod:with(patients-36, acs-38)\n",
      "case(period-42, during-39)\n",
      "det(period-42, the-40)\n",
      "amod(period-42, same-41)\n",
      "nmod:during(compared-33, period-42)\n",
      "\n",
      "Parsing [sent. 119 len. 7]: we excluded patients with incomplete data .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBN excluded)\n",
      "      (NP (NNS patients))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ incomplete) (NNS data))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(excluded-2, we-1)\n",
      "root(ROOT-0, excluded-2)\n",
      "dobj(excluded-2, patients-3)\n",
      "case(data-6, with-4)\n",
      "amod(data-6, incomplete-5)\n",
      "nmod:with(excluded-2, data-6)\n",
      "\n",
      "Parsing [sent. 120 len. 15]: medications compared included clopidogrel , acetylsalicylic acid , Î²-blockers , ACEI , and statins .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS medications))\n",
      "      (VP (VBN compared)))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (NN clopidogrel))\n",
      "        (, ,)\n",
      "        (NP (JJ acetylsalicylic) (NN acid))\n",
      "        (, ,)\n",
      "        (NP (NNS Î²-blockers))\n",
      "        (, ,)\n",
      "        (NP (NNP ACEI))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (NNS statins))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(included-3, medications-1)\n",
      "acl(medications-1, compared-2)\n",
      "root(ROOT-0, included-3)\n",
      "dobj(included-3, clopidogrel-4)\n",
      "amod(acid-7, acetylsalicylic-6)\n",
      "dobj(included-3, acid-7)\n",
      "conj:and(clopidogrel-4, acid-7)\n",
      "dobj(included-3, Î²-blockers-9)\n",
      "conj:and(clopidogrel-4, Î²-blockers-9)\n",
      "dobj(included-3, ACEI-11)\n",
      "conj:and(clopidogrel-4, ACEI-11)\n",
      "cc(clopidogrel-4, and-13)\n",
      "dobj(included-3, statins-14)\n",
      "conj:and(clopidogrel-4, statins-14)\n",
      "\n",
      "Parsing [sent. 121 len. 15]: ecg qt and qtc , as well as electrolytes , were recorded and compared .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN ecg) (NN qt)\n",
      "        (CC and)\n",
      "        (NN qtc))\n",
      "      (, ,)\n",
      "      (CONJP (RB as) (RB well) (IN as))\n",
      "      (NP (NNS electrolytes))\n",
      "      (, ,))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN recorded)\n",
      "        (CC and)\n",
      "        (VBN compared)))\n",
      "    (. .)))\n",
      "\n",
      "compound(qt-2, ecg-1)\n",
      "nsubjpass(recorded-12, qt-2)\n",
      "nsubjpass(compared-14, qt-2)\n",
      "cc(qt-2, and-3)\n",
      "conj:and(qt-2, qtc-4)\n",
      "nsubjpass(recorded-12, qtc-4)\n",
      "cc(qt-2, as-6)\n",
      "mwe(as-6, well-7)\n",
      "mwe(as-6, as-8)\n",
      "conj:and(qt-2, electrolytes-9)\n",
      "nsubjpass(recorded-12, electrolytes-9)\n",
      "auxpass(recorded-12, were-11)\n",
      "root(ROOT-0, recorded-12)\n",
      "cc(recorded-12, and-13)\n",
      "conj:and(recorded-12, compared-14)\n",
      "\n",
      "Parsing [sent. 122 len. 21]: data were extracted by two investigators with a 20 % sample re-evaluated by the other extractor as a reliability measure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS data))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN extracted)\n",
      "        (PP (IN by)\n",
      "          (NP (CD two) (NNS investigators)))\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (DT a)\n",
      "              (ADJP (CD 20) (NN %))\n",
      "              (NN sample))\n",
      "            (VP (VBN re-evaluated)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ other) (NN extractor))\n",
      "                  (PP (IN as)\n",
      "                    (NP (DT a) (JJ reliability) (NN measure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(extracted-3, data-1)\n",
      "auxpass(extracted-3, were-2)\n",
      "root(ROOT-0, extracted-3)\n",
      "case(investigators-6, by-4)\n",
      "nummod(investigators-6, two-5)\n",
      "nmod:by(extracted-3, investigators-6)\n",
      "case(sample-11, with-7)\n",
      "det(sample-11, a-8)\n",
      "compound(%-10, 20-9)\n",
      "amod(sample-11, %-10)\n",
      "nmod:with(extracted-3, sample-11)\n",
      "acl(sample-11, re-evaluated-12)\n",
      "case(extractor-16, by-13)\n",
      "det(extractor-16, the-14)\n",
      "amod(extractor-16, other-15)\n",
      "nmod:by(re-evaluated-12, extractor-16)\n",
      "case(measure-20, as-17)\n",
      "det(measure-20, a-18)\n",
      "amod(measure-20, reliability-19)\n",
      "nmod:as(extractor-16, measure-20)\n",
      "\n",
      "Parsing [sent. 123 len. 13]: descriptive statistics including medians and interquartile ranges were measured for continuous variables .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ descriptive) (NNS statistics))\n",
      "      (PP (VBG including)\n",
      "        (NP\n",
      "          (NP (NNS medians))\n",
      "          (CC and)\n",
      "          (NP (JJ interquartile) (NNS ranges)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN measured)\n",
      "        (PP (IN for)\n",
      "          (NP (JJ continuous) (NNS variables)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(statistics-2, descriptive-1)\n",
      "nsubjpass(measured-9, statistics-2)\n",
      "case(medians-4, including-3)\n",
      "nmod:including(statistics-2, medians-4)\n",
      "cc(medians-4, and-5)\n",
      "amod(ranges-7, interquartile-6)\n",
      "nmod:including(statistics-2, ranges-7)\n",
      "conj:and(medians-4, ranges-7)\n",
      "auxpass(measured-9, were-8)\n",
      "root(ROOT-0, measured-9)\n",
      "case(variables-12, for-10)\n",
      "amod(variables-12, continuous-11)\n",
      "nmod:for(measured-9, variables-12)\n",
      "\n",
      "Parsing [sent. 124 len. 19]: comparisons were made using two-tailed t tests for parametric data and the mann-whitney u test for nonparametric data .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS comparisons))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN made)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ two-tailed) (NN t) (NNS tests))\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ parametric) (NNS data))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT the) (JJ mann-whitney) (NN u) (NN test))\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ nonparametric) (NNS data)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(made-3, comparisons-1)\n",
      "auxpass(made-3, were-2)\n",
      "root(ROOT-0, made-3)\n",
      "xcomp(made-3, using-4)\n",
      "amod(tests-7, two-tailed-5)\n",
      "compound(tests-7, t-6)\n",
      "dobj(using-4, tests-7)\n",
      "case(data-10, for-8)\n",
      "amod(data-10, parametric-9)\n",
      "nmod:for(tests-7, data-10)\n",
      "cc(tests-7, and-11)\n",
      "det(test-15, the-12)\n",
      "amod(test-15, mann-whitney-13)\n",
      "compound(test-15, u-14)\n",
      "dobj(using-4, test-15)\n",
      "conj:and(tests-7, test-15)\n",
      "case(data-18, for-16)\n",
      "amod(data-18, nonparametric-17)\n",
      "nmod:for(test-15, data-18)\n",
      "\n",
      "Parsing [sent. 125 len. 42]: heart failure with preserved ejection fraction -LRB- hfpef -RRB- makes up half of diagnosed heart failure cases and has similar outcomes compared to heart failure with reduced ejection fraction -LRB- hfref -RRB- but a discrepancy in knowledge and approach to treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN heart) (NN failure))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ preserved) (NN ejection) (NN fraction))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN hfpef))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (VP\n",
      "      (VP (VBZ makes)\n",
      "        (PRT (RP up))\n",
      "        (NP\n",
      "          (NP (NN half))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ diagnosed) (NN heart) (NN failure) (NNS cases)))))\n",
      "      (CC and)\n",
      "      (VP (VBZ has)\n",
      "        (NP\n",
      "          (NP (JJ similar) (NNS outcomes))\n",
      "          (PP (VBN compared)\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN heart) (NN failure))\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (VBN reduced) (NN ejection) (NN fraction))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN hfref))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (PP (CC but)\n",
      "                      (NP\n",
      "                        (NP (DT a) (NN discrepancy))\n",
      "                        (PP (IN in)\n",
      "                          (NP (NN knowledge)\n",
      "                            (CC and)\n",
      "                            (NN approach)))))))))))\n",
      "        (PP (TO to)\n",
      "          (NP (NN treatment)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(makes-10, failure-2)\n",
      "nsubj(has-19, failure-2)\n",
      "case(fraction-6, with-3)\n",
      "amod(fraction-6, preserved-4)\n",
      "compound(fraction-6, ejection-5)\n",
      "nmod:with(failure-2, fraction-6)\n",
      "appos(fraction-6, hfpef-8)\n",
      "root(ROOT-0, makes-10)\n",
      "compound:prt(makes-10, up-11)\n",
      "dobj(makes-10, half-12)\n",
      "case(cases-17, of-13)\n",
      "amod(cases-17, diagnosed-14)\n",
      "compound(cases-17, heart-15)\n",
      "compound(cases-17, failure-16)\n",
      "nmod:of(half-12, cases-17)\n",
      "cc(makes-10, and-18)\n",
      "conj:and(makes-10, has-19)\n",
      "amod(outcomes-21, similar-20)\n",
      "dobj(has-19, outcomes-21)\n",
      "case(failure-25, compared-22)\n",
      "mwe(compared-22, to-23)\n",
      "compound(failure-25, heart-24)\n",
      "acl(outcomes-21, failure-25)\n",
      "case(fraction-29, with-26)\n",
      "amod(fraction-29, reduced-27)\n",
      "compound(fraction-29, ejection-28)\n",
      "nmod:with(failure-25, fraction-29)\n",
      "appos(fraction-29, hfref-31)\n",
      "case(discrepancy-35, but-33)\n",
      "det(discrepancy-35, a-34)\n",
      "nmod:but(fraction-29, discrepancy-35)\n",
      "case(knowledge-37, in-36)\n",
      "nmod:in(discrepancy-35, knowledge-37)\n",
      "cc(knowledge-37, and-38)\n",
      "nmod:in(discrepancy-35, approach-39)\n",
      "conj:and(knowledge-37, approach-39)\n",
      "case(treatment-41, to-40)\n",
      "nmod:to(has-19, treatment-41)\n",
      "\n",
      "Parsing [sent. 126 len. 36]: hfpef is diagnosed using the following criteria : symptoms , preserved ejection fraction -LRB- greater than 50 % -RRB- , and evidence of abnormal left ventricular filling or relaxation , or diastolic distensibility or stiffness .\n",
      "(ROOT\n",
      "  (SINV\n",
      "    (S\n",
      "      (NP (NN hfpef))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN diagnosed)\n",
      "          (S\n",
      "            (VP (VBG using)\n",
      "              (NP\n",
      "                (NP (DT the) (VBG following) (NNS criteria))\n",
      "                (: :)\n",
      "                (NP (NNS symptoms))))))))\n",
      "    (, ,)\n",
      "    (VP (VBD preserved))\n",
      "    (NP\n",
      "      (NP (NN ejection) (NN fraction))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (QP (JJR greater) (IN than) (CD 50))\n",
      "          (NN %))\n",
      "        (-RRB- -RRB-))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP (NN evidence))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (JJ abnormal) (JJ left) (NN ventricular) (NN filling))\n",
      "              (CC or)\n",
      "              (NP (NN relaxation)))\n",
      "            (, ,)\n",
      "            (CC or)\n",
      "            (NP\n",
      "              (NP (JJ diastolic) (NN distensibility))\n",
      "              (CC or)\n",
      "              (NP (NNS stiffness)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(diagnosed-3, hfpef-1)\n",
      "auxpass(diagnosed-3, is-2)\n",
      "ccomp(preserved-11, diagnosed-3)\n",
      "xcomp(diagnosed-3, using-4)\n",
      "det(criteria-7, the-5)\n",
      "amod(criteria-7, following-6)\n",
      "dobj(using-4, criteria-7)\n",
      "dep(criteria-7, symptoms-9)\n",
      "root(ROOT-0, preserved-11)\n",
      "compound(fraction-13, ejection-12)\n",
      "nsubj(preserved-11, fraction-13)\n",
      "advmod(50-17, greater-15)\n",
      "advmod(50-17, than-16)\n",
      "nummod(%-18, 50-17)\n",
      "appos(fraction-13, %-18)\n",
      "cc(fraction-13, and-21)\n",
      "nsubj(preserved-11, evidence-22)\n",
      "conj:and(fraction-13, evidence-22)\n",
      "case(filling-27, of-23)\n",
      "amod(filling-27, abnormal-24)\n",
      "amod(filling-27, left-25)\n",
      "compound(filling-27, ventricular-26)\n",
      "nmod:of(evidence-22, filling-27)\n",
      "cc(filling-27, or-28)\n",
      "nmod:of(evidence-22, relaxation-29)\n",
      "conj:or(filling-27, relaxation-29)\n",
      "cc(filling-27, or-31)\n",
      "amod(distensibility-33, diastolic-32)\n",
      "nmod:of(evidence-22, distensibility-33)\n",
      "conj:or(filling-27, distensibility-33)\n",
      "cc(distensibility-33, or-34)\n",
      "conj:or(filling-27, stiffness-35)\n",
      "conj:or(distensibility-33, stiffness-35)\n",
      "\n",
      "Parsing [sent. 127 len. 41]: studies conducted to examine the efficacy of angiotensin receptor blockers -LRB- irbesartan and candesartan -RRB- , thiazide diuretics -LRB- chlorthalidone -RRB- , and ACEI -LRB- perindopril -RRB- in the treatment of hfpef , showed moderate efficacy but no clear benefit .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS studies))\n",
      "      (VP (VBN conducted)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB examine)\n",
      "              (NP\n",
      "                (NP (DT the) (NN efficacy))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN irbesartan)\n",
      "                          (CC and)\n",
      "                          (NNS candesartan))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (JJ thiazide) (NNS diuretics))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN chlorthalidone))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (CC and)\n",
      "                    (NP\n",
      "                      (NP (NNP ACEI))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (ADJP (JJ perindopril))\n",
      "                        (-RRB- -RRB-))))))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN treatment))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN hfpef))))))))))\n",
      "    (, ,)\n",
      "    (VP (VBD showed)\n",
      "      (NP\n",
      "        (NP (JJ moderate) (NN efficacy))\n",
      "        (PP (CC but)\n",
      "          (NP (DT no) (JJ clear) (NN benefit)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(showed-34, studies-1)\n",
      "acl(studies-1, conducted-2)\n",
      "mark(examine-4, to-3)\n",
      "xcomp(conducted-2, examine-4)\n",
      "det(efficacy-6, the-5)\n",
      "dobj(examine-4, efficacy-6)\n",
      "case(blockers-10, of-7)\n",
      "compound(blockers-10, angiotensin-8)\n",
      "compound(blockers-10, receptor-9)\n",
      "nmod:of(efficacy-6, blockers-10)\n",
      "appos(blockers-10, irbesartan-12)\n",
      "cc(irbesartan-12, and-13)\n",
      "appos(blockers-10, candesartan-14)\n",
      "conj:and(irbesartan-12, candesartan-14)\n",
      "amod(diuretics-18, thiazide-17)\n",
      "nmod:of(efficacy-6, diuretics-18)\n",
      "conj:and(blockers-10, diuretics-18)\n",
      "appos(diuretics-18, chlorthalidone-20)\n",
      "cc(blockers-10, and-23)\n",
      "nmod:of(efficacy-6, ACEI-24)\n",
      "conj:and(blockers-10, ACEI-24)\n",
      "dep(ACEI-24, perindopril-26)\n",
      "case(treatment-30, in-28)\n",
      "det(treatment-30, the-29)\n",
      "nmod:in(examine-4, treatment-30)\n",
      "case(hfpef-32, of-31)\n",
      "nmod:of(treatment-30, hfpef-32)\n",
      "root(ROOT-0, showed-34)\n",
      "amod(efficacy-36, moderate-35)\n",
      "dobj(showed-34, efficacy-36)\n",
      "case(benefit-40, but-37)\n",
      "neg(benefit-40, no-38)\n",
      "amod(benefit-40, clear-39)\n",
      "nmod:but(efficacy-36, benefit-40)\n",
      "\n",
      "Parsing [sent. 128 len. 40]: recently , the fda has approved a novel drug , which combines an angiotensin receptor neprilysin inhibitor and angiotensin receptor blocker -LRB- valsartan -RRB- named lcz696 -LRB- entresto -RRB- for possible treatment of heart failure with reduced ejection fraction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB recently))\n",
      "    (, ,)\n",
      "    (NP (DT the) (NN fda))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN approved)\n",
      "        (NP\n",
      "          (NP (DT a) (NN novel) (NN drug))\n",
      "          (, ,)\n",
      "          (SBAR\n",
      "            (WHNP (WDT which))\n",
      "            (S\n",
      "              (VP (VBZ combines)\n",
      "                (NP\n",
      "                  (NP (DT an) (NN angiotensin) (NN receptor) (NN neprilysin) (NN inhibitor)\n",
      "                    (CC and)\n",
      "                    (NN angiotensin) (NN receptor) (NN blocker))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (NN valsartan))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (VP (VBN named)\n",
      "                    (NP\n",
      "                      (NP (JJ lcz696) (-LRB- -LRB-) (NN entresto) (-RRB- -RRB-))\n",
      "                      (PP (IN for)\n",
      "                        (NP\n",
      "                          (NP (JJ possible) (NN treatment))\n",
      "                          (PP (IN of)\n",
      "                            (NP (NN heart) (NN failure))))))\n",
      "                    (PP (IN with)\n",
      "                      (NP (VBN reduced) (NN ejection) (NN fraction)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(approved-6, recently-1)\n",
      "det(fda-4, the-3)\n",
      "nsubj(approved-6, fda-4)\n",
      "aux(approved-6, has-5)\n",
      "root(ROOT-0, approved-6)\n",
      "det(drug-9, a-7)\n",
      "compound(drug-9, novel-8)\n",
      "dobj(approved-6, drug-9)\n",
      "nsubj(combines-12, drug-9)\n",
      "ref(drug-9, which-11)\n",
      "acl:relcl(drug-9, combines-12)\n",
      "det(inhibitor-17, an-13)\n",
      "compound(inhibitor-17, angiotensin-14)\n",
      "compound(inhibitor-17, receptor-15)\n",
      "compound(inhibitor-17, neprilysin-16)\n",
      "dobj(combines-12, inhibitor-17)\n",
      "cc(inhibitor-17, and-18)\n",
      "compound(blocker-21, angiotensin-19)\n",
      "compound(blocker-21, receptor-20)\n",
      "dobj(combines-12, blocker-21)\n",
      "conj:and(inhibitor-17, blocker-21)\n",
      "appos(inhibitor-17, valsartan-23)\n",
      "acl(inhibitor-17, named-25)\n",
      "amod(entresto-28, lcz696-26)\n",
      "dobj(named-25, entresto-28)\n",
      "case(treatment-32, for-30)\n",
      "amod(treatment-32, possible-31)\n",
      "nmod:for(entresto-28, treatment-32)\n",
      "case(failure-35, of-33)\n",
      "compound(failure-35, heart-34)\n",
      "nmod:of(treatment-32, failure-35)\n",
      "case(fraction-39, with-36)\n",
      "amod(fraction-39, reduced-37)\n",
      "compound(fraction-39, ejection-38)\n",
      "nmod:with(named-25, fraction-39)\n",
      "\n",
      "Parsing [sent. 129 len. 29]: in this article , we will discuss the failure of previous treatment modalities and the promise that lcz696 -LRB- entresto -RRB- may hold for treating patients with hfpef .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (DT this) (NN article)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (MD will)\n",
      "      (VP (VB discuss)\n",
      "        (NP\n",
      "          (NP (DT the) (NN failure))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ previous) (NN treatment) (NNS modalities))\n",
      "              (CC and)\n",
      "              (NP (DT the) (NN promise)))))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (NNS lcz696))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP entresto))\n",
      "                (-RRB- -RRB-)))\n",
      "            (VP (MD may)\n",
      "              (VP (VB hold)\n",
      "                (PP (IN for)\n",
      "                  (S\n",
      "                    (VP (VBG treating)\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP (NN hfpef))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "case(article-3, in-1)\n",
      "det(article-3, this-2)\n",
      "nmod:in(discuss-7, article-3)\n",
      "nsubj(discuss-7, we-5)\n",
      "aux(discuss-7, will-6)\n",
      "root(ROOT-0, discuss-7)\n",
      "det(failure-9, the-8)\n",
      "dobj(discuss-7, failure-9)\n",
      "case(modalities-13, of-10)\n",
      "amod(modalities-13, previous-11)\n",
      "compound(modalities-13, treatment-12)\n",
      "nmod:of(failure-9, modalities-13)\n",
      "cc(modalities-13, and-14)\n",
      "det(promise-16, the-15)\n",
      "nmod:of(failure-9, promise-16)\n",
      "conj:and(modalities-13, promise-16)\n",
      "mark(hold-23, that-17)\n",
      "nsubj(hold-23, lcz696-18)\n",
      "appos(lcz696-18, entresto-20)\n",
      "aux(hold-23, may-22)\n",
      "ccomp(discuss-7, hold-23)\n",
      "mark(treating-25, for-24)\n",
      "advcl(hold-23, treating-25)\n",
      "dobj(treating-25, patients-26)\n",
      "case(hfpef-28, with-27)\n",
      "nmod:with(treating-25, hfpef-28)\n",
      "\n",
      "Parsing [sent. 130 len. 18]: several medications have been used perioperatively in patients undergoing noncardiac surgery in an attempt to improve outcomes .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ several) (NNS medications))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN been)\n",
      "        (VP (VBN used)\n",
      "          (ADVP (RB perioperatively))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (VP (VBG undergoing)\n",
      "                (NP (JJ noncardiac) (NN surgery))\n",
      "                (PP (IN in)\n",
      "                  (NP (DT an) (NN attempt)\n",
      "                    (S\n",
      "                      (VP (TO to)\n",
      "                        (VP (VB improve)\n",
      "                          (NP (NNS outcomes)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(medications-2, several-1)\n",
      "nsubjpass(used-5, medications-2)\n",
      "aux(used-5, have-3)\n",
      "auxpass(used-5, been-4)\n",
      "root(ROOT-0, used-5)\n",
      "advmod(used-5, perioperatively-6)\n",
      "case(patients-8, in-7)\n",
      "nmod:in(used-5, patients-8)\n",
      "acl(patients-8, undergoing-9)\n",
      "amod(surgery-11, noncardiac-10)\n",
      "dobj(undergoing-9, surgery-11)\n",
      "case(attempt-14, in-12)\n",
      "det(attempt-14, an-13)\n",
      "nmod:in(undergoing-9, attempt-14)\n",
      "mark(improve-16, to-15)\n",
      "acl(attempt-14, improve-16)\n",
      "dobj(improve-16, outcomes-17)\n",
      "\n",
      "Parsing [sent. 131 len. 41]: antiplatelet therapy for primary prevention of cardiovascular events should generally be discontinued seven to 10 days before surgery to avoid increasing the risk of bleeding , unless the risk of a major adverse cardiac event exceeds the risk of bleeding .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ antiplatelet) (NN therapy))\n",
      "      (PP (IN for)\n",
      "        (NP\n",
      "          (NP (JJ primary) (NN prevention))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ cardiovascular) (NNS events))))))\n",
      "    (VP (MD should)\n",
      "      (ADVP (RB generally))\n",
      "      (VP (VB be)\n",
      "        (VP (VBN discontinued)\n",
      "          (PP\n",
      "            (NP\n",
      "              (QP (CD seven) (TO to) (CD 10))\n",
      "              (NNS days))\n",
      "            (IN before)\n",
      "            (NP (NN surgery)))\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB avoid)\n",
      "                (S\n",
      "                  (VP (VBG increasing)\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN risk))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NN bleeding))))))\n",
      "                (, ,)\n",
      "                (SBAR (IN unless)\n",
      "                  (S\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN risk))\n",
      "                      (PP (IN of)\n",
      "                        (NP (DT a) (JJ major) (JJ adverse) (JJ cardiac) (NN event))))\n",
      "                    (VP (VBZ exceeds)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN risk))\n",
      "                        (PP (IN of)\n",
      "                          (NP (NN bleeding)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-2, antiplatelet-1)\n",
      "nsubjpass(discontinued-12, therapy-2)\n",
      "nsubj:xsubj(avoid-20, therapy-2)\n",
      "case(prevention-5, for-3)\n",
      "amod(prevention-5, primary-4)\n",
      "nmod:for(therapy-2, prevention-5)\n",
      "case(events-8, of-6)\n",
      "amod(events-8, cardiovascular-7)\n",
      "nmod:of(prevention-5, events-8)\n",
      "aux(discontinued-12, should-9)\n",
      "advmod(discontinued-12, generally-10)\n",
      "auxpass(discontinued-12, be-11)\n",
      "root(ROOT-0, discontinued-12)\n",
      "compound(10-15, seven-13)\n",
      "dep(10-15, to-14)\n",
      "nummod(days-16, 10-15)\n",
      "nmod:before(discontinued-12, days-16)\n",
      "case(days-16, before-17)\n",
      "dep(days-16, surgery-18)\n",
      "mark(avoid-20, to-19)\n",
      "xcomp(discontinued-12, avoid-20)\n",
      "xcomp(avoid-20, increasing-21)\n",
      "det(risk-23, the-22)\n",
      "dobj(increasing-21, risk-23)\n",
      "case(bleeding-25, of-24)\n",
      "nmod:of(risk-23, bleeding-25)\n",
      "mark(exceeds-36, unless-27)\n",
      "det(risk-29, the-28)\n",
      "nsubj(exceeds-36, risk-29)\n",
      "case(event-35, of-30)\n",
      "det(event-35, a-31)\n",
      "amod(event-35, major-32)\n",
      "amod(event-35, adverse-33)\n",
      "amod(event-35, cardiac-34)\n",
      "nmod:of(risk-29, event-35)\n",
      "advcl(avoid-20, exceeds-36)\n",
      "det(risk-38, the-37)\n",
      "dobj(exceeds-36, risk-38)\n",
      "case(bleeding-40, of-39)\n",
      "nmod:of(risk-38, bleeding-40)\n",
      "\n",
      "Parsing [sent. 132 len. 24]: antiplatelet therapy for secondary prevention should be continued perioperatively , except before procedures with very high bleeding risk , such as intracranial procedures .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ antiplatelet) (NN therapy))\n",
      "      (PP (IN for)\n",
      "        (NP (JJ secondary) (NN prevention))))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN continued)\n",
      "          (PP\n",
      "            (ADVP (RB perioperatively))\n",
      "            (, ,) (IN except) (IN before)\n",
      "            (NP\n",
      "              (NP (NNS procedures))\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (ADJP (RB very) (JJ high))\n",
      "                  (NN bleeding) (NN risk)))\n",
      "              (, ,)\n",
      "              (PP (JJ such) (IN as)\n",
      "                (NP (JJ intracranial) (NNS procedures))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-2, antiplatelet-1)\n",
      "nsubjpass(continued-8, therapy-2)\n",
      "case(prevention-5, for-3)\n",
      "amod(prevention-5, secondary-4)\n",
      "nmod:for(therapy-2, prevention-5)\n",
      "aux(continued-8, should-6)\n",
      "auxpass(continued-8, be-7)\n",
      "root(ROOT-0, continued-8)\n",
      "advmod(procedures-13, perioperatively-9)\n",
      "case(procedures-13, except-11)\n",
      "case(procedures-13, before-12)\n",
      "nmod:before(continued-8, procedures-13)\n",
      "case(risk-18, with-14)\n",
      "advmod(high-16, very-15)\n",
      "amod(risk-18, high-16)\n",
      "compound(risk-18, bleeding-17)\n",
      "nmod:with(procedures-13, risk-18)\n",
      "case(procedures-23, such-20)\n",
      "mwe(such-20, as-21)\n",
      "amod(procedures-23, intracranial-22)\n",
      "nmod:such_as(procedures-13, procedures-23)\n",
      "\n",
      "Parsing [sent. 133 len. 50]: antiplatelet drugs should be continued and surgery delayed , if possible , for at least 14 days after percutaneous coronary intervention without stent placement , 30 days after percutaneous coronary intervention with bare-metal stent placement , and six to 12 months after percutaneous coronary intervention with drug-eluting stent placement .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN antiplatelet) (NNS drugs))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN surgery))\n",
      "      (VP (VBN delayed)\n",
      "        (PRN (, ,)\n",
      "          (SBAR (IN if)\n",
      "            (FRAG (JJ possible)))\n",
      "          (, ,))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (QP (IN at) (JJS least) (CD 14))\n",
      "                (NNS days))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN without)\n",
      "                    (NP (JJ stent) (NN placement))))))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP (CD 30) (NNS days))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ bare-metal) (NN stent) (NN placement))))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP\n",
      "                (QP (CD six) (TO to) (CD 12))\n",
      "                (NNS months))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ drug-eluting) (NN stent) (NN placement))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(drugs-2, antiplatelet-1)\n",
      "nsubjpass(continued-5, drugs-2)\n",
      "aux(continued-5, should-3)\n",
      "auxpass(continued-5, be-4)\n",
      "root(ROOT-0, continued-5)\n",
      "cc(continued-5, and-6)\n",
      "nsubj(delayed-8, surgery-7)\n",
      "conj:and(continued-5, delayed-8)\n",
      "mark(possible-11, if-10)\n",
      "parataxis(delayed-8, possible-11)\n",
      "case(days-17, for-13)\n",
      "case(least-15, at-14)\n",
      "nmod:npmod(14-16, least-15)\n",
      "nummod(days-17, 14-16)\n",
      "nmod:for(delayed-8, days-17)\n",
      "case(intervention-21, after-18)\n",
      "amod(intervention-21, percutaneous-19)\n",
      "amod(intervention-21, coronary-20)\n",
      "nmod:after(days-17, intervention-21)\n",
      "case(placement-24, without-22)\n",
      "amod(placement-24, stent-23)\n",
      "nmod:without(intervention-21, placement-24)\n",
      "nummod(days-27, 30-26)\n",
      "nmod:for(delayed-8, days-27)\n",
      "conj:and(days-17, days-27)\n",
      "case(intervention-31, after-28)\n",
      "amod(intervention-31, percutaneous-29)\n",
      "amod(intervention-31, coronary-30)\n",
      "nmod:after(days-27, intervention-31)\n",
      "case(placement-35, with-32)\n",
      "amod(placement-35, bare-metal-33)\n",
      "compound(placement-35, stent-34)\n",
      "nmod:with(intervention-31, placement-35)\n",
      "cc(days-17, and-37)\n",
      "compound(12-40, six-38)\n",
      "dep(12-40, to-39)\n",
      "nummod(months-41, 12-40)\n",
      "nmod:for(delayed-8, months-41)\n",
      "conj:and(days-17, months-41)\n",
      "case(intervention-45, after-42)\n",
      "amod(intervention-45, percutaneous-43)\n",
      "amod(intervention-45, coronary-44)\n",
      "nmod:after(months-41, intervention-45)\n",
      "case(placement-49, with-46)\n",
      "amod(placement-49, drug-eluting-47)\n",
      "compound(placement-49, stent-48)\n",
      "nmod:with(intervention-45, placement-49)\n",
      "\n",
      "Parsing [sent. 134 len. 52]: perioperative beta blockers are recommended for patients already receiving these agents , and it is reasonable to consider starting therapy in patients with known or strongly suspected coronary artery disease or who are at high risk of perioperative cardiac events and are undergoing procedures with a high risk of cardiovascular complications .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ perioperative) (NN beta) (NNS blockers))\n",
      "      (VP (VBP are)\n",
      "        (VP (VBN recommended)\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (VP\n",
      "                (ADVP (RB already))\n",
      "                (VBG receiving)\n",
      "                (NP (DT these) (NNS agents))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ reasonable)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB consider)\n",
      "                (S\n",
      "                  (VP (VBG starting)\n",
      "                    (NP\n",
      "                      (NP (NN therapy))\n",
      "                      (PP (IN in)\n",
      "                        (NP (NNS patients))))\n",
      "                    (PP (IN with)\n",
      "                      (S\n",
      "                        (VP\n",
      "                          (VP (VBN known))\n",
      "                          (CC or)\n",
      "                          (VP\n",
      "                            (ADVP (RB strongly))\n",
      "                            (VBN suspected)\n",
      "                            (NP\n",
      "                              (NP (JJ coronary) (NN artery) (NN disease))\n",
      "                              (CC or)\n",
      "                              (SBAR\n",
      "                                (WHNP (WP who))\n",
      "                                (S\n",
      "                                  (VP (VBP are)\n",
      "                                    (PP (IN at)\n",
      "                                      (NP\n",
      "                                        (NP (JJ high) (NN risk))\n",
      "                                        (PP (IN of)\n",
      "                                          (NP (JJ perioperative) (JJ cardiac) (NNS events))))))))))\n",
      "                          (CC and)\n",
      "                          (VP (VBP are)\n",
      "                            (VP (VBG undergoing)\n",
      "                              (NP (NNS procedures))\n",
      "                              (PP (IN with)\n",
      "                                (NP\n",
      "                                  (NP (DT a) (JJ high) (NN risk))\n",
      "                                  (PP (IN of)\n",
      "                                    (NP (JJ cardiovascular) (NNS complications))))))))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(blockers-3, perioperative-1)\n",
      "compound(blockers-3, beta-2)\n",
      "nsubjpass(recommended-5, blockers-3)\n",
      "auxpass(recommended-5, are-4)\n",
      "root(ROOT-0, recommended-5)\n",
      "case(patients-7, for-6)\n",
      "nmod:for(recommended-5, patients-7)\n",
      "advmod(receiving-9, already-8)\n",
      "acl(patients-7, receiving-9)\n",
      "det(agents-11, these-10)\n",
      "dobj(receiving-9, agents-11)\n",
      "cc(recommended-5, and-13)\n",
      "nsubj(reasonable-16, it-14)\n",
      "nsubj:xsubj(consider-18, it-14)\n",
      "cop(reasonable-16, is-15)\n",
      "conj:and(recommended-5, reasonable-16)\n",
      "mark(consider-18, to-17)\n",
      "xcomp(reasonable-16, consider-18)\n",
      "xcomp(consider-18, starting-19)\n",
      "dobj(starting-19, therapy-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(therapy-20, patients-22)\n",
      "mark(known-24, with-23)\n",
      "advcl(starting-19, known-24)\n",
      "cc(known-24, or-25)\n",
      "advmod(suspected-27, strongly-26)\n",
      "advcl(starting-19, suspected-27)\n",
      "conj:or(known-24, suspected-27)\n",
      "amod(disease-30, coronary-28)\n",
      "compound(disease-30, artery-29)\n",
      "dobj(suspected-27, disease-30)\n",
      "cc(disease-30, or-31)\n",
      "nsubj(risk-36, who-32)\n",
      "cop(risk-36, are-33)\n",
      "case(risk-36, at-34)\n",
      "amod(risk-36, high-35)\n",
      "dobj(suspected-27, risk-36)\n",
      "conj:or(disease-30, risk-36)\n",
      "case(events-40, of-37)\n",
      "amod(events-40, perioperative-38)\n",
      "amod(events-40, cardiac-39)\n",
      "nmod:of(risk-36, events-40)\n",
      "cc(known-24, and-41)\n",
      "aux(undergoing-43, are-42)\n",
      "advcl(starting-19, undergoing-43)\n",
      "conj:and(known-24, undergoing-43)\n",
      "dobj(undergoing-43, procedures-44)\n",
      "case(risk-48, with-45)\n",
      "det(risk-48, a-46)\n",
      "amod(risk-48, high-47)\n",
      "nmod:with(undergoing-43, risk-48)\n",
      "case(complications-51, of-49)\n",
      "amod(complications-51, cardiovascular-50)\n",
      "nmod:of(risk-48, complications-51)\n",
      "\n",
      "Parsing [sent. 135 len. 21]: long-term statin therapy should be continued perioperatively or started in patients with clinical indications who are not already receiving statins .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ long-term) (NN statin) (NN therapy))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP\n",
      "          (VP (VBN continued)\n",
      "            (ADVP (RB perioperatively)))\n",
      "          (CC or)\n",
      "          (VP (VBN started)\n",
      "            (PP (IN in)\n",
      "              (NP (NNS patients))))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (JJ clinical) (NNS indications))\n",
      "              (SBAR\n",
      "                (WHNP (WP who))\n",
      "                (S\n",
      "                  (VP (VBP are) (RB not)\n",
      "                    (ADVP (RB already))\n",
      "                    (VP (VBG receiving)\n",
      "                      (NP (NNS statins)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-3, long-term-1)\n",
      "compound(therapy-3, statin-2)\n",
      "nsubjpass(continued-6, therapy-3)\n",
      "nsubjpass(started-9, therapy-3)\n",
      "aux(continued-6, should-4)\n",
      "auxpass(continued-6, be-5)\n",
      "root(ROOT-0, continued-6)\n",
      "advmod(continued-6, perioperatively-7)\n",
      "cc(continued-6, or-8)\n",
      "conj:or(continued-6, started-9)\n",
      "case(patients-11, in-10)\n",
      "nmod:in(started-9, patients-11)\n",
      "case(indications-14, with-12)\n",
      "amod(indications-14, clinical-13)\n",
      "nmod:with(continued-6, indications-14)\n",
      "nsubj(receiving-19, indications-14)\n",
      "ref(indications-14, who-15)\n",
      "aux(receiving-19, are-16)\n",
      "neg(receiving-19, not-17)\n",
      "advmod(receiving-19, already-18)\n",
      "acl:relcl(indications-14, receiving-19)\n",
      "dobj(receiving-19, statins-20)\n",
      "\n",
      "Parsing [sent. 136 len. 15]: clonidine should not be started perioperatively , but long-term clonidine regimens may be continued .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN clonidine))\n",
      "      (VP (MD should) (RB not)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN started)\n",
      "            (ADVP (RB perioperatively))))))\n",
      "    (, ,)\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (JJ long-term) (NN clonidine) (NNS regimens))\n",
      "      (VP (MD may)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(started-5, clonidine-1)\n",
      "aux(started-5, should-2)\n",
      "neg(started-5, not-3)\n",
      "auxpass(started-5, be-4)\n",
      "root(ROOT-0, started-5)\n",
      "advmod(started-5, perioperatively-6)\n",
      "cc(started-5, but-8)\n",
      "amod(regimens-11, long-term-9)\n",
      "compound(regimens-11, clonidine-10)\n",
      "nsubjpass(continued-14, regimens-11)\n",
      "aux(continued-14, may-12)\n",
      "auxpass(continued-14, be-13)\n",
      "conj:but(started-5, continued-14)\n",
      "\n",
      "Parsing [sent. 137 len. 25]: ACEI and angiotensin receptor blockers generally can be continued perioperatively if patients are hemodynamically stable and have good renal function and normal electrolyte levels .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI)\n",
      "      (CC and)\n",
      "      (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "    (ADVP (RB generally))\n",
      "    (VP (MD can)\n",
      "      (VP\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)\n",
      "            (ADVP (RB perioperatively))\n",
      "            (SBAR (IN if)\n",
      "              (S\n",
      "                (NP (NNS patients))\n",
      "                (VP (VBP are)\n",
      "                  (ADJP (RB hemodynamically) (JJ stable)))))))\n",
      "        (CC and)\n",
      "        (VP (VB have)\n",
      "          (NP (JJ good) (JJ renal) (NN function)\n",
      "            (CC and)\n",
      "            (JJ normal) (NN electrolyte) (NNS levels)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(blockers-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, angiotensin-3)\n",
      "compound(blockers-5, angiotensin-3)\n",
      "compound(blockers-5, receptor-4)\n",
      "nsubjpass(continued-9, blockers-5)\n",
      "nsubj(have-17, blockers-5)\n",
      "advmod(continued-9, generally-6)\n",
      "aux(continued-9, can-7)\n",
      "auxpass(continued-9, be-8)\n",
      "root(ROOT-0, continued-9)\n",
      "advmod(continued-9, perioperatively-10)\n",
      "mark(stable-15, if-11)\n",
      "nsubj(stable-15, patients-12)\n",
      "cop(stable-15, are-13)\n",
      "advmod(stable-15, hemodynamically-14)\n",
      "advcl(continued-9, stable-15)\n",
      "cc(continued-9, and-16)\n",
      "conj:and(continued-9, have-17)\n",
      "amod(function-20, good-18)\n",
      "amod(function-20, renal-19)\n",
      "dobj(have-17, function-20)\n",
      "cc(function-20, and-21)\n",
      "amod(levels-24, normal-22)\n",
      "compound(levels-24, electrolyte-23)\n",
      "dobj(have-17, levels-24)\n",
      "conj:and(function-20, levels-24)\n",
      "\n",
      "Parsing [sent. 138 len. 28]: to assess drug adherence of patients with hypertension , an analytical method was developed and validated using ultra performance liquid chromatography tandem mass spectrometry -LRB- uplc-ms/ms -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (VP (TO to)\n",
      "        (VP (VB assess)\n",
      "          (NP\n",
      "            (NP (NN drug) (NN adherence))\n",
      "            (PP (IN of)\n",
      "              (NP (NNS patients))))\n",
      "          (PP (IN with)\n",
      "            (NP (NN hypertension))))))\n",
      "    (, ,)\n",
      "    (NP (DT an) (JJ analytical) (NN method))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN developed)\n",
      "        (CC and)\n",
      "        (VBN validated)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP (NN ultra) (NN performance) (NN liquid) (NN chromatography) (NN tandem))\n",
      "              (ADJP (RB mass) (JJ spectrometry))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNS uplc-ms/ms))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(assess-2, to-1)\n",
      "advcl(developed-14, assess-2)\n",
      "compound(adherence-4, drug-3)\n",
      "dobj(assess-2, adherence-4)\n",
      "case(patients-6, of-5)\n",
      "nmod:of(adherence-4, patients-6)\n",
      "case(hypertension-8, with-7)\n",
      "nmod:with(assess-2, hypertension-8)\n",
      "det(method-12, an-10)\n",
      "amod(method-12, analytical-11)\n",
      "nsubjpass(developed-14, method-12)\n",
      "nsubjpass(validated-16, method-12)\n",
      "auxpass(developed-14, was-13)\n",
      "root(ROOT-0, developed-14)\n",
      "cc(developed-14, and-15)\n",
      "conj:and(developed-14, validated-16)\n",
      "xcomp(developed-14, using-17)\n",
      "compound(tandem-22, ultra-18)\n",
      "compound(tandem-22, performance-19)\n",
      "compound(tandem-22, liquid-20)\n",
      "compound(tandem-22, chromatography-21)\n",
      "dobj(using-17, tandem-22)\n",
      "advmod(spectrometry-24, mass-23)\n",
      "amod(tandem-22, spectrometry-24)\n",
      "appos(tandem-22, uplc-ms/ms-26)\n",
      "\n",
      "Parsing [sent. 139 len. 65]: the method includes eight frequently prescribed antihypertensive drugs from four classes and their active metabolites : ACEI enalapril and perindopril -LRB- active metabolites respectively enalaprilate and perindoprilate -RRB- , angiotensin ii receptor blockers losartan -LRB- with the active metabolite losartan carboxylic acid -RRB- and valsartan , calcium channel blockers amlodipine and nifedipine and diuretics hydrochlorothiazide and spironolactone -LRB- with the active metabolite canrenone -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (DT the) (NN method))\n",
      "      (VP (VBZ includes)\n",
      "        (NP (CD eight))\n",
      "        (UCP\n",
      "          (VP\n",
      "            (ADVP (RB frequently))\n",
      "            (VBN prescribed)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ antihypertensive) (NNS drugs))\n",
      "                (PP (IN from)\n",
      "                  (NP\n",
      "                    (NP (CD four) (NNS classes))\n",
      "                    (CC and)\n",
      "                    (NP (PRP$ their) (JJ active) (NNS metabolites)))))\n",
      "              (: :)\n",
      "              (NP\n",
      "                (NP (NNP ACEI))\n",
      "                (ADJP (JJ enalapril)\n",
      "                  (CC and)\n",
      "                  (JJ perindopril)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (S\n",
      "                  (NP (JJ active) (NNS metabolites))\n",
      "                  (ADVP (RB respectively))\n",
      "                  (VP (VBP enalaprilate)\n",
      "                    (CC and)\n",
      "                    (VBP perindoprilate)))\n",
      "                (-RRB- -RRB-))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN angiotensin) (NN ii) (NN receptor) (NNS blockers))\n",
      "                (VP (VBN losartan)\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (PP (IN with)\n",
      "                      (NP (DT the) (JJ active) (JJ metabolite) (NN losartan) (JJ carboxylic) (NN acid)))\n",
      "                    (-RRB- -RRB-))))))\n",
      "          (CC and)\n",
      "          (ADJP (JJ valsartan)))))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "      (ADJP (JJ amlodipine)\n",
      "        (CC and)\n",
      "        (JJ nifedipine)))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NNS diuretics))\n",
      "      (ADJP\n",
      "        (ADJP (JJ hydrochlorothiazide)\n",
      "          (CC and)\n",
      "          (JJ spironolactone))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (PP (IN with)\n",
      "            (NP (DT the) (JJ active) (NN metabolite) (NN canrenone)))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "det(method-2, the-1)\n",
      "nsubj(includes-3, method-2)\n",
      "nsubj(amlodipine-50, method-2)\n",
      "nsubj(hydrochlorothiazide-55, method-2)\n",
      "root(ROOT-0, includes-3)\n",
      "dobj(includes-3, eight-4)\n",
      "advmod(prescribed-6, frequently-5)\n",
      "dep(includes-3, prescribed-6)\n",
      "amod(drugs-8, antihypertensive-7)\n",
      "dobj(prescribed-6, drugs-8)\n",
      "case(classes-11, from-9)\n",
      "nummod(classes-11, four-10)\n",
      "nmod:from(drugs-8, classes-11)\n",
      "cc(classes-11, and-12)\n",
      "nmod:poss(metabolites-15, their-13)\n",
      "amod(metabolites-15, active-14)\n",
      "nmod:from(drugs-8, metabolites-15)\n",
      "conj:and(classes-11, metabolites-15)\n",
      "dep(drugs-8, ACEI-17)\n",
      "amod(ACEI-17, enalapril-18)\n",
      "cc(enalapril-18, and-19)\n",
      "amod(ACEI-17, perindopril-20)\n",
      "conj:and(enalapril-18, perindopril-20)\n",
      "amod(metabolites-23, active-22)\n",
      "nsubj(enalaprilate-25, metabolites-23)\n",
      "nsubj(perindoprilate-27, metabolites-23)\n",
      "advmod(enalaprilate-25, respectively-24)\n",
      "dep(drugs-8, enalaprilate-25)\n",
      "cc(enalaprilate-25, and-26)\n",
      "dep(drugs-8, perindoprilate-27)\n",
      "conj:and(enalaprilate-25, perindoprilate-27)\n",
      "compound(blockers-33, angiotensin-30)\n",
      "compound(blockers-33, ii-31)\n",
      "compound(blockers-33, receptor-32)\n",
      "appos(drugs-8, blockers-33)\n",
      "acl(blockers-33, losartan-34)\n",
      "case(acid-42, with-36)\n",
      "det(acid-42, the-37)\n",
      "amod(acid-42, active-38)\n",
      "amod(acid-42, metabolite-39)\n",
      "compound(acid-42, losartan-40)\n",
      "amod(acid-42, carboxylic-41)\n",
      "dep(losartan-34, acid-42)\n",
      "cc(prescribed-6, and-44)\n",
      "dep(includes-3, valsartan-45)\n",
      "conj:and(prescribed-6, valsartan-45)\n",
      "compound(blockers-49, calcium-47)\n",
      "compound(blockers-49, channel-48)\n",
      "dep(amlodipine-50, blockers-49)\n",
      "conj:and(includes-3, amlodipine-50)\n",
      "cc(amlodipine-50, and-51)\n",
      "conj:and(includes-3, nifedipine-52)\n",
      "conj:and(amlodipine-50, nifedipine-52)\n",
      "cc(includes-3, and-53)\n",
      "dep(hydrochlorothiazide-55, diuretics-54)\n",
      "conj:and(includes-3, hydrochlorothiazide-55)\n",
      "cc(hydrochlorothiazide-55, and-56)\n",
      "conj:and(includes-3, spironolactone-57)\n",
      "conj:and(hydrochlorothiazide-55, spironolactone-57)\n",
      "case(canrenone-63, with-59)\n",
      "det(canrenone-63, the-60)\n",
      "amod(canrenone-63, active-61)\n",
      "compound(canrenone-63, metabolite-62)\n",
      "dep(hydrochlorothiazide-55, canrenone-63)\n",
      "\n",
      "Parsing [sent. 140 len. 21]: this study demonstrates that ACEI-is/arbs therapy decreases the loss of residual renal function , mainly for patients with peritoneal dialysis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN study))\n",
      "    (VP (VBZ demonstrates)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP ACEI-is/arbs) (NN therapy))\n",
      "          (VP (VBZ decreases)\n",
      "            (NP\n",
      "              (NP (DT the) (NN loss))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ residual) (JJ renal) (NN function))))\n",
      "            (, ,)\n",
      "            (PP\n",
      "              (ADVP (RB mainly))\n",
      "              (IN for)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ peritoneal) (NN dialysis)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(study-2, this-1)\n",
      "nsubj(demonstrates-3, study-2)\n",
      "root(ROOT-0, demonstrates-3)\n",
      "mark(decreases-7, that-4)\n",
      "compound(therapy-6, ACEI-is/arbs-5)\n",
      "nsubj(decreases-7, therapy-6)\n",
      "ccomp(demonstrates-3, decreases-7)\n",
      "det(loss-9, the-8)\n",
      "dobj(decreases-7, loss-9)\n",
      "case(function-13, of-10)\n",
      "amod(function-13, residual-11)\n",
      "amod(function-13, renal-12)\n",
      "nmod:of(loss-9, function-13)\n",
      "advmod(patients-17, mainly-15)\n",
      "case(patients-17, for-16)\n",
      "nmod:for(decreases-7, patients-17)\n",
      "case(dialysis-20, with-18)\n",
      "amod(dialysis-20, peritoneal-19)\n",
      "nmod:with(patients-17, dialysis-20)\n",
      "\n",
      "Parsing [sent. 141 len. 28]: overall , ACEI-is and arbs do not reduce cardiovascular events in dialysis patients , however , treatment with arb seems to reduce cardiovascular events including heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ overall) (, ,) (NNS ACEI-is)\n",
      "        (CC and)\n",
      "        (NNS arbs))\n",
      "      (VP (VBP do) (RB not)\n",
      "        (VP (VB reduce)\n",
      "          (NP (JJ cardiovascular) (NNS events))\n",
      "          (PP (IN in)\n",
      "            (NP (NN dialysis) (NNS patients)))\n",
      "          (, ,)\n",
      "          (ADVP (RB however)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN treatment))\n",
      "      (PP (IN with)\n",
      "        (NP (NN arb))))\n",
      "    (VP (VBZ seems)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB reduce)\n",
      "            (NP\n",
      "              (NP (JJ cardiovascular) (NNS events))\n",
      "              (PP (VBG including)\n",
      "                (NP (NN heart) (NN failure))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(reduce-8, overall-1)\n",
      "conj:and(overall-1, ACEI-is-3)\n",
      "nsubj(reduce-8, ACEI-is-3)\n",
      "cc(overall-1, and-4)\n",
      "conj:and(overall-1, arbs-5)\n",
      "nsubj(reduce-8, arbs-5)\n",
      "aux(reduce-8, do-6)\n",
      "neg(reduce-8, not-7)\n",
      "ccomp(seems-20, reduce-8)\n",
      "amod(events-10, cardiovascular-9)\n",
      "dobj(reduce-8, events-10)\n",
      "case(patients-13, in-11)\n",
      "compound(patients-13, dialysis-12)\n",
      "nmod:in(reduce-8, patients-13)\n",
      "advmod(reduce-8, however-15)\n",
      "nsubj(seems-20, treatment-17)\n",
      "nsubj:xsubj(reduce-22, treatment-17)\n",
      "case(arb-19, with-18)\n",
      "nmod:with(treatment-17, arb-19)\n",
      "root(ROOT-0, seems-20)\n",
      "mark(reduce-22, to-21)\n",
      "xcomp(seems-20, reduce-22)\n",
      "amod(events-24, cardiovascular-23)\n",
      "dobj(reduce-22, events-24)\n",
      "case(failure-27, including-25)\n",
      "compound(failure-27, heart-26)\n",
      "nmod:including(events-24, failure-27)\n",
      "\n",
      "Parsing [sent. 142 len. 13]: ACEI-is and arbs do not induce an extra risk of side effects .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS ACEI-is)\n",
      "      (CC and)\n",
      "      (NNS arbs))\n",
      "    (VP (VBP do) (RB not)\n",
      "      (VP (VB induce)\n",
      "        (NP\n",
      "          (NP (DT an) (JJ extra) (NN risk))\n",
      "          (PP (IN of)\n",
      "            (NP (NN side) (NNS effects))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(induce-6, ACEI-is-1)\n",
      "cc(ACEI-is-1, and-2)\n",
      "conj:and(ACEI-is-1, arbs-3)\n",
      "nsubj(induce-6, arbs-3)\n",
      "aux(induce-6, do-4)\n",
      "neg(induce-6, not-5)\n",
      "root(ROOT-0, induce-6)\n",
      "det(risk-9, an-7)\n",
      "amod(risk-9, extra-8)\n",
      "dobj(induce-6, risk-9)\n",
      "case(effects-12, of-10)\n",
      "compound(effects-12, side-11)\n",
      "nmod:of(risk-9, effects-12)\n",
      "\n",
      "Parsing [sent. 143 len. 11]: eleven trials included 1856 participants who were receiving dialysis therapy .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS eleven) (NNS trials))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (CD 1856) (NNS participants))\n",
      "        (SBAR\n",
      "          (WHNP (WP who))\n",
      "          (S\n",
      "            (VP (VBD were)\n",
      "              (VP (VBG receiving)\n",
      "                (NP (NN dialysis) (NN therapy))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(trials-2, eleven-1)\n",
      "nsubj(included-3, trials-2)\n",
      "root(ROOT-0, included-3)\n",
      "nummod(participants-5, 1856-4)\n",
      "dobj(included-3, participants-5)\n",
      "nsubj(receiving-8, participants-5)\n",
      "ref(participants-5, who-6)\n",
      "aux(receiving-8, were-7)\n",
      "acl:relcl(participants-5, receiving-8)\n",
      "compound(therapy-10, dialysis-9)\n",
      "dobj(receiving-8, therapy-10)\n",
      "\n",
      "Parsing [sent. 144 len. 42]: compared with placebo or other active agents groups , arb therapy reduced the risk of heart failure events by 33 % -LRB- rr 0.67 , 95 % ci 0.47 to 0.93 -RRB- with similar decrement in blood pressure in dialysis patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (VBN compared)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (NN placebo))\n",
      "          (CC or)\n",
      "          (NP (JJ other) (JJ active) (NNS agents) (NNS groups)))))\n",
      "    (, ,)\n",
      "    (NP (NN arb) (NN therapy))\n",
      "    (VP (VBD reduced)\n",
      "      (NP\n",
      "        (NP (DT the) (NN risk))\n",
      "        (PP (IN of)\n",
      "          (NP (NN heart) (NN failure) (NNS events))))\n",
      "      (PP (IN by)\n",
      "        (NP\n",
      "          (NP (CD 33) (NN %))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP\n",
      "                (ADJP\n",
      "                  (QP (CD rr) (CD 0.67)))\n",
      "                (, ,)\n",
      "                (ADJP (CD 95) (NN %))\n",
      "                (NN ci) (NN 0.47))\n",
      "              (PP (TO to)\n",
      "                (NP (CD 0.93))))\n",
      "            (-RRB- -RRB-))))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ similar) (NN decrement))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NN blood) (NN pressure))\n",
      "              (PP (IN in)\n",
      "                (NP (NN dialysis) (NNS patients))))))))\n",
      "    (. .)))\n",
      "\n",
      "case(placebo-3, compared-1)\n",
      "mwe(compared-1, with-2)\n",
      "advcl(reduced-12, placebo-3)\n",
      "cc(placebo-3, or-4)\n",
      "amod(groups-8, other-5)\n",
      "amod(groups-8, active-6)\n",
      "compound(groups-8, agents-7)\n",
      "conj:or(placebo-3, groups-8)\n",
      "advcl(reduced-12, groups-8)\n",
      "compound(therapy-11, arb-10)\n",
      "nsubj(reduced-12, therapy-11)\n",
      "root(ROOT-0, reduced-12)\n",
      "det(risk-14, the-13)\n",
      "dobj(reduced-12, risk-14)\n",
      "case(events-18, of-15)\n",
      "compound(events-18, heart-16)\n",
      "compound(events-18, failure-17)\n",
      "nmod:of(risk-14, events-18)\n",
      "case(%-21, by-19)\n",
      "nummod(%-21, 33-20)\n",
      "nmod:by(reduced-12, %-21)\n",
      "compound(0.67-24, rr-23)\n",
      "nummod(0.47-29, 0.67-24)\n",
      "compound(%-27, 95-26)\n",
      "amod(0.47-29, %-27)\n",
      "compound(0.47-29, ci-28)\n",
      "dep(%-21, 0.47-29)\n",
      "case(0.93-31, to-30)\n",
      "nmod:to(0.47-29, 0.93-31)\n",
      "case(decrement-35, with-33)\n",
      "amod(decrement-35, similar-34)\n",
      "nmod:with(reduced-12, decrement-35)\n",
      "case(pressure-38, in-36)\n",
      "compound(pressure-38, blood-37)\n",
      "nmod:in(decrement-35, pressure-38)\n",
      "case(patients-41, in-39)\n",
      "compound(patients-41, dialysis-40)\n",
      "nmod:in(pressure-38, patients-41)\n",
      "\n",
      "Parsing [sent. 145 len. 20]: indirect comparison suggested that fewer cardiovascular events happened during treatment with arb -LRB- 0.77 , 0.63 to 0.94 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ indirect) (NN comparison))\n",
      "    (VP (VBD suggested)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (JJR fewer) (JJ cardiovascular) (NNS events))\n",
      "          (VP (VBD happened)\n",
      "            (PP (IN during)\n",
      "              (NP (NN treatment)))\n",
      "            (PP (IN with)\n",
      "              (NP (NN arb)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 0.77))\n",
      "                (, ,)\n",
      "                (NP (CD 0.63) (TO to) (CD 0.94)))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(comparison-2, indirect-1)\n",
      "nsubj(suggested-3, comparison-2)\n",
      "root(ROOT-0, suggested-3)\n",
      "mark(happened-8, that-4)\n",
      "amod(events-7, fewer-5)\n",
      "amod(events-7, cardiovascular-6)\n",
      "nsubj(happened-8, events-7)\n",
      "ccomp(suggested-3, happened-8)\n",
      "case(treatment-10, during-9)\n",
      "nmod:during(happened-8, treatment-10)\n",
      "case(arb-12, with-11)\n",
      "nmod:with(happened-8, arb-12)\n",
      "dep(happened-8, 0.77-14)\n",
      "nummod(0.94-18, 0.63-16)\n",
      "dep(0.94-18, to-17)\n",
      "appos(0.77-14, 0.94-18)\n",
      "\n",
      "Parsing [sent. 146 len. 55]: the results indicated no significant differences between the two treatment regimens with regard to frequency of myocardial infarction -LRB- 1.0 , 0.45 to 2.22 -RRB- , stroke -LRB- 1.16 , 0.69 to 1.96 -RRB- , cardiovascular death -LRB- 0.89 , 0.64 to 1.26 -RRB- and all-cause mortality -LRB- 0.94 , 0.75 to 1.17 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNS results))\n",
      "    (VP (VBD indicated)\n",
      "      (NP\n",
      "        (NP (DT no) (JJ significant) (NNS differences))\n",
      "        (PP (IN between)\n",
      "          (NP (DT the) (CD two) (NN treatment) (NNS regimens))))\n",
      "      (PP (IN with)\n",
      "        (NP (NN regard)))\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (NN frequency))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ myocardial) (NN infarction))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 1.0))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.45) (TO to) (CD 2.22)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN stroke))\n",
      "                (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (CD 1.16))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (QP (CD 0.69) (TO to) (CD 1.96))))\n",
      "                (-RRB- -RRB-))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (JJ cardiovascular) (NN death))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (NNP 0.89))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.64) (TO to) (CD 1.26)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (JJ all-cause) (NN mortality))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 0.94))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.75) (TO to) (CD 1.17)))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(results-2, the-1)\n",
      "nsubj(indicated-3, results-2)\n",
      "root(ROOT-0, indicated-3)\n",
      "neg(differences-6, no-4)\n",
      "amod(differences-6, significant-5)\n",
      "dobj(indicated-3, differences-6)\n",
      "case(regimens-11, between-7)\n",
      "det(regimens-11, the-8)\n",
      "nummod(regimens-11, two-9)\n",
      "compound(regimens-11, treatment-10)\n",
      "nmod:between(differences-6, regimens-11)\n",
      "case(regard-13, with-12)\n",
      "nmod:with(indicated-3, regard-13)\n",
      "case(frequency-15, to-14)\n",
      "nmod:to(indicated-3, frequency-15)\n",
      "case(infarction-18, of-16)\n",
      "amod(infarction-18, myocardial-17)\n",
      "nmod:of(frequency-15, infarction-18)\n",
      "dep(infarction-18, 1.0-20)\n",
      "nummod(2.22-24, 0.45-22)\n",
      "dep(2.22-24, to-23)\n",
      "appos(1.0-20, 2.22-24)\n",
      "nmod:of(frequency-15, stroke-27)\n",
      "conj:and(infarction-18, stroke-27)\n",
      "dep(stroke-27, 1.16-29)\n",
      "compound(1.96-33, 0.69-31)\n",
      "dep(1.96-33, to-32)\n",
      "appos(1.16-29, 1.96-33)\n",
      "amod(death-37, cardiovascular-36)\n",
      "nmod:of(frequency-15, death-37)\n",
      "conj:and(infarction-18, death-37)\n",
      "dep(death-37, 0.89-39)\n",
      "nummod(1.26-43, 0.64-41)\n",
      "dep(1.26-43, to-42)\n",
      "appos(0.89-39, 1.26-43)\n",
      "cc(infarction-18, and-45)\n",
      "amod(mortality-47, all-cause-46)\n",
      "nmod:of(frequency-15, mortality-47)\n",
      "conj:and(infarction-18, mortality-47)\n",
      "dep(mortality-47, 0.94-49)\n",
      "nummod(1.17-53, 0.75-51)\n",
      "dep(1.17-53, to-52)\n",
      "appos(0.94-49, 1.17-53)\n",
      "\n",
      "Parsing [sent. 147 len. 60]: five studies reported the renoprotective effect and revealed that ACEI/arb therapy significantly slowed the rate of decline in both residual renal function -LRB- md 0.93 ml/min/1 .73 m -LRB- 2 -RRB- , 0.38 to 1.47 ml/min/1 .73 m -LRB- 2 -RRB- -RRB- and urine volume -LRB- md 167 ml , 95 % ci 21 ml to 357 ml -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (CD five) (NNS studies))\n",
      "    (VP\n",
      "      (VP (VBD reported)\n",
      "        (NP (DT the) (JJ renoprotective) (NN effect)))\n",
      "      (CC and)\n",
      "      (VP (VBD revealed)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP (NNP ACEI/arb) (NN therapy))\n",
      "            (ADVP (RB significantly))\n",
      "            (VP (VBD slowed)\n",
      "              (NP\n",
      "                (NP (DT the) (NN rate))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN decline))))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT both) (JJ residual) (JJ renal) (NN function))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NN md))\n",
      "                      (NP\n",
      "                        (NP (CD 0.93) (JJ ml/min/1) (CD .73) (NNS m))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 2))\n",
      "                          (-RRB- -RRB-))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP\n",
      "                            (QP (CD 0.38) (TO to) (CD 1.47))\n",
      "                            (JJ ml/min/1) (CD .73) (NNS m))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (CD 2))\n",
      "                            (-RRB- -RRB-)))))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (CC and)\n",
      "                  (NP (NN urine) (NN volume))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (QP (CD md) (CD 167))\n",
      "                        (NNP ml) (, ,)\n",
      "                        (ADJP (CD 95) (NN %))\n",
      "                        (JJ ci) (CD 21) (NN ml))\n",
      "                      (PP (TO to)\n",
      "                        (NP (CD 357) (NN ml))))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nummod(studies-2, five-1)\n",
      "nsubj(reported-3, studies-2)\n",
      "nsubj(revealed-8, studies-2)\n",
      "root(ROOT-0, reported-3)\n",
      "det(effect-6, the-4)\n",
      "amod(effect-6, renoprotective-5)\n",
      "dobj(reported-3, effect-6)\n",
      "cc(reported-3, and-7)\n",
      "conj:and(reported-3, revealed-8)\n",
      "mark(slowed-13, that-9)\n",
      "compound(therapy-11, ACEI/arb-10)\n",
      "nsubj(slowed-13, therapy-11)\n",
      "advmod(slowed-13, significantly-12)\n",
      "ccomp(revealed-8, slowed-13)\n",
      "det(rate-15, the-14)\n",
      "dobj(slowed-13, rate-15)\n",
      "case(decline-17, of-16)\n",
      "nmod:of(rate-15, decline-17)\n",
      "case(function-22, in-18)\n",
      "det(function-22, both-19)\n",
      "amod(function-22, residual-20)\n",
      "amod(function-22, renal-21)\n",
      "nmod:in(slowed-13, function-22)\n",
      "dep(function-22, md-24)\n",
      "nummod(m-28, 0.93-25)\n",
      "amod(m-28, ml/min/1-26)\n",
      "nummod(m-28, .73-27)\n",
      "dep(md-24, m-28)\n",
      "appos(m-28, 2-30)\n",
      "compound(1.47-35, 0.38-33)\n",
      "dep(1.47-35, to-34)\n",
      "nummod(m-38, 1.47-35)\n",
      "amod(m-38, ml/min/1-36)\n",
      "nummod(m-38, .73-37)\n",
      "appos(m-28, m-38)\n",
      "appos(m-38, 2-40)\n",
      "cc(function-22, and-43)\n",
      "compound(volume-45, urine-44)\n",
      "nmod:in(slowed-13, volume-45)\n",
      "conj:and(function-22, volume-45)\n",
      "compound(167-48, md-47)\n",
      "nummod(ml-55, 167-48)\n",
      "compound(ml-55, ml-49)\n",
      "compound(%-52, 95-51)\n",
      "amod(ml-55, %-52)\n",
      "amod(ml-55, ci-53)\n",
      "nummod(ml-55, 21-54)\n",
      "dep(function-22, ml-55)\n",
      "case(ml-58, to-56)\n",
      "nummod(ml-58, 357-57)\n",
      "nmod:to(ml-55, ml-58)\n",
      "\n",
      "Parsing [sent. 148 len. 13]: no difference in drug-related adverse events was observed in both treatment groups .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT no) (NN difference))\n",
      "      (PP (IN in)\n",
      "        (NP (JJ drug-related) (JJ adverse) (NNS events))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN in)\n",
      "          (NP (DT both) (NN treatment) (NNS groups)))))\n",
      "    (. .)))\n",
      "\n",
      "neg(difference-2, no-1)\n",
      "nsubjpass(observed-8, difference-2)\n",
      "case(events-6, in-3)\n",
      "amod(events-6, drug-related-4)\n",
      "amod(events-6, adverse-5)\n",
      "nmod:in(difference-2, events-6)\n",
      "auxpass(observed-8, was-7)\n",
      "root(ROOT-0, observed-8)\n",
      "case(groups-12, in-9)\n",
      "det(groups-12, both-10)\n",
      "compound(groups-12, treatment-11)\n",
      "nmod:in(observed-8, groups-12)\n",
      "\n",
      "Parsing [sent. 149 len. 32]: the role of ACEI and angiotensin receptor blockers -LRB- arbs -RRB- reducing risk of cardiovascular events -LRB- cves -RRB- and preserving kidney function in patients with chronic kidney disease is well-documented .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN role))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NNP ACEI)\n",
      "              (CC and)\n",
      "              (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNS arbs))\n",
      "              (-RRB- -RRB-)))\n",
      "          (VP\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP (NN risk))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ cardiovascular) (NNS events))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNS cves))\n",
      "                      (-RRB- -RRB-))))))\n",
      "            (CC and)\n",
      "            (VP (VBG preserving)\n",
      "              (NP (NN kidney) (NN function))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NNS patients))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ chronic) (NN kidney) (NN disease))))))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ well-documented)))\n",
      "    (. .)))\n",
      "\n",
      "det(role-2, the-1)\n",
      "nsubj(well-documented-31, role-2)\n",
      "case(blockers-8, of-3)\n",
      "compound(blockers-8, ACEI-4)\n",
      "cc(ACEI-4, and-5)\n",
      "conj:and(ACEI-4, angiotensin-6)\n",
      "compound(blockers-8, angiotensin-6)\n",
      "compound(blockers-8, receptor-7)\n",
      "nmod:of(role-2, blockers-8)\n",
      "appos(blockers-8, arbs-10)\n",
      "dep(blockers-8, reducing-12)\n",
      "dobj(reducing-12, risk-13)\n",
      "case(events-16, of-14)\n",
      "amod(events-16, cardiovascular-15)\n",
      "nmod:of(risk-13, events-16)\n",
      "appos(events-16, cves-18)\n",
      "cc(reducing-12, and-20)\n",
      "dep(blockers-8, preserving-21)\n",
      "conj:and(reducing-12, preserving-21)\n",
      "compound(function-23, kidney-22)\n",
      "dobj(preserving-21, function-23)\n",
      "case(patients-25, in-24)\n",
      "nmod:in(preserving-21, patients-25)\n",
      "case(disease-29, with-26)\n",
      "amod(disease-29, chronic-27)\n",
      "compound(disease-29, kidney-28)\n",
      "nmod:with(patients-25, disease-29)\n",
      "cop(well-documented-31, is-30)\n",
      "root(ROOT-0, well-documented-31)\n",
      "\n",
      "Parsing [sent. 150 len. 18]: however , the efficacy and safety of these agents in dialysis patients is still a controversial issue .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN efficacy)\n",
      "        (CC and)\n",
      "        (NN safety))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT these) (NNS agents))\n",
      "          (PP (IN in)\n",
      "            (NP (NN dialysis) (NNS patients))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB still))\n",
      "      (NP (DT a) (JJ controversial) (NN issue)))\n",
      "    (. .)))\n",
      "\n",
      "advmod(issue-17, however-1)\n",
      "det(efficacy-4, the-3)\n",
      "nsubj(issue-17, efficacy-4)\n",
      "cc(efficacy-4, and-5)\n",
      "conj:and(efficacy-4, safety-6)\n",
      "nsubj(issue-17, safety-6)\n",
      "case(agents-9, of-7)\n",
      "det(agents-9, these-8)\n",
      "nmod:of(efficacy-4, agents-9)\n",
      "case(patients-12, in-10)\n",
      "compound(patients-12, dialysis-11)\n",
      "nmod:in(agents-9, patients-12)\n",
      "cop(issue-17, is-13)\n",
      "advmod(issue-17, still-14)\n",
      "det(issue-17, a-15)\n",
      "amod(issue-17, controversial-16)\n",
      "root(ROOT-0, issue-17)\n",
      "\n",
      "Parsing [sent. 151 len. 56]: mex and aceimex groups improved all physical functional status outcomes , decreased systolic -LRB- sbp -RRB- and diastolic blood pressure -LRB- p < 0.001 -RRB- and augmented the physical functioning , role physical and physical component score -LRB- pcs -RRB- -LRB- p < 0.05 -RRB- , but also bodily pain -LRB- p < 0.05 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN mex)\n",
      "      (CC and)\n",
      "      (NN aceimex) (NNS groups))\n",
      "    (VP\n",
      "      (VP (VBD improved)\n",
      "        (NP (DT all)\n",
      "          (ADJP (JJ physical) (JJ functional))\n",
      "          (NN status) (NNS outcomes)))\n",
      "      (, ,)\n",
      "      (VP (VBD decreased)\n",
      "        (NP\n",
      "          (NP (JJ systolic) (-LRB- -LRB-) (NN sbp) (-RRB- -RRB-))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (JJ diastolic) (NN blood) (NN pressure))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p)\n",
      "                (QP (CD <) (CD 0.001)))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (CC and)\n",
      "      (VP (VBD augmented)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (JJ physical) (NN functioning))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NN role) (JJ physical)\n",
      "                  (CC and)\n",
      "                  (JJ physical) (NN component) (NN score))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN pcs))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN p)\n",
      "                  (NP (CD <) (CD 0.05)))\n",
      "                (-RRB- -RRB-))))\n",
      "          (, ,)\n",
      "          (CONJP (CC but)\n",
      "            (RB also))\n",
      "          (NP\n",
      "            (NP (JJ bodily) (NN pain))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p) (NNP <) (NNP 0.05))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(groups-4, mex-1)\n",
      "cc(mex-1, and-2)\n",
      "conj:and(mex-1, aceimex-3)\n",
      "compound(groups-4, aceimex-3)\n",
      "nsubj(improved-5, groups-4)\n",
      "nsubj(decreased-12, groups-4)\n",
      "nsubj(augmented-27, groups-4)\n",
      "root(ROOT-0, improved-5)\n",
      "det(outcomes-10, all-6)\n",
      "amod(functional-8, physical-7)\n",
      "amod(outcomes-10, functional-8)\n",
      "compound(outcomes-10, status-9)\n",
      "dobj(improved-5, outcomes-10)\n",
      "conj:and(improved-5, decreased-12)\n",
      "amod(sbp-15, systolic-13)\n",
      "dobj(decreased-12, sbp-15)\n",
      "cc(sbp-15, and-17)\n",
      "amod(pressure-20, diastolic-18)\n",
      "compound(pressure-20, blood-19)\n",
      "dobj(decreased-12, pressure-20)\n",
      "conj:and(sbp-15, pressure-20)\n",
      "appos(pressure-20, p-22)\n",
      "compound(0.001-24, <-23)\n",
      "nummod(p-22, 0.001-24)\n",
      "cc(improved-5, and-26)\n",
      "conj:and(improved-5, augmented-27)\n",
      "det(functioning-30, the-28)\n",
      "amod(functioning-30, physical-29)\n",
      "dobj(augmented-27, functioning-30)\n",
      "nmod:npmod(physical-33, role-32)\n",
      "appos(functioning-30, physical-33)\n",
      "cc(physical-33, and-34)\n",
      "amod(score-37, physical-35)\n",
      "compound(score-37, component-36)\n",
      "appos(functioning-30, score-37)\n",
      "conj:and(physical-33, score-37)\n",
      "appos(physical-33, pcs-39)\n",
      "dep(physical-33, p-42)\n",
      "nummod(0.05-44, <-43)\n",
      "dobj(p-42, 0.05-44)\n",
      "cc(functioning-30, but-47)\n",
      "advmod(pain-50, also-48)\n",
      "amod(pain-50, bodily-49)\n",
      "dobj(augmented-27, pain-50)\n",
      "conj:and(functioning-30, pain-50)\n",
      "compound(0.05-54, p-52)\n",
      "compound(0.05-54, <-53)\n",
      "appos(pain-50, 0.05-54)\n",
      "\n",
      "Parsing [sent. 152 len. 48]: the ACEI group reduced the upper body strength , upper and lower body flexibility and aerobic endurance -LRB- p < 0.05 -RRB- ; worsened the anthropometric profile , and sbp -LRB- p < 0.001 -RRB- ; and decreased general health and pcs -LRB- p < 0.05 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNP ACEI) (NN group))\n",
      "    (VP (VBD reduced)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (DT the) (JJ upper) (NN body) (NN strength))\n",
      "          (, ,)\n",
      "          (NP (JJ upper))\n",
      "          (CC and)\n",
      "          (NP (JJR lower) (NN body) (NN flexibility)))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ aerobic) (NNS endurance))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (: ;)\n",
      "        (NP\n",
      "          (NP\n",
      "            (ADVP (RB worsened))\n",
      "            (DT the) (JJ anthropometric) (NN profile))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (NN sbp))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p)\n",
      "                (QP (CD <) (CD 0.001)))\n",
      "              (-RRB- -RRB-))))\n",
      "        (: ;)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (VBN decreased) (JJ general) (NN health))\n",
      "            (CC and)\n",
      "            (NP (NN pcs)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "det(group-3, the-1)\n",
      "compound(group-3, ACEI-2)\n",
      "nsubj(reduced-4, group-3)\n",
      "root(ROOT-0, reduced-4)\n",
      "det(strength-8, the-5)\n",
      "amod(strength-8, upper-6)\n",
      "compound(strength-8, body-7)\n",
      "dobj(reduced-4, strength-8)\n",
      "dobj(reduced-4, upper-10)\n",
      "conj:and(strength-8, upper-10)\n",
      "cc(strength-8, and-11)\n",
      "amod(flexibility-14, lower-12)\n",
      "compound(flexibility-14, body-13)\n",
      "dobj(reduced-4, flexibility-14)\n",
      "conj:and(strength-8, flexibility-14)\n",
      "cc(strength-8, and-15)\n",
      "amod(endurance-17, aerobic-16)\n",
      "dobj(reduced-4, endurance-17)\n",
      "conj:and(strength-8, endurance-17)\n",
      "dep(endurance-17, p-19)\n",
      "nummod(0.05-21, <-20)\n",
      "dobj(p-19, 0.05-21)\n",
      "advmod(profile-27, worsened-24)\n",
      "det(profile-27, the-25)\n",
      "amod(profile-27, anthropometric-26)\n",
      "dobj(reduced-4, profile-27)\n",
      "conj:and(strength-8, profile-27)\n",
      "cc(profile-27, and-29)\n",
      "conj:and(strength-8, sbp-30)\n",
      "conj:and(profile-27, sbp-30)\n",
      "appos(sbp-30, p-32)\n",
      "compound(0.001-34, <-33)\n",
      "nummod(p-32, 0.001-34)\n",
      "cc(strength-8, and-37)\n",
      "amod(health-40, decreased-38)\n",
      "amod(health-40, general-39)\n",
      "dobj(reduced-4, health-40)\n",
      "conj:and(strength-8, health-40)\n",
      "cc(health-40, and-41)\n",
      "conj:and(strength-8, pcs-42)\n",
      "conj:and(health-40, pcs-42)\n",
      "dep(health-40, p-44)\n",
      "nummod(0.05-46, <-45)\n",
      "dobj(p-44, 0.05-46)\n",
      "\n",
      "Parsed file: KeywordSentences.txt [152 sentences].\n",
      "Parsed 4222 words in 152 sentences (48.96 wds/sec; 1.76 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.7 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsing [sent. 1 len. 44]: renin-angiotensin-aldosterone system -LRB- raas -RRB- antagonists , including ACEI , angiotensin receptor blockers -LRB- arb -RRB- , and mineralocorticoid receptor antagonists -LRB- mra -RRB- decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia , especially when used in combination .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ renin-angiotensin-aldosterone) (NN system)\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNS raas))\n",
      "          (-RRB- -RRB-))\n",
      "        (NNS antagonists))\n",
      "      (, ,)\n",
      "      (PP (VBG including)\n",
      "        (NP (NNP ACEI)))\n",
      "      (, ,))\n",
      "    (VP (VBD angiotensin)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN receptor) (NNS blockers))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN arb))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ mineralocorticoid) (NN receptor) (NNS antagonists))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN mra))\n",
      "            (-RRB- -RRB-))))\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (VB decrease)\n",
      "            (NP (NN mortality)\n",
      "              (CC and)\n",
      "              (NN morbidity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN heart) (NN failure))))\n",
      "          (CC but)\n",
      "          (VP (VB increase)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP (NN hyperkalemia)))))))\n",
      "      (, ,)\n",
      "      (SBAR\n",
      "        (WHADVP (RB especially) (WRB when))\n",
      "        (S\n",
      "          (VP (VBN used)\n",
      "            (PP (IN in)\n",
      "              (NP (NN combination)))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(antagonists-6, renin-angiotensin-aldosterone-1)\n",
      "compound(antagonists-6, system-2)\n",
      "appos(antagonists-6, raas-4)\n",
      "nsubj(angiotensin-11, antagonists-6)\n",
      "case(ACEI-9, including-8)\n",
      "nmod:including(antagonists-6, ACEI-9)\n",
      "root(ROOT-0, angiotensin-11)\n",
      "compound(blockers-13, receptor-12)\n",
      "dobj(angiotensin-11, blockers-13)\n",
      "appos(blockers-13, arb-15)\n",
      "cc(blockers-13, and-18)\n",
      "amod(antagonists-21, mineralocorticoid-19)\n",
      "compound(antagonists-21, receptor-20)\n",
      "dobj(angiotensin-11, antagonists-21)\n",
      "conj:and(blockers-13, antagonists-21)\n",
      "appos(antagonists-21, mra-23)\n",
      "dep(angiotensin-11, decrease-25)\n",
      "dobj(decrease-25, mortality-26)\n",
      "cc(mortality-26, and-27)\n",
      "dobj(decrease-25, morbidity-28)\n",
      "conj:and(mortality-26, morbidity-28)\n",
      "case(failure-31, in-29)\n",
      "compound(failure-31, heart-30)\n",
      "nmod:in(decrease-25, failure-31)\n",
      "cc(decrease-25, but-32)\n",
      "dep(angiotensin-11, increase-33)\n",
      "conj:but(decrease-25, increase-33)\n",
      "det(risk-35, the-34)\n",
      "dobj(increase-33, risk-35)\n",
      "case(hyperkalemia-37, of-36)\n",
      "nmod:of(risk-35, hyperkalemia-37)\n",
      "advmod(when-40, especially-39)\n",
      "advmod(used-41, when-40)\n",
      "advcl(angiotensin-11, used-41)\n",
      "case(combination-43, in-42)\n",
      "nmod:in(used-41, combination-43)\n",
      "\n",
      "Parsing [sent. 2 len. 28]: prevention of hyperkalemia and its associated complications requires careful patient selection , counseling regarding dietary potassium intake , awareness of drug interactions , and regular laboratory surveillance .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN prevention))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN hyperkalemia))\n",
      "          (CC and)\n",
      "          (NP (PRP$ its) (JJ associated) (NNS complications)))))\n",
      "    (VP (VBZ requires)\n",
      "      (NP\n",
      "        (NP (JJ careful) (NN patient) (NN selection))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN counseling))\n",
      "          (PP (VBG regarding)\n",
      "            (NP\n",
      "              (NP (JJ dietary) (NN potassium) (NN intake))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN awareness))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN drug) (NNS interactions))))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (JJ regular) (NN laboratory) (NN surveillance)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(requires-8, prevention-1)\n",
      "case(hyperkalemia-3, of-2)\n",
      "nmod:of(prevention-1, hyperkalemia-3)\n",
      "cc(hyperkalemia-3, and-4)\n",
      "nmod:poss(complications-7, its-5)\n",
      "amod(complications-7, associated-6)\n",
      "nmod:of(prevention-1, complications-7)\n",
      "conj:and(hyperkalemia-3, complications-7)\n",
      "root(ROOT-0, requires-8)\n",
      "amod(selection-11, careful-9)\n",
      "compound(selection-11, patient-10)\n",
      "dobj(requires-8, selection-11)\n",
      "appos(selection-11, counseling-13)\n",
      "case(intake-17, regarding-14)\n",
      "amod(intake-17, dietary-15)\n",
      "compound(intake-17, potassium-16)\n",
      "nmod:regarding(counseling-13, intake-17)\n",
      "nmod:regarding(counseling-13, awareness-19)\n",
      "conj:and(intake-17, awareness-19)\n",
      "case(interactions-22, of-20)\n",
      "compound(interactions-22, drug-21)\n",
      "nmod:of(awareness-19, interactions-22)\n",
      "cc(intake-17, and-24)\n",
      "amod(surveillance-27, regular-25)\n",
      "compound(surveillance-27, laboratory-26)\n",
      "nmod:regarding(counseling-13, surveillance-27)\n",
      "conj:and(intake-17, surveillance-27)\n",
      "\n",
      "Parsing [sent. 3 len. 29]: recent data suggests that the risk of hyperkalemia may be further moderated through the use of combined angiotensin-neprilysin inhibitors , novel mras , and novel potassium binding agents .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ recent) (NNS data))\n",
      "    (VP (VBZ suggests)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN risk))\n",
      "            (PP (IN of)\n",
      "              (NP (NN hyperkalemia))))\n",
      "          (VP (MD may)\n",
      "            (VP (VB be)\n",
      "              (VP (RBR further) (VBN moderated)\n",
      "                (PP (IN through)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN use))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (VBN combined) (JJ angiotensin-neprilysin) (NNS inhibitors))\n",
      "                        (, ,)\n",
      "                        (NP (NN novel) (NNS mras))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP (NN novel) (NN potassium) (VBG binding) (NNS agents))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(data-2, recent-1)\n",
      "nsubj(suggests-3, data-2)\n",
      "root(ROOT-0, suggests-3)\n",
      "mark(moderated-12, that-4)\n",
      "det(risk-6, the-5)\n",
      "nsubjpass(moderated-12, risk-6)\n",
      "case(hyperkalemia-8, of-7)\n",
      "nmod:of(risk-6, hyperkalemia-8)\n",
      "aux(moderated-12, may-9)\n",
      "auxpass(moderated-12, be-10)\n",
      "advmod(moderated-12, further-11)\n",
      "ccomp(suggests-3, moderated-12)\n",
      "case(use-15, through-13)\n",
      "det(use-15, the-14)\n",
      "nmod:through(moderated-12, use-15)\n",
      "case(inhibitors-19, of-16)\n",
      "amod(inhibitors-19, combined-17)\n",
      "amod(inhibitors-19, angiotensin-neprilysin-18)\n",
      "nmod:of(use-15, inhibitors-19)\n",
      "compound(mras-22, novel-21)\n",
      "nmod:of(use-15, mras-22)\n",
      "conj:and(inhibitors-19, mras-22)\n",
      "cc(inhibitors-19, and-24)\n",
      "compound(agents-28, novel-25)\n",
      "compound(agents-28, potassium-26)\n",
      "amod(agents-28, binding-27)\n",
      "nmod:of(use-15, agents-28)\n",
      "conj:and(inhibitors-19, agents-28)\n",
      "\n",
      "Parsing [sent. 4 len. 19]: clinicians should be mindful of the risk of hyperkalemia when prescribing raas inhibitors to patients with heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS clinicians))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ mindful)\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP (NN hyperkalemia))))))\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (VBG prescribing) (NNS raas))\n",
      "            (VP (VBZ inhibitors)\n",
      "              (PP (TO to)\n",
      "                (NP\n",
      "                  (NP (NNS patients))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN heart) (NN failure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(mindful-4, clinicians-1)\n",
      "aux(mindful-4, should-2)\n",
      "cop(mindful-4, be-3)\n",
      "root(ROOT-0, mindful-4)\n",
      "case(risk-7, of-5)\n",
      "det(risk-7, the-6)\n",
      "nmod:of(mindful-4, risk-7)\n",
      "case(hyperkalemia-9, of-8)\n",
      "nmod:of(risk-7, hyperkalemia-9)\n",
      "advmod(inhibitors-13, when-10)\n",
      "amod(raas-12, prescribing-11)\n",
      "nsubj(inhibitors-13, raas-12)\n",
      "advcl(mindful-4, inhibitors-13)\n",
      "case(patients-15, to-14)\n",
      "nmod:to(inhibitors-13, patients-15)\n",
      "case(failure-18, with-16)\n",
      "compound(failure-18, heart-17)\n",
      "nmod:with(patients-15, failure-18)\n",
      "\n",
      "Parsing [sent. 5 len. 33]: in patients at highest risk , such as those with diabetes , the elderly , and advanced chronic kidney disease , more intensive laboratory surveillance of potassium and creatinine may be required .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP\n",
      "        (NP (NNS patients))\n",
      "        (PP (IN at)\n",
      "          (NP (JJS highest) (NN risk)))\n",
      "        (, ,)\n",
      "        (PP (JJ such) (IN as)\n",
      "          (NP\n",
      "            (NP (DT those))\n",
      "            (PP (IN with)\n",
      "              (NP (NN diabetes)))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the)\n",
      "        (ADJP (JJ elderly) (, ,)\n",
      "          (CC and)\n",
      "          (JJ advanced))\n",
      "        (JJ chronic) (NN kidney) (NN disease) (, ,)\n",
      "        (ADJP (RBR more) (JJ intensive))\n",
      "        (NN laboratory) (NN surveillance))\n",
      "      (PP (IN of)\n",
      "        (NP (NN potassium)\n",
      "          (CC and)\n",
      "          (NN creatinine))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN required))))\n",
      "    (. .)))\n",
      "\n",
      "case(patients-2, in-1)\n",
      "nmod:in(required-32, patients-2)\n",
      "case(risk-5, at-3)\n",
      "amod(risk-5, highest-4)\n",
      "nmod:at(patients-2, risk-5)\n",
      "case(those-9, such-7)\n",
      "mwe(such-7, as-8)\n",
      "nmod:such_as(patients-2, those-9)\n",
      "case(diabetes-11, with-10)\n",
      "nmod:with(those-9, diabetes-11)\n",
      "det(surveillance-25, the-13)\n",
      "amod(surveillance-25, elderly-14)\n",
      "cc(elderly-14, and-16)\n",
      "conj:and(elderly-14, advanced-17)\n",
      "amod(surveillance-25, advanced-17)\n",
      "amod(surveillance-25, chronic-18)\n",
      "compound(surveillance-25, kidney-19)\n",
      "compound(surveillance-25, disease-20)\n",
      "advmod(intensive-23, more-22)\n",
      "amod(surveillance-25, intensive-23)\n",
      "compound(surveillance-25, laboratory-24)\n",
      "nsubjpass(required-32, surveillance-25)\n",
      "case(potassium-27, of-26)\n",
      "nmod:of(surveillance-25, potassium-27)\n",
      "cc(potassium-27, and-28)\n",
      "nmod:of(surveillance-25, creatinine-29)\n",
      "conj:and(potassium-27, creatinine-29)\n",
      "aux(required-32, may-30)\n",
      "auxpass(required-32, be-31)\n",
      "root(ROOT-0, required-32)\n",
      "\n",
      "Parsing [sent. 6 len. 18]: novel therapies hold promise for reducing the risk of hyperkalemia and enhancing the tolerability of raas antagonists .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN novel) (NNS therapies))\n",
      "    (VP (VBP hold)\n",
      "      (NP (NN promise))\n",
      "      (PP (IN for)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN risk))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN hyperkalemia)))))\n",
      "            (CC and)\n",
      "            (VP (VBG enhancing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN tolerability))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ raas) (NNS antagonists)))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(therapies-2, novel-1)\n",
      "nsubj(hold-3, therapies-2)\n",
      "root(ROOT-0, hold-3)\n",
      "dobj(hold-3, promise-4)\n",
      "mark(reducing-6, for-5)\n",
      "advcl(hold-3, reducing-6)\n",
      "det(risk-8, the-7)\n",
      "dobj(reducing-6, risk-8)\n",
      "case(hyperkalemia-10, of-9)\n",
      "nmod:of(risk-8, hyperkalemia-10)\n",
      "cc(reducing-6, and-11)\n",
      "advcl(hold-3, enhancing-12)\n",
      "conj:and(reducing-6, enhancing-12)\n",
      "det(tolerability-14, the-13)\n",
      "dobj(enhancing-12, tolerability-14)\n",
      "case(antagonists-17, of-15)\n",
      "amod(antagonists-17, raas-16)\n",
      "nmod:of(tolerability-14, antagonists-17)\n",
      "\n",
      "Parsing [sent. 7 len. 12]: heart failure is a disease with a high prevalence and incidence .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN heart) (NN failure))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (NN disease))\n",
      "        (PP (IN with)\n",
      "          (NP (DT a) (JJ high) (NN prevalence)\n",
      "            (CC and)\n",
      "            (NN incidence)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(disease-5, failure-2)\n",
      "cop(disease-5, is-3)\n",
      "det(disease-5, a-4)\n",
      "root(ROOT-0, disease-5)\n",
      "case(prevalence-9, with-6)\n",
      "det(prevalence-9, a-7)\n",
      "amod(prevalence-9, high-8)\n",
      "nmod:with(disease-5, prevalence-9)\n",
      "cc(prevalence-9, and-10)\n",
      "nmod:with(disease-5, incidence-11)\n",
      "conj:and(prevalence-9, incidence-11)\n",
      "\n",
      "Parsing [sent. 8 len. 25]: new therapeutic approaches are needed to prevent the onset of heart failure and to reduce the high morbidity and mortality associated with this disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ new) (JJ therapeutic) (NNS approaches))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN needed)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (TO to)\n",
      "              (VP (VB prevent)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN onset))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN heart) (NN failure))))))\n",
      "            (CC and)\n",
      "            (VP (TO to)\n",
      "              (VP (VB reduce)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ high) (NN morbidity)\n",
      "                    (CC and)\n",
      "                    (NN mortality))\n",
      "                  (VP (VBN associated)\n",
      "                    (PP (IN with)\n",
      "                      (NP (DT this) (NN disease)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(approaches-3, new-1)\n",
      "amod(approaches-3, therapeutic-2)\n",
      "nsubjpass(needed-5, approaches-3)\n",
      "auxpass(needed-5, are-4)\n",
      "root(ROOT-0, needed-5)\n",
      "mark(prevent-7, to-6)\n",
      "ccomp(needed-5, prevent-7)\n",
      "det(onset-9, the-8)\n",
      "dobj(prevent-7, onset-9)\n",
      "case(failure-12, of-10)\n",
      "compound(failure-12, heart-11)\n",
      "nmod:of(onset-9, failure-12)\n",
      "cc(prevent-7, and-13)\n",
      "mark(reduce-15, to-14)\n",
      "ccomp(needed-5, reduce-15)\n",
      "conj:and(prevent-7, reduce-15)\n",
      "det(morbidity-18, the-16)\n",
      "amod(morbidity-18, high-17)\n",
      "dobj(reduce-15, morbidity-18)\n",
      "cc(morbidity-18, and-19)\n",
      "dobj(reduce-15, mortality-20)\n",
      "conj:and(morbidity-18, mortality-20)\n",
      "acl(morbidity-18, associated-21)\n",
      "case(disease-24, with-22)\n",
      "det(disease-24, this-23)\n",
      "nmod:with(associated-21, disease-24)\n",
      "\n",
      "Parsing [sent. 9 len. 31]: an optimized therapy of arterial hypertension in patients with risk factors and the use of the sglt2 inhibitor empagliflozin in type 2 diabetics are proven strategies to prevent heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT an) (JJ optimized) (NN therapy))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (JJ arterial) (NN hypertension))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN risk) (NNS factors))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT the) (NN use))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (DT the) (JJ sglt2) (NN inhibitor) (NN empagliflozin))\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (ADJP (NN type) (CD 2))\n",
      "                        (NNS diabetics)))))))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN proven)\n",
      "        (NP (NNS strategies))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB prevent)\n",
      "              (NP (NN heart) (NN failure)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(therapy-3, an-1)\n",
      "amod(therapy-3, optimized-2)\n",
      "nsubjpass(proven-25, therapy-3)\n",
      "case(hypertension-6, of-4)\n",
      "amod(hypertension-6, arterial-5)\n",
      "nmod:of(therapy-3, hypertension-6)\n",
      "case(patients-8, in-7)\n",
      "nmod:in(hypertension-6, patients-8)\n",
      "case(factors-11, with-9)\n",
      "compound(factors-11, risk-10)\n",
      "nmod:with(patients-8, factors-11)\n",
      "cc(patients-8, and-12)\n",
      "det(use-14, the-13)\n",
      "nmod:in(hypertension-6, use-14)\n",
      "conj:and(patients-8, use-14)\n",
      "case(empagliflozin-19, of-15)\n",
      "det(empagliflozin-19, the-16)\n",
      "amod(empagliflozin-19, sglt2-17)\n",
      "compound(empagliflozin-19, inhibitor-18)\n",
      "nmod:of(use-14, empagliflozin-19)\n",
      "case(diabetics-23, in-20)\n",
      "amod(diabetics-23, type-21)\n",
      "compound(type-21, 2-22)\n",
      "nmod:in(empagliflozin-19, diabetics-23)\n",
      "auxpass(proven-25, are-24)\n",
      "root(ROOT-0, proven-25)\n",
      "dobj(proven-25, strategies-26)\n",
      "mark(prevent-28, to-27)\n",
      "advcl(proven-25, prevent-28)\n",
      "compound(failure-30, heart-29)\n",
      "dobj(prevent-28, failure-30)\n",
      "\n",
      "Parsing [sent. 10 len. 14]: the therapeutic options in heart failure with preserved ejection fraction are still insufficient .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (JJ therapeutic) (NNS options))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN heart) (NN failure))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ preserved) (NN ejection) (NN fraction))))))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB still))\n",
      "      (ADJP (JJ insufficient)))\n",
      "    (. .)))\n",
      "\n",
      "det(options-3, the-1)\n",
      "amod(options-3, therapeutic-2)\n",
      "nsubj(insufficient-13, options-3)\n",
      "case(failure-6, in-4)\n",
      "compound(failure-6, heart-5)\n",
      "nmod:in(options-3, failure-6)\n",
      "case(fraction-10, with-7)\n",
      "amod(fraction-10, preserved-8)\n",
      "compound(fraction-10, ejection-9)\n",
      "nmod:with(failure-6, fraction-10)\n",
      "cop(insufficient-13, are-11)\n",
      "advmod(insufficient-13, still-12)\n",
      "root(ROOT-0, insufficient-13)\n",
      "\n",
      "Parsing [sent. 11 len. 26]: in heart failure with reduced ejection fraction sacubitril/valsartan , the first approved angiotensin receptor-neprilysin inhibitor , is superior to an ACEI -LRB- ACEI -RRB- inhibitor .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP\n",
      "        (NP (NN heart) (NN failure))\n",
      "        (PP (IN with)\n",
      "          (NP (VBN reduced) (NN ejection)))))\n",
      "    (NP\n",
      "      (NP (NN fraction) (NN sacubitril/valsartan))\n",
      "      (, ,)\n",
      "      (NP (DT the) (JJ first) (JJ approved) (NN angiotensin) (NN receptor-neprilysin) (NN inhibitor))\n",
      "      (, ,))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ superior)\n",
      "        (PP (TO to)\n",
      "          (NP (DT an) (NNP ACEI)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP ACEI))\n",
      "              (-RRB- -RRB-))\n",
      "            (NN inhibitor)))))\n",
      "    (. .)))\n",
      "\n",
      "case(failure-3, in-1)\n",
      "compound(failure-3, heart-2)\n",
      "nmod:in(superior-18, failure-3)\n",
      "case(ejection-6, with-4)\n",
      "amod(ejection-6, reduced-5)\n",
      "nmod:with(failure-3, ejection-6)\n",
      "compound(sacubitril/valsartan-8, fraction-7)\n",
      "nsubj(superior-18, sacubitril/valsartan-8)\n",
      "det(inhibitor-15, the-10)\n",
      "amod(inhibitor-15, first-11)\n",
      "amod(inhibitor-15, approved-12)\n",
      "compound(inhibitor-15, angiotensin-13)\n",
      "compound(inhibitor-15, receptor-neprilysin-14)\n",
      "appos(sacubitril/valsartan-8, inhibitor-15)\n",
      "cop(superior-18, is-17)\n",
      "root(ROOT-0, superior-18)\n",
      "case(inhibitor-25, to-19)\n",
      "det(inhibitor-25, an-20)\n",
      "compound(inhibitor-25, ACEI-21)\n",
      "appos(inhibitor-25, ACEI-23)\n",
      "nmod:to(superior-18, inhibitor-25)\n",
      "\n",
      "Parsing [sent. 12 len. 24]: whether digitalis affects the prognosis in heart failure remains unclear ; however , serum concentration should be targeted at the lower therapeutic range .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP (NN digitalis))\n",
      "          (VP (VBZ affects)\n",
      "            (NP\n",
      "              (NP (DT the) (NN prognosis))\n",
      "              (PP (IN in)\n",
      "                (NP (NN heart) (NN failure)))))))\n",
      "      (VP (VBZ remains)\n",
      "        (ADJP (JJ unclear))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (ADVP (RB however))\n",
      "      (, ,)\n",
      "      (NP (NN serum) (NN concentration))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN targeted)\n",
      "            (PP (IN at)\n",
      "              (NP (DT the) (JJR lower) (JJ therapeutic) (NN range)))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(affects-3, whether-1)\n",
      "nsubj(affects-3, digitalis-2)\n",
      "csubj(remains-9, affects-3)\n",
      "det(prognosis-5, the-4)\n",
      "dobj(affects-3, prognosis-5)\n",
      "case(failure-8, in-6)\n",
      "compound(failure-8, heart-7)\n",
      "nmod:in(prognosis-5, failure-8)\n",
      "root(ROOT-0, remains-9)\n",
      "xcomp(remains-9, unclear-10)\n",
      "advmod(targeted-18, however-12)\n",
      "compound(concentration-15, serum-14)\n",
      "nsubjpass(targeted-18, concentration-15)\n",
      "aux(targeted-18, should-16)\n",
      "auxpass(targeted-18, be-17)\n",
      "parataxis(remains-9, targeted-18)\n",
      "case(range-23, at-19)\n",
      "det(range-23, the-20)\n",
      "amod(range-23, lower-21)\n",
      "amod(range-23, therapeutic-22)\n",
      "nmod:at(targeted-18, range-23)\n",
      "\n",
      "Parsing [sent. 13 len. 19]: iron supplementation in heart failure with reduced systolic function and iron deficiency improves symptoms and quality of life .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN iron) (NN supplementation))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN heart) (NN failure))\n",
      "          (PP (IN with)\n",
      "            (NP (VBN reduced) (JJ systolic) (NN function)\n",
      "              (CC and)\n",
      "              (NN iron) (NN deficiency))))))\n",
      "    (VP (VBZ improves)\n",
      "      (NP\n",
      "        (NP (NNS symptoms)\n",
      "          (CC and)\n",
      "          (NN quality))\n",
      "        (PP (IN of)\n",
      "          (NP (NN life)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(supplementation-2, iron-1)\n",
      "nsubj(improves-13, supplementation-2)\n",
      "case(failure-5, in-3)\n",
      "compound(failure-5, heart-4)\n",
      "nmod:in(supplementation-2, failure-5)\n",
      "case(function-9, with-6)\n",
      "amod(function-9, reduced-7)\n",
      "amod(function-9, systolic-8)\n",
      "nmod:with(failure-5, function-9)\n",
      "cc(function-9, and-10)\n",
      "compound(deficiency-12, iron-11)\n",
      "nmod:with(failure-5, deficiency-12)\n",
      "conj:and(function-9, deficiency-12)\n",
      "root(ROOT-0, improves-13)\n",
      "dobj(improves-13, symptoms-14)\n",
      "cc(symptoms-14, and-15)\n",
      "dobj(improves-13, quality-16)\n",
      "conj:and(symptoms-14, quality-16)\n",
      "case(life-18, of-17)\n",
      "nmod:of(symptoms-14, life-18)\n",
      "\n",
      "Parsing [sent. 14 len. 57]: participants -LRB- n = 418 -RRB- underwent one of the following 3 conditions : i -RRB- multicomponent exercise training 3times/week -LRB- mex ; n = 116 -RRB- ; ii -RRB- ACEI used mono-dose daily -LRB- ACEI ; n = 70 -RRB- ; iii -RRB- combined exercise and ACEI drugs -LRB- aceimex ; n = 232 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS participants))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (VP (VBN n)\n",
      "          (S\n",
      "            (VP (SYM =)\n",
      "              (NP (CD 418)))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD underwent)\n",
      "      (S\n",
      "        (NP\n",
      "          (NP (CD one))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (VBG following) (CD 3) (NNS conditions))))\n",
      "        (: :)\n",
      "        (NP (FW i))\n",
      "        (-RRB- -RRB-)\n",
      "        (VP\n",
      "          (VP (VBP multicomponent)\n",
      "            (VP (VB exercise)\n",
      "              (NP (NN training) (NNS 3times/week))\n",
      "              (FRAG (-LRB- -LRB-)\n",
      "                (NP (NN mex))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP (NNP n) (NNP =) (NNP 116) (-RRB- -RRB-))\n",
      "                  (: ;)\n",
      "                  (NP (NN ii)))\n",
      "                (-RRB- -RRB-))))\n",
      "          (PRN\n",
      "            (S\n",
      "              (NP (NNP ACEI))\n",
      "              (VP (VBD used)\n",
      "                (NP\n",
      "                  (NP (JJ mono-dose) (NN daily))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NNP ACEI))\n",
      "                      (: ;)\n",
      "                      (NP\n",
      "                        (NP (NN n))\n",
      "                        (SBAR\n",
      "                          (S\n",
      "                            (VP (SYM =)\n",
      "                              (NP (CD 70)))))))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (: ;)\n",
      "                  (NP (NN iii)))))\n",
      "            (-RRB- -RRB-))\n",
      "          (NP\n",
      "            (NP (VBN combined) (NN exercise))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (CD ACEI) (NNS drugs))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (NN aceimex))\n",
      "                  (: ;)\n",
      "                  (NP\n",
      "                    (NP (NN n))\n",
      "                    (SBAR\n",
      "                      (S\n",
      "                        (VP (SYM =)\n",
      "                          (NP (CD 232)))))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(underwent-7, participants-1)\n",
      "dep(participants-1, n-3)\n",
      "dep(418-5, =-4)\n",
      "ccomp(n-3, 418-5)\n",
      "root(ROOT-0, underwent-7)\n",
      "nsubj(multicomponent-17, one-8)\n",
      "case(conditions-13, of-9)\n",
      "det(conditions-13, the-10)\n",
      "amod(conditions-13, following-11)\n",
      "nummod(conditions-13, 3-12)\n",
      "nmod:of(one-8, conditions-13)\n",
      "nsubj(multicomponent-17, i-15)\n",
      "ccomp(underwent-7, multicomponent-17)\n",
      "xcomp(multicomponent-17, exercise-18)\n",
      "compound(3times/week-20, training-19)\n",
      "dobj(exercise-18, 3times/week-20)\n",
      "dep(exercise-18, mex-22)\n",
      "compound(116-26, n-24)\n",
      "compound(116-26, =-25)\n",
      "dep(mex-22, 116-26)\n",
      "dep(116-26, ii-29)\n",
      "nsubj(used-32, ACEI-31)\n",
      "parataxis(multicomponent-17, used-32)\n",
      "amod(daily-34, mono-dose-33)\n",
      "dobj(used-32, daily-34)\n",
      "dep(daily-34, ACEI-36)\n",
      "dep(ACEI-36, n-38)\n",
      "dep(70-40, =-39)\n",
      "acl:relcl(n-38, 70-40)\n",
      "dep(daily-34, iii-43)\n",
      "amod(exercise-46, combined-45)\n",
      "dobj(multicomponent-17, exercise-46)\n",
      "cc(exercise-46, and-47)\n",
      "nummod(drugs-49, ACEI-48)\n",
      "dobj(multicomponent-17, drugs-49)\n",
      "conj:and(exercise-46, drugs-49)\n",
      "dep(drugs-49, aceimex-51)\n",
      "dep(aceimex-51, n-53)\n",
      "dep(232-55, =-54)\n",
      "acl:relcl(n-53, 232-55)\n",
      "\n",
      "Parsing [sent. 15 len. 37]: the trial was completed by 82 % of the participants -LRB- n = 342 -RRB- : mex -LRB- n = 90 -RRB- ; ACEI -LRB- n = 66 -RRB- ; aceimex -LRB- n = 186 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN trial))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN completed)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (CD 82) (NN %))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NNS participants))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP n)\n",
      "                        (QP (CD =) (CD 342)))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (: :)\n",
      "                    (NP (NN mex)))))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 90)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (NNP ACEI))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 66)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (NN aceimex))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 186)))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(trial-2, the-1)\n",
      "nsubjpass(completed-4, trial-2)\n",
      "auxpass(completed-4, was-3)\n",
      "root(ROOT-0, completed-4)\n",
      "case(%-7, by-5)\n",
      "nummod(%-7, 82-6)\n",
      "nmod:by(completed-4, %-7)\n",
      "case(participants-10, of-8)\n",
      "det(participants-10, the-9)\n",
      "nmod:of(%-7, participants-10)\n",
      "appos(participants-10, n-12)\n",
      "compound(342-14, =-13)\n",
      "nummod(n-12, 342-14)\n",
      "dep(participants-10, mex-17)\n",
      "dep(%-7, n-19)\n",
      "dep(90-21, =-20)\n",
      "ccomp(n-19, 90-21)\n",
      "dep(%-7, ACEI-24)\n",
      "dep(ACEI-24, n-26)\n",
      "dep(66-28, =-27)\n",
      "ccomp(n-26, 66-28)\n",
      "dep(%-7, aceimex-31)\n",
      "dep(aceimex-31, n-33)\n",
      "dep(186-35, =-34)\n",
      "ccomp(n-33, 186-35)\n",
      "\n",
      "Parsing [sent. 16 len. 31]: baseline and 2-year follow-up evaluations included the senior fitness test battery , short form health survey 36 -LRB- sf-36 -RRB- , the health history questionnaires , anthropometric and hemodynamic profile .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN baseline)\n",
      "      (CC and)\n",
      "      (JJ 2-year) (NN follow-up) (NNS evaluations))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ senior) (NN fitness) (NN test) (NN battery))\n",
      "        (, ,)\n",
      "        (NP (JJ short) (NN form) (NN health) (NN survey) (CD 36) (-LRB- -LRB-) (NN sf-36) (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (NP (DT the) (NN health) (NN history) (NN questionnaires))\n",
      "        (, ,)\n",
      "        (NP (NN anthropometric))\n",
      "        (CC and)\n",
      "        (NP (JJ hemodynamic) (NN profile))))\n",
      "    (. .)))\n",
      "\n",
      "compound(evaluations-5, baseline-1)\n",
      "cc(baseline-1, and-2)\n",
      "conj:and(baseline-1, 2-year-3)\n",
      "compound(evaluations-5, 2-year-3)\n",
      "compound(evaluations-5, follow-up-4)\n",
      "nsubj(included-6, evaluations-5)\n",
      "root(ROOT-0, included-6)\n",
      "det(battery-11, the-7)\n",
      "amod(battery-11, senior-8)\n",
      "compound(battery-11, fitness-9)\n",
      "compound(battery-11, test-10)\n",
      "dobj(included-6, battery-11)\n",
      "amod(sf-36-19, short-13)\n",
      "compound(sf-36-19, form-14)\n",
      "compound(sf-36-19, health-15)\n",
      "compound(sf-36-19, survey-16)\n",
      "nummod(sf-36-19, 36-17)\n",
      "dobj(included-6, sf-36-19)\n",
      "conj:and(battery-11, sf-36-19)\n",
      "det(questionnaires-25, the-22)\n",
      "compound(questionnaires-25, health-23)\n",
      "compound(questionnaires-25, history-24)\n",
      "dobj(included-6, questionnaires-25)\n",
      "conj:and(battery-11, questionnaires-25)\n",
      "dobj(included-6, anthropometric-27)\n",
      "conj:and(battery-11, anthropometric-27)\n",
      "cc(battery-11, and-28)\n",
      "amod(profile-30, hemodynamic-29)\n",
      "dobj(included-6, profile-30)\n",
      "conj:and(battery-11, profile-30)\n",
      "\n",
      "Parsing [sent. 17 len. 26]: heart failure -LRB- hf -RRB- prevalence continues to rise and remains a significant burden to patients , caregivers , providers , and the healthcare system .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN heart) (NN failure))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN hf))\n",
      "        (-RRB- -RRB-)))\n",
      "    (ADVP (RB prevalence))\n",
      "    (VP\n",
      "      (VP (VBZ continues)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB rise)))))\n",
      "      (CC and)\n",
      "      (VP (VBZ remains)\n",
      "        (NP (DT a) (JJ significant) (NN burden))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (, ,)\n",
      "            (NP (NNS caregivers))\n",
      "            (, ,)\n",
      "            (NP (NNS providers))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (DT the) (NN healthcare) (NN system))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(continues-7, failure-2)\n",
      "nsubj:xsubj(rise-9, failure-2)\n",
      "nsubj(remains-11, failure-2)\n",
      "appos(failure-2, hf-4)\n",
      "advmod(continues-7, prevalence-6)\n",
      "root(ROOT-0, continues-7)\n",
      "mark(rise-9, to-8)\n",
      "xcomp(continues-7, rise-9)\n",
      "cc(continues-7, and-10)\n",
      "conj:and(continues-7, remains-11)\n",
      "det(burden-14, a-12)\n",
      "amod(burden-14, significant-13)\n",
      "xcomp(remains-11, burden-14)\n",
      "case(patients-16, to-15)\n",
      "nmod:to(remains-11, patients-16)\n",
      "nmod:to(remains-11, caregivers-18)\n",
      "conj:and(patients-16, caregivers-18)\n",
      "nmod:to(remains-11, providers-20)\n",
      "conj:and(patients-16, providers-20)\n",
      "cc(patients-16, and-22)\n",
      "det(system-25, the-23)\n",
      "compound(system-25, healthcare-24)\n",
      "nmod:to(remains-11, system-25)\n",
      "conj:and(patients-16, system-25)\n",
      "\n",
      "Parsing [sent. 18 len. 18]: guideline-directed medical therapy with standard neurohormonal blockade has been the cornerstone of medical management for many years .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ guideline-directed) (JJ medical) (NN therapy))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ standard) (JJ neurohormonal) (NN blockade))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN been)\n",
      "        (NP\n",
      "          (NP (DT the) (NN cornerstone))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ medical) (NN management))))\n",
      "        (PP (IN for)\n",
      "          (NP (JJ many) (NNS years)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-3, guideline-directed-1)\n",
      "amod(therapy-3, medical-2)\n",
      "nsubj(cornerstone-11, therapy-3)\n",
      "case(blockade-7, with-4)\n",
      "amod(blockade-7, standard-5)\n",
      "amod(blockade-7, neurohormonal-6)\n",
      "nmod:with(therapy-3, blockade-7)\n",
      "aux(cornerstone-11, has-8)\n",
      "cop(cornerstone-11, been-9)\n",
      "det(cornerstone-11, the-10)\n",
      "root(ROOT-0, cornerstone-11)\n",
      "case(management-14, of-12)\n",
      "amod(management-14, medical-13)\n",
      "nmod:of(cornerstone-11, management-14)\n",
      "case(years-17, for-15)\n",
      "amod(years-17, many-16)\n",
      "nmod:for(cornerstone-11, years-17)\n",
      "\n",
      "Parsing [sent. 19 len. 28]: despite aggressive utilization of ACEI , angiotensin receptor blockers , beta-blockers , and aldosterone antagonists , hf hospitalizations and readmissions are common and residual mortality remains high .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP\n",
      "        (NP (JJ aggressive) (NN utilization))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNP ACEI))\n",
      "            (, ,)\n",
      "            (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "            (, ,)\n",
      "            (NP (NNS beta-blockers))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (JJ aldosterone) (NNS antagonists))))))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN hf) (NNS hospitalizations)\n",
      "        (CC and)\n",
      "        (NNS readmissions))\n",
      "      (VP (VBP are)\n",
      "        (ADJP (JJ common))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ residual) (NN mortality))\n",
      "      (VP (VBZ remains)\n",
      "        (ADJP (JJ high))))\n",
      "    (. .)))\n",
      "\n",
      "case(utilization-3, despite-1)\n",
      "amod(utilization-3, aggressive-2)\n",
      "nmod:despite(common-22, utilization-3)\n",
      "case(ACEI-5, of-4)\n",
      "nmod:of(utilization-3, ACEI-5)\n",
      "compound(blockers-9, angiotensin-7)\n",
      "compound(blockers-9, receptor-8)\n",
      "nmod:of(utilization-3, blockers-9)\n",
      "conj:and(ACEI-5, blockers-9)\n",
      "nmod:of(utilization-3, beta-blockers-11)\n",
      "conj:and(ACEI-5, beta-blockers-11)\n",
      "cc(ACEI-5, and-13)\n",
      "amod(antagonists-15, aldosterone-14)\n",
      "nmod:of(utilization-3, antagonists-15)\n",
      "conj:and(ACEI-5, antagonists-15)\n",
      "compound(hospitalizations-18, hf-17)\n",
      "nsubj(common-22, hospitalizations-18)\n",
      "cc(hospitalizations-18, and-19)\n",
      "conj:and(hospitalizations-18, readmissions-20)\n",
      "nsubj(common-22, readmissions-20)\n",
      "cop(common-22, are-21)\n",
      "root(ROOT-0, common-22)\n",
      "cc(common-22, and-23)\n",
      "amod(mortality-25, residual-24)\n",
      "nsubj(remains-26, mortality-25)\n",
      "conj:and(common-22, remains-26)\n",
      "xcomp(remains-26, high-27)\n",
      "\n",
      "Parsing [sent. 20 len. 46]: with the development of two novel medical therapies -LRB- sacubitril/valsartan and ivabradine -RRB- , the american college of cardiology , american heart association , and heart failure society of america released a pharmacologic update to provide guidelines for incorporation of these agents into clinical practice .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN with)\n",
      "      (NP\n",
      "        (NP (DT the) (NN development))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (CD two) (JJ novel) (JJ medical) (NNS therapies))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (JJ sacubitril/valsartan)\n",
      "                (CC and)\n",
      "                (JJ ivabradine))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN american) (NN college))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN cardiology))\n",
      "          (, ,)\n",
      "          (NP (NN american) (NN heart) (NN association))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (NN heart) (NN failure) (NN society))\n",
      "            (PP (IN of)\n",
      "              (NP (NN america)))))))\n",
      "    (VP (VBD released)\n",
      "      (NP (DT a) (JJ pharmacologic) (NN update))\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB provide)\n",
      "            (NP\n",
      "              (NP (NNS guidelines))\n",
      "              (PP (IN for)\n",
      "                (NP\n",
      "                  (NP (NN incorporation))\n",
      "                  (PP (IN of)\n",
      "                    (NP (DT these) (NNS agents))))))\n",
      "            (PP (IN into)\n",
      "              (NP (JJ clinical) (NN practice)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(development-3, with-1)\n",
      "det(development-3, the-2)\n",
      "nmod:with(released-31, development-3)\n",
      "case(therapies-8, of-4)\n",
      "nummod(therapies-8, two-5)\n",
      "amod(therapies-8, novel-6)\n",
      "amod(therapies-8, medical-7)\n",
      "nmod:of(development-3, therapies-8)\n",
      "dep(therapies-8, sacubitril/valsartan-10)\n",
      "cc(sacubitril/valsartan-10, and-11)\n",
      "dep(therapies-8, ivabradine-12)\n",
      "conj:and(sacubitril/valsartan-10, ivabradine-12)\n",
      "det(college-17, the-15)\n",
      "compound(college-17, american-16)\n",
      "nsubj(released-31, college-17)\n",
      "case(cardiology-19, of-18)\n",
      "nmod:of(college-17, cardiology-19)\n",
      "compound(association-23, american-21)\n",
      "compound(association-23, heart-22)\n",
      "nmod:of(college-17, association-23)\n",
      "conj:and(cardiology-19, association-23)\n",
      "cc(cardiology-19, and-25)\n",
      "compound(society-28, heart-26)\n",
      "compound(society-28, failure-27)\n",
      "nmod:of(college-17, society-28)\n",
      "conj:and(cardiology-19, society-28)\n",
      "case(america-30, of-29)\n",
      "nmod:of(society-28, america-30)\n",
      "root(ROOT-0, released-31)\n",
      "det(update-34, a-32)\n",
      "amod(update-34, pharmacologic-33)\n",
      "dobj(released-31, update-34)\n",
      "mark(provide-36, to-35)\n",
      "advcl(released-31, provide-36)\n",
      "dobj(provide-36, guidelines-37)\n",
      "case(incorporation-39, for-38)\n",
      "nmod:for(guidelines-37, incorporation-39)\n",
      "case(agents-42, of-40)\n",
      "det(agents-42, these-41)\n",
      "nmod:of(incorporation-39, agents-42)\n",
      "case(practice-45, into-43)\n",
      "amod(practice-45, clinical-44)\n",
      "nmod:into(provide-36, practice-45)\n",
      "\n",
      "Parsing [sent. 21 len. 19]: although effective via different mechanisms of action , both agents now have a prominent role in risk reduction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN although)\n",
      "      (S\n",
      "        (ADJP (JJ effective))\n",
      "        (PP (IN via)\n",
      "          (NP\n",
      "            (NP (JJ different) (NNS mechanisms))\n",
      "            (PP (IN of)\n",
      "              (NP (NN action)))))))\n",
      "    (, ,)\n",
      "    (NP (DT both) (NNS agents))\n",
      "    (ADVP (RB now))\n",
      "    (VP (VBP have)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prominent) (NN role))\n",
      "        (PP (IN in)\n",
      "          (NP (NN risk) (NN reduction)))))\n",
      "    (. .)))\n",
      "\n",
      "mark(effective-2, although-1)\n",
      "advcl(have-12, effective-2)\n",
      "case(mechanisms-5, via-3)\n",
      "amod(mechanisms-5, different-4)\n",
      "dep(effective-2, mechanisms-5)\n",
      "case(action-7, of-6)\n",
      "nmod:of(mechanisms-5, action-7)\n",
      "det(agents-10, both-9)\n",
      "nsubj(have-12, agents-10)\n",
      "advmod(have-12, now-11)\n",
      "root(ROOT-0, have-12)\n",
      "det(role-15, a-13)\n",
      "amod(role-15, prominent-14)\n",
      "dobj(have-12, role-15)\n",
      "case(reduction-18, in-16)\n",
      "compound(reduction-18, risk-17)\n",
      "nmod:in(role-15, reduction-18)\n",
      "\n",
      "Parsing [sent. 22 len. 20]: hf medical regimens often become quite complex , especially when associated with comorbid conditions , and require frequent follow-up .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ hf) (JJ medical) (NNS regimens))\n",
      "    (ADVP (RB often))\n",
      "    (VP\n",
      "      (VP (VBP become)\n",
      "        (NP (RB quite) (JJ complex))\n",
      "        (, ,)\n",
      "        (SBAR\n",
      "          (WHADVP (RB especially) (WRB when))\n",
      "          (S\n",
      "            (VP (JJ associated)\n",
      "              (PP (IN with)\n",
      "                (NP (JJ comorbid) (NNS conditions))))))\n",
      "        (, ,))\n",
      "      (CC and)\n",
      "      (VP (VBP require)\n",
      "        (NP (JJ frequent) (NN follow-up))))\n",
      "    (. .)))\n",
      "\n",
      "amod(regimens-3, hf-1)\n",
      "amod(regimens-3, medical-2)\n",
      "nsubj(become-5, regimens-3)\n",
      "nsubj(require-17, regimens-3)\n",
      "advmod(become-5, often-4)\n",
      "root(ROOT-0, become-5)\n",
      "advmod(complex-7, quite-6)\n",
      "xcomp(become-5, complex-7)\n",
      "advmod(when-10, especially-9)\n",
      "advmod(associated-11, when-10)\n",
      "advcl(become-5, associated-11)\n",
      "case(conditions-14, with-12)\n",
      "amod(conditions-14, comorbid-13)\n",
      "nmod:with(associated-11, conditions-14)\n",
      "cc(become-5, and-16)\n",
      "conj:and(become-5, require-17)\n",
      "amod(follow-up-19, frequent-18)\n",
      "dobj(require-17, follow-up-19)\n",
      "\n",
      "Parsing [sent. 23 len. 16]: providers must be proficient in patient monitoring , medication dose titration , and therapy optimization .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS providers))\n",
      "    (VP (MD must)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ proficient)\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (JJ patient) (NN monitoring))\n",
      "              (, ,)\n",
      "              (NP (NN medication) (NN dose) (NN titration))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NN therapy) (NN optimization)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(proficient-4, providers-1)\n",
      "aux(proficient-4, must-2)\n",
      "cop(proficient-4, be-3)\n",
      "root(ROOT-0, proficient-4)\n",
      "case(monitoring-7, in-5)\n",
      "amod(monitoring-7, patient-6)\n",
      "nmod:in(proficient-4, monitoring-7)\n",
      "compound(titration-11, medication-9)\n",
      "compound(titration-11, dose-10)\n",
      "nmod:in(proficient-4, titration-11)\n",
      "conj:and(monitoring-7, titration-11)\n",
      "cc(monitoring-7, and-13)\n",
      "compound(optimization-15, therapy-14)\n",
      "nmod:in(proficient-4, optimization-15)\n",
      "conj:and(monitoring-7, optimization-15)\n",
      "\n",
      "Parsing [sent. 24 len. 17]: individualized patient care strategies such as guideline-directed therapy can promote long-term adherence and quality of life .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ individualized) (JJ patient) (NN care) (NNS strategies))\n",
      "      (PP (JJ such) (IN as)\n",
      "        (NP (JJ guideline-directed) (NN therapy))))\n",
      "    (VP (MD can)\n",
      "      (VP (VB promote)\n",
      "        (NP\n",
      "          (NP (JJ long-term) (NN adherence)\n",
      "            (CC and)\n",
      "            (NN quality))\n",
      "          (PP (IN of)\n",
      "            (NP (NN life))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(strategies-4, individualized-1)\n",
      "amod(strategies-4, patient-2)\n",
      "compound(strategies-4, care-3)\n",
      "nsubj(promote-10, strategies-4)\n",
      "case(therapy-8, such-5)\n",
      "mwe(such-5, as-6)\n",
      "amod(therapy-8, guideline-directed-7)\n",
      "nmod:such_as(strategies-4, therapy-8)\n",
      "aux(promote-10, can-9)\n",
      "root(ROOT-0, promote-10)\n",
      "amod(adherence-12, long-term-11)\n",
      "dobj(promote-10, adherence-12)\n",
      "cc(adherence-12, and-13)\n",
      "dobj(promote-10, quality-14)\n",
      "conj:and(adherence-12, quality-14)\n",
      "case(life-16, of-15)\n",
      "nmod:of(adherence-12, life-16)\n",
      "\n",
      "Parsing [sent. 25 len. 43]: we included a group with no dd -LRB- n = 649 -RRB- , a group with grade 1 dd -LRB- n = 2875 -RRB- , and those with grades 2 and 3 -LRB- n = 1357 -RRB- who had normal ejection fraction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (DT a) (NN group))\n",
      "          (PP (IN with)\n",
      "            (NP (DT no) (NN dd))))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN n)\n",
      "            (S\n",
      "              (VP (SYM =)\n",
      "                (NP (CD 649)))))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT a) (NN group))\n",
      "          (PP (IN with)\n",
      "            (NP (NN grade) (CD 1) (NN dd))))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN n)\n",
      "            (S\n",
      "              (VP (SYM =)\n",
      "                (NP (CD 2875)))))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (NNS grades) (CD 2)\n",
      "                (CC and)\n",
      "                (CD 3))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 1357)))))\n",
      "                (-RRB- -RRB-))\n",
      "              (SBAR\n",
      "                (WHNP (WP who))\n",
      "                (S\n",
      "                  (VP (VBD had)\n",
      "                    (NP (JJ normal) (NN ejection) (NN fraction))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(included-2, we-1)\n",
      "root(ROOT-0, included-2)\n",
      "det(group-4, a-3)\n",
      "dobj(included-2, group-4)\n",
      "case(dd-7, with-5)\n",
      "neg(dd-7, no-6)\n",
      "nmod:with(group-4, dd-7)\n",
      "dep(group-4, n-9)\n",
      "dep(649-11, =-10)\n",
      "ccomp(n-9, 649-11)\n",
      "det(group-15, a-14)\n",
      "dobj(included-2, group-15)\n",
      "conj:and(group-4, group-15)\n",
      "case(dd-19, with-16)\n",
      "compound(dd-19, grade-17)\n",
      "nummod(dd-19, 1-18)\n",
      "nmod:with(group-15, dd-19)\n",
      "dep(group-4, n-21)\n",
      "dep(2875-23, =-22)\n",
      "ccomp(n-21, 2875-23)\n",
      "cc(group-4, and-26)\n",
      "dobj(included-2, those-27)\n",
      "conj:and(group-4, those-27)\n",
      "case(grades-29, with-28)\n",
      "nmod:with(those-27, grades-29)\n",
      "nsubj(had-39, grades-29)\n",
      "nummod(grades-29, 2-30)\n",
      "cc(grades-29, and-31)\n",
      "nmod:with(those-27, 3-32)\n",
      "conj:and(grades-29, 3-32)\n",
      "nsubj(had-39, 3-32)\n",
      "dep(grades-29, n-34)\n",
      "dep(1357-36, =-35)\n",
      "ccomp(n-34, 1357-36)\n",
      "ref(grades-29, who-38)\n",
      "acl:relcl(grades-29, had-39)\n",
      "amod(fraction-42, normal-40)\n",
      "compound(fraction-42, ejection-41)\n",
      "dobj(had-39, fraction-42)\n",
      "\n",
      "Parsing [sent. 26 len. 22]: the prevalence of grade 2 or 3 dd with preserved ejection fraction was 25 % ; 95 % ci : 24-26 .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT the) (NN prevalence))\n",
      "        (PP (IN of)\n",
      "          (NP (NN grade) (CD 2))))\n",
      "      (CC or)\n",
      "      (NP\n",
      "        (NP (CD 3) (NN dd))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ preserved) (NN ejection) (NN fraction)))))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (CD 25) (NN %))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (ADJP (CD 95) (NN %))\n",
      "            (NN ci)))\n",
      "        (: :)\n",
      "        (NP (CD 24-26))))\n",
      "    (. .)))\n",
      "\n",
      "det(prevalence-2, the-1)\n",
      "nsubj(%-15, prevalence-2)\n",
      "case(grade-4, of-3)\n",
      "nmod:of(prevalence-2, grade-4)\n",
      "nummod(grade-4, 2-5)\n",
      "cc(prevalence-2, or-6)\n",
      "nummod(dd-8, 3-7)\n",
      "conj:or(prevalence-2, dd-8)\n",
      "nsubj(%-15, dd-8)\n",
      "case(fraction-12, with-9)\n",
      "amod(fraction-12, preserved-10)\n",
      "compound(fraction-12, ejection-11)\n",
      "nmod:with(dd-8, fraction-12)\n",
      "cop(%-15, was-13)\n",
      "nummod(%-15, 25-14)\n",
      "root(ROOT-0, %-15)\n",
      "compound(%-18, 95-17)\n",
      "amod(ci-19, %-18)\n",
      "dep(%-15, ci-19)\n",
      "dep(%-15, 24-26-21)\n",
      "\n",
      "Parsing [sent. 27 len. 44]: the absolute change of ACEI-inhibitor use before and after the echocardiogram increased by 14 , 19 , 23 , 27 in patients without dd , those with grade 1 , grade 2 or 3 asymptomatic and grade 2 or 3 symptomatic , respectively .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (JJ absolute) (NN change))\n",
      "      (PP (IN of)\n",
      "        (NP (NNP ACEI-inhibitor))))\n",
      "    (VP (VBP use)\n",
      "      (SBAR (IN before)\n",
      "        (CC and)\n",
      "        (RB after)\n",
      "        (S\n",
      "          (NP (DT the) (NN echocardiogram))\n",
      "          (VP (VBD increased)\n",
      "            (PP (IN by)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (CD 14))\n",
      "                  (, ,)\n",
      "                  (NP (CD 19))\n",
      "                  (, ,)\n",
      "                  (NP (CD 23))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (CD 27))\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (NP (NNS patients))\n",
      "                        (PP (IN without)\n",
      "                          (NP (NN dd))))))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (DT those))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN grade) (CD 1)))))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN grade) (CD 2))\n",
      "                  (CC or)\n",
      "                  (NP (CD 3) (NN asymptomatic)))\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (NN grade) (CD 2))\n",
      "                  (CC or)\n",
      "                  (NP (CD 3) (NN symptomatic)))))\n",
      "            (, ,)\n",
      "            (ADVP (RB respectively))))))\n",
      "    (. .)))\n",
      "\n",
      "det(change-3, the-1)\n",
      "amod(change-3, absolute-2)\n",
      "nsubj(use-6, change-3)\n",
      "case(ACEI-inhibitor-5, of-4)\n",
      "nmod:of(change-3, ACEI-inhibitor-5)\n",
      "root(ROOT-0, use-6)\n",
      "mark(increased-12, before-7)\n",
      "cc(increased-12, and-8)\n",
      "advmod(increased-12, after-9)\n",
      "det(echocardiogram-11, the-10)\n",
      "nsubj(increased-12, echocardiogram-11)\n",
      "advcl(use-6, increased-12)\n",
      "case(14-14, by-13)\n",
      "nmod:by(increased-12, 14-14)\n",
      "amod(14-14, 19-16)\n",
      "amod(14-14, 23-18)\n",
      "appos(14-14, 27-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(27-20, patients-22)\n",
      "case(dd-24, without-23)\n",
      "nmod:without(patients-22, dd-24)\n",
      "appos(14-14, those-26)\n",
      "case(grade-28, with-27)\n",
      "nmod:with(those-26, grade-28)\n",
      "nummod(grade-28, 1-29)\n",
      "nmod:by(increased-12, grade-31)\n",
      "conj:and(14-14, grade-31)\n",
      "nummod(grade-31, 2-32)\n",
      "cc(grade-31, or-33)\n",
      "nummod(asymptomatic-35, 3-34)\n",
      "conj:and(14-14, asymptomatic-35)\n",
      "conj:or(grade-31, asymptomatic-35)\n",
      "cc(14-14, and-36)\n",
      "nmod:by(increased-12, grade-37)\n",
      "conj:and(14-14, grade-37)\n",
      "nummod(grade-37, 2-38)\n",
      "cc(grade-37, or-39)\n",
      "nummod(symptomatic-41, 3-40)\n",
      "conj:and(14-14, symptomatic-41)\n",
      "conj:or(grade-37, symptomatic-41)\n",
      "advmod(increased-12, respectively-43)\n",
      "\n",
      "Parsing [sent. 28 len. 13]: the use of Î²-blocker , statin , and diuretic had similar trends .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN Î²-blocker))\n",
      "          (, ,)\n",
      "          (NP (NN statin))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP (NN diuretic)))))\n",
      "    (VP (VBD had)\n",
      "      (NP (JJ similar) (NNS trends)))\n",
      "    (. .)))\n",
      "\n",
      "det(use-2, the-1)\n",
      "nsubj(had-10, use-2)\n",
      "case(Î²-blocker-4, of-3)\n",
      "nmod:of(use-2, Î²-blocker-4)\n",
      "nmod:of(use-2, statin-6)\n",
      "conj:and(Î²-blocker-4, statin-6)\n",
      "cc(Î²-blocker-4, and-8)\n",
      "nmod:of(use-2, diuretic-9)\n",
      "conj:and(Î²-blocker-4, diuretic-9)\n",
      "root(ROOT-0, had-10)\n",
      "amod(trends-12, similar-11)\n",
      "dobj(had-10, trends-12)\n",
      "\n",
      "Parsing [sent. 29 len. 15]: a total of 514 patients -LRB- 340 females -RRB- aged 22-97 years were studied .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT a) (NN total))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (CD 514) (NNS patients))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD 340) (NNS females))\n",
      "            (-RRB- -RRB-))\n",
      "          (VP (VBN aged)\n",
      "            (NP (CD 22-97) (NNS years))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN studied)))\n",
      "    (. .)))\n",
      "\n",
      "det(total-2, a-1)\n",
      "nsubjpass(studied-14, total-2)\n",
      "case(patients-5, of-3)\n",
      "nummod(patients-5, 514-4)\n",
      "nmod:of(total-2, patients-5)\n",
      "nummod(females-8, 340-7)\n",
      "appos(patients-5, females-8)\n",
      "acl(patients-5, aged-10)\n",
      "nummod(years-12, 22-97-11)\n",
      "nmod:tmod(aged-10, years-12)\n",
      "auxpass(studied-14, were-13)\n",
      "root(ROOT-0, studied-14)\n",
      "\n",
      "Parsing [sent. 30 len. 51]: thirteen percent , 27.6 % , 26.7 % , 22.0 % , and 10.7 % were on 1 , 2 , 3 , 4 , and â¥ 5 medicines , respectively , for control of their blood pressure with the frequency of adverse effects increasing proportionately up to four medicines .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN thirteen) (NN percent))\n",
      "      (, ,)\n",
      "      (NP (CD 27.6) (NN %))\n",
      "      (, ,)\n",
      "      (NP (CD 26.7) (NN %))\n",
      "      (, ,)\n",
      "      (NP (CD 22.0) (NN %))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (CD 10.7) (NN %)))\n",
      "    (VP (VBD were)\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (CD 1))\n",
      "          (, ,)\n",
      "          (NP (CD 2))\n",
      "          (, ,)\n",
      "          (NP (CD 3))\n",
      "          (, ,)\n",
      "          (NP (CD 4))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (QP (CD â¥) (CD 5))\n",
      "            (NNS medicines))))\n",
      "      (, ,)\n",
      "      (ADVP (RB respectively))\n",
      "      (, ,)\n",
      "      (PP (IN for)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (NN control))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (PRP$ their) (NN blood) (NN pressure))\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN frequency))\n",
      "                    (PP (IN of)\n",
      "                      (NP (JJ adverse) (NNS effects))))))))\n",
      "          (VP (VBG increasing)\n",
      "            (NP (NN proportionately))\n",
      "            (PRT (RP up))\n",
      "            (PP (TO to)\n",
      "              (NP (CD four) (NNS medicines)))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(percent-2, thirteen-1)\n",
      "nsubj(1-18, percent-2)\n",
      "nummod(%-5, 27.6-4)\n",
      "conj:and(percent-2, %-5)\n",
      "nsubj(1-18, %-5)\n",
      "nummod(%-8, 26.7-7)\n",
      "conj:and(percent-2, %-8)\n",
      "nsubj(1-18, %-8)\n",
      "nummod(%-11, 22.0-10)\n",
      "conj:and(percent-2, %-11)\n",
      "nsubj(1-18, %-11)\n",
      "cc(percent-2, and-13)\n",
      "nummod(%-15, 10.7-14)\n",
      "conj:and(percent-2, %-15)\n",
      "nsubj(1-18, %-15)\n",
      "cop(1-18, were-16)\n",
      "case(1-18, on-17)\n",
      "root(ROOT-0, 1-18)\n",
      "conj:and(1-18, 2-20)\n",
      "conj:and(1-18, 3-22)\n",
      "conj:and(1-18, 4-24)\n",
      "cc(1-18, and-26)\n",
      "compound(5-28, â¥-27)\n",
      "nummod(medicines-29, 5-28)\n",
      "conj:and(1-18, medicines-29)\n",
      "advmod(1-18, respectively-31)\n",
      "mark(increasing-45, for-33)\n",
      "nsubj(increasing-45, control-34)\n",
      "case(pressure-38, of-35)\n",
      "nmod:poss(pressure-38, their-36)\n",
      "compound(pressure-38, blood-37)\n",
      "nmod:of(control-34, pressure-38)\n",
      "case(frequency-41, with-39)\n",
      "det(frequency-41, the-40)\n",
      "nmod:with(pressure-38, frequency-41)\n",
      "case(effects-44, of-42)\n",
      "amod(effects-44, adverse-43)\n",
      "nmod:of(frequency-41, effects-44)\n",
      "advcl(1-18, increasing-45)\n",
      "dobj(increasing-45, proportionately-46)\n",
      "compound:prt(increasing-45, up-47)\n",
      "case(medicines-50, to-48)\n",
      "nummod(medicines-50, four-49)\n",
      "nmod:to(increasing-45, medicines-50)\n",
      "\n",
      "Parsing [sent. 31 len. 18]: adverse reactions to antihypertensive medicines were reported by a total of 93 -LRB- 18.1 % -RRB- patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ adverse) (NNS reactions))\n",
      "      (PP (TO to)\n",
      "        (NP (JJ antihypertensive) (NNS medicines))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN reported)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (DT a) (NN total))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ 93)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (QP (CD 18.1) (NN %)))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS patients)))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(reactions-2, adverse-1)\n",
      "nsubjpass(reported-7, reactions-2)\n",
      "case(medicines-5, to-3)\n",
      "amod(medicines-5, antihypertensive-4)\n",
      "nmod:to(reactions-2, medicines-5)\n",
      "auxpass(reported-7, were-6)\n",
      "root(ROOT-0, reported-7)\n",
      "case(total-10, by-8)\n",
      "det(total-10, a-9)\n",
      "nmod:by(reported-7, total-10)\n",
      "case(patients-17, of-11)\n",
      "amod(patients-17, 93-12)\n",
      "compound(%-15, 18.1-14)\n",
      "dep(patients-17, %-15)\n",
      "nmod:of(total-10, patients-17)\n",
      "\n",
      "Parsing [sent. 32 len. 53]: diuretics - 27.9 % , calcium channel blockers -LRB- ccbs -RRB- - 26.8 % , and ACEI - 26.8 % accounted for most of the adverse reactions seen , notably frequent micturition and headaches -LRB- ccb -RRB- ; excessive micturition and dizziness -LRB- diuretics -RRB- ; dry irritating cough -LRB- ACEI -RRB- .\n",
      "(ROOT\n",
      "  (NP\n",
      "    (NP (NNS diuretics))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 27.9) (NN %))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBZ ccbs))\n",
      "          (-RRB- -RRB-))))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 26.8) (NN %))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NNP ACEI)))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 26.8) (NN %))\n",
      "      (VP (VBN accounted)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (JJS most))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT the) (JJ adverse) (NNS reactions))\n",
      "                        (VP (VBN seen)))\n",
      "                      (, ,)\n",
      "                      (ADVP (RB notably))\n",
      "                      (NP\n",
      "                        (NP (JJ frequent) (NN micturition)\n",
      "                          (CC and)\n",
      "                          (NNS headaches))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NN ccb))\n",
      "                          (-RRB- -RRB-))))))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP (JJ excessive) (NN micturition))\n",
      "                  (CC and)\n",
      "                  (NP (NN dizziness))))\n",
      "              (-LRB- -LRB-)\n",
      "              (NP (NNS diuretics))\n",
      "              (-RRB- -RRB-))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (JJ dry) (VBG irritating) (NN cough))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP ACEI))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, diuretics-1)\n",
      "nummod(%-4, 27.9-3)\n",
      "dep(diuretics-1, %-4)\n",
      "compound(blockers-8, calcium-6)\n",
      "compound(blockers-8, channel-7)\n",
      "appos(%-4, blockers-8)\n",
      "dep(blockers-8, ccbs-10)\n",
      "nummod(%-14, 26.8-13)\n",
      "dep(diuretics-1, %-14)\n",
      "cc(%-14, and-16)\n",
      "dep(diuretics-1, ACEI-17)\n",
      "conj:and(%-14, ACEI-17)\n",
      "nummod(%-20, 26.8-19)\n",
      "dep(diuretics-1, %-20)\n",
      "acl(%-20, accounted-21)\n",
      "case(most-23, for-22)\n",
      "nmod:for(accounted-21, most-23)\n",
      "case(reactions-27, of-24)\n",
      "det(reactions-27, the-25)\n",
      "amod(reactions-27, adverse-26)\n",
      "nmod:of(most-23, reactions-27)\n",
      "acl(reactions-27, seen-28)\n",
      "advmod(micturition-32, notably-30)\n",
      "amod(micturition-32, frequent-31)\n",
      "appos(reactions-27, micturition-32)\n",
      "cc(micturition-32, and-33)\n",
      "appos(reactions-27, headaches-34)\n",
      "conj:and(micturition-32, headaches-34)\n",
      "appos(micturition-32, ccb-36)\n",
      "amod(micturition-40, excessive-39)\n",
      "dep(most-23, micturition-40)\n",
      "cc(micturition-40, and-41)\n",
      "dep(most-23, dizziness-42)\n",
      "conj:and(micturition-40, dizziness-42)\n",
      "dep(most-23, diuretics-44)\n",
      "amod(cough-49, dry-47)\n",
      "amod(cough-49, irritating-48)\n",
      "dep(most-23, cough-49)\n",
      "appos(cough-49, ACEI-51)\n",
      "\n",
      "Parsing [sent. 33 len. 21]: notable complaints for all patients using the checklist were increased frequency of micturition , reduction in libido , and headaches .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ notable) (NNS complaints))\n",
      "      (PP (IN for)\n",
      "        (NP\n",
      "          (NP (DT all) (NNS patients))\n",
      "          (VP (VBG using)\n",
      "            (NP (DT the) (NN checklist))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN increased)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NN frequency))\n",
      "            (PP (IN of)\n",
      "              (NP (NN micturition))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (NN reduction))\n",
      "            (PP (IN in)\n",
      "              (NP (NN libido))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP (NNS headaches)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(complaints-2, notable-1)\n",
      "nsubjpass(increased-10, complaints-2)\n",
      "case(patients-5, for-3)\n",
      "det(patients-5, all-4)\n",
      "nmod:for(complaints-2, patients-5)\n",
      "acl(patients-5, using-6)\n",
      "det(checklist-8, the-7)\n",
      "dobj(using-6, checklist-8)\n",
      "auxpass(increased-10, were-9)\n",
      "root(ROOT-0, increased-10)\n",
      "dobj(increased-10, frequency-11)\n",
      "case(micturition-13, of-12)\n",
      "nmod:of(frequency-11, micturition-13)\n",
      "dobj(increased-10, reduction-15)\n",
      "conj:and(frequency-11, reduction-15)\n",
      "case(libido-17, in-16)\n",
      "nmod:in(reduction-15, libido-17)\n",
      "cc(frequency-11, and-19)\n",
      "dobj(increased-10, headaches-20)\n",
      "conj:and(frequency-11, headaches-20)\n",
      "\n",
      "Parsing [sent. 34 len. 17]: the reactions resulted in the discontinuation and substitution of therapy in 49.5 % of the patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNS reactions))\n",
      "    (VP (VBD resulted)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the) (NN discontinuation)\n",
      "            (CC and)\n",
      "            (NN substitution))\n",
      "          (PP (IN of)\n",
      "            (NP (NN therapy)))))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (CD 49.5) (NN %))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NNS patients))))))\n",
      "    (. .)))\n",
      "\n",
      "det(reactions-2, the-1)\n",
      "nsubj(resulted-3, reactions-2)\n",
      "root(ROOT-0, resulted-3)\n",
      "case(discontinuation-6, in-4)\n",
      "det(discontinuation-6, the-5)\n",
      "nmod:in(resulted-3, discontinuation-6)\n",
      "cc(discontinuation-6, and-7)\n",
      "nmod:in(resulted-3, substitution-8)\n",
      "conj:and(discontinuation-6, substitution-8)\n",
      "case(therapy-10, of-9)\n",
      "nmod:of(discontinuation-6, therapy-10)\n",
      "case(%-13, in-11)\n",
      "nummod(%-13, 49.5-12)\n",
      "nmod:in(resulted-3, %-13)\n",
      "case(patients-16, of-14)\n",
      "det(patients-16, the-15)\n",
      "nmod:of(%-13, patients-16)\n",
      "\n",
      "Parsing [sent. 35 len. 28]: in clinical setting , congestive heart failure -LRB- chf -RRB- and chronic kidney disease -LRB- ckd -RRB- often co-exist in patients due to common underlying predisposing factors .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (JJ clinical) (NN setting)))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (JJ congestive) (NN heart) (NN failure))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN chf))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (JJ chronic) (NN kidney) (NN disease)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN ckd))\n",
      "        (-RRB- -RRB-)))\n",
      "    (ADVP (RB often))\n",
      "    (VP (VB co-exist)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (ADJP (JJ due)\n",
      "            (PP (TO to)\n",
      "              (NP (JJ common) (JJ underlying) (NN predisposing) (NNS factors)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(setting-3, in-1)\n",
      "amod(setting-3, clinical-2)\n",
      "nmod:in(co-exist-19, setting-3)\n",
      "amod(failure-7, congestive-5)\n",
      "compound(failure-7, heart-6)\n",
      "nsubj(co-exist-19, failure-7)\n",
      "appos(failure-7, chf-9)\n",
      "cc(failure-7, and-11)\n",
      "amod(disease-14, chronic-12)\n",
      "compound(disease-14, kidney-13)\n",
      "conj:and(failure-7, disease-14)\n",
      "nsubj(co-exist-19, disease-14)\n",
      "appos(failure-7, ckd-16)\n",
      "advmod(co-exist-19, often-18)\n",
      "root(ROOT-0, co-exist-19)\n",
      "case(patients-21, in-20)\n",
      "nmod:in(co-exist-19, patients-21)\n",
      "amod(patients-21, due-22)\n",
      "case(factors-27, to-23)\n",
      "amod(factors-27, common-24)\n",
      "amod(factors-27, underlying-25)\n",
      "compound(factors-27, predisposing-26)\n",
      "nmod:to(due-22, factors-27)\n",
      "\n",
      "Parsing [sent. 36 len. 20]: an intricate equilibrium between the cardiovascular and renal system is maintained through rennin angiotensin-aldosterone axis and autonomic nervous system .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT an) (JJ intricate) (NN equilibrium))\n",
      "      (PP (IN between)\n",
      "        (NP (DT the) (JJ cardiovascular)\n",
      "          (CC and)\n",
      "          (JJ renal) (NN system))))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN maintained)\n",
      "        (PP (IN through)\n",
      "          (NP\n",
      "            (NP (JJ rennin) (JJ angiotensin-aldosterone) (NNS axis))\n",
      "            (CC and)\n",
      "            (NP (JJ autonomic) (JJ nervous) (NN system))))))\n",
      "    (. .)))\n",
      "\n",
      "det(equilibrium-3, an-1)\n",
      "amod(equilibrium-3, intricate-2)\n",
      "nsubjpass(maintained-11, equilibrium-3)\n",
      "case(system-9, between-4)\n",
      "det(system-9, the-5)\n",
      "amod(system-9, cardiovascular-6)\n",
      "cc(cardiovascular-6, and-7)\n",
      "conj:and(cardiovascular-6, renal-8)\n",
      "amod(system-9, renal-8)\n",
      "nmod:between(equilibrium-3, system-9)\n",
      "auxpass(maintained-11, is-10)\n",
      "root(ROOT-0, maintained-11)\n",
      "case(axis-15, through-12)\n",
      "amod(axis-15, rennin-13)\n",
      "amod(axis-15, angiotensin-aldosterone-14)\n",
      "nmod:through(maintained-11, axis-15)\n",
      "cc(axis-15, and-16)\n",
      "amod(system-19, autonomic-17)\n",
      "amod(system-19, nervous-18)\n",
      "nmod:through(maintained-11, system-19)\n",
      "conj:and(axis-15, system-19)\n",
      "\n",
      "Parsing [sent. 37 len. 32]: consequent to favorable hemodynamic modification , ACEI and angiotensin receptor blocking -LRB- arb -RRB- therapy have proven to be an indispensable aspect of heart failure management with morbidity and mortality benefit .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (JJ consequent)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (JJ favorable) (JJ hemodynamic) (NN modification))\n",
      "            (, ,)\n",
      "            (NP (NNP ACEI))\n",
      "            (CC and)\n",
      "            (NP (NN angiotensin)))))\n",
      "      (JJ receptor) (FW blocking)\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN arb))\n",
      "        (-RRB- -RRB-))\n",
      "      (NN therapy))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN proven)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ indispensable) (NN aspect))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NN heart) (NN failure) (NN management))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN morbidity)\n",
      "                        (CC and)\n",
      "                        (NN mortality) (NN benefit)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-15, consequent-1)\n",
      "case(modification-5, to-2)\n",
      "amod(modification-5, favorable-3)\n",
      "amod(modification-5, hemodynamic-4)\n",
      "nmod:to(consequent-1, modification-5)\n",
      "nmod:to(consequent-1, ACEI-7)\n",
      "conj:and(modification-5, ACEI-7)\n",
      "cc(modification-5, and-8)\n",
      "nmod:to(consequent-1, angiotensin-9)\n",
      "conj:and(modification-5, angiotensin-9)\n",
      "amod(therapy-15, receptor-10)\n",
      "compound(therapy-15, blocking-11)\n",
      "appos(therapy-15, arb-13)\n",
      "nsubj(proven-17, therapy-15)\n",
      "nsubj:xsubj(aspect-22, therapy-15)\n",
      "aux(proven-17, have-16)\n",
      "root(ROOT-0, proven-17)\n",
      "mark(aspect-22, to-18)\n",
      "cop(aspect-22, be-19)\n",
      "det(aspect-22, an-20)\n",
      "amod(aspect-22, indispensable-21)\n",
      "xcomp(proven-17, aspect-22)\n",
      "case(management-26, of-23)\n",
      "compound(management-26, heart-24)\n",
      "compound(management-26, failure-25)\n",
      "nmod:of(aspect-22, management-26)\n",
      "case(benefit-31, with-27)\n",
      "compound(benefit-31, morbidity-28)\n",
      "cc(morbidity-28, and-29)\n",
      "conj:and(morbidity-28, mortality-30)\n",
      "compound(benefit-31, mortality-30)\n",
      "nmod:with(management-26, benefit-31)\n",
      "\n",
      "Parsing [sent. 38 len. 27]: additionally , progression to end stage renal failure may be halted by renin angiotensin aldosterone system -LRB- raas -RRB- blockade in patients with preexisting renal dysfunction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB additionally))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN progression))\n",
      "      (PP (TO to)\n",
      "        (NP (NN end) (NN stage) (JJ renal) (NN failure))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN halted)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (JJ renin)\n",
      "                (ADJP (RB angiotensin) (JJ aldosterone))\n",
      "                (NN system)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNS raas))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NN blockade))\n",
      "              (PP (IN in)\n",
      "                (NP (NNS patients)))))\n",
      "          (PP (IN with)\n",
      "            (S\n",
      "              (VP (VBG preexisting)\n",
      "                (NP (JJ renal) (NN dysfunction))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(halted-11, additionally-1)\n",
      "nsubjpass(halted-11, progression-3)\n",
      "case(failure-8, to-4)\n",
      "compound(failure-8, end-5)\n",
      "compound(failure-8, stage-6)\n",
      "amod(failure-8, renal-7)\n",
      "nmod:to(progression-3, failure-8)\n",
      "aux(halted-11, may-9)\n",
      "auxpass(halted-11, be-10)\n",
      "root(ROOT-0, halted-11)\n",
      "case(blockade-20, by-12)\n",
      "amod(blockade-20, renin-13)\n",
      "advmod(aldosterone-15, angiotensin-14)\n",
      "amod(blockade-20, aldosterone-15)\n",
      "compound(blockade-20, system-16)\n",
      "appos(blockade-20, raas-18)\n",
      "nmod:by(halted-11, blockade-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(blockade-20, patients-22)\n",
      "mark(preexisting-24, with-23)\n",
      "advcl(halted-11, preexisting-24)\n",
      "amod(dysfunction-26, renal-25)\n",
      "dobj(preexisting-24, dysfunction-26)\n",
      "\n",
      "Parsing [sent. 39 len. 29]: however , concern over the safety of raas blockade in presence of renal impairment has led to profound underutilization of these drugs in chf patients with renal insufficiency .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN concern))\n",
      "      (PP (IN over)\n",
      "        (NP\n",
      "          (NP (DT the) (NN safety))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ raas) (NN blockade))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NN presence))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ renal) (NN impairment))))))))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN led)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (JJ profound) (NN underutilization))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT these) (NNS drugs))\n",
      "                (PP (IN in)\n",
      "                  (NP (NN chf) (NNS patients)))))))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ renal) (NN insufficiency)))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(led-16, however-1)\n",
      "nsubj(led-16, concern-3)\n",
      "case(safety-6, over-4)\n",
      "det(safety-6, the-5)\n",
      "nmod:over(concern-3, safety-6)\n",
      "case(blockade-9, of-7)\n",
      "amod(blockade-9, raas-8)\n",
      "nmod:of(safety-6, blockade-9)\n",
      "case(presence-11, in-10)\n",
      "nmod:in(blockade-9, presence-11)\n",
      "case(impairment-14, of-12)\n",
      "amod(impairment-14, renal-13)\n",
      "nmod:of(presence-11, impairment-14)\n",
      "aux(led-16, has-15)\n",
      "root(ROOT-0, led-16)\n",
      "case(underutilization-19, to-17)\n",
      "amod(underutilization-19, profound-18)\n",
      "nmod:to(led-16, underutilization-19)\n",
      "case(drugs-22, of-20)\n",
      "det(drugs-22, these-21)\n",
      "nmod:of(underutilization-19, drugs-22)\n",
      "case(patients-25, in-23)\n",
      "compound(patients-25, chf-24)\n",
      "nmod:in(drugs-22, patients-25)\n",
      "case(insufficiency-28, with-26)\n",
      "amod(insufficiency-28, renal-27)\n",
      "nmod:with(led-16, insufficiency-28)\n",
      "\n",
      "Parsing [sent. 40 len. 18]: this review aims to provide a simplified guide to pathophysiology and management options of this perplexing situation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN review))\n",
      "    (VP (VBZ aims)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB provide)\n",
      "            (NP (DT a) (VBN simplified) (NN guide))\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN pathophysiology)\n",
      "                  (CC and)\n",
      "                  (NN management) (NNS options))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT this) (JJ perplexing) (NN situation)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(review-2, this-1)\n",
      "nsubj(aims-3, review-2)\n",
      "nsubj:xsubj(provide-5, review-2)\n",
      "root(ROOT-0, aims-3)\n",
      "mark(provide-5, to-4)\n",
      "xcomp(aims-3, provide-5)\n",
      "det(guide-8, a-6)\n",
      "amod(guide-8, simplified-7)\n",
      "dobj(provide-5, guide-8)\n",
      "case(options-13, to-9)\n",
      "compound(options-13, pathophysiology-10)\n",
      "cc(pathophysiology-10, and-11)\n",
      "conj:and(pathophysiology-10, management-12)\n",
      "compound(options-13, management-12)\n",
      "nmod:to(provide-5, options-13)\n",
      "case(situation-17, of-14)\n",
      "det(situation-17, this-15)\n",
      "amod(situation-17, perplexing-16)\n",
      "nmod:of(options-13, situation-17)\n",
      "\n",
      "Parsing [sent. 41 len. 19]: dihydropyridine calcium channel blockers may possess antioxidant properties , and might improve micro and macrovascular structure and function .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ dihydropyridine) (NN calcium) (NN channel) (NNS blockers))\n",
      "    (VP\n",
      "      (VP (MD may)\n",
      "        (VP (VB possess)\n",
      "          (NP (JJ antioxidant) (NNS properties))))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (VP (MD might)\n",
      "        (VP (VB improve)\n",
      "          (NP (JJ micro)\n",
      "            (CC and)\n",
      "            (NN macrovascular) (NN structure)\n",
      "            (CC and)\n",
      "            (NN function)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(blockers-4, dihydropyridine-1)\n",
      "compound(blockers-4, calcium-2)\n",
      "compound(blockers-4, channel-3)\n",
      "nsubj(possess-6, blockers-4)\n",
      "nsubj(improve-12, blockers-4)\n",
      "aux(possess-6, may-5)\n",
      "root(ROOT-0, possess-6)\n",
      "amod(properties-8, antioxidant-7)\n",
      "dobj(possess-6, properties-8)\n",
      "cc(possess-6, and-10)\n",
      "aux(improve-12, might-11)\n",
      "conj:and(possess-6, improve-12)\n",
      "amod(structure-16, micro-13)\n",
      "cc(micro-13, and-14)\n",
      "conj:and(micro-13, macrovascular-15)\n",
      "amod(structure-16, macrovascular-15)\n",
      "dobj(improve-12, structure-16)\n",
      "cc(structure-16, and-17)\n",
      "dobj(improve-12, function-18)\n",
      "conj:and(structure-16, function-18)\n",
      "\n",
      "Parsing [sent. 42 len. 16]: combination treatment with an ACEI may have additional advantages , compared with a thiazide diuretic .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN combination) (NN treatment))\n",
      "      (PP (IN with)\n",
      "        (NP (DT an) (NNP ACEI))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB have)\n",
      "        (NP (JJ additional) (NNS advantages))\n",
      "        (, ,)\n",
      "        (PP (VBN compared)\n",
      "          (PP (IN with)\n",
      "            (NP (DT a) (JJ thiazide) (NN diuretic))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(treatment-2, combination-1)\n",
      "nsubj(have-7, treatment-2)\n",
      "case(ACEI-5, with-3)\n",
      "det(ACEI-5, an-4)\n",
      "nmod:with(treatment-2, ACEI-5)\n",
      "aux(have-7, may-6)\n",
      "root(ROOT-0, have-7)\n",
      "amod(advantages-9, additional-8)\n",
      "dobj(have-7, advantages-9)\n",
      "case(diuretic-15, compared-11)\n",
      "mwe(compared-11, with-12)\n",
      "det(diuretic-15, a-13)\n",
      "amod(diuretic-15, thiazide-14)\n",
      "advcl(have-7, diuretic-15)\n",
      "\n",
      "Parsing [sent. 43 len. 49]: the aim of the present study is to investigate the effects of a short-term treatment with lercanidipine , and to compare two combination treatments : lercanidipine + enalapril vs. lercanidipine + hydrochlorothiazide on structural alterations in retinal arterioles , on skin capillary density and on large artery distensibility .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN aim))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ present) (NN study))))\n",
      "    (VP (VBZ is)\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (TO to)\n",
      "            (VP (VB investigate)\n",
      "              (NP\n",
      "                (NP (DT the) (NNS effects))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT a) (JJ short-term) (NN treatment))))\n",
      "              (PP (IN with)\n",
      "                (NP (NN lercanidipine)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (VP (TO to)\n",
      "            (VP (VB compare)\n",
      "              (NP\n",
      "                (NP (CD two) (NN combination) (NNS treatments))\n",
      "                (: :)\n",
      "                (NP\n",
      "                  (NP (JJ lercanidipine) (JJ +) (NN enalapril))\n",
      "                  (PP (IN vs.)\n",
      "                    (NP\n",
      "                      (NP (JJ lercanidipine) (JJ +) (NN hydrochlorothiazide))\n",
      "                      (PP (IN on)\n",
      "                        (NP\n",
      "                          (NP (JJ structural) (NNS alterations))\n",
      "                          (PP (IN in)\n",
      "                            (NP (JJ retinal) (NNS arterioles))))))))\n",
      "                (, ,))\n",
      "              (PP\n",
      "                (PP (IN on)\n",
      "                  (NP (NN skin) (NN capillary) (NN density)))\n",
      "                (CC and)\n",
      "                (PP (IN on)\n",
      "                  (NP (JJ large) (NN artery) (NN distensibility)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(aim-2, the-1)\n",
      "nsubj(is-7, aim-2)\n",
      "case(study-6, of-3)\n",
      "det(study-6, the-4)\n",
      "amod(study-6, present-5)\n",
      "nmod:of(aim-2, study-6)\n",
      "root(ROOT-0, is-7)\n",
      "mark(investigate-9, to-8)\n",
      "ccomp(is-7, investigate-9)\n",
      "det(effects-11, the-10)\n",
      "dobj(investigate-9, effects-11)\n",
      "case(treatment-15, of-12)\n",
      "det(treatment-15, a-13)\n",
      "amod(treatment-15, short-term-14)\n",
      "nmod:of(effects-11, treatment-15)\n",
      "case(lercanidipine-17, with-16)\n",
      "nmod:with(investigate-9, lercanidipine-17)\n",
      "cc(investigate-9, and-19)\n",
      "mark(compare-21, to-20)\n",
      "ccomp(is-7, compare-21)\n",
      "conj:and(investigate-9, compare-21)\n",
      "conj:and(investigate-9, compare-21')\n",
      "conj:and(compare-21, compare-21')\n",
      "nummod(treatments-24, two-22)\n",
      "compound(treatments-24, combination-23)\n",
      "dobj(compare-21, treatments-24)\n",
      "amod(enalapril-28, lercanidipine-26)\n",
      "amod(enalapril-28, +-27)\n",
      "dep(treatments-24, enalapril-28)\n",
      "case(hydrochlorothiazide-32, vs.-29)\n",
      "amod(hydrochlorothiazide-32, lercanidipine-30)\n",
      "amod(hydrochlorothiazide-32, +-31)\n",
      "nmod:vs.(enalapril-28, hydrochlorothiazide-32)\n",
      "case(alterations-35, on-33)\n",
      "amod(alterations-35, structural-34)\n",
      "nmod:on(hydrochlorothiazide-32, alterations-35)\n",
      "case(arterioles-38, in-36)\n",
      "amod(arterioles-38, retinal-37)\n",
      "nmod:in(alterations-35, arterioles-38)\n",
      "case(density-43, on-40)\n",
      "compound(density-43, skin-41)\n",
      "compound(density-43, capillary-42)\n",
      "nmod:on(compare-21, density-43)\n",
      "cc(compare-21, and-44)\n",
      "case(distensibility-48, on-45)\n",
      "amod(distensibility-48, large-46)\n",
      "compound(distensibility-48, artery-47)\n",
      "nmod:on(compare-21', distensibility-48)\n",
      "\n",
      "Parsing [sent. 44 len. 23]: thirty essential hypertension patients are included in the study , and treated for 4 weeks with lercanidipine 20 mg per day orally .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (CD thirty) (JJ essential))\n",
      "      (NN hypertension) (NNS patients))\n",
      "    (VP (VBP are)\n",
      "      (VP\n",
      "        (VP (VBN included)\n",
      "          (PP (IN in)\n",
      "            (NP (DT the) (NN study))))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (VP (VBN treated)\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (CD 4) (NNS weeks))\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (ADJP (JJ lercanidipine)\n",
      "                      (NP (CD 20)))\n",
      "                    (NN mg))\n",
      "                  (PP (IN per)\n",
      "                    (NP (NN day) (NN orally))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(essential-2, thirty-1)\n",
      "amod(patients-4, essential-2)\n",
      "compound(patients-4, hypertension-3)\n",
      "nsubjpass(included-6, patients-4)\n",
      "nsubjpass(treated-12, patients-4)\n",
      "auxpass(included-6, are-5)\n",
      "root(ROOT-0, included-6)\n",
      "case(study-9, in-7)\n",
      "det(study-9, the-8)\n",
      "nmod:in(included-6, study-9)\n",
      "cc(included-6, and-11)\n",
      "conj:and(included-6, treated-12)\n",
      "case(weeks-15, for-13)\n",
      "nummod(weeks-15, 4-14)\n",
      "nmod:for(treated-12, weeks-15)\n",
      "case(mg-19, with-16)\n",
      "amod(mg-19, lercanidipine-17)\n",
      "dep(lercanidipine-17, 20-18)\n",
      "nmod:with(weeks-15, mg-19)\n",
      "case(orally-22, per-20)\n",
      "compound(orally-22, day-21)\n",
      "nmod:per(mg-19, orally-22)\n",
      "\n",
      "Parsing [sent. 45 len. 28]: then , they were treated for 6 months with lercanidipine + enalapril -LRB- n = 15 -RRB- or lercanidipine + hydrochlorothiazide -LRB- n = 15 -RRB- combinations .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB then))\n",
      "    (, ,)\n",
      "    (NP (PRP they))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN treated)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (CD 6) (NNS months))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ lercanidipine) (JJ +) (NN enalapril))))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 15)))))\n",
      "              (-RRB- -RRB-))\n",
      "            (CC or)\n",
      "            (NP\n",
      "              (ADJP (JJ lercanidipine) (JJ +))\n",
      "              (JJ hydrochlorothiazide)\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 15)))))\n",
      "                (-RRB- -RRB-))\n",
      "              (NN combinations))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(treated-5, then-1)\n",
      "nsubjpass(treated-5, they-3)\n",
      "auxpass(treated-5, were-4)\n",
      "root(ROOT-0, treated-5)\n",
      "case(months-8, for-6)\n",
      "nummod(months-8, 6-7)\n",
      "nmod:for(treated-5, months-8)\n",
      "case(enalapril-12, with-9)\n",
      "amod(enalapril-12, lercanidipine-10)\n",
      "amod(enalapril-12, +-11)\n",
      "nmod:with(months-8, enalapril-12)\n",
      "dep(months-8, n-14)\n",
      "dep(15-16, =-15)\n",
      "ccomp(n-14, 15-16)\n",
      "cc(months-8, or-18)\n",
      "amod(+-20, lercanidipine-19)\n",
      "amod(combinations-27, +-20)\n",
      "amod(combinations-27, hydrochlorothiazide-21)\n",
      "dep(combinations-27, n-23)\n",
      "dep(15-25, =-24)\n",
      "ccomp(n-23, 15-25)\n",
      "nmod:for(treated-5, combinations-27)\n",
      "conj:or(months-8, combinations-27)\n",
      "\n",
      "Parsing [sent. 46 len. 32]: investigations were performed on basal condition , after appropriate wash out of previous treatments , after 4 weeks of lercanidipine monotherapy treatment , and at the end of the combination treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS investigations))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN performed)\n",
      "        (PP\n",
      "          (PP (IN on)\n",
      "            (NP (JJ basal) (NN condition)))\n",
      "          (, ,)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (JJ appropriate) (NN wash))\n",
      "              (PP (RB out) (IN of)\n",
      "                (NP (JJ previous) (NNS treatments)))))\n",
      "          (, ,)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (CD 4) (NNS weeks))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ lercanidipine) (JJ monotherapy) (NN treatment)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (PP (IN at)\n",
      "            (NP\n",
      "              (NP (DT the) (NN end))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN combination) (NN treatment))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(performed-3, investigations-1)\n",
      "nsubjpass(performed-3', investigations-1)\n",
      "nsubjpass(performed-3'', investigations-1)\n",
      "nsubjpass(performed-3''', investigations-1)\n",
      "auxpass(performed-3, were-2)\n",
      "root(ROOT-0, performed-3)\n",
      "conj:and(performed-3, performed-3')\n",
      "conj:and(performed-3, performed-3'')\n",
      "conj:and(performed-3, performed-3''')\n",
      "case(condition-6, on-4)\n",
      "amod(condition-6, basal-5)\n",
      "nmod:on(performed-3, condition-6)\n",
      "case(wash-10, after-8)\n",
      "amod(wash-10, appropriate-9)\n",
      "nmod:after(performed-3'', wash-10)\n",
      "case(treatments-14, out-11)\n",
      "mwe(out-11, of-12)\n",
      "amod(treatments-14, previous-13)\n",
      "nmod:out_of(wash-10, treatments-14)\n",
      "case(weeks-18, after-16)\n",
      "nummod(weeks-18, 4-17)\n",
      "nmod:after(performed-3', weeks-18)\n",
      "case(treatment-22, of-19)\n",
      "amod(treatment-22, lercanidipine-20)\n",
      "amod(treatment-22, monotherapy-21)\n",
      "nmod:of(weeks-18, treatment-22)\n",
      "cc(performed-3, and-24)\n",
      "case(end-27, at-25)\n",
      "det(end-27, the-26)\n",
      "nmod:at(performed-3''', end-27)\n",
      "case(treatment-31, of-28)\n",
      "det(treatment-31, the-29)\n",
      "compound(treatment-31, combination-30)\n",
      "nmod:of(end-27, treatment-31)\n",
      "\n",
      "Parsing [sent. 47 len. 27]: non-invasive measurements of wall-to-lumen ratio -LRB- wlr -RRB- and other morphological parameters of retinal arterioles were performed using either scanning laser doppler flowmetry or adaptive optics .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (ADJP (JJ non-invasive))\n",
      "        (NNS measurements))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ wall-to-lumen) (NN ratio))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NN wlr))\n",
      "              (-RRB- -RRB-)))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (JJ other) (JJ morphological) (NNS parameters))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ retinal) (NNS arterioles)))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN performed)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (CC either)\n",
      "            (VBG scanning)\n",
      "            (NP (NN laser) (NN doppler) (NN flowmetry)\n",
      "              (CC or)\n",
      "              (NN adaptive) (NNS optics))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(measurements-2, non-invasive-1)\n",
      "nsubjpass(performed-17, measurements-2)\n",
      "case(ratio-5, of-3)\n",
      "amod(ratio-5, wall-to-lumen-4)\n",
      "nmod:of(measurements-2, ratio-5)\n",
      "appos(ratio-5, wlr-7)\n",
      "cc(ratio-5, and-9)\n",
      "amod(parameters-12, other-10)\n",
      "amod(parameters-12, morphological-11)\n",
      "nmod:of(measurements-2, parameters-12)\n",
      "conj:and(ratio-5, parameters-12)\n",
      "case(arterioles-15, of-13)\n",
      "amod(arterioles-15, retinal-14)\n",
      "nmod:of(parameters-12, arterioles-15)\n",
      "auxpass(performed-17, were-16)\n",
      "root(ROOT-0, performed-17)\n",
      "xcomp(performed-17, using-18)\n",
      "dep(using-18, either-19)\n",
      "conj(using-18, scanning-20)\n",
      "compound(flowmetry-23, laser-21)\n",
      "compound(flowmetry-23, doppler-22)\n",
      "dobj(using-18, flowmetry-23)\n",
      "cc(flowmetry-23, or-24)\n",
      "compound(optics-26, adaptive-25)\n",
      "dobj(using-18, optics-26)\n",
      "conj:or(flowmetry-23, optics-26)\n",
      "\n",
      "Parsing [sent. 48 len. 25]: capillary density was evaluated by capillaroscopy , while pulse wave velocity was measured , and central blood pressures were assessed by pressure waveform analysis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ capillary) (NN density))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN evaluated)\n",
      "          (PP (IN by)\n",
      "            (NP (NN capillaroscopy)))\n",
      "          (, ,)\n",
      "          (SBAR (IN while)\n",
      "            (S\n",
      "              (NP (NN pulse) (NN wave) (NN velocity))\n",
      "              (VP (VBD was)\n",
      "                (VP (VBN measured))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ central) (NN blood) (NNS pressures))\n",
      "      (VP (VBD were)\n",
      "        (VP (VBN assessed)\n",
      "          (PP (IN by)\n",
      "            (NP (NN pressure) (NN waveform) (NN analysis))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(density-2, capillary-1)\n",
      "nsubjpass(evaluated-4, density-2)\n",
      "auxpass(evaluated-4, was-3)\n",
      "root(ROOT-0, evaluated-4)\n",
      "case(capillaroscopy-6, by-5)\n",
      "nmod:by(evaluated-4, capillaroscopy-6)\n",
      "mark(measured-13, while-8)\n",
      "compound(velocity-11, pulse-9)\n",
      "compound(velocity-11, wave-10)\n",
      "nsubjpass(measured-13, velocity-11)\n",
      "auxpass(measured-13, was-12)\n",
      "advcl(evaluated-4, measured-13)\n",
      "cc(evaluated-4, and-15)\n",
      "amod(pressures-18, central-16)\n",
      "compound(pressures-18, blood-17)\n",
      "nsubjpass(assessed-20, pressures-18)\n",
      "auxpass(assessed-20, were-19)\n",
      "conj:and(evaluated-4, assessed-20)\n",
      "case(analysis-24, by-21)\n",
      "compound(analysis-24, pressure-22)\n",
      "compound(analysis-24, waveform-23)\n",
      "nmod:by(assessed-20, analysis-24)\n",
      "\n",
      "Parsing [sent. 49 len. 49]: a significant improvement of wlr and other indices of retinal artery structure is observed with both technical approaches after treatment with lercanidipine alone , with a further improvement after treatment with lercanidipine + enalapril , while after treatment with lercanidipine + hydrochlorothiazide , the improvement is partially blunted .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT a) (JJ significant) (NN improvement))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN wlr)\n",
      "            (CC and)\n",
      "            (JJ other) (NNS indices))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ retinal) (NN artery) (NN structure))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ observed)\n",
      "        (PP (IN with)\n",
      "          (NP (DT both) (JJ technical) (NNS approaches))))\n",
      "      (PP (IN after)\n",
      "        (NP\n",
      "          (NP (NN treatment))\n",
      "          (PP (IN with)\n",
      "            (NP (NN lercanidipine)))))\n",
      "      (ADVP\n",
      "        (ADVP (RB alone))\n",
      "        (PRN (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (DT a) (JJ further) (NN improvement))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (NN treatment))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ lercanidipine) (JJ +) (NN enalapril)))))))\n",
      "          (, ,))\n",
      "        (SBAR (IN while)\n",
      "          (S\n",
      "            (PP (IN after)\n",
      "              (NP\n",
      "                (NP (NN treatment))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ lercanidipine) (JJ +) (NN hydrochlorothiazide)))))\n",
      "            (, ,)\n",
      "            (NP (DT the) (NN improvement))\n",
      "            (VP (VBZ is)\n",
      "              (ADVP (RB partially))\n",
      "              (VP (VBN blunted)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(improvement-3, a-1)\n",
      "amod(improvement-3, significant-2)\n",
      "nsubj(observed-14, improvement-3)\n",
      "case(indices-8, of-4)\n",
      "compound(indices-8, wlr-5)\n",
      "cc(wlr-5, and-6)\n",
      "conj:and(wlr-5, other-7)\n",
      "compound(indices-8, other-7)\n",
      "nmod:of(improvement-3, indices-8)\n",
      "case(structure-12, of-9)\n",
      "amod(structure-12, retinal-10)\n",
      "compound(structure-12, artery-11)\n",
      "nmod:of(indices-8, structure-12)\n",
      "cop(observed-14, is-13)\n",
      "root(ROOT-0, observed-14)\n",
      "case(approaches-18, with-15)\n",
      "det(approaches-18, both-16)\n",
      "amod(approaches-18, technical-17)\n",
      "nmod:with(observed-14, approaches-18)\n",
      "case(treatment-20, after-19)\n",
      "nmod:after(observed-14, treatment-20)\n",
      "case(lercanidipine-22, with-21)\n",
      "nmod:with(treatment-20, lercanidipine-22)\n",
      "advmod(observed-14, alone-23)\n",
      "case(improvement-28, with-25)\n",
      "det(improvement-28, a-26)\n",
      "amod(improvement-28, further-27)\n",
      "dep(alone-23, improvement-28)\n",
      "case(treatment-30, after-29)\n",
      "nmod:after(improvement-28, treatment-30)\n",
      "case(enalapril-34, with-31)\n",
      "amod(enalapril-34, lercanidipine-32)\n",
      "amod(enalapril-34, +-33)\n",
      "nmod:with(treatment-30, enalapril-34)\n",
      "mark(blunted-48, while-36)\n",
      "case(treatment-38, after-37)\n",
      "nmod:after(blunted-48, treatment-38)\n",
      "case(hydrochlorothiazide-42, with-39)\n",
      "amod(hydrochlorothiazide-42, lercanidipine-40)\n",
      "amod(hydrochlorothiazide-42, +-41)\n",
      "nmod:with(treatment-38, hydrochlorothiazide-42)\n",
      "det(improvement-45, the-44)\n",
      "nsubjpass(blunted-48, improvement-45)\n",
      "auxpass(blunted-48, is-46)\n",
      "advmod(blunted-48, partially-47)\n",
      "advcl(alone-23, blunted-48)\n",
      "\n",
      "Parsing [sent. 50 len. 14]: central systolic and diastolic blood pressures are similarly reduced by both therapeutic strategies .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ central)\n",
      "      (ADJP (JJ systolic)\n",
      "        (CC and)\n",
      "        (JJ diastolic))\n",
      "      (NN blood) (NNS pressures))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB similarly))\n",
      "      (VP (VBN reduced)\n",
      "        (PP (IN by)\n",
      "          (NP (DT both) (JJ therapeutic) (NNS strategies)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(pressures-6, central-1)\n",
      "amod(pressures-6, systolic-2)\n",
      "cc(systolic-2, and-3)\n",
      "conj:and(systolic-2, diastolic-4)\n",
      "amod(pressures-6, diastolic-4)\n",
      "compound(pressures-6, blood-5)\n",
      "nsubjpass(reduced-9, pressures-6)\n",
      "auxpass(reduced-9, are-7)\n",
      "advmod(reduced-9, similarly-8)\n",
      "root(ROOT-0, reduced-9)\n",
      "case(strategies-13, by-10)\n",
      "det(strategies-13, both-11)\n",
      "amod(strategies-13, therapeutic-12)\n",
      "nmod:by(reduced-9, strategies-13)\n",
      "\n",
      "Parsing [sent. 51 len. 12]: capillary density is increased only after treatment with lercanidipine + enalapril .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ capillary) (NN density))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN increased)\n",
      "        (ADVP (RB only))\n",
      "        (PP (IN after)\n",
      "          (NP (NN treatment)))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ lercanidipine) (JJ +) (NN enalapril)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(density-2, capillary-1)\n",
      "nsubjpass(increased-4, density-2)\n",
      "auxpass(increased-4, is-3)\n",
      "root(ROOT-0, increased-4)\n",
      "advmod(increased-4, only-5)\n",
      "case(treatment-7, after-6)\n",
      "nmod:after(increased-4, treatment-7)\n",
      "case(enalapril-11, with-8)\n",
      "amod(enalapril-11, lercanidipine-9)\n",
      "amod(enalapril-11, +-10)\n",
      "nmod:with(increased-4, enalapril-11)\n",
      "\n",
      "Parsing [sent. 52 len. 41]: in conclusion , lercanidipine both in monotherapy and in combination with enalapril but not with hydrochlorothiazide is able to improve microvascular structure ; on the other hand , a decrease in central blood pressure is observed with both therapeutic combinations .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (NN conclusion)))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (S\n",
      "        (VP (VB lercanidipine)\n",
      "          (PP (DT both)\n",
      "            (PP (IN in)\n",
      "              (NP (NN monotherapy)))\n",
      "            (CC and)\n",
      "            (PP (IN in)\n",
      "              (NP (NN combination))))\n",
      "          (PP\n",
      "            (PP (IN with)\n",
      "              (NP (NN enalapril)))\n",
      "            (CONJP (CC but)\n",
      "              (RB not))\n",
      "            (PP (IN with)\n",
      "              (NP (NN hydrochlorothiazide))))))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ able)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB improve)\n",
      "                (NP (NN microvascular) (NN structure))))))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (PP (IN on)\n",
      "        (NP (DT the) (JJ other) (NN hand)))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (NN decrease))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ central) (NN blood) (NN pressure))))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN observed)\n",
      "          (PP (IN with)\n",
      "            (NP (DT both) (JJ therapeutic) (NNS combinations))))))\n",
      "    (. .)))\n",
      "\n",
      "case(conclusion-2, in-1)\n",
      "nmod:in(able-18, conclusion-2)\n",
      "conj(lercanidipine-4, lercanidipine-4')\n",
      "conj:and(lercanidipine-4, lercanidipine-4')\n",
      "csubj(able-18, lercanidipine-4)\n",
      "csubj(able-18, lercanidipine-4')\n",
      "cc:preconj(monotherapy-7, both-5)\n",
      "case(monotherapy-7, in-6)\n",
      "nmod:in(lercanidipine-4, monotherapy-7)\n",
      "cc(lercanidipine-4, and-8)\n",
      "case(combination-10, in-9)\n",
      "nmod:in(lercanidipine-4', combination-10)\n",
      "case(enalapril-12, with-11)\n",
      "nmod:with(lercanidipine-4, enalapril-12)\n",
      "cc(not-14, but-13)\n",
      "cc(lercanidipine-4, not-14)\n",
      "case(hydrochlorothiazide-16, with-15)\n",
      "nmod:with(lercanidipine-4', hydrochlorothiazide-16)\n",
      "cop(able-18, is-17)\n",
      "root(ROOT-0, able-18)\n",
      "mark(improve-20, to-19)\n",
      "xcomp(able-18, improve-20)\n",
      "compound(structure-22, microvascular-21)\n",
      "dobj(improve-20, structure-22)\n",
      "case(hand-27, on-24)\n",
      "det(hand-27, the-25)\n",
      "amod(hand-27, other-26)\n",
      "nmod:on(observed-36, hand-27)\n",
      "det(decrease-30, a-29)\n",
      "nsubjpass(observed-36, decrease-30)\n",
      "case(pressure-34, in-31)\n",
      "amod(pressure-34, central-32)\n",
      "compound(pressure-34, blood-33)\n",
      "nmod:in(decrease-30, pressure-34)\n",
      "auxpass(observed-36, is-35)\n",
      "parataxis(able-18, observed-36)\n",
      "case(combinations-40, with-37)\n",
      "det(combinations-40, both-38)\n",
      "amod(combinations-40, therapeutic-39)\n",
      "nmod:with(observed-36, combinations-40)\n",
      "\n",
      "Parsing [sent. 53 len. 23]: hypereosinophilic syndrome -LRB- hes -RRB- is a heterogeneous group of hematological disorders characterized by a chronic , unexplained hypereosinophilia with tissue damage .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ hypereosinophilic) (NN syndrome))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN hes))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ heterogeneous) (NN group))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (JJ hematological) (NNS disorders))\n",
      "            (VP (VBN characterized)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (DT a) (JJ chronic) (, ,) (JJ unexplained) (NN hypereosinophilia))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN tissue) (NN damage))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(syndrome-2, hypereosinophilic-1)\n",
      "nsubj(group-9, syndrome-2)\n",
      "appos(syndrome-2, hes-4)\n",
      "cop(group-9, is-6)\n",
      "det(group-9, a-7)\n",
      "amod(group-9, heterogeneous-8)\n",
      "root(ROOT-0, group-9)\n",
      "case(disorders-12, of-10)\n",
      "amod(disorders-12, hematological-11)\n",
      "nmod:of(group-9, disorders-12)\n",
      "acl(disorders-12, characterized-13)\n",
      "case(hypereosinophilia-19, by-14)\n",
      "det(hypereosinophilia-19, a-15)\n",
      "amod(hypereosinophilia-19, chronic-16)\n",
      "amod(hypereosinophilia-19, unexplained-18)\n",
      "nmod:by(characterized-13, hypereosinophilia-19)\n",
      "case(damage-22, with-20)\n",
      "compound(damage-22, tissue-21)\n",
      "nmod:with(hypereosinophilia-19, damage-22)\n",
      "\n",
      "Parsing [sent. 54 len. 18]: cardiac involvement occurs in â¼ 20 % of patients with hes and represents a major turning point .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ cardiac) (NN involvement))\n",
      "    (VP\n",
      "      (VP (VBZ occurs)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (CD â¼) (CD 20))\n",
      "              (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN hes))))))))\n",
      "      (CC and)\n",
      "      (VP (VBZ represents)\n",
      "        (NP (DT a) (JJ major) (NN turning) (NN point))))\n",
      "    (. .)))\n",
      "\n",
      "amod(involvement-2, cardiac-1)\n",
      "nsubj(occurs-3, involvement-2)\n",
      "nsubj(represents-13, involvement-2)\n",
      "root(ROOT-0, occurs-3)\n",
      "case(%-7, in-4)\n",
      "compound(20-6, â¼-5)\n",
      "nummod(%-7, 20-6)\n",
      "nmod:in(occurs-3, %-7)\n",
      "case(patients-9, of-8)\n",
      "nmod:of(%-7, patients-9)\n",
      "case(hes-11, with-10)\n",
      "nmod:with(patients-9, hes-11)\n",
      "cc(occurs-3, and-12)\n",
      "conj:and(occurs-3, represents-13)\n",
      "det(point-17, a-14)\n",
      "amod(point-17, major-15)\n",
      "compound(point-17, turning-16)\n",
      "dobj(represents-13, point-17)\n",
      "\n",
      "Parsing [sent. 55 len. 20]: cardiac injuries related to eosinophilia are divided into three chronological phases : eosinophilic infiltration , thrombosis , and fibrosis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ cardiac) (NNS injuries))\n",
      "      (VP (VBN related)\n",
      "        (PP (TO to)\n",
      "          (NP (NN eosinophilia)))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN divided)\n",
      "        (PP (IN into)\n",
      "          (NP\n",
      "            (NP (CD three) (JJ chronological) (NNS phases))\n",
      "            (: :)\n",
      "            (NP (JJ eosinophilic) (NN infiltration))\n",
      "            (, ,)\n",
      "            (NP (NNS thrombosis))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (NN fibrosis))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(injuries-2, cardiac-1)\n",
      "nsubjpass(divided-7, injuries-2)\n",
      "acl(injuries-2, related-3)\n",
      "case(eosinophilia-5, to-4)\n",
      "nmod:to(related-3, eosinophilia-5)\n",
      "auxpass(divided-7, are-6)\n",
      "root(ROOT-0, divided-7)\n",
      "case(phases-11, into-8)\n",
      "nummod(phases-11, three-9)\n",
      "amod(phases-11, chronological-10)\n",
      "nmod:into(divided-7, phases-11)\n",
      "amod(infiltration-14, eosinophilic-13)\n",
      "nmod:into(divided-7, infiltration-14)\n",
      "conj:and(phases-11, infiltration-14)\n",
      "nmod:into(divided-7, thrombosis-16)\n",
      "conj:and(phases-11, thrombosis-16)\n",
      "cc(phases-11, and-18)\n",
      "nmod:into(divided-7, fibrosis-19)\n",
      "conj:and(phases-11, fibrosis-19)\n",
      "\n",
      "Parsing [sent. 56 len. 24]: we report a case of a 33-year-old woman diagnosed with hes , with pulmonary and gastrointestinal involvement and eosinophilic myocarditis in cardiogenic shock .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBP report)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT a) (NN case))\n",
      "            (PP (IN of)\n",
      "              (NP (DT a) (JJ 33-year-old) (NN woman))))\n",
      "          (VP (VBD diagnosed)\n",
      "            (PP (IN with)\n",
      "              (NP (NN hes)))\n",
      "            (, ,)\n",
      "            (PP (IN with)\n",
      "              (NP (JJ pulmonary)\n",
      "                (CC and)\n",
      "                (JJ gastrointestinal) (NN involvement)\n",
      "                (CC and)\n",
      "                (NN eosinophilic) (NNS myocarditis)))\n",
      "            (PP (IN in)\n",
      "              (NP (JJ cardiogenic) (NN shock)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(report-2, we-1)\n",
      "root(ROOT-0, report-2)\n",
      "det(case-4, a-3)\n",
      "nsubj(diagnosed-9, case-4)\n",
      "case(woman-8, of-5)\n",
      "det(woman-8, a-6)\n",
      "amod(woman-8, 33-year-old-7)\n",
      "nmod:of(case-4, woman-8)\n",
      "ccomp(report-2, diagnosed-9)\n",
      "case(hes-11, with-10)\n",
      "nmod:with(diagnosed-9, hes-11)\n",
      "case(involvement-17, with-13)\n",
      "amod(involvement-17, pulmonary-14)\n",
      "cc(pulmonary-14, and-15)\n",
      "conj:and(pulmonary-14, gastrointestinal-16)\n",
      "amod(involvement-17, gastrointestinal-16)\n",
      "nmod:with(diagnosed-9, involvement-17)\n",
      "cc(involvement-17, and-18)\n",
      "compound(myocarditis-20, eosinophilic-19)\n",
      "nmod:with(diagnosed-9, myocarditis-20)\n",
      "conj:and(involvement-17, myocarditis-20)\n",
      "case(shock-23, in-21)\n",
      "amod(shock-23, cardiogenic-22)\n",
      "nmod:in(diagnosed-9, shock-23)\n",
      "\n",
      "Parsing [sent. 57 len. 18]: the evolution was favorable with dobutamine , anticoagulation , corticosteroids , and later , Î²-blockers and ACEI .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN evolution))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ favorable)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN dobutamine))\n",
      "            (, ,)\n",
      "            (NP (NN anticoagulation))\n",
      "            (, ,)\n",
      "            (NP (NNS corticosteroids))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (ADVP (RB later))\n",
      "            (, ,)\n",
      "            (NP (NNS Î²-blockers))\n",
      "            (CC and)\n",
      "            (NP (NNP ACEI))))))\n",
      "    (. .)))\n",
      "\n",
      "det(evolution-2, the-1)\n",
      "nsubj(favorable-4, evolution-2)\n",
      "cop(favorable-4, was-3)\n",
      "root(ROOT-0, favorable-4)\n",
      "case(dobutamine-6, with-5)\n",
      "nmod:with(favorable-4, dobutamine-6)\n",
      "nmod:with(favorable-4, anticoagulation-8)\n",
      "conj:and(dobutamine-6, anticoagulation-8)\n",
      "nmod:with(favorable-4, corticosteroids-10)\n",
      "conj:and(dobutamine-6, corticosteroids-10)\n",
      "cc(dobutamine-6, and-12)\n",
      "advmod(dobutamine-6, later-13)\n",
      "nmod:with(favorable-4, Î²-blockers-15)\n",
      "conj:and(dobutamine-6, Î²-blockers-15)\n",
      "cc(dobutamine-6, and-16)\n",
      "nmod:with(favorable-4, ACEI-17)\n",
      "conj:and(dobutamine-6, ACEI-17)\n",
      "\n",
      "Parsing [sent. 58 len. 12]: cardiac involvement in hes is rare but carries a poor prognosis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ cardiac) (NN involvement))\n",
      "      (PP (IN in)\n",
      "        (NP (NN hes))))\n",
      "    (VP\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ rare)))\n",
      "      (CC but)\n",
      "      (VP (VBZ carries)\n",
      "        (NP (DT a) (JJ poor) (NN prognosis))))\n",
      "    (. .)))\n",
      "\n",
      "amod(involvement-2, cardiac-1)\n",
      "nsubj(rare-6, involvement-2)\n",
      "nsubj(carries-8, involvement-2)\n",
      "case(hes-4, in-3)\n",
      "nmod:in(involvement-2, hes-4)\n",
      "cop(rare-6, is-5)\n",
      "root(ROOT-0, rare-6)\n",
      "cc(rare-6, but-7)\n",
      "conj:but(rare-6, carries-8)\n",
      "det(prognosis-11, a-9)\n",
      "amod(prognosis-11, poor-10)\n",
      "dobj(carries-8, prognosis-11)\n",
      "\n",
      "Parsing [sent. 59 len. 12]: corticosteroids are considered by many to be the mainstay of treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS corticosteroids))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN considered)\n",
      "        (PP (IN by)\n",
      "          (NP (JJ many)))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (NP\n",
      "                (NP (DT the) (NN mainstay))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN treatment)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(considered-3, corticosteroids-1)\n",
      "nsubj:xsubj(mainstay-9, corticosteroids-1)\n",
      "auxpass(considered-3, are-2)\n",
      "root(ROOT-0, considered-3)\n",
      "case(many-5, by-4)\n",
      "nmod:by(considered-3, many-5)\n",
      "mark(mainstay-9, to-6)\n",
      "cop(mainstay-9, be-7)\n",
      "det(mainstay-9, the-8)\n",
      "xcomp(considered-3, mainstay-9)\n",
      "case(treatment-11, of-10)\n",
      "nmod:of(mainstay-9, treatment-11)\n",
      "\n",
      "Parsing [sent. 60 len. 13]: although new treatments have been suggested , only a few seem promising .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN although)\n",
      "      (S\n",
      "        (NP (JJ new) (NNS treatments))\n",
      "        (VP (VBP have)\n",
      "          (VP (VBN been)\n",
      "            (VP (VBN suggested))))))\n",
      "    (, ,)\n",
      "    (ADVP (RB only))\n",
      "    (NP (DT a) (JJ few))\n",
      "    (VP (VBP seem)\n",
      "      (S\n",
      "        (VP (VBG promising))))\n",
      "    (. .)))\n",
      "\n",
      "mark(suggested-6, although-1)\n",
      "amod(treatments-3, new-2)\n",
      "nsubjpass(suggested-6, treatments-3)\n",
      "aux(suggested-6, have-4)\n",
      "auxpass(suggested-6, been-5)\n",
      "advcl(seem-11, suggested-6)\n",
      "advmod(few-10, only-8)\n",
      "det(few-10, a-9)\n",
      "nsubj(seem-11, few-10)\n",
      "root(ROOT-0, seem-11)\n",
      "xcomp(seem-11, promising-12)\n",
      "\n",
      "Parsing [sent. 61 len. 31]: the burden of heart failure has long plagued the productive years of the population , with therapeutic advances in the timely treatment of ischemic heart disease decreasing its associated mortality .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN burden))\n",
      "      (PP (IN of)\n",
      "        (NP (NN heart) (NN failure))))\n",
      "    (VP (VBZ has)\n",
      "      (ADVP (RB long))\n",
      "      (VP (VBN plagued)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ productive) (NNS years))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NN population))))\n",
      "        (, ,)\n",
      "        (PP (IN with)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ therapeutic) (NNS advances))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ timely) (NN treatment))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ ischemic) (NN heart) (NN disease))))))\n",
      "            (VP (VBG decreasing)\n",
      "              (NP (PRP$ its) (VBN associated) (NN mortality)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(burden-2, the-1)\n",
      "nsubj(plagued-8, burden-2)\n",
      "case(failure-5, of-3)\n",
      "compound(failure-5, heart-4)\n",
      "nmod:of(burden-2, failure-5)\n",
      "aux(plagued-8, has-6)\n",
      "advmod(plagued-8, long-7)\n",
      "root(ROOT-0, plagued-8)\n",
      "det(years-11, the-9)\n",
      "amod(years-11, productive-10)\n",
      "dobj(plagued-8, years-11)\n",
      "case(population-14, of-12)\n",
      "det(population-14, the-13)\n",
      "nmod:of(years-11, population-14)\n",
      "mark(decreasing-27, with-16)\n",
      "amod(advances-18, therapeutic-17)\n",
      "nsubj(decreasing-27, advances-18)\n",
      "case(treatment-22, in-19)\n",
      "det(treatment-22, the-20)\n",
      "amod(treatment-22, timely-21)\n",
      "nmod:in(advances-18, treatment-22)\n",
      "case(disease-26, of-23)\n",
      "amod(disease-26, ischemic-24)\n",
      "compound(disease-26, heart-25)\n",
      "nmod:of(treatment-22, disease-26)\n",
      "advcl(plagued-8, decreasing-27)\n",
      "nmod:poss(mortality-30, its-28)\n",
      "amod(mortality-30, associated-29)\n",
      "dobj(decreasing-27, mortality-30)\n",
      "\n",
      "Parsing [sent. 62 len. 13]: ACEI and Î²-blockers have impacted heart failure therapeutics in a revolutionary way .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNP ACEI))\n",
      "      (CC and)\n",
      "      (NP (NNS Î²-blockers)))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN impacted)\n",
      "        (NP (NN heart) (NN failure) (NNS therapeutics))\n",
      "        (PP (IN in)\n",
      "          (NP (DT a) (JJ revolutionary) (NN way)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(impacted-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, Î²-blockers-3)\n",
      "nsubj(impacted-5, Î²-blockers-3)\n",
      "aux(impacted-5, have-4)\n",
      "root(ROOT-0, impacted-5)\n",
      "compound(therapeutics-8, heart-6)\n",
      "compound(therapeutics-8, failure-7)\n",
      "dobj(impacted-5, therapeutics-8)\n",
      "case(way-12, in-9)\n",
      "det(way-12, a-10)\n",
      "amod(way-12, revolutionary-11)\n",
      "nmod:in(impacted-5, way-12)\n",
      "\n",
      "Parsing [sent. 63 len. 44]: the importance of blockade of the renin-angiotensin system and adrenergic stimulation are fully accepted concepts that apply in young and old , symptomatic and asymptomatic , borderline low and very low ejection fraction -LRB- ef -RRB- , left ventricular failure and biventricular failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN importance))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN blockade))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ renin-angiotensin) (NN system))\n",
      "              (CC and)\n",
      "              (NP (JJ adrenergic) (NN stimulation)))))))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB fully))\n",
      "      (VP (VBN accepted)\n",
      "        (NP\n",
      "          (NP (NNS concepts))\n",
      "          (SBAR\n",
      "            (WHNP (WDT that))\n",
      "            (S\n",
      "              (VP (VBP apply)\n",
      "                (PP (IN in)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (ADJP\n",
      "                          (ADJP (JJ young)\n",
      "                            (CC and)\n",
      "                            (JJ old))\n",
      "                          (, ,)\n",
      "                          (ADJP (JJ symptomatic)\n",
      "                            (CC and)\n",
      "                            (JJ asymptomatic))\n",
      "                          (, ,)\n",
      "                          (ADJP (JJ borderline) (JJ low))\n",
      "                          (CC and)\n",
      "                          (ADJP (RB very) (JJ low)))\n",
      "                        (NN ejection) (NN fraction))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN ef))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP (JJ left) (NN ventricular) (NN failure)\n",
      "                      (CC and)\n",
      "                      (NN biventricular) (NN failure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(importance-2, the-1)\n",
      "nsubjpass(accepted-14, importance-2)\n",
      "case(blockade-4, of-3)\n",
      "nmod:of(importance-2, blockade-4)\n",
      "case(system-8, of-5)\n",
      "det(system-8, the-6)\n",
      "amod(system-8, renin-angiotensin-7)\n",
      "nmod:of(blockade-4, system-8)\n",
      "cc(system-8, and-9)\n",
      "amod(stimulation-11, adrenergic-10)\n",
      "nmod:of(blockade-4, stimulation-11)\n",
      "conj:and(system-8, stimulation-11)\n",
      "auxpass(accepted-14, are-12)\n",
      "advmod(accepted-14, fully-13)\n",
      "root(ROOT-0, accepted-14)\n",
      "dobj(accepted-14, concepts-15)\n",
      "nsubj(apply-17, concepts-15)\n",
      "ref(concepts-15, that-16)\n",
      "acl:relcl(concepts-15, apply-17)\n",
      "case(fraction-33, in-18)\n",
      "amod(fraction-33, young-19)\n",
      "cc(young-19, and-20)\n",
      "conj:and(young-19, old-21)\n",
      "amod(fraction-33, old-21)\n",
      "conj:and(young-19, symptomatic-23)\n",
      "amod(fraction-33, symptomatic-23)\n",
      "cc(symptomatic-23, and-24)\n",
      "conj:and(young-19, asymptomatic-25)\n",
      "conj:and(symptomatic-23, asymptomatic-25)\n",
      "amod(low-28, borderline-27)\n",
      "conj:and(young-19, low-28)\n",
      "amod(fraction-33, low-28)\n",
      "cc(young-19, and-29)\n",
      "advmod(low-31, very-30)\n",
      "conj:and(young-19, low-31)\n",
      "amod(fraction-33, low-31)\n",
      "compound(fraction-33, ejection-32)\n",
      "nmod:in(apply-17, fraction-33)\n",
      "appos(fraction-33, ef-35)\n",
      "amod(failure-40, left-38)\n",
      "compound(failure-40, ventricular-39)\n",
      "appos(fraction-33, failure-40)\n",
      "cc(failure-40, and-41)\n",
      "compound(failure-43, biventricular-42)\n",
      "appos(fraction-33, failure-43)\n",
      "conj:and(failure-40, failure-43)\n",
      "\n",
      "Parsing [sent. 64 len. 25]: despite several interventions , both pharmaceutical and device based for the treatment of ensuing heart failure , the incidence is increasing in large proportions .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP\n",
      "        (NP (JJ several) (NNS interventions))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT both) (NN pharmaceutical)\n",
      "            (CC and)\n",
      "            (NN device))\n",
      "          (VP (VBN based)\n",
      "            (PP (IN for)\n",
      "              (NP\n",
      "                (NP (DT the) (NN treatment))\n",
      "                (PP (IN of)\n",
      "                  (NP (VBG ensuing) (NN heart) (NN failure)))))))))\n",
      "    (, ,)\n",
      "    (NP (DT the) (NN incidence))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBG increasing)\n",
      "        (PP (IN in)\n",
      "          (NP (JJ large) (NNS proportions)))))\n",
      "    (. .)))\n",
      "\n",
      "case(interventions-3, despite-1)\n",
      "amod(interventions-3, several-2)\n",
      "nmod:despite(increasing-21, interventions-3)\n",
      "cc:preconj(pharmaceutical-6, both-5)\n",
      "appos(interventions-3, pharmaceutical-6)\n",
      "cc(pharmaceutical-6, and-7)\n",
      "appos(interventions-3, device-8)\n",
      "conj:and(pharmaceutical-6, device-8)\n",
      "acl(pharmaceutical-6, based-9)\n",
      "case(treatment-12, for-10)\n",
      "det(treatment-12, the-11)\n",
      "nmod:for(based-9, treatment-12)\n",
      "case(failure-16, of-13)\n",
      "amod(failure-16, ensuing-14)\n",
      "compound(failure-16, heart-15)\n",
      "nmod:of(treatment-12, failure-16)\n",
      "det(incidence-19, the-18)\n",
      "nsubj(increasing-21, incidence-19)\n",
      "aux(increasing-21, is-20)\n",
      "root(ROOT-0, increasing-21)\n",
      "case(proportions-24, in-22)\n",
      "amod(proportions-24, large-23)\n",
      "nmod:in(increasing-21, proportions-24)\n",
      "\n",
      "Parsing [sent. 65 len. 8]: newer molecules like sacubitril show more promise .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJR newer) (NNS molecules))\n",
      "      (PP (IN like)\n",
      "        (NP (NN sacubitril))))\n",
      "    (VP (VBP show)\n",
      "      (NP (JJR more) (NN promise)))\n",
      "    (. .)))\n",
      "\n",
      "amod(molecules-2, newer-1)\n",
      "nsubj(show-5, molecules-2)\n",
      "case(sacubitril-4, like-3)\n",
      "nmod:like(molecules-2, sacubitril-4)\n",
      "root(ROOT-0, show-5)\n",
      "amod(promise-7, more-6)\n",
      "dobj(show-5, promise-7)\n",
      "\n",
      "Parsing [sent. 66 len. 17]: despite these novel therapies , several patients relentlessly progress to a stage of advanced heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP (DT these) (NN novel) (NNS therapies)))\n",
      "    (, ,)\n",
      "    (NP (JJ several) (NNS patients))\n",
      "    (ADVP (RB relentlessly))\n",
      "    (VP (VB progress)\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (DT a) (NN stage))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ advanced) (NN heart) (NN failure))))))\n",
      "    (. .)))\n",
      "\n",
      "case(therapies-4, despite-1)\n",
      "det(therapies-4, these-2)\n",
      "compound(therapies-4, novel-3)\n",
      "nmod:despite(progress-9, therapies-4)\n",
      "amod(patients-7, several-6)\n",
      "nsubj(progress-9, patients-7)\n",
      "advmod(progress-9, relentlessly-8)\n",
      "root(ROOT-0, progress-9)\n",
      "case(stage-12, to-10)\n",
      "det(stage-12, a-11)\n",
      "nmod:to(progress-9, stage-12)\n",
      "case(failure-16, of-13)\n",
      "amod(failure-16, advanced-14)\n",
      "compound(failure-16, heart-15)\n",
      "nmod:of(stage-12, failure-16)\n",
      "\n",
      "Parsing [sent. 67 len. 18]: the use of left-ventricular-assist devices has variable clinical benefit , with some patients progressing to heart transplantation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ left-ventricular-assist) (NNS devices))))\n",
      "    (VP (VBZ has)\n",
      "      (NP (JJ variable) (JJ clinical) (NN benefit))\n",
      "      (, ,)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (DT some) (NNS patients))\n",
      "          (VP (VBG progressing)\n",
      "            (PP (TO to)\n",
      "              (NP (NN heart) (NN transplantation)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(use-2, the-1)\n",
      "nsubj(has-6, use-2)\n",
      "case(devices-5, of-3)\n",
      "amod(devices-5, left-ventricular-assist-4)\n",
      "nmod:of(use-2, devices-5)\n",
      "root(ROOT-0, has-6)\n",
      "amod(benefit-9, variable-7)\n",
      "amod(benefit-9, clinical-8)\n",
      "dobj(has-6, benefit-9)\n",
      "case(patients-13, with-11)\n",
      "det(patients-13, some-12)\n",
      "nmod:with(has-6, patients-13)\n",
      "acl(patients-13, progressing-14)\n",
      "case(transplantation-17, to-15)\n",
      "compound(transplantation-17, heart-16)\n",
      "nmod:to(progressing-14, transplantation-17)\n",
      "\n",
      "Parsing [sent. 68 len. 12]: liver fibrosis is a common response to many chronic liver diseases .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN liver) (NN fibrosis))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ common) (NN response))\n",
      "        (PP (TO to)\n",
      "          (NP (JJ many) (JJ chronic) (NN liver) (NNS diseases)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(fibrosis-2, liver-1)\n",
      "nsubj(response-6, fibrosis-2)\n",
      "cop(response-6, is-3)\n",
      "det(response-6, a-4)\n",
      "amod(response-6, common-5)\n",
      "root(ROOT-0, response-6)\n",
      "case(diseases-11, to-7)\n",
      "amod(diseases-11, many-8)\n",
      "amod(diseases-11, chronic-9)\n",
      "compound(diseases-11, liver-10)\n",
      "nmod:to(response-6, diseases-11)\n",
      "\n",
      "Parsing [sent. 69 len. 29]: the aim of our study was to explore whether pharmacotherapy for concurrent diseases affects overall mortality , liver-related mortality and liver-related morbidity in patients with chronic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN aim))\n",
      "      (PP (IN of)\n",
      "        (NP (PRP$ our) (NN study))))\n",
      "    (VP (VBD was)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB explore)\n",
      "            (SBAR (IN whether)\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (NN pharmacotherapy))\n",
      "                  (PP (IN for)\n",
      "                    (NP (JJ concurrent) (NNS diseases))))\n",
      "                (VP (VBZ affects)\n",
      "                  (NP\n",
      "                    (NP (JJ overall) (NN mortality))\n",
      "                    (, ,)\n",
      "                    (NP (JJ liver-related) (NN mortality))\n",
      "                    (CC and)\n",
      "                    (NP (JJ liver-related) (NN morbidity)))\n",
      "                  (PP (IN in)\n",
      "                    (NP\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP (JJ chronic) (NN liver) (NN disease))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(aim-2, the-1)\n",
      "nsubj(was-6, aim-2)\n",
      "nsubj:xsubj(explore-8, aim-2)\n",
      "case(study-5, of-3)\n",
      "nmod:poss(study-5, our-4)\n",
      "nmod:of(aim-2, study-5)\n",
      "root(ROOT-0, was-6)\n",
      "mark(explore-8, to-7)\n",
      "xcomp(was-6, explore-8)\n",
      "mark(affects-14, whether-9)\n",
      "nsubj(affects-14, pharmacotherapy-10)\n",
      "case(diseases-13, for-11)\n",
      "amod(diseases-13, concurrent-12)\n",
      "nmod:for(pharmacotherapy-10, diseases-13)\n",
      "ccomp(explore-8, affects-14)\n",
      "amod(mortality-16, overall-15)\n",
      "dobj(affects-14, mortality-16)\n",
      "amod(mortality-19, liver-related-18)\n",
      "dobj(affects-14, mortality-19)\n",
      "conj:and(mortality-16, mortality-19)\n",
      "cc(mortality-16, and-20)\n",
      "amod(morbidity-22, liver-related-21)\n",
      "dobj(affects-14, morbidity-22)\n",
      "conj:and(mortality-16, morbidity-22)\n",
      "case(patients-24, in-23)\n",
      "nmod:in(affects-14, patients-24)\n",
      "case(disease-28, with-25)\n",
      "amod(disease-28, chronic-26)\n",
      "compound(disease-28, liver-27)\n",
      "nmod:with(patients-24, disease-28)\n",
      "\n",
      "Parsing [sent. 70 len. 30]: we performed a register-based cohort study of all patients with a first-time diagnosis of chronic liver disease between 2005 and 2012 in sweden -LRB- n = 70 546 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD performed)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ register-based) (NN cohort) (NN study))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT all) (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (DT a) (JJ first-time) (NN diagnosis)))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ chronic) (NN liver) (NN disease)))\n",
      "            (PP (IN between)\n",
      "              (NP (CD 2005)\n",
      "                (CC and)\n",
      "                (CD 2012)))\n",
      "            (PP (IN in)\n",
      "              (NP (NN sweden)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 70) (CD 546)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(performed-2, we-1)\n",
      "root(ROOT-0, performed-2)\n",
      "det(study-6, a-3)\n",
      "amod(study-6, register-based-4)\n",
      "compound(study-6, cohort-5)\n",
      "dobj(performed-2, study-6)\n",
      "case(patients-9, of-7)\n",
      "det(patients-9, all-8)\n",
      "nmod:of(study-6, patients-9)\n",
      "case(diagnosis-13, with-10)\n",
      "det(diagnosis-13, a-11)\n",
      "amod(diagnosis-13, first-time-12)\n",
      "nmod:with(patients-9, diagnosis-13)\n",
      "case(disease-17, of-14)\n",
      "amod(disease-17, chronic-15)\n",
      "compound(disease-17, liver-16)\n",
      "nmod:of(patients-9, disease-17)\n",
      "case(2005-19, between-18)\n",
      "nmod:between(patients-9, 2005-19)\n",
      "cc(2005-19, and-20)\n",
      "nmod:between(patients-9, 2012-21)\n",
      "conj:and(2005-19, 2012-21)\n",
      "case(sweden-23, in-22)\n",
      "nmod:in(patients-9, sweden-23)\n",
      "dep(patients-9, n-25)\n",
      "dep(546-28, =-26)\n",
      "nummod(546-28, 70-27)\n",
      "ccomp(n-25, 546-28)\n",
      "\n",
      "Parsing [sent. 71 len. 18]: data from the patient register , the prescribed drug register and the death certificate register were linked .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS data))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ patient) (NN register))\n",
      "          (, ,)\n",
      "          (NP (DT the) (JJ prescribed) (NN drug) (NN register))\n",
      "          (CC and)\n",
      "          (NP (DT the) (NN death) (NN certificate) (NN register)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN linked)))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(linked-17, data-1)\n",
      "case(register-5, from-2)\n",
      "det(register-5, the-3)\n",
      "amod(register-5, patient-4)\n",
      "nmod:from(data-1, register-5)\n",
      "det(register-10, the-7)\n",
      "amod(register-10, prescribed-8)\n",
      "compound(register-10, drug-9)\n",
      "nmod:from(data-1, register-10)\n",
      "conj:and(register-5, register-10)\n",
      "cc(register-5, and-11)\n",
      "det(register-15, the-12)\n",
      "compound(register-15, death-13)\n",
      "compound(register-15, certificate-14)\n",
      "nmod:from(data-1, register-15)\n",
      "conj:and(register-5, register-15)\n",
      "auxpass(linked-17, were-16)\n",
      "root(ROOT-0, linked-17)\n",
      "\n",
      "Parsing [sent. 72 len. 27]: we studied whether the use of statins , ACEI , angiotensin receptor blockers and antibiotics affected the risk of total mortality , liver-specific mortality and morbidity .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD studied)\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN use))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS statins))\n",
      "                (, ,)\n",
      "                (NP (NNP ACEI))\n",
      "                (, ,)\n",
      "                (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "                (CC and)\n",
      "                (NP (NNS antibiotics)))))\n",
      "          (VP (VBD affected)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (JJ total) (NN mortality))\n",
      "                  (, ,)\n",
      "                  (NP (JJ liver-specific) (NN mortality))\n",
      "                  (CC and)\n",
      "                  (NP (NN morbidity)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(studied-2, we-1)\n",
      "root(ROOT-0, studied-2)\n",
      "mark(affected-16, whether-3)\n",
      "det(use-5, the-4)\n",
      "nsubj(affected-16, use-5)\n",
      "case(statins-7, of-6)\n",
      "nmod:of(use-5, statins-7)\n",
      "nmod:of(use-5, ACEI-9)\n",
      "conj:and(statins-7, ACEI-9)\n",
      "compound(blockers-13, angiotensin-11)\n",
      "compound(blockers-13, receptor-12)\n",
      "nmod:of(use-5, blockers-13)\n",
      "conj:and(statins-7, blockers-13)\n",
      "cc(statins-7, and-14)\n",
      "nmod:of(use-5, antibiotics-15)\n",
      "conj:and(statins-7, antibiotics-15)\n",
      "ccomp(studied-2, affected-16)\n",
      "det(risk-18, the-17)\n",
      "dobj(affected-16, risk-18)\n",
      "case(mortality-21, of-19)\n",
      "amod(mortality-21, total-20)\n",
      "nmod:of(risk-18, mortality-21)\n",
      "amod(mortality-24, liver-specific-23)\n",
      "nmod:of(risk-18, mortality-24)\n",
      "conj:and(mortality-21, mortality-24)\n",
      "cc(mortality-21, and-25)\n",
      "nmod:of(risk-18, morbidity-26)\n",
      "conj:and(mortality-21, morbidity-26)\n",
      "\n",
      "Parsing [sent. 73 len. 50]: we found a reduction in mortality risk for statin users -LRB- n = 11 245 -RRB- with hazard ratios from 0.57 -LRB- 95 % , ci 0.32-0 .99 -RRB- for patients with autoimmune hepatitis , to 0.84 -LRB- 95 % , ci 0.75-0 .95 -RRB- for alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD found)\n",
      "      (NP\n",
      "        (NP (DT a) (NN reduction))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NN mortality) (NN risk))\n",
      "            (PP (IN for)\n",
      "              (NP (NN statin) (NNS users)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 11) (CD 245)))))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (PP (IN with)\n",
      "        (NP (NN hazard) (NNS ratios)))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD 0.57))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 95) (NN %))\n",
      "                (, ,)\n",
      "                (NP (NN ci) (CD 0.32-0) (NNP .99)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ autoimmune) (NN hepatitis)))))))\n",
      "      (, ,)\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD 0.84))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 95) (NN %))\n",
      "                (, ,)\n",
      "                (NP (NN ci) (CD 0.75-0) (NNP .95)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP (JJ alcoholic) (NN liver) (NN disease))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(found-2, we-1)\n",
      "root(ROOT-0, found-2)\n",
      "det(reduction-4, a-3)\n",
      "dobj(found-2, reduction-4)\n",
      "case(risk-7, in-5)\n",
      "compound(risk-7, mortality-6)\n",
      "nmod:in(reduction-4, risk-7)\n",
      "case(users-10, for-8)\n",
      "compound(users-10, statin-9)\n",
      "nmod:for(risk-7, users-10)\n",
      "dep(risk-7, n-12)\n",
      "dep(245-15, =-13)\n",
      "nummod(245-15, 11-14)\n",
      "ccomp(n-12, 245-15)\n",
      "case(ratios-19, with-17)\n",
      "compound(ratios-19, hazard-18)\n",
      "nmod:with(found-2, ratios-19)\n",
      "case(0.57-21, from-20)\n",
      "nmod:from(found-2, 0.57-21)\n",
      "nummod(%-24, 95-23)\n",
      "dep(0.57-21, %-24)\n",
      "compound(.99-28, ci-26)\n",
      "nummod(.99-28, 0.32-0-27)\n",
      "appos(%-24, .99-28)\n",
      "case(patients-31, for-30)\n",
      "nmod:for(0.57-21, patients-31)\n",
      "case(hepatitis-34, with-32)\n",
      "amod(hepatitis-34, autoimmune-33)\n",
      "nmod:with(patients-31, hepatitis-34)\n",
      "case(0.84-37, to-36)\n",
      "nmod:to(found-2, 0.84-37)\n",
      "nummod(%-40, 95-39)\n",
      "dep(0.84-37, %-40)\n",
      "compound(.95-44, ci-42)\n",
      "nummod(.95-44, 0.75-0-43)\n",
      "appos(%-40, .95-44)\n",
      "case(disease-49, for-46)\n",
      "amod(disease-49, alcoholic-47)\n",
      "compound(disease-49, liver-48)\n",
      "nmod:for(0.84-37, disease-49)\n",
      "\n",
      "Parsing [sent. 74 len. 27]: there was a significant reduced liver-related mortality for patients with alcoholic liver disease who used ACEI , 0.85 -LRB- 95 % , ci 0.65-0 .96 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ significant) (JJ reduced) (JJ liver-related) (NN mortality))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (JJ alcoholic) (NN liver) (NN disease)))))\n",
      "        (SBAR\n",
      "          (WHNP (WP who))\n",
      "          (S\n",
      "            (VP (VBD used)\n",
      "              (NP\n",
      "                (NP (NNP ACEI) (, ,) (NNP 0.85))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 95) (NN %))\n",
      "                    (, ,)\n",
      "                    (NP (NN ci) (CD 0.65-0) (NNP .96)))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "det(mortality-7, a-3)\n",
      "amod(mortality-7, significant-4)\n",
      "amod(mortality-7, reduced-5)\n",
      "amod(mortality-7, liver-related-6)\n",
      "nsubj(was-2, mortality-7)\n",
      "nsubj(used-15, mortality-7)\n",
      "case(patients-9, for-8)\n",
      "nmod:for(mortality-7, patients-9)\n",
      "case(disease-13, with-10)\n",
      "amod(disease-13, alcoholic-11)\n",
      "compound(disease-13, liver-12)\n",
      "nmod:with(patients-9, disease-13)\n",
      "ref(mortality-7, who-14)\n",
      "acl:relcl(mortality-7, used-15)\n",
      "compound(0.85-18, ACEI-16)\n",
      "dobj(used-15, 0.85-18)\n",
      "nummod(%-21, 95-20)\n",
      "dep(0.85-18, %-21)\n",
      "compound(.96-25, ci-23)\n",
      "nummod(.96-25, 0.65-0-24)\n",
      "appos(%-21, .96-25)\n",
      "\n",
      "Parsing [sent. 75 len. 34]: there were increased overall mortality risks for antibiotic users -LRB- n = 44 572 -RRB- , with hazard ratios up to 1.67 -LRB- 95 % ci , 1.55-1 .80 -RRB- for viral hepatitis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD were)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (VBN increased) (JJ overall) (NN mortality) (NNS risks))\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (JJ antibiotic) (NNS users))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 44) (CD 572)))))\n",
      "                (-RRB- -RRB-))))\n",
      "          (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP (NN hazard) (NNS ratios))))\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (IN up) (TO to) (CD 1.67)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (ADJP (CD 95) (NN %))\n",
      "                  (NN ci))\n",
      "                (, ,)\n",
      "                (NP (CD 1.55-1) (CD .80)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP (JJ viral) (NN hepatitis))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(were-2, there-1)\n",
      "root(ROOT-0, were-2)\n",
      "amod(risks-6, increased-3)\n",
      "amod(risks-6, overall-4)\n",
      "compound(risks-6, mortality-5)\n",
      "iobj(were-2, risks-6)\n",
      "case(users-9, for-7)\n",
      "amod(users-9, antibiotic-8)\n",
      "nmod:for(risks-6, users-9)\n",
      "dep(users-9, n-11)\n",
      "dep(572-14, =-12)\n",
      "nummod(572-14, 44-13)\n",
      "ccomp(n-11, 572-14)\n",
      "case(ratios-19, with-17)\n",
      "compound(ratios-19, hazard-18)\n",
      "nmod:with(risks-6, ratios-19)\n",
      "dep(1.67-22, up-20)\n",
      "mwe(up-20, to-21)\n",
      "dep(risks-6, 1.67-22)\n",
      "compound(%-25, 95-24)\n",
      "amod(ci-26, %-25)\n",
      "dep(1.67-22, ci-26)\n",
      "nummod(.80-29, 1.55-1-28)\n",
      "appos(ci-26, .80-29)\n",
      "case(hepatitis-33, for-31)\n",
      "amod(hepatitis-33, viral-32)\n",
      "nmod:for(1.67-22, hepatitis-33)\n",
      "\n",
      "Parsing [sent. 76 len. 25]: statin use was associated with decreased risks of liver-specific mortality and morbidity , and reduced total mortality foremost among patients with alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN statin) (NN use))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (VBN decreased) (NNS risks))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ liver-specific) (NN mortality)\n",
      "                  (CC and)\n",
      "                  (NN morbidity))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (VBN reduced) (JJ total) (NN mortality))\n",
      "              (ADVP (RB foremost)\n",
      "                (PP (IN among)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ alcoholic) (NN liver) (NN disease)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(use-2, statin-1)\n",
      "nsubjpass(associated-4, use-2)\n",
      "auxpass(associated-4, was-3)\n",
      "root(ROOT-0, associated-4)\n",
      "case(risks-7, with-5)\n",
      "amod(risks-7, decreased-6)\n",
      "nmod:with(associated-4, risks-7)\n",
      "case(mortality-10, of-8)\n",
      "amod(mortality-10, liver-specific-9)\n",
      "nmod:of(risks-7, mortality-10)\n",
      "cc(mortality-10, and-11)\n",
      "nmod:of(risks-7, morbidity-12)\n",
      "conj:and(mortality-10, morbidity-12)\n",
      "cc(risks-7, and-14)\n",
      "amod(mortality-17, reduced-15)\n",
      "amod(mortality-17, total-16)\n",
      "nmod:with(associated-4, mortality-17)\n",
      "conj:and(risks-7, mortality-17)\n",
      "advmod(mortality-17, foremost-18)\n",
      "case(patients-20, among-19)\n",
      "nmod:among(foremost-18, patients-20)\n",
      "case(disease-24, with-21)\n",
      "amod(disease-24, alcoholic-22)\n",
      "compound(disease-24, liver-23)\n",
      "nmod:with(patients-20, disease-24)\n",
      "\n",
      "Parsing [sent. 77 len. 14]: ACEI was associated with reduced liver-related mortality among patients with alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (VBN reduced) (JJ liver-related) (NN mortality))\n",
      "            (PP (IN among)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ alcoholic) (NN liver) (NN disease)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(associated-3, ACEI-1)\n",
      "auxpass(associated-3, was-2)\n",
      "root(ROOT-0, associated-3)\n",
      "case(mortality-7, with-4)\n",
      "amod(mortality-7, reduced-5)\n",
      "amod(mortality-7, liver-related-6)\n",
      "nmod:with(associated-3, mortality-7)\n",
      "case(patients-9, among-8)\n",
      "nmod:among(mortality-7, patients-9)\n",
      "case(disease-13, with-10)\n",
      "amod(disease-13, alcoholic-11)\n",
      "compound(disease-13, liver-12)\n",
      "nmod:with(patients-9, disease-13)\n",
      "\n",
      "Parsing [sent. 78 len. 7]: this article is protected by copyright .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN article))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN protected)\n",
      "        (PP (IN by)\n",
      "          (NP (NN copyright)))))\n",
      "    (. .)))\n",
      "\n",
      "det(article-2, this-1)\n",
      "nsubjpass(protected-4, article-2)\n",
      "auxpass(protected-4, is-3)\n",
      "root(ROOT-0, protected-4)\n",
      "case(copyright-6, by-5)\n",
      "nmod:by(protected-4, copyright-6)\n",
      "\n",
      "Parsing [sent. 79 len. 4]: all rights reserved .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT all) (NNS rights))\n",
      "    (VP (VBD reserved))\n",
      "    (. .)))\n",
      "\n",
      "det(rights-2, all-1)\n",
      "nsubj(reserved-3, rights-2)\n",
      "root(ROOT-0, reserved-3)\n",
      "\n",
      "Parsing [sent. 80 len. 44]: fabry 's disease -LRB- fd -RRB- is a severe congenital metabolic disorder characterized by the deficient activity of lysosomal exoglycohydrolase alpha-galactosidase , characterized by glycosphingolipid deposition in several cells , such as capillary endothelial cells , renal , cardiac , and nerve cells .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (NN fabry) (POS 's))\n",
      "        (NN disease))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN fd))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ severe) (JJ congenital) (JJ metabolic) (NN disorder))\n",
      "        (VP (VBN characterized)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ deficient) (NN activity))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ lysosomal) (NN exoglycohydrolase) (NN alpha-galactosidase))\n",
      "                    (, ,)\n",
      "                    (VP (VBN characterized)\n",
      "                      (PP (IN by)\n",
      "                        (NP\n",
      "                          (NP (JJ glycosphingolipid) (NN deposition))\n",
      "                          (PP (IN in)\n",
      "                            (NP (JJ several) (NNS cells))))))\n",
      "                    (, ,))\n",
      "                  (PP (JJ such) (IN as)\n",
      "                    (NP\n",
      "                      (NP (JJ capillary) (JJ endothelial) (NNS cells))\n",
      "                      (, ,)\n",
      "                      (NP (JJ renal))\n",
      "                      (, ,)\n",
      "                      (NP (JJ cardiac))\n",
      "                      (, ,)\n",
      "                      (CC and)\n",
      "                      (NP (NN nerve) (NNS cells)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(disease-3, fabry-1)\n",
      "case(fabry-1, 's-2)\n",
      "nsubj(disorder-12, disease-3)\n",
      "appos(disease-3, fd-5)\n",
      "cop(disorder-12, is-7)\n",
      "det(disorder-12, a-8)\n",
      "amod(disorder-12, severe-9)\n",
      "amod(disorder-12, congenital-10)\n",
      "amod(disorder-12, metabolic-11)\n",
      "root(ROOT-0, disorder-12)\n",
      "acl(disorder-12, characterized-13)\n",
      "case(activity-17, by-14)\n",
      "det(activity-17, the-15)\n",
      "amod(activity-17, deficient-16)\n",
      "nmod:by(characterized-13, activity-17)\n",
      "case(alpha-galactosidase-21, of-18)\n",
      "amod(alpha-galactosidase-21, lysosomal-19)\n",
      "compound(alpha-galactosidase-21, exoglycohydrolase-20)\n",
      "nmod:of(activity-17, alpha-galactosidase-21)\n",
      "acl(alpha-galactosidase-21, characterized-23)\n",
      "case(deposition-26, by-24)\n",
      "amod(deposition-26, glycosphingolipid-25)\n",
      "nmod:by(characterized-23, deposition-26)\n",
      "case(cells-29, in-27)\n",
      "amod(cells-29, several-28)\n",
      "nmod:in(deposition-26, cells-29)\n",
      "case(cells-35, such-31)\n",
      "mwe(such-31, as-32)\n",
      "amod(cells-35, capillary-33)\n",
      "amod(cells-35, endothelial-34)\n",
      "nmod:such_as(alpha-galactosidase-21, cells-35)\n",
      "nmod:such_as(alpha-galactosidase-21, renal-37)\n",
      "conj:and(cells-35, renal-37)\n",
      "nmod:such_as(alpha-galactosidase-21, cardiac-39)\n",
      "conj:and(cells-35, cardiac-39)\n",
      "cc(cells-35, and-41)\n",
      "compound(cells-43, nerve-42)\n",
      "nmod:such_as(alpha-galactosidase-21, cells-43)\n",
      "conj:and(cells-35, cells-43)\n",
      "\n",
      "Parsing [sent. 81 len. 27]: as a systemic disease leading to a contemporaneous myocardial and renal dysfunction , fd might be an example of cardiorenal syndrome type 5 -LRB- crs-5 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN as)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ systemic) (NN disease))\n",
      "        (VP (VBG leading)\n",
      "          (PP (TO to)\n",
      "            (NP\n",
      "              (NP (DT a) (JJ contemporaneous) (NN myocardial))\n",
      "              (CC and)\n",
      "              (NP (JJ renal) (NN dysfunction)))))))\n",
      "    (, ,)\n",
      "    (NP (NN fd))\n",
      "    (VP (MD might)\n",
      "      (VP (VB be)\n",
      "        (NP\n",
      "          (NP (DT an) (NN example))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ cardiorenal) (NN syndrome))\n",
      "                (ADJP (NN type) (CD 5)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (ADJP (JJ crs-5))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(disease-4, as-1)\n",
      "det(disease-4, a-2)\n",
      "amod(disease-4, systemic-3)\n",
      "nmod:as(example-18, disease-4)\n",
      "acl(disease-4, leading-5)\n",
      "case(myocardial-9, to-6)\n",
      "det(myocardial-9, a-7)\n",
      "amod(myocardial-9, contemporaneous-8)\n",
      "nmod:to(leading-5, myocardial-9)\n",
      "cc(myocardial-9, and-10)\n",
      "amod(dysfunction-12, renal-11)\n",
      "nmod:to(leading-5, dysfunction-12)\n",
      "conj:and(myocardial-9, dysfunction-12)\n",
      "nsubj(example-18, fd-14)\n",
      "aux(example-18, might-15)\n",
      "cop(example-18, be-16)\n",
      "det(example-18, an-17)\n",
      "root(ROOT-0, example-18)\n",
      "case(syndrome-21, of-19)\n",
      "amod(syndrome-21, cardiorenal-20)\n",
      "nmod:of(example-18, syndrome-21)\n",
      "amod(syndrome-21, type-22)\n",
      "compound(type-22, 5-23)\n",
      "dep(syndrome-21, crs-5-25)\n",
      "\n",
      "Parsing [sent. 82 len. 29]: kidney damage is commonly characterized by proteinuria , isosthenuria and altered tubular function when occurs at the second-third decade , azotemia and end-stage renal disease in third-fifth decade .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN kidney) (NN damage))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB commonly))\n",
      "      (VP (VBN characterized)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NN proteinuria))\n",
      "            (, ,)\n",
      "            (NP (NN isosthenuria))\n",
      "            (CC and)\n",
      "            (NP (JJ altered) (JJ tubular) (NN function))))\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (VP (VBZ occurs)\n",
      "              (PP (IN at)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ second-third) (NN decade))\n",
      "                  (, ,)\n",
      "                  (NP (NN azotemia))\n",
      "                  (CC and)\n",
      "                  (NP (JJ end-stage) (JJ renal) (NN disease))))\n",
      "              (PP (IN in)\n",
      "                (NP (JJ third-fifth) (NN decade))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(damage-2, kidney-1)\n",
      "nsubjpass(characterized-5, damage-2)\n",
      "auxpass(characterized-5, is-3)\n",
      "advmod(characterized-5, commonly-4)\n",
      "root(ROOT-0, characterized-5)\n",
      "case(proteinuria-7, by-6)\n",
      "nmod:by(characterized-5, proteinuria-7)\n",
      "nmod:by(characterized-5, isosthenuria-9)\n",
      "conj:and(proteinuria-7, isosthenuria-9)\n",
      "cc(proteinuria-7, and-10)\n",
      "amod(function-13, altered-11)\n",
      "amod(function-13, tubular-12)\n",
      "nmod:by(characterized-5, function-13)\n",
      "conj:and(proteinuria-7, function-13)\n",
      "advmod(occurs-15, when-14)\n",
      "advcl(characterized-5, occurs-15)\n",
      "case(decade-19, at-16)\n",
      "det(decade-19, the-17)\n",
      "amod(decade-19, second-third-18)\n",
      "nmod:at(occurs-15, decade-19)\n",
      "nmod:at(occurs-15, azotemia-21)\n",
      "conj:and(decade-19, azotemia-21)\n",
      "cc(decade-19, and-22)\n",
      "amod(disease-25, end-stage-23)\n",
      "amod(disease-25, renal-24)\n",
      "nmod:at(occurs-15, disease-25)\n",
      "conj:and(decade-19, disease-25)\n",
      "case(decade-28, in-26)\n",
      "amod(decade-28, third-fifth-27)\n",
      "nmod:in(occurs-15, decade-28)\n",
      "\n",
      "Parsing [sent. 83 len. 23]: beyond the irreversible glomerular , tubular and vascular damages , the podocytes foot process effacement is the major cause of kidney dysfunction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN beyond)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ irreversible) (NN glomerular))\n",
      "        (, ,)\n",
      "        (NP (JJ tubular))\n",
      "        (CC and)\n",
      "        (NP (NN vascular) (NNS damages))))\n",
      "    (, ,)\n",
      "    (NP (DT the) (JJ podocytes) (NN foot) (NN process) (NN effacement))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ major) (NN cause))\n",
      "        (PP (IN of)\n",
      "          (NP (NN kidney) (NN dysfunction)))))\n",
      "    (. .)))\n",
      "\n",
      "case(glomerular-4, beyond-1)\n",
      "det(glomerular-4, the-2)\n",
      "amod(glomerular-4, irreversible-3)\n",
      "nmod:beyond(cause-19, glomerular-4)\n",
      "conj:and(glomerular-4, tubular-6)\n",
      "nmod:beyond(cause-19, tubular-6)\n",
      "cc(glomerular-4, and-7)\n",
      "compound(damages-9, vascular-8)\n",
      "conj:and(glomerular-4, damages-9)\n",
      "nmod:beyond(cause-19, damages-9)\n",
      "det(effacement-15, the-11)\n",
      "amod(effacement-15, podocytes-12)\n",
      "compound(effacement-15, foot-13)\n",
      "compound(effacement-15, process-14)\n",
      "nsubj(cause-19, effacement-15)\n",
      "cop(cause-19, is-16)\n",
      "det(cause-19, the-17)\n",
      "amod(cause-19, major-18)\n",
      "root(ROOT-0, cause-19)\n",
      "case(dysfunction-22, of-20)\n",
      "compound(dysfunction-22, kidney-21)\n",
      "nmod:of(cause-19, dysfunction-22)\n",
      "\n",
      "Parsing [sent. 84 len. 39]: myocardial damage is usually observed with right and left ventricular hypertrophy , arrhythmias -LRB- due to sinus node and conduction system impairment -RRB- , diastolic dysfunction , congestive heart failure , myocardial ischemia , fibrosis and cardiac death .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ myocardial) (NN damage))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB usually))\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN right)\n",
      "              (CC and)\n",
      "              (JJ left) (NN ventricular) (NN hypertrophy))\n",
      "            (, ,)\n",
      "            (NP (NNS arrhythmias))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (ADJP (JJ due)\n",
      "                (PP (TO to)\n",
      "                  (NP (JJ sinus) (NN node)\n",
      "                    (CC and)\n",
      "                    (NN conduction) (NN system) (NN impairment))))\n",
      "              (-RRB- -RRB-))\n",
      "            (, ,)\n",
      "            (NP (JJ diastolic) (NN dysfunction))\n",
      "            (, ,)\n",
      "            (NP (JJ congestive) (NN heart) (NN failure))\n",
      "            (, ,)\n",
      "            (NP (JJ myocardial) (NN ischemia))\n",
      "            (, ,)\n",
      "            (NP (NN fibrosis))\n",
      "            (CC and)\n",
      "            (NP (JJ cardiac) (NN death))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(damage-2, myocardial-1)\n",
      "nsubjpass(observed-5, damage-2)\n",
      "auxpass(observed-5, is-3)\n",
      "advmod(observed-5, usually-4)\n",
      "root(ROOT-0, observed-5)\n",
      "case(hypertrophy-11, with-6)\n",
      "compound(hypertrophy-11, right-7)\n",
      "cc(right-7, and-8)\n",
      "conj:and(right-7, left-9)\n",
      "compound(hypertrophy-11, left-9)\n",
      "compound(hypertrophy-11, ventricular-10)\n",
      "nmod:with(observed-5, hypertrophy-11)\n",
      "nmod:with(observed-5, arrhythmias-13)\n",
      "conj:and(hypertrophy-11, arrhythmias-13)\n",
      "dep(hypertrophy-11, due-15)\n",
      "case(node-18, to-16)\n",
      "amod(node-18, sinus-17)\n",
      "nmod:to(due-15, node-18)\n",
      "cc(node-18, and-19)\n",
      "compound(impairment-22, conduction-20)\n",
      "compound(impairment-22, system-21)\n",
      "nmod:to(due-15, impairment-22)\n",
      "conj:and(node-18, impairment-22)\n",
      "amod(dysfunction-26, diastolic-25)\n",
      "nmod:with(observed-5, dysfunction-26)\n",
      "conj:and(hypertrophy-11, dysfunction-26)\n",
      "amod(failure-30, congestive-28)\n",
      "compound(failure-30, heart-29)\n",
      "nmod:with(observed-5, failure-30)\n",
      "conj:and(hypertrophy-11, failure-30)\n",
      "amod(ischemia-33, myocardial-32)\n",
      "nmod:with(observed-5, ischemia-33)\n",
      "conj:and(hypertrophy-11, ischemia-33)\n",
      "nmod:with(observed-5, fibrosis-35)\n",
      "conj:and(hypertrophy-11, fibrosis-35)\n",
      "cc(hypertrophy-11, and-36)\n",
      "amod(death-38, cardiac-37)\n",
      "nmod:with(observed-5, death-38)\n",
      "conj:and(hypertrophy-11, death-38)\n",
      "\n",
      "Parsing [sent. 85 len. 67]: the enzymatic replacement therapy is essential for the management of fd , as well as the control of renal -LRB- with anti-proteinuric agents such as ACEI - and/or angiotensin ii receptor blockers -RRB- , brain -LRB- coated aspirin , clopidogrel and statins to prevent strokes -RRB- and heart complications -LRB- calcium channel blockers for ischemic cardiomyopathy , warfarin and amiodarone or cardioverter device for arrhythmias -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (JJ enzymatic) (NN replacement) (NN therapy))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ essential)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (DT the) (NN management))\n",
      "              (PP (IN of)\n",
      "                (NP (NN fd))))\n",
      "            (, ,)\n",
      "            (CONJP (RB as) (RB well) (IN as))\n",
      "            (NP\n",
      "              (NP (DT the) (NN control))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ renal))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (PP (IN with)\n",
      "                        (NP\n",
      "                          (NP (JJ anti-proteinuric) (NNS agents))\n",
      "                          (PP (JJ such) (IN as)\n",
      "                            (NP\n",
      "                              (NP (NNP ACEI))\n",
      "                              (: -)\n",
      "                              (NP (JJ and/or) (NN angiotensin) (NN ii) (NN receptor) (NNS blockers))))))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (NN brain))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (VP (VBN coated)\n",
      "                          (NP (NN aspirin) (, ,) (NN clopidogrel)\n",
      "                            (CC and)\n",
      "                            (NNS statins))\n",
      "                          (S\n",
      "                            (VP (TO to)\n",
      "                              (VP (VB prevent)\n",
      "                                (NP (NNS strokes))))))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (CC and)\n",
      "                    (NP (NN heart) (NNS complications)))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "                        (PP (IN for)\n",
      "                          (NP (JJ ischemic) (NN cardiomyopathy) (, ,) (NN warfarin)\n",
      "                            (CC and)\n",
      "                            (NN amiodarone))))\n",
      "                      (CC or)\n",
      "                      (NP\n",
      "                        (NP (NN cardioverter) (NN device))\n",
      "                        (PP (IN for)\n",
      "                          (NP (NNS arrhythmias)))))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(therapy-4, the-1)\n",
      "amod(therapy-4, enzymatic-2)\n",
      "compound(therapy-4, replacement-3)\n",
      "nsubj(essential-6, therapy-4)\n",
      "cop(essential-6, is-5)\n",
      "root(ROOT-0, essential-6)\n",
      "case(management-9, for-7)\n",
      "det(management-9, the-8)\n",
      "nmod:for(essential-6, management-9)\n",
      "case(fd-11, of-10)\n",
      "nmod:of(management-9, fd-11)\n",
      "cc(management-9, as-13)\n",
      "mwe(as-13, well-14)\n",
      "mwe(as-13, as-15)\n",
      "det(control-17, the-16)\n",
      "nmod:for(essential-6, control-17)\n",
      "conj:and(management-9, control-17)\n",
      "case(renal-19, of-18)\n",
      "nmod:of(control-17, renal-19)\n",
      "case(agents-23, with-21)\n",
      "amod(agents-23, anti-proteinuric-22)\n",
      "nmod:with(renal-19, agents-23)\n",
      "case(ACEI-26, such-24)\n",
      "mwe(such-24, as-25)\n",
      "nmod:such_as(agents-23, ACEI-26)\n",
      "amod(blockers-32, and/or-28)\n",
      "compound(blockers-32, angiotensin-29)\n",
      "compound(blockers-32, ii-30)\n",
      "compound(blockers-32, receptor-31)\n",
      "dep(ACEI-26, blockers-32)\n",
      "nmod:of(control-17, brain-35)\n",
      "conj:and(renal-19, brain-35)\n",
      "dep(brain-35, coated-37)\n",
      "dobj(coated-37, aspirin-38)\n",
      "dobj(coated-37, clopidogrel-40)\n",
      "conj:and(aspirin-38, clopidogrel-40)\n",
      "cc(aspirin-38, and-41)\n",
      "dobj(coated-37, statins-42)\n",
      "conj:and(aspirin-38, statins-42)\n",
      "mark(prevent-44, to-43)\n",
      "advcl(coated-37, prevent-44)\n",
      "dobj(prevent-44, strokes-45)\n",
      "cc(renal-19, and-47)\n",
      "compound(complications-49, heart-48)\n",
      "nmod:of(control-17, complications-49)\n",
      "conj:and(renal-19, complications-49)\n",
      "compound(blockers-53, calcium-51)\n",
      "compound(blockers-53, channel-52)\n",
      "dep(renal-19, blockers-53)\n",
      "case(cardiomyopathy-56, for-54)\n",
      "amod(cardiomyopathy-56, ischemic-55)\n",
      "nmod:for(blockers-53, cardiomyopathy-56)\n",
      "nmod:for(blockers-53, warfarin-58)\n",
      "conj:and(cardiomyopathy-56, warfarin-58)\n",
      "cc(cardiomyopathy-56, and-59)\n",
      "nmod:for(blockers-53, amiodarone-60)\n",
      "conj:and(cardiomyopathy-56, amiodarone-60)\n",
      "cc(blockers-53, or-61)\n",
      "compound(device-63, cardioverter-62)\n",
      "dep(renal-19, device-63)\n",
      "conj:or(blockers-53, device-63)\n",
      "case(arrhythmias-65, for-64)\n",
      "nmod:for(device-63, arrhythmias-65)\n",
      "\n",
      "Parsing [sent. 86 len. 24]: nonsteroidal antiinflammatory agents , Î²-lactam antibiotics , non-Î² lactam antibiotics , and ACEI are the most common classes of drugs that cause angioedema .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ nonsteroidal) (NN antiinflammatory) (NNS agents))\n",
      "      (, ,)\n",
      "      (NP (JJ Î²-lactam) (NNS antibiotics))\n",
      "      (, ,)\n",
      "      (NP (JJ non-Î²) (NN lactam) (NNS antibiotics))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NNP ACEI)))\n",
      "    (VP (VBP are)\n",
      "      (NP\n",
      "        (NP (DT the) (RBS most) (JJ common) (NNS classes))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNS drugs))\n",
      "            (SBAR\n",
      "              (WHNP (WDT that))\n",
      "              (S\n",
      "                (VP (VBP cause)\n",
      "                  (NP (NN angioedema)))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(agents-3, nonsteroidal-1)\n",
      "compound(agents-3, antiinflammatory-2)\n",
      "nsubj(classes-18, agents-3)\n",
      "amod(antibiotics-6, Î²-lactam-5)\n",
      "conj:and(agents-3, antibiotics-6)\n",
      "nsubj(classes-18, antibiotics-6)\n",
      "amod(antibiotics-10, non-Î²-8)\n",
      "compound(antibiotics-10, lactam-9)\n",
      "conj:and(agents-3, antibiotics-10)\n",
      "nsubj(classes-18, antibiotics-10)\n",
      "cc(agents-3, and-12)\n",
      "conj:and(agents-3, ACEI-13)\n",
      "nsubj(classes-18, ACEI-13)\n",
      "cop(classes-18, are-14)\n",
      "det(classes-18, the-15)\n",
      "advmod(classes-18, most-16)\n",
      "amod(classes-18, common-17)\n",
      "root(ROOT-0, classes-18)\n",
      "case(drugs-20, of-19)\n",
      "nmod:of(classes-18, drugs-20)\n",
      "nsubj(cause-22, drugs-20)\n",
      "ref(drugs-20, that-21)\n",
      "acl:relcl(drugs-20, cause-22)\n",
      "dobj(cause-22, angioedema-23)\n",
      "\n",
      "Parsing [sent. 87 len. 30]: drug-induced angioedema is known to occur via mechanisms mediated by histamine , bradykinin , or leukotriene , and an understanding of these mechanisms is crucial in guiding therapeutic decisions .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ drug-induced) (NN angioedema))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN known)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB occur)\n",
      "                (PP (IN via)\n",
      "                  (NP\n",
      "                    (NP (NNS mechanisms))\n",
      "                    (VP (VBN mediated)\n",
      "                      (PP (IN by)\n",
      "                        (NP\n",
      "                          (NP (NN histamine))\n",
      "                          (, ,)\n",
      "                          (NP (NN bradykinin))\n",
      "                          (, ,)\n",
      "                          (CC or)\n",
      "                          (NP (NN leukotriene)))))))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT an) (NN understanding))\n",
      "        (PP (IN of)\n",
      "          (NP (DT these) (NNS mechanisms))))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ crucial)\n",
      "          (PP (IN in)\n",
      "            (NP (VBG guiding) (JJ therapeutic) (NNS decisions))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(angioedema-2, drug-induced-1)\n",
      "nsubjpass(known-4, angioedema-2)\n",
      "nsubj:xsubj(occur-6, angioedema-2)\n",
      "auxpass(known-4, is-3)\n",
      "root(ROOT-0, known-4)\n",
      "mark(occur-6, to-5)\n",
      "xcomp(known-4, occur-6)\n",
      "case(mechanisms-8, via-7)\n",
      "nmod:via(occur-6, mechanisms-8)\n",
      "acl(mechanisms-8, mediated-9)\n",
      "case(histamine-11, by-10)\n",
      "nmod:by(mediated-9, histamine-11)\n",
      "nmod:by(mediated-9, bradykinin-13)\n",
      "conj:or(histamine-11, bradykinin-13)\n",
      "cc(histamine-11, or-15)\n",
      "nmod:by(mediated-9, leukotriene-16)\n",
      "conj:or(histamine-11, leukotriene-16)\n",
      "cc(known-4, and-18)\n",
      "det(understanding-20, an-19)\n",
      "nsubj(crucial-25, understanding-20)\n",
      "case(mechanisms-23, of-21)\n",
      "det(mechanisms-23, these-22)\n",
      "nmod:of(understanding-20, mechanisms-23)\n",
      "cop(crucial-25, is-24)\n",
      "conj:and(known-4, crucial-25)\n",
      "case(decisions-29, in-26)\n",
      "amod(decisions-29, guiding-27)\n",
      "amod(decisions-29, therapeutic-28)\n",
      "nmod:in(crucial-25, decisions-29)\n",
      "\n",
      "Parsing [sent. 88 len. 35]: nonallergic angioedema occurs in patients with genetic variants that affect metabolism or synthesis of bradykinin , substance p , prostaglandins , or leukotrienes , or when patients are taking drugs that have synergistic mechanisms .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ nonallergic) (NN angioedema))\n",
      "    (VP (VBZ occurs)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ genetic) (NNS variants)))))\n",
      "      (SBAR\n",
      "        (SBAR\n",
      "          (WHNP (WDT that))\n",
      "          (S\n",
      "            (VP (VBP affect)\n",
      "              (NP\n",
      "                (NP (NN metabolism)\n",
      "                  (CC or)\n",
      "                  (NN synthesis))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NN bradykinin))\n",
      "                    (, ,)\n",
      "                    (NP (NN substance) (NN p))\n",
      "                    (, ,)\n",
      "                    (NP (NNS prostaglandins))\n",
      "                    (, ,)\n",
      "                    (CC or)\n",
      "                    (NP (NNS leukotrienes))))))))\n",
      "        (, ,)\n",
      "        (CC or)\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (NNS patients))\n",
      "            (VP (VBP are)\n",
      "              (VP (VBG taking)\n",
      "                (NP\n",
      "                  (NP (NNS drugs))\n",
      "                  (SBAR\n",
      "                    (WHNP (WDT that))\n",
      "                    (S\n",
      "                      (VP (VBP have)\n",
      "                        (NP (JJ synergistic) (NNS mechanisms))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(angioedema-2, nonallergic-1)\n",
      "nsubj(occurs-3, angioedema-2)\n",
      "root(ROOT-0, occurs-3)\n",
      "case(patients-5, in-4)\n",
      "nmod:in(occurs-3, patients-5)\n",
      "case(variants-8, with-6)\n",
      "amod(variants-8, genetic-7)\n",
      "nmod:with(patients-5, variants-8)\n",
      "nsubj(affect-10, that-9)\n",
      "dep(occurs-3, affect-10)\n",
      "dobj(affect-10, metabolism-11)\n",
      "cc(metabolism-11, or-12)\n",
      "dobj(affect-10, synthesis-13)\n",
      "conj:or(metabolism-11, synthesis-13)\n",
      "case(bradykinin-15, of-14)\n",
      "nmod:of(metabolism-11, bradykinin-15)\n",
      "compound(p-18, substance-17)\n",
      "nmod:of(metabolism-11, p-18)\n",
      "conj:or(bradykinin-15, p-18)\n",
      "nmod:of(metabolism-11, prostaglandins-20)\n",
      "conj:or(bradykinin-15, prostaglandins-20)\n",
      "cc(bradykinin-15, or-22)\n",
      "nmod:of(metabolism-11, leukotrienes-23)\n",
      "conj:or(bradykinin-15, leukotrienes-23)\n",
      "cc(affect-10, or-25)\n",
      "advmod(taking-29, when-26)\n",
      "nsubj(taking-29, patients-27)\n",
      "aux(taking-29, are-28)\n",
      "dep(occurs-3, taking-29)\n",
      "conj:or(affect-10, taking-29)\n",
      "dobj(taking-29, drugs-30)\n",
      "nsubj(have-32, drugs-30)\n",
      "ref(drugs-30, that-31)\n",
      "acl:relcl(drugs-30, have-32)\n",
      "amod(mechanisms-34, synergistic-33)\n",
      "dobj(have-32, mechanisms-34)\n",
      "\n",
      "Parsing [sent. 89 len. 15]: the mainstay in treatment of nonallergic drug-induced angioedema is cessation of the offending agents .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN mainstay))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN treatment))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ nonallergic) (JJ drug-induced) (NN angioedema))))))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (NN cessation))\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ offending) (NNS agents)))))\n",
      "    (. .)))\n",
      "\n",
      "det(mainstay-2, the-1)\n",
      "nsubj(cessation-10, mainstay-2)\n",
      "case(treatment-4, in-3)\n",
      "nmod:in(mainstay-2, treatment-4)\n",
      "case(angioedema-8, of-5)\n",
      "amod(angioedema-8, nonallergic-6)\n",
      "amod(angioedema-8, drug-induced-7)\n",
      "nmod:of(treatment-4, angioedema-8)\n",
      "cop(cessation-10, is-9)\n",
      "root(ROOT-0, cessation-10)\n",
      "case(agents-14, of-11)\n",
      "det(agents-14, the-12)\n",
      "amod(agents-14, offending-13)\n",
      "nmod:of(cessation-10, agents-14)\n",
      "\n",
      "Parsing [sent. 90 len. 50]: raas , a major pharmacological target in cardiovascular medicine , is inhibited by pharmacological classes including ACEI -LRB- ACEI -RRB- inhibitors -LRB- aceis -RRB- , angiotensin-ii type 1 blockers -LRB- arbs -RRB- and aldosterone receptors antagonists , in addition to the recently introduced direct renin inhibitors -LRB- dris -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS raas))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ major) (JJ pharmacological) (NN target))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ cardiovascular) (NN medicine))))\n",
      "      (, ,))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP (JJ inhibited)\n",
      "            (PP (IN by)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (JJ pharmacological) (NNS classes))\n",
      "                  (PP (VBG including)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (NNP ACEI)\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP ACEI))\n",
      "                            (-RRB- -RRB-))\n",
      "                          (NNP inhibitors))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NNS aceis))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (, ,)\n",
      "                      (NP\n",
      "                        (NP (JJ angiotensin-ii) (NN type) (CD 1) (NNS blockers))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NNS arbs))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (CC and)\n",
      "                      (NP (JJ aldosterone) (NNS receptors) (NNS antagonists))\n",
      "                      (, ,))))\n",
      "                (CONJP (IN in) (NN addition) (TO to))\n",
      "                (NP (DT the)\n",
      "                  (ADJP (RB recently) (VBN introduced))\n",
      "                  (JJ direct) (NN renin)))))\n",
      "          (NNS inhibitors))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNS dris))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(inhibitors-46, raas-1)\n",
      "det(target-6, a-3)\n",
      "amod(target-6, major-4)\n",
      "amod(target-6, pharmacological-5)\n",
      "appos(raas-1, target-6)\n",
      "case(medicine-9, in-7)\n",
      "amod(medicine-9, cardiovascular-8)\n",
      "nmod:in(target-6, medicine-9)\n",
      "cop(inhibitors-46, is-11)\n",
      "amod(inhibitors-46, inhibited-12)\n",
      "case(classes-15, by-13)\n",
      "amod(classes-15, pharmacological-14)\n",
      "nmod:by(inhibited-12, classes-15)\n",
      "case(inhibitors-21, including-16)\n",
      "compound(inhibitors-21, ACEI-17)\n",
      "appos(inhibitors-21, ACEI-19)\n",
      "nmod:including(classes-15, inhibitors-21)\n",
      "appos(inhibitors-21, aceis-23)\n",
      "amod(blockers-29, angiotensin-ii-26)\n",
      "compound(blockers-29, type-27)\n",
      "nummod(blockers-29, 1-28)\n",
      "nmod:including(classes-15, blockers-29)\n",
      "conj:and(inhibitors-21, blockers-29)\n",
      "appos(blockers-29, arbs-31)\n",
      "cc(inhibitors-21, and-33)\n",
      "amod(antagonists-36, aldosterone-34)\n",
      "compound(antagonists-36, receptors-35)\n",
      "nmod:including(classes-15, antagonists-36)\n",
      "conj:and(inhibitors-21, antagonists-36)\n",
      "cc(classes-15, in-38)\n",
      "dep(in-38, addition-39)\n",
      "dep(in-38, to-40)\n",
      "det(renin-45, the-41)\n",
      "advmod(introduced-43, recently-42)\n",
      "amod(renin-45, introduced-43)\n",
      "amod(renin-45, direct-44)\n",
      "nmod:by(inhibited-12, renin-45)\n",
      "conj:in(classes-15, renin-45)\n",
      "root(ROOT-0, inhibitors-46)\n",
      "appos(inhibitors-46, dris-48)\n",
      "\n",
      "Parsing [sent. 91 len. 36]: however , currently used raas inhibitors still can not achieve their desired effects and are associated with certain drawbacks , such as adverse side effects , incomplete blockage of the system and poor end-organ protection .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (ADVP (RB currently))\n",
      "    (VP (VBD used)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP (NNS raas) (NNS inhibitors))\n",
      "          (ADVP (RB still))\n",
      "          (VP\n",
      "            (VP (MD can) (RB not)\n",
      "              (VP (VB achieve)\n",
      "                (NP (PRP$ their) (VBN desired) (NNS effects))))\n",
      "            (CC and)\n",
      "            (VP (VBP are)\n",
      "              (VP (VBN associated)\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP (JJ certain) (NNS drawbacks))\n",
      "                    (, ,)\n",
      "                    (PP (JJ such) (IN as)\n",
      "                      (NP (JJ adverse) (NN side) (NNS effects)))\n",
      "                    (, ,)\n",
      "                    (ADJP (JJ incomplete) (JJ blockage))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN system))\n",
      "                        (CC and)\n",
      "                        (NP (JJ poor) (JJ end-organ) (NN protection))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(used-4, however-1)\n",
      "advmod(used-4, currently-3)\n",
      "root(ROOT-0, used-4)\n",
      "compound(inhibitors-6, raas-5)\n",
      "nsubj(achieve-10, inhibitors-6)\n",
      "nsubjpass(associated-16, inhibitors-6)\n",
      "advmod(achieve-10, still-7)\n",
      "aux(achieve-10, can-8)\n",
      "neg(achieve-10, not-9)\n",
      "ccomp(used-4, achieve-10)\n",
      "nmod:poss(effects-13, their-11)\n",
      "amod(effects-13, desired-12)\n",
      "dobj(achieve-10, effects-13)\n",
      "cc(achieve-10, and-14)\n",
      "auxpass(associated-16, are-15)\n",
      "ccomp(used-4, associated-16)\n",
      "conj:and(achieve-10, associated-16)\n",
      "case(drawbacks-19, with-17)\n",
      "amod(drawbacks-19, certain-18)\n",
      "nmod:with(associated-16, drawbacks-19)\n",
      "case(effects-25, such-21)\n",
      "mwe(such-21, as-22)\n",
      "amod(effects-25, adverse-23)\n",
      "compound(effects-25, side-24)\n",
      "nmod:such_as(drawbacks-19, effects-25)\n",
      "amod(blockage-28, incomplete-27)\n",
      "amod(drawbacks-19, blockage-28)\n",
      "case(system-31, of-29)\n",
      "det(system-31, the-30)\n",
      "nmod:of(drawbacks-19, system-31)\n",
      "cc(system-31, and-32)\n",
      "amod(protection-35, poor-33)\n",
      "amod(protection-35, end-organ-34)\n",
      "nmod:of(drawbacks-19, protection-35)\n",
      "conj:and(system-31, protection-35)\n",
      "\n",
      "Parsing [sent. 92 len. 42]: in this review , we discuss the efficiency and specificity of the current raas inhibitors and propose some recommendations for achieving better treatments with better end-organ protection.hypertension research advance online publication , 6 july 2017 ; doi :10.1038 / hr .2017.65 .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (DT this) (NN review)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP\n",
      "      (VP (VB discuss)\n",
      "        (NP\n",
      "          (NP (DT the) (NN efficiency)\n",
      "            (CC and)\n",
      "            (NN specificity))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (JJ current) (NNS raas) (NNS inhibitors)))))\n",
      "      (CC and)\n",
      "      (VP (VB propose)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT some) (NNS recommendations))\n",
      "            (PP (IN for)\n",
      "              (S\n",
      "                (VP (VBG achieving)\n",
      "                  (NP (JJR better) (NNS treatments))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJR better) (JJ end-organ) (NN protection.hypertension) (NN research) (NN advance) (JJ online) (NNS publication)))))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (CD 6))\n",
      "            (NP (NNP july) (CD 2017)))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (QP (CD doi) (CD :10.1038))\n",
      "            (NNS /))\n",
      "          (NP (NN hr) (CD .2017.65)))))\n",
      "    (. .)))\n",
      "\n",
      "case(review-3, in-1)\n",
      "det(review-3, this-2)\n",
      "nmod:in(discuss-6, review-3)\n",
      "nsubj(discuss-6, we-5)\n",
      "nsubj(propose-17, we-5)\n",
      "root(ROOT-0, discuss-6)\n",
      "det(efficiency-8, the-7)\n",
      "dobj(discuss-6, efficiency-8)\n",
      "cc(efficiency-8, and-9)\n",
      "dobj(discuss-6, specificity-10)\n",
      "conj:and(efficiency-8, specificity-10)\n",
      "case(inhibitors-15, of-11)\n",
      "det(inhibitors-15, the-12)\n",
      "amod(inhibitors-15, current-13)\n",
      "compound(inhibitors-15, raas-14)\n",
      "nmod:of(efficiency-8, inhibitors-15)\n",
      "cc(discuss-6, and-16)\n",
      "conj:and(discuss-6, propose-17)\n",
      "det(recommendations-19, some-18)\n",
      "dobj(propose-17, recommendations-19)\n",
      "mark(achieving-21, for-20)\n",
      "acl(recommendations-19, achieving-21)\n",
      "amod(treatments-23, better-22)\n",
      "dobj(achieving-21, treatments-23)\n",
      "case(publication-31, with-24)\n",
      "amod(publication-31, better-25)\n",
      "amod(publication-31, end-organ-26)\n",
      "compound(publication-31, protection.hypertension-27)\n",
      "compound(publication-31, research-28)\n",
      "compound(publication-31, advance-29)\n",
      "amod(publication-31, online-30)\n",
      "nmod:with(achieving-21, publication-31)\n",
      "appos(recommendations-19, 6-33)\n",
      "dep(6-33, july-34)\n",
      "nummod(july-34, 2017-35)\n",
      "compound(:10.1038-38, doi-37)\n",
      "nummod(/-39, :10.1038-38)\n",
      "dep(recommendations-19, /-39)\n",
      "dep(recommendations-19, hr-40)\n",
      "nummod(hr-40, .2017.65-41)\n",
      "\n",
      "Parsing [sent. 93 len. 25]: the progression of chronic kidney disease ckd is largely independent of the underlying kidney disorder once renal function has fallen below a critical level .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN progression))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ chronic) (NN kidney) (NN disease) (NN ckd))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (RB largely) (JJ independent)\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ underlying) (NN kidney) (NN disorder))))\n",
      "      (SBAR (IN once)\n",
      "        (S\n",
      "          (NP (JJ renal) (NN function))\n",
      "          (VP (VBZ has)\n",
      "            (VP (VBN fallen)\n",
      "              (PP (IN below)\n",
      "                (NP (DT a) (JJ critical) (NN level))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(progression-2, the-1)\n",
      "nsubj(independent-10, progression-2)\n",
      "case(ckd-7, of-3)\n",
      "amod(ckd-7, chronic-4)\n",
      "compound(ckd-7, kidney-5)\n",
      "compound(ckd-7, disease-6)\n",
      "nmod:of(progression-2, ckd-7)\n",
      "cop(independent-10, is-8)\n",
      "advmod(independent-10, largely-9)\n",
      "root(ROOT-0, independent-10)\n",
      "case(disorder-15, of-11)\n",
      "det(disorder-15, the-12)\n",
      "amod(disorder-15, underlying-13)\n",
      "compound(disorder-15, kidney-14)\n",
      "nmod:of(independent-10, disorder-15)\n",
      "mark(fallen-20, once-16)\n",
      "amod(function-18, renal-17)\n",
      "nsubj(fallen-20, function-18)\n",
      "aux(fallen-20, has-19)\n",
      "advcl(independent-10, fallen-20)\n",
      "case(level-24, below-21)\n",
      "det(level-24, a-22)\n",
      "amod(level-24, critical-23)\n",
      "nmod:below(fallen-20, level-24)\n",
      "\n",
      "Parsing [sent. 94 len. 19]: hypertension is an independent risk factor for disease progression in both adult and pediatric patients with kidney disorders .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN hypertension))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an) (JJ independent) (NN risk) (NN factor))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN disease) (NN progression))\n",
      "              (PP (IN in)\n",
      "                (NP (DT both) (NN adult))))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (JJ pediatric) (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (NN kidney) (NNS disorders))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(factor-6, hypertension-1)\n",
      "cop(factor-6, is-2)\n",
      "det(factor-6, an-3)\n",
      "amod(factor-6, independent-4)\n",
      "compound(factor-6, risk-5)\n",
      "root(ROOT-0, factor-6)\n",
      "case(progression-9, for-7)\n",
      "compound(progression-9, disease-8)\n",
      "nmod:for(factor-6, progression-9)\n",
      "case(adult-12, in-10)\n",
      "det(adult-12, both-11)\n",
      "nmod:in(progression-9, adult-12)\n",
      "cc(progression-9, and-13)\n",
      "amod(patients-15, pediatric-14)\n",
      "nmod:for(factor-6, patients-15)\n",
      "conj:and(progression-9, patients-15)\n",
      "case(disorders-18, with-16)\n",
      "compound(disorders-18, kidney-17)\n",
      "nmod:with(patients-15, disorders-18)\n",
      "\n",
      "Parsing [sent. 95 len. 33]: optimal blood pressure control -LRB- 130 / 80mm hg -RRB- represents a main goal of conservative therapy in patients with chronic kidney disease ckd but it is rarely achieved in clinical practice .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (JJ optimal) (NN blood) (NN pressure) (NN control))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (QP (CD 130) (CD /))\n",
      "            (NN 80mm) (NN hg))\n",
      "          (-RRB- -RRB-)))\n",
      "      (VP (VBZ represents)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ main) (NN goal))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ conservative) (NN therapy))))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (JJ chronic) (NN kidney) (NN disease) (NN ckd)))))))\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBZ is)\n",
      "        (ADVP (RB rarely))\n",
      "        (VP (VBN achieved)\n",
      "          (PP (IN in)\n",
      "            (NP (JJ clinical) (NN practice))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(control-4, optimal-1)\n",
      "compound(control-4, blood-2)\n",
      "compound(control-4, pressure-3)\n",
      "nsubj(represents-11, control-4)\n",
      "compound(/-7, 130-6)\n",
      "nummod(hg-9, /-7)\n",
      "compound(hg-9, 80mm-8)\n",
      "appos(control-4, hg-9)\n",
      "root(ROOT-0, represents-11)\n",
      "det(goal-14, a-12)\n",
      "amod(goal-14, main-13)\n",
      "dobj(represents-11, goal-14)\n",
      "case(therapy-17, of-15)\n",
      "amod(therapy-17, conservative-16)\n",
      "nmod:of(goal-14, therapy-17)\n",
      "case(patients-19, in-18)\n",
      "nmod:in(represents-11, patients-19)\n",
      "case(ckd-24, with-20)\n",
      "amod(ckd-24, chronic-21)\n",
      "compound(ckd-24, kidney-22)\n",
      "compound(ckd-24, disease-23)\n",
      "nmod:with(patients-19, ckd-24)\n",
      "cc(represents-11, but-25)\n",
      "nsubjpass(achieved-29, it-26)\n",
      "auxpass(achieved-29, is-27)\n",
      "advmod(achieved-29, rarely-28)\n",
      "conj:but(represents-11, achieved-29)\n",
      "case(practice-32, in-30)\n",
      "amod(practice-32, clinical-31)\n",
      "nmod:in(achieved-29, practice-32)\n",
      "\n",
      "Parsing [sent. 96 len. 18]: ACEI and angiotensin receptor blockers are more effective than other drugs in slowing progression of proteinuric ckd .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI)\n",
      "      (CC and)\n",
      "      (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "    (VP (VBP are)\n",
      "      (ADJP (RBR more) (JJ effective)\n",
      "        (PP (IN than)\n",
      "          (NP\n",
      "            (NP (JJ other) (NNS drugs))\n",
      "            (PP (IN in)\n",
      "              (NP\n",
      "                (NP (VBG slowing) (NN progression))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ proteinuric) (NN ckd)))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(blockers-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, angiotensin-3)\n",
      "compound(blockers-5, angiotensin-3)\n",
      "compound(blockers-5, receptor-4)\n",
      "nsubj(effective-8, blockers-5)\n",
      "cop(effective-8, are-6)\n",
      "advmod(effective-8, more-7)\n",
      "root(ROOT-0, effective-8)\n",
      "case(drugs-11, than-9)\n",
      "amod(drugs-11, other-10)\n",
      "nmod:than(effective-8, drugs-11)\n",
      "case(progression-14, in-12)\n",
      "amod(progression-14, slowing-13)\n",
      "nmod:in(drugs-11, progression-14)\n",
      "case(ckd-17, of-15)\n",
      "amod(ckd-17, proteinuric-16)\n",
      "nmod:of(progression-14, ckd-17)\n",
      "\n",
      "Parsing [sent. 97 len. 20]: dietary salt restriction -LRB- â¤ 100 meq/die of nacl -RRB- may be useful to correct the extracellular volume expansion .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ dietary) (NN salt) (NN restriction))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP\n",
      "            (QP (CD â¤) (CD 100))\n",
      "            (NN meq/die))\n",
      "          (PP (IN of)\n",
      "            (NP (NN nacl))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ useful)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB correct)\n",
      "                (NP (DT the) (NN extracellular) (NN volume) (NN expansion))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(restriction-3, dietary-1)\n",
      "compound(restriction-3, salt-2)\n",
      "nsubj(useful-13, restriction-3)\n",
      "nsubj:xsubj(correct-15, restriction-3)\n",
      "compound(100-6, â¤-5)\n",
      "nummod(meq/die-7, 100-6)\n",
      "dep(restriction-3, meq/die-7)\n",
      "case(nacl-9, of-8)\n",
      "nmod:of(meq/die-7, nacl-9)\n",
      "aux(useful-13, may-11)\n",
      "cop(useful-13, be-12)\n",
      "root(ROOT-0, useful-13)\n",
      "mark(correct-15, to-14)\n",
      "xcomp(useful-13, correct-15)\n",
      "det(expansion-19, the-16)\n",
      "compound(expansion-19, extracellular-17)\n",
      "compound(expansion-19, volume-18)\n",
      "dobj(correct-15, expansion-19)\n",
      "\n",
      "Parsing [sent. 98 len. 33]: if this intervention fails , hypertension can be treated by thiazide diuretics in patients with mild ckd , whereas loop diuretics at adequate doses are indicated in patients with more advanced ckd .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN if)\n",
      "      (S\n",
      "        (NP (DT this) (NN intervention))\n",
      "        (VP (VBZ fails))))\n",
      "    (, ,)\n",
      "    (NP (NN hypertension))\n",
      "    (VP (MD can)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN treated)\n",
      "          (PP (IN by)\n",
      "            (NP (JJ thiazide) (NNS diuretics)))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ mild) (NN ckd)))))\n",
      "          (, ,)\n",
      "          (SBAR (IN whereas)\n",
      "            (S\n",
      "              (NP\n",
      "                (NP (NN loop) (NNS diuretics))\n",
      "                (PP (IN at)\n",
      "                  (NP (JJ adequate) (NNS doses))))\n",
      "              (VP (VBP are)\n",
      "                (VP (VBN indicated)\n",
      "                  (PP (IN in)\n",
      "                    (NP\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP\n",
      "                          (ADJP (RBR more) (JJ advanced))\n",
      "                          (NN ckd))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(fails-4, if-1)\n",
      "det(intervention-3, this-2)\n",
      "nsubj(fails-4, intervention-3)\n",
      "advcl(treated-9, fails-4)\n",
      "nsubjpass(treated-9, hypertension-6)\n",
      "aux(treated-9, can-7)\n",
      "auxpass(treated-9, be-8)\n",
      "root(ROOT-0, treated-9)\n",
      "case(diuretics-12, by-10)\n",
      "amod(diuretics-12, thiazide-11)\n",
      "nmod:by(treated-9, diuretics-12)\n",
      "case(patients-14, in-13)\n",
      "nmod:in(treated-9, patients-14)\n",
      "case(ckd-17, with-15)\n",
      "amod(ckd-17, mild-16)\n",
      "nmod:with(patients-14, ckd-17)\n",
      "mark(indicated-26, whereas-19)\n",
      "compound(diuretics-21, loop-20)\n",
      "nsubjpass(indicated-26, diuretics-21)\n",
      "case(doses-24, at-22)\n",
      "amod(doses-24, adequate-23)\n",
      "nmod:at(diuretics-21, doses-24)\n",
      "auxpass(indicated-26, are-25)\n",
      "advcl(treated-9, indicated-26)\n",
      "case(patients-28, in-27)\n",
      "nmod:in(indicated-26, patients-28)\n",
      "case(ckd-32, with-29)\n",
      "advmod(advanced-31, more-30)\n",
      "amod(ckd-32, advanced-31)\n",
      "nmod:with(patients-28, ckd-32)\n",
      "\n",
      "Parsing [sent. 99 len. 49]: the beneficial effects of ACEI -LRB- ACEI -RRB- inhibitors and angiotensin ii -LRB- aii -RRB- receptor antagonists in patients with heart failure secondary to reduced ejection fraction -LRB- hfref -RRB- are felt to result from prevention of the adverse effects of aii on systemic afterload and renal homeostasis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "        (PP (IN of)\n",
      "          (NP (NNP ACEI)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP ACEI))\n",
      "              (-RRB- -RRB-))\n",
      "            (NN inhibitors))))\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP\n",
      "            (QP (CD angiotensin) (CD ii)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN aii))\n",
      "            (-RRB- -RRB-))\n",
      "          (NN receptor) (NNS antagonists))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NN heart) (NN failure))\n",
      "                  (ADJP (JJ secondary)\n",
      "                    (PP (TO to)\n",
      "                      (NP (JJ reduced) (NN ejection) (NN fraction)))))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN hfref))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN felt)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB result)\n",
      "              (PP (IN from)\n",
      "                (NP\n",
      "                  (NP (NN prevention))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (DT the) (JJ adverse) (NNS effects))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NN aii)))))))\n",
      "              (PP (IN on)\n",
      "                (NP (JJ systemic) (JJ afterload)\n",
      "                  (CC and)\n",
      "                  (JJ renal) (NNS homeostasis))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(effects-3, the-1)\n",
      "amod(effects-3, beneficial-2)\n",
      "nsubjpass(felt-32, effects-3)\n",
      "nsubj:xsubj(result-34, effects-3)\n",
      "case(inhibitors-9, of-4)\n",
      "compound(inhibitors-9, ACEI-5)\n",
      "appos(inhibitors-9, ACEI-7)\n",
      "nmod:of(effects-3, inhibitors-9)\n",
      "cc(effects-3, and-10)\n",
      "compound(ii-12, angiotensin-11)\n",
      "nummod(antagonists-17, ii-12)\n",
      "appos(antagonists-17, aii-14)\n",
      "compound(antagonists-17, receptor-16)\n",
      "conj:and(effects-3, antagonists-17)\n",
      "nsubjpass(felt-32, antagonists-17)\n",
      "nsubj:xsubj(result-34, antagonists-17)\n",
      "case(patients-19, in-18)\n",
      "nmod:in(antagonists-17, patients-19)\n",
      "case(failure-22, with-20)\n",
      "compound(failure-22, heart-21)\n",
      "nmod:with(patients-19, failure-22)\n",
      "amod(failure-22, secondary-23)\n",
      "case(fraction-27, to-24)\n",
      "amod(fraction-27, reduced-25)\n",
      "compound(fraction-27, ejection-26)\n",
      "nmod:to(secondary-23, fraction-27)\n",
      "appos(failure-22, hfref-29)\n",
      "auxpass(felt-32, are-31)\n",
      "root(ROOT-0, felt-32)\n",
      "mark(result-34, to-33)\n",
      "xcomp(felt-32, result-34)\n",
      "case(prevention-36, from-35)\n",
      "nmod:from(result-34, prevention-36)\n",
      "case(effects-40, of-37)\n",
      "det(effects-40, the-38)\n",
      "amod(effects-40, adverse-39)\n",
      "nmod:of(prevention-36, effects-40)\n",
      "case(aii-42, of-41)\n",
      "nmod:of(effects-40, aii-42)\n",
      "case(afterload-45, on-43)\n",
      "amod(afterload-45, systemic-44)\n",
      "nmod:on(result-34, afterload-45)\n",
      "cc(afterload-45, and-46)\n",
      "amod(homeostasis-48, renal-47)\n",
      "nmod:on(result-34, homeostasis-48)\n",
      "conj:and(afterload-45, homeostasis-48)\n",
      "\n",
      "Parsing [sent. 100 len. 30]: however , aii can activate the sympathetic nervous system and part of the beneficial effects of ACEI and aii antagonists may result from their ability to inhibit such activation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN aii))\n",
      "      (VP (MD can)\n",
      "        (VP (VB activate)\n",
      "          (NP\n",
      "            (NP (DT the)\n",
      "              (ADJP (JJ sympathetic) (JJ nervous))\n",
      "              (NN system))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (NN part))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NNP ACEI))))))))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN aii) (NNS antagonists))\n",
      "      (VP (MD may)\n",
      "        (VP (VB result)\n",
      "          (PP (IN from)\n",
      "            (NP (PRP$ their) (NN ability)\n",
      "              (S\n",
      "                (VP (TO to)\n",
      "                  (VP (VB inhibit)\n",
      "                    (NP (JJ such) (NN activation))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(activate-5, however-1)\n",
      "nsubj(activate-5, aii-3)\n",
      "aux(activate-5, can-4)\n",
      "root(ROOT-0, activate-5)\n",
      "det(system-9, the-6)\n",
      "amod(nervous-8, sympathetic-7)\n",
      "amod(system-9, nervous-8)\n",
      "dobj(activate-5, system-9)\n",
      "cc(system-9, and-10)\n",
      "dobj(activate-5, part-11)\n",
      "conj:and(system-9, part-11)\n",
      "case(effects-15, of-12)\n",
      "det(effects-15, the-13)\n",
      "amod(effects-15, beneficial-14)\n",
      "nmod:of(part-11, effects-15)\n",
      "case(ACEI-17, of-16)\n",
      "nmod:of(effects-15, ACEI-17)\n",
      "cc(activate-5, and-18)\n",
      "compound(antagonists-20, aii-19)\n",
      "nsubj(result-22, antagonists-20)\n",
      "aux(result-22, may-21)\n",
      "conj:and(activate-5, result-22)\n",
      "case(ability-25, from-23)\n",
      "nmod:poss(ability-25, their-24)\n",
      "nmod:from(result-22, ability-25)\n",
      "mark(inhibit-27, to-26)\n",
      "acl(ability-25, inhibit-27)\n",
      "amod(activation-29, such-28)\n",
      "dobj(inhibit-27, activation-29)\n",
      "\n",
      "Parsing [sent. 101 len. 48]: we examined the acute effects of the ACEI captopril -LRB- 25 mg , n = 9 -RRB- and the aii receptor antagonist losartan -LRB- 50 mg , n = 10 -RRB- on hemodynamics as well as total body and cardiac norepinephrine spillover in patients with chronic hfref .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD examined)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ acute) (NNS effects))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT the) (NNP ACEI) (NN captopril))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 25) (NN mg))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (SBAR\n",
      "                    (S\n",
      "                      (VP (SYM =)\n",
      "                        (NP (CD 9)))))))\n",
      "              (-RRB- -RRB-))\n",
      "            (CC and)\n",
      "            (NP (DT the) (JJ aii) (NN receptor) (NN antagonist) (NN losartan))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 50) (NN mg))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (SBAR\n",
      "                    (S\n",
      "                      (VP (SYM =)\n",
      "                        (NP (CD 10)))))))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (NNS hemodynamics))\n",
      "          (CONJP (RB as) (RB well) (IN as))\n",
      "          (NP (JJ total) (NN body)\n",
      "            (CC and)\n",
      "            (JJ cardiac) (NN norepinephrine) (NN spillover))))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ chronic) (NN hfref))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(examined-2, we-1)\n",
      "root(ROOT-0, examined-2)\n",
      "det(effects-5, the-3)\n",
      "amod(effects-5, acute-4)\n",
      "dobj(examined-2, effects-5)\n",
      "case(captopril-9, of-6)\n",
      "det(captopril-9, the-7)\n",
      "compound(captopril-9, ACEI-8)\n",
      "nmod:of(effects-5, captopril-9)\n",
      "nummod(mg-12, 25-11)\n",
      "dep(captopril-9, mg-12)\n",
      "appos(mg-12, n-14)\n",
      "dep(9-16, =-15)\n",
      "acl:relcl(n-14, 9-16)\n",
      "cc(captopril-9, and-18)\n",
      "det(losartan-23, the-19)\n",
      "amod(losartan-23, aii-20)\n",
      "compound(losartan-23, receptor-21)\n",
      "compound(losartan-23, antagonist-22)\n",
      "nmod:of(effects-5, losartan-23)\n",
      "conj:and(captopril-9, losartan-23)\n",
      "nummod(mg-26, 50-25)\n",
      "dep(captopril-9, mg-26)\n",
      "appos(mg-26, n-28)\n",
      "dep(10-30, =-29)\n",
      "acl:relcl(n-28, 10-30)\n",
      "case(hemodynamics-33, on-32)\n",
      "nmod:on(examined-2, hemodynamics-33)\n",
      "cc(hemodynamics-33, as-34)\n",
      "mwe(as-34, well-35)\n",
      "mwe(as-34, as-36)\n",
      "amod(body-38, total-37)\n",
      "nmod:on(examined-2, body-38)\n",
      "conj:and(hemodynamics-33, body-38)\n",
      "cc(body-38, and-39)\n",
      "amod(spillover-42, cardiac-40)\n",
      "compound(spillover-42, norepinephrine-41)\n",
      "conj:and(hemodynamics-33, spillover-42)\n",
      "conj:and(body-38, spillover-42)\n",
      "case(patients-44, in-43)\n",
      "nmod:in(examined-2, patients-44)\n",
      "case(hfref-47, with-45)\n",
      "amod(hfref-47, chronic-46)\n",
      "nmod:with(patients-44, hfref-47)\n",
      "\n",
      "Parsing [sent. 102 len. 20]: hemodynamic and neurochemical measurements were made at baseline and at 1 , 2 and 4 hours after oral dosing .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (JJ hemodynamic)\n",
      "        (CC and)\n",
      "        (JJ neurochemical))\n",
      "      (NNS measurements))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN made)\n",
      "        (PP\n",
      "          (PP (IN at)\n",
      "            (NP (NN baseline)))\n",
      "          (CC and)\n",
      "          (PP (IN at)\n",
      "            (NP (CD 1) (, ,) (CD 2)\n",
      "              (CC and)\n",
      "              (CD 4)))\n",
      "          (NP (NNS hours)))\n",
      "        (PP (IN after)\n",
      "          (NP (JJ oral) (NN dosing)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(measurements-4, hemodynamic-1)\n",
      "cc(hemodynamic-1, and-2)\n",
      "conj:and(hemodynamic-1, neurochemical-3)\n",
      "amod(measurements-4, neurochemical-3)\n",
      "nsubjpass(made-6, measurements-4)\n",
      "auxpass(made-6, were-5)\n",
      "root(ROOT-0, made-6)\n",
      "case(baseline-8, at-7)\n",
      "nmod:at(hours-16, baseline-8)\n",
      "cc(hours-16, and-9)\n",
      "case(1-11, at-10)\n",
      "nmod(made-6, 1-11)\n",
      "conj:and(hours-16, 1-11)\n",
      "nummod(1-11, 2-13)\n",
      "cc(1-11, and-14)\n",
      "conj:and(1-11, 4-15)\n",
      "conj:and(hours-16, 4-15)\n",
      "nmod(made-6, hours-16)\n",
      "case(dosing-19, after-17)\n",
      "amod(dosing-19, oral-18)\n",
      "nmod:after(made-6, dosing-19)\n",
      "\n",
      "Parsing [sent. 103 len. 25]: administration of both drugs caused significant reductions in systemic arterial , cardiac filling and pulmonary artery pressures -LRB- p < 0.05 vs baseline -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN administration))\n",
      "      (PP (IN of)\n",
      "        (NP (DT both) (NNS drugs))))\n",
      "    (VP (VBD caused)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (JJ significant) (NNS reductions))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ systemic) (NN arterial))))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (JJ cardiac) (NN filling))\n",
      "          (CC and)\n",
      "          (NP (JJ pulmonary) (NN artery) (NNS pressures)))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN p)\n",
      "            (S\n",
      "              (VP (VBG <)\n",
      "                (NP (CD 0.05) (NN vs) (NN baseline)))))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(caused-5, administration-1)\n",
      "case(drugs-4, of-2)\n",
      "det(drugs-4, both-3)\n",
      "nmod:of(administration-1, drugs-4)\n",
      "root(ROOT-0, caused-5)\n",
      "amod(reductions-7, significant-6)\n",
      "dobj(caused-5, reductions-7)\n",
      "case(arterial-10, in-8)\n",
      "amod(arterial-10, systemic-9)\n",
      "nmod:in(reductions-7, arterial-10)\n",
      "amod(filling-13, cardiac-12)\n",
      "appos(reductions-7, filling-13)\n",
      "cc(filling-13, and-14)\n",
      "amod(pressures-17, pulmonary-15)\n",
      "compound(pressures-17, artery-16)\n",
      "appos(reductions-7, pressures-17)\n",
      "conj:and(filling-13, pressures-17)\n",
      "dep(reductions-7, p-19)\n",
      "xcomp(p-19, <-20)\n",
      "nummod(baseline-23, 0.05-21)\n",
      "compound(baseline-23, vs-22)\n",
      "dobj(<-20, baseline-23)\n",
      "\n",
      "Parsing [sent. 104 len. 13]: there was no significant difference in the magnitude of those hemodynamic effects .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT no) (JJ significant) (NN difference))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN magnitude))\n",
      "            (PP (IN of)\n",
      "              (NP (DT those) (JJ hemodynamic) (NNS effects)))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "neg(difference-5, no-3)\n",
      "amod(difference-5, significant-4)\n",
      "nsubj(was-2, difference-5)\n",
      "case(magnitude-8, in-6)\n",
      "det(magnitude-8, the-7)\n",
      "nmod:in(difference-5, magnitude-8)\n",
      "case(effects-12, of-9)\n",
      "det(effects-12, those-10)\n",
      "amod(effects-12, hemodynamic-11)\n",
      "nmod:of(magnitude-8, effects-12)\n",
      "\n",
      "Parsing [sent. 105 len. 23]: plasma concentrations of aii were significantly decreased by captopril and increased by losartan -LRB- p < 0.05 vs baseline for both -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN plasma) (NNS concentrations))\n",
      "      (PP (IN of)\n",
      "        (NP (NN aii))))\n",
      "    (VP (VBD were)\n",
      "      (ADVP (RB significantly))\n",
      "      (VP\n",
      "        (VP (VBN decreased)\n",
      "          (PP (IN by)\n",
      "            (NP (NN captopril))))\n",
      "        (CC and)\n",
      "        (VP (VBN increased)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (NN losartan))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN p)\n",
      "                  (S\n",
      "                    (VP (VBG <)\n",
      "                      (NP (CD 0.05) (NN vs) (NN baseline))\n",
      "                      (PP (IN for)\n",
      "                        (NP (DT both))))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(concentrations-2, plasma-1)\n",
      "nsubjpass(decreased-7, concentrations-2)\n",
      "nsubjpass(increased-11, concentrations-2)\n",
      "case(aii-4, of-3)\n",
      "nmod:of(concentrations-2, aii-4)\n",
      "auxpass(decreased-7, were-5)\n",
      "advmod(decreased-7, significantly-6)\n",
      "root(ROOT-0, decreased-7)\n",
      "case(captopril-9, by-8)\n",
      "nmod:by(decreased-7, captopril-9)\n",
      "cc(decreased-7, and-10)\n",
      "conj:and(decreased-7, increased-11)\n",
      "case(losartan-13, by-12)\n",
      "nmod:by(increased-11, losartan-13)\n",
      "dep(losartan-13, p-15)\n",
      "xcomp(p-15, <-16)\n",
      "nummod(baseline-19, 0.05-17)\n",
      "compound(baseline-19, vs-18)\n",
      "dobj(<-16, baseline-19)\n",
      "case(both-21, for-20)\n",
      "nmod:for(<-16, both-21)\n",
      "\n",
      "Parsing [sent. 106 len. 37]: total body sympathetic activity increased in response to both captopril and losartan -LRB- p < 0.05 vs baseline for both -RRB- , however there was no change in cardiac sympathetic activity in response to either drug .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ total) (NN body) (JJ sympathetic) (NN activity))\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN in)\n",
      "          (NP (NN response)))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (DT both) (NN captopril)\n",
      "              (CC and)\n",
      "              (NN losartan))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (NN p) (NNS <))\n",
      "                (NP\n",
      "                  (NP (CD 0.05) (NN vs) (NN baseline))\n",
      "                  (PP (IN for)\n",
      "                    (NP (DT both)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (, ,)\n",
      "    (ADVP (RB however))\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT no) (NN change))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (JJ cardiac) (JJ sympathetic) (NN activity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN response))))))\n",
      "      (PP (TO to)\n",
      "        (NP (DT either) (NN drug))))\n",
      "    (. .)))\n",
      "\n",
      "amod(activity-4, total-1)\n",
      "compound(activity-4, body-2)\n",
      "amod(activity-4, sympathetic-3)\n",
      "nsubj(was-25, activity-4)\n",
      "acl(activity-4, increased-5)\n",
      "case(response-7, in-6)\n",
      "nmod:in(increased-5, response-7)\n",
      "case(captopril-10, to-8)\n",
      "cc:preconj(captopril-10, both-9)\n",
      "nmod:to(increased-5, captopril-10)\n",
      "cc(captopril-10, and-11)\n",
      "nmod:to(increased-5, losartan-12)\n",
      "conj:and(captopril-10, losartan-12)\n",
      "compound(<-15, p-14)\n",
      "dep(captopril-10, <-15)\n",
      "nummod(baseline-18, 0.05-16)\n",
      "compound(baseline-18, vs-17)\n",
      "dep(<-15, baseline-18)\n",
      "case(both-20, for-19)\n",
      "nmod:for(baseline-18, both-20)\n",
      "expl(was-25, however-23)\n",
      "dep(however-23, there-24)\n",
      "root(ROOT-0, was-25)\n",
      "neg(change-27, no-26)\n",
      "nsubj(was-25, change-27)\n",
      "case(activity-31, in-28)\n",
      "amod(activity-31, cardiac-29)\n",
      "amod(activity-31, sympathetic-30)\n",
      "nmod:in(change-27, activity-31)\n",
      "case(response-33, in-32)\n",
      "nmod:in(activity-31, response-33)\n",
      "case(drug-36, to-34)\n",
      "det(drug-36, either-35)\n",
      "nmod:to(was-25, drug-36)\n",
      "\n",
      "Parsing [sent. 107 len. 29]: the results of the current study do not support the hypothesis that the acute inhibition of the renin angiotensin system has sympathoinhibitory effects in patients with chronic hfref .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NNS results))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ current) (NN study))))\n",
      "    (VP (VBP do) (RB not)\n",
      "      (VP (VB support)\n",
      "        (NP (DT the) (NNS hypothesis))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (DT the) (JJ acute) (NN inhibition))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN renin) (NN angiotensin) (NN system))))\n",
      "            (VP (VBZ has)\n",
      "              (NP\n",
      "                (NP (JJ sympathoinhibitory) (NNS effects))\n",
      "                (PP (IN in)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ chronic) (NN hfref)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(results-2, the-1)\n",
      "nsubj(support-9, results-2)\n",
      "case(study-6, of-3)\n",
      "det(study-6, the-4)\n",
      "amod(study-6, current-5)\n",
      "nmod:of(results-2, study-6)\n",
      "aux(support-9, do-7)\n",
      "neg(support-9, not-8)\n",
      "root(ROOT-0, support-9)\n",
      "det(hypothesis-11, the-10)\n",
      "dobj(support-9, hypothesis-11)\n",
      "mark(has-21, that-12)\n",
      "det(inhibition-15, the-13)\n",
      "amod(inhibition-15, acute-14)\n",
      "nsubj(has-21, inhibition-15)\n",
      "case(system-20, of-16)\n",
      "det(system-20, the-17)\n",
      "compound(system-20, renin-18)\n",
      "compound(system-20, angiotensin-19)\n",
      "nmod:of(inhibition-15, system-20)\n",
      "ccomp(support-9, has-21)\n",
      "amod(effects-23, sympathoinhibitory-22)\n",
      "dobj(has-21, effects-23)\n",
      "case(patients-25, in-24)\n",
      "nmod:in(effects-23, patients-25)\n",
      "case(hfref-28, with-26)\n",
      "amod(hfref-28, chronic-27)\n",
      "nmod:with(patients-25, hfref-28)\n",
      "\n",
      "Parsing [sent. 108 len. 39]: the improvement of the physical functioning and hrqol in older hypertensive adults using ACEI medications only occur if they adopt an exercise training regimen , increasing also the management of the blood pressure and other cardiovascular risk factors .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN improvement))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ physical) (NN functioning)\n",
      "            (CC and)\n",
      "            (NN hrqol))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (JJR older) (NN hypertensive) (NNS adults))\n",
      "              (VP (VBG using)\n",
      "                (NP (CD ACEI) (NNS medications))))))))\n",
      "    (ADVP (RB only))\n",
      "    (VP (VBP occur)\n",
      "      (SBAR (IN if)\n",
      "        (S\n",
      "          (NP (PRP they))\n",
      "          (VP (VBP adopt)\n",
      "            (NP (DT an) (NN exercise) (NN training) (NN regimen))\n",
      "            (, ,)\n",
      "            (S\n",
      "              (VP (VBG increasing)\n",
      "                (ADVP (RB also))\n",
      "                (NP\n",
      "                  (NP (DT the) (NN management))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN blood) (NN pressure))\n",
      "                      (CC and)\n",
      "                      (NP (JJ other) (JJ cardiovascular) (NN risk) (NNS factors)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(improvement-2, the-1)\n",
      "nsubj(occur-17, improvement-2)\n",
      "case(functioning-6, of-3)\n",
      "det(functioning-6, the-4)\n",
      "amod(functioning-6, physical-5)\n",
      "nmod:of(improvement-2, functioning-6)\n",
      "cc(functioning-6, and-7)\n",
      "nmod:of(improvement-2, hrqol-8)\n",
      "conj:and(functioning-6, hrqol-8)\n",
      "case(adults-12, in-9)\n",
      "amod(adults-12, older-10)\n",
      "compound(adults-12, hypertensive-11)\n",
      "nmod:in(functioning-6, adults-12)\n",
      "acl(adults-12, using-13)\n",
      "nummod(medications-15, ACEI-14)\n",
      "dobj(using-13, medications-15)\n",
      "advmod(occur-17, only-16)\n",
      "root(ROOT-0, occur-17)\n",
      "mark(adopt-20, if-18)\n",
      "nsubj(adopt-20, they-19)\n",
      "advcl(occur-17, adopt-20)\n",
      "det(regimen-24, an-21)\n",
      "compound(regimen-24, exercise-22)\n",
      "compound(regimen-24, training-23)\n",
      "dobj(adopt-20, regimen-24)\n",
      "advcl(adopt-20, increasing-26)\n",
      "advmod(increasing-26, also-27)\n",
      "det(management-29, the-28)\n",
      "dobj(increasing-26, management-29)\n",
      "case(pressure-33, of-30)\n",
      "det(pressure-33, the-31)\n",
      "compound(pressure-33, blood-32)\n",
      "nmod:of(management-29, pressure-33)\n",
      "cc(pressure-33, and-34)\n",
      "amod(factors-38, other-35)\n",
      "amod(factors-38, cardiovascular-36)\n",
      "compound(factors-38, risk-37)\n",
      "nmod:of(management-29, factors-38)\n",
      "conj:and(pressure-33, factors-38)\n",
      "\n",
      "Parsing [sent. 109 len. 15]: agreement in the 20 % sampling between investigators was high -LRB- 96 % -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN agreement))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the)\n",
      "            (ADJP (CD 20) (NN %))\n",
      "            (NN sampling))\n",
      "          (PP (IN between)\n",
      "            (NP (NNS investigators))))))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ high))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 96) (NN %))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(high-10, agreement-1)\n",
      "case(sampling-6, in-2)\n",
      "det(sampling-6, the-3)\n",
      "compound(%-5, 20-4)\n",
      "amod(sampling-6, %-5)\n",
      "nmod:in(agreement-1, sampling-6)\n",
      "case(investigators-8, between-7)\n",
      "nmod:between(sampling-6, investigators-8)\n",
      "cop(high-10, was-9)\n",
      "root(ROOT-0, high-10)\n",
      "nummod(%-13, 96-12)\n",
      "dep(high-10, %-13)\n",
      "\n",
      "Parsing [sent. 110 len. 30]: the mean qtc in the acs group was 457 ms and the mean qtc in the etoh withdrawal-related group was 468 ms -LRB- diff 11 , not significant -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ mean) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (NN acs) (NN group))))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (QP (CD 457) (CD ms)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ mean) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (JJ etoh) (JJ withdrawal-related) (NN group))))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP (CD 468) (NN ms))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (NN diff) (CD 11))\n",
      "              (, ,)\n",
      "              (NP (RB not) (JJ significant)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "det(qtc-3, the-1)\n",
      "amod(qtc-3, mean-2)\n",
      "nsubj(ms-10, qtc-3)\n",
      "case(group-7, in-4)\n",
      "det(group-7, the-5)\n",
      "compound(group-7, acs-6)\n",
      "nmod:in(qtc-3, group-7)\n",
      "cop(ms-10, was-8)\n",
      "compound(ms-10, 457-9)\n",
      "root(ROOT-0, ms-10)\n",
      "cc(ms-10, and-11)\n",
      "det(qtc-14, the-12)\n",
      "amod(qtc-14, mean-13)\n",
      "nsubj(ms-22, qtc-14)\n",
      "case(group-19, in-15)\n",
      "det(group-19, the-16)\n",
      "amod(group-19, etoh-17)\n",
      "amod(group-19, withdrawal-related-18)\n",
      "nmod:in(qtc-14, group-19)\n",
      "cop(ms-22, was-20)\n",
      "nummod(ms-22, 468-21)\n",
      "conj:and(ms-10, ms-22)\n",
      "dep(ms-22, diff-24)\n",
      "nummod(diff-24, 11-25)\n",
      "neg(significant-28, not-27)\n",
      "appos(diff-24, significant-28)\n",
      "\n",
      "Parsing [sent. 111 len. 35]: significantly more patients had a prolonged qtc in the etoh withdrawal group than in the acs group 62 % vs 46 % ; diff 16 ; 95 % ci -LRB- 0.1 , 30 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (RB significantly) (JJR more))\n",
      "      (NNS patients))\n",
      "    (VP (VBD had)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prolonged) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))\n",
      "      (PP (IN than) (IN in)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN acs) (NN group) (CD 62) (NN %) (NN vs))\n",
      "            (ADJP (CD 46) (NN %)))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (NP (NN diff) (CD 16))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP\n",
      "                (ADJP (CD 95) (NN %))\n",
      "                (NN ci))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (CD 0.1))\n",
      "                (, ,)\n",
      "                (NP (CD 30))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(more-2, significantly-1)\n",
      "amod(patients-3, more-2)\n",
      "nsubj(had-4, patients-3)\n",
      "root(ROOT-0, had-4)\n",
      "det(qtc-7, a-5)\n",
      "amod(qtc-7, prolonged-6)\n",
      "dobj(had-4, qtc-7)\n",
      "case(group-12, in-8)\n",
      "det(group-12, the-9)\n",
      "amod(group-12, etoh-10)\n",
      "compound(group-12, withdrawal-11)\n",
      "nmod:in(qtc-7, group-12)\n",
      "case(vs-20, than-13)\n",
      "case(vs-20, in-14)\n",
      "det(vs-20, the-15)\n",
      "compound(vs-20, acs-16)\n",
      "compound(vs-20, group-17)\n",
      "nummod(vs-20, 62-18)\n",
      "compound(vs-20, %-19)\n",
      "nmod:in(had-4, vs-20)\n",
      "compound(%-22, 46-21)\n",
      "amod(vs-20, %-22)\n",
      "dep(vs-20, diff-24)\n",
      "nummod(diff-24, 16-25)\n",
      "compound(%-28, 95-27)\n",
      "amod(ci-29, %-28)\n",
      "dep(diff-24, ci-29)\n",
      "appos(ci-29, 0.1-31)\n",
      "dep(0.1-31, 30-33)\n",
      "\n",
      "Parsing [sent. 112 len. 43]: there was significantly more use of clopidogrel , acetylsalicylic acid , ACEI , and statins -LRB- p < 0.05 for all -RRB- in the acs group compared with the etoh withdrawal group ; however , there was no difference in Î²-blocker usage .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP\n",
      "            (ADJP (RB significantly) (JJR more))\n",
      "            (NN use))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN clopidogrel))\n",
      "              (, ,)\n",
      "              (NP (JJ acetylsalicylic) (NN acid))\n",
      "              (, ,)\n",
      "              (NP (NNP ACEI))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NNS statins))))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05))\n",
      "              (PP (IN for)\n",
      "                (NP (DT all))))\n",
      "            (-RRB- -RRB-)))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN acs) (NN group))\n",
      "            (PP (VBN compared)\n",
      "              (PP (IN with)\n",
      "                (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (ADVP (RB however))\n",
      "      (, ,)\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP (DT no) (NN difference))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ Î²-blocker) (NN usage))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "advmod(more-4, significantly-3)\n",
      "amod(use-5, more-4)\n",
      "nsubj(was-2, use-5)\n",
      "case(clopidogrel-7, of-6)\n",
      "nmod:of(use-5, clopidogrel-7)\n",
      "amod(acid-10, acetylsalicylic-9)\n",
      "nmod:of(use-5, acid-10)\n",
      "conj:and(clopidogrel-7, acid-10)\n",
      "nmod:of(use-5, ACEI-12)\n",
      "conj:and(clopidogrel-7, ACEI-12)\n",
      "cc(clopidogrel-7, and-14)\n",
      "nmod:of(use-5, statins-15)\n",
      "conj:and(clopidogrel-7, statins-15)\n",
      "dep(use-5, p-17)\n",
      "nummod(0.05-19, <-18)\n",
      "dobj(p-17, 0.05-19)\n",
      "case(all-21, for-20)\n",
      "nmod:for(p-17, all-21)\n",
      "case(group-26, in-23)\n",
      "det(group-26, the-24)\n",
      "compound(group-26, acs-25)\n",
      "nmod:in(was-2, group-26)\n",
      "case(group-32, compared-27)\n",
      "mwe(compared-27, with-28)\n",
      "det(group-32, the-29)\n",
      "amod(group-32, etoh-30)\n",
      "compound(group-32, withdrawal-31)\n",
      "nmod:compared_with(group-26, group-32)\n",
      "advmod(was-37, however-34)\n",
      "expl(was-37, there-36)\n",
      "parataxis(was-2, was-37)\n",
      "neg(difference-39, no-38)\n",
      "nsubj(was-37, difference-39)\n",
      "case(usage-42, in-40)\n",
      "amod(usage-42, Î²-blocker-41)\n",
      "nmod:in(difference-39, usage-42)\n",
      "\n",
      "Parsing [sent. 113 len. 36]: there was a significantly higher admission rate : 100 % of acs compared with 76 % of the etoh withdrawal group -LRB- p < 0.01 , diff 24 , 95 % confidence interval 18-29 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP (DT a)\n",
      "          (ADJP (RB significantly) (JJR higher))\n",
      "          (NN admission) (NN rate))))\n",
      "    (: :)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (CD 100) (NN %))\n",
      "        (PP (IN of)\n",
      "          (NP (NN acs))))\n",
      "      (PP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (CD 76) (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NNP p) (NNP <) (NNP 0.01))\n",
      "          (, ,)\n",
      "          (NP (NN diff) (CD 24))\n",
      "          (, ,)\n",
      "          (NP (CD 95) (NN %) (NN confidence) (JJ interval) (NNS 18-29)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "det(rate-7, a-3)\n",
      "advmod(higher-5, significantly-4)\n",
      "amod(rate-7, higher-5)\n",
      "compound(rate-7, admission-6)\n",
      "nsubj(was-2, rate-7)\n",
      "nummod(%-10, 100-9)\n",
      "parataxis(was-2, %-10)\n",
      "case(acs-12, of-11)\n",
      "nmod:of(%-10, acs-12)\n",
      "case(%-16, compared-13)\n",
      "mwe(compared-13, with-14)\n",
      "nummod(%-16, 76-15)\n",
      "advcl(%-10, %-16)\n",
      "case(group-21, of-17)\n",
      "det(group-21, the-18)\n",
      "amod(group-21, etoh-19)\n",
      "compound(group-21, withdrawal-20)\n",
      "nmod:of(%-16, group-21)\n",
      "compound(0.01-25, p-23)\n",
      "compound(0.01-25, <-24)\n",
      "dep(%-10, 0.01-25)\n",
      "appos(0.01-25, diff-27)\n",
      "nummod(diff-27, 24-28)\n",
      "nummod(18-29-34, 95-30)\n",
      "compound(18-29-34, %-31)\n",
      "compound(18-29-34, confidence-32)\n",
      "amod(18-29-34, interval-33)\n",
      "appos(0.01-25, 18-29-34)\n",
      "\n",
      "Parsing [sent. 114 len. 10]: electrolytes were not significantly different in the two groups .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS electrolytes))\n",
      "    (VP (VBD were) (RB not)\n",
      "      (ADJP (RB significantly) (JJ different)\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (CD two) (NNS groups)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(different-5, electrolytes-1)\n",
      "cop(different-5, were-2)\n",
      "neg(different-5, not-3)\n",
      "advmod(different-5, significantly-4)\n",
      "root(ROOT-0, different-5)\n",
      "case(groups-9, in-6)\n",
      "det(groups-9, the-7)\n",
      "nummod(groups-9, two-8)\n",
      "nmod:in(different-5, groups-9)\n",
      "\n",
      "Parsing [sent. 115 len. 22]: the study compared two cohort groups , those with acs and those with etoh withdrawal-related ed visits over a 1-year period .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN study))\n",
      "    (VP (VBD compared)\n",
      "      (NP\n",
      "        (NP (CD two) (JJ cohort) (NNS groups))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP (NN acs))))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ etoh) (JJ withdrawal-related) (NN ed) (NNS visits)))))\n",
      "      (PP (IN over)\n",
      "        (NP (DT a) (JJ 1-year) (NN period))))\n",
      "    (. .)))\n",
      "\n",
      "det(study-2, the-1)\n",
      "nsubj(compared-3, study-2)\n",
      "root(ROOT-0, compared-3)\n",
      "nummod(groups-6, two-4)\n",
      "amod(groups-6, cohort-5)\n",
      "dobj(compared-3, groups-6)\n",
      "dobj(compared-3, those-8)\n",
      "conj:and(groups-6, those-8)\n",
      "case(acs-10, with-9)\n",
      "nmod:with(those-8, acs-10)\n",
      "cc(groups-6, and-11)\n",
      "dobj(compared-3, those-12)\n",
      "conj:and(groups-6, those-12)\n",
      "case(visits-17, with-13)\n",
      "amod(visits-17, etoh-14)\n",
      "amod(visits-17, withdrawal-related-15)\n",
      "compound(visits-17, ed-16)\n",
      "nmod:with(those-12, visits-17)\n",
      "case(period-21, over-18)\n",
      "det(period-21, a-19)\n",
      "amod(period-21, 1-year-20)\n",
      "nmod:over(compared-3, period-21)\n",
      "\n",
      "Parsing [sent. 116 len. 13]: we compared ecg qtc , cardiac medication use , and electrolyte differences .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD compared)\n",
      "      (NP\n",
      "        (NP (NN ecg) (NN qtc))\n",
      "        (, ,)\n",
      "        (NP (JJ cardiac) (NN medication) (NN use))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (JJ electrolyte) (NNS differences))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(compared-2, we-1)\n",
      "root(ROOT-0, compared-2)\n",
      "compound(qtc-4, ecg-3)\n",
      "dobj(compared-2, qtc-4)\n",
      "amod(use-8, cardiac-6)\n",
      "compound(use-8, medication-7)\n",
      "dobj(compared-2, use-8)\n",
      "conj:and(qtc-4, use-8)\n",
      "cc(qtc-4, and-10)\n",
      "amod(differences-12, electrolyte-11)\n",
      "dobj(compared-2, differences-12)\n",
      "conj:and(qtc-4, differences-12)\n",
      "\n",
      "Parsing [sent. 117 len. 23]: we considered a qtc of > 450 ms elevated for men and > 470 ms elevated for women based on the literature .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD considered)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT a) (NN qtc))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (QP (CD >) (CD 450))\n",
      "                (NN ms))))\n",
      "          (VP (VBD elevated)\n",
      "            (SBAR (IN for)\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (NNS men))\n",
      "                  (CC and)\n",
      "                  (NP\n",
      "                    (QP (CD >) (CD 470))\n",
      "                    (NN ms)))\n",
      "                (VP (VBD elevated)\n",
      "                  (PP (IN for)\n",
      "                    (NP (NNS women)))\n",
      "                  (PP (VBN based)\n",
      "                    (PP (IN on)\n",
      "                      (NP (DT the) (NN literature)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(considered-2, we-1)\n",
      "root(ROOT-0, considered-2)\n",
      "det(qtc-4, a-3)\n",
      "nsubj(elevated-9, qtc-4)\n",
      "case(ms-8, of-5)\n",
      "compound(450-7, >-6)\n",
      "nummod(ms-8, 450-7)\n",
      "nmod:of(qtc-4, ms-8)\n",
      "ccomp(considered-2, elevated-9)\n",
      "mark(elevated-16, for-10)\n",
      "nsubj(elevated-16, men-11)\n",
      "cc(men-11, and-12)\n",
      "compound(470-14, >-13)\n",
      "nummod(ms-15, 470-14)\n",
      "conj:and(men-11, ms-15)\n",
      "nsubj(elevated-16, ms-15)\n",
      "advcl(elevated-9, elevated-16)\n",
      "case(women-18, for-17)\n",
      "nmod:for(elevated-16, women-18)\n",
      "case(literature-22, based-19)\n",
      "mwe(based-19, on-20)\n",
      "det(literature-22, the-21)\n",
      "advcl(elevated-16, literature-22)\n",
      "\n",
      "Parsing [sent. 118 len. 43]: fifty subjects in whom an ecg , serum osmolality , and etoh level were recorded within 2 hours of one another and who were administered a clinical institute withdrawal assessment protocol were compared with 203 patients with acs during the same period .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ fifty) (NNS subjects))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (SBAR\n",
      "            (WHNP (WP whom))\n",
      "            (S\n",
      "              (NP\n",
      "                (NP (DT an) (NN ecg))\n",
      "                (, ,)\n",
      "                (NP (NN serum) (NN osmolality))\n",
      "                (, ,)\n",
      "                (CC and)\n",
      "                (NP (JJ etoh) (NN level)))\n",
      "              (VP (VBD were)\n",
      "                (VP (VBN recorded)\n",
      "                  (PP (IN within)\n",
      "                    (NP\n",
      "                      (NP (CD 2) (NNS hours))\n",
      "                      (PP (IN of)\n",
      "                        (NP (CD one) (DT another)))))))))\n",
      "          (CC and)\n",
      "          (SBAR\n",
      "            (WHNP (WP who))\n",
      "            (S\n",
      "              (VP (VBD were)\n",
      "                (VP (VBN administered)\n",
      "                  (NP (DT a) (JJ clinical) (NN institute) (NN withdrawal) (NN assessment) (NN protocol)))))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (CD 203) (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (NN acs)))))\n",
      "        (PP (IN during)\n",
      "          (NP (DT the) (JJ same) (NN period)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(subjects-2, fifty-1)\n",
      "nsubjpass(compared-33, subjects-2)\n",
      "case(recorded-15, in-3)\n",
      "dobj(recorded-15, whom-4)\n",
      "det(ecg-6, an-5)\n",
      "nsubjpass(recorded-15, ecg-6)\n",
      "compound(osmolality-9, serum-8)\n",
      "conj:and(ecg-6, osmolality-9)\n",
      "nsubjpass(recorded-15, osmolality-9)\n",
      "cc(ecg-6, and-11)\n",
      "amod(level-13, etoh-12)\n",
      "conj:and(ecg-6, level-13)\n",
      "nsubjpass(recorded-15, level-13)\n",
      "auxpass(recorded-15, were-14)\n",
      "nmod:in(subjects-2, recorded-15)\n",
      "case(hours-18, within-16)\n",
      "nummod(hours-18, 2-17)\n",
      "nmod:within(recorded-15, hours-18)\n",
      "case(one-20, of-19)\n",
      "nmod:of(hours-18, one-20)\n",
      "dep(one-20, another-21)\n",
      "cc(recorded-15, and-22)\n",
      "nsubjpass(administered-25, who-23)\n",
      "auxpass(administered-25, were-24)\n",
      "nmod:in(subjects-2, administered-25)\n",
      "conj:and(recorded-15, administered-25)\n",
      "det(protocol-31, a-26)\n",
      "amod(protocol-31, clinical-27)\n",
      "compound(protocol-31, institute-28)\n",
      "compound(protocol-31, withdrawal-29)\n",
      "compound(protocol-31, assessment-30)\n",
      "dobj(administered-25, protocol-31)\n",
      "auxpass(compared-33, were-32)\n",
      "root(ROOT-0, compared-33)\n",
      "case(patients-36, with-34)\n",
      "nummod(patients-36, 203-35)\n",
      "nmod:with(compared-33, patients-36)\n",
      "case(acs-38, with-37)\n",
      "nmod:with(patients-36, acs-38)\n",
      "case(period-42, during-39)\n",
      "det(period-42, the-40)\n",
      "amod(period-42, same-41)\n",
      "nmod:during(compared-33, period-42)\n",
      "\n",
      "Parsing [sent. 119 len. 7]: we excluded patients with incomplete data .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBN excluded)\n",
      "      (NP (NNS patients))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ incomplete) (NNS data))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(excluded-2, we-1)\n",
      "root(ROOT-0, excluded-2)\n",
      "dobj(excluded-2, patients-3)\n",
      "case(data-6, with-4)\n",
      "amod(data-6, incomplete-5)\n",
      "nmod:with(excluded-2, data-6)\n",
      "\n",
      "Parsing [sent. 120 len. 15]: medications compared included clopidogrel , acetylsalicylic acid , Î²-blockers , ACEI , and statins .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS medications))\n",
      "      (VP (VBN compared)))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (NN clopidogrel))\n",
      "        (, ,)\n",
      "        (NP (JJ acetylsalicylic) (NN acid))\n",
      "        (, ,)\n",
      "        (NP (NNS Î²-blockers))\n",
      "        (, ,)\n",
      "        (NP (NNP ACEI))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (NNS statins))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(included-3, medications-1)\n",
      "acl(medications-1, compared-2)\n",
      "root(ROOT-0, included-3)\n",
      "dobj(included-3, clopidogrel-4)\n",
      "amod(acid-7, acetylsalicylic-6)\n",
      "dobj(included-3, acid-7)\n",
      "conj:and(clopidogrel-4, acid-7)\n",
      "dobj(included-3, Î²-blockers-9)\n",
      "conj:and(clopidogrel-4, Î²-blockers-9)\n",
      "dobj(included-3, ACEI-11)\n",
      "conj:and(clopidogrel-4, ACEI-11)\n",
      "cc(clopidogrel-4, and-13)\n",
      "dobj(included-3, statins-14)\n",
      "conj:and(clopidogrel-4, statins-14)\n",
      "\n",
      "Parsing [sent. 121 len. 15]: ecg qt and qtc , as well as electrolytes , were recorded and compared .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN ecg) (NN qt)\n",
      "        (CC and)\n",
      "        (NN qtc))\n",
      "      (, ,)\n",
      "      (CONJP (RB as) (RB well) (IN as))\n",
      "      (NP (NNS electrolytes))\n",
      "      (, ,))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN recorded)\n",
      "        (CC and)\n",
      "        (VBN compared)))\n",
      "    (. .)))\n",
      "\n",
      "compound(qt-2, ecg-1)\n",
      "nsubjpass(recorded-12, qt-2)\n",
      "nsubjpass(compared-14, qt-2)\n",
      "cc(qt-2, and-3)\n",
      "conj:and(qt-2, qtc-4)\n",
      "nsubjpass(recorded-12, qtc-4)\n",
      "cc(qt-2, as-6)\n",
      "mwe(as-6, well-7)\n",
      "mwe(as-6, as-8)\n",
      "conj:and(qt-2, electrolytes-9)\n",
      "nsubjpass(recorded-12, electrolytes-9)\n",
      "auxpass(recorded-12, were-11)\n",
      "root(ROOT-0, recorded-12)\n",
      "cc(recorded-12, and-13)\n",
      "conj:and(recorded-12, compared-14)\n",
      "\n",
      "Parsing [sent. 122 len. 21]: data were extracted by two investigators with a 20 % sample re-evaluated by the other extractor as a reliability measure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS data))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN extracted)\n",
      "        (PP (IN by)\n",
      "          (NP (CD two) (NNS investigators)))\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (DT a)\n",
      "              (ADJP (CD 20) (NN %))\n",
      "              (NN sample))\n",
      "            (VP (VBN re-evaluated)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ other) (NN extractor))\n",
      "                  (PP (IN as)\n",
      "                    (NP (DT a) (JJ reliability) (NN measure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(extracted-3, data-1)\n",
      "auxpass(extracted-3, were-2)\n",
      "root(ROOT-0, extracted-3)\n",
      "case(investigators-6, by-4)\n",
      "nummod(investigators-6, two-5)\n",
      "nmod:by(extracted-3, investigators-6)\n",
      "case(sample-11, with-7)\n",
      "det(sample-11, a-8)\n",
      "compound(%-10, 20-9)\n",
      "amod(sample-11, %-10)\n",
      "nmod:with(extracted-3, sample-11)\n",
      "acl(sample-11, re-evaluated-12)\n",
      "case(extractor-16, by-13)\n",
      "det(extractor-16, the-14)\n",
      "amod(extractor-16, other-15)\n",
      "nmod:by(re-evaluated-12, extractor-16)\n",
      "case(measure-20, as-17)\n",
      "det(measure-20, a-18)\n",
      "amod(measure-20, reliability-19)\n",
      "nmod:as(extractor-16, measure-20)\n",
      "\n",
      "Parsing [sent. 123 len. 13]: descriptive statistics including medians and interquartile ranges were measured for continuous variables .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ descriptive) (NNS statistics))\n",
      "      (PP (VBG including)\n",
      "        (NP\n",
      "          (NP (NNS medians))\n",
      "          (CC and)\n",
      "          (NP (JJ interquartile) (NNS ranges)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN measured)\n",
      "        (PP (IN for)\n",
      "          (NP (JJ continuous) (NNS variables)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(statistics-2, descriptive-1)\n",
      "nsubjpass(measured-9, statistics-2)\n",
      "case(medians-4, including-3)\n",
      "nmod:including(statistics-2, medians-4)\n",
      "cc(medians-4, and-5)\n",
      "amod(ranges-7, interquartile-6)\n",
      "nmod:including(statistics-2, ranges-7)\n",
      "conj:and(medians-4, ranges-7)\n",
      "auxpass(measured-9, were-8)\n",
      "root(ROOT-0, measured-9)\n",
      "case(variables-12, for-10)\n",
      "amod(variables-12, continuous-11)\n",
      "nmod:for(measured-9, variables-12)\n",
      "\n",
      "Parsing [sent. 124 len. 19]: comparisons were made using two-tailed t tests for parametric data and the mann-whitney u test for nonparametric data .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS comparisons))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN made)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ two-tailed) (NN t) (NNS tests))\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ parametric) (NNS data))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT the) (JJ mann-whitney) (NN u) (NN test))\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ nonparametric) (NNS data)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(made-3, comparisons-1)\n",
      "auxpass(made-3, were-2)\n",
      "root(ROOT-0, made-3)\n",
      "xcomp(made-3, using-4)\n",
      "amod(tests-7, two-tailed-5)\n",
      "compound(tests-7, t-6)\n",
      "dobj(using-4, tests-7)\n",
      "case(data-10, for-8)\n",
      "amod(data-10, parametric-9)\n",
      "nmod:for(tests-7, data-10)\n",
      "cc(tests-7, and-11)\n",
      "det(test-15, the-12)\n",
      "amod(test-15, mann-whitney-13)\n",
      "compound(test-15, u-14)\n",
      "dobj(using-4, test-15)\n",
      "conj:and(tests-7, test-15)\n",
      "case(data-18, for-16)\n",
      "amod(data-18, nonparametric-17)\n",
      "nmod:for(test-15, data-18)\n",
      "\n",
      "Parsing [sent. 125 len. 42]: heart failure with preserved ejection fraction -LRB- hfpef -RRB- makes up half of diagnosed heart failure cases and has similar outcomes compared to heart failure with reduced ejection fraction -LRB- hfref -RRB- but a discrepancy in knowledge and approach to treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN heart) (NN failure))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ preserved) (NN ejection) (NN fraction))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN hfpef))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (VP\n",
      "      (VP (VBZ makes)\n",
      "        (PRT (RP up))\n",
      "        (NP\n",
      "          (NP (NN half))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ diagnosed) (NN heart) (NN failure) (NNS cases)))))\n",
      "      (CC and)\n",
      "      (VP (VBZ has)\n",
      "        (NP\n",
      "          (NP (JJ similar) (NNS outcomes))\n",
      "          (PP (VBN compared)\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN heart) (NN failure))\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (VBN reduced) (NN ejection) (NN fraction))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN hfref))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (PP (CC but)\n",
      "                      (NP\n",
      "                        (NP (DT a) (NN discrepancy))\n",
      "                        (PP (IN in)\n",
      "                          (NP (NN knowledge)\n",
      "                            (CC and)\n",
      "                            (NN approach)))))))))))\n",
      "        (PP (TO to)\n",
      "          (NP (NN treatment)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(makes-10, failure-2)\n",
      "nsubj(has-19, failure-2)\n",
      "case(fraction-6, with-3)\n",
      "amod(fraction-6, preserved-4)\n",
      "compound(fraction-6, ejection-5)\n",
      "nmod:with(failure-2, fraction-6)\n",
      "appos(fraction-6, hfpef-8)\n",
      "root(ROOT-0, makes-10)\n",
      "compound:prt(makes-10, up-11)\n",
      "dobj(makes-10, half-12)\n",
      "case(cases-17, of-13)\n",
      "amod(cases-17, diagnosed-14)\n",
      "compound(cases-17, heart-15)\n",
      "compound(cases-17, failure-16)\n",
      "nmod:of(half-12, cases-17)\n",
      "cc(makes-10, and-18)\n",
      "conj:and(makes-10, has-19)\n",
      "amod(outcomes-21, similar-20)\n",
      "dobj(has-19, outcomes-21)\n",
      "case(failure-25, compared-22)\n",
      "mwe(compared-22, to-23)\n",
      "compound(failure-25, heart-24)\n",
      "acl(outcomes-21, failure-25)\n",
      "case(fraction-29, with-26)\n",
      "amod(fraction-29, reduced-27)\n",
      "compound(fraction-29, ejection-28)\n",
      "nmod:with(failure-25, fraction-29)\n",
      "appos(fraction-29, hfref-31)\n",
      "case(discrepancy-35, but-33)\n",
      "det(discrepancy-35, a-34)\n",
      "nmod:but(fraction-29, discrepancy-35)\n",
      "case(knowledge-37, in-36)\n",
      "nmod:in(discrepancy-35, knowledge-37)\n",
      "cc(knowledge-37, and-38)\n",
      "nmod:in(discrepancy-35, approach-39)\n",
      "conj:and(knowledge-37, approach-39)\n",
      "case(treatment-41, to-40)\n",
      "nmod:to(has-19, treatment-41)\n",
      "\n",
      "Parsing [sent. 126 len. 36]: hfpef is diagnosed using the following criteria : symptoms , preserved ejection fraction -LRB- greater than 50 % -RRB- , and evidence of abnormal left ventricular filling or relaxation , or diastolic distensibility or stiffness .\n",
      "(ROOT\n",
      "  (SINV\n",
      "    (S\n",
      "      (NP (NN hfpef))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN diagnosed)\n",
      "          (S\n",
      "            (VP (VBG using)\n",
      "              (NP\n",
      "                (NP (DT the) (VBG following) (NNS criteria))\n",
      "                (: :)\n",
      "                (NP (NNS symptoms))))))))\n",
      "    (, ,)\n",
      "    (VP (VBD preserved))\n",
      "    (NP\n",
      "      (NP (NN ejection) (NN fraction))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (QP (JJR greater) (IN than) (CD 50))\n",
      "          (NN %))\n",
      "        (-RRB- -RRB-))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP (NN evidence))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (JJ abnormal) (JJ left) (NN ventricular) (NN filling))\n",
      "              (CC or)\n",
      "              (NP (NN relaxation)))\n",
      "            (, ,)\n",
      "            (CC or)\n",
      "            (NP\n",
      "              (NP (JJ diastolic) (NN distensibility))\n",
      "              (CC or)\n",
      "              (NP (NNS stiffness)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(diagnosed-3, hfpef-1)\n",
      "auxpass(diagnosed-3, is-2)\n",
      "ccomp(preserved-11, diagnosed-3)\n",
      "xcomp(diagnosed-3, using-4)\n",
      "det(criteria-7, the-5)\n",
      "amod(criteria-7, following-6)\n",
      "dobj(using-4, criteria-7)\n",
      "dep(criteria-7, symptoms-9)\n",
      "root(ROOT-0, preserved-11)\n",
      "compound(fraction-13, ejection-12)\n",
      "nsubj(preserved-11, fraction-13)\n",
      "advmod(50-17, greater-15)\n",
      "advmod(50-17, than-16)\n",
      "nummod(%-18, 50-17)\n",
      "appos(fraction-13, %-18)\n",
      "cc(fraction-13, and-21)\n",
      "nsubj(preserved-11, evidence-22)\n",
      "conj:and(fraction-13, evidence-22)\n",
      "case(filling-27, of-23)\n",
      "amod(filling-27, abnormal-24)\n",
      "amod(filling-27, left-25)\n",
      "compound(filling-27, ventricular-26)\n",
      "nmod:of(evidence-22, filling-27)\n",
      "cc(filling-27, or-28)\n",
      "nmod:of(evidence-22, relaxation-29)\n",
      "conj:or(filling-27, relaxation-29)\n",
      "cc(filling-27, or-31)\n",
      "amod(distensibility-33, diastolic-32)\n",
      "nmod:of(evidence-22, distensibility-33)\n",
      "conj:or(filling-27, distensibility-33)\n",
      "cc(distensibility-33, or-34)\n",
      "conj:or(filling-27, stiffness-35)\n",
      "conj:or(distensibility-33, stiffness-35)\n",
      "\n",
      "Parsing [sent. 127 len. 41]: studies conducted to examine the efficacy of angiotensin receptor blockers -LRB- irbesartan and candesartan -RRB- , thiazide diuretics -LRB- chlorthalidone -RRB- , and ACEI -LRB- perindopril -RRB- in the treatment of hfpef , showed moderate efficacy but no clear benefit .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS studies))\n",
      "      (VP (VBN conducted)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB examine)\n",
      "              (NP\n",
      "                (NP (DT the) (NN efficacy))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN irbesartan)\n",
      "                          (CC and)\n",
      "                          (NNS candesartan))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (JJ thiazide) (NNS diuretics))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN chlorthalidone))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (CC and)\n",
      "                    (NP\n",
      "                      (NP (NNP ACEI))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (ADJP (JJ perindopril))\n",
      "                        (-RRB- -RRB-))))))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN treatment))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN hfpef))))))))))\n",
      "    (, ,)\n",
      "    (VP (VBD showed)\n",
      "      (NP\n",
      "        (NP (JJ moderate) (NN efficacy))\n",
      "        (PP (CC but)\n",
      "          (NP (DT no) (JJ clear) (NN benefit)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(showed-34, studies-1)\n",
      "acl(studies-1, conducted-2)\n",
      "mark(examine-4, to-3)\n",
      "xcomp(conducted-2, examine-4)\n",
      "det(efficacy-6, the-5)\n",
      "dobj(examine-4, efficacy-6)\n",
      "case(blockers-10, of-7)\n",
      "compound(blockers-10, angiotensin-8)\n",
      "compound(blockers-10, receptor-9)\n",
      "nmod:of(efficacy-6, blockers-10)\n",
      "appos(blockers-10, irbesartan-12)\n",
      "cc(irbesartan-12, and-13)\n",
      "appos(blockers-10, candesartan-14)\n",
      "conj:and(irbesartan-12, candesartan-14)\n",
      "amod(diuretics-18, thiazide-17)\n",
      "nmod:of(efficacy-6, diuretics-18)\n",
      "conj:and(blockers-10, diuretics-18)\n",
      "appos(diuretics-18, chlorthalidone-20)\n",
      "cc(blockers-10, and-23)\n",
      "nmod:of(efficacy-6, ACEI-24)\n",
      "conj:and(blockers-10, ACEI-24)\n",
      "dep(ACEI-24, perindopril-26)\n",
      "case(treatment-30, in-28)\n",
      "det(treatment-30, the-29)\n",
      "nmod:in(examine-4, treatment-30)\n",
      "case(hfpef-32, of-31)\n",
      "nmod:of(treatment-30, hfpef-32)\n",
      "root(ROOT-0, showed-34)\n",
      "amod(efficacy-36, moderate-35)\n",
      "dobj(showed-34, efficacy-36)\n",
      "case(benefit-40, but-37)\n",
      "neg(benefit-40, no-38)\n",
      "amod(benefit-40, clear-39)\n",
      "nmod:but(efficacy-36, benefit-40)\n",
      "\n",
      "Parsing [sent. 128 len. 40]: recently , the fda has approved a novel drug , which combines an angiotensin receptor neprilysin inhibitor and angiotensin receptor blocker -LRB- valsartan -RRB- named lcz696 -LRB- entresto -RRB- for possible treatment of heart failure with reduced ejection fraction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB recently))\n",
      "    (, ,)\n",
      "    (NP (DT the) (NN fda))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN approved)\n",
      "        (NP\n",
      "          (NP (DT a) (NN novel) (NN drug))\n",
      "          (, ,)\n",
      "          (SBAR\n",
      "            (WHNP (WDT which))\n",
      "            (S\n",
      "              (VP (VBZ combines)\n",
      "                (NP\n",
      "                  (NP (DT an) (NN angiotensin) (NN receptor) (NN neprilysin) (NN inhibitor)\n",
      "                    (CC and)\n",
      "                    (NN angiotensin) (NN receptor) (NN blocker))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (NN valsartan))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (VP (VBN named)\n",
      "                    (NP\n",
      "                      (NP (JJ lcz696) (-LRB- -LRB-) (NN entresto) (-RRB- -RRB-))\n",
      "                      (PP (IN for)\n",
      "                        (NP\n",
      "                          (NP (JJ possible) (NN treatment))\n",
      "                          (PP (IN of)\n",
      "                            (NP (NN heart) (NN failure))))))\n",
      "                    (PP (IN with)\n",
      "                      (NP (VBN reduced) (NN ejection) (NN fraction)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(approved-6, recently-1)\n",
      "det(fda-4, the-3)\n",
      "nsubj(approved-6, fda-4)\n",
      "aux(approved-6, has-5)\n",
      "root(ROOT-0, approved-6)\n",
      "det(drug-9, a-7)\n",
      "compound(drug-9, novel-8)\n",
      "dobj(approved-6, drug-9)\n",
      "nsubj(combines-12, drug-9)\n",
      "ref(drug-9, which-11)\n",
      "acl:relcl(drug-9, combines-12)\n",
      "det(inhibitor-17, an-13)\n",
      "compound(inhibitor-17, angiotensin-14)\n",
      "compound(inhibitor-17, receptor-15)\n",
      "compound(inhibitor-17, neprilysin-16)\n",
      "dobj(combines-12, inhibitor-17)\n",
      "cc(inhibitor-17, and-18)\n",
      "compound(blocker-21, angiotensin-19)\n",
      "compound(blocker-21, receptor-20)\n",
      "dobj(combines-12, blocker-21)\n",
      "conj:and(inhibitor-17, blocker-21)\n",
      "appos(inhibitor-17, valsartan-23)\n",
      "acl(inhibitor-17, named-25)\n",
      "amod(entresto-28, lcz696-26)\n",
      "dobj(named-25, entresto-28)\n",
      "case(treatment-32, for-30)\n",
      "amod(treatment-32, possible-31)\n",
      "nmod:for(entresto-28, treatment-32)\n",
      "case(failure-35, of-33)\n",
      "compound(failure-35, heart-34)\n",
      "nmod:of(treatment-32, failure-35)\n",
      "case(fraction-39, with-36)\n",
      "amod(fraction-39, reduced-37)\n",
      "compound(fraction-39, ejection-38)\n",
      "nmod:with(named-25, fraction-39)\n",
      "\n",
      "Parsing [sent. 129 len. 29]: in this article , we will discuss the failure of previous treatment modalities and the promise that lcz696 -LRB- entresto -RRB- may hold for treating patients with hfpef .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (DT this) (NN article)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (MD will)\n",
      "      (VP (VB discuss)\n",
      "        (NP\n",
      "          (NP (DT the) (NN failure))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ previous) (NN treatment) (NNS modalities))\n",
      "              (CC and)\n",
      "              (NP (DT the) (NN promise)))))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (NNS lcz696))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP entresto))\n",
      "                (-RRB- -RRB-)))\n",
      "            (VP (MD may)\n",
      "              (VP (VB hold)\n",
      "                (PP (IN for)\n",
      "                  (S\n",
      "                    (VP (VBG treating)\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP (NN hfpef))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "case(article-3, in-1)\n",
      "det(article-3, this-2)\n",
      "nmod:in(discuss-7, article-3)\n",
      "nsubj(discuss-7, we-5)\n",
      "aux(discuss-7, will-6)\n",
      "root(ROOT-0, discuss-7)\n",
      "det(failure-9, the-8)\n",
      "dobj(discuss-7, failure-9)\n",
      "case(modalities-13, of-10)\n",
      "amod(modalities-13, previous-11)\n",
      "compound(modalities-13, treatment-12)\n",
      "nmod:of(failure-9, modalities-13)\n",
      "cc(modalities-13, and-14)\n",
      "det(promise-16, the-15)\n",
      "nmod:of(failure-9, promise-16)\n",
      "conj:and(modalities-13, promise-16)\n",
      "mark(hold-23, that-17)\n",
      "nsubj(hold-23, lcz696-18)\n",
      "appos(lcz696-18, entresto-20)\n",
      "aux(hold-23, may-22)\n",
      "ccomp(discuss-7, hold-23)\n",
      "mark(treating-25, for-24)\n",
      "advcl(hold-23, treating-25)\n",
      "dobj(treating-25, patients-26)\n",
      "case(hfpef-28, with-27)\n",
      "nmod:with(treating-25, hfpef-28)\n",
      "\n",
      "Parsing [sent. 130 len. 18]: several medications have been used perioperatively in patients undergoing noncardiac surgery in an attempt to improve outcomes .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ several) (NNS medications))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN been)\n",
      "        (VP (VBN used)\n",
      "          (ADVP (RB perioperatively))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (VP (VBG undergoing)\n",
      "                (NP (JJ noncardiac) (NN surgery))\n",
      "                (PP (IN in)\n",
      "                  (NP (DT an) (NN attempt)\n",
      "                    (S\n",
      "                      (VP (TO to)\n",
      "                        (VP (VB improve)\n",
      "                          (NP (NNS outcomes)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(medications-2, several-1)\n",
      "nsubjpass(used-5, medications-2)\n",
      "aux(used-5, have-3)\n",
      "auxpass(used-5, been-4)\n",
      "root(ROOT-0, used-5)\n",
      "advmod(used-5, perioperatively-6)\n",
      "case(patients-8, in-7)\n",
      "nmod:in(used-5, patients-8)\n",
      "acl(patients-8, undergoing-9)\n",
      "amod(surgery-11, noncardiac-10)\n",
      "dobj(undergoing-9, surgery-11)\n",
      "case(attempt-14, in-12)\n",
      "det(attempt-14, an-13)\n",
      "nmod:in(undergoing-9, attempt-14)\n",
      "mark(improve-16, to-15)\n",
      "acl(attempt-14, improve-16)\n",
      "dobj(improve-16, outcomes-17)\n",
      "\n",
      "Parsing [sent. 131 len. 41]: antiplatelet therapy for primary prevention of cardiovascular events should generally be discontinued seven to 10 days before surgery to avoid increasing the risk of bleeding , unless the risk of a major adverse cardiac event exceeds the risk of bleeding .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ antiplatelet) (NN therapy))\n",
      "      (PP (IN for)\n",
      "        (NP\n",
      "          (NP (JJ primary) (NN prevention))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ cardiovascular) (NNS events))))))\n",
      "    (VP (MD should)\n",
      "      (ADVP (RB generally))\n",
      "      (VP (VB be)\n",
      "        (VP (VBN discontinued)\n",
      "          (PP\n",
      "            (NP\n",
      "              (QP (CD seven) (TO to) (CD 10))\n",
      "              (NNS days))\n",
      "            (IN before)\n",
      "            (NP (NN surgery)))\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB avoid)\n",
      "                (S\n",
      "                  (VP (VBG increasing)\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN risk))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NN bleeding))))))\n",
      "                (, ,)\n",
      "                (SBAR (IN unless)\n",
      "                  (S\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN risk))\n",
      "                      (PP (IN of)\n",
      "                        (NP (DT a) (JJ major) (JJ adverse) (JJ cardiac) (NN event))))\n",
      "                    (VP (VBZ exceeds)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN risk))\n",
      "                        (PP (IN of)\n",
      "                          (NP (NN bleeding)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-2, antiplatelet-1)\n",
      "nsubjpass(discontinued-12, therapy-2)\n",
      "nsubj:xsubj(avoid-20, therapy-2)\n",
      "case(prevention-5, for-3)\n",
      "amod(prevention-5, primary-4)\n",
      "nmod:for(therapy-2, prevention-5)\n",
      "case(events-8, of-6)\n",
      "amod(events-8, cardiovascular-7)\n",
      "nmod:of(prevention-5, events-8)\n",
      "aux(discontinued-12, should-9)\n",
      "advmod(discontinued-12, generally-10)\n",
      "auxpass(discontinued-12, be-11)\n",
      "root(ROOT-0, discontinued-12)\n",
      "compound(10-15, seven-13)\n",
      "dep(10-15, to-14)\n",
      "nummod(days-16, 10-15)\n",
      "nmod:before(discontinued-12, days-16)\n",
      "case(days-16, before-17)\n",
      "dep(days-16, surgery-18)\n",
      "mark(avoid-20, to-19)\n",
      "xcomp(discontinued-12, avoid-20)\n",
      "xcomp(avoid-20, increasing-21)\n",
      "det(risk-23, the-22)\n",
      "dobj(increasing-21, risk-23)\n",
      "case(bleeding-25, of-24)\n",
      "nmod:of(risk-23, bleeding-25)\n",
      "mark(exceeds-36, unless-27)\n",
      "det(risk-29, the-28)\n",
      "nsubj(exceeds-36, risk-29)\n",
      "case(event-35, of-30)\n",
      "det(event-35, a-31)\n",
      "amod(event-35, major-32)\n",
      "amod(event-35, adverse-33)\n",
      "amod(event-35, cardiac-34)\n",
      "nmod:of(risk-29, event-35)\n",
      "advcl(avoid-20, exceeds-36)\n",
      "det(risk-38, the-37)\n",
      "dobj(exceeds-36, risk-38)\n",
      "case(bleeding-40, of-39)\n",
      "nmod:of(risk-38, bleeding-40)\n",
      "\n",
      "Parsing [sent. 132 len. 24]: antiplatelet therapy for secondary prevention should be continued perioperatively , except before procedures with very high bleeding risk , such as intracranial procedures .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ antiplatelet) (NN therapy))\n",
      "      (PP (IN for)\n",
      "        (NP (JJ secondary) (NN prevention))))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN continued)\n",
      "          (PP\n",
      "            (ADVP (RB perioperatively))\n",
      "            (, ,) (IN except) (IN before)\n",
      "            (NP\n",
      "              (NP (NNS procedures))\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (ADJP (RB very) (JJ high))\n",
      "                  (NN bleeding) (NN risk)))\n",
      "              (, ,)\n",
      "              (PP (JJ such) (IN as)\n",
      "                (NP (JJ intracranial) (NNS procedures))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-2, antiplatelet-1)\n",
      "nsubjpass(continued-8, therapy-2)\n",
      "case(prevention-5, for-3)\n",
      "amod(prevention-5, secondary-4)\n",
      "nmod:for(therapy-2, prevention-5)\n",
      "aux(continued-8, should-6)\n",
      "auxpass(continued-8, be-7)\n",
      "root(ROOT-0, continued-8)\n",
      "advmod(procedures-13, perioperatively-9)\n",
      "case(procedures-13, except-11)\n",
      "case(procedures-13, before-12)\n",
      "nmod:before(continued-8, procedures-13)\n",
      "case(risk-18, with-14)\n",
      "advmod(high-16, very-15)\n",
      "amod(risk-18, high-16)\n",
      "compound(risk-18, bleeding-17)\n",
      "nmod:with(procedures-13, risk-18)\n",
      "case(procedures-23, such-20)\n",
      "mwe(such-20, as-21)\n",
      "amod(procedures-23, intracranial-22)\n",
      "nmod:such_as(procedures-13, procedures-23)\n",
      "\n",
      "Parsing [sent. 133 len. 50]: antiplatelet drugs should be continued and surgery delayed , if possible , for at least 14 days after percutaneous coronary intervention without stent placement , 30 days after percutaneous coronary intervention with bare-metal stent placement , and six to 12 months after percutaneous coronary intervention with drug-eluting stent placement .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN antiplatelet) (NNS drugs))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN surgery))\n",
      "      (VP (VBN delayed)\n",
      "        (PRN (, ,)\n",
      "          (SBAR (IN if)\n",
      "            (FRAG (JJ possible)))\n",
      "          (, ,))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (QP (IN at) (JJS least) (CD 14))\n",
      "                (NNS days))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN without)\n",
      "                    (NP (JJ stent) (NN placement))))))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP (CD 30) (NNS days))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ bare-metal) (NN stent) (NN placement))))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP\n",
      "                (QP (CD six) (TO to) (CD 12))\n",
      "                (NNS months))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ drug-eluting) (NN stent) (NN placement))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(drugs-2, antiplatelet-1)\n",
      "nsubjpass(continued-5, drugs-2)\n",
      "aux(continued-5, should-3)\n",
      "auxpass(continued-5, be-4)\n",
      "root(ROOT-0, continued-5)\n",
      "cc(continued-5, and-6)\n",
      "nsubj(delayed-8, surgery-7)\n",
      "conj:and(continued-5, delayed-8)\n",
      "mark(possible-11, if-10)\n",
      "parataxis(delayed-8, possible-11)\n",
      "case(days-17, for-13)\n",
      "case(least-15, at-14)\n",
      "nmod:npmod(14-16, least-15)\n",
      "nummod(days-17, 14-16)\n",
      "nmod:for(delayed-8, days-17)\n",
      "case(intervention-21, after-18)\n",
      "amod(intervention-21, percutaneous-19)\n",
      "amod(intervention-21, coronary-20)\n",
      "nmod:after(days-17, intervention-21)\n",
      "case(placement-24, without-22)\n",
      "amod(placement-24, stent-23)\n",
      "nmod:without(intervention-21, placement-24)\n",
      "nummod(days-27, 30-26)\n",
      "nmod:for(delayed-8, days-27)\n",
      "conj:and(days-17, days-27)\n",
      "case(intervention-31, after-28)\n",
      "amod(intervention-31, percutaneous-29)\n",
      "amod(intervention-31, coronary-30)\n",
      "nmod:after(days-27, intervention-31)\n",
      "case(placement-35, with-32)\n",
      "amod(placement-35, bare-metal-33)\n",
      "compound(placement-35, stent-34)\n",
      "nmod:with(intervention-31, placement-35)\n",
      "cc(days-17, and-37)\n",
      "compound(12-40, six-38)\n",
      "dep(12-40, to-39)\n",
      "nummod(months-41, 12-40)\n",
      "nmod:for(delayed-8, months-41)\n",
      "conj:and(days-17, months-41)\n",
      "case(intervention-45, after-42)\n",
      "amod(intervention-45, percutaneous-43)\n",
      "amod(intervention-45, coronary-44)\n",
      "nmod:after(months-41, intervention-45)\n",
      "case(placement-49, with-46)\n",
      "amod(placement-49, drug-eluting-47)\n",
      "compound(placement-49, stent-48)\n",
      "nmod:with(intervention-45, placement-49)\n",
      "\n",
      "Parsing [sent. 134 len. 52]: perioperative beta blockers are recommended for patients already receiving these agents , and it is reasonable to consider starting therapy in patients with known or strongly suspected coronary artery disease or who are at high risk of perioperative cardiac events and are undergoing procedures with a high risk of cardiovascular complications .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ perioperative) (NN beta) (NNS blockers))\n",
      "      (VP (VBP are)\n",
      "        (VP (VBN recommended)\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (VP\n",
      "                (ADVP (RB already))\n",
      "                (VBG receiving)\n",
      "                (NP (DT these) (NNS agents))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ reasonable)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB consider)\n",
      "                (S\n",
      "                  (VP (VBG starting)\n",
      "                    (NP\n",
      "                      (NP (NN therapy))\n",
      "                      (PP (IN in)\n",
      "                        (NP (NNS patients))))\n",
      "                    (PP (IN with)\n",
      "                      (S\n",
      "                        (VP\n",
      "                          (VP (VBN known))\n",
      "                          (CC or)\n",
      "                          (VP\n",
      "                            (ADVP (RB strongly))\n",
      "                            (VBN suspected)\n",
      "                            (NP\n",
      "                              (NP (JJ coronary) (NN artery) (NN disease))\n",
      "                              (CC or)\n",
      "                              (SBAR\n",
      "                                (WHNP (WP who))\n",
      "                                (S\n",
      "                                  (VP (VBP are)\n",
      "                                    (PP (IN at)\n",
      "                                      (NP\n",
      "                                        (NP (JJ high) (NN risk))\n",
      "                                        (PP (IN of)\n",
      "                                          (NP (JJ perioperative) (JJ cardiac) (NNS events))))))))))\n",
      "                          (CC and)\n",
      "                          (VP (VBP are)\n",
      "                            (VP (VBG undergoing)\n",
      "                              (NP (NNS procedures))\n",
      "                              (PP (IN with)\n",
      "                                (NP\n",
      "                                  (NP (DT a) (JJ high) (NN risk))\n",
      "                                  (PP (IN of)\n",
      "                                    (NP (JJ cardiovascular) (NNS complications))))))))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(blockers-3, perioperative-1)\n",
      "compound(blockers-3, beta-2)\n",
      "nsubjpass(recommended-5, blockers-3)\n",
      "auxpass(recommended-5, are-4)\n",
      "root(ROOT-0, recommended-5)\n",
      "case(patients-7, for-6)\n",
      "nmod:for(recommended-5, patients-7)\n",
      "advmod(receiving-9, already-8)\n",
      "acl(patients-7, receiving-9)\n",
      "det(agents-11, these-10)\n",
      "dobj(receiving-9, agents-11)\n",
      "cc(recommended-5, and-13)\n",
      "nsubj(reasonable-16, it-14)\n",
      "nsubj:xsubj(consider-18, it-14)\n",
      "cop(reasonable-16, is-15)\n",
      "conj:and(recommended-5, reasonable-16)\n",
      "mark(consider-18, to-17)\n",
      "xcomp(reasonable-16, consider-18)\n",
      "xcomp(consider-18, starting-19)\n",
      "dobj(starting-19, therapy-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(therapy-20, patients-22)\n",
      "mark(known-24, with-23)\n",
      "advcl(starting-19, known-24)\n",
      "cc(known-24, or-25)\n",
      "advmod(suspected-27, strongly-26)\n",
      "advcl(starting-19, suspected-27)\n",
      "conj:or(known-24, suspected-27)\n",
      "amod(disease-30, coronary-28)\n",
      "compound(disease-30, artery-29)\n",
      "dobj(suspected-27, disease-30)\n",
      "cc(disease-30, or-31)\n",
      "nsubj(risk-36, who-32)\n",
      "cop(risk-36, are-33)\n",
      "case(risk-36, at-34)\n",
      "amod(risk-36, high-35)\n",
      "dobj(suspected-27, risk-36)\n",
      "conj:or(disease-30, risk-36)\n",
      "case(events-40, of-37)\n",
      "amod(events-40, perioperative-38)\n",
      "amod(events-40, cardiac-39)\n",
      "nmod:of(risk-36, events-40)\n",
      "cc(known-24, and-41)\n",
      "aux(undergoing-43, are-42)\n",
      "advcl(starting-19, undergoing-43)\n",
      "conj:and(known-24, undergoing-43)\n",
      "dobj(undergoing-43, procedures-44)\n",
      "case(risk-48, with-45)\n",
      "det(risk-48, a-46)\n",
      "amod(risk-48, high-47)\n",
      "nmod:with(undergoing-43, risk-48)\n",
      "case(complications-51, of-49)\n",
      "amod(complications-51, cardiovascular-50)\n",
      "nmod:of(risk-48, complications-51)\n",
      "\n",
      "Parsing [sent. 135 len. 21]: long-term statin therapy should be continued perioperatively or started in patients with clinical indications who are not already receiving statins .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ long-term) (NN statin) (NN therapy))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP\n",
      "          (VP (VBN continued)\n",
      "            (ADVP (RB perioperatively)))\n",
      "          (CC or)\n",
      "          (VP (VBN started)\n",
      "            (PP (IN in)\n",
      "              (NP (NNS patients))))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (JJ clinical) (NNS indications))\n",
      "              (SBAR\n",
      "                (WHNP (WP who))\n",
      "                (S\n",
      "                  (VP (VBP are) (RB not)\n",
      "                    (ADVP (RB already))\n",
      "                    (VP (VBG receiving)\n",
      "                      (NP (NNS statins)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-3, long-term-1)\n",
      "compound(therapy-3, statin-2)\n",
      "nsubjpass(continued-6, therapy-3)\n",
      "nsubjpass(started-9, therapy-3)\n",
      "aux(continued-6, should-4)\n",
      "auxpass(continued-6, be-5)\n",
      "root(ROOT-0, continued-6)\n",
      "advmod(continued-6, perioperatively-7)\n",
      "cc(continued-6, or-8)\n",
      "conj:or(continued-6, started-9)\n",
      "case(patients-11, in-10)\n",
      "nmod:in(started-9, patients-11)\n",
      "case(indications-14, with-12)\n",
      "amod(indications-14, clinical-13)\n",
      "nmod:with(continued-6, indications-14)\n",
      "nsubj(receiving-19, indications-14)\n",
      "ref(indications-14, who-15)\n",
      "aux(receiving-19, are-16)\n",
      "neg(receiving-19, not-17)\n",
      "advmod(receiving-19, already-18)\n",
      "acl:relcl(indications-14, receiving-19)\n",
      "dobj(receiving-19, statins-20)\n",
      "\n",
      "Parsing [sent. 136 len. 15]: clonidine should not be started perioperatively , but long-term clonidine regimens may be continued .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN clonidine))\n",
      "      (VP (MD should) (RB not)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN started)\n",
      "            (ADVP (RB perioperatively))))))\n",
      "    (, ,)\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (JJ long-term) (NN clonidine) (NNS regimens))\n",
      "      (VP (MD may)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(started-5, clonidine-1)\n",
      "aux(started-5, should-2)\n",
      "neg(started-5, not-3)\n",
      "auxpass(started-5, be-4)\n",
      "root(ROOT-0, started-5)\n",
      "advmod(started-5, perioperatively-6)\n",
      "cc(started-5, but-8)\n",
      "amod(regimens-11, long-term-9)\n",
      "compound(regimens-11, clonidine-10)\n",
      "nsubjpass(continued-14, regimens-11)\n",
      "aux(continued-14, may-12)\n",
      "auxpass(continued-14, be-13)\n",
      "conj:but(started-5, continued-14)\n",
      "\n",
      "Parsing [sent. 137 len. 25]: ACEI and angiotensin receptor blockers generally can be continued perioperatively if patients are hemodynamically stable and have good renal function and normal electrolyte levels .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI)\n",
      "      (CC and)\n",
      "      (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "    (ADVP (RB generally))\n",
      "    (VP (MD can)\n",
      "      (VP\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)\n",
      "            (ADVP (RB perioperatively))\n",
      "            (SBAR (IN if)\n",
      "              (S\n",
      "                (NP (NNS patients))\n",
      "                (VP (VBP are)\n",
      "                  (ADJP (RB hemodynamically) (JJ stable)))))))\n",
      "        (CC and)\n",
      "        (VP (VB have)\n",
      "          (NP (JJ good) (JJ renal) (NN function)\n",
      "            (CC and)\n",
      "            (JJ normal) (NN electrolyte) (NNS levels)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(blockers-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, angiotensin-3)\n",
      "compound(blockers-5, angiotensin-3)\n",
      "compound(blockers-5, receptor-4)\n",
      "nsubjpass(continued-9, blockers-5)\n",
      "nsubj(have-17, blockers-5)\n",
      "advmod(continued-9, generally-6)\n",
      "aux(continued-9, can-7)\n",
      "auxpass(continued-9, be-8)\n",
      "root(ROOT-0, continued-9)\n",
      "advmod(continued-9, perioperatively-10)\n",
      "mark(stable-15, if-11)\n",
      "nsubj(stable-15, patients-12)\n",
      "cop(stable-15, are-13)\n",
      "advmod(stable-15, hemodynamically-14)\n",
      "advcl(continued-9, stable-15)\n",
      "cc(continued-9, and-16)\n",
      "conj:and(continued-9, have-17)\n",
      "amod(function-20, good-18)\n",
      "amod(function-20, renal-19)\n",
      "dobj(have-17, function-20)\n",
      "cc(function-20, and-21)\n",
      "amod(levels-24, normal-22)\n",
      "compound(levels-24, electrolyte-23)\n",
      "dobj(have-17, levels-24)\n",
      "conj:and(function-20, levels-24)\n",
      "\n",
      "Parsing [sent. 138 len. 28]: to assess drug adherence of patients with hypertension , an analytical method was developed and validated using ultra performance liquid chromatography tandem mass spectrometry -LRB- uplc-ms/ms -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (VP (TO to)\n",
      "        (VP (VB assess)\n",
      "          (NP\n",
      "            (NP (NN drug) (NN adherence))\n",
      "            (PP (IN of)\n",
      "              (NP (NNS patients))))\n",
      "          (PP (IN with)\n",
      "            (NP (NN hypertension))))))\n",
      "    (, ,)\n",
      "    (NP (DT an) (JJ analytical) (NN method))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN developed)\n",
      "        (CC and)\n",
      "        (VBN validated)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP (NN ultra) (NN performance) (NN liquid) (NN chromatography) (NN tandem))\n",
      "              (ADJP (RB mass) (JJ spectrometry))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNS uplc-ms/ms))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(assess-2, to-1)\n",
      "advcl(developed-14, assess-2)\n",
      "compound(adherence-4, drug-3)\n",
      "dobj(assess-2, adherence-4)\n",
      "case(patients-6, of-5)\n",
      "nmod:of(adherence-4, patients-6)\n",
      "case(hypertension-8, with-7)\n",
      "nmod:with(assess-2, hypertension-8)\n",
      "det(method-12, an-10)\n",
      "amod(method-12, analytical-11)\n",
      "nsubjpass(developed-14, method-12)\n",
      "nsubjpass(validated-16, method-12)\n",
      "auxpass(developed-14, was-13)\n",
      "root(ROOT-0, developed-14)\n",
      "cc(developed-14, and-15)\n",
      "conj:and(developed-14, validated-16)\n",
      "xcomp(developed-14, using-17)\n",
      "compound(tandem-22, ultra-18)\n",
      "compound(tandem-22, performance-19)\n",
      "compound(tandem-22, liquid-20)\n",
      "compound(tandem-22, chromatography-21)\n",
      "dobj(using-17, tandem-22)\n",
      "advmod(spectrometry-24, mass-23)\n",
      "amod(tandem-22, spectrometry-24)\n",
      "appos(tandem-22, uplc-ms/ms-26)\n",
      "\n",
      "Parsing [sent. 139 len. 65]: the method includes eight frequently prescribed antihypertensive drugs from four classes and their active metabolites : ACEI enalapril and perindopril -LRB- active metabolites respectively enalaprilate and perindoprilate -RRB- , angiotensin ii receptor blockers losartan -LRB- with the active metabolite losartan carboxylic acid -RRB- and valsartan , calcium channel blockers amlodipine and nifedipine and diuretics hydrochlorothiazide and spironolactone -LRB- with the active metabolite canrenone -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (DT the) (NN method))\n",
      "      (VP (VBZ includes)\n",
      "        (NP (CD eight))\n",
      "        (UCP\n",
      "          (VP\n",
      "            (ADVP (RB frequently))\n",
      "            (VBN prescribed)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ antihypertensive) (NNS drugs))\n",
      "                (PP (IN from)\n",
      "                  (NP\n",
      "                    (NP (CD four) (NNS classes))\n",
      "                    (CC and)\n",
      "                    (NP (PRP$ their) (JJ active) (NNS metabolites)))))\n",
      "              (: :)\n",
      "              (NP\n",
      "                (NP (NNP ACEI))\n",
      "                (ADJP (JJ enalapril)\n",
      "                  (CC and)\n",
      "                  (JJ perindopril)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (S\n",
      "                  (NP (JJ active) (NNS metabolites))\n",
      "                  (ADVP (RB respectively))\n",
      "                  (VP (VBP enalaprilate)\n",
      "                    (CC and)\n",
      "                    (VBP perindoprilate)))\n",
      "                (-RRB- -RRB-))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN angiotensin) (NN ii) (NN receptor) (NNS blockers))\n",
      "                (VP (VBN losartan)\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (PP (IN with)\n",
      "                      (NP (DT the) (JJ active) (JJ metabolite) (NN losartan) (JJ carboxylic) (NN acid)))\n",
      "                    (-RRB- -RRB-))))))\n",
      "          (CC and)\n",
      "          (ADJP (JJ valsartan)))))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "      (ADJP (JJ amlodipine)\n",
      "        (CC and)\n",
      "        (JJ nifedipine)))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NNS diuretics))\n",
      "      (ADJP\n",
      "        (ADJP (JJ hydrochlorothiazide)\n",
      "          (CC and)\n",
      "          (JJ spironolactone))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (PP (IN with)\n",
      "            (NP (DT the) (JJ active) (NN metabolite) (NN canrenone)))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "det(method-2, the-1)\n",
      "nsubj(includes-3, method-2)\n",
      "nsubj(amlodipine-50, method-2)\n",
      "nsubj(hydrochlorothiazide-55, method-2)\n",
      "root(ROOT-0, includes-3)\n",
      "dobj(includes-3, eight-4)\n",
      "advmod(prescribed-6, frequently-5)\n",
      "dep(includes-3, prescribed-6)\n",
      "amod(drugs-8, antihypertensive-7)\n",
      "dobj(prescribed-6, drugs-8)\n",
      "case(classes-11, from-9)\n",
      "nummod(classes-11, four-10)\n",
      "nmod:from(drugs-8, classes-11)\n",
      "cc(classes-11, and-12)\n",
      "nmod:poss(metabolites-15, their-13)\n",
      "amod(metabolites-15, active-14)\n",
      "nmod:from(drugs-8, metabolites-15)\n",
      "conj:and(classes-11, metabolites-15)\n",
      "dep(drugs-8, ACEI-17)\n",
      "amod(ACEI-17, enalapril-18)\n",
      "cc(enalapril-18, and-19)\n",
      "amod(ACEI-17, perindopril-20)\n",
      "conj:and(enalapril-18, perindopril-20)\n",
      "amod(metabolites-23, active-22)\n",
      "nsubj(enalaprilate-25, metabolites-23)\n",
      "nsubj(perindoprilate-27, metabolites-23)\n",
      "advmod(enalaprilate-25, respectively-24)\n",
      "dep(drugs-8, enalaprilate-25)\n",
      "cc(enalaprilate-25, and-26)\n",
      "dep(drugs-8, perindoprilate-27)\n",
      "conj:and(enalaprilate-25, perindoprilate-27)\n",
      "compound(blockers-33, angiotensin-30)\n",
      "compound(blockers-33, ii-31)\n",
      "compound(blockers-33, receptor-32)\n",
      "appos(drugs-8, blockers-33)\n",
      "acl(blockers-33, losartan-34)\n",
      "case(acid-42, with-36)\n",
      "det(acid-42, the-37)\n",
      "amod(acid-42, active-38)\n",
      "amod(acid-42, metabolite-39)\n",
      "compound(acid-42, losartan-40)\n",
      "amod(acid-42, carboxylic-41)\n",
      "dep(losartan-34, acid-42)\n",
      "cc(prescribed-6, and-44)\n",
      "dep(includes-3, valsartan-45)\n",
      "conj:and(prescribed-6, valsartan-45)\n",
      "compound(blockers-49, calcium-47)\n",
      "compound(blockers-49, channel-48)\n",
      "dep(amlodipine-50, blockers-49)\n",
      "conj:and(includes-3, amlodipine-50)\n",
      "cc(amlodipine-50, and-51)\n",
      "conj:and(includes-3, nifedipine-52)\n",
      "conj:and(amlodipine-50, nifedipine-52)\n",
      "cc(includes-3, and-53)\n",
      "dep(hydrochlorothiazide-55, diuretics-54)\n",
      "conj:and(includes-3, hydrochlorothiazide-55)\n",
      "cc(hydrochlorothiazide-55, and-56)\n",
      "conj:and(includes-3, spironolactone-57)\n",
      "conj:and(hydrochlorothiazide-55, spironolactone-57)\n",
      "case(canrenone-63, with-59)\n",
      "det(canrenone-63, the-60)\n",
      "amod(canrenone-63, active-61)\n",
      "compound(canrenone-63, metabolite-62)\n",
      "dep(hydrochlorothiazide-55, canrenone-63)\n",
      "\n",
      "Parsing [sent. 140 len. 21]: this study demonstrates that ACEI-is/arbs therapy decreases the loss of residual renal function , mainly for patients with peritoneal dialysis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN study))\n",
      "    (VP (VBZ demonstrates)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP ACEI-is/arbs) (NN therapy))\n",
      "          (VP (VBZ decreases)\n",
      "            (NP\n",
      "              (NP (DT the) (NN loss))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ residual) (JJ renal) (NN function))))\n",
      "            (, ,)\n",
      "            (PP\n",
      "              (ADVP (RB mainly))\n",
      "              (IN for)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ peritoneal) (NN dialysis)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(study-2, this-1)\n",
      "nsubj(demonstrates-3, study-2)\n",
      "root(ROOT-0, demonstrates-3)\n",
      "mark(decreases-7, that-4)\n",
      "compound(therapy-6, ACEI-is/arbs-5)\n",
      "nsubj(decreases-7, therapy-6)\n",
      "ccomp(demonstrates-3, decreases-7)\n",
      "det(loss-9, the-8)\n",
      "dobj(decreases-7, loss-9)\n",
      "case(function-13, of-10)\n",
      "amod(function-13, residual-11)\n",
      "amod(function-13, renal-12)\n",
      "nmod:of(loss-9, function-13)\n",
      "advmod(patients-17, mainly-15)\n",
      "case(patients-17, for-16)\n",
      "nmod:for(decreases-7, patients-17)\n",
      "case(dialysis-20, with-18)\n",
      "amod(dialysis-20, peritoneal-19)\n",
      "nmod:with(patients-17, dialysis-20)\n",
      "\n",
      "Parsing [sent. 141 len. 28]: overall , ACEI-is and arbs do not reduce cardiovascular events in dialysis patients , however , treatment with arb seems to reduce cardiovascular events including heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ overall) (, ,) (NNS ACEI-is)\n",
      "        (CC and)\n",
      "        (NNS arbs))\n",
      "      (VP (VBP do) (RB not)\n",
      "        (VP (VB reduce)\n",
      "          (NP (JJ cardiovascular) (NNS events))\n",
      "          (PP (IN in)\n",
      "            (NP (NN dialysis) (NNS patients)))\n",
      "          (, ,)\n",
      "          (ADVP (RB however)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN treatment))\n",
      "      (PP (IN with)\n",
      "        (NP (NN arb))))\n",
      "    (VP (VBZ seems)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB reduce)\n",
      "            (NP\n",
      "              (NP (JJ cardiovascular) (NNS events))\n",
      "              (PP (VBG including)\n",
      "                (NP (NN heart) (NN failure))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(reduce-8, overall-1)\n",
      "conj:and(overall-1, ACEI-is-3)\n",
      "nsubj(reduce-8, ACEI-is-3)\n",
      "cc(overall-1, and-4)\n",
      "conj:and(overall-1, arbs-5)\n",
      "nsubj(reduce-8, arbs-5)\n",
      "aux(reduce-8, do-6)\n",
      "neg(reduce-8, not-7)\n",
      "ccomp(seems-20, reduce-8)\n",
      "amod(events-10, cardiovascular-9)\n",
      "dobj(reduce-8, events-10)\n",
      "case(patients-13, in-11)\n",
      "compound(patients-13, dialysis-12)\n",
      "nmod:in(reduce-8, patients-13)\n",
      "advmod(reduce-8, however-15)\n",
      "nsubj(seems-20, treatment-17)\n",
      "nsubj:xsubj(reduce-22, treatment-17)\n",
      "case(arb-19, with-18)\n",
      "nmod:with(treatment-17, arb-19)\n",
      "root(ROOT-0, seems-20)\n",
      "mark(reduce-22, to-21)\n",
      "xcomp(seems-20, reduce-22)\n",
      "amod(events-24, cardiovascular-23)\n",
      "dobj(reduce-22, events-24)\n",
      "case(failure-27, including-25)\n",
      "compound(failure-27, heart-26)\n",
      "nmod:including(events-24, failure-27)\n",
      "\n",
      "Parsing [sent. 142 len. 13]: ACEI-is and arbs do not induce an extra risk of side effects .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS ACEI-is)\n",
      "      (CC and)\n",
      "      (NNS arbs))\n",
      "    (VP (VBP do) (RB not)\n",
      "      (VP (VB induce)\n",
      "        (NP\n",
      "          (NP (DT an) (JJ extra) (NN risk))\n",
      "          (PP (IN of)\n",
      "            (NP (NN side) (NNS effects))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(induce-6, ACEI-is-1)\n",
      "cc(ACEI-is-1, and-2)\n",
      "conj:and(ACEI-is-1, arbs-3)\n",
      "nsubj(induce-6, arbs-3)\n",
      "aux(induce-6, do-4)\n",
      "neg(induce-6, not-5)\n",
      "root(ROOT-0, induce-6)\n",
      "det(risk-9, an-7)\n",
      "amod(risk-9, extra-8)\n",
      "dobj(induce-6, risk-9)\n",
      "case(effects-12, of-10)\n",
      "compound(effects-12, side-11)\n",
      "nmod:of(risk-9, effects-12)\n",
      "\n",
      "Parsing [sent. 143 len. 11]: eleven trials included 1856 participants who were receiving dialysis therapy .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS eleven) (NNS trials))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (CD 1856) (NNS participants))\n",
      "        (SBAR\n",
      "          (WHNP (WP who))\n",
      "          (S\n",
      "            (VP (VBD were)\n",
      "              (VP (VBG receiving)\n",
      "                (NP (NN dialysis) (NN therapy))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(trials-2, eleven-1)\n",
      "nsubj(included-3, trials-2)\n",
      "root(ROOT-0, included-3)\n",
      "nummod(participants-5, 1856-4)\n",
      "dobj(included-3, participants-5)\n",
      "nsubj(receiving-8, participants-5)\n",
      "ref(participants-5, who-6)\n",
      "aux(receiving-8, were-7)\n",
      "acl:relcl(participants-5, receiving-8)\n",
      "compound(therapy-10, dialysis-9)\n",
      "dobj(receiving-8, therapy-10)\n",
      "\n",
      "Parsing [sent. 144 len. 42]: compared with placebo or other active agents groups , arb therapy reduced the risk of heart failure events by 33 % -LRB- rr 0.67 , 95 % ci 0.47 to 0.93 -RRB- with similar decrement in blood pressure in dialysis patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (VBN compared)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (NN placebo))\n",
      "          (CC or)\n",
      "          (NP (JJ other) (JJ active) (NNS agents) (NNS groups)))))\n",
      "    (, ,)\n",
      "    (NP (NN arb) (NN therapy))\n",
      "    (VP (VBD reduced)\n",
      "      (NP\n",
      "        (NP (DT the) (NN risk))\n",
      "        (PP (IN of)\n",
      "          (NP (NN heart) (NN failure) (NNS events))))\n",
      "      (PP (IN by)\n",
      "        (NP\n",
      "          (NP (CD 33) (NN %))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP\n",
      "                (ADJP\n",
      "                  (QP (CD rr) (CD 0.67)))\n",
      "                (, ,)\n",
      "                (ADJP (CD 95) (NN %))\n",
      "                (NN ci) (NN 0.47))\n",
      "              (PP (TO to)\n",
      "                (NP (CD 0.93))))\n",
      "            (-RRB- -RRB-))))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ similar) (NN decrement))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NN blood) (NN pressure))\n",
      "              (PP (IN in)\n",
      "                (NP (NN dialysis) (NNS patients))))))))\n",
      "    (. .)))\n",
      "\n",
      "case(placebo-3, compared-1)\n",
      "mwe(compared-1, with-2)\n",
      "advcl(reduced-12, placebo-3)\n",
      "cc(placebo-3, or-4)\n",
      "amod(groups-8, other-5)\n",
      "amod(groups-8, active-6)\n",
      "compound(groups-8, agents-7)\n",
      "conj:or(placebo-3, groups-8)\n",
      "advcl(reduced-12, groups-8)\n",
      "compound(therapy-11, arb-10)\n",
      "nsubj(reduced-12, therapy-11)\n",
      "root(ROOT-0, reduced-12)\n",
      "det(risk-14, the-13)\n",
      "dobj(reduced-12, risk-14)\n",
      "case(events-18, of-15)\n",
      "compound(events-18, heart-16)\n",
      "compound(events-18, failure-17)\n",
      "nmod:of(risk-14, events-18)\n",
      "case(%-21, by-19)\n",
      "nummod(%-21, 33-20)\n",
      "nmod:by(reduced-12, %-21)\n",
      "compound(0.67-24, rr-23)\n",
      "nummod(0.47-29, 0.67-24)\n",
      "compound(%-27, 95-26)\n",
      "amod(0.47-29, %-27)\n",
      "compound(0.47-29, ci-28)\n",
      "dep(%-21, 0.47-29)\n",
      "case(0.93-31, to-30)\n",
      "nmod:to(0.47-29, 0.93-31)\n",
      "case(decrement-35, with-33)\n",
      "amod(decrement-35, similar-34)\n",
      "nmod:with(reduced-12, decrement-35)\n",
      "case(pressure-38, in-36)\n",
      "compound(pressure-38, blood-37)\n",
      "nmod:in(decrement-35, pressure-38)\n",
      "case(patients-41, in-39)\n",
      "compound(patients-41, dialysis-40)\n",
      "nmod:in(pressure-38, patients-41)\n",
      "\n",
      "Parsing [sent. 145 len. 20]: indirect comparison suggested that fewer cardiovascular events happened during treatment with arb -LRB- 0.77 , 0.63 to 0.94 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ indirect) (NN comparison))\n",
      "    (VP (VBD suggested)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (JJR fewer) (JJ cardiovascular) (NNS events))\n",
      "          (VP (VBD happened)\n",
      "            (PP (IN during)\n",
      "              (NP (NN treatment)))\n",
      "            (PP (IN with)\n",
      "              (NP (NN arb)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 0.77))\n",
      "                (, ,)\n",
      "                (NP (CD 0.63) (TO to) (CD 0.94)))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(comparison-2, indirect-1)\n",
      "nsubj(suggested-3, comparison-2)\n",
      "root(ROOT-0, suggested-3)\n",
      "mark(happened-8, that-4)\n",
      "amod(events-7, fewer-5)\n",
      "amod(events-7, cardiovascular-6)\n",
      "nsubj(happened-8, events-7)\n",
      "ccomp(suggested-3, happened-8)\n",
      "case(treatment-10, during-9)\n",
      "nmod:during(happened-8, treatment-10)\n",
      "case(arb-12, with-11)\n",
      "nmod:with(happened-8, arb-12)\n",
      "dep(happened-8, 0.77-14)\n",
      "nummod(0.94-18, 0.63-16)\n",
      "dep(0.94-18, to-17)\n",
      "appos(0.77-14, 0.94-18)\n",
      "\n",
      "Parsing [sent. 146 len. 55]: the results indicated no significant differences between the two treatment regimens with regard to frequency of myocardial infarction -LRB- 1.0 , 0.45 to 2.22 -RRB- , stroke -LRB- 1.16 , 0.69 to 1.96 -RRB- , cardiovascular death -LRB- 0.89 , 0.64 to 1.26 -RRB- and all-cause mortality -LRB- 0.94 , 0.75 to 1.17 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNS results))\n",
      "    (VP (VBD indicated)\n",
      "      (NP\n",
      "        (NP (DT no) (JJ significant) (NNS differences))\n",
      "        (PP (IN between)\n",
      "          (NP (DT the) (CD two) (NN treatment) (NNS regimens))))\n",
      "      (PP (IN with)\n",
      "        (NP (NN regard)))\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (NN frequency))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ myocardial) (NN infarction))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 1.0))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.45) (TO to) (CD 2.22)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN stroke))\n",
      "                (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (CD 1.16))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (QP (CD 0.69) (TO to) (CD 1.96))))\n",
      "                (-RRB- -RRB-))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (JJ cardiovascular) (NN death))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (NNP 0.89))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.64) (TO to) (CD 1.26)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (JJ all-cause) (NN mortality))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 0.94))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.75) (TO to) (CD 1.17)))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(results-2, the-1)\n",
      "nsubj(indicated-3, results-2)\n",
      "root(ROOT-0, indicated-3)\n",
      "neg(differences-6, no-4)\n",
      "amod(differences-6, significant-5)\n",
      "dobj(indicated-3, differences-6)\n",
      "case(regimens-11, between-7)\n",
      "det(regimens-11, the-8)\n",
      "nummod(regimens-11, two-9)\n",
      "compound(regimens-11, treatment-10)\n",
      "nmod:between(differences-6, regimens-11)\n",
      "case(regard-13, with-12)\n",
      "nmod:with(indicated-3, regard-13)\n",
      "case(frequency-15, to-14)\n",
      "nmod:to(indicated-3, frequency-15)\n",
      "case(infarction-18, of-16)\n",
      "amod(infarction-18, myocardial-17)\n",
      "nmod:of(frequency-15, infarction-18)\n",
      "dep(infarction-18, 1.0-20)\n",
      "nummod(2.22-24, 0.45-22)\n",
      "dep(2.22-24, to-23)\n",
      "appos(1.0-20, 2.22-24)\n",
      "nmod:of(frequency-15, stroke-27)\n",
      "conj:and(infarction-18, stroke-27)\n",
      "dep(stroke-27, 1.16-29)\n",
      "compound(1.96-33, 0.69-31)\n",
      "dep(1.96-33, to-32)\n",
      "appos(1.16-29, 1.96-33)\n",
      "amod(death-37, cardiovascular-36)\n",
      "nmod:of(frequency-15, death-37)\n",
      "conj:and(infarction-18, death-37)\n",
      "dep(death-37, 0.89-39)\n",
      "nummod(1.26-43, 0.64-41)\n",
      "dep(1.26-43, to-42)\n",
      "appos(0.89-39, 1.26-43)\n",
      "cc(infarction-18, and-45)\n",
      "amod(mortality-47, all-cause-46)\n",
      "nmod:of(frequency-15, mortality-47)\n",
      "conj:and(infarction-18, mortality-47)\n",
      "dep(mortality-47, 0.94-49)\n",
      "nummod(1.17-53, 0.75-51)\n",
      "dep(1.17-53, to-52)\n",
      "appos(0.94-49, 1.17-53)\n",
      "\n",
      "Parsing [sent. 147 len. 60]: five studies reported the renoprotective effect and revealed that ACEI/arb therapy significantly slowed the rate of decline in both residual renal function -LRB- md 0.93 ml/min/1 .73 m -LRB- 2 -RRB- , 0.38 to 1.47 ml/min/1 .73 m -LRB- 2 -RRB- -RRB- and urine volume -LRB- md 167 ml , 95 % ci 21 ml to 357 ml -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (CD five) (NNS studies))\n",
      "    (VP\n",
      "      (VP (VBD reported)\n",
      "        (NP (DT the) (JJ renoprotective) (NN effect)))\n",
      "      (CC and)\n",
      "      (VP (VBD revealed)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP (NNP ACEI/arb) (NN therapy))\n",
      "            (ADVP (RB significantly))\n",
      "            (VP (VBD slowed)\n",
      "              (NP\n",
      "                (NP (DT the) (NN rate))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN decline))))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT both) (JJ residual) (JJ renal) (NN function))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NN md))\n",
      "                      (NP\n",
      "                        (NP (CD 0.93) (JJ ml/min/1) (CD .73) (NNS m))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 2))\n",
      "                          (-RRB- -RRB-))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP\n",
      "                            (QP (CD 0.38) (TO to) (CD 1.47))\n",
      "                            (JJ ml/min/1) (CD .73) (NNS m))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (CD 2))\n",
      "                            (-RRB- -RRB-)))))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (CC and)\n",
      "                  (NP (NN urine) (NN volume))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (QP (CD md) (CD 167))\n",
      "                        (NNP ml) (, ,)\n",
      "                        (ADJP (CD 95) (NN %))\n",
      "                        (JJ ci) (CD 21) (NN ml))\n",
      "                      (PP (TO to)\n",
      "                        (NP (CD 357) (NN ml))))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nummod(studies-2, five-1)\n",
      "nsubj(reported-3, studies-2)\n",
      "nsubj(revealed-8, studies-2)\n",
      "root(ROOT-0, reported-3)\n",
      "det(effect-6, the-4)\n",
      "amod(effect-6, renoprotective-5)\n",
      "dobj(reported-3, effect-6)\n",
      "cc(reported-3, and-7)\n",
      "conj:and(reported-3, revealed-8)\n",
      "mark(slowed-13, that-9)\n",
      "compound(therapy-11, ACEI/arb-10)\n",
      "nsubj(slowed-13, therapy-11)\n",
      "advmod(slowed-13, significantly-12)\n",
      "ccomp(revealed-8, slowed-13)\n",
      "det(rate-15, the-14)\n",
      "dobj(slowed-13, rate-15)\n",
      "case(decline-17, of-16)\n",
      "nmod:of(rate-15, decline-17)\n",
      "case(function-22, in-18)\n",
      "det(function-22, both-19)\n",
      "amod(function-22, residual-20)\n",
      "amod(function-22, renal-21)\n",
      "nmod:in(slowed-13, function-22)\n",
      "dep(function-22, md-24)\n",
      "nummod(m-28, 0.93-25)\n",
      "amod(m-28, ml/min/1-26)\n",
      "nummod(m-28, .73-27)\n",
      "dep(md-24, m-28)\n",
      "appos(m-28, 2-30)\n",
      "compound(1.47-35, 0.38-33)\n",
      "dep(1.47-35, to-34)\n",
      "nummod(m-38, 1.47-35)\n",
      "amod(m-38, ml/min/1-36)\n",
      "nummod(m-38, .73-37)\n",
      "appos(m-28, m-38)\n",
      "appos(m-38, 2-40)\n",
      "cc(function-22, and-43)\n",
      "compound(volume-45, urine-44)\n",
      "nmod:in(slowed-13, volume-45)\n",
      "conj:and(function-22, volume-45)\n",
      "compound(167-48, md-47)\n",
      "nummod(ml-55, 167-48)\n",
      "compound(ml-55, ml-49)\n",
      "compound(%-52, 95-51)\n",
      "amod(ml-55, %-52)\n",
      "amod(ml-55, ci-53)\n",
      "nummod(ml-55, 21-54)\n",
      "dep(function-22, ml-55)\n",
      "case(ml-58, to-56)\n",
      "nummod(ml-58, 357-57)\n",
      "nmod:to(ml-55, ml-58)\n",
      "\n",
      "Parsing [sent. 148 len. 13]: no difference in drug-related adverse events was observed in both treatment groups .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT no) (NN difference))\n",
      "      (PP (IN in)\n",
      "        (NP (JJ drug-related) (JJ adverse) (NNS events))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN in)\n",
      "          (NP (DT both) (NN treatment) (NNS groups)))))\n",
      "    (. .)))\n",
      "\n",
      "neg(difference-2, no-1)\n",
      "nsubjpass(observed-8, difference-2)\n",
      "case(events-6, in-3)\n",
      "amod(events-6, drug-related-4)\n",
      "amod(events-6, adverse-5)\n",
      "nmod:in(difference-2, events-6)\n",
      "auxpass(observed-8, was-7)\n",
      "root(ROOT-0, observed-8)\n",
      "case(groups-12, in-9)\n",
      "det(groups-12, both-10)\n",
      "compound(groups-12, treatment-11)\n",
      "nmod:in(observed-8, groups-12)\n",
      "\n",
      "Parsing [sent. 149 len. 32]: the role of ACEI and angiotensin receptor blockers -LRB- arbs -RRB- reducing risk of cardiovascular events -LRB- cves -RRB- and preserving kidney function in patients with chronic kidney disease is well-documented .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN role))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NNP ACEI)\n",
      "              (CC and)\n",
      "              (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNS arbs))\n",
      "              (-RRB- -RRB-)))\n",
      "          (VP\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP (NN risk))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ cardiovascular) (NNS events))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNS cves))\n",
      "                      (-RRB- -RRB-))))))\n",
      "            (CC and)\n",
      "            (VP (VBG preserving)\n",
      "              (NP (NN kidney) (NN function))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NNS patients))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ chronic) (NN kidney) (NN disease))))))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ well-documented)))\n",
      "    (. .)))\n",
      "\n",
      "det(role-2, the-1)\n",
      "nsubj(well-documented-31, role-2)\n",
      "case(blockers-8, of-3)\n",
      "compound(blockers-8, ACEI-4)\n",
      "cc(ACEI-4, and-5)\n",
      "conj:and(ACEI-4, angiotensin-6)\n",
      "compound(blockers-8, angiotensin-6)\n",
      "compound(blockers-8, receptor-7)\n",
      "nmod:of(role-2, blockers-8)\n",
      "appos(blockers-8, arbs-10)\n",
      "dep(blockers-8, reducing-12)\n",
      "dobj(reducing-12, risk-13)\n",
      "case(events-16, of-14)\n",
      "amod(events-16, cardiovascular-15)\n",
      "nmod:of(risk-13, events-16)\n",
      "appos(events-16, cves-18)\n",
      "cc(reducing-12, and-20)\n",
      "dep(blockers-8, preserving-21)\n",
      "conj:and(reducing-12, preserving-21)\n",
      "compound(function-23, kidney-22)\n",
      "dobj(preserving-21, function-23)\n",
      "case(patients-25, in-24)\n",
      "nmod:in(preserving-21, patients-25)\n",
      "case(disease-29, with-26)\n",
      "amod(disease-29, chronic-27)\n",
      "compound(disease-29, kidney-28)\n",
      "nmod:with(patients-25, disease-29)\n",
      "cop(well-documented-31, is-30)\n",
      "root(ROOT-0, well-documented-31)\n",
      "\n",
      "Parsing [sent. 150 len. 18]: however , the efficacy and safety of these agents in dialysis patients is still a controversial issue .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN efficacy)\n",
      "        (CC and)\n",
      "        (NN safety))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT these) (NNS agents))\n",
      "          (PP (IN in)\n",
      "            (NP (NN dialysis) (NNS patients))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB still))\n",
      "      (NP (DT a) (JJ controversial) (NN issue)))\n",
      "    (. .)))\n",
      "\n",
      "advmod(issue-17, however-1)\n",
      "det(efficacy-4, the-3)\n",
      "nsubj(issue-17, efficacy-4)\n",
      "cc(efficacy-4, and-5)\n",
      "conj:and(efficacy-4, safety-6)\n",
      "nsubj(issue-17, safety-6)\n",
      "case(agents-9, of-7)\n",
      "det(agents-9, these-8)\n",
      "nmod:of(efficacy-4, agents-9)\n",
      "case(patients-12, in-10)\n",
      "compound(patients-12, dialysis-11)\n",
      "nmod:in(agents-9, patients-12)\n",
      "cop(issue-17, is-13)\n",
      "advmod(issue-17, still-14)\n",
      "det(issue-17, a-15)\n",
      "amod(issue-17, controversial-16)\n",
      "root(ROOT-0, issue-17)\n",
      "\n",
      "Parsing [sent. 151 len. 56]: mex and aceimex groups improved all physical functional status outcomes , decreased systolic -LRB- sbp -RRB- and diastolic blood pressure -LRB- p < 0.001 -RRB- and augmented the physical functioning , role physical and physical component score -LRB- pcs -RRB- -LRB- p < 0.05 -RRB- , but also bodily pain -LRB- p < 0.05 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN mex)\n",
      "      (CC and)\n",
      "      (NN aceimex) (NNS groups))\n",
      "    (VP\n",
      "      (VP (VBD improved)\n",
      "        (NP (DT all)\n",
      "          (ADJP (JJ physical) (JJ functional))\n",
      "          (NN status) (NNS outcomes)))\n",
      "      (, ,)\n",
      "      (VP (VBD decreased)\n",
      "        (NP\n",
      "          (NP (JJ systolic) (-LRB- -LRB-) (NN sbp) (-RRB- -RRB-))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (JJ diastolic) (NN blood) (NN pressure))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p)\n",
      "                (QP (CD <) (CD 0.001)))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (CC and)\n",
      "      (VP (VBD augmented)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (JJ physical) (NN functioning))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NN role) (JJ physical)\n",
      "                  (CC and)\n",
      "                  (JJ physical) (NN component) (NN score))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN pcs))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN p)\n",
      "                  (NP (CD <) (CD 0.05)))\n",
      "                (-RRB- -RRB-))))\n",
      "          (, ,)\n",
      "          (CONJP (CC but)\n",
      "            (RB also))\n",
      "          (NP\n",
      "            (NP (JJ bodily) (NN pain))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p) (NNP <) (NNP 0.05))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(groups-4, mex-1)\n",
      "cc(mex-1, and-2)\n",
      "conj:and(mex-1, aceimex-3)\n",
      "compound(groups-4, aceimex-3)\n",
      "nsubj(improved-5, groups-4)\n",
      "nsubj(decreased-12, groups-4)\n",
      "nsubj(augmented-27, groups-4)\n",
      "root(ROOT-0, improved-5)\n",
      "det(outcomes-10, all-6)\n",
      "amod(functional-8, physical-7)\n",
      "amod(outcomes-10, functional-8)\n",
      "compound(outcomes-10, status-9)\n",
      "dobj(improved-5, outcomes-10)\n",
      "conj:and(improved-5, decreased-12)\n",
      "amod(sbp-15, systolic-13)\n",
      "dobj(decreased-12, sbp-15)\n",
      "cc(sbp-15, and-17)\n",
      "amod(pressure-20, diastolic-18)\n",
      "compound(pressure-20, blood-19)\n",
      "dobj(decreased-12, pressure-20)\n",
      "conj:and(sbp-15, pressure-20)\n",
      "appos(pressure-20, p-22)\n",
      "compound(0.001-24, <-23)\n",
      "nummod(p-22, 0.001-24)\n",
      "cc(improved-5, and-26)\n",
      "conj:and(improved-5, augmented-27)\n",
      "det(functioning-30, the-28)\n",
      "amod(functioning-30, physical-29)\n",
      "dobj(augmented-27, functioning-30)\n",
      "nmod:npmod(physical-33, role-32)\n",
      "appos(functioning-30, physical-33)\n",
      "cc(physical-33, and-34)\n",
      "amod(score-37, physical-35)\n",
      "compound(score-37, component-36)\n",
      "appos(functioning-30, score-37)\n",
      "conj:and(physical-33, score-37)\n",
      "appos(physical-33, pcs-39)\n",
      "dep(physical-33, p-42)\n",
      "nummod(0.05-44, <-43)\n",
      "dobj(p-42, 0.05-44)\n",
      "cc(functioning-30, but-47)\n",
      "advmod(pain-50, also-48)\n",
      "amod(pain-50, bodily-49)\n",
      "dobj(augmented-27, pain-50)\n",
      "conj:and(functioning-30, pain-50)\n",
      "compound(0.05-54, p-52)\n",
      "compound(0.05-54, <-53)\n",
      "appos(pain-50, 0.05-54)\n",
      "\n",
      "Parsing [sent. 152 len. 48]: the ACEI group reduced the upper body strength , upper and lower body flexibility and aerobic endurance -LRB- p < 0.05 -RRB- ; worsened the anthropometric profile , and sbp -LRB- p < 0.001 -RRB- ; and decreased general health and pcs -LRB- p < 0.05 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNP ACEI) (NN group))\n",
      "    (VP (VBD reduced)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (DT the) (JJ upper) (NN body) (NN strength))\n",
      "          (, ,)\n",
      "          (NP (JJ upper))\n",
      "          (CC and)\n",
      "          (NP (JJR lower) (NN body) (NN flexibility)))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ aerobic) (NNS endurance))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (: ;)\n",
      "        (NP\n",
      "          (NP\n",
      "            (ADVP (RB worsened))\n",
      "            (DT the) (JJ anthropometric) (NN profile))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (NN sbp))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p)\n",
      "                (QP (CD <) (CD 0.001)))\n",
      "              (-RRB- -RRB-))))\n",
      "        (: ;)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (VBN decreased) (JJ general) (NN health))\n",
      "            (CC and)\n",
      "            (NP (NN pcs)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "det(group-3, the-1)\n",
      "compound(group-3, ACEI-2)\n",
      "nsubj(reduced-4, group-3)\n",
      "root(ROOT-0, reduced-4)\n",
      "det(strength-8, the-5)\n",
      "amod(strength-8, upper-6)\n",
      "compound(strength-8, body-7)\n",
      "dobj(reduced-4, strength-8)\n",
      "dobj(reduced-4, upper-10)\n",
      "conj:and(strength-8, upper-10)\n",
      "cc(strength-8, and-11)\n",
      "amod(flexibility-14, lower-12)\n",
      "compound(flexibility-14, body-13)\n",
      "dobj(reduced-4, flexibility-14)\n",
      "conj:and(strength-8, flexibility-14)\n",
      "cc(strength-8, and-15)\n",
      "amod(endurance-17, aerobic-16)\n",
      "dobj(reduced-4, endurance-17)\n",
      "conj:and(strength-8, endurance-17)\n",
      "dep(endurance-17, p-19)\n",
      "nummod(0.05-21, <-20)\n",
      "dobj(p-19, 0.05-21)\n",
      "advmod(profile-27, worsened-24)\n",
      "det(profile-27, the-25)\n",
      "amod(profile-27, anthropometric-26)\n",
      "dobj(reduced-4, profile-27)\n",
      "conj:and(strength-8, profile-27)\n",
      "cc(profile-27, and-29)\n",
      "conj:and(strength-8, sbp-30)\n",
      "conj:and(profile-27, sbp-30)\n",
      "appos(sbp-30, p-32)\n",
      "compound(0.001-34, <-33)\n",
      "nummod(p-32, 0.001-34)\n",
      "cc(strength-8, and-37)\n",
      "amod(health-40, decreased-38)\n",
      "amod(health-40, general-39)\n",
      "dobj(reduced-4, health-40)\n",
      "conj:and(strength-8, health-40)\n",
      "cc(health-40, and-41)\n",
      "conj:and(strength-8, pcs-42)\n",
      "conj:and(health-40, pcs-42)\n",
      "dep(health-40, p-44)\n",
      "nummod(0.05-46, <-45)\n",
      "dobj(p-44, 0.05-46)\n",
      "\n",
      "Parsed file: KeywordSentences.txt [152 sentences].\n",
      "Parsed 4222 words in 152 sentences (48.50 wds/sec; 1.75 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.6 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsing [sent. 1 len. 44]: renin-angiotensin-aldosterone system -LRB- raas -RRB- antagonists , including ACEI , angiotensin receptor blockers -LRB- arb -RRB- , and mineralocorticoid receptor antagonists -LRB- mra -RRB- decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia , especially when used in combination .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ renin-angiotensin-aldosterone) (NN system)\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNS raas))\n",
      "          (-RRB- -RRB-))\n",
      "        (NNS antagonists))\n",
      "      (, ,)\n",
      "      (PP (VBG including)\n",
      "        (NP (NNP ACEI)))\n",
      "      (, ,))\n",
      "    (VP (VBD angiotensin)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN receptor) (NNS blockers))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN arb))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ mineralocorticoid) (NN receptor) (NNS antagonists))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN mra))\n",
      "            (-RRB- -RRB-))))\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (VB decrease)\n",
      "            (NP (NN mortality)\n",
      "              (CC and)\n",
      "              (NN morbidity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN heart) (NN failure))))\n",
      "          (CC but)\n",
      "          (VP (VB increase)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP (NN hyperkalemia)))))))\n",
      "      (, ,)\n",
      "      (SBAR\n",
      "        (WHADVP (RB especially) (WRB when))\n",
      "        (S\n",
      "          (VP (VBN used)\n",
      "            (PP (IN in)\n",
      "              (NP (NN combination)))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(antagonists-6, renin-angiotensin-aldosterone-1)\n",
      "compound(antagonists-6, system-2)\n",
      "appos(antagonists-6, raas-4)\n",
      "nsubj(angiotensin-11, antagonists-6)\n",
      "case(ACEI-9, including-8)\n",
      "nmod:including(antagonists-6, ACEI-9)\n",
      "root(ROOT-0, angiotensin-11)\n",
      "compound(blockers-13, receptor-12)\n",
      "dobj(angiotensin-11, blockers-13)\n",
      "appos(blockers-13, arb-15)\n",
      "cc(blockers-13, and-18)\n",
      "amod(antagonists-21, mineralocorticoid-19)\n",
      "compound(antagonists-21, receptor-20)\n",
      "dobj(angiotensin-11, antagonists-21)\n",
      "conj:and(blockers-13, antagonists-21)\n",
      "appos(antagonists-21, mra-23)\n",
      "dep(angiotensin-11, decrease-25)\n",
      "dobj(decrease-25, mortality-26)\n",
      "cc(mortality-26, and-27)\n",
      "dobj(decrease-25, morbidity-28)\n",
      "conj:and(mortality-26, morbidity-28)\n",
      "case(failure-31, in-29)\n",
      "compound(failure-31, heart-30)\n",
      "nmod:in(decrease-25, failure-31)\n",
      "cc(decrease-25, but-32)\n",
      "dep(angiotensin-11, increase-33)\n",
      "conj:but(decrease-25, increase-33)\n",
      "det(risk-35, the-34)\n",
      "dobj(increase-33, risk-35)\n",
      "case(hyperkalemia-37, of-36)\n",
      "nmod:of(risk-35, hyperkalemia-37)\n",
      "advmod(when-40, especially-39)\n",
      "advmod(used-41, when-40)\n",
      "advcl(angiotensin-11, used-41)\n",
      "case(combination-43, in-42)\n",
      "nmod:in(used-41, combination-43)\n",
      "\n",
      "Parsing [sent. 2 len. 28]: prevention of hyperkalemia and its associated complications requires careful patient selection , counseling regarding dietary potassium intake , awareness of drug interactions , and regular laboratory surveillance .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN prevention))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN hyperkalemia))\n",
      "          (CC and)\n",
      "          (NP (PRP$ its) (JJ associated) (NNS complications)))))\n",
      "    (VP (VBZ requires)\n",
      "      (NP\n",
      "        (NP (JJ careful) (NN patient) (NN selection))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN counseling))\n",
      "          (PP (VBG regarding)\n",
      "            (NP\n",
      "              (NP (JJ dietary) (NN potassium) (NN intake))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN awareness))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN drug) (NNS interactions))))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (JJ regular) (NN laboratory) (NN surveillance)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(requires-8, prevention-1)\n",
      "case(hyperkalemia-3, of-2)\n",
      "nmod:of(prevention-1, hyperkalemia-3)\n",
      "cc(hyperkalemia-3, and-4)\n",
      "nmod:poss(complications-7, its-5)\n",
      "amod(complications-7, associated-6)\n",
      "nmod:of(prevention-1, complications-7)\n",
      "conj:and(hyperkalemia-3, complications-7)\n",
      "root(ROOT-0, requires-8)\n",
      "amod(selection-11, careful-9)\n",
      "compound(selection-11, patient-10)\n",
      "dobj(requires-8, selection-11)\n",
      "appos(selection-11, counseling-13)\n",
      "case(intake-17, regarding-14)\n",
      "amod(intake-17, dietary-15)\n",
      "compound(intake-17, potassium-16)\n",
      "nmod:regarding(counseling-13, intake-17)\n",
      "nmod:regarding(counseling-13, awareness-19)\n",
      "conj:and(intake-17, awareness-19)\n",
      "case(interactions-22, of-20)\n",
      "compound(interactions-22, drug-21)\n",
      "nmod:of(awareness-19, interactions-22)\n",
      "cc(intake-17, and-24)\n",
      "amod(surveillance-27, regular-25)\n",
      "compound(surveillance-27, laboratory-26)\n",
      "nmod:regarding(counseling-13, surveillance-27)\n",
      "conj:and(intake-17, surveillance-27)\n",
      "\n",
      "Parsing [sent. 3 len. 29]: recent data suggests that the risk of hyperkalemia may be further moderated through the use of combined angiotensin-neprilysin inhibitors , novel mras , and novel potassium binding agents .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ recent) (NNS data))\n",
      "    (VP (VBZ suggests)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN risk))\n",
      "            (PP (IN of)\n",
      "              (NP (NN hyperkalemia))))\n",
      "          (VP (MD may)\n",
      "            (VP (VB be)\n",
      "              (VP (RBR further) (VBN moderated)\n",
      "                (PP (IN through)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN use))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (VBN combined) (JJ angiotensin-neprilysin) (NNS inhibitors))\n",
      "                        (, ,)\n",
      "                        (NP (NN novel) (NNS mras))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP (NN novel) (NN potassium) (VBG binding) (NNS agents))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(data-2, recent-1)\n",
      "nsubj(suggests-3, data-2)\n",
      "root(ROOT-0, suggests-3)\n",
      "mark(moderated-12, that-4)\n",
      "det(risk-6, the-5)\n",
      "nsubjpass(moderated-12, risk-6)\n",
      "case(hyperkalemia-8, of-7)\n",
      "nmod:of(risk-6, hyperkalemia-8)\n",
      "aux(moderated-12, may-9)\n",
      "auxpass(moderated-12, be-10)\n",
      "advmod(moderated-12, further-11)\n",
      "ccomp(suggests-3, moderated-12)\n",
      "case(use-15, through-13)\n",
      "det(use-15, the-14)\n",
      "nmod:through(moderated-12, use-15)\n",
      "case(inhibitors-19, of-16)\n",
      "amod(inhibitors-19, combined-17)\n",
      "amod(inhibitors-19, angiotensin-neprilysin-18)\n",
      "nmod:of(use-15, inhibitors-19)\n",
      "compound(mras-22, novel-21)\n",
      "nmod:of(use-15, mras-22)\n",
      "conj:and(inhibitors-19, mras-22)\n",
      "cc(inhibitors-19, and-24)\n",
      "compound(agents-28, novel-25)\n",
      "compound(agents-28, potassium-26)\n",
      "amod(agents-28, binding-27)\n",
      "nmod:of(use-15, agents-28)\n",
      "conj:and(inhibitors-19, agents-28)\n",
      "\n",
      "Parsing [sent. 4 len. 19]: clinicians should be mindful of the risk of hyperkalemia when prescribing raas inhibitors to patients with heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS clinicians))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ mindful)\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP (NN hyperkalemia))))))\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (VBG prescribing) (NNS raas))\n",
      "            (VP (VBZ inhibitors)\n",
      "              (PP (TO to)\n",
      "                (NP\n",
      "                  (NP (NNS patients))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN heart) (NN failure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(mindful-4, clinicians-1)\n",
      "aux(mindful-4, should-2)\n",
      "cop(mindful-4, be-3)\n",
      "root(ROOT-0, mindful-4)\n",
      "case(risk-7, of-5)\n",
      "det(risk-7, the-6)\n",
      "nmod:of(mindful-4, risk-7)\n",
      "case(hyperkalemia-9, of-8)\n",
      "nmod:of(risk-7, hyperkalemia-9)\n",
      "advmod(inhibitors-13, when-10)\n",
      "amod(raas-12, prescribing-11)\n",
      "nsubj(inhibitors-13, raas-12)\n",
      "advcl(mindful-4, inhibitors-13)\n",
      "case(patients-15, to-14)\n",
      "nmod:to(inhibitors-13, patients-15)\n",
      "case(failure-18, with-16)\n",
      "compound(failure-18, heart-17)\n",
      "nmod:with(patients-15, failure-18)\n",
      "\n",
      "Parsing [sent. 5 len. 33]: in patients at highest risk , such as those with diabetes , the elderly , and advanced chronic kidney disease , more intensive laboratory surveillance of potassium and creatinine may be required .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP\n",
      "        (NP (NNS patients))\n",
      "        (PP (IN at)\n",
      "          (NP (JJS highest) (NN risk)))\n",
      "        (, ,)\n",
      "        (PP (JJ such) (IN as)\n",
      "          (NP\n",
      "            (NP (DT those))\n",
      "            (PP (IN with)\n",
      "              (NP (NN diabetes)))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the)\n",
      "        (ADJP (JJ elderly) (, ,)\n",
      "          (CC and)\n",
      "          (JJ advanced))\n",
      "        (JJ chronic) (NN kidney) (NN disease) (, ,)\n",
      "        (ADJP (RBR more) (JJ intensive))\n",
      "        (NN laboratory) (NN surveillance))\n",
      "      (PP (IN of)\n",
      "        (NP (NN potassium)\n",
      "          (CC and)\n",
      "          (NN creatinine))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN required))))\n",
      "    (. .)))\n",
      "\n",
      "case(patients-2, in-1)\n",
      "nmod:in(required-32, patients-2)\n",
      "case(risk-5, at-3)\n",
      "amod(risk-5, highest-4)\n",
      "nmod:at(patients-2, risk-5)\n",
      "case(those-9, such-7)\n",
      "mwe(such-7, as-8)\n",
      "nmod:such_as(patients-2, those-9)\n",
      "case(diabetes-11, with-10)\n",
      "nmod:with(those-9, diabetes-11)\n",
      "det(surveillance-25, the-13)\n",
      "amod(surveillance-25, elderly-14)\n",
      "cc(elderly-14, and-16)\n",
      "conj:and(elderly-14, advanced-17)\n",
      "amod(surveillance-25, advanced-17)\n",
      "amod(surveillance-25, chronic-18)\n",
      "compound(surveillance-25, kidney-19)\n",
      "compound(surveillance-25, disease-20)\n",
      "advmod(intensive-23, more-22)\n",
      "amod(surveillance-25, intensive-23)\n",
      "compound(surveillance-25, laboratory-24)\n",
      "nsubjpass(required-32, surveillance-25)\n",
      "case(potassium-27, of-26)\n",
      "nmod:of(surveillance-25, potassium-27)\n",
      "cc(potassium-27, and-28)\n",
      "nmod:of(surveillance-25, creatinine-29)\n",
      "conj:and(potassium-27, creatinine-29)\n",
      "aux(required-32, may-30)\n",
      "auxpass(required-32, be-31)\n",
      "root(ROOT-0, required-32)\n",
      "\n",
      "Parsing [sent. 6 len. 18]: novel therapies hold promise for reducing the risk of hyperkalemia and enhancing the tolerability of raas antagonists .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN novel) (NNS therapies))\n",
      "    (VP (VBP hold)\n",
      "      (NP (NN promise))\n",
      "      (PP (IN for)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN risk))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN hyperkalemia)))))\n",
      "            (CC and)\n",
      "            (VP (VBG enhancing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN tolerability))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ raas) (NNS antagonists)))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(therapies-2, novel-1)\n",
      "nsubj(hold-3, therapies-2)\n",
      "root(ROOT-0, hold-3)\n",
      "dobj(hold-3, promise-4)\n",
      "mark(reducing-6, for-5)\n",
      "advcl(hold-3, reducing-6)\n",
      "det(risk-8, the-7)\n",
      "dobj(reducing-6, risk-8)\n",
      "case(hyperkalemia-10, of-9)\n",
      "nmod:of(risk-8, hyperkalemia-10)\n",
      "cc(reducing-6, and-11)\n",
      "advcl(hold-3, enhancing-12)\n",
      "conj:and(reducing-6, enhancing-12)\n",
      "det(tolerability-14, the-13)\n",
      "dobj(enhancing-12, tolerability-14)\n",
      "case(antagonists-17, of-15)\n",
      "amod(antagonists-17, raas-16)\n",
      "nmod:of(tolerability-14, antagonists-17)\n",
      "\n",
      "Parsing [sent. 7 len. 12]: heart failure is a disease with a high prevalence and incidence .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN heart) (NN failure))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (NN disease))\n",
      "        (PP (IN with)\n",
      "          (NP (DT a) (JJ high) (NN prevalence)\n",
      "            (CC and)\n",
      "            (NN incidence)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(disease-5, failure-2)\n",
      "cop(disease-5, is-3)\n",
      "det(disease-5, a-4)\n",
      "root(ROOT-0, disease-5)\n",
      "case(prevalence-9, with-6)\n",
      "det(prevalence-9, a-7)\n",
      "amod(prevalence-9, high-8)\n",
      "nmod:with(disease-5, prevalence-9)\n",
      "cc(prevalence-9, and-10)\n",
      "nmod:with(disease-5, incidence-11)\n",
      "conj:and(prevalence-9, incidence-11)\n",
      "\n",
      "Parsing [sent. 8 len. 25]: new therapeutic approaches are needed to prevent the onset of heart failure and to reduce the high morbidity and mortality associated with this disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ new) (JJ therapeutic) (NNS approaches))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN needed)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (TO to)\n",
      "              (VP (VB prevent)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN onset))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN heart) (NN failure))))))\n",
      "            (CC and)\n",
      "            (VP (TO to)\n",
      "              (VP (VB reduce)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ high) (NN morbidity)\n",
      "                    (CC and)\n",
      "                    (NN mortality))\n",
      "                  (VP (VBN associated)\n",
      "                    (PP (IN with)\n",
      "                      (NP (DT this) (NN disease)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(approaches-3, new-1)\n",
      "amod(approaches-3, therapeutic-2)\n",
      "nsubjpass(needed-5, approaches-3)\n",
      "auxpass(needed-5, are-4)\n",
      "root(ROOT-0, needed-5)\n",
      "mark(prevent-7, to-6)\n",
      "ccomp(needed-5, prevent-7)\n",
      "det(onset-9, the-8)\n",
      "dobj(prevent-7, onset-9)\n",
      "case(failure-12, of-10)\n",
      "compound(failure-12, heart-11)\n",
      "nmod:of(onset-9, failure-12)\n",
      "cc(prevent-7, and-13)\n",
      "mark(reduce-15, to-14)\n",
      "ccomp(needed-5, reduce-15)\n",
      "conj:and(prevent-7, reduce-15)\n",
      "det(morbidity-18, the-16)\n",
      "amod(morbidity-18, high-17)\n",
      "dobj(reduce-15, morbidity-18)\n",
      "cc(morbidity-18, and-19)\n",
      "dobj(reduce-15, mortality-20)\n",
      "conj:and(morbidity-18, mortality-20)\n",
      "acl(morbidity-18, associated-21)\n",
      "case(disease-24, with-22)\n",
      "det(disease-24, this-23)\n",
      "nmod:with(associated-21, disease-24)\n",
      "\n",
      "Parsing [sent. 9 len. 31]: an optimized therapy of arterial hypertension in patients with risk factors and the use of the sglt2 inhibitor empagliflozin in type 2 diabetics are proven strategies to prevent heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT an) (JJ optimized) (NN therapy))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (JJ arterial) (NN hypertension))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN risk) (NNS factors))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT the) (NN use))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (DT the) (JJ sglt2) (NN inhibitor) (NN empagliflozin))\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (ADJP (NN type) (CD 2))\n",
      "                        (NNS diabetics)))))))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN proven)\n",
      "        (NP (NNS strategies))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB prevent)\n",
      "              (NP (NN heart) (NN failure)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(therapy-3, an-1)\n",
      "amod(therapy-3, optimized-2)\n",
      "nsubjpass(proven-25, therapy-3)\n",
      "case(hypertension-6, of-4)\n",
      "amod(hypertension-6, arterial-5)\n",
      "nmod:of(therapy-3, hypertension-6)\n",
      "case(patients-8, in-7)\n",
      "nmod:in(hypertension-6, patients-8)\n",
      "case(factors-11, with-9)\n",
      "compound(factors-11, risk-10)\n",
      "nmod:with(patients-8, factors-11)\n",
      "cc(patients-8, and-12)\n",
      "det(use-14, the-13)\n",
      "nmod:in(hypertension-6, use-14)\n",
      "conj:and(patients-8, use-14)\n",
      "case(empagliflozin-19, of-15)\n",
      "det(empagliflozin-19, the-16)\n",
      "amod(empagliflozin-19, sglt2-17)\n",
      "compound(empagliflozin-19, inhibitor-18)\n",
      "nmod:of(use-14, empagliflozin-19)\n",
      "case(diabetics-23, in-20)\n",
      "amod(diabetics-23, type-21)\n",
      "compound(type-21, 2-22)\n",
      "nmod:in(empagliflozin-19, diabetics-23)\n",
      "auxpass(proven-25, are-24)\n",
      "root(ROOT-0, proven-25)\n",
      "dobj(proven-25, strategies-26)\n",
      "mark(prevent-28, to-27)\n",
      "advcl(proven-25, prevent-28)\n",
      "compound(failure-30, heart-29)\n",
      "dobj(prevent-28, failure-30)\n",
      "\n",
      "Parsing [sent. 10 len. 14]: the therapeutic options in heart failure with preserved ejection fraction are still insufficient .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (JJ therapeutic) (NNS options))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN heart) (NN failure))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ preserved) (NN ejection) (NN fraction))))))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB still))\n",
      "      (ADJP (JJ insufficient)))\n",
      "    (. .)))\n",
      "\n",
      "det(options-3, the-1)\n",
      "amod(options-3, therapeutic-2)\n",
      "nsubj(insufficient-13, options-3)\n",
      "case(failure-6, in-4)\n",
      "compound(failure-6, heart-5)\n",
      "nmod:in(options-3, failure-6)\n",
      "case(fraction-10, with-7)\n",
      "amod(fraction-10, preserved-8)\n",
      "compound(fraction-10, ejection-9)\n",
      "nmod:with(failure-6, fraction-10)\n",
      "cop(insufficient-13, are-11)\n",
      "advmod(insufficient-13, still-12)\n",
      "root(ROOT-0, insufficient-13)\n",
      "\n",
      "Parsing [sent. 11 len. 26]: in heart failure with reduced ejection fraction sacubitril/valsartan , the first approved angiotensin receptor-neprilysin inhibitor , is superior to an ACEI -LRB- ACEI -RRB- inhibitor .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP\n",
      "        (NP (NN heart) (NN failure))\n",
      "        (PP (IN with)\n",
      "          (NP (VBN reduced) (NN ejection)))))\n",
      "    (NP\n",
      "      (NP (NN fraction) (NN sacubitril/valsartan))\n",
      "      (, ,)\n",
      "      (NP (DT the) (JJ first) (JJ approved) (NN angiotensin) (NN receptor-neprilysin) (NN inhibitor))\n",
      "      (, ,))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ superior)\n",
      "        (PP (TO to)\n",
      "          (NP (DT an) (NNP ACEI)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP ACEI))\n",
      "              (-RRB- -RRB-))\n",
      "            (NN inhibitor)))))\n",
      "    (. .)))\n",
      "\n",
      "case(failure-3, in-1)\n",
      "compound(failure-3, heart-2)\n",
      "nmod:in(superior-18, failure-3)\n",
      "case(ejection-6, with-4)\n",
      "amod(ejection-6, reduced-5)\n",
      "nmod:with(failure-3, ejection-6)\n",
      "compound(sacubitril/valsartan-8, fraction-7)\n",
      "nsubj(superior-18, sacubitril/valsartan-8)\n",
      "det(inhibitor-15, the-10)\n",
      "amod(inhibitor-15, first-11)\n",
      "amod(inhibitor-15, approved-12)\n",
      "compound(inhibitor-15, angiotensin-13)\n",
      "compound(inhibitor-15, receptor-neprilysin-14)\n",
      "appos(sacubitril/valsartan-8, inhibitor-15)\n",
      "cop(superior-18, is-17)\n",
      "root(ROOT-0, superior-18)\n",
      "case(inhibitor-25, to-19)\n",
      "det(inhibitor-25, an-20)\n",
      "compound(inhibitor-25, ACEI-21)\n",
      "appos(inhibitor-25, ACEI-23)\n",
      "nmod:to(superior-18, inhibitor-25)\n",
      "\n",
      "Parsing [sent. 12 len. 24]: whether digitalis affects the prognosis in heart failure remains unclear ; however , serum concentration should be targeted at the lower therapeutic range .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP (NN digitalis))\n",
      "          (VP (VBZ affects)\n",
      "            (NP\n",
      "              (NP (DT the) (NN prognosis))\n",
      "              (PP (IN in)\n",
      "                (NP (NN heart) (NN failure)))))))\n",
      "      (VP (VBZ remains)\n",
      "        (ADJP (JJ unclear))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (ADVP (RB however))\n",
      "      (, ,)\n",
      "      (NP (NN serum) (NN concentration))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN targeted)\n",
      "            (PP (IN at)\n",
      "              (NP (DT the) (JJR lower) (JJ therapeutic) (NN range)))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(affects-3, whether-1)\n",
      "nsubj(affects-3, digitalis-2)\n",
      "csubj(remains-9, affects-3)\n",
      "det(prognosis-5, the-4)\n",
      "dobj(affects-3, prognosis-5)\n",
      "case(failure-8, in-6)\n",
      "compound(failure-8, heart-7)\n",
      "nmod:in(prognosis-5, failure-8)\n",
      "root(ROOT-0, remains-9)\n",
      "xcomp(remains-9, unclear-10)\n",
      "advmod(targeted-18, however-12)\n",
      "compound(concentration-15, serum-14)\n",
      "nsubjpass(targeted-18, concentration-15)\n",
      "aux(targeted-18, should-16)\n",
      "auxpass(targeted-18, be-17)\n",
      "parataxis(remains-9, targeted-18)\n",
      "case(range-23, at-19)\n",
      "det(range-23, the-20)\n",
      "amod(range-23, lower-21)\n",
      "amod(range-23, therapeutic-22)\n",
      "nmod:at(targeted-18, range-23)\n",
      "\n",
      "Parsing [sent. 13 len. 19]: iron supplementation in heart failure with reduced systolic function and iron deficiency improves symptoms and quality of life .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN iron) (NN supplementation))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN heart) (NN failure))\n",
      "          (PP (IN with)\n",
      "            (NP (VBN reduced) (JJ systolic) (NN function)\n",
      "              (CC and)\n",
      "              (NN iron) (NN deficiency))))))\n",
      "    (VP (VBZ improves)\n",
      "      (NP\n",
      "        (NP (NNS symptoms)\n",
      "          (CC and)\n",
      "          (NN quality))\n",
      "        (PP (IN of)\n",
      "          (NP (NN life)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(supplementation-2, iron-1)\n",
      "nsubj(improves-13, supplementation-2)\n",
      "case(failure-5, in-3)\n",
      "compound(failure-5, heart-4)\n",
      "nmod:in(supplementation-2, failure-5)\n",
      "case(function-9, with-6)\n",
      "amod(function-9, reduced-7)\n",
      "amod(function-9, systolic-8)\n",
      "nmod:with(failure-5, function-9)\n",
      "cc(function-9, and-10)\n",
      "compound(deficiency-12, iron-11)\n",
      "nmod:with(failure-5, deficiency-12)\n",
      "conj:and(function-9, deficiency-12)\n",
      "root(ROOT-0, improves-13)\n",
      "dobj(improves-13, symptoms-14)\n",
      "cc(symptoms-14, and-15)\n",
      "dobj(improves-13, quality-16)\n",
      "conj:and(symptoms-14, quality-16)\n",
      "case(life-18, of-17)\n",
      "nmod:of(symptoms-14, life-18)\n",
      "\n",
      "Parsing [sent. 14 len. 57]: participants -LRB- n = 418 -RRB- underwent one of the following 3 conditions : i -RRB- multicomponent exercise training 3times/week -LRB- mex ; n = 116 -RRB- ; ii -RRB- ACEI used mono-dose daily -LRB- ACEI ; n = 70 -RRB- ; iii -RRB- combined exercise and ACEI drugs -LRB- aceimex ; n = 232 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS participants))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (VP (VBN n)\n",
      "          (S\n",
      "            (VP (SYM =)\n",
      "              (NP (CD 418)))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD underwent)\n",
      "      (S\n",
      "        (NP\n",
      "          (NP (CD one))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (VBG following) (CD 3) (NNS conditions))))\n",
      "        (: :)\n",
      "        (NP (FW i))\n",
      "        (-RRB- -RRB-)\n",
      "        (VP\n",
      "          (VP (VBP multicomponent)\n",
      "            (VP (VB exercise)\n",
      "              (NP (NN training) (NNS 3times/week))\n",
      "              (FRAG (-LRB- -LRB-)\n",
      "                (NP (NN mex))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP (NNP n) (NNP =) (NNP 116) (-RRB- -RRB-))\n",
      "                  (: ;)\n",
      "                  (NP (NN ii)))\n",
      "                (-RRB- -RRB-))))\n",
      "          (PRN\n",
      "            (S\n",
      "              (NP (NNP ACEI))\n",
      "              (VP (VBD used)\n",
      "                (NP\n",
      "                  (NP (JJ mono-dose) (NN daily))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NNP ACEI))\n",
      "                      (: ;)\n",
      "                      (NP\n",
      "                        (NP (NN n))\n",
      "                        (SBAR\n",
      "                          (S\n",
      "                            (VP (SYM =)\n",
      "                              (NP (CD 70)))))))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (: ;)\n",
      "                  (NP (NN iii)))))\n",
      "            (-RRB- -RRB-))\n",
      "          (NP\n",
      "            (NP (VBN combined) (NN exercise))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (CD ACEI) (NNS drugs))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (NN aceimex))\n",
      "                  (: ;)\n",
      "                  (NP\n",
      "                    (NP (NN n))\n",
      "                    (SBAR\n",
      "                      (S\n",
      "                        (VP (SYM =)\n",
      "                          (NP (CD 232)))))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(underwent-7, participants-1)\n",
      "dep(participants-1, n-3)\n",
      "dep(418-5, =-4)\n",
      "ccomp(n-3, 418-5)\n",
      "root(ROOT-0, underwent-7)\n",
      "nsubj(multicomponent-17, one-8)\n",
      "case(conditions-13, of-9)\n",
      "det(conditions-13, the-10)\n",
      "amod(conditions-13, following-11)\n",
      "nummod(conditions-13, 3-12)\n",
      "nmod:of(one-8, conditions-13)\n",
      "nsubj(multicomponent-17, i-15)\n",
      "ccomp(underwent-7, multicomponent-17)\n",
      "xcomp(multicomponent-17, exercise-18)\n",
      "compound(3times/week-20, training-19)\n",
      "dobj(exercise-18, 3times/week-20)\n",
      "dep(exercise-18, mex-22)\n",
      "compound(116-26, n-24)\n",
      "compound(116-26, =-25)\n",
      "dep(mex-22, 116-26)\n",
      "dep(116-26, ii-29)\n",
      "nsubj(used-32, ACEI-31)\n",
      "parataxis(multicomponent-17, used-32)\n",
      "amod(daily-34, mono-dose-33)\n",
      "dobj(used-32, daily-34)\n",
      "dep(daily-34, ACEI-36)\n",
      "dep(ACEI-36, n-38)\n",
      "dep(70-40, =-39)\n",
      "acl:relcl(n-38, 70-40)\n",
      "dep(daily-34, iii-43)\n",
      "amod(exercise-46, combined-45)\n",
      "dobj(multicomponent-17, exercise-46)\n",
      "cc(exercise-46, and-47)\n",
      "nummod(drugs-49, ACEI-48)\n",
      "dobj(multicomponent-17, drugs-49)\n",
      "conj:and(exercise-46, drugs-49)\n",
      "dep(drugs-49, aceimex-51)\n",
      "dep(aceimex-51, n-53)\n",
      "dep(232-55, =-54)\n",
      "acl:relcl(n-53, 232-55)\n",
      "\n",
      "Parsing [sent. 15 len. 37]: the trial was completed by 82 % of the participants -LRB- n = 342 -RRB- : mex -LRB- n = 90 -RRB- ; ACEI -LRB- n = 66 -RRB- ; aceimex -LRB- n = 186 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN trial))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN completed)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (CD 82) (NN %))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NNS participants))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNP n)\n",
      "                        (QP (CD =) (CD 342)))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (: :)\n",
      "                    (NP (NN mex)))))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 90)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (NNP ACEI))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 66)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (NN aceimex))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 186)))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(trial-2, the-1)\n",
      "nsubjpass(completed-4, trial-2)\n",
      "auxpass(completed-4, was-3)\n",
      "root(ROOT-0, completed-4)\n",
      "case(%-7, by-5)\n",
      "nummod(%-7, 82-6)\n",
      "nmod:by(completed-4, %-7)\n",
      "case(participants-10, of-8)\n",
      "det(participants-10, the-9)\n",
      "nmod:of(%-7, participants-10)\n",
      "appos(participants-10, n-12)\n",
      "compound(342-14, =-13)\n",
      "nummod(n-12, 342-14)\n",
      "dep(participants-10, mex-17)\n",
      "dep(%-7, n-19)\n",
      "dep(90-21, =-20)\n",
      "ccomp(n-19, 90-21)\n",
      "dep(%-7, ACEI-24)\n",
      "dep(ACEI-24, n-26)\n",
      "dep(66-28, =-27)\n",
      "ccomp(n-26, 66-28)\n",
      "dep(%-7, aceimex-31)\n",
      "dep(aceimex-31, n-33)\n",
      "dep(186-35, =-34)\n",
      "ccomp(n-33, 186-35)\n",
      "\n",
      "Parsing [sent. 16 len. 31]: baseline and 2-year follow-up evaluations included the senior fitness test battery , short form health survey 36 -LRB- sf-36 -RRB- , the health history questionnaires , anthropometric and hemodynamic profile .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN baseline)\n",
      "      (CC and)\n",
      "      (JJ 2-year) (NN follow-up) (NNS evaluations))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ senior) (NN fitness) (NN test) (NN battery))\n",
      "        (, ,)\n",
      "        (NP (JJ short) (NN form) (NN health) (NN survey) (CD 36) (-LRB- -LRB-) (NN sf-36) (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (NP (DT the) (NN health) (NN history) (NN questionnaires))\n",
      "        (, ,)\n",
      "        (NP (NN anthropometric))\n",
      "        (CC and)\n",
      "        (NP (JJ hemodynamic) (NN profile))))\n",
      "    (. .)))\n",
      "\n",
      "compound(evaluations-5, baseline-1)\n",
      "cc(baseline-1, and-2)\n",
      "conj:and(baseline-1, 2-year-3)\n",
      "compound(evaluations-5, 2-year-3)\n",
      "compound(evaluations-5, follow-up-4)\n",
      "nsubj(included-6, evaluations-5)\n",
      "root(ROOT-0, included-6)\n",
      "det(battery-11, the-7)\n",
      "amod(battery-11, senior-8)\n",
      "compound(battery-11, fitness-9)\n",
      "compound(battery-11, test-10)\n",
      "dobj(included-6, battery-11)\n",
      "amod(sf-36-19, short-13)\n",
      "compound(sf-36-19, form-14)\n",
      "compound(sf-36-19, health-15)\n",
      "compound(sf-36-19, survey-16)\n",
      "nummod(sf-36-19, 36-17)\n",
      "dobj(included-6, sf-36-19)\n",
      "conj:and(battery-11, sf-36-19)\n",
      "det(questionnaires-25, the-22)\n",
      "compound(questionnaires-25, health-23)\n",
      "compound(questionnaires-25, history-24)\n",
      "dobj(included-6, questionnaires-25)\n",
      "conj:and(battery-11, questionnaires-25)\n",
      "dobj(included-6, anthropometric-27)\n",
      "conj:and(battery-11, anthropometric-27)\n",
      "cc(battery-11, and-28)\n",
      "amod(profile-30, hemodynamic-29)\n",
      "dobj(included-6, profile-30)\n",
      "conj:and(battery-11, profile-30)\n",
      "\n",
      "Parsing [sent. 17 len. 26]: heart failure -LRB- hf -RRB- prevalence continues to rise and remains a significant burden to patients , caregivers , providers , and the healthcare system .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN heart) (NN failure))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN hf))\n",
      "        (-RRB- -RRB-)))\n",
      "    (ADVP (RB prevalence))\n",
      "    (VP\n",
      "      (VP (VBZ continues)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB rise)))))\n",
      "      (CC and)\n",
      "      (VP (VBZ remains)\n",
      "        (NP (DT a) (JJ significant) (NN burden))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (, ,)\n",
      "            (NP (NNS caregivers))\n",
      "            (, ,)\n",
      "            (NP (NNS providers))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (DT the) (NN healthcare) (NN system))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(continues-7, failure-2)\n",
      "nsubj:xsubj(rise-9, failure-2)\n",
      "nsubj(remains-11, failure-2)\n",
      "appos(failure-2, hf-4)\n",
      "advmod(continues-7, prevalence-6)\n",
      "root(ROOT-0, continues-7)\n",
      "mark(rise-9, to-8)\n",
      "xcomp(continues-7, rise-9)\n",
      "cc(continues-7, and-10)\n",
      "conj:and(continues-7, remains-11)\n",
      "det(burden-14, a-12)\n",
      "amod(burden-14, significant-13)\n",
      "xcomp(remains-11, burden-14)\n",
      "case(patients-16, to-15)\n",
      "nmod:to(remains-11, patients-16)\n",
      "nmod:to(remains-11, caregivers-18)\n",
      "conj:and(patients-16, caregivers-18)\n",
      "nmod:to(remains-11, providers-20)\n",
      "conj:and(patients-16, providers-20)\n",
      "cc(patients-16, and-22)\n",
      "det(system-25, the-23)\n",
      "compound(system-25, healthcare-24)\n",
      "nmod:to(remains-11, system-25)\n",
      "conj:and(patients-16, system-25)\n",
      "\n",
      "Parsing [sent. 18 len. 18]: guideline-directed medical therapy with standard neurohormonal blockade has been the cornerstone of medical management for many years .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ guideline-directed) (JJ medical) (NN therapy))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ standard) (JJ neurohormonal) (NN blockade))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN been)\n",
      "        (NP\n",
      "          (NP (DT the) (NN cornerstone))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ medical) (NN management))))\n",
      "        (PP (IN for)\n",
      "          (NP (JJ many) (NNS years)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-3, guideline-directed-1)\n",
      "amod(therapy-3, medical-2)\n",
      "nsubj(cornerstone-11, therapy-3)\n",
      "case(blockade-7, with-4)\n",
      "amod(blockade-7, standard-5)\n",
      "amod(blockade-7, neurohormonal-6)\n",
      "nmod:with(therapy-3, blockade-7)\n",
      "aux(cornerstone-11, has-8)\n",
      "cop(cornerstone-11, been-9)\n",
      "det(cornerstone-11, the-10)\n",
      "root(ROOT-0, cornerstone-11)\n",
      "case(management-14, of-12)\n",
      "amod(management-14, medical-13)\n",
      "nmod:of(cornerstone-11, management-14)\n",
      "case(years-17, for-15)\n",
      "amod(years-17, many-16)\n",
      "nmod:for(cornerstone-11, years-17)\n",
      "\n",
      "Parsing [sent. 19 len. 28]: despite aggressive utilization of ACEI , angiotensin receptor blockers , beta-blockers , and aldosterone antagonists , hf hospitalizations and readmissions are common and residual mortality remains high .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP\n",
      "        (NP (JJ aggressive) (NN utilization))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNP ACEI))\n",
      "            (, ,)\n",
      "            (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "            (, ,)\n",
      "            (NP (NNS beta-blockers))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (JJ aldosterone) (NNS antagonists))))))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN hf) (NNS hospitalizations)\n",
      "        (CC and)\n",
      "        (NNS readmissions))\n",
      "      (VP (VBP are)\n",
      "        (ADJP (JJ common))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ residual) (NN mortality))\n",
      "      (VP (VBZ remains)\n",
      "        (ADJP (JJ high))))\n",
      "    (. .)))\n",
      "\n",
      "case(utilization-3, despite-1)\n",
      "amod(utilization-3, aggressive-2)\n",
      "nmod:despite(common-22, utilization-3)\n",
      "case(ACEI-5, of-4)\n",
      "nmod:of(utilization-3, ACEI-5)\n",
      "compound(blockers-9, angiotensin-7)\n",
      "compound(blockers-9, receptor-8)\n",
      "nmod:of(utilization-3, blockers-9)\n",
      "conj:and(ACEI-5, blockers-9)\n",
      "nmod:of(utilization-3, beta-blockers-11)\n",
      "conj:and(ACEI-5, beta-blockers-11)\n",
      "cc(ACEI-5, and-13)\n",
      "amod(antagonists-15, aldosterone-14)\n",
      "nmod:of(utilization-3, antagonists-15)\n",
      "conj:and(ACEI-5, antagonists-15)\n",
      "compound(hospitalizations-18, hf-17)\n",
      "nsubj(common-22, hospitalizations-18)\n",
      "cc(hospitalizations-18, and-19)\n",
      "conj:and(hospitalizations-18, readmissions-20)\n",
      "nsubj(common-22, readmissions-20)\n",
      "cop(common-22, are-21)\n",
      "root(ROOT-0, common-22)\n",
      "cc(common-22, and-23)\n",
      "amod(mortality-25, residual-24)\n",
      "nsubj(remains-26, mortality-25)\n",
      "conj:and(common-22, remains-26)\n",
      "xcomp(remains-26, high-27)\n",
      "\n",
      "Parsing [sent. 20 len. 46]: with the development of two novel medical therapies -LRB- sacubitril/valsartan and ivabradine -RRB- , the american college of cardiology , american heart association , and heart failure society of america released a pharmacologic update to provide guidelines for incorporation of these agents into clinical practice .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN with)\n",
      "      (NP\n",
      "        (NP (DT the) (NN development))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (CD two) (JJ novel) (JJ medical) (NNS therapies))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (JJ sacubitril/valsartan)\n",
      "                (CC and)\n",
      "                (JJ ivabradine))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN american) (NN college))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN cardiology))\n",
      "          (, ,)\n",
      "          (NP (NN american) (NN heart) (NN association))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (NN heart) (NN failure) (NN society))\n",
      "            (PP (IN of)\n",
      "              (NP (NN america)))))))\n",
      "    (VP (VBD released)\n",
      "      (NP (DT a) (JJ pharmacologic) (NN update))\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB provide)\n",
      "            (NP\n",
      "              (NP (NNS guidelines))\n",
      "              (PP (IN for)\n",
      "                (NP\n",
      "                  (NP (NN incorporation))\n",
      "                  (PP (IN of)\n",
      "                    (NP (DT these) (NNS agents))))))\n",
      "            (PP (IN into)\n",
      "              (NP (JJ clinical) (NN practice)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(development-3, with-1)\n",
      "det(development-3, the-2)\n",
      "nmod:with(released-31, development-3)\n",
      "case(therapies-8, of-4)\n",
      "nummod(therapies-8, two-5)\n",
      "amod(therapies-8, novel-6)\n",
      "amod(therapies-8, medical-7)\n",
      "nmod:of(development-3, therapies-8)\n",
      "dep(therapies-8, sacubitril/valsartan-10)\n",
      "cc(sacubitril/valsartan-10, and-11)\n",
      "dep(therapies-8, ivabradine-12)\n",
      "conj:and(sacubitril/valsartan-10, ivabradine-12)\n",
      "det(college-17, the-15)\n",
      "compound(college-17, american-16)\n",
      "nsubj(released-31, college-17)\n",
      "case(cardiology-19, of-18)\n",
      "nmod:of(college-17, cardiology-19)\n",
      "compound(association-23, american-21)\n",
      "compound(association-23, heart-22)\n",
      "nmod:of(college-17, association-23)\n",
      "conj:and(cardiology-19, association-23)\n",
      "cc(cardiology-19, and-25)\n",
      "compound(society-28, heart-26)\n",
      "compound(society-28, failure-27)\n",
      "nmod:of(college-17, society-28)\n",
      "conj:and(cardiology-19, society-28)\n",
      "case(america-30, of-29)\n",
      "nmod:of(society-28, america-30)\n",
      "root(ROOT-0, released-31)\n",
      "det(update-34, a-32)\n",
      "amod(update-34, pharmacologic-33)\n",
      "dobj(released-31, update-34)\n",
      "mark(provide-36, to-35)\n",
      "advcl(released-31, provide-36)\n",
      "dobj(provide-36, guidelines-37)\n",
      "case(incorporation-39, for-38)\n",
      "nmod:for(guidelines-37, incorporation-39)\n",
      "case(agents-42, of-40)\n",
      "det(agents-42, these-41)\n",
      "nmod:of(incorporation-39, agents-42)\n",
      "case(practice-45, into-43)\n",
      "amod(practice-45, clinical-44)\n",
      "nmod:into(provide-36, practice-45)\n",
      "\n",
      "Parsing [sent. 21 len. 19]: although effective via different mechanisms of action , both agents now have a prominent role in risk reduction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN although)\n",
      "      (S\n",
      "        (ADJP (JJ effective))\n",
      "        (PP (IN via)\n",
      "          (NP\n",
      "            (NP (JJ different) (NNS mechanisms))\n",
      "            (PP (IN of)\n",
      "              (NP (NN action)))))))\n",
      "    (, ,)\n",
      "    (NP (DT both) (NNS agents))\n",
      "    (ADVP (RB now))\n",
      "    (VP (VBP have)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prominent) (NN role))\n",
      "        (PP (IN in)\n",
      "          (NP (NN risk) (NN reduction)))))\n",
      "    (. .)))\n",
      "\n",
      "mark(effective-2, although-1)\n",
      "advcl(have-12, effective-2)\n",
      "case(mechanisms-5, via-3)\n",
      "amod(mechanisms-5, different-4)\n",
      "dep(effective-2, mechanisms-5)\n",
      "case(action-7, of-6)\n",
      "nmod:of(mechanisms-5, action-7)\n",
      "det(agents-10, both-9)\n",
      "nsubj(have-12, agents-10)\n",
      "advmod(have-12, now-11)\n",
      "root(ROOT-0, have-12)\n",
      "det(role-15, a-13)\n",
      "amod(role-15, prominent-14)\n",
      "dobj(have-12, role-15)\n",
      "case(reduction-18, in-16)\n",
      "compound(reduction-18, risk-17)\n",
      "nmod:in(role-15, reduction-18)\n",
      "\n",
      "Parsing [sent. 22 len. 20]: hf medical regimens often become quite complex , especially when associated with comorbid conditions , and require frequent follow-up .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ hf) (JJ medical) (NNS regimens))\n",
      "    (ADVP (RB often))\n",
      "    (VP\n",
      "      (VP (VBP become)\n",
      "        (NP (RB quite) (JJ complex))\n",
      "        (, ,)\n",
      "        (SBAR\n",
      "          (WHADVP (RB especially) (WRB when))\n",
      "          (S\n",
      "            (VP (JJ associated)\n",
      "              (PP (IN with)\n",
      "                (NP (JJ comorbid) (NNS conditions))))))\n",
      "        (, ,))\n",
      "      (CC and)\n",
      "      (VP (VBP require)\n",
      "        (NP (JJ frequent) (NN follow-up))))\n",
      "    (. .)))\n",
      "\n",
      "amod(regimens-3, hf-1)\n",
      "amod(regimens-3, medical-2)\n",
      "nsubj(become-5, regimens-3)\n",
      "nsubj(require-17, regimens-3)\n",
      "advmod(become-5, often-4)\n",
      "root(ROOT-0, become-5)\n",
      "advmod(complex-7, quite-6)\n",
      "xcomp(become-5, complex-7)\n",
      "advmod(when-10, especially-9)\n",
      "advmod(associated-11, when-10)\n",
      "advcl(become-5, associated-11)\n",
      "case(conditions-14, with-12)\n",
      "amod(conditions-14, comorbid-13)\n",
      "nmod:with(associated-11, conditions-14)\n",
      "cc(become-5, and-16)\n",
      "conj:and(become-5, require-17)\n",
      "amod(follow-up-19, frequent-18)\n",
      "dobj(require-17, follow-up-19)\n",
      "\n",
      "Parsing [sent. 23 len. 16]: providers must be proficient in patient monitoring , medication dose titration , and therapy optimization .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS providers))\n",
      "    (VP (MD must)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ proficient)\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (JJ patient) (NN monitoring))\n",
      "              (, ,)\n",
      "              (NP (NN medication) (NN dose) (NN titration))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NN therapy) (NN optimization)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(proficient-4, providers-1)\n",
      "aux(proficient-4, must-2)\n",
      "cop(proficient-4, be-3)\n",
      "root(ROOT-0, proficient-4)\n",
      "case(monitoring-7, in-5)\n",
      "amod(monitoring-7, patient-6)\n",
      "nmod:in(proficient-4, monitoring-7)\n",
      "compound(titration-11, medication-9)\n",
      "compound(titration-11, dose-10)\n",
      "nmod:in(proficient-4, titration-11)\n",
      "conj:and(monitoring-7, titration-11)\n",
      "cc(monitoring-7, and-13)\n",
      "compound(optimization-15, therapy-14)\n",
      "nmod:in(proficient-4, optimization-15)\n",
      "conj:and(monitoring-7, optimization-15)\n",
      "\n",
      "Parsing [sent. 24 len. 17]: individualized patient care strategies such as guideline-directed therapy can promote long-term adherence and quality of life .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ individualized) (JJ patient) (NN care) (NNS strategies))\n",
      "      (PP (JJ such) (IN as)\n",
      "        (NP (JJ guideline-directed) (NN therapy))))\n",
      "    (VP (MD can)\n",
      "      (VP (VB promote)\n",
      "        (NP\n",
      "          (NP (JJ long-term) (NN adherence)\n",
      "            (CC and)\n",
      "            (NN quality))\n",
      "          (PP (IN of)\n",
      "            (NP (NN life))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(strategies-4, individualized-1)\n",
      "amod(strategies-4, patient-2)\n",
      "compound(strategies-4, care-3)\n",
      "nsubj(promote-10, strategies-4)\n",
      "case(therapy-8, such-5)\n",
      "mwe(such-5, as-6)\n",
      "amod(therapy-8, guideline-directed-7)\n",
      "nmod:such_as(strategies-4, therapy-8)\n",
      "aux(promote-10, can-9)\n",
      "root(ROOT-0, promote-10)\n",
      "amod(adherence-12, long-term-11)\n",
      "dobj(promote-10, adherence-12)\n",
      "cc(adherence-12, and-13)\n",
      "dobj(promote-10, quality-14)\n",
      "conj:and(adherence-12, quality-14)\n",
      "case(life-16, of-15)\n",
      "nmod:of(adherence-12, life-16)\n",
      "\n",
      "Parsing [sent. 25 len. 43]: we included a group with no dd -LRB- n = 649 -RRB- , a group with grade 1 dd -LRB- n = 2875 -RRB- , and those with grades 2 and 3 -LRB- n = 1357 -RRB- who had normal ejection fraction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (DT a) (NN group))\n",
      "          (PP (IN with)\n",
      "            (NP (DT no) (NN dd))))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN n)\n",
      "            (S\n",
      "              (VP (SYM =)\n",
      "                (NP (CD 649)))))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT a) (NN group))\n",
      "          (PP (IN with)\n",
      "            (NP (NN grade) (CD 1) (NN dd))))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN n)\n",
      "            (S\n",
      "              (VP (SYM =)\n",
      "                (NP (CD 2875)))))\n",
      "          (-RRB- -RRB-))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (NNS grades) (CD 2)\n",
      "                (CC and)\n",
      "                (CD 3))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 1357)))))\n",
      "                (-RRB- -RRB-))\n",
      "              (SBAR\n",
      "                (WHNP (WP who))\n",
      "                (S\n",
      "                  (VP (VBD had)\n",
      "                    (NP (JJ normal) (NN ejection) (NN fraction))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(included-2, we-1)\n",
      "root(ROOT-0, included-2)\n",
      "det(group-4, a-3)\n",
      "dobj(included-2, group-4)\n",
      "case(dd-7, with-5)\n",
      "neg(dd-7, no-6)\n",
      "nmod:with(group-4, dd-7)\n",
      "dep(group-4, n-9)\n",
      "dep(649-11, =-10)\n",
      "ccomp(n-9, 649-11)\n",
      "det(group-15, a-14)\n",
      "dobj(included-2, group-15)\n",
      "conj:and(group-4, group-15)\n",
      "case(dd-19, with-16)\n",
      "compound(dd-19, grade-17)\n",
      "nummod(dd-19, 1-18)\n",
      "nmod:with(group-15, dd-19)\n",
      "dep(group-4, n-21)\n",
      "dep(2875-23, =-22)\n",
      "ccomp(n-21, 2875-23)\n",
      "cc(group-4, and-26)\n",
      "dobj(included-2, those-27)\n",
      "conj:and(group-4, those-27)\n",
      "case(grades-29, with-28)\n",
      "nmod:with(those-27, grades-29)\n",
      "nsubj(had-39, grades-29)\n",
      "nummod(grades-29, 2-30)\n",
      "cc(grades-29, and-31)\n",
      "nmod:with(those-27, 3-32)\n",
      "conj:and(grades-29, 3-32)\n",
      "nsubj(had-39, 3-32)\n",
      "dep(grades-29, n-34)\n",
      "dep(1357-36, =-35)\n",
      "ccomp(n-34, 1357-36)\n",
      "ref(grades-29, who-38)\n",
      "acl:relcl(grades-29, had-39)\n",
      "amod(fraction-42, normal-40)\n",
      "compound(fraction-42, ejection-41)\n",
      "dobj(had-39, fraction-42)\n",
      "\n",
      "Parsing [sent. 26 len. 22]: the prevalence of grade 2 or 3 dd with preserved ejection fraction was 25 % ; 95 % ci : 24-26 .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT the) (NN prevalence))\n",
      "        (PP (IN of)\n",
      "          (NP (NN grade) (CD 2))))\n",
      "      (CC or)\n",
      "      (NP\n",
      "        (NP (CD 3) (NN dd))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ preserved) (NN ejection) (NN fraction)))))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (CD 25) (NN %))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (ADJP (CD 95) (NN %))\n",
      "            (NN ci)))\n",
      "        (: :)\n",
      "        (NP (CD 24-26))))\n",
      "    (. .)))\n",
      "\n",
      "det(prevalence-2, the-1)\n",
      "nsubj(%-15, prevalence-2)\n",
      "case(grade-4, of-3)\n",
      "nmod:of(prevalence-2, grade-4)\n",
      "nummod(grade-4, 2-5)\n",
      "cc(prevalence-2, or-6)\n",
      "nummod(dd-8, 3-7)\n",
      "conj:or(prevalence-2, dd-8)\n",
      "nsubj(%-15, dd-8)\n",
      "case(fraction-12, with-9)\n",
      "amod(fraction-12, preserved-10)\n",
      "compound(fraction-12, ejection-11)\n",
      "nmod:with(dd-8, fraction-12)\n",
      "cop(%-15, was-13)\n",
      "nummod(%-15, 25-14)\n",
      "root(ROOT-0, %-15)\n",
      "compound(%-18, 95-17)\n",
      "amod(ci-19, %-18)\n",
      "dep(%-15, ci-19)\n",
      "dep(%-15, 24-26-21)\n",
      "\n",
      "Parsing [sent. 27 len. 44]: the absolute change of ACEI-inhibitor use before and after the echocardiogram increased by 14 , 19 , 23 , 27 in patients without dd , those with grade 1 , grade 2 or 3 asymptomatic and grade 2 or 3 symptomatic , respectively .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (JJ absolute) (NN change))\n",
      "      (PP (IN of)\n",
      "        (NP (NNP ACEI-inhibitor))))\n",
      "    (VP (VBP use)\n",
      "      (SBAR (IN before)\n",
      "        (CC and)\n",
      "        (RB after)\n",
      "        (S\n",
      "          (NP (DT the) (NN echocardiogram))\n",
      "          (VP (VBD increased)\n",
      "            (PP (IN by)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (CD 14))\n",
      "                  (, ,)\n",
      "                  (NP (CD 19))\n",
      "                  (, ,)\n",
      "                  (NP (CD 23))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (CD 27))\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (NP (NNS patients))\n",
      "                        (PP (IN without)\n",
      "                          (NP (NN dd))))))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (DT those))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN grade) (CD 1)))))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN grade) (CD 2))\n",
      "                  (CC or)\n",
      "                  (NP (CD 3) (NN asymptomatic)))\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (NN grade) (CD 2))\n",
      "                  (CC or)\n",
      "                  (NP (CD 3) (NN symptomatic)))))\n",
      "            (, ,)\n",
      "            (ADVP (RB respectively))))))\n",
      "    (. .)))\n",
      "\n",
      "det(change-3, the-1)\n",
      "amod(change-3, absolute-2)\n",
      "nsubj(use-6, change-3)\n",
      "case(ACEI-inhibitor-5, of-4)\n",
      "nmod:of(change-3, ACEI-inhibitor-5)\n",
      "root(ROOT-0, use-6)\n",
      "mark(increased-12, before-7)\n",
      "cc(increased-12, and-8)\n",
      "advmod(increased-12, after-9)\n",
      "det(echocardiogram-11, the-10)\n",
      "nsubj(increased-12, echocardiogram-11)\n",
      "advcl(use-6, increased-12)\n",
      "case(14-14, by-13)\n",
      "nmod:by(increased-12, 14-14)\n",
      "amod(14-14, 19-16)\n",
      "amod(14-14, 23-18)\n",
      "appos(14-14, 27-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(27-20, patients-22)\n",
      "case(dd-24, without-23)\n",
      "nmod:without(patients-22, dd-24)\n",
      "appos(14-14, those-26)\n",
      "case(grade-28, with-27)\n",
      "nmod:with(those-26, grade-28)\n",
      "nummod(grade-28, 1-29)\n",
      "nmod:by(increased-12, grade-31)\n",
      "conj:and(14-14, grade-31)\n",
      "nummod(grade-31, 2-32)\n",
      "cc(grade-31, or-33)\n",
      "nummod(asymptomatic-35, 3-34)\n",
      "conj:and(14-14, asymptomatic-35)\n",
      "conj:or(grade-31, asymptomatic-35)\n",
      "cc(14-14, and-36)\n",
      "nmod:by(increased-12, grade-37)\n",
      "conj:and(14-14, grade-37)\n",
      "nummod(grade-37, 2-38)\n",
      "cc(grade-37, or-39)\n",
      "nummod(symptomatic-41, 3-40)\n",
      "conj:and(14-14, symptomatic-41)\n",
      "conj:or(grade-37, symptomatic-41)\n",
      "advmod(increased-12, respectively-43)\n",
      "\n",
      "Parsing [sent. 28 len. 13]: the use of Î²-blocker , statin , and diuretic had similar trends .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN Î²-blocker))\n",
      "          (, ,)\n",
      "          (NP (NN statin))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP (NN diuretic)))))\n",
      "    (VP (VBD had)\n",
      "      (NP (JJ similar) (NNS trends)))\n",
      "    (. .)))\n",
      "\n",
      "det(use-2, the-1)\n",
      "nsubj(had-10, use-2)\n",
      "case(Î²-blocker-4, of-3)\n",
      "nmod:of(use-2, Î²-blocker-4)\n",
      "nmod:of(use-2, statin-6)\n",
      "conj:and(Î²-blocker-4, statin-6)\n",
      "cc(Î²-blocker-4, and-8)\n",
      "nmod:of(use-2, diuretic-9)\n",
      "conj:and(Î²-blocker-4, diuretic-9)\n",
      "root(ROOT-0, had-10)\n",
      "amod(trends-12, similar-11)\n",
      "dobj(had-10, trends-12)\n",
      "\n",
      "Parsing [sent. 29 len. 15]: a total of 514 patients -LRB- 340 females -RRB- aged 22-97 years were studied .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT a) (NN total))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (CD 514) (NNS patients))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD 340) (NNS females))\n",
      "            (-RRB- -RRB-))\n",
      "          (VP (VBN aged)\n",
      "            (NP (CD 22-97) (NNS years))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN studied)))\n",
      "    (. .)))\n",
      "\n",
      "det(total-2, a-1)\n",
      "nsubjpass(studied-14, total-2)\n",
      "case(patients-5, of-3)\n",
      "nummod(patients-5, 514-4)\n",
      "nmod:of(total-2, patients-5)\n",
      "nummod(females-8, 340-7)\n",
      "appos(patients-5, females-8)\n",
      "acl(patients-5, aged-10)\n",
      "nummod(years-12, 22-97-11)\n",
      "nmod:tmod(aged-10, years-12)\n",
      "auxpass(studied-14, were-13)\n",
      "root(ROOT-0, studied-14)\n",
      "\n",
      "Parsing [sent. 30 len. 51]: thirteen percent , 27.6 % , 26.7 % , 22.0 % , and 10.7 % were on 1 , 2 , 3 , 4 , and â¥ 5 medicines , respectively , for control of their blood pressure with the frequency of adverse effects increasing proportionately up to four medicines .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN thirteen) (NN percent))\n",
      "      (, ,)\n",
      "      (NP (CD 27.6) (NN %))\n",
      "      (, ,)\n",
      "      (NP (CD 26.7) (NN %))\n",
      "      (, ,)\n",
      "      (NP (CD 22.0) (NN %))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (CD 10.7) (NN %)))\n",
      "    (VP (VBD were)\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (CD 1))\n",
      "          (, ,)\n",
      "          (NP (CD 2))\n",
      "          (, ,)\n",
      "          (NP (CD 3))\n",
      "          (, ,)\n",
      "          (NP (CD 4))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (QP (CD â¥) (CD 5))\n",
      "            (NNS medicines))))\n",
      "      (, ,)\n",
      "      (ADVP (RB respectively))\n",
      "      (, ,)\n",
      "      (PP (IN for)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (NN control))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (PRP$ their) (NN blood) (NN pressure))\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN frequency))\n",
      "                    (PP (IN of)\n",
      "                      (NP (JJ adverse) (NNS effects))))))))\n",
      "          (VP (VBG increasing)\n",
      "            (NP (NN proportionately))\n",
      "            (PRT (RP up))\n",
      "            (PP (TO to)\n",
      "              (NP (CD four) (NNS medicines)))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(percent-2, thirteen-1)\n",
      "nsubj(1-18, percent-2)\n",
      "nummod(%-5, 27.6-4)\n",
      "conj:and(percent-2, %-5)\n",
      "nsubj(1-18, %-5)\n",
      "nummod(%-8, 26.7-7)\n",
      "conj:and(percent-2, %-8)\n",
      "nsubj(1-18, %-8)\n",
      "nummod(%-11, 22.0-10)\n",
      "conj:and(percent-2, %-11)\n",
      "nsubj(1-18, %-11)\n",
      "cc(percent-2, and-13)\n",
      "nummod(%-15, 10.7-14)\n",
      "conj:and(percent-2, %-15)\n",
      "nsubj(1-18, %-15)\n",
      "cop(1-18, were-16)\n",
      "case(1-18, on-17)\n",
      "root(ROOT-0, 1-18)\n",
      "conj:and(1-18, 2-20)\n",
      "conj:and(1-18, 3-22)\n",
      "conj:and(1-18, 4-24)\n",
      "cc(1-18, and-26)\n",
      "compound(5-28, â¥-27)\n",
      "nummod(medicines-29, 5-28)\n",
      "conj:and(1-18, medicines-29)\n",
      "advmod(1-18, respectively-31)\n",
      "mark(increasing-45, for-33)\n",
      "nsubj(increasing-45, control-34)\n",
      "case(pressure-38, of-35)\n",
      "nmod:poss(pressure-38, their-36)\n",
      "compound(pressure-38, blood-37)\n",
      "nmod:of(control-34, pressure-38)\n",
      "case(frequency-41, with-39)\n",
      "det(frequency-41, the-40)\n",
      "nmod:with(pressure-38, frequency-41)\n",
      "case(effects-44, of-42)\n",
      "amod(effects-44, adverse-43)\n",
      "nmod:of(frequency-41, effects-44)\n",
      "advcl(1-18, increasing-45)\n",
      "dobj(increasing-45, proportionately-46)\n",
      "compound:prt(increasing-45, up-47)\n",
      "case(medicines-50, to-48)\n",
      "nummod(medicines-50, four-49)\n",
      "nmod:to(increasing-45, medicines-50)\n",
      "\n",
      "Parsing [sent. 31 len. 18]: adverse reactions to antihypertensive medicines were reported by a total of 93 -LRB- 18.1 % -RRB- patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ adverse) (NNS reactions))\n",
      "      (PP (TO to)\n",
      "        (NP (JJ antihypertensive) (NNS medicines))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN reported)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (DT a) (NN total))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ 93)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (QP (CD 18.1) (NN %)))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS patients)))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(reactions-2, adverse-1)\n",
      "nsubjpass(reported-7, reactions-2)\n",
      "case(medicines-5, to-3)\n",
      "amod(medicines-5, antihypertensive-4)\n",
      "nmod:to(reactions-2, medicines-5)\n",
      "auxpass(reported-7, were-6)\n",
      "root(ROOT-0, reported-7)\n",
      "case(total-10, by-8)\n",
      "det(total-10, a-9)\n",
      "nmod:by(reported-7, total-10)\n",
      "case(patients-17, of-11)\n",
      "amod(patients-17, 93-12)\n",
      "compound(%-15, 18.1-14)\n",
      "dep(patients-17, %-15)\n",
      "nmod:of(total-10, patients-17)\n",
      "\n",
      "Parsing [sent. 32 len. 53]: diuretics - 27.9 % , calcium channel blockers -LRB- ccbs -RRB- - 26.8 % , and ACEI - 26.8 % accounted for most of the adverse reactions seen , notably frequent micturition and headaches -LRB- ccb -RRB- ; excessive micturition and dizziness -LRB- diuretics -RRB- ; dry irritating cough -LRB- ACEI -RRB- .\n",
      "(ROOT\n",
      "  (NP\n",
      "    (NP (NNS diuretics))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 27.9) (NN %))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBZ ccbs))\n",
      "          (-RRB- -RRB-))))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 26.8) (NN %))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NNP ACEI)))\n",
      "    (: -)\n",
      "    (NP\n",
      "      (NP (CD 26.8) (NN %))\n",
      "      (VP (VBN accounted)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (JJS most))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT the) (JJ adverse) (NNS reactions))\n",
      "                        (VP (VBN seen)))\n",
      "                      (, ,)\n",
      "                      (ADVP (RB notably))\n",
      "                      (NP\n",
      "                        (NP (JJ frequent) (NN micturition)\n",
      "                          (CC and)\n",
      "                          (NNS headaches))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NN ccb))\n",
      "                          (-RRB- -RRB-))))))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP (JJ excessive) (NN micturition))\n",
      "                  (CC and)\n",
      "                  (NP (NN dizziness))))\n",
      "              (-LRB- -LRB-)\n",
      "              (NP (NNS diuretics))\n",
      "              (-RRB- -RRB-))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP (JJ dry) (VBG irritating) (NN cough))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP ACEI))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, diuretics-1)\n",
      "nummod(%-4, 27.9-3)\n",
      "dep(diuretics-1, %-4)\n",
      "compound(blockers-8, calcium-6)\n",
      "compound(blockers-8, channel-7)\n",
      "appos(%-4, blockers-8)\n",
      "dep(blockers-8, ccbs-10)\n",
      "nummod(%-14, 26.8-13)\n",
      "dep(diuretics-1, %-14)\n",
      "cc(%-14, and-16)\n",
      "dep(diuretics-1, ACEI-17)\n",
      "conj:and(%-14, ACEI-17)\n",
      "nummod(%-20, 26.8-19)\n",
      "dep(diuretics-1, %-20)\n",
      "acl(%-20, accounted-21)\n",
      "case(most-23, for-22)\n",
      "nmod:for(accounted-21, most-23)\n",
      "case(reactions-27, of-24)\n",
      "det(reactions-27, the-25)\n",
      "amod(reactions-27, adverse-26)\n",
      "nmod:of(most-23, reactions-27)\n",
      "acl(reactions-27, seen-28)\n",
      "advmod(micturition-32, notably-30)\n",
      "amod(micturition-32, frequent-31)\n",
      "appos(reactions-27, micturition-32)\n",
      "cc(micturition-32, and-33)\n",
      "appos(reactions-27, headaches-34)\n",
      "conj:and(micturition-32, headaches-34)\n",
      "appos(micturition-32, ccb-36)\n",
      "amod(micturition-40, excessive-39)\n",
      "dep(most-23, micturition-40)\n",
      "cc(micturition-40, and-41)\n",
      "dep(most-23, dizziness-42)\n",
      "conj:and(micturition-40, dizziness-42)\n",
      "dep(most-23, diuretics-44)\n",
      "amod(cough-49, dry-47)\n",
      "amod(cough-49, irritating-48)\n",
      "dep(most-23, cough-49)\n",
      "appos(cough-49, ACEI-51)\n",
      "\n",
      "Parsing [sent. 33 len. 21]: notable complaints for all patients using the checklist were increased frequency of micturition , reduction in libido , and headaches .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ notable) (NNS complaints))\n",
      "      (PP (IN for)\n",
      "        (NP\n",
      "          (NP (DT all) (NNS patients))\n",
      "          (VP (VBG using)\n",
      "            (NP (DT the) (NN checklist))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN increased)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NN frequency))\n",
      "            (PP (IN of)\n",
      "              (NP (NN micturition))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (NN reduction))\n",
      "            (PP (IN in)\n",
      "              (NP (NN libido))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP (NNS headaches)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(complaints-2, notable-1)\n",
      "nsubjpass(increased-10, complaints-2)\n",
      "case(patients-5, for-3)\n",
      "det(patients-5, all-4)\n",
      "nmod:for(complaints-2, patients-5)\n",
      "acl(patients-5, using-6)\n",
      "det(checklist-8, the-7)\n",
      "dobj(using-6, checklist-8)\n",
      "auxpass(increased-10, were-9)\n",
      "root(ROOT-0, increased-10)\n",
      "dobj(increased-10, frequency-11)\n",
      "case(micturition-13, of-12)\n",
      "nmod:of(frequency-11, micturition-13)\n",
      "dobj(increased-10, reduction-15)\n",
      "conj:and(frequency-11, reduction-15)\n",
      "case(libido-17, in-16)\n",
      "nmod:in(reduction-15, libido-17)\n",
      "cc(frequency-11, and-19)\n",
      "dobj(increased-10, headaches-20)\n",
      "conj:and(frequency-11, headaches-20)\n",
      "\n",
      "Parsing [sent. 34 len. 17]: the reactions resulted in the discontinuation and substitution of therapy in 49.5 % of the patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNS reactions))\n",
      "    (VP (VBD resulted)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the) (NN discontinuation)\n",
      "            (CC and)\n",
      "            (NN substitution))\n",
      "          (PP (IN of)\n",
      "            (NP (NN therapy)))))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (CD 49.5) (NN %))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NNS patients))))))\n",
      "    (. .)))\n",
      "\n",
      "det(reactions-2, the-1)\n",
      "nsubj(resulted-3, reactions-2)\n",
      "root(ROOT-0, resulted-3)\n",
      "case(discontinuation-6, in-4)\n",
      "det(discontinuation-6, the-5)\n",
      "nmod:in(resulted-3, discontinuation-6)\n",
      "cc(discontinuation-6, and-7)\n",
      "nmod:in(resulted-3, substitution-8)\n",
      "conj:and(discontinuation-6, substitution-8)\n",
      "case(therapy-10, of-9)\n",
      "nmod:of(discontinuation-6, therapy-10)\n",
      "case(%-13, in-11)\n",
      "nummod(%-13, 49.5-12)\n",
      "nmod:in(resulted-3, %-13)\n",
      "case(patients-16, of-14)\n",
      "det(patients-16, the-15)\n",
      "nmod:of(%-13, patients-16)\n",
      "\n",
      "Parsing [sent. 35 len. 28]: in clinical setting , congestive heart failure -LRB- chf -RRB- and chronic kidney disease -LRB- ckd -RRB- often co-exist in patients due to common underlying predisposing factors .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (JJ clinical) (NN setting)))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (JJ congestive) (NN heart) (NN failure))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN chf))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (JJ chronic) (NN kidney) (NN disease)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN ckd))\n",
      "        (-RRB- -RRB-)))\n",
      "    (ADVP (RB often))\n",
      "    (VP (VB co-exist)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (ADJP (JJ due)\n",
      "            (PP (TO to)\n",
      "              (NP (JJ common) (JJ underlying) (NN predisposing) (NNS factors)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(setting-3, in-1)\n",
      "amod(setting-3, clinical-2)\n",
      "nmod:in(co-exist-19, setting-3)\n",
      "amod(failure-7, congestive-5)\n",
      "compound(failure-7, heart-6)\n",
      "nsubj(co-exist-19, failure-7)\n",
      "appos(failure-7, chf-9)\n",
      "cc(failure-7, and-11)\n",
      "amod(disease-14, chronic-12)\n",
      "compound(disease-14, kidney-13)\n",
      "conj:and(failure-7, disease-14)\n",
      "nsubj(co-exist-19, disease-14)\n",
      "appos(failure-7, ckd-16)\n",
      "advmod(co-exist-19, often-18)\n",
      "root(ROOT-0, co-exist-19)\n",
      "case(patients-21, in-20)\n",
      "nmod:in(co-exist-19, patients-21)\n",
      "amod(patients-21, due-22)\n",
      "case(factors-27, to-23)\n",
      "amod(factors-27, common-24)\n",
      "amod(factors-27, underlying-25)\n",
      "compound(factors-27, predisposing-26)\n",
      "nmod:to(due-22, factors-27)\n",
      "\n",
      "Parsing [sent. 36 len. 20]: an intricate equilibrium between the cardiovascular and renal system is maintained through rennin angiotensin-aldosterone axis and autonomic nervous system .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT an) (JJ intricate) (NN equilibrium))\n",
      "      (PP (IN between)\n",
      "        (NP (DT the) (JJ cardiovascular)\n",
      "          (CC and)\n",
      "          (JJ renal) (NN system))))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN maintained)\n",
      "        (PP (IN through)\n",
      "          (NP\n",
      "            (NP (JJ rennin) (JJ angiotensin-aldosterone) (NNS axis))\n",
      "            (CC and)\n",
      "            (NP (JJ autonomic) (JJ nervous) (NN system))))))\n",
      "    (. .)))\n",
      "\n",
      "det(equilibrium-3, an-1)\n",
      "amod(equilibrium-3, intricate-2)\n",
      "nsubjpass(maintained-11, equilibrium-3)\n",
      "case(system-9, between-4)\n",
      "det(system-9, the-5)\n",
      "amod(system-9, cardiovascular-6)\n",
      "cc(cardiovascular-6, and-7)\n",
      "conj:and(cardiovascular-6, renal-8)\n",
      "amod(system-9, renal-8)\n",
      "nmod:between(equilibrium-3, system-9)\n",
      "auxpass(maintained-11, is-10)\n",
      "root(ROOT-0, maintained-11)\n",
      "case(axis-15, through-12)\n",
      "amod(axis-15, rennin-13)\n",
      "amod(axis-15, angiotensin-aldosterone-14)\n",
      "nmod:through(maintained-11, axis-15)\n",
      "cc(axis-15, and-16)\n",
      "amod(system-19, autonomic-17)\n",
      "amod(system-19, nervous-18)\n",
      "nmod:through(maintained-11, system-19)\n",
      "conj:and(axis-15, system-19)\n",
      "\n",
      "Parsing [sent. 37 len. 32]: consequent to favorable hemodynamic modification , ACEI and angiotensin receptor blocking -LRB- arb -RRB- therapy have proven to be an indispensable aspect of heart failure management with morbidity and mortality benefit .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (JJ consequent)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (JJ favorable) (JJ hemodynamic) (NN modification))\n",
      "            (, ,)\n",
      "            (NP (NNP ACEI))\n",
      "            (CC and)\n",
      "            (NP (NN angiotensin)))))\n",
      "      (JJ receptor) (FW blocking)\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN arb))\n",
      "        (-RRB- -RRB-))\n",
      "      (NN therapy))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN proven)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ indispensable) (NN aspect))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NN heart) (NN failure) (NN management))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN morbidity)\n",
      "                        (CC and)\n",
      "                        (NN mortality) (NN benefit)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-15, consequent-1)\n",
      "case(modification-5, to-2)\n",
      "amod(modification-5, favorable-3)\n",
      "amod(modification-5, hemodynamic-4)\n",
      "nmod:to(consequent-1, modification-5)\n",
      "nmod:to(consequent-1, ACEI-7)\n",
      "conj:and(modification-5, ACEI-7)\n",
      "cc(modification-5, and-8)\n",
      "nmod:to(consequent-1, angiotensin-9)\n",
      "conj:and(modification-5, angiotensin-9)\n",
      "amod(therapy-15, receptor-10)\n",
      "compound(therapy-15, blocking-11)\n",
      "appos(therapy-15, arb-13)\n",
      "nsubj(proven-17, therapy-15)\n",
      "nsubj:xsubj(aspect-22, therapy-15)\n",
      "aux(proven-17, have-16)\n",
      "root(ROOT-0, proven-17)\n",
      "mark(aspect-22, to-18)\n",
      "cop(aspect-22, be-19)\n",
      "det(aspect-22, an-20)\n",
      "amod(aspect-22, indispensable-21)\n",
      "xcomp(proven-17, aspect-22)\n",
      "case(management-26, of-23)\n",
      "compound(management-26, heart-24)\n",
      "compound(management-26, failure-25)\n",
      "nmod:of(aspect-22, management-26)\n",
      "case(benefit-31, with-27)\n",
      "compound(benefit-31, morbidity-28)\n",
      "cc(morbidity-28, and-29)\n",
      "conj:and(morbidity-28, mortality-30)\n",
      "compound(benefit-31, mortality-30)\n",
      "nmod:with(management-26, benefit-31)\n",
      "\n",
      "Parsing [sent. 38 len. 27]: additionally , progression to end stage renal failure may be halted by renin angiotensin aldosterone system -LRB- raas -RRB- blockade in patients with preexisting renal dysfunction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB additionally))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN progression))\n",
      "      (PP (TO to)\n",
      "        (NP (NN end) (NN stage) (JJ renal) (NN failure))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN halted)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (JJ renin)\n",
      "                (ADJP (RB angiotensin) (JJ aldosterone))\n",
      "                (NN system)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNS raas))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NN blockade))\n",
      "              (PP (IN in)\n",
      "                (NP (NNS patients)))))\n",
      "          (PP (IN with)\n",
      "            (S\n",
      "              (VP (VBG preexisting)\n",
      "                (NP (JJ renal) (NN dysfunction))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(halted-11, additionally-1)\n",
      "nsubjpass(halted-11, progression-3)\n",
      "case(failure-8, to-4)\n",
      "compound(failure-8, end-5)\n",
      "compound(failure-8, stage-6)\n",
      "amod(failure-8, renal-7)\n",
      "nmod:to(progression-3, failure-8)\n",
      "aux(halted-11, may-9)\n",
      "auxpass(halted-11, be-10)\n",
      "root(ROOT-0, halted-11)\n",
      "case(blockade-20, by-12)\n",
      "amod(blockade-20, renin-13)\n",
      "advmod(aldosterone-15, angiotensin-14)\n",
      "amod(blockade-20, aldosterone-15)\n",
      "compound(blockade-20, system-16)\n",
      "appos(blockade-20, raas-18)\n",
      "nmod:by(halted-11, blockade-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(blockade-20, patients-22)\n",
      "mark(preexisting-24, with-23)\n",
      "advcl(halted-11, preexisting-24)\n",
      "amod(dysfunction-26, renal-25)\n",
      "dobj(preexisting-24, dysfunction-26)\n",
      "\n",
      "Parsing [sent. 39 len. 29]: however , concern over the safety of raas blockade in presence of renal impairment has led to profound underutilization of these drugs in chf patients with renal insufficiency .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN concern))\n",
      "      (PP (IN over)\n",
      "        (NP\n",
      "          (NP (DT the) (NN safety))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ raas) (NN blockade))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NN presence))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ renal) (NN impairment))))))))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN led)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (JJ profound) (NN underutilization))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT these) (NNS drugs))\n",
      "                (PP (IN in)\n",
      "                  (NP (NN chf) (NNS patients)))))))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ renal) (NN insufficiency)))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(led-16, however-1)\n",
      "nsubj(led-16, concern-3)\n",
      "case(safety-6, over-4)\n",
      "det(safety-6, the-5)\n",
      "nmod:over(concern-3, safety-6)\n",
      "case(blockade-9, of-7)\n",
      "amod(blockade-9, raas-8)\n",
      "nmod:of(safety-6, blockade-9)\n",
      "case(presence-11, in-10)\n",
      "nmod:in(blockade-9, presence-11)\n",
      "case(impairment-14, of-12)\n",
      "amod(impairment-14, renal-13)\n",
      "nmod:of(presence-11, impairment-14)\n",
      "aux(led-16, has-15)\n",
      "root(ROOT-0, led-16)\n",
      "case(underutilization-19, to-17)\n",
      "amod(underutilization-19, profound-18)\n",
      "nmod:to(led-16, underutilization-19)\n",
      "case(drugs-22, of-20)\n",
      "det(drugs-22, these-21)\n",
      "nmod:of(underutilization-19, drugs-22)\n",
      "case(patients-25, in-23)\n",
      "compound(patients-25, chf-24)\n",
      "nmod:in(drugs-22, patients-25)\n",
      "case(insufficiency-28, with-26)\n",
      "amod(insufficiency-28, renal-27)\n",
      "nmod:with(led-16, insufficiency-28)\n",
      "\n",
      "Parsing [sent. 40 len. 18]: this review aims to provide a simplified guide to pathophysiology and management options of this perplexing situation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN review))\n",
      "    (VP (VBZ aims)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB provide)\n",
      "            (NP (DT a) (VBN simplified) (NN guide))\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN pathophysiology)\n",
      "                  (CC and)\n",
      "                  (NN management) (NNS options))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT this) (JJ perplexing) (NN situation)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(review-2, this-1)\n",
      "nsubj(aims-3, review-2)\n",
      "nsubj:xsubj(provide-5, review-2)\n",
      "root(ROOT-0, aims-3)\n",
      "mark(provide-5, to-4)\n",
      "xcomp(aims-3, provide-5)\n",
      "det(guide-8, a-6)\n",
      "amod(guide-8, simplified-7)\n",
      "dobj(provide-5, guide-8)\n",
      "case(options-13, to-9)\n",
      "compound(options-13, pathophysiology-10)\n",
      "cc(pathophysiology-10, and-11)\n",
      "conj:and(pathophysiology-10, management-12)\n",
      "compound(options-13, management-12)\n",
      "nmod:to(provide-5, options-13)\n",
      "case(situation-17, of-14)\n",
      "det(situation-17, this-15)\n",
      "amod(situation-17, perplexing-16)\n",
      "nmod:of(options-13, situation-17)\n",
      "\n",
      "Parsing [sent. 41 len. 19]: dihydropyridine calcium channel blockers may possess antioxidant properties , and might improve micro and macrovascular structure and function .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ dihydropyridine) (NN calcium) (NN channel) (NNS blockers))\n",
      "    (VP\n",
      "      (VP (MD may)\n",
      "        (VP (VB possess)\n",
      "          (NP (JJ antioxidant) (NNS properties))))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (VP (MD might)\n",
      "        (VP (VB improve)\n",
      "          (NP (JJ micro)\n",
      "            (CC and)\n",
      "            (NN macrovascular) (NN structure)\n",
      "            (CC and)\n",
      "            (NN function)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(blockers-4, dihydropyridine-1)\n",
      "compound(blockers-4, calcium-2)\n",
      "compound(blockers-4, channel-3)\n",
      "nsubj(possess-6, blockers-4)\n",
      "nsubj(improve-12, blockers-4)\n",
      "aux(possess-6, may-5)\n",
      "root(ROOT-0, possess-6)\n",
      "amod(properties-8, antioxidant-7)\n",
      "dobj(possess-6, properties-8)\n",
      "cc(possess-6, and-10)\n",
      "aux(improve-12, might-11)\n",
      "conj:and(possess-6, improve-12)\n",
      "amod(structure-16, micro-13)\n",
      "cc(micro-13, and-14)\n",
      "conj:and(micro-13, macrovascular-15)\n",
      "amod(structure-16, macrovascular-15)\n",
      "dobj(improve-12, structure-16)\n",
      "cc(structure-16, and-17)\n",
      "dobj(improve-12, function-18)\n",
      "conj:and(structure-16, function-18)\n",
      "\n",
      "Parsing [sent. 42 len. 16]: combination treatment with an ACEI may have additional advantages , compared with a thiazide diuretic .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN combination) (NN treatment))\n",
      "      (PP (IN with)\n",
      "        (NP (DT an) (NNP ACEI))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB have)\n",
      "        (NP (JJ additional) (NNS advantages))\n",
      "        (, ,)\n",
      "        (PP (VBN compared)\n",
      "          (PP (IN with)\n",
      "            (NP (DT a) (JJ thiazide) (NN diuretic))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(treatment-2, combination-1)\n",
      "nsubj(have-7, treatment-2)\n",
      "case(ACEI-5, with-3)\n",
      "det(ACEI-5, an-4)\n",
      "nmod:with(treatment-2, ACEI-5)\n",
      "aux(have-7, may-6)\n",
      "root(ROOT-0, have-7)\n",
      "amod(advantages-9, additional-8)\n",
      "dobj(have-7, advantages-9)\n",
      "case(diuretic-15, compared-11)\n",
      "mwe(compared-11, with-12)\n",
      "det(diuretic-15, a-13)\n",
      "amod(diuretic-15, thiazide-14)\n",
      "advcl(have-7, diuretic-15)\n",
      "\n",
      "Parsing [sent. 43 len. 49]: the aim of the present study is to investigate the effects of a short-term treatment with lercanidipine , and to compare two combination treatments : lercanidipine + enalapril vs. lercanidipine + hydrochlorothiazide on structural alterations in retinal arterioles , on skin capillary density and on large artery distensibility .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN aim))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ present) (NN study))))\n",
      "    (VP (VBZ is)\n",
      "      (S\n",
      "        (VP\n",
      "          (VP (TO to)\n",
      "            (VP (VB investigate)\n",
      "              (NP\n",
      "                (NP (DT the) (NNS effects))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT a) (JJ short-term) (NN treatment))))\n",
      "              (PP (IN with)\n",
      "                (NP (NN lercanidipine)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (VP (TO to)\n",
      "            (VP (VB compare)\n",
      "              (NP\n",
      "                (NP (CD two) (NN combination) (NNS treatments))\n",
      "                (: :)\n",
      "                (NP\n",
      "                  (NP (JJ lercanidipine) (JJ +) (NN enalapril))\n",
      "                  (PP (IN vs.)\n",
      "                    (NP\n",
      "                      (NP (JJ lercanidipine) (JJ +) (NN hydrochlorothiazide))\n",
      "                      (PP (IN on)\n",
      "                        (NP\n",
      "                          (NP (JJ structural) (NNS alterations))\n",
      "                          (PP (IN in)\n",
      "                            (NP (JJ retinal) (NNS arterioles))))))))\n",
      "                (, ,))\n",
      "              (PP\n",
      "                (PP (IN on)\n",
      "                  (NP (NN skin) (NN capillary) (NN density)))\n",
      "                (CC and)\n",
      "                (PP (IN on)\n",
      "                  (NP (JJ large) (NN artery) (NN distensibility)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(aim-2, the-1)\n",
      "nsubj(is-7, aim-2)\n",
      "case(study-6, of-3)\n",
      "det(study-6, the-4)\n",
      "amod(study-6, present-5)\n",
      "nmod:of(aim-2, study-6)\n",
      "root(ROOT-0, is-7)\n",
      "mark(investigate-9, to-8)\n",
      "ccomp(is-7, investigate-9)\n",
      "det(effects-11, the-10)\n",
      "dobj(investigate-9, effects-11)\n",
      "case(treatment-15, of-12)\n",
      "det(treatment-15, a-13)\n",
      "amod(treatment-15, short-term-14)\n",
      "nmod:of(effects-11, treatment-15)\n",
      "case(lercanidipine-17, with-16)\n",
      "nmod:with(investigate-9, lercanidipine-17)\n",
      "cc(investigate-9, and-19)\n",
      "mark(compare-21, to-20)\n",
      "ccomp(is-7, compare-21)\n",
      "conj:and(investigate-9, compare-21)\n",
      "conj:and(investigate-9, compare-21')\n",
      "conj:and(compare-21, compare-21')\n",
      "nummod(treatments-24, two-22)\n",
      "compound(treatments-24, combination-23)\n",
      "dobj(compare-21, treatments-24)\n",
      "amod(enalapril-28, lercanidipine-26)\n",
      "amod(enalapril-28, +-27)\n",
      "dep(treatments-24, enalapril-28)\n",
      "case(hydrochlorothiazide-32, vs.-29)\n",
      "amod(hydrochlorothiazide-32, lercanidipine-30)\n",
      "amod(hydrochlorothiazide-32, +-31)\n",
      "nmod:vs.(enalapril-28, hydrochlorothiazide-32)\n",
      "case(alterations-35, on-33)\n",
      "amod(alterations-35, structural-34)\n",
      "nmod:on(hydrochlorothiazide-32, alterations-35)\n",
      "case(arterioles-38, in-36)\n",
      "amod(arterioles-38, retinal-37)\n",
      "nmod:in(alterations-35, arterioles-38)\n",
      "case(density-43, on-40)\n",
      "compound(density-43, skin-41)\n",
      "compound(density-43, capillary-42)\n",
      "nmod:on(compare-21, density-43)\n",
      "cc(compare-21, and-44)\n",
      "case(distensibility-48, on-45)\n",
      "amod(distensibility-48, large-46)\n",
      "compound(distensibility-48, artery-47)\n",
      "nmod:on(compare-21', distensibility-48)\n",
      "\n",
      "Parsing [sent. 44 len. 23]: thirty essential hypertension patients are included in the study , and treated for 4 weeks with lercanidipine 20 mg per day orally .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (CD thirty) (JJ essential))\n",
      "      (NN hypertension) (NNS patients))\n",
      "    (VP (VBP are)\n",
      "      (VP\n",
      "        (VP (VBN included)\n",
      "          (PP (IN in)\n",
      "            (NP (DT the) (NN study))))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (VP (VBN treated)\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (CD 4) (NNS weeks))\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (ADJP (JJ lercanidipine)\n",
      "                      (NP (CD 20)))\n",
      "                    (NN mg))\n",
      "                  (PP (IN per)\n",
      "                    (NP (NN day) (NN orally))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(essential-2, thirty-1)\n",
      "amod(patients-4, essential-2)\n",
      "compound(patients-4, hypertension-3)\n",
      "nsubjpass(included-6, patients-4)\n",
      "nsubjpass(treated-12, patients-4)\n",
      "auxpass(included-6, are-5)\n",
      "root(ROOT-0, included-6)\n",
      "case(study-9, in-7)\n",
      "det(study-9, the-8)\n",
      "nmod:in(included-6, study-9)\n",
      "cc(included-6, and-11)\n",
      "conj:and(included-6, treated-12)\n",
      "case(weeks-15, for-13)\n",
      "nummod(weeks-15, 4-14)\n",
      "nmod:for(treated-12, weeks-15)\n",
      "case(mg-19, with-16)\n",
      "amod(mg-19, lercanidipine-17)\n",
      "dep(lercanidipine-17, 20-18)\n",
      "nmod:with(weeks-15, mg-19)\n",
      "case(orally-22, per-20)\n",
      "compound(orally-22, day-21)\n",
      "nmod:per(mg-19, orally-22)\n",
      "\n",
      "Parsing [sent. 45 len. 28]: then , they were treated for 6 months with lercanidipine + enalapril -LRB- n = 15 -RRB- or lercanidipine + hydrochlorothiazide -LRB- n = 15 -RRB- combinations .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB then))\n",
      "    (, ,)\n",
      "    (NP (PRP they))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN treated)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (CD 6) (NNS months))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ lercanidipine) (JJ +) (NN enalapril))))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 15)))))\n",
      "              (-RRB- -RRB-))\n",
      "            (CC or)\n",
      "            (NP\n",
      "              (ADJP (JJ lercanidipine) (JJ +))\n",
      "              (JJ hydrochlorothiazide)\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 15)))))\n",
      "                (-RRB- -RRB-))\n",
      "              (NN combinations))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(treated-5, then-1)\n",
      "nsubjpass(treated-5, they-3)\n",
      "auxpass(treated-5, were-4)\n",
      "root(ROOT-0, treated-5)\n",
      "case(months-8, for-6)\n",
      "nummod(months-8, 6-7)\n",
      "nmod:for(treated-5, months-8)\n",
      "case(enalapril-12, with-9)\n",
      "amod(enalapril-12, lercanidipine-10)\n",
      "amod(enalapril-12, +-11)\n",
      "nmod:with(months-8, enalapril-12)\n",
      "dep(months-8, n-14)\n",
      "dep(15-16, =-15)\n",
      "ccomp(n-14, 15-16)\n",
      "cc(months-8, or-18)\n",
      "amod(+-20, lercanidipine-19)\n",
      "amod(combinations-27, +-20)\n",
      "amod(combinations-27, hydrochlorothiazide-21)\n",
      "dep(combinations-27, n-23)\n",
      "dep(15-25, =-24)\n",
      "ccomp(n-23, 15-25)\n",
      "nmod:for(treated-5, combinations-27)\n",
      "conj:or(months-8, combinations-27)\n",
      "\n",
      "Parsing [sent. 46 len. 32]: investigations were performed on basal condition , after appropriate wash out of previous treatments , after 4 weeks of lercanidipine monotherapy treatment , and at the end of the combination treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS investigations))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN performed)\n",
      "        (PP\n",
      "          (PP (IN on)\n",
      "            (NP (JJ basal) (NN condition)))\n",
      "          (, ,)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (JJ appropriate) (NN wash))\n",
      "              (PP (RB out) (IN of)\n",
      "                (NP (JJ previous) (NNS treatments)))))\n",
      "          (, ,)\n",
      "          (PP (IN after)\n",
      "            (NP\n",
      "              (NP (CD 4) (NNS weeks))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ lercanidipine) (JJ monotherapy) (NN treatment)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (PP (IN at)\n",
      "            (NP\n",
      "              (NP (DT the) (NN end))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN combination) (NN treatment))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(performed-3, investigations-1)\n",
      "nsubjpass(performed-3', investigations-1)\n",
      "nsubjpass(performed-3'', investigations-1)\n",
      "nsubjpass(performed-3''', investigations-1)\n",
      "auxpass(performed-3, were-2)\n",
      "root(ROOT-0, performed-3)\n",
      "conj:and(performed-3, performed-3')\n",
      "conj:and(performed-3, performed-3'')\n",
      "conj:and(performed-3, performed-3''')\n",
      "case(condition-6, on-4)\n",
      "amod(condition-6, basal-5)\n",
      "nmod:on(performed-3, condition-6)\n",
      "case(wash-10, after-8)\n",
      "amod(wash-10, appropriate-9)\n",
      "nmod:after(performed-3'', wash-10)\n",
      "case(treatments-14, out-11)\n",
      "mwe(out-11, of-12)\n",
      "amod(treatments-14, previous-13)\n",
      "nmod:out_of(wash-10, treatments-14)\n",
      "case(weeks-18, after-16)\n",
      "nummod(weeks-18, 4-17)\n",
      "nmod:after(performed-3', weeks-18)\n",
      "case(treatment-22, of-19)\n",
      "amod(treatment-22, lercanidipine-20)\n",
      "amod(treatment-22, monotherapy-21)\n",
      "nmod:of(weeks-18, treatment-22)\n",
      "cc(performed-3, and-24)\n",
      "case(end-27, at-25)\n",
      "det(end-27, the-26)\n",
      "nmod:at(performed-3''', end-27)\n",
      "case(treatment-31, of-28)\n",
      "det(treatment-31, the-29)\n",
      "compound(treatment-31, combination-30)\n",
      "nmod:of(end-27, treatment-31)\n",
      "\n",
      "Parsing [sent. 47 len. 27]: non-invasive measurements of wall-to-lumen ratio -LRB- wlr -RRB- and other morphological parameters of retinal arterioles were performed using either scanning laser doppler flowmetry or adaptive optics .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (ADJP (JJ non-invasive))\n",
      "        (NNS measurements))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ wall-to-lumen) (NN ratio))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NN wlr))\n",
      "              (-RRB- -RRB-)))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (JJ other) (JJ morphological) (NNS parameters))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ retinal) (NNS arterioles)))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN performed)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (CC either)\n",
      "            (VBG scanning)\n",
      "            (NP (NN laser) (NN doppler) (NN flowmetry)\n",
      "              (CC or)\n",
      "              (NN adaptive) (NNS optics))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(measurements-2, non-invasive-1)\n",
      "nsubjpass(performed-17, measurements-2)\n",
      "case(ratio-5, of-3)\n",
      "amod(ratio-5, wall-to-lumen-4)\n",
      "nmod:of(measurements-2, ratio-5)\n",
      "appos(ratio-5, wlr-7)\n",
      "cc(ratio-5, and-9)\n",
      "amod(parameters-12, other-10)\n",
      "amod(parameters-12, morphological-11)\n",
      "nmod:of(measurements-2, parameters-12)\n",
      "conj:and(ratio-5, parameters-12)\n",
      "case(arterioles-15, of-13)\n",
      "amod(arterioles-15, retinal-14)\n",
      "nmod:of(parameters-12, arterioles-15)\n",
      "auxpass(performed-17, were-16)\n",
      "root(ROOT-0, performed-17)\n",
      "xcomp(performed-17, using-18)\n",
      "dep(using-18, either-19)\n",
      "conj(using-18, scanning-20)\n",
      "compound(flowmetry-23, laser-21)\n",
      "compound(flowmetry-23, doppler-22)\n",
      "dobj(using-18, flowmetry-23)\n",
      "cc(flowmetry-23, or-24)\n",
      "compound(optics-26, adaptive-25)\n",
      "dobj(using-18, optics-26)\n",
      "conj:or(flowmetry-23, optics-26)\n",
      "\n",
      "Parsing [sent. 48 len. 25]: capillary density was evaluated by capillaroscopy , while pulse wave velocity was measured , and central blood pressures were assessed by pressure waveform analysis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ capillary) (NN density))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN evaluated)\n",
      "          (PP (IN by)\n",
      "            (NP (NN capillaroscopy)))\n",
      "          (, ,)\n",
      "          (SBAR (IN while)\n",
      "            (S\n",
      "              (NP (NN pulse) (NN wave) (NN velocity))\n",
      "              (VP (VBD was)\n",
      "                (VP (VBN measured))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ central) (NN blood) (NNS pressures))\n",
      "      (VP (VBD were)\n",
      "        (VP (VBN assessed)\n",
      "          (PP (IN by)\n",
      "            (NP (NN pressure) (NN waveform) (NN analysis))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(density-2, capillary-1)\n",
      "nsubjpass(evaluated-4, density-2)\n",
      "auxpass(evaluated-4, was-3)\n",
      "root(ROOT-0, evaluated-4)\n",
      "case(capillaroscopy-6, by-5)\n",
      "nmod:by(evaluated-4, capillaroscopy-6)\n",
      "mark(measured-13, while-8)\n",
      "compound(velocity-11, pulse-9)\n",
      "compound(velocity-11, wave-10)\n",
      "nsubjpass(measured-13, velocity-11)\n",
      "auxpass(measured-13, was-12)\n",
      "advcl(evaluated-4, measured-13)\n",
      "cc(evaluated-4, and-15)\n",
      "amod(pressures-18, central-16)\n",
      "compound(pressures-18, blood-17)\n",
      "nsubjpass(assessed-20, pressures-18)\n",
      "auxpass(assessed-20, were-19)\n",
      "conj:and(evaluated-4, assessed-20)\n",
      "case(analysis-24, by-21)\n",
      "compound(analysis-24, pressure-22)\n",
      "compound(analysis-24, waveform-23)\n",
      "nmod:by(assessed-20, analysis-24)\n",
      "\n",
      "Parsing [sent. 49 len. 49]: a significant improvement of wlr and other indices of retinal artery structure is observed with both technical approaches after treatment with lercanidipine alone , with a further improvement after treatment with lercanidipine + enalapril , while after treatment with lercanidipine + hydrochlorothiazide , the improvement is partially blunted .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT a) (JJ significant) (NN improvement))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN wlr)\n",
      "            (CC and)\n",
      "            (JJ other) (NNS indices))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ retinal) (NN artery) (NN structure))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ observed)\n",
      "        (PP (IN with)\n",
      "          (NP (DT both) (JJ technical) (NNS approaches))))\n",
      "      (PP (IN after)\n",
      "        (NP\n",
      "          (NP (NN treatment))\n",
      "          (PP (IN with)\n",
      "            (NP (NN lercanidipine)))))\n",
      "      (ADVP\n",
      "        (ADVP (RB alone))\n",
      "        (PRN (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (DT a) (JJ further) (NN improvement))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (NN treatment))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ lercanidipine) (JJ +) (NN enalapril)))))))\n",
      "          (, ,))\n",
      "        (SBAR (IN while)\n",
      "          (S\n",
      "            (PP (IN after)\n",
      "              (NP\n",
      "                (NP (NN treatment))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ lercanidipine) (JJ +) (NN hydrochlorothiazide)))))\n",
      "            (, ,)\n",
      "            (NP (DT the) (NN improvement))\n",
      "            (VP (VBZ is)\n",
      "              (ADVP (RB partially))\n",
      "              (VP (VBN blunted)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(improvement-3, a-1)\n",
      "amod(improvement-3, significant-2)\n",
      "nsubj(observed-14, improvement-3)\n",
      "case(indices-8, of-4)\n",
      "compound(indices-8, wlr-5)\n",
      "cc(wlr-5, and-6)\n",
      "conj:and(wlr-5, other-7)\n",
      "compound(indices-8, other-7)\n",
      "nmod:of(improvement-3, indices-8)\n",
      "case(structure-12, of-9)\n",
      "amod(structure-12, retinal-10)\n",
      "compound(structure-12, artery-11)\n",
      "nmod:of(indices-8, structure-12)\n",
      "cop(observed-14, is-13)\n",
      "root(ROOT-0, observed-14)\n",
      "case(approaches-18, with-15)\n",
      "det(approaches-18, both-16)\n",
      "amod(approaches-18, technical-17)\n",
      "nmod:with(observed-14, approaches-18)\n",
      "case(treatment-20, after-19)\n",
      "nmod:after(observed-14, treatment-20)\n",
      "case(lercanidipine-22, with-21)\n",
      "nmod:with(treatment-20, lercanidipine-22)\n",
      "advmod(observed-14, alone-23)\n",
      "case(improvement-28, with-25)\n",
      "det(improvement-28, a-26)\n",
      "amod(improvement-28, further-27)\n",
      "dep(alone-23, improvement-28)\n",
      "case(treatment-30, after-29)\n",
      "nmod:after(improvement-28, treatment-30)\n",
      "case(enalapril-34, with-31)\n",
      "amod(enalapril-34, lercanidipine-32)\n",
      "amod(enalapril-34, +-33)\n",
      "nmod:with(treatment-30, enalapril-34)\n",
      "mark(blunted-48, while-36)\n",
      "case(treatment-38, after-37)\n",
      "nmod:after(blunted-48, treatment-38)\n",
      "case(hydrochlorothiazide-42, with-39)\n",
      "amod(hydrochlorothiazide-42, lercanidipine-40)\n",
      "amod(hydrochlorothiazide-42, +-41)\n",
      "nmod:with(treatment-38, hydrochlorothiazide-42)\n",
      "det(improvement-45, the-44)\n",
      "nsubjpass(blunted-48, improvement-45)\n",
      "auxpass(blunted-48, is-46)\n",
      "advmod(blunted-48, partially-47)\n",
      "advcl(alone-23, blunted-48)\n",
      "\n",
      "Parsing [sent. 50 len. 14]: central systolic and diastolic blood pressures are similarly reduced by both therapeutic strategies .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ central)\n",
      "      (ADJP (JJ systolic)\n",
      "        (CC and)\n",
      "        (JJ diastolic))\n",
      "      (NN blood) (NNS pressures))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB similarly))\n",
      "      (VP (VBN reduced)\n",
      "        (PP (IN by)\n",
      "          (NP (DT both) (JJ therapeutic) (NNS strategies)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(pressures-6, central-1)\n",
      "amod(pressures-6, systolic-2)\n",
      "cc(systolic-2, and-3)\n",
      "conj:and(systolic-2, diastolic-4)\n",
      "amod(pressures-6, diastolic-4)\n",
      "compound(pressures-6, blood-5)\n",
      "nsubjpass(reduced-9, pressures-6)\n",
      "auxpass(reduced-9, are-7)\n",
      "advmod(reduced-9, similarly-8)\n",
      "root(ROOT-0, reduced-9)\n",
      "case(strategies-13, by-10)\n",
      "det(strategies-13, both-11)\n",
      "amod(strategies-13, therapeutic-12)\n",
      "nmod:by(reduced-9, strategies-13)\n",
      "\n",
      "Parsing [sent. 51 len. 12]: capillary density is increased only after treatment with lercanidipine + enalapril .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ capillary) (NN density))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN increased)\n",
      "        (ADVP (RB only))\n",
      "        (PP (IN after)\n",
      "          (NP (NN treatment)))\n",
      "        (PP (IN with)\n",
      "          (NP (JJ lercanidipine) (JJ +) (NN enalapril)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(density-2, capillary-1)\n",
      "nsubjpass(increased-4, density-2)\n",
      "auxpass(increased-4, is-3)\n",
      "root(ROOT-0, increased-4)\n",
      "advmod(increased-4, only-5)\n",
      "case(treatment-7, after-6)\n",
      "nmod:after(increased-4, treatment-7)\n",
      "case(enalapril-11, with-8)\n",
      "amod(enalapril-11, lercanidipine-9)\n",
      "amod(enalapril-11, +-10)\n",
      "nmod:with(increased-4, enalapril-11)\n",
      "\n",
      "Parsing [sent. 52 len. 41]: in conclusion , lercanidipine both in monotherapy and in combination with enalapril but not with hydrochlorothiazide is able to improve microvascular structure ; on the other hand , a decrease in central blood pressure is observed with both therapeutic combinations .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (NN conclusion)))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (S\n",
      "        (VP (VB lercanidipine)\n",
      "          (PP (DT both)\n",
      "            (PP (IN in)\n",
      "              (NP (NN monotherapy)))\n",
      "            (CC and)\n",
      "            (PP (IN in)\n",
      "              (NP (NN combination))))\n",
      "          (PP\n",
      "            (PP (IN with)\n",
      "              (NP (NN enalapril)))\n",
      "            (CONJP (CC but)\n",
      "              (RB not))\n",
      "            (PP (IN with)\n",
      "              (NP (NN hydrochlorothiazide))))))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ able)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB improve)\n",
      "                (NP (NN microvascular) (NN structure))))))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (PP (IN on)\n",
      "        (NP (DT the) (JJ other) (NN hand)))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (NN decrease))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ central) (NN blood) (NN pressure))))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN observed)\n",
      "          (PP (IN with)\n",
      "            (NP (DT both) (JJ therapeutic) (NNS combinations))))))\n",
      "    (. .)))\n",
      "\n",
      "case(conclusion-2, in-1)\n",
      "nmod:in(able-18, conclusion-2)\n",
      "conj(lercanidipine-4, lercanidipine-4')\n",
      "conj:and(lercanidipine-4, lercanidipine-4')\n",
      "csubj(able-18, lercanidipine-4)\n",
      "csubj(able-18, lercanidipine-4')\n",
      "cc:preconj(monotherapy-7, both-5)\n",
      "case(monotherapy-7, in-6)\n",
      "nmod:in(lercanidipine-4, monotherapy-7)\n",
      "cc(lercanidipine-4, and-8)\n",
      "case(combination-10, in-9)\n",
      "nmod:in(lercanidipine-4', combination-10)\n",
      "case(enalapril-12, with-11)\n",
      "nmod:with(lercanidipine-4, enalapril-12)\n",
      "cc(not-14, but-13)\n",
      "cc(lercanidipine-4, not-14)\n",
      "case(hydrochlorothiazide-16, with-15)\n",
      "nmod:with(lercanidipine-4', hydrochlorothiazide-16)\n",
      "cop(able-18, is-17)\n",
      "root(ROOT-0, able-18)\n",
      "mark(improve-20, to-19)\n",
      "xcomp(able-18, improve-20)\n",
      "compound(structure-22, microvascular-21)\n",
      "dobj(improve-20, structure-22)\n",
      "case(hand-27, on-24)\n",
      "det(hand-27, the-25)\n",
      "amod(hand-27, other-26)\n",
      "nmod:on(observed-36, hand-27)\n",
      "det(decrease-30, a-29)\n",
      "nsubjpass(observed-36, decrease-30)\n",
      "case(pressure-34, in-31)\n",
      "amod(pressure-34, central-32)\n",
      "compound(pressure-34, blood-33)\n",
      "nmod:in(decrease-30, pressure-34)\n",
      "auxpass(observed-36, is-35)\n",
      "parataxis(able-18, observed-36)\n",
      "case(combinations-40, with-37)\n",
      "det(combinations-40, both-38)\n",
      "amod(combinations-40, therapeutic-39)\n",
      "nmod:with(observed-36, combinations-40)\n",
      "\n",
      "Parsing [sent. 53 len. 23]: hypereosinophilic syndrome -LRB- hes -RRB- is a heterogeneous group of hematological disorders characterized by a chronic , unexplained hypereosinophilia with tissue damage .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ hypereosinophilic) (NN syndrome))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN hes))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ heterogeneous) (NN group))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (JJ hematological) (NNS disorders))\n",
      "            (VP (VBN characterized)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (DT a) (JJ chronic) (, ,) (JJ unexplained) (NN hypereosinophilia))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN tissue) (NN damage))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(syndrome-2, hypereosinophilic-1)\n",
      "nsubj(group-9, syndrome-2)\n",
      "appos(syndrome-2, hes-4)\n",
      "cop(group-9, is-6)\n",
      "det(group-9, a-7)\n",
      "amod(group-9, heterogeneous-8)\n",
      "root(ROOT-0, group-9)\n",
      "case(disorders-12, of-10)\n",
      "amod(disorders-12, hematological-11)\n",
      "nmod:of(group-9, disorders-12)\n",
      "acl(disorders-12, characterized-13)\n",
      "case(hypereosinophilia-19, by-14)\n",
      "det(hypereosinophilia-19, a-15)\n",
      "amod(hypereosinophilia-19, chronic-16)\n",
      "amod(hypereosinophilia-19, unexplained-18)\n",
      "nmod:by(characterized-13, hypereosinophilia-19)\n",
      "case(damage-22, with-20)\n",
      "compound(damage-22, tissue-21)\n",
      "nmod:with(hypereosinophilia-19, damage-22)\n",
      "\n",
      "Parsing [sent. 54 len. 18]: cardiac involvement occurs in â¼ 20 % of patients with hes and represents a major turning point .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ cardiac) (NN involvement))\n",
      "    (VP\n",
      "      (VP (VBZ occurs)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (CD â¼) (CD 20))\n",
      "              (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN hes))))))))\n",
      "      (CC and)\n",
      "      (VP (VBZ represents)\n",
      "        (NP (DT a) (JJ major) (NN turning) (NN point))))\n",
      "    (. .)))\n",
      "\n",
      "amod(involvement-2, cardiac-1)\n",
      "nsubj(occurs-3, involvement-2)\n",
      "nsubj(represents-13, involvement-2)\n",
      "root(ROOT-0, occurs-3)\n",
      "case(%-7, in-4)\n",
      "compound(20-6, â¼-5)\n",
      "nummod(%-7, 20-6)\n",
      "nmod:in(occurs-3, %-7)\n",
      "case(patients-9, of-8)\n",
      "nmod:of(%-7, patients-9)\n",
      "case(hes-11, with-10)\n",
      "nmod:with(patients-9, hes-11)\n",
      "cc(occurs-3, and-12)\n",
      "conj:and(occurs-3, represents-13)\n",
      "det(point-17, a-14)\n",
      "amod(point-17, major-15)\n",
      "compound(point-17, turning-16)\n",
      "dobj(represents-13, point-17)\n",
      "\n",
      "Parsing [sent. 55 len. 20]: cardiac injuries related to eosinophilia are divided into three chronological phases : eosinophilic infiltration , thrombosis , and fibrosis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ cardiac) (NNS injuries))\n",
      "      (VP (VBN related)\n",
      "        (PP (TO to)\n",
      "          (NP (NN eosinophilia)))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN divided)\n",
      "        (PP (IN into)\n",
      "          (NP\n",
      "            (NP (CD three) (JJ chronological) (NNS phases))\n",
      "            (: :)\n",
      "            (NP (JJ eosinophilic) (NN infiltration))\n",
      "            (, ,)\n",
      "            (NP (NNS thrombosis))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (NN fibrosis))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(injuries-2, cardiac-1)\n",
      "nsubjpass(divided-7, injuries-2)\n",
      "acl(injuries-2, related-3)\n",
      "case(eosinophilia-5, to-4)\n",
      "nmod:to(related-3, eosinophilia-5)\n",
      "auxpass(divided-7, are-6)\n",
      "root(ROOT-0, divided-7)\n",
      "case(phases-11, into-8)\n",
      "nummod(phases-11, three-9)\n",
      "amod(phases-11, chronological-10)\n",
      "nmod:into(divided-7, phases-11)\n",
      "amod(infiltration-14, eosinophilic-13)\n",
      "nmod:into(divided-7, infiltration-14)\n",
      "conj:and(phases-11, infiltration-14)\n",
      "nmod:into(divided-7, thrombosis-16)\n",
      "conj:and(phases-11, thrombosis-16)\n",
      "cc(phases-11, and-18)\n",
      "nmod:into(divided-7, fibrosis-19)\n",
      "conj:and(phases-11, fibrosis-19)\n",
      "\n",
      "Parsing [sent. 56 len. 24]: we report a case of a 33-year-old woman diagnosed with hes , with pulmonary and gastrointestinal involvement and eosinophilic myocarditis in cardiogenic shock .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBP report)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT a) (NN case))\n",
      "            (PP (IN of)\n",
      "              (NP (DT a) (JJ 33-year-old) (NN woman))))\n",
      "          (VP (VBD diagnosed)\n",
      "            (PP (IN with)\n",
      "              (NP (NN hes)))\n",
      "            (, ,)\n",
      "            (PP (IN with)\n",
      "              (NP (JJ pulmonary)\n",
      "                (CC and)\n",
      "                (JJ gastrointestinal) (NN involvement)\n",
      "                (CC and)\n",
      "                (NN eosinophilic) (NNS myocarditis)))\n",
      "            (PP (IN in)\n",
      "              (NP (JJ cardiogenic) (NN shock)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(report-2, we-1)\n",
      "root(ROOT-0, report-2)\n",
      "det(case-4, a-3)\n",
      "nsubj(diagnosed-9, case-4)\n",
      "case(woman-8, of-5)\n",
      "det(woman-8, a-6)\n",
      "amod(woman-8, 33-year-old-7)\n",
      "nmod:of(case-4, woman-8)\n",
      "ccomp(report-2, diagnosed-9)\n",
      "case(hes-11, with-10)\n",
      "nmod:with(diagnosed-9, hes-11)\n",
      "case(involvement-17, with-13)\n",
      "amod(involvement-17, pulmonary-14)\n",
      "cc(pulmonary-14, and-15)\n",
      "conj:and(pulmonary-14, gastrointestinal-16)\n",
      "amod(involvement-17, gastrointestinal-16)\n",
      "nmod:with(diagnosed-9, involvement-17)\n",
      "cc(involvement-17, and-18)\n",
      "compound(myocarditis-20, eosinophilic-19)\n",
      "nmod:with(diagnosed-9, myocarditis-20)\n",
      "conj:and(involvement-17, myocarditis-20)\n",
      "case(shock-23, in-21)\n",
      "amod(shock-23, cardiogenic-22)\n",
      "nmod:in(diagnosed-9, shock-23)\n",
      "\n",
      "Parsing [sent. 57 len. 18]: the evolution was favorable with dobutamine , anticoagulation , corticosteroids , and later , Î²-blockers and ACEI .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN evolution))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ favorable)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN dobutamine))\n",
      "            (, ,)\n",
      "            (NP (NN anticoagulation))\n",
      "            (, ,)\n",
      "            (NP (NNS corticosteroids))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (ADVP (RB later))\n",
      "            (, ,)\n",
      "            (NP (NNS Î²-blockers))\n",
      "            (CC and)\n",
      "            (NP (NNP ACEI))))))\n",
      "    (. .)))\n",
      "\n",
      "det(evolution-2, the-1)\n",
      "nsubj(favorable-4, evolution-2)\n",
      "cop(favorable-4, was-3)\n",
      "root(ROOT-0, favorable-4)\n",
      "case(dobutamine-6, with-5)\n",
      "nmod:with(favorable-4, dobutamine-6)\n",
      "nmod:with(favorable-4, anticoagulation-8)\n",
      "conj:and(dobutamine-6, anticoagulation-8)\n",
      "nmod:with(favorable-4, corticosteroids-10)\n",
      "conj:and(dobutamine-6, corticosteroids-10)\n",
      "cc(dobutamine-6, and-12)\n",
      "advmod(dobutamine-6, later-13)\n",
      "nmod:with(favorable-4, Î²-blockers-15)\n",
      "conj:and(dobutamine-6, Î²-blockers-15)\n",
      "cc(dobutamine-6, and-16)\n",
      "nmod:with(favorable-4, ACEI-17)\n",
      "conj:and(dobutamine-6, ACEI-17)\n",
      "\n",
      "Parsing [sent. 58 len. 12]: cardiac involvement in hes is rare but carries a poor prognosis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ cardiac) (NN involvement))\n",
      "      (PP (IN in)\n",
      "        (NP (NN hes))))\n",
      "    (VP\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ rare)))\n",
      "      (CC but)\n",
      "      (VP (VBZ carries)\n",
      "        (NP (DT a) (JJ poor) (NN prognosis))))\n",
      "    (. .)))\n",
      "\n",
      "amod(involvement-2, cardiac-1)\n",
      "nsubj(rare-6, involvement-2)\n",
      "nsubj(carries-8, involvement-2)\n",
      "case(hes-4, in-3)\n",
      "nmod:in(involvement-2, hes-4)\n",
      "cop(rare-6, is-5)\n",
      "root(ROOT-0, rare-6)\n",
      "cc(rare-6, but-7)\n",
      "conj:but(rare-6, carries-8)\n",
      "det(prognosis-11, a-9)\n",
      "amod(prognosis-11, poor-10)\n",
      "dobj(carries-8, prognosis-11)\n",
      "\n",
      "Parsing [sent. 59 len. 12]: corticosteroids are considered by many to be the mainstay of treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS corticosteroids))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN considered)\n",
      "        (PP (IN by)\n",
      "          (NP (JJ many)))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (NP\n",
      "                (NP (DT the) (NN mainstay))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN treatment)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(considered-3, corticosteroids-1)\n",
      "nsubj:xsubj(mainstay-9, corticosteroids-1)\n",
      "auxpass(considered-3, are-2)\n",
      "root(ROOT-0, considered-3)\n",
      "case(many-5, by-4)\n",
      "nmod:by(considered-3, many-5)\n",
      "mark(mainstay-9, to-6)\n",
      "cop(mainstay-9, be-7)\n",
      "det(mainstay-9, the-8)\n",
      "xcomp(considered-3, mainstay-9)\n",
      "case(treatment-11, of-10)\n",
      "nmod:of(mainstay-9, treatment-11)\n",
      "\n",
      "Parsing [sent. 60 len. 13]: although new treatments have been suggested , only a few seem promising .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN although)\n",
      "      (S\n",
      "        (NP (JJ new) (NNS treatments))\n",
      "        (VP (VBP have)\n",
      "          (VP (VBN been)\n",
      "            (VP (VBN suggested))))))\n",
      "    (, ,)\n",
      "    (ADVP (RB only))\n",
      "    (NP (DT a) (JJ few))\n",
      "    (VP (VBP seem)\n",
      "      (S\n",
      "        (VP (VBG promising))))\n",
      "    (. .)))\n",
      "\n",
      "mark(suggested-6, although-1)\n",
      "amod(treatments-3, new-2)\n",
      "nsubjpass(suggested-6, treatments-3)\n",
      "aux(suggested-6, have-4)\n",
      "auxpass(suggested-6, been-5)\n",
      "advcl(seem-11, suggested-6)\n",
      "advmod(few-10, only-8)\n",
      "det(few-10, a-9)\n",
      "nsubj(seem-11, few-10)\n",
      "root(ROOT-0, seem-11)\n",
      "xcomp(seem-11, promising-12)\n",
      "\n",
      "Parsing [sent. 61 len. 31]: the burden of heart failure has long plagued the productive years of the population , with therapeutic advances in the timely treatment of ischemic heart disease decreasing its associated mortality .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN burden))\n",
      "      (PP (IN of)\n",
      "        (NP (NN heart) (NN failure))))\n",
      "    (VP (VBZ has)\n",
      "      (ADVP (RB long))\n",
      "      (VP (VBN plagued)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ productive) (NNS years))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NN population))))\n",
      "        (, ,)\n",
      "        (PP (IN with)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ therapeutic) (NNS advances))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ timely) (NN treatment))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ ischemic) (NN heart) (NN disease))))))\n",
      "            (VP (VBG decreasing)\n",
      "              (NP (PRP$ its) (VBN associated) (NN mortality)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(burden-2, the-1)\n",
      "nsubj(plagued-8, burden-2)\n",
      "case(failure-5, of-3)\n",
      "compound(failure-5, heart-4)\n",
      "nmod:of(burden-2, failure-5)\n",
      "aux(plagued-8, has-6)\n",
      "advmod(plagued-8, long-7)\n",
      "root(ROOT-0, plagued-8)\n",
      "det(years-11, the-9)\n",
      "amod(years-11, productive-10)\n",
      "dobj(plagued-8, years-11)\n",
      "case(population-14, of-12)\n",
      "det(population-14, the-13)\n",
      "nmod:of(years-11, population-14)\n",
      "mark(decreasing-27, with-16)\n",
      "amod(advances-18, therapeutic-17)\n",
      "nsubj(decreasing-27, advances-18)\n",
      "case(treatment-22, in-19)\n",
      "det(treatment-22, the-20)\n",
      "amod(treatment-22, timely-21)\n",
      "nmod:in(advances-18, treatment-22)\n",
      "case(disease-26, of-23)\n",
      "amod(disease-26, ischemic-24)\n",
      "compound(disease-26, heart-25)\n",
      "nmod:of(treatment-22, disease-26)\n",
      "advcl(plagued-8, decreasing-27)\n",
      "nmod:poss(mortality-30, its-28)\n",
      "amod(mortality-30, associated-29)\n",
      "dobj(decreasing-27, mortality-30)\n",
      "\n",
      "Parsing [sent. 62 len. 13]: ACEI and Î²-blockers have impacted heart failure therapeutics in a revolutionary way .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNP ACEI))\n",
      "      (CC and)\n",
      "      (NP (NNS Î²-blockers)))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN impacted)\n",
      "        (NP (NN heart) (NN failure) (NNS therapeutics))\n",
      "        (PP (IN in)\n",
      "          (NP (DT a) (JJ revolutionary) (NN way)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(impacted-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, Î²-blockers-3)\n",
      "nsubj(impacted-5, Î²-blockers-3)\n",
      "aux(impacted-5, have-4)\n",
      "root(ROOT-0, impacted-5)\n",
      "compound(therapeutics-8, heart-6)\n",
      "compound(therapeutics-8, failure-7)\n",
      "dobj(impacted-5, therapeutics-8)\n",
      "case(way-12, in-9)\n",
      "det(way-12, a-10)\n",
      "amod(way-12, revolutionary-11)\n",
      "nmod:in(impacted-5, way-12)\n",
      "\n",
      "Parsing [sent. 63 len. 44]: the importance of blockade of the renin-angiotensin system and adrenergic stimulation are fully accepted concepts that apply in young and old , symptomatic and asymptomatic , borderline low and very low ejection fraction -LRB- ef -RRB- , left ventricular failure and biventricular failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN importance))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN blockade))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ renin-angiotensin) (NN system))\n",
      "              (CC and)\n",
      "              (NP (JJ adrenergic) (NN stimulation)))))))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB fully))\n",
      "      (VP (VBN accepted)\n",
      "        (NP\n",
      "          (NP (NNS concepts))\n",
      "          (SBAR\n",
      "            (WHNP (WDT that))\n",
      "            (S\n",
      "              (VP (VBP apply)\n",
      "                (PP (IN in)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (ADJP\n",
      "                          (ADJP (JJ young)\n",
      "                            (CC and)\n",
      "                            (JJ old))\n",
      "                          (, ,)\n",
      "                          (ADJP (JJ symptomatic)\n",
      "                            (CC and)\n",
      "                            (JJ asymptomatic))\n",
      "                          (, ,)\n",
      "                          (ADJP (JJ borderline) (JJ low))\n",
      "                          (CC and)\n",
      "                          (ADJP (RB very) (JJ low)))\n",
      "                        (NN ejection) (NN fraction))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN ef))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP (JJ left) (NN ventricular) (NN failure)\n",
      "                      (CC and)\n",
      "                      (NN biventricular) (NN failure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(importance-2, the-1)\n",
      "nsubjpass(accepted-14, importance-2)\n",
      "case(blockade-4, of-3)\n",
      "nmod:of(importance-2, blockade-4)\n",
      "case(system-8, of-5)\n",
      "det(system-8, the-6)\n",
      "amod(system-8, renin-angiotensin-7)\n",
      "nmod:of(blockade-4, system-8)\n",
      "cc(system-8, and-9)\n",
      "amod(stimulation-11, adrenergic-10)\n",
      "nmod:of(blockade-4, stimulation-11)\n",
      "conj:and(system-8, stimulation-11)\n",
      "auxpass(accepted-14, are-12)\n",
      "advmod(accepted-14, fully-13)\n",
      "root(ROOT-0, accepted-14)\n",
      "dobj(accepted-14, concepts-15)\n",
      "nsubj(apply-17, concepts-15)\n",
      "ref(concepts-15, that-16)\n",
      "acl:relcl(concepts-15, apply-17)\n",
      "case(fraction-33, in-18)\n",
      "amod(fraction-33, young-19)\n",
      "cc(young-19, and-20)\n",
      "conj:and(young-19, old-21)\n",
      "amod(fraction-33, old-21)\n",
      "conj:and(young-19, symptomatic-23)\n",
      "amod(fraction-33, symptomatic-23)\n",
      "cc(symptomatic-23, and-24)\n",
      "conj:and(young-19, asymptomatic-25)\n",
      "conj:and(symptomatic-23, asymptomatic-25)\n",
      "amod(low-28, borderline-27)\n",
      "conj:and(young-19, low-28)\n",
      "amod(fraction-33, low-28)\n",
      "cc(young-19, and-29)\n",
      "advmod(low-31, very-30)\n",
      "conj:and(young-19, low-31)\n",
      "amod(fraction-33, low-31)\n",
      "compound(fraction-33, ejection-32)\n",
      "nmod:in(apply-17, fraction-33)\n",
      "appos(fraction-33, ef-35)\n",
      "amod(failure-40, left-38)\n",
      "compound(failure-40, ventricular-39)\n",
      "appos(fraction-33, failure-40)\n",
      "cc(failure-40, and-41)\n",
      "compound(failure-43, biventricular-42)\n",
      "appos(fraction-33, failure-43)\n",
      "conj:and(failure-40, failure-43)\n",
      "\n",
      "Parsing [sent. 64 len. 25]: despite several interventions , both pharmaceutical and device based for the treatment of ensuing heart failure , the incidence is increasing in large proportions .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP\n",
      "        (NP (JJ several) (NNS interventions))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT both) (NN pharmaceutical)\n",
      "            (CC and)\n",
      "            (NN device))\n",
      "          (VP (VBN based)\n",
      "            (PP (IN for)\n",
      "              (NP\n",
      "                (NP (DT the) (NN treatment))\n",
      "                (PP (IN of)\n",
      "                  (NP (VBG ensuing) (NN heart) (NN failure)))))))))\n",
      "    (, ,)\n",
      "    (NP (DT the) (NN incidence))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBG increasing)\n",
      "        (PP (IN in)\n",
      "          (NP (JJ large) (NNS proportions)))))\n",
      "    (. .)))\n",
      "\n",
      "case(interventions-3, despite-1)\n",
      "amod(interventions-3, several-2)\n",
      "nmod:despite(increasing-21, interventions-3)\n",
      "cc:preconj(pharmaceutical-6, both-5)\n",
      "appos(interventions-3, pharmaceutical-6)\n",
      "cc(pharmaceutical-6, and-7)\n",
      "appos(interventions-3, device-8)\n",
      "conj:and(pharmaceutical-6, device-8)\n",
      "acl(pharmaceutical-6, based-9)\n",
      "case(treatment-12, for-10)\n",
      "det(treatment-12, the-11)\n",
      "nmod:for(based-9, treatment-12)\n",
      "case(failure-16, of-13)\n",
      "amod(failure-16, ensuing-14)\n",
      "compound(failure-16, heart-15)\n",
      "nmod:of(treatment-12, failure-16)\n",
      "det(incidence-19, the-18)\n",
      "nsubj(increasing-21, incidence-19)\n",
      "aux(increasing-21, is-20)\n",
      "root(ROOT-0, increasing-21)\n",
      "case(proportions-24, in-22)\n",
      "amod(proportions-24, large-23)\n",
      "nmod:in(increasing-21, proportions-24)\n",
      "\n",
      "Parsing [sent. 65 len. 8]: newer molecules like sacubitril show more promise .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJR newer) (NNS molecules))\n",
      "      (PP (IN like)\n",
      "        (NP (NN sacubitril))))\n",
      "    (VP (VBP show)\n",
      "      (NP (JJR more) (NN promise)))\n",
      "    (. .)))\n",
      "\n",
      "amod(molecules-2, newer-1)\n",
      "nsubj(show-5, molecules-2)\n",
      "case(sacubitril-4, like-3)\n",
      "nmod:like(molecules-2, sacubitril-4)\n",
      "root(ROOT-0, show-5)\n",
      "amod(promise-7, more-6)\n",
      "dobj(show-5, promise-7)\n",
      "\n",
      "Parsing [sent. 66 len. 17]: despite these novel therapies , several patients relentlessly progress to a stage of advanced heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN despite)\n",
      "      (NP (DT these) (NN novel) (NNS therapies)))\n",
      "    (, ,)\n",
      "    (NP (JJ several) (NNS patients))\n",
      "    (ADVP (RB relentlessly))\n",
      "    (VP (VB progress)\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (DT a) (NN stage))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ advanced) (NN heart) (NN failure))))))\n",
      "    (. .)))\n",
      "\n",
      "case(therapies-4, despite-1)\n",
      "det(therapies-4, these-2)\n",
      "compound(therapies-4, novel-3)\n",
      "nmod:despite(progress-9, therapies-4)\n",
      "amod(patients-7, several-6)\n",
      "nsubj(progress-9, patients-7)\n",
      "advmod(progress-9, relentlessly-8)\n",
      "root(ROOT-0, progress-9)\n",
      "case(stage-12, to-10)\n",
      "det(stage-12, a-11)\n",
      "nmod:to(progress-9, stage-12)\n",
      "case(failure-16, of-13)\n",
      "amod(failure-16, advanced-14)\n",
      "compound(failure-16, heart-15)\n",
      "nmod:of(stage-12, failure-16)\n",
      "\n",
      "Parsing [sent. 67 len. 18]: the use of left-ventricular-assist devices has variable clinical benefit , with some patients progressing to heart transplantation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ left-ventricular-assist) (NNS devices))))\n",
      "    (VP (VBZ has)\n",
      "      (NP (JJ variable) (JJ clinical) (NN benefit))\n",
      "      (, ,)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (DT some) (NNS patients))\n",
      "          (VP (VBG progressing)\n",
      "            (PP (TO to)\n",
      "              (NP (NN heart) (NN transplantation)))))))\n",
      "    (. .)))\n",
      "\n",
      "det(use-2, the-1)\n",
      "nsubj(has-6, use-2)\n",
      "case(devices-5, of-3)\n",
      "amod(devices-5, left-ventricular-assist-4)\n",
      "nmod:of(use-2, devices-5)\n",
      "root(ROOT-0, has-6)\n",
      "amod(benefit-9, variable-7)\n",
      "amod(benefit-9, clinical-8)\n",
      "dobj(has-6, benefit-9)\n",
      "case(patients-13, with-11)\n",
      "det(patients-13, some-12)\n",
      "nmod:with(has-6, patients-13)\n",
      "acl(patients-13, progressing-14)\n",
      "case(transplantation-17, to-15)\n",
      "compound(transplantation-17, heart-16)\n",
      "nmod:to(progressing-14, transplantation-17)\n",
      "\n",
      "Parsing [sent. 68 len. 12]: liver fibrosis is a common response to many chronic liver diseases .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN liver) (NN fibrosis))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ common) (NN response))\n",
      "        (PP (TO to)\n",
      "          (NP (JJ many) (JJ chronic) (NN liver) (NNS diseases)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(fibrosis-2, liver-1)\n",
      "nsubj(response-6, fibrosis-2)\n",
      "cop(response-6, is-3)\n",
      "det(response-6, a-4)\n",
      "amod(response-6, common-5)\n",
      "root(ROOT-0, response-6)\n",
      "case(diseases-11, to-7)\n",
      "amod(diseases-11, many-8)\n",
      "amod(diseases-11, chronic-9)\n",
      "compound(diseases-11, liver-10)\n",
      "nmod:to(response-6, diseases-11)\n",
      "\n",
      "Parsing [sent. 69 len. 29]: the aim of our study was to explore whether pharmacotherapy for concurrent diseases affects overall mortality , liver-related mortality and liver-related morbidity in patients with chronic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN aim))\n",
      "      (PP (IN of)\n",
      "        (NP (PRP$ our) (NN study))))\n",
      "    (VP (VBD was)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB explore)\n",
      "            (SBAR (IN whether)\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (NN pharmacotherapy))\n",
      "                  (PP (IN for)\n",
      "                    (NP (JJ concurrent) (NNS diseases))))\n",
      "                (VP (VBZ affects)\n",
      "                  (NP\n",
      "                    (NP (JJ overall) (NN mortality))\n",
      "                    (, ,)\n",
      "                    (NP (JJ liver-related) (NN mortality))\n",
      "                    (CC and)\n",
      "                    (NP (JJ liver-related) (NN morbidity)))\n",
      "                  (PP (IN in)\n",
      "                    (NP\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP (JJ chronic) (NN liver) (NN disease))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(aim-2, the-1)\n",
      "nsubj(was-6, aim-2)\n",
      "nsubj:xsubj(explore-8, aim-2)\n",
      "case(study-5, of-3)\n",
      "nmod:poss(study-5, our-4)\n",
      "nmod:of(aim-2, study-5)\n",
      "root(ROOT-0, was-6)\n",
      "mark(explore-8, to-7)\n",
      "xcomp(was-6, explore-8)\n",
      "mark(affects-14, whether-9)\n",
      "nsubj(affects-14, pharmacotherapy-10)\n",
      "case(diseases-13, for-11)\n",
      "amod(diseases-13, concurrent-12)\n",
      "nmod:for(pharmacotherapy-10, diseases-13)\n",
      "ccomp(explore-8, affects-14)\n",
      "amod(mortality-16, overall-15)\n",
      "dobj(affects-14, mortality-16)\n",
      "amod(mortality-19, liver-related-18)\n",
      "dobj(affects-14, mortality-19)\n",
      "conj:and(mortality-16, mortality-19)\n",
      "cc(mortality-16, and-20)\n",
      "amod(morbidity-22, liver-related-21)\n",
      "dobj(affects-14, morbidity-22)\n",
      "conj:and(mortality-16, morbidity-22)\n",
      "case(patients-24, in-23)\n",
      "nmod:in(affects-14, patients-24)\n",
      "case(disease-28, with-25)\n",
      "amod(disease-28, chronic-26)\n",
      "compound(disease-28, liver-27)\n",
      "nmod:with(patients-24, disease-28)\n",
      "\n",
      "Parsing [sent. 70 len. 30]: we performed a register-based cohort study of all patients with a first-time diagnosis of chronic liver disease between 2005 and 2012 in sweden -LRB- n = 70 546 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD performed)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ register-based) (NN cohort) (NN study))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT all) (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (DT a) (JJ first-time) (NN diagnosis)))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ chronic) (NN liver) (NN disease)))\n",
      "            (PP (IN between)\n",
      "              (NP (CD 2005)\n",
      "                (CC and)\n",
      "                (CD 2012)))\n",
      "            (PP (IN in)\n",
      "              (NP (NN sweden)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 70) (CD 546)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(performed-2, we-1)\n",
      "root(ROOT-0, performed-2)\n",
      "det(study-6, a-3)\n",
      "amod(study-6, register-based-4)\n",
      "compound(study-6, cohort-5)\n",
      "dobj(performed-2, study-6)\n",
      "case(patients-9, of-7)\n",
      "det(patients-9, all-8)\n",
      "nmod:of(study-6, patients-9)\n",
      "case(diagnosis-13, with-10)\n",
      "det(diagnosis-13, a-11)\n",
      "amod(diagnosis-13, first-time-12)\n",
      "nmod:with(patients-9, diagnosis-13)\n",
      "case(disease-17, of-14)\n",
      "amod(disease-17, chronic-15)\n",
      "compound(disease-17, liver-16)\n",
      "nmod:of(patients-9, disease-17)\n",
      "case(2005-19, between-18)\n",
      "nmod:between(patients-9, 2005-19)\n",
      "cc(2005-19, and-20)\n",
      "nmod:between(patients-9, 2012-21)\n",
      "conj:and(2005-19, 2012-21)\n",
      "case(sweden-23, in-22)\n",
      "nmod:in(patients-9, sweden-23)\n",
      "dep(patients-9, n-25)\n",
      "dep(546-28, =-26)\n",
      "nummod(546-28, 70-27)\n",
      "ccomp(n-25, 546-28)\n",
      "\n",
      "Parsing [sent. 71 len. 18]: data from the patient register , the prescribed drug register and the death certificate register were linked .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS data))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ patient) (NN register))\n",
      "          (, ,)\n",
      "          (NP (DT the) (JJ prescribed) (NN drug) (NN register))\n",
      "          (CC and)\n",
      "          (NP (DT the) (NN death) (NN certificate) (NN register)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN linked)))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(linked-17, data-1)\n",
      "case(register-5, from-2)\n",
      "det(register-5, the-3)\n",
      "amod(register-5, patient-4)\n",
      "nmod:from(data-1, register-5)\n",
      "det(register-10, the-7)\n",
      "amod(register-10, prescribed-8)\n",
      "compound(register-10, drug-9)\n",
      "nmod:from(data-1, register-10)\n",
      "conj:and(register-5, register-10)\n",
      "cc(register-5, and-11)\n",
      "det(register-15, the-12)\n",
      "compound(register-15, death-13)\n",
      "compound(register-15, certificate-14)\n",
      "nmod:from(data-1, register-15)\n",
      "conj:and(register-5, register-15)\n",
      "auxpass(linked-17, were-16)\n",
      "root(ROOT-0, linked-17)\n",
      "\n",
      "Parsing [sent. 72 len. 27]: we studied whether the use of statins , ACEI , angiotensin receptor blockers and antibiotics affected the risk of total mortality , liver-specific mortality and morbidity .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD studied)\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN use))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS statins))\n",
      "                (, ,)\n",
      "                (NP (NNP ACEI))\n",
      "                (, ,)\n",
      "                (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "                (CC and)\n",
      "                (NP (NNS antibiotics)))))\n",
      "          (VP (VBD affected)\n",
      "            (NP\n",
      "              (NP (DT the) (NN risk))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (JJ total) (NN mortality))\n",
      "                  (, ,)\n",
      "                  (NP (JJ liver-specific) (NN mortality))\n",
      "                  (CC and)\n",
      "                  (NP (NN morbidity)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(studied-2, we-1)\n",
      "root(ROOT-0, studied-2)\n",
      "mark(affected-16, whether-3)\n",
      "det(use-5, the-4)\n",
      "nsubj(affected-16, use-5)\n",
      "case(statins-7, of-6)\n",
      "nmod:of(use-5, statins-7)\n",
      "nmod:of(use-5, ACEI-9)\n",
      "conj:and(statins-7, ACEI-9)\n",
      "compound(blockers-13, angiotensin-11)\n",
      "compound(blockers-13, receptor-12)\n",
      "nmod:of(use-5, blockers-13)\n",
      "conj:and(statins-7, blockers-13)\n",
      "cc(statins-7, and-14)\n",
      "nmod:of(use-5, antibiotics-15)\n",
      "conj:and(statins-7, antibiotics-15)\n",
      "ccomp(studied-2, affected-16)\n",
      "det(risk-18, the-17)\n",
      "dobj(affected-16, risk-18)\n",
      "case(mortality-21, of-19)\n",
      "amod(mortality-21, total-20)\n",
      "nmod:of(risk-18, mortality-21)\n",
      "amod(mortality-24, liver-specific-23)\n",
      "nmod:of(risk-18, mortality-24)\n",
      "conj:and(mortality-21, mortality-24)\n",
      "cc(mortality-21, and-25)\n",
      "nmod:of(risk-18, morbidity-26)\n",
      "conj:and(mortality-21, morbidity-26)\n",
      "\n",
      "Parsing [sent. 73 len. 50]: we found a reduction in mortality risk for statin users -LRB- n = 11 245 -RRB- with hazard ratios from 0.57 -LRB- 95 % , ci 0.32-0 .99 -RRB- for patients with autoimmune hepatitis , to 0.84 -LRB- 95 % , ci 0.75-0 .95 -RRB- for alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD found)\n",
      "      (NP\n",
      "        (NP (DT a) (NN reduction))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NN mortality) (NN risk))\n",
      "            (PP (IN for)\n",
      "              (NP (NN statin) (NNS users)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (VP (VBN n)\n",
      "                (S\n",
      "                  (VP (SYM =)\n",
      "                    (NP (CD 11) (CD 245)))))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (PP (IN with)\n",
      "        (NP (NN hazard) (NNS ratios)))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD 0.57))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 95) (NN %))\n",
      "                (, ,)\n",
      "                (NP (NN ci) (CD 0.32-0) (NNP .99)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ autoimmune) (NN hepatitis)))))))\n",
      "      (, ,)\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD 0.84))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 95) (NN %))\n",
      "                (, ,)\n",
      "                (NP (NN ci) (CD 0.75-0) (NNP .95)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP (JJ alcoholic) (NN liver) (NN disease))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(found-2, we-1)\n",
      "root(ROOT-0, found-2)\n",
      "det(reduction-4, a-3)\n",
      "dobj(found-2, reduction-4)\n",
      "case(risk-7, in-5)\n",
      "compound(risk-7, mortality-6)\n",
      "nmod:in(reduction-4, risk-7)\n",
      "case(users-10, for-8)\n",
      "compound(users-10, statin-9)\n",
      "nmod:for(risk-7, users-10)\n",
      "dep(risk-7, n-12)\n",
      "dep(245-15, =-13)\n",
      "nummod(245-15, 11-14)\n",
      "ccomp(n-12, 245-15)\n",
      "case(ratios-19, with-17)\n",
      "compound(ratios-19, hazard-18)\n",
      "nmod:with(found-2, ratios-19)\n",
      "case(0.57-21, from-20)\n",
      "nmod:from(found-2, 0.57-21)\n",
      "nummod(%-24, 95-23)\n",
      "dep(0.57-21, %-24)\n",
      "compound(.99-28, ci-26)\n",
      "nummod(.99-28, 0.32-0-27)\n",
      "appos(%-24, .99-28)\n",
      "case(patients-31, for-30)\n",
      "nmod:for(0.57-21, patients-31)\n",
      "case(hepatitis-34, with-32)\n",
      "amod(hepatitis-34, autoimmune-33)\n",
      "nmod:with(patients-31, hepatitis-34)\n",
      "case(0.84-37, to-36)\n",
      "nmod:to(found-2, 0.84-37)\n",
      "nummod(%-40, 95-39)\n",
      "dep(0.84-37, %-40)\n",
      "compound(.95-44, ci-42)\n",
      "nummod(.95-44, 0.75-0-43)\n",
      "appos(%-40, .95-44)\n",
      "case(disease-49, for-46)\n",
      "amod(disease-49, alcoholic-47)\n",
      "compound(disease-49, liver-48)\n",
      "nmod:for(0.84-37, disease-49)\n",
      "\n",
      "Parsing [sent. 74 len. 27]: there was a significant reduced liver-related mortality for patients with alcoholic liver disease who used ACEI , 0.85 -LRB- 95 % , ci 0.65-0 .96 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ significant) (JJ reduced) (JJ liver-related) (NN mortality))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (JJ alcoholic) (NN liver) (NN disease)))))\n",
      "        (SBAR\n",
      "          (WHNP (WP who))\n",
      "          (S\n",
      "            (VP (VBD used)\n",
      "              (NP\n",
      "                (NP (NNP ACEI) (, ,) (NNP 0.85))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 95) (NN %))\n",
      "                    (, ,)\n",
      "                    (NP (NN ci) (CD 0.65-0) (NNP .96)))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "det(mortality-7, a-3)\n",
      "amod(mortality-7, significant-4)\n",
      "amod(mortality-7, reduced-5)\n",
      "amod(mortality-7, liver-related-6)\n",
      "nsubj(was-2, mortality-7)\n",
      "nsubj(used-15, mortality-7)\n",
      "case(patients-9, for-8)\n",
      "nmod:for(mortality-7, patients-9)\n",
      "case(disease-13, with-10)\n",
      "amod(disease-13, alcoholic-11)\n",
      "compound(disease-13, liver-12)\n",
      "nmod:with(patients-9, disease-13)\n",
      "ref(mortality-7, who-14)\n",
      "acl:relcl(mortality-7, used-15)\n",
      "compound(0.85-18, ACEI-16)\n",
      "dobj(used-15, 0.85-18)\n",
      "nummod(%-21, 95-20)\n",
      "dep(0.85-18, %-21)\n",
      "compound(.96-25, ci-23)\n",
      "nummod(.96-25, 0.65-0-24)\n",
      "appos(%-21, .96-25)\n",
      "\n",
      "Parsing [sent. 75 len. 34]: there were increased overall mortality risks for antibiotic users -LRB- n = 44 572 -RRB- , with hazard ratios up to 1.67 -LRB- 95 % ci , 1.55-1 .80 -RRB- for viral hepatitis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD were)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (VBN increased) (JJ overall) (NN mortality) (NNS risks))\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (JJ antibiotic) (NNS users))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN n)\n",
      "                  (S\n",
      "                    (VP (SYM =)\n",
      "                      (NP (CD 44) (CD 572)))))\n",
      "                (-RRB- -RRB-))))\n",
      "          (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP (NN hazard) (NNS ratios))))\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (IN up) (TO to) (CD 1.67)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (ADJP (CD 95) (NN %))\n",
      "                  (NN ci))\n",
      "                (, ,)\n",
      "                (NP (CD 1.55-1) (CD .80)))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (IN for)\n",
      "            (NP (JJ viral) (NN hepatitis))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(were-2, there-1)\n",
      "root(ROOT-0, were-2)\n",
      "amod(risks-6, increased-3)\n",
      "amod(risks-6, overall-4)\n",
      "compound(risks-6, mortality-5)\n",
      "iobj(were-2, risks-6)\n",
      "case(users-9, for-7)\n",
      "amod(users-9, antibiotic-8)\n",
      "nmod:for(risks-6, users-9)\n",
      "dep(users-9, n-11)\n",
      "dep(572-14, =-12)\n",
      "nummod(572-14, 44-13)\n",
      "ccomp(n-11, 572-14)\n",
      "case(ratios-19, with-17)\n",
      "compound(ratios-19, hazard-18)\n",
      "nmod:with(risks-6, ratios-19)\n",
      "dep(1.67-22, up-20)\n",
      "mwe(up-20, to-21)\n",
      "dep(risks-6, 1.67-22)\n",
      "compound(%-25, 95-24)\n",
      "amod(ci-26, %-25)\n",
      "dep(1.67-22, ci-26)\n",
      "nummod(.80-29, 1.55-1-28)\n",
      "appos(ci-26, .80-29)\n",
      "case(hepatitis-33, for-31)\n",
      "amod(hepatitis-33, viral-32)\n",
      "nmod:for(1.67-22, hepatitis-33)\n",
      "\n",
      "Parsing [sent. 76 len. 25]: statin use was associated with decreased risks of liver-specific mortality and morbidity , and reduced total mortality foremost among patients with alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN statin) (NN use))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (VBN decreased) (NNS risks))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ liver-specific) (NN mortality)\n",
      "                  (CC and)\n",
      "                  (NN morbidity))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (VBN reduced) (JJ total) (NN mortality))\n",
      "              (ADVP (RB foremost)\n",
      "                (PP (IN among)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ alcoholic) (NN liver) (NN disease)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(use-2, statin-1)\n",
      "nsubjpass(associated-4, use-2)\n",
      "auxpass(associated-4, was-3)\n",
      "root(ROOT-0, associated-4)\n",
      "case(risks-7, with-5)\n",
      "amod(risks-7, decreased-6)\n",
      "nmod:with(associated-4, risks-7)\n",
      "case(mortality-10, of-8)\n",
      "amod(mortality-10, liver-specific-9)\n",
      "nmod:of(risks-7, mortality-10)\n",
      "cc(mortality-10, and-11)\n",
      "nmod:of(risks-7, morbidity-12)\n",
      "conj:and(mortality-10, morbidity-12)\n",
      "cc(risks-7, and-14)\n",
      "amod(mortality-17, reduced-15)\n",
      "amod(mortality-17, total-16)\n",
      "nmod:with(associated-4, mortality-17)\n",
      "conj:and(risks-7, mortality-17)\n",
      "advmod(mortality-17, foremost-18)\n",
      "case(patients-20, among-19)\n",
      "nmod:among(foremost-18, patients-20)\n",
      "case(disease-24, with-21)\n",
      "amod(disease-24, alcoholic-22)\n",
      "compound(disease-24, liver-23)\n",
      "nmod:with(patients-20, disease-24)\n",
      "\n",
      "Parsing [sent. 77 len. 14]: ACEI was associated with reduced liver-related mortality among patients with alcoholic liver disease .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (VBN reduced) (JJ liver-related) (NN mortality))\n",
      "            (PP (IN among)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ alcoholic) (NN liver) (NN disease)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(associated-3, ACEI-1)\n",
      "auxpass(associated-3, was-2)\n",
      "root(ROOT-0, associated-3)\n",
      "case(mortality-7, with-4)\n",
      "amod(mortality-7, reduced-5)\n",
      "amod(mortality-7, liver-related-6)\n",
      "nmod:with(associated-3, mortality-7)\n",
      "case(patients-9, among-8)\n",
      "nmod:among(mortality-7, patients-9)\n",
      "case(disease-13, with-10)\n",
      "amod(disease-13, alcoholic-11)\n",
      "compound(disease-13, liver-12)\n",
      "nmod:with(patients-9, disease-13)\n",
      "\n",
      "Parsing [sent. 78 len. 7]: this article is protected by copyright .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN article))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN protected)\n",
      "        (PP (IN by)\n",
      "          (NP (NN copyright)))))\n",
      "    (. .)))\n",
      "\n",
      "det(article-2, this-1)\n",
      "nsubjpass(protected-4, article-2)\n",
      "auxpass(protected-4, is-3)\n",
      "root(ROOT-0, protected-4)\n",
      "case(copyright-6, by-5)\n",
      "nmod:by(protected-4, copyright-6)\n",
      "\n",
      "Parsing [sent. 79 len. 4]: all rights reserved .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT all) (NNS rights))\n",
      "    (VP (VBD reserved))\n",
      "    (. .)))\n",
      "\n",
      "det(rights-2, all-1)\n",
      "nsubj(reserved-3, rights-2)\n",
      "root(ROOT-0, reserved-3)\n",
      "\n",
      "Parsing [sent. 80 len. 44]: fabry 's disease -LRB- fd -RRB- is a severe congenital metabolic disorder characterized by the deficient activity of lysosomal exoglycohydrolase alpha-galactosidase , characterized by glycosphingolipid deposition in several cells , such as capillary endothelial cells , renal , cardiac , and nerve cells .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (NN fabry) (POS 's))\n",
      "        (NN disease))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN fd))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ severe) (JJ congenital) (JJ metabolic) (NN disorder))\n",
      "        (VP (VBN characterized)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ deficient) (NN activity))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ lysosomal) (NN exoglycohydrolase) (NN alpha-galactosidase))\n",
      "                    (, ,)\n",
      "                    (VP (VBN characterized)\n",
      "                      (PP (IN by)\n",
      "                        (NP\n",
      "                          (NP (JJ glycosphingolipid) (NN deposition))\n",
      "                          (PP (IN in)\n",
      "                            (NP (JJ several) (NNS cells))))))\n",
      "                    (, ,))\n",
      "                  (PP (JJ such) (IN as)\n",
      "                    (NP\n",
      "                      (NP (JJ capillary) (JJ endothelial) (NNS cells))\n",
      "                      (, ,)\n",
      "                      (NP (JJ renal))\n",
      "                      (, ,)\n",
      "                      (NP (JJ cardiac))\n",
      "                      (, ,)\n",
      "                      (CC and)\n",
      "                      (NP (NN nerve) (NNS cells)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nmod:poss(disease-3, fabry-1)\n",
      "case(fabry-1, 's-2)\n",
      "nsubj(disorder-12, disease-3)\n",
      "appos(disease-3, fd-5)\n",
      "cop(disorder-12, is-7)\n",
      "det(disorder-12, a-8)\n",
      "amod(disorder-12, severe-9)\n",
      "amod(disorder-12, congenital-10)\n",
      "amod(disorder-12, metabolic-11)\n",
      "root(ROOT-0, disorder-12)\n",
      "acl(disorder-12, characterized-13)\n",
      "case(activity-17, by-14)\n",
      "det(activity-17, the-15)\n",
      "amod(activity-17, deficient-16)\n",
      "nmod:by(characterized-13, activity-17)\n",
      "case(alpha-galactosidase-21, of-18)\n",
      "amod(alpha-galactosidase-21, lysosomal-19)\n",
      "compound(alpha-galactosidase-21, exoglycohydrolase-20)\n",
      "nmod:of(activity-17, alpha-galactosidase-21)\n",
      "acl(alpha-galactosidase-21, characterized-23)\n",
      "case(deposition-26, by-24)\n",
      "amod(deposition-26, glycosphingolipid-25)\n",
      "nmod:by(characterized-23, deposition-26)\n",
      "case(cells-29, in-27)\n",
      "amod(cells-29, several-28)\n",
      "nmod:in(deposition-26, cells-29)\n",
      "case(cells-35, such-31)\n",
      "mwe(such-31, as-32)\n",
      "amod(cells-35, capillary-33)\n",
      "amod(cells-35, endothelial-34)\n",
      "nmod:such_as(alpha-galactosidase-21, cells-35)\n",
      "nmod:such_as(alpha-galactosidase-21, renal-37)\n",
      "conj:and(cells-35, renal-37)\n",
      "nmod:such_as(alpha-galactosidase-21, cardiac-39)\n",
      "conj:and(cells-35, cardiac-39)\n",
      "cc(cells-35, and-41)\n",
      "compound(cells-43, nerve-42)\n",
      "nmod:such_as(alpha-galactosidase-21, cells-43)\n",
      "conj:and(cells-35, cells-43)\n",
      "\n",
      "Parsing [sent. 81 len. 27]: as a systemic disease leading to a contemporaneous myocardial and renal dysfunction , fd might be an example of cardiorenal syndrome type 5 -LRB- crs-5 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN as)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ systemic) (NN disease))\n",
      "        (VP (VBG leading)\n",
      "          (PP (TO to)\n",
      "            (NP\n",
      "              (NP (DT a) (JJ contemporaneous) (NN myocardial))\n",
      "              (CC and)\n",
      "              (NP (JJ renal) (NN dysfunction)))))))\n",
      "    (, ,)\n",
      "    (NP (NN fd))\n",
      "    (VP (MD might)\n",
      "      (VP (VB be)\n",
      "        (NP\n",
      "          (NP (DT an) (NN example))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ cardiorenal) (NN syndrome))\n",
      "                (ADJP (NN type) (CD 5)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (ADJP (JJ crs-5))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "case(disease-4, as-1)\n",
      "det(disease-4, a-2)\n",
      "amod(disease-4, systemic-3)\n",
      "nmod:as(example-18, disease-4)\n",
      "acl(disease-4, leading-5)\n",
      "case(myocardial-9, to-6)\n",
      "det(myocardial-9, a-7)\n",
      "amod(myocardial-9, contemporaneous-8)\n",
      "nmod:to(leading-5, myocardial-9)\n",
      "cc(myocardial-9, and-10)\n",
      "amod(dysfunction-12, renal-11)\n",
      "nmod:to(leading-5, dysfunction-12)\n",
      "conj:and(myocardial-9, dysfunction-12)\n",
      "nsubj(example-18, fd-14)\n",
      "aux(example-18, might-15)\n",
      "cop(example-18, be-16)\n",
      "det(example-18, an-17)\n",
      "root(ROOT-0, example-18)\n",
      "case(syndrome-21, of-19)\n",
      "amod(syndrome-21, cardiorenal-20)\n",
      "nmod:of(example-18, syndrome-21)\n",
      "amod(syndrome-21, type-22)\n",
      "compound(type-22, 5-23)\n",
      "dep(syndrome-21, crs-5-25)\n",
      "\n",
      "Parsing [sent. 82 len. 29]: kidney damage is commonly characterized by proteinuria , isosthenuria and altered tubular function when occurs at the second-third decade , azotemia and end-stage renal disease in third-fifth decade .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN kidney) (NN damage))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB commonly))\n",
      "      (VP (VBN characterized)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NN proteinuria))\n",
      "            (, ,)\n",
      "            (NP (NN isosthenuria))\n",
      "            (CC and)\n",
      "            (NP (JJ altered) (JJ tubular) (NN function))))\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (VP (VBZ occurs)\n",
      "              (PP (IN at)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ second-third) (NN decade))\n",
      "                  (, ,)\n",
      "                  (NP (NN azotemia))\n",
      "                  (CC and)\n",
      "                  (NP (JJ end-stage) (JJ renal) (NN disease))))\n",
      "              (PP (IN in)\n",
      "                (NP (JJ third-fifth) (NN decade))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(damage-2, kidney-1)\n",
      "nsubjpass(characterized-5, damage-2)\n",
      "auxpass(characterized-5, is-3)\n",
      "advmod(characterized-5, commonly-4)\n",
      "root(ROOT-0, characterized-5)\n",
      "case(proteinuria-7, by-6)\n",
      "nmod:by(characterized-5, proteinuria-7)\n",
      "nmod:by(characterized-5, isosthenuria-9)\n",
      "conj:and(proteinuria-7, isosthenuria-9)\n",
      "cc(proteinuria-7, and-10)\n",
      "amod(function-13, altered-11)\n",
      "amod(function-13, tubular-12)\n",
      "nmod:by(characterized-5, function-13)\n",
      "conj:and(proteinuria-7, function-13)\n",
      "advmod(occurs-15, when-14)\n",
      "advcl(characterized-5, occurs-15)\n",
      "case(decade-19, at-16)\n",
      "det(decade-19, the-17)\n",
      "amod(decade-19, second-third-18)\n",
      "nmod:at(occurs-15, decade-19)\n",
      "nmod:at(occurs-15, azotemia-21)\n",
      "conj:and(decade-19, azotemia-21)\n",
      "cc(decade-19, and-22)\n",
      "amod(disease-25, end-stage-23)\n",
      "amod(disease-25, renal-24)\n",
      "nmod:at(occurs-15, disease-25)\n",
      "conj:and(decade-19, disease-25)\n",
      "case(decade-28, in-26)\n",
      "amod(decade-28, third-fifth-27)\n",
      "nmod:in(occurs-15, decade-28)\n",
      "\n",
      "Parsing [sent. 83 len. 23]: beyond the irreversible glomerular , tubular and vascular damages , the podocytes foot process effacement is the major cause of kidney dysfunction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN beyond)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ irreversible) (NN glomerular))\n",
      "        (, ,)\n",
      "        (NP (JJ tubular))\n",
      "        (CC and)\n",
      "        (NP (NN vascular) (NNS damages))))\n",
      "    (, ,)\n",
      "    (NP (DT the) (JJ podocytes) (NN foot) (NN process) (NN effacement))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ major) (NN cause))\n",
      "        (PP (IN of)\n",
      "          (NP (NN kidney) (NN dysfunction)))))\n",
      "    (. .)))\n",
      "\n",
      "case(glomerular-4, beyond-1)\n",
      "det(glomerular-4, the-2)\n",
      "amod(glomerular-4, irreversible-3)\n",
      "nmod:beyond(cause-19, glomerular-4)\n",
      "conj:and(glomerular-4, tubular-6)\n",
      "nmod:beyond(cause-19, tubular-6)\n",
      "cc(glomerular-4, and-7)\n",
      "compound(damages-9, vascular-8)\n",
      "conj:and(glomerular-4, damages-9)\n",
      "nmod:beyond(cause-19, damages-9)\n",
      "det(effacement-15, the-11)\n",
      "amod(effacement-15, podocytes-12)\n",
      "compound(effacement-15, foot-13)\n",
      "compound(effacement-15, process-14)\n",
      "nsubj(cause-19, effacement-15)\n",
      "cop(cause-19, is-16)\n",
      "det(cause-19, the-17)\n",
      "amod(cause-19, major-18)\n",
      "root(ROOT-0, cause-19)\n",
      "case(dysfunction-22, of-20)\n",
      "compound(dysfunction-22, kidney-21)\n",
      "nmod:of(cause-19, dysfunction-22)\n",
      "\n",
      "Parsing [sent. 84 len. 39]: myocardial damage is usually observed with right and left ventricular hypertrophy , arrhythmias -LRB- due to sinus node and conduction system impairment -RRB- , diastolic dysfunction , congestive heart failure , myocardial ischemia , fibrosis and cardiac death .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ myocardial) (NN damage))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB usually))\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN right)\n",
      "              (CC and)\n",
      "              (JJ left) (NN ventricular) (NN hypertrophy))\n",
      "            (, ,)\n",
      "            (NP (NNS arrhythmias))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (ADJP (JJ due)\n",
      "                (PP (TO to)\n",
      "                  (NP (JJ sinus) (NN node)\n",
      "                    (CC and)\n",
      "                    (NN conduction) (NN system) (NN impairment))))\n",
      "              (-RRB- -RRB-))\n",
      "            (, ,)\n",
      "            (NP (JJ diastolic) (NN dysfunction))\n",
      "            (, ,)\n",
      "            (NP (JJ congestive) (NN heart) (NN failure))\n",
      "            (, ,)\n",
      "            (NP (JJ myocardial) (NN ischemia))\n",
      "            (, ,)\n",
      "            (NP (NN fibrosis))\n",
      "            (CC and)\n",
      "            (NP (JJ cardiac) (NN death))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(damage-2, myocardial-1)\n",
      "nsubjpass(observed-5, damage-2)\n",
      "auxpass(observed-5, is-3)\n",
      "advmod(observed-5, usually-4)\n",
      "root(ROOT-0, observed-5)\n",
      "case(hypertrophy-11, with-6)\n",
      "compound(hypertrophy-11, right-7)\n",
      "cc(right-7, and-8)\n",
      "conj:and(right-7, left-9)\n",
      "compound(hypertrophy-11, left-9)\n",
      "compound(hypertrophy-11, ventricular-10)\n",
      "nmod:with(observed-5, hypertrophy-11)\n",
      "nmod:with(observed-5, arrhythmias-13)\n",
      "conj:and(hypertrophy-11, arrhythmias-13)\n",
      "dep(hypertrophy-11, due-15)\n",
      "case(node-18, to-16)\n",
      "amod(node-18, sinus-17)\n",
      "nmod:to(due-15, node-18)\n",
      "cc(node-18, and-19)\n",
      "compound(impairment-22, conduction-20)\n",
      "compound(impairment-22, system-21)\n",
      "nmod:to(due-15, impairment-22)\n",
      "conj:and(node-18, impairment-22)\n",
      "amod(dysfunction-26, diastolic-25)\n",
      "nmod:with(observed-5, dysfunction-26)\n",
      "conj:and(hypertrophy-11, dysfunction-26)\n",
      "amod(failure-30, congestive-28)\n",
      "compound(failure-30, heart-29)\n",
      "nmod:with(observed-5, failure-30)\n",
      "conj:and(hypertrophy-11, failure-30)\n",
      "amod(ischemia-33, myocardial-32)\n",
      "nmod:with(observed-5, ischemia-33)\n",
      "conj:and(hypertrophy-11, ischemia-33)\n",
      "nmod:with(observed-5, fibrosis-35)\n",
      "conj:and(hypertrophy-11, fibrosis-35)\n",
      "cc(hypertrophy-11, and-36)\n",
      "amod(death-38, cardiac-37)\n",
      "nmod:with(observed-5, death-38)\n",
      "conj:and(hypertrophy-11, death-38)\n",
      "\n",
      "Parsing [sent. 85 len. 67]: the enzymatic replacement therapy is essential for the management of fd , as well as the control of renal -LRB- with anti-proteinuric agents such as ACEI - and/or angiotensin ii receptor blockers -RRB- , brain -LRB- coated aspirin , clopidogrel and statins to prevent strokes -RRB- and heart complications -LRB- calcium channel blockers for ischemic cardiomyopathy , warfarin and amiodarone or cardioverter device for arrhythmias -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (JJ enzymatic) (NN replacement) (NN therapy))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ essential)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (DT the) (NN management))\n",
      "              (PP (IN of)\n",
      "                (NP (NN fd))))\n",
      "            (, ,)\n",
      "            (CONJP (RB as) (RB well) (IN as))\n",
      "            (NP\n",
      "              (NP (DT the) (NN control))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ renal))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (PP (IN with)\n",
      "                        (NP\n",
      "                          (NP (JJ anti-proteinuric) (NNS agents))\n",
      "                          (PP (JJ such) (IN as)\n",
      "                            (NP\n",
      "                              (NP (NNP ACEI))\n",
      "                              (: -)\n",
      "                              (NP (JJ and/or) (NN angiotensin) (NN ii) (NN receptor) (NNS blockers))))))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (NN brain))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (VP (VBN coated)\n",
      "                          (NP (NN aspirin) (, ,) (NN clopidogrel)\n",
      "                            (CC and)\n",
      "                            (NNS statins))\n",
      "                          (S\n",
      "                            (VP (TO to)\n",
      "                              (VP (VB prevent)\n",
      "                                (NP (NNS strokes))))))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (CC and)\n",
      "                    (NP (NN heart) (NNS complications)))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "                        (PP (IN for)\n",
      "                          (NP (JJ ischemic) (NN cardiomyopathy) (, ,) (NN warfarin)\n",
      "                            (CC and)\n",
      "                            (NN amiodarone))))\n",
      "                      (CC or)\n",
      "                      (NP\n",
      "                        (NP (NN cardioverter) (NN device))\n",
      "                        (PP (IN for)\n",
      "                          (NP (NNS arrhythmias)))))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(therapy-4, the-1)\n",
      "amod(therapy-4, enzymatic-2)\n",
      "compound(therapy-4, replacement-3)\n",
      "nsubj(essential-6, therapy-4)\n",
      "cop(essential-6, is-5)\n",
      "root(ROOT-0, essential-6)\n",
      "case(management-9, for-7)\n",
      "det(management-9, the-8)\n",
      "nmod:for(essential-6, management-9)\n",
      "case(fd-11, of-10)\n",
      "nmod:of(management-9, fd-11)\n",
      "cc(management-9, as-13)\n",
      "mwe(as-13, well-14)\n",
      "mwe(as-13, as-15)\n",
      "det(control-17, the-16)\n",
      "nmod:for(essential-6, control-17)\n",
      "conj:and(management-9, control-17)\n",
      "case(renal-19, of-18)\n",
      "nmod:of(control-17, renal-19)\n",
      "case(agents-23, with-21)\n",
      "amod(agents-23, anti-proteinuric-22)\n",
      "nmod:with(renal-19, agents-23)\n",
      "case(ACEI-26, such-24)\n",
      "mwe(such-24, as-25)\n",
      "nmod:such_as(agents-23, ACEI-26)\n",
      "amod(blockers-32, and/or-28)\n",
      "compound(blockers-32, angiotensin-29)\n",
      "compound(blockers-32, ii-30)\n",
      "compound(blockers-32, receptor-31)\n",
      "dep(ACEI-26, blockers-32)\n",
      "nmod:of(control-17, brain-35)\n",
      "conj:and(renal-19, brain-35)\n",
      "dep(brain-35, coated-37)\n",
      "dobj(coated-37, aspirin-38)\n",
      "dobj(coated-37, clopidogrel-40)\n",
      "conj:and(aspirin-38, clopidogrel-40)\n",
      "cc(aspirin-38, and-41)\n",
      "dobj(coated-37, statins-42)\n",
      "conj:and(aspirin-38, statins-42)\n",
      "mark(prevent-44, to-43)\n",
      "advcl(coated-37, prevent-44)\n",
      "dobj(prevent-44, strokes-45)\n",
      "cc(renal-19, and-47)\n",
      "compound(complications-49, heart-48)\n",
      "nmod:of(control-17, complications-49)\n",
      "conj:and(renal-19, complications-49)\n",
      "compound(blockers-53, calcium-51)\n",
      "compound(blockers-53, channel-52)\n",
      "dep(renal-19, blockers-53)\n",
      "case(cardiomyopathy-56, for-54)\n",
      "amod(cardiomyopathy-56, ischemic-55)\n",
      "nmod:for(blockers-53, cardiomyopathy-56)\n",
      "nmod:for(blockers-53, warfarin-58)\n",
      "conj:and(cardiomyopathy-56, warfarin-58)\n",
      "cc(cardiomyopathy-56, and-59)\n",
      "nmod:for(blockers-53, amiodarone-60)\n",
      "conj:and(cardiomyopathy-56, amiodarone-60)\n",
      "cc(blockers-53, or-61)\n",
      "compound(device-63, cardioverter-62)\n",
      "dep(renal-19, device-63)\n",
      "conj:or(blockers-53, device-63)\n",
      "case(arrhythmias-65, for-64)\n",
      "nmod:for(device-63, arrhythmias-65)\n",
      "\n",
      "Parsing [sent. 86 len. 24]: nonsteroidal antiinflammatory agents , Î²-lactam antibiotics , non-Î² lactam antibiotics , and ACEI are the most common classes of drugs that cause angioedema .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ nonsteroidal) (NN antiinflammatory) (NNS agents))\n",
      "      (, ,)\n",
      "      (NP (JJ Î²-lactam) (NNS antibiotics))\n",
      "      (, ,)\n",
      "      (NP (JJ non-Î²) (NN lactam) (NNS antibiotics))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NNP ACEI)))\n",
      "    (VP (VBP are)\n",
      "      (NP\n",
      "        (NP (DT the) (RBS most) (JJ common) (NNS classes))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNS drugs))\n",
      "            (SBAR\n",
      "              (WHNP (WDT that))\n",
      "              (S\n",
      "                (VP (VBP cause)\n",
      "                  (NP (NN angioedema)))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(agents-3, nonsteroidal-1)\n",
      "compound(agents-3, antiinflammatory-2)\n",
      "nsubj(classes-18, agents-3)\n",
      "amod(antibiotics-6, Î²-lactam-5)\n",
      "conj:and(agents-3, antibiotics-6)\n",
      "nsubj(classes-18, antibiotics-6)\n",
      "amod(antibiotics-10, non-Î²-8)\n",
      "compound(antibiotics-10, lactam-9)\n",
      "conj:and(agents-3, antibiotics-10)\n",
      "nsubj(classes-18, antibiotics-10)\n",
      "cc(agents-3, and-12)\n",
      "conj:and(agents-3, ACEI-13)\n",
      "nsubj(classes-18, ACEI-13)\n",
      "cop(classes-18, are-14)\n",
      "det(classes-18, the-15)\n",
      "advmod(classes-18, most-16)\n",
      "amod(classes-18, common-17)\n",
      "root(ROOT-0, classes-18)\n",
      "case(drugs-20, of-19)\n",
      "nmod:of(classes-18, drugs-20)\n",
      "nsubj(cause-22, drugs-20)\n",
      "ref(drugs-20, that-21)\n",
      "acl:relcl(drugs-20, cause-22)\n",
      "dobj(cause-22, angioedema-23)\n",
      "\n",
      "Parsing [sent. 87 len. 30]: drug-induced angioedema is known to occur via mechanisms mediated by histamine , bradykinin , or leukotriene , and an understanding of these mechanisms is crucial in guiding therapeutic decisions .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ drug-induced) (NN angioedema))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN known)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB occur)\n",
      "                (PP (IN via)\n",
      "                  (NP\n",
      "                    (NP (NNS mechanisms))\n",
      "                    (VP (VBN mediated)\n",
      "                      (PP (IN by)\n",
      "                        (NP\n",
      "                          (NP (NN histamine))\n",
      "                          (, ,)\n",
      "                          (NP (NN bradykinin))\n",
      "                          (, ,)\n",
      "                          (CC or)\n",
      "                          (NP (NN leukotriene)))))))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT an) (NN understanding))\n",
      "        (PP (IN of)\n",
      "          (NP (DT these) (NNS mechanisms))))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ crucial)\n",
      "          (PP (IN in)\n",
      "            (NP (VBG guiding) (JJ therapeutic) (NNS decisions))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(angioedema-2, drug-induced-1)\n",
      "nsubjpass(known-4, angioedema-2)\n",
      "nsubj:xsubj(occur-6, angioedema-2)\n",
      "auxpass(known-4, is-3)\n",
      "root(ROOT-0, known-4)\n",
      "mark(occur-6, to-5)\n",
      "xcomp(known-4, occur-6)\n",
      "case(mechanisms-8, via-7)\n",
      "nmod:via(occur-6, mechanisms-8)\n",
      "acl(mechanisms-8, mediated-9)\n",
      "case(histamine-11, by-10)\n",
      "nmod:by(mediated-9, histamine-11)\n",
      "nmod:by(mediated-9, bradykinin-13)\n",
      "conj:or(histamine-11, bradykinin-13)\n",
      "cc(histamine-11, or-15)\n",
      "nmod:by(mediated-9, leukotriene-16)\n",
      "conj:or(histamine-11, leukotriene-16)\n",
      "cc(known-4, and-18)\n",
      "det(understanding-20, an-19)\n",
      "nsubj(crucial-25, understanding-20)\n",
      "case(mechanisms-23, of-21)\n",
      "det(mechanisms-23, these-22)\n",
      "nmod:of(understanding-20, mechanisms-23)\n",
      "cop(crucial-25, is-24)\n",
      "conj:and(known-4, crucial-25)\n",
      "case(decisions-29, in-26)\n",
      "amod(decisions-29, guiding-27)\n",
      "amod(decisions-29, therapeutic-28)\n",
      "nmod:in(crucial-25, decisions-29)\n",
      "\n",
      "Parsing [sent. 88 len. 35]: nonallergic angioedema occurs in patients with genetic variants that affect metabolism or synthesis of bradykinin , substance p , prostaglandins , or leukotrienes , or when patients are taking drugs that have synergistic mechanisms .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ nonallergic) (NN angioedema))\n",
      "    (VP (VBZ occurs)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ genetic) (NNS variants)))))\n",
      "      (SBAR\n",
      "        (SBAR\n",
      "          (WHNP (WDT that))\n",
      "          (S\n",
      "            (VP (VBP affect)\n",
      "              (NP\n",
      "                (NP (NN metabolism)\n",
      "                  (CC or)\n",
      "                  (NN synthesis))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NN bradykinin))\n",
      "                    (, ,)\n",
      "                    (NP (NN substance) (NN p))\n",
      "                    (, ,)\n",
      "                    (NP (NNS prostaglandins))\n",
      "                    (, ,)\n",
      "                    (CC or)\n",
      "                    (NP (NNS leukotrienes))))))))\n",
      "        (, ,)\n",
      "        (CC or)\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (NNS patients))\n",
      "            (VP (VBP are)\n",
      "              (VP (VBG taking)\n",
      "                (NP\n",
      "                  (NP (NNS drugs))\n",
      "                  (SBAR\n",
      "                    (WHNP (WDT that))\n",
      "                    (S\n",
      "                      (VP (VBP have)\n",
      "                        (NP (JJ synergistic) (NNS mechanisms))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(angioedema-2, nonallergic-1)\n",
      "nsubj(occurs-3, angioedema-2)\n",
      "root(ROOT-0, occurs-3)\n",
      "case(patients-5, in-4)\n",
      "nmod:in(occurs-3, patients-5)\n",
      "case(variants-8, with-6)\n",
      "amod(variants-8, genetic-7)\n",
      "nmod:with(patients-5, variants-8)\n",
      "nsubj(affect-10, that-9)\n",
      "dep(occurs-3, affect-10)\n",
      "dobj(affect-10, metabolism-11)\n",
      "cc(metabolism-11, or-12)\n",
      "dobj(affect-10, synthesis-13)\n",
      "conj:or(metabolism-11, synthesis-13)\n",
      "case(bradykinin-15, of-14)\n",
      "nmod:of(metabolism-11, bradykinin-15)\n",
      "compound(p-18, substance-17)\n",
      "nmod:of(metabolism-11, p-18)\n",
      "conj:or(bradykinin-15, p-18)\n",
      "nmod:of(metabolism-11, prostaglandins-20)\n",
      "conj:or(bradykinin-15, prostaglandins-20)\n",
      "cc(bradykinin-15, or-22)\n",
      "nmod:of(metabolism-11, leukotrienes-23)\n",
      "conj:or(bradykinin-15, leukotrienes-23)\n",
      "cc(affect-10, or-25)\n",
      "advmod(taking-29, when-26)\n",
      "nsubj(taking-29, patients-27)\n",
      "aux(taking-29, are-28)\n",
      "dep(occurs-3, taking-29)\n",
      "conj:or(affect-10, taking-29)\n",
      "dobj(taking-29, drugs-30)\n",
      "nsubj(have-32, drugs-30)\n",
      "ref(drugs-30, that-31)\n",
      "acl:relcl(drugs-30, have-32)\n",
      "amod(mechanisms-34, synergistic-33)\n",
      "dobj(have-32, mechanisms-34)\n",
      "\n",
      "Parsing [sent. 89 len. 15]: the mainstay in treatment of nonallergic drug-induced angioedema is cessation of the offending agents .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN mainstay))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN treatment))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ nonallergic) (JJ drug-induced) (NN angioedema))))))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (NN cessation))\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ offending) (NNS agents)))))\n",
      "    (. .)))\n",
      "\n",
      "det(mainstay-2, the-1)\n",
      "nsubj(cessation-10, mainstay-2)\n",
      "case(treatment-4, in-3)\n",
      "nmod:in(mainstay-2, treatment-4)\n",
      "case(angioedema-8, of-5)\n",
      "amod(angioedema-8, nonallergic-6)\n",
      "amod(angioedema-8, drug-induced-7)\n",
      "nmod:of(treatment-4, angioedema-8)\n",
      "cop(cessation-10, is-9)\n",
      "root(ROOT-0, cessation-10)\n",
      "case(agents-14, of-11)\n",
      "det(agents-14, the-12)\n",
      "amod(agents-14, offending-13)\n",
      "nmod:of(cessation-10, agents-14)\n",
      "\n",
      "Parsing [sent. 90 len. 50]: raas , a major pharmacological target in cardiovascular medicine , is inhibited by pharmacological classes including ACEI -LRB- ACEI -RRB- inhibitors -LRB- aceis -RRB- , angiotensin-ii type 1 blockers -LRB- arbs -RRB- and aldosterone receptors antagonists , in addition to the recently introduced direct renin inhibitors -LRB- dris -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS raas))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ major) (JJ pharmacological) (NN target))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ cardiovascular) (NN medicine))))\n",
      "      (, ,))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP (JJ inhibited)\n",
      "            (PP (IN by)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (JJ pharmacological) (NNS classes))\n",
      "                  (PP (VBG including)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (NNP ACEI)\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NNP ACEI))\n",
      "                            (-RRB- -RRB-))\n",
      "                          (NNP inhibitors))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NNS aceis))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (, ,)\n",
      "                      (NP\n",
      "                        (NP (JJ angiotensin-ii) (NN type) (CD 1) (NNS blockers))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NNS arbs))\n",
      "                          (-RRB- -RRB-)))\n",
      "                      (CC and)\n",
      "                      (NP (JJ aldosterone) (NNS receptors) (NNS antagonists))\n",
      "                      (, ,))))\n",
      "                (CONJP (IN in) (NN addition) (TO to))\n",
      "                (NP (DT the)\n",
      "                  (ADJP (RB recently) (VBN introduced))\n",
      "                  (JJ direct) (NN renin)))))\n",
      "          (NNS inhibitors))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NNS dris))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(inhibitors-46, raas-1)\n",
      "det(target-6, a-3)\n",
      "amod(target-6, major-4)\n",
      "amod(target-6, pharmacological-5)\n",
      "appos(raas-1, target-6)\n",
      "case(medicine-9, in-7)\n",
      "amod(medicine-9, cardiovascular-8)\n",
      "nmod:in(target-6, medicine-9)\n",
      "cop(inhibitors-46, is-11)\n",
      "amod(inhibitors-46, inhibited-12)\n",
      "case(classes-15, by-13)\n",
      "amod(classes-15, pharmacological-14)\n",
      "nmod:by(inhibited-12, classes-15)\n",
      "case(inhibitors-21, including-16)\n",
      "compound(inhibitors-21, ACEI-17)\n",
      "appos(inhibitors-21, ACEI-19)\n",
      "nmod:including(classes-15, inhibitors-21)\n",
      "appos(inhibitors-21, aceis-23)\n",
      "amod(blockers-29, angiotensin-ii-26)\n",
      "compound(blockers-29, type-27)\n",
      "nummod(blockers-29, 1-28)\n",
      "nmod:including(classes-15, blockers-29)\n",
      "conj:and(inhibitors-21, blockers-29)\n",
      "appos(blockers-29, arbs-31)\n",
      "cc(inhibitors-21, and-33)\n",
      "amod(antagonists-36, aldosterone-34)\n",
      "compound(antagonists-36, receptors-35)\n",
      "nmod:including(classes-15, antagonists-36)\n",
      "conj:and(inhibitors-21, antagonists-36)\n",
      "cc(classes-15, in-38)\n",
      "dep(in-38, addition-39)\n",
      "dep(in-38, to-40)\n",
      "det(renin-45, the-41)\n",
      "advmod(introduced-43, recently-42)\n",
      "amod(renin-45, introduced-43)\n",
      "amod(renin-45, direct-44)\n",
      "nmod:by(inhibited-12, renin-45)\n",
      "conj:in(classes-15, renin-45)\n",
      "root(ROOT-0, inhibitors-46)\n",
      "appos(inhibitors-46, dris-48)\n",
      "\n",
      "Parsing [sent. 91 len. 36]: however , currently used raas inhibitors still can not achieve their desired effects and are associated with certain drawbacks , such as adverse side effects , incomplete blockage of the system and poor end-organ protection .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (ADVP (RB currently))\n",
      "    (VP (VBD used)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP (NNS raas) (NNS inhibitors))\n",
      "          (ADVP (RB still))\n",
      "          (VP\n",
      "            (VP (MD can) (RB not)\n",
      "              (VP (VB achieve)\n",
      "                (NP (PRP$ their) (VBN desired) (NNS effects))))\n",
      "            (CC and)\n",
      "            (VP (VBP are)\n",
      "              (VP (VBN associated)\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP (JJ certain) (NNS drawbacks))\n",
      "                    (, ,)\n",
      "                    (PP (JJ such) (IN as)\n",
      "                      (NP (JJ adverse) (NN side) (NNS effects)))\n",
      "                    (, ,)\n",
      "                    (ADJP (JJ incomplete) (JJ blockage))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN system))\n",
      "                        (CC and)\n",
      "                        (NP (JJ poor) (JJ end-organ) (NN protection))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(used-4, however-1)\n",
      "advmod(used-4, currently-3)\n",
      "root(ROOT-0, used-4)\n",
      "compound(inhibitors-6, raas-5)\n",
      "nsubj(achieve-10, inhibitors-6)\n",
      "nsubjpass(associated-16, inhibitors-6)\n",
      "advmod(achieve-10, still-7)\n",
      "aux(achieve-10, can-8)\n",
      "neg(achieve-10, not-9)\n",
      "ccomp(used-4, achieve-10)\n",
      "nmod:poss(effects-13, their-11)\n",
      "amod(effects-13, desired-12)\n",
      "dobj(achieve-10, effects-13)\n",
      "cc(achieve-10, and-14)\n",
      "auxpass(associated-16, are-15)\n",
      "ccomp(used-4, associated-16)\n",
      "conj:and(achieve-10, associated-16)\n",
      "case(drawbacks-19, with-17)\n",
      "amod(drawbacks-19, certain-18)\n",
      "nmod:with(associated-16, drawbacks-19)\n",
      "case(effects-25, such-21)\n",
      "mwe(such-21, as-22)\n",
      "amod(effects-25, adverse-23)\n",
      "compound(effects-25, side-24)\n",
      "nmod:such_as(drawbacks-19, effects-25)\n",
      "amod(blockage-28, incomplete-27)\n",
      "amod(drawbacks-19, blockage-28)\n",
      "case(system-31, of-29)\n",
      "det(system-31, the-30)\n",
      "nmod:of(drawbacks-19, system-31)\n",
      "cc(system-31, and-32)\n",
      "amod(protection-35, poor-33)\n",
      "amod(protection-35, end-organ-34)\n",
      "nmod:of(drawbacks-19, protection-35)\n",
      "conj:and(system-31, protection-35)\n",
      "\n",
      "Parsing [sent. 92 len. 42]: in this review , we discuss the efficiency and specificity of the current raas inhibitors and propose some recommendations for achieving better treatments with better end-organ protection.hypertension research advance online publication , 6 july 2017 ; doi :10.1038 / hr .2017.65 .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (DT this) (NN review)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP\n",
      "      (VP (VB discuss)\n",
      "        (NP\n",
      "          (NP (DT the) (NN efficiency)\n",
      "            (CC and)\n",
      "            (NN specificity))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (JJ current) (NNS raas) (NNS inhibitors)))))\n",
      "      (CC and)\n",
      "      (VP (VB propose)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT some) (NNS recommendations))\n",
      "            (PP (IN for)\n",
      "              (S\n",
      "                (VP (VBG achieving)\n",
      "                  (NP (JJR better) (NNS treatments))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJR better) (JJ end-organ) (NN protection.hypertension) (NN research) (NN advance) (JJ online) (NNS publication)))))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (CD 6))\n",
      "            (NP (NNP july) (CD 2017)))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (QP (CD doi) (CD :10.1038))\n",
      "            (NNS /))\n",
      "          (NP (NN hr) (CD .2017.65)))))\n",
      "    (. .)))\n",
      "\n",
      "case(review-3, in-1)\n",
      "det(review-3, this-2)\n",
      "nmod:in(discuss-6, review-3)\n",
      "nsubj(discuss-6, we-5)\n",
      "nsubj(propose-17, we-5)\n",
      "root(ROOT-0, discuss-6)\n",
      "det(efficiency-8, the-7)\n",
      "dobj(discuss-6, efficiency-8)\n",
      "cc(efficiency-8, and-9)\n",
      "dobj(discuss-6, specificity-10)\n",
      "conj:and(efficiency-8, specificity-10)\n",
      "case(inhibitors-15, of-11)\n",
      "det(inhibitors-15, the-12)\n",
      "amod(inhibitors-15, current-13)\n",
      "compound(inhibitors-15, raas-14)\n",
      "nmod:of(efficiency-8, inhibitors-15)\n",
      "cc(discuss-6, and-16)\n",
      "conj:and(discuss-6, propose-17)\n",
      "det(recommendations-19, some-18)\n",
      "dobj(propose-17, recommendations-19)\n",
      "mark(achieving-21, for-20)\n",
      "acl(recommendations-19, achieving-21)\n",
      "amod(treatments-23, better-22)\n",
      "dobj(achieving-21, treatments-23)\n",
      "case(publication-31, with-24)\n",
      "amod(publication-31, better-25)\n",
      "amod(publication-31, end-organ-26)\n",
      "compound(publication-31, protection.hypertension-27)\n",
      "compound(publication-31, research-28)\n",
      "compound(publication-31, advance-29)\n",
      "amod(publication-31, online-30)\n",
      "nmod:with(achieving-21, publication-31)\n",
      "appos(recommendations-19, 6-33)\n",
      "dep(6-33, july-34)\n",
      "nummod(july-34, 2017-35)\n",
      "compound(:10.1038-38, doi-37)\n",
      "nummod(/-39, :10.1038-38)\n",
      "dep(recommendations-19, /-39)\n",
      "dep(recommendations-19, hr-40)\n",
      "nummod(hr-40, .2017.65-41)\n",
      "\n",
      "Parsing [sent. 93 len. 25]: the progression of chronic kidney disease ckd is largely independent of the underlying kidney disorder once renal function has fallen below a critical level .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN progression))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ chronic) (NN kidney) (NN disease) (NN ckd))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (RB largely) (JJ independent)\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ underlying) (NN kidney) (NN disorder))))\n",
      "      (SBAR (IN once)\n",
      "        (S\n",
      "          (NP (JJ renal) (NN function))\n",
      "          (VP (VBZ has)\n",
      "            (VP (VBN fallen)\n",
      "              (PP (IN below)\n",
      "                (NP (DT a) (JJ critical) (NN level))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(progression-2, the-1)\n",
      "nsubj(independent-10, progression-2)\n",
      "case(ckd-7, of-3)\n",
      "amod(ckd-7, chronic-4)\n",
      "compound(ckd-7, kidney-5)\n",
      "compound(ckd-7, disease-6)\n",
      "nmod:of(progression-2, ckd-7)\n",
      "cop(independent-10, is-8)\n",
      "advmod(independent-10, largely-9)\n",
      "root(ROOT-0, independent-10)\n",
      "case(disorder-15, of-11)\n",
      "det(disorder-15, the-12)\n",
      "amod(disorder-15, underlying-13)\n",
      "compound(disorder-15, kidney-14)\n",
      "nmod:of(independent-10, disorder-15)\n",
      "mark(fallen-20, once-16)\n",
      "amod(function-18, renal-17)\n",
      "nsubj(fallen-20, function-18)\n",
      "aux(fallen-20, has-19)\n",
      "advcl(independent-10, fallen-20)\n",
      "case(level-24, below-21)\n",
      "det(level-24, a-22)\n",
      "amod(level-24, critical-23)\n",
      "nmod:below(fallen-20, level-24)\n",
      "\n",
      "Parsing [sent. 94 len. 19]: hypertension is an independent risk factor for disease progression in both adult and pediatric patients with kidney disorders .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN hypertension))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an) (JJ independent) (NN risk) (NN factor))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN disease) (NN progression))\n",
      "              (PP (IN in)\n",
      "                (NP (DT both) (NN adult))))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (JJ pediatric) (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (NN kidney) (NNS disorders))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(factor-6, hypertension-1)\n",
      "cop(factor-6, is-2)\n",
      "det(factor-6, an-3)\n",
      "amod(factor-6, independent-4)\n",
      "compound(factor-6, risk-5)\n",
      "root(ROOT-0, factor-6)\n",
      "case(progression-9, for-7)\n",
      "compound(progression-9, disease-8)\n",
      "nmod:for(factor-6, progression-9)\n",
      "case(adult-12, in-10)\n",
      "det(adult-12, both-11)\n",
      "nmod:in(progression-9, adult-12)\n",
      "cc(progression-9, and-13)\n",
      "amod(patients-15, pediatric-14)\n",
      "nmod:for(factor-6, patients-15)\n",
      "conj:and(progression-9, patients-15)\n",
      "case(disorders-18, with-16)\n",
      "compound(disorders-18, kidney-17)\n",
      "nmod:with(patients-15, disorders-18)\n",
      "\n",
      "Parsing [sent. 95 len. 33]: optimal blood pressure control -LRB- 130 / 80mm hg -RRB- represents a main goal of conservative therapy in patients with chronic kidney disease ckd but it is rarely achieved in clinical practice .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (JJ optimal) (NN blood) (NN pressure) (NN control))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (QP (CD 130) (CD /))\n",
      "            (NN 80mm) (NN hg))\n",
      "          (-RRB- -RRB-)))\n",
      "      (VP (VBZ represents)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ main) (NN goal))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ conservative) (NN therapy))))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (JJ chronic) (NN kidney) (NN disease) (NN ckd)))))))\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBZ is)\n",
      "        (ADVP (RB rarely))\n",
      "        (VP (VBN achieved)\n",
      "          (PP (IN in)\n",
      "            (NP (JJ clinical) (NN practice))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(control-4, optimal-1)\n",
      "compound(control-4, blood-2)\n",
      "compound(control-4, pressure-3)\n",
      "nsubj(represents-11, control-4)\n",
      "compound(/-7, 130-6)\n",
      "nummod(hg-9, /-7)\n",
      "compound(hg-9, 80mm-8)\n",
      "appos(control-4, hg-9)\n",
      "root(ROOT-0, represents-11)\n",
      "det(goal-14, a-12)\n",
      "amod(goal-14, main-13)\n",
      "dobj(represents-11, goal-14)\n",
      "case(therapy-17, of-15)\n",
      "amod(therapy-17, conservative-16)\n",
      "nmod:of(goal-14, therapy-17)\n",
      "case(patients-19, in-18)\n",
      "nmod:in(represents-11, patients-19)\n",
      "case(ckd-24, with-20)\n",
      "amod(ckd-24, chronic-21)\n",
      "compound(ckd-24, kidney-22)\n",
      "compound(ckd-24, disease-23)\n",
      "nmod:with(patients-19, ckd-24)\n",
      "cc(represents-11, but-25)\n",
      "nsubjpass(achieved-29, it-26)\n",
      "auxpass(achieved-29, is-27)\n",
      "advmod(achieved-29, rarely-28)\n",
      "conj:but(represents-11, achieved-29)\n",
      "case(practice-32, in-30)\n",
      "amod(practice-32, clinical-31)\n",
      "nmod:in(achieved-29, practice-32)\n",
      "\n",
      "Parsing [sent. 96 len. 18]: ACEI and angiotensin receptor blockers are more effective than other drugs in slowing progression of proteinuric ckd .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI)\n",
      "      (CC and)\n",
      "      (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "    (VP (VBP are)\n",
      "      (ADJP (RBR more) (JJ effective)\n",
      "        (PP (IN than)\n",
      "          (NP\n",
      "            (NP (JJ other) (NNS drugs))\n",
      "            (PP (IN in)\n",
      "              (NP\n",
      "                (NP (VBG slowing) (NN progression))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ proteinuric) (NN ckd)))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(blockers-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, angiotensin-3)\n",
      "compound(blockers-5, angiotensin-3)\n",
      "compound(blockers-5, receptor-4)\n",
      "nsubj(effective-8, blockers-5)\n",
      "cop(effective-8, are-6)\n",
      "advmod(effective-8, more-7)\n",
      "root(ROOT-0, effective-8)\n",
      "case(drugs-11, than-9)\n",
      "amod(drugs-11, other-10)\n",
      "nmod:than(effective-8, drugs-11)\n",
      "case(progression-14, in-12)\n",
      "amod(progression-14, slowing-13)\n",
      "nmod:in(drugs-11, progression-14)\n",
      "case(ckd-17, of-15)\n",
      "amod(ckd-17, proteinuric-16)\n",
      "nmod:of(progression-14, ckd-17)\n",
      "\n",
      "Parsing [sent. 97 len. 20]: dietary salt restriction -LRB- â¤ 100 meq/die of nacl -RRB- may be useful to correct the extracellular volume expansion .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ dietary) (NN salt) (NN restriction))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP\n",
      "            (QP (CD â¤) (CD 100))\n",
      "            (NN meq/die))\n",
      "          (PP (IN of)\n",
      "            (NP (NN nacl))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (MD may)\n",
      "      (VP (VB be)\n",
      "        (ADJP (JJ useful)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB correct)\n",
      "                (NP (DT the) (NN extracellular) (NN volume) (NN expansion))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(restriction-3, dietary-1)\n",
      "compound(restriction-3, salt-2)\n",
      "nsubj(useful-13, restriction-3)\n",
      "nsubj:xsubj(correct-15, restriction-3)\n",
      "compound(100-6, â¤-5)\n",
      "nummod(meq/die-7, 100-6)\n",
      "dep(restriction-3, meq/die-7)\n",
      "case(nacl-9, of-8)\n",
      "nmod:of(meq/die-7, nacl-9)\n",
      "aux(useful-13, may-11)\n",
      "cop(useful-13, be-12)\n",
      "root(ROOT-0, useful-13)\n",
      "mark(correct-15, to-14)\n",
      "xcomp(useful-13, correct-15)\n",
      "det(expansion-19, the-16)\n",
      "compound(expansion-19, extracellular-17)\n",
      "compound(expansion-19, volume-18)\n",
      "dobj(correct-15, expansion-19)\n",
      "\n",
      "Parsing [sent. 98 len. 33]: if this intervention fails , hypertension can be treated by thiazide diuretics in patients with mild ckd , whereas loop diuretics at adequate doses are indicated in patients with more advanced ckd .\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN if)\n",
      "      (S\n",
      "        (NP (DT this) (NN intervention))\n",
      "        (VP (VBZ fails))))\n",
      "    (, ,)\n",
      "    (NP (NN hypertension))\n",
      "    (VP (MD can)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN treated)\n",
      "          (PP (IN by)\n",
      "            (NP (JJ thiazide) (NNS diuretics)))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (PP (IN with)\n",
      "                (NP (JJ mild) (NN ckd)))))\n",
      "          (, ,)\n",
      "          (SBAR (IN whereas)\n",
      "            (S\n",
      "              (NP\n",
      "                (NP (NN loop) (NNS diuretics))\n",
      "                (PP (IN at)\n",
      "                  (NP (JJ adequate) (NNS doses))))\n",
      "              (VP (VBP are)\n",
      "                (VP (VBN indicated)\n",
      "                  (PP (IN in)\n",
      "                    (NP\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP\n",
      "                          (ADJP (RBR more) (JJ advanced))\n",
      "                          (NN ckd))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(fails-4, if-1)\n",
      "det(intervention-3, this-2)\n",
      "nsubj(fails-4, intervention-3)\n",
      "advcl(treated-9, fails-4)\n",
      "nsubjpass(treated-9, hypertension-6)\n",
      "aux(treated-9, can-7)\n",
      "auxpass(treated-9, be-8)\n",
      "root(ROOT-0, treated-9)\n",
      "case(diuretics-12, by-10)\n",
      "amod(diuretics-12, thiazide-11)\n",
      "nmod:by(treated-9, diuretics-12)\n",
      "case(patients-14, in-13)\n",
      "nmod:in(treated-9, patients-14)\n",
      "case(ckd-17, with-15)\n",
      "amod(ckd-17, mild-16)\n",
      "nmod:with(patients-14, ckd-17)\n",
      "mark(indicated-26, whereas-19)\n",
      "compound(diuretics-21, loop-20)\n",
      "nsubjpass(indicated-26, diuretics-21)\n",
      "case(doses-24, at-22)\n",
      "amod(doses-24, adequate-23)\n",
      "nmod:at(diuretics-21, doses-24)\n",
      "auxpass(indicated-26, are-25)\n",
      "advcl(treated-9, indicated-26)\n",
      "case(patients-28, in-27)\n",
      "nmod:in(indicated-26, patients-28)\n",
      "case(ckd-32, with-29)\n",
      "advmod(advanced-31, more-30)\n",
      "amod(ckd-32, advanced-31)\n",
      "nmod:with(patients-28, ckd-32)\n",
      "\n",
      "Parsing [sent. 99 len. 49]: the beneficial effects of ACEI -LRB- ACEI -RRB- inhibitors and angiotensin ii -LRB- aii -RRB- receptor antagonists in patients with heart failure secondary to reduced ejection fraction -LRB- hfref -RRB- are felt to result from prevention of the adverse effects of aii on systemic afterload and renal homeostasis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "        (PP (IN of)\n",
      "          (NP (NNP ACEI)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP ACEI))\n",
      "              (-RRB- -RRB-))\n",
      "            (NN inhibitors))))\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP\n",
      "            (QP (CD angiotensin) (CD ii)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN aii))\n",
      "            (-RRB- -RRB-))\n",
      "          (NN receptor) (NNS antagonists))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NN heart) (NN failure))\n",
      "                  (ADJP (JJ secondary)\n",
      "                    (PP (TO to)\n",
      "                      (NP (JJ reduced) (NN ejection) (NN fraction)))))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN hfref))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN felt)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB result)\n",
      "              (PP (IN from)\n",
      "                (NP\n",
      "                  (NP (NN prevention))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (DT the) (JJ adverse) (NNS effects))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NN aii)))))))\n",
      "              (PP (IN on)\n",
      "                (NP (JJ systemic) (JJ afterload)\n",
      "                  (CC and)\n",
      "                  (JJ renal) (NNS homeostasis))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(effects-3, the-1)\n",
      "amod(effects-3, beneficial-2)\n",
      "nsubjpass(felt-32, effects-3)\n",
      "nsubj:xsubj(result-34, effects-3)\n",
      "case(inhibitors-9, of-4)\n",
      "compound(inhibitors-9, ACEI-5)\n",
      "appos(inhibitors-9, ACEI-7)\n",
      "nmod:of(effects-3, inhibitors-9)\n",
      "cc(effects-3, and-10)\n",
      "compound(ii-12, angiotensin-11)\n",
      "nummod(antagonists-17, ii-12)\n",
      "appos(antagonists-17, aii-14)\n",
      "compound(antagonists-17, receptor-16)\n",
      "conj:and(effects-3, antagonists-17)\n",
      "nsubjpass(felt-32, antagonists-17)\n",
      "nsubj:xsubj(result-34, antagonists-17)\n",
      "case(patients-19, in-18)\n",
      "nmod:in(antagonists-17, patients-19)\n",
      "case(failure-22, with-20)\n",
      "compound(failure-22, heart-21)\n",
      "nmod:with(patients-19, failure-22)\n",
      "amod(failure-22, secondary-23)\n",
      "case(fraction-27, to-24)\n",
      "amod(fraction-27, reduced-25)\n",
      "compound(fraction-27, ejection-26)\n",
      "nmod:to(secondary-23, fraction-27)\n",
      "appos(failure-22, hfref-29)\n",
      "auxpass(felt-32, are-31)\n",
      "root(ROOT-0, felt-32)\n",
      "mark(result-34, to-33)\n",
      "xcomp(felt-32, result-34)\n",
      "case(prevention-36, from-35)\n",
      "nmod:from(result-34, prevention-36)\n",
      "case(effects-40, of-37)\n",
      "det(effects-40, the-38)\n",
      "amod(effects-40, adverse-39)\n",
      "nmod:of(prevention-36, effects-40)\n",
      "case(aii-42, of-41)\n",
      "nmod:of(effects-40, aii-42)\n",
      "case(afterload-45, on-43)\n",
      "amod(afterload-45, systemic-44)\n",
      "nmod:on(result-34, afterload-45)\n",
      "cc(afterload-45, and-46)\n",
      "amod(homeostasis-48, renal-47)\n",
      "nmod:on(result-34, homeostasis-48)\n",
      "conj:and(afterload-45, homeostasis-48)\n",
      "\n",
      "Parsing [sent. 100 len. 30]: however , aii can activate the sympathetic nervous system and part of the beneficial effects of ACEI and aii antagonists may result from their ability to inhibit such activation .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN aii))\n",
      "      (VP (MD can)\n",
      "        (VP (VB activate)\n",
      "          (NP\n",
      "            (NP (DT the)\n",
      "              (ADJP (JJ sympathetic) (JJ nervous))\n",
      "              (NN system))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (NN part))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NNP ACEI))))))))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN aii) (NNS antagonists))\n",
      "      (VP (MD may)\n",
      "        (VP (VB result)\n",
      "          (PP (IN from)\n",
      "            (NP (PRP$ their) (NN ability)\n",
      "              (S\n",
      "                (VP (TO to)\n",
      "                  (VP (VB inhibit)\n",
      "                    (NP (JJ such) (NN activation))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(activate-5, however-1)\n",
      "nsubj(activate-5, aii-3)\n",
      "aux(activate-5, can-4)\n",
      "root(ROOT-0, activate-5)\n",
      "det(system-9, the-6)\n",
      "amod(nervous-8, sympathetic-7)\n",
      "amod(system-9, nervous-8)\n",
      "dobj(activate-5, system-9)\n",
      "cc(system-9, and-10)\n",
      "dobj(activate-5, part-11)\n",
      "conj:and(system-9, part-11)\n",
      "case(effects-15, of-12)\n",
      "det(effects-15, the-13)\n",
      "amod(effects-15, beneficial-14)\n",
      "nmod:of(part-11, effects-15)\n",
      "case(ACEI-17, of-16)\n",
      "nmod:of(effects-15, ACEI-17)\n",
      "cc(activate-5, and-18)\n",
      "compound(antagonists-20, aii-19)\n",
      "nsubj(result-22, antagonists-20)\n",
      "aux(result-22, may-21)\n",
      "conj:and(activate-5, result-22)\n",
      "case(ability-25, from-23)\n",
      "nmod:poss(ability-25, their-24)\n",
      "nmod:from(result-22, ability-25)\n",
      "mark(inhibit-27, to-26)\n",
      "acl(ability-25, inhibit-27)\n",
      "amod(activation-29, such-28)\n",
      "dobj(inhibit-27, activation-29)\n",
      "\n",
      "Parsing [sent. 101 len. 48]: we examined the acute effects of the ACEI captopril -LRB- 25 mg , n = 9 -RRB- and the aii receptor antagonist losartan -LRB- 50 mg , n = 10 -RRB- on hemodynamics as well as total body and cardiac norepinephrine spillover in patients with chronic hfref .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD examined)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ acute) (NNS effects))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT the) (NNP ACEI) (NN captopril))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 25) (NN mg))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (SBAR\n",
      "                    (S\n",
      "                      (VP (SYM =)\n",
      "                        (NP (CD 9)))))))\n",
      "              (-RRB- -RRB-))\n",
      "            (CC and)\n",
      "            (NP (DT the) (JJ aii) (NN receptor) (NN antagonist) (NN losartan))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 50) (NN mg))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (SBAR\n",
      "                    (S\n",
      "                      (VP (SYM =)\n",
      "                        (NP (CD 10)))))))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (NNS hemodynamics))\n",
      "          (CONJP (RB as) (RB well) (IN as))\n",
      "          (NP (JJ total) (NN body)\n",
      "            (CC and)\n",
      "            (JJ cardiac) (NN norepinephrine) (NN spillover))))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ chronic) (NN hfref))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(examined-2, we-1)\n",
      "root(ROOT-0, examined-2)\n",
      "det(effects-5, the-3)\n",
      "amod(effects-5, acute-4)\n",
      "dobj(examined-2, effects-5)\n",
      "case(captopril-9, of-6)\n",
      "det(captopril-9, the-7)\n",
      "compound(captopril-9, ACEI-8)\n",
      "nmod:of(effects-5, captopril-9)\n",
      "nummod(mg-12, 25-11)\n",
      "dep(captopril-9, mg-12)\n",
      "appos(mg-12, n-14)\n",
      "dep(9-16, =-15)\n",
      "acl:relcl(n-14, 9-16)\n",
      "cc(captopril-9, and-18)\n",
      "det(losartan-23, the-19)\n",
      "amod(losartan-23, aii-20)\n",
      "compound(losartan-23, receptor-21)\n",
      "compound(losartan-23, antagonist-22)\n",
      "nmod:of(effects-5, losartan-23)\n",
      "conj:and(captopril-9, losartan-23)\n",
      "nummod(mg-26, 50-25)\n",
      "dep(captopril-9, mg-26)\n",
      "appos(mg-26, n-28)\n",
      "dep(10-30, =-29)\n",
      "acl:relcl(n-28, 10-30)\n",
      "case(hemodynamics-33, on-32)\n",
      "nmod:on(examined-2, hemodynamics-33)\n",
      "cc(hemodynamics-33, as-34)\n",
      "mwe(as-34, well-35)\n",
      "mwe(as-34, as-36)\n",
      "amod(body-38, total-37)\n",
      "nmod:on(examined-2, body-38)\n",
      "conj:and(hemodynamics-33, body-38)\n",
      "cc(body-38, and-39)\n",
      "amod(spillover-42, cardiac-40)\n",
      "compound(spillover-42, norepinephrine-41)\n",
      "conj:and(hemodynamics-33, spillover-42)\n",
      "conj:and(body-38, spillover-42)\n",
      "case(patients-44, in-43)\n",
      "nmod:in(examined-2, patients-44)\n",
      "case(hfref-47, with-45)\n",
      "amod(hfref-47, chronic-46)\n",
      "nmod:with(patients-44, hfref-47)\n",
      "\n",
      "Parsing [sent. 102 len. 20]: hemodynamic and neurochemical measurements were made at baseline and at 1 , 2 and 4 hours after oral dosing .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (JJ hemodynamic)\n",
      "        (CC and)\n",
      "        (JJ neurochemical))\n",
      "      (NNS measurements))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN made)\n",
      "        (PP\n",
      "          (PP (IN at)\n",
      "            (NP (NN baseline)))\n",
      "          (CC and)\n",
      "          (PP (IN at)\n",
      "            (NP (CD 1) (, ,) (CD 2)\n",
      "              (CC and)\n",
      "              (CD 4)))\n",
      "          (NP (NNS hours)))\n",
      "        (PP (IN after)\n",
      "          (NP (JJ oral) (NN dosing)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(measurements-4, hemodynamic-1)\n",
      "cc(hemodynamic-1, and-2)\n",
      "conj:and(hemodynamic-1, neurochemical-3)\n",
      "amod(measurements-4, neurochemical-3)\n",
      "nsubjpass(made-6, measurements-4)\n",
      "auxpass(made-6, were-5)\n",
      "root(ROOT-0, made-6)\n",
      "case(baseline-8, at-7)\n",
      "nmod:at(hours-16, baseline-8)\n",
      "cc(hours-16, and-9)\n",
      "case(1-11, at-10)\n",
      "nmod(made-6, 1-11)\n",
      "conj:and(hours-16, 1-11)\n",
      "nummod(1-11, 2-13)\n",
      "cc(1-11, and-14)\n",
      "conj:and(1-11, 4-15)\n",
      "conj:and(hours-16, 4-15)\n",
      "nmod(made-6, hours-16)\n",
      "case(dosing-19, after-17)\n",
      "amod(dosing-19, oral-18)\n",
      "nmod:after(made-6, dosing-19)\n",
      "\n",
      "Parsing [sent. 103 len. 25]: administration of both drugs caused significant reductions in systemic arterial , cardiac filling and pulmonary artery pressures -LRB- p < 0.05 vs baseline -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN administration))\n",
      "      (PP (IN of)\n",
      "        (NP (DT both) (NNS drugs))))\n",
      "    (VP (VBD caused)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (JJ significant) (NNS reductions))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ systemic) (NN arterial))))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (JJ cardiac) (NN filling))\n",
      "          (CC and)\n",
      "          (NP (JJ pulmonary) (NN artery) (NNS pressures)))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN p)\n",
      "            (S\n",
      "              (VP (VBG <)\n",
      "                (NP (CD 0.05) (NN vs) (NN baseline)))))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(caused-5, administration-1)\n",
      "case(drugs-4, of-2)\n",
      "det(drugs-4, both-3)\n",
      "nmod:of(administration-1, drugs-4)\n",
      "root(ROOT-0, caused-5)\n",
      "amod(reductions-7, significant-6)\n",
      "dobj(caused-5, reductions-7)\n",
      "case(arterial-10, in-8)\n",
      "amod(arterial-10, systemic-9)\n",
      "nmod:in(reductions-7, arterial-10)\n",
      "amod(filling-13, cardiac-12)\n",
      "appos(reductions-7, filling-13)\n",
      "cc(filling-13, and-14)\n",
      "amod(pressures-17, pulmonary-15)\n",
      "compound(pressures-17, artery-16)\n",
      "appos(reductions-7, pressures-17)\n",
      "conj:and(filling-13, pressures-17)\n",
      "dep(reductions-7, p-19)\n",
      "xcomp(p-19, <-20)\n",
      "nummod(baseline-23, 0.05-21)\n",
      "compound(baseline-23, vs-22)\n",
      "dobj(<-20, baseline-23)\n",
      "\n",
      "Parsing [sent. 104 len. 13]: there was no significant difference in the magnitude of those hemodynamic effects .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT no) (JJ significant) (NN difference))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN magnitude))\n",
      "            (PP (IN of)\n",
      "              (NP (DT those) (JJ hemodynamic) (NNS effects)))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "neg(difference-5, no-3)\n",
      "amod(difference-5, significant-4)\n",
      "nsubj(was-2, difference-5)\n",
      "case(magnitude-8, in-6)\n",
      "det(magnitude-8, the-7)\n",
      "nmod:in(difference-5, magnitude-8)\n",
      "case(effects-12, of-9)\n",
      "det(effects-12, those-10)\n",
      "amod(effects-12, hemodynamic-11)\n",
      "nmod:of(magnitude-8, effects-12)\n",
      "\n",
      "Parsing [sent. 105 len. 23]: plasma concentrations of aii were significantly decreased by captopril and increased by losartan -LRB- p < 0.05 vs baseline for both -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN plasma) (NNS concentrations))\n",
      "      (PP (IN of)\n",
      "        (NP (NN aii))))\n",
      "    (VP (VBD were)\n",
      "      (ADVP (RB significantly))\n",
      "      (VP\n",
      "        (VP (VBN decreased)\n",
      "          (PP (IN by)\n",
      "            (NP (NN captopril))))\n",
      "        (CC and)\n",
      "        (VP (VBN increased)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP (NN losartan))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN p)\n",
      "                  (S\n",
      "                    (VP (VBG <)\n",
      "                      (NP (CD 0.05) (NN vs) (NN baseline))\n",
      "                      (PP (IN for)\n",
      "                        (NP (DT both))))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(concentrations-2, plasma-1)\n",
      "nsubjpass(decreased-7, concentrations-2)\n",
      "nsubjpass(increased-11, concentrations-2)\n",
      "case(aii-4, of-3)\n",
      "nmod:of(concentrations-2, aii-4)\n",
      "auxpass(decreased-7, were-5)\n",
      "advmod(decreased-7, significantly-6)\n",
      "root(ROOT-0, decreased-7)\n",
      "case(captopril-9, by-8)\n",
      "nmod:by(decreased-7, captopril-9)\n",
      "cc(decreased-7, and-10)\n",
      "conj:and(decreased-7, increased-11)\n",
      "case(losartan-13, by-12)\n",
      "nmod:by(increased-11, losartan-13)\n",
      "dep(losartan-13, p-15)\n",
      "xcomp(p-15, <-16)\n",
      "nummod(baseline-19, 0.05-17)\n",
      "compound(baseline-19, vs-18)\n",
      "dobj(<-16, baseline-19)\n",
      "case(both-21, for-20)\n",
      "nmod:for(<-16, both-21)\n",
      "\n",
      "Parsing [sent. 106 len. 37]: total body sympathetic activity increased in response to both captopril and losartan -LRB- p < 0.05 vs baseline for both -RRB- , however there was no change in cardiac sympathetic activity in response to either drug .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ total) (NN body) (JJ sympathetic) (NN activity))\n",
      "      (VP (VBN increased)\n",
      "        (PP (IN in)\n",
      "          (NP (NN response)))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (DT both) (NN captopril)\n",
      "              (CC and)\n",
      "              (NN losartan))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (NN p) (NNS <))\n",
      "                (NP\n",
      "                  (NP (CD 0.05) (NN vs) (NN baseline))\n",
      "                  (PP (IN for)\n",
      "                    (NP (DT both)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (, ,)\n",
      "    (ADVP (RB however))\n",
      "    (NP (EX there))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT no) (NN change))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (JJ cardiac) (JJ sympathetic) (NN activity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN response))))))\n",
      "      (PP (TO to)\n",
      "        (NP (DT either) (NN drug))))\n",
      "    (. .)))\n",
      "\n",
      "amod(activity-4, total-1)\n",
      "compound(activity-4, body-2)\n",
      "amod(activity-4, sympathetic-3)\n",
      "nsubj(was-25, activity-4)\n",
      "acl(activity-4, increased-5)\n",
      "case(response-7, in-6)\n",
      "nmod:in(increased-5, response-7)\n",
      "case(captopril-10, to-8)\n",
      "cc:preconj(captopril-10, both-9)\n",
      "nmod:to(increased-5, captopril-10)\n",
      "cc(captopril-10, and-11)\n",
      "nmod:to(increased-5, losartan-12)\n",
      "conj:and(captopril-10, losartan-12)\n",
      "compound(<-15, p-14)\n",
      "dep(captopril-10, <-15)\n",
      "nummod(baseline-18, 0.05-16)\n",
      "compound(baseline-18, vs-17)\n",
      "dep(<-15, baseline-18)\n",
      "case(both-20, for-19)\n",
      "nmod:for(baseline-18, both-20)\n",
      "expl(was-25, however-23)\n",
      "dep(however-23, there-24)\n",
      "root(ROOT-0, was-25)\n",
      "neg(change-27, no-26)\n",
      "nsubj(was-25, change-27)\n",
      "case(activity-31, in-28)\n",
      "amod(activity-31, cardiac-29)\n",
      "amod(activity-31, sympathetic-30)\n",
      "nmod:in(change-27, activity-31)\n",
      "case(response-33, in-32)\n",
      "nmod:in(activity-31, response-33)\n",
      "case(drug-36, to-34)\n",
      "det(drug-36, either-35)\n",
      "nmod:to(was-25, drug-36)\n",
      "\n",
      "Parsing [sent. 107 len. 29]: the results of the current study do not support the hypothesis that the acute inhibition of the renin angiotensin system has sympathoinhibitory effects in patients with chronic hfref .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NNS results))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ current) (NN study))))\n",
      "    (VP (VBP do) (RB not)\n",
      "      (VP (VB support)\n",
      "        (NP (DT the) (NNS hypothesis))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (DT the) (JJ acute) (NN inhibition))\n",
      "              (PP (IN of)\n",
      "                (NP (DT the) (NN renin) (NN angiotensin) (NN system))))\n",
      "            (VP (VBZ has)\n",
      "              (NP\n",
      "                (NP (JJ sympathoinhibitory) (NNS effects))\n",
      "                (PP (IN in)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ chronic) (NN hfref)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(results-2, the-1)\n",
      "nsubj(support-9, results-2)\n",
      "case(study-6, of-3)\n",
      "det(study-6, the-4)\n",
      "amod(study-6, current-5)\n",
      "nmod:of(results-2, study-6)\n",
      "aux(support-9, do-7)\n",
      "neg(support-9, not-8)\n",
      "root(ROOT-0, support-9)\n",
      "det(hypothesis-11, the-10)\n",
      "dobj(support-9, hypothesis-11)\n",
      "mark(has-21, that-12)\n",
      "det(inhibition-15, the-13)\n",
      "amod(inhibition-15, acute-14)\n",
      "nsubj(has-21, inhibition-15)\n",
      "case(system-20, of-16)\n",
      "det(system-20, the-17)\n",
      "compound(system-20, renin-18)\n",
      "compound(system-20, angiotensin-19)\n",
      "nmod:of(inhibition-15, system-20)\n",
      "ccomp(support-9, has-21)\n",
      "amod(effects-23, sympathoinhibitory-22)\n",
      "dobj(has-21, effects-23)\n",
      "case(patients-25, in-24)\n",
      "nmod:in(effects-23, patients-25)\n",
      "case(hfref-28, with-26)\n",
      "amod(hfref-28, chronic-27)\n",
      "nmod:with(patients-25, hfref-28)\n",
      "\n",
      "Parsing [sent. 108 len. 39]: the improvement of the physical functioning and hrqol in older hypertensive adults using ACEI medications only occur if they adopt an exercise training regimen , increasing also the management of the blood pressure and other cardiovascular risk factors .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN improvement))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ physical) (NN functioning)\n",
      "            (CC and)\n",
      "            (NN hrqol))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (JJR older) (NN hypertensive) (NNS adults))\n",
      "              (VP (VBG using)\n",
      "                (NP (CD ACEI) (NNS medications))))))))\n",
      "    (ADVP (RB only))\n",
      "    (VP (VBP occur)\n",
      "      (SBAR (IN if)\n",
      "        (S\n",
      "          (NP (PRP they))\n",
      "          (VP (VBP adopt)\n",
      "            (NP (DT an) (NN exercise) (NN training) (NN regimen))\n",
      "            (, ,)\n",
      "            (S\n",
      "              (VP (VBG increasing)\n",
      "                (ADVP (RB also))\n",
      "                (NP\n",
      "                  (NP (DT the) (NN management))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN blood) (NN pressure))\n",
      "                      (CC and)\n",
      "                      (NP (JJ other) (JJ cardiovascular) (NN risk) (NNS factors)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(improvement-2, the-1)\n",
      "nsubj(occur-17, improvement-2)\n",
      "case(functioning-6, of-3)\n",
      "det(functioning-6, the-4)\n",
      "amod(functioning-6, physical-5)\n",
      "nmod:of(improvement-2, functioning-6)\n",
      "cc(functioning-6, and-7)\n",
      "nmod:of(improvement-2, hrqol-8)\n",
      "conj:and(functioning-6, hrqol-8)\n",
      "case(adults-12, in-9)\n",
      "amod(adults-12, older-10)\n",
      "compound(adults-12, hypertensive-11)\n",
      "nmod:in(functioning-6, adults-12)\n",
      "acl(adults-12, using-13)\n",
      "nummod(medications-15, ACEI-14)\n",
      "dobj(using-13, medications-15)\n",
      "advmod(occur-17, only-16)\n",
      "root(ROOT-0, occur-17)\n",
      "mark(adopt-20, if-18)\n",
      "nsubj(adopt-20, they-19)\n",
      "advcl(occur-17, adopt-20)\n",
      "det(regimen-24, an-21)\n",
      "compound(regimen-24, exercise-22)\n",
      "compound(regimen-24, training-23)\n",
      "dobj(adopt-20, regimen-24)\n",
      "advcl(adopt-20, increasing-26)\n",
      "advmod(increasing-26, also-27)\n",
      "det(management-29, the-28)\n",
      "dobj(increasing-26, management-29)\n",
      "case(pressure-33, of-30)\n",
      "det(pressure-33, the-31)\n",
      "compound(pressure-33, blood-32)\n",
      "nmod:of(management-29, pressure-33)\n",
      "cc(pressure-33, and-34)\n",
      "amod(factors-38, other-35)\n",
      "amod(factors-38, cardiovascular-36)\n",
      "compound(factors-38, risk-37)\n",
      "nmod:of(management-29, factors-38)\n",
      "conj:and(pressure-33, factors-38)\n",
      "\n",
      "Parsing [sent. 109 len. 15]: agreement in the 20 % sampling between investigators was high -LRB- 96 % -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN agreement))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the)\n",
      "            (ADJP (CD 20) (NN %))\n",
      "            (NN sampling))\n",
      "          (PP (IN between)\n",
      "            (NP (NNS investigators))))))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ high))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 96) (NN %))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(high-10, agreement-1)\n",
      "case(sampling-6, in-2)\n",
      "det(sampling-6, the-3)\n",
      "compound(%-5, 20-4)\n",
      "amod(sampling-6, %-5)\n",
      "nmod:in(agreement-1, sampling-6)\n",
      "case(investigators-8, between-7)\n",
      "nmod:between(sampling-6, investigators-8)\n",
      "cop(high-10, was-9)\n",
      "root(ROOT-0, high-10)\n",
      "nummod(%-13, 96-12)\n",
      "dep(high-10, %-13)\n",
      "\n",
      "Parsing [sent. 110 len. 30]: the mean qtc in the acs group was 457 ms and the mean qtc in the etoh withdrawal-related group was 468 ms -LRB- diff 11 , not significant -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ mean) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (NN acs) (NN group))))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (QP (CD 457) (CD ms)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ mean) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (JJ etoh) (JJ withdrawal-related) (NN group))))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP (CD 468) (NN ms))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (NN diff) (CD 11))\n",
      "              (, ,)\n",
      "              (NP (RB not) (JJ significant)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "det(qtc-3, the-1)\n",
      "amod(qtc-3, mean-2)\n",
      "nsubj(ms-10, qtc-3)\n",
      "case(group-7, in-4)\n",
      "det(group-7, the-5)\n",
      "compound(group-7, acs-6)\n",
      "nmod:in(qtc-3, group-7)\n",
      "cop(ms-10, was-8)\n",
      "compound(ms-10, 457-9)\n",
      "root(ROOT-0, ms-10)\n",
      "cc(ms-10, and-11)\n",
      "det(qtc-14, the-12)\n",
      "amod(qtc-14, mean-13)\n",
      "nsubj(ms-22, qtc-14)\n",
      "case(group-19, in-15)\n",
      "det(group-19, the-16)\n",
      "amod(group-19, etoh-17)\n",
      "amod(group-19, withdrawal-related-18)\n",
      "nmod:in(qtc-14, group-19)\n",
      "cop(ms-22, was-20)\n",
      "nummod(ms-22, 468-21)\n",
      "conj:and(ms-10, ms-22)\n",
      "dep(ms-22, diff-24)\n",
      "nummod(diff-24, 11-25)\n",
      "neg(significant-28, not-27)\n",
      "appos(diff-24, significant-28)\n",
      "\n",
      "Parsing [sent. 111 len. 35]: significantly more patients had a prolonged qtc in the etoh withdrawal group than in the acs group 62 % vs 46 % ; diff 16 ; 95 % ci -LRB- 0.1 , 30 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (ADJP (RB significantly) (JJR more))\n",
      "      (NNS patients))\n",
      "    (VP (VBD had)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prolonged) (NN qtc))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))\n",
      "      (PP (IN than) (IN in)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN acs) (NN group) (CD 62) (NN %) (NN vs))\n",
      "            (ADJP (CD 46) (NN %)))\n",
      "          (: ;)\n",
      "          (NP\n",
      "            (NP (NN diff) (CD 16))\n",
      "            (: ;)\n",
      "            (NP\n",
      "              (NP\n",
      "                (ADJP (CD 95) (NN %))\n",
      "                (NN ci))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (CD 0.1))\n",
      "                (, ,)\n",
      "                (NP (CD 30))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(more-2, significantly-1)\n",
      "amod(patients-3, more-2)\n",
      "nsubj(had-4, patients-3)\n",
      "root(ROOT-0, had-4)\n",
      "det(qtc-7, a-5)\n",
      "amod(qtc-7, prolonged-6)\n",
      "dobj(had-4, qtc-7)\n",
      "case(group-12, in-8)\n",
      "det(group-12, the-9)\n",
      "amod(group-12, etoh-10)\n",
      "compound(group-12, withdrawal-11)\n",
      "nmod:in(qtc-7, group-12)\n",
      "case(vs-20, than-13)\n",
      "case(vs-20, in-14)\n",
      "det(vs-20, the-15)\n",
      "compound(vs-20, acs-16)\n",
      "compound(vs-20, group-17)\n",
      "nummod(vs-20, 62-18)\n",
      "compound(vs-20, %-19)\n",
      "nmod:in(had-4, vs-20)\n",
      "compound(%-22, 46-21)\n",
      "amod(vs-20, %-22)\n",
      "dep(vs-20, diff-24)\n",
      "nummod(diff-24, 16-25)\n",
      "compound(%-28, 95-27)\n",
      "amod(ci-29, %-28)\n",
      "dep(diff-24, ci-29)\n",
      "appos(ci-29, 0.1-31)\n",
      "dep(0.1-31, 30-33)\n",
      "\n",
      "Parsing [sent. 112 len. 43]: there was significantly more use of clopidogrel , acetylsalicylic acid , ACEI , and statins -LRB- p < 0.05 for all -RRB- in the acs group compared with the etoh withdrawal group ; however , there was no difference in Î²-blocker usage .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP\n",
      "            (ADJP (RB significantly) (JJR more))\n",
      "            (NN use))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN clopidogrel))\n",
      "              (, ,)\n",
      "              (NP (JJ acetylsalicylic) (NN acid))\n",
      "              (, ,)\n",
      "              (NP (NNP ACEI))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NNS statins))))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05))\n",
      "              (PP (IN for)\n",
      "                (NP (DT all))))\n",
      "            (-RRB- -RRB-)))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN acs) (NN group))\n",
      "            (PP (VBN compared)\n",
      "              (PP (IN with)\n",
      "                (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))))))\n",
      "    (: ;)\n",
      "    (S\n",
      "      (ADVP (RB however))\n",
      "      (, ,)\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP\n",
      "          (NP (DT no) (NN difference))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ Î²-blocker) (NN usage))))))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "advmod(more-4, significantly-3)\n",
      "amod(use-5, more-4)\n",
      "nsubj(was-2, use-5)\n",
      "case(clopidogrel-7, of-6)\n",
      "nmod:of(use-5, clopidogrel-7)\n",
      "amod(acid-10, acetylsalicylic-9)\n",
      "nmod:of(use-5, acid-10)\n",
      "conj:and(clopidogrel-7, acid-10)\n",
      "nmod:of(use-5, ACEI-12)\n",
      "conj:and(clopidogrel-7, ACEI-12)\n",
      "cc(clopidogrel-7, and-14)\n",
      "nmod:of(use-5, statins-15)\n",
      "conj:and(clopidogrel-7, statins-15)\n",
      "dep(use-5, p-17)\n",
      "nummod(0.05-19, <-18)\n",
      "dobj(p-17, 0.05-19)\n",
      "case(all-21, for-20)\n",
      "nmod:for(p-17, all-21)\n",
      "case(group-26, in-23)\n",
      "det(group-26, the-24)\n",
      "compound(group-26, acs-25)\n",
      "nmod:in(was-2, group-26)\n",
      "case(group-32, compared-27)\n",
      "mwe(compared-27, with-28)\n",
      "det(group-32, the-29)\n",
      "amod(group-32, etoh-30)\n",
      "compound(group-32, withdrawal-31)\n",
      "nmod:compared_with(group-26, group-32)\n",
      "advmod(was-37, however-34)\n",
      "expl(was-37, there-36)\n",
      "parataxis(was-2, was-37)\n",
      "neg(difference-39, no-38)\n",
      "nsubj(was-37, difference-39)\n",
      "case(usage-42, in-40)\n",
      "amod(usage-42, Î²-blocker-41)\n",
      "nmod:in(difference-39, usage-42)\n",
      "\n",
      "Parsing [sent. 113 len. 36]: there was a significantly higher admission rate : 100 % of acs compared with 76 % of the etoh withdrawal group -LRB- p < 0.01 , diff 24 , 95 % confidence interval 18-29 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (EX there))\n",
      "      (VP (VBD was)\n",
      "        (NP (DT a)\n",
      "          (ADJP (RB significantly) (JJR higher))\n",
      "          (NN admission) (NN rate))))\n",
      "    (: :)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (CD 100) (NN %))\n",
      "        (PP (IN of)\n",
      "          (NP (NN acs))))\n",
      "      (PP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (CD 76) (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (JJ etoh) (NN withdrawal) (NN group))))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NNP p) (NNP <) (NNP 0.01))\n",
      "          (, ,)\n",
      "          (NP (NN diff) (CD 24))\n",
      "          (, ,)\n",
      "          (NP (CD 95) (NN %) (NN confidence) (JJ interval) (NNS 18-29)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "expl(was-2, there-1)\n",
      "root(ROOT-0, was-2)\n",
      "det(rate-7, a-3)\n",
      "advmod(higher-5, significantly-4)\n",
      "amod(rate-7, higher-5)\n",
      "compound(rate-7, admission-6)\n",
      "nsubj(was-2, rate-7)\n",
      "nummod(%-10, 100-9)\n",
      "parataxis(was-2, %-10)\n",
      "case(acs-12, of-11)\n",
      "nmod:of(%-10, acs-12)\n",
      "case(%-16, compared-13)\n",
      "mwe(compared-13, with-14)\n",
      "nummod(%-16, 76-15)\n",
      "advcl(%-10, %-16)\n",
      "case(group-21, of-17)\n",
      "det(group-21, the-18)\n",
      "amod(group-21, etoh-19)\n",
      "compound(group-21, withdrawal-20)\n",
      "nmod:of(%-16, group-21)\n",
      "compound(0.01-25, p-23)\n",
      "compound(0.01-25, <-24)\n",
      "dep(%-10, 0.01-25)\n",
      "appos(0.01-25, diff-27)\n",
      "nummod(diff-27, 24-28)\n",
      "nummod(18-29-34, 95-30)\n",
      "compound(18-29-34, %-31)\n",
      "compound(18-29-34, confidence-32)\n",
      "amod(18-29-34, interval-33)\n",
      "appos(0.01-25, 18-29-34)\n",
      "\n",
      "Parsing [sent. 114 len. 10]: electrolytes were not significantly different in the two groups .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS electrolytes))\n",
      "    (VP (VBD were) (RB not)\n",
      "      (ADJP (RB significantly) (JJ different)\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (CD two) (NNS groups)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(different-5, electrolytes-1)\n",
      "cop(different-5, were-2)\n",
      "neg(different-5, not-3)\n",
      "advmod(different-5, significantly-4)\n",
      "root(ROOT-0, different-5)\n",
      "case(groups-9, in-6)\n",
      "det(groups-9, the-7)\n",
      "nummod(groups-9, two-8)\n",
      "nmod:in(different-5, groups-9)\n",
      "\n",
      "Parsing [sent. 115 len. 22]: the study compared two cohort groups , those with acs and those with etoh withdrawal-related ed visits over a 1-year period .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NN study))\n",
      "    (VP (VBD compared)\n",
      "      (NP\n",
      "        (NP (CD two) (JJ cohort) (NNS groups))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP (NN acs))))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT those))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ etoh) (JJ withdrawal-related) (NN ed) (NNS visits)))))\n",
      "      (PP (IN over)\n",
      "        (NP (DT a) (JJ 1-year) (NN period))))\n",
      "    (. .)))\n",
      "\n",
      "det(study-2, the-1)\n",
      "nsubj(compared-3, study-2)\n",
      "root(ROOT-0, compared-3)\n",
      "nummod(groups-6, two-4)\n",
      "amod(groups-6, cohort-5)\n",
      "dobj(compared-3, groups-6)\n",
      "dobj(compared-3, those-8)\n",
      "conj:and(groups-6, those-8)\n",
      "case(acs-10, with-9)\n",
      "nmod:with(those-8, acs-10)\n",
      "cc(groups-6, and-11)\n",
      "dobj(compared-3, those-12)\n",
      "conj:and(groups-6, those-12)\n",
      "case(visits-17, with-13)\n",
      "amod(visits-17, etoh-14)\n",
      "amod(visits-17, withdrawal-related-15)\n",
      "compound(visits-17, ed-16)\n",
      "nmod:with(those-12, visits-17)\n",
      "case(period-21, over-18)\n",
      "det(period-21, a-19)\n",
      "amod(period-21, 1-year-20)\n",
      "nmod:over(compared-3, period-21)\n",
      "\n",
      "Parsing [sent. 116 len. 13]: we compared ecg qtc , cardiac medication use , and electrolyte differences .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD compared)\n",
      "      (NP\n",
      "        (NP (NN ecg) (NN qtc))\n",
      "        (, ,)\n",
      "        (NP (JJ cardiac) (NN medication) (NN use))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (JJ electrolyte) (NNS differences))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(compared-2, we-1)\n",
      "root(ROOT-0, compared-2)\n",
      "compound(qtc-4, ecg-3)\n",
      "dobj(compared-2, qtc-4)\n",
      "amod(use-8, cardiac-6)\n",
      "compound(use-8, medication-7)\n",
      "dobj(compared-2, use-8)\n",
      "conj:and(qtc-4, use-8)\n",
      "cc(qtc-4, and-10)\n",
      "amod(differences-12, electrolyte-11)\n",
      "dobj(compared-2, differences-12)\n",
      "conj:and(qtc-4, differences-12)\n",
      "\n",
      "Parsing [sent. 117 len. 23]: we considered a qtc of > 450 ms elevated for men and > 470 ms elevated for women based on the literature .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD considered)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT a) (NN qtc))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (QP (CD >) (CD 450))\n",
      "                (NN ms))))\n",
      "          (VP (VBD elevated)\n",
      "            (SBAR (IN for)\n",
      "              (S\n",
      "                (NP\n",
      "                  (NP (NNS men))\n",
      "                  (CC and)\n",
      "                  (NP\n",
      "                    (QP (CD >) (CD 470))\n",
      "                    (NN ms)))\n",
      "                (VP (VBD elevated)\n",
      "                  (PP (IN for)\n",
      "                    (NP (NNS women)))\n",
      "                  (PP (VBN based)\n",
      "                    (PP (IN on)\n",
      "                      (NP (DT the) (NN literature)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(considered-2, we-1)\n",
      "root(ROOT-0, considered-2)\n",
      "det(qtc-4, a-3)\n",
      "nsubj(elevated-9, qtc-4)\n",
      "case(ms-8, of-5)\n",
      "compound(450-7, >-6)\n",
      "nummod(ms-8, 450-7)\n",
      "nmod:of(qtc-4, ms-8)\n",
      "ccomp(considered-2, elevated-9)\n",
      "mark(elevated-16, for-10)\n",
      "nsubj(elevated-16, men-11)\n",
      "cc(men-11, and-12)\n",
      "compound(470-14, >-13)\n",
      "nummod(ms-15, 470-14)\n",
      "conj:and(men-11, ms-15)\n",
      "nsubj(elevated-16, ms-15)\n",
      "advcl(elevated-9, elevated-16)\n",
      "case(women-18, for-17)\n",
      "nmod:for(elevated-16, women-18)\n",
      "case(literature-22, based-19)\n",
      "mwe(based-19, on-20)\n",
      "det(literature-22, the-21)\n",
      "advcl(elevated-16, literature-22)\n",
      "\n",
      "Parsing [sent. 118 len. 43]: fifty subjects in whom an ecg , serum osmolality , and etoh level were recorded within 2 hours of one another and who were administered a clinical institute withdrawal assessment protocol were compared with 203 patients with acs during the same period .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ fifty) (NNS subjects))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (SBAR\n",
      "            (WHNP (WP whom))\n",
      "            (S\n",
      "              (NP\n",
      "                (NP (DT an) (NN ecg))\n",
      "                (, ,)\n",
      "                (NP (NN serum) (NN osmolality))\n",
      "                (, ,)\n",
      "                (CC and)\n",
      "                (NP (JJ etoh) (NN level)))\n",
      "              (VP (VBD were)\n",
      "                (VP (VBN recorded)\n",
      "                  (PP (IN within)\n",
      "                    (NP\n",
      "                      (NP (CD 2) (NNS hours))\n",
      "                      (PP (IN of)\n",
      "                        (NP (CD one) (DT another)))))))))\n",
      "          (CC and)\n",
      "          (SBAR\n",
      "            (WHNP (WP who))\n",
      "            (S\n",
      "              (VP (VBD were)\n",
      "                (VP (VBN administered)\n",
      "                  (NP (DT a) (JJ clinical) (NN institute) (NN withdrawal) (NN assessment) (NN protocol)))))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (CD 203) (NNS patients))\n",
      "            (PP (IN with)\n",
      "              (NP (NN acs)))))\n",
      "        (PP (IN during)\n",
      "          (NP (DT the) (JJ same) (NN period)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(subjects-2, fifty-1)\n",
      "nsubjpass(compared-33, subjects-2)\n",
      "case(recorded-15, in-3)\n",
      "dobj(recorded-15, whom-4)\n",
      "det(ecg-6, an-5)\n",
      "nsubjpass(recorded-15, ecg-6)\n",
      "compound(osmolality-9, serum-8)\n",
      "conj:and(ecg-6, osmolality-9)\n",
      "nsubjpass(recorded-15, osmolality-9)\n",
      "cc(ecg-6, and-11)\n",
      "amod(level-13, etoh-12)\n",
      "conj:and(ecg-6, level-13)\n",
      "nsubjpass(recorded-15, level-13)\n",
      "auxpass(recorded-15, were-14)\n",
      "nmod:in(subjects-2, recorded-15)\n",
      "case(hours-18, within-16)\n",
      "nummod(hours-18, 2-17)\n",
      "nmod:within(recorded-15, hours-18)\n",
      "case(one-20, of-19)\n",
      "nmod:of(hours-18, one-20)\n",
      "dep(one-20, another-21)\n",
      "cc(recorded-15, and-22)\n",
      "nsubjpass(administered-25, who-23)\n",
      "auxpass(administered-25, were-24)\n",
      "nmod:in(subjects-2, administered-25)\n",
      "conj:and(recorded-15, administered-25)\n",
      "det(protocol-31, a-26)\n",
      "amod(protocol-31, clinical-27)\n",
      "compound(protocol-31, institute-28)\n",
      "compound(protocol-31, withdrawal-29)\n",
      "compound(protocol-31, assessment-30)\n",
      "dobj(administered-25, protocol-31)\n",
      "auxpass(compared-33, were-32)\n",
      "root(ROOT-0, compared-33)\n",
      "case(patients-36, with-34)\n",
      "nummod(patients-36, 203-35)\n",
      "nmod:with(compared-33, patients-36)\n",
      "case(acs-38, with-37)\n",
      "nmod:with(patients-36, acs-38)\n",
      "case(period-42, during-39)\n",
      "det(period-42, the-40)\n",
      "amod(period-42, same-41)\n",
      "nmod:during(compared-33, period-42)\n",
      "\n",
      "Parsing [sent. 119 len. 7]: we excluded patients with incomplete data .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP we))\n",
      "    (VP (VBN excluded)\n",
      "      (NP (NNS patients))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ incomplete) (NNS data))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(excluded-2, we-1)\n",
      "root(ROOT-0, excluded-2)\n",
      "dobj(excluded-2, patients-3)\n",
      "case(data-6, with-4)\n",
      "amod(data-6, incomplete-5)\n",
      "nmod:with(excluded-2, data-6)\n",
      "\n",
      "Parsing [sent. 120 len. 15]: medications compared included clopidogrel , acetylsalicylic acid , Î²-blockers , ACEI , and statins .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS medications))\n",
      "      (VP (VBN compared)))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (NN clopidogrel))\n",
      "        (, ,)\n",
      "        (NP (JJ acetylsalicylic) (NN acid))\n",
      "        (, ,)\n",
      "        (NP (NNS Î²-blockers))\n",
      "        (, ,)\n",
      "        (NP (NNP ACEI))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (NNS statins))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(included-3, medications-1)\n",
      "acl(medications-1, compared-2)\n",
      "root(ROOT-0, included-3)\n",
      "dobj(included-3, clopidogrel-4)\n",
      "amod(acid-7, acetylsalicylic-6)\n",
      "dobj(included-3, acid-7)\n",
      "conj:and(clopidogrel-4, acid-7)\n",
      "dobj(included-3, Î²-blockers-9)\n",
      "conj:and(clopidogrel-4, Î²-blockers-9)\n",
      "dobj(included-3, ACEI-11)\n",
      "conj:and(clopidogrel-4, ACEI-11)\n",
      "cc(clopidogrel-4, and-13)\n",
      "dobj(included-3, statins-14)\n",
      "conj:and(clopidogrel-4, statins-14)\n",
      "\n",
      "Parsing [sent. 121 len. 15]: ecg qt and qtc , as well as electrolytes , were recorded and compared .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN ecg) (NN qt)\n",
      "        (CC and)\n",
      "        (NN qtc))\n",
      "      (, ,)\n",
      "      (CONJP (RB as) (RB well) (IN as))\n",
      "      (NP (NNS electrolytes))\n",
      "      (, ,))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN recorded)\n",
      "        (CC and)\n",
      "        (VBN compared)))\n",
      "    (. .)))\n",
      "\n",
      "compound(qt-2, ecg-1)\n",
      "nsubjpass(recorded-12, qt-2)\n",
      "nsubjpass(compared-14, qt-2)\n",
      "cc(qt-2, and-3)\n",
      "conj:and(qt-2, qtc-4)\n",
      "nsubjpass(recorded-12, qtc-4)\n",
      "cc(qt-2, as-6)\n",
      "mwe(as-6, well-7)\n",
      "mwe(as-6, as-8)\n",
      "conj:and(qt-2, electrolytes-9)\n",
      "nsubjpass(recorded-12, electrolytes-9)\n",
      "auxpass(recorded-12, were-11)\n",
      "root(ROOT-0, recorded-12)\n",
      "cc(recorded-12, and-13)\n",
      "conj:and(recorded-12, compared-14)\n",
      "\n",
      "Parsing [sent. 122 len. 21]: data were extracted by two investigators with a 20 % sample re-evaluated by the other extractor as a reliability measure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS data))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN extracted)\n",
      "        (PP (IN by)\n",
      "          (NP (CD two) (NNS investigators)))\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (DT a)\n",
      "              (ADJP (CD 20) (NN %))\n",
      "              (NN sample))\n",
      "            (VP (VBN re-evaluated)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ other) (NN extractor))\n",
      "                  (PP (IN as)\n",
      "                    (NP (DT a) (JJ reliability) (NN measure))))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(extracted-3, data-1)\n",
      "auxpass(extracted-3, were-2)\n",
      "root(ROOT-0, extracted-3)\n",
      "case(investigators-6, by-4)\n",
      "nummod(investigators-6, two-5)\n",
      "nmod:by(extracted-3, investigators-6)\n",
      "case(sample-11, with-7)\n",
      "det(sample-11, a-8)\n",
      "compound(%-10, 20-9)\n",
      "amod(sample-11, %-10)\n",
      "nmod:with(extracted-3, sample-11)\n",
      "acl(sample-11, re-evaluated-12)\n",
      "case(extractor-16, by-13)\n",
      "det(extractor-16, the-14)\n",
      "amod(extractor-16, other-15)\n",
      "nmod:by(re-evaluated-12, extractor-16)\n",
      "case(measure-20, as-17)\n",
      "det(measure-20, a-18)\n",
      "amod(measure-20, reliability-19)\n",
      "nmod:as(extractor-16, measure-20)\n",
      "\n",
      "Parsing [sent. 123 len. 13]: descriptive statistics including medians and interquartile ranges were measured for continuous variables .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ descriptive) (NNS statistics))\n",
      "      (PP (VBG including)\n",
      "        (NP\n",
      "          (NP (NNS medians))\n",
      "          (CC and)\n",
      "          (NP (JJ interquartile) (NNS ranges)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN measured)\n",
      "        (PP (IN for)\n",
      "          (NP (JJ continuous) (NNS variables)))))\n",
      "    (. .)))\n",
      "\n",
      "amod(statistics-2, descriptive-1)\n",
      "nsubjpass(measured-9, statistics-2)\n",
      "case(medians-4, including-3)\n",
      "nmod:including(statistics-2, medians-4)\n",
      "cc(medians-4, and-5)\n",
      "amod(ranges-7, interquartile-6)\n",
      "nmod:including(statistics-2, ranges-7)\n",
      "conj:and(medians-4, ranges-7)\n",
      "auxpass(measured-9, were-8)\n",
      "root(ROOT-0, measured-9)\n",
      "case(variables-12, for-10)\n",
      "amod(variables-12, continuous-11)\n",
      "nmod:for(measured-9, variables-12)\n",
      "\n",
      "Parsing [sent. 124 len. 19]: comparisons were made using two-tailed t tests for parametric data and the mann-whitney u test for nonparametric data .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS comparisons))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN made)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ two-tailed) (NN t) (NNS tests))\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ parametric) (NNS data))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT the) (JJ mann-whitney) (NN u) (NN test))\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ nonparametric) (NNS data)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(made-3, comparisons-1)\n",
      "auxpass(made-3, were-2)\n",
      "root(ROOT-0, made-3)\n",
      "xcomp(made-3, using-4)\n",
      "amod(tests-7, two-tailed-5)\n",
      "compound(tests-7, t-6)\n",
      "dobj(using-4, tests-7)\n",
      "case(data-10, for-8)\n",
      "amod(data-10, parametric-9)\n",
      "nmod:for(tests-7, data-10)\n",
      "cc(tests-7, and-11)\n",
      "det(test-15, the-12)\n",
      "amod(test-15, mann-whitney-13)\n",
      "compound(test-15, u-14)\n",
      "dobj(using-4, test-15)\n",
      "conj:and(tests-7, test-15)\n",
      "case(data-18, for-16)\n",
      "amod(data-18, nonparametric-17)\n",
      "nmod:for(test-15, data-18)\n",
      "\n",
      "Parsing [sent. 125 len. 42]: heart failure with preserved ejection fraction -LRB- hfpef -RRB- makes up half of diagnosed heart failure cases and has similar outcomes compared to heart failure with reduced ejection fraction -LRB- hfref -RRB- but a discrepancy in knowledge and approach to treatment .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN heart) (NN failure))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ preserved) (NN ejection) (NN fraction))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN hfpef))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (VP\n",
      "      (VP (VBZ makes)\n",
      "        (PRT (RP up))\n",
      "        (NP\n",
      "          (NP (NN half))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ diagnosed) (NN heart) (NN failure) (NNS cases)))))\n",
      "      (CC and)\n",
      "      (VP (VBZ has)\n",
      "        (NP\n",
      "          (NP (JJ similar) (NNS outcomes))\n",
      "          (PP (VBN compared)\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN heart) (NN failure))\n",
      "                (PP (IN with)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (VBN reduced) (NN ejection) (NN fraction))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN hfref))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (PP (CC but)\n",
      "                      (NP\n",
      "                        (NP (DT a) (NN discrepancy))\n",
      "                        (PP (IN in)\n",
      "                          (NP (NN knowledge)\n",
      "                            (CC and)\n",
      "                            (NN approach)))))))))))\n",
      "        (PP (TO to)\n",
      "          (NP (NN treatment)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(failure-2, heart-1)\n",
      "nsubj(makes-10, failure-2)\n",
      "nsubj(has-19, failure-2)\n",
      "case(fraction-6, with-3)\n",
      "amod(fraction-6, preserved-4)\n",
      "compound(fraction-6, ejection-5)\n",
      "nmod:with(failure-2, fraction-6)\n",
      "appos(fraction-6, hfpef-8)\n",
      "root(ROOT-0, makes-10)\n",
      "compound:prt(makes-10, up-11)\n",
      "dobj(makes-10, half-12)\n",
      "case(cases-17, of-13)\n",
      "amod(cases-17, diagnosed-14)\n",
      "compound(cases-17, heart-15)\n",
      "compound(cases-17, failure-16)\n",
      "nmod:of(half-12, cases-17)\n",
      "cc(makes-10, and-18)\n",
      "conj:and(makes-10, has-19)\n",
      "amod(outcomes-21, similar-20)\n",
      "dobj(has-19, outcomes-21)\n",
      "case(failure-25, compared-22)\n",
      "mwe(compared-22, to-23)\n",
      "compound(failure-25, heart-24)\n",
      "acl(outcomes-21, failure-25)\n",
      "case(fraction-29, with-26)\n",
      "amod(fraction-29, reduced-27)\n",
      "compound(fraction-29, ejection-28)\n",
      "nmod:with(failure-25, fraction-29)\n",
      "appos(fraction-29, hfref-31)\n",
      "case(discrepancy-35, but-33)\n",
      "det(discrepancy-35, a-34)\n",
      "nmod:but(fraction-29, discrepancy-35)\n",
      "case(knowledge-37, in-36)\n",
      "nmod:in(discrepancy-35, knowledge-37)\n",
      "cc(knowledge-37, and-38)\n",
      "nmod:in(discrepancy-35, approach-39)\n",
      "conj:and(knowledge-37, approach-39)\n",
      "case(treatment-41, to-40)\n",
      "nmod:to(has-19, treatment-41)\n",
      "\n",
      "Parsing [sent. 126 len. 36]: hfpef is diagnosed using the following criteria : symptoms , preserved ejection fraction -LRB- greater than 50 % -RRB- , and evidence of abnormal left ventricular filling or relaxation , or diastolic distensibility or stiffness .\n",
      "(ROOT\n",
      "  (SINV\n",
      "    (S\n",
      "      (NP (NN hfpef))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN diagnosed)\n",
      "          (S\n",
      "            (VP (VBG using)\n",
      "              (NP\n",
      "                (NP (DT the) (VBG following) (NNS criteria))\n",
      "                (: :)\n",
      "                (NP (NNS symptoms))))))))\n",
      "    (, ,)\n",
      "    (VP (VBD preserved))\n",
      "    (NP\n",
      "      (NP (NN ejection) (NN fraction))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (QP (JJR greater) (IN than) (CD 50))\n",
      "          (NN %))\n",
      "        (-RRB- -RRB-))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP (NN evidence))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (JJ abnormal) (JJ left) (NN ventricular) (NN filling))\n",
      "              (CC or)\n",
      "              (NP (NN relaxation)))\n",
      "            (, ,)\n",
      "            (CC or)\n",
      "            (NP\n",
      "              (NP (JJ diastolic) (NN distensibility))\n",
      "              (CC or)\n",
      "              (NP (NNS stiffness)))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(diagnosed-3, hfpef-1)\n",
      "auxpass(diagnosed-3, is-2)\n",
      "ccomp(preserved-11, diagnosed-3)\n",
      "xcomp(diagnosed-3, using-4)\n",
      "det(criteria-7, the-5)\n",
      "amod(criteria-7, following-6)\n",
      "dobj(using-4, criteria-7)\n",
      "dep(criteria-7, symptoms-9)\n",
      "root(ROOT-0, preserved-11)\n",
      "compound(fraction-13, ejection-12)\n",
      "nsubj(preserved-11, fraction-13)\n",
      "advmod(50-17, greater-15)\n",
      "advmod(50-17, than-16)\n",
      "nummod(%-18, 50-17)\n",
      "appos(fraction-13, %-18)\n",
      "cc(fraction-13, and-21)\n",
      "nsubj(preserved-11, evidence-22)\n",
      "conj:and(fraction-13, evidence-22)\n",
      "case(filling-27, of-23)\n",
      "amod(filling-27, abnormal-24)\n",
      "amod(filling-27, left-25)\n",
      "compound(filling-27, ventricular-26)\n",
      "nmod:of(evidence-22, filling-27)\n",
      "cc(filling-27, or-28)\n",
      "nmod:of(evidence-22, relaxation-29)\n",
      "conj:or(filling-27, relaxation-29)\n",
      "cc(filling-27, or-31)\n",
      "amod(distensibility-33, diastolic-32)\n",
      "nmod:of(evidence-22, distensibility-33)\n",
      "conj:or(filling-27, distensibility-33)\n",
      "cc(distensibility-33, or-34)\n",
      "conj:or(filling-27, stiffness-35)\n",
      "conj:or(distensibility-33, stiffness-35)\n",
      "\n",
      "Parsing [sent. 127 len. 41]: studies conducted to examine the efficacy of angiotensin receptor blockers -LRB- irbesartan and candesartan -RRB- , thiazide diuretics -LRB- chlorthalidone -RRB- , and ACEI -LRB- perindopril -RRB- in the treatment of hfpef , showed moderate efficacy but no clear benefit .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS studies))\n",
      "      (VP (VBN conducted)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB examine)\n",
      "              (NP\n",
      "                (NP (DT the) (NN efficacy))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN irbesartan)\n",
      "                          (CC and)\n",
      "                          (NNS candesartan))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (JJ thiazide) (NNS diuretics))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN chlorthalidone))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (CC and)\n",
      "                    (NP\n",
      "                      (NP (NNP ACEI))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (ADJP (JJ perindopril))\n",
      "                        (-RRB- -RRB-))))))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN treatment))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN hfpef))))))))))\n",
      "    (, ,)\n",
      "    (VP (VBD showed)\n",
      "      (NP\n",
      "        (NP (JJ moderate) (NN efficacy))\n",
      "        (PP (CC but)\n",
      "          (NP (DT no) (JJ clear) (NN benefit)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(showed-34, studies-1)\n",
      "acl(studies-1, conducted-2)\n",
      "mark(examine-4, to-3)\n",
      "xcomp(conducted-2, examine-4)\n",
      "det(efficacy-6, the-5)\n",
      "dobj(examine-4, efficacy-6)\n",
      "case(blockers-10, of-7)\n",
      "compound(blockers-10, angiotensin-8)\n",
      "compound(blockers-10, receptor-9)\n",
      "nmod:of(efficacy-6, blockers-10)\n",
      "appos(blockers-10, irbesartan-12)\n",
      "cc(irbesartan-12, and-13)\n",
      "appos(blockers-10, candesartan-14)\n",
      "conj:and(irbesartan-12, candesartan-14)\n",
      "amod(diuretics-18, thiazide-17)\n",
      "nmod:of(efficacy-6, diuretics-18)\n",
      "conj:and(blockers-10, diuretics-18)\n",
      "appos(diuretics-18, chlorthalidone-20)\n",
      "cc(blockers-10, and-23)\n",
      "nmod:of(efficacy-6, ACEI-24)\n",
      "conj:and(blockers-10, ACEI-24)\n",
      "dep(ACEI-24, perindopril-26)\n",
      "case(treatment-30, in-28)\n",
      "det(treatment-30, the-29)\n",
      "nmod:in(examine-4, treatment-30)\n",
      "case(hfpef-32, of-31)\n",
      "nmod:of(treatment-30, hfpef-32)\n",
      "root(ROOT-0, showed-34)\n",
      "amod(efficacy-36, moderate-35)\n",
      "dobj(showed-34, efficacy-36)\n",
      "case(benefit-40, but-37)\n",
      "neg(benefit-40, no-38)\n",
      "amod(benefit-40, clear-39)\n",
      "nmod:but(efficacy-36, benefit-40)\n",
      "\n",
      "Parsing [sent. 128 len. 40]: recently , the fda has approved a novel drug , which combines an angiotensin receptor neprilysin inhibitor and angiotensin receptor blocker -LRB- valsartan -RRB- named lcz696 -LRB- entresto -RRB- for possible treatment of heart failure with reduced ejection fraction .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB recently))\n",
      "    (, ,)\n",
      "    (NP (DT the) (NN fda))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN approved)\n",
      "        (NP\n",
      "          (NP (DT a) (NN novel) (NN drug))\n",
      "          (, ,)\n",
      "          (SBAR\n",
      "            (WHNP (WDT which))\n",
      "            (S\n",
      "              (VP (VBZ combines)\n",
      "                (NP\n",
      "                  (NP (DT an) (NN angiotensin) (NN receptor) (NN neprilysin) (NN inhibitor)\n",
      "                    (CC and)\n",
      "                    (NN angiotensin) (NN receptor) (NN blocker))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (NN valsartan))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (VP (VBN named)\n",
      "                    (NP\n",
      "                      (NP (JJ lcz696) (-LRB- -LRB-) (NN entresto) (-RRB- -RRB-))\n",
      "                      (PP (IN for)\n",
      "                        (NP\n",
      "                          (NP (JJ possible) (NN treatment))\n",
      "                          (PP (IN of)\n",
      "                            (NP (NN heart) (NN failure))))))\n",
      "                    (PP (IN with)\n",
      "                      (NP (VBN reduced) (NN ejection) (NN fraction)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "advmod(approved-6, recently-1)\n",
      "det(fda-4, the-3)\n",
      "nsubj(approved-6, fda-4)\n",
      "aux(approved-6, has-5)\n",
      "root(ROOT-0, approved-6)\n",
      "det(drug-9, a-7)\n",
      "compound(drug-9, novel-8)\n",
      "dobj(approved-6, drug-9)\n",
      "nsubj(combines-12, drug-9)\n",
      "ref(drug-9, which-11)\n",
      "acl:relcl(drug-9, combines-12)\n",
      "det(inhibitor-17, an-13)\n",
      "compound(inhibitor-17, angiotensin-14)\n",
      "compound(inhibitor-17, receptor-15)\n",
      "compound(inhibitor-17, neprilysin-16)\n",
      "dobj(combines-12, inhibitor-17)\n",
      "cc(inhibitor-17, and-18)\n",
      "compound(blocker-21, angiotensin-19)\n",
      "compound(blocker-21, receptor-20)\n",
      "dobj(combines-12, blocker-21)\n",
      "conj:and(inhibitor-17, blocker-21)\n",
      "appos(inhibitor-17, valsartan-23)\n",
      "acl(inhibitor-17, named-25)\n",
      "amod(entresto-28, lcz696-26)\n",
      "dobj(named-25, entresto-28)\n",
      "case(treatment-32, for-30)\n",
      "amod(treatment-32, possible-31)\n",
      "nmod:for(entresto-28, treatment-32)\n",
      "case(failure-35, of-33)\n",
      "compound(failure-35, heart-34)\n",
      "nmod:of(treatment-32, failure-35)\n",
      "case(fraction-39, with-36)\n",
      "amod(fraction-39, reduced-37)\n",
      "compound(fraction-39, ejection-38)\n",
      "nmod:with(named-25, fraction-39)\n",
      "\n",
      "Parsing [sent. 129 len. 29]: in this article , we will discuss the failure of previous treatment modalities and the promise that lcz696 -LRB- entresto -RRB- may hold for treating patients with hfpef .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN in)\n",
      "      (NP (DT this) (NN article)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (MD will)\n",
      "      (VP (VB discuss)\n",
      "        (NP\n",
      "          (NP (DT the) (NN failure))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ previous) (NN treatment) (NNS modalities))\n",
      "              (CC and)\n",
      "              (NP (DT the) (NN promise)))))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (NNS lcz696))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNP entresto))\n",
      "                (-RRB- -RRB-)))\n",
      "            (VP (MD may)\n",
      "              (VP (VB hold)\n",
      "                (PP (IN for)\n",
      "                  (S\n",
      "                    (VP (VBG treating)\n",
      "                      (NP (NNS patients))\n",
      "                      (PP (IN with)\n",
      "                        (NP (NN hfpef))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "case(article-3, in-1)\n",
      "det(article-3, this-2)\n",
      "nmod:in(discuss-7, article-3)\n",
      "nsubj(discuss-7, we-5)\n",
      "aux(discuss-7, will-6)\n",
      "root(ROOT-0, discuss-7)\n",
      "det(failure-9, the-8)\n",
      "dobj(discuss-7, failure-9)\n",
      "case(modalities-13, of-10)\n",
      "amod(modalities-13, previous-11)\n",
      "compound(modalities-13, treatment-12)\n",
      "nmod:of(failure-9, modalities-13)\n",
      "cc(modalities-13, and-14)\n",
      "det(promise-16, the-15)\n",
      "nmod:of(failure-9, promise-16)\n",
      "conj:and(modalities-13, promise-16)\n",
      "mark(hold-23, that-17)\n",
      "nsubj(hold-23, lcz696-18)\n",
      "appos(lcz696-18, entresto-20)\n",
      "aux(hold-23, may-22)\n",
      "ccomp(discuss-7, hold-23)\n",
      "mark(treating-25, for-24)\n",
      "advcl(hold-23, treating-25)\n",
      "dobj(treating-25, patients-26)\n",
      "case(hfpef-28, with-27)\n",
      "nmod:with(treating-25, hfpef-28)\n",
      "\n",
      "Parsing [sent. 130 len. 18]: several medications have been used perioperatively in patients undergoing noncardiac surgery in an attempt to improve outcomes .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ several) (NNS medications))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN been)\n",
      "        (VP (VBN used)\n",
      "          (ADVP (RB perioperatively))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (VP (VBG undergoing)\n",
      "                (NP (JJ noncardiac) (NN surgery))\n",
      "                (PP (IN in)\n",
      "                  (NP (DT an) (NN attempt)\n",
      "                    (S\n",
      "                      (VP (TO to)\n",
      "                        (VP (VB improve)\n",
      "                          (NP (NNS outcomes)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(medications-2, several-1)\n",
      "nsubjpass(used-5, medications-2)\n",
      "aux(used-5, have-3)\n",
      "auxpass(used-5, been-4)\n",
      "root(ROOT-0, used-5)\n",
      "advmod(used-5, perioperatively-6)\n",
      "case(patients-8, in-7)\n",
      "nmod:in(used-5, patients-8)\n",
      "acl(patients-8, undergoing-9)\n",
      "amod(surgery-11, noncardiac-10)\n",
      "dobj(undergoing-9, surgery-11)\n",
      "case(attempt-14, in-12)\n",
      "det(attempt-14, an-13)\n",
      "nmod:in(undergoing-9, attempt-14)\n",
      "mark(improve-16, to-15)\n",
      "acl(attempt-14, improve-16)\n",
      "dobj(improve-16, outcomes-17)\n",
      "\n",
      "Parsing [sent. 131 len. 41]: antiplatelet therapy for primary prevention of cardiovascular events should generally be discontinued seven to 10 days before surgery to avoid increasing the risk of bleeding , unless the risk of a major adverse cardiac event exceeds the risk of bleeding .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ antiplatelet) (NN therapy))\n",
      "      (PP (IN for)\n",
      "        (NP\n",
      "          (NP (JJ primary) (NN prevention))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ cardiovascular) (NNS events))))))\n",
      "    (VP (MD should)\n",
      "      (ADVP (RB generally))\n",
      "      (VP (VB be)\n",
      "        (VP (VBN discontinued)\n",
      "          (PP\n",
      "            (NP\n",
      "              (QP (CD seven) (TO to) (CD 10))\n",
      "              (NNS days))\n",
      "            (IN before)\n",
      "            (NP (NN surgery)))\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB avoid)\n",
      "                (S\n",
      "                  (VP (VBG increasing)\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN risk))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NN bleeding))))))\n",
      "                (, ,)\n",
      "                (SBAR (IN unless)\n",
      "                  (S\n",
      "                    (NP\n",
      "                      (NP (DT the) (NN risk))\n",
      "                      (PP (IN of)\n",
      "                        (NP (DT a) (JJ major) (JJ adverse) (JJ cardiac) (NN event))))\n",
      "                    (VP (VBZ exceeds)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN risk))\n",
      "                        (PP (IN of)\n",
      "                          (NP (NN bleeding)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-2, antiplatelet-1)\n",
      "nsubjpass(discontinued-12, therapy-2)\n",
      "nsubj:xsubj(avoid-20, therapy-2)\n",
      "case(prevention-5, for-3)\n",
      "amod(prevention-5, primary-4)\n",
      "nmod:for(therapy-2, prevention-5)\n",
      "case(events-8, of-6)\n",
      "amod(events-8, cardiovascular-7)\n",
      "nmod:of(prevention-5, events-8)\n",
      "aux(discontinued-12, should-9)\n",
      "advmod(discontinued-12, generally-10)\n",
      "auxpass(discontinued-12, be-11)\n",
      "root(ROOT-0, discontinued-12)\n",
      "compound(10-15, seven-13)\n",
      "dep(10-15, to-14)\n",
      "nummod(days-16, 10-15)\n",
      "nmod:before(discontinued-12, days-16)\n",
      "case(days-16, before-17)\n",
      "dep(days-16, surgery-18)\n",
      "mark(avoid-20, to-19)\n",
      "xcomp(discontinued-12, avoid-20)\n",
      "xcomp(avoid-20, increasing-21)\n",
      "det(risk-23, the-22)\n",
      "dobj(increasing-21, risk-23)\n",
      "case(bleeding-25, of-24)\n",
      "nmod:of(risk-23, bleeding-25)\n",
      "mark(exceeds-36, unless-27)\n",
      "det(risk-29, the-28)\n",
      "nsubj(exceeds-36, risk-29)\n",
      "case(event-35, of-30)\n",
      "det(event-35, a-31)\n",
      "amod(event-35, major-32)\n",
      "amod(event-35, adverse-33)\n",
      "amod(event-35, cardiac-34)\n",
      "nmod:of(risk-29, event-35)\n",
      "advcl(avoid-20, exceeds-36)\n",
      "det(risk-38, the-37)\n",
      "dobj(exceeds-36, risk-38)\n",
      "case(bleeding-40, of-39)\n",
      "nmod:of(risk-38, bleeding-40)\n",
      "\n",
      "Parsing [sent. 132 len. 24]: antiplatelet therapy for secondary prevention should be continued perioperatively , except before procedures with very high bleeding risk , such as intracranial procedures .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ antiplatelet) (NN therapy))\n",
      "      (PP (IN for)\n",
      "        (NP (JJ secondary) (NN prevention))))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN continued)\n",
      "          (PP\n",
      "            (ADVP (RB perioperatively))\n",
      "            (, ,) (IN except) (IN before)\n",
      "            (NP\n",
      "              (NP (NNS procedures))\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (ADJP (RB very) (JJ high))\n",
      "                  (NN bleeding) (NN risk)))\n",
      "              (, ,)\n",
      "              (PP (JJ such) (IN as)\n",
      "                (NP (JJ intracranial) (NNS procedures))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-2, antiplatelet-1)\n",
      "nsubjpass(continued-8, therapy-2)\n",
      "case(prevention-5, for-3)\n",
      "amod(prevention-5, secondary-4)\n",
      "nmod:for(therapy-2, prevention-5)\n",
      "aux(continued-8, should-6)\n",
      "auxpass(continued-8, be-7)\n",
      "root(ROOT-0, continued-8)\n",
      "advmod(procedures-13, perioperatively-9)\n",
      "case(procedures-13, except-11)\n",
      "case(procedures-13, before-12)\n",
      "nmod:before(continued-8, procedures-13)\n",
      "case(risk-18, with-14)\n",
      "advmod(high-16, very-15)\n",
      "amod(risk-18, high-16)\n",
      "compound(risk-18, bleeding-17)\n",
      "nmod:with(procedures-13, risk-18)\n",
      "case(procedures-23, such-20)\n",
      "mwe(such-20, as-21)\n",
      "amod(procedures-23, intracranial-22)\n",
      "nmod:such_as(procedures-13, procedures-23)\n",
      "\n",
      "Parsing [sent. 133 len. 50]: antiplatelet drugs should be continued and surgery delayed , if possible , for at least 14 days after percutaneous coronary intervention without stent placement , 30 days after percutaneous coronary intervention with bare-metal stent placement , and six to 12 months after percutaneous coronary intervention with drug-eluting stent placement .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN antiplatelet) (NNS drugs))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN surgery))\n",
      "      (VP (VBN delayed)\n",
      "        (PRN (, ,)\n",
      "          (SBAR (IN if)\n",
      "            (FRAG (JJ possible)))\n",
      "          (, ,))\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (QP (IN at) (JJS least) (CD 14))\n",
      "                (NNS days))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN without)\n",
      "                    (NP (JJ stent) (NN placement))))))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP (CD 30) (NNS days))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ bare-metal) (NN stent) (NN placement))))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP\n",
      "                (QP (CD six) (TO to) (CD 12))\n",
      "                (NNS months))\n",
      "              (PP (IN after)\n",
      "                (NP\n",
      "                  (NP (JJ percutaneous) (JJ coronary) (NN intervention))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ drug-eluting) (NN stent) (NN placement))))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(drugs-2, antiplatelet-1)\n",
      "nsubjpass(continued-5, drugs-2)\n",
      "aux(continued-5, should-3)\n",
      "auxpass(continued-5, be-4)\n",
      "root(ROOT-0, continued-5)\n",
      "cc(continued-5, and-6)\n",
      "nsubj(delayed-8, surgery-7)\n",
      "conj:and(continued-5, delayed-8)\n",
      "mark(possible-11, if-10)\n",
      "parataxis(delayed-8, possible-11)\n",
      "case(days-17, for-13)\n",
      "case(least-15, at-14)\n",
      "nmod:npmod(14-16, least-15)\n",
      "nummod(days-17, 14-16)\n",
      "nmod:for(delayed-8, days-17)\n",
      "case(intervention-21, after-18)\n",
      "amod(intervention-21, percutaneous-19)\n",
      "amod(intervention-21, coronary-20)\n",
      "nmod:after(days-17, intervention-21)\n",
      "case(placement-24, without-22)\n",
      "amod(placement-24, stent-23)\n",
      "nmod:without(intervention-21, placement-24)\n",
      "nummod(days-27, 30-26)\n",
      "nmod:for(delayed-8, days-27)\n",
      "conj:and(days-17, days-27)\n",
      "case(intervention-31, after-28)\n",
      "amod(intervention-31, percutaneous-29)\n",
      "amod(intervention-31, coronary-30)\n",
      "nmod:after(days-27, intervention-31)\n",
      "case(placement-35, with-32)\n",
      "amod(placement-35, bare-metal-33)\n",
      "compound(placement-35, stent-34)\n",
      "nmod:with(intervention-31, placement-35)\n",
      "cc(days-17, and-37)\n",
      "compound(12-40, six-38)\n",
      "dep(12-40, to-39)\n",
      "nummod(months-41, 12-40)\n",
      "nmod:for(delayed-8, months-41)\n",
      "conj:and(days-17, months-41)\n",
      "case(intervention-45, after-42)\n",
      "amod(intervention-45, percutaneous-43)\n",
      "amod(intervention-45, coronary-44)\n",
      "nmod:after(months-41, intervention-45)\n",
      "case(placement-49, with-46)\n",
      "amod(placement-49, drug-eluting-47)\n",
      "compound(placement-49, stent-48)\n",
      "nmod:with(intervention-45, placement-49)\n",
      "\n",
      "Parsing [sent. 134 len. 52]: perioperative beta blockers are recommended for patients already receiving these agents , and it is reasonable to consider starting therapy in patients with known or strongly suspected coronary artery disease or who are at high risk of perioperative cardiac events and are undergoing procedures with a high risk of cardiovascular complications .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ perioperative) (NN beta) (NNS blockers))\n",
      "      (VP (VBP are)\n",
      "        (VP (VBN recommended)\n",
      "          (PP (IN for)\n",
      "            (NP\n",
      "              (NP (NNS patients))\n",
      "              (VP\n",
      "                (ADVP (RB already))\n",
      "                (VBG receiving)\n",
      "                (NP (DT these) (NNS agents))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (PRP it))\n",
      "      (VP (VBZ is)\n",
      "        (ADJP (JJ reasonable)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB consider)\n",
      "                (S\n",
      "                  (VP (VBG starting)\n",
      "                    (NP\n",
      "                      (NP (NN therapy))\n",
      "                      (PP (IN in)\n",
      "                        (NP (NNS patients))))\n",
      "                    (PP (IN with)\n",
      "                      (S\n",
      "                        (VP\n",
      "                          (VP (VBN known))\n",
      "                          (CC or)\n",
      "                          (VP\n",
      "                            (ADVP (RB strongly))\n",
      "                            (VBN suspected)\n",
      "                            (NP\n",
      "                              (NP (JJ coronary) (NN artery) (NN disease))\n",
      "                              (CC or)\n",
      "                              (SBAR\n",
      "                                (WHNP (WP who))\n",
      "                                (S\n",
      "                                  (VP (VBP are)\n",
      "                                    (PP (IN at)\n",
      "                                      (NP\n",
      "                                        (NP (JJ high) (NN risk))\n",
      "                                        (PP (IN of)\n",
      "                                          (NP (JJ perioperative) (JJ cardiac) (NNS events))))))))))\n",
      "                          (CC and)\n",
      "                          (VP (VBP are)\n",
      "                            (VP (VBG undergoing)\n",
      "                              (NP (NNS procedures))\n",
      "                              (PP (IN with)\n",
      "                                (NP\n",
      "                                  (NP (DT a) (JJ high) (NN risk))\n",
      "                                  (PP (IN of)\n",
      "                                    (NP (JJ cardiovascular) (NNS complications))))))))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(blockers-3, perioperative-1)\n",
      "compound(blockers-3, beta-2)\n",
      "nsubjpass(recommended-5, blockers-3)\n",
      "auxpass(recommended-5, are-4)\n",
      "root(ROOT-0, recommended-5)\n",
      "case(patients-7, for-6)\n",
      "nmod:for(recommended-5, patients-7)\n",
      "advmod(receiving-9, already-8)\n",
      "acl(patients-7, receiving-9)\n",
      "det(agents-11, these-10)\n",
      "dobj(receiving-9, agents-11)\n",
      "cc(recommended-5, and-13)\n",
      "nsubj(reasonable-16, it-14)\n",
      "nsubj:xsubj(consider-18, it-14)\n",
      "cop(reasonable-16, is-15)\n",
      "conj:and(recommended-5, reasonable-16)\n",
      "mark(consider-18, to-17)\n",
      "xcomp(reasonable-16, consider-18)\n",
      "xcomp(consider-18, starting-19)\n",
      "dobj(starting-19, therapy-20)\n",
      "case(patients-22, in-21)\n",
      "nmod:in(therapy-20, patients-22)\n",
      "mark(known-24, with-23)\n",
      "advcl(starting-19, known-24)\n",
      "cc(known-24, or-25)\n",
      "advmod(suspected-27, strongly-26)\n",
      "advcl(starting-19, suspected-27)\n",
      "conj:or(known-24, suspected-27)\n",
      "amod(disease-30, coronary-28)\n",
      "compound(disease-30, artery-29)\n",
      "dobj(suspected-27, disease-30)\n",
      "cc(disease-30, or-31)\n",
      "nsubj(risk-36, who-32)\n",
      "cop(risk-36, are-33)\n",
      "case(risk-36, at-34)\n",
      "amod(risk-36, high-35)\n",
      "dobj(suspected-27, risk-36)\n",
      "conj:or(disease-30, risk-36)\n",
      "case(events-40, of-37)\n",
      "amod(events-40, perioperative-38)\n",
      "amod(events-40, cardiac-39)\n",
      "nmod:of(risk-36, events-40)\n",
      "cc(known-24, and-41)\n",
      "aux(undergoing-43, are-42)\n",
      "advcl(starting-19, undergoing-43)\n",
      "conj:and(known-24, undergoing-43)\n",
      "dobj(undergoing-43, procedures-44)\n",
      "case(risk-48, with-45)\n",
      "det(risk-48, a-46)\n",
      "amod(risk-48, high-47)\n",
      "nmod:with(undergoing-43, risk-48)\n",
      "case(complications-51, of-49)\n",
      "amod(complications-51, cardiovascular-50)\n",
      "nmod:of(risk-48, complications-51)\n",
      "\n",
      "Parsing [sent. 135 len. 21]: long-term statin therapy should be continued perioperatively or started in patients with clinical indications who are not already receiving statins .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ long-term) (NN statin) (NN therapy))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP\n",
      "          (VP (VBN continued)\n",
      "            (ADVP (RB perioperatively)))\n",
      "          (CC or)\n",
      "          (VP (VBN started)\n",
      "            (PP (IN in)\n",
      "              (NP (NNS patients))))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (JJ clinical) (NNS indications))\n",
      "              (SBAR\n",
      "                (WHNP (WP who))\n",
      "                (S\n",
      "                  (VP (VBP are) (RB not)\n",
      "                    (ADVP (RB already))\n",
      "                    (VP (VBG receiving)\n",
      "                      (NP (NNS statins)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(therapy-3, long-term-1)\n",
      "compound(therapy-3, statin-2)\n",
      "nsubjpass(continued-6, therapy-3)\n",
      "nsubjpass(started-9, therapy-3)\n",
      "aux(continued-6, should-4)\n",
      "auxpass(continued-6, be-5)\n",
      "root(ROOT-0, continued-6)\n",
      "advmod(continued-6, perioperatively-7)\n",
      "cc(continued-6, or-8)\n",
      "conj:or(continued-6, started-9)\n",
      "case(patients-11, in-10)\n",
      "nmod:in(started-9, patients-11)\n",
      "case(indications-14, with-12)\n",
      "amod(indications-14, clinical-13)\n",
      "nmod:with(continued-6, indications-14)\n",
      "nsubj(receiving-19, indications-14)\n",
      "ref(indications-14, who-15)\n",
      "aux(receiving-19, are-16)\n",
      "neg(receiving-19, not-17)\n",
      "advmod(receiving-19, already-18)\n",
      "acl:relcl(indications-14, receiving-19)\n",
      "dobj(receiving-19, statins-20)\n",
      "\n",
      "Parsing [sent. 136 len. 15]: clonidine should not be started perioperatively , but long-term clonidine regimens may be continued .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN clonidine))\n",
      "      (VP (MD should) (RB not)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN started)\n",
      "            (ADVP (RB perioperatively))))))\n",
      "    (, ,)\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (JJ long-term) (NN clonidine) (NNS regimens))\n",
      "      (VP (MD may)\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)))))\n",
      "    (. .)))\n",
      "\n",
      "nsubjpass(started-5, clonidine-1)\n",
      "aux(started-5, should-2)\n",
      "neg(started-5, not-3)\n",
      "auxpass(started-5, be-4)\n",
      "root(ROOT-0, started-5)\n",
      "advmod(started-5, perioperatively-6)\n",
      "cc(started-5, but-8)\n",
      "amod(regimens-11, long-term-9)\n",
      "compound(regimens-11, clonidine-10)\n",
      "nsubjpass(continued-14, regimens-11)\n",
      "aux(continued-14, may-12)\n",
      "auxpass(continued-14, be-13)\n",
      "conj:but(started-5, continued-14)\n",
      "\n",
      "Parsing [sent. 137 len. 25]: ACEI and angiotensin receptor blockers generally can be continued perioperatively if patients are hemodynamically stable and have good renal function and normal electrolyte levels .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ACEI)\n",
      "      (CC and)\n",
      "      (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "    (ADVP (RB generally))\n",
      "    (VP (MD can)\n",
      "      (VP\n",
      "        (VP (VB be)\n",
      "          (VP (VBN continued)\n",
      "            (ADVP (RB perioperatively))\n",
      "            (SBAR (IN if)\n",
      "              (S\n",
      "                (NP (NNS patients))\n",
      "                (VP (VBP are)\n",
      "                  (ADJP (RB hemodynamically) (JJ stable)))))))\n",
      "        (CC and)\n",
      "        (VP (VB have)\n",
      "          (NP (JJ good) (JJ renal) (NN function)\n",
      "            (CC and)\n",
      "            (JJ normal) (NN electrolyte) (NNS levels)))))\n",
      "    (. .)))\n",
      "\n",
      "compound(blockers-5, ACEI-1)\n",
      "cc(ACEI-1, and-2)\n",
      "conj:and(ACEI-1, angiotensin-3)\n",
      "compound(blockers-5, angiotensin-3)\n",
      "compound(blockers-5, receptor-4)\n",
      "nsubjpass(continued-9, blockers-5)\n",
      "nsubj(have-17, blockers-5)\n",
      "advmod(continued-9, generally-6)\n",
      "aux(continued-9, can-7)\n",
      "auxpass(continued-9, be-8)\n",
      "root(ROOT-0, continued-9)\n",
      "advmod(continued-9, perioperatively-10)\n",
      "mark(stable-15, if-11)\n",
      "nsubj(stable-15, patients-12)\n",
      "cop(stable-15, are-13)\n",
      "advmod(stable-15, hemodynamically-14)\n",
      "advcl(continued-9, stable-15)\n",
      "cc(continued-9, and-16)\n",
      "conj:and(continued-9, have-17)\n",
      "amod(function-20, good-18)\n",
      "amod(function-20, renal-19)\n",
      "dobj(have-17, function-20)\n",
      "cc(function-20, and-21)\n",
      "amod(levels-24, normal-22)\n",
      "compound(levels-24, electrolyte-23)\n",
      "dobj(have-17, levels-24)\n",
      "conj:and(function-20, levels-24)\n",
      "\n",
      "Parsing [sent. 138 len. 28]: to assess drug adherence of patients with hypertension , an analytical method was developed and validated using ultra performance liquid chromatography tandem mass spectrometry -LRB- uplc-ms/ms -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (VP (TO to)\n",
      "        (VP (VB assess)\n",
      "          (NP\n",
      "            (NP (NN drug) (NN adherence))\n",
      "            (PP (IN of)\n",
      "              (NP (NNS patients))))\n",
      "          (PP (IN with)\n",
      "            (NP (NN hypertension))))))\n",
      "    (, ,)\n",
      "    (NP (DT an) (JJ analytical) (NN method))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN developed)\n",
      "        (CC and)\n",
      "        (VBN validated)\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP (NN ultra) (NN performance) (NN liquid) (NN chromatography) (NN tandem))\n",
      "              (ADJP (RB mass) (JJ spectrometry))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NNS uplc-ms/ms))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "mark(assess-2, to-1)\n",
      "advcl(developed-14, assess-2)\n",
      "compound(adherence-4, drug-3)\n",
      "dobj(assess-2, adherence-4)\n",
      "case(patients-6, of-5)\n",
      "nmod:of(adherence-4, patients-6)\n",
      "case(hypertension-8, with-7)\n",
      "nmod:with(assess-2, hypertension-8)\n",
      "det(method-12, an-10)\n",
      "amod(method-12, analytical-11)\n",
      "nsubjpass(developed-14, method-12)\n",
      "nsubjpass(validated-16, method-12)\n",
      "auxpass(developed-14, was-13)\n",
      "root(ROOT-0, developed-14)\n",
      "cc(developed-14, and-15)\n",
      "conj:and(developed-14, validated-16)\n",
      "xcomp(developed-14, using-17)\n",
      "compound(tandem-22, ultra-18)\n",
      "compound(tandem-22, performance-19)\n",
      "compound(tandem-22, liquid-20)\n",
      "compound(tandem-22, chromatography-21)\n",
      "dobj(using-17, tandem-22)\n",
      "advmod(spectrometry-24, mass-23)\n",
      "amod(tandem-22, spectrometry-24)\n",
      "appos(tandem-22, uplc-ms/ms-26)\n",
      "\n",
      "Parsing [sent. 139 len. 65]: the method includes eight frequently prescribed antihypertensive drugs from four classes and their active metabolites : ACEI enalapril and perindopril -LRB- active metabolites respectively enalaprilate and perindoprilate -RRB- , angiotensin ii receptor blockers losartan -LRB- with the active metabolite losartan carboxylic acid -RRB- and valsartan , calcium channel blockers amlodipine and nifedipine and diuretics hydrochlorothiazide and spironolactone -LRB- with the active metabolite canrenone -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (DT the) (NN method))\n",
      "      (VP (VBZ includes)\n",
      "        (NP (CD eight))\n",
      "        (UCP\n",
      "          (VP\n",
      "            (ADVP (RB frequently))\n",
      "            (VBN prescribed)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ antihypertensive) (NNS drugs))\n",
      "                (PP (IN from)\n",
      "                  (NP\n",
      "                    (NP (CD four) (NNS classes))\n",
      "                    (CC and)\n",
      "                    (NP (PRP$ their) (JJ active) (NNS metabolites)))))\n",
      "              (: :)\n",
      "              (NP\n",
      "                (NP (NNP ACEI))\n",
      "                (ADJP (JJ enalapril)\n",
      "                  (CC and)\n",
      "                  (JJ perindopril)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (S\n",
      "                  (NP (JJ active) (NNS metabolites))\n",
      "                  (ADVP (RB respectively))\n",
      "                  (VP (VBP enalaprilate)\n",
      "                    (CC and)\n",
      "                    (VBP perindoprilate)))\n",
      "                (-RRB- -RRB-))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN angiotensin) (NN ii) (NN receptor) (NNS blockers))\n",
      "                (VP (VBN losartan)\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (PP (IN with)\n",
      "                      (NP (DT the) (JJ active) (JJ metabolite) (NN losartan) (JJ carboxylic) (NN acid)))\n",
      "                    (-RRB- -RRB-))))))\n",
      "          (CC and)\n",
      "          (ADJP (JJ valsartan)))))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (NP (NN calcium) (NN channel) (NNS blockers))\n",
      "      (ADJP (JJ amlodipine)\n",
      "        (CC and)\n",
      "        (JJ nifedipine)))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NNS diuretics))\n",
      "      (ADJP\n",
      "        (ADJP (JJ hydrochlorothiazide)\n",
      "          (CC and)\n",
      "          (JJ spironolactone))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (PP (IN with)\n",
      "            (NP (DT the) (JJ active) (NN metabolite) (NN canrenone)))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "det(method-2, the-1)\n",
      "nsubj(includes-3, method-2)\n",
      "nsubj(amlodipine-50, method-2)\n",
      "nsubj(hydrochlorothiazide-55, method-2)\n",
      "root(ROOT-0, includes-3)\n",
      "dobj(includes-3, eight-4)\n",
      "advmod(prescribed-6, frequently-5)\n",
      "dep(includes-3, prescribed-6)\n",
      "amod(drugs-8, antihypertensive-7)\n",
      "dobj(prescribed-6, drugs-8)\n",
      "case(classes-11, from-9)\n",
      "nummod(classes-11, four-10)\n",
      "nmod:from(drugs-8, classes-11)\n",
      "cc(classes-11, and-12)\n",
      "nmod:poss(metabolites-15, their-13)\n",
      "amod(metabolites-15, active-14)\n",
      "nmod:from(drugs-8, metabolites-15)\n",
      "conj:and(classes-11, metabolites-15)\n",
      "dep(drugs-8, ACEI-17)\n",
      "amod(ACEI-17, enalapril-18)\n",
      "cc(enalapril-18, and-19)\n",
      "amod(ACEI-17, perindopril-20)\n",
      "conj:and(enalapril-18, perindopril-20)\n",
      "amod(metabolites-23, active-22)\n",
      "nsubj(enalaprilate-25, metabolites-23)\n",
      "nsubj(perindoprilate-27, metabolites-23)\n",
      "advmod(enalaprilate-25, respectively-24)\n",
      "dep(drugs-8, enalaprilate-25)\n",
      "cc(enalaprilate-25, and-26)\n",
      "dep(drugs-8, perindoprilate-27)\n",
      "conj:and(enalaprilate-25, perindoprilate-27)\n",
      "compound(blockers-33, angiotensin-30)\n",
      "compound(blockers-33, ii-31)\n",
      "compound(blockers-33, receptor-32)\n",
      "appos(drugs-8, blockers-33)\n",
      "acl(blockers-33, losartan-34)\n",
      "case(acid-42, with-36)\n",
      "det(acid-42, the-37)\n",
      "amod(acid-42, active-38)\n",
      "amod(acid-42, metabolite-39)\n",
      "compound(acid-42, losartan-40)\n",
      "amod(acid-42, carboxylic-41)\n",
      "dep(losartan-34, acid-42)\n",
      "cc(prescribed-6, and-44)\n",
      "dep(includes-3, valsartan-45)\n",
      "conj:and(prescribed-6, valsartan-45)\n",
      "compound(blockers-49, calcium-47)\n",
      "compound(blockers-49, channel-48)\n",
      "dep(amlodipine-50, blockers-49)\n",
      "conj:and(includes-3, amlodipine-50)\n",
      "cc(amlodipine-50, and-51)\n",
      "conj:and(includes-3, nifedipine-52)\n",
      "conj:and(amlodipine-50, nifedipine-52)\n",
      "cc(includes-3, and-53)\n",
      "dep(hydrochlorothiazide-55, diuretics-54)\n",
      "conj:and(includes-3, hydrochlorothiazide-55)\n",
      "cc(hydrochlorothiazide-55, and-56)\n",
      "conj:and(includes-3, spironolactone-57)\n",
      "conj:and(hydrochlorothiazide-55, spironolactone-57)\n",
      "case(canrenone-63, with-59)\n",
      "det(canrenone-63, the-60)\n",
      "amod(canrenone-63, active-61)\n",
      "compound(canrenone-63, metabolite-62)\n",
      "dep(hydrochlorothiazide-55, canrenone-63)\n",
      "\n",
      "Parsing [sent. 140 len. 21]: this study demonstrates that ACEI-is/arbs therapy decreases the loss of residual renal function , mainly for patients with peritoneal dialysis .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT this) (NN study))\n",
      "    (VP (VBZ demonstrates)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP ACEI-is/arbs) (NN therapy))\n",
      "          (VP (VBZ decreases)\n",
      "            (NP\n",
      "              (NP (DT the) (NN loss))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ residual) (JJ renal) (NN function))))\n",
      "            (, ,)\n",
      "            (PP\n",
      "              (ADVP (RB mainly))\n",
      "              (IN for)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ peritoneal) (NN dialysis)))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(study-2, this-1)\n",
      "nsubj(demonstrates-3, study-2)\n",
      "root(ROOT-0, demonstrates-3)\n",
      "mark(decreases-7, that-4)\n",
      "compound(therapy-6, ACEI-is/arbs-5)\n",
      "nsubj(decreases-7, therapy-6)\n",
      "ccomp(demonstrates-3, decreases-7)\n",
      "det(loss-9, the-8)\n",
      "dobj(decreases-7, loss-9)\n",
      "case(function-13, of-10)\n",
      "amod(function-13, residual-11)\n",
      "amod(function-13, renal-12)\n",
      "nmod:of(loss-9, function-13)\n",
      "advmod(patients-17, mainly-15)\n",
      "case(patients-17, for-16)\n",
      "nmod:for(decreases-7, patients-17)\n",
      "case(dialysis-20, with-18)\n",
      "amod(dialysis-20, peritoneal-19)\n",
      "nmod:with(patients-17, dialysis-20)\n",
      "\n",
      "Parsing [sent. 141 len. 28]: overall , ACEI-is and arbs do not reduce cardiovascular events in dialysis patients , however , treatment with arb seems to reduce cardiovascular events including heart failure .\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (JJ overall) (, ,) (NNS ACEI-is)\n",
      "        (CC and)\n",
      "        (NNS arbs))\n",
      "      (VP (VBP do) (RB not)\n",
      "        (VP (VB reduce)\n",
      "          (NP (JJ cardiovascular) (NNS events))\n",
      "          (PP (IN in)\n",
      "            (NP (NN dialysis) (NNS patients)))\n",
      "          (, ,)\n",
      "          (ADVP (RB however)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN treatment))\n",
      "      (PP (IN with)\n",
      "        (NP (NN arb))))\n",
      "    (VP (VBZ seems)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB reduce)\n",
      "            (NP\n",
      "              (NP (JJ cardiovascular) (NNS events))\n",
      "              (PP (VBG including)\n",
      "                (NP (NN heart) (NN failure))))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(reduce-8, overall-1)\n",
      "conj:and(overall-1, ACEI-is-3)\n",
      "nsubj(reduce-8, ACEI-is-3)\n",
      "cc(overall-1, and-4)\n",
      "conj:and(overall-1, arbs-5)\n",
      "nsubj(reduce-8, arbs-5)\n",
      "aux(reduce-8, do-6)\n",
      "neg(reduce-8, not-7)\n",
      "ccomp(seems-20, reduce-8)\n",
      "amod(events-10, cardiovascular-9)\n",
      "dobj(reduce-8, events-10)\n",
      "case(patients-13, in-11)\n",
      "compound(patients-13, dialysis-12)\n",
      "nmod:in(reduce-8, patients-13)\n",
      "advmod(reduce-8, however-15)\n",
      "nsubj(seems-20, treatment-17)\n",
      "nsubj:xsubj(reduce-22, treatment-17)\n",
      "case(arb-19, with-18)\n",
      "nmod:with(treatment-17, arb-19)\n",
      "root(ROOT-0, seems-20)\n",
      "mark(reduce-22, to-21)\n",
      "xcomp(seems-20, reduce-22)\n",
      "amod(events-24, cardiovascular-23)\n",
      "dobj(reduce-22, events-24)\n",
      "case(failure-27, including-25)\n",
      "compound(failure-27, heart-26)\n",
      "nmod:including(events-24, failure-27)\n",
      "\n",
      "Parsing [sent. 142 len. 13]: ACEI-is and arbs do not induce an extra risk of side effects .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS ACEI-is)\n",
      "      (CC and)\n",
      "      (NNS arbs))\n",
      "    (VP (VBP do) (RB not)\n",
      "      (VP (VB induce)\n",
      "        (NP\n",
      "          (NP (DT an) (JJ extra) (NN risk))\n",
      "          (PP (IN of)\n",
      "            (NP (NN side) (NNS effects))))))\n",
      "    (. .)))\n",
      "\n",
      "nsubj(induce-6, ACEI-is-1)\n",
      "cc(ACEI-is-1, and-2)\n",
      "conj:and(ACEI-is-1, arbs-3)\n",
      "nsubj(induce-6, arbs-3)\n",
      "aux(induce-6, do-4)\n",
      "neg(induce-6, not-5)\n",
      "root(ROOT-0, induce-6)\n",
      "det(risk-9, an-7)\n",
      "amod(risk-9, extra-8)\n",
      "dobj(induce-6, risk-9)\n",
      "case(effects-12, of-10)\n",
      "compound(effects-12, side-11)\n",
      "nmod:of(risk-9, effects-12)\n",
      "\n",
      "Parsing [sent. 143 len. 11]: eleven trials included 1856 participants who were receiving dialysis therapy .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS eleven) (NNS trials))\n",
      "    (VP (VBD included)\n",
      "      (NP\n",
      "        (NP (CD 1856) (NNS participants))\n",
      "        (SBAR\n",
      "          (WHNP (WP who))\n",
      "          (S\n",
      "            (VP (VBD were)\n",
      "              (VP (VBG receiving)\n",
      "                (NP (NN dialysis) (NN therapy))))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(trials-2, eleven-1)\n",
      "nsubj(included-3, trials-2)\n",
      "root(ROOT-0, included-3)\n",
      "nummod(participants-5, 1856-4)\n",
      "dobj(included-3, participants-5)\n",
      "nsubj(receiving-8, participants-5)\n",
      "ref(participants-5, who-6)\n",
      "aux(receiving-8, were-7)\n",
      "acl:relcl(participants-5, receiving-8)\n",
      "compound(therapy-10, dialysis-9)\n",
      "dobj(receiving-8, therapy-10)\n",
      "\n",
      "Parsing [sent. 144 len. 42]: compared with placebo or other active agents groups , arb therapy reduced the risk of heart failure events by 33 % -LRB- rr 0.67 , 95 % ci 0.47 to 0.93 -RRB- with similar decrement in blood pressure in dialysis patients .\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (VBN compared)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (NN placebo))\n",
      "          (CC or)\n",
      "          (NP (JJ other) (JJ active) (NNS agents) (NNS groups)))))\n",
      "    (, ,)\n",
      "    (NP (NN arb) (NN therapy))\n",
      "    (VP (VBD reduced)\n",
      "      (NP\n",
      "        (NP (DT the) (NN risk))\n",
      "        (PP (IN of)\n",
      "          (NP (NN heart) (NN failure) (NNS events))))\n",
      "      (PP (IN by)\n",
      "        (NP\n",
      "          (NP (CD 33) (NN %))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP\n",
      "                (ADJP\n",
      "                  (QP (CD rr) (CD 0.67)))\n",
      "                (, ,)\n",
      "                (ADJP (CD 95) (NN %))\n",
      "                (NN ci) (NN 0.47))\n",
      "              (PP (TO to)\n",
      "                (NP (CD 0.93))))\n",
      "            (-RRB- -RRB-))))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ similar) (NN decrement))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NN blood) (NN pressure))\n",
      "              (PP (IN in)\n",
      "                (NP (NN dialysis) (NNS patients))))))))\n",
      "    (. .)))\n",
      "\n",
      "case(placebo-3, compared-1)\n",
      "mwe(compared-1, with-2)\n",
      "advcl(reduced-12, placebo-3)\n",
      "cc(placebo-3, or-4)\n",
      "amod(groups-8, other-5)\n",
      "amod(groups-8, active-6)\n",
      "compound(groups-8, agents-7)\n",
      "conj:or(placebo-3, groups-8)\n",
      "advcl(reduced-12, groups-8)\n",
      "compound(therapy-11, arb-10)\n",
      "nsubj(reduced-12, therapy-11)\n",
      "root(ROOT-0, reduced-12)\n",
      "det(risk-14, the-13)\n",
      "dobj(reduced-12, risk-14)\n",
      "case(events-18, of-15)\n",
      "compound(events-18, heart-16)\n",
      "compound(events-18, failure-17)\n",
      "nmod:of(risk-14, events-18)\n",
      "case(%-21, by-19)\n",
      "nummod(%-21, 33-20)\n",
      "nmod:by(reduced-12, %-21)\n",
      "compound(0.67-24, rr-23)\n",
      "nummod(0.47-29, 0.67-24)\n",
      "compound(%-27, 95-26)\n",
      "amod(0.47-29, %-27)\n",
      "compound(0.47-29, ci-28)\n",
      "dep(%-21, 0.47-29)\n",
      "case(0.93-31, to-30)\n",
      "nmod:to(0.47-29, 0.93-31)\n",
      "case(decrement-35, with-33)\n",
      "amod(decrement-35, similar-34)\n",
      "nmod:with(reduced-12, decrement-35)\n",
      "case(pressure-38, in-36)\n",
      "compound(pressure-38, blood-37)\n",
      "nmod:in(decrement-35, pressure-38)\n",
      "case(patients-41, in-39)\n",
      "compound(patients-41, dialysis-40)\n",
      "nmod:in(pressure-38, patients-41)\n",
      "\n",
      "Parsing [sent. 145 len. 20]: indirect comparison suggested that fewer cardiovascular events happened during treatment with arb -LRB- 0.77 , 0.63 to 0.94 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ indirect) (NN comparison))\n",
      "    (VP (VBD suggested)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (JJR fewer) (JJ cardiovascular) (NNS events))\n",
      "          (VP (VBD happened)\n",
      "            (PP (IN during)\n",
      "              (NP (NN treatment)))\n",
      "            (PP (IN with)\n",
      "              (NP (NN arb)))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (CD 0.77))\n",
      "                (, ,)\n",
      "                (NP (CD 0.63) (TO to) (CD 0.94)))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "amod(comparison-2, indirect-1)\n",
      "nsubj(suggested-3, comparison-2)\n",
      "root(ROOT-0, suggested-3)\n",
      "mark(happened-8, that-4)\n",
      "amod(events-7, fewer-5)\n",
      "amod(events-7, cardiovascular-6)\n",
      "nsubj(happened-8, events-7)\n",
      "ccomp(suggested-3, happened-8)\n",
      "case(treatment-10, during-9)\n",
      "nmod:during(happened-8, treatment-10)\n",
      "case(arb-12, with-11)\n",
      "nmod:with(happened-8, arb-12)\n",
      "dep(happened-8, 0.77-14)\n",
      "nummod(0.94-18, 0.63-16)\n",
      "dep(0.94-18, to-17)\n",
      "appos(0.77-14, 0.94-18)\n",
      "\n",
      "Parsing [sent. 146 len. 55]: the results indicated no significant differences between the two treatment regimens with regard to frequency of myocardial infarction -LRB- 1.0 , 0.45 to 2.22 -RRB- , stroke -LRB- 1.16 , 0.69 to 1.96 -RRB- , cardiovascular death -LRB- 0.89 , 0.64 to 1.26 -RRB- and all-cause mortality -LRB- 0.94 , 0.75 to 1.17 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNS results))\n",
      "    (VP (VBD indicated)\n",
      "      (NP\n",
      "        (NP (DT no) (JJ significant) (NNS differences))\n",
      "        (PP (IN between)\n",
      "          (NP (DT the) (CD two) (NN treatment) (NNS regimens))))\n",
      "      (PP (IN with)\n",
      "        (NP (NN regard)))\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (NN frequency))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (JJ myocardial) (NN infarction))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 1.0))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.45) (TO to) (CD 2.22)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN stroke))\n",
      "                (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (CD 1.16))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (QP (CD 0.69) (TO to) (CD 1.96))))\n",
      "                (-RRB- -RRB-))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (JJ cardiovascular) (NN death))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (NNP 0.89))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.64) (TO to) (CD 1.26)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (JJ all-cause) (NN mortality))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (NP (CD 0.94))\n",
      "                    (, ,)\n",
      "                    (NP (CD 0.75) (TO to) (CD 1.17)))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "det(results-2, the-1)\n",
      "nsubj(indicated-3, results-2)\n",
      "root(ROOT-0, indicated-3)\n",
      "neg(differences-6, no-4)\n",
      "amod(differences-6, significant-5)\n",
      "dobj(indicated-3, differences-6)\n",
      "case(regimens-11, between-7)\n",
      "det(regimens-11, the-8)\n",
      "nummod(regimens-11, two-9)\n",
      "compound(regimens-11, treatment-10)\n",
      "nmod:between(differences-6, regimens-11)\n",
      "case(regard-13, with-12)\n",
      "nmod:with(indicated-3, regard-13)\n",
      "case(frequency-15, to-14)\n",
      "nmod:to(indicated-3, frequency-15)\n",
      "case(infarction-18, of-16)\n",
      "amod(infarction-18, myocardial-17)\n",
      "nmod:of(frequency-15, infarction-18)\n",
      "dep(infarction-18, 1.0-20)\n",
      "nummod(2.22-24, 0.45-22)\n",
      "dep(2.22-24, to-23)\n",
      "appos(1.0-20, 2.22-24)\n",
      "nmod:of(frequency-15, stroke-27)\n",
      "conj:and(infarction-18, stroke-27)\n",
      "dep(stroke-27, 1.16-29)\n",
      "compound(1.96-33, 0.69-31)\n",
      "dep(1.96-33, to-32)\n",
      "appos(1.16-29, 1.96-33)\n",
      "amod(death-37, cardiovascular-36)\n",
      "nmod:of(frequency-15, death-37)\n",
      "conj:and(infarction-18, death-37)\n",
      "dep(death-37, 0.89-39)\n",
      "nummod(1.26-43, 0.64-41)\n",
      "dep(1.26-43, to-42)\n",
      "appos(0.89-39, 1.26-43)\n",
      "cc(infarction-18, and-45)\n",
      "amod(mortality-47, all-cause-46)\n",
      "nmod:of(frequency-15, mortality-47)\n",
      "conj:and(infarction-18, mortality-47)\n",
      "dep(mortality-47, 0.94-49)\n",
      "nummod(1.17-53, 0.75-51)\n",
      "dep(1.17-53, to-52)\n",
      "appos(0.94-49, 1.17-53)\n",
      "\n",
      "Parsing [sent. 147 len. 60]: five studies reported the renoprotective effect and revealed that ACEI/arb therapy significantly slowed the rate of decline in both residual renal function -LRB- md 0.93 ml/min/1 .73 m -LRB- 2 -RRB- , 0.38 to 1.47 ml/min/1 .73 m -LRB- 2 -RRB- -RRB- and urine volume -LRB- md 167 ml , 95 % ci 21 ml to 357 ml -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (CD five) (NNS studies))\n",
      "    (VP\n",
      "      (VP (VBD reported)\n",
      "        (NP (DT the) (JJ renoprotective) (NN effect)))\n",
      "      (CC and)\n",
      "      (VP (VBD revealed)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP (NNP ACEI/arb) (NN therapy))\n",
      "            (ADVP (RB significantly))\n",
      "            (VP (VBD slowed)\n",
      "              (NP\n",
      "                (NP (DT the) (NN rate))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN decline))))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT both) (JJ residual) (JJ renal) (NN function))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NN md))\n",
      "                      (NP\n",
      "                        (NP (CD 0.93) (JJ ml/min/1) (CD .73) (NNS m))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 2))\n",
      "                          (-RRB- -RRB-))\n",
      "                        (, ,)\n",
      "                        (NP\n",
      "                          (NP\n",
      "                            (QP (CD 0.38) (TO to) (CD 1.47))\n",
      "                            (JJ ml/min/1) (CD .73) (NNS m))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (CD 2))\n",
      "                            (-RRB- -RRB-)))))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (CC and)\n",
      "                  (NP (NN urine) (NN volume))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (QP (CD md) (CD 167))\n",
      "                        (NNP ml) (, ,)\n",
      "                        (ADJP (CD 95) (NN %))\n",
      "                        (JJ ci) (CD 21) (NN ml))\n",
      "                      (PP (TO to)\n",
      "                        (NP (CD 357) (NN ml))))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "nummod(studies-2, five-1)\n",
      "nsubj(reported-3, studies-2)\n",
      "nsubj(revealed-8, studies-2)\n",
      "root(ROOT-0, reported-3)\n",
      "det(effect-6, the-4)\n",
      "amod(effect-6, renoprotective-5)\n",
      "dobj(reported-3, effect-6)\n",
      "cc(reported-3, and-7)\n",
      "conj:and(reported-3, revealed-8)\n",
      "mark(slowed-13, that-9)\n",
      "compound(therapy-11, ACEI/arb-10)\n",
      "nsubj(slowed-13, therapy-11)\n",
      "advmod(slowed-13, significantly-12)\n",
      "ccomp(revealed-8, slowed-13)\n",
      "det(rate-15, the-14)\n",
      "dobj(slowed-13, rate-15)\n",
      "case(decline-17, of-16)\n",
      "nmod:of(rate-15, decline-17)\n",
      "case(function-22, in-18)\n",
      "det(function-22, both-19)\n",
      "amod(function-22, residual-20)\n",
      "amod(function-22, renal-21)\n",
      "nmod:in(slowed-13, function-22)\n",
      "dep(function-22, md-24)\n",
      "nummod(m-28, 0.93-25)\n",
      "amod(m-28, ml/min/1-26)\n",
      "nummod(m-28, .73-27)\n",
      "dep(md-24, m-28)\n",
      "appos(m-28, 2-30)\n",
      "compound(1.47-35, 0.38-33)\n",
      "dep(1.47-35, to-34)\n",
      "nummod(m-38, 1.47-35)\n",
      "amod(m-38, ml/min/1-36)\n",
      "nummod(m-38, .73-37)\n",
      "appos(m-28, m-38)\n",
      "appos(m-38, 2-40)\n",
      "cc(function-22, and-43)\n",
      "compound(volume-45, urine-44)\n",
      "nmod:in(slowed-13, volume-45)\n",
      "conj:and(function-22, volume-45)\n",
      "compound(167-48, md-47)\n",
      "nummod(ml-55, 167-48)\n",
      "compound(ml-55, ml-49)\n",
      "compound(%-52, 95-51)\n",
      "amod(ml-55, %-52)\n",
      "amod(ml-55, ci-53)\n",
      "nummod(ml-55, 21-54)\n",
      "dep(function-22, ml-55)\n",
      "case(ml-58, to-56)\n",
      "nummod(ml-58, 357-57)\n",
      "nmod:to(ml-55, ml-58)\n",
      "\n",
      "Parsing [sent. 148 len. 13]: no difference in drug-related adverse events was observed in both treatment groups .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT no) (NN difference))\n",
      "      (PP (IN in)\n",
      "        (NP (JJ drug-related) (JJ adverse) (NNS events))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN in)\n",
      "          (NP (DT both) (NN treatment) (NNS groups)))))\n",
      "    (. .)))\n",
      "\n",
      "neg(difference-2, no-1)\n",
      "nsubjpass(observed-8, difference-2)\n",
      "case(events-6, in-3)\n",
      "amod(events-6, drug-related-4)\n",
      "amod(events-6, adverse-5)\n",
      "nmod:in(difference-2, events-6)\n",
      "auxpass(observed-8, was-7)\n",
      "root(ROOT-0, observed-8)\n",
      "case(groups-12, in-9)\n",
      "det(groups-12, both-10)\n",
      "compound(groups-12, treatment-11)\n",
      "nmod:in(observed-8, groups-12)\n",
      "\n",
      "Parsing [sent. 149 len. 32]: the role of ACEI and angiotensin receptor blockers -LRB- arbs -RRB- reducing risk of cardiovascular events -LRB- cves -RRB- and preserving kidney function in patients with chronic kidney disease is well-documented .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT the) (NN role))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NNP ACEI)\n",
      "              (CC and)\n",
      "              (NN angiotensin) (NN receptor) (NNS blockers))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNS arbs))\n",
      "              (-RRB- -RRB-)))\n",
      "          (VP\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP (NN risk))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (JJ cardiovascular) (NNS events))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NNS cves))\n",
      "                      (-RRB- -RRB-))))))\n",
      "            (CC and)\n",
      "            (VP (VBG preserving)\n",
      "              (NP (NN kidney) (NN function))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NNS patients))\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ chronic) (NN kidney) (NN disease))))))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ well-documented)))\n",
      "    (. .)))\n",
      "\n",
      "det(role-2, the-1)\n",
      "nsubj(well-documented-31, role-2)\n",
      "case(blockers-8, of-3)\n",
      "compound(blockers-8, ACEI-4)\n",
      "cc(ACEI-4, and-5)\n",
      "conj:and(ACEI-4, angiotensin-6)\n",
      "compound(blockers-8, angiotensin-6)\n",
      "compound(blockers-8, receptor-7)\n",
      "nmod:of(role-2, blockers-8)\n",
      "appos(blockers-8, arbs-10)\n",
      "dep(blockers-8, reducing-12)\n",
      "dobj(reducing-12, risk-13)\n",
      "case(events-16, of-14)\n",
      "amod(events-16, cardiovascular-15)\n",
      "nmod:of(risk-13, events-16)\n",
      "appos(events-16, cves-18)\n",
      "cc(reducing-12, and-20)\n",
      "dep(blockers-8, preserving-21)\n",
      "conj:and(reducing-12, preserving-21)\n",
      "compound(function-23, kidney-22)\n",
      "dobj(preserving-21, function-23)\n",
      "case(patients-25, in-24)\n",
      "nmod:in(preserving-21, patients-25)\n",
      "case(disease-29, with-26)\n",
      "amod(disease-29, chronic-27)\n",
      "compound(disease-29, kidney-28)\n",
      "nmod:with(patients-25, disease-29)\n",
      "cop(well-documented-31, is-30)\n",
      "root(ROOT-0, well-documented-31)\n",
      "\n",
      "Parsing [sent. 150 len. 18]: however , the efficacy and safety of these agents in dialysis patients is still a controversial issue .\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB however))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN efficacy)\n",
      "        (CC and)\n",
      "        (NN safety))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT these) (NNS agents))\n",
      "          (PP (IN in)\n",
      "            (NP (NN dialysis) (NNS patients))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADVP (RB still))\n",
      "      (NP (DT a) (JJ controversial) (NN issue)))\n",
      "    (. .)))\n",
      "\n",
      "advmod(issue-17, however-1)\n",
      "det(efficacy-4, the-3)\n",
      "nsubj(issue-17, efficacy-4)\n",
      "cc(efficacy-4, and-5)\n",
      "conj:and(efficacy-4, safety-6)\n",
      "nsubj(issue-17, safety-6)\n",
      "case(agents-9, of-7)\n",
      "det(agents-9, these-8)\n",
      "nmod:of(efficacy-4, agents-9)\n",
      "case(patients-12, in-10)\n",
      "compound(patients-12, dialysis-11)\n",
      "nmod:in(agents-9, patients-12)\n",
      "cop(issue-17, is-13)\n",
      "advmod(issue-17, still-14)\n",
      "det(issue-17, a-15)\n",
      "amod(issue-17, controversial-16)\n",
      "root(ROOT-0, issue-17)\n",
      "\n",
      "Parsing [sent. 151 len. 56]: mex and aceimex groups improved all physical functional status outcomes , decreased systolic -LRB- sbp -RRB- and diastolic blood pressure -LRB- p < 0.001 -RRB- and augmented the physical functioning , role physical and physical component score -LRB- pcs -RRB- -LRB- p < 0.05 -RRB- , but also bodily pain -LRB- p < 0.05 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN mex)\n",
      "      (CC and)\n",
      "      (NN aceimex) (NNS groups))\n",
      "    (VP\n",
      "      (VP (VBD improved)\n",
      "        (NP (DT all)\n",
      "          (ADJP (JJ physical) (JJ functional))\n",
      "          (NN status) (NNS outcomes)))\n",
      "      (, ,)\n",
      "      (VP (VBD decreased)\n",
      "        (NP\n",
      "          (NP (JJ systolic) (-LRB- -LRB-) (NN sbp) (-RRB- -RRB-))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (JJ diastolic) (NN blood) (NN pressure))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p)\n",
      "                (QP (CD <) (CD 0.001)))\n",
      "              (-RRB- -RRB-)))))\n",
      "      (CC and)\n",
      "      (VP (VBD augmented)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (JJ physical) (NN functioning))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NN role) (JJ physical)\n",
      "                  (CC and)\n",
      "                  (JJ physical) (NN component) (NN score))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN pcs))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN p)\n",
      "                  (NP (CD <) (CD 0.05)))\n",
      "                (-RRB- -RRB-))))\n",
      "          (, ,)\n",
      "          (CONJP (CC but)\n",
      "            (RB also))\n",
      "          (NP\n",
      "            (NP (JJ bodily) (NN pain))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p) (NNP <) (NNP 0.05))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "compound(groups-4, mex-1)\n",
      "cc(mex-1, and-2)\n",
      "conj:and(mex-1, aceimex-3)\n",
      "compound(groups-4, aceimex-3)\n",
      "nsubj(improved-5, groups-4)\n",
      "nsubj(decreased-12, groups-4)\n",
      "nsubj(augmented-27, groups-4)\n",
      "root(ROOT-0, improved-5)\n",
      "det(outcomes-10, all-6)\n",
      "amod(functional-8, physical-7)\n",
      "amod(outcomes-10, functional-8)\n",
      "compound(outcomes-10, status-9)\n",
      "dobj(improved-5, outcomes-10)\n",
      "conj:and(improved-5, decreased-12)\n",
      "amod(sbp-15, systolic-13)\n",
      "dobj(decreased-12, sbp-15)\n",
      "cc(sbp-15, and-17)\n",
      "amod(pressure-20, diastolic-18)\n",
      "compound(pressure-20, blood-19)\n",
      "dobj(decreased-12, pressure-20)\n",
      "conj:and(sbp-15, pressure-20)\n",
      "appos(pressure-20, p-22)\n",
      "compound(0.001-24, <-23)\n",
      "nummod(p-22, 0.001-24)\n",
      "cc(improved-5, and-26)\n",
      "conj:and(improved-5, augmented-27)\n",
      "det(functioning-30, the-28)\n",
      "amod(functioning-30, physical-29)\n",
      "dobj(augmented-27, functioning-30)\n",
      "nmod:npmod(physical-33, role-32)\n",
      "appos(functioning-30, physical-33)\n",
      "cc(physical-33, and-34)\n",
      "amod(score-37, physical-35)\n",
      "compound(score-37, component-36)\n",
      "appos(functioning-30, score-37)\n",
      "conj:and(physical-33, score-37)\n",
      "appos(physical-33, pcs-39)\n",
      "dep(physical-33, p-42)\n",
      "nummod(0.05-44, <-43)\n",
      "dobj(p-42, 0.05-44)\n",
      "cc(functioning-30, but-47)\n",
      "advmod(pain-50, also-48)\n",
      "amod(pain-50, bodily-49)\n",
      "dobj(augmented-27, pain-50)\n",
      "conj:and(functioning-30, pain-50)\n",
      "compound(0.05-54, p-52)\n",
      "compound(0.05-54, <-53)\n",
      "appos(pain-50, 0.05-54)\n",
      "\n",
      "Parsing [sent. 152 len. 48]: the ACEI group reduced the upper body strength , upper and lower body flexibility and aerobic endurance -LRB- p < 0.05 -RRB- ; worsened the anthropometric profile , and sbp -LRB- p < 0.001 -RRB- ; and decreased general health and pcs -LRB- p < 0.05 -RRB- .\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT the) (NNP ACEI) (NN group))\n",
      "    (VP (VBD reduced)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (DT the) (JJ upper) (NN body) (NN strength))\n",
      "          (, ,)\n",
      "          (NP (JJ upper))\n",
      "          (CC and)\n",
      "          (NP (JJR lower) (NN body) (NN flexibility)))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ aerobic) (NNS endurance))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (: ;)\n",
      "        (NP\n",
      "          (NP\n",
      "            (ADVP (RB worsened))\n",
      "            (DT the) (JJ anthropometric) (NN profile))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (NN sbp))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NNP p)\n",
      "                (QP (CD <) (CD 0.001)))\n",
      "              (-RRB- -RRB-))))\n",
      "        (: ;)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (VBN decreased) (JJ general) (NN health))\n",
      "            (CC and)\n",
      "            (NP (NN pcs)))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (VP (VBN p)\n",
      "              (NP (CD <) (CD 0.05)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "det(group-3, the-1)\n",
      "compound(group-3, ACEI-2)\n",
      "nsubj(reduced-4, group-3)\n",
      "root(ROOT-0, reduced-4)\n",
      "det(strength-8, the-5)\n",
      "amod(strength-8, upper-6)\n",
      "compound(strength-8, body-7)\n",
      "dobj(reduced-4, strength-8)\n",
      "dobj(reduced-4, upper-10)\n",
      "conj:and(strength-8, upper-10)\n",
      "cc(strength-8, and-11)\n",
      "amod(flexibility-14, lower-12)\n",
      "compound(flexibility-14, body-13)\n",
      "dobj(reduced-4, flexibility-14)\n",
      "conj:and(strength-8, flexibility-14)\n",
      "cc(strength-8, and-15)\n",
      "amod(endurance-17, aerobic-16)\n",
      "dobj(reduced-4, endurance-17)\n",
      "conj:and(strength-8, endurance-17)\n",
      "dep(endurance-17, p-19)\n",
      "nummod(0.05-21, <-20)\n",
      "dobj(p-19, 0.05-21)\n",
      "advmod(profile-27, worsened-24)\n",
      "det(profile-27, the-25)\n",
      "amod(profile-27, anthropometric-26)\n",
      "dobj(reduced-4, profile-27)\n",
      "conj:and(strength-8, profile-27)\n",
      "cc(profile-27, and-29)\n",
      "conj:and(strength-8, sbp-30)\n",
      "conj:and(profile-27, sbp-30)\n",
      "appos(sbp-30, p-32)\n",
      "compound(0.001-34, <-33)\n",
      "nummod(p-32, 0.001-34)\n",
      "cc(strength-8, and-37)\n",
      "amod(health-40, decreased-38)\n",
      "amod(health-40, general-39)\n",
      "dobj(reduced-4, health-40)\n",
      "conj:and(strength-8, health-40)\n",
      "cc(health-40, and-41)\n",
      "conj:and(strength-8, pcs-42)\n",
      "conj:and(health-40, pcs-42)\n",
      "dep(health-40, p-44)\n",
      "nummod(0.05-46, <-45)\n",
      "dobj(p-44, 0.05-46)\n",
      "\n",
      "Parsed file: KeywordSentences.txt [152 sentences].\n",
      "Parsed 4222 words in 152 sentences (44.44 wds/sec; 1.60 sents/sec).\n",
      "1 loop, best of 3: 1min 27s per loop\n"
     ]
    }
   ],
   "source": [
    "%%timeit\n",
    "! ./lexparser.sh  KeywordSentences.txt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Testing with RNN Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "#!/usr/bin/env bash\r\n",
      "#\r\n",
      "# Runs the English PCFG parser on one or more files, printing trees only\r\n",
      "\r\n",
      "if [ ! $# -ge 1 ]; then\r\n",
      "  echo Usage: `basename $0` 'file(s)'\r\n",
      "  echo\r\n",
      "  exit\r\n",
      "fi\r\n",
      "\r\n",
      "scriptdir=`dirname $0`\r\n",
      "\r\n",
      "java -mx500m -cp \"$scriptdir/*:\" edu.stanford.nlp.parser.lexparser.LexicalizedParser \\\r\n",
      " -outputFormat \"penn,typedDependencies\" edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz $*\r\n"
     ]
    }
   ],
   "source": [
    "!cat ./lexparser_rnn.sh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsed file: KeywordSentences.txt [0 sentences].\n",
      "Parsed 0 words in 0 sentences (0.00 wds/sec; 0.00 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsed file: KeywordSentences.txt [0 sentences].\n",
      "Parsed 0 words in 0 sentences (0.00 wds/sec; 0.00 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsed file: KeywordSentences.txt [0 sentences].\n",
      "Parsed 0 words in 0 sentences (0.00 wds/sec; 0.00 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsed file: KeywordSentences.txt [0 sentences].\n",
      "Parsed 0 words in 0 sentences (0.00 wds/sec; 0.00 sents/sec).\n",
      "1 loop, best of 3: 989 ms per loop\n"
     ]
    }
   ],
   "source": [
    "%%timeit\n",
    "! ./lexparser_rnn.sh  KeywordSentences.txt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Test with Caseless PCFG  Model"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "#!/usr/bin/env bash\r\n",
      "#\r\n",
      "# Runs the English PCFG parser on one or more files, printing trees only\r\n",
      "\r\n",
      "if [ ! $# -ge 1 ]; then\r\n",
      "  echo Usage: `basename $0` 'file(s)'\r\n",
      "  echo\r\n",
      "  exit\r\n",
      "fi\r\n",
      "\r\n",
      "scriptdir=`dirname $0`\r\n",
      "\r\n",
      "java -mx500m -cp \"$scriptdir/*:\" edu.stanford.nlp.parser.lexparser.LexicalizedParser \\\r\n",
      " -outputFormat \"penn,typedDependencies\" edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz $*\r\n"
     ]
    }
   ],
   "source": [
    "!cat ./lexparser_caseless.sh"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": false,
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsed file: KeywordSentences.txt [0 sentences].\n",
      "Parsed 0 words in 0 sentences (0.00 wds/sec; 0.00 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsed file: KeywordSentences.txt [0 sentences].\n",
      "Parsed 0 words in 0 sentences (0.00 wds/sec; 0.00 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz ... done [0.6 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsed file: KeywordSentences.txt [0 sentences].\n",
      "Parsed 0 words in 0 sentences (0.00 wds/sec; 0.00 sents/sec).\n",
      "[main] INFO edu.stanford.nlp.parser.lexparser.LexicalizedParser - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.caseless.ser.gz ... done [0.5 sec].\n",
      "Parsing file: KeywordSentences.txt\n",
      "Parsed file: KeywordSentences.txt [0 sentences].\n",
      "Parsed 0 words in 0 sentences (0.00 wds/sec; 0.00 sents/sec).\n",
      "1 loop, best of 3: 1.03 s per loop\n"
     ]
    }
   ],
   "source": [
    "%%timeit\n",
    "! ./lexparser_caseless.sh  KeywordSentences.txt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Command Line Sentiment Analysis\n",
    "\n",
    "This creates an output file with tuples and sentiments! We can modify which annotators we use. I think maybe just the sentiment and the ner is all we need."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator tokenize\n",
      "[main] INFO edu.stanford.nlp.pipeline.TokenizerAnnotator - No tokenizer type provided. Defaulting to PTBTokenizer.\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator ssplit\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator pos\n",
      "[main] INFO edu.stanford.nlp.tagger.maxent.MaxentTagger - Loading POS tagger from edu/stanford/nlp/models/pos-tagger/english-left3words/english-left3words-distsim.tagger ... done [0.8 sec].\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator lemma\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator ner\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.all.3class.distsim.crf.ser.gz ... done [2.2 sec].\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.muc.7class.distsim.crf.ser.gz ... done [1.3 sec].\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.conll.4class.distsim.crf.ser.gz ... done [0.6 sec].\n",
      "[main] INFO edu.stanford.nlp.time.JollyDayHolidays - Initializing JollyDayHoliday for SUTime from classpath edu/stanford/nlp/models/sutime/jollyday/Holidays_sutime.xml as sutime.binder.1.\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator parse\n",
      "[main] INFO edu.stanford.nlp.parser.common.ParserGrammar - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.6 sec].\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator dcoref\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator sentiment\n",
      "\n",
      "Processing file /home/adam/Documents/MIDS/W266/Project/parsing/KeywordSentences.txt ... writing to /home/adam/Documents/MIDS/W266/Project/parsing/KeywordSentences.txt.out\n",
      "Annotating file /home/adam/Documents/MIDS/W266/Project/parsing/KeywordSentences.txt ... done [0.1 sec].\n",
      "\n",
      "Annotation pipeline timing information:\n",
      "TokenizerAnnotator: 0.1 sec.\n",
      "WordsToSentencesAnnotator: 0.0 sec.\n",
      "POSTaggerAnnotator: 0.0 sec.\n",
      "MorphaAnnotator: 0.0 sec.\n",
      "NERCombinerAnnotator: 0.0 sec.\n",
      "ParserAnnotator: 0.0 sec.\n",
      "DeterministicCorefAnnotator: 0.0 sec.\n",
      "SentimentAnnotator: 0.0 sec.\n",
      "TOTAL: 0.1 sec. for 0 tokens at 0.0 tokens/sec.\n",
      "Pipeline setup: 7.5 sec.\n",
      "Total time for StanfordCoreNLP pipeline: 7.6 sec.\n"
     ]
    }
   ],
   "source": [
    "!java -cp \"*\" -Xmx2g edu.stanford.nlp.pipeline.StanfordCoreNLP -annotators tokenize,ssplit,pos,lemma,ner,parse,dcoref,sentiment -file KeywordSentences.txt -outputFormat text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "!cat *.out >> output_file.json"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "!cat output_file.json"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Sentences of note:\n",
    "\n",
    "`Plasma concentrations of AII were significantly decreased by captopril and increased by losartan`.\n",
    "`nmod:of(concentrations-2, AII-4)`\n",
    "`nmod:agent(decreased-7, captopril-9)`\n",
    "`nmod:by(increased-11, losartan-13)`\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "## Experimenting with Selected Abstracts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 161,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "#From <https://www.ncbi.nlm.nih.gov/pubmed/28656517>\n",
    "\n",
    "!echo \"Renin-angiotensin-aldosterone system (RAAS) antagonists, including angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and mineralocorticoid receptor antagonists (MRA) decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia, especially when used in combination. Prevention of hyperkalemia and its associated complications requires careful patient selection, counseling regarding dietary potassium intake, awareness of drug interactions, and regular laboratory surveillance. Recent data suggests that the risk of hyperkalemia may be further moderated through the use of combined angiotensin-neprilysin inhibitors, novel MRAs, and novel potassium binding agents. Clinicians should be mindful of the risk of hyperkalemia when prescribing RAAS inhibitors to patients with heart failure. In patients at highest risk, such as those with diabetes, the elderly, and advanced chronic kidney disease, more intensive laboratory surveillance of potassium and creatinine may be required. Novel therapies hold promise for reducing the risk of hyperkalemia and enhancing the tolerability of RAAS antagonists.\" > sample_abstract.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 162,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Renin-angiotensin-aldosterone system (RAAS) antagonists, including angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and mineralocorticoid receptor antagonists (MRA) decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia, especially when used in combination. Prevention of hyperkalemia and its associated complications requires careful patient selection, counseling regarding dietary potassium intake, awareness of drug interactions, and regular laboratory surveillance. Recent data suggests that the risk of hyperkalemia may be further moderated through the use of combined angiotensin-neprilysin inhibitors, novel MRAs, and novel potassium binding agents. Clinicians should be mindful of the risk of hyperkalemia when prescribing RAAS inhibitors to patients with heart failure. In patients at highest risk, such as those with diabetes, the elderly, and advanced chronic kidney disease, more intensive laboratory surveillance of potassium and creatinine may be required. Novel therapies hold promise for reducing the risk of hyperkalemia and enhancing the tolerability of RAAS antagonists.\r\n"
     ]
    }
   ],
   "source": [
    "!head sample_abstract.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 163,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator tokenize\n",
      "[main] INFO edu.stanford.nlp.pipeline.TokenizerAnnotator - No tokenizer type provided. Defaulting to PTBTokenizer.\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator ssplit\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator pos\n",
      "[main] INFO edu.stanford.nlp.tagger.maxent.MaxentTagger - Loading POS tagger from edu/stanford/nlp/models/pos-tagger/english-left3words/english-left3words-distsim.tagger ... done [1.4 sec].\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator lemma\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator ner\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.all.3class.distsim.crf.ser.gz ... done [2.2 sec].\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.muc.7class.distsim.crf.ser.gz ... done [1.8 sec].\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.conll.4class.distsim.crf.ser.gz ... done [0.8 sec].\n",
      "[main] INFO edu.stanford.nlp.time.JollyDayHolidays - Initializing JollyDayHoliday for SUTime from classpath edu/stanford/nlp/models/sutime/jollyday/Holidays_sutime.xml as sutime.binder.1.\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator parse\n",
      "[main] INFO edu.stanford.nlp.parser.common.ParserGrammar - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.4 sec].\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator dcoref\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator sentiment\n",
      "\n",
      "Processing file /Users/lisabarcelo/Desktop/W266/food_drug_interaction/drafts/sample_abstract.txt ... writing to /Users/lisabarcelo/Desktop/W266/food_drug_interaction/drafts/sample_abstract.txt.out\n",
      "Annotating file /Users/lisabarcelo/Desktop/W266/food_drug_interaction/drafts/sample_abstract.txt ... done [6.7 sec].\n",
      "\n",
      "Annotation pipeline timing information:\n",
      "TokenizerAnnotator: 0.2 sec.\n",
      "WordsToSentencesAnnotator: 0.0 sec.\n",
      "POSTaggerAnnotator: 0.1 sec.\n",
      "MorphaAnnotator: 0.1 sec.\n",
      "NERCombinerAnnotator: 0.7 sec.\n",
      "ParserAnnotator: 5.1 sec.\n",
      "DeterministicCorefAnnotator: 0.3 sec.\n",
      "SentimentAnnotator: 0.2 sec.\n",
      "TOTAL: 6.7 sec. for 176 tokens at 26.4 tokens/sec.\n",
      "Pipeline setup: 11.5 sec.\n",
      "Total time for StanfordCoreNLP pipeline: 18.3 sec.\n"
     ]
    }
   ],
   "source": [
    "!java -cp \"*\" -Xmx2g edu.stanford.nlp.pipeline.StanfordCoreNLP -annotators tokenize,ssplit,pos,lemma,ner,parse,dcoref,sentiment -file sample_abstract.txt -outputFormat text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sentence #1 (49 tokens, sentiment: Very negative):\r\n",
      "Renin-angiotensin-aldosterone system (RAAS) antagonists, including angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), and mineralocorticoid receptor antagonists (MRA) decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia, especially when used in combination.\r\n",
      "[Text=Renin-angiotensin-aldosterone CharacterOffsetBegin=0 CharacterOffsetEnd=29 PartOfSpeech=NN Lemma=renin-angiotensin-aldosterone NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=system CharacterOffsetBegin=30 CharacterOffsetEnd=36 PartOfSpeech=NN Lemma=system NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=-LRB- CharacterOffsetBegin=37 CharacterOffsetEnd=38 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=RAAS CharacterOffsetBegin=38 CharacterOffsetEnd=42 PartOfSpeech=NN Lemma=raas NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=-RRB- CharacterOffsetBegin=42 CharacterOffsetEnd=43 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=antagonists CharacterOffsetBegin=44 CharacterOffsetEnd=55 PartOfSpeech=NNS Lemma=antagonist NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=55 CharacterOffsetEnd=56 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=including CharacterOffsetBegin=57 CharacterOffsetEnd=66 PartOfSpeech=VBG Lemma=include NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=angiotensin-converting CharacterOffsetBegin=67 CharacterOffsetEnd=89 PartOfSpeech=JJ Lemma=angiotensin-converting NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=enzyme CharacterOffsetBegin=90 CharacterOffsetEnd=96 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=inhibitors CharacterOffsetBegin=97 CharacterOffsetEnd=107 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=-LRB- CharacterOffsetBegin=108 CharacterOffsetEnd=109 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=ACEI CharacterOffsetBegin=109 CharacterOffsetEnd=113 PartOfSpeech=NN Lemma=acei NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=-RRB- CharacterOffsetBegin=113 CharacterOffsetEnd=114 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=114 CharacterOffsetEnd=115 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=angiotensin CharacterOffsetBegin=116 CharacterOffsetEnd=127 PartOfSpeech=NN Lemma=angiotensin NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=receptor CharacterOffsetBegin=128 CharacterOffsetEnd=136 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=blockers CharacterOffsetBegin=137 CharacterOffsetEnd=145 PartOfSpeech=NNS Lemma=blocker NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=-LRB- CharacterOffsetBegin=146 CharacterOffsetEnd=147 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=ARB CharacterOffsetBegin=147 CharacterOffsetEnd=150 PartOfSpeech=NN Lemma=arb NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=-RRB- CharacterOffsetBegin=150 CharacterOffsetEnd=151 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=151 CharacterOffsetEnd=152 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=and CharacterOffsetBegin=153 CharacterOffsetEnd=156 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=mineralocorticoid CharacterOffsetBegin=157 CharacterOffsetEnd=174 PartOfSpeech=NN Lemma=mineralocorticoid NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=receptor CharacterOffsetBegin=175 CharacterOffsetEnd=183 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=antagonists CharacterOffsetBegin=184 CharacterOffsetEnd=195 PartOfSpeech=NNS Lemma=antagonist NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=-LRB- CharacterOffsetBegin=196 CharacterOffsetEnd=197 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=MRA CharacterOffsetBegin=197 CharacterOffsetEnd=200 PartOfSpeech=NN Lemma=mra NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\r\n",
      "[Text=-RRB- CharacterOffsetBegin=200 CharacterOffsetEnd=201 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=decrease CharacterOffsetBegin=202 CharacterOffsetEnd=210 PartOfSpeech=NN Lemma=decrease NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=mortality CharacterOffsetBegin=211 CharacterOffsetEnd=220 PartOfSpeech=NN Lemma=mortality NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=and CharacterOffsetBegin=221 CharacterOffsetEnd=224 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=morbidity CharacterOffsetBegin=225 CharacterOffsetEnd=234 PartOfSpeech=NN Lemma=morbidity NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=in CharacterOffsetBegin=235 CharacterOffsetEnd=237 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=heart CharacterOffsetBegin=238 CharacterOffsetEnd=243 PartOfSpeech=NN Lemma=heart NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=failure CharacterOffsetBegin=244 CharacterOffsetEnd=251 PartOfSpeech=NN Lemma=failure NamedEntityTag=O SentimentClass=Very negative]\r\n",
      "[Text=but CharacterOffsetBegin=252 CharacterOffsetEnd=255 PartOfSpeech=CC Lemma=but NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=increase CharacterOffsetBegin=256 CharacterOffsetEnd=264 PartOfSpeech=VBP Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=the CharacterOffsetBegin=265 CharacterOffsetEnd=268 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=risk CharacterOffsetBegin=269 CharacterOffsetEnd=273 PartOfSpeech=NN Lemma=risk NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=274 CharacterOffsetEnd=276 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=hyperkalemia CharacterOffsetBegin=277 CharacterOffsetEnd=289 PartOfSpeech=NN Lemma=hyperkalemia NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=289 CharacterOffsetEnd=290 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=especially CharacterOffsetBegin=291 CharacterOffsetEnd=301 PartOfSpeech=RB Lemma=especially NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=when CharacterOffsetBegin=302 CharacterOffsetEnd=306 PartOfSpeech=WRB Lemma=when NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=used CharacterOffsetBegin=307 CharacterOffsetEnd=311 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=in CharacterOffsetBegin=312 CharacterOffsetEnd=314 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=combination CharacterOffsetBegin=315 CharacterOffsetEnd=326 PartOfSpeech=NN Lemma=combination NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=. CharacterOffsetBegin=326 CharacterOffsetEnd=327 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "(ROOT\r\n",
      "  (NP\r\n",
      "    (NP\r\n",
      "      (NP (NN Renin-angiotensin-aldosterone) (NN system))\r\n",
      "      (PRN (-LRB- -LRB-)\r\n",
      "        (NP (NN RAAS))\r\n",
      "        (-RRB- -RRB-)))\r\n",
      "    (NP\r\n",
      "      (NP\r\n",
      "        (NP\r\n",
      "          (NP (NNS antagonists))\r\n",
      "          (, ,)\r\n",
      "          (PP (VBG including)\r\n",
      "            (NP (JJ angiotensin-converting) (NN enzyme) (NNS inhibitors))))\r\n",
      "        (PRN (-LRB- -LRB-)\r\n",
      "          (NP (NN ACEI))\r\n",
      "          (-RRB- -RRB-)))\r\n",
      "      (, ,)\r\n",
      "      (NP\r\n",
      "        (NP (NN angiotensin) (NN receptor) (NNS blockers))\r\n",
      "        (PRN (-LRB- -LRB-)\r\n",
      "          (NP (NN ARB))\r\n",
      "          (-RRB- -RRB-)))\r\n",
      "      (, ,)\r\n",
      "      (CC and)\r\n",
      "      (NP\r\n",
      "        (NP (NN mineralocorticoid) (NN receptor) (NNS antagonists))\r\n",
      "        (PRN (-LRB- -LRB-)\r\n",
      "          (NP (NN MRA))\r\n",
      "          (-RRB- -RRB-))\r\n",
      "        (SBAR\r\n",
      "          (S\r\n",
      "            (NP\r\n",
      "              (NP (NN decrease) (NN mortality)\r\n",
      "                (CC and)\r\n",
      "                (NN morbidity))\r\n",
      "              (PP (IN in)\r\n",
      "                (NP (NN heart) (NN failure))))\r\n",
      "            (ADVP (CC but))\r\n",
      "            (VP (VBP increase)\r\n",
      "              (NP\r\n",
      "                (NP (DT the) (NN risk))\r\n",
      "                (PP (IN of)\r\n",
      "                  (NP (NN hyperkalemia))))\r\n",
      "              (, ,)\r\n",
      "              (SBAR\r\n",
      "                (WHADVP (RB especially) (WRB when))\r\n",
      "                (S\r\n",
      "                  (VP (VBN used)\r\n",
      "                    (PP (IN in)\r\n",
      "                      (NP (NN combination)))))))))))\r\n",
      "    (. .)))\r\n",
      "\r\n",
      "root(ROOT-0, system-2)\r\n",
      "compound(system-2, Renin-angiotensin-aldosterone-1)\r\n",
      "punct(RAAS-4, -LRB--3)\r\n",
      "appos(system-2, RAAS-4)\r\n",
      "punct(RAAS-4, -RRB--5)\r\n",
      "dep(system-2, antagonists-6)\r\n",
      "punct(antagonists-6, ,-7)\r\n",
      "case(inhibitors-11, including-8)\r\n",
      "amod(inhibitors-11, angiotensin-converting-9)\r\n",
      "compound(inhibitors-11, enzyme-10)\r\n",
      "nmod:including(antagonists-6, inhibitors-11)\r\n",
      "punct(ACEI-13, -LRB--12)\r\n",
      "appos(antagonists-6, ACEI-13)\r\n",
      "punct(ACEI-13, -RRB--14)\r\n",
      "punct(antagonists-6, ,-15)\r\n",
      "compound(blockers-18, angiotensin-16)\r\n",
      "compound(blockers-18, receptor-17)\r\n",
      "dep(system-2, blockers-18)\r\n",
      "conj:and(antagonists-6, blockers-18)\r\n",
      "punct(ARB-20, -LRB--19)\r\n",
      "appos(blockers-18, ARB-20)\r\n",
      "punct(ARB-20, -RRB--21)\r\n",
      "punct(antagonists-6, ,-22)\r\n",
      "cc(antagonists-6, and-23)\r\n",
      "compound(antagonists-26, mineralocorticoid-24)\r\n",
      "compound(antagonists-26, receptor-25)\r\n",
      "dep(system-2, antagonists-26)\r\n",
      "conj:and(antagonists-6, antagonists-26)\r\n",
      "punct(MRA-28, -LRB--27)\r\n",
      "appos(antagonists-26, MRA-28)\r\n",
      "punct(MRA-28, -RRB--29)\r\n",
      "compound(mortality-31, decrease-30)\r\n",
      "nsubj(increase-38, mortality-31)\r\n",
      "cc(mortality-31, and-32)\r\n",
      "conj:and(mortality-31, morbidity-33)\r\n",
      "nsubj(increase-38, morbidity-33)\r\n",
      "case(failure-36, in-34)\r\n",
      "compound(failure-36, heart-35)\r\n",
      "nmod:in(mortality-31, failure-36)\r\n",
      "advmod(increase-38, but-37)\r\n",
      "acl:relcl(antagonists-26, increase-38)\r\n",
      "det(risk-40, the-39)\r\n",
      "dobj(increase-38, risk-40)\r\n",
      "case(hyperkalemia-42, of-41)\r\n",
      "nmod:of(risk-40, hyperkalemia-42)\r\n",
      "punct(increase-38, ,-43)\r\n",
      "advmod(when-45, especially-44)\r\n",
      "advmod(used-46, when-45)\r\n",
      "advcl(increase-38, used-46)\r\n",
      "case(combination-48, in-47)\r\n",
      "nmod:in(used-46, combination-48)\r\n",
      "punct(system-2, .-49)\r\n",
      "\r\n",
      "Sentence #2 (28 tokens, sentiment: Negative):\r\n",
      "Prevention of hyperkalemia and its associated complications requires careful patient selection, counseling regarding dietary potassium intake, awareness of drug interactions, and regular laboratory surveillance.\r\n",
      "[Text=Prevention CharacterOffsetBegin=328 CharacterOffsetEnd=338 PartOfSpeech=NNP Lemma=Prevention NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=339 CharacterOffsetEnd=341 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=hyperkalemia CharacterOffsetBegin=342 CharacterOffsetEnd=354 PartOfSpeech=NN Lemma=hyperkalemia NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=and CharacterOffsetBegin=355 CharacterOffsetEnd=358 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=its CharacterOffsetBegin=359 CharacterOffsetEnd=362 PartOfSpeech=PRP$ Lemma=its NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=associated CharacterOffsetBegin=363 CharacterOffsetEnd=373 PartOfSpeech=VBN Lemma=associate NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=complications CharacterOffsetBegin=374 CharacterOffsetEnd=387 PartOfSpeech=NNS Lemma=complication NamedEntityTag=O SentimentClass=Negative]\r\n",
      "[Text=requires CharacterOffsetBegin=388 CharacterOffsetEnd=396 PartOfSpeech=VBZ Lemma=require NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=careful CharacterOffsetBegin=397 CharacterOffsetEnd=404 PartOfSpeech=JJ Lemma=careful NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=patient CharacterOffsetBegin=405 CharacterOffsetEnd=412 PartOfSpeech=NN Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=selection CharacterOffsetBegin=413 CharacterOffsetEnd=422 PartOfSpeech=NN Lemma=selection NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=422 CharacterOffsetEnd=423 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=counseling CharacterOffsetBegin=424 CharacterOffsetEnd=434 PartOfSpeech=VBG Lemma=counsel NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=regarding CharacterOffsetBegin=435 CharacterOffsetEnd=444 PartOfSpeech=VBG Lemma=regard NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=dietary CharacterOffsetBegin=445 CharacterOffsetEnd=452 PartOfSpeech=JJ Lemma=dietary NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=potassium CharacterOffsetBegin=453 CharacterOffsetEnd=462 PartOfSpeech=NN Lemma=potassium NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=intake CharacterOffsetBegin=463 CharacterOffsetEnd=469 PartOfSpeech=NN Lemma=intake NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=469 CharacterOffsetEnd=470 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=awareness CharacterOffsetBegin=471 CharacterOffsetEnd=480 PartOfSpeech=NN Lemma=awareness NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=481 CharacterOffsetEnd=483 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=drug CharacterOffsetBegin=484 CharacterOffsetEnd=488 PartOfSpeech=NN Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=interactions CharacterOffsetBegin=489 CharacterOffsetEnd=501 PartOfSpeech=NNS Lemma=interaction NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=501 CharacterOffsetEnd=502 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=and CharacterOffsetBegin=503 CharacterOffsetEnd=506 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=regular CharacterOffsetBegin=507 CharacterOffsetEnd=514 PartOfSpeech=JJ Lemma=regular NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=laboratory CharacterOffsetBegin=515 CharacterOffsetEnd=525 PartOfSpeech=NN Lemma=laboratory NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=surveillance CharacterOffsetBegin=526 CharacterOffsetEnd=538 PartOfSpeech=NN Lemma=surveillance NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=. CharacterOffsetBegin=538 CharacterOffsetEnd=539 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "(ROOT\r\n",
      "  (S\r\n",
      "    (NP\r\n",
      "      (NP (NNP Prevention))\r\n",
      "      (PP (IN of)\r\n",
      "        (NP\r\n",
      "          (NP (NN hyperkalemia))\r\n",
      "          (CC and)\r\n",
      "          (NP (PRP$ its) (VBN associated) (NNS complications)))))\r\n",
      "    (VP (VBZ requires)\r\n",
      "      (NP (JJ careful) (NN patient) (NN selection))\r\n",
      "      (, ,)\r\n",
      "      (S\r\n",
      "        (VP (VBG counseling)\r\n",
      "          (PP (VBG regarding)\r\n",
      "            (NP\r\n",
      "              (NP (JJ dietary) (NN potassium) (NN intake))\r\n",
      "              (, ,)\r\n",
      "              (NP\r\n",
      "                (NP (NN awareness))\r\n",
      "                (PP (IN of)\r\n",
      "                  (NP (NN drug) (NNS interactions))))\r\n",
      "              (, ,)\r\n",
      "              (CC and)\r\n",
      "              (NP (JJ regular) (NN laboratory) (NN surveillance)))))))\r\n",
      "    (. .)))\r\n",
      "\r\n",
      "root(ROOT-0, requires-8)\r\n",
      "nsubj(requires-8, Prevention-1)\r\n",
      "case(hyperkalemia-3, of-2)\r\n",
      "nmod:of(Prevention-1, hyperkalemia-3)\r\n",
      "cc(hyperkalemia-3, and-4)\r\n",
      "nmod:poss(complications-7, its-5)\r\n",
      "amod(complications-7, associated-6)\r\n",
      "nmod:of(Prevention-1, complications-7)\r\n",
      "conj:and(hyperkalemia-3, complications-7)\r\n",
      "amod(selection-11, careful-9)\r\n",
      "compound(selection-11, patient-10)\r\n",
      "dobj(requires-8, selection-11)\r\n",
      "punct(requires-8, ,-12)\r\n",
      "advcl(requires-8, counseling-13)\r\n",
      "case(intake-17, regarding-14)\r\n",
      "amod(intake-17, dietary-15)\r\n",
      "compound(intake-17, potassium-16)\r\n",
      "nmod:regarding(counseling-13, intake-17)\r\n",
      "punct(intake-17, ,-18)\r\n",
      "nmod:regarding(counseling-13, awareness-19)\r\n",
      "conj:and(intake-17, awareness-19)\r\n",
      "case(interactions-22, of-20)\r\n",
      "compound(interactions-22, drug-21)\r\n",
      "nmod:of(awareness-19, interactions-22)\r\n",
      "punct(intake-17, ,-23)\r\n",
      "cc(intake-17, and-24)\r\n",
      "amod(surveillance-27, regular-25)\r\n",
      "compound(surveillance-27, laboratory-26)\r\n",
      "nmod:regarding(counseling-13, surveillance-27)\r\n",
      "conj:and(intake-17, surveillance-27)\r\n",
      "punct(requires-8, .-28)\r\n",
      "\r\n",
      "Sentence #3 (29 tokens, sentiment: Negative):\r\n",
      "Recent data suggests that the risk of hyperkalemia may be further moderated through the use of combined angiotensin-neprilysin inhibitors, novel MRAs, and novel potassium binding agents.\r\n",
      "[Text=Recent CharacterOffsetBegin=540 CharacterOffsetEnd=546 PartOfSpeech=JJ Lemma=recent NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=data CharacterOffsetBegin=547 CharacterOffsetEnd=551 PartOfSpeech=NNS Lemma=datum NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=suggests CharacterOffsetBegin=552 CharacterOffsetEnd=560 PartOfSpeech=VBZ Lemma=suggest NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=that CharacterOffsetBegin=561 CharacterOffsetEnd=565 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=the CharacterOffsetBegin=566 CharacterOffsetEnd=569 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=risk CharacterOffsetBegin=570 CharacterOffsetEnd=574 PartOfSpeech=NN Lemma=risk NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=575 CharacterOffsetEnd=577 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=hyperkalemia CharacterOffsetBegin=578 CharacterOffsetEnd=590 PartOfSpeech=NN Lemma=hyperkalemia NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=may CharacterOffsetBegin=591 CharacterOffsetEnd=594 PartOfSpeech=MD Lemma=may NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=be CharacterOffsetBegin=595 CharacterOffsetEnd=597 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=further CharacterOffsetBegin=598 CharacterOffsetEnd=605 PartOfSpeech=JJ Lemma=further NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=moderated CharacterOffsetBegin=606 CharacterOffsetEnd=615 PartOfSpeech=VBN Lemma=moderate NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=through CharacterOffsetBegin=616 CharacterOffsetEnd=623 PartOfSpeech=IN Lemma=through NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=the CharacterOffsetBegin=624 CharacterOffsetEnd=627 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=use CharacterOffsetBegin=628 CharacterOffsetEnd=631 PartOfSpeech=NN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=632 CharacterOffsetEnd=634 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=combined CharacterOffsetBegin=635 CharacterOffsetEnd=643 PartOfSpeech=JJ Lemma=combined NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=angiotensin-neprilysin CharacterOffsetBegin=644 CharacterOffsetEnd=666 PartOfSpeech=NN Lemma=angiotensin-neprilysin NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=inhibitors CharacterOffsetBegin=667 CharacterOffsetEnd=677 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=677 CharacterOffsetEnd=678 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=novel CharacterOffsetBegin=679 CharacterOffsetEnd=684 PartOfSpeech=JJ Lemma=novel NamedEntityTag=O SentimentClass=Positive]\r\n",
      "[Text=MRAs CharacterOffsetBegin=685 CharacterOffsetEnd=689 PartOfSpeech=NNS Lemma=mra NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=689 CharacterOffsetEnd=690 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=and CharacterOffsetBegin=691 CharacterOffsetEnd=694 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=novel CharacterOffsetBegin=695 CharacterOffsetEnd=700 PartOfSpeech=JJ Lemma=novel NamedEntityTag=O SentimentClass=Positive]\r\n",
      "[Text=potassium CharacterOffsetBegin=701 CharacterOffsetEnd=710 PartOfSpeech=NN Lemma=potassium NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=binding CharacterOffsetBegin=711 CharacterOffsetEnd=718 PartOfSpeech=VBG Lemma=bind NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=agents CharacterOffsetBegin=719 CharacterOffsetEnd=725 PartOfSpeech=NNS Lemma=agent NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=. CharacterOffsetBegin=725 CharacterOffsetEnd=726 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "(ROOT\r\n",
      "  (S\r\n",
      "    (NP (JJ Recent) (NNS data))\r\n",
      "    (VP (VBZ suggests)\r\n",
      "      (SBAR (IN that)\r\n",
      "        (S\r\n",
      "          (NP\r\n",
      "            (NP (DT the) (NN risk))\r\n",
      "            (PP (IN of)\r\n",
      "              (NP (NN hyperkalemia))))\r\n",
      "          (VP (MD may)\r\n",
      "            (VP (VB be)\r\n",
      "              (NP\r\n",
      "                (NP\r\n",
      "                  (NP (JJ further))\r\n",
      "                  (VP (VBN moderated)\r\n",
      "                    (PP (IN through)\r\n",
      "                      (NP\r\n",
      "                        (NP (DT the) (NN use))\r\n",
      "                        (PP (IN of)\r\n",
      "                          (NP (JJ combined) (NN angiotensin-neprilysin) (NNS inhibitors)))))))\r\n",
      "                (, ,)\r\n",
      "                (NP (JJ novel) (NNS MRAs))\r\n",
      "                (, ,)\r\n",
      "                (CC and)\r\n",
      "                (NP\r\n",
      "                  (ADJP (JJ novel))\r\n",
      "                  (NN potassium) (VBG binding) (NNS agents))))))))\r\n",
      "    (. .)))\r\n",
      "\r\n",
      "root(ROOT-0, suggests-3)\r\n",
      "amod(data-2, Recent-1)\r\n",
      "nsubj(suggests-3, data-2)\r\n",
      "mark(further-11, that-4)\r\n",
      "det(risk-6, the-5)\r\n",
      "nsubj(further-11, risk-6)\r\n",
      "case(hyperkalemia-8, of-7)\r\n",
      "nmod:of(risk-6, hyperkalemia-8)\r\n",
      "aux(further-11, may-9)\r\n",
      "cop(further-11, be-10)\r\n",
      "ccomp(suggests-3, further-11)\r\n",
      "acl(further-11, moderated-12)\r\n",
      "case(use-15, through-13)\r\n",
      "det(use-15, the-14)\r\n",
      "nmod:through(moderated-12, use-15)\r\n",
      "case(inhibitors-19, of-16)\r\n",
      "amod(inhibitors-19, combined-17)\r\n",
      "compound(inhibitors-19, angiotensin-neprilysin-18)\r\n",
      "nmod:of(use-15, inhibitors-19)\r\n",
      "punct(further-11, ,-20)\r\n",
      "amod(MRAs-22, novel-21)\r\n",
      "ccomp(suggests-3, MRAs-22)\r\n",
      "conj:and(further-11, MRAs-22)\r\n",
      "punct(further-11, ,-23)\r\n",
      "cc(further-11, and-24)\r\n",
      "amod(agents-28, novel-25)\r\n",
      "compound(agents-28, potassium-26)\r\n",
      "amod(agents-28, binding-27)\r\n",
      "ccomp(suggests-3, agents-28)\r\n",
      "conj:and(further-11, agents-28)\r\n",
      "punct(suggests-3, .-29)\r\n",
      "\r\n",
      "Sentence #4 (19 tokens, sentiment: Negative):\r\n",
      "Clinicians should be mindful of the risk of hyperkalemia when prescribing RAAS inhibitors to patients with heart failure.\r\n",
      "[Text=Clinicians CharacterOffsetBegin=727 CharacterOffsetEnd=737 PartOfSpeech=NNS Lemma=clinician NamedEntityTag=MISC SentimentClass=Neutral]\r\n",
      "[Text=should CharacterOffsetBegin=738 CharacterOffsetEnd=744 PartOfSpeech=MD Lemma=should NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=be CharacterOffsetBegin=745 CharacterOffsetEnd=747 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=mindful CharacterOffsetBegin=748 CharacterOffsetEnd=755 PartOfSpeech=JJ Lemma=mindful NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=756 CharacterOffsetEnd=758 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=the CharacterOffsetBegin=759 CharacterOffsetEnd=762 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=risk CharacterOffsetBegin=763 CharacterOffsetEnd=767 PartOfSpeech=NN Lemma=risk NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=768 CharacterOffsetEnd=770 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=hyperkalemia CharacterOffsetBegin=771 CharacterOffsetEnd=783 PartOfSpeech=NN Lemma=hyperkalemia NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=when CharacterOffsetBegin=784 CharacterOffsetEnd=788 PartOfSpeech=WRB Lemma=when NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=prescribing CharacterOffsetBegin=789 CharacterOffsetEnd=800 PartOfSpeech=VBG Lemma=prescribe NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=RAAS CharacterOffsetBegin=801 CharacterOffsetEnd=805 PartOfSpeech=NN Lemma=raas NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=inhibitors CharacterOffsetBegin=806 CharacterOffsetEnd=816 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=to CharacterOffsetBegin=817 CharacterOffsetEnd=819 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=patients CharacterOffsetBegin=820 CharacterOffsetEnd=828 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=with CharacterOffsetBegin=829 CharacterOffsetEnd=833 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=heart CharacterOffsetBegin=834 CharacterOffsetEnd=839 PartOfSpeech=NN Lemma=heart NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=failure CharacterOffsetBegin=840 CharacterOffsetEnd=847 PartOfSpeech=NN Lemma=failure NamedEntityTag=O SentimentClass=Very negative]\r\n",
      "[Text=. CharacterOffsetBegin=847 CharacterOffsetEnd=848 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "(ROOT\r\n",
      "  (S\r\n",
      "    (NP (NNS Clinicians))\r\n",
      "    (VP (MD should)\r\n",
      "      (VP (VB be)\r\n",
      "        (ADJP (JJ mindful)\r\n",
      "          (PP (IN of)\r\n",
      "            (NP\r\n",
      "              (NP (DT the) (NN risk))\r\n",
      "              (PP (IN of)\r\n",
      "                (NP (NN hyperkalemia))))))\r\n",
      "        (SBAR\r\n",
      "          (WHADVP (WRB when))\r\n",
      "          (S\r\n",
      "            (VP (VBG prescribing)\r\n",
      "              (NP (NN RAAS) (NNS inhibitors))\r\n",
      "              (PP (TO to)\r\n",
      "                (NP\r\n",
      "                  (NP (NNS patients))\r\n",
      "                  (PP (IN with)\r\n",
      "                    (NP (NN heart) (NN failure))))))))))\r\n",
      "    (. .)))\r\n",
      "\r\n",
      "root(ROOT-0, mindful-4)\r\n",
      "nsubj(mindful-4, Clinicians-1)\r\n",
      "aux(mindful-4, should-2)\r\n",
      "cop(mindful-4, be-3)\r\n",
      "case(risk-7, of-5)\r\n",
      "det(risk-7, the-6)\r\n",
      "nmod:of(mindful-4, risk-7)\r\n",
      "case(hyperkalemia-9, of-8)\r\n",
      "nmod:of(risk-7, hyperkalemia-9)\r\n",
      "advmod(prescribing-11, when-10)\r\n",
      "advcl(mindful-4, prescribing-11)\r\n",
      "compound(inhibitors-13, RAAS-12)\r\n",
      "dobj(prescribing-11, inhibitors-13)\r\n",
      "case(patients-15, to-14)\r\n",
      "nmod:to(prescribing-11, patients-15)\r\n",
      "case(failure-18, with-16)\r\n",
      "compound(failure-18, heart-17)\r\n",
      "nmod:with(patients-15, failure-18)\r\n",
      "punct(mindful-4, .-19)\r\n",
      "\r\n",
      "Sentence #5 (33 tokens, sentiment: Negative):\r\n",
      "In patients at highest risk, such as those with diabetes, the elderly, and advanced chronic kidney disease, more intensive laboratory surveillance of potassium and creatinine may be required.\r\n",
      "[Text=In CharacterOffsetBegin=849 CharacterOffsetEnd=851 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=patients CharacterOffsetBegin=852 CharacterOffsetEnd=860 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=at CharacterOffsetBegin=861 CharacterOffsetEnd=863 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=highest CharacterOffsetBegin=864 CharacterOffsetEnd=871 PartOfSpeech=JJS Lemma=highest NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=risk CharacterOffsetBegin=872 CharacterOffsetEnd=876 PartOfSpeech=NN Lemma=risk NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=876 CharacterOffsetEnd=877 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=such CharacterOffsetBegin=878 CharacterOffsetEnd=882 PartOfSpeech=JJ Lemma=such NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=as CharacterOffsetBegin=883 CharacterOffsetEnd=885 PartOfSpeech=IN Lemma=as NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=those CharacterOffsetBegin=886 CharacterOffsetEnd=891 PartOfSpeech=DT Lemma=those NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=with CharacterOffsetBegin=892 CharacterOffsetEnd=896 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=diabetes CharacterOffsetBegin=897 CharacterOffsetEnd=905 PartOfSpeech=NN Lemma=diabetes NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=905 CharacterOffsetEnd=906 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=the CharacterOffsetBegin=907 CharacterOffsetEnd=910 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=elderly CharacterOffsetBegin=911 CharacterOffsetEnd=918 PartOfSpeech=JJ Lemma=elderly NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=, CharacterOffsetBegin=918 CharacterOffsetEnd=919 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=and CharacterOffsetBegin=920 CharacterOffsetEnd=923 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=advanced CharacterOffsetBegin=924 CharacterOffsetEnd=932 PartOfSpeech=VBD Lemma=advance NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=chronic CharacterOffsetBegin=933 CharacterOffsetEnd=940 PartOfSpeech=JJ Lemma=chronic NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=kidney CharacterOffsetBegin=941 CharacterOffsetEnd=947 PartOfSpeech=NN Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=disease CharacterOffsetBegin=948 CharacterOffsetEnd=955 PartOfSpeech=NN Lemma=disease NamedEntityTag=O SentimentClass=Negative]\r\n",
      "[Text=, CharacterOffsetBegin=955 CharacterOffsetEnd=956 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=more CharacterOffsetBegin=957 CharacterOffsetEnd=961 PartOfSpeech=JJR Lemma=more NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=intensive CharacterOffsetBegin=962 CharacterOffsetEnd=971 PartOfSpeech=JJ Lemma=intensive NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=laboratory CharacterOffsetBegin=972 CharacterOffsetEnd=982 PartOfSpeech=NN Lemma=laboratory NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=surveillance CharacterOffsetBegin=983 CharacterOffsetEnd=995 PartOfSpeech=NN Lemma=surveillance NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=996 CharacterOffsetEnd=998 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=potassium CharacterOffsetBegin=999 CharacterOffsetEnd=1008 PartOfSpeech=NN Lemma=potassium NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=and CharacterOffsetBegin=1009 CharacterOffsetEnd=1012 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=creatinine CharacterOffsetBegin=1013 CharacterOffsetEnd=1023 PartOfSpeech=NN Lemma=creatinine NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=may CharacterOffsetBegin=1024 CharacterOffsetEnd=1027 PartOfSpeech=MD Lemma=may NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=be CharacterOffsetBegin=1028 CharacterOffsetEnd=1030 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=required CharacterOffsetBegin=1031 CharacterOffsetEnd=1039 PartOfSpeech=VBN Lemma=require NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=. CharacterOffsetBegin=1039 CharacterOffsetEnd=1040 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "(ROOT\r\n",
      "  (S\r\n",
      "    (PP (IN In)\r\n",
      "      (NP\r\n",
      "        (NP\r\n",
      "          (NP (NNS patients))\r\n",
      "          (PP (IN at)\r\n",
      "            (NP (JJS highest) (NN risk))))\r\n",
      "        (, ,)\r\n",
      "        (UCP\r\n",
      "          (PP (JJ such) (IN as)\r\n",
      "            (NP\r\n",
      "              (NP (DT those))\r\n",
      "              (PP (IN with)\r\n",
      "                (NP\r\n",
      "                  (NP (NN diabetes))\r\n",
      "                  (, ,)\r\n",
      "                  (NP (DT the) (JJ elderly))\r\n",
      "                  (, ,)))))\r\n",
      "          (CC and)\r\n",
      "          (S\r\n",
      "            (VP (VBD advanced)\r\n",
      "              (NP (JJ chronic) (NN kidney) (NN disease)))))))\r\n",
      "    (, ,)\r\n",
      "    (NP\r\n",
      "      (NP (JJR more) (JJ intensive) (NN laboratory) (NN surveillance))\r\n",
      "      (PP (IN of)\r\n",
      "        (NP (NN potassium)\r\n",
      "          (CC and)\r\n",
      "          (NN creatinine))))\r\n",
      "    (VP (MD may)\r\n",
      "      (VP (VB be)\r\n",
      "        (VP (VBN required))))\r\n",
      "    (. .)))\r\n",
      "\r\n",
      "root(ROOT-0, required-32)\r\n",
      "case(patients-2, In-1)\r\n",
      "nmod:in(required-32, patients-2)\r\n",
      "case(risk-5, at-3)\r\n",
      "amod(risk-5, highest-4)\r\n",
      "nmod:at(patients-2, risk-5)\r\n",
      "punct(patients-2, ,-6)\r\n",
      "case(those-9, such-7)\r\n",
      "mwe(such-7, as-8)\r\n",
      "nmod:such_as(patients-2, those-9)\r\n",
      "case(diabetes-11, with-10)\r\n",
      "nmod:with(those-9, diabetes-11)\r\n",
      "punct(diabetes-11, ,-12)\r\n",
      "det(elderly-14, the-13)\r\n",
      "appos(diabetes-11, elderly-14)\r\n",
      "punct(diabetes-11, ,-15)\r\n",
      "cc(those-9, and-16)\r\n",
      "nmod:such_as(patients-2, advanced-17)\r\n",
      "conj:and(those-9, advanced-17)\r\n",
      "amod(disease-20, chronic-18)\r\n",
      "compound(disease-20, kidney-19)\r\n",
      "dobj(advanced-17, disease-20)\r\n",
      "punct(required-32, ,-21)\r\n",
      "amod(surveillance-25, more-22)\r\n",
      "amod(surveillance-25, intensive-23)\r\n",
      "compound(surveillance-25, laboratory-24)\r\n",
      "nsubjpass(required-32, surveillance-25)\r\n",
      "case(potassium-27, of-26)\r\n",
      "nmod:of(surveillance-25, potassium-27)\r\n",
      "cc(potassium-27, and-28)\r\n",
      "nmod:of(surveillance-25, creatinine-29)\r\n",
      "conj:and(potassium-27, creatinine-29)\r\n",
      "aux(required-32, may-30)\r\n",
      "auxpass(required-32, be-31)\r\n",
      "punct(required-32, .-33)\r\n",
      "\r\n",
      "Sentence #6 (18 tokens, sentiment: Negative):\r\n",
      "Novel therapies hold promise for reducing the risk of hyperkalemia and enhancing the tolerability of RAAS antagonists.\r\n",
      "[Text=Novel CharacterOffsetBegin=1041 CharacterOffsetEnd=1046 PartOfSpeech=JJ Lemma=novel NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=therapies CharacterOffsetBegin=1047 CharacterOffsetEnd=1056 PartOfSpeech=NNS Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=hold CharacterOffsetBegin=1057 CharacterOffsetEnd=1061 PartOfSpeech=VBP Lemma=hold NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=promise CharacterOffsetBegin=1062 CharacterOffsetEnd=1069 PartOfSpeech=NN Lemma=promise NamedEntityTag=O SentimentClass=Positive]\r\n",
      "[Text=for CharacterOffsetBegin=1070 CharacterOffsetEnd=1073 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=reducing CharacterOffsetBegin=1074 CharacterOffsetEnd=1082 PartOfSpeech=VBG Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=the CharacterOffsetBegin=1083 CharacterOffsetEnd=1086 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=risk CharacterOffsetBegin=1087 CharacterOffsetEnd=1091 PartOfSpeech=NN Lemma=risk NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=1092 CharacterOffsetEnd=1094 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=hyperkalemia CharacterOffsetBegin=1095 CharacterOffsetEnd=1107 PartOfSpeech=NN Lemma=hyperkalemia NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=and CharacterOffsetBegin=1108 CharacterOffsetEnd=1111 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=enhancing CharacterOffsetBegin=1112 CharacterOffsetEnd=1121 PartOfSpeech=VBG Lemma=enhance NamedEntityTag=O SentimentClass=Positive]\r\n",
      "[Text=the CharacterOffsetBegin=1122 CharacterOffsetEnd=1125 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=tolerability CharacterOffsetBegin=1126 CharacterOffsetEnd=1138 PartOfSpeech=NN Lemma=tolerability NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=of CharacterOffsetBegin=1139 CharacterOffsetEnd=1141 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=RAAS CharacterOffsetBegin=1142 CharacterOffsetEnd=1146 PartOfSpeech=NN Lemma=raas NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=antagonists CharacterOffsetBegin=1147 CharacterOffsetEnd=1158 PartOfSpeech=NNS Lemma=antagonist NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "[Text=. CharacterOffsetBegin=1158 CharacterOffsetEnd=1159 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\r\n",
      "(ROOT\r\n",
      "  (S\r\n",
      "    (NP (JJ Novel) (NNS therapies))\r\n",
      "    (VP (VBP hold)\r\n",
      "      (NP (NN promise))\r\n",
      "      (PP (IN for)\r\n",
      "        (S\r\n",
      "          (VP\r\n",
      "            (VP (VBG reducing)\r\n",
      "              (NP\r\n",
      "                (NP (DT the) (NN risk))\r\n",
      "                (PP (IN of)\r\n",
      "                  (NP (NN hyperkalemia)))))\r\n",
      "            (CC and)\r\n",
      "            (VP (VBG enhancing)\r\n",
      "              (NP\r\n",
      "                (NP (DT the) (NN tolerability))\r\n",
      "                (PP (IN of)\r\n",
      "                  (NP (NN RAAS) (NNS antagonists)))))))))\r\n",
      "    (. .)))\r\n",
      "\r\n",
      "root(ROOT-0, hold-3)\r\n",
      "amod(therapies-2, Novel-1)\r\n",
      "nsubj(hold-3, therapies-2)\r\n",
      "dobj(hold-3, promise-4)\r\n",
      "mark(reducing-6, for-5)\r\n",
      "advcl:for(hold-3, reducing-6)\r\n",
      "det(risk-8, the-7)\r\n",
      "dobj(reducing-6, risk-8)\r\n",
      "case(hyperkalemia-10, of-9)\r\n",
      "nmod:of(risk-8, hyperkalemia-10)\r\n",
      "cc(reducing-6, and-11)\r\n",
      "advcl:for(hold-3, enhancing-12)\r\n",
      "conj:and(reducing-6, enhancing-12)\r\n",
      "det(tolerability-14, the-13)\r\n",
      "dobj(enhancing-12, tolerability-14)\r\n",
      "case(antagonists-17, of-15)\r\n",
      "compound(antagonists-17, RAAS-16)\r\n",
      "nmod:of(tolerability-14, antagonists-17)\r\n",
      "punct(hold-3, .-18)\r\n",
      "\r\n",
      "Coreference set:\r\n",
      "\t(2,5,[5,6]) -> (1,2,[1,50]), that is: \"its\" -> \"Renin-angiotensin-aldosterone system -LRB- RAAS -RRB- antagonists , including angiotensin-converting enzyme inhibitors -LRB- ACEI -RRB- , angiotensin receptor blockers -LRB- ARB -RRB- , and mineralocorticoid receptor antagonists -LRB- MRA -RRB- decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia , especially when used in combination .\"\r\n",
      "Coreference set:\r\n",
      "\t(1,26,[24,49]) -> (1,6,[6,7]), that is: \"mineralocorticoid receptor antagonists -LRB- MRA -RRB- decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia , especially when used in combination\" -> \"antagonists\"\r\n",
      "Coreference set:\r\n",
      "\t(4,18,[17,19]) -> (1,36,[35,37]), that is: \"heart failure\" -> \"heart failure\"\r\n",
      "Coreference set:\r\n",
      "\t(3,6,[5,9]) -> (1,40,[39,43]), that is: \"the risk of hyperkalemia\" -> \"the risk of hyperkalemia\"\r\n",
      "\t(3,11,[11,20]) -> (1,40,[39,43]), that is: \"further moderated through the use of combined angiotensin-neprilysin inhibitors\" -> \"the risk of hyperkalemia\"\r\n",
      "\t(4,7,[6,10]) -> (1,40,[39,43]), that is: \"the risk of hyperkalemia\" -> \"the risk of hyperkalemia\"\r\n",
      "\t(6,8,[7,11]) -> (1,40,[39,43]), that is: \"the risk of hyperkalemia\" -> \"the risk of hyperkalemia\"\r\n"
     ]
    }
   ],
   "source": [
    "!cat sample_abstract.txt.out"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Our takeaway sentence is that \"ACE Inhibitors (ACEI) [...] decrease mortality and morbidity in heart failure but increase the risk of hyperkalemia...\".\n",
    "\n",
    "`amod(inhibitors-11, angiotensin-converting-9)`\n",
    "\n",
    "`dobj(increase-38, risk-40)`\n",
    "\n",
    "`nmod:of(risk-40, hyperkalemia-42)`\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Experimenting with specific drug names instead of a drug class\n",
    "\n",
    "It didn't look like we had a lot of interactions between drugs and molecules, so I wonder if we change our serach terms a little bit to include the drug names. The search terms are not case sensitive.\n",
    "\n",
    "`Drugs in class: Captopril, Lisinopril, Ramipril, Benazepril`"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 165,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Num abstracts:  899\n",
      "Saving to more_abstracts2.json\n",
      "Sentences:  938\n"
     ]
    }
   ],
   "source": [
    "search_term = ['Captopril', 'Lisinopril','Ramipril','Benazepril']\n",
    "max_results = 100\n",
    "for i in search_term:\n",
    "    query2 = pb.PubMedQuery(i, max_results)\n",
    "    \n",
    "ids2 = query2.id_getter()\n",
    "print \"Num abstracts: \", len(ids2)\n",
    "\n",
    "abstracts2 = query.abstract_getter(ids2)\n",
    "\n",
    "json_file2 = 'more_abstracts2.json'\n",
    "print 'Saving to ' + json_file2\n",
    "with open(json_file2, 'w') as outfile:\n",
    "    json.dump(abstracts2, outfile, indent=4)\n",
    "    \n",
    "    \n",
    "sentences2 = []\n",
    "with open('more_abstracts2.json') as data_file:    \n",
    "    data = json.load(data_file)\n",
    "    for abstract in data.itervalues():\n",
    "        sentences2.append(sent_tokenize(abstract))\n",
    "    # flatten the list of abstracts into one long list of sentences\n",
    "    sentences2 = [sent for s in sentences2 for sent in s]\n",
    "    print \"Sentences: \",len(sentences2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[u'Benazepril plays an important role in down-regulating the expression of TGFbeta1 and decreasing the accumulation of ECM by blocking intrarenal renin-angiotensin system.',\n",
       " u'To study the expression of type I transforming growth factor beta receptor (TGFbetaRI) in renal cortex in streptozotocin-induced diabetic rats and the regulation of benazepril.',\n",
       " u'Experimental glomerulosclerosis in rats was induced by adriamycin.',\n",
       " u'The treated group was given benazepril (4 mg x kg(-1) x d(-1)).',\n",
       " u'Intrarenal angiotensin converting enzyme (ACE) activity and angiotensin II (AngII) concentration were measured with colorimetry and radioimmunoassay respectively.']"
      ]
     },
     "execution_count": 169,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#Just looking at some sentences\n",
    "sentences2[:5]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 218,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Overwriting KeywordSentences2.py\n"
     ]
    }
   ],
   "source": [
    "%%writefile KeywordSentences2.py\n",
    "import json\n",
    "\n",
    "#change keyword to ACE\n",
    "keywords = ['Captopril', 'Lisinopril','Ramipril','Benazepril']\n",
    "with open('more_abstracts2.json') as data_file:    \n",
    "    data = json.load(data_file)\n",
    "    #pick snippets related to ACE inhibitors\n",
    "    for i in range(len(data.keys())):\n",
    "        try:\n",
    "            if any(k in data[str(i)] for k in keywords):\n",
    "                print data[str(i)] + '\\n'\n",
    "            else:\n",
    "                next\n",
    "        except:\n",
    "            next\n",
    "            "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 219,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "!python KeywordSentences2.py > KeywordSentences2.txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 220,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "A number of experimental and clinical investigations support the notion that angiotensin-converting enzyme inhibitor (ACEi) and angiotensin II type 1 receptor blocker (ARB) compounds attenuate renal fibrosis. Fibrosis can be attenuated by either suppressing matrix formation or facilitating matrix degradation. In this study, drugs of ACEi and ARB classes were tested for their ability to facilitate matrix degradation in the kidney. A murine model system in which cyclosporin A (CsA) treatment for a specified period caused interstitial matrix deposition in the kidney was used. CsA was then discontinued, and experimental procedures were initiated to investigate matrix degradation. Benazepril, an ACEi, facilitated matrix degradation via the bradykinin (BK) B2 receptor on tubular epithelial cells in the kidney, whereas CGP-48933, an ARB, did not. In this murine model of CsA nephropathy under ACE blockade, plasminogen activator inhibitor-1 (PAI-1) expression was decreased in tubular epithelial cells, possibly leading to conversion of plasminogen to plasmin by plasminogen activator and subsequent activation of matrix metalloproteinases. These findings were confirmed in this study by measurements of plasmin activity, collagenolytic activity, and matrix metalloproteinase activities in the kidneys. In tubular epithelial cells stimulated in vitro, BK suppressed PAI-1 gene expression. All of these results suggest that ACEi can decrease PAI-1 expression via BK, thereby facilitating matrix degradation via activation of degradative enzymes to reduce interstitial matrix deposition.\r\n",
      "\r\n",
      "Plasmin is an important factor in the degradation of extracellular matrix. In the study reported here we examined the expression of plasminogen-activator inhibitor-1 (PAI-1), urokinase-type plasminogen activator (uPA), and uPA receptor (uPAR), as well as the relevance of such expression to the production of type IV collagen, a major component of extracellular matrix, in the renal tissue of rats with streptozotocin-induced diabetes. Because angiotensin II is involved in the synthesis of PAI-1 and uPA, we also examined the effect of benazepril, an angiotensin-converting-enzyme inhibitor, on the expression of PAI-1, uPA, and uPAR messenger RNAs (mRNAs) and type IV collagen protein. Rats with streptozocin-induced diabetes-some untreated and some treated with 30 mg/L benazepril-and nondiabetic control rats were sacrificed at 4, 12, or 24 weeks after induction of diabetes. We examined the expression of PAI-1, uPA, and uPAR mRNAs through the use of in situ hybridization and that of type IV collagen by means of immunohistochemical methods. In control rats, we detected weak signals for PAI-1, uPA, and uPAR mRNAs in glomeruli. Diabetic rats exhibited high levels of expression of PAI-1, uPA, and uPAR mRNAs and type IV collagen protein, mainly in mesangial cells. These mRNAs were synthesized in various renal cells (epithelial, mesangial, and endothelial cells and Bowman's capsule). Benazepril inhibited increases in all 3 mRNAs, especially in the mesangium; reduced type IV collagen expression; and attenuated mesangial expansion. Our results indicated that altered expression of PAI-1, uPA, and uPAR in diabetic nephropathy was associated with mesangial expansion and that the beneficial effects of ACE-I may be at least associated with such expression.\r\n",
      "\r\n",
      "The effects of the combined use of angiotensin converting enzyme inhibitor (ACEI) benazepril and angiotensin II type 1 receptor antagonist (AT1RA) valsartan on apoptosis and the expression of apoptosis-related proteins Fas and FasL in the kidney of rats with adriamycin-induced nephritic glomerulosclerosis was investigated. Uninephrectomy and the injection of adriamycin induced the rat model of glomerulosclerosis. Benazepril (6 mg/kg), valsantan (20 mg/kg), or benazepril (3 mg/kg) plus valsantan (20 mg/kg) was respectively delivered daily by gavage to the rats in three treatment groups for 12 weeks. Apoptosis was examined by means of terminal-deoxynucleotidyl transferase mediated d-UTP nick end labeling (TUNEL). Immunohistochemistry was adopted to detect the expression of Fas and FasL. Software of pathological analysis quantitated the levels of Fas and FasL. The results showed that as compared with those in the control group, the kidneys in the model group had more severe glomerulosclerosis, much more apoptotic cells and higher levels of expression of Fas and FasL. The degree of glomerulosclerosis, the number of apoptotic cells and the levels of expression of Fas and FasL were reduced by benazepril and valsartan. The combined use of benazepril and valsartan had the best therapeutic effect. It was concluded that benazepril and valsartan could suppress the excessive apoptosis of kidney cells by lowering the expression of the apoptosis-related proteins Fas and FasL, so as to postpone the process of glomerulosclerosis. The combined use of benazepril and valsartan has better therapeutic effect.\r\n",
      "\r\n",
      "Benazepril was safe and tolerable when applied in hypertensive patients.\r\n",
      "\r\n",
      "Benazepril increases the microvessel density and collateral flow, promotes the creation of collateral circulation in ischemic area, but captopril has not such effects.\r\n",
      "\r\n",
      "Benazepril hydrochloride is an angiotensin-converting enzyme inhibitor. Previous clinical trials show that antihypertensive treatment with benazepril provides effective blood pressure (BP) control and is generally well tolerated by patients with hypertension. However, the long-term antihypertensive effects and tolerability of benazepril remain to be established in Chinese patients with hypertension.\r\n",
      "\r\n",
      "The study was a prospective, randomized, double-blinded, placebo-controlled clinical trial. A total of 162 dogs with New York Heart Association (NYHA) class II-IV heart failure caused by chronic valvular disease (CVD) or dilated cardiomyopathy (DCM) were enrolled. Benazepril (minimum dosage, 0.25 mg/kg) or placebo were administered orally once daily for up to 34 months. In this paper, we report results of plasma alanine aminotransferase (ALT), creatinine, potassium and urea.\r\n",
      "\r\n",
      "Benazepril was well tolerated during long-term therapy in dogs with CHF and no specific precautions appear to be necessary regarding plasma ALT, creatinine, potassium or urea. The possible action of benazepril in improving renal function (evidenced via lower plasma creatinine) merits further investigation.\r\n",
      "\r\n",
      "To study the effect of the Compound of traditional Chinese drugs and Benazepril on gene expression of renal endothelin and its receptor of experimental diabetic nephropathy(DN). To discove the mechanism of the compound of traditional Chinese drugs in treating DN.\r\n",
      "\r\n",
      "Streptozotocin DN model was built and influenced with the compound of traditional Chinese drugs and Benazepril. The changes of Upro, Glu, HbA1C and (PT-PCR) mRNA expression levels of ET-1, ETA-R of the renal cortex were tested, and thus the histopathological character of the kidney was analysed.\r\n",
      "\r\n",
      "The compound of traditional Chinese drugs and Benazepril have significant difference from normal saline in the improvement of Upro, Glu, HbA1C. The compound of traditional Chinese drugs have significant difference from Benazepril in the improvement of Glu, HbA1C. The mRNA expression level of ET-1, ETA-R of the renal cortex of DN model was raised. After influenced by the compound of traditional Chinese drugs and Benazepril, the over-expression level de-creased (still higher than normal control ones). The compound of traditional Chinese drugs were more effective than Benazepril to inhibit the proliferation of the stalk region and the third cells.\r\n",
      "\r\n",
      "ET takes part in the process of diabetic glo-Merulosclerosis. Both the compound of traditional Chinese drugs and Benazepril can influence the expression quantity from the level of gene transcription of ET and its receptor. The compound of traditional Chinese drugs can not only reduce urinary albumin of DN, but also improve blood glucose, glycosylated hemoglubin. And it can inhibit nonenzymatic glucosylation of protein as well as the proliferation of the stalk region and the third cells.\r\n",
      "\r\n",
      "Both benazepril and amlodipine were similarly effective in reducing systolic blood pressure (SBP) (-17.6 mmHg with benazepril and -19.8 mmHg with amlodipine; P<0.001 versus placebo), and diastolic blood pressure (DBP) (-11.1 mmHg, -13.2 mmHg, respectively). Combination therapy produced greater reduction in SBP/DBP values (-28.3/-20.5 mmHg; P<0.001 versus placebo, P<0.01 versus benazepril and amlodipine). Benazepril monotherapy significantly decreased plasma PAI-1 activity (-8.4 IU/ml, P<0.05) while it did not influence t-PA activity (+0.02 IU/ml). Amlodipine monotherapy produced a significant increase in t-PA activity (+0.27 IU/ml, P<0.05) while it did not influence PAI-1 activity (+0.8 IU/ml). The amlodipine/benazepril combination produced both a significant decrease in plasma PAI-1 activity (-8.7 IU, P<0.05) and a significant increase in t-PA activity (+0.26 IU/ml, P<0.05).\r\n",
      "\r\n",
      "The disposition and effect of benazepril and its active metabolite, benazeprilat, were evaluated in cats using a pharmacokinetic/pharmacodynamic model. Cats received single 1 mg/kg doses of intravenous 14C-benazeprilat and oral 14C-benazepril.HCl, and single and repeat (eight daily) oral administrations of 0.25, 0.5 and 1.0 mg/kg nonlabelled benazepril.HCl. The pharmacokinetic endpoints were plasma concentrations of benazepril and benazeprilat, and recovery of radioactivity in faeces and urine. The pharmacodynamic endpoint was plasma angiotensin-converting enzyme (ACE) activity. Benazeprilat data were fitted to an equation corresponding to a single-compartment model with a volume equal to the blood space (Vc = 0.093 L/kg). Within this space, benazeprilat was bound nonlinearly to ACE, which was mainly tissular (89.4%) rather than circulating (10.6%). Free benazeprilat was eliminated quickly from the central compartment (t1/2 approximately 1.0 h; Cl approximately 0.125 L/kg/h), elimination being principally biliary ( approximately 85%) rather than urinary ( approximately 15%). Nevertheless, inhibition of ACE was long-lasting (t1/2 16-23 h) due to high affinity binding of benazeprilat to ACE (Kd approximately 3.5 mmol/L, IC50 approximately 4.3 mmol/L). Simulations using the model predict a lack of proportionality between dose of benazepril, plasma benazeprilat concentrations and effect due to the nonlinear binding of benazeprilat to ACE. For example, increasing the dose of benazepril (e.g. above 0.125 mg/kg q24 h) produced only small incremental inhibition of ACE (either peak effect or duration of action).\r\n",
      "\r\n",
      "Albuminuria and hypertension are predictors of poor renal and cardiovascular outcome in diabetic patients. This study tested whether dual blockade of the renin-angiotensin system (RAS) with both an angiotensin-converting enzyme (ACE) inhibitor (ACE-I) and an Angiotensin-II receptor blocker (ARB) is superior to either drug alone in type I diabetic patients with diabetic nephropathy (DN). A randomized double-blind crossover trial was performed with 8-wk treatment with placebo, 20 mg of benazepril once daily, 80 mg of valsartan once daily, and the combination of 20 mg of benazepril and 80 mg of valsartan. Twenty type I diabetic patients with DN were included. At the end of each treatment period, albuminuria, 24-h BP, and GFR were measured. Eighteen patients completed the study. Placebo values were: albuminuria [mean (95% CI)], 701 (490 to 1002) mg/24 h; BP [mean (SEM)], 144 (4)/79 (2) mmHg, and GFR [mean (SEM)], 82 (7) ml/min per 1.73 m(2). Treatment with benazepril, valsartan, or dual blockade significantly reduced albuminuria and BP compared with placebo. Benazepril and valsartan were equally effective. Dual blockade induced an additional reduction in albuminuria of 43 % (29 to 54 %) compared with any type of monotherapy, and a reduction in systolic BP of 6 (0 to 13) mmHg and 7 (1 to 14) mmHg (versus benazepril and valsartan, respectively) and a reduction of 7 (4 to 10) mmHg diastolic compared with both monotherapies. GFR was reversibly reduced on dual blockade compared with monotherapy and placebo. All treatments were safe and well tolerated. In conclusion, dual blockade of the RAS may offer additional renal and cardiovascular protection in type I diabetic patients with DN.\r\n",
      "\r\n",
      "Eighty-nine patients with essential hypertension and 102 normotensive subjects were included in this study. All subjects were genotyped by polymerase chain reaction for the insertion/deletion polymorphism of the angiotensin-converting enzyme gene. Blood pressure was measured before and after taking Benazepril 10 mg, once daily, for 2 months.\r\n",
      "\r\n",
      "Uninephrectomized Spraque-Dawley rats were used to induce diabetes by intraperitoneal injection of streptozotocin (65 mg.kg-1). Benazepril (10 mg.kg-1) was given daily by gavage from the next day of the induction to diabetes for 12 weeks. Apoptosis was evaluated by means of terminal-deoxynucleotidyl transferase mediated d-UTP nick end labeling (TUNEL). Flow cytometry and immunohistochemistry were used to detect the expression of Fas and Fas-L.\r\n",
      "\r\n",
      "The angiotensin converting enzyme (ACE) inhibitors are widely used in the management of essential hypertension, stable chronic heart failure, myocardial infarction (MI) and diabetic nephropathy. There is an increasing number of new agents to add to the nine ACE inhibitors (benazepril, cilazapril, delapril, fosinopril, lisinopril, pentopril, perindopril, quinapril and ramipril) reviewed in this journal in 1990. The pharmacokinetic properties of five newer ACE inhibitors (trandolapril, moexipril, spirapril, temocapril and imidapril) are reviewed in this update. All of these new agents are characterised by having a carboxyl functional groups and requiring hepatic activation to form pharmacologically active metabolites. They achieve peak plasma concentrations at similar times (t(max)) to those of established agents. Three of these agents (trandolapril, moexipril and imidapril) require dosage reductions in patients with renal impairment. Dosage reductions of moexipril and temocapril are recommended for elderly patients, and dosages of moexipril should be lower in patients who are hepatically impaired. Moexipril should be taken 1 hour before meals, whereas other ACE inhibitors can be taken without regard to meals. The pharmacokinetics of warfarin are not altered by concomitant administration with trandolapril or moexipril. Although imidapril and spirapril have no effect on digoxin pharmacokinetics, the area under the concentration-time curve of imidapril and the peak plasma concentration of the active metabolite imidaprilat are decreased when imidapril is given together with digoxin. Although six ACE inhibitors (captopril, enalapril, fosinopril, lisinopril, quinapril and ramipril) have been approved for use in heart failure by the US Food and Drug Administration, an overview of 32 clinical trials of ACE inhibitors in heart failure showed that no significant heterogeneity in mortality was found among enalapril, ramipril, quinapril, captopril, lisinopril, benazepril, perindopril and cilazapril. Initiation of therapy with captopril, ramipril, and trandolapril at least 3 days after an acute MI resulted in all-cause mortality risk reductions of 18 to 27%. Captopril has been shown to have similar morbidity and mortality benefits to those of diuretics and beta-blockers in hypertensive patients. Captopril has been shown to delay the progression of diabetic nephropathy, and enalapril and lisinopril prevent the development of nephropathy in normoalbuminuric patients with diabetes. ACE inhibitors are generally characterised by flat dose-response curves. Lisinopril is the only ACE inhibitor that exhibits a linear dose-response curve. Despite the fact that most ACE inhibitors are recommended for once-daily administration, only fosinopril, ramipril, and trandolapril have trough-to-peak effect ratios in excess of 50%.\r\n",
      "\r\n",
      "To evaluate the efficacy and safety of Benazepril used among the essential hypertensives.\r\n",
      "\r\n",
      "1 831 essential hypertensive patients aged 35 to 75 were randomly selected from a community and followed for 18 months. The level of blood pressure, status of taking Benazepril and side effects were sequencially collected.\r\n",
      "\r\n",
      "1/3 of the patients had taken antihypertensive drug before the study and the rate of compliance was over 96%. The effective rate of Benazepril was 73.6% at three months and increased to 84.7% at 18 months. Comparing with the baseline data, SBP and DBP declined 10.8 mmHg and 6.7 mmHg respectively. The rate of side effect was 22.7%. Cough was most commonly seen among side effects. The peak of first recording on side effect occurred at three months including 60% of them mild.\r\n",
      "\r\n",
      "Results showed that Benazepril had good efficacy and safety for the essential hypertension patients in a long-term observation.\r\n",
      "\r\n",
      "Captopril, enalapril, and lisinopril are angiotensin-converting enzyme (ACE) inhibitors widely prescribed for hypertension and heart failure. Cutaneous side effects of captopril include angio-edema, anaphylactoid reactions, maculopapular eruptions, pitiryasis rosea-like rash, toxic erythema, and exfoliative dermatitis. Some of the immunological captopril-induced cutaneous adverse reactions have been diagnosed in recent years by patch tests. A case of a cutaneous immune adverse reaction to captopril with tolerance to enalapril and lisinopril demonstrated both by patch tests and double-blind challenge tests is reported for the first time. A 71-year-old nonatopic woman suffered a generalized pruriginous maculopapular rash. Two months earlier, she had started oral treatment with captopril 50 mg t.i.d and glibenclamide 5 mg daily. After the rash appeared, she stopped both drugs and the reaction cleared. A skin biopsy from one of the lesions showed perivascular lymphocytic infiltrate of the upper dermis. Skin prick tests with captopril and glibenclamide and patch tests with enalapril, lisinopril, and glibenclamide at 1% and 10% pet., and with mercaptobenzothiazole (a sulfhydryl group-containing chemical at 1% pet were negative. Only patch tests with captopril at 1% and 10% concentrations were positive at 48 h. Oral double-blind challenge tests with glibenclamide, enalapril, lisinopril, and placebo showed good tolerance. The patient was advised to avoid only captopril. Because captopril is the only ACE inhibitor containing a sulfhydryl group and has occasionally been implicated in complex immunological diseases, this chemical group has been considered the culprit of allergic reactions to captopril. The lack of cross-reactivity between captopril, enalapril, and benazepril has been demonstrated in a few patients by patch tests. In our patient, patch tests identified captopril as the drug responsible for a probably immune adverse reaction not due to the sulfhydryl group. Patch tests are useful and safe in the diagnostic work-up of allergic drug reactions and in studies of cross-sensitivity among ACE inhibitors.\r\n",
      "\r\n",
      "Benazepril therapy as a component of antihypertensive treatment of persons with chronic renal insufficiency initially costs money, but investment costs are recouped quickly and return on investment continues to grow. The impact of end-stage renal disease on patient health and healthcare costs is great. Thus, the quality-adjusted survival benefits and overall cost savings seen in benazepril recipients over a prolonged period (2 to 7 years) indicate that the strategy of prescribing benazepril to reduce progression of renal disease in patients with renal insufficiency is both clinically and economically beneficial compared with current antihypertensive regimens without ACE inhibition.\r\n",
      "\r\n",
      "Benazepril plays an important role in down-regulating the expression of TGFbeta1 and decreasing the accumulation of ECM by blocking intrarenal renin-angiotensin system.\r\n",
      "\r\n",
      "It is suggested that there is an interaction between TGFbetaR I and the pathogenesis of diabetic nephropathy. Benazepril can supress the expression of TGFbetaR I in renal cortex.\r\n",
      "\r\n",
      "To explore the intensity of inhibition of Shenkang Injection (SKI) and Benazepril on various ingredients of human glomerular mesangial extracellular matrix (ECM).\r\n",
      "\r\n",
      "Effect of SKI, a herbal preparation for lowering adverse Qi, despelling turbidness, supplementing Qi and activating circulation, and Benazepril were observed by cultured glomerular mesangial cell technique in vitro.\r\n",
      "\r\n",
      "SKI could inhibit the fibronetin, laminin, and type IV collagen of ECM, and the action was dose-dependent. Benazepril could also inhibit the fibronetin and type IV collagen of ECM but was weaker in intensity.\r\n",
      "\r\n",
      "The effect of SKI was superior to Benazepril in inhibiting ECM.\r\n",
      "\r\n",
      "A reversed-phase high-performance liquid chromatographic (HPLC) method was developed and validated for the kinetic investigation of the chemical and enzymatic hydrolysis of benazepril hydrochloride. Kinetic studies on the acidic hydrolysis of benazepril hydrochloride were carried out in 0.1 M hydrochloric acid solution at 50, 53, 58 and 63 degrees C. Benazepril hydrochloride appeared stable in a pH 7.4 phosphate buffered solution at 37 degrees C and showed susceptibility to undergoing in vitro enzymatic hydrolysis with porcine liver esterase (PLE) in a pH 7.4 buffered solution at 37 degrees C. Benazeprilat appeared to be the major degradation product in both (chemical and enzymatic) studies of hydrolysis. Statistical evaluation of the proposed HPLC methods revealed their good linearity and reproducibility. Relative standard deviation (R.S.D.) was less than 4.76, while detection limits for benazepril hydrochloride and benazeprilat were 13.0 x 10(-7) and 9.0 x 10(-7) M, respectively. Treatment of the kinetic data of the acidic hydrolysis was carried out by non-linear regression analysis and k values were determined. The kinetic parameters of the enzymatic hydrolysis were determined by non-linear regression analysis of the data using the equation of Michaelis-Menten.\r\n",
      "\r\n",
      "Combination therapy is required in many patients to achieve goal blood pressure (BP). Calcium antagonists are highly effective antihypertensive drugs in a broad range of demographic groups. Yet, higher doses are associated with an increased frequency of lower extremity edema. The purpose of our open label, single-center clinical trial was to evaluate the use of concomitant pharmacologic therapies to attenuate the lower extremity edema associated with dihydropyridine calcium antagonists therapy using a water displacement technique. Forty-seven patients received 5 mg/day of oral amlodipine for a period of 6 weeks after a 4-week wash-out off of all antihypertensive medications to establish baseline BP. They were then randomized to receive either an additional 5 mg of amlodipine, 25 mg of hydrochlorothiazide (HCTZ), or 20 mg of benazepril for an additional 6 weeks. Blood pressure determinations and water displacement measurements were obtained at the end of the 4-week placebo wash-out period, after 6 weeks of 5 mg/day of oral amlodipine therapy, and after an additional 6 weeks of 5 mg of amlodipine and randomized drug therapy. Adjusted BP reductions (based on pretreatment BP) were -6.8/-3.8 mm Hg for the 10-mg amlodipine group, -9.9/-8.2 mm Hg for the amlodipine (5 mg)/HCTZ (25 mg) group, and -26.2/-16.4 mm Hg for the amlodipine (5 mg)/benazepril (20 mg) group (P < .0167, group 3 v group 1 diastolic BP, which was statistically significant by the improved Bonferroni method). Seventeen of the 47 patients developed at least a 10% increase in lower extremity edema water displacement in response to 5 mg/day of oral amlodipine therapy (36.2%). Adding 5 mg of amlodipine to a baseline of 5 mg of amlodipine resulted in no net change in lower extremity edema (+58.0 mL,+ 0.6% change, n=5). Adding 25 mg of HCTZ reduced lower extremity edema by a mean of 136.3 mL (-11.1% change, n=4). Benazepril reduced water displacement by 204.4 mL (-14.3% change, n=8). Our pilot study indicates that adding an angiotensin converting enzyme inhibitor to a dihydropyridine calcium channel blocker is the most effective way to not only reduce systolic and diastolic BP but also attenuate lower extremity edema. Due to the inherent daily variability of lower extremity edema, power calculations indicate many patients (n=702, 356 in each group) would be needed to compare the antiedema efficacy of the angiotensin converting enzyme inhibitor and the thiazide diuretic.\r\n",
      "\r\n",
      "Prescribing trends and the cost of antihypertensive drugs were studied in 300 patients attending an internal medicine clinic. Beta-blockers were the most frequently used group of drugs (46.7%), followed by calcium-channel antagonists (34.3%) and angiotensin-converting enzyme inhibitors (30%). Diuretics were used in only 13.2% of the prescriptions. Atenolol (36%), amlodipine (29.3%) and enalapril (19%) were the most frequently used individual drugs. Propranolol, furosemide, amlodipine and atenolol were the least expensive drugs used, with annual drug acquisition costs of Rs 80, 102, 182 and 318, respectively. Benazepril (Rs 1778), diltiazem SR (Rs 1777), lisinopril (Rs 1660), prazosin (Rs 1416) and losartan (Rs 1365) were the most expensive drugs in terms of annual drug acquisition costs.\r\n",
      "\r\n"
     ]
    }
   ],
   "source": [
    "!cat KeywordSentences2.txt"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "## Experimenting with Sentiment Analysis"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 222,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator tokenize\n",
      "[main] INFO edu.stanford.nlp.pipeline.TokenizerAnnotator - No tokenizer type provided. Defaulting to PTBTokenizer.\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator ssplit\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator pos\n",
      "[main] INFO edu.stanford.nlp.tagger.maxent.MaxentTagger - Loading POS tagger from edu/stanford/nlp/models/pos-tagger/english-left3words/english-left3words-distsim.tagger ... done [1.4 sec].\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator lemma\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator ner\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.all.3class.distsim.crf.ser.gz ... done [2.0 sec].\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.muc.7class.distsim.crf.ser.gz ... done [1.8 sec].\n",
      "[main] INFO edu.stanford.nlp.ie.AbstractSequenceClassifier - Loading classifier from edu/stanford/nlp/models/ner/english.conll.4class.distsim.crf.ser.gz ... done [0.8 sec].\n",
      "[main] INFO edu.stanford.nlp.time.JollyDayHolidays - Initializing JollyDayHoliday for SUTime from classpath edu/stanford/nlp/models/sutime/jollyday/Holidays_sutime.xml as sutime.binder.1.\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator parse\n",
      "[main] INFO edu.stanford.nlp.parser.common.ParserGrammar - Loading parser from serialized file edu/stanford/nlp/models/lexparser/englishPCFG.ser.gz ... done [0.5 sec].\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator dcoref\n",
      "[main] INFO edu.stanford.nlp.pipeline.StanfordCoreNLP - Adding annotator sentiment\n",
      "\n",
      "Processing file /Users/lisabarcelo/Desktop/W266/food_drug_interaction/drafts/KeywordSentences2.txt ... writing to /Users/lisabarcelo/Desktop/W266/food_drug_interaction/drafts/KeywordSentences2.txt.out\n",
      "Annotating file /Users/lisabarcelo/Desktop/W266/food_drug_interaction/drafts/KeywordSentences2.txt ... done [74.5 sec].\n",
      "\n",
      "Annotation pipeline timing information:\n",
      "TokenizerAnnotator: 0.1 sec.\n",
      "WordsToSentencesAnnotator: 0.0 sec.\n",
      "POSTaggerAnnotator: 0.5 sec.\n",
      "MorphaAnnotator: 0.1 sec.\n",
      "NERCombinerAnnotator: 6.4 sec.\n",
      "ParserAnnotator: 55.9 sec.\n",
      "DeterministicCorefAnnotator: 11.1 sec.\n",
      "SentimentAnnotator: 0.4 sec.\n",
      "TOTAL: 74.5 sec. for 4353 tokens at 58.4 tokens/sec.\n",
      "Pipeline setup: 10.7 sec.\n",
      "Total time for StanfordCoreNLP pipeline: 85.4 sec.\n"
     ]
    }
   ],
   "source": [
    "!java -cp \"*\" -Xmx2g edu.stanford.nlp.pipeline.StanfordCoreNLP -annotators tokenize,ssplit,pos,lemma,ner,parse,dcoref,sentiment -file KeywordSentences2.txt -outputFormat text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 223,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Sentence #1 (32 tokens, sentiment: Negative):\n",
      "A number of experimental and clinical investigations support the notion that angiotensin-converting enzyme inhibitor (ACEi) and angiotensin II type 1 receptor blocker (ARB) compounds attenuate renal fibrosis.\n",
      "[Text=A CharacterOffsetBegin=0 CharacterOffsetEnd=1 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=number CharacterOffsetBegin=2 CharacterOffsetEnd=8 PartOfSpeech=NN Lemma=number NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=9 CharacterOffsetEnd=11 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=experimental CharacterOffsetBegin=12 CharacterOffsetEnd=24 PartOfSpeech=JJ Lemma=experimental NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=25 CharacterOffsetEnd=28 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=clinical CharacterOffsetBegin=29 CharacterOffsetEnd=37 PartOfSpeech=JJ Lemma=clinical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=investigations CharacterOffsetBegin=38 CharacterOffsetEnd=52 PartOfSpeech=NNS Lemma=investigation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=support CharacterOffsetBegin=53 CharacterOffsetEnd=60 PartOfSpeech=VBP Lemma=support NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=61 CharacterOffsetEnd=64 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=notion CharacterOffsetBegin=65 CharacterOffsetEnd=71 PartOfSpeech=NN Lemma=notion NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=72 CharacterOffsetEnd=76 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin-converting CharacterOffsetBegin=77 CharacterOffsetEnd=99 PartOfSpeech=JJ Lemma=angiotensin-converting NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=100 CharacterOffsetEnd=106 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=107 CharacterOffsetEnd=116 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=117 CharacterOffsetEnd=118 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACEi CharacterOffsetBegin=118 CharacterOffsetEnd=122 PartOfSpeech=NN Lemma=acei NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=122 CharacterOffsetEnd=123 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=124 CharacterOffsetEnd=127 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin CharacterOffsetBegin=128 CharacterOffsetEnd=139 PartOfSpeech=NN Lemma=angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=II CharacterOffsetBegin=140 CharacterOffsetEnd=142 PartOfSpeech=CD Lemma=ii NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=143 CharacterOffsetEnd=147 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1 CharacterOffsetBegin=148 CharacterOffsetEnd=149 PartOfSpeech=CD Lemma=1 NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=receptor CharacterOffsetBegin=150 CharacterOffsetEnd=158 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blocker CharacterOffsetBegin=159 CharacterOffsetEnd=166 PartOfSpeech=NN Lemma=blocker NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=167 CharacterOffsetEnd=168 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ARB CharacterOffsetBegin=168 CharacterOffsetEnd=171 PartOfSpeech=NN Lemma=arb NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=171 CharacterOffsetEnd=172 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compounds CharacterOffsetBegin=173 CharacterOffsetEnd=182 PartOfSpeech=NNS Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=attenuate CharacterOffsetBegin=183 CharacterOffsetEnd=192 PartOfSpeech=VBP Lemma=attenuate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=193 CharacterOffsetEnd=198 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=fibrosis CharacterOffsetBegin=199 CharacterOffsetEnd=207 PartOfSpeech=NN Lemma=fibrosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=207 CharacterOffsetEnd=208 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT A) (NN number))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ experimental)\n",
      "          (CC and)\n",
      "          (JJ clinical) (NNS investigations))))\n",
      "    (VP (VBP support)\n",
      "      (NP (DT the) (NN notion))\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (JJ angiotensin-converting) (NN enzyme) (NN inhibitor))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NN ACEi))\n",
      "                (-RRB- -RRB-)))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (NN angiotensin) (CD II))\n",
      "              (NP\n",
      "                (ADJP (NN type) (CD 1))\n",
      "                (NN receptor) (NN blocker)\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN ARB))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NNS compounds))))\n",
      "          (VP (VBP attenuate)\n",
      "            (NP (JJ renal) (NN fibrosis))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, support-8)\n",
      "det:qmod(investigations-7, A-1)\n",
      "mwe(A-1, number-2)\n",
      "mwe(A-1, of-3)\n",
      "amod(investigations-7, experimental-4)\n",
      "cc(experimental-4, and-5)\n",
      "conj:and(experimental-4, clinical-6)\n",
      "amod(investigations-7, clinical-6)\n",
      "nsubj(support-8, investigations-7)\n",
      "det(notion-10, the-9)\n",
      "dobj(support-8, notion-10)\n",
      "mark(attenuate-29, that-11)\n",
      "amod(inhibitor-14, angiotensin-converting-12)\n",
      "compound(inhibitor-14, enzyme-13)\n",
      "nsubj(attenuate-29, inhibitor-14)\n",
      "punct(ACEi-16, -LRB--15)\n",
      "appos(inhibitor-14, ACEi-16)\n",
      "punct(ACEi-16, -RRB--17)\n",
      "cc(inhibitor-14, and-18)\n",
      "conj:and(inhibitor-14, angiotensin-19)\n",
      "nsubj(attenuate-29, angiotensin-19)\n",
      "nummod(angiotensin-19, II-20)\n",
      "amod(compounds-28, type-21)\n",
      "compound(type-21, 1-22)\n",
      "compound(compounds-28, receptor-23)\n",
      "compound(compounds-28, blocker-24)\n",
      "punct(ARB-26, -LRB--25)\n",
      "appos(compounds-28, ARB-26)\n",
      "punct(ARB-26, -RRB--27)\n",
      "dep(angiotensin-19, compounds-28)\n",
      "ccomp(support-8, attenuate-29)\n",
      "amod(fibrosis-31, renal-30)\n",
      "dobj(attenuate-29, fibrosis-31)\n",
      "punct(support-8, .-32)\n",
      "\n",
      "Sentence #2 (14 tokens, sentiment: Negative):\n",
      "Fibrosis can be attenuated by either suppressing matrix formation or facilitating matrix degradation.\n",
      "[Text=Fibrosis CharacterOffsetBegin=209 CharacterOffsetEnd=217 PartOfSpeech=NN Lemma=fibrosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=can CharacterOffsetBegin=218 CharacterOffsetEnd=221 PartOfSpeech=MD Lemma=can NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=222 CharacterOffsetEnd=224 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=attenuated CharacterOffsetBegin=225 CharacterOffsetEnd=235 PartOfSpeech=VBN Lemma=attenuate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=236 CharacterOffsetEnd=238 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=either CharacterOffsetBegin=239 CharacterOffsetEnd=245 PartOfSpeech=CC Lemma=either NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=suppressing CharacterOffsetBegin=246 CharacterOffsetEnd=257 PartOfSpeech=VBG Lemma=suppress NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=258 CharacterOffsetEnd=264 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=formation CharacterOffsetBegin=265 CharacterOffsetEnd=274 PartOfSpeech=NN Lemma=formation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=275 CharacterOffsetEnd=277 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=facilitating CharacterOffsetBegin=278 CharacterOffsetEnd=290 PartOfSpeech=VBG Lemma=facilitate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=291 CharacterOffsetEnd=297 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degradation CharacterOffsetBegin=298 CharacterOffsetEnd=309 PartOfSpeech=NN Lemma=degradation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=309 CharacterOffsetEnd=310 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Fibrosis))\n",
      "    (VP (MD can)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN attenuated)\n",
      "          (PP (IN by)\n",
      "            (S\n",
      "              (VP (CC either)\n",
      "                (VP (VBG suppressing)\n",
      "                  (NP (NN matrix) (NN formation)))\n",
      "                (CC or)\n",
      "                (VP (VBG facilitating)\n",
      "                  (NP (NN matrix) (NN degradation)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, attenuated-4)\n",
      "nsubjpass(attenuated-4, Fibrosis-1)\n",
      "aux(attenuated-4, can-2)\n",
      "auxpass(attenuated-4, be-3)\n",
      "mark(suppressing-7, by-5)\n",
      "cc:preconj(suppressing-7, either-6)\n",
      "advcl:by(attenuated-4, suppressing-7)\n",
      "compound(formation-9, matrix-8)\n",
      "dobj(suppressing-7, formation-9)\n",
      "cc(suppressing-7, or-10)\n",
      "advcl:by(attenuated-4, facilitating-11)\n",
      "conj:or(suppressing-7, facilitating-11)\n",
      "compound(degradation-13, matrix-12)\n",
      "dobj(facilitating-11, degradation-13)\n",
      "punct(attenuated-4, .-14)\n",
      "\n",
      "Sentence #3 (23 tokens, sentiment: Negative):\n",
      "In this study, drugs of ACEi and ARB classes were tested for their ability to facilitate matrix degradation in the kidney.\n",
      "[Text=In CharacterOffsetBegin=311 CharacterOffsetEnd=313 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=314 CharacterOffsetEnd=318 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=319 CharacterOffsetEnd=324 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=324 CharacterOffsetEnd=325 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=326 CharacterOffsetEnd=331 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=332 CharacterOffsetEnd=334 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACEi CharacterOffsetBegin=335 CharacterOffsetEnd=339 PartOfSpeech=NN Lemma=acei NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=340 CharacterOffsetEnd=343 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ARB CharacterOffsetBegin=344 CharacterOffsetEnd=347 PartOfSpeech=NN Lemma=arb NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=classes CharacterOffsetBegin=348 CharacterOffsetEnd=355 PartOfSpeech=NNS Lemma=class NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=356 CharacterOffsetEnd=360 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tested CharacterOffsetBegin=361 CharacterOffsetEnd=367 PartOfSpeech=VBN Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=368 CharacterOffsetEnd=371 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=their CharacterOffsetBegin=372 CharacterOffsetEnd=377 PartOfSpeech=PRP$ Lemma=they NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ability CharacterOffsetBegin=378 CharacterOffsetEnd=385 PartOfSpeech=NN Lemma=ability NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=386 CharacterOffsetEnd=388 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=facilitate CharacterOffsetBegin=389 CharacterOffsetEnd=399 PartOfSpeech=VB Lemma=facilitate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=400 CharacterOffsetEnd=406 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degradation CharacterOffsetBegin=407 CharacterOffsetEnd=418 PartOfSpeech=NN Lemma=degradation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=419 CharacterOffsetEnd=421 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=422 CharacterOffsetEnd=425 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kidney CharacterOffsetBegin=426 CharacterOffsetEnd=432 PartOfSpeech=NN Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=432 CharacterOffsetEnd=433 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (DT this) (NN study)))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NNS drugs))\n",
      "      (PP (IN of)\n",
      "        (NP (NN ACEi)\n",
      "          (CC and)\n",
      "          (NN ARB) (NNS classes))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN tested)\n",
      "        (PP (IN for)\n",
      "          (NP (PRP$ their) (NN ability)\n",
      "            (S\n",
      "              (VP (TO to)\n",
      "                (VP (VB facilitate)\n",
      "                  (NP (NN matrix) (NN degradation))\n",
      "                  (PP (IN in)\n",
      "                    (NP (DT the) (NN kidney))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, tested-12)\n",
      "case(study-3, In-1)\n",
      "det(study-3, this-2)\n",
      "nmod:in(tested-12, study-3)\n",
      "punct(tested-12, ,-4)\n",
      "nsubjpass(tested-12, drugs-5)\n",
      "case(classes-10, of-6)\n",
      "compound(classes-10, ACEi-7)\n",
      "cc(ACEi-7, and-8)\n",
      "conj:and(ACEi-7, ARB-9)\n",
      "compound(classes-10, ARB-9)\n",
      "nmod:of(drugs-5, classes-10)\n",
      "auxpass(tested-12, were-11)\n",
      "case(ability-15, for-13)\n",
      "nmod:poss(ability-15, their-14)\n",
      "nmod:for(tested-12, ability-15)\n",
      "mark(facilitate-17, to-16)\n",
      "acl:to(ability-15, facilitate-17)\n",
      "compound(degradation-19, matrix-18)\n",
      "dobj(facilitate-17, degradation-19)\n",
      "case(kidney-22, in-20)\n",
      "det(kidney-22, the-21)\n",
      "nmod:in(facilitate-17, kidney-22)\n",
      "punct(tested-12, .-23)\n",
      "\n",
      "Sentence #4 (26 tokens, sentiment: Negative):\n",
      "A murine model system in which cyclosporin A (CsA) treatment for a specified period caused interstitial matrix deposition in the kidney was used.\n",
      "[Text=A CharacterOffsetBegin=434 CharacterOffsetEnd=435 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=murine CharacterOffsetBegin=436 CharacterOffsetEnd=442 PartOfSpeech=JJ Lemma=murine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=443 CharacterOffsetEnd=448 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=system CharacterOffsetBegin=449 CharacterOffsetEnd=455 PartOfSpeech=NN Lemma=system NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=456 CharacterOffsetEnd=458 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=which CharacterOffsetBegin=459 CharacterOffsetEnd=464 PartOfSpeech=WDT Lemma=which NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cyclosporin CharacterOffsetBegin=465 CharacterOffsetEnd=476 PartOfSpeech=NN Lemma=cyclosporin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=A CharacterOffsetBegin=477 CharacterOffsetEnd=478 PartOfSpeech=NN Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=479 CharacterOffsetEnd=480 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=CsA CharacterOffsetBegin=480 CharacterOffsetEnd=483 PartOfSpeech=NN Lemma=csa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=483 CharacterOffsetEnd=484 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=treatment CharacterOffsetBegin=485 CharacterOffsetEnd=494 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=495 CharacterOffsetEnd=498 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=499 CharacterOffsetEnd=500 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=specified CharacterOffsetBegin=501 CharacterOffsetEnd=510 PartOfSpeech=JJ Lemma=specified NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=period CharacterOffsetBegin=511 CharacterOffsetEnd=517 PartOfSpeech=NN Lemma=period NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=caused CharacterOffsetBegin=518 CharacterOffsetEnd=524 PartOfSpeech=VBD Lemma=cause NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=interstitial CharacterOffsetBegin=525 CharacterOffsetEnd=537 PartOfSpeech=JJ Lemma=interstitial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=538 CharacterOffsetEnd=544 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=deposition CharacterOffsetBegin=545 CharacterOffsetEnd=555 PartOfSpeech=NN Lemma=deposition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=556 CharacterOffsetEnd=558 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=559 CharacterOffsetEnd=562 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kidney CharacterOffsetBegin=563 CharacterOffsetEnd=569 PartOfSpeech=NN Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=570 CharacterOffsetEnd=573 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=574 CharacterOffsetEnd=578 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=578 CharacterOffsetEnd=579 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT A) (JJ murine) (NN model) (NN system))\n",
      "      (SBAR\n",
      "        (WHPP (IN in)\n",
      "          (WHNP (WDT which)))\n",
      "        (S\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NN cyclosporin) (NN A))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN CsA))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (NN treatment))\n",
      "            (PP (IN for)\n",
      "              (NP (DT a) (JJ specified) (NN period))))\n",
      "          (VP (VBD caused)\n",
      "            (NP (JJ interstitial) (NN matrix) (NN deposition))\n",
      "            (PP (IN in)\n",
      "              (NP (DT the) (NN kidney)))))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN used)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, used-25)\n",
      "det(system-4, A-1)\n",
      "amod(system-4, murine-2)\n",
      "compound(system-4, model-3)\n",
      "nmod:in(caused-17, system-4)\n",
      "nsubjpass(used-25, system-4)\n",
      "case(which-6, in-5)\n",
      "ref(system-4, which-6)\n",
      "compound(A-8, cyclosporin-7)\n",
      "compound(treatment-12, A-8)\n",
      "punct(CsA-10, -LRB--9)\n",
      "appos(A-8, CsA-10)\n",
      "punct(CsA-10, -RRB--11)\n",
      "nsubj(caused-17, treatment-12)\n",
      "case(period-16, for-13)\n",
      "det(period-16, a-14)\n",
      "amod(period-16, specified-15)\n",
      "nmod:for(treatment-12, period-16)\n",
      "acl:relcl(system-4, caused-17)\n",
      "amod(deposition-20, interstitial-18)\n",
      "compound(deposition-20, matrix-19)\n",
      "dobj(caused-17, deposition-20)\n",
      "case(kidney-23, in-21)\n",
      "det(kidney-23, the-22)\n",
      "nmod:in(caused-17, kidney-23)\n",
      "auxpass(used-25, was-24)\n",
      "punct(used-25, .-26)\n",
      "\n",
      "Sentence #5 (15 tokens, sentiment: Negative):\n",
      "CsA was then discontinued, and experimental procedures were initiated to investigate matrix degradation.\n",
      "[Text=CsA CharacterOffsetBegin=580 CharacterOffsetEnd=583 PartOfSpeech=NN Lemma=csa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=584 CharacterOffsetEnd=587 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=then CharacterOffsetBegin=588 CharacterOffsetEnd=592 PartOfSpeech=RB Lemma=then NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=discontinued CharacterOffsetBegin=593 CharacterOffsetEnd=605 PartOfSpeech=VBN Lemma=discontinue NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=605 CharacterOffsetEnd=606 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=607 CharacterOffsetEnd=610 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=experimental CharacterOffsetBegin=611 CharacterOffsetEnd=623 PartOfSpeech=JJ Lemma=experimental NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=procedures CharacterOffsetBegin=624 CharacterOffsetEnd=634 PartOfSpeech=NNS Lemma=procedure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=635 CharacterOffsetEnd=639 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=initiated CharacterOffsetBegin=640 CharacterOffsetEnd=649 PartOfSpeech=VBN Lemma=initiate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=650 CharacterOffsetEnd=652 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=investigate CharacterOffsetBegin=653 CharacterOffsetEnd=664 PartOfSpeech=VB Lemma=investigate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=665 CharacterOffsetEnd=671 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degradation CharacterOffsetBegin=672 CharacterOffsetEnd=683 PartOfSpeech=NN Lemma=degradation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=683 CharacterOffsetEnd=684 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN CsA))\n",
      "      (VP (VBD was)\n",
      "        (VP\n",
      "          (ADVP (RB then))\n",
      "          (VBN discontinued))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ experimental) (NNS procedures))\n",
      "      (VP (VBD were)\n",
      "        (VP (VBN initiated)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB investigate)\n",
      "                (NP (NN matrix) (NN degradation))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, discontinued-4)\n",
      "nsubjpass(discontinued-4, CsA-1)\n",
      "auxpass(discontinued-4, was-2)\n",
      "advmod(discontinued-4, then-3)\n",
      "punct(discontinued-4, ,-5)\n",
      "cc(discontinued-4, and-6)\n",
      "amod(procedures-8, experimental-7)\n",
      "nsubjpass(initiated-10, procedures-8)\n",
      "nsubj:xsubj(investigate-12, procedures-8)\n",
      "auxpass(initiated-10, were-9)\n",
      "conj:and(discontinued-4, initiated-10)\n",
      "mark(investigate-12, to-11)\n",
      "xcomp(initiated-10, investigate-12)\n",
      "compound(degradation-14, matrix-13)\n",
      "dobj(investigate-12, degradation-14)\n",
      "punct(discontinued-4, .-15)\n",
      "\n",
      "Sentence #6 (33 tokens, sentiment: Negative):\n",
      "Benazepril, an ACEi, facilitated matrix degradation via the bradykinin (BK) B2 receptor on tubular epithelial cells in the kidney, whereas CGP-48933, an ARB, did not.\n",
      "[Text=Benazepril CharacterOffsetBegin=685 CharacterOffsetEnd=695 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=PERSON SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=695 CharacterOffsetEnd=696 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=697 CharacterOffsetEnd=699 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACEi CharacterOffsetBegin=700 CharacterOffsetEnd=704 PartOfSpeech=NN Lemma=acei NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=704 CharacterOffsetEnd=705 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=facilitated CharacterOffsetBegin=706 CharacterOffsetEnd=717 PartOfSpeech=VBD Lemma=facilitate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=718 CharacterOffsetEnd=724 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degradation CharacterOffsetBegin=725 CharacterOffsetEnd=736 PartOfSpeech=NN Lemma=degradation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=via CharacterOffsetBegin=737 CharacterOffsetEnd=740 PartOfSpeech=IN Lemma=via NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=741 CharacterOffsetEnd=744 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=bradykinin CharacterOffsetBegin=745 CharacterOffsetEnd=755 PartOfSpeech=NN Lemma=bradykinin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=756 CharacterOffsetEnd=757 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BK CharacterOffsetBegin=757 CharacterOffsetEnd=759 PartOfSpeech=NN Lemma=bk NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=759 CharacterOffsetEnd=760 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=B2 CharacterOffsetBegin=761 CharacterOffsetEnd=763 PartOfSpeech=NN Lemma=b2 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=receptor CharacterOffsetBegin=764 CharacterOffsetEnd=772 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=773 CharacterOffsetEnd=775 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tubular CharacterOffsetBegin=776 CharacterOffsetEnd=783 PartOfSpeech=JJ Lemma=tubular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=epithelial CharacterOffsetBegin=784 CharacterOffsetEnd=794 PartOfSpeech=JJ Lemma=epithelial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=795 CharacterOffsetEnd=800 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=801 CharacterOffsetEnd=803 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=804 CharacterOffsetEnd=807 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kidney CharacterOffsetBegin=808 CharacterOffsetEnd=814 PartOfSpeech=NN Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=814 CharacterOffsetEnd=815 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=whereas CharacterOffsetBegin=816 CharacterOffsetEnd=823 PartOfSpeech=IN Lemma=whereas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=CGP-48933 CharacterOffsetBegin=824 CharacterOffsetEnd=833 PartOfSpeech=NN Lemma=cgp-48933 NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=833 CharacterOffsetEnd=834 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=835 CharacterOffsetEnd=837 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ARB CharacterOffsetBegin=838 CharacterOffsetEnd=841 PartOfSpeech=NN Lemma=arb NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=841 CharacterOffsetEnd=842 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=did CharacterOffsetBegin=843 CharacterOffsetEnd=846 PartOfSpeech=VBD Lemma=do NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=not CharacterOffsetBegin=847 CharacterOffsetEnd=850 PartOfSpeech=RB Lemma=not NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=. CharacterOffsetBegin=850 CharacterOffsetEnd=851 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNP Benazepril))\n",
      "      (, ,)\n",
      "      (NP (DT an) (NN ACEi))\n",
      "      (, ,))\n",
      "    (VP (VBD facilitated)\n",
      "      (NP\n",
      "        (NP (NN matrix) (NN degradation))\n",
      "        (PP (IN via)\n",
      "          (NP (DT the) (NN bradykinin)))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NN BK))\n",
      "          (-RRB- -RRB-))\n",
      "        (NP\n",
      "          (NP (NN B2) (NN receptor))\n",
      "          (PP (IN on)\n",
      "            (NP\n",
      "              (NP (JJ tubular) (JJ epithelial) (NNS cells))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN kidney))\n",
      "                  (, ,)\n",
      "                  (SBAR (IN whereas)\n",
      "                    (S\n",
      "                      (NP\n",
      "                        (NP (NN CGP-48933))\n",
      "                        (, ,)\n",
      "                        (NP (DT an) (NN ARB))\n",
      "                        (, ,))\n",
      "                      (VP (VBD did) (RB not)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, facilitated-6)\n",
      "nsubj(facilitated-6, Benazepril-1)\n",
      "punct(Benazepril-1, ,-2)\n",
      "det(ACEi-4, an-3)\n",
      "appos(Benazepril-1, ACEi-4)\n",
      "punct(Benazepril-1, ,-5)\n",
      "compound(degradation-8, matrix-7)\n",
      "dobj(facilitated-6, degradation-8)\n",
      "case(bradykinin-11, via-9)\n",
      "det(bradykinin-11, the-10)\n",
      "nmod:via(degradation-8, bradykinin-11)\n",
      "punct(BK-13, -LRB--12)\n",
      "appos(degradation-8, BK-13)\n",
      "punct(BK-13, -RRB--14)\n",
      "compound(receptor-16, B2-15)\n",
      "dep(degradation-8, receptor-16)\n",
      "case(cells-20, on-17)\n",
      "amod(cells-20, tubular-18)\n",
      "amod(cells-20, epithelial-19)\n",
      "nmod:on(receptor-16, cells-20)\n",
      "case(kidney-23, in-21)\n",
      "det(kidney-23, the-22)\n",
      "nmod:in(cells-20, kidney-23)\n",
      "punct(kidney-23, ,-24)\n",
      "mark(did-31, whereas-25)\n",
      "nsubj(did-31, CGP-48933-26)\n",
      "punct(CGP-48933-26, ,-27)\n",
      "det(ARB-29, an-28)\n",
      "appos(CGP-48933-26, ARB-29)\n",
      "punct(CGP-48933-26, ,-30)\n",
      "acl:relcl(kidney-23, did-31)\n",
      "neg(did-31, not-32)\n",
      "punct(facilitated-6, .-33)\n",
      "\n",
      "Sentence #7 (43 tokens, sentiment: Very negative):\n",
      "In this murine model of CsA nephropathy under ACE blockade, plasminogen activator inhibitor-1 (PAI-1) expression was decreased in tubular epithelial cells, possibly leading to conversion of plasminogen to plasmin by plasminogen activator and subsequent activation of matrix metalloproteinases.\n",
      "[Text=In CharacterOffsetBegin=852 CharacterOffsetEnd=854 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=855 CharacterOffsetEnd=859 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=murine CharacterOffsetBegin=860 CharacterOffsetEnd=866 PartOfSpeech=JJ Lemma=murine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=867 CharacterOffsetEnd=872 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=873 CharacterOffsetEnd=875 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=CsA CharacterOffsetBegin=876 CharacterOffsetEnd=879 PartOfSpeech=NN Lemma=csa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephropathy CharacterOffsetBegin=880 CharacterOffsetEnd=891 PartOfSpeech=NN Lemma=nephropathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=under CharacterOffsetBegin=892 CharacterOffsetEnd=897 PartOfSpeech=IN Lemma=under NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=898 CharacterOffsetEnd=901 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blockade CharacterOffsetBegin=902 CharacterOffsetEnd=910 PartOfSpeech=NN Lemma=blockade NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=910 CharacterOffsetEnd=911 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasminogen CharacterOffsetBegin=912 CharacterOffsetEnd=923 PartOfSpeech=NN Lemma=plasminogen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activator CharacterOffsetBegin=924 CharacterOffsetEnd=933 PartOfSpeech=NN Lemma=activator NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor-1 CharacterOffsetBegin=934 CharacterOffsetEnd=945 PartOfSpeech=NN Lemma=inhibitor-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=946 CharacterOffsetEnd=947 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=947 CharacterOffsetEnd=952 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=952 CharacterOffsetEnd=953 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=954 CharacterOffsetEnd=964 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=965 CharacterOffsetEnd=968 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=decreased CharacterOffsetBegin=969 CharacterOffsetEnd=978 PartOfSpeech=VBN Lemma=decrease NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=979 CharacterOffsetEnd=981 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tubular CharacterOffsetBegin=982 CharacterOffsetEnd=989 PartOfSpeech=JJ Lemma=tubular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=epithelial CharacterOffsetBegin=990 CharacterOffsetEnd=1000 PartOfSpeech=JJ Lemma=epithelial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=1001 CharacterOffsetEnd=1006 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1006 CharacterOffsetEnd=1007 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=possibly CharacterOffsetBegin=1008 CharacterOffsetEnd=1016 PartOfSpeech=RB Lemma=possibly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=leading CharacterOffsetBegin=1017 CharacterOffsetEnd=1024 PartOfSpeech=VBG Lemma=lead NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=1025 CharacterOffsetEnd=1027 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=conversion CharacterOffsetBegin=1028 CharacterOffsetEnd=1038 PartOfSpeech=NN Lemma=conversion NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1039 CharacterOffsetEnd=1041 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasminogen CharacterOffsetBegin=1042 CharacterOffsetEnd=1053 PartOfSpeech=NN Lemma=plasminogen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=1054 CharacterOffsetEnd=1056 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasmin CharacterOffsetBegin=1057 CharacterOffsetEnd=1064 PartOfSpeech=NN Lemma=plasmin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=1065 CharacterOffsetEnd=1067 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasminogen CharacterOffsetBegin=1068 CharacterOffsetEnd=1079 PartOfSpeech=NN Lemma=plasminogen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activator CharacterOffsetBegin=1080 CharacterOffsetEnd=1089 PartOfSpeech=NN Lemma=activator NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=1090 CharacterOffsetEnd=1093 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=subsequent CharacterOffsetBegin=1094 CharacterOffsetEnd=1104 PartOfSpeech=JJ Lemma=subsequent NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activation CharacterOffsetBegin=1105 CharacterOffsetEnd=1115 PartOfSpeech=NN Lemma=activation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1116 CharacterOffsetEnd=1118 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=1119 CharacterOffsetEnd=1125 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=metalloproteinases CharacterOffsetBegin=1126 CharacterOffsetEnd=1144 PartOfSpeech=NNS Lemma=metalloproteinase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=1144 CharacterOffsetEnd=1145 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP\n",
      "        (NP (DT this) (JJ murine) (NN model))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NN CsA) (NN nephropathy))\n",
      "            (PP (IN under)\n",
      "              (NP\n",
      "                (NP (NN ACE) (NN blockade))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN plasminogen) (NN activator) (NN inhibitor-1))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (NN PAI-1))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (NP (NN expression))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN decreased)\n",
      "        (PP (IN in)\n",
      "          (NP (JJ tubular) (JJ epithelial) (NNS cells)))\n",
      "        (, ,)\n",
      "        (S\n",
      "          (ADVP (RB possibly))\n",
      "          (VP (VBG leading)\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (NN conversion))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN plasminogen)))))\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NN plasmin))\n",
      "                  (PP (IN by)\n",
      "                    (NP (NN plasminogen) (NN activator))))\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (JJ subsequent) (NN activation))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN matrix) (NNS metalloproteinases))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, decreased-20)\n",
      "case(model-4, In-1)\n",
      "det(model-4, this-2)\n",
      "amod(model-4, murine-3)\n",
      "nmod:in(decreased-20, model-4)\n",
      "case(nephropathy-7, of-5)\n",
      "compound(nephropathy-7, CsA-6)\n",
      "nmod:of(model-4, nephropathy-7)\n",
      "case(blockade-10, under-8)\n",
      "compound(blockade-10, ACE-9)\n",
      "nmod:under(nephropathy-7, blockade-10)\n",
      "punct(blockade-10, ,-11)\n",
      "compound(inhibitor-1-14, plasminogen-12)\n",
      "compound(inhibitor-1-14, activator-13)\n",
      "appos(blockade-10, inhibitor-1-14)\n",
      "punct(PAI-1-16, -LRB--15)\n",
      "appos(inhibitor-1-14, PAI-1-16)\n",
      "punct(PAI-1-16, -RRB--17)\n",
      "nsubjpass(decreased-20, expression-18)\n",
      "auxpass(decreased-20, was-19)\n",
      "case(cells-24, in-21)\n",
      "amod(cells-24, tubular-22)\n",
      "amod(cells-24, epithelial-23)\n",
      "nmod:in(decreased-20, cells-24)\n",
      "punct(decreased-20, ,-25)\n",
      "advmod(leading-27, possibly-26)\n",
      "xcomp(decreased-20, leading-27)\n",
      "case(conversion-29, to-28)\n",
      "nmod:to(leading-27, conversion-29)\n",
      "case(plasminogen-31, of-30)\n",
      "nmod:of(conversion-29, plasminogen-31)\n",
      "case(plasmin-33, to-32)\n",
      "nmod:to(leading-27, plasmin-33)\n",
      "case(activator-36, by-34)\n",
      "compound(activator-36, plasminogen-35)\n",
      "nmod:by(plasmin-33, activator-36)\n",
      "cc(plasmin-33, and-37)\n",
      "amod(activation-39, subsequent-38)\n",
      "nmod:to(leading-27, activation-39)\n",
      "conj:and(plasmin-33, activation-39)\n",
      "case(metalloproteinases-42, of-40)\n",
      "compound(metalloproteinases-42, matrix-41)\n",
      "nmod:of(activation-39, metalloproteinases-42)\n",
      "punct(decreased-20, .-43)\n",
      "\n",
      "Sentence #8 (24 tokens, sentiment: Negative):\n",
      "These findings were confirmed in this study by measurements of plasmin activity, collagenolytic activity, and matrix metalloproteinase activities in the kidneys.\n",
      "[Text=These CharacterOffsetBegin=1146 CharacterOffsetEnd=1151 PartOfSpeech=DT Lemma=these NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=findings CharacterOffsetBegin=1152 CharacterOffsetEnd=1160 PartOfSpeech=NNS Lemma=finding NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=1161 CharacterOffsetEnd=1165 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=confirmed CharacterOffsetBegin=1166 CharacterOffsetEnd=1175 PartOfSpeech=VBN Lemma=confirm NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=1176 CharacterOffsetEnd=1178 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=1179 CharacterOffsetEnd=1183 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=1184 CharacterOffsetEnd=1189 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=1190 CharacterOffsetEnd=1192 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=measurements CharacterOffsetBegin=1193 CharacterOffsetEnd=1205 PartOfSpeech=NNS Lemma=measurement NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1206 CharacterOffsetEnd=1208 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasmin CharacterOffsetBegin=1209 CharacterOffsetEnd=1216 PartOfSpeech=JJ Lemma=plasmin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=1217 CharacterOffsetEnd=1225 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1225 CharacterOffsetEnd=1226 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=collagenolytic CharacterOffsetBegin=1227 CharacterOffsetEnd=1241 PartOfSpeech=JJ Lemma=collagenolytic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=1242 CharacterOffsetEnd=1250 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1250 CharacterOffsetEnd=1251 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=1252 CharacterOffsetEnd=1255 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=1256 CharacterOffsetEnd=1262 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=metalloproteinase CharacterOffsetBegin=1263 CharacterOffsetEnd=1280 PartOfSpeech=NN Lemma=metalloproteinase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activities CharacterOffsetBegin=1281 CharacterOffsetEnd=1291 PartOfSpeech=NNS Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=1292 CharacterOffsetEnd=1294 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=1295 CharacterOffsetEnd=1298 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kidneys CharacterOffsetBegin=1299 CharacterOffsetEnd=1306 PartOfSpeech=NNS Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=1306 CharacterOffsetEnd=1307 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT These) (NNS findings))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN confirmed)\n",
      "        (PP (IN in)\n",
      "          (NP (DT this) (NN study)))\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NNS measurements))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (JJ plasmin) (NN activity))\n",
      "                (, ,)\n",
      "                (NP (JJ collagenolytic) (NN activity))\n",
      "                (, ,)\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (NN matrix) (NN metalloproteinase) (NNS activities))\n",
      "                  (PP (IN in)\n",
      "                    (NP (DT the) (NNS kidneys))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, confirmed-4)\n",
      "det(findings-2, These-1)\n",
      "nsubjpass(confirmed-4, findings-2)\n",
      "auxpass(confirmed-4, were-3)\n",
      "case(study-7, in-5)\n",
      "det(study-7, this-6)\n",
      "nmod:in(confirmed-4, study-7)\n",
      "case(measurements-9, by-8)\n",
      "nmod:agent(confirmed-4, measurements-9)\n",
      "case(activity-12, of-10)\n",
      "amod(activity-12, plasmin-11)\n",
      "nmod:of(measurements-9, activity-12)\n",
      "punct(activity-12, ,-13)\n",
      "amod(activity-15, collagenolytic-14)\n",
      "nmod:of(measurements-9, activity-15)\n",
      "conj:and(activity-12, activity-15)\n",
      "punct(activity-12, ,-16)\n",
      "cc(activity-12, and-17)\n",
      "compound(activities-20, matrix-18)\n",
      "compound(activities-20, metalloproteinase-19)\n",
      "nmod:of(measurements-9, activities-20)\n",
      "conj:and(activity-12, activities-20)\n",
      "case(kidneys-23, in-21)\n",
      "det(kidneys-23, the-22)\n",
      "nmod:in(activities-20, kidneys-23)\n",
      "punct(confirmed-4, .-24)\n",
      "\n",
      "Sentence #9 (14 tokens, sentiment: Negative):\n",
      "In tubular epithelial cells stimulated in vitro, BK suppressed PAI-1 gene expression.\n",
      "[Text=In CharacterOffsetBegin=1308 CharacterOffsetEnd=1310 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tubular CharacterOffsetBegin=1311 CharacterOffsetEnd=1318 PartOfSpeech=JJ Lemma=tubular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=epithelial CharacterOffsetBegin=1319 CharacterOffsetEnd=1329 PartOfSpeech=JJ Lemma=epithelial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=1330 CharacterOffsetEnd=1335 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=stimulated CharacterOffsetBegin=1336 CharacterOffsetEnd=1346 PartOfSpeech=VBN Lemma=stimulate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=1347 CharacterOffsetEnd=1349 PartOfSpeech=FW Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=vitro CharacterOffsetBegin=1350 CharacterOffsetEnd=1355 PartOfSpeech=FW Lemma=vitro NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1355 CharacterOffsetEnd=1356 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BK CharacterOffsetBegin=1357 CharacterOffsetEnd=1359 PartOfSpeech=NN Lemma=bk NamedEntityTag=LOCATION SentimentClass=Neutral]\n",
      "[Text=suppressed CharacterOffsetBegin=1360 CharacterOffsetEnd=1370 PartOfSpeech=VBD Lemma=suppress NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=1371 CharacterOffsetEnd=1376 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=gene CharacterOffsetBegin=1377 CharacterOffsetEnd=1381 PartOfSpeech=NN Lemma=gene NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=1382 CharacterOffsetEnd=1392 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=1392 CharacterOffsetEnd=1393 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP\n",
      "        (NP (JJ tubular) (JJ epithelial) (NNS cells))\n",
      "        (VP (VBN stimulated)\n",
      "          (ADVP (FW in) (FW vitro)))))\n",
      "    (, ,)\n",
      "    (NP (NN BK))\n",
      "    (VP (VBD suppressed)\n",
      "      (NP (NN PAI-1) (NN gene) (NN expression)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, suppressed-10)\n",
      "case(cells-4, In-1)\n",
      "amod(cells-4, tubular-2)\n",
      "amod(cells-4, epithelial-3)\n",
      "nmod:in(suppressed-10, cells-4)\n",
      "acl(cells-4, stimulated-5)\n",
      "compound(vitro-7, in-6)\n",
      "advmod(stimulated-5, vitro-7)\n",
      "punct(suppressed-10, ,-8)\n",
      "nsubj(suppressed-10, BK-9)\n",
      "compound(expression-13, PAI-1-11)\n",
      "compound(expression-13, gene-12)\n",
      "dobj(suppressed-10, expression-13)\n",
      "punct(suppressed-10, .-14)\n",
      "\n",
      "Sentence #10 (29 tokens, sentiment: Negative):\n",
      "All of these results suggest that ACEi can decrease PAI-1 expression via BK, thereby facilitating matrix degradation via activation of degradative enzymes to reduce interstitial matrix deposition.\n",
      "[Text=All CharacterOffsetBegin=1394 CharacterOffsetEnd=1397 PartOfSpeech=DT Lemma=all NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1398 CharacterOffsetEnd=1400 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=these CharacterOffsetBegin=1401 CharacterOffsetEnd=1406 PartOfSpeech=DT Lemma=these NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=results CharacterOffsetBegin=1407 CharacterOffsetEnd=1414 PartOfSpeech=NNS Lemma=result NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=suggest CharacterOffsetBegin=1415 CharacterOffsetEnd=1422 PartOfSpeech=VBP Lemma=suggest NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=1423 CharacterOffsetEnd=1427 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACEi CharacterOffsetBegin=1428 CharacterOffsetEnd=1432 PartOfSpeech=NNS Lemma=aceus NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=can CharacterOffsetBegin=1433 CharacterOffsetEnd=1436 PartOfSpeech=MD Lemma=can NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=decrease CharacterOffsetBegin=1437 CharacterOffsetEnd=1445 PartOfSpeech=VB Lemma=decrease NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=1446 CharacterOffsetEnd=1451 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=1452 CharacterOffsetEnd=1462 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=via CharacterOffsetBegin=1463 CharacterOffsetEnd=1466 PartOfSpeech=IN Lemma=via NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BK CharacterOffsetBegin=1467 CharacterOffsetEnd=1469 PartOfSpeech=NNP Lemma=BK NamedEntityTag=LOCATION SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1469 CharacterOffsetEnd=1470 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=thereby CharacterOffsetBegin=1471 CharacterOffsetEnd=1478 PartOfSpeech=RB Lemma=thereby NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=facilitating CharacterOffsetBegin=1479 CharacterOffsetEnd=1491 PartOfSpeech=VBG Lemma=facilitate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=1492 CharacterOffsetEnd=1498 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degradation CharacterOffsetBegin=1499 CharacterOffsetEnd=1510 PartOfSpeech=NN Lemma=degradation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=via CharacterOffsetBegin=1511 CharacterOffsetEnd=1514 PartOfSpeech=IN Lemma=via NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activation CharacterOffsetBegin=1515 CharacterOffsetEnd=1525 PartOfSpeech=NN Lemma=activation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1526 CharacterOffsetEnd=1528 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degradative CharacterOffsetBegin=1529 CharacterOffsetEnd=1540 PartOfSpeech=JJ Lemma=degradative NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzymes CharacterOffsetBegin=1541 CharacterOffsetEnd=1548 PartOfSpeech=NNS Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=1549 CharacterOffsetEnd=1551 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduce CharacterOffsetBegin=1552 CharacterOffsetEnd=1558 PartOfSpeech=VB Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=interstitial CharacterOffsetBegin=1559 CharacterOffsetEnd=1571 PartOfSpeech=JJ Lemma=interstitial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=1572 CharacterOffsetEnd=1578 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=deposition CharacterOffsetBegin=1579 CharacterOffsetEnd=1589 PartOfSpeech=NN Lemma=deposition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=1589 CharacterOffsetEnd=1590 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT All))\n",
      "      (PP (IN of)\n",
      "        (NP (DT these) (NNS results))))\n",
      "    (VP (VBP suggest)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNS ACEi))\n",
      "          (VP (MD can)\n",
      "            (VP (VB decrease)\n",
      "              (NP\n",
      "                (NP (NN PAI-1) (NN expression))\n",
      "                (PP (IN via)\n",
      "                  (NP (NNP BK))))\n",
      "              (, ,)\n",
      "              (S\n",
      "                (ADVP (RB thereby))\n",
      "                (VP (VBG facilitating)\n",
      "                  (NP\n",
      "                    (NP (NN matrix) (NN degradation))\n",
      "                    (PP (IN via)\n",
      "                      (NP\n",
      "                        (NP (NN activation))\n",
      "                        (PP (IN of)\n",
      "                          (NP (JJ degradative) (NNS enzymes))))))\n",
      "                  (S\n",
      "                    (VP (TO to)\n",
      "                      (VP (VB reduce)\n",
      "                        (NP (JJ interstitial) (NN matrix) (NN deposition))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, suggest-5)\n",
      "det:qmod(results-4, All-1)\n",
      "mwe(All-1, of-2)\n",
      "det(results-4, these-3)\n",
      "nsubj(suggest-5, results-4)\n",
      "mark(decrease-9, that-6)\n",
      "nsubj(decrease-9, ACEi-7)\n",
      "aux(decrease-9, can-8)\n",
      "ccomp(suggest-5, decrease-9)\n",
      "compound(expression-11, PAI-1-10)\n",
      "dobj(decrease-9, expression-11)\n",
      "case(BK-13, via-12)\n",
      "nmod:via(expression-11, BK-13)\n",
      "punct(decrease-9, ,-14)\n",
      "advmod(facilitating-16, thereby-15)\n",
      "advcl(decrease-9, facilitating-16)\n",
      "compound(degradation-18, matrix-17)\n",
      "dobj(facilitating-16, degradation-18)\n",
      "case(activation-20, via-19)\n",
      "nmod:via(degradation-18, activation-20)\n",
      "case(enzymes-23, of-21)\n",
      "amod(enzymes-23, degradative-22)\n",
      "nmod:of(activation-20, enzymes-23)\n",
      "mark(reduce-25, to-24)\n",
      "advcl:to(facilitating-16, reduce-25)\n",
      "amod(deposition-28, interstitial-26)\n",
      "compound(deposition-28, matrix-27)\n",
      "dobj(reduce-25, deposition-28)\n",
      "punct(suggest-5, .-29)\n",
      "\n",
      "Sentence #11 (12 tokens, sentiment: Positive):\n",
      "Plasmin is an important factor in the degradation of extracellular matrix.\n",
      "[Text=Plasmin CharacterOffsetBegin=1592 CharacterOffsetEnd=1599 PartOfSpeech=NNP Lemma=Plasmin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=1600 CharacterOffsetEnd=1602 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=1603 CharacterOffsetEnd=1605 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=important CharacterOffsetBegin=1606 CharacterOffsetEnd=1615 PartOfSpeech=JJ Lemma=important NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=factor CharacterOffsetBegin=1616 CharacterOffsetEnd=1622 PartOfSpeech=NN Lemma=factor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=1623 CharacterOffsetEnd=1625 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=1626 CharacterOffsetEnd=1629 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degradation CharacterOffsetBegin=1630 CharacterOffsetEnd=1641 PartOfSpeech=NN Lemma=degradation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1642 CharacterOffsetEnd=1644 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extracellular CharacterOffsetBegin=1645 CharacterOffsetEnd=1658 PartOfSpeech=JJ Lemma=extracellular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=1659 CharacterOffsetEnd=1665 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=1665 CharacterOffsetEnd=1666 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Plasmin))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an) (JJ important) (NN factor))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN degradation))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ extracellular) (NN matrix)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, factor-5)\n",
      "nsubj(factor-5, Plasmin-1)\n",
      "cop(factor-5, is-2)\n",
      "det(factor-5, an-3)\n",
      "amod(factor-5, important-4)\n",
      "case(degradation-8, in-6)\n",
      "det(degradation-8, the-7)\n",
      "nmod:in(factor-5, degradation-8)\n",
      "case(matrix-11, of-9)\n",
      "amod(matrix-11, extracellular-10)\n",
      "nmod:of(degradation-8, matrix-11)\n",
      "punct(factor-5, .-12)\n",
      "\n",
      "Sentence #12 (63 tokens, sentiment: Negative):\n",
      "In the study reported here we examined the expression of plasminogen-activator inhibitor-1 (PAI-1), urokinase-type plasminogen activator (uPA), and uPA receptor (uPAR), as well as the relevance of such expression to the production of type IV collagen, a major component of extracellular matrix, in the renal tissue of rats with streptozotocin-induced diabetes.\n",
      "[Text=In CharacterOffsetBegin=1667 CharacterOffsetEnd=1669 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=1670 CharacterOffsetEnd=1673 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=1674 CharacterOffsetEnd=1679 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reported CharacterOffsetBegin=1680 CharacterOffsetEnd=1688 PartOfSpeech=VBD Lemma=report NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=here CharacterOffsetBegin=1689 CharacterOffsetEnd=1693 PartOfSpeech=RB Lemma=here NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=we CharacterOffsetBegin=1694 CharacterOffsetEnd=1696 PartOfSpeech=PRP Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=examined CharacterOffsetBegin=1697 CharacterOffsetEnd=1705 PartOfSpeech=VBD Lemma=examine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=1706 CharacterOffsetEnd=1709 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=1710 CharacterOffsetEnd=1720 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1721 CharacterOffsetEnd=1723 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasminogen-activator CharacterOffsetBegin=1724 CharacterOffsetEnd=1745 PartOfSpeech=JJ Lemma=plasminogen-activator NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor-1 CharacterOffsetBegin=1746 CharacterOffsetEnd=1757 PartOfSpeech=NN Lemma=inhibitor-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=1758 CharacterOffsetEnd=1759 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=1759 CharacterOffsetEnd=1764 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=1764 CharacterOffsetEnd=1765 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1765 CharacterOffsetEnd=1766 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=urokinase-type CharacterOffsetBegin=1767 CharacterOffsetEnd=1781 PartOfSpeech=JJ Lemma=urokinase-type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasminogen CharacterOffsetBegin=1782 CharacterOffsetEnd=1793 PartOfSpeech=NN Lemma=plasminogen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activator CharacterOffsetBegin=1794 CharacterOffsetEnd=1803 PartOfSpeech=NN Lemma=activator NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=1804 CharacterOffsetEnd=1805 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPA CharacterOffsetBegin=1805 CharacterOffsetEnd=1808 PartOfSpeech=NN Lemma=upa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=1808 CharacterOffsetEnd=1809 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1809 CharacterOffsetEnd=1810 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=1811 CharacterOffsetEnd=1814 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPA CharacterOffsetBegin=1815 CharacterOffsetEnd=1818 PartOfSpeech=NN Lemma=upa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=receptor CharacterOffsetBegin=1819 CharacterOffsetEnd=1827 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=1828 CharacterOffsetEnd=1829 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPAR CharacterOffsetBegin=1829 CharacterOffsetEnd=1833 PartOfSpeech=NN Lemma=upar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=1833 CharacterOffsetEnd=1834 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1834 CharacterOffsetEnd=1835 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=as CharacterOffsetBegin=1836 CharacterOffsetEnd=1838 PartOfSpeech=RB Lemma=as NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=well CharacterOffsetBegin=1839 CharacterOffsetEnd=1843 PartOfSpeech=RB Lemma=well NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=as CharacterOffsetBegin=1844 CharacterOffsetEnd=1846 PartOfSpeech=IN Lemma=as NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=1847 CharacterOffsetEnd=1850 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=relevance CharacterOffsetBegin=1851 CharacterOffsetEnd=1860 PartOfSpeech=NN Lemma=relevance NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1861 CharacterOffsetEnd=1863 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=such CharacterOffsetBegin=1864 CharacterOffsetEnd=1868 PartOfSpeech=JJ Lemma=such NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=1869 CharacterOffsetEnd=1879 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=1880 CharacterOffsetEnd=1882 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=1883 CharacterOffsetEnd=1886 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=production CharacterOffsetBegin=1887 CharacterOffsetEnd=1897 PartOfSpeech=NN Lemma=production NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1898 CharacterOffsetEnd=1900 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=1901 CharacterOffsetEnd=1905 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=IV CharacterOffsetBegin=1906 CharacterOffsetEnd=1908 PartOfSpeech=CD Lemma=iv NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=collagen CharacterOffsetBegin=1909 CharacterOffsetEnd=1917 PartOfSpeech=NN Lemma=collagen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1917 CharacterOffsetEnd=1918 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=1919 CharacterOffsetEnd=1920 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=major CharacterOffsetBegin=1921 CharacterOffsetEnd=1926 PartOfSpeech=JJ Lemma=major NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=component CharacterOffsetBegin=1927 CharacterOffsetEnd=1936 PartOfSpeech=NN Lemma=component NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1937 CharacterOffsetEnd=1939 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extracellular CharacterOffsetBegin=1940 CharacterOffsetEnd=1953 PartOfSpeech=JJ Lemma=extracellular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=1954 CharacterOffsetEnd=1960 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=1960 CharacterOffsetEnd=1961 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=1962 CharacterOffsetEnd=1964 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=1965 CharacterOffsetEnd=1968 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=1969 CharacterOffsetEnd=1974 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tissue CharacterOffsetBegin=1975 CharacterOffsetEnd=1981 PartOfSpeech=NN Lemma=tissue NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=1982 CharacterOffsetEnd=1984 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rats CharacterOffsetBegin=1985 CharacterOffsetEnd=1989 PartOfSpeech=NNS Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=1990 CharacterOffsetEnd=1994 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=streptozotocin-induced CharacterOffsetBegin=1995 CharacterOffsetEnd=2017 PartOfSpeech=JJ Lemma=streptozotocin-induced NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetes CharacterOffsetBegin=2018 CharacterOffsetEnd=2026 PartOfSpeech=NN Lemma=diabetes NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=2026 CharacterOffsetEnd=2027 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (SINV\n",
      "    (PP (IN In)\n",
      "      (NP (DT the) (NN study)))\n",
      "    (VP (VBD reported)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (ADVP (RB here))\n",
      "          (NP (PRP we))\n",
      "          (VP (VBD examined)\n",
      "            (NP\n",
      "              (NP (DT the) (NN expression))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (JJ plasminogen-activator) (NN inhibitor-1))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN PAI-1))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (JJ urokinase-type) (NN plasminogen) (NN activator))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN uPA))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (, ,)\n",
      "                    (CC and)\n",
      "                    (NP\n",
      "                      (NP (NN uPA) (NN receptor))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN uPAR))\n",
      "                        (-RRB- -RRB-))))\n",
      "                  (, ,)\n",
      "                  (CONJP (RB as) (RB well) (IN as))\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN relevance))\n",
      "                    (PP (IN of)\n",
      "                      (NP (JJ such) (NN expression)))))))\n",
      "            (PP (TO to)\n",
      "              (NP\n",
      "                (NP (DT the) (NN production))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN type)))))))))\n",
      "    (NP\n",
      "      (NP (CD IV) (NN collagen))\n",
      "      (, ,)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ major) (NN component))\n",
      "        (PP (IN of)\n",
      "          (NP (JJ extracellular) (NN matrix)))\n",
      "        (, ,)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ renal) (NN tissue))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NNS rats))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ streptozotocin-induced) (NN diabetes)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, reported-4)\n",
      "case(study-3, In-1)\n",
      "det(study-3, the-2)\n",
      "nmod:in(reported-4, study-3)\n",
      "advmod(examined-7, here-5)\n",
      "nsubj(examined-7, we-6)\n",
      "ccomp(reported-4, examined-7)\n",
      "det(expression-9, the-8)\n",
      "dobj(examined-7, expression-9)\n",
      "case(inhibitor-1-12, of-10)\n",
      "amod(inhibitor-1-12, plasminogen-activator-11)\n",
      "nmod:of(expression-9, inhibitor-1-12)\n",
      "punct(PAI-1-14, -LRB--13)\n",
      "appos(inhibitor-1-12, PAI-1-14)\n",
      "punct(PAI-1-14, -RRB--15)\n",
      "punct(inhibitor-1-12, ,-16)\n",
      "amod(activator-19, urokinase-type-17)\n",
      "compound(activator-19, plasminogen-18)\n",
      "nmod:of(expression-9, activator-19)\n",
      "conj:and(inhibitor-1-12, activator-19)\n",
      "punct(uPA-21, -LRB--20)\n",
      "appos(activator-19, uPA-21)\n",
      "punct(uPA-21, -RRB--22)\n",
      "punct(inhibitor-1-12, ,-23)\n",
      "cc(inhibitor-1-12, and-24)\n",
      "compound(receptor-26, uPA-25)\n",
      "nmod:of(expression-9, receptor-26)\n",
      "conj:and(inhibitor-1-12, receptor-26)\n",
      "punct(uPAR-28, -LRB--27)\n",
      "appos(receptor-26, uPAR-28)\n",
      "punct(uPAR-28, -RRB--29)\n",
      "punct(inhibitor-1-12, ,-30)\n",
      "cc(inhibitor-1-12, as-31)\n",
      "mwe(as-31, well-32)\n",
      "mwe(as-31, as-33)\n",
      "det(relevance-35, the-34)\n",
      "nmod:of(expression-9, relevance-35)\n",
      "conj:and(inhibitor-1-12, relevance-35)\n",
      "case(expression-38, of-36)\n",
      "amod(expression-38, such-37)\n",
      "nmod:of(relevance-35, expression-38)\n",
      "case(production-41, to-39)\n",
      "det(production-41, the-40)\n",
      "nmod:to(examined-7, production-41)\n",
      "case(type-43, of-42)\n",
      "nmod:of(production-41, type-43)\n",
      "nummod(collagen-45, IV-44)\n",
      "nsubj(reported-4, collagen-45)\n",
      "punct(collagen-45, ,-46)\n",
      "det(component-49, a-47)\n",
      "amod(component-49, major-48)\n",
      "appos(collagen-45, component-49)\n",
      "case(matrix-52, of-50)\n",
      "amod(matrix-52, extracellular-51)\n",
      "nmod:of(component-49, matrix-52)\n",
      "punct(component-49, ,-53)\n",
      "case(tissue-57, in-54)\n",
      "det(tissue-57, the-55)\n",
      "amod(tissue-57, renal-56)\n",
      "nmod:in(component-49, tissue-57)\n",
      "case(rats-59, of-58)\n",
      "nmod:of(tissue-57, rats-59)\n",
      "case(diabetes-62, with-60)\n",
      "amod(diabetes-62, streptozotocin-induced-61)\n",
      "nmod:with(rats-59, diabetes-62)\n",
      "punct(reported-4, .-63)\n",
      "\n",
      "Sentence #13 (46 tokens, sentiment: Negative):\n",
      "Because angiotensin II is involved in the synthesis of PAI-1 and uPA, we also examined the effect of benazepril, an angiotensin-converting-enzyme inhibitor, on the expression of PAI-1, uPA, and uPAR messenger RNAs (mRNAs) and type IV collagen protein.\n",
      "[Text=Because CharacterOffsetBegin=2028 CharacterOffsetEnd=2035 PartOfSpeech=IN Lemma=because NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin CharacterOffsetBegin=2036 CharacterOffsetEnd=2047 PartOfSpeech=NN Lemma=angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=II CharacterOffsetBegin=2048 CharacterOffsetEnd=2050 PartOfSpeech=CD Lemma=ii NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=2051 CharacterOffsetEnd=2053 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=involved CharacterOffsetBegin=2054 CharacterOffsetEnd=2062 PartOfSpeech=VBN Lemma=involve NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=2063 CharacterOffsetEnd=2065 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=2066 CharacterOffsetEnd=2069 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=synthesis CharacterOffsetBegin=2070 CharacterOffsetEnd=2079 PartOfSpeech=NN Lemma=synthesis NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=2080 CharacterOffsetEnd=2082 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=2083 CharacterOffsetEnd=2088 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2089 CharacterOffsetEnd=2092 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPA CharacterOffsetBegin=2093 CharacterOffsetEnd=2096 PartOfSpeech=NN Lemma=upa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2096 CharacterOffsetEnd=2097 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=we CharacterOffsetBegin=2098 CharacterOffsetEnd=2100 PartOfSpeech=PRP Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=also CharacterOffsetBegin=2101 CharacterOffsetEnd=2105 PartOfSpeech=RB Lemma=also NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=examined CharacterOffsetBegin=2106 CharacterOffsetEnd=2114 PartOfSpeech=VBD Lemma=examine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=2115 CharacterOffsetEnd=2118 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=2119 CharacterOffsetEnd=2125 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2126 CharacterOffsetEnd=2128 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=2129 CharacterOffsetEnd=2139 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2139 CharacterOffsetEnd=2140 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=2141 CharacterOffsetEnd=2143 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin-converting-enzyme CharacterOffsetBegin=2144 CharacterOffsetEnd=2173 PartOfSpeech=JJ Lemma=angiotensin-converting-enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=2174 CharacterOffsetEnd=2183 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2183 CharacterOffsetEnd=2184 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=2185 CharacterOffsetEnd=2187 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=2188 CharacterOffsetEnd=2191 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=2192 CharacterOffsetEnd=2202 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2203 CharacterOffsetEnd=2205 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=2206 CharacterOffsetEnd=2211 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2211 CharacterOffsetEnd=2212 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPA CharacterOffsetBegin=2213 CharacterOffsetEnd=2216 PartOfSpeech=NN Lemma=upa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2216 CharacterOffsetEnd=2217 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2218 CharacterOffsetEnd=2221 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPAR CharacterOffsetBegin=2222 CharacterOffsetEnd=2226 PartOfSpeech=NN Lemma=upar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=messenger CharacterOffsetBegin=2227 CharacterOffsetEnd=2236 PartOfSpeech=NN Lemma=messenger NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=RNAs CharacterOffsetBegin=2237 CharacterOffsetEnd=2241 PartOfSpeech=NNS Lemma=rna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=2242 CharacterOffsetEnd=2243 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mRNAs CharacterOffsetBegin=2243 CharacterOffsetEnd=2248 PartOfSpeech=NNS Lemma=mrna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=2248 CharacterOffsetEnd=2249 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2250 CharacterOffsetEnd=2253 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=2254 CharacterOffsetEnd=2258 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=IV CharacterOffsetBegin=2259 CharacterOffsetEnd=2261 PartOfSpeech=CD Lemma=iv NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=collagen CharacterOffsetBegin=2262 CharacterOffsetEnd=2270 PartOfSpeech=NN Lemma=collagen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=protein CharacterOffsetBegin=2271 CharacterOffsetEnd=2278 PartOfSpeech=NN Lemma=protein NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=2278 CharacterOffsetEnd=2279 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN Because)\n",
      "      (S\n",
      "        (NP (NN angiotensin) (CD II))\n",
      "        (VP (VBZ is)\n",
      "          (VP (VBN involved)\n",
      "            (PP (IN in)\n",
      "              (NP\n",
      "                (NP (DT the) (NN synthesis))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN PAI-1)\n",
      "                    (CC and)\n",
      "                    (NN uPA)))))))))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (ADVP (RB also))\n",
      "    (VP (VBD examined)\n",
      "      (NP\n",
      "        (NP (DT the) (NN effect))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NN benazepril))\n",
      "            (, ,)\n",
      "            (NP (DT an) (JJ angiotensin-converting-enzyme) (NN inhibitor))\n",
      "            (, ,))))\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (NN expression))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NN PAI-1))\n",
      "                (, ,)\n",
      "                (NP (NN uPA))\n",
      "                (, ,)\n",
      "                (CC and)\n",
      "                (NP (NN uPAR) (NN messenger) (NNS RNAs))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNS mRNAs))\n",
      "                  (-RRB- -RRB-)))))\n",
      "          (CC and)\n",
      "          (NP (NN type) (CD IV) (NN collagen) (NN protein)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, examined-16)\n",
      "mark(involved-5, Because-1)\n",
      "nsubjpass(involved-5, angiotensin-2)\n",
      "nummod(angiotensin-2, II-3)\n",
      "auxpass(involved-5, is-4)\n",
      "advcl:because(examined-16, involved-5)\n",
      "case(synthesis-8, in-6)\n",
      "det(synthesis-8, the-7)\n",
      "nmod:in(involved-5, synthesis-8)\n",
      "case(PAI-1-10, of-9)\n",
      "nmod:of(synthesis-8, PAI-1-10)\n",
      "cc(PAI-1-10, and-11)\n",
      "nmod:of(synthesis-8, uPA-12)\n",
      "conj:and(PAI-1-10, uPA-12)\n",
      "punct(examined-16, ,-13)\n",
      "nsubj(examined-16, we-14)\n",
      "advmod(examined-16, also-15)\n",
      "det(effect-18, the-17)\n",
      "dobj(examined-16, effect-18)\n",
      "case(benazepril-20, of-19)\n",
      "nmod:of(effect-18, benazepril-20)\n",
      "punct(benazepril-20, ,-21)\n",
      "det(inhibitor-24, an-22)\n",
      "amod(inhibitor-24, angiotensin-converting-enzyme-23)\n",
      "appos(benazepril-20, inhibitor-24)\n",
      "punct(benazepril-20, ,-25)\n",
      "case(expression-28, on-26)\n",
      "det(expression-28, the-27)\n",
      "nmod:on(examined-16, expression-28)\n",
      "case(PAI-1-30, of-29)\n",
      "nmod:of(expression-28, PAI-1-30)\n",
      "punct(PAI-1-30, ,-31)\n",
      "nmod:of(expression-28, uPA-32)\n",
      "conj:and(PAI-1-30, uPA-32)\n",
      "punct(PAI-1-30, ,-33)\n",
      "cc(PAI-1-30, and-34)\n",
      "compound(RNAs-37, uPAR-35)\n",
      "compound(RNAs-37, messenger-36)\n",
      "nmod:of(expression-28, RNAs-37)\n",
      "conj:and(PAI-1-30, RNAs-37)\n",
      "punct(mRNAs-39, -LRB--38)\n",
      "appos(PAI-1-30, mRNAs-39)\n",
      "punct(mRNAs-39, -RRB--40)\n",
      "cc(expression-28, and-41)\n",
      "compound(protein-45, type-42)\n",
      "nummod(protein-45, IV-43)\n",
      "compound(protein-45, collagen-44)\n",
      "nmod:on(examined-16, protein-45)\n",
      "conj:and(expression-28, protein-45)\n",
      "punct(examined-16, .-46)\n",
      "\n",
      "Sentence #14 (30 tokens, sentiment: Negative):\n",
      "Rats with streptozocin-induced diabetes-some untreated and some treated with 30 mg/L benazepril-and nondiabetic control rats were sacrificed at 4, 12, or 24 weeks after induction of diabetes.\n",
      "[Text=Rats CharacterOffsetBegin=2280 CharacterOffsetEnd=2284 PartOfSpeech=NNS Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=2285 CharacterOffsetEnd=2289 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=streptozocin-induced CharacterOffsetBegin=2290 CharacterOffsetEnd=2310 PartOfSpeech=JJ Lemma=streptozocin-induced NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetes-some CharacterOffsetBegin=2311 CharacterOffsetEnd=2324 PartOfSpeech=JJ Lemma=diabetes-some NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=untreated CharacterOffsetBegin=2325 CharacterOffsetEnd=2334 PartOfSpeech=JJ Lemma=untreated NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2335 CharacterOffsetEnd=2338 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=some CharacterOffsetBegin=2339 CharacterOffsetEnd=2343 PartOfSpeech=DT Lemma=some NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=treated CharacterOffsetBegin=2344 CharacterOffsetEnd=2351 PartOfSpeech=VBN Lemma=treat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=2352 CharacterOffsetEnd=2356 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=30 CharacterOffsetBegin=2357 CharacterOffsetEnd=2359 PartOfSpeech=CD Lemma=30 NamedEntityTag=NUMBER NormalizedNamedEntityTag=30.0 SentimentClass=Neutral]\n",
      "[Text=mg/L CharacterOffsetBegin=2360 CharacterOffsetEnd=2364 PartOfSpeech=NN Lemma=mg/l NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril-and CharacterOffsetBegin=2365 CharacterOffsetEnd=2379 PartOfSpeech=NN Lemma=benazepril-and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nondiabetic CharacterOffsetBegin=2380 CharacterOffsetEnd=2391 PartOfSpeech=JJ Lemma=nondiabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=control CharacterOffsetBegin=2392 CharacterOffsetEnd=2399 PartOfSpeech=NN Lemma=control NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rats CharacterOffsetBegin=2400 CharacterOffsetEnd=2404 PartOfSpeech=NNS Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=2405 CharacterOffsetEnd=2409 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=sacrificed CharacterOffsetBegin=2410 CharacterOffsetEnd=2420 PartOfSpeech=VBN Lemma=sacrifice NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=2421 CharacterOffsetEnd=2423 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=4 CharacterOffsetBegin=2424 CharacterOffsetEnd=2425 PartOfSpeech=CD Lemma=4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=4.0 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2425 CharacterOffsetEnd=2426 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=12 CharacterOffsetBegin=2427 CharacterOffsetEnd=2429 PartOfSpeech=CD Lemma=12 NamedEntityTag=NUMBER NormalizedNamedEntityTag=12.0 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2429 CharacterOffsetEnd=2430 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=2431 CharacterOffsetEnd=2433 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=24 CharacterOffsetBegin=2434 CharacterOffsetEnd=2436 PartOfSpeech=CD Lemma=24 NamedEntityTag=DURATION NormalizedNamedEntityTag=P24W Timex=<TIMEX3 tid=\"t1\" type=\"DURATION\" value=\"P24W\">24 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=weeks CharacterOffsetBegin=2437 CharacterOffsetEnd=2442 PartOfSpeech=NNS Lemma=week NamedEntityTag=DURATION NormalizedNamedEntityTag=P24W Timex=<TIMEX3 tid=\"t1\" type=\"DURATION\" value=\"P24W\">24 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=after CharacterOffsetBegin=2443 CharacterOffsetEnd=2448 PartOfSpeech=IN Lemma=after NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=induction CharacterOffsetBegin=2449 CharacterOffsetEnd=2458 PartOfSpeech=NN Lemma=induction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2459 CharacterOffsetEnd=2461 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetes CharacterOffsetBegin=2462 CharacterOffsetEnd=2470 PartOfSpeech=NN Lemma=diabetes NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=2470 CharacterOffsetEnd=2471 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS Rats))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ streptozocin-induced))\n",
      "            (ADJP (JJ diabetes-some) (JJ untreated)))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (DT some))\n",
      "            (VP (VBN treated)\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (NP (CD 30) (NN mg/L) (NN benazepril-and))\n",
      "                  (NP (JJ nondiabetic) (NN control) (NNS rats)))))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN sacrificed)\n",
      "        (PP (IN at)\n",
      "          (NP\n",
      "            (NP (CD 4))\n",
      "            (, ,)\n",
      "            (NP (CD 12))\n",
      "            (, ,)\n",
      "            (CC or)\n",
      "            (NP (CD 24) (NNS weeks))))\n",
      "        (PP (IN after)\n",
      "          (NP\n",
      "            (NP (NN induction))\n",
      "            (PP (IN of)\n",
      "              (NP (NN diabetes)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, sacrificed-17)\n",
      "nsubjpass(sacrificed-17, Rats-1)\n",
      "case(streptozocin-induced-3, with-2)\n",
      "nmod:with(Rats-1, streptozocin-induced-3)\n",
      "amod(untreated-5, diabetes-some-4)\n",
      "amod(streptozocin-induced-3, untreated-5)\n",
      "cc(streptozocin-induced-3, and-6)\n",
      "nmod:with(Rats-1, some-7)\n",
      "conj:and(streptozocin-induced-3, some-7)\n",
      "acl(some-7, treated-8)\n",
      "case(benazepril-and-12, with-9)\n",
      "nummod(benazepril-and-12, 30-10)\n",
      "compound(benazepril-and-12, mg/L-11)\n",
      "nmod:with(treated-8, benazepril-and-12)\n",
      "amod(rats-15, nondiabetic-13)\n",
      "compound(rats-15, control-14)\n",
      "dep(benazepril-and-12, rats-15)\n",
      "auxpass(sacrificed-17, were-16)\n",
      "case(4-19, at-18)\n",
      "nmod:at(sacrificed-17, 4-19)\n",
      "punct(4-19, ,-20)\n",
      "nmod:at(sacrificed-17, 12-21)\n",
      "conj:or(4-19, 12-21)\n",
      "punct(4-19, ,-22)\n",
      "cc(4-19, or-23)\n",
      "nummod(weeks-25, 24-24)\n",
      "nmod:at(sacrificed-17, weeks-25)\n",
      "conj:or(4-19, weeks-25)\n",
      "case(induction-27, after-26)\n",
      "nmod:after(sacrificed-17, induction-27)\n",
      "case(diabetes-29, of-28)\n",
      "nmod:of(induction-27, diabetes-29)\n",
      "punct(sacrificed-17, .-30)\n",
      "\n",
      "Sentence #15 (31 tokens, sentiment: Negative):\n",
      "We examined the expression of PAI-1, uPA, and uPAR mRNAs through the use of in situ hybridization and that of type IV collagen by means of immunohistochemical methods.\n",
      "[Text=We CharacterOffsetBegin=2472 CharacterOffsetEnd=2474 PartOfSpeech=PRP Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=examined CharacterOffsetBegin=2475 CharacterOffsetEnd=2483 PartOfSpeech=VBD Lemma=examine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=2484 CharacterOffsetEnd=2487 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=2488 CharacterOffsetEnd=2498 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2499 CharacterOffsetEnd=2501 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=2502 CharacterOffsetEnd=2507 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2507 CharacterOffsetEnd=2508 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPA CharacterOffsetBegin=2509 CharacterOffsetEnd=2512 PartOfSpeech=NN Lemma=upa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2512 CharacterOffsetEnd=2513 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2514 CharacterOffsetEnd=2517 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPAR CharacterOffsetBegin=2518 CharacterOffsetEnd=2522 PartOfSpeech=NN Lemma=upar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mRNAs CharacterOffsetBegin=2523 CharacterOffsetEnd=2528 PartOfSpeech=NNS Lemma=mrna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=through CharacterOffsetBegin=2529 CharacterOffsetEnd=2536 PartOfSpeech=IN Lemma=through NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=2537 CharacterOffsetEnd=2540 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=use CharacterOffsetBegin=2541 CharacterOffsetEnd=2544 PartOfSpeech=NN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2545 CharacterOffsetEnd=2547 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=2548 CharacterOffsetEnd=2550 PartOfSpeech=FW Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=situ CharacterOffsetBegin=2551 CharacterOffsetEnd=2555 PartOfSpeech=FW Lemma=situ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hybridization CharacterOffsetBegin=2556 CharacterOffsetEnd=2569 PartOfSpeech=NN Lemma=hybridization NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2570 CharacterOffsetEnd=2573 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=2574 CharacterOffsetEnd=2578 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2579 CharacterOffsetEnd=2581 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=2582 CharacterOffsetEnd=2586 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=IV CharacterOffsetBegin=2587 CharacterOffsetEnd=2589 PartOfSpeech=CD Lemma=iv NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=collagen CharacterOffsetBegin=2590 CharacterOffsetEnd=2598 PartOfSpeech=NN Lemma=collagen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=2599 CharacterOffsetEnd=2601 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=means CharacterOffsetBegin=2602 CharacterOffsetEnd=2607 PartOfSpeech=NNS Lemma=means NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2608 CharacterOffsetEnd=2610 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=immunohistochemical CharacterOffsetBegin=2611 CharacterOffsetEnd=2630 PartOfSpeech=JJ Lemma=immunohistochemical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=methods CharacterOffsetBegin=2631 CharacterOffsetEnd=2638 PartOfSpeech=NNS Lemma=method NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=2638 CharacterOffsetEnd=2639 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP We))\n",
      "    (VP\n",
      "      (VP (VBD examined)\n",
      "        (NP\n",
      "          (NP (DT the) (NN expression))\n",
      "          (PP (IN of)\n",
      "            (NP (NN PAI-1) (, ,) (NN uPA) (, ,)\n",
      "              (CC and)\n",
      "              (NN uPAR) (NNS mRNAs))))\n",
      "        (PP (IN through)\n",
      "          (NP\n",
      "            (NP (DT the) (NN use))\n",
      "            (PP (IN of)\n",
      "              (X\n",
      "                (ADVP (FW in) (FW situ))\n",
      "                (NP (NN hybridization)))))))\n",
      "      (CC and)\n",
      "      (VP\n",
      "        (ADJP (IN that)\n",
      "          (PP (IN of)\n",
      "            (NP (NN type) (CD IV) (NN collagen))))\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NNS means))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ immunohistochemical) (NNS methods)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, examined-2)\n",
      "nsubj(examined-2, We-1)\n",
      "det(expression-4, the-3)\n",
      "dobj(examined-2, expression-4)\n",
      "case(uPA-8, of-5)\n",
      "compound(uPA-8, PAI-1-6)\n",
      "punct(uPA-8, ,-7)\n",
      "nmod:of(expression-4, uPA-8)\n",
      "punct(uPA-8, ,-9)\n",
      "cc(uPA-8, and-10)\n",
      "compound(mRNAs-12, uPAR-11)\n",
      "nmod:of(expression-4, mRNAs-12)\n",
      "conj:and(uPA-8, mRNAs-12)\n",
      "case(use-15, through-13)\n",
      "det(use-15, the-14)\n",
      "nmod:through(examined-2, use-15)\n",
      "case(hybridization-19, of-16)\n",
      "compound(situ-18, in-17)\n",
      "dep(hybridization-19, situ-18)\n",
      "acl:of(use-15, hybridization-19)\n",
      "cc(examined-2, and-20)\n",
      "conj:and(examined-2, that-21)\n",
      "case(collagen-25, of-22)\n",
      "compound(collagen-25, type-23)\n",
      "nummod(collagen-25, IV-24)\n",
      "nmod:of(that-21, collagen-25)\n",
      "case(methods-30, by-26)\n",
      "mwe(by-26, means-27)\n",
      "mwe(by-26, of-28)\n",
      "amod(methods-30, immunohistochemical-29)\n",
      "nmod:by_means_of(that-21, methods-30)\n",
      "punct(examined-2, .-31)\n",
      "\n",
      "Sentence #16 (19 tokens, sentiment: Negative):\n",
      "In control rats, we detected weak signals for PAI-1, uPA, and uPAR mRNAs in glomeruli.\n",
      "[Text=In CharacterOffsetBegin=2640 CharacterOffsetEnd=2642 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=control CharacterOffsetBegin=2643 CharacterOffsetEnd=2650 PartOfSpeech=NN Lemma=control NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rats CharacterOffsetBegin=2651 CharacterOffsetEnd=2655 PartOfSpeech=NNS Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2655 CharacterOffsetEnd=2656 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=we CharacterOffsetBegin=2657 CharacterOffsetEnd=2659 PartOfSpeech=PRP Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=detected CharacterOffsetBegin=2660 CharacterOffsetEnd=2668 PartOfSpeech=VBD Lemma=detect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=weak CharacterOffsetBegin=2669 CharacterOffsetEnd=2673 PartOfSpeech=JJ Lemma=weak NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=signals CharacterOffsetBegin=2674 CharacterOffsetEnd=2681 PartOfSpeech=NNS Lemma=signal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=2682 CharacterOffsetEnd=2685 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=2686 CharacterOffsetEnd=2691 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2691 CharacterOffsetEnd=2692 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPA CharacterOffsetBegin=2693 CharacterOffsetEnd=2696 PartOfSpeech=NN Lemma=upa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2696 CharacterOffsetEnd=2697 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2698 CharacterOffsetEnd=2701 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPAR CharacterOffsetBegin=2702 CharacterOffsetEnd=2706 PartOfSpeech=NN Lemma=upar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mRNAs CharacterOffsetBegin=2707 CharacterOffsetEnd=2712 PartOfSpeech=NNS Lemma=mrna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=2713 CharacterOffsetEnd=2715 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glomeruli CharacterOffsetBegin=2716 CharacterOffsetEnd=2725 PartOfSpeech=NNS Lemma=glomerulus NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=2725 CharacterOffsetEnd=2726 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (NN control) (NNS rats)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (VBD detected)\n",
      "      (NP (JJ weak) (NNS signals))\n",
      "      (PP (IN for)\n",
      "        (NP (NN PAI-1) (, ,) (NN uPA) (, ,)\n",
      "          (CC and)\n",
      "          (NN uPAR) (NNS mRNAs)))\n",
      "      (PP (IN in)\n",
      "        (NP (NNS glomeruli))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, detected-6)\n",
      "case(rats-3, In-1)\n",
      "compound(rats-3, control-2)\n",
      "nmod:in(detected-6, rats-3)\n",
      "punct(detected-6, ,-4)\n",
      "nsubj(detected-6, we-5)\n",
      "amod(signals-8, weak-7)\n",
      "dobj(detected-6, signals-8)\n",
      "case(uPA-12, for-9)\n",
      "compound(uPA-12, PAI-1-10)\n",
      "punct(uPA-12, ,-11)\n",
      "nmod:for(detected-6, uPA-12)\n",
      "punct(uPA-12, ,-13)\n",
      "cc(uPA-12, and-14)\n",
      "compound(mRNAs-16, uPAR-15)\n",
      "nmod:for(detected-6, mRNAs-16)\n",
      "conj:and(uPA-12, mRNAs-16)\n",
      "case(glomeruli-18, in-17)\n",
      "nmod:in(detected-6, glomeruli-18)\n",
      "punct(detected-6, .-19)\n",
      "\n",
      "Sentence #17 (26 tokens, sentiment: Negative):\n",
      "Diabetic rats exhibited high levels of expression of PAI-1, uPA, and uPAR mRNAs and type IV collagen protein, mainly in mesangial cells.\n",
      "[Text=Diabetic CharacterOffsetBegin=2727 CharacterOffsetEnd=2735 PartOfSpeech=NNP Lemma=Diabetic NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=rats CharacterOffsetBegin=2736 CharacterOffsetEnd=2740 PartOfSpeech=NNS Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=exhibited CharacterOffsetBegin=2741 CharacterOffsetEnd=2750 PartOfSpeech=VBD Lemma=exhibit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=high CharacterOffsetBegin=2751 CharacterOffsetEnd=2755 PartOfSpeech=JJ Lemma=high NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=levels CharacterOffsetBegin=2756 CharacterOffsetEnd=2762 PartOfSpeech=NNS Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2763 CharacterOffsetEnd=2765 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=2766 CharacterOffsetEnd=2776 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=2777 CharacterOffsetEnd=2779 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=2780 CharacterOffsetEnd=2785 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2785 CharacterOffsetEnd=2786 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPA CharacterOffsetBegin=2787 CharacterOffsetEnd=2790 PartOfSpeech=NN Lemma=upa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2790 CharacterOffsetEnd=2791 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2792 CharacterOffsetEnd=2795 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPAR CharacterOffsetBegin=2796 CharacterOffsetEnd=2800 PartOfSpeech=NN Lemma=upar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mRNAs CharacterOffsetBegin=2801 CharacterOffsetEnd=2806 PartOfSpeech=NNS Lemma=mrna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2807 CharacterOffsetEnd=2810 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=2811 CharacterOffsetEnd=2815 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=IV CharacterOffsetBegin=2816 CharacterOffsetEnd=2818 PartOfSpeech=CD Lemma=iv NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=collagen CharacterOffsetBegin=2819 CharacterOffsetEnd=2827 PartOfSpeech=NN Lemma=collagen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=protein CharacterOffsetBegin=2828 CharacterOffsetEnd=2835 PartOfSpeech=NN Lemma=protein NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2835 CharacterOffsetEnd=2836 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mainly CharacterOffsetBegin=2837 CharacterOffsetEnd=2843 PartOfSpeech=RB Lemma=mainly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=2844 CharacterOffsetEnd=2846 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mesangial CharacterOffsetBegin=2847 CharacterOffsetEnd=2856 PartOfSpeech=JJ Lemma=mesangial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=2857 CharacterOffsetEnd=2862 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=2862 CharacterOffsetEnd=2863 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Diabetic) (NNS rats))\n",
      "    (VP (VBD exhibited)\n",
      "      (NP\n",
      "        (NP (JJ high) (NNS levels))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN expression))\n",
      "              (PP (IN of)\n",
      "                (NP (NN PAI-1) (, ,) (NN uPA) (, ,)\n",
      "                  (CC and)\n",
      "                  (NN uPAR) (NNS mRNAs))))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (NN type) (CD IV) (NN collagen) (NN protein))\n",
      "              (, ,)\n",
      "              (ADVP (RB mainly))))))\n",
      "      (PP (IN in)\n",
      "        (NP (JJ mesangial) (NNS cells))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, exhibited-3)\n",
      "compound(rats-2, Diabetic-1)\n",
      "nsubj(exhibited-3, rats-2)\n",
      "amod(levels-5, high-4)\n",
      "dobj(exhibited-3, levels-5)\n",
      "case(expression-7, of-6)\n",
      "nmod:of(levels-5, expression-7)\n",
      "case(uPA-11, of-8)\n",
      "compound(uPA-11, PAI-1-9)\n",
      "punct(uPA-11, ,-10)\n",
      "nmod:of(expression-7, uPA-11)\n",
      "punct(uPA-11, ,-12)\n",
      "cc(uPA-11, and-13)\n",
      "compound(mRNAs-15, uPAR-14)\n",
      "nmod:of(expression-7, mRNAs-15)\n",
      "conj:and(uPA-11, mRNAs-15)\n",
      "cc(expression-7, and-16)\n",
      "compound(protein-20, type-17)\n",
      "nummod(protein-20, IV-18)\n",
      "compound(protein-20, collagen-19)\n",
      "nmod:of(levels-5, protein-20)\n",
      "conj:and(expression-7, protein-20)\n",
      "punct(protein-20, ,-21)\n",
      "advmod(protein-20, mainly-22)\n",
      "case(cells-25, in-23)\n",
      "amod(cells-25, mesangial-24)\n",
      "nmod:in(exhibited-3, cells-25)\n",
      "punct(exhibited-3, .-26)\n",
      "\n",
      "Sentence #18 (22 tokens, sentiment: Negative):\n",
      "These mRNAs were synthesized in various renal cells (epithelial, mesangial, and endothelial cells and Bowman's capsule).\n",
      "[Text=These CharacterOffsetBegin=2864 CharacterOffsetEnd=2869 PartOfSpeech=DT Lemma=these NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mRNAs CharacterOffsetBegin=2870 CharacterOffsetEnd=2875 PartOfSpeech=NNS Lemma=mrna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=2876 CharacterOffsetEnd=2880 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=synthesized CharacterOffsetBegin=2881 CharacterOffsetEnd=2892 PartOfSpeech=VBN Lemma=synthesize NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=2893 CharacterOffsetEnd=2895 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=various CharacterOffsetBegin=2896 CharacterOffsetEnd=2903 PartOfSpeech=JJ Lemma=various NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=2904 CharacterOffsetEnd=2909 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=2910 CharacterOffsetEnd=2915 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=2916 CharacterOffsetEnd=2917 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=epithelial CharacterOffsetBegin=2917 CharacterOffsetEnd=2927 PartOfSpeech=JJ Lemma=epithelial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2927 CharacterOffsetEnd=2928 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mesangial CharacterOffsetBegin=2929 CharacterOffsetEnd=2938 PartOfSpeech=JJ Lemma=mesangial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=2938 CharacterOffsetEnd=2939 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2940 CharacterOffsetEnd=2943 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=endothelial CharacterOffsetBegin=2944 CharacterOffsetEnd=2955 PartOfSpeech=JJ Lemma=endothelial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=2956 CharacterOffsetEnd=2961 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=2962 CharacterOffsetEnd=2965 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Bowman CharacterOffsetBegin=2966 CharacterOffsetEnd=2972 PartOfSpeech=NNP Lemma=Bowman NamedEntityTag=PERSON SentimentClass=Neutral]\n",
      "[Text='s CharacterOffsetBegin=2972 CharacterOffsetEnd=2974 PartOfSpeech=POS Lemma='s NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=capsule CharacterOffsetBegin=2975 CharacterOffsetEnd=2982 PartOfSpeech=NN Lemma=capsule NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=-RRB- CharacterOffsetBegin=2982 CharacterOffsetEnd=2983 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=2983 CharacterOffsetEnd=2984 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT These) (NNS mRNAs))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN synthesized)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (JJ various) (JJ renal) (NNS cells))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (JJ epithelial))\n",
      "                (, ,)\n",
      "                (NP (JJ mesangial))\n",
      "                (, ,)\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (JJ endothelial) (NNS cells))\n",
      "                  (CC and)\n",
      "                  (NP\n",
      "                    (NP (NNP Bowman) (POS 's))\n",
      "                    (NN capsule))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, synthesized-4)\n",
      "det(mRNAs-2, These-1)\n",
      "nsubjpass(synthesized-4, mRNAs-2)\n",
      "auxpass(synthesized-4, were-3)\n",
      "case(cells-8, in-5)\n",
      "amod(cells-8, various-6)\n",
      "amod(cells-8, renal-7)\n",
      "nmod:in(synthesized-4, cells-8)\n",
      "punct(epithelial-10, -LRB--9)\n",
      "dep(cells-8, epithelial-10)\n",
      "punct(epithelial-10, ,-11)\n",
      "dep(cells-8, mesangial-12)\n",
      "conj:and(epithelial-10, mesangial-12)\n",
      "punct(epithelial-10, ,-13)\n",
      "cc(epithelial-10, and-14)\n",
      "amod(cells-16, endothelial-15)\n",
      "dep(cells-8, cells-16)\n",
      "conj:and(epithelial-10, cells-16)\n",
      "cc(cells-16, and-17)\n",
      "nmod:poss(capsule-20, Bowman-18)\n",
      "case(Bowman-18, 's-19)\n",
      "conj:and(epithelial-10, capsule-20)\n",
      "conj:and(cells-16, capsule-20)\n",
      "punct(epithelial-10, -RRB--21)\n",
      "punct(synthesized-4, .-22)\n",
      "\n",
      "Sentence #19 (24 tokens, sentiment: Negative):\n",
      "Benazepril inhibited increases in all 3 mRNAs, especially in the mesangium; reduced type IV collagen expression; and attenuated mesangial expansion.\n",
      "[Text=Benazepril CharacterOffsetBegin=2985 CharacterOffsetEnd=2995 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibited CharacterOffsetBegin=2996 CharacterOffsetEnd=3005 PartOfSpeech=VBD Lemma=inhibit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=increases CharacterOffsetBegin=3006 CharacterOffsetEnd=3015 PartOfSpeech=NNS Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=3016 CharacterOffsetEnd=3018 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=all CharacterOffsetBegin=3019 CharacterOffsetEnd=3022 PartOfSpeech=DT Lemma=all NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=3 CharacterOffsetBegin=3023 CharacterOffsetEnd=3024 PartOfSpeech=CD Lemma=3 NamedEntityTag=NUMBER NormalizedNamedEntityTag=3.0 SentimentClass=Neutral]\n",
      "[Text=mRNAs CharacterOffsetBegin=3025 CharacterOffsetEnd=3030 PartOfSpeech=NNS Lemma=mrna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=3030 CharacterOffsetEnd=3031 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=especially CharacterOffsetBegin=3032 CharacterOffsetEnd=3042 PartOfSpeech=RB Lemma=especially NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=3043 CharacterOffsetEnd=3045 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=3046 CharacterOffsetEnd=3049 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mesangium CharacterOffsetBegin=3050 CharacterOffsetEnd=3059 PartOfSpeech=NN Lemma=mesangium NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=; CharacterOffsetBegin=3059 CharacterOffsetEnd=3060 PartOfSpeech=: Lemma=; NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduced CharacterOffsetBegin=3061 CharacterOffsetEnd=3068 PartOfSpeech=VBN Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=3069 CharacterOffsetEnd=3073 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=IV CharacterOffsetBegin=3074 CharacterOffsetEnd=3076 PartOfSpeech=CD Lemma=iv NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=collagen CharacterOffsetBegin=3077 CharacterOffsetEnd=3085 PartOfSpeech=NN Lemma=collagen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=3086 CharacterOffsetEnd=3096 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=; CharacterOffsetBegin=3096 CharacterOffsetEnd=3097 PartOfSpeech=: Lemma=; NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=3098 CharacterOffsetEnd=3101 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=attenuated CharacterOffsetBegin=3102 CharacterOffsetEnd=3112 PartOfSpeech=VBD Lemma=attenuate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mesangial CharacterOffsetBegin=3113 CharacterOffsetEnd=3122 PartOfSpeech=JJ Lemma=mesangial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expansion CharacterOffsetBegin=3123 CharacterOffsetEnd=3132 PartOfSpeech=NN Lemma=expansion NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=3132 CharacterOffsetEnd=3133 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Benazepril))\n",
      "    (VP\n",
      "      (VP (VBD inhibited)\n",
      "        (NP (NNS increases))\n",
      "        (PP (IN in)\n",
      "          (NP (DT all) (CD 3) (NNS mRNAs))))\n",
      "      (, ,)\n",
      "      (VP\n",
      "        (ADVP (RB especially))\n",
      "        (PP (IN in)\n",
      "          (NP (DT the) (NN mesangium))))\n",
      "      (: ;)\n",
      "      (VP (VBN reduced)\n",
      "        (NP\n",
      "          (ADJP (NN type) (CD IV))\n",
      "          (NN collagen) (NN expression)))\n",
      "      (: ;)\n",
      "      (CC and)\n",
      "      (VP (VBD attenuated)\n",
      "        (NP (JJ mesangial) (NN expansion))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, inhibited-2)\n",
      "nsubj(inhibited-2, Benazepril-1)\n",
      "nsubj(reduced-14, Benazepril-1)\n",
      "nsubj(attenuated-21, Benazepril-1)\n",
      "dobj(inhibited-2, increases-3)\n",
      "case(mRNAs-7, in-4)\n",
      "det(mRNAs-7, all-5)\n",
      "nummod(mRNAs-7, 3-6)\n",
      "nmod:in(inhibited-2, mRNAs-7)\n",
      "punct(inhibited-2, ,-8)\n",
      "conj:and(inhibited-2, especially-9)\n",
      "case(mesangium-12, in-10)\n",
      "det(mesangium-12, the-11)\n",
      "nmod:in(especially-9, mesangium-12)\n",
      "punct(inhibited-2, ;-13)\n",
      "conj:and(inhibited-2, reduced-14)\n",
      "amod(expression-18, type-15)\n",
      "compound(type-15, IV-16)\n",
      "compound(expression-18, collagen-17)\n",
      "dobj(reduced-14, expression-18)\n",
      "punct(inhibited-2, ;-19)\n",
      "cc(inhibited-2, and-20)\n",
      "conj:and(inhibited-2, attenuated-21)\n",
      "amod(expansion-23, mesangial-22)\n",
      "dobj(attenuated-21, expansion-23)\n",
      "punct(inhibited-2, .-24)\n",
      "\n",
      "Sentence #20 (37 tokens, sentiment: Negative):\n",
      "Our results indicated that altered expression of PAI-1, uPA, and uPAR in diabetic nephropathy was associated with mesangial expansion and that the beneficial effects of ACE-I may be at least associated with such expression.\n",
      "[Text=Our CharacterOffsetBegin=3134 CharacterOffsetEnd=3137 PartOfSpeech=PRP$ Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=results CharacterOffsetBegin=3138 CharacterOffsetEnd=3145 PartOfSpeech=NNS Lemma=result NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=indicated CharacterOffsetBegin=3146 CharacterOffsetEnd=3155 PartOfSpeech=VBD Lemma=indicate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=3156 CharacterOffsetEnd=3160 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=altered CharacterOffsetBegin=3161 CharacterOffsetEnd=3168 PartOfSpeech=JJ Lemma=altered NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=expression CharacterOffsetBegin=3169 CharacterOffsetEnd=3179 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=3180 CharacterOffsetEnd=3182 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=3183 CharacterOffsetEnd=3188 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=3188 CharacterOffsetEnd=3189 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPA CharacterOffsetBegin=3190 CharacterOffsetEnd=3193 PartOfSpeech=NN Lemma=upa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=3193 CharacterOffsetEnd=3194 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=3195 CharacterOffsetEnd=3198 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=uPAR CharacterOffsetBegin=3199 CharacterOffsetEnd=3203 PartOfSpeech=NN Lemma=upar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=3204 CharacterOffsetEnd=3206 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=3207 CharacterOffsetEnd=3215 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephropathy CharacterOffsetBegin=3216 CharacterOffsetEnd=3227 PartOfSpeech=NN Lemma=nephropathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=3228 CharacterOffsetEnd=3231 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=associated CharacterOffsetBegin=3232 CharacterOffsetEnd=3242 PartOfSpeech=VBN Lemma=associate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=3243 CharacterOffsetEnd=3247 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mesangial CharacterOffsetBegin=3248 CharacterOffsetEnd=3257 PartOfSpeech=JJ Lemma=mesangial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expansion CharacterOffsetBegin=3258 CharacterOffsetEnd=3267 PartOfSpeech=NN Lemma=expansion NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=3268 CharacterOffsetEnd=3271 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=3272 CharacterOffsetEnd=3276 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=3277 CharacterOffsetEnd=3280 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=beneficial CharacterOffsetBegin=3281 CharacterOffsetEnd=3291 PartOfSpeech=JJ Lemma=beneficial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effects CharacterOffsetBegin=3292 CharacterOffsetEnd=3299 PartOfSpeech=NNS Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=3300 CharacterOffsetEnd=3302 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE-I CharacterOffsetBegin=3303 CharacterOffsetEnd=3308 PartOfSpeech=NN Lemma=ace-i NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=may CharacterOffsetBegin=3309 CharacterOffsetEnd=3312 PartOfSpeech=MD Lemma=may NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=3313 CharacterOffsetEnd=3315 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=3316 CharacterOffsetEnd=3318 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=least CharacterOffsetBegin=3319 CharacterOffsetEnd=3324 PartOfSpeech=JJS Lemma=least NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=associated CharacterOffsetBegin=3325 CharacterOffsetEnd=3335 PartOfSpeech=VBN Lemma=associate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=3336 CharacterOffsetEnd=3340 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=such CharacterOffsetBegin=3341 CharacterOffsetEnd=3345 PartOfSpeech=JJ Lemma=such NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=3346 CharacterOffsetEnd=3356 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=3356 CharacterOffsetEnd=3357 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (NNS results))\n",
      "    (VP (VBD indicated)\n",
      "      (SBAR\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (JJ altered) (NN expression))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NN PAI-1) (, ,) (NN uPA) (, ,)\n",
      "                    (CC and)\n",
      "                    (NN uPAR))\n",
      "                  (PP (IN in)\n",
      "                    (NP (JJ diabetic) (NN nephropathy))))))\n",
      "            (VP (VBD was)\n",
      "              (VP (VBN associated)\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ mesangial) (NN expansion)))))))\n",
      "        (CC and)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP\n",
      "              (NP (DT the) (JJ beneficial) (NNS effects))\n",
      "              (PP (IN of)\n",
      "                (NP (NN ACE-I))))\n",
      "            (VP (MD may)\n",
      "              (VP (VB be)\n",
      "                (VP\n",
      "                  (ADVP (IN at) (JJS least))\n",
      "                  (VBN associated)\n",
      "                  (PP (IN with)\n",
      "                    (NP (JJ such) (NN expression))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, indicated-3)\n",
      "nmod:poss(results-2, Our-1)\n",
      "nsubj(indicated-3, results-2)\n",
      "mark(associated-18, that-4)\n",
      "amod(expression-6, altered-5)\n",
      "nsubjpass(associated-18, expression-6)\n",
      "case(PAI-1-8, of-7)\n",
      "nmod:of(expression-6, PAI-1-8)\n",
      "punct(PAI-1-8, ,-9)\n",
      "nmod:of(expression-6, uPA-10)\n",
      "conj:and(PAI-1-8, uPA-10)\n",
      "punct(PAI-1-8, ,-11)\n",
      "cc(PAI-1-8, and-12)\n",
      "nmod:of(expression-6, uPAR-13)\n",
      "conj:and(PAI-1-8, uPAR-13)\n",
      "case(nephropathy-16, in-14)\n",
      "amod(nephropathy-16, diabetic-15)\n",
      "nmod:in(PAI-1-8, nephropathy-16)\n",
      "auxpass(associated-18, was-17)\n",
      "ccomp(indicated-3, associated-18)\n",
      "case(expansion-21, with-19)\n",
      "amod(expansion-21, mesangial-20)\n",
      "nmod:with(associated-18, expansion-21)\n",
      "cc(associated-18, and-22)\n",
      "mark(associated-33, that-23)\n",
      "det(effects-26, the-24)\n",
      "amod(effects-26, beneficial-25)\n",
      "nsubjpass(associated-33, effects-26)\n",
      "case(ACE-I-28, of-27)\n",
      "nmod:of(effects-26, ACE-I-28)\n",
      "aux(associated-33, may-29)\n",
      "auxpass(associated-33, be-30)\n",
      "advmod(associated-33, at-31)\n",
      "mwe(at-31, least-32)\n",
      "ccomp(indicated-3, associated-33)\n",
      "conj:and(associated-18, associated-33)\n",
      "case(expression-36, with-34)\n",
      "amod(expression-36, such-35)\n",
      "nmod:with(associated-33, expression-36)\n",
      "punct(indicated-3, .-37)\n",
      "\n",
      "Sentence #21 (49 tokens, sentiment: Negative):\n",
      "The effects of the combined use of angiotensin converting enzyme inhibitor (ACEI) benazepril and angiotensin II type 1 receptor antagonist (AT1RA) valsartan on apoptosis and the expression of apoptosis-related proteins Fas and FasL in the kidney of rats with adriamycin-induced nephritic glomerulosclerosis was investigated.\n",
      "[Text=The CharacterOffsetBegin=3359 CharacterOffsetEnd=3362 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effects CharacterOffsetBegin=3363 CharacterOffsetEnd=3370 PartOfSpeech=NNS Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=3371 CharacterOffsetEnd=3373 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=3374 CharacterOffsetEnd=3377 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=combined CharacterOffsetBegin=3378 CharacterOffsetEnd=3386 PartOfSpeech=VBN Lemma=combine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=use CharacterOffsetBegin=3387 CharacterOffsetEnd=3390 PartOfSpeech=NN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=3391 CharacterOffsetEnd=3393 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin CharacterOffsetBegin=3394 CharacterOffsetEnd=3405 PartOfSpeech=NN Lemma=angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=converting CharacterOffsetBegin=3406 CharacterOffsetEnd=3416 PartOfSpeech=VBG Lemma=convert NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=3417 CharacterOffsetEnd=3423 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=3424 CharacterOffsetEnd=3433 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=3434 CharacterOffsetEnd=3435 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACEI CharacterOffsetBegin=3435 CharacterOffsetEnd=3439 PartOfSpeech=NN Lemma=acei NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=3439 CharacterOffsetEnd=3440 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=3441 CharacterOffsetEnd=3451 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=3452 CharacterOffsetEnd=3455 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin CharacterOffsetBegin=3456 CharacterOffsetEnd=3467 PartOfSpeech=NN Lemma=angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=II CharacterOffsetBegin=3468 CharacterOffsetEnd=3470 PartOfSpeech=CD Lemma=ii NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=3471 CharacterOffsetEnd=3475 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1 CharacterOffsetBegin=3476 CharacterOffsetEnd=3477 PartOfSpeech=CD Lemma=1 NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=receptor CharacterOffsetBegin=3478 CharacterOffsetEnd=3486 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antagonist CharacterOffsetBegin=3487 CharacterOffsetEnd=3497 PartOfSpeech=NN Lemma=antagonist NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=3498 CharacterOffsetEnd=3499 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=AT1RA CharacterOffsetBegin=3499 CharacterOffsetEnd=3504 PartOfSpeech=NN Lemma=at1ra NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=3504 CharacterOffsetEnd=3505 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=3506 CharacterOffsetEnd=3515 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=3516 CharacterOffsetEnd=3518 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=apoptosis CharacterOffsetBegin=3519 CharacterOffsetEnd=3528 PartOfSpeech=NN Lemma=apoptosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=3529 CharacterOffsetEnd=3532 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=3533 CharacterOffsetEnd=3536 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=3537 CharacterOffsetEnd=3547 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=3548 CharacterOffsetEnd=3550 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=apoptosis-related CharacterOffsetBegin=3551 CharacterOffsetEnd=3568 PartOfSpeech=JJ Lemma=apoptosis-related NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=proteins CharacterOffsetBegin=3569 CharacterOffsetEnd=3577 PartOfSpeech=NNS Lemma=protein NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Fas CharacterOffsetBegin=3578 CharacterOffsetEnd=3581 PartOfSpeech=NN Lemma=fas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=3582 CharacterOffsetEnd=3585 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=FasL CharacterOffsetBegin=3586 CharacterOffsetEnd=3590 PartOfSpeech=NN Lemma=fasl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=3591 CharacterOffsetEnd=3593 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=3594 CharacterOffsetEnd=3597 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kidney CharacterOffsetBegin=3598 CharacterOffsetEnd=3604 PartOfSpeech=NN Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=3605 CharacterOffsetEnd=3607 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rats CharacterOffsetBegin=3608 CharacterOffsetEnd=3612 PartOfSpeech=NNS Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=3613 CharacterOffsetEnd=3617 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=adriamycin-induced CharacterOffsetBegin=3618 CharacterOffsetEnd=3636 PartOfSpeech=JJ Lemma=adriamycin-induced NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephritic CharacterOffsetBegin=3637 CharacterOffsetEnd=3646 PartOfSpeech=JJ Lemma=nephritic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glomerulosclerosis CharacterOffsetBegin=3647 CharacterOffsetEnd=3665 PartOfSpeech=NN Lemma=glomerulosclerosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=3666 CharacterOffsetEnd=3669 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=investigated CharacterOffsetBegin=3670 CharacterOffsetEnd=3682 PartOfSpeech=VBN Lemma=investigate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=3682 CharacterOffsetEnd=3683 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NNS effects))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT the) (VBN combined) (NN use))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN angiotensin))\n",
      "              (VP (VBG converting)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (NN enzyme) (NN inhibitor))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN ACEI))\n",
      "                      (-RRB- -RRB-)))\n",
      "                  (X\n",
      "                    (X\n",
      "                      (NP\n",
      "                        (NP (NN benazepril))\n",
      "                        (CC and)\n",
      "                        (NP (NN angiotensin)))\n",
      "                      (NP (CD II) (NN type))\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (NP\n",
      "                            (NP\n",
      "                              (NP (CD 1) (NN receptor) (NN antagonist))\n",
      "                              (PRN (-LRB- -LRB-)\n",
      "                                (NP (NN AT1RA))\n",
      "                                (-RRB- -RRB-)))\n",
      "                            (NN valsartan))\n",
      "                          (PP (IN on)\n",
      "                            (NP (NN apoptosis))))\n",
      "                        (CC and)\n",
      "                        (NP\n",
      "                          (NP (DT the) (NN expression))\n",
      "                          (PP (IN of)\n",
      "                            (NP (JJ apoptosis-related) (NNS proteins))))))\n",
      "                    (NP\n",
      "                      (NP (NN Fas)\n",
      "                        (CC and)\n",
      "                        (NN FasL))\n",
      "                      (PP (IN in)\n",
      "                        (NP\n",
      "                          (NP (DT the) (NN kidney))\n",
      "                          (PP (IN of)\n",
      "                            (NP (NNS rats))))))))\n",
      "                (PP (IN with)\n",
      "                  (NP (JJ adriamycin-induced) (JJ nephritic) (NN glomerulosclerosis)))))))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN investigated)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, investigated-48)\n",
      "det(effects-2, The-1)\n",
      "nsubjpass(investigated-48, effects-2)\n",
      "case(use-6, of-3)\n",
      "det(use-6, the-4)\n",
      "amod(use-6, combined-5)\n",
      "nmod:of(effects-2, use-6)\n",
      "case(angiotensin-8, of-7)\n",
      "nmod:of(use-6, angiotensin-8)\n",
      "acl(angiotensin-8, converting-9)\n",
      "compound(inhibitor-11, enzyme-10)\n",
      "dobj(converting-9, inhibitor-11)\n",
      "punct(ACEI-13, -LRB--12)\n",
      "appos(inhibitor-11, ACEI-13)\n",
      "punct(ACEI-13, -RRB--14)\n",
      "dep(valsartan-26, benazepril-15)\n",
      "cc(benazepril-15, and-16)\n",
      "conj:and(benazepril-15, angiotensin-17)\n",
      "dep(valsartan-26, angiotensin-17)\n",
      "nummod(type-19, II-18)\n",
      "dep(valsartan-26, type-19)\n",
      "nummod(antagonist-22, 1-20)\n",
      "compound(antagonist-22, receptor-21)\n",
      "compound(valsartan-26, antagonist-22)\n",
      "punct(AT1RA-24, -LRB--23)\n",
      "appos(antagonist-22, AT1RA-24)\n",
      "punct(AT1RA-24, -RRB--25)\n",
      "dep(Fas-35, valsartan-26)\n",
      "case(apoptosis-28, on-27)\n",
      "nmod:on(valsartan-26, apoptosis-28)\n",
      "cc(valsartan-26, and-29)\n",
      "det(expression-31, the-30)\n",
      "conj:and(valsartan-26, expression-31)\n",
      "dep(Fas-35, expression-31)\n",
      "case(proteins-34, of-32)\n",
      "amod(proteins-34, apoptosis-related-33)\n",
      "nmod:of(expression-31, proteins-34)\n",
      "dep(inhibitor-11, Fas-35)\n",
      "cc(Fas-35, and-36)\n",
      "dep(inhibitor-11, FasL-37)\n",
      "conj:and(Fas-35, FasL-37)\n",
      "case(kidney-40, in-38)\n",
      "det(kidney-40, the-39)\n",
      "nmod:in(Fas-35, kidney-40)\n",
      "case(rats-42, of-41)\n",
      "nmod:of(kidney-40, rats-42)\n",
      "case(glomerulosclerosis-46, with-43)\n",
      "amod(glomerulosclerosis-46, adriamycin-induced-44)\n",
      "amod(glomerulosclerosis-46, nephritic-45)\n",
      "nmod:with(converting-9, glomerulosclerosis-46)\n",
      "auxpass(investigated-48, was-47)\n",
      "punct(investigated-48, .-49)\n",
      "\n",
      "Sentence #22 (13 tokens, sentiment: Negative):\n",
      "Uninephrectomy and the injection of adriamycin induced the rat model of glomerulosclerosis.\n",
      "[Text=Uninephrectomy CharacterOffsetBegin=3684 CharacterOffsetEnd=3698 PartOfSpeech=NNP Lemma=Uninephrectomy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=3699 CharacterOffsetEnd=3702 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=3703 CharacterOffsetEnd=3706 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=injection CharacterOffsetBegin=3707 CharacterOffsetEnd=3716 PartOfSpeech=NN Lemma=injection NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=3717 CharacterOffsetEnd=3719 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=adriamycin CharacterOffsetBegin=3720 CharacterOffsetEnd=3730 PartOfSpeech=NN Lemma=adriamycin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=induced CharacterOffsetBegin=3731 CharacterOffsetEnd=3738 PartOfSpeech=VBD Lemma=induce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=3739 CharacterOffsetEnd=3742 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rat CharacterOffsetBegin=3743 CharacterOffsetEnd=3746 PartOfSpeech=NN Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=3747 CharacterOffsetEnd=3752 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=3753 CharacterOffsetEnd=3755 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glomerulosclerosis CharacterOffsetBegin=3756 CharacterOffsetEnd=3774 PartOfSpeech=NN Lemma=glomerulosclerosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=3774 CharacterOffsetEnd=3775 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNP Uninephrectomy))\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP (DT the) (NN injection))\n",
      "        (PP (IN of)\n",
      "          (NP (NN adriamycin)))))\n",
      "    (VP (VBD induced)\n",
      "      (NP\n",
      "        (NP (DT the) (NN rat) (NN model))\n",
      "        (PP (IN of)\n",
      "          (NP (NN glomerulosclerosis)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, induced-7)\n",
      "nsubj(induced-7, Uninephrectomy-1)\n",
      "cc(Uninephrectomy-1, and-2)\n",
      "det(injection-4, the-3)\n",
      "conj:and(Uninephrectomy-1, injection-4)\n",
      "nsubj(induced-7, injection-4)\n",
      "case(adriamycin-6, of-5)\n",
      "nmod:of(injection-4, adriamycin-6)\n",
      "det(model-10, the-8)\n",
      "compound(model-10, rat-9)\n",
      "dobj(induced-7, model-10)\n",
      "case(glomerulosclerosis-12, of-11)\n",
      "nmod:of(model-10, glomerulosclerosis-12)\n",
      "punct(induced-7, .-13)\n",
      "\n",
      "Sentence #23 (41 tokens, sentiment: Negative):\n",
      "Benazepril (6 mg/kg), valsantan (20 mg/kg), or benazepril (3 mg/kg) plus valsantan (20 mg/kg) was respectively delivered daily by gavage to the rats in three treatment groups for 12 weeks.\n",
      "[Text=Benazepril CharacterOffsetBegin=3776 CharacterOffsetEnd=3786 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=3787 CharacterOffsetEnd=3788 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=6 CharacterOffsetBegin=3788 CharacterOffsetEnd=3789 PartOfSpeech=CD Lemma=6 NamedEntityTag=NUMBER NormalizedNamedEntityTag=6.0 SentimentClass=Neutral]\n",
      "[Text=mg/kg CharacterOffsetBegin=3790 CharacterOffsetEnd=3795 PartOfSpeech=NN Lemma=mg/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=3795 CharacterOffsetEnd=3796 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=3796 CharacterOffsetEnd=3797 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsantan CharacterOffsetBegin=3798 CharacterOffsetEnd=3807 PartOfSpeech=NN Lemma=valsantan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=3808 CharacterOffsetEnd=3809 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=20 CharacterOffsetBegin=3809 CharacterOffsetEnd=3811 PartOfSpeech=CD Lemma=20 NamedEntityTag=NUMBER NormalizedNamedEntityTag=20.0 SentimentClass=Neutral]\n",
      "[Text=mg/kg CharacterOffsetBegin=3812 CharacterOffsetEnd=3817 PartOfSpeech=NN Lemma=mg/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=3817 CharacterOffsetEnd=3818 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=3818 CharacterOffsetEnd=3819 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=3820 CharacterOffsetEnd=3822 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=3823 CharacterOffsetEnd=3833 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=3834 CharacterOffsetEnd=3835 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=3 CharacterOffsetBegin=3835 CharacterOffsetEnd=3836 PartOfSpeech=CD Lemma=3 NamedEntityTag=NUMBER NormalizedNamedEntityTag=3.0 SentimentClass=Neutral]\n",
      "[Text=mg/kg CharacterOffsetBegin=3837 CharacterOffsetEnd=3842 PartOfSpeech=NN Lemma=mg/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=3842 CharacterOffsetEnd=3843 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plus CharacterOffsetBegin=3844 CharacterOffsetEnd=3848 PartOfSpeech=CC Lemma=plus NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=valsantan CharacterOffsetBegin=3849 CharacterOffsetEnd=3858 PartOfSpeech=NN Lemma=valsantan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=3859 CharacterOffsetEnd=3860 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=20 CharacterOffsetBegin=3860 CharacterOffsetEnd=3862 PartOfSpeech=CD Lemma=20 NamedEntityTag=NUMBER NormalizedNamedEntityTag=20.0 SentimentClass=Neutral]\n",
      "[Text=mg/kg CharacterOffsetBegin=3863 CharacterOffsetEnd=3868 PartOfSpeech=NN Lemma=mg/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=3868 CharacterOffsetEnd=3869 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=3870 CharacterOffsetEnd=3873 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=respectively CharacterOffsetBegin=3874 CharacterOffsetEnd=3886 PartOfSpeech=RB Lemma=respectively NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=delivered CharacterOffsetBegin=3887 CharacterOffsetEnd=3896 PartOfSpeech=VBN Lemma=deliver NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=3897 CharacterOffsetEnd=3902 PartOfSpeech=RB Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t2\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=3903 CharacterOffsetEnd=3905 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=gavage CharacterOffsetBegin=3906 CharacterOffsetEnd=3912 PartOfSpeech=NN Lemma=gavage NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=3913 CharacterOffsetEnd=3915 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=3916 CharacterOffsetEnd=3919 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rats CharacterOffsetBegin=3920 CharacterOffsetEnd=3924 PartOfSpeech=NNS Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=3925 CharacterOffsetEnd=3927 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=three CharacterOffsetBegin=3928 CharacterOffsetEnd=3933 PartOfSpeech=CD Lemma=three NamedEntityTag=NUMBER NormalizedNamedEntityTag=3.0 SentimentClass=Neutral]\n",
      "[Text=treatment CharacterOffsetBegin=3934 CharacterOffsetEnd=3943 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=groups CharacterOffsetBegin=3944 CharacterOffsetEnd=3950 PartOfSpeech=NNS Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=3951 CharacterOffsetEnd=3954 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=12 CharacterOffsetBegin=3955 CharacterOffsetEnd=3957 PartOfSpeech=CD Lemma=12 NamedEntityTag=DURATION NormalizedNamedEntityTag=P12W Timex=<TIMEX3 tid=\"t3\" type=\"DURATION\" value=\"P12W\">12 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=weeks CharacterOffsetBegin=3958 CharacterOffsetEnd=3963 PartOfSpeech=NNS Lemma=week NamedEntityTag=DURATION NormalizedNamedEntityTag=P12W Timex=<TIMEX3 tid=\"t3\" type=\"DURATION\" value=\"P12W\">12 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=3963 CharacterOffsetEnd=3964 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN Benazepril))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD 6) (NN mg/kg))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN valsantan))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD 20) (NN mg/kg))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (CC or)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (NN benazepril))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (CD 3) (NN mg/kg))\n",
      "              (-RRB- -RRB-)))\n",
      "          (PP (CC plus)\n",
      "            (NP (NN valsantan)))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 20) (NN mg/kg))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD was)\n",
      "      (ADVP (RB respectively))\n",
      "      (VP (VBN delivered)\n",
      "        (ADVP (RB daily))\n",
      "        (PP (IN by)\n",
      "          (NP (NN gavage)))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (DT the) (NNS rats))\n",
      "            (PP (IN in)\n",
      "              (NP\n",
      "                (NP (CD three) (NN treatment) (NNS groups))\n",
      "                (PP (IN for)\n",
      "                  (NP (CD 12) (NNS weeks)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, delivered-27)\n",
      "nsubjpass(delivered-27, Benazepril-1)\n",
      "punct(mg/kg-4, -LRB--2)\n",
      "nummod(mg/kg-4, 6-3)\n",
      "appos(Benazepril-1, mg/kg-4)\n",
      "punct(mg/kg-4, -RRB--5)\n",
      "punct(Benazepril-1, ,-6)\n",
      "conj:or(Benazepril-1, valsantan-7)\n",
      "nsubjpass(delivered-27, valsantan-7)\n",
      "punct(mg/kg-10, -LRB--8)\n",
      "nummod(mg/kg-10, 20-9)\n",
      "appos(valsantan-7, mg/kg-10)\n",
      "punct(mg/kg-10, -RRB--11)\n",
      "punct(Benazepril-1, ,-12)\n",
      "cc(Benazepril-1, or-13)\n",
      "conj:or(Benazepril-1, benazepril-14)\n",
      "nsubjpass(delivered-27, benazepril-14)\n",
      "punct(mg/kg-17, -LRB--15)\n",
      "nummod(mg/kg-17, 3-16)\n",
      "appos(benazepril-14, mg/kg-17)\n",
      "punct(mg/kg-17, -RRB--18)\n",
      "case(valsantan-20, plus-19)\n",
      "nmod:plus(benazepril-14, valsantan-20)\n",
      "punct(mg/kg-23, -LRB--21)\n",
      "nummod(mg/kg-23, 20-22)\n",
      "appos(Benazepril-1, mg/kg-23)\n",
      "punct(mg/kg-23, -RRB--24)\n",
      "auxpass(delivered-27, was-25)\n",
      "advmod(delivered-27, respectively-26)\n",
      "advmod(delivered-27, daily-28)\n",
      "case(gavage-30, by-29)\n",
      "nmod:agent(delivered-27, gavage-30)\n",
      "case(rats-33, to-31)\n",
      "det(rats-33, the-32)\n",
      "nmod:to(delivered-27, rats-33)\n",
      "case(groups-37, in-34)\n",
      "nummod(groups-37, three-35)\n",
      "compound(groups-37, treatment-36)\n",
      "nmod:in(rats-33, groups-37)\n",
      "case(weeks-40, for-38)\n",
      "nummod(weeks-40, 12-39)\n",
      "nmod:for(groups-37, weeks-40)\n",
      "punct(delivered-27, .-41)\n",
      "\n",
      "Sentence #24 (17 tokens, sentiment: Negative):\n",
      "Apoptosis was examined by means of terminal-deoxynucleotidyl transferase mediated d-UTP nick end labeling (TUNEL).\n",
      "[Text=Apoptosis CharacterOffsetBegin=3965 CharacterOffsetEnd=3974 PartOfSpeech=NN Lemma=apoptosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=3975 CharacterOffsetEnd=3978 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=examined CharacterOffsetBegin=3979 CharacterOffsetEnd=3987 PartOfSpeech=VBN Lemma=examine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=3988 CharacterOffsetEnd=3990 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=means CharacterOffsetBegin=3991 CharacterOffsetEnd=3996 PartOfSpeech=NNS Lemma=means NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=3997 CharacterOffsetEnd=3999 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=terminal-deoxynucleotidyl CharacterOffsetBegin=4000 CharacterOffsetEnd=4025 PartOfSpeech=JJ Lemma=terminal-deoxynucleotidyl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=transferase CharacterOffsetBegin=4026 CharacterOffsetEnd=4037 PartOfSpeech=NN Lemma=transferase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mediated CharacterOffsetBegin=4038 CharacterOffsetEnd=4046 PartOfSpeech=VBN Lemma=mediate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=d-UTP CharacterOffsetBegin=4047 CharacterOffsetEnd=4052 PartOfSpeech=NN Lemma=d-utp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nick CharacterOffsetBegin=4053 CharacterOffsetEnd=4057 PartOfSpeech=NN Lemma=nick NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=end CharacterOffsetBegin=4058 CharacterOffsetEnd=4061 PartOfSpeech=NN Lemma=end NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=labeling CharacterOffsetBegin=4062 CharacterOffsetEnd=4070 PartOfSpeech=NN Lemma=labeling NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=4071 CharacterOffsetEnd=4072 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=TUNEL CharacterOffsetBegin=4072 CharacterOffsetEnd=4077 PartOfSpeech=NN Lemma=tunel NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=4077 CharacterOffsetEnd=4078 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=4078 CharacterOffsetEnd=4079 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Apoptosis))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN examined)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NNS means))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (JJ terminal-deoxynucleotidyl) (NN transferase))\n",
      "                (VP (VBN mediated)\n",
      "                  (NP\n",
      "                    (NP (NN d-UTP) (NN nick) (NN end) (NN labeling))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN TUNEL))\n",
      "                      (-RRB- -RRB-))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, examined-3)\n",
      "nsubjpass(examined-3, Apoptosis-1)\n",
      "auxpass(examined-3, was-2)\n",
      "case(transferase-8, by-4)\n",
      "mwe(by-4, means-5)\n",
      "mwe(by-4, of-6)\n",
      "amod(transferase-8, terminal-deoxynucleotidyl-7)\n",
      "nmod:agent(examined-3, transferase-8)\n",
      "acl(transferase-8, mediated-9)\n",
      "compound(labeling-13, d-UTP-10)\n",
      "compound(labeling-13, nick-11)\n",
      "compound(labeling-13, end-12)\n",
      "dobj(mediated-9, labeling-13)\n",
      "punct(TUNEL-15, -LRB--14)\n",
      "appos(labeling-13, TUNEL-15)\n",
      "punct(TUNEL-15, -RRB--16)\n",
      "punct(examined-3, .-17)\n",
      "\n",
      "Sentence #25 (12 tokens, sentiment: Negative):\n",
      "Immunohistochemistry was adopted to detect the expression of Fas and FasL.\n",
      "[Text=Immunohistochemistry CharacterOffsetBegin=4080 CharacterOffsetEnd=4100 PartOfSpeech=NN Lemma=immunohistochemistry NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=4101 CharacterOffsetEnd=4104 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=adopted CharacterOffsetBegin=4105 CharacterOffsetEnd=4112 PartOfSpeech=VBN Lemma=adopt NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=4113 CharacterOffsetEnd=4115 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=detect CharacterOffsetBegin=4116 CharacterOffsetEnd=4122 PartOfSpeech=VB Lemma=detect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4123 CharacterOffsetEnd=4126 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=4127 CharacterOffsetEnd=4137 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4138 CharacterOffsetEnd=4140 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Fas CharacterOffsetBegin=4141 CharacterOffsetEnd=4144 PartOfSpeech=NN Lemma=fas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4145 CharacterOffsetEnd=4148 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=FasL CharacterOffsetBegin=4149 CharacterOffsetEnd=4153 PartOfSpeech=NN Lemma=fasl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=4153 CharacterOffsetEnd=4154 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Immunohistochemistry))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN adopted)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB detect)\n",
      "              (NP\n",
      "                (NP (DT the) (NN expression))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN Fas)\n",
      "                    (CC and)\n",
      "                    (NN FasL)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, adopted-3)\n",
      "nsubjpass(adopted-3, Immunohistochemistry-1)\n",
      "nsubj:xsubj(detect-5, Immunohistochemistry-1)\n",
      "auxpass(adopted-3, was-2)\n",
      "mark(detect-5, to-4)\n",
      "xcomp(adopted-3, detect-5)\n",
      "det(expression-7, the-6)\n",
      "dobj(detect-5, expression-7)\n",
      "case(Fas-9, of-8)\n",
      "nmod:of(expression-7, Fas-9)\n",
      "cc(Fas-9, and-10)\n",
      "nmod:of(expression-7, FasL-11)\n",
      "conj:and(Fas-9, FasL-11)\n",
      "punct(adopted-3, .-12)\n",
      "\n",
      "Sentence #26 (12 tokens, sentiment: Negative):\n",
      "Software of pathological analysis quantitated the levels of Fas and FasL.\n",
      "[Text=Software CharacterOffsetBegin=4155 CharacterOffsetEnd=4163 PartOfSpeech=NNP Lemma=Software NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4164 CharacterOffsetEnd=4166 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pathological CharacterOffsetBegin=4167 CharacterOffsetEnd=4179 PartOfSpeech=JJ Lemma=pathological NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=analysis CharacterOffsetBegin=4180 CharacterOffsetEnd=4188 PartOfSpeech=NN Lemma=analysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=quantitated CharacterOffsetBegin=4189 CharacterOffsetEnd=4200 PartOfSpeech=VBD Lemma=quantitate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4201 CharacterOffsetEnd=4204 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=levels CharacterOffsetBegin=4205 CharacterOffsetEnd=4211 PartOfSpeech=NNS Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4212 CharacterOffsetEnd=4214 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Fas CharacterOffsetBegin=4215 CharacterOffsetEnd=4218 PartOfSpeech=NN Lemma=fas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4219 CharacterOffsetEnd=4222 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=FasL CharacterOffsetBegin=4223 CharacterOffsetEnd=4227 PartOfSpeech=NN Lemma=fasl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=4227 CharacterOffsetEnd=4228 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNP Software))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ pathological) (NN analysis))))\n",
      "    (VP (VBD quantitated)\n",
      "      (NP\n",
      "        (NP (DT the) (NNS levels))\n",
      "        (PP (IN of)\n",
      "          (NP (NN Fas)\n",
      "            (CC and)\n",
      "            (NN FasL)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, quantitated-5)\n",
      "nsubj(quantitated-5, Software-1)\n",
      "case(analysis-4, of-2)\n",
      "amod(analysis-4, pathological-3)\n",
      "nmod:of(Software-1, analysis-4)\n",
      "det(levels-7, the-6)\n",
      "dobj(quantitated-5, levels-7)\n",
      "case(Fas-9, of-8)\n",
      "nmod:of(levels-7, Fas-9)\n",
      "cc(Fas-9, and-10)\n",
      "nmod:of(levels-7, FasL-11)\n",
      "conj:and(Fas-9, FasL-11)\n",
      "punct(quantitated-5, .-12)\n",
      "\n",
      "Sentence #27 (38 tokens, sentiment: Negative):\n",
      "The results showed that as compared with those in the control group, the kidneys in the model group had more severe glomerulosclerosis, much more apoptotic cells and higher levels of expression of Fas and FasL.\n",
      "[Text=The CharacterOffsetBegin=4229 CharacterOffsetEnd=4232 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=results CharacterOffsetBegin=4233 CharacterOffsetEnd=4240 PartOfSpeech=NNS Lemma=result NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=showed CharacterOffsetBegin=4241 CharacterOffsetEnd=4247 PartOfSpeech=VBD Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=4248 CharacterOffsetEnd=4252 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=as CharacterOffsetBegin=4253 CharacterOffsetEnd=4255 PartOfSpeech=IN Lemma=as NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compared CharacterOffsetBegin=4256 CharacterOffsetEnd=4264 PartOfSpeech=VBN Lemma=compare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=4265 CharacterOffsetEnd=4269 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=those CharacterOffsetBegin=4270 CharacterOffsetEnd=4275 PartOfSpeech=DT Lemma=those NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=4276 CharacterOffsetEnd=4278 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4279 CharacterOffsetEnd=4282 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=control CharacterOffsetBegin=4283 CharacterOffsetEnd=4290 PartOfSpeech=NN Lemma=control NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=4291 CharacterOffsetEnd=4296 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=4296 CharacterOffsetEnd=4297 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4298 CharacterOffsetEnd=4301 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kidneys CharacterOffsetBegin=4302 CharacterOffsetEnd=4309 PartOfSpeech=NNS Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=4310 CharacterOffsetEnd=4312 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4313 CharacterOffsetEnd=4316 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=4317 CharacterOffsetEnd=4322 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=group CharacterOffsetBegin=4323 CharacterOffsetEnd=4328 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=had CharacterOffsetBegin=4329 CharacterOffsetEnd=4332 PartOfSpeech=VBD Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=more CharacterOffsetBegin=4333 CharacterOffsetEnd=4337 PartOfSpeech=RBR Lemma=more NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=severe CharacterOffsetBegin=4338 CharacterOffsetEnd=4344 PartOfSpeech=JJ Lemma=severe NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glomerulosclerosis CharacterOffsetBegin=4345 CharacterOffsetEnd=4363 PartOfSpeech=NN Lemma=glomerulosclerosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=4363 CharacterOffsetEnd=4364 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=much CharacterOffsetBegin=4365 CharacterOffsetEnd=4369 PartOfSpeech=RB Lemma=much NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=more CharacterOffsetBegin=4370 CharacterOffsetEnd=4374 PartOfSpeech=RBR Lemma=more NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=apoptotic CharacterOffsetBegin=4375 CharacterOffsetEnd=4384 PartOfSpeech=JJ Lemma=apoptotic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=4385 CharacterOffsetEnd=4390 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4391 CharacterOffsetEnd=4394 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=higher CharacterOffsetBegin=4395 CharacterOffsetEnd=4401 PartOfSpeech=JJR Lemma=higher NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=levels CharacterOffsetBegin=4402 CharacterOffsetEnd=4408 PartOfSpeech=NNS Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4409 CharacterOffsetEnd=4411 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=4412 CharacterOffsetEnd=4422 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4423 CharacterOffsetEnd=4425 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Fas CharacterOffsetBegin=4426 CharacterOffsetEnd=4429 PartOfSpeech=NN Lemma=fas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4430 CharacterOffsetEnd=4433 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=FasL CharacterOffsetBegin=4434 CharacterOffsetEnd=4438 PartOfSpeech=NN Lemma=fasl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=4438 CharacterOffsetEnd=4439 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT The) (NNS results))\n",
      "    (VP (VBD showed)\n",
      "      (SBAR (IN that) (IN as)\n",
      "        (S\n",
      "          (PP (VBN compared)\n",
      "            (PP (IN with)\n",
      "              (NP\n",
      "                (NP (DT those))\n",
      "                (PP (IN in)\n",
      "                  (NP (DT the) (NN control) (NN group))))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (DT the) (NNS kidneys))\n",
      "            (PP (IN in)\n",
      "              (NP (DT the) (NN model) (NN group))))\n",
      "          (VP (VBD had)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP\n",
      "                  (ADJP (RBR more) (JJ severe))\n",
      "                  (NN glomerulosclerosis))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (ADJP (RB much) (RBR more) (JJ apoptotic))\n",
      "                  (NNS cells))\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (JJR higher) (NNS levels))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN expression)))))\n",
      "              (PP (IN of)\n",
      "                (NP (NN Fas)\n",
      "                  (CC and)\n",
      "                  (NN FasL))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, showed-3)\n",
      "det(results-2, The-1)\n",
      "nsubj(showed-3, results-2)\n",
      "mark(had-20, that-4)\n",
      "mark(had-20, as-5)\n",
      "case(those-8, compared-6)\n",
      "mwe(compared-6, with-7)\n",
      "advcl:compared_with(had-20, those-8)\n",
      "case(group-12, in-9)\n",
      "det(group-12, the-10)\n",
      "compound(group-12, control-11)\n",
      "nmod:in(those-8, group-12)\n",
      "punct(had-20, ,-13)\n",
      "det(kidneys-15, the-14)\n",
      "nsubj(had-20, kidneys-15)\n",
      "case(group-19, in-16)\n",
      "det(group-19, the-17)\n",
      "compound(group-19, model-18)\n",
      "nmod:in(kidneys-15, group-19)\n",
      "advcl:as(showed-3, had-20)\n",
      "advmod(severe-22, more-21)\n",
      "amod(glomerulosclerosis-23, severe-22)\n",
      "dobj(had-20, glomerulosclerosis-23)\n",
      "punct(glomerulosclerosis-23, ,-24)\n",
      "advmod(apoptotic-27, much-25)\n",
      "advmod(apoptotic-27, more-26)\n",
      "amod(cells-28, apoptotic-27)\n",
      "dobj(had-20, cells-28)\n",
      "conj:and(glomerulosclerosis-23, cells-28)\n",
      "cc(glomerulosclerosis-23, and-29)\n",
      "amod(levels-31, higher-30)\n",
      "dobj(had-20, levels-31)\n",
      "conj:and(glomerulosclerosis-23, levels-31)\n",
      "case(expression-33, of-32)\n",
      "nmod:of(levels-31, expression-33)\n",
      "case(Fas-35, of-34)\n",
      "nmod:of(glomerulosclerosis-23, Fas-35)\n",
      "cc(Fas-35, and-36)\n",
      "nmod:of(glomerulosclerosis-23, FasL-37)\n",
      "conj:and(Fas-35, FasL-37)\n",
      "punct(showed-3, .-38)\n",
      "\n",
      "Sentence #28 (26 tokens, sentiment: Negative):\n",
      "The degree of glomerulosclerosis, the number of apoptotic cells and the levels of expression of Fas and FasL were reduced by benazepril and valsartan.\n",
      "[Text=The CharacterOffsetBegin=4440 CharacterOffsetEnd=4443 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degree CharacterOffsetBegin=4444 CharacterOffsetEnd=4450 PartOfSpeech=NN Lemma=degree NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4451 CharacterOffsetEnd=4453 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glomerulosclerosis CharacterOffsetBegin=4454 CharacterOffsetEnd=4472 PartOfSpeech=NN Lemma=glomerulosclerosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=4472 CharacterOffsetEnd=4473 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4474 CharacterOffsetEnd=4477 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=number CharacterOffsetBegin=4478 CharacterOffsetEnd=4484 PartOfSpeech=NN Lemma=number NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4485 CharacterOffsetEnd=4487 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=apoptotic CharacterOffsetBegin=4488 CharacterOffsetEnd=4497 PartOfSpeech=JJ Lemma=apoptotic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=4498 CharacterOffsetEnd=4503 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4504 CharacterOffsetEnd=4507 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4508 CharacterOffsetEnd=4511 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=levels CharacterOffsetBegin=4512 CharacterOffsetEnd=4518 PartOfSpeech=NNS Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4519 CharacterOffsetEnd=4521 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=4522 CharacterOffsetEnd=4532 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4533 CharacterOffsetEnd=4535 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Fas CharacterOffsetBegin=4536 CharacterOffsetEnd=4539 PartOfSpeech=NN Lemma=fas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4540 CharacterOffsetEnd=4543 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=FasL CharacterOffsetBegin=4544 CharacterOffsetEnd=4548 PartOfSpeech=NN Lemma=fasl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=4549 CharacterOffsetEnd=4553 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduced CharacterOffsetBegin=4554 CharacterOffsetEnd=4561 PartOfSpeech=VBN Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=4562 CharacterOffsetEnd=4564 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=4565 CharacterOffsetEnd=4575 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4576 CharacterOffsetEnd=4579 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=4580 CharacterOffsetEnd=4589 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=4589 CharacterOffsetEnd=4590 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN degree))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN glomerulosclerosis))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (DT the) (NN number))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ apoptotic) (NNS cells))))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (DT the) (NNS levels))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NN expression))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN Fas)\n",
      "                    (CC and)\n",
      "                    (NN FasL)))))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN reduced)\n",
      "        (PP (IN by)\n",
      "          (NP (NN benazepril)\n",
      "            (CC and)\n",
      "            (NN valsartan)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, reduced-21)\n",
      "det(degree-2, The-1)\n",
      "nsubjpass(reduced-21, degree-2)\n",
      "case(glomerulosclerosis-4, of-3)\n",
      "nmod:of(degree-2, glomerulosclerosis-4)\n",
      "punct(glomerulosclerosis-4, ,-5)\n",
      "det(number-7, the-6)\n",
      "nmod:of(degree-2, number-7)\n",
      "conj:and(glomerulosclerosis-4, number-7)\n",
      "case(cells-10, of-8)\n",
      "amod(cells-10, apoptotic-9)\n",
      "nmod:of(number-7, cells-10)\n",
      "cc(glomerulosclerosis-4, and-11)\n",
      "det(levels-13, the-12)\n",
      "nmod:of(degree-2, levels-13)\n",
      "conj:and(glomerulosclerosis-4, levels-13)\n",
      "case(expression-15, of-14)\n",
      "nmod:of(levels-13, expression-15)\n",
      "case(Fas-17, of-16)\n",
      "nmod:of(expression-15, Fas-17)\n",
      "cc(Fas-17, and-18)\n",
      "nmod:of(expression-15, FasL-19)\n",
      "conj:and(Fas-17, FasL-19)\n",
      "auxpass(reduced-21, were-20)\n",
      "case(benazepril-23, by-22)\n",
      "nmod:agent(reduced-21, benazepril-23)\n",
      "cc(benazepril-23, and-24)\n",
      "nmod:agent(reduced-21, valsartan-25)\n",
      "conj:and(benazepril-23, valsartan-25)\n",
      "punct(reduced-21, .-26)\n",
      "\n",
      "Sentence #29 (13 tokens, sentiment: Positive):\n",
      "The combined use of benazepril and valsartan had the best therapeutic effect.\n",
      "[Text=The CharacterOffsetBegin=4591 CharacterOffsetEnd=4594 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=combined CharacterOffsetBegin=4595 CharacterOffsetEnd=4603 PartOfSpeech=VBN Lemma=combine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=use CharacterOffsetBegin=4604 CharacterOffsetEnd=4607 PartOfSpeech=NN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4608 CharacterOffsetEnd=4610 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=4611 CharacterOffsetEnd=4621 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4622 CharacterOffsetEnd=4625 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=4626 CharacterOffsetEnd=4635 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=had CharacterOffsetBegin=4636 CharacterOffsetEnd=4639 PartOfSpeech=VBD Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4640 CharacterOffsetEnd=4643 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=best CharacterOffsetBegin=4644 CharacterOffsetEnd=4648 PartOfSpeech=JJS Lemma=best NamedEntityTag=O SentimentClass=Very positive]\n",
      "[Text=therapeutic CharacterOffsetBegin=4649 CharacterOffsetEnd=4660 PartOfSpeech=JJ Lemma=therapeutic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=4661 CharacterOffsetEnd=4667 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=4667 CharacterOffsetEnd=4668 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (VBN combined) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP (NN benazepril)\n",
      "          (CC and)\n",
      "          (NN valsartan))))\n",
      "    (VP (VBD had)\n",
      "      (NP (DT the) (JJS best) (JJ therapeutic) (NN effect)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, had-8)\n",
      "det(use-3, The-1)\n",
      "amod(use-3, combined-2)\n",
      "nsubj(had-8, use-3)\n",
      "case(benazepril-5, of-4)\n",
      "nmod:of(use-3, benazepril-5)\n",
      "cc(benazepril-5, and-6)\n",
      "nmod:of(use-3, valsartan-7)\n",
      "conj:and(benazepril-5, valsartan-7)\n",
      "det(effect-12, the-9)\n",
      "amod(effect-12, best-10)\n",
      "amod(effect-12, therapeutic-11)\n",
      "dobj(had-8, effect-12)\n",
      "punct(had-8, .-13)\n",
      "\n",
      "Sentence #30 (36 tokens, sentiment: Negative):\n",
      "It was concluded that benazepril and valsartan could suppress the excessive apoptosis of kidney cells by lowering the expression of the apoptosis-related proteins Fas and FasL, so as to postpone the process of glomerulosclerosis.\n",
      "[Text=It CharacterOffsetBegin=4669 CharacterOffsetEnd=4671 PartOfSpeech=PRP Lemma=it NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=4672 CharacterOffsetEnd=4675 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=concluded CharacterOffsetBegin=4676 CharacterOffsetEnd=4685 PartOfSpeech=VBN Lemma=conclude NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=4686 CharacterOffsetEnd=4690 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=4691 CharacterOffsetEnd=4701 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4702 CharacterOffsetEnd=4705 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=4706 CharacterOffsetEnd=4715 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=could CharacterOffsetBegin=4716 CharacterOffsetEnd=4721 PartOfSpeech=MD Lemma=could NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=suppress CharacterOffsetBegin=4722 CharacterOffsetEnd=4730 PartOfSpeech=VB Lemma=suppress NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4731 CharacterOffsetEnd=4734 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=excessive CharacterOffsetBegin=4735 CharacterOffsetEnd=4744 PartOfSpeech=JJ Lemma=excessive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=apoptosis CharacterOffsetBegin=4745 CharacterOffsetEnd=4754 PartOfSpeech=NN Lemma=apoptosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4755 CharacterOffsetEnd=4757 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kidney CharacterOffsetBegin=4758 CharacterOffsetEnd=4764 PartOfSpeech=NN Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=4765 CharacterOffsetEnd=4770 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=4771 CharacterOffsetEnd=4773 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lowering CharacterOffsetBegin=4774 CharacterOffsetEnd=4782 PartOfSpeech=VBG Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4783 CharacterOffsetEnd=4786 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=4787 CharacterOffsetEnd=4797 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4798 CharacterOffsetEnd=4800 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4801 CharacterOffsetEnd=4804 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=apoptosis-related CharacterOffsetBegin=4805 CharacterOffsetEnd=4822 PartOfSpeech=JJ Lemma=apoptosis-related NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=proteins CharacterOffsetBegin=4823 CharacterOffsetEnd=4831 PartOfSpeech=NNS Lemma=protein NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Fas CharacterOffsetBegin=4832 CharacterOffsetEnd=4835 PartOfSpeech=NN Lemma=fas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4836 CharacterOffsetEnd=4839 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=FasL CharacterOffsetBegin=4840 CharacterOffsetEnd=4844 PartOfSpeech=NN Lemma=fasl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=4844 CharacterOffsetEnd=4845 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=so CharacterOffsetBegin=4846 CharacterOffsetEnd=4848 PartOfSpeech=RB Lemma=so NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=as CharacterOffsetBegin=4849 CharacterOffsetEnd=4851 PartOfSpeech=IN Lemma=as NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=4852 CharacterOffsetEnd=4854 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=postpone CharacterOffsetBegin=4855 CharacterOffsetEnd=4863 PartOfSpeech=VB Lemma=postpone NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=4864 CharacterOffsetEnd=4867 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=process CharacterOffsetBegin=4868 CharacterOffsetEnd=4875 PartOfSpeech=NN Lemma=process NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4876 CharacterOffsetEnd=4878 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glomerulosclerosis CharacterOffsetBegin=4879 CharacterOffsetEnd=4897 PartOfSpeech=NN Lemma=glomerulosclerosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=4897 CharacterOffsetEnd=4898 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP It))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN concluded)\n",
      "        (SBAR\n",
      "          (SBAR (IN that)\n",
      "            (S\n",
      "              (NP (NN benazepril)\n",
      "                (CC and)\n",
      "                (NN valsartan))\n",
      "              (VP (MD could)\n",
      "                (VP (VB suppress)\n",
      "                  (NP\n",
      "                    (NP (DT the) (JJ excessive) (NN apoptosis))\n",
      "                    (PP (IN of)\n",
      "                      (NP (NN kidney) (NNS cells))))\n",
      "                  (PP (IN by)\n",
      "                    (S\n",
      "                      (VP (VBG lowering)\n",
      "                        (NP\n",
      "                          (NP (DT the) (NN expression))\n",
      "                          (PP (IN of)\n",
      "                            (NP (DT the) (JJ apoptosis-related) (NNS proteins) (NN Fas)\n",
      "                              (CC and)\n",
      "                              (NN FasL)))))))))))\n",
      "          (, ,) (RB so)\n",
      "          (SBAR (IN as)\n",
      "            (S\n",
      "              (VP (TO to)\n",
      "                (VP (VB postpone)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN process))\n",
      "                    (PP (IN of)\n",
      "                      (NP (NN glomerulosclerosis)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, concluded-3)\n",
      "nsubjpass(concluded-3, It-1)\n",
      "auxpass(concluded-3, was-2)\n",
      "mark(suppress-9, that-4)\n",
      "nsubj(suppress-9, benazepril-5)\n",
      "cc(benazepril-5, and-6)\n",
      "conj:and(benazepril-5, valsartan-7)\n",
      "nsubj(suppress-9, valsartan-7)\n",
      "aux(suppress-9, could-8)\n",
      "advcl:that(concluded-3, suppress-9)\n",
      "det(apoptosis-12, the-10)\n",
      "amod(apoptosis-12, excessive-11)\n",
      "dobj(suppress-9, apoptosis-12)\n",
      "case(cells-15, of-13)\n",
      "compound(cells-15, kidney-14)\n",
      "nmod:of(apoptosis-12, cells-15)\n",
      "mark(lowering-17, by-16)\n",
      "advcl:by(suppress-9, lowering-17)\n",
      "det(expression-19, the-18)\n",
      "dobj(lowering-17, expression-19)\n",
      "case(Fas-24, of-20)\n",
      "det(Fas-24, the-21)\n",
      "amod(Fas-24, apoptosis-related-22)\n",
      "compound(Fas-24, proteins-23)\n",
      "nmod:of(expression-19, Fas-24)\n",
      "cc(Fas-24, and-25)\n",
      "nmod:of(expression-19, FasL-26)\n",
      "conj:and(Fas-24, FasL-26)\n",
      "punct(suppress-9, ,-27)\n",
      "advmod(suppress-9, so-28)\n",
      "mark(postpone-31, as-29)\n",
      "mark(postpone-31, to-30)\n",
      "dep(suppress-9, postpone-31)\n",
      "det(process-33, the-32)\n",
      "dobj(postpone-31, process-33)\n",
      "case(glomerulosclerosis-35, of-34)\n",
      "nmod:of(process-33, glomerulosclerosis-35)\n",
      "punct(concluded-3, .-36)\n",
      "\n",
      "Sentence #31 (12 tokens, sentiment: Negative):\n",
      "The combined use of benazepril and valsartan has better therapeutic effect.\n",
      "[Text=The CharacterOffsetBegin=4899 CharacterOffsetEnd=4902 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=combined CharacterOffsetBegin=4903 CharacterOffsetEnd=4911 PartOfSpeech=VBN Lemma=combine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=use CharacterOffsetBegin=4912 CharacterOffsetEnd=4915 PartOfSpeech=NN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=4916 CharacterOffsetEnd=4918 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=4919 CharacterOffsetEnd=4929 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=4930 CharacterOffsetEnd=4933 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=4934 CharacterOffsetEnd=4943 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=has CharacterOffsetBegin=4944 CharacterOffsetEnd=4947 PartOfSpeech=VBZ Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=better CharacterOffsetBegin=4948 CharacterOffsetEnd=4954 PartOfSpeech=JJR Lemma=better NamedEntityTag=O SentimentClass=Very positive]\n",
      "[Text=therapeutic CharacterOffsetBegin=4955 CharacterOffsetEnd=4966 PartOfSpeech=JJ Lemma=therapeutic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=4967 CharacterOffsetEnd=4973 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=4973 CharacterOffsetEnd=4974 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (VBN combined) (NN use))\n",
      "      (PP (IN of)\n",
      "        (NP (NN benazepril)\n",
      "          (CC and)\n",
      "          (NN valsartan))))\n",
      "    (VP (VBZ has)\n",
      "      (NP (JJR better) (JJ therapeutic) (NN effect)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, has-8)\n",
      "det(use-3, The-1)\n",
      "amod(use-3, combined-2)\n",
      "nsubj(has-8, use-3)\n",
      "case(benazepril-5, of-4)\n",
      "nmod:of(use-3, benazepril-5)\n",
      "cc(benazepril-5, and-6)\n",
      "nmod:of(use-3, valsartan-7)\n",
      "conj:and(benazepril-5, valsartan-7)\n",
      "amod(effect-11, better-9)\n",
      "amod(effect-11, therapeutic-10)\n",
      "dobj(has-8, effect-11)\n",
      "punct(has-8, .-12)\n",
      "\n",
      "Sentence #32 (11 tokens, sentiment: Negative):\n",
      "Benazepril was safe and tolerable when applied in hypertensive patients.\n",
      "[Text=Benazepril CharacterOffsetBegin=4976 CharacterOffsetEnd=4986 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=4987 CharacterOffsetEnd=4990 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=safe CharacterOffsetBegin=4991 CharacterOffsetEnd=4995 PartOfSpeech=JJ Lemma=safe NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=and CharacterOffsetBegin=4996 CharacterOffsetEnd=4999 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tolerable CharacterOffsetBegin=5000 CharacterOffsetEnd=5009 PartOfSpeech=JJ Lemma=tolerable NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=when CharacterOffsetBegin=5010 CharacterOffsetEnd=5014 PartOfSpeech=WRB Lemma=when NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=applied CharacterOffsetBegin=5015 CharacterOffsetEnd=5022 PartOfSpeech=VBN Lemma=apply NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=5023 CharacterOffsetEnd=5025 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hypertensive CharacterOffsetBegin=5026 CharacterOffsetEnd=5038 PartOfSpeech=JJ Lemma=hypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=5039 CharacterOffsetEnd=5047 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=5047 CharacterOffsetEnd=5048 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Benazepril))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ safe)\n",
      "        (CC and)\n",
      "        (JJ tolerable))\n",
      "      (SBAR\n",
      "        (WHADVP (WRB when))\n",
      "        (S\n",
      "          (VP (VBN applied)\n",
      "            (PP (IN in)\n",
      "              (NP (JJ hypertensive) (NNS patients)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, safe-3)\n",
      "nsubj(safe-3, Benazepril-1)\n",
      "nsubj(tolerable-5, Benazepril-1)\n",
      "cop(safe-3, was-2)\n",
      "cc(safe-3, and-4)\n",
      "conj:and(safe-3, tolerable-5)\n",
      "advmod(applied-7, when-6)\n",
      "advcl(safe-3, applied-7)\n",
      "case(patients-10, in-8)\n",
      "amod(patients-10, hypertensive-9)\n",
      "nmod:in(applied-7, patients-10)\n",
      "punct(safe-3, .-11)\n",
      "\n",
      "Sentence #33 (26 tokens, sentiment: Negative):\n",
      "Benazepril increases the microvessel density and collateral flow, promotes the creation of collateral circulation in ischemic area, but captopril has not such effects.\n",
      "[Text=Benazepril CharacterOffsetBegin=5050 CharacterOffsetEnd=5060 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=increases CharacterOffsetBegin=5061 CharacterOffsetEnd=5070 PartOfSpeech=VBZ Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=5071 CharacterOffsetEnd=5074 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=microvessel CharacterOffsetBegin=5075 CharacterOffsetEnd=5086 PartOfSpeech=NN Lemma=microvessel NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=density CharacterOffsetBegin=5087 CharacterOffsetEnd=5094 PartOfSpeech=NN Lemma=density NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=5095 CharacterOffsetEnd=5098 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=collateral CharacterOffsetBegin=5099 CharacterOffsetEnd=5109 PartOfSpeech=NN Lemma=collateral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=flow CharacterOffsetBegin=5110 CharacterOffsetEnd=5114 PartOfSpeech=NN Lemma=flow NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=5114 CharacterOffsetEnd=5115 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=promotes CharacterOffsetBegin=5116 CharacterOffsetEnd=5124 PartOfSpeech=VBZ Lemma=promote NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=5125 CharacterOffsetEnd=5128 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=creation CharacterOffsetBegin=5129 CharacterOffsetEnd=5137 PartOfSpeech=NN Lemma=creation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=5138 CharacterOffsetEnd=5140 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=collateral CharacterOffsetBegin=5141 CharacterOffsetEnd=5151 PartOfSpeech=NN Lemma=collateral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=circulation CharacterOffsetBegin=5152 CharacterOffsetEnd=5163 PartOfSpeech=NN Lemma=circulation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=5164 CharacterOffsetEnd=5166 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ischemic CharacterOffsetBegin=5167 CharacterOffsetEnd=5175 PartOfSpeech=JJ Lemma=ischemic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=area CharacterOffsetBegin=5176 CharacterOffsetEnd=5180 PartOfSpeech=NN Lemma=area NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=5180 CharacterOffsetEnd=5181 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=but CharacterOffsetBegin=5182 CharacterOffsetEnd=5185 PartOfSpeech=CC Lemma=but NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=5186 CharacterOffsetEnd=5195 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=has CharacterOffsetBegin=5196 CharacterOffsetEnd=5199 PartOfSpeech=VBZ Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=not CharacterOffsetBegin=5200 CharacterOffsetEnd=5203 PartOfSpeech=RB Lemma=not NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=such CharacterOffsetBegin=5204 CharacterOffsetEnd=5208 PartOfSpeech=JJ Lemma=such NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effects CharacterOffsetBegin=5209 CharacterOffsetEnd=5216 PartOfSpeech=NNS Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=5216 CharacterOffsetEnd=5217 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NNP Benazepril))\n",
      "      (VP (VBZ increases)\n",
      "        (NP (DT the) (NN microvessel) (NN density)\n",
      "          (CC and)\n",
      "          (NN collateral) (NN flow))))\n",
      "    (, ,)\n",
      "    (VP (VBZ promotes)\n",
      "      (NP\n",
      "        (NP (DT the) (NN creation))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NN collateral) (NN circulation))\n",
      "            (PP (IN in)\n",
      "              (NP (JJ ischemic) (NN area)))))))\n",
      "    (, ,)\n",
      "    (CC but)\n",
      "    (S\n",
      "      (NP (NN captopril))\n",
      "      (VP (VBZ has)\n",
      "        (NP (RB not) (JJ such) (NNS effects))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, promotes-10)\n",
      "nsubj(increases-2, Benazepril-1)\n",
      "ccomp(promotes-10, increases-2)\n",
      "det(density-5, the-3)\n",
      "compound(density-5, microvessel-4)\n",
      "dobj(increases-2, density-5)\n",
      "cc(density-5, and-6)\n",
      "compound(flow-8, collateral-7)\n",
      "dobj(increases-2, flow-8)\n",
      "conj:and(density-5, flow-8)\n",
      "punct(promotes-10, ,-9)\n",
      "det(creation-12, the-11)\n",
      "dobj(promotes-10, creation-12)\n",
      "case(circulation-15, of-13)\n",
      "compound(circulation-15, collateral-14)\n",
      "nmod:of(creation-12, circulation-15)\n",
      "case(area-18, in-16)\n",
      "amod(area-18, ischemic-17)\n",
      "nmod:in(circulation-15, area-18)\n",
      "punct(promotes-10, ,-19)\n",
      "cc(promotes-10, but-20)\n",
      "nsubj(has-22, captopril-21)\n",
      "conj:but(promotes-10, has-22)\n",
      "neg(effects-25, not-23)\n",
      "amod(effects-25, such-24)\n",
      "dobj(has-22, effects-25)\n",
      "punct(promotes-10, .-26)\n",
      "\n",
      "Sentence #34 (8 tokens, sentiment: Negative):\n",
      "Benazepril hydrochloride is an angiotensin-converting enzyme inhibitor.\n",
      "[Text=Benazepril CharacterOffsetBegin=5219 CharacterOffsetEnd=5229 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrochloride CharacterOffsetBegin=5230 CharacterOffsetEnd=5243 PartOfSpeech=NN Lemma=hydrochloride NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=5244 CharacterOffsetEnd=5246 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=5247 CharacterOffsetEnd=5249 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin-converting CharacterOffsetBegin=5250 CharacterOffsetEnd=5272 PartOfSpeech=JJ Lemma=angiotensin-converting NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=5273 CharacterOffsetEnd=5279 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=5280 CharacterOffsetEnd=5289 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=5289 CharacterOffsetEnd=5290 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Benazepril) (NN hydrochloride))\n",
      "    (VP (VBZ is)\n",
      "      (NP (DT an) (JJ angiotensin-converting) (NN enzyme) (NN inhibitor)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, inhibitor-7)\n",
      "compound(hydrochloride-2, Benazepril-1)\n",
      "nsubj(inhibitor-7, hydrochloride-2)\n",
      "cop(inhibitor-7, is-3)\n",
      "det(inhibitor-7, an-4)\n",
      "amod(inhibitor-7, angiotensin-converting-5)\n",
      "compound(inhibitor-7, enzyme-6)\n",
      "punct(inhibitor-7, .-8)\n",
      "\n",
      "Sentence #35 (27 tokens, sentiment: Negative):\n",
      "Previous clinical trials show that antihypertensive treatment with benazepril provides effective blood pressure (BP) control and is generally well tolerated by patients with hypertension.\n",
      "[Text=Previous CharacterOffsetBegin=5291 CharacterOffsetEnd=5299 PartOfSpeech=JJ Lemma=previous NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=clinical CharacterOffsetBegin=5300 CharacterOffsetEnd=5308 PartOfSpeech=JJ Lemma=clinical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trials CharacterOffsetBegin=5309 CharacterOffsetEnd=5315 PartOfSpeech=NNS Lemma=trial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=show CharacterOffsetBegin=5316 CharacterOffsetEnd=5320 PartOfSpeech=VBP Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=5321 CharacterOffsetEnd=5325 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antihypertensive CharacterOffsetBegin=5326 CharacterOffsetEnd=5342 PartOfSpeech=JJ Lemma=antihypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=treatment CharacterOffsetBegin=5343 CharacterOffsetEnd=5352 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=5353 CharacterOffsetEnd=5357 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=5358 CharacterOffsetEnd=5368 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=provides CharacterOffsetBegin=5369 CharacterOffsetEnd=5377 PartOfSpeech=VBZ Lemma=provide NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=effective CharacterOffsetBegin=5378 CharacterOffsetEnd=5387 PartOfSpeech=JJ Lemma=effective NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=blood CharacterOffsetBegin=5388 CharacterOffsetEnd=5393 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=pressure CharacterOffsetBegin=5394 CharacterOffsetEnd=5402 PartOfSpeech=NN Lemma=pressure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=5403 CharacterOffsetEnd=5404 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=5404 CharacterOffsetEnd=5406 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=5406 CharacterOffsetEnd=5407 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=control CharacterOffsetBegin=5408 CharacterOffsetEnd=5415 PartOfSpeech=NN Lemma=control NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=5416 CharacterOffsetEnd=5419 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=5420 CharacterOffsetEnd=5422 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=generally CharacterOffsetBegin=5423 CharacterOffsetEnd=5432 PartOfSpeech=RB Lemma=generally NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=well CharacterOffsetBegin=5433 CharacterOffsetEnd=5437 PartOfSpeech=RB Lemma=well NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=tolerated CharacterOffsetBegin=5438 CharacterOffsetEnd=5447 PartOfSpeech=VBN Lemma=tolerate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=5448 CharacterOffsetEnd=5450 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=5451 CharacterOffsetEnd=5459 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=5460 CharacterOffsetEnd=5464 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hypertension CharacterOffsetBegin=5465 CharacterOffsetEnd=5477 PartOfSpeech=NN Lemma=hypertension NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=5477 CharacterOffsetEnd=5478 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ Previous) (JJ clinical) (NNS trials))\n",
      "    (VP (VBP show)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (JJ antihypertensive) (NN treatment))\n",
      "            (PP (IN with)\n",
      "              (NP (NN benazepril))))\n",
      "          (VP\n",
      "            (VP (VBZ provides)\n",
      "              (NP\n",
      "                (NP (JJ effective) (NN blood) (NN pressure))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN BP))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (NP (NN control)))\n",
      "            (CC and)\n",
      "            (VP (VBZ is)\n",
      "              (ADVP (RB generally))\n",
      "              (VP\n",
      "                (ADVP (RB well))\n",
      "                (VBN tolerated)\n",
      "                (PP (IN by)\n",
      "                  (NP\n",
      "                    (NP (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP (NN hypertension)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, show-4)\n",
      "amod(trials-3, Previous-1)\n",
      "amod(trials-3, clinical-2)\n",
      "nsubj(show-4, trials-3)\n",
      "mark(provides-10, that-5)\n",
      "amod(treatment-7, antihypertensive-6)\n",
      "nsubj(provides-10, treatment-7)\n",
      "nsubjpass(tolerated-22, treatment-7)\n",
      "case(benazepril-9, with-8)\n",
      "nmod:with(treatment-7, benazepril-9)\n",
      "ccomp(show-4, provides-10)\n",
      "amod(pressure-13, effective-11)\n",
      "compound(pressure-13, blood-12)\n",
      "iobj(provides-10, pressure-13)\n",
      "punct(BP-15, -LRB--14)\n",
      "appos(pressure-13, BP-15)\n",
      "punct(BP-15, -RRB--16)\n",
      "dobj(provides-10, control-17)\n",
      "cc(provides-10, and-18)\n",
      "auxpass(tolerated-22, is-19)\n",
      "advmod(tolerated-22, generally-20)\n",
      "advmod(tolerated-22, well-21)\n",
      "ccomp(show-4, tolerated-22)\n",
      "conj:and(provides-10, tolerated-22)\n",
      "case(patients-24, by-23)\n",
      "nmod:agent(tolerated-22, patients-24)\n",
      "case(hypertension-26, with-25)\n",
      "nmod:with(patients-24, hypertension-26)\n",
      "punct(show-4, .-27)\n",
      "\n",
      "Sentence #36 (20 tokens, sentiment: Neutral):\n",
      "However, the long-term antihypertensive effects and tolerability of benazepril remain to be established in Chinese patients with hypertension.\n",
      "[Text=However CharacterOffsetBegin=5479 CharacterOffsetEnd=5486 PartOfSpeech=RB Lemma=however NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=, CharacterOffsetBegin=5486 CharacterOffsetEnd=5487 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=5488 CharacterOffsetEnd=5491 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=long-term CharacterOffsetBegin=5492 CharacterOffsetEnd=5501 PartOfSpeech=JJ Lemma=long-term NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antihypertensive CharacterOffsetBegin=5502 CharacterOffsetEnd=5518 PartOfSpeech=JJ Lemma=antihypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effects CharacterOffsetBegin=5519 CharacterOffsetEnd=5526 PartOfSpeech=NNS Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=5527 CharacterOffsetEnd=5530 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tolerability CharacterOffsetBegin=5531 CharacterOffsetEnd=5543 PartOfSpeech=NN Lemma=tolerability NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=5544 CharacterOffsetEnd=5546 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=5547 CharacterOffsetEnd=5557 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=remain CharacterOffsetBegin=5558 CharacterOffsetEnd=5564 PartOfSpeech=VBP Lemma=remain NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=5565 CharacterOffsetEnd=5567 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=5568 CharacterOffsetEnd=5570 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=established CharacterOffsetBegin=5571 CharacterOffsetEnd=5582 PartOfSpeech=VBN Lemma=establish NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=5583 CharacterOffsetEnd=5585 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Chinese CharacterOffsetBegin=5586 CharacterOffsetEnd=5593 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=5594 CharacterOffsetEnd=5602 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=5603 CharacterOffsetEnd=5607 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hypertension CharacterOffsetBegin=5608 CharacterOffsetEnd=5620 PartOfSpeech=NN Lemma=hypertension NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=5620 CharacterOffsetEnd=5621 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB However))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (JJ long-term) (JJ antihypertensive) (NNS effects))\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP (NN tolerability))\n",
      "        (PP (IN of)\n",
      "          (NP (NN benazepril)))))\n",
      "    (VP (VBP remain)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB be)\n",
      "            (VP (VBN established)\n",
      "              (PP (IN in)\n",
      "                (NP (JJ Chinese) (NNS patients)))\n",
      "              (PP (IN with)\n",
      "                (NP (NN hypertension))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, remain-11)\n",
      "advmod(remain-11, However-1)\n",
      "punct(remain-11, ,-2)\n",
      "det(effects-6, the-3)\n",
      "amod(effects-6, long-term-4)\n",
      "amod(effects-6, antihypertensive-5)\n",
      "nsubj(remain-11, effects-6)\n",
      "nsubjpass:xsubj(established-14, effects-6)\n",
      "cc(effects-6, and-7)\n",
      "conj:and(effects-6, tolerability-8)\n",
      "nsubj(remain-11, tolerability-8)\n",
      "nsubjpass:xsubj(established-14, tolerability-8)\n",
      "case(benazepril-10, of-9)\n",
      "nmod:of(tolerability-8, benazepril-10)\n",
      "mark(established-14, to-12)\n",
      "auxpass(established-14, be-13)\n",
      "xcomp(remain-11, established-14)\n",
      "case(patients-17, in-15)\n",
      "amod(patients-17, Chinese-16)\n",
      "nmod:in(established-14, patients-17)\n",
      "case(hypertension-19, with-18)\n",
      "nmod:with(established-14, hypertension-19)\n",
      "punct(remain-11, .-20)\n",
      "\n",
      "Sentence #37 (14 tokens, sentiment: Negative):\n",
      "The study was a prospective, randomized, double-blinded, placebo-controlled clinical trial.\n",
      "[Text=The CharacterOffsetBegin=5623 CharacterOffsetEnd=5626 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=5627 CharacterOffsetEnd=5632 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=5633 CharacterOffsetEnd=5636 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=5637 CharacterOffsetEnd=5638 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=prospective CharacterOffsetBegin=5639 CharacterOffsetEnd=5650 PartOfSpeech=JJ Lemma=prospective NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=5650 CharacterOffsetEnd=5651 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=randomized CharacterOffsetBegin=5652 CharacterOffsetEnd=5662 PartOfSpeech=VBN Lemma=randomize NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=5662 CharacterOffsetEnd=5663 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=double-blinded CharacterOffsetBegin=5664 CharacterOffsetEnd=5678 PartOfSpeech=JJ Lemma=double-blinded NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=5678 CharacterOffsetEnd=5679 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=placebo-controlled CharacterOffsetBegin=5680 CharacterOffsetEnd=5698 PartOfSpeech=JJ Lemma=placebo-controlled NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=clinical CharacterOffsetBegin=5699 CharacterOffsetEnd=5707 PartOfSpeech=JJ Lemma=clinical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trial CharacterOffsetBegin=5708 CharacterOffsetEnd=5713 PartOfSpeech=NN Lemma=trial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=5713 CharacterOffsetEnd=5714 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT The) (NN study))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (DT a) (JJ prospective))\n",
      "        (, ,)\n",
      "        (VP (VBN randomized) (, ,)\n",
      "          (NP (JJ double-blinded) (, ,) (JJ placebo-controlled) (JJ clinical) (NN trial)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, prospective-5)\n",
      "det(study-2, The-1)\n",
      "nsubj(prospective-5, study-2)\n",
      "cop(prospective-5, was-3)\n",
      "det(prospective-5, a-4)\n",
      "punct(prospective-5, ,-6)\n",
      "acl(prospective-5, randomized-7)\n",
      "punct(randomized-7, ,-8)\n",
      "amod(trial-13, double-blinded-9)\n",
      "punct(trial-13, ,-10)\n",
      "amod(trial-13, placebo-controlled-11)\n",
      "amod(trial-13, clinical-12)\n",
      "dobj(randomized-7, trial-13)\n",
      "punct(prospective-5, .-14)\n",
      "\n",
      "Sentence #38 (34 tokens, sentiment: Negative):\n",
      "A total of 162 dogs with New York Heart Association (NYHA) class II-IV heart failure caused by chronic valvular disease (CVD) or dilated cardiomyopathy (DCM) were enrolled.\n",
      "[Text=A CharacterOffsetBegin=5715 CharacterOffsetEnd=5716 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=total CharacterOffsetBegin=5717 CharacterOffsetEnd=5722 PartOfSpeech=NN Lemma=total NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=5723 CharacterOffsetEnd=5725 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=162 CharacterOffsetBegin=5726 CharacterOffsetEnd=5729 PartOfSpeech=CD Lemma=162 NamedEntityTag=NUMBER NormalizedNamedEntityTag=162.0 SentimentClass=Neutral]\n",
      "[Text=dogs CharacterOffsetBegin=5730 CharacterOffsetEnd=5734 PartOfSpeech=NNS Lemma=dog NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=with CharacterOffsetBegin=5735 CharacterOffsetEnd=5739 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=New CharacterOffsetBegin=5740 CharacterOffsetEnd=5743 PartOfSpeech=NNP Lemma=New NamedEntityTag=ORGANIZATION SentimentClass=Positive]\n",
      "[Text=York CharacterOffsetBegin=5744 CharacterOffsetEnd=5748 PartOfSpeech=NNP Lemma=York NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=Heart CharacterOffsetBegin=5749 CharacterOffsetEnd=5754 PartOfSpeech=NNP Lemma=Heart NamedEntityTag=ORGANIZATION SentimentClass=Positive]\n",
      "[Text=Association CharacterOffsetBegin=5755 CharacterOffsetEnd=5766 PartOfSpeech=NNP Lemma=Association NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=5767 CharacterOffsetEnd=5768 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=NYHA CharacterOffsetBegin=5768 CharacterOffsetEnd=5772 PartOfSpeech=NNP Lemma=NYHA NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=5772 CharacterOffsetEnd=5773 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=class CharacterOffsetBegin=5774 CharacterOffsetEnd=5779 PartOfSpeech=NN Lemma=class NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=II-IV CharacterOffsetBegin=5780 CharacterOffsetEnd=5785 PartOfSpeech=NN Lemma=ii-iv NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=heart CharacterOffsetBegin=5786 CharacterOffsetEnd=5791 PartOfSpeech=NN Lemma=heart NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=failure CharacterOffsetBegin=5792 CharacterOffsetEnd=5799 PartOfSpeech=NN Lemma=failure NamedEntityTag=O SentimentClass=Very negative]\n",
      "[Text=caused CharacterOffsetBegin=5800 CharacterOffsetEnd=5806 PartOfSpeech=VBN Lemma=cause NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=5807 CharacterOffsetEnd=5809 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chronic CharacterOffsetBegin=5810 CharacterOffsetEnd=5817 PartOfSpeech=JJ Lemma=chronic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valvular CharacterOffsetBegin=5818 CharacterOffsetEnd=5826 PartOfSpeech=JJ Lemma=valvular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=disease CharacterOffsetBegin=5827 CharacterOffsetEnd=5834 PartOfSpeech=NN Lemma=disease NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=-LRB- CharacterOffsetBegin=5835 CharacterOffsetEnd=5836 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=CVD CharacterOffsetBegin=5836 CharacterOffsetEnd=5839 PartOfSpeech=NN Lemma=cvd NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=5839 CharacterOffsetEnd=5840 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=5841 CharacterOffsetEnd=5843 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dilated CharacterOffsetBegin=5844 CharacterOffsetEnd=5851 PartOfSpeech=JJ Lemma=dilated NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cardiomyopathy CharacterOffsetBegin=5852 CharacterOffsetEnd=5866 PartOfSpeech=NN Lemma=cardiomyopathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=5867 CharacterOffsetEnd=5868 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DCM CharacterOffsetBegin=5868 CharacterOffsetEnd=5871 PartOfSpeech=NN Lemma=dcm NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=5871 CharacterOffsetEnd=5872 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=5873 CharacterOffsetEnd=5877 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enrolled CharacterOffsetBegin=5878 CharacterOffsetEnd=5886 PartOfSpeech=VBN Lemma=enrol NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=5886 CharacterOffsetEnd=5887 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT A) (NN total))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (CD 162) (NNS dogs))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NNP New) (NNP York) (NNP Heart) (NNP Association))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NNP NYHA))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (NP\n",
      "                (NP (NN class) (NN II-IV) (NN heart) (NN failure))\n",
      "                (VP (VBN caused)\n",
      "                  (PP (IN by)\n",
      "                    (NP\n",
      "                      (NP (JJ chronic) (JJ valvular) (NN disease))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN CVD))\n",
      "                        (-RRB- -RRB-))\n",
      "                      (CC or)\n",
      "                      (NP (JJ dilated) (NN cardiomyopathy))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (NN DCM))\n",
      "                        (-RRB- -RRB-)))))))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN enrolled)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, enrolled-33)\n",
      "det:qmod(dogs-5, A-1)\n",
      "mwe(A-1, total-2)\n",
      "mwe(A-1, of-3)\n",
      "nummod(dogs-5, 162-4)\n",
      "nsubjpass(enrolled-33, dogs-5)\n",
      "case(Association-10, with-6)\n",
      "compound(Association-10, New-7)\n",
      "compound(Association-10, York-8)\n",
      "compound(Association-10, Heart-9)\n",
      "nmod:with(dogs-5, Association-10)\n",
      "punct(NYHA-12, -LRB--11)\n",
      "appos(Association-10, NYHA-12)\n",
      "punct(NYHA-12, -RRB--13)\n",
      "compound(failure-17, class-14)\n",
      "compound(failure-17, II-IV-15)\n",
      "compound(failure-17, heart-16)\n",
      "dep(Association-10, failure-17)\n",
      "acl(failure-17, caused-18)\n",
      "case(disease-22, by-19)\n",
      "amod(disease-22, chronic-20)\n",
      "amod(disease-22, valvular-21)\n",
      "nmod:by(caused-18, disease-22)\n",
      "punct(CVD-24, -LRB--23)\n",
      "appos(disease-22, CVD-24)\n",
      "punct(CVD-24, -RRB--25)\n",
      "cc(disease-22, or-26)\n",
      "amod(cardiomyopathy-28, dilated-27)\n",
      "nmod:by(caused-18, cardiomyopathy-28)\n",
      "conj:or(disease-22, cardiomyopathy-28)\n",
      "punct(DCM-30, -LRB--29)\n",
      "appos(disease-22, DCM-30)\n",
      "punct(DCM-30, -RRB--31)\n",
      "auxpass(enrolled-33, were-32)\n",
      "punct(enrolled-33, .-34)\n",
      "\n",
      "Sentence #39 (21 tokens, sentiment: Negative):\n",
      "Benazepril (minimum dosage, 0.25 mg/kg) or placebo were administered orally once daily for up to 34 months.\n",
      "[Text=Benazepril CharacterOffsetBegin=5888 CharacterOffsetEnd=5898 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=5899 CharacterOffsetEnd=5900 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=minimum CharacterOffsetBegin=5900 CharacterOffsetEnd=5907 PartOfSpeech=NN Lemma=minimum NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dosage CharacterOffsetBegin=5908 CharacterOffsetEnd=5914 PartOfSpeech=NN Lemma=dosage NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=5914 CharacterOffsetEnd=5915 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.25 CharacterOffsetBegin=5916 CharacterOffsetEnd=5920 PartOfSpeech=CD Lemma=0.25 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.25 SentimentClass=Neutral]\n",
      "[Text=mg/kg CharacterOffsetBegin=5921 CharacterOffsetEnd=5926 PartOfSpeech=NN Lemma=mg/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=5926 CharacterOffsetEnd=5927 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=5928 CharacterOffsetEnd=5930 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=placebo CharacterOffsetBegin=5931 CharacterOffsetEnd=5938 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=5939 CharacterOffsetEnd=5943 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=administered CharacterOffsetBegin=5944 CharacterOffsetEnd=5956 PartOfSpeech=VBN Lemma=administer NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=orally CharacterOffsetBegin=5957 CharacterOffsetEnd=5963 PartOfSpeech=RB Lemma=orally NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=once CharacterOffsetBegin=5964 CharacterOffsetEnd=5968 PartOfSpeech=RB Lemma=once NamedEntityTag=DATE NormalizedNamedEntityTag=PAST_REF Timex=<TIMEX3 tid=\"t4\" type=\"DATE\" value=\"PAST_REF\">once</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=5969 CharacterOffsetEnd=5974 PartOfSpeech=JJ Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t5\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=5975 CharacterOffsetEnd=5978 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=up CharacterOffsetBegin=5979 CharacterOffsetEnd=5981 PartOfSpeech=RB Lemma=up NamedEntityTag=DURATION NormalizedNamedEntityTag=P34M Timex=<TIMEX3 mod=\"EQUAL_OR_LESS\" tid=\"t6\" type=\"DURATION\" value=\"P34M\">up to 34 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=5982 CharacterOffsetEnd=5984 PartOfSpeech=TO Lemma=to NamedEntityTag=DURATION NormalizedNamedEntityTag=P34M Timex=<TIMEX3 mod=\"EQUAL_OR_LESS\" tid=\"t6\" type=\"DURATION\" value=\"P34M\">up to 34 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=34 CharacterOffsetBegin=5985 CharacterOffsetEnd=5987 PartOfSpeech=CD Lemma=34 NamedEntityTag=DURATION NormalizedNamedEntityTag=P34M Timex=<TIMEX3 mod=\"EQUAL_OR_LESS\" tid=\"t6\" type=\"DURATION\" value=\"P34M\">up to 34 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=months CharacterOffsetBegin=5988 CharacterOffsetEnd=5994 PartOfSpeech=NNS Lemma=month NamedEntityTag=DURATION NormalizedNamedEntityTag=P34M Timex=<TIMEX3 mod=\"EQUAL_OR_LESS\" tid=\"t6\" type=\"DURATION\" value=\"P34M\">up to 34 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=5994 CharacterOffsetEnd=5995 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (NN Benazepril))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (NP (NN minimum) (NN dosage))\n",
      "            (, ,)\n",
      "            (NP (CD 0.25) (NN mg/kg)))\n",
      "          (-RRB- -RRB-)))\n",
      "      (CC or)\n",
      "      (NP (NN placebo)))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN administered)\n",
      "        (ADVP (RB orally))\n",
      "        (ADVP (RB once) (JJ daily)\n",
      "          (PP (IN for)\n",
      "            (ADVP (RB up)\n",
      "              (PP (TO to)\n",
      "                (NP (CD 34) (NNS months))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, administered-12)\n",
      "nsubjpass(administered-12, Benazepril-1)\n",
      "punct(dosage-4, -LRB--2)\n",
      "compound(dosage-4, minimum-3)\n",
      "dep(Benazepril-1, dosage-4)\n",
      "punct(dosage-4, ,-5)\n",
      "nummod(mg/kg-7, 0.25-6)\n",
      "appos(dosage-4, mg/kg-7)\n",
      "punct(dosage-4, -RRB--8)\n",
      "cc(Benazepril-1, or-9)\n",
      "conj:or(Benazepril-1, placebo-10)\n",
      "nsubjpass(administered-12, placebo-10)\n",
      "auxpass(administered-12, were-11)\n",
      "advmod(administered-12, orally-13)\n",
      "advmod(daily-15, once-14)\n",
      "advmod(administered-12, daily-15)\n",
      "case(up-17, for-16)\n",
      "advcl:for(daily-15, up-17)\n",
      "case(months-20, to-18)\n",
      "nummod(months-20, 34-19)\n",
      "nmod:to(up-17, months-20)\n",
      "punct(administered-12, .-21)\n",
      "\n",
      "Sentence #40 (21 tokens, sentiment: Negative):\n",
      "In this paper, we report results of plasma alanine aminotransferase (ALT), creatinine, potassium and urea.\n",
      "[Text=In CharacterOffsetBegin=5996 CharacterOffsetEnd=5998 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=5999 CharacterOffsetEnd=6003 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=paper CharacterOffsetBegin=6004 CharacterOffsetEnd=6009 PartOfSpeech=NN Lemma=paper NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6009 CharacterOffsetEnd=6010 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=we CharacterOffsetBegin=6011 CharacterOffsetEnd=6013 PartOfSpeech=PRP Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=report CharacterOffsetBegin=6014 CharacterOffsetEnd=6020 PartOfSpeech=VBP Lemma=report NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=results CharacterOffsetBegin=6021 CharacterOffsetEnd=6028 PartOfSpeech=NNS Lemma=result NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6029 CharacterOffsetEnd=6031 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasma CharacterOffsetBegin=6032 CharacterOffsetEnd=6038 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=alanine CharacterOffsetBegin=6039 CharacterOffsetEnd=6046 PartOfSpeech=NN Lemma=alanine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=aminotransferase CharacterOffsetBegin=6047 CharacterOffsetEnd=6063 PartOfSpeech=NN Lemma=aminotransferase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=6064 CharacterOffsetEnd=6065 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ALT CharacterOffsetBegin=6065 CharacterOffsetEnd=6068 PartOfSpeech=NN Lemma=alt NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=6068 CharacterOffsetEnd=6069 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6069 CharacterOffsetEnd=6070 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=creatinine CharacterOffsetBegin=6071 CharacterOffsetEnd=6081 PartOfSpeech=NN Lemma=creatinine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6081 CharacterOffsetEnd=6082 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=potassium CharacterOffsetBegin=6083 CharacterOffsetEnd=6092 PartOfSpeech=NN Lemma=potassium NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=6093 CharacterOffsetEnd=6096 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=urea CharacterOffsetBegin=6097 CharacterOffsetEnd=6101 PartOfSpeech=NN Lemma=urea NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=6101 CharacterOffsetEnd=6102 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (DT this) (NN paper)))\n",
      "    (, ,)\n",
      "    (NP (PRP we))\n",
      "    (VP (VBP report)\n",
      "      (NP\n",
      "        (NP (NNS results))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN plasma) (NN alanine) (NN aminotransferase))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (NN ALT))\n",
      "                (-RRB- -RRB-)))\n",
      "            (, ,)\n",
      "            (NP (NN creatinine) (, ,) (NN potassium)\n",
      "              (CC and)\n",
      "              (NN urea))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, report-6)\n",
      "case(paper-3, In-1)\n",
      "det(paper-3, this-2)\n",
      "nmod:in(report-6, paper-3)\n",
      "punct(report-6, ,-4)\n",
      "nsubj(report-6, we-5)\n",
      "dobj(report-6, results-7)\n",
      "case(aminotransferase-11, of-8)\n",
      "compound(aminotransferase-11, plasma-9)\n",
      "compound(aminotransferase-11, alanine-10)\n",
      "nmod:of(results-7, aminotransferase-11)\n",
      "punct(ALT-13, -LRB--12)\n",
      "appos(aminotransferase-11, ALT-13)\n",
      "punct(ALT-13, -RRB--14)\n",
      "punct(aminotransferase-11, ,-15)\n",
      "appos(aminotransferase-11, creatinine-16)\n",
      "punct(creatinine-16, ,-17)\n",
      "appos(aminotransferase-11, potassium-18)\n",
      "conj:and(creatinine-16, potassium-18)\n",
      "cc(creatinine-16, and-19)\n",
      "appos(aminotransferase-11, urea-20)\n",
      "conj:and(creatinine-16, urea-20)\n",
      "punct(report-6, .-21)\n",
      "\n",
      "Sentence #41 (29 tokens, sentiment: Negative):\n",
      "Benazepril was well tolerated during long-term therapy in dogs with CHF and no specific precautions appear to be necessary regarding plasma ALT, creatinine, potassium or urea.\n",
      "[Text=Benazepril CharacterOffsetBegin=6104 CharacterOffsetEnd=6114 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=6115 CharacterOffsetEnd=6118 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=well CharacterOffsetBegin=6119 CharacterOffsetEnd=6123 PartOfSpeech=RB Lemma=well NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=tolerated CharacterOffsetBegin=6124 CharacterOffsetEnd=6133 PartOfSpeech=VBN Lemma=tolerate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=during CharacterOffsetBegin=6134 CharacterOffsetEnd=6140 PartOfSpeech=IN Lemma=during NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=long-term CharacterOffsetBegin=6141 CharacterOffsetEnd=6150 PartOfSpeech=JJ Lemma=long-term NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=6151 CharacterOffsetEnd=6158 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=6159 CharacterOffsetEnd=6161 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dogs CharacterOffsetBegin=6162 CharacterOffsetEnd=6166 PartOfSpeech=NNS Lemma=dog NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=with CharacterOffsetBegin=6167 CharacterOffsetEnd=6171 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=CHF CharacterOffsetBegin=6172 CharacterOffsetEnd=6175 PartOfSpeech=NN Lemma=chf NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=6176 CharacterOffsetEnd=6179 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=no CharacterOffsetBegin=6180 CharacterOffsetEnd=6182 PartOfSpeech=DT Lemma=no NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=specific CharacterOffsetBegin=6183 CharacterOffsetEnd=6191 PartOfSpeech=JJ Lemma=specific NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=precautions CharacterOffsetBegin=6192 CharacterOffsetEnd=6203 PartOfSpeech=NNS Lemma=precaution NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=appear CharacterOffsetBegin=6204 CharacterOffsetEnd=6210 PartOfSpeech=VBP Lemma=appear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=6211 CharacterOffsetEnd=6213 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=6214 CharacterOffsetEnd=6216 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=necessary CharacterOffsetBegin=6217 CharacterOffsetEnd=6226 PartOfSpeech=JJ Lemma=necessary NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=regarding CharacterOffsetBegin=6227 CharacterOffsetEnd=6236 PartOfSpeech=VBG Lemma=regard NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasma CharacterOffsetBegin=6237 CharacterOffsetEnd=6243 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ALT CharacterOffsetBegin=6244 CharacterOffsetEnd=6247 PartOfSpeech=NNP Lemma=ALT NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6247 CharacterOffsetEnd=6248 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=creatinine CharacterOffsetBegin=6249 CharacterOffsetEnd=6259 PartOfSpeech=NN Lemma=creatinine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6259 CharacterOffsetEnd=6260 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=potassium CharacterOffsetBegin=6261 CharacterOffsetEnd=6270 PartOfSpeech=NN Lemma=potassium NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=6271 CharacterOffsetEnd=6273 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=urea CharacterOffsetBegin=6274 CharacterOffsetEnd=6278 PartOfSpeech=NN Lemma=urea NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=6278 CharacterOffsetEnd=6279 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NNP Benazepril))\n",
      "      (VP (VBD was)\n",
      "        (ADVP (RB well))\n",
      "        (VP (VBN tolerated)\n",
      "          (PP (IN during)\n",
      "            (NP\n",
      "              (NP (JJ long-term) (NN therapy))\n",
      "              (PP (IN in)\n",
      "                (NP\n",
      "                  (NP (NNS dogs))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN CHF))))))))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (DT no) (JJ specific) (NNS precautions))\n",
      "      (VP (VBP appear)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB be)\n",
      "              (ADJP (JJ necessary))\n",
      "              (PP (VBG regarding)\n",
      "                (NP\n",
      "                  (NP (NN plasma) (NNP ALT))\n",
      "                  (, ,)\n",
      "                  (NP (NN creatinine) (, ,) (NN potassium)\n",
      "                    (CC or)\n",
      "                    (NN urea)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, tolerated-4)\n",
      "nsubjpass(tolerated-4, Benazepril-1)\n",
      "auxpass(tolerated-4, was-2)\n",
      "advmod(tolerated-4, well-3)\n",
      "case(therapy-7, during-5)\n",
      "amod(therapy-7, long-term-6)\n",
      "nmod:during(tolerated-4, therapy-7)\n",
      "case(dogs-9, in-8)\n",
      "nmod:in(therapy-7, dogs-9)\n",
      "case(CHF-11, with-10)\n",
      "nmod:with(dogs-9, CHF-11)\n",
      "cc(tolerated-4, and-12)\n",
      "neg(precautions-15, no-13)\n",
      "amod(precautions-15, specific-14)\n",
      "nsubj(appear-16, precautions-15)\n",
      "nsubj:xsubj(necessary-19, precautions-15)\n",
      "conj:and(tolerated-4, appear-16)\n",
      "mark(necessary-19, to-17)\n",
      "cop(necessary-19, be-18)\n",
      "xcomp(appear-16, necessary-19)\n",
      "case(ALT-22, regarding-20)\n",
      "compound(ALT-22, plasma-21)\n",
      "nmod:regarding(necessary-19, ALT-22)\n",
      "punct(ALT-22, ,-23)\n",
      "appos(ALT-22, creatinine-24)\n",
      "punct(creatinine-24, ,-25)\n",
      "appos(ALT-22, potassium-26)\n",
      "conj:or(creatinine-24, potassium-26)\n",
      "cc(creatinine-24, or-27)\n",
      "appos(ALT-22, urea-28)\n",
      "conj:or(creatinine-24, urea-28)\n",
      "punct(tolerated-4, .-29)\n",
      "\n",
      "Sentence #42 (20 tokens, sentiment: Negative):\n",
      "The possible action of benazepril in improving renal function (evidenced via lower plasma creatinine) merits further investigation.\n",
      "[Text=The CharacterOffsetBegin=6280 CharacterOffsetEnd=6283 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=possible CharacterOffsetBegin=6284 CharacterOffsetEnd=6292 PartOfSpeech=JJ Lemma=possible NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=action CharacterOffsetBegin=6293 CharacterOffsetEnd=6299 PartOfSpeech=NN Lemma=action NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6300 CharacterOffsetEnd=6302 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=6303 CharacterOffsetEnd=6313 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=6314 CharacterOffsetEnd=6316 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=improving CharacterOffsetBegin=6317 CharacterOffsetEnd=6326 PartOfSpeech=VBG Lemma=improve NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=6327 CharacterOffsetEnd=6332 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=function CharacterOffsetBegin=6333 CharacterOffsetEnd=6341 PartOfSpeech=NN Lemma=function NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=6342 CharacterOffsetEnd=6343 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=evidenced CharacterOffsetBegin=6343 CharacterOffsetEnd=6352 PartOfSpeech=VBN Lemma=evidence NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=via CharacterOffsetBegin=6353 CharacterOffsetEnd=6356 PartOfSpeech=IN Lemma=via NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=6357 CharacterOffsetEnd=6362 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasma CharacterOffsetBegin=6363 CharacterOffsetEnd=6369 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=creatinine CharacterOffsetBegin=6370 CharacterOffsetEnd=6380 PartOfSpeech=NN Lemma=creatinine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=6380 CharacterOffsetEnd=6381 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=merits CharacterOffsetBegin=6382 CharacterOffsetEnd=6388 PartOfSpeech=NNS Lemma=merit NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=further CharacterOffsetBegin=6389 CharacterOffsetEnd=6396 PartOfSpeech=RB Lemma=further NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=investigation CharacterOffsetBegin=6397 CharacterOffsetEnd=6410 PartOfSpeech=NN Lemma=investigation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=6410 CharacterOffsetEnd=6411 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (NP\n",
      "    (NP (DT The) (JJ possible) (NN action))\n",
      "    (PP (IN of)\n",
      "      (NP\n",
      "        (NP (NN benazepril))\n",
      "        (PP (IN in)\n",
      "          (VP (VBG improving)\n",
      "            (NP\n",
      "              (NP (JJ renal) (NN function))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (VP (VBN evidenced)\n",
      "                  (PP (IN via)\n",
      "                    (NP (JJR lower) (NN plasma) (NN creatinine))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (NP-TMP\n",
      "              (NP (NNS merits))\n",
      "              (NP (RB further) (NN investigation)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, action-3)\n",
      "det(action-3, The-1)\n",
      "amod(action-3, possible-2)\n",
      "case(benazepril-5, of-4)\n",
      "nmod:of(action-3, benazepril-5)\n",
      "case(improving-7, in-6)\n",
      "acl:in(benazepril-5, improving-7)\n",
      "amod(function-9, renal-8)\n",
      "dobj(improving-7, function-9)\n",
      "punct(evidenced-11, -LRB--10)\n",
      "dep(function-9, evidenced-11)\n",
      "case(creatinine-15, via-12)\n",
      "amod(creatinine-15, lower-13)\n",
      "compound(creatinine-15, plasma-14)\n",
      "nmod:via(evidenced-11, creatinine-15)\n",
      "punct(evidenced-11, -RRB--16)\n",
      "nmod:tmod(improving-7, merits-17)\n",
      "advmod(investigation-19, further-18)\n",
      "dep(merits-17, investigation-19)\n",
      "punct(action-3, .-20)\n",
      "\n",
      "Sentence #43 (30 tokens, sentiment: Negative):\n",
      "To study the effect of the Compound of traditional Chinese drugs and Benazepril on gene expression of renal endothelin and its receptor of experimental diabetic nephropathy(DN).\n",
      "[Text=To CharacterOffsetBegin=6413 CharacterOffsetEnd=6415 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=6416 CharacterOffsetEnd=6421 PartOfSpeech=VB Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=6422 CharacterOffsetEnd=6425 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=6426 CharacterOffsetEnd=6432 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6433 CharacterOffsetEnd=6435 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=6436 CharacterOffsetEnd=6439 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Compound CharacterOffsetBegin=6440 CharacterOffsetEnd=6448 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6449 CharacterOffsetEnd=6451 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=6452 CharacterOffsetEnd=6463 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=6464 CharacterOffsetEnd=6471 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=6472 CharacterOffsetEnd=6477 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=6478 CharacterOffsetEnd=6481 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=6482 CharacterOffsetEnd=6492 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=6493 CharacterOffsetEnd=6495 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=gene CharacterOffsetBegin=6496 CharacterOffsetEnd=6500 PartOfSpeech=NN Lemma=gene NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=6501 CharacterOffsetEnd=6511 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6512 CharacterOffsetEnd=6514 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=6515 CharacterOffsetEnd=6520 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=endothelin CharacterOffsetBegin=6521 CharacterOffsetEnd=6531 PartOfSpeech=NN Lemma=endothelin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=6532 CharacterOffsetEnd=6535 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=its CharacterOffsetBegin=6536 CharacterOffsetEnd=6539 PartOfSpeech=PRP$ Lemma=its NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=receptor CharacterOffsetBegin=6540 CharacterOffsetEnd=6548 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6549 CharacterOffsetEnd=6551 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=experimental CharacterOffsetBegin=6552 CharacterOffsetEnd=6564 PartOfSpeech=JJ Lemma=experimental NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=6565 CharacterOffsetEnd=6573 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephropathy CharacterOffsetBegin=6574 CharacterOffsetEnd=6585 PartOfSpeech=NN Lemma=nephropathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=6585 CharacterOffsetEnd=6586 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DN CharacterOffsetBegin=6586 CharacterOffsetEnd=6588 PartOfSpeech=JJ Lemma=dn NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=6588 CharacterOffsetEnd=6589 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=6589 CharacterOffsetEnd=6590 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (VP (TO To)\n",
      "      (VP (VB study)\n",
      "        (NP\n",
      "          (NP (DT the) (NN effect))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (NN Compound))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (JJ traditional) (JJ Chinese) (NNS drugs))\n",
      "                  (CC and)\n",
      "                  (NP (NN Benazepril)))))))\n",
      "        (PP (IN on)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NN gene) (NN expression))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ renal) (NN endothelin))))\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (PRP$ its) (NN receptor))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (JJ experimental) (JJ diabetic) (NN nephropathy))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (JJ DN))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, study-2)\n",
      "mark(study-2, To-1)\n",
      "det(effect-4, the-3)\n",
      "dobj(study-2, effect-4)\n",
      "case(Compound-7, of-5)\n",
      "det(Compound-7, the-6)\n",
      "nmod:of(effect-4, Compound-7)\n",
      "case(drugs-11, of-8)\n",
      "amod(drugs-11, traditional-9)\n",
      "amod(drugs-11, Chinese-10)\n",
      "nmod:of(Compound-7, drugs-11)\n",
      "cc(drugs-11, and-12)\n",
      "nmod:of(Compound-7, Benazepril-13)\n",
      "conj:and(drugs-11, Benazepril-13)\n",
      "case(expression-16, on-14)\n",
      "compound(expression-16, gene-15)\n",
      "nmod:on(study-2, expression-16)\n",
      "case(endothelin-19, of-17)\n",
      "amod(endothelin-19, renal-18)\n",
      "nmod:of(expression-16, endothelin-19)\n",
      "cc(expression-16, and-20)\n",
      "nmod:poss(receptor-22, its-21)\n",
      "nmod:on(study-2, receptor-22)\n",
      "conj:and(expression-16, receptor-22)\n",
      "case(nephropathy-26, of-23)\n",
      "amod(nephropathy-26, experimental-24)\n",
      "amod(nephropathy-26, diabetic-25)\n",
      "nmod:of(receptor-22, nephropathy-26)\n",
      "punct(DN-28, -LRB--27)\n",
      "dep(nephropathy-26, DN-28)\n",
      "punct(DN-28, -RRB--29)\n",
      "punct(study-2, .-30)\n",
      "\n",
      "Sentence #44 (15 tokens, sentiment: Negative):\n",
      "To discove the mechanism of the compound of traditional Chinese drugs in treating DN.\n",
      "[Text=To CharacterOffsetBegin=6591 CharacterOffsetEnd=6593 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=discove CharacterOffsetBegin=6594 CharacterOffsetEnd=6601 PartOfSpeech=VB Lemma=discove NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=6602 CharacterOffsetEnd=6605 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mechanism CharacterOffsetBegin=6606 CharacterOffsetEnd=6615 PartOfSpeech=NN Lemma=mechanism NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6616 CharacterOffsetEnd=6618 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=6619 CharacterOffsetEnd=6622 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compound CharacterOffsetBegin=6623 CharacterOffsetEnd=6631 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6632 CharacterOffsetEnd=6634 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=6635 CharacterOffsetEnd=6646 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=6647 CharacterOffsetEnd=6654 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=6655 CharacterOffsetEnd=6660 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=6661 CharacterOffsetEnd=6663 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=treating CharacterOffsetBegin=6664 CharacterOffsetEnd=6672 PartOfSpeech=VBG Lemma=treat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DN CharacterOffsetBegin=6673 CharacterOffsetEnd=6675 PartOfSpeech=JJ Lemma=dn NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=6675 CharacterOffsetEnd=6676 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (VP (TO To)\n",
      "      (VP (VB discove)\n",
      "        (NP\n",
      "          (NP (DT the) (NN mechanism))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (DT the) (NN compound))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ traditional) (JJ Chinese) (NNS drugs))))))\n",
      "        (PP (IN in)\n",
      "          (S\n",
      "            (VP (VBG treating)\n",
      "              (NP (JJ DN)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, discove-2)\n",
      "mark(discove-2, To-1)\n",
      "det(mechanism-4, the-3)\n",
      "dobj(discove-2, mechanism-4)\n",
      "case(compound-7, of-5)\n",
      "det(compound-7, the-6)\n",
      "nmod:of(mechanism-4, compound-7)\n",
      "case(drugs-11, of-8)\n",
      "amod(drugs-11, traditional-9)\n",
      "amod(drugs-11, Chinese-10)\n",
      "nmod:of(compound-7, drugs-11)\n",
      "mark(treating-13, in-12)\n",
      "advcl:in(discove-2, treating-13)\n",
      "dobj(treating-13, DN-14)\n",
      "punct(discove-2, .-15)\n",
      "\n",
      "Sentence #45 (17 tokens, sentiment: Negative):\n",
      "Streptozotocin DN model was built and influenced with the compound of traditional Chinese drugs and Benazepril.\n",
      "[Text=Streptozotocin CharacterOffsetBegin=6678 CharacterOffsetEnd=6692 PartOfSpeech=NNP Lemma=Streptozotocin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DN CharacterOffsetBegin=6693 CharacterOffsetEnd=6695 PartOfSpeech=JJ Lemma=dn NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=6696 CharacterOffsetEnd=6701 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=was CharacterOffsetBegin=6702 CharacterOffsetEnd=6705 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=built CharacterOffsetBegin=6706 CharacterOffsetEnd=6711 PartOfSpeech=VBN Lemma=build NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=6712 CharacterOffsetEnd=6715 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=influenced CharacterOffsetBegin=6716 CharacterOffsetEnd=6726 PartOfSpeech=VBN Lemma=influence NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=6727 CharacterOffsetEnd=6731 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=6732 CharacterOffsetEnd=6735 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compound CharacterOffsetBegin=6736 CharacterOffsetEnd=6744 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6745 CharacterOffsetEnd=6747 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=6748 CharacterOffsetEnd=6759 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=6760 CharacterOffsetEnd=6767 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=6768 CharacterOffsetEnd=6773 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=6774 CharacterOffsetEnd=6777 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=6778 CharacterOffsetEnd=6788 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=6788 CharacterOffsetEnd=6789 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Streptozotocin) (JJ DN) (NN model))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN built)\n",
      "        (CC and)\n",
      "        (VBN influenced)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (DT the) (NN compound))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (JJ traditional) (JJ Chinese) (NNS drugs))\n",
      "                (CC and)\n",
      "                (NP (NNP Benazepril))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, built-5)\n",
      "compound(model-3, Streptozotocin-1)\n",
      "amod(model-3, DN-2)\n",
      "nsubjpass(built-5, model-3)\n",
      "nsubjpass(influenced-7, model-3)\n",
      "auxpass(built-5, was-4)\n",
      "cc(built-5, and-6)\n",
      "conj:and(built-5, influenced-7)\n",
      "case(compound-10, with-8)\n",
      "det(compound-10, the-9)\n",
      "nmod:with(built-5, compound-10)\n",
      "case(drugs-14, of-11)\n",
      "amod(drugs-14, traditional-12)\n",
      "amod(drugs-14, Chinese-13)\n",
      "nmod:of(compound-10, drugs-14)\n",
      "cc(drugs-14, and-15)\n",
      "nmod:of(compound-10, Benazepril-16)\n",
      "conj:and(drugs-14, Benazepril-16)\n",
      "punct(built-5, .-17)\n",
      "\n",
      "Sentence #46 (37 tokens, sentiment: Very negative):\n",
      "The changes of Upro, Glu, HbA1C and (PT-PCR) mRNA expression levels of ET-1, ETA-R of the renal cortex were tested, and thus the histopathological character of the kidney was analysed.\n",
      "[Text=The CharacterOffsetBegin=6790 CharacterOffsetEnd=6793 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=changes CharacterOffsetBegin=6794 CharacterOffsetEnd=6801 PartOfSpeech=NNS Lemma=change NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6802 CharacterOffsetEnd=6804 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Upro CharacterOffsetBegin=6805 CharacterOffsetEnd=6809 PartOfSpeech=NNP Lemma=Upro NamedEntityTag=LOCATION SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6809 CharacterOffsetEnd=6810 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Glu CharacterOffsetBegin=6811 CharacterOffsetEnd=6814 PartOfSpeech=NNP Lemma=Glu NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6814 CharacterOffsetEnd=6815 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=HbA1C CharacterOffsetBegin=6816 CharacterOffsetEnd=6821 PartOfSpeech=NN Lemma=hba1c NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=6822 CharacterOffsetEnd=6825 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=6826 CharacterOffsetEnd=6827 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PT-PCR CharacterOffsetBegin=6827 CharacterOffsetEnd=6833 PartOfSpeech=NN Lemma=pt-pcr NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=6833 CharacterOffsetEnd=6834 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mRNA CharacterOffsetBegin=6835 CharacterOffsetEnd=6839 PartOfSpeech=NN Lemma=mrna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=6840 CharacterOffsetEnd=6850 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=levels CharacterOffsetBegin=6851 CharacterOffsetEnd=6857 PartOfSpeech=NNS Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6858 CharacterOffsetEnd=6860 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ET-1 CharacterOffsetBegin=6861 CharacterOffsetEnd=6865 PartOfSpeech=NN Lemma=et-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6865 CharacterOffsetEnd=6866 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ETA-R CharacterOffsetBegin=6867 CharacterOffsetEnd=6872 PartOfSpeech=NN Lemma=eta-r NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6873 CharacterOffsetEnd=6875 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=6876 CharacterOffsetEnd=6879 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=6880 CharacterOffsetEnd=6885 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cortex CharacterOffsetBegin=6886 CharacterOffsetEnd=6892 PartOfSpeech=NN Lemma=cortex NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=6893 CharacterOffsetEnd=6897 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tested CharacterOffsetBegin=6898 CharacterOffsetEnd=6904 PartOfSpeech=VBN Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=6904 CharacterOffsetEnd=6905 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=6906 CharacterOffsetEnd=6909 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=thus CharacterOffsetBegin=6910 CharacterOffsetEnd=6914 PartOfSpeech=RB Lemma=thus NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=6915 CharacterOffsetEnd=6918 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=histopathological CharacterOffsetBegin=6919 CharacterOffsetEnd=6936 PartOfSpeech=JJ Lemma=histopathological NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=character CharacterOffsetBegin=6937 CharacterOffsetEnd=6946 PartOfSpeech=NN Lemma=character NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6947 CharacterOffsetEnd=6949 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=6950 CharacterOffsetEnd=6953 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kidney CharacterOffsetBegin=6954 CharacterOffsetEnd=6960 PartOfSpeech=NN Lemma=kidney NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=6961 CharacterOffsetEnd=6964 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=analysed CharacterOffsetBegin=6965 CharacterOffsetEnd=6973 PartOfSpeech=VBN Lemma=analyse NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=6973 CharacterOffsetEnd=6974 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT The) (NNS changes))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NNP Upro))\n",
      "            (, ,)\n",
      "            (NP (NNP Glu))\n",
      "            (, ,)\n",
      "            (NP (NN HbA1C))\n",
      "            (CC and)\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NN PT-PCR))\n",
      "              (-RRB- -RRB-))\n",
      "            (NP\n",
      "              (NP (NN mRNA) (NN expression) (NNS levels))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NN ET-1))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (NN ETA-R))\n",
      "                    (PP (IN of)\n",
      "                      (NP (DT the) (JJ renal) (NN cortex))))))))))\n",
      "      (VP (VBD were)\n",
      "        (VP (VBN tested))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (ADVP (RB thus))\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (JJ histopathological) (NN character))\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (NN kidney))))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN analysed))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, tested-25)\n",
      "det(changes-2, The-1)\n",
      "nsubjpass(tested-25, changes-2)\n",
      "case(Upro-4, of-3)\n",
      "nmod:of(changes-2, Upro-4)\n",
      "punct(Upro-4, ,-5)\n",
      "nmod:of(changes-2, Glu-6)\n",
      "conj:and(Upro-4, Glu-6)\n",
      "punct(Upro-4, ,-7)\n",
      "nmod:of(changes-2, HbA1C-8)\n",
      "conj:and(Upro-4, HbA1C-8)\n",
      "cc(Upro-4, and-9)\n",
      "punct(PT-PCR-11, -LRB--10)\n",
      "appos(Upro-4, PT-PCR-11)\n",
      "punct(PT-PCR-11, -RRB--12)\n",
      "compound(levels-15, mRNA-13)\n",
      "compound(levels-15, expression-14)\n",
      "nmod:of(changes-2, levels-15)\n",
      "conj:and(Upro-4, levels-15)\n",
      "case(ET-1-17, of-16)\n",
      "nmod:of(levels-15, ET-1-17)\n",
      "punct(ET-1-17, ,-18)\n",
      "appos(ET-1-17, ETA-R-19)\n",
      "case(cortex-23, of-20)\n",
      "det(cortex-23, the-21)\n",
      "amod(cortex-23, renal-22)\n",
      "nmod:of(ETA-R-19, cortex-23)\n",
      "auxpass(tested-25, were-24)\n",
      "punct(tested-25, ,-26)\n",
      "cc(tested-25, and-27)\n",
      "advmod(analysed-36, thus-28)\n",
      "det(character-31, the-29)\n",
      "amod(character-31, histopathological-30)\n",
      "nsubjpass(analysed-36, character-31)\n",
      "case(kidney-34, of-32)\n",
      "det(kidney-34, the-33)\n",
      "nmod:of(character-31, kidney-34)\n",
      "auxpass(analysed-36, was-35)\n",
      "conj:and(tested-25, analysed-36)\n",
      "punct(tested-25, .-37)\n",
      "\n",
      "Sentence #47 (24 tokens, sentiment: Negative):\n",
      "The compound of traditional Chinese drugs and Benazepril have significant difference from normal saline in the improvement of Upro, Glu, HbA1C.\n",
      "[Text=The CharacterOffsetBegin=6976 CharacterOffsetEnd=6979 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compound CharacterOffsetBegin=6980 CharacterOffsetEnd=6988 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=6989 CharacterOffsetEnd=6991 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=6992 CharacterOffsetEnd=7003 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=7004 CharacterOffsetEnd=7011 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=7012 CharacterOffsetEnd=7017 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=7018 CharacterOffsetEnd=7021 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=7022 CharacterOffsetEnd=7032 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=have CharacterOffsetBegin=7033 CharacterOffsetEnd=7037 PartOfSpeech=VBP Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=significant CharacterOffsetBegin=7038 CharacterOffsetEnd=7049 PartOfSpeech=JJ Lemma=significant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=difference CharacterOffsetBegin=7050 CharacterOffsetEnd=7060 PartOfSpeech=NN Lemma=difference NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=from CharacterOffsetBegin=7061 CharacterOffsetEnd=7065 PartOfSpeech=IN Lemma=from NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=normal CharacterOffsetBegin=7066 CharacterOffsetEnd=7072 PartOfSpeech=JJ Lemma=normal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=saline CharacterOffsetBegin=7073 CharacterOffsetEnd=7079 PartOfSpeech=NN Lemma=saline NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=7080 CharacterOffsetEnd=7082 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7083 CharacterOffsetEnd=7086 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=improvement CharacterOffsetBegin=7087 CharacterOffsetEnd=7098 PartOfSpeech=NN Lemma=improvement NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=7099 CharacterOffsetEnd=7101 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Upro CharacterOffsetBegin=7102 CharacterOffsetEnd=7106 PartOfSpeech=NNP Lemma=Upro NamedEntityTag=LOCATION SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=7106 CharacterOffsetEnd=7107 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Glu CharacterOffsetBegin=7108 CharacterOffsetEnd=7111 PartOfSpeech=NNP Lemma=Glu NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=7111 CharacterOffsetEnd=7112 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=HbA1C CharacterOffsetBegin=7113 CharacterOffsetEnd=7118 PartOfSpeech=NN Lemma=hba1c NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=7118 CharacterOffsetEnd=7119 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN compound))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (JJ traditional) (JJ Chinese) (NNS drugs))\n",
      "          (CC and)\n",
      "          (NP (NNP Benazepril)))))\n",
      "    (VP (VBP have)\n",
      "      (NP (JJ significant) (NN difference))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP (JJ normal) (NN saline))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (DT the) (NN improvement))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NNP Upro) (, ,) (NNP Glu))\n",
      "                  (, ,)\n",
      "                  (NP (NN HbA1C)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, have-9)\n",
      "det(compound-2, The-1)\n",
      "nsubj(have-9, compound-2)\n",
      "case(drugs-6, of-3)\n",
      "amod(drugs-6, traditional-4)\n",
      "amod(drugs-6, Chinese-5)\n",
      "nmod:of(compound-2, drugs-6)\n",
      "cc(drugs-6, and-7)\n",
      "nmod:of(compound-2, Benazepril-8)\n",
      "conj:and(drugs-6, Benazepril-8)\n",
      "amod(difference-11, significant-10)\n",
      "dobj(have-9, difference-11)\n",
      "case(saline-14, from-12)\n",
      "amod(saline-14, normal-13)\n",
      "nmod:from(have-9, saline-14)\n",
      "case(improvement-17, in-15)\n",
      "det(improvement-17, the-16)\n",
      "nmod:in(saline-14, improvement-17)\n",
      "case(Glu-21, of-18)\n",
      "compound(Glu-21, Upro-19)\n",
      "punct(Glu-21, ,-20)\n",
      "nmod:of(improvement-17, Glu-21)\n",
      "punct(Glu-21, ,-22)\n",
      "appos(Glu-21, HbA1C-23)\n",
      "punct(have-9, .-24)\n",
      "\n",
      "Sentence #48 (19 tokens, sentiment: Negative):\n",
      "The compound of traditional Chinese drugs have significant difference from Benazepril in the improvement of Glu, HbA1C.\n",
      "[Text=The CharacterOffsetBegin=7120 CharacterOffsetEnd=7123 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compound CharacterOffsetBegin=7124 CharacterOffsetEnd=7132 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7133 CharacterOffsetEnd=7135 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=7136 CharacterOffsetEnd=7147 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=7148 CharacterOffsetEnd=7155 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=7156 CharacterOffsetEnd=7161 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=have CharacterOffsetBegin=7162 CharacterOffsetEnd=7166 PartOfSpeech=VBP Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=significant CharacterOffsetBegin=7167 CharacterOffsetEnd=7178 PartOfSpeech=JJ Lemma=significant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=difference CharacterOffsetBegin=7179 CharacterOffsetEnd=7189 PartOfSpeech=NN Lemma=difference NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=from CharacterOffsetBegin=7190 CharacterOffsetEnd=7194 PartOfSpeech=IN Lemma=from NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=7195 CharacterOffsetEnd=7205 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=7206 CharacterOffsetEnd=7208 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7209 CharacterOffsetEnd=7212 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=improvement CharacterOffsetBegin=7213 CharacterOffsetEnd=7224 PartOfSpeech=NN Lemma=improvement NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=7225 CharacterOffsetEnd=7227 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Glu CharacterOffsetBegin=7228 CharacterOffsetEnd=7231 PartOfSpeech=NNP Lemma=Glu NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=7231 CharacterOffsetEnd=7232 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=HbA1C CharacterOffsetBegin=7233 CharacterOffsetEnd=7238 PartOfSpeech=NN Lemma=hba1c NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=7238 CharacterOffsetEnd=7239 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN compound))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ traditional) (JJ Chinese) (NNS drugs))))\n",
      "    (VP (VBP have)\n",
      "      (NP (JJ significant) (NN difference))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP (NNP Benazepril))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (DT the) (NN improvement))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NNP Glu))\n",
      "                  (, ,)\n",
      "                  (NP (NN HbA1C)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, have-7)\n",
      "det(compound-2, The-1)\n",
      "nsubj(have-7, compound-2)\n",
      "case(drugs-6, of-3)\n",
      "amod(drugs-6, traditional-4)\n",
      "amod(drugs-6, Chinese-5)\n",
      "nmod:of(compound-2, drugs-6)\n",
      "amod(difference-9, significant-8)\n",
      "dobj(have-7, difference-9)\n",
      "case(Benazepril-11, from-10)\n",
      "nmod:from(have-7, Benazepril-11)\n",
      "case(improvement-14, in-12)\n",
      "det(improvement-14, the-13)\n",
      "nmod:in(Benazepril-11, improvement-14)\n",
      "case(Glu-16, of-15)\n",
      "nmod:of(improvement-14, Glu-16)\n",
      "punct(Glu-16, ,-17)\n",
      "appos(Glu-16, HbA1C-18)\n",
      "punct(have-7, .-19)\n",
      "\n",
      "Sentence #49 (18 tokens, sentiment: Negative):\n",
      "The mRNA expression level of ET-1, ETA-R of the renal cortex of DN model was raised.\n",
      "[Text=The CharacterOffsetBegin=7240 CharacterOffsetEnd=7243 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mRNA CharacterOffsetBegin=7244 CharacterOffsetEnd=7248 PartOfSpeech=NN Lemma=mrna NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=7249 CharacterOffsetEnd=7259 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=level CharacterOffsetBegin=7260 CharacterOffsetEnd=7265 PartOfSpeech=NN Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7266 CharacterOffsetEnd=7268 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ET-1 CharacterOffsetBegin=7269 CharacterOffsetEnd=7273 PartOfSpeech=NN Lemma=et-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=7273 CharacterOffsetEnd=7274 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ETA-R CharacterOffsetBegin=7275 CharacterOffsetEnd=7280 PartOfSpeech=NN Lemma=eta-r NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7281 CharacterOffsetEnd=7283 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7284 CharacterOffsetEnd=7287 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=7288 CharacterOffsetEnd=7293 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cortex CharacterOffsetBegin=7294 CharacterOffsetEnd=7300 PartOfSpeech=NN Lemma=cortex NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7301 CharacterOffsetEnd=7303 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DN CharacterOffsetBegin=7304 CharacterOffsetEnd=7306 PartOfSpeech=JJ Lemma=dn NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=7307 CharacterOffsetEnd=7312 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=was CharacterOffsetBegin=7313 CharacterOffsetEnd=7316 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=raised CharacterOffsetBegin=7317 CharacterOffsetEnd=7323 PartOfSpeech=VBN Lemma=raise NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=7323 CharacterOffsetEnd=7324 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN mRNA) (NN expression) (NN level))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN ET-1))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (NN ETA-R))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT the) (JJ renal) (NN cortex))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ DN) (NN model)))))))))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN raised)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, raised-17)\n",
      "det(level-4, The-1)\n",
      "compound(level-4, mRNA-2)\n",
      "compound(level-4, expression-3)\n",
      "nsubjpass(raised-17, level-4)\n",
      "case(ET-1-6, of-5)\n",
      "nmod:of(level-4, ET-1-6)\n",
      "punct(ET-1-6, ,-7)\n",
      "appos(ET-1-6, ETA-R-8)\n",
      "case(cortex-12, of-9)\n",
      "det(cortex-12, the-10)\n",
      "amod(cortex-12, renal-11)\n",
      "nmod:of(ETA-R-8, cortex-12)\n",
      "case(model-15, of-13)\n",
      "amod(model-15, DN-14)\n",
      "nmod:of(cortex-12, model-15)\n",
      "auxpass(raised-17, was-16)\n",
      "punct(raised-17, .-18)\n",
      "\n",
      "Sentence #50 (25 tokens, sentiment: Negative):\n",
      "After influenced by the compound of traditional Chinese drugs and Benazepril, the over-expression level de-creased (still higher than normal control ones).\n",
      "[Text=After CharacterOffsetBegin=7325 CharacterOffsetEnd=7330 PartOfSpeech=IN Lemma=after NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=influenced CharacterOffsetBegin=7331 CharacterOffsetEnd=7341 PartOfSpeech=VBN Lemma=influence NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=7342 CharacterOffsetEnd=7344 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7345 CharacterOffsetEnd=7348 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compound CharacterOffsetBegin=7349 CharacterOffsetEnd=7357 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7358 CharacterOffsetEnd=7360 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=7361 CharacterOffsetEnd=7372 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=7373 CharacterOffsetEnd=7380 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=7381 CharacterOffsetEnd=7386 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=7387 CharacterOffsetEnd=7390 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=7391 CharacterOffsetEnd=7401 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=7401 CharacterOffsetEnd=7402 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7403 CharacterOffsetEnd=7406 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=over-expression CharacterOffsetBegin=7407 CharacterOffsetEnd=7422 PartOfSpeech=NN Lemma=over-expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=level CharacterOffsetBegin=7423 CharacterOffsetEnd=7428 PartOfSpeech=NN Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=de-creased CharacterOffsetBegin=7429 CharacterOffsetEnd=7439 PartOfSpeech=JJ Lemma=de-creased NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=7440 CharacterOffsetEnd=7441 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=still CharacterOffsetBegin=7441 CharacterOffsetEnd=7446 PartOfSpeech=RB Lemma=still NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=higher CharacterOffsetBegin=7447 CharacterOffsetEnd=7453 PartOfSpeech=JJR Lemma=higher NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=than CharacterOffsetBegin=7454 CharacterOffsetEnd=7458 PartOfSpeech=IN Lemma=than NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=normal CharacterOffsetBegin=7459 CharacterOffsetEnd=7465 PartOfSpeech=JJ Lemma=normal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=control CharacterOffsetBegin=7466 CharacterOffsetEnd=7473 PartOfSpeech=JJ Lemma=control NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ones CharacterOffsetBegin=7474 CharacterOffsetEnd=7478 PartOfSpeech=NNS Lemma=one NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=7478 CharacterOffsetEnd=7479 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=7479 CharacterOffsetEnd=7480 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (FRAG\n",
      "    (SBAR (IN After)\n",
      "      (S\n",
      "        (VP (VBN influenced)\n",
      "          (PP (IN by)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (DT the) (NN compound))\n",
      "                (PP (IN of)\n",
      "                  (NP (JJ traditional) (JJ Chinese) (NNS drugs))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (NNP Benazepril))\n",
      "                (, ,)\n",
      "                (NP (DT the) (NN over-expression) (NN level) (JJ de-creased)))))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (ADVP (RB still))\n",
      "            (ADJP (JJR higher)\n",
      "              (PP (IN than)\n",
      "                (NP (JJ normal) (JJ control) (NNS ones))))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, influenced-2)\n",
      "mark(influenced-2, After-1)\n",
      "case(compound-5, by-3)\n",
      "det(compound-5, the-4)\n",
      "nmod:by(influenced-2, compound-5)\n",
      "case(drugs-9, of-6)\n",
      "amod(drugs-9, traditional-7)\n",
      "amod(drugs-9, Chinese-8)\n",
      "nmod:of(compound-5, drugs-9)\n",
      "cc(compound-5, and-10)\n",
      "nmod:by(influenced-2, Benazepril-11)\n",
      "conj:and(compound-5, Benazepril-11)\n",
      "punct(Benazepril-11, ,-12)\n",
      "det(level-15, the-13)\n",
      "compound(level-15, over-expression-14)\n",
      "appos(Benazepril-11, level-15)\n",
      "amod(level-15, de-creased-16)\n",
      "punct(higher-19, -LRB--17)\n",
      "dep(higher-19, still-18)\n",
      "dep(influenced-2, higher-19)\n",
      "case(ones-23, than-20)\n",
      "amod(ones-23, normal-21)\n",
      "amod(ones-23, control-22)\n",
      "nmod:than(higher-19, ones-23)\n",
      "punct(higher-19, -RRB--24)\n",
      "punct(influenced-2, .-25)\n",
      "\n",
      "Sentence #51 (24 tokens, sentiment: Negative):\n",
      "The compound of traditional Chinese drugs were more effective than Benazepril to inhibit the proliferation of the stalk region and the third cells.\n",
      "[Text=The CharacterOffsetBegin=7481 CharacterOffsetEnd=7484 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compound CharacterOffsetBegin=7485 CharacterOffsetEnd=7493 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7494 CharacterOffsetEnd=7496 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=7497 CharacterOffsetEnd=7508 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=7509 CharacterOffsetEnd=7516 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=7517 CharacterOffsetEnd=7522 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=7523 CharacterOffsetEnd=7527 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=more CharacterOffsetBegin=7528 CharacterOffsetEnd=7532 PartOfSpeech=RBR Lemma=more NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effective CharacterOffsetBegin=7533 CharacterOffsetEnd=7542 PartOfSpeech=JJ Lemma=effective NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=than CharacterOffsetBegin=7543 CharacterOffsetEnd=7547 PartOfSpeech=IN Lemma=than NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=7548 CharacterOffsetEnd=7558 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=7559 CharacterOffsetEnd=7561 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibit CharacterOffsetBegin=7562 CharacterOffsetEnd=7569 PartOfSpeech=VB Lemma=inhibit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7570 CharacterOffsetEnd=7573 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=proliferation CharacterOffsetBegin=7574 CharacterOffsetEnd=7587 PartOfSpeech=NN Lemma=proliferation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7588 CharacterOffsetEnd=7590 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7591 CharacterOffsetEnd=7594 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=stalk CharacterOffsetBegin=7595 CharacterOffsetEnd=7600 PartOfSpeech=NN Lemma=stalk NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=region CharacterOffsetBegin=7601 CharacterOffsetEnd=7607 PartOfSpeech=NN Lemma=region NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=7608 CharacterOffsetEnd=7611 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7612 CharacterOffsetEnd=7615 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=third CharacterOffsetBegin=7616 CharacterOffsetEnd=7621 PartOfSpeech=JJ Lemma=third NamedEntityTag=ORDINAL NormalizedNamedEntityTag=3.0 SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=7622 CharacterOffsetEnd=7627 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=7627 CharacterOffsetEnd=7628 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN compound))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ traditional) (JJ Chinese) (NNS drugs))))\n",
      "    (VP (VBD were)\n",
      "      (ADJP (RBR more) (JJ effective)\n",
      "        (PP (IN than)\n",
      "          (NP (NNP Benazepril))))\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB inhibit)\n",
      "            (NP\n",
      "              (NP (DT the) (NN proliferation))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN stalk) (NN region))\n",
      "                  (CC and)\n",
      "                  (NP (DT the) (JJ third) (NNS cells)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, effective-9)\n",
      "det(compound-2, The-1)\n",
      "nsubj(effective-9, compound-2)\n",
      "nsubj:xsubj(inhibit-13, compound-2)\n",
      "case(drugs-6, of-3)\n",
      "amod(drugs-6, traditional-4)\n",
      "amod(drugs-6, Chinese-5)\n",
      "nmod:of(compound-2, drugs-6)\n",
      "cop(effective-9, were-7)\n",
      "advmod(effective-9, more-8)\n",
      "case(Benazepril-11, than-10)\n",
      "nmod:than(effective-9, Benazepril-11)\n",
      "mark(inhibit-13, to-12)\n",
      "xcomp(effective-9, inhibit-13)\n",
      "det(proliferation-15, the-14)\n",
      "dobj(inhibit-13, proliferation-15)\n",
      "case(region-19, of-16)\n",
      "det(region-19, the-17)\n",
      "compound(region-19, stalk-18)\n",
      "nmod:of(proliferation-15, region-19)\n",
      "cc(region-19, and-20)\n",
      "det(cells-23, the-21)\n",
      "amod(cells-23, third-22)\n",
      "nmod:of(proliferation-15, cells-23)\n",
      "conj:and(region-19, cells-23)\n",
      "punct(effective-9, .-24)\n",
      "\n",
      "Sentence #52 (10 tokens, sentiment: Neutral):\n",
      "ET takes part in the process of diabetic glo-Merulosclerosis.\n",
      "[Text=ET CharacterOffsetBegin=7630 CharacterOffsetEnd=7632 PartOfSpeech=NNP Lemma=ET NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=takes CharacterOffsetBegin=7633 CharacterOffsetEnd=7638 PartOfSpeech=VBZ Lemma=take NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=part CharacterOffsetBegin=7639 CharacterOffsetEnd=7643 PartOfSpeech=NN Lemma=part NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=7644 CharacterOffsetEnd=7646 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7647 CharacterOffsetEnd=7650 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=process CharacterOffsetBegin=7651 CharacterOffsetEnd=7658 PartOfSpeech=NN Lemma=process NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7659 CharacterOffsetEnd=7661 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=7662 CharacterOffsetEnd=7670 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glo-Merulosclerosis CharacterOffsetBegin=7671 CharacterOffsetEnd=7690 PartOfSpeech=NN Lemma=glo-merulosclerosis NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=7690 CharacterOffsetEnd=7691 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP ET))\n",
      "    (VP (VBZ takes)\n",
      "      (NP (NN part))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (DT the) (NN process))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ diabetic) (NN glo-Merulosclerosis))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, takes-2)\n",
      "nsubj(takes-2, ET-1)\n",
      "dobj(takes-2, part-3)\n",
      "case(process-6, in-4)\n",
      "det(process-6, the-5)\n",
      "nmod:in(takes-2, process-6)\n",
      "case(glo-Merulosclerosis-9, of-7)\n",
      "amod(glo-Merulosclerosis-9, diabetic-8)\n",
      "nmod:of(process-6, glo-Merulosclerosis-9)\n",
      "punct(takes-2, .-10)\n",
      "\n",
      "Sentence #53 (26 tokens, sentiment: Negative):\n",
      "Both the compound of traditional Chinese drugs and Benazepril can influence the expression quantity from the level of gene transcription of ET and its receptor.\n",
      "[Text=Both CharacterOffsetBegin=7692 CharacterOffsetEnd=7696 PartOfSpeech=CC Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7697 CharacterOffsetEnd=7700 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compound CharacterOffsetBegin=7701 CharacterOffsetEnd=7709 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7710 CharacterOffsetEnd=7712 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=7713 CharacterOffsetEnd=7724 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=7725 CharacterOffsetEnd=7732 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=7733 CharacterOffsetEnd=7738 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=7739 CharacterOffsetEnd=7742 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=7743 CharacterOffsetEnd=7753 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=can CharacterOffsetBegin=7754 CharacterOffsetEnd=7757 PartOfSpeech=MD Lemma=can NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=influence CharacterOffsetBegin=7758 CharacterOffsetEnd=7767 PartOfSpeech=VB Lemma=influence NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=the CharacterOffsetBegin=7768 CharacterOffsetEnd=7771 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=7772 CharacterOffsetEnd=7782 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=quantity CharacterOffsetBegin=7783 CharacterOffsetEnd=7791 PartOfSpeech=NN Lemma=quantity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=from CharacterOffsetBegin=7792 CharacterOffsetEnd=7796 PartOfSpeech=IN Lemma=from NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=7797 CharacterOffsetEnd=7800 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=level CharacterOffsetBegin=7801 CharacterOffsetEnd=7806 PartOfSpeech=NN Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7807 CharacterOffsetEnd=7809 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=gene CharacterOffsetBegin=7810 CharacterOffsetEnd=7814 PartOfSpeech=NN Lemma=gene NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=transcription CharacterOffsetBegin=7815 CharacterOffsetEnd=7828 PartOfSpeech=NN Lemma=transcription NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7829 CharacterOffsetEnd=7831 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ET CharacterOffsetBegin=7832 CharacterOffsetEnd=7834 PartOfSpeech=NNP Lemma=ET NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=7835 CharacterOffsetEnd=7838 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=its CharacterOffsetBegin=7839 CharacterOffsetEnd=7842 PartOfSpeech=PRP$ Lemma=its NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=receptor CharacterOffsetBegin=7843 CharacterOffsetEnd=7851 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=7851 CharacterOffsetEnd=7852 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (CC Both)\n",
      "      (NP (DT the) (NN compound))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ traditional) (JJ Chinese) (NNS drugs)))\n",
      "      (CC and)\n",
      "      (NP (NNP Benazepril)))\n",
      "    (VP (MD can)\n",
      "      (VP (VB influence)\n",
      "        (NP (DT the) (NN expression) (NN quantity))\n",
      "        (PP (IN from)\n",
      "          (NP\n",
      "            (NP (DT the) (NN level))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NN gene) (NN transcription))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NNP ET))\n",
      "                    (CC and)\n",
      "                    (NP (PRP$ its) (NN receptor))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, influence-11)\n",
      "cc:preconj(compound-3, Both-1)\n",
      "det(compound-3, the-2)\n",
      "nsubj(influence-11, compound-3)\n",
      "case(drugs-7, of-4)\n",
      "amod(drugs-7, traditional-5)\n",
      "amod(drugs-7, Chinese-6)\n",
      "nmod:of(compound-3, drugs-7)\n",
      "cc(compound-3, and-8)\n",
      "conj:and(compound-3, Benazepril-9)\n",
      "nsubj(influence-11, Benazepril-9)\n",
      "aux(influence-11, can-10)\n",
      "det(quantity-14, the-12)\n",
      "compound(quantity-14, expression-13)\n",
      "dobj(influence-11, quantity-14)\n",
      "case(level-17, from-15)\n",
      "det(level-17, the-16)\n",
      "nmod:from(influence-11, level-17)\n",
      "case(transcription-20, of-18)\n",
      "compound(transcription-20, gene-19)\n",
      "nmod:of(level-17, transcription-20)\n",
      "case(ET-22, of-21)\n",
      "nmod:of(transcription-20, ET-22)\n",
      "cc(ET-22, and-23)\n",
      "nmod:poss(receptor-25, its-24)\n",
      "nmod:of(transcription-20, receptor-25)\n",
      "conj:and(ET-22, receptor-25)\n",
      "punct(influence-11, .-26)\n",
      "\n",
      "Sentence #54 (24 tokens, sentiment: Negative):\n",
      "The compound of traditional Chinese drugs can not only reduce urinary albumin of DN, but also improve blood glucose, glycosylated hemoglubin.\n",
      "[Text=The CharacterOffsetBegin=7853 CharacterOffsetEnd=7856 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compound CharacterOffsetBegin=7857 CharacterOffsetEnd=7865 PartOfSpeech=NN Lemma=compound NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7866 CharacterOffsetEnd=7868 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=traditional CharacterOffsetBegin=7869 CharacterOffsetEnd=7880 PartOfSpeech=JJ Lemma=traditional NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Chinese CharacterOffsetBegin=7881 CharacterOffsetEnd=7888 PartOfSpeech=JJ Lemma=chinese NamedEntityTag=MISC SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=7889 CharacterOffsetEnd=7894 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=can CharacterOffsetBegin=7895 CharacterOffsetEnd=7898 PartOfSpeech=MD Lemma=can NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=not CharacterOffsetBegin=7899 CharacterOffsetEnd=7902 PartOfSpeech=RB Lemma=not NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=only CharacterOffsetBegin=7903 CharacterOffsetEnd=7907 PartOfSpeech=RB Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduce CharacterOffsetBegin=7908 CharacterOffsetEnd=7914 PartOfSpeech=VB Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=urinary CharacterOffsetBegin=7915 CharacterOffsetEnd=7922 PartOfSpeech=JJ Lemma=urinary NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=albumin CharacterOffsetBegin=7923 CharacterOffsetEnd=7930 PartOfSpeech=NN Lemma=albumin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=7931 CharacterOffsetEnd=7933 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DN CharacterOffsetBegin=7934 CharacterOffsetEnd=7936 PartOfSpeech=JJ Lemma=dn NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=7936 CharacterOffsetEnd=7937 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=but CharacterOffsetBegin=7938 CharacterOffsetEnd=7941 PartOfSpeech=CC Lemma=but NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=also CharacterOffsetBegin=7942 CharacterOffsetEnd=7946 PartOfSpeech=RB Lemma=also NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=improve CharacterOffsetBegin=7947 CharacterOffsetEnd=7954 PartOfSpeech=VB Lemma=improve NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blood CharacterOffsetBegin=7955 CharacterOffsetEnd=7960 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=glucose CharacterOffsetBegin=7961 CharacterOffsetEnd=7968 PartOfSpeech=NN Lemma=glucose NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=7968 CharacterOffsetEnd=7969 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glycosylated CharacterOffsetBegin=7970 CharacterOffsetEnd=7982 PartOfSpeech=VBN Lemma=glycosylate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hemoglubin CharacterOffsetBegin=7983 CharacterOffsetEnd=7993 PartOfSpeech=NN Lemma=hemoglubin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=7993 CharacterOffsetEnd=7994 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN compound))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ traditional) (JJ Chinese) (NNS drugs))))\n",
      "    (VP (MD can) (RB not)\n",
      "      (ADVP (RB only))\n",
      "      (VP\n",
      "        (VP (VB reduce)\n",
      "          (NP\n",
      "            (NP (JJ urinary) (NN albumin))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ DN)))))\n",
      "        (, ,)\n",
      "        (CC but)\n",
      "        (ADVP (RB also))\n",
      "        (VP (VB improve)\n",
      "          (NP\n",
      "            (NP (NN blood) (NN glucose))\n",
      "            (, ,)\n",
      "            (VP (VBN glycosylated)\n",
      "              (NP (NN hemoglubin)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, reduce-10)\n",
      "det(compound-2, The-1)\n",
      "nsubj(reduce-10, compound-2)\n",
      "nsubj(improve-18, compound-2)\n",
      "case(drugs-6, of-3)\n",
      "amod(drugs-6, traditional-4)\n",
      "amod(drugs-6, Chinese-5)\n",
      "nmod:of(compound-2, drugs-6)\n",
      "aux(reduce-10, can-7)\n",
      "neg(reduce-10, not-8)\n",
      "advmod(reduce-10, only-9)\n",
      "amod(albumin-12, urinary-11)\n",
      "dobj(reduce-10, albumin-12)\n",
      "case(DN-14, of-13)\n",
      "nmod:of(albumin-12, DN-14)\n",
      "punct(reduce-10, ,-15)\n",
      "cc(reduce-10, but-16)\n",
      "advmod(improve-18, also-17)\n",
      "conj:and(reduce-10, improve-18)\n",
      "compound(glucose-20, blood-19)\n",
      "dobj(improve-18, glucose-20)\n",
      "punct(glucose-20, ,-21)\n",
      "acl(glucose-20, glycosylated-22)\n",
      "dobj(glycosylated-22, hemoglubin-23)\n",
      "punct(reduce-10, .-24)\n",
      "\n",
      "Sentence #55 (22 tokens, sentiment: Negative):\n",
      "And it can inhibit nonenzymatic glucosylation of protein as well as the proliferation of the stalk region and the third cells.\n",
      "[Text=And CharacterOffsetBegin=7995 CharacterOffsetEnd=7998 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=it CharacterOffsetBegin=7999 CharacterOffsetEnd=8001 PartOfSpeech=PRP Lemma=it NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=can CharacterOffsetBegin=8002 CharacterOffsetEnd=8005 PartOfSpeech=MD Lemma=can NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibit CharacterOffsetBegin=8006 CharacterOffsetEnd=8013 PartOfSpeech=VB Lemma=inhibit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nonenzymatic CharacterOffsetBegin=8014 CharacterOffsetEnd=8026 PartOfSpeech=JJ Lemma=nonenzymatic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glucosylation CharacterOffsetBegin=8027 CharacterOffsetEnd=8040 PartOfSpeech=NN Lemma=glucosylation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=8041 CharacterOffsetEnd=8043 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=protein CharacterOffsetBegin=8044 CharacterOffsetEnd=8051 PartOfSpeech=NN Lemma=protein NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=as CharacterOffsetBegin=8052 CharacterOffsetEnd=8054 PartOfSpeech=RB Lemma=as NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=well CharacterOffsetBegin=8055 CharacterOffsetEnd=8059 PartOfSpeech=RB Lemma=well NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=as CharacterOffsetBegin=8060 CharacterOffsetEnd=8062 PartOfSpeech=IN Lemma=as NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=8063 CharacterOffsetEnd=8066 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=proliferation CharacterOffsetBegin=8067 CharacterOffsetEnd=8080 PartOfSpeech=NN Lemma=proliferation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=8081 CharacterOffsetEnd=8083 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=8084 CharacterOffsetEnd=8087 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=stalk CharacterOffsetBegin=8088 CharacterOffsetEnd=8093 PartOfSpeech=NN Lemma=stalk NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=region CharacterOffsetBegin=8094 CharacterOffsetEnd=8100 PartOfSpeech=NN Lemma=region NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=8101 CharacterOffsetEnd=8104 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=8105 CharacterOffsetEnd=8108 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=third CharacterOffsetBegin=8109 CharacterOffsetEnd=8114 PartOfSpeech=JJ Lemma=third NamedEntityTag=ORDINAL NormalizedNamedEntityTag=3.0 SentimentClass=Neutral]\n",
      "[Text=cells CharacterOffsetBegin=8115 CharacterOffsetEnd=8120 PartOfSpeech=NNS Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=8120 CharacterOffsetEnd=8121 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S (CC And)\n",
      "    (NP (PRP it))\n",
      "    (VP (MD can)\n",
      "      (VP (VB inhibit)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ nonenzymatic) (NN glucosylation))\n",
      "            (PP (IN of)\n",
      "              (NP (NN protein))))\n",
      "          (CONJP (RB as) (RB well) (IN as))\n",
      "          (NP\n",
      "            (NP (DT the) (NN proliferation))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT the) (NN stalk) (NN region))\n",
      "                (CC and)\n",
      "                (NP (DT the) (JJ third) (NNS cells))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, inhibit-4)\n",
      "cc(inhibit-4, And-1)\n",
      "nsubj(inhibit-4, it-2)\n",
      "aux(inhibit-4, can-3)\n",
      "amod(glucosylation-6, nonenzymatic-5)\n",
      "dobj(inhibit-4, glucosylation-6)\n",
      "case(protein-8, of-7)\n",
      "nmod:of(glucosylation-6, protein-8)\n",
      "cc(glucosylation-6, as-9)\n",
      "mwe(as-9, well-10)\n",
      "mwe(as-9, as-11)\n",
      "det(proliferation-13, the-12)\n",
      "dobj(inhibit-4, proliferation-13)\n",
      "conj:and(glucosylation-6, proliferation-13)\n",
      "case(region-17, of-14)\n",
      "det(region-17, the-15)\n",
      "compound(region-17, stalk-16)\n",
      "nmod:of(proliferation-13, region-17)\n",
      "cc(region-17, and-18)\n",
      "det(cells-21, the-19)\n",
      "amod(cells-21, third-20)\n",
      "nmod:of(proliferation-13, cells-21)\n",
      "conj:and(region-17, cells-21)\n",
      "punct(inhibit-4, .-22)\n",
      "\n",
      "Sentence #56 (50 tokens, sentiment: Negative):\n",
      "Both benazepril and amlodipine were similarly effective in reducing systolic blood pressure (SBP) (-17.6 mmHg with benazepril and -19.8 mmHg with amlodipine; P<0.001 versus placebo), and diastolic blood pressure (DBP) (-11.1 mmHg, -13.2 mmHg, respectively).\n",
      "[Text=Both CharacterOffsetBegin=8123 CharacterOffsetEnd=8127 PartOfSpeech=DT Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=8128 CharacterOffsetEnd=8138 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=8139 CharacterOffsetEnd=8142 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=8143 CharacterOffsetEnd=8153 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=8154 CharacterOffsetEnd=8158 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=similarly CharacterOffsetBegin=8159 CharacterOffsetEnd=8168 PartOfSpeech=RB Lemma=similarly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effective CharacterOffsetBegin=8169 CharacterOffsetEnd=8178 PartOfSpeech=JJ Lemma=effective NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=in CharacterOffsetBegin=8179 CharacterOffsetEnd=8181 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reducing CharacterOffsetBegin=8182 CharacterOffsetEnd=8190 PartOfSpeech=VBG Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=systolic CharacterOffsetBegin=8191 CharacterOffsetEnd=8199 PartOfSpeech=JJ Lemma=systolic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blood CharacterOffsetBegin=8200 CharacterOffsetEnd=8205 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=pressure CharacterOffsetBegin=8206 CharacterOffsetEnd=8214 PartOfSpeech=NN Lemma=pressure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8215 CharacterOffsetEnd=8216 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SBP CharacterOffsetBegin=8216 CharacterOffsetEnd=8219 PartOfSpeech=NN Lemma=sbp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8219 CharacterOffsetEnd=8220 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8221 CharacterOffsetEnd=8222 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-17.6 CharacterOffsetBegin=8222 CharacterOffsetEnd=8227 PartOfSpeech=CD Lemma=-17.6 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-17.6 SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=8228 CharacterOffsetEnd=8232 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=8233 CharacterOffsetEnd=8237 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=8238 CharacterOffsetEnd=8248 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=8249 CharacterOffsetEnd=8252 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-19.8 CharacterOffsetBegin=8253 CharacterOffsetEnd=8258 PartOfSpeech=CD Lemma=-19.8 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-19.8 SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=8259 CharacterOffsetEnd=8263 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=8264 CharacterOffsetEnd=8268 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=8269 CharacterOffsetEnd=8279 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=; CharacterOffsetBegin=8279 CharacterOffsetEnd=8280 PartOfSpeech=: Lemma=; NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=P CharacterOffsetBegin=8281 CharacterOffsetEnd=8282 PartOfSpeech=NN Lemma=p NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=< CharacterOffsetBegin=8282 CharacterOffsetEnd=8283 PartOfSpeech=JJR Lemma=< NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.001 CharacterOffsetBegin=8283 CharacterOffsetEnd=8288 PartOfSpeech=CD Lemma=0.001 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.001 SentimentClass=Neutral]\n",
      "[Text=versus CharacterOffsetBegin=8289 CharacterOffsetEnd=8295 PartOfSpeech=CC Lemma=versus NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=placebo CharacterOffsetBegin=8296 CharacterOffsetEnd=8303 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8303 CharacterOffsetEnd=8304 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=8304 CharacterOffsetEnd=8305 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=8306 CharacterOffsetEnd=8309 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diastolic CharacterOffsetBegin=8310 CharacterOffsetEnd=8319 PartOfSpeech=JJ Lemma=diastolic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blood CharacterOffsetBegin=8320 CharacterOffsetEnd=8325 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=pressure CharacterOffsetBegin=8326 CharacterOffsetEnd=8334 PartOfSpeech=NN Lemma=pressure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8335 CharacterOffsetEnd=8336 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DBP CharacterOffsetBegin=8336 CharacterOffsetEnd=8339 PartOfSpeech=NN Lemma=dbp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8339 CharacterOffsetEnd=8340 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8341 CharacterOffsetEnd=8342 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-11.1 CharacterOffsetBegin=8342 CharacterOffsetEnd=8347 PartOfSpeech=CD Lemma=-11.1 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-11.1 SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=8348 CharacterOffsetEnd=8352 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=8352 CharacterOffsetEnd=8353 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-13.2 CharacterOffsetBegin=8354 CharacterOffsetEnd=8359 PartOfSpeech=CD Lemma=-13.2 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-13.2 SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=8360 CharacterOffsetEnd=8364 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=8364 CharacterOffsetEnd=8365 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=respectively CharacterOffsetBegin=8366 CharacterOffsetEnd=8378 PartOfSpeech=RB Lemma=respectively NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8378 CharacterOffsetEnd=8379 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=8379 CharacterOffsetEnd=8380 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT Both) (NN benazepril)\n",
      "      (CC and)\n",
      "      (NN amlodipine))\n",
      "    (VP (VBD were)\n",
      "      (ADJP (RB similarly) (JJ effective)\n",
      "        (PP (IN in)\n",
      "          (S\n",
      "            (VP (VBG reducing)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ systolic) (NN blood) (NN pressure))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN SBP))\n",
      "                      (-RRB- -RRB-)))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (CD -17.6) (NN mmHg))\n",
      "                        (PP (IN with)\n",
      "                          (NP (NN benazepril))))\n",
      "                      (CC and)\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (NP (CD -19.8) (NN mmHg))\n",
      "                          (PP (IN with)\n",
      "                            (NP (NN amlodipine))))\n",
      "                        (: ;)\n",
      "                        (NP\n",
      "                          (NP (NN P))\n",
      "                          (ADJP\n",
      "                            (ADJP (JJR <))\n",
      "                            (PRN\n",
      "                              (NP-TMP (CD 0.001))\n",
      "                              (PP (CC versus)\n",
      "                                (NP (NN placebo))))))))\n",
      "                    (-RRB- -RRB-)))\n",
      "                (, ,)\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (JJ diastolic) (NN blood) (NN pressure))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN DBP))\n",
      "                      (-RRB- -RRB-)))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (CD -11.1) (NN mmHg))\n",
      "                        (, ,)\n",
      "                        (NP (CD -13.2) (NN mmHg)))\n",
      "                      (, ,)\n",
      "                      (ADVP (RB respectively)))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, effective-7)\n",
      "cc:preconj(benazepril-2, Both-1)\n",
      "nsubj(effective-7, benazepril-2)\n",
      "cc(benazepril-2, and-3)\n",
      "conj:and(benazepril-2, amlodipine-4)\n",
      "nsubj(effective-7, amlodipine-4)\n",
      "cop(effective-7, were-5)\n",
      "advmod(effective-7, similarly-6)\n",
      "mark(reducing-9, in-8)\n",
      "advcl:in(effective-7, reducing-9)\n",
      "amod(pressure-12, systolic-10)\n",
      "compound(pressure-12, blood-11)\n",
      "dobj(reducing-9, pressure-12)\n",
      "punct(SBP-14, -LRB--13)\n",
      "appos(pressure-12, SBP-14)\n",
      "punct(SBP-14, -RRB--15)\n",
      "punct(mmHg-18, -LRB--16)\n",
      "nummod(mmHg-18, -17.6-17)\n",
      "dep(pressure-12, mmHg-18)\n",
      "case(benazepril-20, with-19)\n",
      "nmod:with(mmHg-18, benazepril-20)\n",
      "cc(mmHg-18, and-21)\n",
      "nummod(mmHg-23, -19.8-22)\n",
      "dep(pressure-12, mmHg-23)\n",
      "conj:and(mmHg-18, mmHg-23)\n",
      "case(amlodipine-25, with-24)\n",
      "nmod:with(mmHg-23, amlodipine-25)\n",
      "punct(mmHg-23, ;-26)\n",
      "dep(mmHg-23, P-27)\n",
      "amod(P-27, <-28)\n",
      "dep(<-28, 0.001-29)\n",
      "case(placebo-31, versus-30)\n",
      "nmod:versus(0.001-29, placebo-31)\n",
      "punct(mmHg-18, -RRB--32)\n",
      "punct(pressure-12, ,-33)\n",
      "cc(pressure-12, and-34)\n",
      "amod(pressure-37, diastolic-35)\n",
      "compound(pressure-37, blood-36)\n",
      "dobj(reducing-9, pressure-37)\n",
      "conj:and(pressure-12, pressure-37)\n",
      "punct(DBP-39, -LRB--38)\n",
      "appos(pressure-37, DBP-39)\n",
      "punct(DBP-39, -RRB--40)\n",
      "punct(mmHg-43, -LRB--41)\n",
      "nummod(mmHg-43, -11.1-42)\n",
      "dep(pressure-37, mmHg-43)\n",
      "punct(mmHg-43, ,-44)\n",
      "nummod(mmHg-46, -13.2-45)\n",
      "appos(mmHg-43, mmHg-46)\n",
      "punct(mmHg-43, ,-47)\n",
      "advmod(mmHg-43, respectively-48)\n",
      "punct(mmHg-43, -RRB--49)\n",
      "punct(effective-7, .-50)\n",
      "\n",
      "Sentence #57 (29 tokens, sentiment: Negative):\n",
      "Combination therapy produced greater reduction in SBP/DBP values (-28.3/-20.5 mmHg; P<0.001 versus placebo, P<0.01 versus benazepril and amlodipine).\n",
      "[Text=Combination CharacterOffsetBegin=8381 CharacterOffsetEnd=8392 PartOfSpeech=NN Lemma=combination NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=8393 CharacterOffsetEnd=8400 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=produced CharacterOffsetBegin=8401 CharacterOffsetEnd=8409 PartOfSpeech=VBD Lemma=produce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=greater CharacterOffsetBegin=8410 CharacterOffsetEnd=8417 PartOfSpeech=JJR Lemma=greater NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=reduction CharacterOffsetBegin=8418 CharacterOffsetEnd=8427 PartOfSpeech=NN Lemma=reduction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=8428 CharacterOffsetEnd=8430 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SBP/DBP CharacterOffsetBegin=8431 CharacterOffsetEnd=8438 PartOfSpeech=NN Lemma=sbp/dbp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=values CharacterOffsetBegin=8439 CharacterOffsetEnd=8445 PartOfSpeech=NNS Lemma=value NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8446 CharacterOffsetEnd=8447 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-28.3 CharacterOffsetBegin=8447 CharacterOffsetEnd=8452 PartOfSpeech=CD Lemma=-28.3 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-28.3 SentimentClass=Neutral]\n",
      "[Text=/ CharacterOffsetBegin=8452 CharacterOffsetEnd=8453 PartOfSpeech=: Lemma=/ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-20.5 CharacterOffsetBegin=8453 CharacterOffsetEnd=8458 PartOfSpeech=CD Lemma=-20.5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-20.5 SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=8459 CharacterOffsetEnd=8463 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=; CharacterOffsetBegin=8463 CharacterOffsetEnd=8464 PartOfSpeech=: Lemma=; NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=P CharacterOffsetBegin=8465 CharacterOffsetEnd=8466 PartOfSpeech=NN Lemma=p NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=< CharacterOffsetBegin=8466 CharacterOffsetEnd=8467 PartOfSpeech=JJR Lemma=< NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.001 CharacterOffsetBegin=8467 CharacterOffsetEnd=8472 PartOfSpeech=CD Lemma=0.001 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.001 SentimentClass=Neutral]\n",
      "[Text=versus CharacterOffsetBegin=8473 CharacterOffsetEnd=8479 PartOfSpeech=CC Lemma=versus NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=placebo CharacterOffsetBegin=8480 CharacterOffsetEnd=8487 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=8487 CharacterOffsetEnd=8488 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=P CharacterOffsetBegin=8489 CharacterOffsetEnd=8490 PartOfSpeech=NN Lemma=p NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=< CharacterOffsetBegin=8490 CharacterOffsetEnd=8491 PartOfSpeech=JJR Lemma=< NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.01 CharacterOffsetBegin=8491 CharacterOffsetEnd=8495 PartOfSpeech=CD Lemma=0.01 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.01 SentimentClass=Neutral]\n",
      "[Text=versus CharacterOffsetBegin=8496 CharacterOffsetEnd=8502 PartOfSpeech=CC Lemma=versus NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=8503 CharacterOffsetEnd=8513 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=8514 CharacterOffsetEnd=8517 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=8518 CharacterOffsetEnd=8528 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8528 CharacterOffsetEnd=8529 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=8529 CharacterOffsetEnd=8530 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Combination) (NN therapy))\n",
      "    (VP (VBD produced)\n",
      "      (NP (JJR greater) (NN reduction))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN SBP/DBP) (NNS values))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD -28.3))\n",
      "            (: /)\n",
      "            (NP\n",
      "              (NP (CD -20.5) (NN mmHg))\n",
      "              (: ;)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NN P))\n",
      "                  (ADJP\n",
      "                    (ADJP\n",
      "                      (ADJP (JJR <))\n",
      "                      (PRN\n",
      "                        (NP-TMP (CD 0.001))\n",
      "                        (PP (CC versus)\n",
      "                          (NP (NN placebo)))))\n",
      "                    (, ,)\n",
      "                    (ADJP\n",
      "                      (NP (NN P))\n",
      "                      (JJR <))\n",
      "                    (NP (CD 0.01))))\n",
      "                (PP (CC versus)\n",
      "                  (NP (NN benazepril)\n",
      "                    (CC and)\n",
      "                    (NN amlodipine)))))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, produced-3)\n",
      "compound(therapy-2, Combination-1)\n",
      "nsubj(produced-3, therapy-2)\n",
      "amod(reduction-5, greater-4)\n",
      "dobj(produced-3, reduction-5)\n",
      "case(values-8, in-6)\n",
      "compound(values-8, SBP/DBP-7)\n",
      "nmod:in(produced-3, values-8)\n",
      "punct(-28.3-10, -LRB--9)\n",
      "dep(values-8, -28.3-10)\n",
      "punct(-28.3-10, /-11)\n",
      "nummod(mmHg-13, -20.5-12)\n",
      "dep(-28.3-10, mmHg-13)\n",
      "punct(mmHg-13, ;-14)\n",
      "dep(mmHg-13, P-15)\n",
      "amod(P-15, <-16)\n",
      "dep(<-16, 0.001-17)\n",
      "case(placebo-19, versus-18)\n",
      "nmod:versus(0.001-17, placebo-19)\n",
      "punct(<-16, ,-20)\n",
      "nmod:npmod(<-22, P-21)\n",
      "dep(<-16, <-22)\n",
      "dep(<-16, 0.01-23)\n",
      "case(benazepril-25, versus-24)\n",
      "nmod:versus(P-15, benazepril-25)\n",
      "cc(benazepril-25, and-26)\n",
      "nmod:versus(P-15, amlodipine-27)\n",
      "conj:and(benazepril-25, amlodipine-27)\n",
      "punct(-28.3-10, -RRB--28)\n",
      "punct(produced-3, .-29)\n",
      "\n",
      "Sentence #58 (27 tokens, sentiment: Negative):\n",
      "Benazepril monotherapy significantly decreased plasma PAI-1 activity (-8.4 IU/ml, P<0.05) while it did not influence t-PA activity (+0.02 IU/ml).\n",
      "[Text=Benazepril CharacterOffsetBegin=8531 CharacterOffsetEnd=8541 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=monotherapy CharacterOffsetBegin=8542 CharacterOffsetEnd=8553 PartOfSpeech=NNP Lemma=monotherapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=significantly CharacterOffsetBegin=8554 CharacterOffsetEnd=8567 PartOfSpeech=RB Lemma=significantly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=decreased CharacterOffsetBegin=8568 CharacterOffsetEnd=8577 PartOfSpeech=VBD Lemma=decrease NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasma CharacterOffsetBegin=8578 CharacterOffsetEnd=8584 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=8585 CharacterOffsetEnd=8590 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=8591 CharacterOffsetEnd=8599 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8600 CharacterOffsetEnd=8601 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-8.4 CharacterOffsetBegin=8601 CharacterOffsetEnd=8605 PartOfSpeech=CD Lemma=-8.4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-8.4 SentimentClass=Neutral]\n",
      "[Text=IU/ml CharacterOffsetBegin=8606 CharacterOffsetEnd=8611 PartOfSpeech=NN Lemma=iu/ml NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=8611 CharacterOffsetEnd=8612 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=P CharacterOffsetBegin=8613 CharacterOffsetEnd=8614 PartOfSpeech=NN Lemma=p NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=< CharacterOffsetBegin=8614 CharacterOffsetEnd=8615 PartOfSpeech=JJR Lemma=< NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.05 CharacterOffsetBegin=8615 CharacterOffsetEnd=8619 PartOfSpeech=CD Lemma=0.05 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.05 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8619 CharacterOffsetEnd=8620 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=while CharacterOffsetBegin=8621 CharacterOffsetEnd=8626 PartOfSpeech=IN Lemma=while NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=it CharacterOffsetBegin=8627 CharacterOffsetEnd=8629 PartOfSpeech=PRP Lemma=it NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=did CharacterOffsetBegin=8630 CharacterOffsetEnd=8633 PartOfSpeech=VBD Lemma=do NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=not CharacterOffsetBegin=8634 CharacterOffsetEnd=8637 PartOfSpeech=RB Lemma=not NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=influence CharacterOffsetBegin=8638 CharacterOffsetEnd=8647 PartOfSpeech=VB Lemma=influence NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=t-PA CharacterOffsetBegin=8648 CharacterOffsetEnd=8652 PartOfSpeech=NN Lemma=t-pa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=8653 CharacterOffsetEnd=8661 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8662 CharacterOffsetEnd=8663 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=+0.02 CharacterOffsetBegin=8663 CharacterOffsetEnd=8668 PartOfSpeech=CD Lemma=+0.02 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.02 SentimentClass=Neutral]\n",
      "[Text=IU/ml CharacterOffsetBegin=8669 CharacterOffsetEnd=8674 PartOfSpeech=NN Lemma=iu/ml NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8674 CharacterOffsetEnd=8675 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=8675 CharacterOffsetEnd=8676 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Benazepril) (NNP monotherapy))\n",
      "    (ADVP (RB significantly))\n",
      "    (VP (VBD decreased)\n",
      "      (NP\n",
      "        (NP (NN plasma) (NN PAI-1) (NN activity))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (CD -8.4) (NN IU/ml))\n",
      "              (, ,)\n",
      "              (NP\n",
      "                (NP (NN P))\n",
      "                (NP (JJR <))))\n",
      "            (NP (CD 0.05)))\n",
      "          (-RRB- -RRB-)))\n",
      "      (SBAR (IN while)\n",
      "        (S\n",
      "          (NP (PRP it))\n",
      "          (VP (VBD did) (RB not)\n",
      "            (VP (VB influence)\n",
      "              (NP\n",
      "                (NP (NN t-PA) (NN activity))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (CD +0.02) (NN IU/ml))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, decreased-4)\n",
      "compound(monotherapy-2, Benazepril-1)\n",
      "nsubj(decreased-4, monotherapy-2)\n",
      "advmod(decreased-4, significantly-3)\n",
      "compound(activity-7, plasma-5)\n",
      "compound(activity-7, PAI-1-6)\n",
      "dobj(decreased-4, activity-7)\n",
      "punct(IU/ml-10, -LRB--8)\n",
      "nummod(IU/ml-10, -8.4-9)\n",
      "dep(activity-7, IU/ml-10)\n",
      "punct(IU/ml-10, ,-11)\n",
      "appos(IU/ml-10, P-12)\n",
      "dep(P-12, <-13)\n",
      "dep(IU/ml-10, 0.05-14)\n",
      "punct(IU/ml-10, -RRB--15)\n",
      "mark(influence-20, while-16)\n",
      "nsubj(influence-20, it-17)\n",
      "aux(influence-20, did-18)\n",
      "neg(influence-20, not-19)\n",
      "advcl:while(decreased-4, influence-20)\n",
      "compound(activity-22, t-PA-21)\n",
      "dobj(influence-20, activity-22)\n",
      "punct(IU/ml-25, -LRB--23)\n",
      "nummod(IU/ml-25, +0.02-24)\n",
      "appos(activity-22, IU/ml-25)\n",
      "punct(IU/ml-25, -RRB--26)\n",
      "punct(decreased-4, .-27)\n",
      "\n",
      "Sentence #59 (29 tokens, sentiment: Negative):\n",
      "Amlodipine monotherapy produced a significant increase in t-PA activity (+0.27 IU/ml, P<0.05) while it did not influence PAI-1 activity (+0.8 IU/ml).\n",
      "[Text=Amlodipine CharacterOffsetBegin=8677 CharacterOffsetEnd=8687 PartOfSpeech=NNP Lemma=Amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=monotherapy CharacterOffsetBegin=8688 CharacterOffsetEnd=8699 PartOfSpeech=NNP Lemma=monotherapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=produced CharacterOffsetBegin=8700 CharacterOffsetEnd=8708 PartOfSpeech=VBD Lemma=produce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=8709 CharacterOffsetEnd=8710 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=significant CharacterOffsetBegin=8711 CharacterOffsetEnd=8722 PartOfSpeech=JJ Lemma=significant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=increase CharacterOffsetBegin=8723 CharacterOffsetEnd=8731 PartOfSpeech=NN Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=8732 CharacterOffsetEnd=8734 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=t-PA CharacterOffsetBegin=8735 CharacterOffsetEnd=8739 PartOfSpeech=NN Lemma=t-pa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=8740 CharacterOffsetEnd=8748 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8749 CharacterOffsetEnd=8750 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=+0.27 CharacterOffsetBegin=8750 CharacterOffsetEnd=8755 PartOfSpeech=CD Lemma=+0.27 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.27 SentimentClass=Neutral]\n",
      "[Text=IU/ml CharacterOffsetBegin=8756 CharacterOffsetEnd=8761 PartOfSpeech=NN Lemma=iu/ml NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=8761 CharacterOffsetEnd=8762 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=P CharacterOffsetBegin=8763 CharacterOffsetEnd=8764 PartOfSpeech=NN Lemma=p NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=< CharacterOffsetBegin=8764 CharacterOffsetEnd=8765 PartOfSpeech=JJR Lemma=< NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.05 CharacterOffsetBegin=8765 CharacterOffsetEnd=8769 PartOfSpeech=CD Lemma=0.05 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.05 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8769 CharacterOffsetEnd=8770 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=while CharacterOffsetBegin=8771 CharacterOffsetEnd=8776 PartOfSpeech=IN Lemma=while NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=it CharacterOffsetBegin=8777 CharacterOffsetEnd=8779 PartOfSpeech=PRP Lemma=it NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=did CharacterOffsetBegin=8780 CharacterOffsetEnd=8783 PartOfSpeech=VBD Lemma=do NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=not CharacterOffsetBegin=8784 CharacterOffsetEnd=8787 PartOfSpeech=RB Lemma=not NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=influence CharacterOffsetBegin=8788 CharacterOffsetEnd=8797 PartOfSpeech=VB Lemma=influence NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=PAI-1 CharacterOffsetBegin=8798 CharacterOffsetEnd=8803 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=8804 CharacterOffsetEnd=8812 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8813 CharacterOffsetEnd=8814 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=+0.8 CharacterOffsetBegin=8814 CharacterOffsetEnd=8818 PartOfSpeech=CD Lemma=+0.8 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.8 SentimentClass=Neutral]\n",
      "[Text=IU/ml CharacterOffsetBegin=8819 CharacterOffsetEnd=8824 PartOfSpeech=NN Lemma=iu/ml NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8824 CharacterOffsetEnd=8825 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=8825 CharacterOffsetEnd=8826 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Amlodipine) (NNP monotherapy))\n",
      "    (VP (VBD produced)\n",
      "      (NP (DT a) (JJ significant) (NN increase))\n",
      "      (PP (IN in)\n",
      "        (NP (NN t-PA) (NN activity)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (CD +0.27) (NN IU/ml))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP (NN P))\n",
      "              (NP (JJR <))))\n",
      "          (NP (CD 0.05)))\n",
      "        (-RRB- -RRB-))\n",
      "      (SBAR (IN while)\n",
      "        (S\n",
      "          (NP (PRP it))\n",
      "          (VP (VBD did) (RB not)\n",
      "            (VP (VB influence)\n",
      "              (NP\n",
      "                (NP (NN PAI-1) (NN activity))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (CD +0.8) (NN IU/ml))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, produced-3)\n",
      "compound(monotherapy-2, Amlodipine-1)\n",
      "nsubj(produced-3, monotherapy-2)\n",
      "det(increase-6, a-4)\n",
      "amod(increase-6, significant-5)\n",
      "dobj(produced-3, increase-6)\n",
      "case(activity-9, in-7)\n",
      "compound(activity-9, t-PA-8)\n",
      "nmod:in(produced-3, activity-9)\n",
      "punct(IU/ml-12, -LRB--10)\n",
      "nummod(IU/ml-12, +0.27-11)\n",
      "dep(produced-3, IU/ml-12)\n",
      "punct(IU/ml-12, ,-13)\n",
      "appos(IU/ml-12, P-14)\n",
      "dep(P-14, <-15)\n",
      "dep(IU/ml-12, 0.05-16)\n",
      "punct(IU/ml-12, -RRB--17)\n",
      "mark(influence-22, while-18)\n",
      "nsubj(influence-22, it-19)\n",
      "aux(influence-22, did-20)\n",
      "neg(influence-22, not-21)\n",
      "advcl:while(produced-3, influence-22)\n",
      "compound(activity-24, PAI-1-23)\n",
      "dobj(influence-22, activity-24)\n",
      "punct(IU/ml-27, -LRB--25)\n",
      "nummod(IU/ml-27, +0.8-26)\n",
      "appos(activity-24, IU/ml-27)\n",
      "punct(IU/ml-27, -RRB--28)\n",
      "punct(produced-3, .-29)\n",
      "\n",
      "Sentence #60 (36 tokens, sentiment: Negative):\n",
      "The amlodipine/benazepril combination produced both a significant decrease in plasma PAI-1 activity (-8.7 IU, P<0.05) and a significant increase in t-PA activity (+0.26 IU/ml, P<0.05).\n",
      "[Text=The CharacterOffsetBegin=8827 CharacterOffsetEnd=8830 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine/benazepril CharacterOffsetBegin=8831 CharacterOffsetEnd=8852 PartOfSpeech=NN Lemma=amlodipine/benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=combination CharacterOffsetBegin=8853 CharacterOffsetEnd=8864 PartOfSpeech=NN Lemma=combination NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=produced CharacterOffsetBegin=8865 CharacterOffsetEnd=8873 PartOfSpeech=VBD Lemma=produce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=both CharacterOffsetBegin=8874 CharacterOffsetEnd=8878 PartOfSpeech=CC Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=8879 CharacterOffsetEnd=8880 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=significant CharacterOffsetBegin=8881 CharacterOffsetEnd=8892 PartOfSpeech=JJ Lemma=significant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=decrease CharacterOffsetBegin=8893 CharacterOffsetEnd=8901 PartOfSpeech=NN Lemma=decrease NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=8902 CharacterOffsetEnd=8904 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasma CharacterOffsetBegin=8905 CharacterOffsetEnd=8911 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PAI-1 CharacterOffsetBegin=8912 CharacterOffsetEnd=8917 PartOfSpeech=NN Lemma=pai-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=8918 CharacterOffsetEnd=8926 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8927 CharacterOffsetEnd=8928 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-8.7 CharacterOffsetBegin=8928 CharacterOffsetEnd=8932 PartOfSpeech=CD Lemma=-8.7 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-8.7 SentimentClass=Neutral]\n",
      "[Text=IU CharacterOffsetBegin=8933 CharacterOffsetEnd=8935 PartOfSpeech=NN Lemma=iu NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=8935 CharacterOffsetEnd=8936 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=P CharacterOffsetBegin=8937 CharacterOffsetEnd=8938 PartOfSpeech=NN Lemma=p NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=< CharacterOffsetBegin=8938 CharacterOffsetEnd=8939 PartOfSpeech=JJR Lemma=< NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.05 CharacterOffsetBegin=8939 CharacterOffsetEnd=8943 PartOfSpeech=CD Lemma=0.05 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.05 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=8943 CharacterOffsetEnd=8944 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=8945 CharacterOffsetEnd=8948 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=8949 CharacterOffsetEnd=8950 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=significant CharacterOffsetBegin=8951 CharacterOffsetEnd=8962 PartOfSpeech=JJ Lemma=significant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=increase CharacterOffsetBegin=8963 CharacterOffsetEnd=8971 PartOfSpeech=NN Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=8972 CharacterOffsetEnd=8974 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=t-PA CharacterOffsetBegin=8975 CharacterOffsetEnd=8979 PartOfSpeech=NN Lemma=t-pa NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=8980 CharacterOffsetEnd=8988 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=8989 CharacterOffsetEnd=8990 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=+0.26 CharacterOffsetBegin=8990 CharacterOffsetEnd=8995 PartOfSpeech=CD Lemma=+0.26 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.26 SentimentClass=Neutral]\n",
      "[Text=IU/ml CharacterOffsetBegin=8996 CharacterOffsetEnd=9001 PartOfSpeech=NN Lemma=iu/ml NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=9001 CharacterOffsetEnd=9002 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=P CharacterOffsetBegin=9003 CharacterOffsetEnd=9004 PartOfSpeech=NN Lemma=p NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=< CharacterOffsetBegin=9004 CharacterOffsetEnd=9005 PartOfSpeech=JJR Lemma=< NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.05 CharacterOffsetBegin=9005 CharacterOffsetEnd=9009 PartOfSpeech=CD Lemma=0.05 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.05 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=9009 CharacterOffsetEnd=9010 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=9010 CharacterOffsetEnd=9011 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT The) (NN amlodipine/benazepril) (NN combination))\n",
      "    (VP (VBD produced)\n",
      "      (NP (CC both)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ significant) (NN decrease))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NN plasma) (NN PAI-1) (NN activity))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (CD -8.7) (NN IU))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (NN P))\n",
      "                      (NP (JJR <))))\n",
      "                  (NP (CD 0.05)))\n",
      "                (-RRB- -RRB-)))))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ significant) (NN increase))\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NN t-PA) (NN activity))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (CD +0.26) (NN IU/ml))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (NP (NN P))\n",
      "                      (NP (JJR <))))\n",
      "                  (NP (CD 0.05)))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, produced-4)\n",
      "det(combination-3, The-1)\n",
      "compound(combination-3, amlodipine/benazepril-2)\n",
      "nsubj(produced-4, combination-3)\n",
      "cc:preconj(decrease-8, both-5)\n",
      "det(decrease-8, a-6)\n",
      "amod(decrease-8, significant-7)\n",
      "dobj(produced-4, decrease-8)\n",
      "case(activity-12, in-9)\n",
      "compound(activity-12, plasma-10)\n",
      "compound(activity-12, PAI-1-11)\n",
      "nmod:in(decrease-8, activity-12)\n",
      "punct(IU-15, -LRB--13)\n",
      "nummod(IU-15, -8.7-14)\n",
      "dep(activity-12, IU-15)\n",
      "punct(IU-15, ,-16)\n",
      "appos(IU-15, P-17)\n",
      "dep(P-17, <-18)\n",
      "dep(IU-15, 0.05-19)\n",
      "punct(IU-15, -RRB--20)\n",
      "cc(decrease-8, and-21)\n",
      "det(increase-24, a-22)\n",
      "amod(increase-24, significant-23)\n",
      "dobj(produced-4, increase-24)\n",
      "conj:and(decrease-8, increase-24)\n",
      "case(activity-27, in-25)\n",
      "compound(activity-27, t-PA-26)\n",
      "nmod:in(increase-24, activity-27)\n",
      "punct(IU/ml-30, -LRB--28)\n",
      "nummod(IU/ml-30, +0.26-29)\n",
      "dep(activity-27, IU/ml-30)\n",
      "punct(IU/ml-30, ,-31)\n",
      "appos(IU/ml-30, P-32)\n",
      "dep(P-32, <-33)\n",
      "dep(IU/ml-30, 0.05-34)\n",
      "punct(IU/ml-30, -RRB--35)\n",
      "punct(produced-4, .-36)\n",
      "\n",
      "Sentence #61 (22 tokens, sentiment: Negative):\n",
      "The disposition and effect of benazepril and its active metabolite, benazeprilat, were evaluated in cats using a pharmacokinetic/pharmacodynamic model.\n",
      "[Text=The CharacterOffsetBegin=9013 CharacterOffsetEnd=9016 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=disposition CharacterOffsetBegin=9017 CharacterOffsetEnd=9028 PartOfSpeech=NN Lemma=disposition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9029 CharacterOffsetEnd=9032 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=9033 CharacterOffsetEnd=9039 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=9040 CharacterOffsetEnd=9042 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=9043 CharacterOffsetEnd=9053 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9054 CharacterOffsetEnd=9057 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=its CharacterOffsetBegin=9058 CharacterOffsetEnd=9061 PartOfSpeech=PRP$ Lemma=its NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=active CharacterOffsetBegin=9062 CharacterOffsetEnd=9068 PartOfSpeech=JJ Lemma=active NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=metabolite CharacterOffsetBegin=9069 CharacterOffsetEnd=9079 PartOfSpeech=NN Lemma=metabolite NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=9079 CharacterOffsetEnd=9080 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazeprilat CharacterOffsetBegin=9081 CharacterOffsetEnd=9093 PartOfSpeech=NN Lemma=benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=9093 CharacterOffsetEnd=9094 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=9095 CharacterOffsetEnd=9099 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=evaluated CharacterOffsetBegin=9100 CharacterOffsetEnd=9109 PartOfSpeech=VBN Lemma=evaluate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=9110 CharacterOffsetEnd=9112 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cats CharacterOffsetBegin=9113 CharacterOffsetEnd=9117 PartOfSpeech=NNS Lemma=cat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=using CharacterOffsetBegin=9118 CharacterOffsetEnd=9123 PartOfSpeech=VBG Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=9124 CharacterOffsetEnd=9125 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pharmacokinetic/pharmacodynamic CharacterOffsetBegin=9126 CharacterOffsetEnd=9157 PartOfSpeech=JJ Lemma=pharmacokinetic/pharmacodynamic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=9158 CharacterOffsetEnd=9163 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=. CharacterOffsetBegin=9163 CharacterOffsetEnd=9164 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT The) (NN disposition)\n",
      "          (CC and)\n",
      "          (NN effect))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NN benazepril))\n",
      "            (CC and)\n",
      "            (NP (PRP$ its) (JJ active) (NN metabolite)))))\n",
      "      (, ,)\n",
      "      (NP (NN benazeprilat))\n",
      "      (, ,))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN evaluated)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS cats))\n",
      "            (VP (VBG using)\n",
      "              (NP (DT a) (JJ pharmacokinetic/pharmacodynamic) (NN model)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, evaluated-15)\n",
      "det(disposition-2, The-1)\n",
      "nsubjpass(evaluated-15, disposition-2)\n",
      "cc(disposition-2, and-3)\n",
      "conj:and(disposition-2, effect-4)\n",
      "nsubjpass(evaluated-15, effect-4)\n",
      "case(benazepril-6, of-5)\n",
      "nmod:of(disposition-2, benazepril-6)\n",
      "cc(benazepril-6, and-7)\n",
      "nmod:poss(metabolite-10, its-8)\n",
      "amod(metabolite-10, active-9)\n",
      "nmod:of(disposition-2, metabolite-10)\n",
      "conj:and(benazepril-6, metabolite-10)\n",
      "punct(disposition-2, ,-11)\n",
      "appos(disposition-2, benazeprilat-12)\n",
      "punct(disposition-2, ,-13)\n",
      "auxpass(evaluated-15, were-14)\n",
      "case(cats-17, in-16)\n",
      "nmod:in(evaluated-15, cats-17)\n",
      "acl(cats-17, using-18)\n",
      "det(model-21, a-19)\n",
      "amod(model-21, pharmacokinetic/pharmacodynamic-20)\n",
      "dobj(using-18, model-21)\n",
      "punct(evaluated-15, .-22)\n",
      "\n",
      "Sentence #62 (13 tokens, sentiment: Negative):\n",
      "Cats received single 1 mg/kg doses of intravenous 14C-benazeprilat and oral 14C-benazepril.\n",
      "[Text=Cats CharacterOffsetBegin=9165 CharacterOffsetEnd=9169 PartOfSpeech=NNS Lemma=cat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=received CharacterOffsetBegin=9170 CharacterOffsetEnd=9178 PartOfSpeech=VBD Lemma=receive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=single CharacterOffsetBegin=9179 CharacterOffsetEnd=9185 PartOfSpeech=JJ Lemma=single NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1 CharacterOffsetBegin=9186 CharacterOffsetEnd=9187 PartOfSpeech=CD Lemma=1 NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=mg/kg CharacterOffsetBegin=9188 CharacterOffsetEnd=9193 PartOfSpeech=NN Lemma=mg/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=doses CharacterOffsetBegin=9194 CharacterOffsetEnd=9199 PartOfSpeech=NNS Lemma=dose NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=9200 CharacterOffsetEnd=9202 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=intravenous CharacterOffsetBegin=9203 CharacterOffsetEnd=9214 PartOfSpeech=JJ Lemma=intravenous NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=14C-benazeprilat CharacterOffsetBegin=9215 CharacterOffsetEnd=9231 PartOfSpeech=NN Lemma=14c-benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9232 CharacterOffsetEnd=9235 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=oral CharacterOffsetBegin=9236 CharacterOffsetEnd=9240 PartOfSpeech=JJ Lemma=oral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=14C-benazepril CharacterOffsetBegin=9241 CharacterOffsetEnd=9255 PartOfSpeech=NN Lemma=14c-benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=9255 CharacterOffsetEnd=9256 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS Cats))\n",
      "    (VP (VBD received)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP (JJ single)\n",
      "            (NP-TMP (CD 1)))\n",
      "          (NN mg/kg) (NNS doses))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (JJ intravenous) (NN 14C-benazeprilat))\n",
      "            (CC and)\n",
      "            (NP (JJ oral) (NN 14C-benazepril))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, received-2)\n",
      "nsubj(received-2, Cats-1)\n",
      "amod(doses-6, single-3)\n",
      "nmod:tmod(single-3, 1-4)\n",
      "compound(doses-6, mg/kg-5)\n",
      "dobj(received-2, doses-6)\n",
      "case(14C-benazeprilat-9, of-7)\n",
      "amod(14C-benazeprilat-9, intravenous-8)\n",
      "nmod:of(doses-6, 14C-benazeprilat-9)\n",
      "cc(14C-benazeprilat-9, and-10)\n",
      "amod(14C-benazepril-12, oral-11)\n",
      "nmod:of(doses-6, 14C-benazepril-12)\n",
      "conj:and(14C-benazeprilat-9, 14C-benazepril-12)\n",
      "punct(received-2, .-13)\n",
      "\n",
      "Sentence #63 (22 tokens, sentiment: Negative):\n",
      "HCl, and single and repeat (eight daily) oral administrations of 0.25, 0.5 and 1.0 mg/kg nonlabelled benazepril.HCl.\n",
      "[Text=HCl CharacterOffsetBegin=9256 CharacterOffsetEnd=9259 PartOfSpeech=NN Lemma=hcl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=9259 CharacterOffsetEnd=9260 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9261 CharacterOffsetEnd=9264 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=single CharacterOffsetBegin=9265 CharacterOffsetEnd=9271 PartOfSpeech=JJ Lemma=single NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9272 CharacterOffsetEnd=9275 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=repeat CharacterOffsetBegin=9276 CharacterOffsetEnd=9282 PartOfSpeech=NN Lemma=repeat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=9283 CharacterOffsetEnd=9284 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=eight CharacterOffsetBegin=9284 CharacterOffsetEnd=9289 PartOfSpeech=CD Lemma=eight NamedEntityTag=NUMBER NormalizedNamedEntityTag=8.0 SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=9290 CharacterOffsetEnd=9295 PartOfSpeech=JJ Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t7\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=9295 CharacterOffsetEnd=9296 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=oral CharacterOffsetBegin=9297 CharacterOffsetEnd=9301 PartOfSpeech=JJ Lemma=oral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=administrations CharacterOffsetBegin=9302 CharacterOffsetEnd=9317 PartOfSpeech=NNS Lemma=administration NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=9318 CharacterOffsetEnd=9320 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.25 CharacterOffsetBegin=9321 CharacterOffsetEnd=9325 PartOfSpeech=CD Lemma=0.25 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.25 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=9325 CharacterOffsetEnd=9326 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.5 CharacterOffsetBegin=9327 CharacterOffsetEnd=9330 PartOfSpeech=CD Lemma=0.5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.5 SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9331 CharacterOffsetEnd=9334 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1.0 CharacterOffsetBegin=9335 CharacterOffsetEnd=9338 PartOfSpeech=CD Lemma=1.0 NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=mg/kg CharacterOffsetBegin=9339 CharacterOffsetEnd=9344 PartOfSpeech=NN Lemma=mg/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nonlabelled CharacterOffsetBegin=9345 CharacterOffsetEnd=9356 PartOfSpeech=JJ Lemma=nonlabelled NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril.HCl CharacterOffsetBegin=9357 CharacterOffsetEnd=9371 PartOfSpeech=NN Lemma=benazepril.hcl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=9371 CharacterOffsetEnd=9372 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (NP\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (NN HCl))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ single))\n",
      "          (CC and)\n",
      "          (NP (NN repeat))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (ADJP\n",
      "          (NP (CD eight))\n",
      "          (JJ daily))\n",
      "        (-RRB- -RRB-)))\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (JJ oral) (NNS administrations))\n",
      "        (PP (IN of)\n",
      "          (NP (CD 0.25) (, ,) (CD 0.5)\n",
      "            (CC and)\n",
      "            (CD 1.0))))\n",
      "      (NP (NN mg/kg) (JJ nonlabelled) (NN benazepril.HCl)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, HCl-1)\n",
      "punct(HCl-1, ,-2)\n",
      "cc(HCl-1, and-3)\n",
      "conj:and(HCl-1, single-4)\n",
      "cc(single-4, and-5)\n",
      "conj:and(HCl-1, repeat-6)\n",
      "conj:and(single-4, repeat-6)\n",
      "punct(daily-9, -LRB--7)\n",
      "nmod:npmod(daily-9, eight-8)\n",
      "dep(HCl-1, daily-9)\n",
      "punct(daily-9, -RRB--10)\n",
      "amod(administrations-12, oral-11)\n",
      "dep(HCl-1, administrations-12)\n",
      "case(0.25-14, of-13)\n",
      "nmod:of(administrations-12, 0.25-14)\n",
      "punct(0.25-14, ,-15)\n",
      "nummod(0.25-14, 0.5-16)\n",
      "cc(0.25-14, and-17)\n",
      "nmod:of(administrations-12, 1.0-18)\n",
      "conj:and(0.25-14, 1.0-18)\n",
      "compound(benazepril.HCl-21, mg/kg-19)\n",
      "amod(benazepril.HCl-21, nonlabelled-20)\n",
      "dep(administrations-12, benazepril.HCl-21)\n",
      "punct(HCl-1, .-22)\n",
      "\n",
      "Sentence #64 (20 tokens, sentiment: Negative):\n",
      "The pharmacokinetic endpoints were plasma concentrations of benazepril and benazeprilat, and recovery of radioactivity in faeces and urine.\n",
      "[Text=The CharacterOffsetBegin=9373 CharacterOffsetEnd=9376 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pharmacokinetic CharacterOffsetBegin=9377 CharacterOffsetEnd=9392 PartOfSpeech=JJ Lemma=pharmacokinetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=endpoints CharacterOffsetBegin=9393 CharacterOffsetEnd=9402 PartOfSpeech=NNS Lemma=endpoint NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=9403 CharacterOffsetEnd=9407 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasma CharacterOffsetBegin=9408 CharacterOffsetEnd=9414 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=concentrations CharacterOffsetBegin=9415 CharacterOffsetEnd=9429 PartOfSpeech=NNS Lemma=concentration NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=9430 CharacterOffsetEnd=9432 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=9433 CharacterOffsetEnd=9443 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9444 CharacterOffsetEnd=9447 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazeprilat CharacterOffsetBegin=9448 CharacterOffsetEnd=9460 PartOfSpeech=NN Lemma=benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=9460 CharacterOffsetEnd=9461 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9462 CharacterOffsetEnd=9465 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=recovery CharacterOffsetBegin=9466 CharacterOffsetEnd=9474 PartOfSpeech=NN Lemma=recovery NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=9475 CharacterOffsetEnd=9477 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=radioactivity CharacterOffsetBegin=9478 CharacterOffsetEnd=9491 PartOfSpeech=NN Lemma=radioactivity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=9492 CharacterOffsetEnd=9494 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=faeces CharacterOffsetBegin=9495 CharacterOffsetEnd=9501 PartOfSpeech=NNS Lemma=faeces NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=9502 CharacterOffsetEnd=9505 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=urine CharacterOffsetBegin=9506 CharacterOffsetEnd=9511 PartOfSpeech=NN Lemma=urine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=9511 CharacterOffsetEnd=9512 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT The) (JJ pharmacokinetic) (NNS endpoints))\n",
      "    (VP (VBD were)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN plasma) (NNS concentrations))\n",
      "          (PP (IN of)\n",
      "            (NP (NN benazepril)\n",
      "              (CC and)\n",
      "              (NN benazeprilat))))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (NN recovery))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN radioactivity))\n",
      "              (PP (IN in)\n",
      "                (NP (NNS faeces)\n",
      "                  (CC and)\n",
      "                  (NN urine))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, concentrations-6)\n",
      "det(endpoints-3, The-1)\n",
      "amod(endpoints-3, pharmacokinetic-2)\n",
      "nsubj(concentrations-6, endpoints-3)\n",
      "cop(concentrations-6, were-4)\n",
      "compound(concentrations-6, plasma-5)\n",
      "case(benazepril-8, of-7)\n",
      "nmod:of(concentrations-6, benazepril-8)\n",
      "cc(benazepril-8, and-9)\n",
      "nmod:of(concentrations-6, benazeprilat-10)\n",
      "conj:and(benazepril-8, benazeprilat-10)\n",
      "punct(concentrations-6, ,-11)\n",
      "cc(concentrations-6, and-12)\n",
      "conj:and(concentrations-6, recovery-13)\n",
      "case(radioactivity-15, of-14)\n",
      "nmod:of(recovery-13, radioactivity-15)\n",
      "case(faeces-17, in-16)\n",
      "nmod:in(radioactivity-15, faeces-17)\n",
      "cc(faeces-17, and-18)\n",
      "nmod:in(radioactivity-15, urine-19)\n",
      "conj:and(faeces-17, urine-19)\n",
      "punct(concentrations-6, .-20)\n",
      "\n",
      "Sentence #65 (12 tokens, sentiment: Negative):\n",
      "The pharmacodynamic endpoint was plasma angiotensin-converting enzyme (ACE) activity.\n",
      "[Text=The CharacterOffsetBegin=9513 CharacterOffsetEnd=9516 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pharmacodynamic CharacterOffsetBegin=9517 CharacterOffsetEnd=9532 PartOfSpeech=JJ Lemma=pharmacodynamic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=endpoint CharacterOffsetBegin=9533 CharacterOffsetEnd=9541 PartOfSpeech=NN Lemma=endpoint NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=9542 CharacterOffsetEnd=9545 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasma CharacterOffsetBegin=9546 CharacterOffsetEnd=9552 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin-converting CharacterOffsetBegin=9553 CharacterOffsetEnd=9575 PartOfSpeech=JJ Lemma=angiotensin-converting NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=9576 CharacterOffsetEnd=9582 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=9583 CharacterOffsetEnd=9584 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=9584 CharacterOffsetEnd=9587 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=9587 CharacterOffsetEnd=9588 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activity CharacterOffsetBegin=9589 CharacterOffsetEnd=9597 PartOfSpeech=NN Lemma=activity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=9597 CharacterOffsetEnd=9598 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT The) (JJ pharmacodynamic) (NN endpoint))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN plasma) (JJ angiotensin-converting) (NN enzyme))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN ACE))\n",
      "            (-RRB- -RRB-)))\n",
      "        (NP (NN activity))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, enzyme-7)\n",
      "det(endpoint-3, The-1)\n",
      "amod(endpoint-3, pharmacodynamic-2)\n",
      "nsubj(enzyme-7, endpoint-3)\n",
      "cop(enzyme-7, was-4)\n",
      "compound(enzyme-7, plasma-5)\n",
      "amod(enzyme-7, angiotensin-converting-6)\n",
      "punct(ACE-9, -LRB--8)\n",
      "appos(enzyme-7, ACE-9)\n",
      "punct(ACE-9, -RRB--10)\n",
      "dep(enzyme-7, activity-11)\n",
      "punct(enzyme-7, .-12)\n",
      "\n",
      "Sentence #66 (27 tokens, sentiment: Negative):\n",
      "Benazeprilat data were fitted to an equation corresponding to a single-compartment model with a volume equal to the blood space (Vc = 0.093 L/kg).\n",
      "[Text=Benazeprilat CharacterOffsetBegin=9599 CharacterOffsetEnd=9611 PartOfSpeech=NNP Lemma=Benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=data CharacterOffsetBegin=9612 CharacterOffsetEnd=9616 PartOfSpeech=NNS Lemma=datum NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=9617 CharacterOffsetEnd=9621 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=fitted CharacterOffsetBegin=9622 CharacterOffsetEnd=9628 PartOfSpeech=VBN Lemma=fit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=9629 CharacterOffsetEnd=9631 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=9632 CharacterOffsetEnd=9634 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=equation CharacterOffsetBegin=9635 CharacterOffsetEnd=9643 PartOfSpeech=NN Lemma=equation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=corresponding CharacterOffsetBegin=9644 CharacterOffsetEnd=9657 PartOfSpeech=VBG Lemma=correspond NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=9658 CharacterOffsetEnd=9660 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=9661 CharacterOffsetEnd=9662 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=single-compartment CharacterOffsetBegin=9663 CharacterOffsetEnd=9681 PartOfSpeech=JJ Lemma=single-compartment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=9682 CharacterOffsetEnd=9687 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=with CharacterOffsetBegin=9688 CharacterOffsetEnd=9692 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=9693 CharacterOffsetEnd=9694 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=volume CharacterOffsetBegin=9695 CharacterOffsetEnd=9701 PartOfSpeech=NN Lemma=volume NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=equal CharacterOffsetBegin=9702 CharacterOffsetEnd=9707 PartOfSpeech=JJ Lemma=equal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=9708 CharacterOffsetEnd=9710 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=9711 CharacterOffsetEnd=9714 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blood CharacterOffsetBegin=9715 CharacterOffsetEnd=9720 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=space CharacterOffsetBegin=9721 CharacterOffsetEnd=9726 PartOfSpeech=NN Lemma=space NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=9727 CharacterOffsetEnd=9728 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Vc CharacterOffsetBegin=9728 CharacterOffsetEnd=9730 PartOfSpeech=NN Lemma=vc NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text== CharacterOffsetBegin=9731 CharacterOffsetEnd=9732 PartOfSpeech=JJ Lemma== NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.093 CharacterOffsetBegin=9733 CharacterOffsetEnd=9738 PartOfSpeech=CD Lemma=0.093 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.093 SentimentClass=Neutral]\n",
      "[Text=L/kg CharacterOffsetBegin=9739 CharacterOffsetEnd=9743 PartOfSpeech=NN Lemma=l/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=9743 CharacterOffsetEnd=9744 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=9744 CharacterOffsetEnd=9745 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Benazeprilat) (NNS data))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN fitted)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (DT an) (NN equation))\n",
      "            (VP (VBG corresponding)\n",
      "              (PP (TO to)\n",
      "                (NP\n",
      "                  (NP (DT a) (JJ single-compartment) (NN model))\n",
      "                  (PP (IN with)\n",
      "                    (NP\n",
      "                      (NP\n",
      "                        (NP (DT a) (NN volume))\n",
      "                        (ADJP (JJ equal)\n",
      "                          (PP (TO to)\n",
      "                            (NP (DT the) (NN blood) (NN space)))))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP\n",
      "                          (NP (NN Vc) (JJ =))\n",
      "                          (NP (CD 0.093) (NN L/kg)))\n",
      "                        (-RRB- -RRB-)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, fitted-4)\n",
      "compound(data-2, Benazeprilat-1)\n",
      "nsubjpass(fitted-4, data-2)\n",
      "auxpass(fitted-4, were-3)\n",
      "case(equation-7, to-5)\n",
      "det(equation-7, an-6)\n",
      "nmod:to(fitted-4, equation-7)\n",
      "acl(equation-7, corresponding-8)\n",
      "case(model-12, to-9)\n",
      "det(model-12, a-10)\n",
      "amod(model-12, single-compartment-11)\n",
      "nmod:to(corresponding-8, model-12)\n",
      "case(volume-15, with-13)\n",
      "det(volume-15, a-14)\n",
      "nmod:with(model-12, volume-15)\n",
      "amod(volume-15, equal-16)\n",
      "case(space-20, to-17)\n",
      "det(space-20, the-18)\n",
      "compound(space-20, blood-19)\n",
      "nmod:to(equal-16, space-20)\n",
      "punct(Vc-22, -LRB--21)\n",
      "dep(volume-15, Vc-22)\n",
      "amod(Vc-22, =-23)\n",
      "nummod(L/kg-25, 0.093-24)\n",
      "dep(Vc-22, L/kg-25)\n",
      "punct(Vc-22, -RRB--26)\n",
      "punct(fitted-4, .-27)\n",
      "\n",
      "Sentence #67 (27 tokens, sentiment: Negative):\n",
      "Within this space, benazeprilat was bound nonlinearly to ACE, which was mainly tissular (89.4%) rather than circulating (10.6%).\n",
      "[Text=Within CharacterOffsetBegin=9746 CharacterOffsetEnd=9752 PartOfSpeech=IN Lemma=within NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=9753 CharacterOffsetEnd=9757 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=space CharacterOffsetBegin=9758 CharacterOffsetEnd=9763 PartOfSpeech=NN Lemma=space NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=9763 CharacterOffsetEnd=9764 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazeprilat CharacterOffsetBegin=9765 CharacterOffsetEnd=9777 PartOfSpeech=NN Lemma=benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=9778 CharacterOffsetEnd=9781 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=bound CharacterOffsetBegin=9782 CharacterOffsetEnd=9787 PartOfSpeech=VBN Lemma=bind NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=nonlinearly CharacterOffsetBegin=9788 CharacterOffsetEnd=9799 PartOfSpeech=RB Lemma=nonlinearly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=9800 CharacterOffsetEnd=9802 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=9803 CharacterOffsetEnd=9806 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=9806 CharacterOffsetEnd=9807 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=which CharacterOffsetBegin=9808 CharacterOffsetEnd=9813 PartOfSpeech=WDT Lemma=which NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=9814 CharacterOffsetEnd=9817 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mainly CharacterOffsetBegin=9818 CharacterOffsetEnd=9824 PartOfSpeech=RB Lemma=mainly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tissular CharacterOffsetBegin=9825 CharacterOffsetEnd=9833 PartOfSpeech=JJ Lemma=tissular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=9834 CharacterOffsetEnd=9835 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=89.4 CharacterOffsetBegin=9835 CharacterOffsetEnd=9839 PartOfSpeech=CD Lemma=89.4 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%89.4 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=9839 CharacterOffsetEnd=9840 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%89.4 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=9840 CharacterOffsetEnd=9841 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rather CharacterOffsetBegin=9842 CharacterOffsetEnd=9848 PartOfSpeech=RB Lemma=rather NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=than CharacterOffsetBegin=9849 CharacterOffsetEnd=9853 PartOfSpeech=IN Lemma=than NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=circulating CharacterOffsetBegin=9854 CharacterOffsetEnd=9865 PartOfSpeech=VBG Lemma=circulate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=9866 CharacterOffsetEnd=9867 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10.6 CharacterOffsetBegin=9867 CharacterOffsetEnd=9871 PartOfSpeech=CD Lemma=10.6 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%10.6 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=9871 CharacterOffsetEnd=9872 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%10.6 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=9872 CharacterOffsetEnd=9873 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=9873 CharacterOffsetEnd=9874 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN Within)\n",
      "      (NP (DT this) (NN space)))\n",
      "    (, ,)\n",
      "    (NP (NN benazeprilat))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (VBN bound) (RB nonlinearly)\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (NN ACE))\n",
      "            (, ,)\n",
      "            (SBAR\n",
      "              (WHNP (WDT which))\n",
      "              (S\n",
      "                (VP (VBD was)\n",
      "                  (ADJP\n",
      "                    (ADVP (RB mainly))\n",
      "                    (JJ tissular)\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (CD 89.4) (NN %))\n",
      "                      (-RRB- -RRB-)))\n",
      "                  (PP (RB rather) (IN than)\n",
      "                    (S\n",
      "                      (VP (VBG circulating)\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (CD 10.6) (NN %))\n",
      "                          (-RRB- -RRB-))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, bound-7)\n",
      "case(space-3, Within-1)\n",
      "det(space-3, this-2)\n",
      "nmod:within(bound-7, space-3)\n",
      "punct(bound-7, ,-4)\n",
      "nsubjpass(bound-7, benazeprilat-5)\n",
      "auxpass(bound-7, was-6)\n",
      "advmod(bound-7, nonlinearly-8)\n",
      "case(ACE-10, to-9)\n",
      "nmod:to(bound-7, ACE-10)\n",
      "nsubj(tissular-15, ACE-10)\n",
      "punct(ACE-10, ,-11)\n",
      "ref(ACE-10, which-12)\n",
      "cop(tissular-15, was-13)\n",
      "advmod(tissular-15, mainly-14)\n",
      "acl:relcl(ACE-10, tissular-15)\n",
      "punct(%-18, -LRB--16)\n",
      "nummod(%-18, 89.4-17)\n",
      "dep(tissular-15, %-18)\n",
      "punct(%-18, -RRB--19)\n",
      "mark(circulating-22, rather-20)\n",
      "mwe(rather-20, than-21)\n",
      "advcl:rather_than(tissular-15, circulating-22)\n",
      "punct(%-25, -LRB--23)\n",
      "nummod(%-25, 10.6-24)\n",
      "dep(circulating-22, %-25)\n",
      "punct(%-25, -RRB--26)\n",
      "punct(bound-7, .-27)\n",
      "\n",
      "Sentence #68 (39 tokens, sentiment: Negative):\n",
      "Free benazeprilat was eliminated quickly from the central compartment (t1/2 approximately 1.0 h; Cl approximately 0.125 L/kg/h), elimination being principally biliary ( approximately 85%) rather than urinary ( approximately 15%).\n",
      "[Text=Free CharacterOffsetBegin=9875 CharacterOffsetEnd=9879 PartOfSpeech=NNP Lemma=Free NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazeprilat CharacterOffsetBegin=9880 CharacterOffsetEnd=9892 PartOfSpeech=NN Lemma=benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=9893 CharacterOffsetEnd=9896 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=eliminated CharacterOffsetBegin=9897 CharacterOffsetEnd=9907 PartOfSpeech=VBN Lemma=eliminate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=quickly CharacterOffsetBegin=9908 CharacterOffsetEnd=9915 PartOfSpeech=RB Lemma=quickly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=from CharacterOffsetBegin=9916 CharacterOffsetEnd=9920 PartOfSpeech=IN Lemma=from NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=9921 CharacterOffsetEnd=9924 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=central CharacterOffsetBegin=9925 CharacterOffsetEnd=9932 PartOfSpeech=JJ Lemma=central NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compartment CharacterOffsetBegin=9933 CharacterOffsetEnd=9944 PartOfSpeech=NN Lemma=compartment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=9945 CharacterOffsetEnd=9946 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=t1/2 CharacterOffsetBegin=9946 CharacterOffsetEnd=9950 PartOfSpeech=NN Lemma=t1/2 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=approximately CharacterOffsetBegin=9951 CharacterOffsetEnd=9964 PartOfSpeech=RB Lemma=approximately NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1.0 CharacterOffsetBegin=9965 CharacterOffsetEnd=9968 PartOfSpeech=CD Lemma=1.0 NamedEntityTag=NUMBER NormalizedNamedEntityTag=~1.0 SentimentClass=Neutral]\n",
      "[Text=h CharacterOffsetBegin=9969 CharacterOffsetEnd=9970 PartOfSpeech=NN Lemma=h NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=; CharacterOffsetBegin=9970 CharacterOffsetEnd=9971 PartOfSpeech=: Lemma=; NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Cl CharacterOffsetBegin=9972 CharacterOffsetEnd=9974 PartOfSpeech=NN Lemma=cl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=approximately CharacterOffsetBegin=9975 CharacterOffsetEnd=9988 PartOfSpeech=RB Lemma=approximately NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.125 CharacterOffsetBegin=9989 CharacterOffsetEnd=9994 PartOfSpeech=CD Lemma=0.125 NamedEntityTag=NUMBER NormalizedNamedEntityTag=~0.125 SentimentClass=Neutral]\n",
      "[Text=L/kg/h CharacterOffsetBegin=9995 CharacterOffsetEnd=10001 PartOfSpeech=NN Lemma=l/kg/h NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10001 CharacterOffsetEnd=10002 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=10002 CharacterOffsetEnd=10003 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=elimination CharacterOffsetBegin=10004 CharacterOffsetEnd=10015 PartOfSpeech=NN Lemma=elimination NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=being CharacterOffsetBegin=10016 CharacterOffsetEnd=10021 PartOfSpeech=VBG Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=principally CharacterOffsetBegin=10022 CharacterOffsetEnd=10033 PartOfSpeech=RB Lemma=principally NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=biliary CharacterOffsetBegin=10034 CharacterOffsetEnd=10041 PartOfSpeech=JJ Lemma=biliary NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10042 CharacterOffsetEnd=10043 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=approximately CharacterOffsetBegin=10044 CharacterOffsetEnd=10057 PartOfSpeech=RB Lemma=approximately NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=85 CharacterOffsetBegin=10058 CharacterOffsetEnd=10060 PartOfSpeech=CD Lemma=85 NamedEntityTag=PERCENT NormalizedNamedEntityTag=~%85.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=10060 CharacterOffsetEnd=10061 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=~%85.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10061 CharacterOffsetEnd=10062 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rather CharacterOffsetBegin=10063 CharacterOffsetEnd=10069 PartOfSpeech=RB Lemma=rather NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=than CharacterOffsetBegin=10070 CharacterOffsetEnd=10074 PartOfSpeech=IN Lemma=than NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=urinary CharacterOffsetBegin=10075 CharacterOffsetEnd=10082 PartOfSpeech=JJ Lemma=urinary NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10083 CharacterOffsetEnd=10084 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=approximately CharacterOffsetBegin=10085 CharacterOffsetEnd=10098 PartOfSpeech=RB Lemma=approximately NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=15 CharacterOffsetBegin=10099 CharacterOffsetEnd=10101 PartOfSpeech=CD Lemma=15 NamedEntityTag=PERCENT NormalizedNamedEntityTag=~%15.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=10101 CharacterOffsetEnd=10102 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=~%15.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10102 CharacterOffsetEnd=10103 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=10103 CharacterOffsetEnd=10104 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Free) (NN benazeprilat))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN eliminated)\n",
      "        (ADVP (RB quickly))\n",
      "        (PP (IN from)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (DT the) (JJ central) (NN compartment))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (NN t1/2))\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (QP (RB approximately) (CD 1.0))\n",
      "                      (NN h))\n",
      "                    (: ;)\n",
      "                    (NP\n",
      "                      (NP (NN Cl))\n",
      "                      (NP\n",
      "                        (QP (RB approximately) (CD 0.125))\n",
      "                        (NN L/kg/h)))))\n",
      "                (-RRB- -RRB-)))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP (NN elimination))\n",
      "              (VP (VBG being)\n",
      "                (ADJP\n",
      "                  (ADJP\n",
      "                    (ADJP\n",
      "                      (ADJP (RB principally) (JJ biliary))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP\n",
      "                          (QP (RB approximately) (CD 85))\n",
      "                          (NN %))\n",
      "                        (-RRB- -RRB-)))\n",
      "                    (PP (RB rather) (IN than)\n",
      "                      (ADJP (JJ urinary))))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (QP (RB approximately) (CD 15))\n",
      "                      (NN %))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, eliminated-4)\n",
      "compound(benazeprilat-2, Free-1)\n",
      "nsubjpass(eliminated-4, benazeprilat-2)\n",
      "auxpass(eliminated-4, was-3)\n",
      "advmod(eliminated-4, quickly-5)\n",
      "case(compartment-9, from-6)\n",
      "det(compartment-9, the-7)\n",
      "amod(compartment-9, central-8)\n",
      "nmod:from(eliminated-4, compartment-9)\n",
      "punct(t1/2-11, -LRB--10)\n",
      "dep(compartment-9, t1/2-11)\n",
      "advmod(1.0-13, approximately-12)\n",
      "nummod(h-14, 1.0-13)\n",
      "dep(t1/2-11, h-14)\n",
      "punct(h-14, ;-15)\n",
      "dep(h-14, Cl-16)\n",
      "advmod(0.125-18, approximately-17)\n",
      "nummod(L/kg/h-19, 0.125-18)\n",
      "dep(Cl-16, L/kg/h-19)\n",
      "punct(t1/2-11, -RRB--20)\n",
      "punct(compartment-9, ,-21)\n",
      "appos(compartment-9, elimination-22)\n",
      "cop(biliary-25, being-23)\n",
      "advmod(biliary-25, principally-24)\n",
      "acl(elimination-22, biliary-25)\n",
      "punct(%-29, -LRB--26)\n",
      "advmod(85-28, approximately-27)\n",
      "nummod(%-29, 85-28)\n",
      "dep(biliary-25, %-29)\n",
      "punct(%-29, -RRB--30)\n",
      "case(urinary-33, rather-31)\n",
      "mwe(rather-31, than-32)\n",
      "advcl:rather_than(biliary-25, urinary-33)\n",
      "punct(%-37, -LRB--34)\n",
      "advmod(15-36, approximately-35)\n",
      "nummod(%-37, 15-36)\n",
      "dep(biliary-25, %-37)\n",
      "punct(%-37, -RRB--38)\n",
      "punct(eliminated-4, .-39)\n",
      "\n",
      "Sentence #69 (33 tokens, sentiment: Negative):\n",
      "Nevertheless, inhibition of ACE was long-lasting (t1/2 16-23 h) due to high affinity binding of benazeprilat to ACE (Kd approximately 3.5 mmol/L, IC50 approximately 4.3 mmol/L).\n",
      "[Text=Nevertheless CharacterOffsetBegin=10105 CharacterOffsetEnd=10117 PartOfSpeech=RB Lemma=nevertheless NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=10117 CharacterOffsetEnd=10118 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibition CharacterOffsetBegin=10119 CharacterOffsetEnd=10129 PartOfSpeech=NN Lemma=inhibition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10130 CharacterOffsetEnd=10132 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=10133 CharacterOffsetEnd=10136 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=10137 CharacterOffsetEnd=10140 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=long-lasting CharacterOffsetBegin=10141 CharacterOffsetEnd=10153 PartOfSpeech=JJ Lemma=long-lasting NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10154 CharacterOffsetEnd=10155 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=t1/2 CharacterOffsetBegin=10155 CharacterOffsetEnd=10159 PartOfSpeech=NN Lemma=t1/2 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=16-23 CharacterOffsetBegin=10160 CharacterOffsetEnd=10165 PartOfSpeech=CD Lemma=16-23 NamedEntityTag=DATE NormalizedNamedEntityTag=******16/******23 SentimentClass=Neutral]\n",
      "[Text=h CharacterOffsetBegin=10166 CharacterOffsetEnd=10167 PartOfSpeech=NN Lemma=h NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10167 CharacterOffsetEnd=10168 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=due CharacterOffsetBegin=10169 CharacterOffsetEnd=10172 PartOfSpeech=JJ Lemma=due NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=10173 CharacterOffsetEnd=10175 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=high CharacterOffsetBegin=10176 CharacterOffsetEnd=10180 PartOfSpeech=JJ Lemma=high NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=affinity CharacterOffsetBegin=10181 CharacterOffsetEnd=10189 PartOfSpeech=NN Lemma=affinity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=binding CharacterOffsetBegin=10190 CharacterOffsetEnd=10197 PartOfSpeech=NN Lemma=binding NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10198 CharacterOffsetEnd=10200 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazeprilat CharacterOffsetBegin=10201 CharacterOffsetEnd=10213 PartOfSpeech=NN Lemma=benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=10214 CharacterOffsetEnd=10216 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=10217 CharacterOffsetEnd=10220 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10221 CharacterOffsetEnd=10222 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Kd CharacterOffsetBegin=10222 CharacterOffsetEnd=10224 PartOfSpeech=NN Lemma=kd NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=approximately CharacterOffsetBegin=10225 CharacterOffsetEnd=10238 PartOfSpeech=RB Lemma=approximately NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=3.5 CharacterOffsetBegin=10239 CharacterOffsetEnd=10242 PartOfSpeech=CD Lemma=3.5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=~3.5 SentimentClass=Neutral]\n",
      "[Text=mmol/L CharacterOffsetBegin=10243 CharacterOffsetEnd=10249 PartOfSpeech=NN Lemma=mmol/l NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=10249 CharacterOffsetEnd=10250 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=IC50 CharacterOffsetBegin=10251 CharacterOffsetEnd=10255 PartOfSpeech=NN Lemma=ic50 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=approximately CharacterOffsetBegin=10256 CharacterOffsetEnd=10269 PartOfSpeech=RB Lemma=approximately NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=4.3 CharacterOffsetBegin=10270 CharacterOffsetEnd=10273 PartOfSpeech=CD Lemma=4.3 NamedEntityTag=NUMBER NormalizedNamedEntityTag=~4.3 SentimentClass=Neutral]\n",
      "[Text=mmol/L CharacterOffsetBegin=10274 CharacterOffsetEnd=10280 PartOfSpeech=NN Lemma=mmol/l NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10280 CharacterOffsetEnd=10281 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=10281 CharacterOffsetEnd=10282 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB Nevertheless))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN inhibition))\n",
      "      (PP (IN of)\n",
      "        (NP (NN ACE))))\n",
      "    (VP (VBD was)\n",
      "      (NP\n",
      "        (NP (JJ long-lasting))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (NP (NN t1/2))\n",
      "            (NP (CD 16-23) (NN h)))\n",
      "          (-RRB- -RRB-))\n",
      "        (ADJP (JJ due)\n",
      "          (PP (TO to)\n",
      "            (NP\n",
      "              (NP (JJ high) (NN affinity) (NN binding))\n",
      "              (PP (IN of)\n",
      "                (NP (NN benazeprilat)))))))\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (NN ACE))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (NN Kd))\n",
      "              (NP\n",
      "                (NP\n",
      "                  (QP (RB approximately) (CD 3.5))\n",
      "                  (NN mmol/L))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN IC50))\n",
      "                  (NP\n",
      "                    (QP (RB approximately) (CD 4.3))\n",
      "                    (NN mmol/L)))))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, long-lasting-7)\n",
      "advmod(long-lasting-7, Nevertheless-1)\n",
      "punct(long-lasting-7, ,-2)\n",
      "nsubj(long-lasting-7, inhibition-3)\n",
      "case(ACE-5, of-4)\n",
      "nmod:of(inhibition-3, ACE-5)\n",
      "cop(long-lasting-7, was-6)\n",
      "punct(t1/2-9, -LRB--8)\n",
      "dep(long-lasting-7, t1/2-9)\n",
      "nummod(h-11, 16-23-10)\n",
      "dep(t1/2-9, h-11)\n",
      "punct(t1/2-9, -RRB--12)\n",
      "amod(long-lasting-7, due-13)\n",
      "case(binding-17, to-14)\n",
      "amod(binding-17, high-15)\n",
      "compound(binding-17, affinity-16)\n",
      "nmod:to(due-13, binding-17)\n",
      "case(benazeprilat-19, of-18)\n",
      "nmod:of(binding-17, benazeprilat-19)\n",
      "case(ACE-21, to-20)\n",
      "nmod:to(long-lasting-7, ACE-21)\n",
      "punct(Kd-23, -LRB--22)\n",
      "dep(ACE-21, Kd-23)\n",
      "advmod(3.5-25, approximately-24)\n",
      "nummod(mmol/L-26, 3.5-25)\n",
      "dep(Kd-23, mmol/L-26)\n",
      "punct(mmol/L-26, ,-27)\n",
      "appos(mmol/L-26, IC50-28)\n",
      "advmod(4.3-30, approximately-29)\n",
      "nummod(mmol/L-31, 4.3-30)\n",
      "dep(IC50-28, mmol/L-31)\n",
      "punct(Kd-23, -RRB--32)\n",
      "punct(long-lasting-7, .-33)\n",
      "\n",
      "Sentence #70 (29 tokens, sentiment: Negative):\n",
      "Simulations using the model predict a lack of proportionality between dose of benazepril, plasma benazeprilat concentrations and effect due to the nonlinear binding of benazeprilat to ACE.\n",
      "[Text=Simulations CharacterOffsetBegin=10283 CharacterOffsetEnd=10294 PartOfSpeech=NNS Lemma=simulation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=using CharacterOffsetBegin=10295 CharacterOffsetEnd=10300 PartOfSpeech=VBG Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=10301 CharacterOffsetEnd=10304 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=model CharacterOffsetBegin=10305 CharacterOffsetEnd=10310 PartOfSpeech=NN Lemma=model NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=predict CharacterOffsetBegin=10311 CharacterOffsetEnd=10318 PartOfSpeech=VBP Lemma=predict NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=10319 CharacterOffsetEnd=10320 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lack CharacterOffsetBegin=10321 CharacterOffsetEnd=10325 PartOfSpeech=NN Lemma=lack NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10326 CharacterOffsetEnd=10328 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=proportionality CharacterOffsetBegin=10329 CharacterOffsetEnd=10344 PartOfSpeech=NN Lemma=proportionality NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=between CharacterOffsetBegin=10345 CharacterOffsetEnd=10352 PartOfSpeech=IN Lemma=between NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dose CharacterOffsetBegin=10353 CharacterOffsetEnd=10357 PartOfSpeech=NN Lemma=dose NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10358 CharacterOffsetEnd=10360 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=10361 CharacterOffsetEnd=10371 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=10371 CharacterOffsetEnd=10372 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plasma CharacterOffsetBegin=10373 CharacterOffsetEnd=10379 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazeprilat CharacterOffsetBegin=10380 CharacterOffsetEnd=10392 PartOfSpeech=NN Lemma=benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=concentrations CharacterOffsetBegin=10393 CharacterOffsetEnd=10407 PartOfSpeech=NNS Lemma=concentration NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=10408 CharacterOffsetEnd=10411 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=10412 CharacterOffsetEnd=10418 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=due CharacterOffsetBegin=10419 CharacterOffsetEnd=10422 PartOfSpeech=JJ Lemma=due NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=10423 CharacterOffsetEnd=10425 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=10426 CharacterOffsetEnd=10429 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nonlinear CharacterOffsetBegin=10430 CharacterOffsetEnd=10439 PartOfSpeech=JJ Lemma=nonlinear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=binding CharacterOffsetBegin=10440 CharacterOffsetEnd=10447 PartOfSpeech=NN Lemma=binding NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10448 CharacterOffsetEnd=10450 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazeprilat CharacterOffsetBegin=10451 CharacterOffsetEnd=10463 PartOfSpeech=NN Lemma=benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=10464 CharacterOffsetEnd=10466 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=10467 CharacterOffsetEnd=10470 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=10470 CharacterOffsetEnd=10471 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNS Simulations))\n",
      "      (VP (VBG using)\n",
      "        (NP (DT the) (NN model))))\n",
      "    (VP (VBP predict)\n",
      "      (S\n",
      "        (NP\n",
      "          (NP (DT a) (NN lack))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN proportionality))\n",
      "              (PP (IN between)\n",
      "                (NP\n",
      "                  (NP (NN dose))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (NN benazepril))\n",
      "                      (, ,)\n",
      "                      (NP (NN plasma) (NN benazeprilat) (NNS concentrations))\n",
      "                      (CC and)\n",
      "                      (NP (NN effect)))))))))\n",
      "        (ADJP (JJ due)\n",
      "          (PP (TO to)\n",
      "            (NP\n",
      "              (NP (DT the) (JJ nonlinear) (NN binding))\n",
      "              (PP (IN of)\n",
      "                (NP (NN benazeprilat)))))))\n",
      "      (PP (TO to)\n",
      "        (NP (NN ACE))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, predict-5)\n",
      "nsubj(predict-5, Simulations-1)\n",
      "acl(Simulations-1, using-2)\n",
      "det(model-4, the-3)\n",
      "dobj(using-2, model-4)\n",
      "det(lack-7, a-6)\n",
      "nsubj(due-20, lack-7)\n",
      "case(proportionality-9, of-8)\n",
      "nmod:of(lack-7, proportionality-9)\n",
      "case(dose-11, between-10)\n",
      "nmod:between(proportionality-9, dose-11)\n",
      "case(benazepril-13, of-12)\n",
      "nmod:of(dose-11, benazepril-13)\n",
      "punct(benazepril-13, ,-14)\n",
      "compound(concentrations-17, plasma-15)\n",
      "compound(concentrations-17, benazeprilat-16)\n",
      "nmod:of(dose-11, concentrations-17)\n",
      "conj:and(benazepril-13, concentrations-17)\n",
      "cc(benazepril-13, and-18)\n",
      "nmod:of(dose-11, effect-19)\n",
      "conj:and(benazepril-13, effect-19)\n",
      "xcomp(predict-5, due-20)\n",
      "case(binding-24, to-21)\n",
      "det(binding-24, the-22)\n",
      "amod(binding-24, nonlinear-23)\n",
      "nmod:to(due-20, binding-24)\n",
      "case(benazeprilat-26, of-25)\n",
      "nmod:of(binding-24, benazeprilat-26)\n",
      "case(ACE-28, to-27)\n",
      "nmod:to(predict-5, ACE-28)\n",
      "punct(predict-5, .-29)\n",
      "\n",
      "Sentence #71 (33 tokens, sentiment: Negative):\n",
      "For example, increasing the dose of benazepril (e.g. above 0.125 mg/kg q24 h) produced only small incremental inhibition of ACE (either peak effect or duration of action).\n",
      "[Text=For CharacterOffsetBegin=10472 CharacterOffsetEnd=10475 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=example CharacterOffsetBegin=10476 CharacterOffsetEnd=10483 PartOfSpeech=NN Lemma=example NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=10483 CharacterOffsetEnd=10484 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=increasing CharacterOffsetBegin=10485 CharacterOffsetEnd=10495 PartOfSpeech=VBG Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=10496 CharacterOffsetEnd=10499 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dose CharacterOffsetBegin=10500 CharacterOffsetEnd=10504 PartOfSpeech=NN Lemma=dose NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10505 CharacterOffsetEnd=10507 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=10508 CharacterOffsetEnd=10518 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10519 CharacterOffsetEnd=10520 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=e.g. CharacterOffsetBegin=10520 CharacterOffsetEnd=10524 PartOfSpeech=FW Lemma=e.g. NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=above CharacterOffsetBegin=10525 CharacterOffsetEnd=10530 PartOfSpeech=IN Lemma=above NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.125 CharacterOffsetBegin=10531 CharacterOffsetEnd=10536 PartOfSpeech=CD Lemma=0.125 NamedEntityTag=NUMBER NormalizedNamedEntityTag=>0.125 SentimentClass=Neutral]\n",
      "[Text=mg/kg CharacterOffsetBegin=10537 CharacterOffsetEnd=10542 PartOfSpeech=NN Lemma=mg/kg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=q24 CharacterOffsetBegin=10543 CharacterOffsetEnd=10546 PartOfSpeech=NN Lemma=q24 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=h CharacterOffsetBegin=10547 CharacterOffsetEnd=10548 PartOfSpeech=NN Lemma=h NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10548 CharacterOffsetEnd=10549 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=produced CharacterOffsetBegin=10550 CharacterOffsetEnd=10558 PartOfSpeech=VBD Lemma=produce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=only CharacterOffsetBegin=10559 CharacterOffsetEnd=10563 PartOfSpeech=RB Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=small CharacterOffsetBegin=10564 CharacterOffsetEnd=10569 PartOfSpeech=JJ Lemma=small NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=incremental CharacterOffsetBegin=10570 CharacterOffsetEnd=10581 PartOfSpeech=JJ Lemma=incremental NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibition CharacterOffsetBegin=10582 CharacterOffsetEnd=10592 PartOfSpeech=NN Lemma=inhibition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10593 CharacterOffsetEnd=10595 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=10596 CharacterOffsetEnd=10599 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10600 CharacterOffsetEnd=10601 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=either CharacterOffsetBegin=10601 CharacterOffsetEnd=10607 PartOfSpeech=CC Lemma=either NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=peak CharacterOffsetBegin=10608 CharacterOffsetEnd=10612 PartOfSpeech=JJ Lemma=peak NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=effect CharacterOffsetBegin=10613 CharacterOffsetEnd=10619 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=10620 CharacterOffsetEnd=10622 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=duration CharacterOffsetBegin=10623 CharacterOffsetEnd=10631 PartOfSpeech=NN Lemma=duration NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10632 CharacterOffsetEnd=10634 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=action CharacterOffsetBegin=10635 CharacterOffsetEnd=10641 PartOfSpeech=NN Lemma=action NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10641 CharacterOffsetEnd=10642 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=10642 CharacterOffsetEnd=10643 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN For)\n",
      "      (NP (NN example)))\n",
      "    (, ,)\n",
      "    (S\n",
      "      (VP (VBG increasing)\n",
      "        (NP\n",
      "          (NP (DT the) (NN dose))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN benazepril))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP\n",
      "                  (NP (FW e.g.))\n",
      "                  (PP (IN above)\n",
      "                    (NP (CD 0.125) (NN mg/kg) (NN q24) (NN h))))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (VP (VBD produced)\n",
      "      (NP\n",
      "        (NP (RB only) (JJ small) (JJ incremental) (NN inhibition))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (NN ACE))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (PP (CC either)\n",
      "                (NP\n",
      "                  (NP (JJ peak) (NN effect)\n",
      "                    (CC or)\n",
      "                    (NN duration))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN action)))))\n",
      "              (-RRB- -RRB-))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, produced-17)\n",
      "case(example-2, For-1)\n",
      "nmod:for(produced-17, example-2)\n",
      "punct(produced-17, ,-3)\n",
      "csubj(produced-17, increasing-4)\n",
      "det(dose-6, the-5)\n",
      "dobj(increasing-4, dose-6)\n",
      "case(benazepril-8, of-7)\n",
      "nmod:of(dose-6, benazepril-8)\n",
      "punct(e.g.-10, -LRB--9)\n",
      "dep(benazepril-8, e.g.-10)\n",
      "case(h-15, above-11)\n",
      "nummod(h-15, 0.125-12)\n",
      "compound(h-15, mg/kg-13)\n",
      "compound(h-15, q24-14)\n",
      "nmod:above(e.g.-10, h-15)\n",
      "punct(e.g.-10, -RRB--16)\n",
      "advmod(inhibition-21, only-18)\n",
      "amod(inhibition-21, small-19)\n",
      "amod(inhibition-21, incremental-20)\n",
      "dobj(produced-17, inhibition-21)\n",
      "case(ACE-23, of-22)\n",
      "nmod:of(inhibition-21, ACE-23)\n",
      "punct(effect-27, -LRB--24)\n",
      "case(effect-27, either-25)\n",
      "amod(effect-27, peak-26)\n",
      "nmod:either(ACE-23, effect-27)\n",
      "cc(effect-27, or-28)\n",
      "nmod:either(ACE-23, duration-29)\n",
      "conj:or(effect-27, duration-29)\n",
      "case(action-31, of-30)\n",
      "nmod:of(effect-27, action-31)\n",
      "punct(effect-27, -RRB--32)\n",
      "punct(produced-17, .-33)\n",
      "\n",
      "Sentence #72 (15 tokens, sentiment: Negative):\n",
      "Albuminuria and hypertension are predictors of poor renal and cardiovascular outcome in diabetic patients.\n",
      "[Text=Albuminuria CharacterOffsetBegin=10645 CharacterOffsetEnd=10656 PartOfSpeech=NN Lemma=albuminuria NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=10657 CharacterOffsetEnd=10660 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hypertension CharacterOffsetBegin=10661 CharacterOffsetEnd=10673 PartOfSpeech=NN Lemma=hypertension NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=10674 CharacterOffsetEnd=10677 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=predictors CharacterOffsetBegin=10678 CharacterOffsetEnd=10688 PartOfSpeech=NNS Lemma=predictor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10689 CharacterOffsetEnd=10691 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=poor CharacterOffsetBegin=10692 CharacterOffsetEnd=10696 PartOfSpeech=JJ Lemma=poor NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=renal CharacterOffsetBegin=10697 CharacterOffsetEnd=10702 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=10703 CharacterOffsetEnd=10706 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cardiovascular CharacterOffsetBegin=10707 CharacterOffsetEnd=10721 PartOfSpeech=JJ Lemma=cardiovascular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=outcome CharacterOffsetBegin=10722 CharacterOffsetEnd=10729 PartOfSpeech=NN Lemma=outcome NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=10730 CharacterOffsetEnd=10732 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=10733 CharacterOffsetEnd=10741 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=10742 CharacterOffsetEnd=10750 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=10750 CharacterOffsetEnd=10751 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Albuminuria)\n",
      "      (CC and)\n",
      "      (NN hypertension))\n",
      "    (VP (VBP are)\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NNS predictors))\n",
      "          (PP (IN of)\n",
      "            (NP (JJ poor) (JJ renal))))\n",
      "        (CC and)\n",
      "        (NP\n",
      "          (NP (JJ cardiovascular) (NN outcome))\n",
      "          (PP (IN in)\n",
      "            (NP (JJ diabetic) (NNS patients))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, predictors-5)\n",
      "nsubj(predictors-5, Albuminuria-1)\n",
      "cc(Albuminuria-1, and-2)\n",
      "conj:and(Albuminuria-1, hypertension-3)\n",
      "nsubj(predictors-5, hypertension-3)\n",
      "cop(predictors-5, are-4)\n",
      "case(renal-8, of-6)\n",
      "amod(renal-8, poor-7)\n",
      "nmod:of(predictors-5, renal-8)\n",
      "cc(predictors-5, and-9)\n",
      "amod(outcome-11, cardiovascular-10)\n",
      "conj:and(predictors-5, outcome-11)\n",
      "case(patients-14, in-12)\n",
      "amod(patients-14, diabetic-13)\n",
      "nmod:in(outcome-11, patients-14)\n",
      "punct(predictors-5, .-15)\n",
      "\n",
      "Sentence #73 (51 tokens, sentiment: Negative):\n",
      "This study tested whether dual blockade of the renin-angiotensin system (RAS) with both an angiotensin-converting enzyme (ACE) inhibitor (ACE-I) and an Angiotensin-II receptor blocker (ARB) is superior to either drug alone in type I diabetic patients with diabetic nephropathy (DN).\n",
      "[Text=This CharacterOffsetBegin=10752 CharacterOffsetEnd=10756 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=10757 CharacterOffsetEnd=10762 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tested CharacterOffsetBegin=10763 CharacterOffsetEnd=10769 PartOfSpeech=VBD Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=whether CharacterOffsetBegin=10770 CharacterOffsetEnd=10777 PartOfSpeech=IN Lemma=whether NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dual CharacterOffsetBegin=10778 CharacterOffsetEnd=10782 PartOfSpeech=JJ Lemma=dual NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blockade CharacterOffsetBegin=10783 CharacterOffsetEnd=10791 PartOfSpeech=NN Lemma=blockade NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=10792 CharacterOffsetEnd=10794 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=10795 CharacterOffsetEnd=10798 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renin-angiotensin CharacterOffsetBegin=10799 CharacterOffsetEnd=10816 PartOfSpeech=JJ Lemma=renin-angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=system CharacterOffsetBegin=10817 CharacterOffsetEnd=10823 PartOfSpeech=NN Lemma=system NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10824 CharacterOffsetEnd=10825 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=RAS CharacterOffsetBegin=10825 CharacterOffsetEnd=10828 PartOfSpeech=NN Lemma=ras NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10828 CharacterOffsetEnd=10829 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=10830 CharacterOffsetEnd=10834 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=both CharacterOffsetBegin=10835 CharacterOffsetEnd=10839 PartOfSpeech=CC Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=10840 CharacterOffsetEnd=10842 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin-converting CharacterOffsetBegin=10843 CharacterOffsetEnd=10865 PartOfSpeech=JJ Lemma=angiotensin-converting NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=10866 CharacterOffsetEnd=10872 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10873 CharacterOffsetEnd=10874 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=10874 CharacterOffsetEnd=10877 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10877 CharacterOffsetEnd=10878 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=10879 CharacterOffsetEnd=10888 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10889 CharacterOffsetEnd=10890 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE-I CharacterOffsetBegin=10890 CharacterOffsetEnd=10895 PartOfSpeech=NN Lemma=ace-i NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10895 CharacterOffsetEnd=10896 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=10897 CharacterOffsetEnd=10900 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=10901 CharacterOffsetEnd=10903 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Angiotensin-II CharacterOffsetBegin=10904 CharacterOffsetEnd=10918 PartOfSpeech=NN Lemma=angiotensin-ii NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=receptor CharacterOffsetBegin=10919 CharacterOffsetEnd=10927 PartOfSpeech=NN Lemma=receptor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blocker CharacterOffsetBegin=10928 CharacterOffsetEnd=10935 PartOfSpeech=NN Lemma=blocker NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=10936 CharacterOffsetEnd=10937 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ARB CharacterOffsetBegin=10937 CharacterOffsetEnd=10940 PartOfSpeech=NN Lemma=arb NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=10940 CharacterOffsetEnd=10941 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=10942 CharacterOffsetEnd=10944 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=superior CharacterOffsetBegin=10945 CharacterOffsetEnd=10953 PartOfSpeech=JJ Lemma=superior NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=to CharacterOffsetBegin=10954 CharacterOffsetEnd=10956 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=either CharacterOffsetBegin=10957 CharacterOffsetEnd=10963 PartOfSpeech=CC Lemma=either NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drug CharacterOffsetBegin=10964 CharacterOffsetEnd=10968 PartOfSpeech=NN Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=alone CharacterOffsetBegin=10969 CharacterOffsetEnd=10974 PartOfSpeech=RB Lemma=alone NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=10975 CharacterOffsetEnd=10977 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=10978 CharacterOffsetEnd=10982 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=I CharacterOffsetBegin=10983 CharacterOffsetEnd=10984 PartOfSpeech=CD Lemma=i NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=10985 CharacterOffsetEnd=10993 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=10994 CharacterOffsetEnd=11002 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=11003 CharacterOffsetEnd=11007 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=11008 CharacterOffsetEnd=11016 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephropathy CharacterOffsetBegin=11017 CharacterOffsetEnd=11028 PartOfSpeech=NN Lemma=nephropathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11029 CharacterOffsetEnd=11030 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DN CharacterOffsetBegin=11030 CharacterOffsetEnd=11032 PartOfSpeech=JJ Lemma=dn NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11032 CharacterOffsetEnd=11033 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=11033 CharacterOffsetEnd=11034 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT This) (NN study))\n",
      "    (VP (VBD tested)\n",
      "      (SBAR (IN whether)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (JJ dual) (NN blockade))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (DT the) (JJ renin-angiotensin) (NN system))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN RAS))\n",
      "                      (-RRB- -RRB-)))\n",
      "                  (PP (IN with)\n",
      "                    (NP (CC both)\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (NP (DT an) (JJ angiotensin-converting) (NN enzyme))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NN ACE))\n",
      "                            (-RRB- -RRB-)))\n",
      "                        (NP\n",
      "                          (NP (NN inhibitor))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (NN ACE-I))\n",
      "                            (-RRB- -RRB-))))\n",
      "                      (CC and)\n",
      "                      (NP (DT an) (NN Angiotensin-II) (NN receptor) (NN blocker)))))))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NN ARB))\n",
      "              (-RRB- -RRB-)))\n",
      "          (VP (VBZ is)\n",
      "            (ADJP (JJ superior)\n",
      "              (PP (TO to)\n",
      "                (NP\n",
      "                  (NP (CC either)\n",
      "                    (NN drug))\n",
      "                  (ADVP (RB alone))\n",
      "                  (PP (IN in)\n",
      "                    (NP (NN type)))\n",
      "                  (NP\n",
      "                    (NP (CD I) (JJ diabetic) (NNS patients))\n",
      "                    (PP (IN with)\n",
      "                      (NP\n",
      "                        (NP (JJ diabetic) (NN nephropathy))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (JJ DN))\n",
      "                          (-RRB- -RRB-))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, tested-3)\n",
      "det(study-2, This-1)\n",
      "nsubj(tested-3, study-2)\n",
      "mark(superior-35, whether-4)\n",
      "amod(blockade-6, dual-5)\n",
      "nsubj(superior-35, blockade-6)\n",
      "case(system-10, of-7)\n",
      "det(system-10, the-8)\n",
      "amod(system-10, renin-angiotensin-9)\n",
      "nmod:of(blockade-6, system-10)\n",
      "punct(RAS-12, -LRB--11)\n",
      "appos(system-10, RAS-12)\n",
      "punct(RAS-12, -RRB--13)\n",
      "case(enzyme-18, with-14)\n",
      "cc:preconj(enzyme-18, both-15)\n",
      "det(enzyme-18, an-16)\n",
      "amod(enzyme-18, angiotensin-converting-17)\n",
      "nmod:with(system-10, enzyme-18)\n",
      "punct(ACE-20, -LRB--19)\n",
      "appos(enzyme-18, ACE-20)\n",
      "punct(ACE-20, -RRB--21)\n",
      "dep(enzyme-18, inhibitor-22)\n",
      "punct(ACE-I-24, -LRB--23)\n",
      "appos(inhibitor-22, ACE-I-24)\n",
      "punct(ACE-I-24, -RRB--25)\n",
      "cc(enzyme-18, and-26)\n",
      "det(blocker-30, an-27)\n",
      "compound(blocker-30, Angiotensin-II-28)\n",
      "compound(blocker-30, receptor-29)\n",
      "nmod:with(system-10, blocker-30)\n",
      "conj:and(enzyme-18, blocker-30)\n",
      "punct(ARB-32, -LRB--31)\n",
      "appos(blockade-6, ARB-32)\n",
      "punct(ARB-32, -RRB--33)\n",
      "cop(superior-35, is-34)\n",
      "ccomp(tested-3, superior-35)\n",
      "case(drug-38, to-36)\n",
      "dep(drug-38, either-37)\n",
      "nmod:to(superior-35, drug-38)\n",
      "advmod(drug-38, alone-39)\n",
      "case(type-41, in-40)\n",
      "nmod:in(drug-38, type-41)\n",
      "nummod(patients-44, I-42)\n",
      "amod(patients-44, diabetic-43)\n",
      "dep(drug-38, patients-44)\n",
      "case(nephropathy-47, with-45)\n",
      "amod(nephropathy-47, diabetic-46)\n",
      "nmod:with(patients-44, nephropathy-47)\n",
      "punct(DN-49, -LRB--48)\n",
      "dep(nephropathy-47, DN-49)\n",
      "punct(DN-49, -RRB--50)\n",
      "punct(tested-3, .-51)\n",
      "\n",
      "Sentence #74 (41 tokens, sentiment: Negative):\n",
      "A randomized double-blind crossover trial was performed with 8-wk treatment with placebo, 20 mg of benazepril once daily, 80 mg of valsartan once daily, and the combination of 20 mg of benazepril and 80 mg of valsartan.\n",
      "[Text=A CharacterOffsetBegin=11035 CharacterOffsetEnd=11036 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=randomized CharacterOffsetBegin=11037 CharacterOffsetEnd=11047 PartOfSpeech=VBN Lemma=randomize NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=double-blind CharacterOffsetBegin=11048 CharacterOffsetEnd=11060 PartOfSpeech=JJ Lemma=double-blind NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=crossover CharacterOffsetBegin=11061 CharacterOffsetEnd=11070 PartOfSpeech=NN Lemma=crossover NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trial CharacterOffsetBegin=11071 CharacterOffsetEnd=11076 PartOfSpeech=NN Lemma=trial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=11077 CharacterOffsetEnd=11080 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=performed CharacterOffsetBegin=11081 CharacterOffsetEnd=11090 PartOfSpeech=VBN Lemma=perform NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=11091 CharacterOffsetEnd=11095 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=8-wk CharacterOffsetBegin=11096 CharacterOffsetEnd=11100 PartOfSpeech=JJ Lemma=8-wk NamedEntityTag=DURATION NormalizedNamedEntityTag=P8W Timex=<TIMEX3 tid=\"t8\" type=\"DURATION\" value=\"P8W\">8-wk</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=treatment CharacterOffsetBegin=11101 CharacterOffsetEnd=11110 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=11111 CharacterOffsetEnd=11115 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=placebo CharacterOffsetBegin=11116 CharacterOffsetEnd=11123 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11123 CharacterOffsetEnd=11124 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=20 CharacterOffsetBegin=11125 CharacterOffsetEnd=11127 PartOfSpeech=CD Lemma=20 NamedEntityTag=NUMBER NormalizedNamedEntityTag=20.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=11128 CharacterOffsetEnd=11130 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11131 CharacterOffsetEnd=11133 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=11134 CharacterOffsetEnd=11144 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=once CharacterOffsetBegin=11145 CharacterOffsetEnd=11149 PartOfSpeech=RB Lemma=once NamedEntityTag=DATE NormalizedNamedEntityTag=PAST_REF Timex=<TIMEX3 tid=\"t9\" type=\"DATE\" value=\"PAST_REF\">once</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=11150 CharacterOffsetEnd=11155 PartOfSpeech=RB Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t10\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11155 CharacterOffsetEnd=11156 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=80 CharacterOffsetBegin=11157 CharacterOffsetEnd=11159 PartOfSpeech=CD Lemma=80 NamedEntityTag=NUMBER NormalizedNamedEntityTag=80.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=11160 CharacterOffsetEnd=11162 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11163 CharacterOffsetEnd=11165 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=11166 CharacterOffsetEnd=11175 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=once CharacterOffsetBegin=11176 CharacterOffsetEnd=11180 PartOfSpeech=RB Lemma=once NamedEntityTag=DATE NormalizedNamedEntityTag=PAST_REF Timex=<TIMEX3 tid=\"t11\" type=\"DATE\" value=\"PAST_REF\">once</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=11181 CharacterOffsetEnd=11186 PartOfSpeech=RB Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t12\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11186 CharacterOffsetEnd=11187 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11188 CharacterOffsetEnd=11191 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=11192 CharacterOffsetEnd=11195 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=combination CharacterOffsetBegin=11196 CharacterOffsetEnd=11207 PartOfSpeech=NN Lemma=combination NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11208 CharacterOffsetEnd=11210 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=20 CharacterOffsetBegin=11211 CharacterOffsetEnd=11213 PartOfSpeech=CD Lemma=20 NamedEntityTag=NUMBER NormalizedNamedEntityTag=20.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=11214 CharacterOffsetEnd=11216 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11217 CharacterOffsetEnd=11219 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=11220 CharacterOffsetEnd=11230 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11231 CharacterOffsetEnd=11234 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=80 CharacterOffsetBegin=11235 CharacterOffsetEnd=11237 PartOfSpeech=CD Lemma=80 NamedEntityTag=NUMBER NormalizedNamedEntityTag=80.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=11238 CharacterOffsetEnd=11240 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11241 CharacterOffsetEnd=11243 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=11244 CharacterOffsetEnd=11253 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=11253 CharacterOffsetEnd=11254 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT A)\n",
      "      (S\n",
      "        (S\n",
      "          (VP (VBN randomized)\n",
      "            (NP (JJ double-blind) (NN crossover) (NN trial))))\n",
      "        (VP (VBD was))))\n",
      "    (VP (VBN performed)\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ 8-wk) (NN treatment))\n",
      "            (PP (IN with)\n",
      "              (NP (NN placebo))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (CD 20) (NN mg))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NN benazepril))\n",
      "                (ADVP (RB once) (RB daily)))))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (CD 80) (NN mg))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NN valsartan))\n",
      "                (ADVP (RB once) (RB daily)))))\n",
      "          (, ,)\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (DT the) (NN combination))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (CD 20) (NN mg))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN benazepril))))\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (CD 80) (NN mg))\n",
      "                  (PP (IN of)\n",
      "                    (NP (NN valsartan))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, performed-7)\n",
      "nsubj(performed-7, A-1)\n",
      "csubj(was-6, randomized-2)\n",
      "amod(trial-5, double-blind-3)\n",
      "compound(trial-5, crossover-4)\n",
      "dobj(randomized-2, trial-5)\n",
      "dep(A-1, was-6)\n",
      "case(treatment-10, with-8)\n",
      "amod(treatment-10, 8-wk-9)\n",
      "nmod:with(performed-7, treatment-10)\n",
      "case(placebo-12, with-11)\n",
      "nmod:with(treatment-10, placebo-12)\n",
      "punct(treatment-10, ,-13)\n",
      "nummod(mg-15, 20-14)\n",
      "nmod:with(performed-7, mg-15)\n",
      "conj:and(treatment-10, mg-15)\n",
      "case(benazepril-17, of-16)\n",
      "nmod:of(mg-15, benazepril-17)\n",
      "advmod(daily-19, once-18)\n",
      "advmod(benazepril-17, daily-19)\n",
      "punct(treatment-10, ,-20)\n",
      "nummod(mg-22, 80-21)\n",
      "nmod:with(performed-7, mg-22)\n",
      "conj:and(treatment-10, mg-22)\n",
      "case(valsartan-24, of-23)\n",
      "nmod:of(mg-22, valsartan-24)\n",
      "advmod(daily-26, once-25)\n",
      "advmod(valsartan-24, daily-26)\n",
      "punct(treatment-10, ,-27)\n",
      "cc(treatment-10, and-28)\n",
      "det(combination-30, the-29)\n",
      "nmod:with(performed-7, combination-30)\n",
      "conj:and(treatment-10, combination-30)\n",
      "case(mg-33, of-31)\n",
      "nummod(mg-33, 20-32)\n",
      "nmod:of(combination-30, mg-33)\n",
      "case(benazepril-35, of-34)\n",
      "nmod:of(mg-33, benazepril-35)\n",
      "cc(mg-33, and-36)\n",
      "nummod(mg-38, 80-37)\n",
      "nmod:of(combination-30, mg-38)\n",
      "conj:and(mg-33, mg-38)\n",
      "case(valsartan-40, of-39)\n",
      "nmod:of(mg-38, valsartan-40)\n",
      "punct(performed-7, .-41)\n",
      "\n",
      "Sentence #75 (10 tokens, sentiment: Neutral):\n",
      "Twenty type I diabetic patients with DN were included.\n",
      "[Text=Twenty CharacterOffsetBegin=11255 CharacterOffsetEnd=11261 PartOfSpeech=CD Lemma=twenty NamedEntityTag=NUMBER NormalizedNamedEntityTag=20.0 SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=11262 CharacterOffsetEnd=11266 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=I CharacterOffsetBegin=11267 CharacterOffsetEnd=11268 PartOfSpeech=CD Lemma=i NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=11269 CharacterOffsetEnd=11277 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=11278 CharacterOffsetEnd=11286 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=11287 CharacterOffsetEnd=11291 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DN CharacterOffsetBegin=11292 CharacterOffsetEnd=11294 PartOfSpeech=JJ Lemma=dn NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=11295 CharacterOffsetEnd=11299 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=included CharacterOffsetBegin=11300 CharacterOffsetEnd=11308 PartOfSpeech=VBN Lemma=include NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=11308 CharacterOffsetEnd=11309 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (CD Twenty)\n",
      "        (ADJP\n",
      "          (NP (NN type) (CD I))\n",
      "          (JJ diabetic))\n",
      "        (NNS patients))\n",
      "      (PP (IN with)\n",
      "        (NP (JJ DN))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN included)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, included-9)\n",
      "nummod(patients-5, Twenty-1)\n",
      "nmod:npmod(diabetic-4, type-2)\n",
      "nummod(type-2, I-3)\n",
      "amod(patients-5, diabetic-4)\n",
      "nsubjpass(included-9, patients-5)\n",
      "case(DN-7, with-6)\n",
      "nmod:with(patients-5, DN-7)\n",
      "auxpass(included-9, were-8)\n",
      "punct(included-9, .-10)\n",
      "\n",
      "Sentence #76 (18 tokens, sentiment: Negative):\n",
      "At the end of each treatment period, albuminuria, 24-h BP, and GFR were measured.\n",
      "[Text=At CharacterOffsetBegin=11310 CharacterOffsetEnd=11312 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=11313 CharacterOffsetEnd=11316 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=end CharacterOffsetBegin=11317 CharacterOffsetEnd=11320 PartOfSpeech=NN Lemma=end NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11321 CharacterOffsetEnd=11323 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=each CharacterOffsetBegin=11324 CharacterOffsetEnd=11328 PartOfSpeech=DT Lemma=each NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=treatment CharacterOffsetBegin=11329 CharacterOffsetEnd=11338 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=period CharacterOffsetBegin=11339 CharacterOffsetEnd=11345 PartOfSpeech=NN Lemma=period NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11345 CharacterOffsetEnd=11346 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=albuminuria CharacterOffsetBegin=11347 CharacterOffsetEnd=11358 PartOfSpeech=NN Lemma=albuminuria NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11358 CharacterOffsetEnd=11359 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=24-h CharacterOffsetBegin=11360 CharacterOffsetEnd=11364 PartOfSpeech=JJ Lemma=24-h NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=11365 CharacterOffsetEnd=11367 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11367 CharacterOffsetEnd=11368 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11369 CharacterOffsetEnd=11372 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=GFR CharacterOffsetBegin=11373 CharacterOffsetEnd=11376 PartOfSpeech=NN Lemma=gfr NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=11377 CharacterOffsetEnd=11381 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=measured CharacterOffsetBegin=11382 CharacterOffsetEnd=11390 PartOfSpeech=VBN Lemma=measure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=11390 CharacterOffsetEnd=11391 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN At)\n",
      "      (NP\n",
      "        (NP (DT the) (NN end))\n",
      "        (PP (IN of)\n",
      "          (NP (DT each) (NN treatment) (NN period)))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (NN albuminuria))\n",
      "      (, ,)\n",
      "      (NP (JJ 24-h) (NN BP))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NN GFR)))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN measured)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, measured-17)\n",
      "case(end-3, At-1)\n",
      "det(end-3, the-2)\n",
      "nmod:at(measured-17, end-3)\n",
      "case(period-7, of-4)\n",
      "det(period-7, each-5)\n",
      "compound(period-7, treatment-6)\n",
      "nmod:of(end-3, period-7)\n",
      "punct(measured-17, ,-8)\n",
      "nsubjpass(measured-17, albuminuria-9)\n",
      "punct(albuminuria-9, ,-10)\n",
      "amod(BP-12, 24-h-11)\n",
      "conj:and(albuminuria-9, BP-12)\n",
      "nsubjpass(measured-17, BP-12)\n",
      "punct(albuminuria-9, ,-13)\n",
      "cc(albuminuria-9, and-14)\n",
      "conj:and(albuminuria-9, GFR-15)\n",
      "nsubjpass(measured-17, GFR-15)\n",
      "auxpass(measured-17, were-16)\n",
      "punct(measured-17, .-18)\n",
      "\n",
      "Sentence #77 (6 tokens, sentiment: Neutral):\n",
      "Eighteen patients completed the study.\n",
      "[Text=Eighteen CharacterOffsetBegin=11392 CharacterOffsetEnd=11400 PartOfSpeech=CD Lemma=eighteen NamedEntityTag=NUMBER NormalizedNamedEntityTag=18.0 SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=11401 CharacterOffsetEnd=11409 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=completed CharacterOffsetBegin=11410 CharacterOffsetEnd=11419 PartOfSpeech=VBD Lemma=complete NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=11420 CharacterOffsetEnd=11423 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=11424 CharacterOffsetEnd=11429 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=11429 CharacterOffsetEnd=11430 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (CD Eighteen) (NNS patients))\n",
      "    (VP (VBD completed)\n",
      "      (NP (DT the) (NN study)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, completed-3)\n",
      "nummod(patients-2, Eighteen-1)\n",
      "nsubj(completed-3, patients-2)\n",
      "det(study-5, the-4)\n",
      "dobj(completed-3, study-5)\n",
      "punct(completed-3, .-6)\n",
      "\n",
      "Sentence #78 (63 tokens, sentiment: Negative):\n",
      "Placebo values were: albuminuria [mean (95% CI)], 701 (490 to 1002) mg/24 h; BP [mean (SEM)], 144 (4)/79 (2) mmHg, and GFR [mean (SEM)], 82 (7) ml/min per 1.73 m(2).\n",
      "[Text=Placebo CharacterOffsetBegin=11431 CharacterOffsetEnd=11438 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=values CharacterOffsetBegin=11439 CharacterOffsetEnd=11445 PartOfSpeech=NNS Lemma=value NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=11446 CharacterOffsetEnd=11450 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=: CharacterOffsetBegin=11450 CharacterOffsetEnd=11451 PartOfSpeech=: Lemma=: NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=albuminuria CharacterOffsetBegin=11452 CharacterOffsetEnd=11463 PartOfSpeech=NN Lemma=albuminuria NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LSB- CharacterOffsetBegin=11464 CharacterOffsetEnd=11465 PartOfSpeech=-LRB- Lemma=-lsb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mean CharacterOffsetBegin=11465 CharacterOffsetEnd=11469 PartOfSpeech=NN Lemma=mean NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=-LRB- CharacterOffsetBegin=11470 CharacterOffsetEnd=11471 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=95 CharacterOffsetBegin=11471 CharacterOffsetEnd=11473 PartOfSpeech=CD Lemma=95 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%95.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=11473 CharacterOffsetEnd=11474 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%95.0 SentimentClass=Neutral]\n",
      "[Text=CI CharacterOffsetBegin=11475 CharacterOffsetEnd=11477 PartOfSpeech=NN Lemma=ci NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11477 CharacterOffsetEnd=11478 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RSB- CharacterOffsetBegin=11478 CharacterOffsetEnd=11479 PartOfSpeech=-RRB- Lemma=-rsb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11479 CharacterOffsetEnd=11480 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=701 CharacterOffsetBegin=11481 CharacterOffsetEnd=11484 PartOfSpeech=CD Lemma=701 NamedEntityTag=NUMBER NormalizedNamedEntityTag=701.0 SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11485 CharacterOffsetEnd=11486 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=490 CharacterOffsetBegin=11486 CharacterOffsetEnd=11489 PartOfSpeech=CD Lemma=490 NamedEntityTag=NUMBER NormalizedNamedEntityTag=490.0 SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=11490 CharacterOffsetEnd=11492 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1002 CharacterOffsetBegin=11493 CharacterOffsetEnd=11497 PartOfSpeech=CD Lemma=1002 NamedEntityTag=DATE NormalizedNamedEntityTag=1002 Timex=<TIMEX3 tid=\"t13\" type=\"DATE\" value=\"1002\">1002</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11497 CharacterOffsetEnd=11498 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mg/24 CharacterOffsetBegin=11499 CharacterOffsetEnd=11504 PartOfSpeech=NN Lemma=mg/24 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=h CharacterOffsetBegin=11505 CharacterOffsetEnd=11506 PartOfSpeech=NN Lemma=h NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=; CharacterOffsetBegin=11506 CharacterOffsetEnd=11507 PartOfSpeech=: Lemma=; NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=11508 CharacterOffsetEnd=11510 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LSB- CharacterOffsetBegin=11511 CharacterOffsetEnd=11512 PartOfSpeech=-LRB- Lemma=-lsb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mean CharacterOffsetBegin=11512 CharacterOffsetEnd=11516 PartOfSpeech=NN Lemma=mean NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=-LRB- CharacterOffsetBegin=11517 CharacterOffsetEnd=11518 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SEM CharacterOffsetBegin=11518 CharacterOffsetEnd=11521 PartOfSpeech=NN Lemma=sem NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11521 CharacterOffsetEnd=11522 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RSB- CharacterOffsetBegin=11522 CharacterOffsetEnd=11523 PartOfSpeech=-RRB- Lemma=-rsb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11523 CharacterOffsetEnd=11524 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=144 CharacterOffsetBegin=11525 CharacterOffsetEnd=11528 PartOfSpeech=CD Lemma=144 NamedEntityTag=NUMBER NormalizedNamedEntityTag=144.0 SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11529 CharacterOffsetEnd=11530 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=4 CharacterOffsetBegin=11530 CharacterOffsetEnd=11531 PartOfSpeech=CD Lemma=4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=4.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11531 CharacterOffsetEnd=11532 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=/ CharacterOffsetBegin=11532 CharacterOffsetEnd=11533 PartOfSpeech=: Lemma=/ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=79 CharacterOffsetBegin=11533 CharacterOffsetEnd=11535 PartOfSpeech=CD Lemma=79 NamedEntityTag=NUMBER NormalizedNamedEntityTag=79.0 SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11536 CharacterOffsetEnd=11537 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=2 CharacterOffsetBegin=11537 CharacterOffsetEnd=11538 PartOfSpeech=CD Lemma=2 NamedEntityTag=NUMBER NormalizedNamedEntityTag=2.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11538 CharacterOffsetEnd=11539 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=11540 CharacterOffsetEnd=11544 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11544 CharacterOffsetEnd=11545 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11546 CharacterOffsetEnd=11549 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=GFR CharacterOffsetBegin=11550 CharacterOffsetEnd=11553 PartOfSpeech=NN Lemma=gfr NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LSB- CharacterOffsetBegin=11554 CharacterOffsetEnd=11555 PartOfSpeech=-LRB- Lemma=-lsb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mean CharacterOffsetBegin=11555 CharacterOffsetEnd=11559 PartOfSpeech=NN Lemma=mean NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=-LRB- CharacterOffsetBegin=11560 CharacterOffsetEnd=11561 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SEM CharacterOffsetBegin=11561 CharacterOffsetEnd=11564 PartOfSpeech=NN Lemma=sem NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11564 CharacterOffsetEnd=11565 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RSB- CharacterOffsetBegin=11565 CharacterOffsetEnd=11566 PartOfSpeech=-RRB- Lemma=-rsb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11566 CharacterOffsetEnd=11567 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=82 CharacterOffsetBegin=11568 CharacterOffsetEnd=11570 PartOfSpeech=CD Lemma=82 NamedEntityTag=NUMBER NormalizedNamedEntityTag=82.0 SentimentClass=Positive]\n",
      "[Text=-LRB- CharacterOffsetBegin=11571 CharacterOffsetEnd=11572 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=7 CharacterOffsetBegin=11572 CharacterOffsetEnd=11573 PartOfSpeech=CD Lemma=7 NamedEntityTag=NUMBER NormalizedNamedEntityTag=7.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11573 CharacterOffsetEnd=11574 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ml/min CharacterOffsetBegin=11575 CharacterOffsetEnd=11581 PartOfSpeech=JJ Lemma=ml/min NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=per CharacterOffsetBegin=11582 CharacterOffsetEnd=11585 PartOfSpeech=IN Lemma=per NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1.73 CharacterOffsetBegin=11586 CharacterOffsetEnd=11590 PartOfSpeech=CD Lemma=1.73 NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.73 SentimentClass=Neutral]\n",
      "[Text=m CharacterOffsetBegin=11591 CharacterOffsetEnd=11592 PartOfSpeech=NN Lemma=m NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11592 CharacterOffsetEnd=11593 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=2 CharacterOffsetBegin=11593 CharacterOffsetEnd=11594 PartOfSpeech=CD Lemma=2 NamedEntityTag=NUMBER NormalizedNamedEntityTag=2.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11594 CharacterOffsetEnd=11595 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=11595 CharacterOffsetEnd=11596 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Placebo) (NNS values))\n",
      "    (VP (VBD were) (: :)\n",
      "      (S\n",
      "        (NP (NN albuminuria) (-LRB- -LSB-) (NN mean))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (NP (CD 95) (NN %))\n",
      "            (NP (NN CI)))\n",
      "          (-RRB- -RRB-))\n",
      "        (VP\n",
      "          (VP (-RRB- -RSB-) (, ,)\n",
      "            (FRAG\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (CD 701))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (QP (CD 490) (TO to) (CD 1002)))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (NP (NN mg/24) (NN h)))\n",
      "                (: ;)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (NN BP) (-LRB- -LSB-))\n",
      "                    (NN mean)\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN SEM))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (-RRB- -RSB-))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (CD 144))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (CD 4))\n",
      "                      (-RRB- -RRB-)))))\n",
      "              (: /)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (CD 79))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (CD 2))\n",
      "                      (-RRB- -RRB-))\n",
      "                    (NP (NN mmHg)))\n",
      "                  (, ,)\n",
      "                  (CC and)\n",
      "                  (NP (NN GFR)))\n",
      "                (PP (-LRB- -LSB-)\n",
      "                  (NP\n",
      "                    (NP (NN mean))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN SEM))\n",
      "                      (-RRB- -RRB-)))))\n",
      "              (-RRB- -RSB-)))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (CD 82))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (CD 7))\n",
      "              (-RRB- -RRB-))\n",
      "            (ADJP (JJ ml/min)\n",
      "              (PP (IN per)\n",
      "                (NP\n",
      "                  (NP (CD 1.73) (NN m))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (CD 2))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, were-3)\n",
      "compound(values-2, Placebo-1)\n",
      "nsubj(were-3, values-2)\n",
      "punct(were-3, :-4)\n",
      "compound(mean-7, albuminuria-5)\n",
      "punct(mean-7, -LSB--6)\n",
      "nsubj(701-15, mean-7)\n",
      "punct(%-10, -LRB--8)\n",
      "nummod(%-10, 95-9)\n",
      "dep(701-15, %-10)\n",
      "dep(%-10, CI-11)\n",
      "punct(%-10, -RRB--12)\n",
      "punct(701-15, -RSB--13)\n",
      "punct(701-15, ,-14)\n",
      "ccomp(were-3, 701-15)\n",
      "punct(1002-19, -LRB--16)\n",
      "compound(1002-19, 490-17)\n",
      "dep(1002-19, to-18)\n",
      "dep(701-15, 1002-19)\n",
      "punct(1002-19, -RRB--20)\n",
      "compound(h-22, mg/24-21)\n",
      "dep(701-15, h-22)\n",
      "punct(701-15, ;-23)\n",
      "compound(mean-26, BP-24)\n",
      "punct(BP-24, -LSB--25)\n",
      "dep(701-15, mean-26)\n",
      "punct(SEM-28, -LRB--27)\n",
      "appos(mean-26, SEM-28)\n",
      "punct(SEM-28, -RRB--29)\n",
      "punct(mean-26, -RSB--30)\n",
      "punct(mean-26, ,-31)\n",
      "appos(mean-26, 144-32)\n",
      "punct(4-34, -LRB--33)\n",
      "appos(144-32, 4-34)\n",
      "punct(4-34, -RRB--35)\n",
      "punct(701-15, /-36)\n",
      "dep(701-15, 79-37)\n",
      "punct(2-39, -LRB--38)\n",
      "appos(79-37, 2-39)\n",
      "punct(2-39, -RRB--40)\n",
      "dep(79-37, mmHg-41)\n",
      "punct(79-37, ,-42)\n",
      "cc(79-37, and-43)\n",
      "dep(701-15, GFR-44)\n",
      "conj:and(79-37, GFR-44)\n",
      "punct(mean-46, -LSB--45)\n",
      "nmod(79-37, mean-46)\n",
      "punct(SEM-48, -LRB--47)\n",
      "appos(mean-46, SEM-48)\n",
      "punct(SEM-48, -RRB--49)\n",
      "punct(701-15, -RSB--50)\n",
      "punct(701-15, ,-51)\n",
      "dobj(701-15, 82-52)\n",
      "punct(7-54, -LRB--53)\n",
      "appos(82-52, 7-54)\n",
      "punct(7-54, -RRB--55)\n",
      "amod(82-52, ml/min-56)\n",
      "case(m-59, per-57)\n",
      "nummod(m-59, 1.73-58)\n",
      "nmod:per(ml/min-56, m-59)\n",
      "punct(2-61, -LRB--60)\n",
      "appos(m-59, 2-61)\n",
      "punct(2-61, -RRB--62)\n",
      "punct(were-3, .-63)\n",
      "\n",
      "Sentence #79 (18 tokens, sentiment: Negative):\n",
      "Treatment with benazepril, valsartan, or dual blockade significantly reduced albuminuria and BP compared with placebo.\n",
      "[Text=Treatment CharacterOffsetBegin=11597 CharacterOffsetEnd=11606 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=11607 CharacterOffsetEnd=11611 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=11612 CharacterOffsetEnd=11622 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11622 CharacterOffsetEnd=11623 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=11624 CharacterOffsetEnd=11633 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11633 CharacterOffsetEnd=11634 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=11635 CharacterOffsetEnd=11637 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dual CharacterOffsetBegin=11638 CharacterOffsetEnd=11642 PartOfSpeech=JJ Lemma=dual NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blockade CharacterOffsetBegin=11643 CharacterOffsetEnd=11651 PartOfSpeech=NN Lemma=blockade NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=significantly CharacterOffsetBegin=11652 CharacterOffsetEnd=11665 PartOfSpeech=RB Lemma=significantly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduced CharacterOffsetBegin=11666 CharacterOffsetEnd=11673 PartOfSpeech=VBD Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=albuminuria CharacterOffsetBegin=11674 CharacterOffsetEnd=11685 PartOfSpeech=NN Lemma=albuminuria NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11686 CharacterOffsetEnd=11689 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=11690 CharacterOffsetEnd=11692 PartOfSpeech=NN Lemma=bp NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=compared CharacterOffsetBegin=11693 CharacterOffsetEnd=11701 PartOfSpeech=VBN Lemma=compare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=11702 CharacterOffsetEnd=11706 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=placebo CharacterOffsetBegin=11707 CharacterOffsetEnd=11714 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=11714 CharacterOffsetEnd=11715 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN Treatment))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (NN benazepril))\n",
      "          (, ,)\n",
      "          (NP (NN valsartan))\n",
      "          (, ,)\n",
      "          (CC or)\n",
      "          (NP (JJ dual) (NN blockade)))))\n",
      "    (ADVP (RB significantly))\n",
      "    (VP (VBD reduced)\n",
      "      (NP (NN albuminuria)\n",
      "        (CC and)\n",
      "        (NN BP))\n",
      "      (PP (VBN compared)\n",
      "        (PP (IN with)\n",
      "          (NP (NN placebo)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, reduced-11)\n",
      "nsubj(reduced-11, Treatment-1)\n",
      "case(benazepril-3, with-2)\n",
      "nmod:with(Treatment-1, benazepril-3)\n",
      "punct(benazepril-3, ,-4)\n",
      "nmod:with(Treatment-1, valsartan-5)\n",
      "conj:or(benazepril-3, valsartan-5)\n",
      "punct(benazepril-3, ,-6)\n",
      "cc(benazepril-3, or-7)\n",
      "amod(blockade-9, dual-8)\n",
      "nmod:with(Treatment-1, blockade-9)\n",
      "conj:or(benazepril-3, blockade-9)\n",
      "advmod(reduced-11, significantly-10)\n",
      "dobj(reduced-11, albuminuria-12)\n",
      "cc(albuminuria-12, and-13)\n",
      "dobj(reduced-11, BP-14)\n",
      "conj:and(albuminuria-12, BP-14)\n",
      "case(placebo-17, compared-15)\n",
      "mwe(compared-15, with-16)\n",
      "advcl:compared_with(reduced-11, placebo-17)\n",
      "punct(reduced-11, .-18)\n",
      "\n",
      "Sentence #80 (7 tokens, sentiment: Negative):\n",
      "Benazepril and valsartan were equally effective.\n",
      "[Text=Benazepril CharacterOffsetBegin=11716 CharacterOffsetEnd=11726 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11727 CharacterOffsetEnd=11730 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=11731 CharacterOffsetEnd=11740 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=11741 CharacterOffsetEnd=11745 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=equally CharacterOffsetBegin=11746 CharacterOffsetEnd=11753 PartOfSpeech=RB Lemma=equally NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effective CharacterOffsetBegin=11754 CharacterOffsetEnd=11763 PartOfSpeech=JJ Lemma=effective NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=. CharacterOffsetBegin=11763 CharacterOffsetEnd=11764 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NNP Benazepril))\n",
      "      (CC and)\n",
      "      (NP (NN valsartan)))\n",
      "    (VP (VBD were)\n",
      "      (ADJP (RB equally) (JJ effective)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, effective-6)\n",
      "nsubj(effective-6, Benazepril-1)\n",
      "cc(Benazepril-1, and-2)\n",
      "conj:and(Benazepril-1, valsartan-3)\n",
      "nsubj(effective-6, valsartan-3)\n",
      "cop(effective-6, were-4)\n",
      "advmod(effective-6, equally-5)\n",
      "punct(effective-6, .-7)\n",
      "\n",
      "Sentence #81 (71 tokens, sentiment: Negative):\n",
      "Dual blockade induced an additional reduction in albuminuria of 43 % (29 to 54 %) compared with any type of monotherapy, and a reduction in systolic BP of 6 (0 to 13) mmHg and 7 (1 to 14) mmHg (versus benazepril and valsartan, respectively) and a reduction of 7 (4 to 10) mmHg diastolic compared with both monotherapies.\n",
      "[Text=Dual CharacterOffsetBegin=11765 CharacterOffsetEnd=11769 PartOfSpeech=JJ Lemma=dual NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blockade CharacterOffsetBegin=11770 CharacterOffsetEnd=11778 PartOfSpeech=NN Lemma=blockade NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=induced CharacterOffsetBegin=11779 CharacterOffsetEnd=11786 PartOfSpeech=VBD Lemma=induce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=11787 CharacterOffsetEnd=11789 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=additional CharacterOffsetBegin=11790 CharacterOffsetEnd=11800 PartOfSpeech=JJ Lemma=additional NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduction CharacterOffsetBegin=11801 CharacterOffsetEnd=11810 PartOfSpeech=NN Lemma=reduction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=11811 CharacterOffsetEnd=11813 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=albuminuria CharacterOffsetBegin=11814 CharacterOffsetEnd=11825 PartOfSpeech=NN Lemma=albuminuria NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11826 CharacterOffsetEnd=11828 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=43 CharacterOffsetBegin=11829 CharacterOffsetEnd=11831 PartOfSpeech=CD Lemma=43 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%43.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=11832 CharacterOffsetEnd=11833 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%43.0 SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11834 CharacterOffsetEnd=11835 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=29 CharacterOffsetBegin=11835 CharacterOffsetEnd=11837 PartOfSpeech=CD Lemma=29 NamedEntityTag=NUMBER NormalizedNamedEntityTag=29.0 SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=11838 CharacterOffsetEnd=11840 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=54 CharacterOffsetBegin=11841 CharacterOffsetEnd=11843 PartOfSpeech=CD Lemma=54 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%54.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=11844 CharacterOffsetEnd=11845 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%54.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11845 CharacterOffsetEnd=11846 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compared CharacterOffsetBegin=11847 CharacterOffsetEnd=11855 PartOfSpeech=VBN Lemma=compare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=11856 CharacterOffsetEnd=11860 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=any CharacterOffsetBegin=11861 CharacterOffsetEnd=11864 PartOfSpeech=DT Lemma=any NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=11865 CharacterOffsetEnd=11869 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11870 CharacterOffsetEnd=11872 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=monotherapy CharacterOffsetBegin=11873 CharacterOffsetEnd=11884 PartOfSpeech=NN Lemma=monotherapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11884 CharacterOffsetEnd=11885 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11886 CharacterOffsetEnd=11889 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=11890 CharacterOffsetEnd=11891 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduction CharacterOffsetBegin=11892 CharacterOffsetEnd=11901 PartOfSpeech=NN Lemma=reduction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=11902 CharacterOffsetEnd=11904 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=systolic CharacterOffsetBegin=11905 CharacterOffsetEnd=11913 PartOfSpeech=JJ Lemma=systolic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=11914 CharacterOffsetEnd=11916 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=11917 CharacterOffsetEnd=11919 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=6 CharacterOffsetBegin=11920 CharacterOffsetEnd=11921 PartOfSpeech=CD Lemma=6 NamedEntityTag=NUMBER NormalizedNamedEntityTag=6.0 SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11922 CharacterOffsetEnd=11923 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0 CharacterOffsetBegin=11923 CharacterOffsetEnd=11924 PartOfSpeech=CD Lemma=0 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=11925 CharacterOffsetEnd=11927 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=13 CharacterOffsetBegin=11928 CharacterOffsetEnd=11930 PartOfSpeech=CD Lemma=13 NamedEntityTag=NUMBER NormalizedNamedEntityTag=13.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11930 CharacterOffsetEnd=11931 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=11932 CharacterOffsetEnd=11936 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11937 CharacterOffsetEnd=11940 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=7 CharacterOffsetBegin=11941 CharacterOffsetEnd=11942 PartOfSpeech=CD Lemma=7 NamedEntityTag=NUMBER NormalizedNamedEntityTag=7.0 SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11943 CharacterOffsetEnd=11944 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1 CharacterOffsetBegin=11944 CharacterOffsetEnd=11945 PartOfSpeech=CD Lemma=1 NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=11946 CharacterOffsetEnd=11948 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=14 CharacterOffsetBegin=11949 CharacterOffsetEnd=11951 PartOfSpeech=CD Lemma=14 NamedEntityTag=NUMBER NormalizedNamedEntityTag=14.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=11951 CharacterOffsetEnd=11952 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=11953 CharacterOffsetEnd=11957 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=11958 CharacterOffsetEnd=11959 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=versus CharacterOffsetBegin=11959 CharacterOffsetEnd=11965 PartOfSpeech=CC Lemma=versus NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=11966 CharacterOffsetEnd=11976 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=11977 CharacterOffsetEnd=11980 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=valsartan CharacterOffsetBegin=11981 CharacterOffsetEnd=11990 PartOfSpeech=NN Lemma=valsartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=11990 CharacterOffsetEnd=11991 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=respectively CharacterOffsetBegin=11992 CharacterOffsetEnd=12004 PartOfSpeech=RB Lemma=respectively NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=12004 CharacterOffsetEnd=12005 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=12006 CharacterOffsetEnd=12009 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=12010 CharacterOffsetEnd=12011 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduction CharacterOffsetBegin=12012 CharacterOffsetEnd=12021 PartOfSpeech=NN Lemma=reduction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=12022 CharacterOffsetEnd=12024 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=7 CharacterOffsetBegin=12025 CharacterOffsetEnd=12026 PartOfSpeech=CD Lemma=7 NamedEntityTag=NUMBER NormalizedNamedEntityTag=7.0 SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=12027 CharacterOffsetEnd=12028 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=4 CharacterOffsetBegin=12028 CharacterOffsetEnd=12029 PartOfSpeech=CD Lemma=4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=4.0 SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=12030 CharacterOffsetEnd=12032 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10 CharacterOffsetBegin=12033 CharacterOffsetEnd=12035 PartOfSpeech=CD Lemma=10 NamedEntityTag=NUMBER NormalizedNamedEntityTag=10.0 SentimentClass=Positive]\n",
      "[Text=-RRB- CharacterOffsetBegin=12035 CharacterOffsetEnd=12036 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=12037 CharacterOffsetEnd=12041 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diastolic CharacterOffsetBegin=12042 CharacterOffsetEnd=12051 PartOfSpeech=NN Lemma=diastolic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compared CharacterOffsetBegin=12052 CharacterOffsetEnd=12060 PartOfSpeech=VBN Lemma=compare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=12061 CharacterOffsetEnd=12065 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=both CharacterOffsetBegin=12066 CharacterOffsetEnd=12070 PartOfSpeech=CC Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=monotherapies CharacterOffsetBegin=12071 CharacterOffsetEnd=12084 PartOfSpeech=NNS Lemma=monotherapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12084 CharacterOffsetEnd=12085 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ Dual) (NN blockade))\n",
      "    (VP (VBD induced)\n",
      "      (NP (DT an) (JJ additional) (NN reduction))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN albuminuria))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (CD 43) (NN %))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP\n",
      "                        (QP (CD 29) (TO to) (CD 54))\n",
      "                        (NN %))\n",
      "                      (-RRB- -RRB-)))\n",
      "                  (PP (VBN compared)\n",
      "                    (PP (IN with)\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (NP (DT any) (NN type))\n",
      "                          (PP (IN of)\n",
      "                            (NP (NN monotherapy))))\n",
      "                        (, ,)\n",
      "                        (CC and)\n",
      "                        (NP\n",
      "                          (NP (DT a) (NN reduction))\n",
      "                          (PP (IN in)\n",
      "                            (NP\n",
      "                              (NP (JJ systolic) (NN BP))\n",
      "                              (PP (IN of)\n",
      "                                (NP (CD 6))))))))))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (QP (CD 0) (TO to) (CD 13)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NN mmHg))\n",
      "                  (CC and)\n",
      "                  (NP (CD 7)))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP\n",
      "                    (QP (CD 1) (TO to) (CD 14)))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (NP\n",
      "                (NP (NN mmHg))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (PP (CC versus)\n",
      "                    (NP\n",
      "                      (NP (NN benazepril)\n",
      "                        (CC and)\n",
      "                        (NN valsartan))\n",
      "                      (, ,)\n",
      "                      (ADVP (RB respectively))))\n",
      "                  (-RRB- -RRB-)))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (DT a)\n",
      "                  (NP\n",
      "                    (NP (NN reduction))\n",
      "                    (PP (IN of)\n",
      "                      (NP (CD 7)))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP\n",
      "                        (QP (CD 4) (TO to) (CD 10)))\n",
      "                      (-RRB- -RRB-)))\n",
      "                  (NN mmHg) (NN diastolic))\n",
      "                (PP (VBN compared)\n",
      "                  (PP (IN with)\n",
      "                    (CC both)\n",
      "                    (NP (NNS monotherapies))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, induced-3)\n",
      "amod(blockade-2, Dual-1)\n",
      "nsubj(induced-3, blockade-2)\n",
      "det(reduction-6, an-4)\n",
      "amod(reduction-6, additional-5)\n",
      "dobj(induced-3, reduction-6)\n",
      "case(albuminuria-8, in-7)\n",
      "nmod:in(induced-3, albuminuria-8)\n",
      "case(%-11, of-9)\n",
      "nummod(%-11, 43-10)\n",
      "nmod:of(albuminuria-8, %-11)\n",
      "punct(%-16, -LRB--12)\n",
      "compound(54-15, 29-13)\n",
      "dep(54-15, to-14)\n",
      "nummod(%-16, 54-15)\n",
      "appos(%-11, %-16)\n",
      "punct(%-16, -RRB--17)\n",
      "case(type-21, compared-18)\n",
      "mwe(compared-18, with-19)\n",
      "det(type-21, any-20)\n",
      "nmod:compared_with(%-11, type-21)\n",
      "case(monotherapy-23, of-22)\n",
      "nmod:of(type-21, monotherapy-23)\n",
      "punct(type-21, ,-24)\n",
      "cc(type-21, and-25)\n",
      "det(reduction-27, a-26)\n",
      "nmod:compared_with(%-11, reduction-27)\n",
      "conj:and(type-21, reduction-27)\n",
      "case(BP-30, in-28)\n",
      "amod(BP-30, systolic-29)\n",
      "nmod:in(reduction-27, BP-30)\n",
      "case(6-32, of-31)\n",
      "nmod:of(BP-30, 6-32)\n",
      "punct(13-36, -LRB--33)\n",
      "compound(13-36, 0-34)\n",
      "dep(13-36, to-35)\n",
      "dep(%-11, 13-36)\n",
      "punct(13-36, -RRB--37)\n",
      "dep(%-11, mmHg-38)\n",
      "cc(mmHg-38, and-39)\n",
      "dep(%-11, 7-40)\n",
      "conj:and(mmHg-38, 7-40)\n",
      "punct(14-44, -LRB--41)\n",
      "compound(14-44, 1-42)\n",
      "dep(14-44, to-43)\n",
      "dep(mmHg-38, 14-44)\n",
      "punct(14-44, -RRB--45)\n",
      "dep(%-11, mmHg-46)\n",
      "punct(benazepril-49, -LRB--47)\n",
      "case(benazepril-49, versus-48)\n",
      "nmod:versus(mmHg-46, benazepril-49)\n",
      "cc(benazepril-49, and-50)\n",
      "nmod:versus(mmHg-46, valsartan-51)\n",
      "conj:and(benazepril-49, valsartan-51)\n",
      "punct(benazepril-49, ,-52)\n",
      "advmod(benazepril-49, respectively-53)\n",
      "punct(benazepril-49, -RRB--54)\n",
      "cc(%-11, and-55)\n",
      "det(diastolic-66, a-56)\n",
      "compound(diastolic-66, reduction-57)\n",
      "case(7-59, of-58)\n",
      "nmod:of(reduction-57, 7-59)\n",
      "punct(10-63, -LRB--60)\n",
      "compound(10-63, 4-61)\n",
      "dep(10-63, to-62)\n",
      "dep(reduction-57, 10-63)\n",
      "punct(10-63, -RRB--64)\n",
      "compound(diastolic-66, mmHg-65)\n",
      "nmod:of(albuminuria-8, diastolic-66)\n",
      "conj:and(%-11, diastolic-66)\n",
      "case(with-68, compared-67)\n",
      "acl:compared(diastolic-66, with-68)\n",
      "dep(with-68, both-69)\n",
      "conj(with-68, monotherapies-70)\n",
      "punct(induced-3, .-71)\n",
      "\n",
      "Sentence #82 (13 tokens, sentiment: Negative):\n",
      "GFR was reversibly reduced on dual blockade compared with monotherapy and placebo.\n",
      "[Text=GFR CharacterOffsetBegin=12086 CharacterOffsetEnd=12089 PartOfSpeech=NN Lemma=gfr NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=12090 CharacterOffsetEnd=12093 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reversibly CharacterOffsetBegin=12094 CharacterOffsetEnd=12104 PartOfSpeech=RB Lemma=reversibly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduced CharacterOffsetBegin=12105 CharacterOffsetEnd=12112 PartOfSpeech=VBN Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=12113 CharacterOffsetEnd=12115 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dual CharacterOffsetBegin=12116 CharacterOffsetEnd=12120 PartOfSpeech=JJ Lemma=dual NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blockade CharacterOffsetBegin=12121 CharacterOffsetEnd=12129 PartOfSpeech=NN Lemma=blockade NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compared CharacterOffsetBegin=12130 CharacterOffsetEnd=12138 PartOfSpeech=VBN Lemma=compare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=12139 CharacterOffsetEnd=12143 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=monotherapy CharacterOffsetBegin=12144 CharacterOffsetEnd=12155 PartOfSpeech=NN Lemma=monotherapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=12156 CharacterOffsetEnd=12159 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=placebo CharacterOffsetBegin=12160 CharacterOffsetEnd=12167 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12167 CharacterOffsetEnd=12168 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN GFR))\n",
      "    (VP (VBD was)\n",
      "      (ADVP (RB reversibly))\n",
      "      (VP (VBN reduced)\n",
      "        (PP (IN on)\n",
      "          (NP (JJ dual) (NN blockade)))\n",
      "        (PP (VBN compared)\n",
      "          (PP (IN with)\n",
      "            (NP (NN monotherapy)\n",
      "              (CC and)\n",
      "              (NN placebo))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, reduced-4)\n",
      "nsubjpass(reduced-4, GFR-1)\n",
      "auxpass(reduced-4, was-2)\n",
      "advmod(reduced-4, reversibly-3)\n",
      "case(blockade-7, on-5)\n",
      "amod(blockade-7, dual-6)\n",
      "nmod:on(reduced-4, blockade-7)\n",
      "case(monotherapy-10, compared-8)\n",
      "mwe(compared-8, with-9)\n",
      "advcl:compared_with(reduced-4, monotherapy-10)\n",
      "cc(monotherapy-10, and-11)\n",
      "advcl:compared_with(reduced-4, placebo-12)\n",
      "conj:and(monotherapy-10, placebo-12)\n",
      "punct(reduced-4, .-13)\n",
      "\n",
      "Sentence #83 (8 tokens, sentiment: Positive):\n",
      "All treatments were safe and well tolerated.\n",
      "[Text=All CharacterOffsetBegin=12169 CharacterOffsetEnd=12172 PartOfSpeech=DT Lemma=all NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=treatments CharacterOffsetBegin=12173 CharacterOffsetEnd=12183 PartOfSpeech=NNS Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=12184 CharacterOffsetEnd=12188 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=safe CharacterOffsetBegin=12189 CharacterOffsetEnd=12193 PartOfSpeech=JJ Lemma=safe NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=and CharacterOffsetBegin=12194 CharacterOffsetEnd=12197 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=well CharacterOffsetBegin=12198 CharacterOffsetEnd=12202 PartOfSpeech=RB Lemma=well NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=tolerated CharacterOffsetBegin=12203 CharacterOffsetEnd=12212 PartOfSpeech=VBD Lemma=tolerate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12212 CharacterOffsetEnd=12213 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT All) (NNS treatments))\n",
      "    (VP\n",
      "      (VP (VBD were)\n",
      "        (ADJP (JJ safe)))\n",
      "      (CC and)\n",
      "      (ADVP (RB well))\n",
      "      (VP (VBD tolerated)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, safe-4)\n",
      "det(treatments-2, All-1)\n",
      "nsubj(safe-4, treatments-2)\n",
      "nsubj(tolerated-7, treatments-2)\n",
      "cop(safe-4, were-3)\n",
      "cc(safe-4, and-5)\n",
      "advmod(tolerated-7, well-6)\n",
      "conj:and(safe-4, tolerated-7)\n",
      "punct(safe-4, .-8)\n",
      "\n",
      "Sentence #84 (23 tokens, sentiment: Negative):\n",
      "In conclusion, dual blockade of the RAS may offer additional renal and cardiovascular protection in type I diabetic patients with DN.\n",
      "[Text=In CharacterOffsetBegin=12214 CharacterOffsetEnd=12216 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=conclusion CharacterOffsetBegin=12217 CharacterOffsetEnd=12227 PartOfSpeech=NN Lemma=conclusion NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=12227 CharacterOffsetEnd=12228 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dual CharacterOffsetBegin=12229 CharacterOffsetEnd=12233 PartOfSpeech=JJ Lemma=dual NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blockade CharacterOffsetBegin=12234 CharacterOffsetEnd=12242 PartOfSpeech=NN Lemma=blockade NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=12243 CharacterOffsetEnd=12245 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=12246 CharacterOffsetEnd=12249 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=RAS CharacterOffsetBegin=12250 CharacterOffsetEnd=12253 PartOfSpeech=NN Lemma=ras NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=may CharacterOffsetBegin=12254 CharacterOffsetEnd=12257 PartOfSpeech=MD Lemma=may NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=offer CharacterOffsetBegin=12258 CharacterOffsetEnd=12263 PartOfSpeech=VB Lemma=offer NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=additional CharacterOffsetBegin=12264 CharacterOffsetEnd=12274 PartOfSpeech=JJ Lemma=additional NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=12275 CharacterOffsetEnd=12280 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=12281 CharacterOffsetEnd=12284 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cardiovascular CharacterOffsetBegin=12285 CharacterOffsetEnd=12299 PartOfSpeech=JJ Lemma=cardiovascular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=protection CharacterOffsetBegin=12300 CharacterOffsetEnd=12310 PartOfSpeech=NN Lemma=protection NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=12311 CharacterOffsetEnd=12313 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=12314 CharacterOffsetEnd=12318 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=I CharacterOffsetBegin=12319 CharacterOffsetEnd=12320 PartOfSpeech=CD Lemma=i NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=12321 CharacterOffsetEnd=12329 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=12330 CharacterOffsetEnd=12338 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=12339 CharacterOffsetEnd=12343 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DN CharacterOffsetBegin=12344 CharacterOffsetEnd=12346 PartOfSpeech=JJ Lemma=dn NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12346 CharacterOffsetEnd=12347 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (NN conclusion)))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (JJ dual) (NN blockade))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (NN RAS))))\n",
      "    (VP (MD may)\n",
      "      (VP (VB offer)\n",
      "        (NP (JJ additional) (JJ renal)\n",
      "          (CC and)\n",
      "          (JJ cardiovascular) (NN protection))\n",
      "        (PP (IN in)\n",
      "          (NP (NN type)))\n",
      "        (PP\n",
      "          (NP (CD I) (JJ diabetic) (NNS patients))\n",
      "          (IN with)\n",
      "          (ADJP (JJ DN)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, offer-10)\n",
      "case(conclusion-2, In-1)\n",
      "nmod:in(offer-10, conclusion-2)\n",
      "punct(offer-10, ,-3)\n",
      "amod(blockade-5, dual-4)\n",
      "nsubj(offer-10, blockade-5)\n",
      "case(RAS-8, of-6)\n",
      "det(RAS-8, the-7)\n",
      "nmod:of(blockade-5, RAS-8)\n",
      "aux(offer-10, may-9)\n",
      "amod(renal-12, additional-11)\n",
      "dobj(offer-10, renal-12)\n",
      "cc(renal-12, and-13)\n",
      "amod(protection-15, cardiovascular-14)\n",
      "dobj(offer-10, protection-15)\n",
      "conj:and(renal-12, protection-15)\n",
      "case(type-17, in-16)\n",
      "nmod:in(offer-10, type-17)\n",
      "nummod(patients-20, I-18)\n",
      "amod(patients-20, diabetic-19)\n",
      "nmod:with(offer-10, patients-20)\n",
      "case(patients-20, with-21)\n",
      "dep(patients-20, DN-22)\n",
      "punct(offer-10, .-23)\n",
      "\n",
      "Sentence #85 (15 tokens, sentiment: Negative):\n",
      "Eighty-nine patients with essential hypertension and 102 normotensive subjects were included in this study.\n",
      "[Text=Eighty-nine CharacterOffsetBegin=12349 CharacterOffsetEnd=12360 PartOfSpeech=CD Lemma=eighty-nine NamedEntityTag=NUMBER NormalizedNamedEntityTag=89.0 SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=12361 CharacterOffsetEnd=12369 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=12370 CharacterOffsetEnd=12374 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=essential CharacterOffsetBegin=12375 CharacterOffsetEnd=12384 PartOfSpeech=JJ Lemma=essential NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=hypertension CharacterOffsetBegin=12385 CharacterOffsetEnd=12397 PartOfSpeech=NN Lemma=hypertension NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=12398 CharacterOffsetEnd=12401 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=102 CharacterOffsetBegin=12402 CharacterOffsetEnd=12405 PartOfSpeech=CD Lemma=102 NamedEntityTag=NUMBER NormalizedNamedEntityTag=102.0 SentimentClass=Neutral]\n",
      "[Text=normotensive CharacterOffsetBegin=12406 CharacterOffsetEnd=12418 PartOfSpeech=JJ Lemma=normotensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=subjects CharacterOffsetBegin=12419 CharacterOffsetEnd=12427 PartOfSpeech=NNS Lemma=subject NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=12428 CharacterOffsetEnd=12432 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=included CharacterOffsetBegin=12433 CharacterOffsetEnd=12441 PartOfSpeech=VBN Lemma=include NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=12442 CharacterOffsetEnd=12444 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=12445 CharacterOffsetEnd=12449 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=12450 CharacterOffsetEnd=12455 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12455 CharacterOffsetEnd=12456 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (CD Eighty-nine) (NNS patients))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (JJ essential) (NN hypertension))\n",
      "          (CC and)\n",
      "          (NP (CD 102) (JJ normotensive) (NNS subjects)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN included)\n",
      "        (PP (IN in)\n",
      "          (NP (DT this) (NN study)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, included-11)\n",
      "nummod(patients-2, Eighty-nine-1)\n",
      "nsubjpass(included-11, patients-2)\n",
      "case(hypertension-5, with-3)\n",
      "amod(hypertension-5, essential-4)\n",
      "nmod:with(patients-2, hypertension-5)\n",
      "cc(hypertension-5, and-6)\n",
      "nummod(subjects-9, 102-7)\n",
      "amod(subjects-9, normotensive-8)\n",
      "nmod:with(patients-2, subjects-9)\n",
      "conj:and(hypertension-5, subjects-9)\n",
      "auxpass(included-11, were-10)\n",
      "case(study-14, in-12)\n",
      "det(study-14, this-13)\n",
      "nmod:in(included-11, study-14)\n",
      "punct(included-11, .-15)\n",
      "\n",
      "Sentence #86 (18 tokens, sentiment: Negative):\n",
      "All subjects were genotyped by polymerase chain reaction for the insertion/deletion polymorphism of the angiotensin-converting enzyme gene.\n",
      "[Text=All CharacterOffsetBegin=12457 CharacterOffsetEnd=12460 PartOfSpeech=DT Lemma=all NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=subjects CharacterOffsetBegin=12461 CharacterOffsetEnd=12469 PartOfSpeech=NNS Lemma=subject NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=12470 CharacterOffsetEnd=12474 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=genotyped CharacterOffsetBegin=12475 CharacterOffsetEnd=12484 PartOfSpeech=VBN Lemma=genotype NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=12485 CharacterOffsetEnd=12487 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=polymerase CharacterOffsetBegin=12488 CharacterOffsetEnd=12498 PartOfSpeech=NN Lemma=polymerase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chain CharacterOffsetBegin=12499 CharacterOffsetEnd=12504 PartOfSpeech=NN Lemma=chain NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reaction CharacterOffsetBegin=12505 CharacterOffsetEnd=12513 PartOfSpeech=NN Lemma=reaction NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=for CharacterOffsetBegin=12514 CharacterOffsetEnd=12517 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=12518 CharacterOffsetEnd=12521 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=insertion/deletion CharacterOffsetBegin=12522 CharacterOffsetEnd=12540 PartOfSpeech=NN Lemma=insertion/deletion NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=polymorphism CharacterOffsetBegin=12541 CharacterOffsetEnd=12553 PartOfSpeech=NN Lemma=polymorphism NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=12554 CharacterOffsetEnd=12556 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=12557 CharacterOffsetEnd=12560 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin-converting CharacterOffsetBegin=12561 CharacterOffsetEnd=12583 PartOfSpeech=JJ Lemma=angiotensin-converting NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=12584 CharacterOffsetEnd=12590 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=gene CharacterOffsetBegin=12591 CharacterOffsetEnd=12595 PartOfSpeech=NN Lemma=gene NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12595 CharacterOffsetEnd=12596 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT All) (NNS subjects))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN genotyped)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NN polymerase) (NN chain) (NN reaction))\n",
      "            (PP (IN for)\n",
      "              (NP\n",
      "                (NP (DT the) (NN insertion/deletion) (NN polymorphism))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT the) (JJ angiotensin-converting) (NN enzyme) (NN gene)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, genotyped-4)\n",
      "det(subjects-2, All-1)\n",
      "nsubjpass(genotyped-4, subjects-2)\n",
      "auxpass(genotyped-4, were-3)\n",
      "case(reaction-8, by-5)\n",
      "compound(reaction-8, polymerase-6)\n",
      "compound(reaction-8, chain-7)\n",
      "nmod:agent(genotyped-4, reaction-8)\n",
      "case(polymorphism-12, for-9)\n",
      "det(polymorphism-12, the-10)\n",
      "compound(polymorphism-12, insertion/deletion-11)\n",
      "nmod:for(reaction-8, polymorphism-12)\n",
      "case(gene-17, of-13)\n",
      "det(gene-17, the-14)\n",
      "amod(gene-17, angiotensin-converting-15)\n",
      "compound(gene-17, enzyme-16)\n",
      "nmod:of(polymorphism-12, gene-17)\n",
      "punct(genotyped-4, .-18)\n",
      "\n",
      "Sentence #87 (19 tokens, sentiment: Negative):\n",
      "Blood pressure was measured before and after taking Benazepril 10 mg, once daily, for 2 months.\n",
      "[Text=Blood CharacterOffsetBegin=12597 CharacterOffsetEnd=12602 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pressure CharacterOffsetBegin=12603 CharacterOffsetEnd=12611 PartOfSpeech=NN Lemma=pressure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=12612 CharacterOffsetEnd=12615 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=measured CharacterOffsetBegin=12616 CharacterOffsetEnd=12624 PartOfSpeech=VBN Lemma=measure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=before CharacterOffsetBegin=12625 CharacterOffsetEnd=12631 PartOfSpeech=IN Lemma=before NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=12632 CharacterOffsetEnd=12635 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=after CharacterOffsetBegin=12636 CharacterOffsetEnd=12641 PartOfSpeech=IN Lemma=after NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=taking CharacterOffsetBegin=12642 CharacterOffsetEnd=12648 PartOfSpeech=VBG Lemma=take NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=12649 CharacterOffsetEnd=12659 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10 CharacterOffsetBegin=12660 CharacterOffsetEnd=12662 PartOfSpeech=CD Lemma=10 NamedEntityTag=NUMBER NormalizedNamedEntityTag=10.0 SentimentClass=Positive]\n",
      "[Text=mg CharacterOffsetBegin=12663 CharacterOffsetEnd=12665 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=12665 CharacterOffsetEnd=12666 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=once CharacterOffsetBegin=12667 CharacterOffsetEnd=12671 PartOfSpeech=RB Lemma=once NamedEntityTag=DATE NormalizedNamedEntityTag=PAST_REF Timex=<TIMEX3 tid=\"t14\" type=\"DATE\" value=\"PAST_REF\">once</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=12672 CharacterOffsetEnd=12677 PartOfSpeech=RB Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t15\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=12677 CharacterOffsetEnd=12678 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=12679 CharacterOffsetEnd=12682 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=2 CharacterOffsetBegin=12683 CharacterOffsetEnd=12684 PartOfSpeech=CD Lemma=2 NamedEntityTag=DURATION NormalizedNamedEntityTag=P2M Timex=<TIMEX3 tid=\"t16\" type=\"DURATION\" value=\"P2M\">2 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=months CharacterOffsetBegin=12685 CharacterOffsetEnd=12691 PartOfSpeech=NNS Lemma=month NamedEntityTag=DURATION NormalizedNamedEntityTag=P2M Timex=<TIMEX3 tid=\"t16\" type=\"DURATION\" value=\"P2M\">2 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12691 CharacterOffsetEnd=12692 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Blood) (NN pressure))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN measured)\n",
      "        (PP (IN before)\n",
      "          (CC and)\n",
      "          (IN after)\n",
      "          (S\n",
      "            (VP (VBG taking)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (NNP Benazepril) (CD 10) (NN mg))\n",
      "                  (, ,)\n",
      "                  (ADVP (RB once) (RB daily))\n",
      "                  (, ,))\n",
      "                (PP (IN for)\n",
      "                  (NP (CD 2) (NNS months)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, measured-4)\n",
      "compound(pressure-2, Blood-1)\n",
      "nsubjpass(measured-4, pressure-2)\n",
      "auxpass(measured-4, was-3)\n",
      "mark(taking-8, before-5)\n",
      "cc(before-5, and-6)\n",
      "conj:and(before-5, after-7)\n",
      "mark(taking-8, after-7)\n",
      "advcl:before(measured-4, taking-8)\n",
      "compound(mg-11, Benazepril-9)\n",
      "nummod(mg-11, 10-10)\n",
      "dobj(taking-8, mg-11)\n",
      "punct(mg-11, ,-12)\n",
      "advmod(daily-14, once-13)\n",
      "advmod(mg-11, daily-14)\n",
      "punct(mg-11, ,-15)\n",
      "case(months-18, for-16)\n",
      "nummod(months-18, 2-17)\n",
      "nmod:for(mg-11, months-18)\n",
      "punct(measured-4, .-19)\n",
      "\n",
      "Sentence #88 (18 tokens, sentiment: Negative):\n",
      "Uninephrectomized Spraque-Dawley rats were used to induce diabetes by intraperitoneal injection of streptozotocin (65 mg.kg-1).\n",
      "[Text=Uninephrectomized CharacterOffsetBegin=12694 CharacterOffsetEnd=12711 PartOfSpeech=JJ Lemma=uninephrectomized NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Spraque-Dawley CharacterOffsetBegin=12712 CharacterOffsetEnd=12726 PartOfSpeech=NN Lemma=spraque-dawley NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rats CharacterOffsetBegin=12727 CharacterOffsetEnd=12731 PartOfSpeech=NNS Lemma=rat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=12732 CharacterOffsetEnd=12736 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=12737 CharacterOffsetEnd=12741 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=12742 CharacterOffsetEnd=12744 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=induce CharacterOffsetBegin=12745 CharacterOffsetEnd=12751 PartOfSpeech=VB Lemma=induce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetes CharacterOffsetBegin=12752 CharacterOffsetEnd=12760 PartOfSpeech=NN Lemma=diabetes NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=12761 CharacterOffsetEnd=12763 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=intraperitoneal CharacterOffsetBegin=12764 CharacterOffsetEnd=12779 PartOfSpeech=JJ Lemma=intraperitoneal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=injection CharacterOffsetBegin=12780 CharacterOffsetEnd=12789 PartOfSpeech=NN Lemma=injection NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=12790 CharacterOffsetEnd=12792 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=streptozotocin CharacterOffsetBegin=12793 CharacterOffsetEnd=12807 PartOfSpeech=NN Lemma=streptozotocin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=12808 CharacterOffsetEnd=12809 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=65 CharacterOffsetBegin=12809 CharacterOffsetEnd=12811 PartOfSpeech=CD Lemma=65 NamedEntityTag=NUMBER NormalizedNamedEntityTag=65.0 SentimentClass=Neutral]\n",
      "[Text=mg.kg-1 CharacterOffsetBegin=12812 CharacterOffsetEnd=12819 PartOfSpeech=NN Lemma=mg.kg-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=12819 CharacterOffsetEnd=12820 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12820 CharacterOffsetEnd=12821 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (JJ Uninephrectomized) (NN Spraque-Dawley) (NNS rats))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN used)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB induce)\n",
      "              (NP (NN diabetes))\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (JJ intraperitoneal) (NN injection))\n",
      "                  (PP (IN of)\n",
      "                    (NP\n",
      "                      (NP (NN streptozotocin))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (CD 65) (NN mg.kg-1))\n",
      "                        (-RRB- -RRB-)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, used-5)\n",
      "amod(rats-3, Uninephrectomized-1)\n",
      "compound(rats-3, Spraque-Dawley-2)\n",
      "nsubjpass(used-5, rats-3)\n",
      "nsubj:xsubj(induce-7, rats-3)\n",
      "auxpass(used-5, were-4)\n",
      "mark(induce-7, to-6)\n",
      "xcomp(used-5, induce-7)\n",
      "dobj(induce-7, diabetes-8)\n",
      "case(injection-11, by-9)\n",
      "amod(injection-11, intraperitoneal-10)\n",
      "nmod:by(induce-7, injection-11)\n",
      "case(streptozotocin-13, of-12)\n",
      "nmod:of(injection-11, streptozotocin-13)\n",
      "punct(mg.kg-1-16, -LRB--14)\n",
      "nummod(mg.kg-1-16, 65-15)\n",
      "appos(streptozotocin-13, mg.kg-1-16)\n",
      "punct(mg.kg-1-16, -RRB--17)\n",
      "punct(used-5, .-18)\n",
      "\n",
      "Sentence #89 (23 tokens, sentiment: Negative):\n",
      "Benazepril (10 mg.kg-1) was given daily by gavage from the next day of the induction to diabetes for 12 weeks.\n",
      "[Text=Benazepril CharacterOffsetBegin=12822 CharacterOffsetEnd=12832 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=12833 CharacterOffsetEnd=12834 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10 CharacterOffsetBegin=12834 CharacterOffsetEnd=12836 PartOfSpeech=CD Lemma=10 NamedEntityTag=NUMBER NormalizedNamedEntityTag=10.0 SentimentClass=Positive]\n",
      "[Text=mg.kg-1 CharacterOffsetBegin=12837 CharacterOffsetEnd=12844 PartOfSpeech=NN Lemma=mg.kg-1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=12844 CharacterOffsetEnd=12845 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=12846 CharacterOffsetEnd=12849 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=given CharacterOffsetBegin=12850 CharacterOffsetEnd=12855 PartOfSpeech=VBN Lemma=give NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=12856 CharacterOffsetEnd=12861 PartOfSpeech=RB Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t17\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=12862 CharacterOffsetEnd=12864 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=gavage CharacterOffsetBegin=12865 CharacterOffsetEnd=12871 PartOfSpeech=NN Lemma=gavage NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=from CharacterOffsetBegin=12872 CharacterOffsetEnd=12876 PartOfSpeech=IN Lemma=from NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=12877 CharacterOffsetEnd=12880 PartOfSpeech=DT Lemma=the NamedEntityTag=DATE NormalizedNamedEntityTag=NEXT_IMMEDIATE P1D Timex=<TIMEX3 alt_value=\"NEXT_IMMEDIATE P1D\" anchorTimeID=\"t0\" temporalFunction=\"true\" tid=\"t18\" type=\"DATE\" valueFromFunction=\"tf0\">the next day</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=next CharacterOffsetBegin=12881 CharacterOffsetEnd=12885 PartOfSpeech=JJ Lemma=next NamedEntityTag=DATE NormalizedNamedEntityTag=NEXT_IMMEDIATE P1D Timex=<TIMEX3 alt_value=\"NEXT_IMMEDIATE P1D\" anchorTimeID=\"t0\" temporalFunction=\"true\" tid=\"t18\" type=\"DATE\" valueFromFunction=\"tf0\">the next day</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=day CharacterOffsetBegin=12886 CharacterOffsetEnd=12889 PartOfSpeech=NN Lemma=day NamedEntityTag=DATE NormalizedNamedEntityTag=NEXT_IMMEDIATE P1D Timex=<TIMEX3 alt_value=\"NEXT_IMMEDIATE P1D\" anchorTimeID=\"t0\" temporalFunction=\"true\" tid=\"t18\" type=\"DATE\" valueFromFunction=\"tf0\">the next day</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=12890 CharacterOffsetEnd=12892 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=12893 CharacterOffsetEnd=12896 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=induction CharacterOffsetBegin=12897 CharacterOffsetEnd=12906 PartOfSpeech=NN Lemma=induction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=12907 CharacterOffsetEnd=12909 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetes CharacterOffsetBegin=12910 CharacterOffsetEnd=12918 PartOfSpeech=NN Lemma=diabetes NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=12919 CharacterOffsetEnd=12922 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=12 CharacterOffsetBegin=12923 CharacterOffsetEnd=12925 PartOfSpeech=CD Lemma=12 NamedEntityTag=DURATION NormalizedNamedEntityTag=P12W Timex=<TIMEX3 tid=\"t19\" type=\"DURATION\" value=\"P12W\">12 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=weeks CharacterOffsetBegin=12926 CharacterOffsetEnd=12931 PartOfSpeech=NNS Lemma=week NamedEntityTag=DURATION NormalizedNamedEntityTag=P12W Timex=<TIMEX3 tid=\"t19\" type=\"DURATION\" value=\"P12W\">12 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=12931 CharacterOffsetEnd=12932 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN Benazepril))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 10) (NN mg.kg-1))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN given)\n",
      "        (ADVP (RB daily))\n",
      "        (PP (IN by)\n",
      "          (NP (NN gavage)))\n",
      "        (PP (IN from)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ next) (NN day))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (NN induction)))))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (NN diabetes))\n",
      "            (PP (IN for)\n",
      "              (NP (CD 12) (NNS weeks)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, given-7)\n",
      "nsubjpass(given-7, Benazepril-1)\n",
      "punct(mg.kg-1-4, -LRB--2)\n",
      "nummod(mg.kg-1-4, 10-3)\n",
      "appos(Benazepril-1, mg.kg-1-4)\n",
      "punct(mg.kg-1-4, -RRB--5)\n",
      "auxpass(given-7, was-6)\n",
      "advmod(given-7, daily-8)\n",
      "case(gavage-10, by-9)\n",
      "nmod:agent(given-7, gavage-10)\n",
      "case(day-14, from-11)\n",
      "det(day-14, the-12)\n",
      "amod(day-14, next-13)\n",
      "nmod:from(given-7, day-14)\n",
      "case(induction-17, of-15)\n",
      "det(induction-17, the-16)\n",
      "nmod:of(day-14, induction-17)\n",
      "case(diabetes-19, to-18)\n",
      "nmod:to(given-7, diabetes-19)\n",
      "case(weeks-22, for-20)\n",
      "nummod(weeks-22, 12-21)\n",
      "nmod:for(diabetes-19, weeks-22)\n",
      "punct(given-7, .-23)\n",
      "\n",
      "Sentence #90 (17 tokens, sentiment: Negative):\n",
      "Apoptosis was evaluated by means of terminal-deoxynucleotidyl transferase mediated d-UTP nick end labeling (TUNEL).\n",
      "[Text=Apoptosis CharacterOffsetBegin=12933 CharacterOffsetEnd=12942 PartOfSpeech=NN Lemma=apoptosis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=12943 CharacterOffsetEnd=12946 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=evaluated CharacterOffsetBegin=12947 CharacterOffsetEnd=12956 PartOfSpeech=VBN Lemma=evaluate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=12957 CharacterOffsetEnd=12959 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=means CharacterOffsetBegin=12960 CharacterOffsetEnd=12965 PartOfSpeech=NNS Lemma=means NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=12966 CharacterOffsetEnd=12968 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=terminal-deoxynucleotidyl CharacterOffsetBegin=12969 CharacterOffsetEnd=12994 PartOfSpeech=JJ Lemma=terminal-deoxynucleotidyl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=transferase CharacterOffsetBegin=12995 CharacterOffsetEnd=13006 PartOfSpeech=NN Lemma=transferase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mediated CharacterOffsetBegin=13007 CharacterOffsetEnd=13015 PartOfSpeech=VBN Lemma=mediate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=d-UTP CharacterOffsetBegin=13016 CharacterOffsetEnd=13021 PartOfSpeech=NN Lemma=d-utp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nick CharacterOffsetBegin=13022 CharacterOffsetEnd=13026 PartOfSpeech=NN Lemma=nick NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=end CharacterOffsetBegin=13027 CharacterOffsetEnd=13030 PartOfSpeech=NN Lemma=end NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=labeling CharacterOffsetBegin=13031 CharacterOffsetEnd=13039 PartOfSpeech=NN Lemma=labeling NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=13040 CharacterOffsetEnd=13041 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=TUNEL CharacterOffsetBegin=13041 CharacterOffsetEnd=13046 PartOfSpeech=NN Lemma=tunel NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=13046 CharacterOffsetEnd=13047 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=13047 CharacterOffsetEnd=13048 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Apoptosis))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN evaluated)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (NNS means))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (JJ terminal-deoxynucleotidyl) (NN transferase))\n",
      "                (VP (VBN mediated)\n",
      "                  (NP\n",
      "                    (NP (NN d-UTP) (NN nick) (NN end) (NN labeling))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN TUNEL))\n",
      "                      (-RRB- -RRB-))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, evaluated-3)\n",
      "nsubjpass(evaluated-3, Apoptosis-1)\n",
      "auxpass(evaluated-3, was-2)\n",
      "case(transferase-8, by-4)\n",
      "mwe(by-4, means-5)\n",
      "mwe(by-4, of-6)\n",
      "amod(transferase-8, terminal-deoxynucleotidyl-7)\n",
      "nmod:agent(evaluated-3, transferase-8)\n",
      "acl(transferase-8, mediated-9)\n",
      "compound(labeling-13, d-UTP-10)\n",
      "compound(labeling-13, nick-11)\n",
      "compound(labeling-13, end-12)\n",
      "dobj(mediated-9, labeling-13)\n",
      "punct(TUNEL-15, -LRB--14)\n",
      "appos(labeling-13, TUNEL-15)\n",
      "punct(TUNEL-15, -RRB--16)\n",
      "punct(evaluated-3, .-17)\n",
      "\n",
      "Sentence #91 (15 tokens, sentiment: Negative):\n",
      "Flow cytometry and immunohistochemistry were used to detect the expression of Fas and Fas-L.\n",
      "[Text=Flow CharacterOffsetBegin=13049 CharacterOffsetEnd=13053 PartOfSpeech=NN Lemma=flow NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cytometry CharacterOffsetBegin=13054 CharacterOffsetEnd=13063 PartOfSpeech=NN Lemma=cytometry NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=13064 CharacterOffsetEnd=13067 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=immunohistochemistry CharacterOffsetBegin=13068 CharacterOffsetEnd=13088 PartOfSpeech=NN Lemma=immunohistochemistry NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=13089 CharacterOffsetEnd=13093 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=13094 CharacterOffsetEnd=13098 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=13099 CharacterOffsetEnd=13101 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=detect CharacterOffsetBegin=13102 CharacterOffsetEnd=13108 PartOfSpeech=VB Lemma=detect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=13109 CharacterOffsetEnd=13112 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=13113 CharacterOffsetEnd=13123 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=13124 CharacterOffsetEnd=13126 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Fas CharacterOffsetBegin=13127 CharacterOffsetEnd=13130 PartOfSpeech=NN Lemma=fas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=13131 CharacterOffsetEnd=13134 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Fas-L CharacterOffsetBegin=13135 CharacterOffsetEnd=13140 PartOfSpeech=NN Lemma=fas-l NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=13140 CharacterOffsetEnd=13141 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN Flow) (NN cytometry))\n",
      "      (CC and)\n",
      "      (NP (NN immunohistochemistry)))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN used)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB detect)\n",
      "              (NP\n",
      "                (NP (DT the) (NN expression))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN Fas)\n",
      "                    (CC and)\n",
      "                    (NN Fas-L)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, used-6)\n",
      "compound(cytometry-2, Flow-1)\n",
      "nsubjpass(used-6, cytometry-2)\n",
      "nsubj:xsubj(detect-8, cytometry-2)\n",
      "cc(cytometry-2, and-3)\n",
      "conj:and(cytometry-2, immunohistochemistry-4)\n",
      "nsubjpass(used-6, immunohistochemistry-4)\n",
      "nsubj:xsubj(detect-8, immunohistochemistry-4)\n",
      "auxpass(used-6, were-5)\n",
      "mark(detect-8, to-7)\n",
      "xcomp(used-6, detect-8)\n",
      "det(expression-10, the-9)\n",
      "dobj(detect-8, expression-10)\n",
      "case(Fas-12, of-11)\n",
      "nmod:of(expression-10, Fas-12)\n",
      "cc(Fas-12, and-13)\n",
      "nmod:of(expression-10, Fas-L-14)\n",
      "conj:and(Fas-12, Fas-L-14)\n",
      "punct(used-6, .-15)\n",
      "\n",
      "Sentence #92 (32 tokens, sentiment: Negative):\n",
      "The angiotensin converting enzyme (ACE) inhibitors are widely used in the management of essential hypertension, stable chronic heart failure, myocardial infarction (MI) and diabetic nephropathy.\n",
      "[Text=The CharacterOffsetBegin=13143 CharacterOffsetEnd=13146 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin CharacterOffsetBegin=13147 CharacterOffsetEnd=13158 PartOfSpeech=NN Lemma=angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=converting CharacterOffsetBegin=13159 CharacterOffsetEnd=13169 PartOfSpeech=VBG Lemma=convert NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=13170 CharacterOffsetEnd=13176 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=13177 CharacterOffsetEnd=13178 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=13178 CharacterOffsetEnd=13181 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=13181 CharacterOffsetEnd=13182 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=13183 CharacterOffsetEnd=13193 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=13194 CharacterOffsetEnd=13197 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=widely CharacterOffsetBegin=13198 CharacterOffsetEnd=13204 PartOfSpeech=RB Lemma=widely NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=13205 CharacterOffsetEnd=13209 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=13210 CharacterOffsetEnd=13212 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=13213 CharacterOffsetEnd=13216 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=management CharacterOffsetBegin=13217 CharacterOffsetEnd=13227 PartOfSpeech=NN Lemma=management NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=13228 CharacterOffsetEnd=13230 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=essential CharacterOffsetBegin=13231 CharacterOffsetEnd=13240 PartOfSpeech=JJ Lemma=essential NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=hypertension CharacterOffsetBegin=13241 CharacterOffsetEnd=13253 PartOfSpeech=NN Lemma=hypertension NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13253 CharacterOffsetEnd=13254 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=stable CharacterOffsetBegin=13255 CharacterOffsetEnd=13261 PartOfSpeech=JJ Lemma=stable NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chronic CharacterOffsetBegin=13262 CharacterOffsetEnd=13269 PartOfSpeech=JJ Lemma=chronic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=heart CharacterOffsetBegin=13270 CharacterOffsetEnd=13275 PartOfSpeech=NN Lemma=heart NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=failure CharacterOffsetBegin=13276 CharacterOffsetEnd=13283 PartOfSpeech=NN Lemma=failure NamedEntityTag=O SentimentClass=Very negative]\n",
      "[Text=, CharacterOffsetBegin=13283 CharacterOffsetEnd=13284 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=myocardial CharacterOffsetBegin=13285 CharacterOffsetEnd=13295 PartOfSpeech=JJ Lemma=myocardial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=infarction CharacterOffsetBegin=13296 CharacterOffsetEnd=13306 PartOfSpeech=NN Lemma=infarction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=13307 CharacterOffsetEnd=13308 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=MI CharacterOffsetBegin=13308 CharacterOffsetEnd=13310 PartOfSpeech=NN Lemma=mi NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=13310 CharacterOffsetEnd=13311 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=13312 CharacterOffsetEnd=13315 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=13316 CharacterOffsetEnd=13324 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephropathy CharacterOffsetBegin=13325 CharacterOffsetEnd=13336 PartOfSpeech=NN Lemma=nephropathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=13336 CharacterOffsetEnd=13337 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN angiotensin))\n",
      "      (VP (VBG converting)\n",
      "        (NP (NN enzyme))))\n",
      "    (PRN (-LRB- -LRB-)\n",
      "      (NP (NN ACE))\n",
      "      (-RRB- -RRB-))\n",
      "    (NP (NNS inhibitors))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB widely))\n",
      "      (VP (VBN used)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (NN management))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (JJ essential) (NN hypertension))\n",
      "                (, ,)\n",
      "                (NP (JJ stable) (JJ chronic) (NN heart) (NN failure))\n",
      "                (, ,)\n",
      "                (NP (JJ myocardial) (NN infarction) (-LRB- -LRB-) (NN MI) (-RRB- -RRB-))\n",
      "                (CC and)\n",
      "                (NP (JJ diabetic) (NN nephropathy))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, used-11)\n",
      "det(angiotensin-2, The-1)\n",
      "nsubjpass(used-11, angiotensin-2)\n",
      "acl(angiotensin-2, converting-3)\n",
      "dobj(converting-3, enzyme-4)\n",
      "punct(ACE-6, -LRB--5)\n",
      "dep(used-11, ACE-6)\n",
      "punct(ACE-6, -RRB--7)\n",
      "nsubjpass(used-11, inhibitors-8)\n",
      "auxpass(used-11, are-9)\n",
      "advmod(used-11, widely-10)\n",
      "case(management-14, in-12)\n",
      "det(management-14, the-13)\n",
      "nmod:in(used-11, management-14)\n",
      "case(hypertension-17, of-15)\n",
      "amod(hypertension-17, essential-16)\n",
      "nmod:of(management-14, hypertension-17)\n",
      "punct(hypertension-17, ,-18)\n",
      "amod(failure-22, stable-19)\n",
      "amod(failure-22, chronic-20)\n",
      "compound(failure-22, heart-21)\n",
      "nmod:of(management-14, failure-22)\n",
      "conj:and(hypertension-17, failure-22)\n",
      "punct(hypertension-17, ,-23)\n",
      "amod(MI-27, myocardial-24)\n",
      "compound(MI-27, infarction-25)\n",
      "punct(MI-27, -LRB--26)\n",
      "nmod:of(management-14, MI-27)\n",
      "conj:and(hypertension-17, MI-27)\n",
      "punct(MI-27, -RRB--28)\n",
      "cc(hypertension-17, and-29)\n",
      "amod(nephropathy-31, diabetic-30)\n",
      "nmod:of(management-14, nephropathy-31)\n",
      "conj:and(hypertension-17, nephropathy-31)\n",
      "punct(used-11, .-32)\n",
      "\n",
      "Sentence #93 (41 tokens, sentiment: Negative):\n",
      "There is an increasing number of new agents to add to the nine ACE inhibitors (benazepril, cilazapril, delapril, fosinopril, lisinopril, pentopril, perindopril, quinapril and ramipril) reviewed in this journal in 1990.\n",
      "[Text=There CharacterOffsetBegin=13338 CharacterOffsetEnd=13343 PartOfSpeech=EX Lemma=there NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=13344 CharacterOffsetEnd=13346 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=13347 CharacterOffsetEnd=13349 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=increasing CharacterOffsetBegin=13350 CharacterOffsetEnd=13360 PartOfSpeech=VBG Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=number CharacterOffsetBegin=13361 CharacterOffsetEnd=13367 PartOfSpeech=NN Lemma=number NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=13368 CharacterOffsetEnd=13370 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=new CharacterOffsetBegin=13371 CharacterOffsetEnd=13374 PartOfSpeech=JJ Lemma=new NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=agents CharacterOffsetBegin=13375 CharacterOffsetEnd=13381 PartOfSpeech=NNS Lemma=agent NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=13382 CharacterOffsetEnd=13384 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=add CharacterOffsetBegin=13385 CharacterOffsetEnd=13388 PartOfSpeech=VB Lemma=add NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=to CharacterOffsetBegin=13389 CharacterOffsetEnd=13391 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=13392 CharacterOffsetEnd=13395 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nine CharacterOffsetBegin=13396 CharacterOffsetEnd=13400 PartOfSpeech=CD Lemma=nine NamedEntityTag=NUMBER NormalizedNamedEntityTag=9.0 SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=13401 CharacterOffsetEnd=13404 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=13405 CharacterOffsetEnd=13415 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=13416 CharacterOffsetEnd=13417 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=13417 CharacterOffsetEnd=13427 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13427 CharacterOffsetEnd=13428 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cilazapril CharacterOffsetBegin=13429 CharacterOffsetEnd=13439 PartOfSpeech=NN Lemma=cilazapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13439 CharacterOffsetEnd=13440 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=delapril CharacterOffsetBegin=13441 CharacterOffsetEnd=13449 PartOfSpeech=NN Lemma=delapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13449 CharacterOffsetEnd=13450 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=fosinopril CharacterOffsetBegin=13451 CharacterOffsetEnd=13461 PartOfSpeech=NN Lemma=fosinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13461 CharacterOffsetEnd=13462 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=13463 CharacterOffsetEnd=13473 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13473 CharacterOffsetEnd=13474 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pentopril CharacterOffsetBegin=13475 CharacterOffsetEnd=13484 PartOfSpeech=NN Lemma=pentopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13484 CharacterOffsetEnd=13485 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=perindopril CharacterOffsetBegin=13486 CharacterOffsetEnd=13497 PartOfSpeech=NN Lemma=perindopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13497 CharacterOffsetEnd=13498 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=quinapril CharacterOffsetBegin=13499 CharacterOffsetEnd=13508 PartOfSpeech=NN Lemma=quinapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=13509 CharacterOffsetEnd=13512 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ramipril CharacterOffsetBegin=13513 CharacterOffsetEnd=13521 PartOfSpeech=NN Lemma=ramipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=13521 CharacterOffsetEnd=13522 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reviewed CharacterOffsetBegin=13523 CharacterOffsetEnd=13531 PartOfSpeech=VBN Lemma=review NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=13532 CharacterOffsetEnd=13534 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=13535 CharacterOffsetEnd=13539 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=journal CharacterOffsetBegin=13540 CharacterOffsetEnd=13547 PartOfSpeech=NN Lemma=journal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=13548 CharacterOffsetEnd=13550 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1990 CharacterOffsetBegin=13551 CharacterOffsetEnd=13555 PartOfSpeech=CD Lemma=1990 NamedEntityTag=DATE NormalizedNamedEntityTag=1990 Timex=<TIMEX3 tid=\"t20\" type=\"DATE\" value=\"1990\">1990</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=13555 CharacterOffsetEnd=13556 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (EX There))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT an) (VBG increasing) (NN number))\n",
      "        (PP (IN of)\n",
      "          (NP (JJ new) (NNS agents)))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB add)\n",
      "              (PP (TO to)\n",
      "                (NP\n",
      "                  (NP (DT the) (CD nine) (NN ACE) (NNS inhibitors))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (NP (NN benazepril))\n",
      "                      (, ,)\n",
      "                      (NP (NN cilazapril) (, ,) (NN delapril) (, ,) (NN fosinopril) (, ,) (NN lisinopril) (, ,) (NN pentopril) (, ,) (NN perindopril) (, ,) (NN quinapril)\n",
      "                        (CC and)\n",
      "                        (NN ramipril)))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (VP (VBN reviewed)\n",
      "                    (PP (IN in)\n",
      "                      (NP\n",
      "                        (NP (DT this) (NN journal))\n",
      "                        (PP (IN in)\n",
      "                          (NP (CD 1990)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, is-2)\n",
      "expl(is-2, There-1)\n",
      "det(number-5, an-3)\n",
      "amod(number-5, increasing-4)\n",
      "nsubj(is-2, number-5)\n",
      "case(agents-8, of-6)\n",
      "amod(agents-8, new-7)\n",
      "nmod:of(number-5, agents-8)\n",
      "mark(add-10, to-9)\n",
      "acl:to(number-5, add-10)\n",
      "case(inhibitors-15, to-11)\n",
      "det(inhibitors-15, the-12)\n",
      "nummod(inhibitors-15, nine-13)\n",
      "compound(inhibitors-15, ACE-14)\n",
      "nmod:to(add-10, inhibitors-15)\n",
      "punct(benazepril-17, -LRB--16)\n",
      "dep(inhibitors-15, benazepril-17)\n",
      "punct(benazepril-17, ,-18)\n",
      "appos(benazepril-17, cilazapril-19)\n",
      "punct(cilazapril-19, ,-20)\n",
      "appos(benazepril-17, delapril-21)\n",
      "conj:and(cilazapril-19, delapril-21)\n",
      "punct(cilazapril-19, ,-22)\n",
      "appos(benazepril-17, fosinopril-23)\n",
      "conj:and(cilazapril-19, fosinopril-23)\n",
      "punct(cilazapril-19, ,-24)\n",
      "appos(benazepril-17, lisinopril-25)\n",
      "conj:and(cilazapril-19, lisinopril-25)\n",
      "punct(cilazapril-19, ,-26)\n",
      "appos(benazepril-17, pentopril-27)\n",
      "conj:and(cilazapril-19, pentopril-27)\n",
      "punct(cilazapril-19, ,-28)\n",
      "appos(benazepril-17, perindopril-29)\n",
      "conj:and(cilazapril-19, perindopril-29)\n",
      "punct(cilazapril-19, ,-30)\n",
      "appos(benazepril-17, quinapril-31)\n",
      "conj:and(cilazapril-19, quinapril-31)\n",
      "cc(cilazapril-19, and-32)\n",
      "appos(benazepril-17, ramipril-33)\n",
      "conj:and(cilazapril-19, ramipril-33)\n",
      "punct(benazepril-17, -RRB--34)\n",
      "acl(inhibitors-15, reviewed-35)\n",
      "case(journal-38, in-36)\n",
      "det(journal-38, this-37)\n",
      "nmod:in(reviewed-35, journal-38)\n",
      "case(1990-40, in-39)\n",
      "nmod:in(journal-38, 1990-40)\n",
      "punct(is-2, .-41)\n",
      "\n",
      "Sentence #94 (25 tokens, sentiment: Negative):\n",
      "The pharmacokinetic properties of five newer ACE inhibitors (trandolapril, moexipril, spirapril, temocapril and imidapril) are reviewed in this update.\n",
      "[Text=The CharacterOffsetBegin=13557 CharacterOffsetEnd=13560 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pharmacokinetic CharacterOffsetBegin=13561 CharacterOffsetEnd=13576 PartOfSpeech=JJ Lemma=pharmacokinetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=properties CharacterOffsetBegin=13577 CharacterOffsetEnd=13587 PartOfSpeech=NNS Lemma=property NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=13588 CharacterOffsetEnd=13590 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=five CharacterOffsetBegin=13591 CharacterOffsetEnd=13595 PartOfSpeech=CD Lemma=five NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=newer CharacterOffsetBegin=13596 CharacterOffsetEnd=13601 PartOfSpeech=JJR Lemma=newer NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=13602 CharacterOffsetEnd=13605 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=13606 CharacterOffsetEnd=13616 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=13617 CharacterOffsetEnd=13618 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trandolapril CharacterOffsetBegin=13618 CharacterOffsetEnd=13630 PartOfSpeech=NN Lemma=trandolapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13630 CharacterOffsetEnd=13631 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=moexipril CharacterOffsetBegin=13632 CharacterOffsetEnd=13641 PartOfSpeech=NN Lemma=moexipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13641 CharacterOffsetEnd=13642 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=spirapril CharacterOffsetBegin=13643 CharacterOffsetEnd=13652 PartOfSpeech=NN Lemma=spirapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=13652 CharacterOffsetEnd=13653 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=temocapril CharacterOffsetBegin=13654 CharacterOffsetEnd=13664 PartOfSpeech=NN Lemma=temocapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=13665 CharacterOffsetEnd=13668 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=imidapril CharacterOffsetBegin=13669 CharacterOffsetEnd=13678 PartOfSpeech=NN Lemma=imidapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=13678 CharacterOffsetEnd=13679 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=13680 CharacterOffsetEnd=13683 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reviewed CharacterOffsetBegin=13684 CharacterOffsetEnd=13692 PartOfSpeech=VBN Lemma=review NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=13693 CharacterOffsetEnd=13695 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=13696 CharacterOffsetEnd=13700 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=update CharacterOffsetBegin=13701 CharacterOffsetEnd=13707 PartOfSpeech=VBP Lemma=update NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=13707 CharacterOffsetEnd=13708 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP (DT The) (JJ pharmacokinetic) (NNS properties))\n",
      "        (PP (IN of)\n",
      "          (NP (CD five) (JJR newer) (NN ACE) (NNS inhibitors))))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (NN trandolapril))\n",
      "          (, ,)\n",
      "          (NP (NN moexipril) (, ,) (NN spirapril) (, ,) (NN temocapril)\n",
      "            (CC and)\n",
      "            (NN imidapril)))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN reviewed)\n",
      "        (SBAR (IN in)\n",
      "          (S\n",
      "            (NP (DT this))\n",
      "            (VP (VBP update))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, reviewed-21)\n",
      "det(properties-3, The-1)\n",
      "amod(properties-3, pharmacokinetic-2)\n",
      "nsubjpass(reviewed-21, properties-3)\n",
      "case(inhibitors-8, of-4)\n",
      "nummod(inhibitors-8, five-5)\n",
      "amod(inhibitors-8, newer-6)\n",
      "compound(inhibitors-8, ACE-7)\n",
      "nmod:of(properties-3, inhibitors-8)\n",
      "punct(trandolapril-10, -LRB--9)\n",
      "dep(properties-3, trandolapril-10)\n",
      "punct(trandolapril-10, ,-11)\n",
      "appos(trandolapril-10, moexipril-12)\n",
      "punct(moexipril-12, ,-13)\n",
      "appos(trandolapril-10, spirapril-14)\n",
      "conj:and(moexipril-12, spirapril-14)\n",
      "punct(moexipril-12, ,-15)\n",
      "appos(trandolapril-10, temocapril-16)\n",
      "conj:and(moexipril-12, temocapril-16)\n",
      "cc(moexipril-12, and-17)\n",
      "appos(trandolapril-10, imidapril-18)\n",
      "conj:and(moexipril-12, imidapril-18)\n",
      "punct(trandolapril-10, -RRB--19)\n",
      "auxpass(reviewed-21, are-20)\n",
      "mark(update-24, in-22)\n",
      "nsubj(update-24, this-23)\n",
      "advcl:in(reviewed-21, update-24)\n",
      "punct(reviewed-21, .-25)\n",
      "\n",
      "Sentence #95 (23 tokens, sentiment: Negative):\n",
      "All of these new agents are characterised by having a carboxyl functional groups and requiring hepatic activation to form pharmacologically active metabolites.\n",
      "[Text=All CharacterOffsetBegin=13709 CharacterOffsetEnd=13712 PartOfSpeech=DT Lemma=all NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=13713 CharacterOffsetEnd=13715 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=these CharacterOffsetBegin=13716 CharacterOffsetEnd=13721 PartOfSpeech=DT Lemma=these NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=new CharacterOffsetBegin=13722 CharacterOffsetEnd=13725 PartOfSpeech=JJ Lemma=new NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=agents CharacterOffsetBegin=13726 CharacterOffsetEnd=13732 PartOfSpeech=NNS Lemma=agent NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=13733 CharacterOffsetEnd=13736 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=characterised CharacterOffsetBegin=13737 CharacterOffsetEnd=13750 PartOfSpeech=VBN Lemma=characterise NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=13751 CharacterOffsetEnd=13753 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=having CharacterOffsetBegin=13754 CharacterOffsetEnd=13760 PartOfSpeech=VBG Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=13761 CharacterOffsetEnd=13762 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=carboxyl CharacterOffsetBegin=13763 CharacterOffsetEnd=13771 PartOfSpeech=NN Lemma=carboxyl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=functional CharacterOffsetBegin=13772 CharacterOffsetEnd=13782 PartOfSpeech=JJ Lemma=functional NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=groups CharacterOffsetBegin=13783 CharacterOffsetEnd=13789 PartOfSpeech=NNS Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=13790 CharacterOffsetEnd=13793 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=requiring CharacterOffsetBegin=13794 CharacterOffsetEnd=13803 PartOfSpeech=VBG Lemma=require NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hepatic CharacterOffsetBegin=13804 CharacterOffsetEnd=13811 PartOfSpeech=JJ Lemma=hepatic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activation CharacterOffsetBegin=13812 CharacterOffsetEnd=13822 PartOfSpeech=NN Lemma=activation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=13823 CharacterOffsetEnd=13825 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=form CharacterOffsetBegin=13826 CharacterOffsetEnd=13830 PartOfSpeech=VB Lemma=form NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pharmacologically CharacterOffsetBegin=13831 CharacterOffsetEnd=13848 PartOfSpeech=RB Lemma=pharmacologically NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=active CharacterOffsetBegin=13849 CharacterOffsetEnd=13855 PartOfSpeech=JJ Lemma=active NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=metabolites CharacterOffsetBegin=13856 CharacterOffsetEnd=13867 PartOfSpeech=NNS Lemma=metabolite NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=13867 CharacterOffsetEnd=13868 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT All))\n",
      "      (PP (IN of)\n",
      "        (NP (DT these) (JJ new) (NNS agents))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN characterised)\n",
      "        (PP (IN by)\n",
      "          (S\n",
      "            (VP\n",
      "              (VP (VBG having)\n",
      "                (NP\n",
      "                  (ADJP\n",
      "                    (NP (DT a) (NN carboxyl))\n",
      "                    (JJ functional))\n",
      "                  (NNS groups)))\n",
      "              (CC and)\n",
      "              (VP (VBG requiring)\n",
      "                (NP (JJ hepatic) (NN activation))\n",
      "                (S\n",
      "                  (VP (TO to)\n",
      "                    (VP (VB form)\n",
      "                      (NP\n",
      "                        (ADJP (RB pharmacologically) (JJ active))\n",
      "                        (NNS metabolites)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, characterised-7)\n",
      "det:qmod(agents-5, All-1)\n",
      "mwe(All-1, of-2)\n",
      "det(agents-5, these-3)\n",
      "amod(agents-5, new-4)\n",
      "nsubjpass(characterised-7, agents-5)\n",
      "auxpass(characterised-7, are-6)\n",
      "mark(having-9, by-8)\n",
      "advcl:by(characterised-7, having-9)\n",
      "det(carboxyl-11, a-10)\n",
      "nmod:npmod(functional-12, carboxyl-11)\n",
      "amod(groups-13, functional-12)\n",
      "dobj(having-9, groups-13)\n",
      "cc(having-9, and-14)\n",
      "advcl:by(characterised-7, requiring-15)\n",
      "conj:and(having-9, requiring-15)\n",
      "amod(activation-17, hepatic-16)\n",
      "dobj(requiring-15, activation-17)\n",
      "nsubj:xsubj(form-19, activation-17)\n",
      "mark(form-19, to-18)\n",
      "xcomp(requiring-15, form-19)\n",
      "advmod(active-21, pharmacologically-20)\n",
      "amod(metabolites-22, active-21)\n",
      "dobj(form-19, metabolites-22)\n",
      "punct(characterised-7, .-23)\n",
      "\n",
      "Sentence #96 (20 tokens, sentiment: Negative):\n",
      "They achieve peak plasma concentrations at similar times (t(max)) to those of established agents.\n",
      "[Text=They CharacterOffsetBegin=13869 CharacterOffsetEnd=13873 PartOfSpeech=PRP Lemma=they NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=achieve CharacterOffsetBegin=13874 CharacterOffsetEnd=13881 PartOfSpeech=VBP Lemma=achieve NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=peak CharacterOffsetBegin=13882 CharacterOffsetEnd=13886 PartOfSpeech=JJ Lemma=peak NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=plasma CharacterOffsetBegin=13887 CharacterOffsetEnd=13893 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=concentrations CharacterOffsetBegin=13894 CharacterOffsetEnd=13908 PartOfSpeech=NNS Lemma=concentration NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=13909 CharacterOffsetEnd=13911 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=similar CharacterOffsetBegin=13912 CharacterOffsetEnd=13919 PartOfSpeech=JJ Lemma=similar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=times CharacterOffsetBegin=13920 CharacterOffsetEnd=13925 PartOfSpeech=NNS Lemma=time NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=13926 CharacterOffsetEnd=13927 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=t CharacterOffsetBegin=13927 CharacterOffsetEnd=13928 PartOfSpeech=NN Lemma=t NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=13928 CharacterOffsetEnd=13929 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=max CharacterOffsetBegin=13929 CharacterOffsetEnd=13932 PartOfSpeech=NN Lemma=max NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=13932 CharacterOffsetEnd=13933 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=13933 CharacterOffsetEnd=13934 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=13935 CharacterOffsetEnd=13937 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=those CharacterOffsetBegin=13938 CharacterOffsetEnd=13943 PartOfSpeech=DT Lemma=those NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=13944 CharacterOffsetEnd=13946 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=established CharacterOffsetBegin=13947 CharacterOffsetEnd=13958 PartOfSpeech=JJ Lemma=established NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=agents CharacterOffsetBegin=13959 CharacterOffsetEnd=13965 PartOfSpeech=NNS Lemma=agent NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=13965 CharacterOffsetEnd=13966 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP They))\n",
      "    (VP (VBP achieve)\n",
      "      (NP (JJ peak) (NN plasma) (NNS concentrations))\n",
      "      (PP (IN at)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (JJ similar) (NNS times))\n",
      "            (-LRB- -LRB-)\n",
      "            (NP (NN t))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP (NN max))\n",
      "              (-RRB- -RRB-))\n",
      "            (-RRB- -RRB-))\n",
      "          (PP (TO to)\n",
      "            (NP\n",
      "              (NP (DT those))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ established) (NNS agents))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, achieve-2)\n",
      "nsubj(achieve-2, They-1)\n",
      "amod(concentrations-5, peak-3)\n",
      "compound(concentrations-5, plasma-4)\n",
      "dobj(achieve-2, concentrations-5)\n",
      "case(times-8, at-6)\n",
      "amod(times-8, similar-7)\n",
      "nmod:at(achieve-2, times-8)\n",
      "punct(times-8, -LRB--9)\n",
      "dep(times-8, t-10)\n",
      "punct(max-12, -LRB--11)\n",
      "appos(times-8, max-12)\n",
      "punct(max-12, -RRB--13)\n",
      "punct(times-8, -RRB--14)\n",
      "case(those-16, to-15)\n",
      "nmod:to(times-8, those-16)\n",
      "case(agents-19, of-17)\n",
      "amod(agents-19, established-18)\n",
      "nmod:of(those-16, agents-19)\n",
      "punct(achieve-2, .-20)\n",
      "\n",
      "Sentence #97 (20 tokens, sentiment: Negative):\n",
      "Three of these agents (trandolapril, moexipril and imidapril) require dosage reductions in patients with renal impairment.\n",
      "[Text=Three CharacterOffsetBegin=13967 CharacterOffsetEnd=13972 PartOfSpeech=CD Lemma=three NamedEntityTag=NUMBER NormalizedNamedEntityTag=3.0 SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=13973 CharacterOffsetEnd=13975 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=these CharacterOffsetBegin=13976 CharacterOffsetEnd=13981 PartOfSpeech=DT Lemma=these NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=agents CharacterOffsetBegin=13982 CharacterOffsetEnd=13988 PartOfSpeech=NNS Lemma=agent NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=13989 CharacterOffsetEnd=13990 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trandolapril CharacterOffsetBegin=13990 CharacterOffsetEnd=14002 PartOfSpeech=NN Lemma=trandolapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14002 CharacterOffsetEnd=14003 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=moexipril CharacterOffsetBegin=14004 CharacterOffsetEnd=14013 PartOfSpeech=NN Lemma=moexipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=14014 CharacterOffsetEnd=14017 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=imidapril CharacterOffsetBegin=14018 CharacterOffsetEnd=14027 PartOfSpeech=NN Lemma=imidapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=14027 CharacterOffsetEnd=14028 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=require CharacterOffsetBegin=14029 CharacterOffsetEnd=14036 PartOfSpeech=VBP Lemma=require NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dosage CharacterOffsetBegin=14037 CharacterOffsetEnd=14043 PartOfSpeech=NN Lemma=dosage NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reductions CharacterOffsetBegin=14044 CharacterOffsetEnd=14054 PartOfSpeech=NNS Lemma=reduction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=14055 CharacterOffsetEnd=14057 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=14058 CharacterOffsetEnd=14066 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=14067 CharacterOffsetEnd=14071 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=14072 CharacterOffsetEnd=14077 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=impairment CharacterOffsetBegin=14078 CharacterOffsetEnd=14088 PartOfSpeech=NN Lemma=impairment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=14088 CharacterOffsetEnd=14089 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (CD Three))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (DT these) (NNS agents))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (NN trandolapril))\n",
      "              (, ,)\n",
      "              (NP (NN moexipril)\n",
      "                (CC and)\n",
      "                (NN imidapril)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (VP (VBP require)\n",
      "      (NP (NN dosage) (NNS reductions))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NNS patients))\n",
      "          (PP (IN with)\n",
      "            (NP (JJ renal) (NN impairment))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, require-12)\n",
      "det:qmod(agents-4, Three-1)\n",
      "mwe(Three-1, of-2)\n",
      "det(agents-4, these-3)\n",
      "nsubj(require-12, agents-4)\n",
      "punct(trandolapril-6, -LRB--5)\n",
      "dep(agents-4, trandolapril-6)\n",
      "punct(trandolapril-6, ,-7)\n",
      "appos(trandolapril-6, moexipril-8)\n",
      "cc(moexipril-8, and-9)\n",
      "appos(trandolapril-6, imidapril-10)\n",
      "conj:and(moexipril-8, imidapril-10)\n",
      "punct(trandolapril-6, -RRB--11)\n",
      "compound(reductions-14, dosage-13)\n",
      "dobj(require-12, reductions-14)\n",
      "case(patients-16, in-15)\n",
      "nmod:in(require-12, patients-16)\n",
      "case(impairment-19, with-17)\n",
      "amod(impairment-19, renal-18)\n",
      "nmod:with(patients-16, impairment-19)\n",
      "punct(require-12, .-20)\n",
      "\n",
      "Sentence #98 (26 tokens, sentiment: Negative):\n",
      "Dosage reductions of moexipril and temocapril are recommended for elderly patients, and dosages of moexipril should be lower in patients who are hepatically impaired.\n",
      "[Text=Dosage CharacterOffsetBegin=14090 CharacterOffsetEnd=14096 PartOfSpeech=NNP Lemma=Dosage NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reductions CharacterOffsetBegin=14097 CharacterOffsetEnd=14107 PartOfSpeech=NNS Lemma=reduction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=14108 CharacterOffsetEnd=14110 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=moexipril CharacterOffsetBegin=14111 CharacterOffsetEnd=14120 PartOfSpeech=NN Lemma=moexipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=14121 CharacterOffsetEnd=14124 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=temocapril CharacterOffsetBegin=14125 CharacterOffsetEnd=14135 PartOfSpeech=NN Lemma=temocapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=14136 CharacterOffsetEnd=14139 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=recommended CharacterOffsetBegin=14140 CharacterOffsetEnd=14151 PartOfSpeech=VBN Lemma=recommend NamedEntityTag=O SentimentClass=Very positive]\n",
      "[Text=for CharacterOffsetBegin=14152 CharacterOffsetEnd=14155 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=elderly CharacterOffsetBegin=14156 CharacterOffsetEnd=14163 PartOfSpeech=JJ Lemma=elderly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=14164 CharacterOffsetEnd=14172 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14172 CharacterOffsetEnd=14173 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=14174 CharacterOffsetEnd=14177 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dosages CharacterOffsetBegin=14178 CharacterOffsetEnd=14185 PartOfSpeech=NNS Lemma=dosage NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=14186 CharacterOffsetEnd=14188 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=moexipril CharacterOffsetBegin=14189 CharacterOffsetEnd=14198 PartOfSpeech=NN Lemma=moexipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=should CharacterOffsetBegin=14199 CharacterOffsetEnd=14205 PartOfSpeech=MD Lemma=should NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=14206 CharacterOffsetEnd=14208 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=14209 CharacterOffsetEnd=14214 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=14215 CharacterOffsetEnd=14217 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=14218 CharacterOffsetEnd=14226 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=who CharacterOffsetBegin=14227 CharacterOffsetEnd=14230 PartOfSpeech=WP Lemma=who NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=14231 CharacterOffsetEnd=14234 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hepatically CharacterOffsetBegin=14235 CharacterOffsetEnd=14246 PartOfSpeech=RB Lemma=hepatically NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=impaired CharacterOffsetBegin=14247 CharacterOffsetEnd=14255 PartOfSpeech=JJ Lemma=impaired NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=14255 CharacterOffsetEnd=14256 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (NNP Dosage) (NNS reductions))\n",
      "        (PP (IN of)\n",
      "          (NP (NN moexipril)\n",
      "            (CC and)\n",
      "            (NN temocapril))))\n",
      "      (VP (VBP are)\n",
      "        (VP (VBN recommended)\n",
      "          (PP (IN for)\n",
      "            (NP (JJ elderly) (NNS patients))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (NNS dosages))\n",
      "        (PP (IN of)\n",
      "          (NP (NN moexipril))))\n",
      "      (VP (MD should)\n",
      "        (VP (VB be)\n",
      "          (ADJP\n",
      "            (ADJP (JJR lower))\n",
      "            (PP (IN in)\n",
      "              (NP\n",
      "                (NP (NNS patients))\n",
      "                (SBAR\n",
      "                  (WHNP (WP who))\n",
      "                  (S\n",
      "                    (VP (VBP are)\n",
      "                      (ADJP (RB hepatically) (JJ impaired)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, recommended-8)\n",
      "compound(reductions-2, Dosage-1)\n",
      "nsubjpass(recommended-8, reductions-2)\n",
      "case(moexipril-4, of-3)\n",
      "nmod:of(reductions-2, moexipril-4)\n",
      "cc(moexipril-4, and-5)\n",
      "nmod:of(reductions-2, temocapril-6)\n",
      "conj:and(moexipril-4, temocapril-6)\n",
      "auxpass(recommended-8, are-7)\n",
      "case(patients-11, for-9)\n",
      "amod(patients-11, elderly-10)\n",
      "nmod:for(recommended-8, patients-11)\n",
      "punct(recommended-8, ,-12)\n",
      "cc(recommended-8, and-13)\n",
      "nsubj(lower-19, dosages-14)\n",
      "case(moexipril-16, of-15)\n",
      "nmod:of(dosages-14, moexipril-16)\n",
      "aux(lower-19, should-17)\n",
      "cop(lower-19, be-18)\n",
      "conj:and(recommended-8, lower-19)\n",
      "case(patients-21, in-20)\n",
      "nmod:in(lower-19, patients-21)\n",
      "nsubj(impaired-25, patients-21)\n",
      "ref(patients-21, who-22)\n",
      "cop(impaired-25, are-23)\n",
      "advmod(impaired-25, hepatically-24)\n",
      "acl:relcl(patients-21, impaired-25)\n",
      "punct(recommended-8, .-26)\n",
      "\n",
      "Sentence #99 (21 tokens, sentiment: Negative):\n",
      "Moexipril should be taken 1 hour before meals, whereas other ACE inhibitors can be taken without regard to meals.\n",
      "[Text=Moexipril CharacterOffsetBegin=14257 CharacterOffsetEnd=14266 PartOfSpeech=NN Lemma=moexipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=should CharacterOffsetBegin=14267 CharacterOffsetEnd=14273 PartOfSpeech=MD Lemma=should NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=14274 CharacterOffsetEnd=14276 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=taken CharacterOffsetBegin=14277 CharacterOffsetEnd=14282 PartOfSpeech=VBN Lemma=take NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=1 CharacterOffsetBegin=14283 CharacterOffsetEnd=14284 PartOfSpeech=CD Lemma=1 NamedEntityTag=DURATION NormalizedNamedEntityTag=PT1H Timex=<TIMEX3 tid=\"t21\" type=\"DURATION\" value=\"PT1H\">1 hour</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=hour CharacterOffsetBegin=14285 CharacterOffsetEnd=14289 PartOfSpeech=NN Lemma=hour NamedEntityTag=DURATION NormalizedNamedEntityTag=PT1H Timex=<TIMEX3 tid=\"t21\" type=\"DURATION\" value=\"PT1H\">1 hour</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=before CharacterOffsetBegin=14290 CharacterOffsetEnd=14296 PartOfSpeech=IN Lemma=before NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=meals CharacterOffsetBegin=14297 CharacterOffsetEnd=14302 PartOfSpeech=NNS Lemma=meal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14302 CharacterOffsetEnd=14303 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=whereas CharacterOffsetBegin=14304 CharacterOffsetEnd=14311 PartOfSpeech=IN Lemma=whereas NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=other CharacterOffsetBegin=14312 CharacterOffsetEnd=14317 PartOfSpeech=JJ Lemma=other NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=14318 CharacterOffsetEnd=14321 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=14322 CharacterOffsetEnd=14332 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=can CharacterOffsetBegin=14333 CharacterOffsetEnd=14336 PartOfSpeech=MD Lemma=can NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=14337 CharacterOffsetEnd=14339 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=taken CharacterOffsetBegin=14340 CharacterOffsetEnd=14345 PartOfSpeech=VBN Lemma=take NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=without CharacterOffsetBegin=14346 CharacterOffsetEnd=14353 PartOfSpeech=IN Lemma=without NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=regard CharacterOffsetBegin=14354 CharacterOffsetEnd=14360 PartOfSpeech=NN Lemma=regard NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=to CharacterOffsetBegin=14361 CharacterOffsetEnd=14363 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=meals CharacterOffsetBegin=14364 CharacterOffsetEnd=14369 PartOfSpeech=NNS Lemma=meal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=14369 CharacterOffsetEnd=14370 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Moexipril))\n",
      "    (VP (MD should)\n",
      "      (VP (VB be)\n",
      "        (VP (VBN taken)\n",
      "          (PP\n",
      "            (NP (CD 1) (NN hour))\n",
      "            (IN before)\n",
      "            (NP (NNS meals)))\n",
      "          (, ,)\n",
      "          (SBAR (IN whereas)\n",
      "            (S\n",
      "              (NP (JJ other) (NN ACE) (NNS inhibitors))\n",
      "              (VP (MD can)\n",
      "                (VP (VB be)\n",
      "                  (VP (VBN taken)\n",
      "                    (PP (IN without)\n",
      "                      (NP (NN regard)))\n",
      "                    (PP (TO to)\n",
      "                      (NP (NNS meals)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, taken-4)\n",
      "nsubjpass(taken-4, Moexipril-1)\n",
      "aux(taken-4, should-2)\n",
      "auxpass(taken-4, be-3)\n",
      "nummod(hour-6, 1-5)\n",
      "nmod:before(taken-4, hour-6)\n",
      "case(hour-6, before-7)\n",
      "dep(hour-6, meals-8)\n",
      "punct(taken-4, ,-9)\n",
      "mark(taken-16, whereas-10)\n",
      "amod(inhibitors-13, other-11)\n",
      "compound(inhibitors-13, ACE-12)\n",
      "nsubjpass(taken-16, inhibitors-13)\n",
      "aux(taken-16, can-14)\n",
      "auxpass(taken-16, be-15)\n",
      "advcl:whereas(taken-4, taken-16)\n",
      "case(regard-18, without-17)\n",
      "nmod:without(taken-16, regard-18)\n",
      "case(meals-20, to-19)\n",
      "nmod:to(taken-16, meals-20)\n",
      "punct(taken-4, .-21)\n",
      "\n",
      "Sentence #100 (15 tokens, sentiment: Negative):\n",
      "The pharmacokinetics of warfarin are not altered by concomitant administration with trandolapril or moexipril.\n",
      "[Text=The CharacterOffsetBegin=14371 CharacterOffsetEnd=14374 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pharmacokinetics CharacterOffsetBegin=14375 CharacterOffsetEnd=14391 PartOfSpeech=NNS Lemma=pharmacokinetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=14392 CharacterOffsetEnd=14394 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=warfarin CharacterOffsetBegin=14395 CharacterOffsetEnd=14403 PartOfSpeech=NN Lemma=warfarin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=14404 CharacterOffsetEnd=14407 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=not CharacterOffsetBegin=14408 CharacterOffsetEnd=14411 PartOfSpeech=RB Lemma=not NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=altered CharacterOffsetBegin=14412 CharacterOffsetEnd=14419 PartOfSpeech=VBN Lemma=alter NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=by CharacterOffsetBegin=14420 CharacterOffsetEnd=14422 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=concomitant CharacterOffsetBegin=14423 CharacterOffsetEnd=14434 PartOfSpeech=JJ Lemma=concomitant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=administration CharacterOffsetBegin=14435 CharacterOffsetEnd=14449 PartOfSpeech=NN Lemma=administration NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=14450 CharacterOffsetEnd=14454 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trandolapril CharacterOffsetBegin=14455 CharacterOffsetEnd=14467 PartOfSpeech=NN Lemma=trandolapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=14468 CharacterOffsetEnd=14470 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=moexipril CharacterOffsetBegin=14471 CharacterOffsetEnd=14480 PartOfSpeech=NN Lemma=moexipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=14480 CharacterOffsetEnd=14481 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NNS pharmacokinetics))\n",
      "      (PP (IN of)\n",
      "        (NP (NN warfarin))))\n",
      "    (VP (VBP are) (RB not)\n",
      "      (VP (VBN altered)\n",
      "        (PP (IN by)\n",
      "          (NP (JJ concomitant) (NN administration)))\n",
      "        (PP (IN with)\n",
      "          (NP (NN trandolapril)\n",
      "            (CC or)\n",
      "            (NN moexipril)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, altered-7)\n",
      "det(pharmacokinetics-2, The-1)\n",
      "nsubjpass(altered-7, pharmacokinetics-2)\n",
      "case(warfarin-4, of-3)\n",
      "nmod:of(pharmacokinetics-2, warfarin-4)\n",
      "auxpass(altered-7, are-5)\n",
      "neg(altered-7, not-6)\n",
      "case(administration-10, by-8)\n",
      "amod(administration-10, concomitant-9)\n",
      "nmod:agent(altered-7, administration-10)\n",
      "case(trandolapril-12, with-11)\n",
      "nmod:with(altered-7, trandolapril-12)\n",
      "cc(trandolapril-12, or-13)\n",
      "nmod:with(altered-7, moexipril-14)\n",
      "conj:or(trandolapril-12, moexipril-14)\n",
      "punct(altered-7, .-15)\n",
      "\n",
      "Sentence #101 (39 tokens, sentiment: Negative):\n",
      "Although imidapril and spirapril have no effect on digoxin pharmacokinetics, the area under the concentration-time curve of imidapril and the peak plasma concentration of the active metabolite imidaprilat are decreased when imidapril is given together with digoxin.\n",
      "[Text=Although CharacterOffsetBegin=14482 CharacterOffsetEnd=14490 PartOfSpeech=IN Lemma=although NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=imidapril CharacterOffsetBegin=14491 CharacterOffsetEnd=14500 PartOfSpeech=NN Lemma=imidapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=14501 CharacterOffsetEnd=14504 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=spirapril CharacterOffsetBegin=14505 CharacterOffsetEnd=14514 PartOfSpeech=NN Lemma=spirapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=have CharacterOffsetBegin=14515 CharacterOffsetEnd=14519 PartOfSpeech=VBP Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=no CharacterOffsetBegin=14520 CharacterOffsetEnd=14522 PartOfSpeech=DT Lemma=no NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=effect CharacterOffsetBegin=14523 CharacterOffsetEnd=14529 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=14530 CharacterOffsetEnd=14532 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=digoxin CharacterOffsetBegin=14533 CharacterOffsetEnd=14540 PartOfSpeech=NN Lemma=digoxin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pharmacokinetics CharacterOffsetBegin=14541 CharacterOffsetEnd=14557 PartOfSpeech=NNS Lemma=pharmacokinetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14557 CharacterOffsetEnd=14558 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=14559 CharacterOffsetEnd=14562 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=area CharacterOffsetBegin=14563 CharacterOffsetEnd=14567 PartOfSpeech=NN Lemma=area NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=under CharacterOffsetBegin=14568 CharacterOffsetEnd=14573 PartOfSpeech=IN Lemma=under NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=14574 CharacterOffsetEnd=14577 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=concentration-time CharacterOffsetBegin=14578 CharacterOffsetEnd=14596 PartOfSpeech=JJ Lemma=concentration-time NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=curve CharacterOffsetBegin=14597 CharacterOffsetEnd=14602 PartOfSpeech=NN Lemma=curve NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=14603 CharacterOffsetEnd=14605 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=imidapril CharacterOffsetBegin=14606 CharacterOffsetEnd=14615 PartOfSpeech=NN Lemma=imidapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=14616 CharacterOffsetEnd=14619 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=14620 CharacterOffsetEnd=14623 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=peak CharacterOffsetBegin=14624 CharacterOffsetEnd=14628 PartOfSpeech=NN Lemma=peak NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=plasma CharacterOffsetBegin=14629 CharacterOffsetEnd=14635 PartOfSpeech=NN Lemma=plasma NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=concentration CharacterOffsetBegin=14636 CharacterOffsetEnd=14649 PartOfSpeech=NN Lemma=concentration NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=14650 CharacterOffsetEnd=14652 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=14653 CharacterOffsetEnd=14656 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=active CharacterOffsetBegin=14657 CharacterOffsetEnd=14663 PartOfSpeech=JJ Lemma=active NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=metabolite CharacterOffsetBegin=14664 CharacterOffsetEnd=14674 PartOfSpeech=NN Lemma=metabolite NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=imidaprilat CharacterOffsetBegin=14675 CharacterOffsetEnd=14686 PartOfSpeech=NN Lemma=imidaprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=14687 CharacterOffsetEnd=14690 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=decreased CharacterOffsetBegin=14691 CharacterOffsetEnd=14700 PartOfSpeech=VBN Lemma=decrease NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=when CharacterOffsetBegin=14701 CharacterOffsetEnd=14705 PartOfSpeech=WRB Lemma=when NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=imidapril CharacterOffsetBegin=14706 CharacterOffsetEnd=14715 PartOfSpeech=NN Lemma=imidapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=14716 CharacterOffsetEnd=14718 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=given CharacterOffsetBegin=14719 CharacterOffsetEnd=14724 PartOfSpeech=VBN Lemma=give NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=together CharacterOffsetBegin=14725 CharacterOffsetEnd=14733 PartOfSpeech=RP Lemma=together NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=14734 CharacterOffsetEnd=14738 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=digoxin CharacterOffsetBegin=14739 CharacterOffsetEnd=14746 PartOfSpeech=NN Lemma=digoxin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=14746 CharacterOffsetEnd=14747 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN Although)\n",
      "      (S\n",
      "        (NP (NN imidapril)\n",
      "          (CC and)\n",
      "          (NN spirapril))\n",
      "        (VP (VBP have)\n",
      "          (NP\n",
      "            (NP (DT no) (NN effect))\n",
      "            (PP (IN on)\n",
      "              (NP (NN digoxin) (NNS pharmacokinetics)))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (NN area))\n",
      "      (PP (IN under)\n",
      "        (NP\n",
      "          (NP\n",
      "            (NP (DT the) (JJ concentration-time) (NN curve))\n",
      "            (PP (IN of)\n",
      "              (NP (NN imidapril))))\n",
      "          (CC and)\n",
      "          (NP\n",
      "            (NP (DT the) (NN peak) (NN plasma) (NN concentration))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (JJ active) (NN metabolite) (NN imidaprilat)))))))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN decreased)\n",
      "        (SBAR\n",
      "          (WHADVP (WRB when))\n",
      "          (S\n",
      "            (NP (NN imidapril))\n",
      "            (VP (VBZ is)\n",
      "              (VP (VBN given)\n",
      "                (PRT (RP together))\n",
      "                (PP (IN with)\n",
      "                  (NP (NN digoxin)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, decreased-31)\n",
      "mark(have-5, Although-1)\n",
      "nsubj(have-5, imidapril-2)\n",
      "cc(imidapril-2, and-3)\n",
      "conj:and(imidapril-2, spirapril-4)\n",
      "nsubj(have-5, spirapril-4)\n",
      "advcl:although(decreased-31, have-5)\n",
      "neg(effect-7, no-6)\n",
      "dobj(have-5, effect-7)\n",
      "case(pharmacokinetics-10, on-8)\n",
      "compound(pharmacokinetics-10, digoxin-9)\n",
      "nmod:on(effect-7, pharmacokinetics-10)\n",
      "punct(decreased-31, ,-11)\n",
      "det(area-13, the-12)\n",
      "nsubjpass(decreased-31, area-13)\n",
      "case(curve-17, under-14)\n",
      "det(curve-17, the-15)\n",
      "amod(curve-17, concentration-time-16)\n",
      "nmod:under(area-13, curve-17)\n",
      "case(imidapril-19, of-18)\n",
      "nmod:of(curve-17, imidapril-19)\n",
      "cc(curve-17, and-20)\n",
      "det(concentration-24, the-21)\n",
      "compound(concentration-24, peak-22)\n",
      "compound(concentration-24, plasma-23)\n",
      "nmod:under(area-13, concentration-24)\n",
      "conj:and(curve-17, concentration-24)\n",
      "case(imidaprilat-29, of-25)\n",
      "det(imidaprilat-29, the-26)\n",
      "amod(imidaprilat-29, active-27)\n",
      "compound(imidaprilat-29, metabolite-28)\n",
      "nmod:of(concentration-24, imidaprilat-29)\n",
      "auxpass(decreased-31, are-30)\n",
      "advmod(given-35, when-32)\n",
      "nsubjpass(given-35, imidapril-33)\n",
      "auxpass(given-35, is-34)\n",
      "advcl(decreased-31, given-35)\n",
      "compound:prt(given-35, together-36)\n",
      "case(digoxin-38, with-37)\n",
      "nmod:with(given-35, digoxin-38)\n",
      "punct(decreased-31, .-39)\n",
      "\n",
      "Sentence #102 (71 tokens, sentiment: Very negative):\n",
      "Although six ACE inhibitors (captopril, enalapril, fosinopril, lisinopril, quinapril and ramipril) have been approved for use in heart failure by the US Food and Drug Administration, an overview of 32 clinical trials of ACE inhibitors in heart failure showed that no significant heterogeneity in mortality was found among enalapril, ramipril, quinapril, captopril, lisinopril, benazepril, perindopril and cilazapril.\n",
      "[Text=Although CharacterOffsetBegin=14748 CharacterOffsetEnd=14756 PartOfSpeech=IN Lemma=although NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=six CharacterOffsetBegin=14757 CharacterOffsetEnd=14760 PartOfSpeech=CD Lemma=six NamedEntityTag=NUMBER NormalizedNamedEntityTag=6.0 SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=14761 CharacterOffsetEnd=14764 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=14765 CharacterOffsetEnd=14775 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=14776 CharacterOffsetEnd=14777 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=14777 CharacterOffsetEnd=14786 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14786 CharacterOffsetEnd=14787 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=14788 CharacterOffsetEnd=14797 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14797 CharacterOffsetEnd=14798 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=fosinopril CharacterOffsetBegin=14799 CharacterOffsetEnd=14809 PartOfSpeech=NN Lemma=fosinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14809 CharacterOffsetEnd=14810 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=14811 CharacterOffsetEnd=14821 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14821 CharacterOffsetEnd=14822 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=quinapril CharacterOffsetBegin=14823 CharacterOffsetEnd=14832 PartOfSpeech=NN Lemma=quinapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=14833 CharacterOffsetEnd=14836 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ramipril CharacterOffsetBegin=14837 CharacterOffsetEnd=14845 PartOfSpeech=NN Lemma=ramipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=14845 CharacterOffsetEnd=14846 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=have CharacterOffsetBegin=14847 CharacterOffsetEnd=14851 PartOfSpeech=VBP Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=been CharacterOffsetBegin=14852 CharacterOffsetEnd=14856 PartOfSpeech=VBN Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=approved CharacterOffsetBegin=14857 CharacterOffsetEnd=14865 PartOfSpeech=VBN Lemma=approve NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=14866 CharacterOffsetEnd=14869 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=use CharacterOffsetBegin=14870 CharacterOffsetEnd=14873 PartOfSpeech=NN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=14874 CharacterOffsetEnd=14876 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=heart CharacterOffsetBegin=14877 CharacterOffsetEnd=14882 PartOfSpeech=NN Lemma=heart NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=failure CharacterOffsetBegin=14883 CharacterOffsetEnd=14890 PartOfSpeech=NN Lemma=failure NamedEntityTag=O SentimentClass=Very negative]\n",
      "[Text=by CharacterOffsetBegin=14891 CharacterOffsetEnd=14893 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=14894 CharacterOffsetEnd=14897 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=US CharacterOffsetBegin=14898 CharacterOffsetEnd=14900 PartOfSpeech=NNP Lemma=US NamedEntityTag=ORGANIZATION SentimentClass=Positive]\n",
      "[Text=Food CharacterOffsetBegin=14901 CharacterOffsetEnd=14905 PartOfSpeech=NNP Lemma=Food NamedEntityTag=ORGANIZATION SentimentClass=Positive]\n",
      "[Text=and CharacterOffsetBegin=14906 CharacterOffsetEnd=14909 PartOfSpeech=CC Lemma=and NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=Drug CharacterOffsetBegin=14910 CharacterOffsetEnd=14914 PartOfSpeech=NNP Lemma=Drug NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=Administration CharacterOffsetBegin=14915 CharacterOffsetEnd=14929 PartOfSpeech=NNP Lemma=Administration NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=14929 CharacterOffsetEnd=14930 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=14931 CharacterOffsetEnd=14933 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=overview CharacterOffsetBegin=14934 CharacterOffsetEnd=14942 PartOfSpeech=NN Lemma=overview NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=14943 CharacterOffsetEnd=14945 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=32 CharacterOffsetBegin=14946 CharacterOffsetEnd=14948 PartOfSpeech=CD Lemma=32 NamedEntityTag=NUMBER NormalizedNamedEntityTag=32.0 SentimentClass=Neutral]\n",
      "[Text=clinical CharacterOffsetBegin=14949 CharacterOffsetEnd=14957 PartOfSpeech=JJ Lemma=clinical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trials CharacterOffsetBegin=14958 CharacterOffsetEnd=14964 PartOfSpeech=NNS Lemma=trial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=14965 CharacterOffsetEnd=14967 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=14968 CharacterOffsetEnd=14971 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=14972 CharacterOffsetEnd=14982 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=14983 CharacterOffsetEnd=14985 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=heart CharacterOffsetBegin=14986 CharacterOffsetEnd=14991 PartOfSpeech=NN Lemma=heart NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=failure CharacterOffsetBegin=14992 CharacterOffsetEnd=14999 PartOfSpeech=NN Lemma=failure NamedEntityTag=O SentimentClass=Very negative]\n",
      "[Text=showed CharacterOffsetBegin=15000 CharacterOffsetEnd=15006 PartOfSpeech=VBD Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=15007 CharacterOffsetEnd=15011 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=no CharacterOffsetBegin=15012 CharacterOffsetEnd=15014 PartOfSpeech=DT Lemma=no NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=significant CharacterOffsetBegin=15015 CharacterOffsetEnd=15026 PartOfSpeech=JJ Lemma=significant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=heterogeneity CharacterOffsetBegin=15027 CharacterOffsetEnd=15040 PartOfSpeech=NN Lemma=heterogeneity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=15041 CharacterOffsetEnd=15043 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mortality CharacterOffsetBegin=15044 CharacterOffsetEnd=15053 PartOfSpeech=NN Lemma=mortality NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=15054 CharacterOffsetEnd=15057 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=found CharacterOffsetBegin=15058 CharacterOffsetEnd=15063 PartOfSpeech=VBN Lemma=find NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=among CharacterOffsetBegin=15064 CharacterOffsetEnd=15069 PartOfSpeech=IN Lemma=among NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=15070 CharacterOffsetEnd=15079 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15079 CharacterOffsetEnd=15080 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ramipril CharacterOffsetBegin=15081 CharacterOffsetEnd=15089 PartOfSpeech=NN Lemma=ramipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15089 CharacterOffsetEnd=15090 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=quinapril CharacterOffsetBegin=15091 CharacterOffsetEnd=15100 PartOfSpeech=NN Lemma=quinapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15100 CharacterOffsetEnd=15101 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=15102 CharacterOffsetEnd=15111 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15111 CharacterOffsetEnd=15112 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=15113 CharacterOffsetEnd=15123 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15123 CharacterOffsetEnd=15124 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=15125 CharacterOffsetEnd=15135 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15135 CharacterOffsetEnd=15136 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=perindopril CharacterOffsetBegin=15137 CharacterOffsetEnd=15148 PartOfSpeech=NN Lemma=perindopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=15149 CharacterOffsetEnd=15152 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cilazapril CharacterOffsetBegin=15153 CharacterOffsetEnd=15163 PartOfSpeech=NN Lemma=cilazapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=15163 CharacterOffsetEnd=15164 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN Although)\n",
      "      (S\n",
      "        (NP\n",
      "          (NP (CD six) (NN ACE) (NNS inhibitors))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (NN captopril))\n",
      "              (, ,)\n",
      "              (NP (NN enalapril) (, ,) (NN fosinopril) (, ,) (NN lisinopril) (, ,) (NN quinapril)\n",
      "                (CC and)\n",
      "                (NN ramipril)))\n",
      "            (-RRB- -RRB-)))\n",
      "        (VP (VBP have)\n",
      "          (VP (VBN been)\n",
      "            (VP (VBN approved)\n",
      "              (PP (IN for)\n",
      "                (NP\n",
      "                  (NP (NN use))\n",
      "                  (PP (IN in)\n",
      "                    (NP (NN heart) (NN failure)))))\n",
      "              (PP (IN by)\n",
      "                (NP (DT the) (NNP US) (NNP Food)\n",
      "                  (CC and)\n",
      "                  (NNP Drug) (NNP Administration))))))))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT an) (NN overview))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (CD 32) (JJ clinical) (NNS trials))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN ACE) (NNS inhibitors))\n",
      "              (PP (IN in)\n",
      "                (NP (NN heart) (NN failure))))))))\n",
      "    (VP (VBD showed)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT no) (JJ significant) (NN heterogeneity))\n",
      "            (PP (IN in)\n",
      "              (NP (NN mortality))))\n",
      "          (VP (VBD was)\n",
      "            (VP (VBN found)\n",
      "              (PP (IN among)\n",
      "                (NP (NN enalapril) (, ,) (NN ramipril) (, ,) (NN quinapril) (, ,) (NN captopril) (, ,) (NN lisinopril) (, ,) (NN benazepril) (, ,) (NN perindopril)\n",
      "                  (CC and)\n",
      "                  (NN cilazapril))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, showed-46)\n",
      "mark(approved-20, Although-1)\n",
      "nummod(inhibitors-4, six-2)\n",
      "compound(inhibitors-4, ACE-3)\n",
      "nsubjpass(approved-20, inhibitors-4)\n",
      "punct(captopril-6, -LRB--5)\n",
      "dep(inhibitors-4, captopril-6)\n",
      "punct(captopril-6, ,-7)\n",
      "appos(captopril-6, enalapril-8)\n",
      "punct(enalapril-8, ,-9)\n",
      "appos(captopril-6, fosinopril-10)\n",
      "conj:and(enalapril-8, fosinopril-10)\n",
      "punct(enalapril-8, ,-11)\n",
      "appos(captopril-6, lisinopril-12)\n",
      "conj:and(enalapril-8, lisinopril-12)\n",
      "punct(enalapril-8, ,-13)\n",
      "appos(captopril-6, quinapril-14)\n",
      "conj:and(enalapril-8, quinapril-14)\n",
      "cc(enalapril-8, and-15)\n",
      "appos(captopril-6, ramipril-16)\n",
      "conj:and(enalapril-8, ramipril-16)\n",
      "punct(captopril-6, -RRB--17)\n",
      "aux(approved-20, have-18)\n",
      "auxpass(approved-20, been-19)\n",
      "advcl:although(showed-46, approved-20)\n",
      "case(use-22, for-21)\n",
      "nmod:for(approved-20, use-22)\n",
      "case(failure-25, in-23)\n",
      "compound(failure-25, heart-24)\n",
      "nmod:in(use-22, failure-25)\n",
      "case(Food-29, by-26)\n",
      "det(Food-29, the-27)\n",
      "compound(Food-29, US-28)\n",
      "nmod:agent(approved-20, Food-29)\n",
      "cc(Food-29, and-30)\n",
      "compound(Administration-32, Drug-31)\n",
      "nmod:agent(approved-20, Administration-32)\n",
      "conj:and(Food-29, Administration-32)\n",
      "punct(showed-46, ,-33)\n",
      "det(overview-35, an-34)\n",
      "nsubj(showed-46, overview-35)\n",
      "case(trials-39, of-36)\n",
      "nummod(trials-39, 32-37)\n",
      "amod(trials-39, clinical-38)\n",
      "nmod:of(overview-35, trials-39)\n",
      "case(inhibitors-42, of-40)\n",
      "compound(inhibitors-42, ACE-41)\n",
      "nmod:of(trials-39, inhibitors-42)\n",
      "case(failure-45, in-43)\n",
      "compound(failure-45, heart-44)\n",
      "nmod:in(inhibitors-42, failure-45)\n",
      "mark(found-54, that-47)\n",
      "neg(heterogeneity-50, no-48)\n",
      "amod(heterogeneity-50, significant-49)\n",
      "nsubjpass(found-54, heterogeneity-50)\n",
      "case(mortality-52, in-51)\n",
      "nmod:in(heterogeneity-50, mortality-52)\n",
      "auxpass(found-54, was-53)\n",
      "ccomp(showed-46, found-54)\n",
      "case(enalapril-56, among-55)\n",
      "nmod:among(found-54, enalapril-56)\n",
      "punct(enalapril-56, ,-57)\n",
      "nmod:among(found-54, ramipril-58)\n",
      "conj:and(enalapril-56, ramipril-58)\n",
      "punct(enalapril-56, ,-59)\n",
      "nmod:among(found-54, quinapril-60)\n",
      "conj:and(enalapril-56, quinapril-60)\n",
      "punct(enalapril-56, ,-61)\n",
      "nmod:among(found-54, captopril-62)\n",
      "conj:and(enalapril-56, captopril-62)\n",
      "punct(enalapril-56, ,-63)\n",
      "nmod:among(found-54, lisinopril-64)\n",
      "conj:and(enalapril-56, lisinopril-64)\n",
      "punct(enalapril-56, ,-65)\n",
      "nmod:among(found-54, benazepril-66)\n",
      "conj:and(enalapril-56, benazepril-66)\n",
      "punct(enalapril-56, ,-67)\n",
      "nmod:among(found-54, perindopril-68)\n",
      "conj:and(enalapril-56, perindopril-68)\n",
      "cc(enalapril-56, and-69)\n",
      "nmod:among(found-54, cilazapril-70)\n",
      "conj:and(enalapril-56, cilazapril-70)\n",
      "punct(showed-46, .-71)\n",
      "\n",
      "Sentence #103 (30 tokens, sentiment: Negative):\n",
      "Initiation of therapy with captopril, ramipril, and trandolapril at least 3 days after an acute MI resulted in all-cause mortality risk reductions of 18 to 27%.\n",
      "[Text=Initiation CharacterOffsetBegin=15165 CharacterOffsetEnd=15175 PartOfSpeech=NN Lemma=initiation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=15176 CharacterOffsetEnd=15178 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=15179 CharacterOffsetEnd=15186 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=15187 CharacterOffsetEnd=15191 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=15192 CharacterOffsetEnd=15201 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15201 CharacterOffsetEnd=15202 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ramipril CharacterOffsetBegin=15203 CharacterOffsetEnd=15211 PartOfSpeech=NN Lemma=ramipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15211 CharacterOffsetEnd=15212 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=15213 CharacterOffsetEnd=15216 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trandolapril CharacterOffsetBegin=15217 CharacterOffsetEnd=15229 PartOfSpeech=NN Lemma=trandolapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=15230 CharacterOffsetEnd=15232 PartOfSpeech=IN Lemma=at NamedEntityTag=DURATION NormalizedNamedEntityTag=P3D Timex=<TIMEX3 mod=\"EQUAL_OR_MORE\" tid=\"t22\" type=\"DURATION\" value=\"P3D\">at least 3 days</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=least CharacterOffsetBegin=15233 CharacterOffsetEnd=15238 PartOfSpeech=JJS Lemma=least NamedEntityTag=DURATION NormalizedNamedEntityTag=P3D Timex=<TIMEX3 mod=\"EQUAL_OR_MORE\" tid=\"t22\" type=\"DURATION\" value=\"P3D\">at least 3 days</TIMEX3> SentimentClass=Negative]\n",
      "[Text=3 CharacterOffsetBegin=15239 CharacterOffsetEnd=15240 PartOfSpeech=CD Lemma=3 NamedEntityTag=DURATION NormalizedNamedEntityTag=P3D Timex=<TIMEX3 mod=\"EQUAL_OR_MORE\" tid=\"t22\" type=\"DURATION\" value=\"P3D\">at least 3 days</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=days CharacterOffsetBegin=15241 CharacterOffsetEnd=15245 PartOfSpeech=NNS Lemma=day NamedEntityTag=DURATION NormalizedNamedEntityTag=P3D Timex=<TIMEX3 mod=\"EQUAL_OR_MORE\" tid=\"t22\" type=\"DURATION\" value=\"P3D\">at least 3 days</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=after CharacterOffsetBegin=15246 CharacterOffsetEnd=15251 PartOfSpeech=IN Lemma=after NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=15252 CharacterOffsetEnd=15254 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=acute CharacterOffsetBegin=15255 CharacterOffsetEnd=15260 PartOfSpeech=JJ Lemma=acute NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=MI CharacterOffsetBegin=15261 CharacterOffsetEnd=15263 PartOfSpeech=NN Lemma=mi NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=resulted CharacterOffsetBegin=15264 CharacterOffsetEnd=15272 PartOfSpeech=VBD Lemma=result NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=15273 CharacterOffsetEnd=15275 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=all-cause CharacterOffsetBegin=15276 CharacterOffsetEnd=15285 PartOfSpeech=JJ Lemma=all-cause NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mortality CharacterOffsetBegin=15286 CharacterOffsetEnd=15295 PartOfSpeech=NN Lemma=mortality NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=risk CharacterOffsetBegin=15296 CharacterOffsetEnd=15300 PartOfSpeech=NN Lemma=risk NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reductions CharacterOffsetBegin=15301 CharacterOffsetEnd=15311 PartOfSpeech=NNS Lemma=reduction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=15312 CharacterOffsetEnd=15314 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=18 CharacterOffsetBegin=15315 CharacterOffsetEnd=15317 PartOfSpeech=CD Lemma=18 NamedEntityTag=NUMBER NormalizedNamedEntityTag=18.0 SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=15318 CharacterOffsetEnd=15320 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=27 CharacterOffsetBegin=15321 CharacterOffsetEnd=15323 PartOfSpeech=CD Lemma=27 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%27.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=15323 CharacterOffsetEnd=15324 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%27.0 SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=15324 CharacterOffsetEnd=15325 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN Initiation))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN therapy))\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (NN captopril) (, ,) (NN ramipril) (, ,)\n",
      "                (CC and)\n",
      "                (NN trandolapril))\n",
      "              (PP\n",
      "                (NP\n",
      "                  (QP (IN at) (JJS least) (CD 3))\n",
      "                  (NNS days))\n",
      "                (IN after)\n",
      "                (NP (DT an) (JJ acute) (NN MI))))))))\n",
      "    (VP (VBD resulted)\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (JJ all-cause) (NN mortality) (NN risk) (NNS reductions))\n",
      "          (PP (IN of)\n",
      "            (NP (CD 18)))))\n",
      "      (PP (TO to)\n",
      "        (NP (CD 27) (NN %))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, resulted-19)\n",
      "nsubj(resulted-19, Initiation-1)\n",
      "case(therapy-3, of-2)\n",
      "nmod:of(Initiation-1, therapy-3)\n",
      "case(captopril-5, with-4)\n",
      "nmod:with(therapy-3, captopril-5)\n",
      "punct(captopril-5, ,-6)\n",
      "nmod:with(therapy-3, ramipril-7)\n",
      "conj:and(captopril-5, ramipril-7)\n",
      "punct(captopril-5, ,-8)\n",
      "cc(captopril-5, and-9)\n",
      "nmod:with(therapy-3, trandolapril-10)\n",
      "conj:and(captopril-5, trandolapril-10)\n",
      "case(least-12, at-11)\n",
      "nmod:npmod(3-13, least-12)\n",
      "nummod(days-14, 3-13)\n",
      "nmod:after(captopril-5, days-14)\n",
      "case(days-14, after-15)\n",
      "det(MI-18, an-16)\n",
      "amod(MI-18, acute-17)\n",
      "dep(days-14, MI-18)\n",
      "case(reductions-24, in-20)\n",
      "amod(reductions-24, all-cause-21)\n",
      "compound(reductions-24, mortality-22)\n",
      "compound(reductions-24, risk-23)\n",
      "nmod:in(resulted-19, reductions-24)\n",
      "case(18-26, of-25)\n",
      "nmod:of(reductions-24, 18-26)\n",
      "case(%-29, to-27)\n",
      "nummod(%-29, 27-28)\n",
      "nmod:to(resulted-19, %-29)\n",
      "punct(resulted-19, .-30)\n",
      "\n",
      "Sentence #104 (21 tokens, sentiment: Negative):\n",
      "Captopril has been shown to have similar morbidity and mortality benefits to those of diuretics and beta-blockers in hypertensive patients.\n",
      "[Text=Captopril CharacterOffsetBegin=15326 CharacterOffsetEnd=15335 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=has CharacterOffsetBegin=15336 CharacterOffsetEnd=15339 PartOfSpeech=VBZ Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=been CharacterOffsetBegin=15340 CharacterOffsetEnd=15344 PartOfSpeech=VBN Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=shown CharacterOffsetBegin=15345 CharacterOffsetEnd=15350 PartOfSpeech=VBN Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=15351 CharacterOffsetEnd=15353 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=have CharacterOffsetBegin=15354 CharacterOffsetEnd=15358 PartOfSpeech=VB Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=similar CharacterOffsetBegin=15359 CharacterOffsetEnd=15366 PartOfSpeech=JJ Lemma=similar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=morbidity CharacterOffsetBegin=15367 CharacterOffsetEnd=15376 PartOfSpeech=NN Lemma=morbidity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=15377 CharacterOffsetEnd=15380 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mortality CharacterOffsetBegin=15381 CharacterOffsetEnd=15390 PartOfSpeech=NN Lemma=mortality NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benefits CharacterOffsetBegin=15391 CharacterOffsetEnd=15399 PartOfSpeech=NNS Lemma=benefit NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=to CharacterOffsetBegin=15400 CharacterOffsetEnd=15402 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=those CharacterOffsetBegin=15403 CharacterOffsetEnd=15408 PartOfSpeech=DT Lemma=those NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=15409 CharacterOffsetEnd=15411 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diuretics CharacterOffsetBegin=15412 CharacterOffsetEnd=15421 PartOfSpeech=NNS Lemma=diuretic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=15422 CharacterOffsetEnd=15425 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=beta-blockers CharacterOffsetBegin=15426 CharacterOffsetEnd=15439 PartOfSpeech=NNS Lemma=beta-blocker NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=15440 CharacterOffsetEnd=15442 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hypertensive CharacterOffsetBegin=15443 CharacterOffsetEnd=15455 PartOfSpeech=JJ Lemma=hypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=15456 CharacterOffsetEnd=15464 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=15464 CharacterOffsetEnd=15465 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Captopril))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN been)\n",
      "        (VP (VBN shown)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB have)\n",
      "                (NP\n",
      "                  (NP (JJ similar) (NN morbidity)\n",
      "                    (CC and)\n",
      "                    (NN mortality) (NNS benefits))\n",
      "                  (PP (TO to)\n",
      "                    (NP\n",
      "                      (NP (DT those))\n",
      "                      (PP (IN of)\n",
      "                        (NP (NNS diuretics)\n",
      "                          (CC and)\n",
      "                          (NNS beta-blockers))))))\n",
      "                (PP (IN in)\n",
      "                  (NP (JJ hypertensive) (NNS patients)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, shown-4)\n",
      "nsubjpass(shown-4, Captopril-1)\n",
      "nsubj:xsubj(have-6, Captopril-1)\n",
      "aux(shown-4, has-2)\n",
      "auxpass(shown-4, been-3)\n",
      "mark(have-6, to-5)\n",
      "xcomp(shown-4, have-6)\n",
      "amod(morbidity-8, similar-7)\n",
      "dobj(have-6, morbidity-8)\n",
      "cc(morbidity-8, and-9)\n",
      "compound(benefits-11, mortality-10)\n",
      "dobj(have-6, benefits-11)\n",
      "conj:and(morbidity-8, benefits-11)\n",
      "case(those-13, to-12)\n",
      "nmod:to(morbidity-8, those-13)\n",
      "case(diuretics-15, of-14)\n",
      "nmod:of(those-13, diuretics-15)\n",
      "cc(diuretics-15, and-16)\n",
      "nmod:of(those-13, beta-blockers-17)\n",
      "conj:and(diuretics-15, beta-blockers-17)\n",
      "case(patients-20, in-18)\n",
      "amod(patients-20, hypertensive-19)\n",
      "nmod:in(have-6, patients-20)\n",
      "punct(shown-4, .-21)\n",
      "\n",
      "Sentence #105 (27 tokens, sentiment: Negative):\n",
      "Captopril has been shown to delay the progression of diabetic nephropathy, and enalapril and lisinopril prevent the development of nephropathy in normoalbuminuric patients with diabetes.\n",
      "[Text=Captopril CharacterOffsetBegin=15466 CharacterOffsetEnd=15475 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=has CharacterOffsetBegin=15476 CharacterOffsetEnd=15479 PartOfSpeech=VBZ Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=been CharacterOffsetBegin=15480 CharacterOffsetEnd=15484 PartOfSpeech=VBN Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=shown CharacterOffsetBegin=15485 CharacterOffsetEnd=15490 PartOfSpeech=VBN Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=15491 CharacterOffsetEnd=15493 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=delay CharacterOffsetBegin=15494 CharacterOffsetEnd=15499 PartOfSpeech=VB Lemma=delay NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=15500 CharacterOffsetEnd=15503 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=progression CharacterOffsetBegin=15504 CharacterOffsetEnd=15515 PartOfSpeech=NN Lemma=progression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=15516 CharacterOffsetEnd=15518 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=15519 CharacterOffsetEnd=15527 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephropathy CharacterOffsetBegin=15528 CharacterOffsetEnd=15539 PartOfSpeech=NN Lemma=nephropathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15539 CharacterOffsetEnd=15540 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=15541 CharacterOffsetEnd=15544 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=15545 CharacterOffsetEnd=15554 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=15555 CharacterOffsetEnd=15558 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=15559 CharacterOffsetEnd=15569 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=prevent CharacterOffsetBegin=15570 CharacterOffsetEnd=15577 PartOfSpeech=VBP Lemma=prevent NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=15578 CharacterOffsetEnd=15581 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=development CharacterOffsetBegin=15582 CharacterOffsetEnd=15593 PartOfSpeech=NN Lemma=development NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=15594 CharacterOffsetEnd=15596 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephropathy CharacterOffsetBegin=15597 CharacterOffsetEnd=15608 PartOfSpeech=NN Lemma=nephropathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=15609 CharacterOffsetEnd=15611 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=normoalbuminuric CharacterOffsetBegin=15612 CharacterOffsetEnd=15628 PartOfSpeech=JJ Lemma=normoalbuminuric NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=15629 CharacterOffsetEnd=15637 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=15638 CharacterOffsetEnd=15642 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetes CharacterOffsetBegin=15643 CharacterOffsetEnd=15651 PartOfSpeech=NN Lemma=diabetes NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=15651 CharacterOffsetEnd=15652 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN Captopril))\n",
      "      (VP (VBZ has)\n",
      "        (VP (VBN been)\n",
      "          (VP (VBN shown)\n",
      "            (S\n",
      "              (VP (TO to)\n",
      "                (VP (VB delay)\n",
      "                  (NP\n",
      "                    (NP (DT the) (NN progression))\n",
      "                    (PP (IN of)\n",
      "                      (NP (JJ diabetic) (NN nephropathy)))))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN enalapril)\n",
      "        (CC and)\n",
      "        (NN lisinopril))\n",
      "      (VP (VBP prevent)\n",
      "        (NP\n",
      "          (NP (DT the) (NN development))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (NN nephropathy))\n",
      "              (PP (IN in)\n",
      "                (NP (JJ normoalbuminuric) (NNS patients))))))\n",
      "        (PP (IN with)\n",
      "          (NP (NN diabetes)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, shown-4)\n",
      "nsubjpass(shown-4, Captopril-1)\n",
      "nsubj:xsubj(delay-6, Captopril-1)\n",
      "aux(shown-4, has-2)\n",
      "auxpass(shown-4, been-3)\n",
      "mark(delay-6, to-5)\n",
      "xcomp(shown-4, delay-6)\n",
      "det(progression-8, the-7)\n",
      "dobj(delay-6, progression-8)\n",
      "case(nephropathy-11, of-9)\n",
      "amod(nephropathy-11, diabetic-10)\n",
      "nmod:of(progression-8, nephropathy-11)\n",
      "punct(shown-4, ,-12)\n",
      "cc(shown-4, and-13)\n",
      "nsubj(prevent-17, enalapril-14)\n",
      "cc(enalapril-14, and-15)\n",
      "conj:and(enalapril-14, lisinopril-16)\n",
      "nsubj(prevent-17, lisinopril-16)\n",
      "conj:and(shown-4, prevent-17)\n",
      "det(development-19, the-18)\n",
      "dobj(prevent-17, development-19)\n",
      "case(nephropathy-21, of-20)\n",
      "nmod:of(development-19, nephropathy-21)\n",
      "case(patients-24, in-22)\n",
      "amod(patients-24, normoalbuminuric-23)\n",
      "nmod:in(nephropathy-21, patients-24)\n",
      "case(diabetes-26, with-25)\n",
      "nmod:with(prevent-17, diabetes-26)\n",
      "punct(shown-4, .-27)\n",
      "\n",
      "Sentence #106 (10 tokens, sentiment: Negative):\n",
      "ACE inhibitors are generally characterised by flat dose-response curves.\n",
      "[Text=ACE CharacterOffsetBegin=15653 CharacterOffsetEnd=15656 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=15657 CharacterOffsetEnd=15667 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=15668 CharacterOffsetEnd=15671 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=generally CharacterOffsetBegin=15672 CharacterOffsetEnd=15681 PartOfSpeech=RB Lemma=generally NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=characterised CharacterOffsetBegin=15682 CharacterOffsetEnd=15695 PartOfSpeech=VBN Lemma=characterise NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=15696 CharacterOffsetEnd=15698 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=flat CharacterOffsetBegin=15699 CharacterOffsetEnd=15703 PartOfSpeech=JJ Lemma=flat NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=dose-response CharacterOffsetBegin=15704 CharacterOffsetEnd=15717 PartOfSpeech=JJ Lemma=dose-response NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=curves CharacterOffsetBegin=15718 CharacterOffsetEnd=15724 PartOfSpeech=NNS Lemma=curve NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=15724 CharacterOffsetEnd=15725 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN ACE) (NNS inhibitors))\n",
      "    (VP (VBP are)\n",
      "      (ADVP (RB generally))\n",
      "      (VP (VBN characterised)\n",
      "        (PP (IN by)\n",
      "          (NP (JJ flat) (JJ dose-response) (NNS curves)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, characterised-5)\n",
      "compound(inhibitors-2, ACE-1)\n",
      "nsubjpass(characterised-5, inhibitors-2)\n",
      "auxpass(characterised-5, are-3)\n",
      "advmod(characterised-5, generally-4)\n",
      "case(curves-9, by-6)\n",
      "amod(curves-9, flat-7)\n",
      "amod(curves-9, dose-response-8)\n",
      "nmod:agent(characterised-5, curves-9)\n",
      "punct(characterised-5, .-10)\n",
      "\n",
      "Sentence #107 (13 tokens, sentiment: Negative):\n",
      "Lisinopril is the only ACE inhibitor that exhibits a linear dose-response curve.\n",
      "[Text=Lisinopril CharacterOffsetBegin=15726 CharacterOffsetEnd=15736 PartOfSpeech=NNP Lemma=Lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=15737 CharacterOffsetEnd=15739 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=15740 CharacterOffsetEnd=15743 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=only CharacterOffsetBegin=15744 CharacterOffsetEnd=15748 PartOfSpeech=JJ Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=15749 CharacterOffsetEnd=15752 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=15753 CharacterOffsetEnd=15762 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=15763 CharacterOffsetEnd=15767 PartOfSpeech=WDT Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=exhibits CharacterOffsetBegin=15768 CharacterOffsetEnd=15776 PartOfSpeech=VBZ Lemma=exhibit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=15777 CharacterOffsetEnd=15778 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=linear CharacterOffsetBegin=15779 CharacterOffsetEnd=15785 PartOfSpeech=JJ Lemma=linear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dose-response CharacterOffsetBegin=15786 CharacterOffsetEnd=15799 PartOfSpeech=JJ Lemma=dose-response NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=curve CharacterOffsetBegin=15800 CharacterOffsetEnd=15805 PartOfSpeech=NN Lemma=curve NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=15805 CharacterOffsetEnd=15806 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Lisinopril))\n",
      "    (VP (VBZ is)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ only) (NN ACE) (NN inhibitor))\n",
      "        (SBAR\n",
      "          (WHNP (WDT that))\n",
      "          (S\n",
      "            (VP (VBZ exhibits)\n",
      "              (NP (DT a) (JJ linear) (JJ dose-response) (NN curve)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, inhibitor-6)\n",
      "nsubj(inhibitor-6, Lisinopril-1)\n",
      "cop(inhibitor-6, is-2)\n",
      "det(inhibitor-6, the-3)\n",
      "amod(inhibitor-6, only-4)\n",
      "compound(inhibitor-6, ACE-5)\n",
      "nsubj(exhibits-8, inhibitor-6)\n",
      "ref(inhibitor-6, that-7)\n",
      "acl:relcl(inhibitor-6, exhibits-8)\n",
      "det(curve-12, a-9)\n",
      "amod(curve-12, linear-10)\n",
      "amod(curve-12, dose-response-11)\n",
      "dobj(exhibits-8, curve-12)\n",
      "punct(inhibitor-6, .-13)\n",
      "\n",
      "Sentence #108 (30 tokens, sentiment: Negative):\n",
      "Despite the fact that most ACE inhibitors are recommended for once-daily administration, only fosinopril, ramipril, and trandolapril have trough-to-peak effect ratios in excess of 50%.\n",
      "[Text=Despite CharacterOffsetBegin=15807 CharacterOffsetEnd=15814 PartOfSpeech=IN Lemma=despite NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=15815 CharacterOffsetEnd=15818 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=fact CharacterOffsetBegin=15819 CharacterOffsetEnd=15823 PartOfSpeech=NN Lemma=fact NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=15824 CharacterOffsetEnd=15828 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=most CharacterOffsetBegin=15829 CharacterOffsetEnd=15833 PartOfSpeech=JJS Lemma=most NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=15834 CharacterOffsetEnd=15837 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=15838 CharacterOffsetEnd=15848 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=15849 CharacterOffsetEnd=15852 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=recommended CharacterOffsetBegin=15853 CharacterOffsetEnd=15864 PartOfSpeech=VBN Lemma=recommend NamedEntityTag=O SentimentClass=Very positive]\n",
      "[Text=for CharacterOffsetBegin=15865 CharacterOffsetEnd=15868 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=once-daily CharacterOffsetBegin=15869 CharacterOffsetEnd=15879 PartOfSpeech=JJ Lemma=once-daily NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=administration CharacterOffsetBegin=15880 CharacterOffsetEnd=15894 PartOfSpeech=NN Lemma=administration NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15894 CharacterOffsetEnd=15895 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=only CharacterOffsetBegin=15896 CharacterOffsetEnd=15900 PartOfSpeech=RB Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=fosinopril CharacterOffsetBegin=15901 CharacterOffsetEnd=15911 PartOfSpeech=NN Lemma=fosinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15911 CharacterOffsetEnd=15912 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ramipril CharacterOffsetBegin=15913 CharacterOffsetEnd=15921 PartOfSpeech=NN Lemma=ramipril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=15921 CharacterOffsetEnd=15922 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=15923 CharacterOffsetEnd=15926 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trandolapril CharacterOffsetBegin=15927 CharacterOffsetEnd=15939 PartOfSpeech=NN Lemma=trandolapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=have CharacterOffsetBegin=15940 CharacterOffsetEnd=15944 PartOfSpeech=VBP Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trough-to-peak CharacterOffsetBegin=15945 CharacterOffsetEnd=15959 PartOfSpeech=JJ Lemma=trough-to-peak NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=15960 CharacterOffsetEnd=15966 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ratios CharacterOffsetBegin=15967 CharacterOffsetEnd=15973 PartOfSpeech=NNS Lemma=ratio NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=15974 CharacterOffsetEnd=15976 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=excess CharacterOffsetBegin=15977 CharacterOffsetEnd=15983 PartOfSpeech=NN Lemma=excess NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=15984 CharacterOffsetEnd=15986 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=50 CharacterOffsetBegin=15987 CharacterOffsetEnd=15989 PartOfSpeech=CD Lemma=50 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%50.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=15989 CharacterOffsetEnd=15990 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%50.0 SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=15990 CharacterOffsetEnd=15991 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN Despite)\n",
      "      (NP\n",
      "        (NP (DT the) (NN fact))\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP (JJS most) (NN ACE) (NNS inhibitors))\n",
      "            (VP (VBP are)\n",
      "              (VP (VBN recommended)\n",
      "                (PP (IN for)\n",
      "                  (NP (JJ once-daily) (NN administration)))))))))\n",
      "    (, ,)\n",
      "    (NP (RB only)\n",
      "      (NP (NN fosinopril))\n",
      "      (, ,)\n",
      "      (NP (NN ramipril))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NN trandolapril)))\n",
      "    (VP (VBP have)\n",
      "      (NP (JJ trough-to-peak) (NN effect) (NNS ratios))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (NN excess))\n",
      "          (PP (IN of)\n",
      "            (NP (CD 50) (NN %))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, have-21)\n",
      "case(fact-3, Despite-1)\n",
      "det(fact-3, the-2)\n",
      "nmod:despite(have-21, fact-3)\n",
      "mark(recommended-9, that-4)\n",
      "amod(inhibitors-7, most-5)\n",
      "compound(inhibitors-7, ACE-6)\n",
      "nsubjpass(recommended-9, inhibitors-7)\n",
      "auxpass(recommended-9, are-8)\n",
      "dep(fact-3, recommended-9)\n",
      "case(administration-12, for-10)\n",
      "amod(administration-12, once-daily-11)\n",
      "nmod:for(recommended-9, administration-12)\n",
      "punct(have-21, ,-13)\n",
      "advmod(fosinopril-15, only-14)\n",
      "nsubj(have-21, fosinopril-15)\n",
      "punct(fosinopril-15, ,-16)\n",
      "conj:and(fosinopril-15, ramipril-17)\n",
      "nsubj(have-21, ramipril-17)\n",
      "punct(fosinopril-15, ,-18)\n",
      "cc(fosinopril-15, and-19)\n",
      "conj:and(fosinopril-15, trandolapril-20)\n",
      "nsubj(have-21, trandolapril-20)\n",
      "amod(ratios-24, trough-to-peak-22)\n",
      "compound(ratios-24, effect-23)\n",
      "dobj(have-21, ratios-24)\n",
      "case(excess-26, in-25)\n",
      "nmod:in(have-21, excess-26)\n",
      "case(%-29, of-27)\n",
      "nummod(%-29, 50-28)\n",
      "nmod:of(excess-26, %-29)\n",
      "punct(have-21, .-30)\n",
      "\n",
      "Sentence #109 (14 tokens, sentiment: Negative):\n",
      "To evaluate the efficacy and safety of Benazepril used among the essential hypertensives.\n",
      "[Text=To CharacterOffsetBegin=15993 CharacterOffsetEnd=15995 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=evaluate CharacterOffsetBegin=15996 CharacterOffsetEnd=16004 PartOfSpeech=VB Lemma=evaluate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=16005 CharacterOffsetEnd=16008 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=efficacy CharacterOffsetBegin=16009 CharacterOffsetEnd=16017 PartOfSpeech=NN Lemma=efficacy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16018 CharacterOffsetEnd=16021 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=safety CharacterOffsetBegin=16022 CharacterOffsetEnd=16028 PartOfSpeech=NN Lemma=safety NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=16029 CharacterOffsetEnd=16031 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=16032 CharacterOffsetEnd=16042 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=16043 CharacterOffsetEnd=16047 PartOfSpeech=VBD Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=among CharacterOffsetBegin=16048 CharacterOffsetEnd=16053 PartOfSpeech=IN Lemma=among NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=16054 CharacterOffsetEnd=16057 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=essential CharacterOffsetBegin=16058 CharacterOffsetEnd=16067 PartOfSpeech=JJ Lemma=essential NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=hypertensives CharacterOffsetBegin=16068 CharacterOffsetEnd=16081 PartOfSpeech=NNS Lemma=hypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16081 CharacterOffsetEnd=16082 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (VP (TO To)\n",
      "        (VP (VB evaluate)\n",
      "          (NP\n",
      "            (NP (DT the) (NN efficacy)\n",
      "              (CC and)\n",
      "              (NN safety))\n",
      "            (PP (IN of)\n",
      "              (NP (NNP Benazepril)))))))\n",
      "    (VP (VBD used)\n",
      "      (PP (IN among)\n",
      "        (NP (DT the) (JJ essential) (NNS hypertensives))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, used-9)\n",
      "mark(evaluate-2, To-1)\n",
      "csubj(used-9, evaluate-2)\n",
      "det(efficacy-4, the-3)\n",
      "dobj(evaluate-2, efficacy-4)\n",
      "cc(efficacy-4, and-5)\n",
      "dobj(evaluate-2, safety-6)\n",
      "conj:and(efficacy-4, safety-6)\n",
      "case(Benazepril-8, of-7)\n",
      "nmod:of(efficacy-4, Benazepril-8)\n",
      "case(hypertensives-13, among-10)\n",
      "det(hypertensives-13, the-11)\n",
      "amod(hypertensives-13, essential-12)\n",
      "nmod:among(used-9, hypertensives-13)\n",
      "punct(used-9, .-14)\n",
      "\n",
      "Sentence #110 (21 tokens, sentiment: Negative):\n",
      "1 831 essential hypertensive patients aged 35 to 75 were randomly selected from a community and followed for 18 months.\n",
      "[Text=1 CharacterOffsetBegin=16084 CharacterOffsetEnd=16085 PartOfSpeech=CD Lemma=1 NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=831 CharacterOffsetBegin=16086 CharacterOffsetEnd=16089 PartOfSpeech=CD Lemma=831 NamedEntityTag=NUMBER NormalizedNamedEntityTag=831.0 SentimentClass=Neutral]\n",
      "[Text=essential CharacterOffsetBegin=16090 CharacterOffsetEnd=16099 PartOfSpeech=JJ Lemma=essential NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=hypertensive CharacterOffsetBegin=16100 CharacterOffsetEnd=16112 PartOfSpeech=JJ Lemma=hypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=16113 CharacterOffsetEnd=16121 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=aged CharacterOffsetBegin=16122 CharacterOffsetEnd=16126 PartOfSpeech=JJ Lemma=aged NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=35 CharacterOffsetBegin=16127 CharacterOffsetEnd=16129 PartOfSpeech=CD Lemma=35 NamedEntityTag=NUMBER NormalizedNamedEntityTag=35.0 SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=16130 CharacterOffsetEnd=16132 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=75 CharacterOffsetBegin=16133 CharacterOffsetEnd=16135 PartOfSpeech=CD Lemma=75 NamedEntityTag=NUMBER NormalizedNamedEntityTag=75.0 SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=16136 CharacterOffsetEnd=16140 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=randomly CharacterOffsetBegin=16141 CharacterOffsetEnd=16149 PartOfSpeech=RB Lemma=randomly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=selected CharacterOffsetBegin=16150 CharacterOffsetEnd=16158 PartOfSpeech=VBN Lemma=select NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=from CharacterOffsetBegin=16159 CharacterOffsetEnd=16163 PartOfSpeech=IN Lemma=from NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=16164 CharacterOffsetEnd=16165 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=community CharacterOffsetBegin=16166 CharacterOffsetEnd=16175 PartOfSpeech=NN Lemma=community NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16176 CharacterOffsetEnd=16179 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=followed CharacterOffsetBegin=16180 CharacterOffsetEnd=16188 PartOfSpeech=VBD Lemma=follow NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=16189 CharacterOffsetEnd=16192 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=18 CharacterOffsetBegin=16193 CharacterOffsetEnd=16195 PartOfSpeech=CD Lemma=18 NamedEntityTag=DURATION NormalizedNamedEntityTag=P18M Timex=<TIMEX3 tid=\"t23\" type=\"DURATION\" value=\"P18M\">18 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=months CharacterOffsetBegin=16196 CharacterOffsetEnd=16202 PartOfSpeech=NNS Lemma=month NamedEntityTag=DURATION NormalizedNamedEntityTag=P18M Timex=<TIMEX3 tid=\"t23\" type=\"DURATION\" value=\"P18M\">18 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16202 CharacterOffsetEnd=16203 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (QP (CD 1) (CD 831))\n",
      "        (JJ essential) (JJ hypertensive) (NNS patients))\n",
      "      (ADJP (JJ aged)\n",
      "        (NP\n",
      "          (QP (CD 35) (TO to) (CD 75)))))\n",
      "    (VP\n",
      "      (VP (VBD were)\n",
      "        (VP\n",
      "          (ADVP (RB randomly))\n",
      "          (VBN selected)\n",
      "          (PP (IN from)\n",
      "            (NP (DT a) (NN community)))))\n",
      "      (CC and)\n",
      "      (VP (VBD followed)\n",
      "        (PP (IN for)\n",
      "          (NP (CD 18) (NNS months)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, selected-12)\n",
      "compound(831-2, 1-1)\n",
      "nummod(patients-5, 831-2)\n",
      "amod(patients-5, essential-3)\n",
      "amod(patients-5, hypertensive-4)\n",
      "nsubjpass(selected-12, patients-5)\n",
      "nsubjpass(followed-17, patients-5)\n",
      "amod(patients-5, aged-6)\n",
      "compound(75-9, 35-7)\n",
      "dep(75-9, to-8)\n",
      "dep(aged-6, 75-9)\n",
      "auxpass(selected-12, were-10)\n",
      "advmod(selected-12, randomly-11)\n",
      "case(community-15, from-13)\n",
      "det(community-15, a-14)\n",
      "nmod:from(selected-12, community-15)\n",
      "cc(selected-12, and-16)\n",
      "conj:and(selected-12, followed-17)\n",
      "case(months-20, for-18)\n",
      "nummod(months-20, 18-19)\n",
      "nmod:for(followed-17, months-20)\n",
      "punct(selected-12, .-21)\n",
      "\n",
      "Sentence #111 (17 tokens, sentiment: Negative):\n",
      "The level of blood pressure, status of taking Benazepril and side effects were sequencially collected.\n",
      "[Text=The CharacterOffsetBegin=16204 CharacterOffsetEnd=16207 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=level CharacterOffsetBegin=16208 CharacterOffsetEnd=16213 PartOfSpeech=NN Lemma=level NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=16214 CharacterOffsetEnd=16216 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blood CharacterOffsetBegin=16217 CharacterOffsetEnd=16222 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=pressure CharacterOffsetBegin=16223 CharacterOffsetEnd=16231 PartOfSpeech=NN Lemma=pressure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=16231 CharacterOffsetEnd=16232 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=status CharacterOffsetBegin=16233 CharacterOffsetEnd=16239 PartOfSpeech=NN Lemma=status NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=16240 CharacterOffsetEnd=16242 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=taking CharacterOffsetBegin=16243 CharacterOffsetEnd=16249 PartOfSpeech=VBG Lemma=take NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=16250 CharacterOffsetEnd=16260 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=PERSON SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16261 CharacterOffsetEnd=16264 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=side CharacterOffsetBegin=16265 CharacterOffsetEnd=16269 PartOfSpeech=JJ Lemma=side NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effects CharacterOffsetBegin=16270 CharacterOffsetEnd=16277 PartOfSpeech=NNS Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=16278 CharacterOffsetEnd=16282 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=sequencially CharacterOffsetBegin=16283 CharacterOffsetEnd=16295 PartOfSpeech=RB Lemma=sequencially NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=collected CharacterOffsetBegin=16296 CharacterOffsetEnd=16305 PartOfSpeech=VBN Lemma=collect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16305 CharacterOffsetEnd=16306 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN level))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN blood) (NN pressure))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP (NN status))\n",
      "            (PP (IN of)\n",
      "              (S\n",
      "                (VP (VBG taking)\n",
      "                  (NP\n",
      "                    (NP (NNP Benazepril))\n",
      "                    (CC and)\n",
      "                    (NP (JJ side) (NNS effects))))))))))\n",
      "    (VP (VBD were)\n",
      "      (VP\n",
      "        (ADVP (RB sequencially))\n",
      "        (VBN collected)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, collected-16)\n",
      "det(level-2, The-1)\n",
      "nsubjpass(collected-16, level-2)\n",
      "case(pressure-5, of-3)\n",
      "compound(pressure-5, blood-4)\n",
      "nmod:of(level-2, pressure-5)\n",
      "punct(pressure-5, ,-6)\n",
      "appos(pressure-5, status-7)\n",
      "mark(taking-9, of-8)\n",
      "acl:of(status-7, taking-9)\n",
      "dobj(taking-9, Benazepril-10)\n",
      "cc(Benazepril-10, and-11)\n",
      "amod(effects-13, side-12)\n",
      "dobj(taking-9, effects-13)\n",
      "conj:and(Benazepril-10, effects-13)\n",
      "auxpass(collected-16, were-14)\n",
      "advmod(collected-16, sequencially-15)\n",
      "punct(collected-16, .-17)\n",
      "\n",
      "Sentence #112 (21 tokens, sentiment: Negative):\n",
      "1/3 of the patients had taken antihypertensive drug before the study and the rate of compliance was over 96%.\n",
      "[Text=1/3 CharacterOffsetBegin=16308 CharacterOffsetEnd=16311 PartOfSpeech=CD Lemma=1/3 NamedEntityTag=NUMBER SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=16312 CharacterOffsetEnd=16314 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=16315 CharacterOffsetEnd=16318 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=16319 CharacterOffsetEnd=16327 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=had CharacterOffsetBegin=16328 CharacterOffsetEnd=16331 PartOfSpeech=VBD Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=taken CharacterOffsetBegin=16332 CharacterOffsetEnd=16337 PartOfSpeech=VBN Lemma=take NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=antihypertensive CharacterOffsetBegin=16338 CharacterOffsetEnd=16354 PartOfSpeech=JJ Lemma=antihypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drug CharacterOffsetBegin=16355 CharacterOffsetEnd=16359 PartOfSpeech=NN Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=before CharacterOffsetBegin=16360 CharacterOffsetEnd=16366 PartOfSpeech=IN Lemma=before NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=16367 CharacterOffsetEnd=16370 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=16371 CharacterOffsetEnd=16376 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16377 CharacterOffsetEnd=16380 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=16381 CharacterOffsetEnd=16384 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rate CharacterOffsetBegin=16385 CharacterOffsetEnd=16389 PartOfSpeech=NN Lemma=rate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=16390 CharacterOffsetEnd=16392 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compliance CharacterOffsetBegin=16393 CharacterOffsetEnd=16403 PartOfSpeech=NN Lemma=compliance NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=16404 CharacterOffsetEnd=16407 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=over CharacterOffsetBegin=16408 CharacterOffsetEnd=16412 PartOfSpeech=IN Lemma=over NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=96 CharacterOffsetBegin=16413 CharacterOffsetEnd=16415 PartOfSpeech=CD Lemma=96 NamedEntityTag=PERCENT NormalizedNamedEntityTag=>%96.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=16415 CharacterOffsetEnd=16416 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=>%96.0 SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16416 CharacterOffsetEnd=16417 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (CD 1/3))\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (NNS patients))))\n",
      "      (VP (VBD had)\n",
      "        (VP (VBN taken)\n",
      "          (NP (JJ antihypertensive) (NN drug))\n",
      "          (PP (IN before)\n",
      "            (NP (DT the) (NN study))))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT the) (NN rate))\n",
      "        (PP (IN of)\n",
      "          (NP (NN compliance))))\n",
      "      (VP (VBD was)\n",
      "        (PP (IN over)\n",
      "          (NP (CD 96) (NN %)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, taken-6)\n",
      "nsubj(taken-6, 1/3-1)\n",
      "case(patients-4, of-2)\n",
      "det(patients-4, the-3)\n",
      "nmod:of(1/3-1, patients-4)\n",
      "aux(taken-6, had-5)\n",
      "amod(drug-8, antihypertensive-7)\n",
      "dobj(taken-6, drug-8)\n",
      "case(study-11, before-9)\n",
      "det(study-11, the-10)\n",
      "nmod:before(taken-6, study-11)\n",
      "cc(taken-6, and-12)\n",
      "det(rate-14, the-13)\n",
      "nsubj(%-20, rate-14)\n",
      "case(compliance-16, of-15)\n",
      "nmod:of(rate-14, compliance-16)\n",
      "cop(%-20, was-17)\n",
      "case(%-20, over-18)\n",
      "nummod(%-20, 96-19)\n",
      "conj:and(taken-6, %-20)\n",
      "punct(taken-6, .-21)\n",
      "\n",
      "Sentence #113 (20 tokens, sentiment: Negative):\n",
      "The effective rate of Benazepril was 73.6% at three months and increased to 84.7% at 18 months.\n",
      "[Text=The CharacterOffsetBegin=16418 CharacterOffsetEnd=16421 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effective CharacterOffsetBegin=16422 CharacterOffsetEnd=16431 PartOfSpeech=JJ Lemma=effective NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=rate CharacterOffsetBegin=16432 CharacterOffsetEnd=16436 PartOfSpeech=NN Lemma=rate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=16437 CharacterOffsetEnd=16439 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=16440 CharacterOffsetEnd=16450 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=16451 CharacterOffsetEnd=16454 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=73.6 CharacterOffsetBegin=16455 CharacterOffsetEnd=16459 PartOfSpeech=CD Lemma=73.6 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%73.6 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=16459 CharacterOffsetEnd=16460 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%73.6 SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=16461 CharacterOffsetEnd=16463 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=three CharacterOffsetBegin=16464 CharacterOffsetEnd=16469 PartOfSpeech=CD Lemma=three NamedEntityTag=DURATION NormalizedNamedEntityTag=P3M Timex=<TIMEX3 tid=\"t24\" type=\"DURATION\" value=\"P3M\">three months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=months CharacterOffsetBegin=16470 CharacterOffsetEnd=16476 PartOfSpeech=NNS Lemma=month NamedEntityTag=DURATION NormalizedNamedEntityTag=P3M Timex=<TIMEX3 tid=\"t24\" type=\"DURATION\" value=\"P3M\">three months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16477 CharacterOffsetEnd=16480 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=increased CharacterOffsetBegin=16481 CharacterOffsetEnd=16490 PartOfSpeech=VBN Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=16491 CharacterOffsetEnd=16493 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=84.7 CharacterOffsetBegin=16494 CharacterOffsetEnd=16498 PartOfSpeech=CD Lemma=84.7 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%84.7 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=16498 CharacterOffsetEnd=16499 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%84.7 SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=16500 CharacterOffsetEnd=16502 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=18 CharacterOffsetBegin=16503 CharacterOffsetEnd=16505 PartOfSpeech=CD Lemma=18 NamedEntityTag=DURATION NormalizedNamedEntityTag=P18M Timex=<TIMEX3 tid=\"t25\" type=\"DURATION\" value=\"P18M\">18 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=months CharacterOffsetBegin=16506 CharacterOffsetEnd=16512 PartOfSpeech=NNS Lemma=month NamedEntityTag=DURATION NormalizedNamedEntityTag=P18M Timex=<TIMEX3 tid=\"t25\" type=\"DURATION\" value=\"P18M\">18 months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16512 CharacterOffsetEnd=16513 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (JJ effective) (NN rate))\n",
      "      (PP (IN of)\n",
      "        (NP (NNP Benazepril))))\n",
      "    (VP (VBD was)\n",
      "      (VP\n",
      "        (VP\n",
      "          (NP (CD 73.6) (NN %))\n",
      "          (PP (IN at)\n",
      "            (NP (CD three) (NNS months))))\n",
      "        (CC and)\n",
      "        (VP (VBN increased)\n",
      "          (PP (TO to)\n",
      "            (NP\n",
      "              (NP (CD 84.7) (NN %))\n",
      "              (PP (IN at)\n",
      "                (NP (CD 18) (NNS months))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, %-8)\n",
      "det(rate-3, The-1)\n",
      "amod(rate-3, effective-2)\n",
      "nsubjpass(%-8, rate-3)\n",
      "nsubjpass(increased-13, rate-3)\n",
      "case(Benazepril-5, of-4)\n",
      "nmod:of(rate-3, Benazepril-5)\n",
      "auxpass(%-8, was-6)\n",
      "nummod(%-8, 73.6-7)\n",
      "case(months-11, at-9)\n",
      "nummod(months-11, three-10)\n",
      "nmod:at(%-8, months-11)\n",
      "cc(%-8, and-12)\n",
      "conj:and(%-8, increased-13)\n",
      "case(%-16, to-14)\n",
      "nummod(%-16, 84.7-15)\n",
      "nmod:to(increased-13, %-16)\n",
      "case(months-19, at-17)\n",
      "nummod(months-19, 18-18)\n",
      "nmod:at(%-16, months-19)\n",
      "punct(%-8, .-20)\n",
      "\n",
      "Sentence #114 (17 tokens, sentiment: Negative):\n",
      "Comparing with the baseline data, SBP and DBP declined 10.8 mmHg and 6.7 mmHg respectively.\n",
      "[Text=Comparing CharacterOffsetBegin=16514 CharacterOffsetEnd=16523 PartOfSpeech=VBG Lemma=compare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=16524 CharacterOffsetEnd=16528 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=16529 CharacterOffsetEnd=16532 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=baseline CharacterOffsetBegin=16533 CharacterOffsetEnd=16541 PartOfSpeech=NN Lemma=baseline NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=data CharacterOffsetBegin=16542 CharacterOffsetEnd=16546 PartOfSpeech=NNS Lemma=datum NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=16546 CharacterOffsetEnd=16547 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SBP CharacterOffsetBegin=16548 CharacterOffsetEnd=16551 PartOfSpeech=NN Lemma=sbp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16552 CharacterOffsetEnd=16555 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=DBP CharacterOffsetBegin=16556 CharacterOffsetEnd=16559 PartOfSpeech=NN Lemma=dbp NamedEntityTag=ORGANIZATION SentimentClass=Neutral]\n",
      "[Text=declined CharacterOffsetBegin=16560 CharacterOffsetEnd=16568 PartOfSpeech=VBD Lemma=decline NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10.8 CharacterOffsetBegin=16569 CharacterOffsetEnd=16573 PartOfSpeech=CD Lemma=10.8 NamedEntityTag=NUMBER NormalizedNamedEntityTag=10.8 SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=16574 CharacterOffsetEnd=16578 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16579 CharacterOffsetEnd=16582 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=6.7 CharacterOffsetBegin=16583 CharacterOffsetEnd=16586 PartOfSpeech=CD Lemma=6.7 NamedEntityTag=NUMBER NormalizedNamedEntityTag=6.7 SentimentClass=Neutral]\n",
      "[Text=mmHg CharacterOffsetBegin=16587 CharacterOffsetEnd=16591 PartOfSpeech=NN Lemma=mmhg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=respectively CharacterOffsetBegin=16592 CharacterOffsetEnd=16604 PartOfSpeech=RB Lemma=respectively NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16604 CharacterOffsetEnd=16605 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (VP (VBG Comparing)\n",
      "        (PP (IN with)\n",
      "          (NP (DT the) (NN baseline) (NNS data)))))\n",
      "    (, ,)\n",
      "    (NP (NN SBP)\n",
      "      (CC and)\n",
      "      (NN DBP))\n",
      "    (VP (VBD declined)\n",
      "      (NP\n",
      "        (NP (CD 10.8) (NN mmHg))\n",
      "        (CC and)\n",
      "        (NP (CD 6.7) (NN mmHg)))\n",
      "      (ADVP (RB respectively)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, declined-10)\n",
      "advcl(declined-10, Comparing-1)\n",
      "case(data-5, with-2)\n",
      "det(data-5, the-3)\n",
      "compound(data-5, baseline-4)\n",
      "nmod:with(Comparing-1, data-5)\n",
      "punct(declined-10, ,-6)\n",
      "nsubj(declined-10, SBP-7)\n",
      "cc(SBP-7, and-8)\n",
      "conj:and(SBP-7, DBP-9)\n",
      "nsubj(declined-10, DBP-9)\n",
      "nummod(mmHg-12, 10.8-11)\n",
      "dobj(declined-10, mmHg-12)\n",
      "cc(mmHg-12, and-13)\n",
      "nummod(mmHg-15, 6.7-14)\n",
      "dobj(declined-10, mmHg-15)\n",
      "conj:and(mmHg-12, mmHg-15)\n",
      "advmod(declined-10, respectively-16)\n",
      "punct(declined-10, .-17)\n",
      "\n",
      "Sentence #115 (9 tokens, sentiment: Negative):\n",
      "The rate of side effect was 22.7%.\n",
      "[Text=The CharacterOffsetBegin=16606 CharacterOffsetEnd=16609 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rate CharacterOffsetBegin=16610 CharacterOffsetEnd=16614 PartOfSpeech=NN Lemma=rate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=16615 CharacterOffsetEnd=16617 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=side CharacterOffsetBegin=16618 CharacterOffsetEnd=16622 PartOfSpeech=JJ Lemma=side NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=16623 CharacterOffsetEnd=16629 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=16630 CharacterOffsetEnd=16633 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=22.7 CharacterOffsetBegin=16634 CharacterOffsetEnd=16638 PartOfSpeech=CD Lemma=22.7 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%22.7 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=16638 CharacterOffsetEnd=16639 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%22.7 SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16639 CharacterOffsetEnd=16640 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN rate))\n",
      "      (PP (IN of)\n",
      "        (NP (JJ side) (NN effect))))\n",
      "    (VP (VBD was)\n",
      "      (NP (CD 22.7) (NN %)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, %-8)\n",
      "det(rate-2, The-1)\n",
      "nsubj(%-8, rate-2)\n",
      "case(effect-5, of-3)\n",
      "amod(effect-5, side-4)\n",
      "nmod:of(rate-2, effect-5)\n",
      "cop(%-8, was-6)\n",
      "nummod(%-8, 22.7-7)\n",
      "punct(%-8, .-9)\n",
      "\n",
      "Sentence #116 (9 tokens, sentiment: Negative):\n",
      "Cough was most commonly seen among side effects.\n",
      "[Text=Cough CharacterOffsetBegin=16641 CharacterOffsetEnd=16646 PartOfSpeech=NN Lemma=cough NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=16647 CharacterOffsetEnd=16650 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=most CharacterOffsetBegin=16651 CharacterOffsetEnd=16655 PartOfSpeech=RBS Lemma=most NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=commonly CharacterOffsetBegin=16656 CharacterOffsetEnd=16664 PartOfSpeech=RB Lemma=commonly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=seen CharacterOffsetBegin=16665 CharacterOffsetEnd=16669 PartOfSpeech=VBN Lemma=see NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=among CharacterOffsetBegin=16670 CharacterOffsetEnd=16675 PartOfSpeech=IN Lemma=among NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=side CharacterOffsetBegin=16676 CharacterOffsetEnd=16680 PartOfSpeech=JJ Lemma=side NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effects CharacterOffsetBegin=16681 CharacterOffsetEnd=16688 PartOfSpeech=NNS Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16688 CharacterOffsetEnd=16689 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Cough))\n",
      "    (VP (VBD was)\n",
      "      (ADVP (RBS most) (RB commonly))\n",
      "      (VP (VBN seen)\n",
      "        (PP (IN among)\n",
      "          (NP (JJ side) (NNS effects)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, seen-5)\n",
      "nsubjpass(seen-5, Cough-1)\n",
      "auxpass(seen-5, was-2)\n",
      "advmod(commonly-4, most-3)\n",
      "advmod(seen-5, commonly-4)\n",
      "case(effects-8, among-6)\n",
      "amod(effects-8, side-7)\n",
      "nmod:among(seen-5, effects-8)\n",
      "punct(seen-5, .-9)\n",
      "\n",
      "Sentence #117 (19 tokens, sentiment: Positive):\n",
      "The peak of first recording on side effect occurred at three months including 60% of them mild.\n",
      "[Text=The CharacterOffsetBegin=16690 CharacterOffsetEnd=16693 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=peak CharacterOffsetBegin=16694 CharacterOffsetEnd=16698 PartOfSpeech=NN Lemma=peak NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=16699 CharacterOffsetEnd=16701 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=first CharacterOffsetBegin=16702 CharacterOffsetEnd=16707 PartOfSpeech=JJ Lemma=first NamedEntityTag=ORDINAL NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=recording CharacterOffsetBegin=16708 CharacterOffsetEnd=16717 PartOfSpeech=NN Lemma=recording NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=on CharacterOffsetBegin=16718 CharacterOffsetEnd=16720 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=side CharacterOffsetBegin=16721 CharacterOffsetEnd=16725 PartOfSpeech=JJ Lemma=side NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=16726 CharacterOffsetEnd=16732 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=occurred CharacterOffsetBegin=16733 CharacterOffsetEnd=16741 PartOfSpeech=VBD Lemma=occur NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=16742 CharacterOffsetEnd=16744 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=three CharacterOffsetBegin=16745 CharacterOffsetEnd=16750 PartOfSpeech=CD Lemma=three NamedEntityTag=DURATION NormalizedNamedEntityTag=P3M Timex=<TIMEX3 tid=\"t26\" type=\"DURATION\" value=\"P3M\">three months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=months CharacterOffsetBegin=16751 CharacterOffsetEnd=16757 PartOfSpeech=NNS Lemma=month NamedEntityTag=DURATION NormalizedNamedEntityTag=P3M Timex=<TIMEX3 tid=\"t26\" type=\"DURATION\" value=\"P3M\">three months</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=including CharacterOffsetBegin=16758 CharacterOffsetEnd=16767 PartOfSpeech=VBG Lemma=include NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=60 CharacterOffsetBegin=16768 CharacterOffsetEnd=16770 PartOfSpeech=CD Lemma=60 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%60.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=16770 CharacterOffsetEnd=16771 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%60.0 SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=16772 CharacterOffsetEnd=16774 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=them CharacterOffsetBegin=16775 CharacterOffsetEnd=16779 PartOfSpeech=PRP Lemma=they NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mild CharacterOffsetBegin=16780 CharacterOffsetEnd=16784 PartOfSpeech=JJ Lemma=mild NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16784 CharacterOffsetEnd=16785 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN peak))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (JJ first) (NN recording))\n",
      "          (PP (IN on)\n",
      "            (NP (JJ side) (NN effect))))))\n",
      "    (VP (VBD occurred)\n",
      "      (PP (IN at)\n",
      "        (NP\n",
      "          (NP (CD three) (NNS months))\n",
      "          (PP (VBG including)\n",
      "            (NP\n",
      "              (NP (CD 60) (NN %))\n",
      "              (PP (IN of)\n",
      "                (NP (PRP them)))))\n",
      "          (ADJP (JJ mild)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, occurred-9)\n",
      "det(peak-2, The-1)\n",
      "nsubj(occurred-9, peak-2)\n",
      "case(recording-5, of-3)\n",
      "amod(recording-5, first-4)\n",
      "nmod:of(peak-2, recording-5)\n",
      "case(effect-8, on-6)\n",
      "amod(effect-8, side-7)\n",
      "nmod:on(recording-5, effect-8)\n",
      "case(months-12, at-10)\n",
      "nummod(months-12, three-11)\n",
      "nmod:at(occurred-9, months-12)\n",
      "case(%-15, including-13)\n",
      "nummod(%-15, 60-14)\n",
      "nmod:including(months-12, %-15)\n",
      "case(them-17, of-16)\n",
      "nmod:of(%-15, them-17)\n",
      "amod(months-12, mild-18)\n",
      "punct(occurred-9, .-19)\n",
      "\n",
      "Sentence #118 (19 tokens, sentiment: Negative):\n",
      "Results showed that Benazepril had good efficacy and safety for the essential hypertension patients in a long-term observation.\n",
      "[Text=Results CharacterOffsetBegin=16787 CharacterOffsetEnd=16794 PartOfSpeech=NNS Lemma=result NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=showed CharacterOffsetBegin=16795 CharacterOffsetEnd=16801 PartOfSpeech=VBD Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=16802 CharacterOffsetEnd=16806 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=16807 CharacterOffsetEnd=16817 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=PERSON SentimentClass=Neutral]\n",
      "[Text=had CharacterOffsetBegin=16818 CharacterOffsetEnd=16821 PartOfSpeech=VBD Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=good CharacterOffsetBegin=16822 CharacterOffsetEnd=16826 PartOfSpeech=JJ Lemma=good NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=efficacy CharacterOffsetBegin=16827 CharacterOffsetEnd=16835 PartOfSpeech=NN Lemma=efficacy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16836 CharacterOffsetEnd=16839 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=safety CharacterOffsetBegin=16840 CharacterOffsetEnd=16846 PartOfSpeech=NN Lemma=safety NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=16847 CharacterOffsetEnd=16850 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=16851 CharacterOffsetEnd=16854 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=essential CharacterOffsetBegin=16855 CharacterOffsetEnd=16864 PartOfSpeech=JJ Lemma=essential NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=hypertension CharacterOffsetBegin=16865 CharacterOffsetEnd=16877 PartOfSpeech=NN Lemma=hypertension NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=16878 CharacterOffsetEnd=16886 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=16887 CharacterOffsetEnd=16889 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=16890 CharacterOffsetEnd=16891 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=long-term CharacterOffsetBegin=16892 CharacterOffsetEnd=16901 PartOfSpeech=JJ Lemma=long-term NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=observation CharacterOffsetBegin=16902 CharacterOffsetEnd=16913 PartOfSpeech=NN Lemma=observation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=16913 CharacterOffsetEnd=16914 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS Results))\n",
      "    (VP (VBD showed)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP (NNP Benazepril))\n",
      "          (VP (VBD had)\n",
      "            (NP (JJ good) (NN efficacy)\n",
      "              (CC and)\n",
      "              (NN safety))\n",
      "            (PP (IN for)\n",
      "              (NP\n",
      "                (NP (DT the) (JJ essential) (NN hypertension) (NNS patients))\n",
      "                (PP (IN in)\n",
      "                  (NP (DT a) (JJ long-term) (NN observation)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, showed-2)\n",
      "nsubj(showed-2, Results-1)\n",
      "mark(had-5, that-3)\n",
      "nsubj(had-5, Benazepril-4)\n",
      "ccomp(showed-2, had-5)\n",
      "amod(efficacy-7, good-6)\n",
      "dobj(had-5, efficacy-7)\n",
      "cc(efficacy-7, and-8)\n",
      "dobj(had-5, safety-9)\n",
      "conj:and(efficacy-7, safety-9)\n",
      "case(patients-14, for-10)\n",
      "det(patients-14, the-11)\n",
      "amod(patients-14, essential-12)\n",
      "compound(patients-14, hypertension-13)\n",
      "nmod:for(had-5, patients-14)\n",
      "case(observation-18, in-15)\n",
      "det(observation-18, a-16)\n",
      "amod(observation-18, long-term-17)\n",
      "nmod:in(patients-14, observation-18)\n",
      "punct(showed-2, .-19)\n",
      "\n",
      "Sentence #119 (21 tokens, sentiment: Negative):\n",
      "Captopril, enalapril, and lisinopril are angiotensin-converting enzyme (ACE) inhibitors widely prescribed for hypertension and heart failure.\n",
      "[Text=Captopril CharacterOffsetBegin=16916 CharacterOffsetEnd=16925 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=16925 CharacterOffsetEnd=16926 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=16927 CharacterOffsetEnd=16936 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=16936 CharacterOffsetEnd=16937 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=16938 CharacterOffsetEnd=16941 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=16942 CharacterOffsetEnd=16952 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=16953 CharacterOffsetEnd=16956 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin-converting CharacterOffsetBegin=16957 CharacterOffsetEnd=16979 PartOfSpeech=JJ Lemma=angiotensin-converting NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=16980 CharacterOffsetEnd=16986 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=16987 CharacterOffsetEnd=16988 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=16988 CharacterOffsetEnd=16991 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=16991 CharacterOffsetEnd=16992 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=16993 CharacterOffsetEnd=17003 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=widely CharacterOffsetBegin=17004 CharacterOffsetEnd=17010 PartOfSpeech=RB Lemma=widely NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=prescribed CharacterOffsetBegin=17011 CharacterOffsetEnd=17021 PartOfSpeech=VBN Lemma=prescribe NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=for CharacterOffsetBegin=17022 CharacterOffsetEnd=17025 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hypertension CharacterOffsetBegin=17026 CharacterOffsetEnd=17038 PartOfSpeech=NN Lemma=hypertension NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=17039 CharacterOffsetEnd=17042 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=heart CharacterOffsetBegin=17043 CharacterOffsetEnd=17048 PartOfSpeech=NN Lemma=heart NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=failure CharacterOffsetBegin=17049 CharacterOffsetEnd=17056 PartOfSpeech=NN Lemma=failure NamedEntityTag=O SentimentClass=Very negative]\n",
      "[Text=. CharacterOffsetBegin=17056 CharacterOffsetEnd=17057 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN Captopril))\n",
      "      (, ,)\n",
      "      (NP (NN enalapril))\n",
      "      (, ,)\n",
      "      (CC and)\n",
      "      (NP (NN lisinopril)))\n",
      "    (VP (VBP are)\n",
      "      (NP\n",
      "        (NP (JJ angiotensin-converting) (NN enzyme)\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN ACE))\n",
      "            (-RRB- -RRB-))\n",
      "          (NNS inhibitors))\n",
      "        (VP\n",
      "          (ADVP (RB widely))\n",
      "          (VBN prescribed)\n",
      "          (PP (IN for)\n",
      "            (NP (NN hypertension)\n",
      "              (CC and)\n",
      "              (NN heart) (NN failure))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, inhibitors-13)\n",
      "nsubj(inhibitors-13, Captopril-1)\n",
      "punct(Captopril-1, ,-2)\n",
      "conj:and(Captopril-1, enalapril-3)\n",
      "nsubj(inhibitors-13, enalapril-3)\n",
      "punct(Captopril-1, ,-4)\n",
      "cc(Captopril-1, and-5)\n",
      "conj:and(Captopril-1, lisinopril-6)\n",
      "nsubj(inhibitors-13, lisinopril-6)\n",
      "cop(inhibitors-13, are-7)\n",
      "amod(inhibitors-13, angiotensin-converting-8)\n",
      "compound(inhibitors-13, enzyme-9)\n",
      "punct(ACE-11, -LRB--10)\n",
      "appos(inhibitors-13, ACE-11)\n",
      "punct(ACE-11, -RRB--12)\n",
      "advmod(prescribed-15, widely-14)\n",
      "acl(inhibitors-13, prescribed-15)\n",
      "case(failure-20, for-16)\n",
      "compound(failure-20, hypertension-17)\n",
      "cc(hypertension-17, and-18)\n",
      "conj:and(hypertension-17, heart-19)\n",
      "compound(failure-20, heart-19)\n",
      "nmod:for(prescribed-15, failure-20)\n",
      "punct(inhibitors-13, .-21)\n",
      "\n",
      "Sentence #120 (25 tokens, sentiment: Negative):\n",
      "Cutaneous side effects of captopril include angio-edema, anaphylactoid reactions, maculopapular eruptions, pitiryasis rosea-like rash, toxic erythema, and exfoliative dermatitis.\n",
      "[Text=Cutaneous CharacterOffsetBegin=17058 CharacterOffsetEnd=17067 PartOfSpeech=JJ Lemma=cutaneous NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=side CharacterOffsetBegin=17068 CharacterOffsetEnd=17072 PartOfSpeech=JJ Lemma=side NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effects CharacterOffsetBegin=17073 CharacterOffsetEnd=17080 PartOfSpeech=NNS Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=17081 CharacterOffsetEnd=17083 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=17084 CharacterOffsetEnd=17093 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=include CharacterOffsetBegin=17094 CharacterOffsetEnd=17101 PartOfSpeech=VBP Lemma=include NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angio-edema CharacterOffsetBegin=17102 CharacterOffsetEnd=17113 PartOfSpeech=NN Lemma=angio-edema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=17113 CharacterOffsetEnd=17114 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=anaphylactoid CharacterOffsetBegin=17115 CharacterOffsetEnd=17128 PartOfSpeech=JJ Lemma=anaphylactoid NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reactions CharacterOffsetBegin=17129 CharacterOffsetEnd=17138 PartOfSpeech=NNS Lemma=reaction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=17138 CharacterOffsetEnd=17139 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=maculopapular CharacterOffsetBegin=17140 CharacterOffsetEnd=17153 PartOfSpeech=JJ Lemma=maculopapular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=eruptions CharacterOffsetBegin=17154 CharacterOffsetEnd=17163 PartOfSpeech=NNS Lemma=eruption NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=17163 CharacterOffsetEnd=17164 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pitiryasis CharacterOffsetBegin=17165 CharacterOffsetEnd=17175 PartOfSpeech=NN Lemma=pitiryasis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rosea-like CharacterOffsetBegin=17176 CharacterOffsetEnd=17186 PartOfSpeech=JJ Lemma=rosea-like NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rash CharacterOffsetBegin=17187 CharacterOffsetEnd=17191 PartOfSpeech=NN Lemma=rash NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=, CharacterOffsetBegin=17191 CharacterOffsetEnd=17192 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=toxic CharacterOffsetBegin=17193 CharacterOffsetEnd=17198 PartOfSpeech=JJ Lemma=toxic NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=erythema CharacterOffsetBegin=17199 CharacterOffsetEnd=17207 PartOfSpeech=NN Lemma=erythema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=17207 CharacterOffsetEnd=17208 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=17209 CharacterOffsetEnd=17212 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=exfoliative CharacterOffsetBegin=17213 CharacterOffsetEnd=17224 PartOfSpeech=JJ Lemma=exfoliative NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dermatitis CharacterOffsetBegin=17225 CharacterOffsetEnd=17235 PartOfSpeech=NN Lemma=dermatitis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=17235 CharacterOffsetEnd=17236 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ Cutaneous) (JJ side) (NNS effects))\n",
      "      (PP (IN of)\n",
      "        (NP (NN captopril))))\n",
      "    (VP (VBP include)\n",
      "      (NP\n",
      "        (NP (NN angio-edema))\n",
      "        (, ,)\n",
      "        (NP (JJ anaphylactoid) (NNS reactions))\n",
      "        (, ,)\n",
      "        (NP (JJ maculopapular) (NNS eruptions))\n",
      "        (, ,)\n",
      "        (NP (NN pitiryasis) (JJ rosea-like) (NN rash))\n",
      "        (, ,)\n",
      "        (NP (JJ toxic) (NN erythema))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (NP (JJ exfoliative) (NN dermatitis))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, include-6)\n",
      "amod(effects-3, Cutaneous-1)\n",
      "amod(effects-3, side-2)\n",
      "nsubj(include-6, effects-3)\n",
      "case(captopril-5, of-4)\n",
      "nmod:of(effects-3, captopril-5)\n",
      "dobj(include-6, angio-edema-7)\n",
      "punct(angio-edema-7, ,-8)\n",
      "amod(reactions-10, anaphylactoid-9)\n",
      "dobj(include-6, reactions-10)\n",
      "conj:and(angio-edema-7, reactions-10)\n",
      "punct(angio-edema-7, ,-11)\n",
      "amod(eruptions-13, maculopapular-12)\n",
      "dobj(include-6, eruptions-13)\n",
      "conj:and(angio-edema-7, eruptions-13)\n",
      "punct(angio-edema-7, ,-14)\n",
      "compound(rash-17, pitiryasis-15)\n",
      "amod(rash-17, rosea-like-16)\n",
      "dobj(include-6, rash-17)\n",
      "conj:and(angio-edema-7, rash-17)\n",
      "punct(angio-edema-7, ,-18)\n",
      "amod(erythema-20, toxic-19)\n",
      "dobj(include-6, erythema-20)\n",
      "conj:and(angio-edema-7, erythema-20)\n",
      "punct(angio-edema-7, ,-21)\n",
      "cc(angio-edema-7, and-22)\n",
      "amod(dermatitis-24, exfoliative-23)\n",
      "dobj(include-6, dermatitis-24)\n",
      "conj:and(angio-edema-7, dermatitis-24)\n",
      "punct(include-6, .-25)\n",
      "\n",
      "Sentence #121 (18 tokens, sentiment: Negative):\n",
      "Some of the immunological captopril-induced cutaneous adverse reactions have been diagnosed in recent years by patch tests.\n",
      "[Text=Some CharacterOffsetBegin=17237 CharacterOffsetEnd=17241 PartOfSpeech=DT Lemma=some NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=17242 CharacterOffsetEnd=17244 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=17245 CharacterOffsetEnd=17248 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=immunological CharacterOffsetBegin=17249 CharacterOffsetEnd=17262 PartOfSpeech=JJ Lemma=immunological NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril-induced CharacterOffsetBegin=17263 CharacterOffsetEnd=17280 PartOfSpeech=JJ Lemma=captopril-induced NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cutaneous CharacterOffsetBegin=17281 CharacterOffsetEnd=17290 PartOfSpeech=JJ Lemma=cutaneous NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=adverse CharacterOffsetBegin=17291 CharacterOffsetEnd=17298 PartOfSpeech=JJ Lemma=adverse NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reactions CharacterOffsetBegin=17299 CharacterOffsetEnd=17308 PartOfSpeech=NNS Lemma=reaction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=have CharacterOffsetBegin=17309 CharacterOffsetEnd=17313 PartOfSpeech=VBP Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=been CharacterOffsetBegin=17314 CharacterOffsetEnd=17318 PartOfSpeech=VBN Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diagnosed CharacterOffsetBegin=17319 CharacterOffsetEnd=17328 PartOfSpeech=VBN Lemma=diagnose NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=17329 CharacterOffsetEnd=17331 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=recent CharacterOffsetBegin=17332 CharacterOffsetEnd=17338 PartOfSpeech=JJ Lemma=recent NamedEntityTag=DURATION NormalizedNamedEntityTag=PXY Timex=<TIMEX3 tid=\"t27\" type=\"DURATION\" value=\"PXY\">recent years</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=years CharacterOffsetBegin=17339 CharacterOffsetEnd=17344 PartOfSpeech=NNS Lemma=year NamedEntityTag=DURATION NormalizedNamedEntityTag=PXY Timex=<TIMEX3 tid=\"t27\" type=\"DURATION\" value=\"PXY\">recent years</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=17345 CharacterOffsetEnd=17347 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patch CharacterOffsetBegin=17348 CharacterOffsetEnd=17353 PartOfSpeech=NN Lemma=patch NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=17354 CharacterOffsetEnd=17359 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=17359 CharacterOffsetEnd=17360 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT Some))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the)\n",
      "          (ADJP (JJ immunological) (JJ captopril-induced))\n",
      "          (JJ cutaneous) (JJ adverse) (NNS reactions))))\n",
      "    (VP (VBP have)\n",
      "      (VP (VBN been)\n",
      "        (VP (VBN diagnosed)\n",
      "          (PP (IN in)\n",
      "            (NP (JJ recent) (NNS years)))\n",
      "          (PP (IN by)\n",
      "            (NP (NN patch) (NNS tests))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, diagnosed-11)\n",
      "det:qmod(reactions-8, Some-1)\n",
      "mwe(Some-1, of-2)\n",
      "det(reactions-8, the-3)\n",
      "amod(captopril-induced-5, immunological-4)\n",
      "amod(reactions-8, captopril-induced-5)\n",
      "amod(reactions-8, cutaneous-6)\n",
      "amod(reactions-8, adverse-7)\n",
      "nsubjpass(diagnosed-11, reactions-8)\n",
      "aux(diagnosed-11, have-9)\n",
      "auxpass(diagnosed-11, been-10)\n",
      "case(years-14, in-12)\n",
      "amod(years-14, recent-13)\n",
      "nmod:in(diagnosed-11, years-14)\n",
      "case(tests-17, by-15)\n",
      "compound(tests-17, patch-16)\n",
      "nmod:agent(diagnosed-11, tests-17)\n",
      "punct(diagnosed-11, .-18)\n",
      "\n",
      "Sentence #122 (32 tokens, sentiment: Negative):\n",
      "A case of a cutaneous immune adverse reaction to captopril with tolerance to enalapril and lisinopril demonstrated both by patch tests and double-blind challenge tests is reported for the first time.\n",
      "[Text=A CharacterOffsetBegin=17361 CharacterOffsetEnd=17362 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=case CharacterOffsetBegin=17363 CharacterOffsetEnd=17367 PartOfSpeech=NN Lemma=case NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=17368 CharacterOffsetEnd=17370 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=17371 CharacterOffsetEnd=17372 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cutaneous CharacterOffsetBegin=17373 CharacterOffsetEnd=17382 PartOfSpeech=JJ Lemma=cutaneous NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=immune CharacterOffsetBegin=17383 CharacterOffsetEnd=17389 PartOfSpeech=JJ Lemma=immune NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=adverse CharacterOffsetBegin=17390 CharacterOffsetEnd=17397 PartOfSpeech=JJ Lemma=adverse NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reaction CharacterOffsetBegin=17398 CharacterOffsetEnd=17406 PartOfSpeech=NN Lemma=reaction NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=to CharacterOffsetBegin=17407 CharacterOffsetEnd=17409 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=17410 CharacterOffsetEnd=17419 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=17420 CharacterOffsetEnd=17424 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tolerance CharacterOffsetBegin=17425 CharacterOffsetEnd=17434 PartOfSpeech=NN Lemma=tolerance NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=17435 CharacterOffsetEnd=17437 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=17438 CharacterOffsetEnd=17447 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=17448 CharacterOffsetEnd=17451 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=17452 CharacterOffsetEnd=17462 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=demonstrated CharacterOffsetBegin=17463 CharacterOffsetEnd=17475 PartOfSpeech=VBD Lemma=demonstrate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=both CharacterOffsetBegin=17476 CharacterOffsetEnd=17480 PartOfSpeech=CC Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=17481 CharacterOffsetEnd=17483 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patch CharacterOffsetBegin=17484 CharacterOffsetEnd=17489 PartOfSpeech=NN Lemma=patch NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=17490 CharacterOffsetEnd=17495 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=17496 CharacterOffsetEnd=17499 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=double-blind CharacterOffsetBegin=17500 CharacterOffsetEnd=17512 PartOfSpeech=JJ Lemma=double-blind NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=challenge CharacterOffsetBegin=17513 CharacterOffsetEnd=17522 PartOfSpeech=NN Lemma=challenge NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=17523 CharacterOffsetEnd=17528 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=17529 CharacterOffsetEnd=17531 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reported CharacterOffsetBegin=17532 CharacterOffsetEnd=17540 PartOfSpeech=VBN Lemma=report NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=17541 CharacterOffsetEnd=17544 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=17545 CharacterOffsetEnd=17548 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=first CharacterOffsetBegin=17549 CharacterOffsetEnd=17554 PartOfSpeech=JJ Lemma=first NamedEntityTag=ORDINAL NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=time CharacterOffsetBegin=17555 CharacterOffsetEnd=17559 PartOfSpeech=NN Lemma=time NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=17559 CharacterOffsetEnd=17560 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (DT A) (NN case))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT a) (JJ cutaneous) (JJ immune) (JJ adverse) (NN reaction))\n",
      "            (PP\n",
      "              (PP (TO to)\n",
      "                (NP\n",
      "                  (NP (NN captopril))\n",
      "                  (PP (IN with)\n",
      "                    (NP (NN tolerance)))))\n",
      "              (PP (TO to)\n",
      "                (NP (NN enalapril)\n",
      "                  (CC and)\n",
      "                  (NN lisinopril)))))))\n",
      "      (VP (VBD demonstrated)\n",
      "        (ADVP (CC both))\n",
      "        (PP (IN by)\n",
      "          (NP (NN patch) (NNS tests)))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (JJ double-blind) (NN challenge) (NNS tests))\n",
      "      (VP (VBZ is)\n",
      "        (VP (VBN reported)\n",
      "          (PP (IN for)\n",
      "            (NP (DT the) (JJ first) (NN time))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, demonstrated-17)\n",
      "det(case-2, A-1)\n",
      "nsubj(demonstrated-17, case-2)\n",
      "case(reaction-8, of-3)\n",
      "det(reaction-8, a-4)\n",
      "amod(reaction-8, cutaneous-5)\n",
      "amod(reaction-8, immune-6)\n",
      "amod(reaction-8, adverse-7)\n",
      "nmod:of(case-2, reaction-8)\n",
      "case(captopril-10, to-9)\n",
      "nmod:to(reaction-8, captopril-10)\n",
      "case(tolerance-12, with-11)\n",
      "nmod:with(captopril-10, tolerance-12)\n",
      "case(enalapril-14, to-13)\n",
      "nmod:to(captopril-10, enalapril-14)\n",
      "cc(enalapril-14, and-15)\n",
      "nmod:to(captopril-10, lisinopril-16)\n",
      "conj:and(enalapril-14, lisinopril-16)\n",
      "advmod(demonstrated-17, both-18)\n",
      "case(tests-21, by-19)\n",
      "compound(tests-21, patch-20)\n",
      "nmod:by(demonstrated-17, tests-21)\n",
      "cc(demonstrated-17, and-22)\n",
      "amod(tests-25, double-blind-23)\n",
      "compound(tests-25, challenge-24)\n",
      "nsubjpass(reported-27, tests-25)\n",
      "auxpass(reported-27, is-26)\n",
      "conj:and(demonstrated-17, reported-27)\n",
      "case(time-31, for-28)\n",
      "det(time-31, the-29)\n",
      "amod(time-31, first-30)\n",
      "nmod:for(reported-27, time-31)\n",
      "punct(demonstrated-17, .-32)\n",
      "\n",
      "Sentence #123 (11 tokens, sentiment: Negative):\n",
      "A 71-year-old nonatopic woman suffered a generalized pruriginous maculopapular rash.\n",
      "[Text=A CharacterOffsetBegin=17561 CharacterOffsetEnd=17562 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=71-year-old CharacterOffsetBegin=17563 CharacterOffsetEnd=17574 PartOfSpeech=JJ Lemma=71-year-old NamedEntityTag=DURATION NormalizedNamedEntityTag=P71Y Timex=<TIMEX3 tid=\"t28\" type=\"DURATION\" value=\"P71Y\">71-year-old</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=nonatopic CharacterOffsetBegin=17575 CharacterOffsetEnd=17584 PartOfSpeech=JJ Lemma=nonatopic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=woman CharacterOffsetBegin=17585 CharacterOffsetEnd=17590 PartOfSpeech=NN Lemma=woman NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=suffered CharacterOffsetBegin=17591 CharacterOffsetEnd=17599 PartOfSpeech=VBD Lemma=suffer NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=a CharacterOffsetBegin=17600 CharacterOffsetEnd=17601 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=generalized CharacterOffsetBegin=17602 CharacterOffsetEnd=17613 PartOfSpeech=VBN Lemma=generalize NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pruriginous CharacterOffsetBegin=17614 CharacterOffsetEnd=17625 PartOfSpeech=JJ Lemma=pruriginous NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=maculopapular CharacterOffsetBegin=17626 CharacterOffsetEnd=17639 PartOfSpeech=JJ Lemma=maculopapular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rash CharacterOffsetBegin=17640 CharacterOffsetEnd=17644 PartOfSpeech=NN Lemma=rash NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=. CharacterOffsetBegin=17644 CharacterOffsetEnd=17645 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT A) (JJ 71-year-old) (JJ nonatopic) (NN woman))\n",
      "    (VP (VBD suffered)\n",
      "      (NP\n",
      "        (NP (DT a))\n",
      "        (VP (VBN generalized)\n",
      "          (NP (JJ pruriginous) (JJ maculopapular) (NN rash)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, suffered-5)\n",
      "det(woman-4, A-1)\n",
      "amod(woman-4, 71-year-old-2)\n",
      "amod(woman-4, nonatopic-3)\n",
      "nsubj(suffered-5, woman-4)\n",
      "dobj(suffered-5, a-6)\n",
      "acl(a-6, generalized-7)\n",
      "amod(rash-10, pruriginous-8)\n",
      "amod(rash-10, maculopapular-9)\n",
      "dobj(generalized-7, rash-10)\n",
      "punct(suffered-5, .-11)\n",
      "\n",
      "Sentence #124 (20 tokens, sentiment: Negative):\n",
      "Two months earlier, she had started oral treatment with captopril 50 mg t.i.d and glibenclamide 5 mg daily.\n",
      "[Text=Two CharacterOffsetBegin=17646 CharacterOffsetEnd=17649 PartOfSpeech=CD Lemma=two NamedEntityTag=DATE NormalizedNamedEntityTag=OFFSET P-2M Timex=<TIMEX3 alt_value=\"OFFSET P-2M\" anchorTimeID=\"t0\" temporalFunction=\"true\" tid=\"t29\" type=\"DATE\" valueFromFunction=\"tf1\">Two months earlier</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=months CharacterOffsetBegin=17650 CharacterOffsetEnd=17656 PartOfSpeech=NNS Lemma=month NamedEntityTag=DATE NormalizedNamedEntityTag=OFFSET P-2M Timex=<TIMEX3 alt_value=\"OFFSET P-2M\" anchorTimeID=\"t0\" temporalFunction=\"true\" tid=\"t29\" type=\"DATE\" valueFromFunction=\"tf1\">Two months earlier</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=earlier CharacterOffsetBegin=17657 CharacterOffsetEnd=17664 PartOfSpeech=RBR Lemma=earlier NamedEntityTag=DATE NormalizedNamedEntityTag=OFFSET P-2M Timex=<TIMEX3 alt_value=\"OFFSET P-2M\" anchorTimeID=\"t0\" temporalFunction=\"true\" tid=\"t29\" type=\"DATE\" valueFromFunction=\"tf1\">Two months earlier</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=17664 CharacterOffsetEnd=17665 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=she CharacterOffsetBegin=17666 CharacterOffsetEnd=17669 PartOfSpeech=PRP Lemma=she NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=had CharacterOffsetBegin=17670 CharacterOffsetEnd=17673 PartOfSpeech=VBD Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=started CharacterOffsetBegin=17674 CharacterOffsetEnd=17681 PartOfSpeech=VBN Lemma=start NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=oral CharacterOffsetBegin=17682 CharacterOffsetEnd=17686 PartOfSpeech=JJ Lemma=oral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=treatment CharacterOffsetBegin=17687 CharacterOffsetEnd=17696 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=17697 CharacterOffsetEnd=17701 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=17702 CharacterOffsetEnd=17711 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=50 CharacterOffsetBegin=17712 CharacterOffsetEnd=17714 PartOfSpeech=CD Lemma=50 NamedEntityTag=NUMBER NormalizedNamedEntityTag=50.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=17715 CharacterOffsetEnd=17717 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=t.i.d CharacterOffsetBegin=17718 CharacterOffsetEnd=17723 PartOfSpeech=NN Lemma=t.i.d NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=17724 CharacterOffsetEnd=17727 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glibenclamide CharacterOffsetBegin=17728 CharacterOffsetEnd=17741 PartOfSpeech=NN Lemma=glibenclamide NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=17742 CharacterOffsetEnd=17743 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=17744 CharacterOffsetEnd=17746 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=17747 CharacterOffsetEnd=17752 PartOfSpeech=RB Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t30\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=17752 CharacterOffsetEnd=17753 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP\n",
      "      (NP (CD Two) (NNS months))\n",
      "      (RBR earlier))\n",
      "    (, ,)\n",
      "    (NP (PRP she))\n",
      "    (VP (VBD had)\n",
      "      (VP (VBN started)\n",
      "        (NP (JJ oral) (NN treatment))\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN captopril) (CD 50) (NN mg) (NN t.i.d))\n",
      "            (CC and)\n",
      "            (NP (NN glibenclamide) (CD 5) (NN mg))))\n",
      "        (ADVP (RB daily))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, started-7)\n",
      "nummod(months-2, Two-1)\n",
      "nmod:npmod(earlier-3, months-2)\n",
      "advmod(started-7, earlier-3)\n",
      "punct(started-7, ,-4)\n",
      "nsubj(started-7, she-5)\n",
      "aux(started-7, had-6)\n",
      "amod(treatment-9, oral-8)\n",
      "dobj(started-7, treatment-9)\n",
      "case(t.i.d-14, with-10)\n",
      "compound(t.i.d-14, captopril-11)\n",
      "nummod(t.i.d-14, 50-12)\n",
      "compound(t.i.d-14, mg-13)\n",
      "nmod:with(started-7, t.i.d-14)\n",
      "cc(t.i.d-14, and-15)\n",
      "compound(mg-18, glibenclamide-16)\n",
      "nummod(mg-18, 5-17)\n",
      "nmod:with(started-7, mg-18)\n",
      "conj:and(t.i.d-14, mg-18)\n",
      "advmod(started-7, daily-19)\n",
      "punct(started-7, .-20)\n",
      "\n",
      "Sentence #125 (14 tokens, sentiment: Negative):\n",
      "After the rash appeared, she stopped both drugs and the reaction cleared.\n",
      "[Text=After CharacterOffsetBegin=17754 CharacterOffsetEnd=17759 PartOfSpeech=IN Lemma=after NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=17760 CharacterOffsetEnd=17763 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=rash CharacterOffsetBegin=17764 CharacterOffsetEnd=17768 PartOfSpeech=NN Lemma=rash NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=appeared CharacterOffsetBegin=17769 CharacterOffsetEnd=17777 PartOfSpeech=VBD Lemma=appear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=17777 CharacterOffsetEnd=17778 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=she CharacterOffsetBegin=17779 CharacterOffsetEnd=17782 PartOfSpeech=PRP Lemma=she NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=stopped CharacterOffsetBegin=17783 CharacterOffsetEnd=17790 PartOfSpeech=VBD Lemma=stop NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=both CharacterOffsetBegin=17791 CharacterOffsetEnd=17795 PartOfSpeech=CC Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=17796 CharacterOffsetEnd=17801 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=17802 CharacterOffsetEnd=17805 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=17806 CharacterOffsetEnd=17809 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reaction CharacterOffsetBegin=17810 CharacterOffsetEnd=17818 PartOfSpeech=NN Lemma=reaction NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=cleared CharacterOffsetBegin=17819 CharacterOffsetEnd=17826 PartOfSpeech=VBN Lemma=clear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=17826 CharacterOffsetEnd=17827 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN After)\n",
      "      (S\n",
      "        (NP (DT the) (NN rash))\n",
      "        (VP (VBD appeared))))\n",
      "    (, ,)\n",
      "    (NP (PRP she))\n",
      "    (VP (VBD stopped)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP (CC both)\n",
      "            (NP (NNS drugs))\n",
      "            (CC and)\n",
      "            (NP (DT the) (NN reaction)))\n",
      "          (VP (VBN cleared)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, stopped-7)\n",
      "mark(appeared-4, After-1)\n",
      "det(rash-3, the-2)\n",
      "nsubj(appeared-4, rash-3)\n",
      "advcl:after(stopped-7, appeared-4)\n",
      "punct(stopped-7, ,-5)\n",
      "nsubj(stopped-7, she-6)\n",
      "cc:preconj(drugs-9, both-8)\n",
      "nsubj(cleared-13, drugs-9)\n",
      "cc(drugs-9, and-10)\n",
      "det(reaction-12, the-11)\n",
      "conj:and(drugs-9, reaction-12)\n",
      "nsubj(cleared-13, reaction-12)\n",
      "ccomp(stopped-7, cleared-13)\n",
      "punct(stopped-7, .-14)\n",
      "\n",
      "Sentence #126 (17 tokens, sentiment: Negative):\n",
      "A skin biopsy from one of the lesions showed perivascular lymphocytic infiltrate of the upper dermis.\n",
      "[Text=A CharacterOffsetBegin=17828 CharacterOffsetEnd=17829 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=skin CharacterOffsetBegin=17830 CharacterOffsetEnd=17834 PartOfSpeech=NN Lemma=skin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=biopsy CharacterOffsetBegin=17835 CharacterOffsetEnd=17841 PartOfSpeech=NN Lemma=biopsy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=from CharacterOffsetBegin=17842 CharacterOffsetEnd=17846 PartOfSpeech=IN Lemma=from NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=one CharacterOffsetBegin=17847 CharacterOffsetEnd=17850 PartOfSpeech=CD Lemma=one NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=17851 CharacterOffsetEnd=17853 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=17854 CharacterOffsetEnd=17857 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lesions CharacterOffsetBegin=17858 CharacterOffsetEnd=17865 PartOfSpeech=NNS Lemma=lesion NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=showed CharacterOffsetBegin=17866 CharacterOffsetEnd=17872 PartOfSpeech=VBD Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=perivascular CharacterOffsetBegin=17873 CharacterOffsetEnd=17885 PartOfSpeech=JJ Lemma=perivascular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lymphocytic CharacterOffsetBegin=17886 CharacterOffsetEnd=17897 PartOfSpeech=JJ Lemma=lymphocytic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=infiltrate CharacterOffsetBegin=17898 CharacterOffsetEnd=17908 PartOfSpeech=NN Lemma=infiltrate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=17909 CharacterOffsetEnd=17911 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=17912 CharacterOffsetEnd=17915 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=upper CharacterOffsetBegin=17916 CharacterOffsetEnd=17921 PartOfSpeech=JJ Lemma=upper NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dermis CharacterOffsetBegin=17922 CharacterOffsetEnd=17928 PartOfSpeech=NN Lemma=dermis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=17928 CharacterOffsetEnd=17929 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT A) (NN skin) (NN biopsy))\n",
      "      (PP (IN from)\n",
      "        (NP\n",
      "          (NP (CD one))\n",
      "          (PP (IN of)\n",
      "            (NP (DT the) (NNS lesions))))))\n",
      "    (VP (VBD showed)\n",
      "      (NP\n",
      "        (NP (JJ perivascular) (JJ lymphocytic) (NN infiltrate))\n",
      "        (PP (IN of)\n",
      "          (NP (DT the) (JJ upper) (NN dermis)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, showed-9)\n",
      "det(biopsy-3, A-1)\n",
      "compound(biopsy-3, skin-2)\n",
      "nsubj(showed-9, biopsy-3)\n",
      "case(one-5, from-4)\n",
      "det:qmod(lesions-8, one-5)\n",
      "mwe(one-5, of-6)\n",
      "det(lesions-8, the-7)\n",
      "nmod(biopsy-3, lesions-8)\n",
      "amod(infiltrate-12, perivascular-10)\n",
      "amod(infiltrate-12, lymphocytic-11)\n",
      "dobj(showed-9, infiltrate-12)\n",
      "case(dermis-16, of-13)\n",
      "det(dermis-16, the-14)\n",
      "amod(dermis-16, upper-15)\n",
      "nmod:of(infiltrate-12, dermis-16)\n",
      "punct(showed-9, .-17)\n",
      "\n",
      "Sentence #127 (40 tokens, sentiment: Very negative):\n",
      "Skin prick tests with captopril and glibenclamide and patch tests with enalapril, lisinopril, and glibenclamide at 1% and 10% pet., and with mercaptobenzothiazole (a sulfhydryl group-containing chemical at 1% pet were negative.\n",
      "[Text=Skin CharacterOffsetBegin=17930 CharacterOffsetEnd=17934 PartOfSpeech=NN Lemma=skin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=prick CharacterOffsetBegin=17935 CharacterOffsetEnd=17940 PartOfSpeech=NN Lemma=prick NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=17941 CharacterOffsetEnd=17946 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=17947 CharacterOffsetEnd=17951 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=17952 CharacterOffsetEnd=17961 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=17962 CharacterOffsetEnd=17965 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glibenclamide CharacterOffsetBegin=17966 CharacterOffsetEnd=17979 PartOfSpeech=NN Lemma=glibenclamide NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=17980 CharacterOffsetEnd=17983 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patch CharacterOffsetBegin=17984 CharacterOffsetEnd=17989 PartOfSpeech=NN Lemma=patch NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=17990 CharacterOffsetEnd=17995 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=17996 CharacterOffsetEnd=18000 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=18001 CharacterOffsetEnd=18010 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18010 CharacterOffsetEnd=18011 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=18012 CharacterOffsetEnd=18022 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18022 CharacterOffsetEnd=18023 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18024 CharacterOffsetEnd=18027 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glibenclamide CharacterOffsetBegin=18028 CharacterOffsetEnd=18041 PartOfSpeech=NN Lemma=glibenclamide NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=18042 CharacterOffsetEnd=18044 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1 CharacterOffsetBegin=18045 CharacterOffsetEnd=18046 PartOfSpeech=CD Lemma=1 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%1.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=18046 CharacterOffsetEnd=18047 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%1.0 SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18048 CharacterOffsetEnd=18051 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10 CharacterOffsetBegin=18052 CharacterOffsetEnd=18054 PartOfSpeech=CD Lemma=10 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%10.0 SentimentClass=Positive]\n",
      "[Text=% CharacterOffsetBegin=18054 CharacterOffsetEnd=18055 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%10.0 SentimentClass=Neutral]\n",
      "[Text=pet. CharacterOffsetBegin=18056 CharacterOffsetEnd=18060 PartOfSpeech=NN Lemma=pet. NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18060 CharacterOffsetEnd=18061 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18062 CharacterOffsetEnd=18065 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=18066 CharacterOffsetEnd=18070 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mercaptobenzothiazole CharacterOffsetBegin=18071 CharacterOffsetEnd=18092 PartOfSpeech=NN Lemma=mercaptobenzothiazole NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=18093 CharacterOffsetEnd=18094 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=18094 CharacterOffsetEnd=18095 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=sulfhydryl CharacterOffsetBegin=18096 CharacterOffsetEnd=18106 PartOfSpeech=NN Lemma=sulfhydryl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group-containing CharacterOffsetBegin=18107 CharacterOffsetEnd=18123 PartOfSpeech=JJ Lemma=group-containing NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chemical CharacterOffsetBegin=18124 CharacterOffsetEnd=18132 PartOfSpeech=NN Lemma=chemical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=18133 CharacterOffsetEnd=18135 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1 CharacterOffsetBegin=18136 CharacterOffsetEnd=18137 PartOfSpeech=CD Lemma=1 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%1.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=18137 CharacterOffsetEnd=18138 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%1.0 SentimentClass=Neutral]\n",
      "[Text=pet CharacterOffsetBegin=18139 CharacterOffsetEnd=18142 PartOfSpeech=NN Lemma=pet NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=18143 CharacterOffsetEnd=18147 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=negative CharacterOffsetBegin=18148 CharacterOffsetEnd=18156 PartOfSpeech=JJ Lemma=negative NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=. CharacterOffsetBegin=18156 CharacterOffsetEnd=18157 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN Skin) (NN prick) (NNS tests))\n",
      "      (PP (IN with)\n",
      "        (NP (NN captopril)\n",
      "          (CC and)\n",
      "          (NN glibenclamide)\n",
      "          (CC and)\n",
      "          (NN patch) (NNS tests)))\n",
      "      (PP\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN enalapril) (, ,) (NN lisinopril) (, ,)\n",
      "              (CC and)\n",
      "              (NN glibenclamide))\n",
      "            (PP (IN at)\n",
      "              (NP\n",
      "                (QP (CD 1) (NN %)\n",
      "                  (CC and)\n",
      "                  (CD 10) (NN %))\n",
      "                (NN pet.)))))\n",
      "        (, ,)\n",
      "        (CC and)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (NN mercaptobenzothiazole))\n",
      "            (-LRB- -LRB-)\n",
      "            (NP (DT a) (NN sulfhydryl) (JJ group-containing) (NN chemical))\n",
      "            (ADVP (IN at)\n",
      "              (NP (CD 1) (NN %)))))\n",
      "        (NP (NN pet))))\n",
      "    (VP (VBD were)\n",
      "      (ADJP (JJ negative)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, negative-39)\n",
      "compound(tests-3, Skin-1)\n",
      "compound(tests-3, prick-2)\n",
      "nsubj(negative-39, tests-3)\n",
      "case(captopril-5, with-4)\n",
      "nmod:with(tests-3, captopril-5)\n",
      "cc(captopril-5, and-6)\n",
      "nmod:with(tests-3, glibenclamide-7)\n",
      "conj:and(captopril-5, glibenclamide-7)\n",
      "cc(captopril-5, and-8)\n",
      "compound(tests-10, patch-9)\n",
      "nmod:with(tests-3, tests-10)\n",
      "conj:and(captopril-5, tests-10)\n",
      "case(enalapril-12, with-11)\n",
      "nmod:with(pet-37, enalapril-12)\n",
      "punct(enalapril-12, ,-13)\n",
      "conj:and(enalapril-12, lisinopril-14)\n",
      "nmod:with(pet-37, lisinopril-14)\n",
      "punct(enalapril-12, ,-15)\n",
      "cc(enalapril-12, and-16)\n",
      "conj:and(enalapril-12, glibenclamide-17)\n",
      "nmod:with(pet-37, glibenclamide-17)\n",
      "case(pet.-24, at-18)\n",
      "nummod(%-20, 1-19)\n",
      "nummod(pet.-24, %-20)\n",
      "cc(%-20, and-21)\n",
      "nummod(%-23, 10-22)\n",
      "conj:and(%-20, %-23)\n",
      "nummod(pet.-24, %-23)\n",
      "nmod:at(enalapril-12, pet.-24)\n",
      "punct(pet-37, ,-25)\n",
      "cc(pet-37, and-26)\n",
      "case(mercaptobenzothiazole-28, with-27)\n",
      "nmod(tests-3, mercaptobenzothiazole-28)\n",
      "conj:and(pet-37, mercaptobenzothiazole-28)\n",
      "punct(mercaptobenzothiazole-28, -LRB--29)\n",
      "det(chemical-33, a-30)\n",
      "compound(chemical-33, sulfhydryl-31)\n",
      "amod(chemical-33, group-containing-32)\n",
      "dep(mercaptobenzothiazole-28, chemical-33)\n",
      "case(%-36, at-34)\n",
      "nummod(%-36, 1-35)\n",
      "advmod(mercaptobenzothiazole-28, %-36)\n",
      "nmod(tests-3, pet-37)\n",
      "cop(negative-39, were-38)\n",
      "punct(negative-39, .-40)\n",
      "\n",
      "Sentence #128 (34 tokens, sentiment: Negative):\n",
      "Only patch tests with captopril at 1% and 10% concentrations were positive at 48 h. Oral double-blind challenge tests with glibenclamide, enalapril, lisinopril, and placebo showed good tolerance.\n",
      "[Text=Only CharacterOffsetBegin=18158 CharacterOffsetEnd=18162 PartOfSpeech=RB Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patch CharacterOffsetBegin=18163 CharacterOffsetEnd=18168 PartOfSpeech=NN Lemma=patch NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=18169 CharacterOffsetEnd=18174 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=18175 CharacterOffsetEnd=18179 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=18180 CharacterOffsetEnd=18189 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=18190 CharacterOffsetEnd=18192 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1 CharacterOffsetBegin=18193 CharacterOffsetEnd=18194 PartOfSpeech=CD Lemma=1 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%1.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=18194 CharacterOffsetEnd=18195 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%1.0 SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18196 CharacterOffsetEnd=18199 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10 CharacterOffsetBegin=18200 CharacterOffsetEnd=18202 PartOfSpeech=CD Lemma=10 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%10.0 SentimentClass=Positive]\n",
      "[Text=% CharacterOffsetBegin=18202 CharacterOffsetEnd=18203 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%10.0 SentimentClass=Neutral]\n",
      "[Text=concentrations CharacterOffsetBegin=18204 CharacterOffsetEnd=18218 PartOfSpeech=NNS Lemma=concentration NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=18219 CharacterOffsetEnd=18223 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=positive CharacterOffsetBegin=18224 CharacterOffsetEnd=18232 PartOfSpeech=JJ Lemma=positive NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=at CharacterOffsetBegin=18233 CharacterOffsetEnd=18235 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=48 CharacterOffsetBegin=18236 CharacterOffsetEnd=18238 PartOfSpeech=CD Lemma=48 NamedEntityTag=NUMBER NormalizedNamedEntityTag=48.0 SentimentClass=Neutral]\n",
      "[Text=h. CharacterOffsetBegin=18239 CharacterOffsetEnd=18241 PartOfSpeech=NN Lemma=h. NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Oral CharacterOffsetBegin=18242 CharacterOffsetEnd=18246 PartOfSpeech=JJ Lemma=oral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=double-blind CharacterOffsetBegin=18247 CharacterOffsetEnd=18259 PartOfSpeech=JJ Lemma=double-blind NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=challenge CharacterOffsetBegin=18260 CharacterOffsetEnd=18269 PartOfSpeech=NN Lemma=challenge NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=18270 CharacterOffsetEnd=18275 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=18276 CharacterOffsetEnd=18280 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glibenclamide CharacterOffsetBegin=18281 CharacterOffsetEnd=18294 PartOfSpeech=NN Lemma=glibenclamide NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18294 CharacterOffsetEnd=18295 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=18296 CharacterOffsetEnd=18305 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18305 CharacterOffsetEnd=18306 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=18307 CharacterOffsetEnd=18317 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18317 CharacterOffsetEnd=18318 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18319 CharacterOffsetEnd=18322 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=placebo CharacterOffsetBegin=18323 CharacterOffsetEnd=18330 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=showed CharacterOffsetBegin=18331 CharacterOffsetEnd=18337 PartOfSpeech=VBD Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=good CharacterOffsetBegin=18338 CharacterOffsetEnd=18342 PartOfSpeech=JJ Lemma=good NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=tolerance CharacterOffsetBegin=18343 CharacterOffsetEnd=18352 PartOfSpeech=NN Lemma=tolerance NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=18352 CharacterOffsetEnd=18353 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (RB Only) (NN patch) (NNS tests))\n",
      "      (PP (IN with)\n",
      "        (NP\n",
      "          (NP (NN captopril))\n",
      "          (PP (IN at)\n",
      "            (NP\n",
      "              (QP (CD 1) (NN %)\n",
      "                (CC and)\n",
      "                (CD 10) (NN %))\n",
      "              (NNS concentrations))))))\n",
      "    (VP (VBD were)\n",
      "      (ADJP (JJ positive)\n",
      "        (PP (IN at)\n",
      "          (NP\n",
      "            (NP (CD 48) (NN h.) (JJ Oral) (JJ double-blind) (NN challenge) (NNS tests))\n",
      "            (PP (IN with)\n",
      "              (NP\n",
      "                (NP (NN glibenclamide) (, ,) (NN enalapril) (, ,) (NN lisinopril) (, ,)\n",
      "                  (CC and)\n",
      "                  (NN placebo))\n",
      "                (VP (VBD showed)\n",
      "                  (NP (JJ good) (NN tolerance)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, positive-14)\n",
      "advmod(tests-3, Only-1)\n",
      "compound(tests-3, patch-2)\n",
      "nsubj(positive-14, tests-3)\n",
      "case(captopril-5, with-4)\n",
      "nmod:with(tests-3, captopril-5)\n",
      "case(concentrations-12, at-6)\n",
      "nummod(%-8, 1-7)\n",
      "nummod(concentrations-12, %-8)\n",
      "cc(%-8, and-9)\n",
      "nummod(%-11, 10-10)\n",
      "conj:and(%-8, %-11)\n",
      "nummod(concentrations-12, %-11)\n",
      "nmod:at(captopril-5, concentrations-12)\n",
      "cop(positive-14, were-13)\n",
      "case(tests-21, at-15)\n",
      "nummod(tests-21, 48-16)\n",
      "compound(tests-21, h.-17)\n",
      "amod(tests-21, Oral-18)\n",
      "amod(tests-21, double-blind-19)\n",
      "compound(tests-21, challenge-20)\n",
      "nmod:at(positive-14, tests-21)\n",
      "case(glibenclamide-23, with-22)\n",
      "nmod:with(tests-21, glibenclamide-23)\n",
      "punct(glibenclamide-23, ,-24)\n",
      "nmod:with(tests-21, enalapril-25)\n",
      "conj:and(glibenclamide-23, enalapril-25)\n",
      "punct(glibenclamide-23, ,-26)\n",
      "nmod:with(tests-21, lisinopril-27)\n",
      "conj:and(glibenclamide-23, lisinopril-27)\n",
      "punct(glibenclamide-23, ,-28)\n",
      "cc(glibenclamide-23, and-29)\n",
      "nmod:with(tests-21, placebo-30)\n",
      "conj:and(glibenclamide-23, placebo-30)\n",
      "acl(glibenclamide-23, showed-31)\n",
      "amod(tolerance-33, good-32)\n",
      "dobj(showed-31, tolerance-33)\n",
      "punct(positive-14, .-34)\n",
      "\n",
      "Sentence #129 (9 tokens, sentiment: Negative):\n",
      "The patient was advised to avoid only captopril.\n",
      "[Text=The CharacterOffsetBegin=18354 CharacterOffsetEnd=18357 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patient CharacterOffsetBegin=18358 CharacterOffsetEnd=18365 PartOfSpeech=NN Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=18366 CharacterOffsetEnd=18369 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=advised CharacterOffsetBegin=18370 CharacterOffsetEnd=18377 PartOfSpeech=VBN Lemma=advise NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=18378 CharacterOffsetEnd=18380 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=avoid CharacterOffsetBegin=18381 CharacterOffsetEnd=18386 PartOfSpeech=VB Lemma=avoid NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=only CharacterOffsetBegin=18387 CharacterOffsetEnd=18391 PartOfSpeech=RB Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=18392 CharacterOffsetEnd=18401 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=18401 CharacterOffsetEnd=18402 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT The) (NN patient))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN advised)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB avoid)\n",
      "              (NP (RB only) (NN captopril)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, advised-4)\n",
      "det(patient-2, The-1)\n",
      "nsubjpass(advised-4, patient-2)\n",
      "nsubj:xsubj(avoid-6, patient-2)\n",
      "auxpass(advised-4, was-3)\n",
      "mark(avoid-6, to-5)\n",
      "xcomp(advised-4, avoid-6)\n",
      "advmod(captopril-8, only-7)\n",
      "dobj(avoid-6, captopril-8)\n",
      "punct(advised-4, .-9)\n",
      "\n",
      "Sentence #130 (35 tokens, sentiment: Negative):\n",
      "Because captopril is the only ACE inhibitor containing a sulfhydryl group and has occasionally been implicated in complex immunological diseases, this chemical group has been considered the culprit of allergic reactions to captopril.\n",
      "[Text=Because CharacterOffsetBegin=18403 CharacterOffsetEnd=18410 PartOfSpeech=IN Lemma=because NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=18411 CharacterOffsetEnd=18420 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=18421 CharacterOffsetEnd=18423 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=18424 CharacterOffsetEnd=18427 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=only CharacterOffsetBegin=18428 CharacterOffsetEnd=18432 PartOfSpeech=JJ Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=18433 CharacterOffsetEnd=18436 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=18437 CharacterOffsetEnd=18446 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=containing CharacterOffsetBegin=18447 CharacterOffsetEnd=18457 PartOfSpeech=VBG Lemma=contain NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=18458 CharacterOffsetEnd=18459 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=sulfhydryl CharacterOffsetBegin=18460 CharacterOffsetEnd=18470 PartOfSpeech=NN Lemma=sulfhydryl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=18471 CharacterOffsetEnd=18476 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18477 CharacterOffsetEnd=18480 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=has CharacterOffsetBegin=18481 CharacterOffsetEnd=18484 PartOfSpeech=VBZ Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=occasionally CharacterOffsetBegin=18485 CharacterOffsetEnd=18497 PartOfSpeech=RB Lemma=occasionally NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=been CharacterOffsetBegin=18498 CharacterOffsetEnd=18502 PartOfSpeech=VBN Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=implicated CharacterOffsetBegin=18503 CharacterOffsetEnd=18513 PartOfSpeech=VBN Lemma=implicate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=18514 CharacterOffsetEnd=18516 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=complex CharacterOffsetBegin=18517 CharacterOffsetEnd=18524 PartOfSpeech=JJ Lemma=complex NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=immunological CharacterOffsetBegin=18525 CharacterOffsetEnd=18538 PartOfSpeech=JJ Lemma=immunological NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diseases CharacterOffsetBegin=18539 CharacterOffsetEnd=18547 PartOfSpeech=NNS Lemma=disease NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18547 CharacterOffsetEnd=18548 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=this CharacterOffsetBegin=18549 CharacterOffsetEnd=18553 PartOfSpeech=DT Lemma=this NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chemical CharacterOffsetBegin=18554 CharacterOffsetEnd=18562 PartOfSpeech=NN Lemma=chemical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=18563 CharacterOffsetEnd=18568 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=has CharacterOffsetBegin=18569 CharacterOffsetEnd=18572 PartOfSpeech=VBZ Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=been CharacterOffsetBegin=18573 CharacterOffsetEnd=18577 PartOfSpeech=VBN Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=considered CharacterOffsetBegin=18578 CharacterOffsetEnd=18588 PartOfSpeech=VBN Lemma=consider NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=18589 CharacterOffsetEnd=18592 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=culprit CharacterOffsetBegin=18593 CharacterOffsetEnd=18600 PartOfSpeech=NN Lemma=culprit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=18601 CharacterOffsetEnd=18603 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=allergic CharacterOffsetBegin=18604 CharacterOffsetEnd=18612 PartOfSpeech=JJ Lemma=allergic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reactions CharacterOffsetBegin=18613 CharacterOffsetEnd=18622 PartOfSpeech=NNS Lemma=reaction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=18623 CharacterOffsetEnd=18625 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=18626 CharacterOffsetEnd=18635 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=18635 CharacterOffsetEnd=18636 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (SBAR (IN Because)\n",
      "      (S\n",
      "        (NP (NN captopril))\n",
      "        (VP\n",
      "          (VP (VBZ is)\n",
      "            (NP (DT the) (JJ only) (NN ACE) (NN inhibitor))\n",
      "            (S\n",
      "              (VP (VBG containing)\n",
      "                (NP (DT a) (NN sulfhydryl) (NN group)))))\n",
      "          (CC and)\n",
      "          (VP (VBZ has)\n",
      "            (ADVP (RB occasionally))\n",
      "            (VP (VBN been)\n",
      "              (VP (VBN implicated)\n",
      "                (PP (IN in)\n",
      "                  (NP (JJ complex) (JJ immunological) (NNS diseases)))))))))\n",
      "    (, ,)\n",
      "    (NP (DT this) (NN chemical) (NN group))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN been)\n",
      "        (VP (VBN considered)\n",
      "          (NP\n",
      "            (NP (DT the) (NN culprit))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ allergic) (NNS reactions))))\n",
      "          (PP (TO to)\n",
      "            (NP (NN captopril))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, considered-27)\n",
      "mark(inhibitor-7, Because-1)\n",
      "nsubj(inhibitor-7, captopril-2)\n",
      "nsubjpass(implicated-16, captopril-2)\n",
      "cop(inhibitor-7, is-3)\n",
      "det(inhibitor-7, the-4)\n",
      "amod(inhibitor-7, only-5)\n",
      "compound(inhibitor-7, ACE-6)\n",
      "advcl:because(considered-27, inhibitor-7)\n",
      "xcomp(inhibitor-7, containing-8)\n",
      "det(group-11, a-9)\n",
      "compound(group-11, sulfhydryl-10)\n",
      "dobj(containing-8, group-11)\n",
      "cc(inhibitor-7, and-12)\n",
      "aux(implicated-16, has-13)\n",
      "advmod(implicated-16, occasionally-14)\n",
      "auxpass(implicated-16, been-15)\n",
      "conj:and(inhibitor-7, implicated-16)\n",
      "advcl:because(considered-27, implicated-16)\n",
      "case(diseases-20, in-17)\n",
      "amod(diseases-20, complex-18)\n",
      "amod(diseases-20, immunological-19)\n",
      "nmod:in(implicated-16, diseases-20)\n",
      "punct(considered-27, ,-21)\n",
      "det(group-24, this-22)\n",
      "compound(group-24, chemical-23)\n",
      "nsubjpass(considered-27, group-24)\n",
      "aux(considered-27, has-25)\n",
      "auxpass(considered-27, been-26)\n",
      "det(culprit-29, the-28)\n",
      "dobj(considered-27, culprit-29)\n",
      "case(reactions-32, of-30)\n",
      "amod(reactions-32, allergic-31)\n",
      "nmod:of(culprit-29, reactions-32)\n",
      "case(captopril-34, to-33)\n",
      "nmod:to(considered-27, captopril-34)\n",
      "punct(considered-27, .-35)\n",
      "\n",
      "Sentence #131 (22 tokens, sentiment: Negative):\n",
      "The lack of cross-reactivity between captopril, enalapril, and benazepril has been demonstrated in a few patients by patch tests.\n",
      "[Text=The CharacterOffsetBegin=18637 CharacterOffsetEnd=18640 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lack CharacterOffsetBegin=18641 CharacterOffsetEnd=18645 PartOfSpeech=NN Lemma=lack NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=18646 CharacterOffsetEnd=18648 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cross-reactivity CharacterOffsetBegin=18649 CharacterOffsetEnd=18665 PartOfSpeech=NN Lemma=cross-reactivity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=between CharacterOffsetBegin=18666 CharacterOffsetEnd=18673 PartOfSpeech=IN Lemma=between NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=18674 CharacterOffsetEnd=18683 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18683 CharacterOffsetEnd=18684 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=18685 CharacterOffsetEnd=18694 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18694 CharacterOffsetEnd=18695 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18696 CharacterOffsetEnd=18699 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=18700 CharacterOffsetEnd=18710 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=has CharacterOffsetBegin=18711 CharacterOffsetEnd=18714 PartOfSpeech=VBZ Lemma=have NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=been CharacterOffsetBegin=18715 CharacterOffsetEnd=18719 PartOfSpeech=VBN Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=demonstrated CharacterOffsetBegin=18720 CharacterOffsetEnd=18732 PartOfSpeech=VBN Lemma=demonstrate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=18733 CharacterOffsetEnd=18735 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=18736 CharacterOffsetEnd=18737 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=few CharacterOffsetBegin=18738 CharacterOffsetEnd=18741 PartOfSpeech=JJ Lemma=few NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=18742 CharacterOffsetEnd=18750 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=18751 CharacterOffsetEnd=18753 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patch CharacterOffsetBegin=18754 CharacterOffsetEnd=18759 PartOfSpeech=NN Lemma=patch NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=18760 CharacterOffsetEnd=18765 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=18765 CharacterOffsetEnd=18766 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN lack))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NN cross-reactivity))\n",
      "          (PP (IN between)\n",
      "            (NP\n",
      "              (NP (NN captopril))\n",
      "              (, ,)\n",
      "              (NP (NN enalapril))\n",
      "              (, ,)\n",
      "              (CC and)\n",
      "              (NP (NN benazepril)))))))\n",
      "    (VP (VBZ has)\n",
      "      (VP (VBN been)\n",
      "        (VP (VBN demonstrated)\n",
      "          (PP (IN in)\n",
      "            (NP (DT a) (JJ few) (NNS patients)))\n",
      "          (PP (IN by)\n",
      "            (NP (NN patch) (NNS tests))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, demonstrated-14)\n",
      "det(lack-2, The-1)\n",
      "nsubjpass(demonstrated-14, lack-2)\n",
      "case(cross-reactivity-4, of-3)\n",
      "nmod:of(lack-2, cross-reactivity-4)\n",
      "case(captopril-6, between-5)\n",
      "nmod:between(cross-reactivity-4, captopril-6)\n",
      "punct(captopril-6, ,-7)\n",
      "nmod:between(cross-reactivity-4, enalapril-8)\n",
      "conj:and(captopril-6, enalapril-8)\n",
      "punct(captopril-6, ,-9)\n",
      "cc(captopril-6, and-10)\n",
      "nmod:between(cross-reactivity-4, benazepril-11)\n",
      "conj:and(captopril-6, benazepril-11)\n",
      "aux(demonstrated-14, has-12)\n",
      "auxpass(demonstrated-14, been-13)\n",
      "case(patients-18, in-15)\n",
      "det(patients-18, a-16)\n",
      "amod(patients-18, few-17)\n",
      "nmod:in(demonstrated-14, patients-18)\n",
      "case(tests-21, by-19)\n",
      "compound(tests-21, patch-20)\n",
      "nmod:agent(demonstrated-14, tests-21)\n",
      "punct(demonstrated-14, .-22)\n",
      "\n",
      "Sentence #132 (25 tokens, sentiment: Negative):\n",
      "In our patient, patch tests identified captopril as the drug responsible for a probably immune adverse reaction not due to the sulfhydryl group.\n",
      "[Text=In CharacterOffsetBegin=18767 CharacterOffsetEnd=18769 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=our CharacterOffsetBegin=18770 CharacterOffsetEnd=18773 PartOfSpeech=PRP$ Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patient CharacterOffsetBegin=18774 CharacterOffsetEnd=18781 PartOfSpeech=NN Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=18781 CharacterOffsetEnd=18782 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patch CharacterOffsetBegin=18783 CharacterOffsetEnd=18788 PartOfSpeech=NN Lemma=patch NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=18789 CharacterOffsetEnd=18794 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=identified CharacterOffsetBegin=18795 CharacterOffsetEnd=18805 PartOfSpeech=VBD Lemma=identify NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=captopril CharacterOffsetBegin=18806 CharacterOffsetEnd=18815 PartOfSpeech=NN Lemma=captopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=as CharacterOffsetBegin=18816 CharacterOffsetEnd=18818 PartOfSpeech=IN Lemma=as NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=18819 CharacterOffsetEnd=18822 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drug CharacterOffsetBegin=18823 CharacterOffsetEnd=18827 PartOfSpeech=NN Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=responsible CharacterOffsetBegin=18828 CharacterOffsetEnd=18839 PartOfSpeech=JJ Lemma=responsible NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=for CharacterOffsetBegin=18840 CharacterOffsetEnd=18843 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=18844 CharacterOffsetEnd=18845 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=probably CharacterOffsetBegin=18846 CharacterOffsetEnd=18854 PartOfSpeech=RB Lemma=probably NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=immune CharacterOffsetBegin=18855 CharacterOffsetEnd=18861 PartOfSpeech=JJ Lemma=immune NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=adverse CharacterOffsetBegin=18862 CharacterOffsetEnd=18869 PartOfSpeech=JJ Lemma=adverse NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reaction CharacterOffsetBegin=18870 CharacterOffsetEnd=18878 PartOfSpeech=NN Lemma=reaction NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=not CharacterOffsetBegin=18879 CharacterOffsetEnd=18882 PartOfSpeech=RB Lemma=not NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=due CharacterOffsetBegin=18883 CharacterOffsetEnd=18886 PartOfSpeech=JJ Lemma=due NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=18887 CharacterOffsetEnd=18889 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=18890 CharacterOffsetEnd=18893 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=sulfhydryl CharacterOffsetBegin=18894 CharacterOffsetEnd=18904 PartOfSpeech=NN Lemma=sulfhydryl NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=18905 CharacterOffsetEnd=18910 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=18910 CharacterOffsetEnd=18911 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (IN In)\n",
      "      (NP (PRP$ our) (NN patient)))\n",
      "    (, ,)\n",
      "    (NP (NN patch) (NNS tests))\n",
      "    (VP (VBD identified)\n",
      "      (NP (NN captopril))\n",
      "      (PP (IN as)\n",
      "        (NP\n",
      "          (NP (DT the) (NN drug))\n",
      "          (ADJP (JJ responsible)\n",
      "            (PP (IN for)\n",
      "              (NP\n",
      "                (NP (DT a)\n",
      "                  (ADJP (RB probably) (JJ immune))\n",
      "                  (JJ adverse) (NN reaction))\n",
      "                (ADJP (RB not) (JJ due)))))))\n",
      "      (PP (TO to)\n",
      "        (NP (DT the) (NN sulfhydryl) (NN group))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, identified-7)\n",
      "case(patient-3, In-1)\n",
      "nmod:poss(patient-3, our-2)\n",
      "nmod:in(identified-7, patient-3)\n",
      "punct(identified-7, ,-4)\n",
      "compound(tests-6, patch-5)\n",
      "nsubj(identified-7, tests-6)\n",
      "dobj(identified-7, captopril-8)\n",
      "case(drug-11, as-9)\n",
      "det(drug-11, the-10)\n",
      "nmod:as(identified-7, drug-11)\n",
      "amod(drug-11, responsible-12)\n",
      "case(reaction-18, for-13)\n",
      "det(reaction-18, a-14)\n",
      "advmod(immune-16, probably-15)\n",
      "amod(reaction-18, immune-16)\n",
      "amod(reaction-18, adverse-17)\n",
      "nmod:for(responsible-12, reaction-18)\n",
      "neg(due-20, not-19)\n",
      "amod(reaction-18, due-20)\n",
      "case(group-24, to-21)\n",
      "det(group-24, the-22)\n",
      "compound(group-24, sulfhydryl-23)\n",
      "nmod:to(identified-7, group-24)\n",
      "punct(identified-7, .-25)\n",
      "\n",
      "Sentence #133 (23 tokens, sentiment: Negative):\n",
      "Patch tests are useful and safe in the diagnostic work-up of allergic drug reactions and in studies of cross-sensitivity among ACE inhibitors.\n",
      "[Text=Patch CharacterOffsetBegin=18912 CharacterOffsetEnd=18917 PartOfSpeech=NNP Lemma=Patch NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=tests CharacterOffsetBegin=18918 CharacterOffsetEnd=18923 PartOfSpeech=NNS Lemma=test NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=18924 CharacterOffsetEnd=18927 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=useful CharacterOffsetBegin=18928 CharacterOffsetEnd=18934 PartOfSpeech=JJ Lemma=useful NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18935 CharacterOffsetEnd=18938 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=safe CharacterOffsetBegin=18939 CharacterOffsetEnd=18943 PartOfSpeech=JJ Lemma=safe NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=in CharacterOffsetBegin=18944 CharacterOffsetEnd=18946 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=18947 CharacterOffsetEnd=18950 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diagnostic CharacterOffsetBegin=18951 CharacterOffsetEnd=18961 PartOfSpeech=JJ Lemma=diagnostic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=work-up CharacterOffsetBegin=18962 CharacterOffsetEnd=18969 PartOfSpeech=NN Lemma=work-up NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=18970 CharacterOffsetEnd=18972 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=allergic CharacterOffsetBegin=18973 CharacterOffsetEnd=18981 PartOfSpeech=JJ Lemma=allergic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drug CharacterOffsetBegin=18982 CharacterOffsetEnd=18986 PartOfSpeech=NN Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reactions CharacterOffsetBegin=18987 CharacterOffsetEnd=18996 PartOfSpeech=NNS Lemma=reaction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=18997 CharacterOffsetEnd=19000 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=19001 CharacterOffsetEnd=19003 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=studies CharacterOffsetBegin=19004 CharacterOffsetEnd=19011 PartOfSpeech=NNS Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=19012 CharacterOffsetEnd=19014 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cross-sensitivity CharacterOffsetBegin=19015 CharacterOffsetEnd=19032 PartOfSpeech=NN Lemma=cross-sensitivity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=among CharacterOffsetBegin=19033 CharacterOffsetEnd=19038 PartOfSpeech=IN Lemma=among NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=19039 CharacterOffsetEnd=19042 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=19043 CharacterOffsetEnd=19053 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=19053 CharacterOffsetEnd=19054 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Patch) (NNS tests))\n",
      "    (VP (VBP are)\n",
      "      (ADJP (JJ useful)\n",
      "        (CC and)\n",
      "        (JJ safe))\n",
      "      (PP\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ diagnostic) (NN work-up))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ allergic) (NN drug) (NNS reactions)))))\n",
      "        (CC and)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS studies))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (NN cross-sensitivity))\n",
      "                (PP (IN among)\n",
      "                  (NP (NN ACE) (NNS inhibitors)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, useful-4)\n",
      "compound(tests-2, Patch-1)\n",
      "nsubj(useful-4, tests-2)\n",
      "nsubj(useful-4', tests-2)\n",
      "nsubj(safe-6, tests-2)\n",
      "cop(useful-4, are-3)\n",
      "conj:and(useful-4, useful-4')\n",
      "cc(useful-4, and-5)\n",
      "conj:and(useful-4, safe-6)\n",
      "case(work-up-10, in-7)\n",
      "det(work-up-10, the-8)\n",
      "amod(work-up-10, diagnostic-9)\n",
      "nmod:in(useful-4, work-up-10)\n",
      "case(reactions-14, of-11)\n",
      "amod(reactions-14, allergic-12)\n",
      "compound(reactions-14, drug-13)\n",
      "nmod:of(work-up-10, reactions-14)\n",
      "cc(useful-4, and-15)\n",
      "case(studies-17, in-16)\n",
      "nmod:in(useful-4', studies-17)\n",
      "case(cross-sensitivity-19, of-18)\n",
      "nmod:of(studies-17, cross-sensitivity-19)\n",
      "case(inhibitors-22, among-20)\n",
      "compound(inhibitors-22, ACE-21)\n",
      "nmod:among(cross-sensitivity-19, inhibitors-22)\n",
      "punct(useful-4, .-23)\n",
      "\n",
      "Sentence #134 (32 tokens, sentiment: Negative):\n",
      "Benazepril therapy as a component of antihypertensive treatment of persons with chronic renal insufficiency initially costs money, but investment costs are recouped quickly and return on investment continues to grow.\n",
      "[Text=Benazepril CharacterOffsetBegin=19056 CharacterOffsetEnd=19066 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=19067 CharacterOffsetEnd=19074 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=as CharacterOffsetBegin=19075 CharacterOffsetEnd=19077 PartOfSpeech=IN Lemma=as NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=19078 CharacterOffsetEnd=19079 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=component CharacterOffsetBegin=19080 CharacterOffsetEnd=19089 PartOfSpeech=NN Lemma=component NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=19090 CharacterOffsetEnd=19092 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antihypertensive CharacterOffsetBegin=19093 CharacterOffsetEnd=19109 PartOfSpeech=JJ Lemma=antihypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=treatment CharacterOffsetBegin=19110 CharacterOffsetEnd=19119 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=19120 CharacterOffsetEnd=19122 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=persons CharacterOffsetBegin=19123 CharacterOffsetEnd=19130 PartOfSpeech=NNS Lemma=person NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=19131 CharacterOffsetEnd=19135 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chronic CharacterOffsetBegin=19136 CharacterOffsetEnd=19143 PartOfSpeech=JJ Lemma=chronic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=19144 CharacterOffsetEnd=19149 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=insufficiency CharacterOffsetBegin=19150 CharacterOffsetEnd=19163 PartOfSpeech=NN Lemma=insufficiency NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=initially CharacterOffsetBegin=19164 CharacterOffsetEnd=19173 PartOfSpeech=RB Lemma=initially NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=costs CharacterOffsetBegin=19174 CharacterOffsetEnd=19179 PartOfSpeech=VBZ Lemma=cost NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=money CharacterOffsetBegin=19180 CharacterOffsetEnd=19185 PartOfSpeech=NN Lemma=money NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=19185 CharacterOffsetEnd=19186 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=but CharacterOffsetBegin=19187 CharacterOffsetEnd=19190 PartOfSpeech=CC Lemma=but NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=investment CharacterOffsetBegin=19191 CharacterOffsetEnd=19201 PartOfSpeech=NN Lemma=investment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=costs CharacterOffsetBegin=19202 CharacterOffsetEnd=19207 PartOfSpeech=NNS Lemma=cost NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=19208 CharacterOffsetEnd=19211 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=recouped CharacterOffsetBegin=19212 CharacterOffsetEnd=19220 PartOfSpeech=VBN Lemma=recoup NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=quickly CharacterOffsetBegin=19221 CharacterOffsetEnd=19228 PartOfSpeech=RB Lemma=quickly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=19229 CharacterOffsetEnd=19232 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=return CharacterOffsetBegin=19233 CharacterOffsetEnd=19239 PartOfSpeech=VB Lemma=return NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=19240 CharacterOffsetEnd=19242 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=investment CharacterOffsetBegin=19243 CharacterOffsetEnd=19253 PartOfSpeech=NN Lemma=investment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=continues CharacterOffsetBegin=19254 CharacterOffsetEnd=19263 PartOfSpeech=VBZ Lemma=continue NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=19264 CharacterOffsetEnd=19266 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=grow CharacterOffsetBegin=19267 CharacterOffsetEnd=19271 PartOfSpeech=VB Lemma=grow NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=19271 CharacterOffsetEnd=19272 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (NN Benazepril) (NN therapy))\n",
      "        (PP (IN as)\n",
      "          (NP\n",
      "            (NP (DT a) (NN component))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (JJ antihypertensive) (NN treatment))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NNS persons))\n",
      "                    (PP (IN with)\n",
      "                      (NP (JJ chronic) (JJ renal) (NN insufficiency))))))))))\n",
      "      (VP\n",
      "        (ADVP (RB initially))\n",
      "        (VBZ costs)\n",
      "        (NP (NN money))))\n",
      "    (, ,)\n",
      "    (CC but)\n",
      "    (S\n",
      "      (S\n",
      "        (NP (NN investment) (NNS costs))\n",
      "        (VP (VBP are)\n",
      "          (VP (VBN recouped)\n",
      "            (ADVP (RB quickly)))))\n",
      "      (CC and)\n",
      "      (S\n",
      "        (S\n",
      "          (VP (VB return)\n",
      "            (PP (IN on)\n",
      "              (NP (NN investment)))))\n",
      "        (VP (VBZ continues)\n",
      "          (S\n",
      "            (VP (TO to)\n",
      "              (VP (VB grow)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, costs-16)\n",
      "compound(therapy-2, Benazepril-1)\n",
      "nsubj(costs-16, therapy-2)\n",
      "case(component-5, as-3)\n",
      "det(component-5, a-4)\n",
      "nmod:as(therapy-2, component-5)\n",
      "case(treatment-8, of-6)\n",
      "amod(treatment-8, antihypertensive-7)\n",
      "nmod:of(component-5, treatment-8)\n",
      "case(persons-10, of-9)\n",
      "nmod:of(treatment-8, persons-10)\n",
      "case(insufficiency-14, with-11)\n",
      "amod(insufficiency-14, chronic-12)\n",
      "amod(insufficiency-14, renal-13)\n",
      "nmod:with(persons-10, insufficiency-14)\n",
      "advmod(costs-16, initially-15)\n",
      "dobj(costs-16, money-17)\n",
      "punct(costs-16, ,-18)\n",
      "cc(costs-16, but-19)\n",
      "compound(costs-21, investment-20)\n",
      "nsubjpass(recouped-23, costs-21)\n",
      "auxpass(recouped-23, are-22)\n",
      "conj:but(costs-16, recouped-23)\n",
      "advmod(recouped-23, quickly-24)\n",
      "cc(recouped-23, and-25)\n",
      "csubj(continues-29, return-26)\n",
      "case(investment-28, on-27)\n",
      "nmod:on(return-26, investment-28)\n",
      "conj:but(costs-16, continues-29)\n",
      "conj:and(recouped-23, continues-29)\n",
      "mark(grow-31, to-30)\n",
      "xcomp(continues-29, grow-31)\n",
      "punct(costs-16, .-32)\n",
      "\n",
      "Sentence #135 (15 tokens, sentiment: Positive):\n",
      "The impact of end-stage renal disease on patient health and healthcare costs is great.\n",
      "[Text=The CharacterOffsetBegin=19273 CharacterOffsetEnd=19276 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=impact CharacterOffsetBegin=19277 CharacterOffsetEnd=19283 PartOfSpeech=NN Lemma=impact NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=19284 CharacterOffsetEnd=19286 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=end-stage CharacterOffsetBegin=19287 CharacterOffsetEnd=19296 PartOfSpeech=JJ Lemma=end-stage NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=19297 CharacterOffsetEnd=19302 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=disease CharacterOffsetBegin=19303 CharacterOffsetEnd=19310 PartOfSpeech=NN Lemma=disease NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=on CharacterOffsetBegin=19311 CharacterOffsetEnd=19313 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patient CharacterOffsetBegin=19314 CharacterOffsetEnd=19321 PartOfSpeech=NN Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=health CharacterOffsetBegin=19322 CharacterOffsetEnd=19328 PartOfSpeech=NN Lemma=health NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=19329 CharacterOffsetEnd=19332 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=healthcare CharacterOffsetBegin=19333 CharacterOffsetEnd=19343 PartOfSpeech=NN Lemma=healthcare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=costs CharacterOffsetBegin=19344 CharacterOffsetEnd=19349 PartOfSpeech=NNS Lemma=cost NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=19350 CharacterOffsetEnd=19352 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=great CharacterOffsetBegin=19353 CharacterOffsetEnd=19358 PartOfSpeech=JJ Lemma=great NamedEntityTag=O SentimentClass=Very positive]\n",
      "[Text=. CharacterOffsetBegin=19358 CharacterOffsetEnd=19359 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN impact))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (JJ end-stage) (JJ renal) (NN disease))\n",
      "          (PP (IN on)\n",
      "            (NP (NN patient) (NN health)\n",
      "              (CC and)\n",
      "              (NN healthcare) (NNS costs))))))\n",
      "    (VP (VBZ is)\n",
      "      (ADJP (JJ great)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, great-14)\n",
      "det(impact-2, The-1)\n",
      "nsubj(great-14, impact-2)\n",
      "case(disease-6, of-3)\n",
      "amod(disease-6, end-stage-4)\n",
      "amod(disease-6, renal-5)\n",
      "nmod:of(impact-2, disease-6)\n",
      "case(health-9, on-7)\n",
      "compound(health-9, patient-8)\n",
      "nmod:on(disease-6, health-9)\n",
      "cc(health-9, and-10)\n",
      "compound(costs-12, healthcare-11)\n",
      "nmod:on(disease-6, costs-12)\n",
      "conj:and(health-9, costs-12)\n",
      "cop(great-14, is-13)\n",
      "punct(great-14, .-15)\n",
      "\n",
      "Sentence #136 (57 tokens, sentiment: Negative):\n",
      "Thus, the quality-adjusted survival benefits and overall cost savings seen in benazepril recipients over a prolonged period (2 to 7 years) indicate that the strategy of prescribing benazepril to reduce progression of renal disease in patients with renal insufficiency is both clinically and economically beneficial compared with current antihypertensive regimens without ACE inhibition.\n",
      "[Text=Thus CharacterOffsetBegin=19360 CharacterOffsetEnd=19364 PartOfSpeech=RB Lemma=thus NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=19364 CharacterOffsetEnd=19365 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=19366 CharacterOffsetEnd=19369 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=quality-adjusted CharacterOffsetBegin=19370 CharacterOffsetEnd=19386 PartOfSpeech=JJ Lemma=quality-adjusted NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=survival CharacterOffsetBegin=19387 CharacterOffsetEnd=19395 PartOfSpeech=NN Lemma=survival NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benefits CharacterOffsetBegin=19396 CharacterOffsetEnd=19404 PartOfSpeech=NNS Lemma=benefit NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=and CharacterOffsetBegin=19405 CharacterOffsetEnd=19408 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=overall CharacterOffsetBegin=19409 CharacterOffsetEnd=19416 PartOfSpeech=JJ Lemma=overall NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cost CharacterOffsetBegin=19417 CharacterOffsetEnd=19421 PartOfSpeech=NN Lemma=cost NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=savings CharacterOffsetBegin=19422 CharacterOffsetEnd=19429 PartOfSpeech=NNS Lemma=savings NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=seen CharacterOffsetBegin=19430 CharacterOffsetEnd=19434 PartOfSpeech=VBN Lemma=see NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=19435 CharacterOffsetEnd=19437 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=19438 CharacterOffsetEnd=19448 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=recipients CharacterOffsetBegin=19449 CharacterOffsetEnd=19459 PartOfSpeech=NNS Lemma=recipient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=over CharacterOffsetBegin=19460 CharacterOffsetEnd=19464 PartOfSpeech=IN Lemma=over NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=19465 CharacterOffsetEnd=19466 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=prolonged CharacterOffsetBegin=19467 CharacterOffsetEnd=19476 PartOfSpeech=JJ Lemma=prolonged NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=period CharacterOffsetBegin=19477 CharacterOffsetEnd=19483 PartOfSpeech=NN Lemma=period NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=19484 CharacterOffsetEnd=19485 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=2 CharacterOffsetBegin=19485 CharacterOffsetEnd=19486 PartOfSpeech=CD Lemma=2 NamedEntityTag=DURATION NormalizedNamedEntityTag=P2Y/P7Y Timex=<TIMEX3 alt_value=\"P2Y/P7Y\" tid=\"t31\" type=\"DURATION\">2 to 7 years</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=19487 CharacterOffsetEnd=19489 PartOfSpeech=TO Lemma=to NamedEntityTag=DURATION NormalizedNamedEntityTag=P2Y/P7Y Timex=<TIMEX3 alt_value=\"P2Y/P7Y\" tid=\"t31\" type=\"DURATION\">2 to 7 years</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=7 CharacterOffsetBegin=19490 CharacterOffsetEnd=19491 PartOfSpeech=CD Lemma=7 NamedEntityTag=DURATION NormalizedNamedEntityTag=P2Y/P7Y Timex=<TIMEX3 alt_value=\"P2Y/P7Y\" tid=\"t31\" type=\"DURATION\">2 to 7 years</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=years CharacterOffsetBegin=19492 CharacterOffsetEnd=19497 PartOfSpeech=NNS Lemma=year NamedEntityTag=DURATION NormalizedNamedEntityTag=P2Y/P7Y Timex=<TIMEX3 alt_value=\"P2Y/P7Y\" tid=\"t31\" type=\"DURATION\">2 to 7 years</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=19497 CharacterOffsetEnd=19498 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=indicate CharacterOffsetBegin=19499 CharacterOffsetEnd=19507 PartOfSpeech=VBP Lemma=indicate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=19508 CharacterOffsetEnd=19512 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=19513 CharacterOffsetEnd=19516 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=strategy CharacterOffsetBegin=19517 CharacterOffsetEnd=19525 PartOfSpeech=NN Lemma=strategy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=19526 CharacterOffsetEnd=19528 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=prescribing CharacterOffsetBegin=19529 CharacterOffsetEnd=19540 PartOfSpeech=VBG Lemma=prescribe NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=19541 CharacterOffsetEnd=19551 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=19552 CharacterOffsetEnd=19554 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduce CharacterOffsetBegin=19555 CharacterOffsetEnd=19561 PartOfSpeech=VB Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=progression CharacterOffsetBegin=19562 CharacterOffsetEnd=19573 PartOfSpeech=NN Lemma=progression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=19574 CharacterOffsetEnd=19576 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=19577 CharacterOffsetEnd=19582 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=disease CharacterOffsetBegin=19583 CharacterOffsetEnd=19590 PartOfSpeech=NN Lemma=disease NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=in CharacterOffsetBegin=19591 CharacterOffsetEnd=19593 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=19594 CharacterOffsetEnd=19602 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=19603 CharacterOffsetEnd=19607 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=19608 CharacterOffsetEnd=19613 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=insufficiency CharacterOffsetBegin=19614 CharacterOffsetEnd=19627 PartOfSpeech=NN Lemma=insufficiency NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=19628 CharacterOffsetEnd=19630 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=both CharacterOffsetBegin=19631 CharacterOffsetEnd=19635 PartOfSpeech=CC Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=clinically CharacterOffsetBegin=19636 CharacterOffsetEnd=19646 PartOfSpeech=RB Lemma=clinically NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=19647 CharacterOffsetEnd=19650 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=economically CharacterOffsetBegin=19651 CharacterOffsetEnd=19663 PartOfSpeech=RB Lemma=economically NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=beneficial CharacterOffsetBegin=19664 CharacterOffsetEnd=19674 PartOfSpeech=JJ Lemma=beneficial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compared CharacterOffsetBegin=19675 CharacterOffsetEnd=19683 PartOfSpeech=VBN Lemma=compare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=19684 CharacterOffsetEnd=19688 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=current CharacterOffsetBegin=19689 CharacterOffsetEnd=19696 PartOfSpeech=JJ Lemma=current NamedEntityTag=DATE NormalizedNamedEntityTag=PRESENT_REF Timex=<TIMEX3 tid=\"t32\" type=\"DATE\" value=\"PRESENT_REF\">current</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=antihypertensive CharacterOffsetBegin=19697 CharacterOffsetEnd=19713 PartOfSpeech=JJ Lemma=antihypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=regimens CharacterOffsetBegin=19714 CharacterOffsetEnd=19722 PartOfSpeech=NNS Lemma=regimen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=without CharacterOffsetBegin=19723 CharacterOffsetEnd=19730 PartOfSpeech=IN Lemma=without NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ACE CharacterOffsetBegin=19731 CharacterOffsetEnd=19734 PartOfSpeech=NN Lemma=ace NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibition CharacterOffsetBegin=19735 CharacterOffsetEnd=19745 PartOfSpeech=NN Lemma=inhibition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=19745 CharacterOffsetEnd=19746 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB Thus))\n",
      "    (, ,)\n",
      "    (NP\n",
      "      (NP (DT the) (JJ quality-adjusted) (NN survival) (NNS benefits))\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP (JJ overall) (NN cost) (NNS savings))\n",
      "        (VP (VBN seen)\n",
      "          (PP (IN in)\n",
      "            (NP\n",
      "              (NP (NN benazepril) (NNS recipients))\n",
      "              (PP (IN over)\n",
      "                (NP\n",
      "                  (NP (DT a) (JJ prolonged) (NN period))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP\n",
      "                      (QP (CD 2) (TO to) (CD 7) (NNS years)))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (VP (VBP indicate)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (DT the) (NN strategy))\n",
      "            (PP (IN of)\n",
      "              (S\n",
      "                (VP (VBG prescribing)\n",
      "                  (NP (NN benazepril))\n",
      "                  (S\n",
      "                    (VP (TO to)\n",
      "                      (VP (VB reduce)\n",
      "                        (NP\n",
      "                          (NP (NN progression))\n",
      "                          (PP (IN of)\n",
      "                            (NP (JJ renal) (NN disease))))\n",
      "                        (PP (IN in)\n",
      "                          (NP\n",
      "                            (NP (NNS patients))\n",
      "                            (PP (IN with)\n",
      "                              (NP (JJ renal) (NN insufficiency))))))))))))\n",
      "          (VP (VBZ is)\n",
      "            (ADVP (CC both)\n",
      "              (RB clinically)\n",
      "              (CC and)\n",
      "              (RB economically))\n",
      "            (ADJP (JJ beneficial))\n",
      "            (PP (VBN compared)\n",
      "              (PP (IN with)\n",
      "                (NP\n",
      "                  (NP (JJ current) (JJ antihypertensive) (NNS regimens))\n",
      "                  (PP (IN without)\n",
      "                    (NP (NN ACE) (NN inhibition))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, indicate-25)\n",
      "advmod(indicate-25, Thus-1)\n",
      "punct(indicate-25, ,-2)\n",
      "det(benefits-6, the-3)\n",
      "amod(benefits-6, quality-adjusted-4)\n",
      "compound(benefits-6, survival-5)\n",
      "nsubj(indicate-25, benefits-6)\n",
      "cc(benefits-6, and-7)\n",
      "amod(savings-10, overall-8)\n",
      "compound(savings-10, cost-9)\n",
      "conj:and(benefits-6, savings-10)\n",
      "nsubj(indicate-25, savings-10)\n",
      "acl(savings-10, seen-11)\n",
      "case(recipients-14, in-12)\n",
      "compound(recipients-14, benazepril-13)\n",
      "nmod:in(seen-11, recipients-14)\n",
      "case(period-18, over-15)\n",
      "det(period-18, a-16)\n",
      "amod(period-18, prolonged-17)\n",
      "nmod:over(recipients-14, period-18)\n",
      "punct(years-23, -LRB--19)\n",
      "compound(years-23, 2-20)\n",
      "dep(years-23, to-21)\n",
      "compound(years-23, 7-22)\n",
      "dep(period-18, years-23)\n",
      "punct(years-23, -RRB--24)\n",
      "mark(beneficial-48, that-26)\n",
      "det(strategy-28, the-27)\n",
      "nsubj(beneficial-48, strategy-28)\n",
      "mark(prescribing-30, of-29)\n",
      "acl:of(strategy-28, prescribing-30)\n",
      "dobj(prescribing-30, benazepril-31)\n",
      "mark(reduce-33, to-32)\n",
      "advcl:to(prescribing-30, reduce-33)\n",
      "dobj(reduce-33, progression-34)\n",
      "case(disease-37, of-35)\n",
      "amod(disease-37, renal-36)\n",
      "nmod:of(progression-34, disease-37)\n",
      "case(patients-39, in-38)\n",
      "nmod:in(reduce-33, patients-39)\n",
      "case(insufficiency-42, with-40)\n",
      "amod(insufficiency-42, renal-41)\n",
      "nmod:with(patients-39, insufficiency-42)\n",
      "cop(beneficial-48, is-43)\n",
      "cc:preconj(clinically-45, both-44)\n",
      "advmod(beneficial-48, clinically-45)\n",
      "cc(clinically-45, and-46)\n",
      "conj:and(clinically-45, economically-47)\n",
      "advmod(beneficial-48, economically-47)\n",
      "ccomp(indicate-25, beneficial-48)\n",
      "case(regimens-53, compared-49)\n",
      "mwe(compared-49, with-50)\n",
      "amod(regimens-53, current-51)\n",
      "amod(regimens-53, antihypertensive-52)\n",
      "advcl:compared_with(beneficial-48, regimens-53)\n",
      "case(inhibition-56, without-54)\n",
      "compound(inhibition-56, ACE-55)\n",
      "nmod:without(regimens-53, inhibition-56)\n",
      "punct(indicate-25, .-57)\n",
      "\n",
      "Sentence #137 (23 tokens, sentiment: Negative):\n",
      "Benazepril plays an important role in down-regulating the expression of TGFbeta1 and decreasing the accumulation of ECM by blocking intrarenal renin-angiotensin system.\n",
      "[Text=Benazepril CharacterOffsetBegin=19748 CharacterOffsetEnd=19758 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=plays CharacterOffsetBegin=19759 CharacterOffsetEnd=19764 PartOfSpeech=VBZ Lemma=play NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=19765 CharacterOffsetEnd=19767 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=important CharacterOffsetBegin=19768 CharacterOffsetEnd=19777 PartOfSpeech=JJ Lemma=important NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=role CharacterOffsetBegin=19778 CharacterOffsetEnd=19782 PartOfSpeech=NN Lemma=role NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=19783 CharacterOffsetEnd=19785 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=down-regulating CharacterOffsetBegin=19786 CharacterOffsetEnd=19801 PartOfSpeech=VBG Lemma=down-regulate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=19802 CharacterOffsetEnd=19805 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=19806 CharacterOffsetEnd=19816 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=19817 CharacterOffsetEnd=19819 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=TGFbeta1 CharacterOffsetBegin=19820 CharacterOffsetEnd=19828 PartOfSpeech=NN Lemma=tgfbeta1 NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=19829 CharacterOffsetEnd=19832 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=decreasing CharacterOffsetBegin=19833 CharacterOffsetEnd=19843 PartOfSpeech=VBG Lemma=decrease NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=19844 CharacterOffsetEnd=19847 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=accumulation CharacterOffsetBegin=19848 CharacterOffsetEnd=19860 PartOfSpeech=NN Lemma=accumulation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=19861 CharacterOffsetEnd=19863 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ECM CharacterOffsetBegin=19864 CharacterOffsetEnd=19867 PartOfSpeech=NN Lemma=ecm NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=19868 CharacterOffsetEnd=19870 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blocking CharacterOffsetBegin=19871 CharacterOffsetEnd=19879 PartOfSpeech=VBG Lemma=block NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=intrarenal CharacterOffsetBegin=19880 CharacterOffsetEnd=19890 PartOfSpeech=JJ Lemma=intrarenal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renin-angiotensin CharacterOffsetBegin=19891 CharacterOffsetEnd=19908 PartOfSpeech=JJ Lemma=renin-angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=system CharacterOffsetBegin=19909 CharacterOffsetEnd=19915 PartOfSpeech=NN Lemma=system NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=19915 CharacterOffsetEnd=19916 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Benazepril))\n",
      "    (VP (VBZ plays)\n",
      "      (NP (DT an) (JJ important) (NN role))\n",
      "      (PP (IN in)\n",
      "        (S\n",
      "          (VP\n",
      "            (VP (VBG down-regulating)\n",
      "              (NP\n",
      "                (NP (DT the) (NN expression))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN TGFbeta1)))))\n",
      "            (CC and)\n",
      "            (VP (VBG decreasing)\n",
      "              (NP\n",
      "                (NP (DT the) (NN accumulation))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN ECM))))\n",
      "              (PP (IN by)\n",
      "                (S\n",
      "                  (VP (VBG blocking)\n",
      "                    (NP (JJ intrarenal) (JJ renin-angiotensin) (NN system))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, plays-2)\n",
      "nsubj(plays-2, Benazepril-1)\n",
      "det(role-5, an-3)\n",
      "amod(role-5, important-4)\n",
      "dobj(plays-2, role-5)\n",
      "mark(down-regulating-7, in-6)\n",
      "advcl:in(plays-2, down-regulating-7)\n",
      "det(expression-9, the-8)\n",
      "dobj(down-regulating-7, expression-9)\n",
      "case(TGFbeta1-11, of-10)\n",
      "nmod:of(expression-9, TGFbeta1-11)\n",
      "cc(down-regulating-7, and-12)\n",
      "advcl:in(plays-2, decreasing-13)\n",
      "conj:and(down-regulating-7, decreasing-13)\n",
      "det(accumulation-15, the-14)\n",
      "dobj(decreasing-13, accumulation-15)\n",
      "case(ECM-17, of-16)\n",
      "nmod:of(accumulation-15, ECM-17)\n",
      "mark(blocking-19, by-18)\n",
      "advcl:by(decreasing-13, blocking-19)\n",
      "amod(system-22, intrarenal-20)\n",
      "amod(system-22, renin-angiotensin-21)\n",
      "dobj(blocking-19, system-22)\n",
      "punct(plays-2, .-23)\n",
      "\n",
      "Sentence #138 (18 tokens, sentiment: Negative):\n",
      "It is suggested that there is an interaction between TGFbetaR I and the pathogenesis of diabetic nephropathy.\n",
      "[Text=It CharacterOffsetBegin=19918 CharacterOffsetEnd=19920 PartOfSpeech=PRP Lemma=it NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=19921 CharacterOffsetEnd=19923 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=suggested CharacterOffsetBegin=19924 CharacterOffsetEnd=19933 PartOfSpeech=VBN Lemma=suggest NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=19934 CharacterOffsetEnd=19938 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=there CharacterOffsetBegin=19939 CharacterOffsetEnd=19944 PartOfSpeech=EX Lemma=there NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=19945 CharacterOffsetEnd=19947 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=19948 CharacterOffsetEnd=19950 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=interaction CharacterOffsetBegin=19951 CharacterOffsetEnd=19962 PartOfSpeech=NN Lemma=interaction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=between CharacterOffsetBegin=19963 CharacterOffsetEnd=19970 PartOfSpeech=IN Lemma=between NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=TGFbetaR CharacterOffsetBegin=19971 CharacterOffsetEnd=19979 PartOfSpeech=NN Lemma=tgfbetar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=I CharacterOffsetBegin=19980 CharacterOffsetEnd=19981 PartOfSpeech=CD Lemma=i NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=19982 CharacterOffsetEnd=19985 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=19986 CharacterOffsetEnd=19989 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pathogenesis CharacterOffsetBegin=19990 CharacterOffsetEnd=20002 PartOfSpeech=NN Lemma=pathogenesis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20003 CharacterOffsetEnd=20005 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diabetic CharacterOffsetBegin=20006 CharacterOffsetEnd=20014 PartOfSpeech=JJ Lemma=diabetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=nephropathy CharacterOffsetBegin=20015 CharacterOffsetEnd=20026 PartOfSpeech=NN Lemma=nephropathy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=20026 CharacterOffsetEnd=20027 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP It))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN suggested)\n",
      "        (SBAR (IN that)\n",
      "          (S\n",
      "            (NP (EX there))\n",
      "            (VP (VBZ is)\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (DT an) (NN interaction))\n",
      "                  (PP (IN between)\n",
      "                    (NP (NN TGFbetaR) (CD I))))\n",
      "                (CC and)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN pathogenesis))\n",
      "                  (PP (IN of)\n",
      "                    (NP (JJ diabetic) (NN nephropathy))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, suggested-3)\n",
      "nsubjpass(suggested-3, It-1)\n",
      "auxpass(suggested-3, is-2)\n",
      "mark(is-6, that-4)\n",
      "expl(is-6, there-5)\n",
      "ccomp(suggested-3, is-6)\n",
      "det(interaction-8, an-7)\n",
      "nsubj(is-6, interaction-8)\n",
      "case(TGFbetaR-10, between-9)\n",
      "nmod:between(interaction-8, TGFbetaR-10)\n",
      "nummod(TGFbetaR-10, I-11)\n",
      "cc(interaction-8, and-12)\n",
      "det(pathogenesis-14, the-13)\n",
      "nsubj(is-6, pathogenesis-14)\n",
      "conj:and(interaction-8, pathogenesis-14)\n",
      "case(nephropathy-17, of-15)\n",
      "amod(nephropathy-17, diabetic-16)\n",
      "nmod:of(pathogenesis-14, nephropathy-17)\n",
      "punct(suggested-3, .-18)\n",
      "\n",
      "Sentence #139 (12 tokens, sentiment: Negative):\n",
      "Benazepril can supress the expression of TGFbetaR I in renal cortex.\n",
      "[Text=Benazepril CharacterOffsetBegin=20028 CharacterOffsetEnd=20038 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=can CharacterOffsetBegin=20039 CharacterOffsetEnd=20042 PartOfSpeech=MD Lemma=can NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=supress CharacterOffsetBegin=20043 CharacterOffsetEnd=20050 PartOfSpeech=VB Lemma=supress NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=20051 CharacterOffsetEnd=20054 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expression CharacterOffsetBegin=20055 CharacterOffsetEnd=20065 PartOfSpeech=NN Lemma=expression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20066 CharacterOffsetEnd=20068 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=TGFbetaR CharacterOffsetBegin=20069 CharacterOffsetEnd=20077 PartOfSpeech=NN Lemma=tgfbetar NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=I CharacterOffsetBegin=20078 CharacterOffsetEnd=20079 PartOfSpeech=NN Lemma=i NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=20080 CharacterOffsetEnd=20082 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=renal CharacterOffsetBegin=20083 CharacterOffsetEnd=20088 PartOfSpeech=JJ Lemma=renal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cortex CharacterOffsetBegin=20089 CharacterOffsetEnd=20095 PartOfSpeech=NN Lemma=cortex NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=20095 CharacterOffsetEnd=20096 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Benazepril))\n",
      "    (VP (MD can)\n",
      "      (VP (VB supress)\n",
      "        (NP\n",
      "          (NP (DT the) (NN expression))\n",
      "          (PP (IN of)\n",
      "            (NP (NN TGFbetaR) (NN I))))\n",
      "        (PP (IN in)\n",
      "          (NP (JJ renal) (NN cortex)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, supress-3)\n",
      "nsubj(supress-3, Benazepril-1)\n",
      "aux(supress-3, can-2)\n",
      "det(expression-5, the-4)\n",
      "dobj(supress-3, expression-5)\n",
      "case(I-8, of-6)\n",
      "compound(I-8, TGFbetaR-7)\n",
      "nmod:of(expression-5, I-8)\n",
      "case(cortex-11, in-9)\n",
      "amod(cortex-11, renal-10)\n",
      "nmod:in(supress-3, cortex-11)\n",
      "punct(supress-3, .-12)\n",
      "\n",
      "Sentence #140 (27 tokens, sentiment: Negative):\n",
      "To explore the intensity of inhibition of Shenkang Injection (SKI) and Benazepril on various ingredients of human glomerular mesangial extracellular matrix (ECM).\n",
      "[Text=To CharacterOffsetBegin=20098 CharacterOffsetEnd=20100 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=explore CharacterOffsetBegin=20101 CharacterOffsetEnd=20108 PartOfSpeech=VB Lemma=explore NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=20109 CharacterOffsetEnd=20112 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=intensity CharacterOffsetBegin=20113 CharacterOffsetEnd=20122 PartOfSpeech=NN Lemma=intensity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20123 CharacterOffsetEnd=20125 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibition CharacterOffsetBegin=20126 CharacterOffsetEnd=20136 PartOfSpeech=NN Lemma=inhibition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20137 CharacterOffsetEnd=20139 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Shenkang CharacterOffsetBegin=20140 CharacterOffsetEnd=20148 PartOfSpeech=NNP Lemma=Shenkang NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Injection CharacterOffsetBegin=20149 CharacterOffsetEnd=20158 PartOfSpeech=NN Lemma=injection NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=20159 CharacterOffsetEnd=20160 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SKI CharacterOffsetBegin=20160 CharacterOffsetEnd=20163 PartOfSpeech=NN Lemma=ski NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=20163 CharacterOffsetEnd=20164 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=20165 CharacterOffsetEnd=20168 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=20169 CharacterOffsetEnd=20179 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=20180 CharacterOffsetEnd=20182 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=various CharacterOffsetBegin=20183 CharacterOffsetEnd=20190 PartOfSpeech=JJ Lemma=various NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ingredients CharacterOffsetBegin=20191 CharacterOffsetEnd=20202 PartOfSpeech=NNS Lemma=ingredient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20203 CharacterOffsetEnd=20205 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=human CharacterOffsetBegin=20206 CharacterOffsetEnd=20211 PartOfSpeech=JJ Lemma=human NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glomerular CharacterOffsetBegin=20212 CharacterOffsetEnd=20222 PartOfSpeech=JJ Lemma=glomerular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mesangial CharacterOffsetBegin=20223 CharacterOffsetEnd=20232 PartOfSpeech=JJ Lemma=mesangial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extracellular CharacterOffsetBegin=20233 CharacterOffsetEnd=20246 PartOfSpeech=JJ Lemma=extracellular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=matrix CharacterOffsetBegin=20247 CharacterOffsetEnd=20253 PartOfSpeech=NN Lemma=matrix NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=20254 CharacterOffsetEnd=20255 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ECM CharacterOffsetBegin=20255 CharacterOffsetEnd=20258 PartOfSpeech=NN Lemma=ecm NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=20258 CharacterOffsetEnd=20259 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=20259 CharacterOffsetEnd=20260 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (VP (TO To)\n",
      "      (VP (VB explore)\n",
      "        (NP\n",
      "          (NP (DT the) (NN intensity))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (NN inhibition))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (NNP Shenkang) (NN Injection))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (NN SKI))\n",
      "                      (-RRB- -RRB-)))))\n",
      "              (CC and)\n",
      "              (NP\n",
      "                (NP (NN Benazepril))\n",
      "                (PP (IN on)\n",
      "                  (NP\n",
      "                    (NP (JJ various) (NNS ingredients))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP\n",
      "                          (ADJP (JJ human) (JJ glomerular))\n",
      "                          (JJ mesangial) (JJ extracellular) (NN matrix))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NN ECM))\n",
      "                          (-RRB- -RRB-))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, explore-2)\n",
      "mark(explore-2, To-1)\n",
      "det(intensity-4, the-3)\n",
      "dobj(explore-2, intensity-4)\n",
      "case(inhibition-6, of-5)\n",
      "nmod:of(intensity-4, inhibition-6)\n",
      "case(Injection-9, of-7)\n",
      "compound(Injection-9, Shenkang-8)\n",
      "nmod:of(inhibition-6, Injection-9)\n",
      "punct(SKI-11, -LRB--10)\n",
      "appos(Injection-9, SKI-11)\n",
      "punct(SKI-11, -RRB--12)\n",
      "cc(inhibition-6, and-13)\n",
      "nmod:of(intensity-4, Benazepril-14)\n",
      "conj:and(inhibition-6, Benazepril-14)\n",
      "case(ingredients-17, on-15)\n",
      "amod(ingredients-17, various-16)\n",
      "nmod:on(Benazepril-14, ingredients-17)\n",
      "case(matrix-23, of-18)\n",
      "amod(glomerular-20, human-19)\n",
      "amod(matrix-23, glomerular-20)\n",
      "amod(matrix-23, mesangial-21)\n",
      "amod(matrix-23, extracellular-22)\n",
      "nmod:of(ingredients-17, matrix-23)\n",
      "punct(ECM-25, -LRB--24)\n",
      "appos(matrix-23, ECM-25)\n",
      "punct(ECM-25, -RRB--26)\n",
      "punct(explore-2, .-27)\n",
      "\n",
      "Sentence #141 (34 tokens, sentiment: Negative):\n",
      "Effect of SKI, a herbal preparation for lowering adverse Qi, despelling turbidness, supplementing Qi and activating circulation, and Benazepril were observed by cultured glomerular mesangial cell technique in vitro.\n",
      "[Text=Effect CharacterOffsetBegin=20262 CharacterOffsetEnd=20268 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20269 CharacterOffsetEnd=20271 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SKI CharacterOffsetBegin=20272 CharacterOffsetEnd=20275 PartOfSpeech=NNS Lemma=ski NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=20275 CharacterOffsetEnd=20276 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=20277 CharacterOffsetEnd=20278 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=herbal CharacterOffsetBegin=20279 CharacterOffsetEnd=20285 PartOfSpeech=JJ Lemma=herbal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=preparation CharacterOffsetBegin=20286 CharacterOffsetEnd=20297 PartOfSpeech=NN Lemma=preparation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=20298 CharacterOffsetEnd=20301 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lowering CharacterOffsetBegin=20302 CharacterOffsetEnd=20310 PartOfSpeech=VBG Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=adverse CharacterOffsetBegin=20311 CharacterOffsetEnd=20318 PartOfSpeech=JJ Lemma=adverse NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Qi CharacterOffsetBegin=20319 CharacterOffsetEnd=20321 PartOfSpeech=NNP Lemma=Qi NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=20321 CharacterOffsetEnd=20322 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=despelling CharacterOffsetBegin=20323 CharacterOffsetEnd=20333 PartOfSpeech=VBG Lemma=despell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=turbidness CharacterOffsetBegin=20334 CharacterOffsetEnd=20344 PartOfSpeech=NN Lemma=turbidness NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=20344 CharacterOffsetEnd=20345 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=supplementing CharacterOffsetBegin=20346 CharacterOffsetEnd=20359 PartOfSpeech=VBG Lemma=supplement NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Qi CharacterOffsetBegin=20360 CharacterOffsetEnd=20362 PartOfSpeech=NNP Lemma=Qi NamedEntityTag=PERSON SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=20363 CharacterOffsetEnd=20366 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=activating CharacterOffsetBegin=20367 CharacterOffsetEnd=20377 PartOfSpeech=VBG Lemma=activate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=circulation CharacterOffsetBegin=20378 CharacterOffsetEnd=20389 PartOfSpeech=NN Lemma=circulation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=20389 CharacterOffsetEnd=20390 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=20391 CharacterOffsetEnd=20394 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=20395 CharacterOffsetEnd=20405 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=20406 CharacterOffsetEnd=20410 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=observed CharacterOffsetBegin=20411 CharacterOffsetEnd=20419 PartOfSpeech=VBN Lemma=observe NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=20420 CharacterOffsetEnd=20422 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cultured CharacterOffsetBegin=20423 CharacterOffsetEnd=20431 PartOfSpeech=VBN Lemma=culture NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=glomerular CharacterOffsetBegin=20432 CharacterOffsetEnd=20442 PartOfSpeech=JJ Lemma=glomerular NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mesangial CharacterOffsetBegin=20443 CharacterOffsetEnd=20452 PartOfSpeech=JJ Lemma=mesangial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cell CharacterOffsetBegin=20453 CharacterOffsetEnd=20457 PartOfSpeech=NN Lemma=cell NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=technique CharacterOffsetBegin=20458 CharacterOffsetEnd=20467 PartOfSpeech=NN Lemma=technique NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=20468 CharacterOffsetEnd=20470 PartOfSpeech=FW Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=vitro CharacterOffsetBegin=20471 CharacterOffsetEnd=20476 PartOfSpeech=FW Lemma=vitro NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=20476 CharacterOffsetEnd=20477 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (NN Effect))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (NNS SKI))\n",
      "          (, ,)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (DT a) (JJ herbal) (NN preparation))\n",
      "              (PP (IN for)\n",
      "                (S\n",
      "                  (VP\n",
      "                    (VP (VBG lowering)\n",
      "                      (NP (JJ adverse) (NNP Qi)))\n",
      "                    (, ,)\n",
      "                    (VP (VBG despelling)\n",
      "                      (NP (NN turbidness)))\n",
      "                    (, ,)\n",
      "                    (VP (VBG supplementing)\n",
      "                      (NP (NNP Qi)))\n",
      "                    (CC and)\n",
      "                    (VP (VBG activating)\n",
      "                      (NP (NN circulation)))))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP (NNP Benazepril))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN observed)\n",
      "        (PP (IN by)\n",
      "          (S\n",
      "            (VP (VBN cultured)\n",
      "              (NP\n",
      "                (ADJP (JJ glomerular) (JJ mesangial))\n",
      "                (NN cell) (NN technique))\n",
      "              (ADVP (FW in) (FW vitro)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, observed-25)\n",
      "nsubjpass(observed-25, Effect-1)\n",
      "case(SKI-3, of-2)\n",
      "nmod:of(Effect-1, SKI-3)\n",
      "punct(SKI-3, ,-4)\n",
      "det(preparation-7, a-5)\n",
      "amod(preparation-7, herbal-6)\n",
      "appos(SKI-3, preparation-7)\n",
      "mark(lowering-9, for-8)\n",
      "acl:for(preparation-7, lowering-9)\n",
      "amod(Qi-11, adverse-10)\n",
      "dobj(lowering-9, Qi-11)\n",
      "punct(lowering-9, ,-12)\n",
      "acl:for(preparation-7, despelling-13)\n",
      "conj:and(lowering-9, despelling-13)\n",
      "dobj(despelling-13, turbidness-14)\n",
      "punct(lowering-9, ,-15)\n",
      "acl:for(preparation-7, supplementing-16)\n",
      "conj:and(lowering-9, supplementing-16)\n",
      "dobj(supplementing-16, Qi-17)\n",
      "cc(lowering-9, and-18)\n",
      "acl:for(preparation-7, activating-19)\n",
      "conj:and(lowering-9, activating-19)\n",
      "dobj(activating-19, circulation-20)\n",
      "punct(preparation-7, ,-21)\n",
      "cc(preparation-7, and-22)\n",
      "appos(SKI-3, Benazepril-23)\n",
      "conj:and(preparation-7, Benazepril-23)\n",
      "auxpass(observed-25, were-24)\n",
      "mark(cultured-27, by-26)\n",
      "advcl:by(observed-25, cultured-27)\n",
      "amod(mesangial-29, glomerular-28)\n",
      "amod(technique-31, mesangial-29)\n",
      "compound(technique-31, cell-30)\n",
      "dobj(cultured-27, technique-31)\n",
      "compound(vitro-33, in-32)\n",
      "advmod(cultured-27, vitro-33)\n",
      "punct(observed-25, .-34)\n",
      "\n",
      "Sentence #142 (21 tokens, sentiment: Negative):\n",
      "SKI could inhibit the fibronetin, laminin, and type IV collagen of ECM, and the action was dose-dependent.\n",
      "[Text=SKI CharacterOffsetBegin=20479 CharacterOffsetEnd=20482 PartOfSpeech=NN Lemma=ski NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=could CharacterOffsetBegin=20483 CharacterOffsetEnd=20488 PartOfSpeech=MD Lemma=could NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibit CharacterOffsetBegin=20489 CharacterOffsetEnd=20496 PartOfSpeech=VB Lemma=inhibit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=20497 CharacterOffsetEnd=20500 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=fibronetin CharacterOffsetBegin=20501 CharacterOffsetEnd=20511 PartOfSpeech=NN Lemma=fibronetin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=20511 CharacterOffsetEnd=20512 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=laminin CharacterOffsetBegin=20513 CharacterOffsetEnd=20520 PartOfSpeech=NN Lemma=laminin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=20520 CharacterOffsetEnd=20521 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=20522 CharacterOffsetEnd=20525 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=20526 CharacterOffsetEnd=20530 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=IV CharacterOffsetBegin=20531 CharacterOffsetEnd=20533 PartOfSpeech=CD Lemma=iv NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=collagen CharacterOffsetBegin=20534 CharacterOffsetEnd=20542 PartOfSpeech=NN Lemma=collagen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20543 CharacterOffsetEnd=20545 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ECM CharacterOffsetBegin=20546 CharacterOffsetEnd=20549 PartOfSpeech=NNP Lemma=ECM NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=20549 CharacterOffsetEnd=20550 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=20551 CharacterOffsetEnd=20554 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=20555 CharacterOffsetEnd=20558 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=action CharacterOffsetBegin=20559 CharacterOffsetEnd=20565 PartOfSpeech=NN Lemma=action NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=20566 CharacterOffsetEnd=20569 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dose-dependent CharacterOffsetBegin=20570 CharacterOffsetEnd=20584 PartOfSpeech=JJ Lemma=dose-dependent NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=20584 CharacterOffsetEnd=20585 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP (NN SKI))\n",
      "      (VP (MD could)\n",
      "        (VP (VB inhibit)\n",
      "          (NP\n",
      "            (NP (DT the) (NN fibronetin))\n",
      "            (, ,)\n",
      "            (NP (NN laminin))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (NP\n",
      "              (NP (NN type) (CD IV) (NN collagen))\n",
      "              (PP (IN of)\n",
      "                (NP (NNP ECM))))))))\n",
      "    (, ,)\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (DT the) (NN action))\n",
      "      (VP (VBD was)\n",
      "        (ADJP (JJ dose-dependent))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, inhibit-3)\n",
      "nsubj(inhibit-3, SKI-1)\n",
      "aux(inhibit-3, could-2)\n",
      "det(fibronetin-5, the-4)\n",
      "dobj(inhibit-3, fibronetin-5)\n",
      "punct(fibronetin-5, ,-6)\n",
      "dobj(inhibit-3, laminin-7)\n",
      "conj:and(fibronetin-5, laminin-7)\n",
      "punct(fibronetin-5, ,-8)\n",
      "cc(fibronetin-5, and-9)\n",
      "compound(collagen-12, type-10)\n",
      "nummod(collagen-12, IV-11)\n",
      "dobj(inhibit-3, collagen-12)\n",
      "conj:and(fibronetin-5, collagen-12)\n",
      "case(ECM-14, of-13)\n",
      "nmod:of(collagen-12, ECM-14)\n",
      "punct(inhibit-3, ,-15)\n",
      "cc(inhibit-3, and-16)\n",
      "det(action-18, the-17)\n",
      "nsubj(dose-dependent-20, action-18)\n",
      "cop(dose-dependent-20, was-19)\n",
      "conj:and(inhibit-3, dose-dependent-20)\n",
      "punct(inhibit-3, .-21)\n",
      "\n",
      "Sentence #143 (18 tokens, sentiment: Negative):\n",
      "Benazepril could also inhibit the fibronetin and type IV collagen of ECM but was weaker in intensity.\n",
      "[Text=Benazepril CharacterOffsetBegin=20586 CharacterOffsetEnd=20596 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=could CharacterOffsetBegin=20597 CharacterOffsetEnd=20602 PartOfSpeech=MD Lemma=could NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=also CharacterOffsetBegin=20603 CharacterOffsetEnd=20607 PartOfSpeech=RB Lemma=also NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibit CharacterOffsetBegin=20608 CharacterOffsetEnd=20615 PartOfSpeech=VB Lemma=inhibit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=20616 CharacterOffsetEnd=20619 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=fibronetin CharacterOffsetBegin=20620 CharacterOffsetEnd=20630 PartOfSpeech=NN Lemma=fibronetin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=20631 CharacterOffsetEnd=20634 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=type CharacterOffsetBegin=20635 CharacterOffsetEnd=20639 PartOfSpeech=NN Lemma=type NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=IV CharacterOffsetBegin=20640 CharacterOffsetEnd=20642 PartOfSpeech=CD Lemma=iv NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0 SentimentClass=Neutral]\n",
      "[Text=collagen CharacterOffsetBegin=20643 CharacterOffsetEnd=20651 PartOfSpeech=NN Lemma=collagen NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20652 CharacterOffsetEnd=20654 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ECM CharacterOffsetBegin=20655 CharacterOffsetEnd=20658 PartOfSpeech=NN Lemma=ecm NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=but CharacterOffsetBegin=20659 CharacterOffsetEnd=20662 PartOfSpeech=CC Lemma=but NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=20663 CharacterOffsetEnd=20666 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=weaker CharacterOffsetBegin=20667 CharacterOffsetEnd=20673 PartOfSpeech=JJR Lemma=weaker NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=20674 CharacterOffsetEnd=20676 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=intensity CharacterOffsetBegin=20677 CharacterOffsetEnd=20686 PartOfSpeech=NN Lemma=intensity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=20686 CharacterOffsetEnd=20687 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Benazepril))\n",
      "    (VP\n",
      "      (VP (MD could)\n",
      "        (ADVP (RB also))\n",
      "        (VP (VB inhibit)\n",
      "          (NP (DT the) (NN fibronetin)\n",
      "            (CC and)\n",
      "            (NN type) (CD IV) (NN collagen))\n",
      "          (PP (IN of)\n",
      "            (NP (NN ECM)))))\n",
      "      (CC but)\n",
      "      (VP (VBD was)\n",
      "        (ADJP (JJR weaker))\n",
      "        (PP (IN in)\n",
      "          (NP (NN intensity)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, inhibit-4)\n",
      "nsubj(inhibit-4, Benazepril-1)\n",
      "nsubj(weaker-15, Benazepril-1)\n",
      "aux(inhibit-4, could-2)\n",
      "advmod(inhibit-4, also-3)\n",
      "det(fibronetin-6, the-5)\n",
      "dobj(inhibit-4, fibronetin-6)\n",
      "cc(fibronetin-6, and-7)\n",
      "compound(collagen-10, type-8)\n",
      "nummod(collagen-10, IV-9)\n",
      "dobj(inhibit-4, collagen-10)\n",
      "conj:and(fibronetin-6, collagen-10)\n",
      "case(ECM-12, of-11)\n",
      "nmod:of(inhibit-4, ECM-12)\n",
      "cc(inhibit-4, but-13)\n",
      "cop(weaker-15, was-14)\n",
      "conj:but(inhibit-4, weaker-15)\n",
      "case(intensity-17, in-16)\n",
      "nmod:in(weaker-15, intensity-17)\n",
      "punct(inhibit-4, .-18)\n",
      "\n",
      "Sentence #144 (12 tokens, sentiment: Negative):\n",
      "The effect of SKI was superior to Benazepril in inhibiting ECM.\n",
      "[Text=The CharacterOffsetBegin=20689 CharacterOffsetEnd=20692 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effect CharacterOffsetBegin=20693 CharacterOffsetEnd=20699 PartOfSpeech=NN Lemma=effect NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20700 CharacterOffsetEnd=20702 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SKI CharacterOffsetBegin=20703 CharacterOffsetEnd=20706 PartOfSpeech=NN Lemma=ski NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=20707 CharacterOffsetEnd=20710 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=superior CharacterOffsetBegin=20711 CharacterOffsetEnd=20719 PartOfSpeech=JJ Lemma=superior NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=to CharacterOffsetBegin=20720 CharacterOffsetEnd=20722 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=20723 CharacterOffsetEnd=20733 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=20734 CharacterOffsetEnd=20736 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibiting CharacterOffsetBegin=20737 CharacterOffsetEnd=20747 PartOfSpeech=VBG Lemma=inhibit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=ECM CharacterOffsetBegin=20748 CharacterOffsetEnd=20751 PartOfSpeech=NNP Lemma=ECM NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=20751 CharacterOffsetEnd=20752 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN effect))\n",
      "      (PP (IN of)\n",
      "        (NP (NN SKI))))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJ superior)\n",
      "        (PP (TO to)\n",
      "          (NP (NNP Benazepril))))\n",
      "      (PP (IN in)\n",
      "        (S\n",
      "          (VP (VBG inhibiting)\n",
      "            (NP (NNP ECM))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, superior-6)\n",
      "det(effect-2, The-1)\n",
      "nsubj(superior-6, effect-2)\n",
      "case(SKI-4, of-3)\n",
      "nmod:of(effect-2, SKI-4)\n",
      "cop(superior-6, was-5)\n",
      "case(Benazepril-8, to-7)\n",
      "nmod:to(superior-6, Benazepril-8)\n",
      "mark(inhibiting-10, in-9)\n",
      "advcl:in(superior-6, inhibiting-10)\n",
      "dobj(inhibiting-10, ECM-11)\n",
      "punct(superior-6, .-12)\n",
      "\n",
      "Sentence #145 (27 tokens, sentiment: Negative):\n",
      "A reversed-phase high-performance liquid chromatographic (HPLC) method was developed and validated for the kinetic investigation of the chemical and enzymatic hydrolysis of benazepril hydrochloride.\n",
      "[Text=A CharacterOffsetBegin=20754 CharacterOffsetEnd=20755 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reversed-phase CharacterOffsetBegin=20756 CharacterOffsetEnd=20770 PartOfSpeech=JJ Lemma=reversed-phase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=high-performance CharacterOffsetBegin=20771 CharacterOffsetEnd=20787 PartOfSpeech=JJ Lemma=high-performance NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=liquid CharacterOffsetBegin=20788 CharacterOffsetEnd=20794 PartOfSpeech=JJ Lemma=liquid NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chromatographic CharacterOffsetBegin=20795 CharacterOffsetEnd=20810 PartOfSpeech=JJ Lemma=chromatographic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=20811 CharacterOffsetEnd=20812 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=HPLC CharacterOffsetBegin=20812 CharacterOffsetEnd=20816 PartOfSpeech=NN Lemma=hplc NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=20816 CharacterOffsetEnd=20817 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=method CharacterOffsetBegin=20818 CharacterOffsetEnd=20824 PartOfSpeech=NN Lemma=method NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=20825 CharacterOffsetEnd=20828 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=developed CharacterOffsetBegin=20829 CharacterOffsetEnd=20838 PartOfSpeech=VBN Lemma=develop NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=and CharacterOffsetBegin=20839 CharacterOffsetEnd=20842 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=validated CharacterOffsetBegin=20843 CharacterOffsetEnd=20852 PartOfSpeech=VBN Lemma=validate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=20853 CharacterOffsetEnd=20856 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=20857 CharacterOffsetEnd=20860 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kinetic CharacterOffsetBegin=20861 CharacterOffsetEnd=20868 PartOfSpeech=JJ Lemma=kinetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=investigation CharacterOffsetBegin=20869 CharacterOffsetEnd=20882 PartOfSpeech=NN Lemma=investigation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20883 CharacterOffsetEnd=20885 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=20886 CharacterOffsetEnd=20889 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chemical CharacterOffsetBegin=20890 CharacterOffsetEnd=20898 PartOfSpeech=NN Lemma=chemical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=20899 CharacterOffsetEnd=20902 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzymatic CharacterOffsetBegin=20903 CharacterOffsetEnd=20912 PartOfSpeech=JJ Lemma=enzymatic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrolysis CharacterOffsetBegin=20913 CharacterOffsetEnd=20923 PartOfSpeech=NN Lemma=hydrolysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20924 CharacterOffsetEnd=20926 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=20927 CharacterOffsetEnd=20937 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrochloride CharacterOffsetBegin=20938 CharacterOffsetEnd=20951 PartOfSpeech=NN Lemma=hydrochloride NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=20951 CharacterOffsetEnd=20952 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (DT A) (JJ reversed-phase) (JJ high-performance)\n",
      "      (ADJP\n",
      "        (ADJP (JJ liquid) (JJ chromatographic))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP (NN HPLC))\n",
      "          (-RRB- -RRB-)))\n",
      "      (NN method))\n",
      "    (VP (VBD was)\n",
      "      (VP (VBN developed)\n",
      "        (CC and)\n",
      "        (VBN validated)\n",
      "        (PP (IN for)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ kinetic) (NN investigation))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (DT the)\n",
      "                  (ADJP (NN chemical)\n",
      "                    (CC and)\n",
      "                    (JJ enzymatic))\n",
      "                  (NN hydrolysis))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN benazepril) (NN hydrochloride)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, developed-11)\n",
      "det(method-9, A-1)\n",
      "amod(method-9, reversed-phase-2)\n",
      "amod(method-9, high-performance-3)\n",
      "amod(chromatographic-5, liquid-4)\n",
      "amod(method-9, chromatographic-5)\n",
      "punct(HPLC-7, -LRB--6)\n",
      "dep(chromatographic-5, HPLC-7)\n",
      "punct(HPLC-7, -RRB--8)\n",
      "nsubjpass(developed-11, method-9)\n",
      "nsubjpass(validated-13, method-9)\n",
      "auxpass(developed-11, was-10)\n",
      "cc(developed-11, and-12)\n",
      "conj:and(developed-11, validated-13)\n",
      "case(investigation-17, for-14)\n",
      "det(investigation-17, the-15)\n",
      "amod(investigation-17, kinetic-16)\n",
      "nmod:for(developed-11, investigation-17)\n",
      "case(hydrolysis-23, of-18)\n",
      "det(hydrolysis-23, the-19)\n",
      "amod(hydrolysis-23, chemical-20)\n",
      "cc(chemical-20, and-21)\n",
      "conj:and(chemical-20, enzymatic-22)\n",
      "amod(hydrolysis-23, enzymatic-22)\n",
      "nmod:of(investigation-17, hydrolysis-23)\n",
      "case(hydrochloride-26, of-24)\n",
      "compound(hydrochloride-26, benazepril-25)\n",
      "nmod:of(hydrolysis-23, hydrochloride-26)\n",
      "punct(developed-11, .-27)\n",
      "\n",
      "Sentence #146 (88 tokens, sentiment: Negative):\n",
      "Kinetic studies on the acidic hydrolysis of benazepril hydrochloride were carried out in 0.1 M hydrochloric acid solution at 50, 53, 58 and 63 degrees C. Benazepril hydrochloride appeared stable in a pH 7.4 phosphate buffered solution at 37 degrees C and showed susceptibility to undergoing in vitro enzymatic hydrolysis with porcine liver esterase (PLE) in a pH 7.4 buffered solution at 37 degrees C. Benazeprilat appeared to be the major degradation product in both (chemical and enzymatic) studies of hydrolysis.\n",
      "[Text=Kinetic CharacterOffsetBegin=20953 CharacterOffsetEnd=20960 PartOfSpeech=JJ Lemma=kinetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=studies CharacterOffsetBegin=20961 CharacterOffsetEnd=20968 PartOfSpeech=NNS Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=20969 CharacterOffsetEnd=20971 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=20972 CharacterOffsetEnd=20975 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=acidic CharacterOffsetBegin=20976 CharacterOffsetEnd=20982 PartOfSpeech=JJ Lemma=acidic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrolysis CharacterOffsetBegin=20983 CharacterOffsetEnd=20993 PartOfSpeech=NN Lemma=hydrolysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=20994 CharacterOffsetEnd=20996 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=20997 CharacterOffsetEnd=21007 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrochloride CharacterOffsetBegin=21008 CharacterOffsetEnd=21021 PartOfSpeech=NN Lemma=hydrochloride NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=21022 CharacterOffsetEnd=21026 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=carried CharacterOffsetBegin=21027 CharacterOffsetEnd=21034 PartOfSpeech=VBN Lemma=carry NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=out CharacterOffsetBegin=21035 CharacterOffsetEnd=21038 PartOfSpeech=RP Lemma=out NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=in CharacterOffsetBegin=21039 CharacterOffsetEnd=21041 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.1 CharacterOffsetBegin=21042 CharacterOffsetEnd=21045 PartOfSpeech=CD Lemma=0.1 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.1 SentimentClass=Neutral]\n",
      "[Text=M CharacterOffsetBegin=21046 CharacterOffsetEnd=21047 PartOfSpeech=NN Lemma=m NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrochloric CharacterOffsetBegin=21048 CharacterOffsetEnd=21060 PartOfSpeech=JJ Lemma=hydrochloric NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=acid CharacterOffsetBegin=21061 CharacterOffsetEnd=21065 PartOfSpeech=NN Lemma=acid NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=solution CharacterOffsetBegin=21066 CharacterOffsetEnd=21074 PartOfSpeech=NN Lemma=solution NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=at CharacterOffsetBegin=21075 CharacterOffsetEnd=21077 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=50 CharacterOffsetBegin=21078 CharacterOffsetEnd=21080 PartOfSpeech=CD Lemma=50 NamedEntityTag=NUMBER NormalizedNamedEntityTag=50.0 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=21080 CharacterOffsetEnd=21081 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=53 CharacterOffsetBegin=21082 CharacterOffsetEnd=21084 PartOfSpeech=CD Lemma=53 NamedEntityTag=NUMBER NormalizedNamedEntityTag=53.0 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=21084 CharacterOffsetEnd=21085 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=58 CharacterOffsetBegin=21086 CharacterOffsetEnd=21088 PartOfSpeech=CD Lemma=58 NamedEntityTag=NUMBER NormalizedNamedEntityTag=58.0 SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=21089 CharacterOffsetEnd=21092 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=63 CharacterOffsetBegin=21093 CharacterOffsetEnd=21095 PartOfSpeech=CD Lemma=63 NamedEntityTag=NUMBER NormalizedNamedEntityTag=63.0 SentimentClass=Neutral]\n",
      "[Text=degrees CharacterOffsetBegin=21096 CharacterOffsetEnd=21103 PartOfSpeech=NNS Lemma=degree NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=C. CharacterOffsetBegin=21104 CharacterOffsetEnd=21106 PartOfSpeech=FW Lemma=c. NamedEntityTag=PERSON SentimentClass=Neutral]\n",
      "[Text=Benazepril CharacterOffsetBegin=21107 CharacterOffsetEnd=21117 PartOfSpeech=FW Lemma=benazepril NamedEntityTag=PERSON SentimentClass=Neutral]\n",
      "[Text=hydrochloride CharacterOffsetBegin=21118 CharacterOffsetEnd=21131 PartOfSpeech=NN Lemma=hydrochloride NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=appeared CharacterOffsetBegin=21132 CharacterOffsetEnd=21140 PartOfSpeech=VBD Lemma=appear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=stable CharacterOffsetBegin=21141 CharacterOffsetEnd=21147 PartOfSpeech=JJ Lemma=stable NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=21148 CharacterOffsetEnd=21150 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=21151 CharacterOffsetEnd=21152 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pH CharacterOffsetBegin=21153 CharacterOffsetEnd=21155 PartOfSpeech=NN Lemma=ph NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=7.4 CharacterOffsetBegin=21156 CharacterOffsetEnd=21159 PartOfSpeech=CD Lemma=7.4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=7.4 SentimentClass=Neutral]\n",
      "[Text=phosphate CharacterOffsetBegin=21160 CharacterOffsetEnd=21169 PartOfSpeech=NN Lemma=phosphate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=buffered CharacterOffsetBegin=21170 CharacterOffsetEnd=21178 PartOfSpeech=VBN Lemma=buffer NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=solution CharacterOffsetBegin=21179 CharacterOffsetEnd=21187 PartOfSpeech=NN Lemma=solution NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=at CharacterOffsetBegin=21188 CharacterOffsetEnd=21190 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=37 CharacterOffsetBegin=21191 CharacterOffsetEnd=21193 PartOfSpeech=CD Lemma=37 NamedEntityTag=NUMBER NormalizedNamedEntityTag=37.0 SentimentClass=Neutral]\n",
      "[Text=degrees CharacterOffsetBegin=21194 CharacterOffsetEnd=21201 PartOfSpeech=NNS Lemma=degree NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=C CharacterOffsetBegin=21202 CharacterOffsetEnd=21203 PartOfSpeech=NN Lemma=c NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=21204 CharacterOffsetEnd=21207 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=showed CharacterOffsetBegin=21208 CharacterOffsetEnd=21214 PartOfSpeech=VBD Lemma=show NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=susceptibility CharacterOffsetBegin=21215 CharacterOffsetEnd=21229 PartOfSpeech=NN Lemma=susceptibility NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=21230 CharacterOffsetEnd=21232 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=undergoing CharacterOffsetBegin=21233 CharacterOffsetEnd=21243 PartOfSpeech=VBG Lemma=undergo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=21244 CharacterOffsetEnd=21246 PartOfSpeech=FW Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=vitro CharacterOffsetBegin=21247 CharacterOffsetEnd=21252 PartOfSpeech=FW Lemma=vitro NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzymatic CharacterOffsetBegin=21253 CharacterOffsetEnd=21262 PartOfSpeech=JJ Lemma=enzymatic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrolysis CharacterOffsetBegin=21263 CharacterOffsetEnd=21273 PartOfSpeech=NN Lemma=hydrolysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=21274 CharacterOffsetEnd=21278 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=porcine CharacterOffsetBegin=21279 CharacterOffsetEnd=21286 PartOfSpeech=NN Lemma=porcine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=liver CharacterOffsetBegin=21287 CharacterOffsetEnd=21292 PartOfSpeech=NN Lemma=liver NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=esterase CharacterOffsetBegin=21293 CharacterOffsetEnd=21301 PartOfSpeech=NN Lemma=esterase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=21302 CharacterOffsetEnd=21303 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=PLE CharacterOffsetBegin=21303 CharacterOffsetEnd=21306 PartOfSpeech=NN Lemma=ple NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=21306 CharacterOffsetEnd=21307 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=21308 CharacterOffsetEnd=21310 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=21311 CharacterOffsetEnd=21312 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pH CharacterOffsetBegin=21313 CharacterOffsetEnd=21315 PartOfSpeech=NN Lemma=ph NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=7.4 CharacterOffsetBegin=21316 CharacterOffsetEnd=21319 PartOfSpeech=CD Lemma=7.4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=7.4 SentimentClass=Neutral]\n",
      "[Text=buffered CharacterOffsetBegin=21320 CharacterOffsetEnd=21328 PartOfSpeech=VBD Lemma=buffer NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=solution CharacterOffsetBegin=21329 CharacterOffsetEnd=21337 PartOfSpeech=NN Lemma=solution NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=at CharacterOffsetBegin=21338 CharacterOffsetEnd=21340 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=37 CharacterOffsetBegin=21341 CharacterOffsetEnd=21343 PartOfSpeech=CD Lemma=37 NamedEntityTag=NUMBER NormalizedNamedEntityTag=37.0 SentimentClass=Neutral]\n",
      "[Text=degrees CharacterOffsetBegin=21344 CharacterOffsetEnd=21351 PartOfSpeech=NNS Lemma=degree NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=C. CharacterOffsetBegin=21352 CharacterOffsetEnd=21354 PartOfSpeech=NNP Lemma=C. NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Benazeprilat CharacterOffsetBegin=21355 CharacterOffsetEnd=21367 PartOfSpeech=NNP Lemma=Benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=appeared CharacterOffsetBegin=21368 CharacterOffsetEnd=21376 PartOfSpeech=VBD Lemma=appear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=21377 CharacterOffsetEnd=21379 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=21380 CharacterOffsetEnd=21382 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=21383 CharacterOffsetEnd=21386 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=major CharacterOffsetBegin=21387 CharacterOffsetEnd=21392 PartOfSpeech=JJ Lemma=major NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=degradation CharacterOffsetBegin=21393 CharacterOffsetEnd=21404 PartOfSpeech=NN Lemma=degradation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=product CharacterOffsetBegin=21405 CharacterOffsetEnd=21412 PartOfSpeech=NN Lemma=product NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=21413 CharacterOffsetEnd=21415 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=both CharacterOffsetBegin=21416 CharacterOffsetEnd=21420 PartOfSpeech=CC Lemma=both NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=21421 CharacterOffsetEnd=21422 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=chemical CharacterOffsetBegin=21422 CharacterOffsetEnd=21430 PartOfSpeech=NN Lemma=chemical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=21431 CharacterOffsetEnd=21434 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzymatic CharacterOffsetBegin=21435 CharacterOffsetEnd=21444 PartOfSpeech=JJ Lemma=enzymatic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=21444 CharacterOffsetEnd=21445 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=studies CharacterOffsetBegin=21446 CharacterOffsetEnd=21453 PartOfSpeech=NNS Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=21454 CharacterOffsetEnd=21456 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrolysis CharacterOffsetBegin=21457 CharacterOffsetEnd=21467 PartOfSpeech=NN Lemma=hydrolysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=21467 CharacterOffsetEnd=21468 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ Kinetic) (NNS studies))\n",
      "      (PP (IN on)\n",
      "        (NP\n",
      "          (NP (DT the) (JJ acidic) (NN hydrolysis))\n",
      "          (PP (IN of)\n",
      "            (NP (NN benazepril) (NN hydrochloride))))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN carried)\n",
      "        (PRT (RP out))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP\n",
      "              (ADJP (CD 0.1) (NN M) (JJ hydrochloric))\n",
      "              (NN acid) (NN solution))\n",
      "            (PP (IN at)\n",
      "              (NP\n",
      "                (NP (CD 50))\n",
      "                (, ,)\n",
      "                (NP (CD 53))\n",
      "                (, ,)\n",
      "                (NP (CD 58))\n",
      "                (CC and)\n",
      "                (NP (CD 63) (NNS degrees))))\n",
      "            (SBAR\n",
      "              (S\n",
      "                (NP (FW C.) (FW Benazepril) (NN hydrochloride))\n",
      "                (VP\n",
      "                  (VP (VBD appeared)\n",
      "                    (NP\n",
      "                      (ADJP (JJ stable)\n",
      "                        (PP (IN in)\n",
      "                          (NP\n",
      "                            (NP (DT a) (NN pH) (CD 7.4) (NN phosphate))\n",
      "                            (VP (VBN buffered)\n",
      "                              (NP (NN solution))\n",
      "                              (PP (IN at)\n",
      "                                (NP (CD 37) (NNS degrees)))))))\n",
      "                      (NN C)))\n",
      "                  (CC and)\n",
      "                  (VP (VBD showed)\n",
      "                    (SBAR\n",
      "                      (S\n",
      "                        (NP\n",
      "                          (NP (NN susceptibility))\n",
      "                          (PP (TO to)\n",
      "                            (S\n",
      "                              (VP (VBG undergoing)\n",
      "                                (ADVP (FW in) (FW vitro)\n",
      "                                  (NP (JJ enzymatic) (NN hydrolysis)))\n",
      "                                (PP (IN with)\n",
      "                                  (NP\n",
      "                                    (NP\n",
      "                                      (NP (NN porcine) (NN liver) (NN esterase))\n",
      "                                      (PRN (-LRB- -LRB-)\n",
      "                                        (NP (NN PLE))\n",
      "                                        (-RRB- -RRB-)))\n",
      "                                    (PP (IN in)\n",
      "                                      (NP (DT a) (NN pH) (CD 7.4)))))))))\n",
      "                        (VP (VBD buffered)\n",
      "                          (NP (NN solution))\n",
      "                          (PP (IN at)\n",
      "                            (NP\n",
      "                              (NP (CD 37) (NNS degrees))\n",
      "                              (SBAR\n",
      "                                (S\n",
      "                                  (NP (NNP C.) (NNP Benazeprilat))\n",
      "                                  (VP (VBD appeared)\n",
      "                                    (S\n",
      "                                      (VP (TO to)\n",
      "                                        (VP (VB be)\n",
      "                                          (NP\n",
      "                                            (NP\n",
      "                                              (NP (DT the) (JJ major) (NN degradation) (NN product))\n",
      "                                              (PP (IN in)))\n",
      "                                            (CC both)\n",
      "                                            (NP\n",
      "                                              (NP\n",
      "                                                (PRN (-LRB- -LRB-)\n",
      "                                                  (NP\n",
      "                                                    (NP (NN chemical))\n",
      "                                                    (CC and)\n",
      "                                                    (NP (JJ enzymatic)))\n",
      "                                                  (-RRB- -RRB-))\n",
      "                                                (NNS studies))\n",
      "                                              (PP (IN of)\n",
      "                                                (NP (NN hydrolysis))))))))))))))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, carried-11)\n",
      "amod(studies-2, Kinetic-1)\n",
      "nsubjpass(carried-11, studies-2)\n",
      "case(hydrolysis-6, on-3)\n",
      "det(hydrolysis-6, the-4)\n",
      "amod(hydrolysis-6, acidic-5)\n",
      "nmod:on(studies-2, hydrolysis-6)\n",
      "case(hydrochloride-9, of-7)\n",
      "compound(hydrochloride-9, benazepril-8)\n",
      "nmod:of(hydrolysis-6, hydrochloride-9)\n",
      "auxpass(carried-11, were-10)\n",
      "compound:prt(carried-11, out-12)\n",
      "case(solution-18, in-13)\n",
      "compound(hydrochloric-16, 0.1-14)\n",
      "nmod:npmod(hydrochloric-16, M-15)\n",
      "amod(solution-18, hydrochloric-16)\n",
      "compound(solution-18, acid-17)\n",
      "nmod:in(carried-11, solution-18)\n",
      "case(50-20, at-19)\n",
      "nmod:at(solution-18, 50-20)\n",
      "punct(50-20, ,-21)\n",
      "nmod:at(solution-18, 53-22)\n",
      "conj:and(50-20, 53-22)\n",
      "punct(50-20, ,-23)\n",
      "nmod:at(solution-18, 58-24)\n",
      "conj:and(50-20, 58-24)\n",
      "cc(50-20, and-25)\n",
      "nummod(degrees-27, 63-26)\n",
      "nmod:at(solution-18, degrees-27)\n",
      "conj:and(50-20, degrees-27)\n",
      "compound(hydrochloride-30, C.-28)\n",
      "compound(hydrochloride-30, Benazepril-29)\n",
      "nsubj(appeared-31, hydrochloride-30)\n",
      "nsubj(showed-45, hydrochloride-30)\n",
      "acl:relcl(solution-18, appeared-31)\n",
      "amod(C-43, stable-32)\n",
      "case(phosphate-37, in-33)\n",
      "det(phosphate-37, a-34)\n",
      "compound(phosphate-37, pH-35)\n",
      "nummod(phosphate-37, 7.4-36)\n",
      "nmod:in(stable-32, phosphate-37)\n",
      "acl(phosphate-37, buffered-38)\n",
      "dobj(buffered-38, solution-39)\n",
      "case(degrees-42, at-40)\n",
      "nummod(degrees-42, 37-41)\n",
      "nmod:at(buffered-38, degrees-42)\n",
      "dobj(appeared-31, C-43)\n",
      "cc(appeared-31, and-44)\n",
      "acl:relcl(solution-18, showed-45)\n",
      "conj:and(appeared-31, showed-45)\n",
      "nsubj(buffered-64, susceptibility-46)\n",
      "mark(undergoing-48, to-47)\n",
      "acl:to(susceptibility-46, undergoing-48)\n",
      "compound(hydrolysis-52, in-49)\n",
      "dep(hydrolysis-52, vitro-50)\n",
      "amod(hydrolysis-52, enzymatic-51)\n",
      "advmod(undergoing-48, hydrolysis-52)\n",
      "case(esterase-56, with-53)\n",
      "compound(esterase-56, porcine-54)\n",
      "compound(esterase-56, liver-55)\n",
      "nmod:with(undergoing-48, esterase-56)\n",
      "punct(PLE-58, -LRB--57)\n",
      "appos(esterase-56, PLE-58)\n",
      "punct(PLE-58, -RRB--59)\n",
      "case(pH-62, in-60)\n",
      "det(pH-62, a-61)\n",
      "nmod:in(esterase-56, pH-62)\n",
      "nummod(pH-62, 7.4-63)\n",
      "ccomp(showed-45, buffered-64)\n",
      "dobj(buffered-64, solution-65)\n",
      "case(degrees-68, at-66)\n",
      "nummod(degrees-68, 37-67)\n",
      "nmod:at(buffered-64, degrees-68)\n",
      "compound(Benazeprilat-70, C.-69)\n",
      "nsubj(appeared-71, Benazeprilat-70)\n",
      "nsubj:xsubj(product-77, Benazeprilat-70)\n",
      "acl:relcl(degrees-68, appeared-71)\n",
      "mark(product-77, to-72)\n",
      "cop(product-77, be-73)\n",
      "det(product-77, the-74)\n",
      "amod(product-77, major-75)\n",
      "compound(product-77, degradation-76)\n",
      "xcomp(appeared-71, product-77)\n",
      "acl(product-77, in-78)\n",
      "dep(product-77, both-79)\n",
      "punct(chemical-81, -LRB--80)\n",
      "dep(studies-85, chemical-81)\n",
      "cc(chemical-81, and-82)\n",
      "conj:and(chemical-81, enzymatic-83)\n",
      "dep(studies-85, enzymatic-83)\n",
      "punct(chemical-81, -RRB--84)\n",
      "conj(product-77, studies-85)\n",
      "case(hydrolysis-87, of-86)\n",
      "nmod:of(studies-85, hydrolysis-87)\n",
      "punct(carried-11, .-88)\n",
      "\n",
      "Sentence #147 (14 tokens, sentiment: Positive):\n",
      "Statistical evaluation of the proposed HPLC methods revealed their good linearity and reproducibility.\n",
      "[Text=Statistical CharacterOffsetBegin=21469 CharacterOffsetEnd=21480 PartOfSpeech=JJ Lemma=statistical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=evaluation CharacterOffsetBegin=21481 CharacterOffsetEnd=21491 PartOfSpeech=NN Lemma=evaluation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=21492 CharacterOffsetEnd=21494 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=21495 CharacterOffsetEnd=21498 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=proposed CharacterOffsetBegin=21499 CharacterOffsetEnd=21507 PartOfSpeech=VBN Lemma=propose NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=HPLC CharacterOffsetBegin=21508 CharacterOffsetEnd=21512 PartOfSpeech=NN Lemma=hplc NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=methods CharacterOffsetBegin=21513 CharacterOffsetEnd=21520 PartOfSpeech=NNS Lemma=method NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=revealed CharacterOffsetBegin=21521 CharacterOffsetEnd=21529 PartOfSpeech=VBD Lemma=reveal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=their CharacterOffsetBegin=21530 CharacterOffsetEnd=21535 PartOfSpeech=PRP$ Lemma=they NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=good CharacterOffsetBegin=21536 CharacterOffsetEnd=21540 PartOfSpeech=JJ Lemma=good NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=linearity CharacterOffsetBegin=21541 CharacterOffsetEnd=21550 PartOfSpeech=NN Lemma=linearity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=21551 CharacterOffsetEnd=21554 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reproducibility CharacterOffsetBegin=21555 CharacterOffsetEnd=21570 PartOfSpeech=NN Lemma=reproducibility NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=21570 CharacterOffsetEnd=21571 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ Statistical) (NN evaluation))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (VBN proposed) (NN HPLC) (NNS methods))))\n",
      "    (VP (VBD revealed)\n",
      "      (NP (PRP$ their) (JJ good) (NN linearity)\n",
      "        (CC and)\n",
      "        (NN reproducibility)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, revealed-8)\n",
      "amod(evaluation-2, Statistical-1)\n",
      "nsubj(revealed-8, evaluation-2)\n",
      "case(methods-7, of-3)\n",
      "det(methods-7, the-4)\n",
      "amod(methods-7, proposed-5)\n",
      "compound(methods-7, HPLC-6)\n",
      "nmod:of(evaluation-2, methods-7)\n",
      "nmod:poss(linearity-11, their-9)\n",
      "amod(linearity-11, good-10)\n",
      "dobj(revealed-8, linearity-11)\n",
      "cc(linearity-11, and-12)\n",
      "dobj(revealed-8, reproducibility-13)\n",
      "conj:and(linearity-11, reproducibility-13)\n",
      "punct(revealed-8, .-14)\n",
      "\n",
      "Sentence #148 (37 tokens, sentiment: Negative):\n",
      "Relative standard deviation (R.S.D.) was less than 4.76, while detection limits for benazepril hydrochloride and benazeprilat were 13.0 x 10(-7) and 9.0 x 10(-7) M, respectively.\n",
      "[Text=Relative CharacterOffsetBegin=21572 CharacterOffsetEnd=21580 PartOfSpeech=JJ Lemma=relative NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=standard CharacterOffsetBegin=21581 CharacterOffsetEnd=21589 PartOfSpeech=JJ Lemma=standard NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=deviation CharacterOffsetBegin=21590 CharacterOffsetEnd=21599 PartOfSpeech=NN Lemma=deviation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=21600 CharacterOffsetEnd=21601 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=R.S.D. CharacterOffsetBegin=21601 CharacterOffsetEnd=21607 PartOfSpeech=NN Lemma=r.s.d. NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=21607 CharacterOffsetEnd=21608 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=21609 CharacterOffsetEnd=21612 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=less CharacterOffsetBegin=21613 CharacterOffsetEnd=21617 PartOfSpeech=JJR Lemma=less NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=than CharacterOffsetBegin=21618 CharacterOffsetEnd=21622 PartOfSpeech=IN Lemma=than NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=4.76 CharacterOffsetBegin=21623 CharacterOffsetEnd=21627 PartOfSpeech=CD Lemma=4.76 NamedEntityTag=NUMBER NormalizedNamedEntityTag=<4.76 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=21627 CharacterOffsetEnd=21628 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=while CharacterOffsetBegin=21629 CharacterOffsetEnd=21634 PartOfSpeech=IN Lemma=while NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=detection CharacterOffsetBegin=21635 CharacterOffsetEnd=21644 PartOfSpeech=NN Lemma=detection NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=limits CharacterOffsetBegin=21645 CharacterOffsetEnd=21651 PartOfSpeech=NNS Lemma=limit NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=21652 CharacterOffsetEnd=21655 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=21656 CharacterOffsetEnd=21666 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrochloride CharacterOffsetBegin=21667 CharacterOffsetEnd=21680 PartOfSpeech=NN Lemma=hydrochloride NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=21681 CharacterOffsetEnd=21684 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazeprilat CharacterOffsetBegin=21685 CharacterOffsetEnd=21697 PartOfSpeech=NN Lemma=benazeprilat NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=21698 CharacterOffsetEnd=21702 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=13.0 CharacterOffsetBegin=21703 CharacterOffsetEnd=21707 PartOfSpeech=CD Lemma=13.0 NamedEntityTag=NUMBER NormalizedNamedEntityTag=13.0 SentimentClass=Neutral]\n",
      "[Text=x CharacterOffsetBegin=21708 CharacterOffsetEnd=21709 PartOfSpeech=CC Lemma=x NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10 CharacterOffsetBegin=21710 CharacterOffsetEnd=21712 PartOfSpeech=CD Lemma=10 NamedEntityTag=NUMBER NormalizedNamedEntityTag=10.0 SentimentClass=Positive]\n",
      "[Text=-LRB- CharacterOffsetBegin=21712 CharacterOffsetEnd=21713 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-7 CharacterOffsetBegin=21713 CharacterOffsetEnd=21715 PartOfSpeech=CD Lemma=-7 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-7.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=21715 CharacterOffsetEnd=21716 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=21717 CharacterOffsetEnd=21720 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=9.0 CharacterOffsetBegin=21721 CharacterOffsetEnd=21724 PartOfSpeech=CD Lemma=9.0 NamedEntityTag=NUMBER NormalizedNamedEntityTag=9.0 SentimentClass=Neutral]\n",
      "[Text=x CharacterOffsetBegin=21725 CharacterOffsetEnd=21726 PartOfSpeech=CC Lemma=x NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10 CharacterOffsetBegin=21727 CharacterOffsetEnd=21729 PartOfSpeech=CD Lemma=10 NamedEntityTag=NUMBER NormalizedNamedEntityTag=10.0 SentimentClass=Positive]\n",
      "[Text=-LRB- CharacterOffsetBegin=21729 CharacterOffsetEnd=21730 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-7 CharacterOffsetBegin=21730 CharacterOffsetEnd=21732 PartOfSpeech=CD Lemma=-7 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-7.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=21732 CharacterOffsetEnd=21733 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=M CharacterOffsetBegin=21734 CharacterOffsetEnd=21735 PartOfSpeech=NN Lemma=m NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=21735 CharacterOffsetEnd=21736 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=respectively CharacterOffsetBegin=21737 CharacterOffsetEnd=21749 PartOfSpeech=RB Lemma=respectively NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=21749 CharacterOffsetEnd=21750 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (JJ Relative) (JJ standard) (NN deviation))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN R.S.D.))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD was)\n",
      "      (ADJP (JJR less))\n",
      "      (PP (IN than)\n",
      "        (NP (CD 4.76)))\n",
      "      (, ,)\n",
      "      (SBAR (IN while)\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (NN detection) (NNS limits))\n",
      "            (PP (IN for)\n",
      "              (NP (NN benazepril) (NN hydrochloride)\n",
      "                (CC and)\n",
      "                (NN benazeprilat))))\n",
      "          (VP (VBD were)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP (CD 13.0))\n",
      "                (CC x)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (CD 10))\n",
      "                    (PRN (-LRB- -LRB-)\n",
      "                      (NP (CD -7))\n",
      "                      (-RRB- -RRB-)))\n",
      "                  (CC and)\n",
      "                  (NP (CD 9.0))))\n",
      "              (CC x)\n",
      "              (NP\n",
      "                (NP (CD 10))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (CD -7))\n",
      "                  (-RRB- -RRB-))\n",
      "                (NP (NN M))))\n",
      "            (, ,)\n",
      "            (ADVP (RB respectively))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, less-8)\n",
      "amod(deviation-3, Relative-1)\n",
      "amod(deviation-3, standard-2)\n",
      "nsubj(less-8, deviation-3)\n",
      "punct(R.S.D.-5, -LRB--4)\n",
      "appos(deviation-3, R.S.D.-5)\n",
      "punct(R.S.D.-5, -RRB--6)\n",
      "cop(less-8, was-7)\n",
      "case(4.76-10, than-9)\n",
      "nmod:than(less-8, 4.76-10)\n",
      "punct(less-8, ,-11)\n",
      "mark(13.0-21, while-12)\n",
      "compound(limits-14, detection-13)\n",
      "nsubj(13.0-21, limits-14)\n",
      "case(hydrochloride-17, for-15)\n",
      "compound(hydrochloride-17, benazepril-16)\n",
      "nmod:for(limits-14, hydrochloride-17)\n",
      "cc(hydrochloride-17, and-18)\n",
      "nmod:for(limits-14, benazeprilat-19)\n",
      "conj:and(hydrochloride-17, benazeprilat-19)\n",
      "cop(13.0-21, were-20)\n",
      "advcl:while(less-8, 13.0-21)\n",
      "cc(13.0-21, x-22)\n",
      "advcl:while(less-8, 10-23)\n",
      "conj:x(13.0-21, 10-23)\n",
      "punct(-7-25, -LRB--24)\n",
      "appos(10-23, -7-25)\n",
      "punct(-7-25, -RRB--26)\n",
      "cc(10-23, and-27)\n",
      "conj:x(13.0-21, 9.0-28)\n",
      "conj:and(10-23, 9.0-28)\n",
      "cc(13.0-21, x-29)\n",
      "advcl:while(less-8, 10-30)\n",
      "conj:x(13.0-21, 10-30)\n",
      "punct(-7-32, -LRB--31)\n",
      "appos(10-30, -7-32)\n",
      "punct(-7-32, -RRB--33)\n",
      "dep(10-30, M-34)\n",
      "punct(13.0-21, ,-35)\n",
      "advmod(13.0-21, respectively-36)\n",
      "punct(less-8, .-37)\n",
      "\n",
      "Sentence #149 (22 tokens, sentiment: Negative):\n",
      "Treatment of the kinetic data of the acidic hydrolysis was carried out by non-linear regression analysis and k values were determined.\n",
      "[Text=Treatment CharacterOffsetBegin=21751 CharacterOffsetEnd=21760 PartOfSpeech=NN Lemma=treatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=21761 CharacterOffsetEnd=21763 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=21764 CharacterOffsetEnd=21767 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kinetic CharacterOffsetBegin=21768 CharacterOffsetEnd=21775 PartOfSpeech=JJ Lemma=kinetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=data CharacterOffsetBegin=21776 CharacterOffsetEnd=21780 PartOfSpeech=NNS Lemma=datum NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=21781 CharacterOffsetEnd=21783 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=21784 CharacterOffsetEnd=21787 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=acidic CharacterOffsetBegin=21788 CharacterOffsetEnd=21794 PartOfSpeech=JJ Lemma=acidic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrolysis CharacterOffsetBegin=21795 CharacterOffsetEnd=21805 PartOfSpeech=NN Lemma=hydrolysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=21806 CharacterOffsetEnd=21809 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=carried CharacterOffsetBegin=21810 CharacterOffsetEnd=21817 PartOfSpeech=VBN Lemma=carry NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=out CharacterOffsetBegin=21818 CharacterOffsetEnd=21821 PartOfSpeech=RP Lemma=out NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=by CharacterOffsetBegin=21822 CharacterOffsetEnd=21824 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=non-linear CharacterOffsetBegin=21825 CharacterOffsetEnd=21835 PartOfSpeech=JJ Lemma=non-linear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=regression CharacterOffsetBegin=21836 CharacterOffsetEnd=21846 PartOfSpeech=NN Lemma=regression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=analysis CharacterOffsetBegin=21847 CharacterOffsetEnd=21855 PartOfSpeech=NN Lemma=analysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=21856 CharacterOffsetEnd=21859 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=k CharacterOffsetBegin=21860 CharacterOffsetEnd=21861 PartOfSpeech=NN Lemma=k NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=values CharacterOffsetBegin=21862 CharacterOffsetEnd=21868 PartOfSpeech=NNS Lemma=value NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=21869 CharacterOffsetEnd=21873 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=determined CharacterOffsetBegin=21874 CharacterOffsetEnd=21884 PartOfSpeech=VBN Lemma=determine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=21884 CharacterOffsetEnd=21885 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (NP\n",
      "        (NP (NN Treatment))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (DT the) (JJ kinetic) (NNS data))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (JJ acidic) (NN hydrolysis))))))\n",
      "      (VP (VBD was)\n",
      "        (VP (VBN carried)\n",
      "          (PRT (RP out))\n",
      "          (PP (IN by)\n",
      "            (NP (JJ non-linear) (NN regression) (NN analysis))))))\n",
      "    (CC and)\n",
      "    (S\n",
      "      (NP (NN k) (NNS values))\n",
      "      (VP (VBD were)\n",
      "        (VP (VBN determined))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, carried-11)\n",
      "nsubjpass(carried-11, Treatment-1)\n",
      "case(data-5, of-2)\n",
      "det(data-5, the-3)\n",
      "amod(data-5, kinetic-4)\n",
      "nmod:of(Treatment-1, data-5)\n",
      "case(hydrolysis-9, of-6)\n",
      "det(hydrolysis-9, the-7)\n",
      "amod(hydrolysis-9, acidic-8)\n",
      "nmod:of(data-5, hydrolysis-9)\n",
      "auxpass(carried-11, was-10)\n",
      "compound:prt(carried-11, out-12)\n",
      "case(analysis-16, by-13)\n",
      "amod(analysis-16, non-linear-14)\n",
      "compound(analysis-16, regression-15)\n",
      "nmod:agent(carried-11, analysis-16)\n",
      "cc(carried-11, and-17)\n",
      "compound(values-19, k-18)\n",
      "nsubjpass(determined-21, values-19)\n",
      "auxpass(determined-21, were-20)\n",
      "conj:and(carried-11, determined-21)\n",
      "punct(carried-11, .-22)\n",
      "\n",
      "Sentence #150 (22 tokens, sentiment: Negative):\n",
      "The kinetic parameters of the enzymatic hydrolysis were determined by non-linear regression analysis of the data using the equation of Michaelis-Menten.\n",
      "[Text=The CharacterOffsetBegin=21886 CharacterOffsetEnd=21889 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=kinetic CharacterOffsetBegin=21890 CharacterOffsetEnd=21897 PartOfSpeech=JJ Lemma=kinetic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=parameters CharacterOffsetBegin=21898 CharacterOffsetEnd=21908 PartOfSpeech=NNS Lemma=parameter NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=21909 CharacterOffsetEnd=21911 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=21912 CharacterOffsetEnd=21915 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzymatic CharacterOffsetBegin=21916 CharacterOffsetEnd=21925 PartOfSpeech=JJ Lemma=enzymatic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrolysis CharacterOffsetBegin=21926 CharacterOffsetEnd=21936 PartOfSpeech=NN Lemma=hydrolysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=21937 CharacterOffsetEnd=21941 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=determined CharacterOffsetBegin=21942 CharacterOffsetEnd=21952 PartOfSpeech=VBN Lemma=determine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=21953 CharacterOffsetEnd=21955 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=non-linear CharacterOffsetBegin=21956 CharacterOffsetEnd=21966 PartOfSpeech=JJ Lemma=non-linear NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=regression CharacterOffsetBegin=21967 CharacterOffsetEnd=21977 PartOfSpeech=NN Lemma=regression NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=analysis CharacterOffsetBegin=21978 CharacterOffsetEnd=21986 PartOfSpeech=NN Lemma=analysis NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=21987 CharacterOffsetEnd=21989 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=21990 CharacterOffsetEnd=21993 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=data CharacterOffsetBegin=21994 CharacterOffsetEnd=21998 PartOfSpeech=NNS Lemma=datum NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=using CharacterOffsetBegin=21999 CharacterOffsetEnd=22004 PartOfSpeech=VBG Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=22005 CharacterOffsetEnd=22008 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=equation CharacterOffsetBegin=22009 CharacterOffsetEnd=22017 PartOfSpeech=NN Lemma=equation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22018 CharacterOffsetEnd=22020 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Michaelis-Menten CharacterOffsetBegin=22021 CharacterOffsetEnd=22037 PartOfSpeech=NNP Lemma=Michaelis-Menten NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=22037 CharacterOffsetEnd=22038 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (JJ kinetic) (NNS parameters))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (JJ enzymatic) (NN hydrolysis))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN determined)\n",
      "        (PP (IN by)\n",
      "          (NP\n",
      "            (NP (JJ non-linear) (NN regression) (NN analysis))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (NNS data)))))\n",
      "        (S\n",
      "          (VP (VBG using)\n",
      "            (NP\n",
      "              (NP (DT the) (NN equation))\n",
      "              (PP (IN of)\n",
      "                (NP (NNP Michaelis-Menten))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, determined-9)\n",
      "det(parameters-3, The-1)\n",
      "amod(parameters-3, kinetic-2)\n",
      "nsubjpass(determined-9, parameters-3)\n",
      "case(hydrolysis-7, of-4)\n",
      "det(hydrolysis-7, the-5)\n",
      "amod(hydrolysis-7, enzymatic-6)\n",
      "nmod:of(parameters-3, hydrolysis-7)\n",
      "auxpass(determined-9, were-8)\n",
      "case(analysis-13, by-10)\n",
      "amod(analysis-13, non-linear-11)\n",
      "compound(analysis-13, regression-12)\n",
      "nmod:agent(determined-9, analysis-13)\n",
      "case(data-16, of-14)\n",
      "det(data-16, the-15)\n",
      "nmod:of(analysis-13, data-16)\n",
      "xcomp(determined-9, using-17)\n",
      "det(equation-19, the-18)\n",
      "dobj(using-17, equation-19)\n",
      "case(Michaelis-Menten-21, of-20)\n",
      "nmod:of(equation-19, Michaelis-Menten-21)\n",
      "punct(determined-9, .-22)\n",
      "\n",
      "Sentence #151 (16 tokens, sentiment: Negative):\n",
      "Combination therapy is required in many patients to achieve goal blood pressure (BP).\n",
      "[Text=Combination CharacterOffsetBegin=22040 CharacterOffsetEnd=22051 PartOfSpeech=NN Lemma=combination NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=22052 CharacterOffsetEnd=22059 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=22060 CharacterOffsetEnd=22062 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=required CharacterOffsetBegin=22063 CharacterOffsetEnd=22071 PartOfSpeech=VBN Lemma=require NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=22072 CharacterOffsetEnd=22074 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=many CharacterOffsetBegin=22075 CharacterOffsetEnd=22079 PartOfSpeech=JJ Lemma=many NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=22080 CharacterOffsetEnd=22088 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=22089 CharacterOffsetEnd=22091 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=achieve CharacterOffsetBegin=22092 CharacterOffsetEnd=22099 PartOfSpeech=VB Lemma=achieve NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=goal CharacterOffsetBegin=22100 CharacterOffsetEnd=22104 PartOfSpeech=NN Lemma=goal NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=blood CharacterOffsetBegin=22105 CharacterOffsetEnd=22110 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=pressure CharacterOffsetBegin=22111 CharacterOffsetEnd=22119 PartOfSpeech=NN Lemma=pressure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=22120 CharacterOffsetEnd=22121 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=22121 CharacterOffsetEnd=22123 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=22123 CharacterOffsetEnd=22124 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=22124 CharacterOffsetEnd=22125 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Combination) (NN therapy))\n",
      "    (VP (VBZ is)\n",
      "      (VP (VBN required)\n",
      "        (PP (IN in)\n",
      "          (NP (JJ many) (NNS patients)))\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB achieve)\n",
      "              (NP\n",
      "                (NP (NN goal) (NN blood) (NN pressure))\n",
      "                (PRN (-LRB- -LRB-)\n",
      "                  (NP (NN BP))\n",
      "                  (-RRB- -RRB-))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, required-4)\n",
      "compound(therapy-2, Combination-1)\n",
      "nsubjpass(required-4, therapy-2)\n",
      "nsubj:xsubj(achieve-9, therapy-2)\n",
      "auxpass(required-4, is-3)\n",
      "case(patients-7, in-5)\n",
      "amod(patients-7, many-6)\n",
      "nmod:in(required-4, patients-7)\n",
      "mark(achieve-9, to-8)\n",
      "xcomp(required-4, achieve-9)\n",
      "compound(pressure-12, goal-10)\n",
      "compound(pressure-12, blood-11)\n",
      "dobj(achieve-9, pressure-12)\n",
      "punct(BP-14, -LRB--13)\n",
      "appos(pressure-12, BP-14)\n",
      "punct(BP-14, -RRB--15)\n",
      "punct(required-4, .-16)\n",
      "\n",
      "Sentence #152 (15 tokens, sentiment: Positive):\n",
      "Calcium antagonists are highly effective antihypertensive drugs in a broad range of demographic groups.\n",
      "[Text=Calcium CharacterOffsetBegin=22126 CharacterOffsetEnd=22133 PartOfSpeech=NN Lemma=calcium NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antagonists CharacterOffsetBegin=22134 CharacterOffsetEnd=22145 PartOfSpeech=NNS Lemma=antagonist NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=22146 CharacterOffsetEnd=22149 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=highly CharacterOffsetBegin=22150 CharacterOffsetEnd=22156 PartOfSpeech=RB Lemma=highly NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effective CharacterOffsetBegin=22157 CharacterOffsetEnd=22166 PartOfSpeech=JJ Lemma=effective NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=antihypertensive CharacterOffsetBegin=22167 CharacterOffsetEnd=22183 PartOfSpeech=JJ Lemma=antihypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=22184 CharacterOffsetEnd=22189 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=22190 CharacterOffsetEnd=22192 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=22193 CharacterOffsetEnd=22194 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=broad CharacterOffsetBegin=22195 CharacterOffsetEnd=22200 PartOfSpeech=JJ Lemma=broad NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=range CharacterOffsetBegin=22201 CharacterOffsetEnd=22206 PartOfSpeech=NN Lemma=range NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22207 CharacterOffsetEnd=22209 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=demographic CharacterOffsetBegin=22210 CharacterOffsetEnd=22221 PartOfSpeech=JJ Lemma=demographic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=groups CharacterOffsetBegin=22222 CharacterOffsetEnd=22228 PartOfSpeech=NNS Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=22228 CharacterOffsetEnd=22229 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Calcium) (NNS antagonists))\n",
      "    (VP (VBP are)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADJP (RB highly) (JJ effective))\n",
      "          (JJ antihypertensive) (NNS drugs))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (DT a) (JJ broad) (NN range))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ demographic) (NNS groups)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, drugs-7)\n",
      "compound(antagonists-2, Calcium-1)\n",
      "nsubj(drugs-7, antagonists-2)\n",
      "cop(drugs-7, are-3)\n",
      "advmod(effective-5, highly-4)\n",
      "amod(drugs-7, effective-5)\n",
      "amod(drugs-7, antihypertensive-6)\n",
      "case(range-11, in-8)\n",
      "det(range-11, a-9)\n",
      "amod(range-11, broad-10)\n",
      "nmod:in(drugs-7, range-11)\n",
      "case(groups-14, of-12)\n",
      "amod(groups-14, demographic-13)\n",
      "nmod:of(range-11, groups-14)\n",
      "punct(drugs-7, .-15)\n",
      "\n",
      "Sentence #153 (15 tokens, sentiment: Negative):\n",
      "Yet, higher doses are associated with an increased frequency of lower extremity edema.\n",
      "[Text=Yet CharacterOffsetBegin=22230 CharacterOffsetEnd=22233 PartOfSpeech=RB Lemma=yet NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=22233 CharacterOffsetEnd=22234 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=higher CharacterOffsetBegin=22235 CharacterOffsetEnd=22241 PartOfSpeech=JJR Lemma=higher NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=doses CharacterOffsetBegin=22242 CharacterOffsetEnd=22247 PartOfSpeech=NNS Lemma=dose NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=are CharacterOffsetBegin=22248 CharacterOffsetEnd=22251 PartOfSpeech=VBP Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=associated CharacterOffsetBegin=22252 CharacterOffsetEnd=22262 PartOfSpeech=VBN Lemma=associate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=22263 CharacterOffsetEnd=22267 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=22268 CharacterOffsetEnd=22270 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=increased CharacterOffsetBegin=22271 CharacterOffsetEnd=22280 PartOfSpeech=VBN Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=frequency CharacterOffsetBegin=22281 CharacterOffsetEnd=22290 PartOfSpeech=NN Lemma=frequency NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22291 CharacterOffsetEnd=22293 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=22294 CharacterOffsetEnd=22299 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extremity CharacterOffsetBegin=22300 CharacterOffsetEnd=22309 PartOfSpeech=NN Lemma=extremity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=edema CharacterOffsetBegin=22310 CharacterOffsetEnd=22315 PartOfSpeech=NN Lemma=edema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=22315 CharacterOffsetEnd=22316 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (ADVP (RB Yet))\n",
      "    (, ,)\n",
      "    (NP (JJR higher) (NNS doses))\n",
      "    (VP (VBP are)\n",
      "      (VP (VBN associated)\n",
      "        (PP (IN with)\n",
      "          (NP\n",
      "            (NP (DT an) (VBN increased) (NN frequency))\n",
      "            (PP (IN of)\n",
      "              (NP (JJR lower) (NN extremity) (NN edema)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, associated-6)\n",
      "advmod(associated-6, Yet-1)\n",
      "punct(associated-6, ,-2)\n",
      "amod(doses-4, higher-3)\n",
      "nsubjpass(associated-6, doses-4)\n",
      "auxpass(associated-6, are-5)\n",
      "case(frequency-10, with-7)\n",
      "det(frequency-10, an-8)\n",
      "amod(frequency-10, increased-9)\n",
      "nmod:with(associated-6, frequency-10)\n",
      "case(edema-14, of-11)\n",
      "amod(edema-14, lower-12)\n",
      "compound(edema-14, extremity-13)\n",
      "nmod:of(frequency-10, edema-14)\n",
      "punct(associated-6, .-15)\n",
      "\n",
      "Sentence #154 (37 tokens, sentiment: Negative):\n",
      "The purpose of our open label, single-center clinical trial was to evaluate the use of concomitant pharmacologic therapies to attenuate the lower extremity edema associated with dihydropyridine calcium antagonists therapy using a water displacement technique.\n",
      "[Text=The CharacterOffsetBegin=22317 CharacterOffsetEnd=22320 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=purpose CharacterOffsetBegin=22321 CharacterOffsetEnd=22328 PartOfSpeech=NN Lemma=purpose NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=of CharacterOffsetBegin=22329 CharacterOffsetEnd=22331 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=our CharacterOffsetBegin=22332 CharacterOffsetEnd=22335 PartOfSpeech=PRP$ Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=open CharacterOffsetBegin=22336 CharacterOffsetEnd=22340 PartOfSpeech=JJ Lemma=open NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=label CharacterOffsetBegin=22341 CharacterOffsetEnd=22346 PartOfSpeech=NN Lemma=label NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=22346 CharacterOffsetEnd=22347 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=single-center CharacterOffsetBegin=22348 CharacterOffsetEnd=22361 PartOfSpeech=JJ Lemma=single-center NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=clinical CharacterOffsetBegin=22362 CharacterOffsetEnd=22370 PartOfSpeech=JJ Lemma=clinical NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trial CharacterOffsetBegin=22371 CharacterOffsetEnd=22376 PartOfSpeech=NN Lemma=trial NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=22377 CharacterOffsetEnd=22380 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=22381 CharacterOffsetEnd=22383 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=evaluate CharacterOffsetBegin=22384 CharacterOffsetEnd=22392 PartOfSpeech=VB Lemma=evaluate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=22393 CharacterOffsetEnd=22396 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=use CharacterOffsetBegin=22397 CharacterOffsetEnd=22400 PartOfSpeech=NN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22401 CharacterOffsetEnd=22403 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=concomitant CharacterOffsetBegin=22404 CharacterOffsetEnd=22415 PartOfSpeech=JJ Lemma=concomitant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pharmacologic CharacterOffsetBegin=22416 CharacterOffsetEnd=22429 PartOfSpeech=JJ Lemma=pharmacologic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapies CharacterOffsetBegin=22430 CharacterOffsetEnd=22439 PartOfSpeech=NNS Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=22440 CharacterOffsetEnd=22442 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=attenuate CharacterOffsetBegin=22443 CharacterOffsetEnd=22452 PartOfSpeech=VB Lemma=attenuate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=22453 CharacterOffsetEnd=22456 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=22457 CharacterOffsetEnd=22462 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extremity CharacterOffsetBegin=22463 CharacterOffsetEnd=22472 PartOfSpeech=NN Lemma=extremity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=edema CharacterOffsetBegin=22473 CharacterOffsetEnd=22478 PartOfSpeech=NN Lemma=edema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=associated CharacterOffsetBegin=22479 CharacterOffsetEnd=22489 PartOfSpeech=VBN Lemma=associate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=22490 CharacterOffsetEnd=22494 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dihydropyridine CharacterOffsetBegin=22495 CharacterOffsetEnd=22510 PartOfSpeech=NN Lemma=dihydropyridine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=calcium CharacterOffsetBegin=22511 CharacterOffsetEnd=22518 PartOfSpeech=NN Lemma=calcium NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antagonists CharacterOffsetBegin=22519 CharacterOffsetEnd=22530 PartOfSpeech=NNS Lemma=antagonist NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=22531 CharacterOffsetEnd=22538 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=using CharacterOffsetBegin=22539 CharacterOffsetEnd=22544 PartOfSpeech=VBG Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=22545 CharacterOffsetEnd=22546 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=water CharacterOffsetBegin=22547 CharacterOffsetEnd=22552 PartOfSpeech=NN Lemma=water NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=displacement CharacterOffsetBegin=22553 CharacterOffsetEnd=22565 PartOfSpeech=NN Lemma=displacement NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=technique CharacterOffsetBegin=22566 CharacterOffsetEnd=22575 PartOfSpeech=NN Lemma=technique NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=22575 CharacterOffsetEnd=22576 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (DT The) (NN purpose))\n",
      "      (PP (IN of)\n",
      "        (NP\n",
      "          (NP (PRP$ our) (JJ open) (NN label))\n",
      "          (, ,)\n",
      "          (NP (JJ single-center) (JJ clinical) (NN trial)))))\n",
      "    (VP (VBD was)\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB evaluate)\n",
      "            (NP\n",
      "              (NP (DT the) (NN use))\n",
      "              (PP (IN of)\n",
      "                (NP (JJ concomitant) (JJ pharmacologic) (NNS therapies))))\n",
      "            (S\n",
      "              (VP (TO to)\n",
      "                (VP (VB attenuate)\n",
      "                  (NP\n",
      "                    (NP (DT the) (JJR lower) (NN extremity) (NN edema))\n",
      "                    (VP (VBN associated)\n",
      "                      (PP (IN with)\n",
      "                        (S\n",
      "                          (NP (NN dihydropyridine) (NN calcium) (NNS antagonists) (NN therapy))\n",
      "                          (VP (VBG using)\n",
      "                            (NP (DT a) (NN water) (NN displacement) (NN technique))))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, was-11)\n",
      "det(purpose-2, The-1)\n",
      "nsubj(was-11, purpose-2)\n",
      "nsubj:xsubj(evaluate-13, purpose-2)\n",
      "case(label-6, of-3)\n",
      "nmod:poss(label-6, our-4)\n",
      "amod(label-6, open-5)\n",
      "nmod:of(purpose-2, label-6)\n",
      "punct(label-6, ,-7)\n",
      "amod(trial-10, single-center-8)\n",
      "amod(trial-10, clinical-9)\n",
      "appos(label-6, trial-10)\n",
      "mark(evaluate-13, to-12)\n",
      "xcomp(was-11, evaluate-13)\n",
      "det(use-15, the-14)\n",
      "dobj(evaluate-13, use-15)\n",
      "case(therapies-19, of-16)\n",
      "amod(therapies-19, concomitant-17)\n",
      "amod(therapies-19, pharmacologic-18)\n",
      "nmod:of(use-15, therapies-19)\n",
      "mark(attenuate-21, to-20)\n",
      "advcl:to(evaluate-13, attenuate-21)\n",
      "det(edema-25, the-22)\n",
      "amod(edema-25, lower-23)\n",
      "compound(edema-25, extremity-24)\n",
      "dobj(attenuate-21, edema-25)\n",
      "acl(edema-25, associated-26)\n",
      "mark(using-32, with-27)\n",
      "compound(therapy-31, dihydropyridine-28)\n",
      "compound(therapy-31, calcium-29)\n",
      "compound(therapy-31, antagonists-30)\n",
      "nsubj(using-32, therapy-31)\n",
      "advcl:with(associated-26, using-32)\n",
      "det(technique-36, a-33)\n",
      "compound(technique-36, water-34)\n",
      "compound(technique-36, displacement-35)\n",
      "dobj(using-32, technique-36)\n",
      "punct(was-11, .-37)\n",
      "\n",
      "Sentence #155 (28 tokens, sentiment: Negative):\n",
      "Forty-seven patients received 5 mg/day of oral amlodipine for a period of 6 weeks after a 4-week wash-out off of all antihypertensive medications to establish baseline BP.\n",
      "[Text=Forty-seven CharacterOffsetBegin=22577 CharacterOffsetEnd=22588 PartOfSpeech=CD Lemma=forty-seven NamedEntityTag=NUMBER NormalizedNamedEntityTag=47.0 SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=22589 CharacterOffsetEnd=22597 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=received CharacterOffsetBegin=22598 CharacterOffsetEnd=22606 PartOfSpeech=VBD Lemma=receive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=22607 CharacterOffsetEnd=22608 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg/day CharacterOffsetBegin=22609 CharacterOffsetEnd=22615 PartOfSpeech=NN Lemma=mg/day NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22616 CharacterOffsetEnd=22618 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=oral CharacterOffsetBegin=22619 CharacterOffsetEnd=22623 PartOfSpeech=JJ Lemma=oral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=22624 CharacterOffsetEnd=22634 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=22635 CharacterOffsetEnd=22638 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=22639 CharacterOffsetEnd=22640 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=period CharacterOffsetBegin=22641 CharacterOffsetEnd=22647 PartOfSpeech=NN Lemma=period NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22648 CharacterOffsetEnd=22650 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=6 CharacterOffsetBegin=22651 CharacterOffsetEnd=22652 PartOfSpeech=CD Lemma=6 NamedEntityTag=DURATION NormalizedNamedEntityTag=P6W Timex=<TIMEX3 tid=\"t33\" type=\"DURATION\" value=\"P6W\">6 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=weeks CharacterOffsetBegin=22653 CharacterOffsetEnd=22658 PartOfSpeech=NNS Lemma=week NamedEntityTag=DURATION NormalizedNamedEntityTag=P6W Timex=<TIMEX3 tid=\"t33\" type=\"DURATION\" value=\"P6W\">6 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=after CharacterOffsetBegin=22659 CharacterOffsetEnd=22664 PartOfSpeech=IN Lemma=after NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=22665 CharacterOffsetEnd=22666 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=4-week CharacterOffsetBegin=22667 CharacterOffsetEnd=22673 PartOfSpeech=JJ Lemma=4-week NamedEntityTag=DURATION NormalizedNamedEntityTag=P4W Timex=<TIMEX3 tid=\"t34\" type=\"DURATION\" value=\"P4W\">4-week</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=wash-out CharacterOffsetBegin=22674 CharacterOffsetEnd=22682 PartOfSpeech=NN Lemma=wash-out NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=off CharacterOffsetBegin=22683 CharacterOffsetEnd=22686 PartOfSpeech=IN Lemma=off NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=of CharacterOffsetBegin=22687 CharacterOffsetEnd=22689 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=all CharacterOffsetBegin=22690 CharacterOffsetEnd=22693 PartOfSpeech=DT Lemma=all NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antihypertensive CharacterOffsetBegin=22694 CharacterOffsetEnd=22710 PartOfSpeech=JJ Lemma=antihypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=medications CharacterOffsetBegin=22711 CharacterOffsetEnd=22722 PartOfSpeech=NNS Lemma=medication NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=22723 CharacterOffsetEnd=22725 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=establish CharacterOffsetBegin=22726 CharacterOffsetEnd=22735 PartOfSpeech=VB Lemma=establish NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=baseline CharacterOffsetBegin=22736 CharacterOffsetEnd=22744 PartOfSpeech=NN Lemma=baseline NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=22745 CharacterOffsetEnd=22747 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=22747 CharacterOffsetEnd=22748 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (CD Forty-seven) (NNS patients))\n",
      "    (VP (VBD received)\n",
      "      (NP\n",
      "        (NP (CD 5) (NN mg/day))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP (JJ oral) (NN amlodipine))\n",
      "            (PP (IN for)\n",
      "              (NP\n",
      "                (NP (DT a) (NN period))\n",
      "                (PP (IN of)\n",
      "                  (NP (CD 6) (NNS weeks))))))))\n",
      "      (PP (IN after)\n",
      "        (NP\n",
      "          (NP (DT a) (JJ 4-week) (NN wash-out))\n",
      "          (ADVP (IN off))\n",
      "          (PP (IN of)\n",
      "            (NP (DT all) (JJ antihypertensive) (NNS medications)))))\n",
      "      (S\n",
      "        (VP (TO to)\n",
      "          (VP (VB establish)\n",
      "            (NP (NN baseline) (NN BP))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, received-3)\n",
      "nummod(patients-2, Forty-seven-1)\n",
      "nsubj(received-3, patients-2)\n",
      "nummod(mg/day-5, 5-4)\n",
      "dobj(received-3, mg/day-5)\n",
      "case(amlodipine-8, of-6)\n",
      "amod(amlodipine-8, oral-7)\n",
      "nmod:of(mg/day-5, amlodipine-8)\n",
      "case(period-11, for-9)\n",
      "det(period-11, a-10)\n",
      "nmod:for(amlodipine-8, period-11)\n",
      "case(weeks-14, of-12)\n",
      "nummod(weeks-14, 6-13)\n",
      "nmod:of(period-11, weeks-14)\n",
      "case(wash-out-18, after-15)\n",
      "det(wash-out-18, a-16)\n",
      "amod(wash-out-18, 4-week-17)\n",
      "nmod:after(received-3, wash-out-18)\n",
      "advmod(wash-out-18, off-19)\n",
      "case(medications-23, of-20)\n",
      "det(medications-23, all-21)\n",
      "amod(medications-23, antihypertensive-22)\n",
      "nmod:of(wash-out-18, medications-23)\n",
      "mark(establish-25, to-24)\n",
      "advcl:to(received-3, establish-25)\n",
      "compound(BP-27, baseline-26)\n",
      "dobj(establish-25, BP-27)\n",
      "punct(received-3, .-28)\n",
      "\n",
      "Sentence #156 (33 tokens, sentiment: Negative):\n",
      "They were then randomized to receive either an additional 5 mg of amlodipine, 25 mg of hydrochlorothiazide (HCTZ), or 20 mg of benazepril for an additional 6 weeks.\n",
      "[Text=They CharacterOffsetBegin=22749 CharacterOffsetEnd=22753 PartOfSpeech=PRP Lemma=they NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=22754 CharacterOffsetEnd=22758 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=then CharacterOffsetBegin=22759 CharacterOffsetEnd=22763 PartOfSpeech=RB Lemma=then NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=randomized CharacterOffsetBegin=22764 CharacterOffsetEnd=22774 PartOfSpeech=VBN Lemma=randomize NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=22775 CharacterOffsetEnd=22777 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=receive CharacterOffsetBegin=22778 CharacterOffsetEnd=22785 PartOfSpeech=VB Lemma=receive NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=either CharacterOffsetBegin=22786 CharacterOffsetEnd=22792 PartOfSpeech=CC Lemma=either NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=22793 CharacterOffsetEnd=22795 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=additional CharacterOffsetBegin=22796 CharacterOffsetEnd=22806 PartOfSpeech=JJ Lemma=additional NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=22807 CharacterOffsetEnd=22808 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=22809 CharacterOffsetEnd=22811 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22812 CharacterOffsetEnd=22814 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=22815 CharacterOffsetEnd=22825 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=22825 CharacterOffsetEnd=22826 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=25 CharacterOffsetBegin=22827 CharacterOffsetEnd=22829 PartOfSpeech=CD Lemma=25 NamedEntityTag=NUMBER NormalizedNamedEntityTag=25.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=22830 CharacterOffsetEnd=22832 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22833 CharacterOffsetEnd=22835 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=hydrochlorothiazide CharacterOffsetBegin=22836 CharacterOffsetEnd=22855 PartOfSpeech=NN Lemma=hydrochlorothiazide NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=22856 CharacterOffsetEnd=22857 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=HCTZ CharacterOffsetBegin=22857 CharacterOffsetEnd=22861 PartOfSpeech=NN Lemma=hctz NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=22861 CharacterOffsetEnd=22862 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=22862 CharacterOffsetEnd=22863 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=or CharacterOffsetBegin=22864 CharacterOffsetEnd=22866 PartOfSpeech=CC Lemma=or NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=20 CharacterOffsetBegin=22867 CharacterOffsetEnd=22869 PartOfSpeech=CD Lemma=20 NamedEntityTag=NUMBER NormalizedNamedEntityTag=20.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=22870 CharacterOffsetEnd=22872 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=22873 CharacterOffsetEnd=22875 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=22876 CharacterOffsetEnd=22886 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=22887 CharacterOffsetEnd=22890 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=22891 CharacterOffsetEnd=22893 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=additional CharacterOffsetBegin=22894 CharacterOffsetEnd=22904 PartOfSpeech=JJ Lemma=additional NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=6 CharacterOffsetBegin=22905 CharacterOffsetEnd=22906 PartOfSpeech=CD Lemma=6 NamedEntityTag=DURATION NormalizedNamedEntityTag=P6W Timex=<TIMEX3 tid=\"t35\" type=\"DURATION\" value=\"P6W\">6 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=weeks CharacterOffsetBegin=22907 CharacterOffsetEnd=22912 PartOfSpeech=NNS Lemma=week NamedEntityTag=DURATION NormalizedNamedEntityTag=P6W Timex=<TIMEX3 tid=\"t35\" type=\"DURATION\" value=\"P6W\">6 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=22912 CharacterOffsetEnd=22913 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP They))\n",
      "    (VP (VBD were)\n",
      "      (ADVP (RB then))\n",
      "      (VP (VBN randomized)\n",
      "        (S\n",
      "          (VP (TO to)\n",
      "            (VP (VB receive)\n",
      "              (PP (CC either)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (DT an) (JJ additional) (CD 5) (NN mg))\n",
      "                    (PP (IN of)\n",
      "                      (NP (NN amlodipine))))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (CD 25) (NN mg))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (NN hydrochlorothiazide))\n",
      "                        (PRN (-LRB- -LRB-)\n",
      "                          (NP (NN HCTZ))\n",
      "                          (-RRB- -RRB-)))))\n",
      "                  (, ,)\n",
      "                  (CC or)\n",
      "                  (NP\n",
      "                    (NP (CD 20) (NN mg))\n",
      "                    (PP (IN of)\n",
      "                      (NP\n",
      "                        (NP (NN benazepril))\n",
      "                        (PP (IN for)\n",
      "                          (NP (DT an) (JJ additional) (CD 6) (NNS weeks)))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, randomized-4)\n",
      "nsubjpass(randomized-4, They-1)\n",
      "nsubj:xsubj(receive-6, They-1)\n",
      "auxpass(randomized-4, were-2)\n",
      "advmod(randomized-4, then-3)\n",
      "mark(receive-6, to-5)\n",
      "xcomp(randomized-4, receive-6)\n",
      "case(mg-11, either-7)\n",
      "det(mg-11, an-8)\n",
      "amod(mg-11, additional-9)\n",
      "nummod(mg-11, 5-10)\n",
      "nmod:either(receive-6, mg-11)\n",
      "case(amlodipine-13, of-12)\n",
      "nmod:of(mg-11, amlodipine-13)\n",
      "punct(mg-11, ,-14)\n",
      "nummod(mg-16, 25-15)\n",
      "nmod:either(receive-6, mg-16)\n",
      "conj:or(mg-11, mg-16)\n",
      "case(hydrochlorothiazide-18, of-17)\n",
      "nmod:of(mg-16, hydrochlorothiazide-18)\n",
      "punct(HCTZ-20, -LRB--19)\n",
      "appos(hydrochlorothiazide-18, HCTZ-20)\n",
      "punct(HCTZ-20, -RRB--21)\n",
      "punct(mg-11, ,-22)\n",
      "cc(mg-11, or-23)\n",
      "nummod(mg-25, 20-24)\n",
      "nmod:either(receive-6, mg-25)\n",
      "conj:or(mg-11, mg-25)\n",
      "case(benazepril-27, of-26)\n",
      "nmod:of(mg-25, benazepril-27)\n",
      "case(weeks-32, for-28)\n",
      "det(weeks-32, an-29)\n",
      "amod(weeks-32, additional-30)\n",
      "nummod(weeks-32, 6-31)\n",
      "nmod:for(benazepril-27, weeks-32)\n",
      "punct(randomized-4, .-33)\n",
      "\n",
      "Sentence #157 (46 tokens, sentiment: Negative):\n",
      "Blood pressure determinations and water displacement measurements were obtained at the end of the 4-week placebo wash-out period, after 6 weeks of 5 mg/day of oral amlodipine therapy, and after an additional 6 weeks of 5 mg of amlodipine and randomized drug therapy.\n",
      "[Text=Blood CharacterOffsetBegin=22914 CharacterOffsetEnd=22919 PartOfSpeech=NN Lemma=blood NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pressure CharacterOffsetBegin=22920 CharacterOffsetEnd=22928 PartOfSpeech=NN Lemma=pressure NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=determinations CharacterOffsetBegin=22929 CharacterOffsetEnd=22943 PartOfSpeech=NNS Lemma=determination NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=22944 CharacterOffsetEnd=22947 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=water CharacterOffsetBegin=22948 CharacterOffsetEnd=22953 PartOfSpeech=NN Lemma=water NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=displacement CharacterOffsetBegin=22954 CharacterOffsetEnd=22966 PartOfSpeech=NN Lemma=displacement NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=measurements CharacterOffsetBegin=22967 CharacterOffsetEnd=22979 PartOfSpeech=NNS Lemma=measurement NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=22980 CharacterOffsetEnd=22984 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=obtained CharacterOffsetBegin=22985 CharacterOffsetEnd=22993 PartOfSpeech=VBN Lemma=obtain NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=at CharacterOffsetBegin=22994 CharacterOffsetEnd=22996 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=22997 CharacterOffsetEnd=23000 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=end CharacterOffsetBegin=23001 CharacterOffsetEnd=23004 PartOfSpeech=NN Lemma=end NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23005 CharacterOffsetEnd=23007 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=23008 CharacterOffsetEnd=23011 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=4-week CharacterOffsetBegin=23012 CharacterOffsetEnd=23018 PartOfSpeech=JJ Lemma=4-week NamedEntityTag=DURATION NormalizedNamedEntityTag=P4W Timex=<TIMEX3 tid=\"t36\" type=\"DURATION\" value=\"P4W\">4-week</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=placebo CharacterOffsetBegin=23019 CharacterOffsetEnd=23026 PartOfSpeech=NN Lemma=placebo NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=wash-out CharacterOffsetBegin=23027 CharacterOffsetEnd=23035 PartOfSpeech=JJ Lemma=wash-out NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=period CharacterOffsetBegin=23036 CharacterOffsetEnd=23042 PartOfSpeech=NN Lemma=period NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23042 CharacterOffsetEnd=23043 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=after CharacterOffsetBegin=23044 CharacterOffsetEnd=23049 PartOfSpeech=IN Lemma=after NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=6 CharacterOffsetBegin=23050 CharacterOffsetEnd=23051 PartOfSpeech=CD Lemma=6 NamedEntityTag=DURATION NormalizedNamedEntityTag=P6W Timex=<TIMEX3 tid=\"t37\" type=\"DURATION\" value=\"P6W\">6 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=weeks CharacterOffsetBegin=23052 CharacterOffsetEnd=23057 PartOfSpeech=NNS Lemma=week NamedEntityTag=DURATION NormalizedNamedEntityTag=P6W Timex=<TIMEX3 tid=\"t37\" type=\"DURATION\" value=\"P6W\">6 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23058 CharacterOffsetEnd=23060 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=23061 CharacterOffsetEnd=23062 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg/day CharacterOffsetBegin=23063 CharacterOffsetEnd=23069 PartOfSpeech=NN Lemma=mg/day NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23070 CharacterOffsetEnd=23072 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=oral CharacterOffsetBegin=23073 CharacterOffsetEnd=23077 PartOfSpeech=JJ Lemma=oral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=23078 CharacterOffsetEnd=23088 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=23089 CharacterOffsetEnd=23096 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23096 CharacterOffsetEnd=23097 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=23098 CharacterOffsetEnd=23101 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=after CharacterOffsetBegin=23102 CharacterOffsetEnd=23107 PartOfSpeech=IN Lemma=after NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=23108 CharacterOffsetEnd=23110 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=additional CharacterOffsetBegin=23111 CharacterOffsetEnd=23121 PartOfSpeech=JJ Lemma=additional NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=6 CharacterOffsetBegin=23122 CharacterOffsetEnd=23123 PartOfSpeech=CD Lemma=6 NamedEntityTag=DURATION NormalizedNamedEntityTag=P6W Timex=<TIMEX3 tid=\"t38\" type=\"DURATION\" value=\"P6W\">6 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=weeks CharacterOffsetBegin=23124 CharacterOffsetEnd=23129 PartOfSpeech=NNS Lemma=week NamedEntityTag=DURATION NormalizedNamedEntityTag=P6W Timex=<TIMEX3 tid=\"t38\" type=\"DURATION\" value=\"P6W\">6 weeks</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23130 CharacterOffsetEnd=23132 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=23133 CharacterOffsetEnd=23134 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=23135 CharacterOffsetEnd=23137 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23138 CharacterOffsetEnd=23140 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=23141 CharacterOffsetEnd=23151 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=23152 CharacterOffsetEnd=23155 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=randomized CharacterOffsetBegin=23156 CharacterOffsetEnd=23166 PartOfSpeech=VBN Lemma=randomize NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drug CharacterOffsetBegin=23167 CharacterOffsetEnd=23171 PartOfSpeech=NN Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=23172 CharacterOffsetEnd=23179 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=23179 CharacterOffsetEnd=23180 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Blood) (NN pressure) (NNS determinations)\n",
      "      (CC and)\n",
      "      (NN water) (NN displacement) (NNS measurements))\n",
      "    (VP (VBD were)\n",
      "      (VP\n",
      "        (VP (VBN obtained)\n",
      "          (PP\n",
      "            (PP (IN at)\n",
      "              (NP\n",
      "                (NP (DT the) (NN end))\n",
      "                (PP (IN of)\n",
      "                  (NP (DT the) (JJ 4-week) (NN placebo) (JJ wash-out) (NN period)))))\n",
      "            (, ,)\n",
      "            (PP (IN after)\n",
      "              (NP\n",
      "                (NP (CD 6) (NNS weeks))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (CD 5) (NN mg/day))\n",
      "                    (PP (IN of)\n",
      "                      (NP (JJ oral) (NN amlodipine) (NN therapy)))))))\n",
      "            (, ,)\n",
      "            (CC and)\n",
      "            (PP (IN after)\n",
      "              (NP\n",
      "                (NP (DT an) (JJ additional) (CD 6) (NNS weeks))\n",
      "                (PP (IN of)\n",
      "                  (NP\n",
      "                    (NP (CD 5) (NN mg))\n",
      "                    (PP (IN of)\n",
      "                      (NP (NN amlodipine)))))))))\n",
      "        (CC and)\n",
      "        (VP (VBN randomized)\n",
      "          (NP (NN drug) (NN therapy)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, obtained-9)\n",
      "compound(determinations-3, Blood-1)\n",
      "compound(determinations-3, pressure-2)\n",
      "nsubjpass(obtained-9, determinations-3)\n",
      "nsubjpass(obtained-9', determinations-3)\n",
      "nsubjpass(obtained-9'', determinations-3)\n",
      "nsubjpass(randomized-43, determinations-3)\n",
      "cc(determinations-3, and-4)\n",
      "compound(measurements-7, water-5)\n",
      "compound(measurements-7, displacement-6)\n",
      "conj:and(determinations-3, measurements-7)\n",
      "nsubjpass(obtained-9, measurements-7)\n",
      "auxpass(obtained-9, were-8)\n",
      "conj:and(obtained-9, obtained-9')\n",
      "conj:and(obtained-9, obtained-9'')\n",
      "case(end-12, at-10)\n",
      "det(end-12, the-11)\n",
      "nmod:at(obtained-9, end-12)\n",
      "case(period-18, of-13)\n",
      "det(period-18, the-14)\n",
      "amod(period-18, 4-week-15)\n",
      "compound(period-18, placebo-16)\n",
      "amod(period-18, wash-out-17)\n",
      "nmod:of(end-12, period-18)\n",
      "punct(end-12, ,-19)\n",
      "case(weeks-22, after-20)\n",
      "nummod(weeks-22, 6-21)\n",
      "nmod:after(obtained-9'', weeks-22)\n",
      "case(mg/day-25, of-23)\n",
      "nummod(mg/day-25, 5-24)\n",
      "nmod:of(weeks-22, mg/day-25)\n",
      "case(therapy-29, of-26)\n",
      "amod(therapy-29, oral-27)\n",
      "compound(therapy-29, amlodipine-28)\n",
      "nmod:of(mg/day-25, therapy-29)\n",
      "punct(end-12, ,-30)\n",
      "cc(obtained-9, and-31)\n",
      "case(weeks-36, after-32)\n",
      "det(weeks-36, an-33)\n",
      "amod(weeks-36, additional-34)\n",
      "nummod(weeks-36, 6-35)\n",
      "nmod:after(obtained-9', weeks-36)\n",
      "case(mg-39, of-37)\n",
      "nummod(mg-39, 5-38)\n",
      "nmod:of(weeks-36, mg-39)\n",
      "case(amlodipine-41, of-40)\n",
      "nmod:of(mg-39, amlodipine-41)\n",
      "cc(obtained-9, and-42)\n",
      "conj:and(obtained-9, randomized-43)\n",
      "compound(therapy-45, drug-44)\n",
      "dobj(randomized-43, therapy-45)\n",
      "punct(obtained-9, .-46)\n",
      "\n",
      "Sentence #158 (85 tokens, sentiment: Negative):\n",
      "Adjusted BP reductions (based on pretreatment BP) were -6.8/-3.8 mm Hg for the 10-mg amlodipine group, -9.9/-8.2 mm Hg for the amlodipine (5 mg)/HCTZ (25 mg) group, and -26.2/-16.4 mm Hg for the amlodipine (5 mg)/benazepril (20 mg) group (P < .0167, group 3 v group 1 diastolic BP, which was statistically significant by the improved Bonferroni method).\n",
      "[Text=Adjusted CharacterOffsetBegin=23181 CharacterOffsetEnd=23189 PartOfSpeech=VBN Lemma=adjust NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=23190 CharacterOffsetEnd=23192 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reductions CharacterOffsetBegin=23193 CharacterOffsetEnd=23203 PartOfSpeech=NNS Lemma=reduction NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23204 CharacterOffsetEnd=23205 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=based CharacterOffsetBegin=23205 CharacterOffsetEnd=23210 PartOfSpeech=VBN Lemma=base NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=on CharacterOffsetBegin=23211 CharacterOffsetEnd=23213 PartOfSpeech=IN Lemma=on NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pretreatment CharacterOffsetBegin=23214 CharacterOffsetEnd=23226 PartOfSpeech=NN Lemma=pretreatment NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=23227 CharacterOffsetEnd=23229 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23229 CharacterOffsetEnd=23230 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=23231 CharacterOffsetEnd=23235 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-6.8 CharacterOffsetBegin=23236 CharacterOffsetEnd=23240 PartOfSpeech=CD Lemma=-6.8 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-6.8 SentimentClass=Neutral]\n",
      "[Text=/ CharacterOffsetBegin=23240 CharacterOffsetEnd=23241 PartOfSpeech=: Lemma=/ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-3.8 CharacterOffsetBegin=23241 CharacterOffsetEnd=23245 PartOfSpeech=CD Lemma=-3.8 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-3.8 SentimentClass=Neutral]\n",
      "[Text=mm CharacterOffsetBegin=23246 CharacterOffsetEnd=23248 PartOfSpeech=NN Lemma=mm NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Hg CharacterOffsetBegin=23249 CharacterOffsetEnd=23251 PartOfSpeech=NN Lemma=hg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=23252 CharacterOffsetEnd=23255 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=23256 CharacterOffsetEnd=23259 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10-mg CharacterOffsetBegin=23260 CharacterOffsetEnd=23265 PartOfSpeech=JJ Lemma=10-mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=23266 CharacterOffsetEnd=23276 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=23277 CharacterOffsetEnd=23282 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23282 CharacterOffsetEnd=23283 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-9.9 CharacterOffsetBegin=23284 CharacterOffsetEnd=23288 PartOfSpeech=CD Lemma=-9.9 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-9.9 SentimentClass=Neutral]\n",
      "[Text=/ CharacterOffsetBegin=23288 CharacterOffsetEnd=23289 PartOfSpeech=: Lemma=/ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-8.2 CharacterOffsetBegin=23289 CharacterOffsetEnd=23293 PartOfSpeech=CD Lemma=-8.2 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-8.2 SentimentClass=Neutral]\n",
      "[Text=mm CharacterOffsetBegin=23294 CharacterOffsetEnd=23296 PartOfSpeech=NN Lemma=mm NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Hg CharacterOffsetBegin=23297 CharacterOffsetEnd=23299 PartOfSpeech=NN Lemma=hg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=23300 CharacterOffsetEnd=23303 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=23304 CharacterOffsetEnd=23307 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=23308 CharacterOffsetEnd=23318 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23319 CharacterOffsetEnd=23320 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=23320 CharacterOffsetEnd=23321 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=23322 CharacterOffsetEnd=23324 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23324 CharacterOffsetEnd=23325 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=/ CharacterOffsetBegin=23325 CharacterOffsetEnd=23326 PartOfSpeech=: Lemma=/ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=HCTZ CharacterOffsetBegin=23326 CharacterOffsetEnd=23330 PartOfSpeech=NN Lemma=hctz NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23331 CharacterOffsetEnd=23332 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=25 CharacterOffsetBegin=23332 CharacterOffsetEnd=23334 PartOfSpeech=CD Lemma=25 NamedEntityTag=NUMBER NormalizedNamedEntityTag=25.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=23335 CharacterOffsetEnd=23337 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23337 CharacterOffsetEnd=23338 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=23339 CharacterOffsetEnd=23344 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23344 CharacterOffsetEnd=23345 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=23346 CharacterOffsetEnd=23349 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-26.2 CharacterOffsetBegin=23350 CharacterOffsetEnd=23355 PartOfSpeech=CD Lemma=-26.2 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-26.2 SentimentClass=Neutral]\n",
      "[Text=/ CharacterOffsetBegin=23355 CharacterOffsetEnd=23356 PartOfSpeech=: Lemma=/ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-16.4 CharacterOffsetBegin=23356 CharacterOffsetEnd=23361 PartOfSpeech=CD Lemma=-16.4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=-16.4 SentimentClass=Neutral]\n",
      "[Text=mm CharacterOffsetBegin=23362 CharacterOffsetEnd=23364 PartOfSpeech=NN Lemma=mm NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Hg CharacterOffsetBegin=23365 CharacterOffsetEnd=23367 PartOfSpeech=NN Lemma=hg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=for CharacterOffsetBegin=23368 CharacterOffsetEnd=23371 PartOfSpeech=IN Lemma=for NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=23372 CharacterOffsetEnd=23375 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=23376 CharacterOffsetEnd=23386 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23387 CharacterOffsetEnd=23388 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=23388 CharacterOffsetEnd=23389 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=23390 CharacterOffsetEnd=23392 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23392 CharacterOffsetEnd=23393 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=/ CharacterOffsetBegin=23393 CharacterOffsetEnd=23394 PartOfSpeech=: Lemma=/ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=benazepril CharacterOffsetBegin=23394 CharacterOffsetEnd=23404 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23405 CharacterOffsetEnd=23406 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=20 CharacterOffsetBegin=23406 CharacterOffsetEnd=23408 PartOfSpeech=CD Lemma=20 NamedEntityTag=NUMBER NormalizedNamedEntityTag=20.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=23409 CharacterOffsetEnd=23411 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23411 CharacterOffsetEnd=23412 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=23413 CharacterOffsetEnd=23418 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23419 CharacterOffsetEnd=23420 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=P CharacterOffsetBegin=23420 CharacterOffsetEnd=23421 PartOfSpeech=NN Lemma=p NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=< CharacterOffsetBegin=23422 CharacterOffsetEnd=23423 PartOfSpeech=JJR Lemma=< NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=.0167 CharacterOffsetBegin=23424 CharacterOffsetEnd=23429 PartOfSpeech=CD Lemma=.0167 NamedEntityTag=NUMBER NormalizedNamedEntityTag=0.0167 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23429 CharacterOffsetEnd=23430 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=23431 CharacterOffsetEnd=23436 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=3 CharacterOffsetBegin=23437 CharacterOffsetEnd=23438 PartOfSpeech=CD Lemma=3 NamedEntityTag=NUMBER NormalizedNamedEntityTag=3.0 SentimentClass=Neutral]\n",
      "[Text=v CharacterOffsetBegin=23439 CharacterOffsetEnd=23440 PartOfSpeech=LS Lemma=v NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=23441 CharacterOffsetEnd=23446 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1 CharacterOffsetBegin=23447 CharacterOffsetEnd=23448 PartOfSpeech=CD Lemma=1 NamedEntityTag=NUMBER NormalizedNamedEntityTag=1.0 SentimentClass=Neutral]\n",
      "[Text=diastolic CharacterOffsetBegin=23449 CharacterOffsetEnd=23458 PartOfSpeech=JJ Lemma=diastolic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=23459 CharacterOffsetEnd=23461 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23461 CharacterOffsetEnd=23462 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=which CharacterOffsetBegin=23463 CharacterOffsetEnd=23468 PartOfSpeech=WDT Lemma=which NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=was CharacterOffsetBegin=23469 CharacterOffsetEnd=23472 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=statistically CharacterOffsetBegin=23473 CharacterOffsetEnd=23486 PartOfSpeech=RB Lemma=statistically NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=significant CharacterOffsetBegin=23487 CharacterOffsetEnd=23498 PartOfSpeech=JJ Lemma=significant NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=23499 CharacterOffsetEnd=23501 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=23502 CharacterOffsetEnd=23505 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=improved CharacterOffsetBegin=23506 CharacterOffsetEnd=23514 PartOfSpeech=VBN Lemma=improve NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=Bonferroni CharacterOffsetBegin=23515 CharacterOffsetEnd=23525 PartOfSpeech=NNP Lemma=Bonferroni NamedEntityTag=PERSON SentimentClass=Neutral]\n",
      "[Text=method CharacterOffsetBegin=23526 CharacterOffsetEnd=23532 PartOfSpeech=NN Lemma=method NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23532 CharacterOffsetEnd=23533 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=23533 CharacterOffsetEnd=23534 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (SINV\n",
      "    (PP (VBN Adjusted)\n",
      "      (NP\n",
      "        (NP (NN BP) (NNS reductions))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (VP (VBN based)\n",
      "            (PP (IN on)\n",
      "              (NP (NN pretreatment) (NN BP))))\n",
      "          (-RRB- -RRB-))))\n",
      "    (VP (VBD were)\n",
      "      (ADVP\n",
      "        (ADVP (CD -6.8))\n",
      "        (PRN (: /)\n",
      "          (FRAG\n",
      "            (NP-TMP\n",
      "              (NP (CD -3.8) (NN mm) (NN Hg))\n",
      "              (PP (IN for)\n",
      "                (NP\n",
      "                  (NP (DT the) (JJ 10-mg) (NN amlodipine) (NN group))\n",
      "                  (, ,)\n",
      "                  (NP (CD -9.9))\n",
      "                  (PRN (: /)\n",
      "                    (NP\n",
      "                      (NP (CD -8.2) (NN mm) (NN Hg))\n",
      "                      (PP (IN for)\n",
      "                        (NP\n",
      "                          (NP (DT the) (NN amlodipine))\n",
      "                          (PRN (-LRB- -LRB-)\n",
      "                            (NP (CD 5) (NN mg))\n",
      "                            (-RRB- -RRB-)))))\n",
      "                    (: /))\n",
      "                  (NP\n",
      "                    (NP\n",
      "                      (NP (NN HCTZ))\n",
      "                      (PRN (-LRB- -LRB-)\n",
      "                        (NP (CD 25) (NN mg))\n",
      "                        (-RRB- -RRB-))\n",
      "                      (NP (NN group)))\n",
      "                    (, ,)\n",
      "                    (CC and)\n",
      "                    (NP (CD -26.2))))))\n",
      "            (: /)\n",
      "            (NP\n",
      "              (NP (CD -16.4) (NN mm) (NN Hg))\n",
      "              (PP (IN for)\n",
      "                (NP\n",
      "                  (NP (DT the) (NN amlodipine))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (CD 5) (NN mg))\n",
      "                    (-RRB- -RRB-))))))\n",
      "          (: /))))\n",
      "    (NP\n",
      "      (NP (NN benazepril))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 20) (NN mg))\n",
      "        (-RRB- -RRB-))\n",
      "      (NP\n",
      "        (NP (NN group))\n",
      "        (PRN (-LRB- -LRB-)\n",
      "          (NP\n",
      "            (NP (NN P))\n",
      "            (ADJP\n",
      "              (NP (JJR <))\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (CD .0167))\n",
      "                  (, ,)\n",
      "                  (NP (NN group) (CD 3)))\n",
      "                (LS v)\n",
      "                (NP\n",
      "                  (NP\n",
      "                    (NP (NN group))\n",
      "                    (ADJP (CD 1) (JJ diastolic) (NN BP)))\n",
      "                  (, ,)\n",
      "                  (SBAR\n",
      "                    (WHNP (WDT which))\n",
      "                    (S\n",
      "                      (VP (VBD was)\n",
      "                        (ADJP (RB statistically) (JJ significant))\n",
      "                        (PP (IN by)\n",
      "                          (NP (DT the) (VBN improved) (NNP Bonferroni) (NN method))))))))))\n",
      "          (-RRB- -RRB-))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, were-10)\n",
      "case(reductions-3, Adjusted-1)\n",
      "compound(reductions-3, BP-2)\n",
      "nmod:adjusted(were-10, reductions-3)\n",
      "punct(based-5, -LRB--4)\n",
      "dep(reductions-3, based-5)\n",
      "case(BP-8, on-6)\n",
      "compound(BP-8, pretreatment-7)\n",
      "nmod:on(based-5, BP-8)\n",
      "punct(based-5, -RRB--9)\n",
      "advmod(were-10, -6.8-11)\n",
      "punct(Hg-15, /-12)\n",
      "nummod(Hg-15, -3.8-13)\n",
      "compound(Hg-15, mm-14)\n",
      "dep(-6.8-11, Hg-15)\n",
      "case(group-20, for-16)\n",
      "det(group-20, the-17)\n",
      "amod(group-20, 10-mg-18)\n",
      "compound(group-20, amlodipine-19)\n",
      "nmod:for(Hg-15, group-20)\n",
      "punct(group-20, ,-21)\n",
      "amod(group-20, -9.9-22)\n",
      "punct(Hg-26, /-23)\n",
      "nummod(Hg-26, -8.2-24)\n",
      "compound(Hg-26, mm-25)\n",
      "dep(group-20, Hg-26)\n",
      "case(amlodipine-29, for-27)\n",
      "det(amlodipine-29, the-28)\n",
      "nmod:for(Hg-26, amlodipine-29)\n",
      "punct(mg-32, -LRB--30)\n",
      "nummod(mg-32, 5-31)\n",
      "appos(amlodipine-29, mg-32)\n",
      "punct(mg-32, -RRB--33)\n",
      "punct(Hg-26, /-34)\n",
      "dep(group-20, HCTZ-35)\n",
      "punct(mg-38, -LRB--36)\n",
      "nummod(mg-38, 25-37)\n",
      "appos(HCTZ-35, mg-38)\n",
      "punct(mg-38, -RRB--39)\n",
      "dep(HCTZ-35, group-40)\n",
      "punct(HCTZ-35, ,-41)\n",
      "cc(HCTZ-35, and-42)\n",
      "dep(group-20, -26.2-43)\n",
      "conj:and(HCTZ-35, -26.2-43)\n",
      "punct(Hg-15, /-44)\n",
      "nummod(Hg-47, -16.4-45)\n",
      "compound(Hg-47, mm-46)\n",
      "dep(Hg-15, Hg-47)\n",
      "case(amlodipine-50, for-48)\n",
      "det(amlodipine-50, the-49)\n",
      "nmod:for(Hg-47, amlodipine-50)\n",
      "punct(mg-53, -LRB--51)\n",
      "nummod(mg-53, 5-52)\n",
      "appos(amlodipine-50, mg-53)\n",
      "punct(mg-53, -RRB--54)\n",
      "punct(Hg-15, /-55)\n",
      "nsubj(were-10, benazepril-56)\n",
      "punct(mg-59, -LRB--57)\n",
      "nummod(mg-59, 20-58)\n",
      "appos(benazepril-56, mg-59)\n",
      "punct(mg-59, -RRB--60)\n",
      "dep(benazepril-56, group-61)\n",
      "punct(P-63, -LRB--62)\n",
      "dep(group-61, P-63)\n",
      "amod(P-63, <-64)\n",
      "dep(<-64, .0167-65)\n",
      "punct(.0167-65, ,-66)\n",
      "appos(.0167-65, group-67)\n",
      "nummod(group-67, 3-68)\n",
      "dep(.0167-65, v-69)\n",
      "dep(.0167-65, group-70)\n",
      "nsubj(significant-78, group-70)\n",
      "compound(BP-73, 1-71)\n",
      "dep(BP-73, diastolic-72)\n",
      "amod(group-70, BP-73)\n",
      "punct(group-70, ,-74)\n",
      "ref(group-70, which-75)\n",
      "cop(significant-78, was-76)\n",
      "advmod(significant-78, statistically-77)\n",
      "acl:relcl(group-70, significant-78)\n",
      "case(method-83, by-79)\n",
      "det(method-83, the-80)\n",
      "amod(method-83, improved-81)\n",
      "compound(method-83, Bonferroni-82)\n",
      "nmod:by(significant-78, method-83)\n",
      "punct(P-63, -RRB--84)\n",
      "punct(were-10, .-85)\n",
      "\n",
      "Sentence #159 (32 tokens, sentiment: Negative):\n",
      "Seventeen of the 47 patients developed at least a 10% increase in lower extremity edema water displacement in response to 5 mg/day of oral amlodipine therapy (36.2%).\n",
      "[Text=Seventeen CharacterOffsetBegin=23535 CharacterOffsetEnd=23544 PartOfSpeech=CD Lemma=seventeen NamedEntityTag=NUMBER NormalizedNamedEntityTag=17.0 SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23545 CharacterOffsetEnd=23547 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=23548 CharacterOffsetEnd=23551 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=47 CharacterOffsetBegin=23552 CharacterOffsetEnd=23554 PartOfSpeech=CD Lemma=47 NamedEntityTag=NUMBER NormalizedNamedEntityTag=47.0 SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=23555 CharacterOffsetEnd=23563 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=developed CharacterOffsetBegin=23564 CharacterOffsetEnd=23573 PartOfSpeech=VBD Lemma=develop NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=at CharacterOffsetBegin=23574 CharacterOffsetEnd=23576 PartOfSpeech=IN Lemma=at NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=least CharacterOffsetBegin=23577 CharacterOffsetEnd=23582 PartOfSpeech=JJS Lemma=least NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=a CharacterOffsetBegin=23583 CharacterOffsetEnd=23584 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=10 CharacterOffsetBegin=23585 CharacterOffsetEnd=23587 PartOfSpeech=CD Lemma=10 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%10.0 SentimentClass=Positive]\n",
      "[Text=% CharacterOffsetBegin=23587 CharacterOffsetEnd=23588 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%10.0 SentimentClass=Neutral]\n",
      "[Text=increase CharacterOffsetBegin=23589 CharacterOffsetEnd=23597 PartOfSpeech=NN Lemma=increase NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=23598 CharacterOffsetEnd=23600 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=23601 CharacterOffsetEnd=23606 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extremity CharacterOffsetBegin=23607 CharacterOffsetEnd=23616 PartOfSpeech=NN Lemma=extremity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=edema CharacterOffsetBegin=23617 CharacterOffsetEnd=23622 PartOfSpeech=NN Lemma=edema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=water CharacterOffsetBegin=23623 CharacterOffsetEnd=23628 PartOfSpeech=NN Lemma=water NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=displacement CharacterOffsetBegin=23629 CharacterOffsetEnd=23641 PartOfSpeech=NN Lemma=displacement NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=in CharacterOffsetBegin=23642 CharacterOffsetEnd=23644 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=response CharacterOffsetBegin=23645 CharacterOffsetEnd=23653 PartOfSpeech=NN Lemma=response NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=23654 CharacterOffsetEnd=23656 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=23657 CharacterOffsetEnd=23658 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg/day CharacterOffsetBegin=23659 CharacterOffsetEnd=23665 PartOfSpeech=NN Lemma=mg/day NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23666 CharacterOffsetEnd=23668 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=oral CharacterOffsetBegin=23669 CharacterOffsetEnd=23673 PartOfSpeech=JJ Lemma=oral NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=23674 CharacterOffsetEnd=23684 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=therapy CharacterOffsetBegin=23685 CharacterOffsetEnd=23692 PartOfSpeech=NN Lemma=therapy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23693 CharacterOffsetEnd=23694 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=36.2 CharacterOffsetBegin=23694 CharacterOffsetEnd=23698 PartOfSpeech=CD Lemma=36.2 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%36.2 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=23698 CharacterOffsetEnd=23699 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%36.2 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23699 CharacterOffsetEnd=23700 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=23700 CharacterOffsetEnd=23701 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (CD Seventeen))\n",
      "      (PP (IN of)\n",
      "        (NP (DT the) (CD 47) (NNS patients))))\n",
      "    (VP (VBD developed)\n",
      "      (NP\n",
      "        (NP\n",
      "          (ADVP (IN at) (JJS least))\n",
      "          (DT a)\n",
      "          (ADJP (CD 10) (NN %))\n",
      "          (ADJP (NN increase)\n",
      "            (PP (IN in)\n",
      "              (NP (JJR lower) (NN extremity) (NN edema) (NN water))))\n",
      "          (NN displacement))\n",
      "        (PP (IN in)\n",
      "          (NP (NN response))))\n",
      "      (PP (TO to)\n",
      "        (NP\n",
      "          (NP (CD 5) (NN mg/day))\n",
      "          (PP (IN of)\n",
      "            (NP\n",
      "              (NP (JJ oral) (NN amlodipine) (NN therapy))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (CD 36.2) (NN %))\n",
      "                (-RRB- -RRB-)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, developed-6)\n",
      "nsubj(developed-6, Seventeen-1)\n",
      "case(patients-5, of-2)\n",
      "det(patients-5, the-3)\n",
      "nummod(patients-5, 47-4)\n",
      "nmod:of(Seventeen-1, patients-5)\n",
      "case(least-8, at-7)\n",
      "advmod(displacement-18, least-8)\n",
      "det(displacement-18, a-9)\n",
      "compound(%-11, 10-10)\n",
      "amod(displacement-18, %-11)\n",
      "amod(displacement-18, increase-12)\n",
      "case(water-17, in-13)\n",
      "amod(water-17, lower-14)\n",
      "compound(water-17, extremity-15)\n",
      "compound(water-17, edema-16)\n",
      "nmod:in(increase-12, water-17)\n",
      "dobj(developed-6, displacement-18)\n",
      "case(response-20, in-19)\n",
      "nmod:in(displacement-18, response-20)\n",
      "case(mg/day-23, to-21)\n",
      "nummod(mg/day-23, 5-22)\n",
      "nmod:to(developed-6, mg/day-23)\n",
      "case(therapy-27, of-24)\n",
      "amod(therapy-27, oral-25)\n",
      "compound(therapy-27, amlodipine-26)\n",
      "nmod:of(mg/day-23, therapy-27)\n",
      "punct(%-30, -LRB--28)\n",
      "nummod(%-30, 36.2-29)\n",
      "appos(therapy-27, %-30)\n",
      "punct(%-30, -RRB--31)\n",
      "punct(developed-6, .-32)\n",
      "\n",
      "Sentence #160 (36 tokens, sentiment: Negative):\n",
      "Adding 5 mg of amlodipine to a baseline of 5 mg of amlodipine resulted in no net change in lower extremity edema (+58.0 mL,+ 0.6% change, n=5).\n",
      "[Text=Adding CharacterOffsetBegin=23702 CharacterOffsetEnd=23708 PartOfSpeech=VBG Lemma=add NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=23709 CharacterOffsetEnd=23710 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=23711 CharacterOffsetEnd=23713 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23714 CharacterOffsetEnd=23716 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=23717 CharacterOffsetEnd=23727 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=23728 CharacterOffsetEnd=23730 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=23731 CharacterOffsetEnd=23732 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=baseline CharacterOffsetBegin=23733 CharacterOffsetEnd=23741 PartOfSpeech=NN Lemma=baseline NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23742 CharacterOffsetEnd=23744 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=23745 CharacterOffsetEnd=23746 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=23747 CharacterOffsetEnd=23749 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23750 CharacterOffsetEnd=23752 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=23753 CharacterOffsetEnd=23763 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=resulted CharacterOffsetBegin=23764 CharacterOffsetEnd=23772 PartOfSpeech=VBD Lemma=result NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=23773 CharacterOffsetEnd=23775 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=no CharacterOffsetBegin=23776 CharacterOffsetEnd=23778 PartOfSpeech=DT Lemma=no NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=net CharacterOffsetBegin=23779 CharacterOffsetEnd=23782 PartOfSpeech=JJ Lemma=net NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=change CharacterOffsetBegin=23783 CharacterOffsetEnd=23789 PartOfSpeech=NN Lemma=change NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=23790 CharacterOffsetEnd=23792 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=23793 CharacterOffsetEnd=23798 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extremity CharacterOffsetBegin=23799 CharacterOffsetEnd=23808 PartOfSpeech=NN Lemma=extremity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=edema CharacterOffsetBegin=23809 CharacterOffsetEnd=23814 PartOfSpeech=NN Lemma=edema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23815 CharacterOffsetEnd=23816 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=+58.0 CharacterOffsetBegin=23816 CharacterOffsetEnd=23821 PartOfSpeech=CD Lemma=+58.0 NamedEntityTag=NUMBER NormalizedNamedEntityTag=58.0 SentimentClass=Neutral]\n",
      "[Text=mL CharacterOffsetBegin=23822 CharacterOffsetEnd=23824 PartOfSpeech=NN Lemma=ml NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23824 CharacterOffsetEnd=23825 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=+ CharacterOffsetBegin=23825 CharacterOffsetEnd=23826 PartOfSpeech=CC Lemma=+ NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=0.6 CharacterOffsetBegin=23827 CharacterOffsetEnd=23830 PartOfSpeech=CD Lemma=0.6 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%0.6 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=23830 CharacterOffsetEnd=23831 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%0.6 SentimentClass=Neutral]\n",
      "[Text=change CharacterOffsetBegin=23832 CharacterOffsetEnd=23838 PartOfSpeech=NN Lemma=change NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23838 CharacterOffsetEnd=23839 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=n CharacterOffsetBegin=23840 CharacterOffsetEnd=23841 PartOfSpeech=NN Lemma=n NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text== CharacterOffsetBegin=23841 CharacterOffsetEnd=23842 PartOfSpeech=JJ Lemma== NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=5 CharacterOffsetBegin=23842 CharacterOffsetEnd=23843 PartOfSpeech=CD Lemma=5 NamedEntityTag=NUMBER NormalizedNamedEntityTag=5.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23843 CharacterOffsetEnd=23844 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=23844 CharacterOffsetEnd=23845 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (S\n",
      "      (VP (VBG Adding)\n",
      "        (NP\n",
      "          (NP (CD 5) (NN mg))\n",
      "          (PP (IN of)\n",
      "            (NP (NN amlodipine))))\n",
      "        (PP (TO to)\n",
      "          (NP\n",
      "            (NP (DT a) (NN baseline))\n",
      "            (PP (IN of)\n",
      "              (NP\n",
      "                (NP (CD 5) (NN mg))\n",
      "                (PP (IN of)\n",
      "                  (NP (NN amlodipine)))))))))\n",
      "    (VP (VBD resulted)\n",
      "      (PP (IN in)\n",
      "        (NP (DT no) (JJ net) (NN change)))\n",
      "      (PP (IN in)\n",
      "        (NP\n",
      "          (NP (JJR lower) (NN extremity) (NN edema))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP\n",
      "                (NP\n",
      "                  (NP (CD +58.0) (NN mL))\n",
      "                  (, ,)\n",
      "                  (CC +)\n",
      "                  (NP (CD 0.6) (NN %) (NN change))\n",
      "                  (, ,))\n",
      "                (NP (NN n)))\n",
      "              (NP (JJ =) (CD 5)))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, resulted-14)\n",
      "csubj(resulted-14, Adding-1)\n",
      "nummod(mg-3, 5-2)\n",
      "dobj(Adding-1, mg-3)\n",
      "case(amlodipine-5, of-4)\n",
      "nmod:of(mg-3, amlodipine-5)\n",
      "case(baseline-8, to-6)\n",
      "det(baseline-8, a-7)\n",
      "nmod:to(Adding-1, baseline-8)\n",
      "case(mg-11, of-9)\n",
      "nummod(mg-11, 5-10)\n",
      "nmod:of(baseline-8, mg-11)\n",
      "case(amlodipine-13, of-12)\n",
      "nmod:of(mg-11, amlodipine-13)\n",
      "case(change-18, in-15)\n",
      "neg(change-18, no-16)\n",
      "amod(change-18, net-17)\n",
      "nmod:in(resulted-14, change-18)\n",
      "case(edema-22, in-19)\n",
      "amod(edema-22, lower-20)\n",
      "compound(edema-22, extremity-21)\n",
      "nmod:in(resulted-14, edema-22)\n",
      "punct(mL-25, -LRB--23)\n",
      "nummod(mL-25, +58.0-24)\n",
      "dep(edema-22, mL-25)\n",
      "punct(mL-25, ,-26)\n",
      "cc(mL-25, +-27)\n",
      "nummod(change-30, 0.6-28)\n",
      "compound(change-30, %-29)\n",
      "dep(edema-22, change-30)\n",
      "conj:+(mL-25, change-30)\n",
      "punct(mL-25, ,-31)\n",
      "dep(mL-25, n-32)\n",
      "amod(5-34, =-33)\n",
      "dep(mL-25, 5-34)\n",
      "punct(mL-25, -RRB--35)\n",
      "punct(resulted-14, .-36)\n",
      "\n",
      "Sentence #161 (25 tokens, sentiment: Negative):\n",
      "Adding 25 mg of HCTZ reduced lower extremity edema by a mean of 136.3 mL (-11.1% change, n=4).\n",
      "[Text=Adding CharacterOffsetBegin=23846 CharacterOffsetEnd=23852 PartOfSpeech=VBG Lemma=add NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=25 CharacterOffsetBegin=23853 CharacterOffsetEnd=23855 PartOfSpeech=CD Lemma=25 NamedEntityTag=NUMBER NormalizedNamedEntityTag=25.0 SentimentClass=Neutral]\n",
      "[Text=mg CharacterOffsetBegin=23856 CharacterOffsetEnd=23858 PartOfSpeech=NN Lemma=mg NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=23859 CharacterOffsetEnd=23861 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=HCTZ CharacterOffsetBegin=23862 CharacterOffsetEnd=23866 PartOfSpeech=NN Lemma=hctz NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduced CharacterOffsetBegin=23867 CharacterOffsetEnd=23874 PartOfSpeech=VBD Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=23875 CharacterOffsetEnd=23880 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extremity CharacterOffsetBegin=23881 CharacterOffsetEnd=23890 PartOfSpeech=NN Lemma=extremity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=edema CharacterOffsetBegin=23891 CharacterOffsetEnd=23896 PartOfSpeech=NN Lemma=edema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=23897 CharacterOffsetEnd=23899 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=23900 CharacterOffsetEnd=23901 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=mean CharacterOffsetBegin=23902 CharacterOffsetEnd=23906 PartOfSpeech=NN Lemma=mean NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=of CharacterOffsetBegin=23907 CharacterOffsetEnd=23909 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=136.3 CharacterOffsetBegin=23910 CharacterOffsetEnd=23915 PartOfSpeech=CD Lemma=136.3 NamedEntityTag=NUMBER NormalizedNamedEntityTag=136.3 SentimentClass=Neutral]\n",
      "[Text=mL CharacterOffsetBegin=23916 CharacterOffsetEnd=23918 PartOfSpeech=NN Lemma=ml NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23919 CharacterOffsetEnd=23920 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-11.1 CharacterOffsetBegin=23920 CharacterOffsetEnd=23925 PartOfSpeech=CD Lemma=-11.1 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%-11.1 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=23925 CharacterOffsetEnd=23926 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%-11.1 SentimentClass=Neutral]\n",
      "[Text=change CharacterOffsetBegin=23927 CharacterOffsetEnd=23933 PartOfSpeech=NN Lemma=change NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=23933 CharacterOffsetEnd=23934 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=n CharacterOffsetBegin=23935 CharacterOffsetEnd=23936 PartOfSpeech=NN Lemma=n NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text== CharacterOffsetBegin=23936 CharacterOffsetEnd=23937 PartOfSpeech=JJ Lemma== NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=4 CharacterOffsetBegin=23937 CharacterOffsetEnd=23938 PartOfSpeech=CD Lemma=4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=4.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=23938 CharacterOffsetEnd=23939 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=23939 CharacterOffsetEnd=23940 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (SINV\n",
      "    (VP (VBG Adding)\n",
      "      (NP\n",
      "        (NP (CD 25) (NN mg))\n",
      "        (PP (IN of)\n",
      "          (NP (NN HCTZ)))))\n",
      "    (VP (VBD reduced)\n",
      "      (NP (JJR lower) (NN extremity) (NN edema))\n",
      "      (PP (IN by)\n",
      "        (NP\n",
      "          (NP (DT a) (NN mean))\n",
      "          (PP (IN of)\n",
      "            (NP (CD 136.3))))))\n",
      "    (NP\n",
      "      (NP (NN mL))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP\n",
      "          (NP (CD -11.1) (NN %))\n",
      "          (NP\n",
      "            (NP (NN change))\n",
      "            (, ,)\n",
      "            (NP\n",
      "              (NP (NN n))\n",
      "              (ADJP (JJ =)\n",
      "                (NP-TMP (CD 4))))))\n",
      "        (-RRB- -RRB-)))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, Adding-1)\n",
      "nummod(mg-3, 25-2)\n",
      "dobj(Adding-1, mg-3)\n",
      "case(HCTZ-5, of-4)\n",
      "nmod:of(mg-3, HCTZ-5)\n",
      "dep(Adding-1, reduced-6)\n",
      "amod(edema-9, lower-7)\n",
      "compound(edema-9, extremity-8)\n",
      "dobj(reduced-6, edema-9)\n",
      "case(mean-12, by-10)\n",
      "det(mean-12, a-11)\n",
      "nmod:by(reduced-6, mean-12)\n",
      "case(136.3-14, of-13)\n",
      "nmod:of(mean-12, 136.3-14)\n",
      "nsubj(Adding-1, mL-15)\n",
      "punct(%-18, -LRB--16)\n",
      "nummod(%-18, -11.1-17)\n",
      "dep(mL-15, %-18)\n",
      "dep(%-18, change-19)\n",
      "punct(change-19, ,-20)\n",
      "appos(change-19, n-21)\n",
      "amod(n-21, =-22)\n",
      "nmod:tmod(=-22, 4-23)\n",
      "punct(%-18, -RRB--24)\n",
      "punct(Adding-1, .-25)\n",
      "\n",
      "Sentence #162 (17 tokens, sentiment: Negative):\n",
      "Benazepril reduced water displacement by 204.4 mL (-14.3% change, n=8).\n",
      "[Text=Benazepril CharacterOffsetBegin=23941 CharacterOffsetEnd=23951 PartOfSpeech=NNP Lemma=Benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduced CharacterOffsetBegin=23952 CharacterOffsetEnd=23959 PartOfSpeech=VBD Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=water CharacterOffsetBegin=23960 CharacterOffsetEnd=23965 PartOfSpeech=NN Lemma=water NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=displacement CharacterOffsetBegin=23966 CharacterOffsetEnd=23978 PartOfSpeech=NN Lemma=displacement NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=by CharacterOffsetBegin=23979 CharacterOffsetEnd=23981 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=204.4 CharacterOffsetBegin=23982 CharacterOffsetEnd=23987 PartOfSpeech=CD Lemma=204.4 NamedEntityTag=NUMBER NormalizedNamedEntityTag=204.4 SentimentClass=Neutral]\n",
      "[Text=mL CharacterOffsetBegin=23988 CharacterOffsetEnd=23990 PartOfSpeech=NN Lemma=ml NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=23991 CharacterOffsetEnd=23992 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-14.3 CharacterOffsetBegin=23992 CharacterOffsetEnd=23997 PartOfSpeech=CD Lemma=-14.3 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%-14.3 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=23997 CharacterOffsetEnd=23998 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%-14.3 SentimentClass=Neutral]\n",
      "[Text=change CharacterOffsetBegin=23999 CharacterOffsetEnd=24005 PartOfSpeech=NN Lemma=change NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=24005 CharacterOffsetEnd=24006 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=n CharacterOffsetBegin=24007 CharacterOffsetEnd=24008 PartOfSpeech=NN Lemma=n NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text== CharacterOffsetBegin=24008 CharacterOffsetEnd=24009 PartOfSpeech=JJ Lemma== NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=8 CharacterOffsetBegin=24009 CharacterOffsetEnd=24010 PartOfSpeech=CD Lemma=8 NamedEntityTag=NUMBER NormalizedNamedEntityTag=8.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=24010 CharacterOffsetEnd=24011 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=24011 CharacterOffsetEnd=24012 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNP Benazepril))\n",
      "    (VP (VBD reduced)\n",
      "      (NP (NN water) (NN displacement))\n",
      "      (PP (IN by)\n",
      "        (NP\n",
      "          (NP (CD 204.4) (NN mL))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP\n",
      "              (NP (CD -14.3) (NN %))\n",
      "              (NP\n",
      "                (NP (NN change))\n",
      "                (, ,)\n",
      "                (NP\n",
      "                  (NP (NN n))\n",
      "                  (ADJP (JJ =)\n",
      "                    (NP-TMP (CD 8))))))\n",
      "            (-RRB- -RRB-)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, reduced-2)\n",
      "nsubj(reduced-2, Benazepril-1)\n",
      "compound(displacement-4, water-3)\n",
      "dobj(reduced-2, displacement-4)\n",
      "case(mL-7, by-5)\n",
      "nummod(mL-7, 204.4-6)\n",
      "nmod:by(reduced-2, mL-7)\n",
      "punct(%-10, -LRB--8)\n",
      "nummod(%-10, -14.3-9)\n",
      "dep(mL-7, %-10)\n",
      "dep(%-10, change-11)\n",
      "punct(change-11, ,-12)\n",
      "appos(change-11, n-13)\n",
      "amod(n-13, =-14)\n",
      "nmod:tmod(=-14, 8-15)\n",
      "punct(%-10, -RRB--16)\n",
      "punct(reduced-2, .-17)\n",
      "\n",
      "Sentence #163 (37 tokens, sentiment: Negative):\n",
      "Our pilot study indicates that adding an angiotensin converting enzyme inhibitor to a dihydropyridine calcium channel blocker is the most effective way to not only reduce systolic and diastolic BP but also attenuate lower extremity edema.\n",
      "[Text=Our CharacterOffsetBegin=24013 CharacterOffsetEnd=24016 PartOfSpeech=PRP$ Lemma=we NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=pilot CharacterOffsetBegin=24017 CharacterOffsetEnd=24022 PartOfSpeech=NN Lemma=pilot NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=study CharacterOffsetBegin=24023 CharacterOffsetEnd=24028 PartOfSpeech=NN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=indicates CharacterOffsetBegin=24029 CharacterOffsetEnd=24038 PartOfSpeech=VBZ Lemma=indicate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=that CharacterOffsetBegin=24039 CharacterOffsetEnd=24043 PartOfSpeech=IN Lemma=that NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=adding CharacterOffsetBegin=24044 CharacterOffsetEnd=24050 PartOfSpeech=VBG Lemma=add NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=an CharacterOffsetBegin=24051 CharacterOffsetEnd=24053 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin CharacterOffsetBegin=24054 CharacterOffsetEnd=24065 PartOfSpeech=NN Lemma=angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=converting CharacterOffsetBegin=24066 CharacterOffsetEnd=24076 PartOfSpeech=VBG Lemma=convert NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=24077 CharacterOffsetEnd=24083 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=24084 CharacterOffsetEnd=24093 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=24094 CharacterOffsetEnd=24096 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=a CharacterOffsetBegin=24097 CharacterOffsetEnd=24098 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=dihydropyridine CharacterOffsetBegin=24099 CharacterOffsetEnd=24114 PartOfSpeech=NN Lemma=dihydropyridine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=calcium CharacterOffsetBegin=24115 CharacterOffsetEnd=24122 PartOfSpeech=NN Lemma=calcium NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=channel CharacterOffsetBegin=24123 CharacterOffsetEnd=24130 PartOfSpeech=NN Lemma=channel NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=blocker CharacterOffsetBegin=24131 CharacterOffsetEnd=24138 PartOfSpeech=NN Lemma=blocker NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=is CharacterOffsetBegin=24139 CharacterOffsetEnd=24141 PartOfSpeech=VBZ Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24142 CharacterOffsetEnd=24145 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=most CharacterOffsetBegin=24146 CharacterOffsetEnd=24150 PartOfSpeech=RBS Lemma=most NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=effective CharacterOffsetBegin=24151 CharacterOffsetEnd=24160 PartOfSpeech=JJ Lemma=effective NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=way CharacterOffsetBegin=24161 CharacterOffsetEnd=24164 PartOfSpeech=NN Lemma=way NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=24165 CharacterOffsetEnd=24167 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=not CharacterOffsetBegin=24168 CharacterOffsetEnd=24171 PartOfSpeech=RB Lemma=not NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=only CharacterOffsetBegin=24172 CharacterOffsetEnd=24176 PartOfSpeech=RB Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=reduce CharacterOffsetBegin=24177 CharacterOffsetEnd=24183 PartOfSpeech=VB Lemma=reduce NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=systolic CharacterOffsetBegin=24184 CharacterOffsetEnd=24192 PartOfSpeech=JJ Lemma=systolic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=24193 CharacterOffsetEnd=24196 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diastolic CharacterOffsetBegin=24197 CharacterOffsetEnd=24206 PartOfSpeech=JJ Lemma=diastolic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=BP CharacterOffsetBegin=24207 CharacterOffsetEnd=24209 PartOfSpeech=NN Lemma=bp NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=but CharacterOffsetBegin=24210 CharacterOffsetEnd=24213 PartOfSpeech=CC Lemma=but NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=also CharacterOffsetBegin=24214 CharacterOffsetEnd=24218 PartOfSpeech=RB Lemma=also NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=attenuate CharacterOffsetBegin=24219 CharacterOffsetEnd=24228 PartOfSpeech=VB Lemma=attenuate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=24229 CharacterOffsetEnd=24234 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extremity CharacterOffsetBegin=24235 CharacterOffsetEnd=24244 PartOfSpeech=NN Lemma=extremity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=edema CharacterOffsetBegin=24245 CharacterOffsetEnd=24250 PartOfSpeech=NN Lemma=edema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=24250 CharacterOffsetEnd=24251 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (PRP$ Our) (NN pilot) (NN study))\n",
      "    (VP (VBZ indicates)\n",
      "      (SBAR (IN that)\n",
      "        (S\n",
      "          (S\n",
      "            (VP (VBG adding)\n",
      "              (NP (DT an) (NN angiotensin))\n",
      "              (S\n",
      "                (VP (VBG converting)\n",
      "                  (NP (NN enzyme) (NN inhibitor))\n",
      "                  (PP (TO to)\n",
      "                    (NP (DT a) (NN dihydropyridine) (NN calcium) (NN channel) (NN blocker)))))))\n",
      "          (VP (VBZ is)\n",
      "            (NP (DT the)\n",
      "              (ADJP (RBS most) (JJ effective))\n",
      "              (NN way)\n",
      "              (S\n",
      "                (VP (TO to)\n",
      "                  (VP (RB not)\n",
      "                    (VP\n",
      "                      (ADVP (RB only))\n",
      "                      (VB reduce)\n",
      "                      (NP\n",
      "                        (ADJP (JJ systolic)\n",
      "                          (CC and)\n",
      "                          (JJ diastolic))\n",
      "                        (NN BP)))\n",
      "                    (CONJP (CC but)\n",
      "                      (RB also))\n",
      "                    (VP (VB attenuate)\n",
      "                      (NP (JJR lower) (NN extremity) (NN edema)))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, indicates-4)\n",
      "nmod:poss(study-3, Our-1)\n",
      "compound(study-3, pilot-2)\n",
      "nsubj(indicates-4, study-3)\n",
      "mark(way-22, that-5)\n",
      "csubj(way-22, adding-6)\n",
      "det(angiotensin-8, an-7)\n",
      "dobj(adding-6, angiotensin-8)\n",
      "advcl(adding-6, converting-9)\n",
      "compound(inhibitor-11, enzyme-10)\n",
      "dobj(converting-9, inhibitor-11)\n",
      "case(blocker-17, to-12)\n",
      "det(blocker-17, a-13)\n",
      "compound(blocker-17, dihydropyridine-14)\n",
      "compound(blocker-17, calcium-15)\n",
      "compound(blocker-17, channel-16)\n",
      "nmod:to(converting-9, blocker-17)\n",
      "cop(way-22, is-18)\n",
      "det(way-22, the-19)\n",
      "advmod(effective-21, most-20)\n",
      "amod(way-22, effective-21)\n",
      "ccomp(indicates-4, way-22)\n",
      "mark(reduce-26, to-23)\n",
      "neg(reduce-26, not-24)\n",
      "advmod(reduce-26, only-25)\n",
      "acl:to(way-22, reduce-26)\n",
      "amod(BP-30, systolic-27)\n",
      "cc(systolic-27, and-28)\n",
      "conj:and(systolic-27, diastolic-29)\n",
      "amod(BP-30, diastolic-29)\n",
      "dobj(reduce-26, BP-30)\n",
      "cc(reduce-26, but-31)\n",
      "advmod(attenuate-33, also-32)\n",
      "acl:to(way-22, attenuate-33)\n",
      "conj:and(reduce-26, attenuate-33)\n",
      "amod(edema-36, lower-34)\n",
      "compound(edema-36, extremity-35)\n",
      "dobj(attenuate-33, edema-36)\n",
      "punct(indicates-4, .-37)\n",
      "\n",
      "Sentence #164 (45 tokens, sentiment: Negative):\n",
      "Due to the inherent daily variability of lower extremity edema, power calculations indicate many patients (n=702, 356 in each group) would be needed to compare the antiedema efficacy of the angiotensin converting enzyme inhibitor and the thiazide diuretic.\n",
      "[Text=Due CharacterOffsetBegin=24252 CharacterOffsetEnd=24255 PartOfSpeech=JJ Lemma=due NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=to CharacterOffsetBegin=24256 CharacterOffsetEnd=24258 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24259 CharacterOffsetEnd=24262 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inherent CharacterOffsetBegin=24263 CharacterOffsetEnd=24271 PartOfSpeech=JJ Lemma=inherent NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=daily CharacterOffsetBegin=24272 CharacterOffsetEnd=24277 PartOfSpeech=JJ Lemma=daily NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1D\" quant=\"EVERY\" tid=\"t39\" type=\"SET\" value=\"P1D\">daily</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=variability CharacterOffsetBegin=24278 CharacterOffsetEnd=24289 PartOfSpeech=NN Lemma=variability NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=24290 CharacterOffsetEnd=24292 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lower CharacterOffsetBegin=24293 CharacterOffsetEnd=24298 PartOfSpeech=JJR Lemma=lower NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=extremity CharacterOffsetBegin=24299 CharacterOffsetEnd=24308 PartOfSpeech=NN Lemma=extremity NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=edema CharacterOffsetBegin=24309 CharacterOffsetEnd=24314 PartOfSpeech=NN Lemma=edema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=24314 CharacterOffsetEnd=24315 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=power CharacterOffsetBegin=24316 CharacterOffsetEnd=24321 PartOfSpeech=NN Lemma=power NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=calculations CharacterOffsetBegin=24322 CharacterOffsetEnd=24334 PartOfSpeech=NNS Lemma=calculation NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=indicate CharacterOffsetBegin=24335 CharacterOffsetEnd=24343 PartOfSpeech=VBP Lemma=indicate NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=many CharacterOffsetBegin=24344 CharacterOffsetEnd=24348 PartOfSpeech=JJ Lemma=many NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=24349 CharacterOffsetEnd=24357 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=24358 CharacterOffsetEnd=24359 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=n CharacterOffsetBegin=24359 CharacterOffsetEnd=24360 PartOfSpeech=NN Lemma=n NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text== CharacterOffsetBegin=24360 CharacterOffsetEnd=24361 PartOfSpeech=JJ Lemma== NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=702 CharacterOffsetBegin=24361 CharacterOffsetEnd=24364 PartOfSpeech=CD Lemma=702 NamedEntityTag=NUMBER NormalizedNamedEntityTag=702.0 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=24364 CharacterOffsetEnd=24365 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=356 CharacterOffsetBegin=24366 CharacterOffsetEnd=24369 PartOfSpeech=CD Lemma=356 NamedEntityTag=NUMBER NormalizedNamedEntityTag=356.0 SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=24370 CharacterOffsetEnd=24372 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=each CharacterOffsetBegin=24373 CharacterOffsetEnd=24377 PartOfSpeech=DT Lemma=each NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=24378 CharacterOffsetEnd=24383 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=24383 CharacterOffsetEnd=24384 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=would CharacterOffsetBegin=24385 CharacterOffsetEnd=24390 PartOfSpeech=MD Lemma=would NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=be CharacterOffsetBegin=24391 CharacterOffsetEnd=24393 PartOfSpeech=VB Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=needed CharacterOffsetBegin=24394 CharacterOffsetEnd=24400 PartOfSpeech=VBN Lemma=need NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=to CharacterOffsetBegin=24401 CharacterOffsetEnd=24403 PartOfSpeech=TO Lemma=to NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=compare CharacterOffsetBegin=24404 CharacterOffsetEnd=24411 PartOfSpeech=VB Lemma=compare NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24412 CharacterOffsetEnd=24415 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antiedema CharacterOffsetBegin=24416 CharacterOffsetEnd=24425 PartOfSpeech=NN Lemma=antiedema NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=efficacy CharacterOffsetBegin=24426 CharacterOffsetEnd=24434 PartOfSpeech=NN Lemma=efficacy NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=24435 CharacterOffsetEnd=24437 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24438 CharacterOffsetEnd=24441 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin CharacterOffsetBegin=24442 CharacterOffsetEnd=24453 PartOfSpeech=NN Lemma=angiotensin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=converting CharacterOffsetBegin=24454 CharacterOffsetEnd=24464 PartOfSpeech=VBG Lemma=convert NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=24465 CharacterOffsetEnd=24471 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitor CharacterOffsetBegin=24472 CharacterOffsetEnd=24481 PartOfSpeech=NN Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=24482 CharacterOffsetEnd=24485 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24486 CharacterOffsetEnd=24489 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=thiazide CharacterOffsetBegin=24490 CharacterOffsetEnd=24498 PartOfSpeech=JJ Lemma=thiazide NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diuretic CharacterOffsetBegin=24499 CharacterOffsetEnd=24507 PartOfSpeech=JJ Lemma=diuretic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=24507 CharacterOffsetEnd=24508 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (PP (JJ Due) (TO to)\n",
      "      (NP\n",
      "        (NP (DT the) (JJ inherent) (JJ daily) (NN variability))\n",
      "        (PP (IN of)\n",
      "          (NP (JJR lower) (NN extremity) (NN edema)))))\n",
      "    (, ,)\n",
      "    (NP (NN power) (NNS calculations))\n",
      "    (VP (VBP indicate)\n",
      "      (SBAR\n",
      "        (S\n",
      "          (NP\n",
      "            (NP (JJ many) (NNS patients))\n",
      "            (PRN (-LRB- -LRB-)\n",
      "              (NP\n",
      "                (NP (NN n))\n",
      "                (NP\n",
      "                  (NP (JJ =) (CD 702))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (CD 356))\n",
      "                    (PP (IN in)\n",
      "                      (NP (DT each) (NN group))))))\n",
      "              (-RRB- -RRB-)))\n",
      "          (VP (MD would)\n",
      "            (VP (VB be)\n",
      "              (VP (VBN needed)\n",
      "                (S\n",
      "                  (VP (TO to)\n",
      "                    (VP (VB compare)\n",
      "                      (NP\n",
      "                        (NP (DT the) (NN antiedema) (NN efficacy))\n",
      "                        (PP (IN of)\n",
      "                          (NP\n",
      "                            (NP (DT the) (NN angiotensin))\n",
      "                            (VP (VBG converting)\n",
      "                              (NP\n",
      "                                (NP (NN enzyme) (NN inhibitor))\n",
      "                                (CC and)\n",
      "                                (NP (DT the) (JJ thiazide) (JJ diuretic))))))))))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, indicate-14)\n",
      "case(variability-6, Due-1)\n",
      "mwe(Due-1, to-2)\n",
      "det(variability-6, the-3)\n",
      "amod(variability-6, inherent-4)\n",
      "amod(variability-6, daily-5)\n",
      "nmod:due_to(indicate-14, variability-6)\n",
      "case(edema-10, of-7)\n",
      "amod(edema-10, lower-8)\n",
      "compound(edema-10, extremity-9)\n",
      "nmod:of(variability-6, edema-10)\n",
      "punct(indicate-14, ,-11)\n",
      "compound(calculations-13, power-12)\n",
      "nsubj(indicate-14, calculations-13)\n",
      "amod(patients-16, many-15)\n",
      "nsubjpass(needed-29, patients-16)\n",
      "nsubj:xsubj(compare-31, patients-16)\n",
      "punct(n-18, -LRB--17)\n",
      "dep(patients-16, n-18)\n",
      "amod(702-20, =-19)\n",
      "dep(n-18, 702-20)\n",
      "punct(702-20, ,-21)\n",
      "appos(702-20, 356-22)\n",
      "case(group-25, in-23)\n",
      "det(group-25, each-24)\n",
      "nmod:in(356-22, group-25)\n",
      "punct(n-18, -RRB--26)\n",
      "aux(needed-29, would-27)\n",
      "auxpass(needed-29, be-28)\n",
      "ccomp(indicate-14, needed-29)\n",
      "mark(compare-31, to-30)\n",
      "xcomp(needed-29, compare-31)\n",
      "det(efficacy-34, the-32)\n",
      "compound(efficacy-34, antiedema-33)\n",
      "dobj(compare-31, efficacy-34)\n",
      "case(angiotensin-37, of-35)\n",
      "det(angiotensin-37, the-36)\n",
      "nmod:of(efficacy-34, angiotensin-37)\n",
      "acl(angiotensin-37, converting-38)\n",
      "compound(inhibitor-40, enzyme-39)\n",
      "dobj(converting-38, inhibitor-40)\n",
      "cc(inhibitor-40, and-41)\n",
      "det(diuretic-44, the-42)\n",
      "amod(diuretic-44, thiazide-43)\n",
      "dobj(converting-38, diuretic-44)\n",
      "conj:and(inhibitor-40, diuretic-44)\n",
      "punct(indicate-14, .-45)\n",
      "\n",
      "Sentence #165 (19 tokens, sentiment: Negative):\n",
      "Prescribing trends and the cost of antihypertensive drugs were studied in 300 patients attending an internal medicine clinic.\n",
      "[Text=Prescribing CharacterOffsetBegin=24510 CharacterOffsetEnd=24521 PartOfSpeech=VBG Lemma=prescribe NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=trends CharacterOffsetBegin=24522 CharacterOffsetEnd=24528 PartOfSpeech=NNS Lemma=trend NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=24529 CharacterOffsetEnd=24532 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24533 CharacterOffsetEnd=24536 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=cost CharacterOffsetBegin=24537 CharacterOffsetEnd=24541 PartOfSpeech=NN Lemma=cost NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=24542 CharacterOffsetEnd=24544 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antihypertensive CharacterOffsetBegin=24545 CharacterOffsetEnd=24561 PartOfSpeech=JJ Lemma=antihypertensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=24562 CharacterOffsetEnd=24567 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=24568 CharacterOffsetEnd=24572 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=studied CharacterOffsetBegin=24573 CharacterOffsetEnd=24580 PartOfSpeech=VBN Lemma=study NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=24581 CharacterOffsetEnd=24583 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=300 CharacterOffsetBegin=24584 CharacterOffsetEnd=24587 PartOfSpeech=CD Lemma=300 NamedEntityTag=NUMBER NormalizedNamedEntityTag=300.0 SentimentClass=Neutral]\n",
      "[Text=patients CharacterOffsetBegin=24588 CharacterOffsetEnd=24596 PartOfSpeech=NNS Lemma=patient NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=attending CharacterOffsetBegin=24597 CharacterOffsetEnd=24606 PartOfSpeech=VBG Lemma=attend NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=an CharacterOffsetBegin=24607 CharacterOffsetEnd=24609 PartOfSpeech=DT Lemma=a NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=internal CharacterOffsetBegin=24610 CharacterOffsetEnd=24618 PartOfSpeech=JJ Lemma=internal NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=medicine CharacterOffsetBegin=24619 CharacterOffsetEnd=24627 PartOfSpeech=NN Lemma=medicine NamedEntityTag=O SentimentClass=Positive]\n",
      "[Text=clinic CharacterOffsetBegin=24628 CharacterOffsetEnd=24634 PartOfSpeech=NN Lemma=clinic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=24634 CharacterOffsetEnd=24635 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP (VBG Prescribing) (NNS trends))\n",
      "      (CC and)\n",
      "      (NP\n",
      "        (NP (DT the) (NN cost))\n",
      "        (PP (IN of)\n",
      "          (NP (JJ antihypertensive) (NNS drugs)))))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN studied)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (CD 300) (NNS patients))\n",
      "            (VP (VBG attending)\n",
      "              (NP (DT an) (JJ internal) (NN medicine) (NN clinic)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, studied-10)\n",
      "amod(trends-2, Prescribing-1)\n",
      "nsubjpass(studied-10, trends-2)\n",
      "cc(trends-2, and-3)\n",
      "det(cost-5, the-4)\n",
      "conj:and(trends-2, cost-5)\n",
      "nsubjpass(studied-10, cost-5)\n",
      "case(drugs-8, of-6)\n",
      "amod(drugs-8, antihypertensive-7)\n",
      "nmod:of(cost-5, drugs-8)\n",
      "auxpass(studied-10, were-9)\n",
      "case(patients-13, in-11)\n",
      "nummod(patients-13, 300-12)\n",
      "nmod:in(studied-10, patients-13)\n",
      "acl(patients-13, attending-14)\n",
      "det(clinic-18, an-15)\n",
      "amod(clinic-18, internal-16)\n",
      "compound(clinic-18, medicine-17)\n",
      "dobj(attending-14, clinic-18)\n",
      "punct(studied-10, .-19)\n",
      "\n",
      "Sentence #166 (31 tokens, sentiment: Negative):\n",
      "Beta-blockers were the most frequently used group of drugs (46.7%), followed by calcium-channel antagonists (34.3%) and angiotensin-converting enzyme inhibitors (30%).\n",
      "[Text=Beta-blockers CharacterOffsetBegin=24636 CharacterOffsetEnd=24649 PartOfSpeech=NNS Lemma=beta-blocker NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=24650 CharacterOffsetEnd=24654 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24655 CharacterOffsetEnd=24658 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=most CharacterOffsetBegin=24659 CharacterOffsetEnd=24663 PartOfSpeech=RBS Lemma=most NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=frequently CharacterOffsetBegin=24664 CharacterOffsetEnd=24674 PartOfSpeech=RB Lemma=frequently NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=24675 CharacterOffsetEnd=24679 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=group CharacterOffsetBegin=24680 CharacterOffsetEnd=24685 PartOfSpeech=NN Lemma=group NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=24686 CharacterOffsetEnd=24688 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=24689 CharacterOffsetEnd=24694 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=24695 CharacterOffsetEnd=24696 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=46.7 CharacterOffsetBegin=24696 CharacterOffsetEnd=24700 PartOfSpeech=CD Lemma=46.7 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%46.7 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=24700 CharacterOffsetEnd=24701 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%46.7 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=24701 CharacterOffsetEnd=24702 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=24702 CharacterOffsetEnd=24703 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=followed CharacterOffsetBegin=24704 CharacterOffsetEnd=24712 PartOfSpeech=VBN Lemma=follow NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=by CharacterOffsetBegin=24713 CharacterOffsetEnd=24715 PartOfSpeech=IN Lemma=by NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=calcium-channel CharacterOffsetBegin=24716 CharacterOffsetEnd=24731 PartOfSpeech=JJ Lemma=calcium-channel NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=antagonists CharacterOffsetBegin=24732 CharacterOffsetEnd=24743 PartOfSpeech=NNS Lemma=antagonist NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=24744 CharacterOffsetEnd=24745 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=34.3 CharacterOffsetBegin=24745 CharacterOffsetEnd=24749 PartOfSpeech=CD Lemma=34.3 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%34.3 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=24749 CharacterOffsetEnd=24750 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%34.3 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=24750 CharacterOffsetEnd=24751 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=24752 CharacterOffsetEnd=24755 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=angiotensin-converting CharacterOffsetBegin=24756 CharacterOffsetEnd=24778 PartOfSpeech=JJ Lemma=angiotensin-converting NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enzyme CharacterOffsetBegin=24779 CharacterOffsetEnd=24785 PartOfSpeech=NN Lemma=enzyme NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=inhibitors CharacterOffsetBegin=24786 CharacterOffsetEnd=24796 PartOfSpeech=NNS Lemma=inhibitor NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=24797 CharacterOffsetEnd=24798 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=30 CharacterOffsetBegin=24798 CharacterOffsetEnd=24800 PartOfSpeech=CD Lemma=30 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%30.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=24800 CharacterOffsetEnd=24801 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%30.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=24801 CharacterOffsetEnd=24802 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=24802 CharacterOffsetEnd=24803 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS Beta-blockers))\n",
      "    (VP (VBD were)\n",
      "      (NP\n",
      "        (NP (DT the)\n",
      "          (ADJP\n",
      "            (ADVP (RBS most) (RB frequently))\n",
      "            (VBN used))\n",
      "          (NN group))\n",
      "        (PP (IN of)\n",
      "          (NP\n",
      "            (NP\n",
      "              (NP (NNS drugs))\n",
      "              (PRN (-LRB- -LRB-)\n",
      "                (NP (CD 46.7) (NN %))\n",
      "                (-RRB- -RRB-)))\n",
      "            (, ,)\n",
      "            (VP (VBN followed)\n",
      "              (PP (IN by)\n",
      "                (NP\n",
      "                  (NP (JJ calcium-channel) (NNS antagonists))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (CD 34.3) (NN %))\n",
      "                    (-RRB- -RRB-))\n",
      "                  (CC and)\n",
      "                  (NP (JJ angiotensin-converting) (NN enzyme) (NNS inhibitors))\n",
      "                  (PRN (-LRB- -LRB-)\n",
      "                    (NP (CD 30) (NN %))\n",
      "                    (-RRB- -RRB-)))))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, group-7)\n",
      "nsubj(group-7, Beta-blockers-1)\n",
      "cop(group-7, were-2)\n",
      "det(group-7, the-3)\n",
      "advmod(frequently-5, most-4)\n",
      "advmod(used-6, frequently-5)\n",
      "amod(group-7, used-6)\n",
      "case(drugs-9, of-8)\n",
      "nmod:of(group-7, drugs-9)\n",
      "punct(%-12, -LRB--10)\n",
      "nummod(%-12, 46.7-11)\n",
      "appos(drugs-9, %-12)\n",
      "punct(%-12, -RRB--13)\n",
      "punct(drugs-9, ,-14)\n",
      "acl(drugs-9, followed-15)\n",
      "case(antagonists-18, by-16)\n",
      "amod(antagonists-18, calcium-channel-17)\n",
      "nmod:by(followed-15, antagonists-18)\n",
      "punct(%-21, -LRB--19)\n",
      "nummod(%-21, 34.3-20)\n",
      "appos(antagonists-18, %-21)\n",
      "punct(%-21, -RRB--22)\n",
      "cc(antagonists-18, and-23)\n",
      "amod(inhibitors-26, angiotensin-converting-24)\n",
      "compound(inhibitors-26, enzyme-25)\n",
      "nmod:by(followed-15, inhibitors-26)\n",
      "conj:and(antagonists-18, inhibitors-26)\n",
      "punct(%-29, -LRB--27)\n",
      "nummod(%-29, 30-28)\n",
      "appos(antagonists-18, %-29)\n",
      "punct(%-29, -RRB--30)\n",
      "punct(group-7, .-31)\n",
      "\n",
      "Sentence #167 (11 tokens, sentiment: Negative):\n",
      "Diuretics were used in only 13.2% of the prescriptions.\n",
      "[Text=Diuretics CharacterOffsetBegin=24804 CharacterOffsetEnd=24813 PartOfSpeech=NNS Lemma=diuretic NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=24814 CharacterOffsetEnd=24818 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=24819 CharacterOffsetEnd=24823 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=24824 CharacterOffsetEnd=24826 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=only CharacterOffsetBegin=24827 CharacterOffsetEnd=24831 PartOfSpeech=RB Lemma=only NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=13.2 CharacterOffsetBegin=24832 CharacterOffsetEnd=24836 PartOfSpeech=CD Lemma=13.2 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%13.2 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=24836 CharacterOffsetEnd=24837 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%13.2 SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=24838 CharacterOffsetEnd=24840 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24841 CharacterOffsetEnd=24844 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=prescriptions CharacterOffsetBegin=24845 CharacterOffsetEnd=24858 PartOfSpeech=NNS Lemma=prescription NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=24858 CharacterOffsetEnd=24859 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NNS Diuretics))\n",
      "    (VP (VBD were)\n",
      "      (VP (VBN used)\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP\n",
      "              (QP (RB only) (CD 13.2))\n",
      "              (NN %))\n",
      "            (PP (IN of)\n",
      "              (NP (DT the) (NNS prescriptions)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, used-3)\n",
      "nsubjpass(used-3, Diuretics-1)\n",
      "auxpass(used-3, were-2)\n",
      "case(%-7, in-4)\n",
      "advmod(13.2-6, only-5)\n",
      "nummod(%-7, 13.2-6)\n",
      "nmod:in(used-3, %-7)\n",
      "case(prescriptions-10, of-8)\n",
      "det(prescriptions-10, the-9)\n",
      "nmod:of(%-7, prescriptions-10)\n",
      "punct(used-3, .-11)\n",
      "\n",
      "Sentence #168 (25 tokens, sentiment: Negative):\n",
      "Atenolol (36%), amlodipine (29.3%) and enalapril (19%) were the most frequently used individual drugs.\n",
      "[Text=Atenolol CharacterOffsetBegin=24860 CharacterOffsetEnd=24868 PartOfSpeech=NNP Lemma=Atenolol NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=24869 CharacterOffsetEnd=24870 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=36 CharacterOffsetBegin=24870 CharacterOffsetEnd=24872 PartOfSpeech=CD Lemma=36 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%36.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=24872 CharacterOffsetEnd=24873 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%36.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=24873 CharacterOffsetEnd=24874 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=24874 CharacterOffsetEnd=24875 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=24876 CharacterOffsetEnd=24886 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=24887 CharacterOffsetEnd=24888 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=29.3 CharacterOffsetBegin=24888 CharacterOffsetEnd=24892 PartOfSpeech=CD Lemma=29.3 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%29.3 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=24892 CharacterOffsetEnd=24893 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%29.3 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=24893 CharacterOffsetEnd=24894 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=24895 CharacterOffsetEnd=24898 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=enalapril CharacterOffsetBegin=24899 CharacterOffsetEnd=24908 PartOfSpeech=NN Lemma=enalapril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=24909 CharacterOffsetEnd=24910 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=19 CharacterOffsetBegin=24910 CharacterOffsetEnd=24912 PartOfSpeech=CD Lemma=19 NamedEntityTag=PERCENT NormalizedNamedEntityTag=%19.0 SentimentClass=Neutral]\n",
      "[Text=% CharacterOffsetBegin=24912 CharacterOffsetEnd=24913 PartOfSpeech=NN Lemma=% NamedEntityTag=PERCENT NormalizedNamedEntityTag=%19.0 SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=24913 CharacterOffsetEnd=24914 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=24915 CharacterOffsetEnd=24919 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=24920 CharacterOffsetEnd=24923 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=most CharacterOffsetBegin=24924 CharacterOffsetEnd=24928 PartOfSpeech=RBS Lemma=most NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=frequently CharacterOffsetBegin=24929 CharacterOffsetEnd=24939 PartOfSpeech=RB Lemma=frequently NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=24940 CharacterOffsetEnd=24944 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=individual CharacterOffsetBegin=24945 CharacterOffsetEnd=24955 PartOfSpeech=JJ Lemma=individual NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=24956 CharacterOffsetEnd=24961 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=24961 CharacterOffsetEnd=24962 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NNP Atenolol))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD 36) (NN %))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN amlodipine))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (CD 29.3) (NN %))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (NN enalapril)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (CD 19) (NN %))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD were)\n",
      "      (ADVP (DT the) (RBS most))\n",
      "      (VP\n",
      "        (ADVP (RB frequently))\n",
      "        (VBN used)\n",
      "        (NP (JJ individual) (NNS drugs))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, used-22)\n",
      "nsubjpass(used-22, Atenolol-1)\n",
      "punct(%-4, -LRB--2)\n",
      "nummod(%-4, 36-3)\n",
      "appos(Atenolol-1, %-4)\n",
      "punct(%-4, -RRB--5)\n",
      "punct(Atenolol-1, ,-6)\n",
      "conj:and(Atenolol-1, amlodipine-7)\n",
      "nsubjpass(used-22, amlodipine-7)\n",
      "punct(%-10, -LRB--8)\n",
      "nummod(%-10, 29.3-9)\n",
      "appos(amlodipine-7, %-10)\n",
      "punct(%-10, -RRB--11)\n",
      "cc(Atenolol-1, and-12)\n",
      "conj:and(Atenolol-1, enalapril-13)\n",
      "nsubjpass(used-22, enalapril-13)\n",
      "punct(%-16, -LRB--14)\n",
      "nummod(%-16, 19-15)\n",
      "appos(Atenolol-1, %-16)\n",
      "punct(%-16, -RRB--17)\n",
      "auxpass(used-22, were-18)\n",
      "det(most-20, the-19)\n",
      "advmod(used-22, most-20)\n",
      "advmod(used-22, frequently-21)\n",
      "amod(drugs-24, individual-23)\n",
      "dobj(used-22, drugs-24)\n",
      "punct(used-22, .-25)\n",
      "\n",
      "Sentence #169 (31 tokens, sentiment: Negative):\n",
      "Propranolol, furosemide, amlodipine and atenolol were the least expensive drugs used, with annual drug acquisition costs of Rs 80, 102, 182 and 318, respectively.\n",
      "[Text=Propranolol CharacterOffsetBegin=24963 CharacterOffsetEnd=24974 PartOfSpeech=NN Lemma=propranolol NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=24974 CharacterOffsetEnd=24975 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=furosemide CharacterOffsetBegin=24976 CharacterOffsetEnd=24986 PartOfSpeech=NN Lemma=furosemide NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=24986 CharacterOffsetEnd=24987 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=amlodipine CharacterOffsetBegin=24988 CharacterOffsetEnd=24998 PartOfSpeech=NN Lemma=amlodipine NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=24999 CharacterOffsetEnd=25002 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=atenolol CharacterOffsetBegin=25003 CharacterOffsetEnd=25011 PartOfSpeech=NN Lemma=atenolol NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=25012 CharacterOffsetEnd=25016 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=25017 CharacterOffsetEnd=25020 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=least CharacterOffsetBegin=25021 CharacterOffsetEnd=25026 PartOfSpeech=JJS Lemma=least NamedEntityTag=O SentimentClass=Negative]\n",
      "[Text=expensive CharacterOffsetBegin=25027 CharacterOffsetEnd=25036 PartOfSpeech=JJ Lemma=expensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=25037 CharacterOffsetEnd=25042 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=used CharacterOffsetBegin=25043 CharacterOffsetEnd=25047 PartOfSpeech=VBN Lemma=use NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=25047 CharacterOffsetEnd=25048 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=with CharacterOffsetBegin=25049 CharacterOffsetEnd=25053 PartOfSpeech=IN Lemma=with NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=annual CharacterOffsetBegin=25054 CharacterOffsetEnd=25060 PartOfSpeech=JJ Lemma=annual NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1Y\" quant=\"EVERY\" tid=\"t40\" type=\"SET\" value=\"P1Y\">annual</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=drug CharacterOffsetBegin=25061 CharacterOffsetEnd=25065 PartOfSpeech=NN Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=acquisition CharacterOffsetBegin=25066 CharacterOffsetEnd=25077 PartOfSpeech=NN Lemma=acquisition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=costs CharacterOffsetBegin=25078 CharacterOffsetEnd=25083 PartOfSpeech=NNS Lemma=cost NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=25084 CharacterOffsetEnd=25086 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Rs CharacterOffsetBegin=25087 CharacterOffsetEnd=25089 PartOfSpeech=NN Lemma=rs NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=80 CharacterOffsetBegin=25090 CharacterOffsetEnd=25092 PartOfSpeech=CD Lemma=80 NamedEntityTag=NUMBER NormalizedNamedEntityTag=80.0 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=25092 CharacterOffsetEnd=25093 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=102 CharacterOffsetBegin=25094 CharacterOffsetEnd=25097 PartOfSpeech=CD Lemma=102 NamedEntityTag=NUMBER NormalizedNamedEntityTag=102.0 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=25097 CharacterOffsetEnd=25098 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=182 CharacterOffsetBegin=25099 CharacterOffsetEnd=25102 PartOfSpeech=CD Lemma=182 NamedEntityTag=NUMBER NormalizedNamedEntityTag=182.0 SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=25103 CharacterOffsetEnd=25106 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=318 CharacterOffsetBegin=25107 CharacterOffsetEnd=25110 PartOfSpeech=CD Lemma=318 NamedEntityTag=NUMBER NormalizedNamedEntityTag=318.0 SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=25110 CharacterOffsetEnd=25111 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=respectively CharacterOffsetBegin=25112 CharacterOffsetEnd=25124 PartOfSpeech=RB Lemma=respectively NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=25124 CharacterOffsetEnd=25125 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP (NN Propranolol) (, ,) (NN furosemide) (, ,) (NN amlodipine)\n",
      "      (CC and)\n",
      "      (NN atenolol))\n",
      "    (VP (VBD were)\n",
      "      (NP\n",
      "        (NP (DT the)\n",
      "          (ADJP (JJS least) (JJ expensive))\n",
      "          (NNS drugs))\n",
      "        (VP (VBN used) (, ,)\n",
      "          (PP (IN with)\n",
      "            (NP\n",
      "              (NP (JJ annual) (NN drug) (NN acquisition) (NNS costs))\n",
      "              (PP (IN of)\n",
      "                (NP\n",
      "                  (NP (NN Rs) (CD 80))\n",
      "                  (, ,)\n",
      "                  (NP\n",
      "                    (NP (CD 102))\n",
      "                    (, ,)\n",
      "                    (NP\n",
      "                      (QP (CD 182)\n",
      "                        (CC and)\n",
      "                        (CD 318))))))))\n",
      "          (, ,)\n",
      "          (ADVP (RB respectively)))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, drugs-12)\n",
      "nsubj(drugs-12, Propranolol-1)\n",
      "punct(Propranolol-1, ,-2)\n",
      "conj:and(Propranolol-1, furosemide-3)\n",
      "nsubj(drugs-12, furosemide-3)\n",
      "punct(Propranolol-1, ,-4)\n",
      "conj:and(Propranolol-1, amlodipine-5)\n",
      "nsubj(drugs-12, amlodipine-5)\n",
      "cc(Propranolol-1, and-6)\n",
      "conj:and(Propranolol-1, atenolol-7)\n",
      "nsubj(drugs-12, atenolol-7)\n",
      "cop(drugs-12, were-8)\n",
      "det(drugs-12, the-9)\n",
      "dep(expensive-11, least-10)\n",
      "amod(drugs-12, expensive-11)\n",
      "acl(drugs-12, used-13)\n",
      "punct(used-13, ,-14)\n",
      "case(costs-19, with-15)\n",
      "amod(costs-19, annual-16)\n",
      "compound(costs-19, drug-17)\n",
      "compound(costs-19, acquisition-18)\n",
      "nmod:with(used-13, costs-19)\n",
      "case(Rs-21, of-20)\n",
      "nmod:of(costs-19, Rs-21)\n",
      "nummod(Rs-21, 80-22)\n",
      "punct(Rs-21, ,-23)\n",
      "appos(Rs-21, 102-24)\n",
      "punct(102-24, ,-25)\n",
      "appos(102-24, 182-26)\n",
      "cc(182-26, and-27)\n",
      "appos(102-24, 318-28)\n",
      "conj:and(182-26, 318-28)\n",
      "punct(used-13, ,-29)\n",
      "advmod(used-13, respectively-30)\n",
      "punct(drugs-12, .-31)\n",
      "\n",
      "Sentence #170 (43 tokens, sentiment: Very negative):\n",
      "Benazepril (Rs 1778), diltiazem SR (Rs 1777), lisinopril (Rs 1660), prazosin (Rs 1416) and losartan (Rs 1365) were the most expensive drugs in terms of annual drug acquisition costs.\n",
      "[Text=Benazepril CharacterOffsetBegin=25126 CharacterOffsetEnd=25136 PartOfSpeech=NN Lemma=benazepril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=25137 CharacterOffsetEnd=25138 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Rs CharacterOffsetBegin=25138 CharacterOffsetEnd=25140 PartOfSpeech=NN Lemma=rs NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1778 CharacterOffsetBegin=25141 CharacterOffsetEnd=25145 PartOfSpeech=CD Lemma=1778 NamedEntityTag=DATE NormalizedNamedEntityTag=1778 Timex=<TIMEX3 tid=\"t41\" type=\"DATE\" value=\"1778\">1778</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=25145 CharacterOffsetEnd=25146 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=25146 CharacterOffsetEnd=25147 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=diltiazem CharacterOffsetBegin=25148 CharacterOffsetEnd=25157 PartOfSpeech=NN Lemma=diltiazem NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=SR CharacterOffsetBegin=25158 CharacterOffsetEnd=25160 PartOfSpeech=NN Lemma=sr NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=25161 CharacterOffsetEnd=25162 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Rs CharacterOffsetBegin=25162 CharacterOffsetEnd=25164 PartOfSpeech=NN Lemma=rs NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1777 CharacterOffsetBegin=25165 CharacterOffsetEnd=25169 PartOfSpeech=CD Lemma=1777 NamedEntityTag=DATE NormalizedNamedEntityTag=1777 Timex=<TIMEX3 tid=\"t42\" type=\"DATE\" value=\"1777\">1777</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=25169 CharacterOffsetEnd=25170 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=25170 CharacterOffsetEnd=25171 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=lisinopril CharacterOffsetBegin=25172 CharacterOffsetEnd=25182 PartOfSpeech=NN Lemma=lisinopril NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=25183 CharacterOffsetEnd=25184 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Rs CharacterOffsetBegin=25184 CharacterOffsetEnd=25186 PartOfSpeech=NN Lemma=rs NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1660 CharacterOffsetBegin=25187 CharacterOffsetEnd=25191 PartOfSpeech=CD Lemma=1660 NamedEntityTag=DATE NormalizedNamedEntityTag=1660 Timex=<TIMEX3 tid=\"t43\" type=\"DATE\" value=\"1660\">1660</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=25191 CharacterOffsetEnd=25192 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=, CharacterOffsetBegin=25192 CharacterOffsetEnd=25193 PartOfSpeech=, Lemma=, NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=prazosin CharacterOffsetBegin=25194 CharacterOffsetEnd=25202 PartOfSpeech=NN Lemma=prazosin NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=25203 CharacterOffsetEnd=25204 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Rs CharacterOffsetBegin=25204 CharacterOffsetEnd=25206 PartOfSpeech=NN Lemma=rs NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1416 CharacterOffsetBegin=25207 CharacterOffsetEnd=25211 PartOfSpeech=CD Lemma=1416 NamedEntityTag=DATE NormalizedNamedEntityTag=1416 Timex=<TIMEX3 tid=\"t44\" type=\"DATE\" value=\"1416\">1416</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=25211 CharacterOffsetEnd=25212 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=and CharacterOffsetBegin=25213 CharacterOffsetEnd=25216 PartOfSpeech=CC Lemma=and NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=losartan CharacterOffsetBegin=25217 CharacterOffsetEnd=25225 PartOfSpeech=NN Lemma=losartan NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=-LRB- CharacterOffsetBegin=25226 CharacterOffsetEnd=25227 PartOfSpeech=-LRB- Lemma=-lrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=Rs CharacterOffsetBegin=25227 CharacterOffsetEnd=25229 PartOfSpeech=NN Lemma=rs NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=1365 CharacterOffsetBegin=25230 CharacterOffsetEnd=25234 PartOfSpeech=CD Lemma=1365 NamedEntityTag=DATE NormalizedNamedEntityTag=1365 Timex=<TIMEX3 tid=\"t45\" type=\"DATE\" value=\"1365\">1365</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=-RRB- CharacterOffsetBegin=25234 CharacterOffsetEnd=25235 PartOfSpeech=-RRB- Lemma=-rrb- NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=were CharacterOffsetBegin=25236 CharacterOffsetEnd=25240 PartOfSpeech=VBD Lemma=be NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=the CharacterOffsetBegin=25241 CharacterOffsetEnd=25244 PartOfSpeech=DT Lemma=the NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=most CharacterOffsetBegin=25245 CharacterOffsetEnd=25249 PartOfSpeech=RBS Lemma=most NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=expensive CharacterOffsetBegin=25250 CharacterOffsetEnd=25259 PartOfSpeech=JJ Lemma=expensive NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=drugs CharacterOffsetBegin=25260 CharacterOffsetEnd=25265 PartOfSpeech=NNS Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=in CharacterOffsetBegin=25266 CharacterOffsetEnd=25268 PartOfSpeech=IN Lemma=in NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=terms CharacterOffsetBegin=25269 CharacterOffsetEnd=25274 PartOfSpeech=NNS Lemma=term NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=of CharacterOffsetBegin=25275 CharacterOffsetEnd=25277 PartOfSpeech=IN Lemma=of NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=annual CharacterOffsetBegin=25278 CharacterOffsetEnd=25284 PartOfSpeech=JJ Lemma=annual NamedEntityTag=SET Timex=<TIMEX3 freq=\"P1X\" periodicity=\"P1Y\" quant=\"EVERY\" tid=\"t46\" type=\"SET\" value=\"P1Y\">annual</TIMEX3> SentimentClass=Neutral]\n",
      "[Text=drug CharacterOffsetBegin=25285 CharacterOffsetEnd=25289 PartOfSpeech=NN Lemma=drug NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=acquisition CharacterOffsetBegin=25290 CharacterOffsetEnd=25301 PartOfSpeech=NN Lemma=acquisition NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=costs CharacterOffsetBegin=25302 CharacterOffsetEnd=25307 PartOfSpeech=NNS Lemma=cost NamedEntityTag=O SentimentClass=Neutral]\n",
      "[Text=. CharacterOffsetBegin=25307 CharacterOffsetEnd=25308 PartOfSpeech=. Lemma=. NamedEntityTag=O SentimentClass=Neutral]\n",
      "(ROOT\n",
      "  (S\n",
      "    (NP\n",
      "      (NP\n",
      "        (NP\n",
      "          (NP (NN Benazepril))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN Rs) (CD 1778))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN diltiazem) (NN SR))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN Rs) (CD 1777))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN lisinopril))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN Rs) (CD 1660))\n",
      "            (-RRB- -RRB-)))\n",
      "        (, ,)\n",
      "        (NP\n",
      "          (NP (NN prazosin))\n",
      "          (PRN (-LRB- -LRB-)\n",
      "            (NP (NN Rs) (CD 1416))\n",
      "            (-RRB- -RRB-)))\n",
      "        (CC and)\n",
      "        (NP (NN losartan)))\n",
      "      (PRN (-LRB- -LRB-)\n",
      "        (NP (NN Rs) (CD 1365))\n",
      "        (-RRB- -RRB-)))\n",
      "    (VP (VBD were)\n",
      "      (NP\n",
      "        (NP (DT the)\n",
      "          (ADJP (RBS most) (JJ expensive))\n",
      "          (NNS drugs))\n",
      "        (PP (IN in)\n",
      "          (NP\n",
      "            (NP (NNS terms))\n",
      "            (PP (IN of)\n",
      "              (NP (JJ annual) (NN drug) (NN acquisition) (NNS costs)))))))\n",
      "    (. .)))\n",
      "\n",
      "root(ROOT-0, drugs-35)\n",
      "nsubj(drugs-35, Benazepril-1)\n",
      "punct(Rs-3, -LRB--2)\n",
      "appos(Benazepril-1, Rs-3)\n",
      "nummod(Rs-3, 1778-4)\n",
      "punct(Rs-3, -RRB--5)\n",
      "punct(Benazepril-1, ,-6)\n",
      "compound(SR-8, diltiazem-7)\n",
      "conj:and(Benazepril-1, SR-8)\n",
      "nsubj(drugs-35, SR-8)\n",
      "punct(Rs-10, -LRB--9)\n",
      "appos(SR-8, Rs-10)\n",
      "nummod(Rs-10, 1777-11)\n",
      "punct(Rs-10, -RRB--12)\n",
      "punct(Benazepril-1, ,-13)\n",
      "conj:and(Benazepril-1, lisinopril-14)\n",
      "nsubj(drugs-35, lisinopril-14)\n",
      "punct(Rs-16, -LRB--15)\n",
      "appos(lisinopril-14, Rs-16)\n",
      "nummod(Rs-16, 1660-17)\n",
      "punct(Rs-16, -RRB--18)\n",
      "punct(Benazepril-1, ,-19)\n",
      "conj:and(Benazepril-1, prazosin-20)\n",
      "nsubj(drugs-35, prazosin-20)\n",
      "punct(Rs-22, -LRB--21)\n",
      "appos(prazosin-20, Rs-22)\n",
      "nummod(Rs-22, 1416-23)\n",
      "punct(Rs-22, -RRB--24)\n",
      "cc(Benazepril-1, and-25)\n",
      "conj:and(Benazepril-1, losartan-26)\n",
      "nsubj(drugs-35, losartan-26)\n",
      "punct(Rs-28, -LRB--27)\n",
      "appos(Benazepril-1, Rs-28)\n",
      "nummod(Rs-28, 1365-29)\n",
      "punct(Rs-28, -RRB--30)\n",
      "cop(drugs-35, were-31)\n",
      "det(drugs-35, the-32)\n",
      "advmod(expensive-34, most-33)\n",
      "amod(drugs-35, expensive-34)\n",
      "case(terms-37, in-36)\n",
      "nmod:in(drugs-35, terms-37)\n",
      "case(costs-42, of-38)\n",
      "amod(costs-42, annual-39)\n",
      "compound(costs-42, drug-40)\n",
      "compound(costs-42, acquisition-41)\n",
      "nmod:of(terms-37, costs-42)\n",
      "punct(drugs-35, .-43)\n",
      "\n",
      "Coreference set:\n",
      "\t(13,3,[3,4]) -> (1,20,[20,21]), that is: \"II\" -> \"II\"\n",
      "\t(21,18,[18,19]) -> (1,20,[20,21]), that is: \"II\" -> \"II\"\n",
      "Coreference set:\n",
      "\t(21,20,[20,21]) -> (1,22,[22,23]), that is: \"1\" -> \"1\"\n",
      "\t(62,4,[4,5]) -> (1,22,[22,23]), that is: \"1\" -> \"1\"\n",
      "\t(81,42,[42,43]) -> (1,22,[22,23]), that is: \"1\" -> \"1\"\n",
      "\t(158,71,[71,72]) -> (1,22,[22,23]), that is: \"1\" -> \"1\"\n",
      "Coreference set:\n",
      "\t(13,2,[2,4]) -> (1,19,[19,29]), that is: \"angiotensin II\" -> \"angiotensin II type 1 receptor blocker -LRB- ARB -RRB- compounds\"\n",
      "Coreference set:\n",
      "\t(3,19,[18,20]) -> (2,13,[12,14]), that is: \"matrix degradation\" -> \"matrix degradation\"\n",
      "\t(5,14,[13,15]) -> (2,13,[12,14]), that is: \"matrix degradation\" -> \"matrix degradation\"\n",
      "Coreference set:\n",
      "\t(8,7,[6,8]) -> (3,3,[2,4]), that is: \"this study\" -> \"this study\"\n",
      "\t(12,3,[2,4]) -> (3,3,[2,4]), that is: \"the study\" -> \"this study\"\n",
      "\t(37,2,[1,3]) -> (3,3,[2,4]), that is: \"The study\" -> \"this study\"\n",
      "\t(37,5,[4,14]) -> (3,3,[2,4]), that is: \"a prospective , randomized , double-blinded , placebo-controlled clinical trial\" -> \"this study\"\n",
      "\t(37,5,[4,6]) -> (3,3,[2,4]), that is: \"a prospective\" -> \"this study\"\n",
      "\t(73,2,[1,3]) -> (3,3,[2,4]), that is: \"This study\" -> \"this study\"\n",
      "\t(77,5,[4,6]) -> (3,3,[2,4]), that is: \"the study\" -> \"this study\"\n",
      "\t(85,14,[13,15]) -> (3,3,[2,4]), that is: \"this study\" -> \"this study\"\n",
      "\t(112,11,[10,12]) -> (3,3,[2,4]), that is: \"the study\" -> \"this study\"\n",
      "Coreference set:\n",
      "\t(4,23,[22,24]) -> (3,22,[21,23]), that is: \"the kidney\" -> \"the kidney\"\n",
      "\t(6,23,[22,33]) -> (3,22,[21,23]), that is: \"the kidney , whereas CGP-48933 , an ARB , did not\" -> \"the kidney\"\n",
      "\t(6,23,[22,24]) -> (3,22,[21,23]), that is: \"the kidney\" -> \"the kidney\"\n",
      "\t(46,34,[33,35]) -> (3,22,[21,23]), that is: \"the kidney\" -> \"the kidney\"\n",
      "Coreference set:\n",
      "\t(6,1,[1,5]) -> (146,29,[28,30]), that is: \"Benazepril , an ACEi\" -> \"C. Benazepril\"\n",
      "\t(6,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(32,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(33,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(41,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(45,16,[16,17]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(47,8,[8,9]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(50,11,[11,17]) -> (146,29,[28,30]), that is: \"Benazepril , the over-expression level de-creased\" -> \"C. Benazepril\"\n",
      "\t(50,11,[11,12]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(51,11,[11,12]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(53,9,[9,10]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(80,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(109,8,[8,9]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(111,10,[10,11]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(113,5,[5,6]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(118,4,[4,5]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(137,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(139,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(141,23,[23,24]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(143,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(144,8,[8,9]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "\t(146,70,[69,71]) -> (146,29,[28,30]), that is: \"C. Benazeprilat\" -> \"C. Benazepril\"\n",
      "\t(162,1,[1,2]) -> (146,29,[28,30]), that is: \"Benazepril\" -> \"C. Benazepril\"\n",
      "Coreference set:\n",
      "\t(10,7,[7,8]) -> (6,4,[3,5]), that is: \"ACEi\" -> \"an ACEi\"\n",
      "Coreference set:\n",
      "\t(7,24,[22,25]) -> (6,20,[18,33]), that is: \"tubular epithelial cells\" -> \"tubular epithelial cells in the kidney , whereas CGP-48933 , an ARB , did not\"\n",
      "\t(30,15,[14,16]) -> (6,20,[18,33]), that is: \"kidney cells\" -> \"tubular epithelial cells in the kidney , whereas CGP-48933 , an ARB , did not\"\n",
      "Coreference set:\n",
      "\t(7,10,[9,11]) -> (7,14,[12,18]), that is: \"ACE blockade\" -> \"plasminogen activator inhibitor-1 -LRB- PAI-1 -RRB-\"\n",
      "Coreference set:\n",
      "\t(7,33,[33,37]) -> (11,1,[1,2]), that is: \"plasmin by plasminogen activator\" -> \"Plasmin\"\n",
      "\t(11,5,[3,12]) -> (11,1,[1,2]), that is: \"an important factor in the degradation of extracellular matrix\" -> \"Plasmin\"\n",
      "Coreference set:\n",
      "\t(13,43,[43,44]) -> (12,44,[44,45]), that is: \"IV\" -> \"IV\"\n",
      "\t(15,24,[24,25]) -> (12,44,[44,45]), that is: \"IV\" -> \"IV\"\n",
      "\t(17,18,[18,19]) -> (12,44,[44,45]), that is: \"IV\" -> \"IV\"\n",
      "\t(19,16,[16,17]) -> (12,44,[44,45]), that is: \"IV\" -> \"IV\"\n",
      "\t(142,11,[11,12]) -> (12,44,[44,45]), that is: \"IV\" -> \"IV\"\n",
      "\t(143,9,[9,10]) -> (12,44,[44,45]), that is: \"IV\" -> \"IV\"\n",
      "Coreference set:\n",
      "\t(13,14,[14,15]) -> (12,6,[6,7]), that is: \"we\" -> \"we\"\n",
      "\t(15,1,[1,2]) -> (12,6,[6,7]), that is: \"We\" -> \"we\"\n",
      "\t(16,5,[5,6]) -> (12,6,[6,7]), that is: \"we\" -> \"we\"\n",
      "Coreference set:\n",
      "\t(12,45,[44,46]) -> (12,49,[47,63]), that is: \"IV collagen\" -> \"a major component of extracellular matrix , in the renal tissue of rats with streptozotocin-induced diabetes\"\n",
      "Coreference set:\n",
      "\t(13,28,[27,46]) -> (19,18,[15,19]), that is: \"the expression of PAI-1 , uPA , and uPAR messenger RNAs -LRB- mRNAs -RRB- and type IV collagen protein\" -> \"type IV collagen expression\"\n",
      "\t(17,7,[7,23]) -> (19,18,[15,19]), that is: \"expression of PAI-1 , uPA , and uPAR mRNAs and type IV collagen protein , mainly\" -> \"type IV collagen expression\"\n",
      "Coreference set:\n",
      "\t(15,4,[3,13]) -> (13,28,[27,41]), that is: \"the expression of PAI-1 , uPA , and uPAR mRNAs\" -> \"the expression of PAI-1 , uPA , and uPAR messenger RNAs -LRB- mRNAs -RRB-\"\n",
      "\t(17,7,[7,16]) -> (13,28,[27,41]), that is: \"expression of PAI-1 , uPA , and uPAR mRNAs\" -> \"the expression of PAI-1 , uPA , and uPAR messenger RNAs -LRB- mRNAs -RRB-\"\n",
      "Coreference set:\n",
      "\t(17,20,[17,23]) -> (13,45,[42,46]), that is: \"type IV collagen protein , mainly\" -> \"type IV collagen protein\"\n",
      "\t(17,20,[17,21]) -> (13,45,[42,46]), that is: \"type IV collagen protein\" -> \"type IV collagen protein\"\n",
      "Coreference set:\n",
      "\t(78,34,[34,35]) -> (14,19,[19,20]), that is: \"4\" -> \"4\"\n",
      "\t(81,61,[61,62]) -> (14,19,[19,20]), that is: \"4\" -> \"4\"\n",
      "\t(161,23,[23,24]) -> (14,19,[19,20]), that is: \"4\" -> \"4\"\n",
      "Coreference set:\n",
      "\t(14,1,[1,16]) -> (16,3,[2,4]), that is: \"Rats with streptozocin-induced diabetes-some untreated and some treated with 30 mg/L benazepril-and nondiabetic control rats\" -> \"control rats\"\n",
      "Coreference set:\n",
      "\t(14,27,[27,30]) -> (89,17,[16,18]), that is: \"induction of diabetes\" -> \"the induction\"\n",
      "Coreference set:\n",
      "\t(15,12,[6,13]) -> (18,2,[1,3]), that is: \"PAI-1 , uPA , and uPAR mRNAs\" -> \"These mRNAs\"\n",
      "\t(16,16,[10,17]) -> (18,2,[1,3]), that is: \"PAI-1 , uPA , and uPAR mRNAs\" -> \"These mRNAs\"\n",
      "\t(17,15,[9,16]) -> (18,2,[1,3]), that is: \"PAI-1 , uPA , and uPAR mRNAs\" -> \"These mRNAs\"\n",
      "Coreference set:\n",
      "\t(21,42,[42,43]) -> (17,2,[1,3]), that is: \"rats\" -> \"Diabetic rats\"\n",
      "Coreference set:\n",
      "\t(18,10,[10,11]) -> (18,16,[15,17]), that is: \"epithelial\" -> \"endothelial cells\"\n",
      "\t(18,16,[15,21]) -> (18,16,[15,17]), that is: \"endothelial cells and Bowman 's capsule\" -> \"endothelial cells\"\n",
      "Coreference set:\n",
      "\t(23,16,[16,17]) -> (19,6,[6,7]), that is: \"3\" -> \"3\"\n",
      "\t(158,68,[68,69]) -> (19,6,[6,7]), that is: \"3\" -> \"3\"\n",
      "Coreference set:\n",
      "\t(27,2,[1,3]) -> (20,2,[1,3]), that is: \"The results\" -> \"Our results\"\n",
      "Coreference set:\n",
      "\t(29,3,[1,8]) -> (21,6,[4,47]), that is: \"The combined use of benazepril and valsartan\" -> \"the combined use of angiotensin converting enzyme inhibitor -LRB- ACEI -RRB- benazepril and angiotensin II type 1 receptor antagonist -LRB- AT1RA -RRB- valsartan on apoptosis and the expression of apoptosis-related proteins Fas and FasL in the kidney of rats with adriamycin-induced nephritic glomerulosclerosis\"\n",
      "\t(31,3,[1,8]) -> (21,6,[4,47]), that is: \"The combined use of benazepril and valsartan\" -> \"the combined use of angiotensin converting enzyme inhibitor -LRB- ACEI -RRB- benazepril and angiotensin II type 1 receptor antagonist -LRB- AT1RA -RRB- valsartan on apoptosis and the expression of apoptosis-related proteins Fas and FasL in the kidney of rats with adriamycin-induced nephritic glomerulosclerosis\"\n",
      "Coreference set:\n",
      "\t(21,8,[8,47]) -> (92,2,[1,5]), that is: \"angiotensin converting enzyme inhibitor -LRB- ACEI -RRB- benazepril and angiotensin II type 1 receptor antagonist -LRB- AT1RA -RRB- valsartan on apoptosis and the expression of apoptosis-related proteins Fas and FasL in the kidney of rats with adriamycin-induced nephritic glomerulosclerosis\" -> \"The angiotensin converting enzyme\"\n",
      "Coreference set:\n",
      "\t(74,24,[24,27]) -> (21,26,[20,29]), that is: \"valsartan once daily\" -> \"1 receptor antagonist -LRB- AT1RA -RRB- valsartan on apoptosis\"\n",
      "Coreference set:\n",
      "\t(25,9,[9,12]) -> (21,35,[35,43]), that is: \"Fas and FasL\" -> \"Fas and FasL in the kidney of rats\"\n",
      "\t(26,9,[9,12]) -> (21,35,[35,43]), that is: \"Fas and FasL\" -> \"Fas and FasL in the kidney of rats\"\n",
      "\t(27,35,[35,38]) -> (21,35,[35,43]), that is: \"Fas and FasL\" -> \"Fas and FasL in the kidney of rats\"\n",
      "\t(28,17,[17,20]) -> (21,35,[35,43]), that is: \"Fas and FasL\" -> \"Fas and FasL in the kidney of rats\"\n",
      "Coreference set:\n",
      "\t(81,32,[32,33]) -> (23,3,[3,4]), that is: \"6\" -> \"6\"\n",
      "Coreference set:\n",
      "\t(23,22,[22,23]) -> (23,9,[9,10]), that is: \"20\" -> \"20\"\n",
      "\t(74,14,[14,15]) -> (23,9,[9,10]), that is: \"20\" -> \"20\"\n",
      "\t(74,32,[32,33]) -> (23,9,[9,10]), that is: \"20\" -> \"20\"\n",
      "\t(156,24,[24,25]) -> (23,9,[9,10]), that is: \"20\" -> \"20\"\n",
      "\t(158,58,[58,59]) -> (23,9,[9,10]), that is: \"20\" -> \"20\"\n",
      "Coreference set:\n",
      "\t(23,23,[22,24]) -> (23,10,[9,11]), that is: \"20 mg/kg\" -> \"20 mg/kg\"\n",
      "Coreference set:\n",
      "\t(89,22,[21,23]) -> (23,40,[39,41]), that is: \"12 weeks\" -> \"12 weeks\"\n",
      "Coreference set:\n",
      "\t(90,5,[5,17]) -> (24,5,[5,17]), that is: \"means of terminal-deoxynucleotidyl transferase mediated d-UTP nick end labeling -LRB- TUNEL -RRB-\" -> \"means of terminal-deoxynucleotidyl transferase mediated d-UTP nick end labeling -LRB- TUNEL -RRB-\"\n",
      "Coreference set:\n",
      "\t(90,13,[10,17]) -> (24,13,[10,17]), that is: \"d-UTP nick end labeling -LRB- TUNEL -RRB-\" -> \"d-UTP nick end labeling -LRB- TUNEL -RRB-\"\n",
      "Coreference set:\n",
      "\t(28,15,[15,20]) -> (25,7,[6,12]), that is: \"expression of Fas and FasL\" -> \"the expression of Fas and FasL\"\n",
      "Coreference set:\n",
      "\t(29,5,[5,8]) -> (28,23,[23,26]), that is: \"benazepril and valsartan\" -> \"benazepril and valsartan\"\n",
      "\t(30,5,[5,8]) -> (28,23,[23,26]), that is: \"benazepril and valsartan\" -> \"benazepril and valsartan\"\n",
      "\t(31,5,[5,8]) -> (28,23,[23,26]), that is: \"benazepril and valsartan\" -> \"benazepril and valsartan\"\n",
      "\t(80,1,[1,4]) -> (28,23,[23,26]), that is: \"Benazepril and valsartan\" -> \"benazepril and valsartan\"\n",
      "\t(81,49,[49,54]) -> (28,23,[23,26]), that is: \"benazepril and valsartan , respectively\" -> \"benazepril and valsartan\"\n",
      "\t(81,49,[49,52]) -> (28,23,[23,26]), that is: \"benazepril and valsartan\" -> \"benazepril and valsartan\"\n",
      "Coreference set:\n",
      "\t(104,20,[19,21]) -> (32,10,[9,11]), that is: \"hypertensive patients\" -> \"hypertensive patients\"\n",
      "Coreference set:\n",
      "\t(34,2,[1,3]) -> (34,7,[4,8]), that is: \"Benazepril hydrochloride\" -> \"an angiotensin-converting enzyme inhibitor\"\n",
      "\t(145,26,[25,27]) -> (34,7,[4,8]), that is: \"benazepril hydrochloride\" -> \"an angiotensin-converting enzyme inhibitor\"\n",
      "\t(146,9,[8,10]) -> (34,7,[4,8]), that is: \"benazepril hydrochloride\" -> \"an angiotensin-converting enzyme inhibitor\"\n",
      "\t(146,30,[28,31]) -> (34,7,[4,8]), that is: \"C. Benazepril hydrochloride\" -> \"an angiotensin-converting enzyme inhibitor\"\n",
      "\t(163,11,[10,12]) -> (34,7,[4,8]), that is: \"enzyme inhibitor\" -> \"an angiotensin-converting enzyme inhibitor\"\n",
      "\t(164,40,[39,41]) -> (34,7,[4,8]), that is: \"enzyme inhibitor\" -> \"an angiotensin-converting enzyme inhibitor\"\n",
      "Coreference set:\n",
      "\t(102,25,[24,26]) -> (38,17,[14,32]), that is: \"heart failure\" -> \"class II-IV heart failure caused by chronic valvular disease -LRB- CVD -RRB- or dilated cardiomyopathy -LRB- DCM -RRB-\"\n",
      "\t(102,45,[44,46]) -> (38,17,[14,32]), that is: \"heart failure\" -> \"class II-IV heart failure caused by chronic valvular disease -LRB- CVD -RRB- or dilated cardiomyopathy -LRB- DCM -RRB-\"\n",
      "Coreference set:\n",
      "\t(63,14,[14,15]) -> (39,6,[6,7]), that is: \"0.25\" -> \"0.25\"\n",
      "Coreference set:\n",
      "\t(118,1,[1,2]) -> (40,7,[7,21]), that is: \"Results\" -> \"results of plasma alanine aminotransferase -LRB- ALT -RRB- , creatinine , potassium and urea\"\n",
      "Coreference set:\n",
      "\t(41,24,[24,29]) -> (40,16,[16,21]), that is: \"creatinine , potassium or urea\" -> \"creatinine , potassium and urea\"\n",
      "Coreference set:\n",
      "\t(142,18,[17,19]) -> (42,3,[1,21]), that is: \"the action\" -> \"The possible action of benazepril in improving renal function -LRB- evidenced via lower plasma creatinine -RRB- merits further investigation .\"\n",
      "Coreference set:\n",
      "\t(43,21,[21,22]) -> (43,4,[3,14]), that is: \"its\" -> \"the effect of the Compound of traditional Chinese drugs and Benazepril\"\n",
      "Coreference set:\n",
      "\t(44,7,[6,12]) -> (43,7,[6,14]), that is: \"the compound of traditional Chinese drugs\" -> \"the Compound of traditional Chinese drugs and Benazepril\"\n",
      "\t(45,10,[9,17]) -> (43,7,[6,14]), that is: \"the compound of traditional Chinese drugs and Benazepril\" -> \"the Compound of traditional Chinese drugs and Benazepril\"\n",
      "\t(47,2,[1,9]) -> (43,7,[6,14]), that is: \"The compound of traditional Chinese drugs and Benazepril\" -> \"the Compound of traditional Chinese drugs and Benazepril\"\n",
      "\t(48,2,[1,7]) -> (43,7,[6,14]), that is: \"The compound of traditional Chinese drugs\" -> \"the Compound of traditional Chinese drugs and Benazepril\"\n",
      "\t(50,5,[4,10]) -> (43,7,[6,14]), that is: \"the compound of traditional Chinese drugs\" -> \"the Compound of traditional Chinese drugs and Benazepril\"\n",
      "\t(51,2,[1,7]) -> (43,7,[6,14]), that is: \"The compound of traditional Chinese drugs\" -> \"the Compound of traditional Chinese drugs and Benazepril\"\n",
      "\t(54,2,[1,7]) -> (43,7,[6,14]), that is: \"The compound of traditional Chinese drugs\" -> \"the Compound of traditional Chinese drugs and Benazepril\"\n",
      "\t(55,2,[2,3]) -> (43,7,[6,14]), that is: \"it\" -> \"the Compound of traditional Chinese drugs and Benazepril\"\n",
      "Coreference set:\n",
      "\t(45,14,[12,17]) -> (43,11,[9,14]), that is: \"traditional Chinese drugs and Benazepril\" -> \"traditional Chinese drugs and Benazepril\"\n",
      "\t(47,6,[4,9]) -> (43,11,[9,14]), that is: \"traditional Chinese drugs and Benazepril\" -> \"traditional Chinese drugs and Benazepril\"\n",
      "Coreference set:\n",
      "\t(44,11,[9,12]) -> (43,11,[9,12]), that is: \"traditional Chinese drugs\" -> \"traditional Chinese drugs\"\n",
      "\t(45,14,[12,15]) -> (43,11,[9,12]), that is: \"traditional Chinese drugs\" -> \"traditional Chinese drugs\"\n",
      "\t(47,6,[4,7]) -> (43,11,[9,12]), that is: \"traditional Chinese drugs\" -> \"traditional Chinese drugs\"\n",
      "\t(48,6,[4,7]) -> (43,11,[9,12]), that is: \"traditional Chinese drugs\" -> \"traditional Chinese drugs\"\n",
      "\t(50,9,[7,10]) -> (43,11,[9,12]), that is: \"traditional Chinese drugs\" -> \"traditional Chinese drugs\"\n",
      "\t(51,6,[4,7]) -> (43,11,[9,12]), that is: \"traditional Chinese drugs\" -> \"traditional Chinese drugs\"\n",
      "\t(53,7,[5,8]) -> (43,11,[9,12]), that is: \"traditional Chinese drugs\" -> \"traditional Chinese drugs\"\n",
      "\t(54,6,[4,7]) -> (43,11,[9,12]), that is: \"traditional Chinese drugs\" -> \"traditional Chinese drugs\"\n",
      "\t(125,9,[9,10]) -> (43,11,[9,12]), that is: \"drugs\" -> \"traditional Chinese drugs\"\n",
      "Coreference set:\n",
      "\t(53,25,[24,26]) -> (43,22,[21,30]), that is: \"its receptor\" -> \"its receptor of experimental diabetic nephropathy -LRB- DN -RRB-\"\n",
      "Coreference set:\n",
      "\t(44,14,[14,15]) -> (43,28,[28,29]), that is: \"DN\" -> \"DN\"\n",
      "\t(54,14,[14,15]) -> (43,28,[28,29]), that is: \"DN\" -> \"DN\"\n",
      "\t(73,49,[49,50]) -> (43,28,[28,29]), that is: \"DN\" -> \"DN\"\n",
      "\t(75,7,[7,8]) -> (43,28,[28,29]), that is: \"DN\" -> \"DN\"\n",
      "Coreference set:\n",
      "\t(47,19,[19,20]) -> (46,4,[4,5]), that is: \"Upro\" -> \"Upro\"\n",
      "Coreference set:\n",
      "\t(47,21,[21,22]) -> (46,6,[6,7]), that is: \"Glu\" -> \"Glu\"\n",
      "\t(48,16,[16,19]) -> (46,6,[6,7]), that is: \"Glu , HbA1C\" -> \"Glu\"\n",
      "\t(48,16,[16,17]) -> (46,6,[6,7]), that is: \"Glu\" -> \"Glu\"\n",
      "Coreference set:\n",
      "\t(49,6,[6,16]) -> (46,17,[17,24]), that is: \"ET-1 , ETA-R of the renal cortex of DN model\" -> \"ET-1 , ETA-R of the renal cortex\"\n",
      "Coreference set:\n",
      "\t(48,14,[13,19]) -> (47,17,[16,24]), that is: \"the improvement of Glu , HbA1C\" -> \"the improvement of Upro , Glu , HbA1C\"\n",
      "Coreference set:\n",
      "\t(55,20,[20,21]) -> (51,22,[22,23]), that is: \"third\" -> \"third\"\n",
      "Coreference set:\n",
      "\t(55,13,[12,22]) -> (51,15,[14,24]), that is: \"the proliferation of the stalk region and the third cells\" -> \"the proliferation of the stalk region and the third cells\"\n",
      "Coreference set:\n",
      "\t(55,17,[15,22]) -> (51,19,[17,24]), that is: \"the stalk region and the third cells\" -> \"the stalk region and the third cells\"\n",
      "Coreference set:\n",
      "\t(55,17,[15,18]) -> (51,19,[17,20]), that is: \"the stalk region\" -> \"the stalk region\"\n",
      "Coreference set:\n",
      "\t(55,21,[19,22]) -> (51,23,[21,24]), that is: \"the third cells\" -> \"the third cells\"\n",
      "Coreference set:\n",
      "\t(53,22,[22,23]) -> (52,1,[1,2]), that is: \"ET\" -> \"ET\"\n",
      "Coreference set:\n",
      "\t(53,24,[24,25]) -> (53,14,[12,15]), that is: \"its\" -> \"the expression quantity\"\n",
      "Coreference set:\n",
      "\t(57,17,[17,18]) -> (56,29,[29,30]), that is: \"0.001\" -> \"0.001\"\n",
      "Coreference set:\n",
      "\t(57,25,[25,28]) -> (56,2,[1,5]), that is: \"benazepril and amlodipine\" -> \"Both benazepril and amlodipine\"\n",
      "Coreference set:\n",
      "\t(57,15,[15,24]) -> (56,27,[27,32]), that is: \"P < 0.001 versus placebo , P < 0.01\" -> \"P < 0.001 versus placebo\"\n",
      "Coreference set:\n",
      "\t(56,46,[45,47]) -> (56,43,[42,44]), that is: \"-13.2 mmHg\" -> \"-11.1 mmHg\"\n",
      "Coreference set:\n",
      "\t(151,2,[1,3]) -> (57,2,[1,3]), that is: \"Combination therapy\" -> \"Combination therapy\"\n",
      "Coreference set:\n",
      "\t(57,8,[7,29]) -> (78,2,[1,3]), that is: \"SBP/DBP values -LRB- -28.3 / -20.5 mmHg ; P < 0.001 versus placebo , P < 0.01 versus benazepril and amlodipine -RRB-\" -> \"Placebo values\"\n",
      "Coreference set:\n",
      "\t(59,16,[16,17]) -> (58,14,[14,15]), that is: \"0.05\" -> \"0.05\"\n",
      "\t(60,19,[19,20]) -> (58,14,[14,15]), that is: \"0.05\" -> \"0.05\"\n",
      "\t(60,34,[34,35]) -> (58,14,[14,15]), that is: \"0.05\" -> \"0.05\"\n",
      "Coreference set:\n",
      "\t(58,17,[17,18]) -> (58,2,[1,3]), that is: \"it\" -> \"Benazepril monotherapy\"\n",
      "Coreference set:\n",
      "\t(58,10,[9,15]) -> (58,10,[9,11]), that is: \"-8.4 IU/ml , P < 0.05\" -> \"-8.4 IU/ml\"\n",
      "\t(58,12,[12,14]) -> (58,10,[9,11]), that is: \"P <\" -> \"-8.4 IU/ml\"\n",
      "\t(59,14,[14,16]) -> (58,10,[9,11]), that is: \"P <\" -> \"-8.4 IU/ml\"\n",
      "\t(60,17,[17,19]) -> (58,10,[9,11]), that is: \"P <\" -> \"-8.4 IU/ml\"\n",
      "\t(60,32,[32,34]) -> (58,10,[9,11]), that is: \"P <\" -> \"-8.4 IU/ml\"\n",
      "Coreference set:\n",
      "\t(59,15,[15,16]) -> (58,13,[13,14]), that is: \"<\" -> \"<\"\n",
      "\t(60,18,[18,19]) -> (58,13,[13,14]), that is: \"<\" -> \"<\"\n",
      "\t(60,33,[33,34]) -> (58,13,[13,14]), that is: \"<\" -> \"<\"\n",
      "\t(158,64,[64,65]) -> (58,13,[13,14]), that is: \"<\" -> \"<\"\n",
      "Coreference set:\n",
      "\t(59,9,[8,10]) -> (58,22,[21,27]), that is: \"t-PA activity\" -> \"t-PA activity -LRB- +0.02 IU/ml -RRB-\"\n",
      "Coreference set:\n",
      "\t(59,19,[19,20]) -> (59,2,[1,3]), that is: \"it\" -> \"Amlodipine monotherapy\"\n",
      "Coreference set:\n",
      "\t(61,8,[8,9]) -> (60,3,[1,4]), that is: \"its\" -> \"The amlodipine/benazepril combination\"\n",
      "Coreference set:\n",
      "\t(62,1,[1,2]) -> (61,17,[17,22]), that is: \"Cats\" -> \"cats using a pharmacokinetic/pharmacodynamic model\"\n",
      "Coreference set:\n",
      "\t(68,13,[13,14]) -> (63,18,[18,19]), that is: \"1.0\" -> \"1.0\"\n",
      "Coreference set:\n",
      "\t(64,6,[5,20]) -> (64,3,[1,4]), that is: \"plasma concentrations of benazepril and benazeprilat , and recovery of radioactivity in faeces and urine\" -> \"The pharmacokinetic endpoints\"\n",
      "\t(64,6,[5,11]) -> (64,3,[1,4]), that is: \"plasma concentrations of benazepril and benazeprilat\" -> \"The pharmacokinetic endpoints\"\n",
      "\t(70,17,[15,18]) -> (64,3,[1,4]), that is: \"plasma benazeprilat concentrations\" -> \"The pharmacokinetic endpoints\"\n",
      "Coreference set:\n",
      "\t(65,7,[5,12]) -> (65,3,[1,4]), that is: \"plasma angiotensin-converting enzyme -LRB- ACE -RRB- activity\" -> \"The pharmacodynamic endpoint\"\n",
      "Coreference set:\n",
      "\t(70,4,[3,5]) -> (66,12,[10,27]), that is: \"the model\" -> \"a single-compartment model with a volume equal to the blood space -LRB- Vc = 0.093 L/kg -RRB-\"\n",
      "Coreference set:\n",
      "\t(67,3,[2,4]) -> (66,20,[18,21]), that is: \"this space\" -> \"the blood space\"\n",
      "Coreference set:\n",
      "\t(71,12,[12,13]) -> (68,18,[18,19]), that is: \"0.125\" -> \"0.125\"\n",
      "Coreference set:\n",
      "\t(68,22,[22,39]) -> (68,9,[7,21]), that is: \"elimination being principally biliary -LRB- approximately 85 % -RRB- rather than urinary -LRB- approximately 15 % -RRB-\" -> \"the central compartment -LRB- t1/2 approximately 1.0 h ; Cl approximately 0.125 L/kg/h -RRB-\"\n",
      "Coreference set:\n",
      "\t(69,7,[7,20]) -> (69,3,[3,6]), that is: \"long-lasting -LRB- t1/2 16-23 h -RRB- due to high affinity binding of benazeprilat\" -> \"inhibition of ACE\"\n",
      "Coreference set:\n",
      "\t(69,28,[28,32]) -> (69,26,[24,27]), that is: \"IC50 approximately 4.3 mmol/L\" -> \"approximately 3.5 mmol/L\"\n",
      "\t(69,31,[29,32]) -> (69,26,[24,27]), that is: \"approximately 4.3 mmol/L\" -> \"approximately 3.5 mmol/L\"\n",
      "Coreference set:\n",
      "\t(74,17,[17,20]) -> (71,8,[8,17]), that is: \"benazepril once daily\" -> \"benazepril -LRB- e.g. above 0.125 mg/kg q24 h -RRB-\"\n",
      "Coreference set:\n",
      "\t(136,56,[55,57]) -> (71,21,[18,33]), that is: \"ACE inhibition\" -> \"only small incremental inhibition of ACE -LRB- either peak effect or duration of action -RRB-\"\n",
      "Coreference set:\n",
      "\t(72,1,[1,4]) -> (72,5,[5,9]), that is: \"Albuminuria and hypertension\" -> \"predictors of poor renal\"\n",
      "\t(72,5,[5,15]) -> (72,5,[5,9]), that is: \"predictors of poor renal and cardiovascular outcome in diabetic patients\" -> \"predictors of poor renal\"\n",
      "Coreference set:\n",
      "\t(75,3,[3,4]) -> (73,42,[42,43]), that is: \"I\" -> \"I\"\n",
      "\t(84,18,[18,19]) -> (73,42,[42,43]), that is: \"I\" -> \"I\"\n",
      "\t(138,11,[11,12]) -> (73,42,[42,43]), that is: \"I\" -> \"I\"\n",
      "Coreference set:\n",
      "\t(74,37,[37,38]) -> (74,21,[21,22]), that is: \"80\" -> \"80\"\n",
      "\t(169,22,[22,23]) -> (74,21,[21,22]), that is: \"80\" -> \"80\"\n",
      "Coreference set:\n",
      "\t(74,22,[21,27]) -> (74,15,[14,20]), that is: \"80 mg of valsartan once daily\" -> \"20 mg of benazepril once daily\"\n",
      "\t(74,30,[29,41]) -> (74,15,[14,20]), that is: \"the combination of 20 mg of benazepril and 80 mg of valsartan\" -> \"20 mg of benazepril once daily\"\n",
      "\t(74,33,[32,41]) -> (74,15,[14,20]), that is: \"20 mg of benazepril and 80 mg of valsartan\" -> \"20 mg of benazepril once daily\"\n",
      "\t(74,33,[32,36]) -> (74,15,[14,20]), that is: \"20 mg of benazepril\" -> \"20 mg of benazepril once daily\"\n",
      "\t(74,38,[37,41]) -> (74,15,[14,20]), that is: \"80 mg of valsartan\" -> \"20 mg of benazepril once daily\"\n",
      "Coreference set:\n",
      "\t(84,20,[18,21]) -> (75,5,[1,8]), that is: \"I diabetic patients\" -> \"Twenty type I diabetic patients with DN\"\n",
      "Coreference set:\n",
      "\t(79,12,[12,15]) -> (76,9,[9,16]), that is: \"albuminuria and BP\" -> \"albuminuria , 24-h BP , and GFR\"\n",
      "Coreference set:\n",
      "\t(78,61,[61,62]) -> (78,39,[39,40]), that is: \"2\" -> \"2\"\n",
      "Coreference set:\n",
      "\t(81,40,[40,41]) -> (78,54,[54,55]), that is: \"7\" -> \"7\"\n",
      "\t(81,59,[59,60]) -> (78,54,[54,55]), that is: \"7\" -> \"7\"\n",
      "Coreference set:\n",
      "\t(78,26,[24,31]) -> (78,32,[32,36]), that is: \"BP -LSB- mean -LRB- SEM -RRB- -RSB-\" -> \"144 -LRB- 4 -RRB-\"\n",
      "\t(78,46,[46,50]) -> (78,32,[32,36]), that is: \"mean -LRB- SEM -RRB-\" -> \"144 -LRB- 4 -RRB-\"\n",
      "Coreference set:\n",
      "\t(87,10,[10,11]) -> (81,63,[61,64]), that is: \"10\" -> \"4 to 10\"\n",
      "\t(89,3,[3,4]) -> (81,63,[61,64]), that is: \"10\" -> \"4 to 10\"\n",
      "Coreference set:\n",
      "\t(169,24,[24,25]) -> (85,7,[7,8]), that is: \"102\" -> \"102\"\n",
      "Coreference set:\n",
      "\t(111,5,[4,6]) -> (87,2,[1,3]), that is: \"blood pressure\" -> \"Blood pressure\"\n",
      "\t(111,7,[7,14]) -> (87,2,[1,3]), that is: \"status of taking Benazepril and side effects\" -> \"Blood pressure\"\n",
      "Coreference set:\n",
      "\t(97,6,[6,11]) -> (94,10,[10,19]), that is: \"trandolapril , moexipril and imidapril\" -> \"trandolapril , moexipril , spirapril , temocapril and imidapril\"\n",
      "\t(100,12,[12,15]) -> (94,10,[10,19]), that is: \"trandolapril or moexipril\" -> \"trandolapril , moexipril , spirapril , temocapril and imidapril\"\n",
      "Coreference set:\n",
      "\t(97,8,[8,11]) -> (94,12,[12,19]), that is: \"moexipril and imidapril\" -> \"moexipril , spirapril , temocapril and imidapril\"\n",
      "\t(98,4,[4,7]) -> (94,12,[12,19]), that is: \"moexipril and temocapril\" -> \"moexipril , spirapril , temocapril and imidapril\"\n",
      "Coreference set:\n",
      "\t(96,1,[1,2]) -> (95,13,[10,14]), that is: \"They\" -> \"a carboxyl functional groups\"\n",
      "Coreference set:\n",
      "\t(99,20,[20,21]) -> (99,8,[8,9]), that is: \"meals\" -> \"meals\"\n",
      "Coreference set:\n",
      "\t(102,4,[2,18]) -> (106,2,[1,3]), that is: \"six ACE inhibitors -LRB- captopril , enalapril , fosinopril , lisinopril , quinapril and ramipril -RRB-\" -> \"ACE inhibitors\"\n",
      "\t(133,22,[21,23]) -> (106,2,[1,3]), that is: \"ACE inhibitors\" -> \"ACE inhibitors\"\n",
      "Coreference set:\n",
      "\t(105,14,[14,17]) -> (102,8,[8,17]), that is: \"enalapril and lisinopril\" -> \"enalapril , fosinopril , lisinopril , quinapril and ramipril\"\n",
      "\t(122,14,[14,17]) -> (102,8,[8,17]), that is: \"enalapril and lisinopril\" -> \"enalapril , fosinopril , lisinopril , quinapril and ramipril\"\n",
      "Coreference set:\n",
      "\t(104,15,[15,18]) -> (167,1,[1,2]), that is: \"diuretics and beta-blockers\" -> \"Diuretics\"\n",
      "Coreference set:\n",
      "\t(107,6,[3,13]) -> (107,1,[1,2]), that is: \"the only ACE inhibitor that exhibits a linear dose-response curve\" -> \"Lisinopril\"\n",
      "\t(130,7,[4,8]) -> (107,1,[1,2]), that is: \"the only ACE inhibitor\" -> \"Lisinopril\"\n",
      "Coreference set:\n",
      "\t(112,4,[3,5]) -> (110,5,[1,10]), that is: \"the patients\" -> \"1 831 essential hypertensive patients aged 35 to 75\"\n",
      "Coreference set:\n",
      "\t(113,19,[18,20]) -> (110,20,[19,21]), that is: \"18 months\" -> \"18 months\"\n",
      "Coreference set:\n",
      "\t(116,8,[7,9]) -> (111,13,[12,14]), that is: \"side effects\" -> \"side effects\"\n",
      "Coreference set:\n",
      "\t(117,17,[17,18]) -> (114,7,[7,10]), that is: \"them\" -> \"SBP and DBP\"\n",
      "Coreference set:\n",
      "\t(122,30,[30,31]) -> (117,4,[4,5]), that is: \"first\" -> \"first\"\n",
      "Coreference set:\n",
      "\t(119,1,[1,7]) -> (119,13,[8,21]), that is: \"Captopril , enalapril , and lisinopril\" -> \"angiotensin-converting enzyme -LRB- ACE -RRB- inhibitors widely prescribed for hypertension and heart failure\"\n",
      "\t(166,26,[24,27]) -> (119,13,[8,21]), that is: \"angiotensin-converting enzyme inhibitors\" -> \"angiotensin-converting enzyme -LRB- ACE -RRB- inhibitors widely prescribed for hypertension and heart failure\"\n",
      "Coreference set:\n",
      "\t(125,3,[2,4]) -> (120,17,[15,18]), that is: \"the rash\" -> \"pitiryasis rosea-like rash\"\n",
      "Coreference set:\n",
      "\t(122,21,[20,22]) -> (121,17,[16,18]), that is: \"patch tests\" -> \"patch tests\"\n",
      "\t(131,21,[20,22]) -> (121,17,[16,18]), that is: \"patch tests\" -> \"patch tests\"\n",
      "\t(132,6,[5,7]) -> (121,17,[16,18]), that is: \"patch tests\" -> \"patch tests\"\n",
      "\t(133,2,[1,3]) -> (121,17,[16,18]), that is: \"Patch tests\" -> \"patch tests\"\n",
      "Coreference set:\n",
      "\t(125,12,[11,13]) -> (122,8,[4,17]), that is: \"the reaction\" -> \"a cutaneous immune adverse reaction to captopril with tolerance to enalapril and lisinopril\"\n",
      "Coreference set:\n",
      "\t(124,5,[5,6]) -> (123,4,[1,5]), that is: \"she\" -> \"A 71-year-old nonatopic woman\"\n",
      "\t(125,6,[6,7]) -> (123,4,[1,5]), that is: \"she\" -> \"A 71-year-old nonatopic woman\"\n",
      "Coreference set:\n",
      "\t(146,20,[20,21]) -> (124,12,[12,13]), that is: \"50\" -> \"50\"\n",
      "Coreference set:\n",
      "\t(155,4,[4,5]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "\t(156,10,[10,11]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "\t(157,24,[24,25]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "\t(157,38,[38,39]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "\t(158,31,[31,32]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "\t(158,52,[52,53]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "\t(159,22,[22,23]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "\t(160,2,[2,3]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "\t(160,10,[10,11]) -> (124,17,[17,18]), that is: \"5\" -> \"5\"\n",
      "Coreference set:\n",
      "\t(128,5,[5,13]) -> (129,8,[7,9]), that is: \"captopril at 1 % and 10 % concentrations\" -> \"only captopril\"\n",
      "Coreference set:\n",
      "\t(132,3,[2,4]) -> (129,2,[1,3]), that is: \"our patient\" -> \"The patient\"\n",
      "Coreference set:\n",
      "\t(132,24,[22,25]) -> (130,11,[9,12]), that is: \"the sulfhydryl group\" -> \"a sulfhydryl group\"\n",
      "Coreference set:\n",
      "\t(138,10,[10,12]) -> (139,8,[7,9]), that is: \"TGFbetaR I\" -> \"TGFbetaR I\"\n",
      "Coreference set:\n",
      "\t(141,1,[1,24]) -> (144,2,[1,5]), that is: \"Effect of SKI , a herbal preparation for lowering adverse Qi , despelling turbidness , supplementing Qi and activating circulation , and Benazepril\" -> \"The effect of SKI\"\n",
      "Coreference set:\n",
      "\t(141,3,[3,4]) -> (141,7,[5,21]), that is: \"SKI\" -> \"a herbal preparation for lowering adverse Qi , despelling turbidness , supplementing Qi and activating circulation\"\n",
      "\t(141,7,[5,24]) -> (141,7,[5,21]), that is: \"a herbal preparation for lowering adverse Qi , despelling turbidness , supplementing Qi and activating circulation , and Benazepril\" -> \"a herbal preparation for lowering adverse Qi , despelling turbidness , supplementing Qi and activating circulation\"\n",
      "Coreference set:\n",
      "\t(141,11,[10,12]) -> (141,17,[17,18]), that is: \"adverse Qi\" -> \"Qi\"\n",
      "Coreference set:\n",
      "\t(144,11,[11,12]) -> (142,14,[14,15]), that is: \"ECM\" -> \"ECM\"\n",
      "Coreference set:\n",
      "\t(145,23,[19,27]) -> (150,7,[5,8]), that is: \"the chemical and enzymatic hydrolysis of benazepril hydrochloride\" -> \"the enzymatic hydrolysis\"\n",
      "Coreference set:\n",
      "\t(146,63,[63,64]) -> (146,36,[36,37]), that is: \"7.4\" -> \"7.4\"\n",
      "Coreference set:\n",
      "\t(146,67,[67,68]) -> (146,41,[41,42]), that is: \"37\" -> \"37\"\n",
      "Coreference set:\n",
      "\t(149,9,[7,10]) -> (146,6,[4,10]), that is: \"the acidic hydrolysis\" -> \"the acidic hydrolysis of benazepril hydrochloride\"\n",
      "Coreference set:\n",
      "\t(147,9,[9,10]) -> (146,83,[83,84]), that is: \"their\" -> \"enzymatic\"\n",
      "Coreference set:\n",
      "\t(148,32,[32,33]) -> (148,25,[25,26]), that is: \"-7\" -> \"-7\"\n",
      "Coreference set:\n",
      "\t(148,14,[13,20]) -> (148,21,[21,22]), that is: \"detection limits for benazepril hydrochloride and benazeprilat\" -> \"13.0\"\n",
      "\t(148,21,[21,35]) -> (148,21,[21,22]), that is: \"13.0 x 10 -LRB- -7 -RRB- and 9.0 x 10 -LRB- -7 -RRB- M\" -> \"13.0\"\n",
      "\t(148,21,[21,29]) -> (148,21,[21,22]), that is: \"13.0 x 10 -LRB- -7 -RRB- and 9.0\" -> \"13.0\"\n",
      "Coreference set:\n",
      "\t(150,16,[15,17]) -> (149,5,[3,10]), that is: \"the data\" -> \"the kinetic data of the acidic hydrolysis\"\n",
      "Coreference set:\n",
      "\t(152,2,[1,3]) -> (152,7,[4,15]), that is: \"Calcium antagonists\" -> \"highly effective antihypertensive drugs in a broad range of demographic groups\"\n",
      "\t(165,8,[7,9]) -> (152,7,[4,15]), that is: \"antihypertensive drugs\" -> \"highly effective antihypertensive drugs in a broad range of demographic groups\"\n",
      "Coreference set:\n",
      "\t(161,9,[7,10]) -> (153,14,[12,15]), that is: \"lower extremity edema\" -> \"lower extremity edema\"\n",
      "\t(163,36,[34,37]) -> (153,14,[12,15]), that is: \"lower extremity edema\" -> \"lower extremity edema\"\n",
      "\t(164,10,[8,11]) -> (153,14,[12,15]), that is: \"lower extremity edema\" -> \"lower extremity edema\"\n",
      "Coreference set:\n",
      "\t(156,1,[1,2]) -> (155,2,[1,3]), that is: \"They\" -> \"Forty-seven patients\"\n",
      "Coreference set:\n",
      "\t(158,37,[37,38]) -> (156,15,[15,16]), that is: \"25\" -> \"25\"\n",
      "\t(161,2,[2,3]) -> (156,15,[15,16]), that is: \"25\" -> \"25\"\n",
      "Coreference set:\n",
      "\t(156,11,[8,33]) -> (158,38,[37,39]), that is: \"an additional 5 mg of amlodipine , 25 mg of hydrochlorothiazide -LRB- HCTZ -RRB- , or 20 mg of benazepril for an additional 6 weeks\" -> \"25 mg\"\n",
      "Coreference set:\n",
      "\t(157,39,[38,42]) -> (156,11,[8,14]), that is: \"5 mg of amlodipine\" -> \"an additional 5 mg of amlodipine\"\n",
      "\t(160,3,[2,6]) -> (156,11,[8,14]), that is: \"5 mg of amlodipine\" -> \"an additional 5 mg of amlodipine\"\n",
      "\t(160,11,[10,14]) -> (156,11,[8,14]), that is: \"5 mg of amlodipine\" -> \"an additional 5 mg of amlodipine\"\n",
      "Coreference set:\n",
      "\t(161,3,[2,6]) -> (156,16,[15,22]), that is: \"25 mg of HCTZ\" -> \"25 mg of hydrochlorothiazide -LRB- HCTZ -RRB-\"\n",
      "Coreference set:\n",
      "\t(158,59,[58,60]) -> (156,25,[24,33]), that is: \"20 mg\" -> \"20 mg of benazepril for an additional 6 weeks\"\n",
      "Coreference set:\n",
      "\t(158,67,[67,69]) -> (158,65,[65,66]), that is: \"group 3\" -> \".0167\"\n",
      "Coreference set:\n",
      "\t(158,20,[17,21]) -> (158,22,[22,23]), that is: \"the 10-mg amlodipine group\" -> \"-9.9\"\n",
      "\t(158,35,[35,41]) -> (158,22,[22,23]), that is: \"HCTZ -LRB- 25 mg -RRB- group\" -> \"-9.9\"\n",
      "Coreference set:\n",
      "\t(158,32,[31,33]) -> (158,29,[28,34]), that is: \"5 mg\" -> \"the amlodipine -LRB- 5 mg -RRB-\"\n",
      "\t(158,50,[49,55]) -> (158,29,[28,34]), that is: \"the amlodipine -LRB- 5 mg -RRB-\" -> \"the amlodipine -LRB- 5 mg -RRB-\"\n",
      "\t(158,53,[52,54]) -> (158,29,[28,34]), that is: \"5 mg\" -> \"the amlodipine -LRB- 5 mg -RRB-\"\n",
      "Coreference set:\n",
      "\t(162,4,[3,5]) -> (159,18,[7,21]), that is: \"water displacement\" -> \"at least a 10 % increase in lower extremity edema water displacement in response\"\n",
      "Coreference set:\n",
      "\t(160,25,[24,26]) -> (160,30,[28,31]), that is: \"+58.0 mL\" -> \"0.6 % change\"\n",
      "Coreference set:\n",
      "\t(161,21,[21,24]) -> (161,19,[19,24]), that is: \"n = 4\" -> \"change , n = 4\"\n",
      "\t(162,11,[11,16]) -> (161,19,[19,24]), that is: \"change , n = 8\" -> \"change , n = 4\"\n",
      "\t(162,13,[13,16]) -> (161,19,[19,24]), that is: \"n = 8\" -> \"change , n = 4\"\n",
      "Coreference set:\n",
      "\t(169,1,[1,8]) -> (169,12,[9,31]), that is: \"Propranolol , furosemide , amlodipine and atenolol\" -> \"the least expensive drugs used , with annual drug acquisition costs of Rs 80 , 102 , 182 and 318 , respectively\"\n",
      "Coreference set:\n",
      "\t(170,42,[39,43]) -> (169,19,[16,29]), that is: \"annual drug acquisition costs\" -> \"annual drug acquisition costs of Rs 80 , 102 , 182 and 318\"\n",
      "Coreference set:\n",
      "\t(170,1,[1,31]) -> (170,35,[32,43]), that is: \"Benazepril -LRB- Rs 1778 -RRB- , diltiazem SR -LRB- Rs 1777 -RRB- , lisinopril -LRB- Rs 1660 -RRB- , prazosin -LRB- Rs 1416 -RRB- and losartan -LRB- Rs 1365 -RRB-\" -> \"the most expensive drugs in terms of annual drug acquisition costs\"\n"
     ]
    }
   ],
   "source": [
    "!cat KeywordSentences2.txt.out"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## It seems like this was a little more focused."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "anaconda-cloud": {},
  "kernelspec": {
   "display_name": "Python [conda env:python2]",
   "language": "python",
   "name": "conda-env-python2-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.12"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
